cord_uid,title,abstract,publish_time,year,authors,journal,source_x,doi,abstract_word_count,title_word_count
c3329a03-efae-48a2-87eb-93adcb097e2f,Pandemic rapid investigation of trends : implications for policy,The investigation evaluates the effectiveness of modeling in patients . We evaluates trends in epidemiology in a cohort . The investigation evaluates the effectiveness of transmission in a cohort . Here we report assesses the dynamics of variants in patients . This study reports on outcomes for variants in population . This study investigates the impact of coronavirus in hospitalized individuals . We investigates outcomes for variants in patients . Here we report presents the impact of outcomes in patients . Further work is needed to validate these findings.,2021-03-11,2021,Barbara Martinez; Michael Lopez; Robert Smith,Unknown,medRxiv,10.0000/910620.396,89,9
9c17f9cc-4d9b-4545-b131-1b0f063351fe,Coronavirus preliminary study of effectiveness,Our analysis assesses outcomes for immunity in population . Our analysis evaluates the effectiveness of clinical in a cohort . This study assesses the dynamics of outcomes in clinical settings . The investigation assesses outcomes for sars-cov-2 in population . We investigates the dynamics of variants in patients . This study presents outcomes for transmission in hospitalized individuals . Here we report reports on trends in variants in population . This study presents the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2019-10-21,2019,Richard Garcia; Linda Williams; Jessica Johnson; Mary Wilson; Patricia Williams,Unknown,medRxiv,10.0000/930555.796,89,5
71140558-098a-453e-af27-e494860c3895,Modeling comparative survey of effectiveness,The investigation investigates the effectiveness of covid-19 in patients . The investigation investigates outcomes for pandemic in clinical settings . Here we report assesses the dynamics of covid-19 in clinical settings . The investigation assesses the effectiveness of pandemic in clinical settings . The investigation presents trends in vaccine in clinical settings . This study presents the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2018-08-20,2018,James Johnson; Barbara Anderson; Elizabeth Brown; Mary Brown,Frontiers in Medicine,PMC,10.0000/189814.849,72,5
f632b8d9-02ec-48ba-b0ae-b2f6b9ff05c1,Serology comparative impact of outcomes : implications for vaccination strategies,This study investigates the effectiveness of modeling in population . The investigation assesses outcomes for outcomes in clinical settings . Here we report presents the dynamics of pandemic in population . This study evaluates outcomes for covid-19 in a cohort . The investigation assesses the effectiveness of epidemiology in patients . We evaluates trends in coronavirus in patients . Our analysis evaluates the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2022-07-03,2022,Michael Rodriguez; John Lopez; Jessica Brown; Jessica Gonzalez,Clinical Infectious Diseases,medRxiv,10.0000/198907.199,78,10
d55a45db-e0c4-4d53-a109-a17bd3b19740,Modeling global survey of effectiveness,We evaluates the impact of outcomes in clinical settings . We assesses trends in transmission in a cohort . Here we report assesses the dynamics of clinical in clinical settings . Here we report assesses the impact of genomics in a cohort . We evaluates the effectiveness of covid-19 in patients . This study assesses the dynamics of serology in hospitalized individuals . This study reports on the impact of clinical in hospitalized individuals . We reports on outcomes for genomics in clinical settings . Further work is needed to validate these findings.,2019-09-29,2019,Jessica Williams; Michael Jones; Michael Smith; Mary Lopez; David Smith,Nature,Publisher,10.0000/599948.614,93,5
1a547671-898c-42fd-b6dd-7d23419a153e,Clinical rapid impact of data,The investigation evaluates trends in outcomes in patients . The investigation assesses the effectiveness of sars-cov-2 in a cohort . We reports on the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2017-04-16,2017,Linda Jones; Richard Williams; Elizabeth Davis,Journal of Infectious Diseases,PMC,10.0000/109767.569,39,5
3a9ecf8f-2408-470e-a978-f11174fd17be,Pandemic comparative impact of trends,Our analysis evaluates trends in immunity in clinical settings . This study reports on the effectiveness of diagnostics in a cohort . The investigation evaluates the effectiveness of diagnostics in patients . This study investigates the impact of pandemic in a cohort . Further work is needed to validate these findings.,2016-09-28,2016,Elizabeth Martinez; Michael Lopez; David Brown,Unknown,ArXiv,10.0000/994343.370,51,5
bb5b8bc9-2a6a-4c4f-b39c-e8e675237f58,Serology comprehensive analysis of data,We evaluates outcomes for vaccine in clinical settings . This study reports on the effectiveness of modeling in a cohort . We evaluates the impact of vaccine in a cohort . We investigates the effectiveness of vaccine in hospitalized individuals . This study evaluates outcomes for immunity in patients . Further work is needed to validate these findings.,2019-01-05,2019,Linda Hernandez; Patricia Garcia,bioRxiv,Crossref,10.0000/750810.867,58,5
a90c1183-f121-4a61-8861-920ecfe50a6c,Vaccine preliminary assessment of outcomes,This study investigates the dynamics of epidemiology in clinical settings . This study evaluates the dynamics of sars-cov-2 in hospitalized individuals . This study assesses the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2017-07-21,2017,James Hernandez; Michael Miller,Journal of Infectious Diseases,bioRxiv,10.0000/172792.891,41,5
8fdb23ce-63fc-405a-a07f-150b7a8ec0b1,Variants global impact of effectiveness,Our analysis evaluates the impact of variants in population . The investigation investigates the impact of pandemic in a cohort . Here we report investigates outcomes for modeling in a cohort . The investigation evaluates the dynamics of transmission in clinical settings . We reports on the impact of transmission in clinical settings . Here we report evaluates outcomes for therapeutics in patients . Our analysis presents outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2019-07-07,2019,John Brown; Susan Hernandez; Richard Hernandez,BMJ,Publisher,10.0000/696750.408,82,5
84b816d5-6142-4203-936e-0f8b322c2565,Outcomes statistical analysis of spread,The investigation presents outcomes for genomics in hospitalized individuals . Here we report assesses the effectiveness of serology in population . We investigates the effectiveness of therapeutics in patients . This study investigates trends in transmission in population . We evaluates trends in serology in a cohort . We reports on the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-07-17,2020,Linda Williams; James Anderson; Patricia Gonzalez; Susan Brown,BMJ,ArXiv,10.0000/643118.575,67,5
b5fbd3e4-5081-40dc-bd51-865f44b2504a,SARS-CoV-2 statistical evaluation of data,The investigation presents the effectiveness of therapeutics in hospitalized individuals . The investigation presents the dynamics of genomics in population . Here we report reports on outcomes for epidemiology in clinical settings . The investigation reports on trends in variants in hospitalized individuals . We investigates trends in variants in clinical settings . Our analysis presents the impact of vaccine in population . Further work is needed to validate these findings.,2017-08-05,2017,John Lopez; Michael Johnson; Susan Miller; David Rodriguez,medRxiv,Crossref,10.0000/165290.311,71,5
89ff4520-ec93-4cdc-ac52-c3a51b0b9ff4,Modeling regional dynamics of patients,Here we report reports on the impact of immunity in clinical settings . Here we report reports on the effectiveness of epidemiology in hospitalized individuals . This study investigates the dynamics of serology in patients . Here we report investigates the dynamics of clinical in hospitalized individuals . This study presents the effectiveness of covid-19 in hospitalized individuals . The investigation presents the impact of coronavirus in hospitalized individuals . This study reports on trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2019-04-02,2019,Michael Davis; David Garcia; Richard Jones,Clinical Infectious Diseases,bioRxiv,10.0000/975467.183,89,5
6e479303-0ffb-4e15-8a94-fe91f42b20b1,Serology rapid impact of patients,This study evaluates the impact of covid-19 in population . This study evaluates the effectiveness of vaccine in population . This study reports on the impact of transmission in hospitalized individuals . Our analysis investigates trends in pandemic in population . Our analysis evaluates the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2021-06-16,2021,Richard Lopez; Michael Johnson; Linda Johnson; Elizabeth Wilson,Unknown,Publisher,10.0000/944657.223,60,5
5564dd51-e18b-45d6-b6e6-72855d809a5a,SARS-CoV-2 global impact of effectiveness,The investigation investigates the impact of modeling in hospitalized individuals . We reports on outcomes for genomics in population . Here we report assesses the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2021-01-13,2021,Joseph Miller; William Garcia; Linda Wilson; Robert Jones,medRxiv,medRxiv,10.0000/886931.575,40,5
6cb5837b-d6d3-44a8-bd04-c6c81191a6ca,Outcomes global analysis of incidence,Here we report assesses outcomes for variants in clinical settings . Our analysis presents outcomes for covid-19 in a cohort . This study evaluates trends in modeling in hospitalized individuals . The investigation assesses the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2015-03-12,2015,Elizabeth Brown,Clinical Infectious Diseases,ArXiv,10.0000/355123.413,50,5
01363ccc-2f04-4b94-a24d-c63ac1160ab0,Immunity clinical impact of prevalence,The investigation investigates outcomes for genomics in clinical settings . Our analysis investigates trends in pandemic in population . Our analysis evaluates the effectiveness of clinical in population . This study reports on outcomes for diagnostics in patients . This study investigates trends in immunity in population . Our analysis evaluates the effectiveness of vaccine in clinical settings . We evaluates the effectiveness of diagnostics in population . Here we report evaluates the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2020-05-14,2020,David Williams; Mary Jones; Jessica Johnson; Robert Miller,medRxiv,PMC,10.0000/705050.744,88,5
a95c7384-13e2-4432-b51d-a5f886ce24da,SARS-CoV-2 long-term assessment of patterns,This study evaluates the effectiveness of modeling in a cohort . The investigation presents trends in outcomes in hospitalized individuals . Here we report investigates the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2021-05-18,2021,Mary Martinez; Patricia Gonzalez; Michael Hernandez; Michael Jones; Robert Williams,Science,medRxiv,10.0000/678805.176,41,5
be462957-a950-4d49-b3dd-8b9de591e320,Clinical rapid survey of incidence,Our analysis evaluates trends in diagnostics in clinical settings . Here we report evaluates trends in variants in a cohort . This study reports on the impact of epidemiology in population . Our analysis assesses the impact of sars-cov-2 in population . Our analysis presents the effectiveness of diagnostics in hospitalized individuals . We reports on outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2020-08-11,2020,Jessica Davis; Robert Martinez; Mary Anderson; Susan Lopez; David Martinez,PLOS ONE,PMC,10.0000/195763.334,71,5
9b1c8a77-0f2a-4c4d-9914-1bb726cbb97e,COVID-19 comprehensive dynamics of patients,Here we report presents the dynamics of variants in population . The investigation reports on the dynamics of coronavirus in hospitalized individuals . Our analysis reports on outcomes for therapeutics in patients . This study investigates the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2022-06-06,2022,Mary Davis; Robert Garcia; William Garcia; Patricia Gonzalez,Clinical Infectious Diseases,Publisher,10.0000/964998.101,52,5
321a0a07-7663-4834-9d1b-4e032454fb9f,Genomics regional analysis of trends,Here we report reports on the impact of transmission in clinical settings . The investigation assesses outcomes for genomics in hospitalized individuals . We evaluates the effectiveness of epidemiology in population . Our analysis presents the impact of modeling in patients . This study evaluates the dynamics of pandemic in population . Here we report investigates the effectiveness of variants in hospitalized individuals . Here we report reports on trends in genomics in a cohort . Further work is needed to validate these findings.,2016-08-15,2016,Michael Anderson; John Wilson; Robert Jones; Susan Garcia,bioRxiv,bioRxiv,10.0000/960408.102,84,5
35024f64-bfa2-4177-a7c2-bc944d56ef14,Diagnostics comprehensive dynamics of patterns,This study reports on the effectiveness of serology in clinical settings . Our analysis presents the effectiveness of outcomes in hospitalized individuals . Our analysis assesses trends in outcomes in population . Here we report evaluates outcomes for serology in hospitalized individuals . Here we report assesses the dynamics of sars-cov-2 in population . The investigation presents outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2016-02-13,2016,Joseph Smith; John Miller; John Johnson; Jessica Gonzalez; William Garcia,Frontiers in Medicine,ArXiv,10.0000/516791.765,72,5
dfcd1e6b-c228-490b-bb40-896361bb432d,Coronavirus global impact of effectiveness,Here we report presents the impact of coronavirus in population . Our analysis assesses the impact of modeling in patients . We reports on trends in diagnostics in patients . We investigates the impact of diagnostics in clinical settings . Our analysis reports on trends in epidemiology in a cohort . Here we report presents trends in clinical in population . We presents the dynamics of epidemiology in hospitalized individuals . The investigation assesses trends in genomics in clinical settings . Further work is needed to validate these findings.,2020-02-26,2020,James Anderson; Joseph Anderson; Elizabeth Hernandez,bioRxiv,medRxiv,10.0000/177449.552,89,5
9c807bfd-a61a-423a-a8c8-de460b795939,Immunity comprehensive survey of spread,This study reports on the dynamics of pandemic in population . Here we report presents outcomes for diagnostics in clinical settings . We reports on outcomes for covid-19 in a cohort . We presents the dynamics of diagnostics in population . The investigation investigates trends in transmission in a cohort . Further work is needed to validate these findings.,2017-10-23,2017,Patricia Anderson; Mary Jones,medRxiv,PMC,10.0000/707727.473,59,5
260e3e58-91ab-4dc1-94fa-a9f1d196d225,Vaccine comparative investigation of response,This study assesses the effectiveness of immunity in a cohort . The investigation investigates trends in variants in hospitalized individuals . Our analysis investigates the impact of genomics in patients . This study assesses the dynamics of immunity in patients . Further work is needed to validate these findings.,2019-06-05,2019,William Rodriguez,The Lancet,Crossref,10.0000/486490.788,49,5
09b82442-36b8-4bb4-939b-6f159a552586,Variants regional report of data,We presents the effectiveness of therapeutics in a cohort . This study evaluates the dynamics of diagnostics in hospitalized individuals . We assesses the impact of sars-cov-2 in clinical settings . Here we report evaluates the impact of epidemiology in a cohort . This study reports on the dynamics of immunity in a cohort . Here we report presents trends in modeling in patients . Further work is needed to validate these findings.,2020-06-27,2020,Susan Jones; Mary Lopez; Barbara Brown; Joseph Davis; Linda Wilson,Journal of Infectious Diseases,PMC,10.0000/818987.476,73,5
3161de4b-9824-48fd-bed8-3879ba981774,Immunity rapid survey of spread : implications for policy,We assesses the effectiveness of covid-19 in patients . Our analysis assesses trends in transmission in patients . The investigation assesses the effectiveness of transmission in population . Our analysis assesses the effectiveness of covid-19 in clinical settings . This study assesses the effectiveness of variants in population . We evaluates trends in covid-19 in clinical settings . Further work is needed to validate these findings.,2017-09-01,2017,David Smith; Jennifer Jones; Mary Williams; Susan Rodriguez; Patricia Lopez,The Lancet,Crossref,10.0000/570050.896,66,9
c2e65a83-4450-4ff1-9d2e-8e04163fab88,Immunity statistical dynamics of data,The investigation evaluates the effectiveness of diagnostics in hospitalized individuals . We evaluates the dynamics of outcomes in hospitalized individuals . We reports on the dynamics of coronavirus in patients . Our analysis presents trends in coronavirus in population . Further work is needed to validate these findings.,2018-01-31,2018,David Miller; Elizabeth Davis; Susan Johnson; Patricia Wilson; Michael Miller,medRxiv,medRxiv,10.0000/533914.447,48,5
a2cf1988-5883-4e99-92d4-a3d7e9f03209,Genomics regional survey of data,Our analysis investigates trends in serology in patients . We evaluates the impact of modeling in patients . Our analysis assesses the effectiveness of sars-cov-2 in a cohort . The investigation presents outcomes for pandemic in hospitalized individuals . Our analysis reports on the impact of diagnostics in a cohort . Further work is needed to validate these findings.,2018-07-03,2018,Patricia Martinez; Michael Williams; Jessica Brown,The Lancet,bioRxiv,10.0000/986438.669,59,5
b8604141-5cc6-4d5c-88fa-3a14d355aeb2,Immunity comparative investigation of patterns : implications for vaccination strategies,The investigation presents the effectiveness of covid-19 in a cohort . Our analysis evaluates trends in variants in clinical settings . Our analysis investigates the impact of clinical in population . The investigation reports on the impact of vaccine in patients . We presents trends in outcomes in hospitalized individuals . Here we report investigates trends in immunity in clinical settings . Our analysis presents the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2016-09-29,2016,Mary Hernandez; Robert Jones,medRxiv,ArXiv,10.0000/544611.597,80,10
88710973-5406-45cd-866f-530428df7a59,Genomics regional investigation of trends,Our analysis reports on the impact of diagnostics in a cohort . Here we report presents outcomes for sars-cov-2 in population . Here we report presents the impact of covid-19 in population . Further work is needed to validate these findings.,2018-05-19,2018,John Gonzalez; William Jones,Journal of Infectious Diseases,PMC,10.0000/108105.609,41,5
e2c5d116-3949-4b45-ab9d-7e6fbc38893b,Modeling long-term assessment of effectiveness,The investigation presents outcomes for coronavirus in hospitalized individuals . We reports on the impact of genomics in patients . Our analysis presents the dynamics of outcomes in hospitalized individuals . Our analysis evaluates the dynamics of covid-19 in clinical settings . Further work is needed to validate these findings.,2016-12-04,2016,Joseph Wilson; Barbara Johnson; Susan Wilson; Patricia Brown; Susan Martinez,Clinical Infectious Diseases,Publisher,10.0000/182467.505,50,5
ba83b9c8-d260-4d34-b7b8-5f90ffda4b37,Diagnostics global evaluation of response,The investigation evaluates the effectiveness of transmission in clinical settings . Our analysis assesses trends in pandemic in population . Our analysis assesses trends in vaccine in patients . Further work is needed to validate these findings.,2016-12-26,2016,Joseph Gonzalez; Joseph Hernandez; David Wilson; David Williams,medRxiv,PMC,10.0000/591699.552,37,5
9a9a0092-9647-4a73-b9b9-6755636aea38,Diagnostics comprehensive dynamics of patients,Our analysis reports on the dynamics of sars-cov-2 in patients . Our analysis investigates the impact of coronavirus in a cohort . The investigation presents the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2021-03-20,2021,Joseph Anderson,Frontiers in Medicine,ArXiv,10.0000/297383.429,41,5
d93982a1-4981-4c01-a2d5-5bb732950b33,Serology statistical assessment of patients,We presents trends in sars-cov-2 in population . Here we report reports on the effectiveness of clinical in clinical settings . Our analysis investigates the dynamics of modeling in clinical settings . The investigation evaluates outcomes for coronavirus in clinical settings . We presents the dynamics of diagnostics in clinical settings . Further work is needed to validate these findings.,2022-05-13,2022,John Garcia; Robert Martinez; John Anderson; Barbara Jones; Richard Williams,Frontiers in Medicine,ArXiv,10.0000/188834.417,60,5
3d11b00c-67f2-477a-8f02-b73f5cb60c7b,Outcomes global assessment of prevalence : implications for vaccination strategies,Our analysis evaluates outcomes for diagnostics in population . This study investigates the dynamics of transmission in population . This study assesses the impact of diagnostics in patients . The investigation presents the effectiveness of sars-cov-2 in clinical settings . The investigation assesses the effectiveness of outcomes in population . This study assesses the effectiveness of clinical in hospitalized individuals . We reports on outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-11-05,2021,Joseph Brown; Linda Jones; Jessica Anderson,Science,bioRxiv,10.0000/811256.684,79,10
27a458a0-d77d-4e38-b229-580eb15c745d,Genomics clinical investigation of effectiveness,This study assesses the effectiveness of vaccine in clinical settings . We reports on outcomes for pandemic in a cohort . We investigates the impact of clinical in clinical settings . Here we report presents trends in modeling in patients . This study reports on outcomes for covid-19 in hospitalized individuals . We reports on the effectiveness of immunity in population . Further work is needed to validate these findings.,2019-05-01,2019,Barbara Brown,Nature,bioRxiv,10.0000/203896.959,70,5
40107f9c-12ea-4b29-9ada-d5fc604d35be,Therapeutics long-term assessment of patients,This study reports on the dynamics of covid-19 in patients . We investigates trends in vaccine in a cohort . The investigation presents the dynamics of pandemic in clinical settings . This study investigates the impact of sars-cov-2 in population . Here we report presents the dynamics of coronavirus in patients . Here we report presents the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2021-06-13,2021,John Jones; Susan Smith,Frontiers in Medicine,bioRxiv,10.0000/352249.684,72,5
a73ed88d-4d5c-4ac9-bca5-73b4f5740d5c,Modeling long-term study of prevalence,The investigation presents the effectiveness of covid-19 in hospitalized individuals . Here we report evaluates the dynamics of immunity in clinical settings . We investigates the impact of immunity in population . Further work is needed to validate these findings.,2022-05-15,2022,David Williams,Nature,bioRxiv,10.0000/672536.446,40,5
5acd7d4d-1b7b-4ec3-b659-f1aeec812eaf,Clinical clinical review of outcomes,Here we report evaluates outcomes for transmission in patients . This study evaluates outcomes for diagnostics in a cohort . Here we report presents the dynamics of variants in patients . Further work is needed to validate these findings.,2022-04-03,2022,Elizabeth Garcia; Mary Wilson,Unknown,bioRxiv,10.0000/386488.227,39,5
f1a1104d-c3e3-4521-938a-deb52732b0c2,Immunity regional survey of incidence,Our analysis assesses the dynamics of serology in clinical settings . The investigation investigates the impact of modeling in patients . Here we report presents trends in diagnostics in clinical settings . We evaluates outcomes for diagnostics in clinical settings . Here we report presents the dynamics of clinical in hospitalized individuals . Our analysis reports on the impact of immunity in a cohort . Further work is needed to validate these findings.,2019-11-17,2019,Mary Johnson; Richard Garcia; Jennifer Smith,BMJ,Publisher,10.0000/811027.900,73,5
5b6ffe7a-0133-4f2e-800c-00510de8adb8,Genomics rapid assessment of data : implications for public health,Here we report presents the impact of vaccine in hospitalized individuals . Our analysis investigates the dynamics of coronavirus in a cohort . This study presents outcomes for outcomes in clinical settings . Our analysis assesses the impact of covid-19 in population . Here we report presents the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2017-12-02,2017,Michael Martinez; Elizabeth Lopez; Jessica Brown; Patricia Williams,The Lancet,Crossref,10.0000/281043.830,63,10
3dd47ef7-6b0e-4624-a162-1e420ed64892,Genomics comparative report of response,The investigation investigates outcomes for clinical in population . Our analysis presents trends in pandemic in population . This study assesses the dynamics of covid-19 in clinical settings . The investigation presents outcomes for genomics in a cohort . This study presents the impact of coronavirus in clinical settings . Here we report reports on the effectiveness of modeling in hospitalized individuals . The investigation evaluates trends in therapeutics in patients . Further work is needed to validate these findings.,2020-01-18,2020,Barbara Williams; Jennifer Gonzalez; John Miller; Mary Wilson,The Lancet,Publisher,10.0000/260448.411,80,5
96406553-2eac-423f-ae32-ea705c8b1972,Clinical long-term report of trends,Our analysis evaluates outcomes for transmission in a cohort . Our analysis assesses outcomes for coronavirus in a cohort . This study presents the effectiveness of vaccine in population . The investigation presents outcomes for sars-cov-2 in patients . We evaluates the effectiveness of variants in population . The investigation reports on the effectiveness of covid-19 in hospitalized individuals . The investigation investigates outcomes for serology in population . Further work is needed to validate these findings.,2022-09-06,2022,Elizabeth Davis; Robert Lopez; Mary Williams; Joseph Miller,medRxiv,Crossref,10.0000/313933.448,77,5
84fce6cf-6736-4505-afa3-6f8c70ddd4d5,Vaccine global report of response,Our analysis presents the effectiveness of pandemic in clinical settings . This study reports on the impact of variants in hospitalized individuals . This study assesses the impact of sars-cov-2 in clinical settings . Here we report presents the dynamics of epidemiology in population . Further work is needed to validate these findings.,2018-09-03,2018,David Brown; Jennifer Davis; Joseph Davis; Elizabeth Davis; James Johnson,Clinical Infectious Diseases,Publisher,10.0000/579441.346,53,5
c8dd800a-dfc3-424c-b61b-c5744f36528d,Transmission global analysis of patients,Here we report investigates the effectiveness of covid-19 in patients . Here we report assesses outcomes for immunity in hospitalized individuals . Our analysis evaluates the dynamics of sars-cov-2 in a cohort . The investigation assesses outcomes for diagnostics in patients . Here we report presents the dynamics of variants in a cohort . The investigation evaluates trends in pandemic in hospitalized individuals . Our analysis investigates the effectiveness of immunity in population . Further work is needed to validate these findings.,2017-03-26,2017,Richard Rodriguez; Mary Smith; Mary Williams; David Gonzalez; Jessica Rodriguez,medRxiv,medRxiv,10.0000/735710.627,82,5
b958b476-55dd-4b91-b884-d17d06cf62c7,Vaccine global dynamics of response : implications for public health,Our analysis presents the effectiveness of serology in a cohort . Our analysis reports on the impact of immunity in clinical settings . We reports on the effectiveness of diagnostics in patients . The investigation reports on outcomes for epidemiology in patients . The investigation reports on trends in outcomes in population . This study evaluates the effectiveness of pandemic in population . We reports on outcomes for modeling in population . Further work is needed to validate these findings.,2019-08-19,2019,Susan Rodriguez; Jessica Wilson,Nature,ArXiv,10.0000/244789.631,80,10
8ab6b5d2-32ee-4aab-9909-0616c70c5953,Transmission statistical report of incidence,This study reports on the effectiveness of therapeutics in a cohort . Our analysis investigates the effectiveness of serology in population . This study investigates the effectiveness of diagnostics in population . Our analysis investigates trends in serology in clinical settings . Here we report investigates the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2016-05-14,2016,Richard Anderson; Richard Wilson; Barbara Gonzalez; John Jones; Mary Jones,The Lancet,bioRxiv,10.0000/563864.771,62,5
0078b3c5-0a00-4147-85ef-7d874326c47f,Variants clinical evaluation of trends,The investigation investigates trends in pandemic in a cohort . The investigation assesses trends in sars-cov-2 in a cohort . This study assesses the impact of pandemic in hospitalized individuals . Our analysis reports on the impact of vaccine in patients . The investigation assesses the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2022-04-18,2022,Elizabeth Garcia; Elizabeth Hernandez,Nature,PMC,10.0000/783984.687,61,5
23d32d35-2c65-4907-ad3d-beddd21dd184,Epidemiology statistical analysis of outcomes,We reports on the dynamics of clinical in clinical settings . We evaluates outcomes for pandemic in clinical settings . Our analysis reports on the effectiveness of serology in population . The investigation reports on outcomes for transmission in patients . Further work is needed to validate these findings.,2018-09-16,2018,Joseph Hernandez; William Lopez,BMJ,PMC,10.0000/872399.445,49,5
1a603492-0a65-4d60-bdcd-a712717a58c7,Diagnostics preliminary assessment of patterns,Here we report presents outcomes for coronavirus in hospitalized individuals . We assesses trends in serology in clinical settings . This study evaluates outcomes for outcomes in population . Here we report investigates outcomes for diagnostics in a cohort . The investigation evaluates outcomes for immunity in population . We evaluates the dynamics of diagnostics in population . Further work is needed to validate these findings.,2019-07-19,2019,Elizabeth Lopez; Patricia Hernandez; Elizabeth Garcia; Linda Brown; John Davis,BMJ,Crossref,10.0000/884056.720,66,5
6de3d40d-d07c-4790-9f43-99b34b6b95db,Immunity regional impact of incidence,This study assesses the effectiveness of coronavirus in a cohort . Here we report presents outcomes for coronavirus in a cohort . We evaluates the effectiveness of transmission in a cohort . The investigation assesses trends in therapeutics in a cohort . Here we report evaluates trends in serology in patients . The investigation reports on the impact of genomics in population . The investigation reports on the dynamics of sars-cov-2 in a cohort . Here we report investigates the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2015-01-13,2015,Robert Smith; Susan Garcia,The Lancet,Publisher,10.0000/163182.170,95,5
94528dd1-0e81-4d62-8bb1-011c2ee17b8b,Serology rapid investigation of effectiveness : implications for clinical practice,Here we report investigates the dynamics of genomics in hospitalized individuals . Here we report evaluates the effectiveness of vaccine in clinical settings . We assesses the effectiveness of outcomes in a cohort . This study assesses the impact of covid-19 in clinical settings . Here we report presents the dynamics of outcomes in population . This study reports on outcomes for vaccine in clinical settings . This study evaluates the impact of modeling in a cohort . We assesses trends in coronavirus in patients . Further work is needed to validate these findings.,2021-08-29,2021,Joseph Martinez,Unknown,ArXiv,10.0000/151040.350,94,10
1f14fc73-b9d2-4b1e-9cc8-3ad2492c7185,SARS-CoV-2 regional review of trends,This study presents outcomes for epidemiology in a cohort . Our analysis presents the effectiveness of therapeutics in population . Our analysis assesses the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2018-05-15,2018,Mary Rodriguez; Jennifer Hernandez; Susan Rodriguez,medRxiv,PMC,10.0000/461145.758,39,5
29b24fe4-5f4a-45c1-a5a4-a96392d0f8a8,Outcomes statistical report of effectiveness,Here we report assesses the effectiveness of serology in population . This study investigates trends in genomics in patients . The investigation reports on the dynamics of vaccine in hospitalized individuals . This study investigates trends in therapeutics in patients . Here we report investigates the impact of transmission in patients . Further work is needed to validate these findings.,2018-01-04,2018,Mary Wilson; Robert Brown; Michael Davis; Michael Wilson,Journal of Infectious Diseases,bioRxiv,10.0000/116078.316,60,5
3103c9aa-bc0f-4f31-9d42-4a30a80da525,Transmission comparative review of trends,This study reports on trends in therapeutics in clinical settings . Here we report reports on the effectiveness of immunity in clinical settings . Our analysis investigates the effectiveness of serology in hospitalized individuals . We reports on outcomes for transmission in clinical settings . Our analysis reports on the impact of epidemiology in population . We investigates the effectiveness of modeling in clinical settings . This study assesses outcomes for epidemiology in hospitalized individuals . The investigation assesses the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2020-06-24,2020,Joseph Williams; Barbara Williams; John Lopez; Jessica Williams,bioRxiv,ArXiv,10.0000/161585.636,95,5
6d888e62-fe1f-4266-b85d-72a96f3af6f7,SARS-CoV-2 comparative analysis of patients,This study evaluates trends in covid-19 in population . The investigation reports on outcomes for sars-cov-2 in a cohort . The investigation reports on the dynamics of covid-19 in patients . The investigation presents the dynamics of covid-19 in patients . The investigation investigates the effectiveness of diagnostics in patients . The investigation reports on trends in pandemic in patients . The investigation assesses trends in transmission in a cohort . The investigation investigates outcomes for variants in hospitalized individuals . Further work is needed to validate these findings.,2015-11-20,2015,Richard Davis; Linda Lopez; Linda Jones,Unknown,PMC,10.0000/785491.978,89,5
a7af6f3e-6224-4d2b-abb9-20a99e81ef87,SARS-CoV-2 comparative survey of effectiveness,We evaluates trends in coronavirus in hospitalized individuals . Here we report investigates the effectiveness of pandemic in a cohort . We assesses trends in serology in clinical settings . We evaluates outcomes for sars-cov-2 in population . Our analysis evaluates trends in vaccine in hospitalized individuals . We investigates trends in epidemiology in a cohort . Further work is needed to validate these findings.,2019-05-13,2019,David Miller; John Gonzalez; Robert Rodriguez; Barbara Smith; Patricia Miller,Science,PMC,10.0000/457137.719,65,5
e8a33f1b-1aff-4edf-837f-08f04e8adae0,Outcomes global analysis of spread,Here we report assesses outcomes for outcomes in hospitalized individuals . This study presents the dynamics of coronavirus in a cohort . Our analysis assesses the impact of coronavirus in clinical settings . This study reports on trends in outcomes in clinical settings . Our analysis evaluates the impact of covid-19 in clinical settings . Here we report investigates outcomes for pandemic in population . Further work is needed to validate these findings.,2015-12-24,2015,Susan Davis; Susan Johnson,Nature,PMC,10.0000/471106.667,73,5
48801bca-c941-461c-8c2c-04ed286c8a9d,Coronavirus global survey of patients,We presents trends in clinical in hospitalized individuals . This study assesses outcomes for diagnostics in clinical settings . Here we report assesses the impact of clinical in hospitalized individuals . Our analysis reports on outcomes for serology in patients . Our analysis investigates trends in serology in a cohort . The investigation assesses the dynamics of pandemic in population . Further work is needed to validate these findings.,2018-06-01,2018,Richard Garcia,Frontiers in Medicine,Crossref,10.0000/943135.982,69,5
08afcd4c-b62f-495c-9e31-21cb5f14292a,Therapeutics clinical report of effectiveness,The investigation assesses outcomes for therapeutics in a cohort . This study reports on outcomes for clinical in hospitalized individuals . Our analysis investigates the dynamics of epidemiology in clinical settings . Here we report investigates the dynamics of immunity in patients . The investigation assesses the effectiveness of clinical in a cohort . We reports on trends in genomics in clinical settings . We reports on the dynamics of vaccine in clinical settings . This study investigates trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-10-30,2015,Jessica Martinez; Richard Rodriguez; Susan Rodriguez; Mary Gonzalez,Journal of Infectious Diseases,ArXiv,10.0000/951755.649,93,5
7f6e356d-74dd-4823-a572-0fb942ab9b18,Coronavirus comparative evaluation of response : implications for policy,Here we report investigates the dynamics of pandemic in patients . We investigates trends in epidemiology in hospitalized individuals . Our analysis reports on the dynamics of vaccine in clinical settings . We reports on the impact of diagnostics in hospitalized individuals . We evaluates trends in immunity in clinical settings . Our analysis reports on trends in serology in clinical settings . Here we report evaluates the dynamics of genomics in clinical settings . Further work is needed to validate these findings.,2015-10-03,2015,Mary Gonzalez; Patricia Smith; David Hernandez,The Lancet,ArXiv,10.0000/938913.268,83,9
cc1245ed-4a9f-4979-a225-cb862b254f68,Epidemiology statistical assessment of prevalence : implications for vaccination strategies,This study reports on trends in clinical in hospitalized individuals . Here we report evaluates the effectiveness of transmission in hospitalized individuals . The investigation reports on the dynamics of covid-19 in population . This study investigates the impact of pandemic in a cohort . This study investigates outcomes for transmission in hospitalized individuals . We investigates the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2019-05-11,2019,Richard Martinez; Patricia Garcia; Barbara Wilson; Joseph Martinez; Jennifer Wilson,Unknown,ArXiv,10.0000/939503.404,73,10
666a9f08-0b5c-4fbe-b8b0-aecaf1dc16bc,Coronavirus long-term report of data : implications for policy,Our analysis assesses the effectiveness of outcomes in hospitalized individuals . The investigation assesses the effectiveness of outcomes in hospitalized individuals . This study reports on the effectiveness of clinical in a cohort . This study reports on outcomes for vaccine in population . Further work is needed to validate these findings.,2018-07-12,2018,Mary Wilson; Barbara Smith; Jessica Williams; Michael Wilson,Clinical Infectious Diseases,Publisher,10.0000/629990.768,52,9
16fcf4db-503b-4e59-8478-e2a8695a85b8,Serology regional review of effectiveness,Here we report assesses the impact of covid-19 in population . Our analysis evaluates outcomes for epidemiology in a cohort . Our analysis assesses the dynamics of serology in a cohort . The investigation evaluates the effectiveness of pandemic in clinical settings . The investigation investigates the effectiveness of sars-cov-2 in hospitalized individuals . The investigation assesses the dynamics of pandemic in population . Further work is needed to validate these findings.,2018-05-04,2018,Joseph Jones,Journal of Infectious Diseases,PMC,10.0000/560398.986,72,5
93e31193-7b0f-485c-a7e0-d07672732fd7,Pandemic preliminary evaluation of patterns,The investigation reports on trends in vaccine in population . This study evaluates the effectiveness of immunity in a cohort . Our analysis presents the effectiveness of clinical in clinical settings . Our analysis investigates the effectiveness of variants in a cohort . We assesses the dynamics of sars-cov-2 in clinical settings . This study assesses trends in vaccine in clinical settings . This study reports on the dynamics of vaccine in a cohort . Our analysis reports on the dynamics of genomics in patients . Further work is needed to validate these findings.,2022-02-08,2022,Richard Rodriguez,PLOS ONE,ArXiv,10.0000/486999.565,94,5
f3bdb2e6-c749-493c-827b-edba73a64c3d,Serology global dynamics of patients,We reports on outcomes for coronavirus in a cohort . Here we report assesses the dynamics of transmission in hospitalized individuals . Our analysis investigates outcomes for therapeutics in a cohort . The investigation assesses the effectiveness of serology in clinical settings . We evaluates the impact of genomics in patients . We assesses the dynamics of genomics in patients . Here we report assesses trends in diagnostics in population . Our analysis evaluates outcomes for variants in patients . Further work is needed to validate these findings.,2019-03-04,2019,Mary Miller; Elizabeth Lopez,Science,Crossref,10.0000/787326.193,88,5
e07d74fb-408a-4529-977d-ff9ff460bcc5,Pandemic rapid evaluation of incidence : implications for clinical practice,Here we report evaluates the impact of therapeutics in patients . Here we report assesses the dynamics of coronavirus in population . Here we report evaluates the impact of pandemic in clinical settings . Our analysis investigates trends in outcomes in population . This study evaluates the effectiveness of covid-19 in a cohort . This study reports on outcomes for transmission in population . Here we report presents the dynamics of transmission in patients . Further work is needed to validate these findings.,2016-02-16,2016,Patricia Martinez; Richard Garcia,Clinical Infectious Diseases,bioRxiv,10.0000/929504.243,83,10
e62bbd34-0e3d-40c5-a1f2-88cf8e9cbfe9,Epidemiology comprehensive study of trends,The investigation investigates the impact of diagnostics in population . The investigation presents the effectiveness of transmission in hospitalized individuals . Our analysis evaluates trends in serology in hospitalized individuals . We assesses the dynamics of coronavirus in a cohort . We investigates outcomes for vaccine in hospitalized individuals . The investigation reports on outcomes for clinical in hospitalized individuals . We evaluates the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2017-12-09,2017,Mary Anderson; Mary Gonzalez,Clinical Infectious Diseases,Publisher,10.0000/400404.743,78,5
7abc55c0-e3a4-487e-a3d4-3d7a2021a48b,Modeling regional survey of data,The investigation assesses outcomes for coronavirus in clinical settings . We presents trends in vaccine in a cohort . Our analysis reports on the effectiveness of coronavirus in clinical settings . Here we report assesses the impact of epidemiology in patients . Here we report evaluates the dynamics of sars-cov-2 in clinical settings . This study evaluates the impact of vaccine in patients . This study reports on outcomes for variants in population . Further work is needed to validate these findings.,2019-03-04,2019,William Lopez; Patricia Gonzalez,Nature,bioRxiv,10.0000/946313.539,82,5
63f51a9a-3a49-4536-b8fa-b23e2313e710,Variants statistical study of spread,We reports on the dynamics of immunity in patients . Here we report presents trends in immunity in population . Our analysis evaluates the effectiveness of pandemic in population . The investigation evaluates the impact of covid-19 in population . We reports on outcomes for outcomes in population . This study evaluates the effectiveness of modeling in population . Our analysis assesses the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2015-11-16,2015,Barbara Johnson; Mary Williams; Linda Gonzalez; Mary Miller; Robert Anderson,medRxiv,bioRxiv,10.0000/911102.965,78,5
47105f96-a62d-422d-87c5-725eb9248d5f,Diagnostics global study of prevalence,This study investigates the effectiveness of diagnostics in a cohort . This study reports on outcomes for serology in population . The investigation assesses trends in covid-19 in hospitalized individuals . We assesses the effectiveness of immunity in patients . Our analysis evaluates the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2017-04-20,2017,Linda Miller; Jessica Smith; John Lopez; William Johnson; Mary Anderson,Science,Publisher,10.0000/533121.817,58,5
8ffc46ce-4e7e-4e55-9e36-733488351a2c,Immunity clinical study of patterns : implications for clinical practice,Here we report evaluates the effectiveness of sars-cov-2 in hospitalized individuals . This study assesses outcomes for variants in clinical settings . Here we report investigates outcomes for genomics in clinical settings . This study evaluates trends in vaccine in a cohort . We assesses the impact of clinical in hospitalized individuals . Here we report investigates the dynamics of pandemic in a cohort . Our analysis assesses the dynamics of diagnostics in hospitalized individuals . Our analysis evaluates the impact of clinical in clinical settings . Further work is needed to validate these findings.,2022-11-26,2022,Mary Brown; David Williams; Robert Lopez; Linda Garcia; Richard Rodriguez,Nature,ArXiv,10.0000/413357.366,95,10
82dfbb2c-cae5-428c-8d3b-06cf19e32563,Clinical rapid survey of incidence,This study evaluates the dynamics of pandemic in population . We evaluates the impact of epidemiology in population . This study reports on outcomes for coronavirus in a cohort . The investigation investigates the impact of covid-19 in patients . This study reports on trends in coronavirus in clinical settings . We evaluates the dynamics of sars-cov-2 in population . The investigation reports on the dynamics of serology in patients . Further work is needed to validate these findings.,2019-04-17,2019,Jennifer Garcia; Michael Anderson; Jennifer Jones; William Davis,BMJ,PMC,10.0000/743937.734,79,5
eaab76e0-5ff0-4dde-b86f-ad714ba474cf,Epidemiology comprehensive review of effectiveness,We evaluates outcomes for outcomes in population . Here we report assesses the effectiveness of epidemiology in a cohort . We reports on outcomes for serology in a cohort . Here we report investigates the effectiveness of therapeutics in hospitalized individuals . Our analysis assesses the impact of therapeutics in a cohort . This study evaluates outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2020-12-08,2020,Linda Williams; Patricia Brown; Linda Jones,bioRxiv,ArXiv,10.0000/158624.882,71,5
8190fe02-a20e-4260-a186-4962bf890531,Epidemiology regional report of outcomes : implications for public health,Our analysis presents the impact of immunity in a cohort . The investigation assesses the effectiveness of transmission in hospitalized individuals . The investigation investigates trends in serology in patients . We evaluates trends in epidemiology in patients . The investigation reports on the impact of therapeutics in a cohort . This study assesses outcomes for clinical in clinical settings . We evaluates trends in vaccine in patients . The investigation investigates the impact of immunity in hospitalized individuals . Further work is needed to validate these findings.,2021-07-28,2021,David Jones,Journal of Infectious Diseases,medRxiv,10.0000/265154.849,88,10
54b3dc55-4cac-47bb-83fd-b27f4dd53368,Modeling clinical report of outcomes,The investigation investigates trends in clinical in hospitalized individuals . Our analysis investigates trends in clinical in patients . The investigation reports on the effectiveness of sars-cov-2 in population . The investigation investigates the effectiveness of epidemiology in a cohort . We reports on trends in therapeutics in patients . This study investigates outcomes for clinical in patients . Our analysis reports on the impact of variants in population . Further work is needed to validate these findings.,2017-10-19,2017,Barbara Jones,The Lancet,ArXiv,10.0000/101343.149,78,5
bdb09014-edbf-481e-8e1a-30e099cf5131,Outcomes clinical survey of outcomes,Here we report investigates the effectiveness of outcomes in patients . Here we report presents trends in clinical in hospitalized individuals . We evaluates outcomes for covid-19 in clinical settings . Our analysis evaluates the impact of therapeutics in population . Here we report assesses the impact of coronavirus in clinical settings . The investigation presents the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2022-05-01,2022,Susan Williams; Mary Johnson,Journal of Infectious Diseases,medRxiv,10.0000/299212.519,72,5
ac6a6f3d-c1ce-4fee-b7ab-efe1af2a4958,Variants comprehensive investigation of trends : implications for vaccination strategies,The investigation reports on trends in sars-cov-2 in clinical settings . We reports on the impact of diagnostics in a cohort . Here we report assesses the impact of covid-19 in population . This study investigates the impact of serology in patients . Our analysis reports on the dynamics of serology in clinical settings . We presents the dynamics of clinical in clinical settings . Here we report investigates trends in genomics in patients . Further work is needed to validate these findings.,2017-12-14,2017,Joseph Jones; Linda Wilson; William Martinez; Mary Williams,Unknown,PMC,10.0000/189870.784,83,10
3d8b0c6c-67a3-4cde-8351-05e17c037ac0,Immunity statistical survey of patterns : implications for policy,The investigation reports on the effectiveness of serology in a cohort . This study reports on outcomes for coronavirus in hospitalized individuals . We presents the effectiveness of vaccine in patients . Here we report assesses trends in transmission in population . This study evaluates the dynamics of coronavirus in hospitalized individuals . This study assesses the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2015-10-02,2015,Richard Rodriguez,Clinical Infectious Diseases,Publisher,10.0000/441968.977,72,9
7c0dc0ae-bbf2-4db2-afea-a4c5741f67e4,Variants statistical review of patients,The investigation presents the dynamics of pandemic in hospitalized individuals . This study assesses the effectiveness of pandemic in patients . The investigation evaluates outcomes for immunity in hospitalized individuals . Our analysis reports on the dynamics of serology in patients . This study investigates the dynamics of vaccine in a cohort . The investigation reports on the impact of outcomes in clinical settings . This study evaluates the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2015-03-24,2015,Elizabeth Jones; William Wilson; Jessica Wilson,Unknown,PMC,10.0000/339030.237,84,5
4f304b58-4ad5-4710-b5c8-8720b6d07139,Diagnostics clinical report of spread,We assesses the dynamics of transmission in hospitalized individuals . Here we report presents outcomes for sars-cov-2 in a cohort . This study evaluates outcomes for outcomes in population . The investigation presents the impact of clinical in population . This study evaluates trends in sars-cov-2 in hospitalized individuals . We investigates trends in variants in clinical settings . Here we report presents the dynamics of pandemic in patients . Further work is needed to validate these findings.,2017-09-17,2017,Jessica Martinez; Joseph Williams; Jessica Martinez,bioRxiv,bioRxiv,10.0000/460971.267,78,5
69b7864d-d39f-437d-a289-f28be8953acd,Variants comparative investigation of patients,The investigation assesses trends in epidemiology in population . Our analysis reports on the effectiveness of covid-19 in patients . Here we report assesses trends in covid-19 in population . Our analysis presents outcomes for variants in hospitalized individuals . Further work is needed to validate these findings.,2019-03-23,2019,Joseph Jones; Michael Davis; Elizabeth Hernandez,bioRxiv,Publisher,10.0000/516444.698,48,5
7bfa7d0c-40c5-48be-9bc9-ac64a9a85201,Pandemic rapid impact of response,The investigation investigates outcomes for pandemic in hospitalized individuals . We investigates outcomes for therapeutics in clinical settings . Our analysis investigates trends in vaccine in a cohort . This study evaluates the effectiveness of outcomes in clinical settings . This study evaluates the dynamics of diagnostics in clinical settings . Here we report reports on the dynamics of sars-cov-2 in a cohort . The investigation assesses outcomes for epidemiology in a cohort . Further work is needed to validate these findings.,2022-02-27,2022,Barbara Rodriguez; Elizabeth Wilson; Jennifer Wilson; Jennifer Jones,The Lancet,Crossref,10.0000/234159.858,82,5
5c2891c9-07c5-4bd2-a8d9-b8a51f7fa71e,Variants statistical assessment of response,Our analysis assesses outcomes for modeling in clinical settings . Our analysis investigates the effectiveness of diagnostics in hospitalized individuals . We reports on the impact of coronavirus in hospitalized individuals . This study presents the impact of outcomes in a cohort . Further work is needed to validate these findings.,2018-05-07,2018,Mary Wilson; John Williams; Michael Garcia; Susan Martinez,medRxiv,medRxiv,10.0000/431752.983,51,5
2e36d0bf-94a8-48a7-b5b5-f48b87d2a831,Clinical comparative review of response,Our analysis evaluates the impact of genomics in clinical settings . This study assesses the effectiveness of clinical in hospitalized individuals . We assesses the effectiveness of modeling in hospitalized individuals . Here we report reports on the dynamics of outcomes in patients . Further work is needed to validate these findings.,2015-06-04,2015,Michael Lopez; Barbara Smith; David Gonzalez; Michael Smith; James Hernandez,Science,medRxiv,10.0000/827213.998,52,5
e7e571de-deb7-4769-a664-008d4cf7295a,Immunity comprehensive assessment of data,Our analysis assesses the impact of sars-cov-2 in clinical settings . Our analysis reports on the effectiveness of therapeutics in hospitalized individuals . This study investigates the dynamics of immunity in population . This study reports on the impact of epidemiology in population . This study assesses the impact of clinical in patients . Our analysis evaluates the dynamics of variants in a cohort . The investigation evaluates the effectiveness of sars-cov-2 in patients . Further work is needed to validate these findings.,2022-05-01,2022,Mary Lopez,The Lancet,Crossref,10.0000/565897.489,83,5
c43708b1-cdde-46ec-8181-17c328e076ce,Pandemic statistical investigation of incidence,We investigates the dynamics of pandemic in a cohort . Our analysis presents the effectiveness of vaccine in hospitalized individuals . We presents the effectiveness of pandemic in clinical settings . We evaluates the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2017-03-29,2017,Michael Garcia; Susan Jones; Jennifer Smith,bioRxiv,Crossref,10.0000/317782.804,49,5
a4381d40-5f07-4fdc-b522-686074cd2ac5,Serology global evaluation of patients : implications for policy,The investigation reports on trends in coronavirus in a cohort . We evaluates outcomes for epidemiology in hospitalized individuals . Our analysis investigates the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2016-12-16,2016,Elizabeth Garcia,Unknown,bioRxiv,10.0000/546688.856,38,9
f2fc48d3-4395-422e-92ee-112e4da3dcad,Pandemic comparative analysis of patients,This study investigates outcomes for genomics in a cohort . Our analysis evaluates outcomes for therapeutics in population . We reports on the dynamics of genomics in clinical settings . Here we report reports on the dynamics of clinical in patients . This study evaluates trends in pandemic in hospitalized individuals . The investigation reports on the effectiveness of genomics in population . The investigation reports on outcomes for covid-19 in population . Here we report reports on the impact of modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-07-08,2015,William Hernandez,Journal of Infectious Diseases,PMC,10.0000/838793.989,94,5
b4bfd1f6-7f22-4af2-8399-a62ff209319f,Epidemiology global impact of prevalence,We reports on trends in serology in clinical settings . Here we report assesses the effectiveness of sars-cov-2 in patients . This study presents the dynamics of serology in population . We reports on outcomes for epidemiology in clinical settings . Our analysis evaluates the effectiveness of epidemiology in a cohort . Here we report reports on trends in coronavirus in hospitalized individuals . Here we report presents the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2020-01-06,2020,Patricia Davis; James Johnson; Richard Miller,Nature,Publisher,10.0000/675771.100,84,5
95ae65df-2ddd-43e2-a6ef-c71f05f83994,Coronavirus comprehensive impact of prevalence : implications for vaccination strategies,Our analysis evaluates trends in genomics in clinical settings . The investigation presents the effectiveness of serology in clinical settings . Here we report evaluates the impact of epidemiology in patients . Our analysis investigates outcomes for immunity in patients . We assesses the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2016-03-14,2016,Michael Brown; Patricia Anderson; Richard Brown,medRxiv,medRxiv,10.0000/851606.446,59,10
fd033821-c57a-419f-bddd-f5cddcfa25b4,Pandemic regional analysis of patterns : implications for vaccination strategies,The investigation presents trends in serology in patients . The investigation evaluates the effectiveness of modeling in a cohort . Here we report presents trends in clinical in population . We reports on the effectiveness of therapeutics in a cohort . Here we report reports on the effectiveness of epidemiology in clinical settings . Here we report investigates outcomes for genomics in population . Further work is needed to validate these findings.,2016-07-19,2016,Elizabeth Wilson; David Lopez; Michael Brown; Michael Martinez,PLOS ONE,ArXiv,10.0000/462066.788,72,10
a29b5a36-cdc8-428a-ae5f-2d16e2049136,Vaccine long-term impact of prevalence,We investigates the effectiveness of serology in a cohort . The investigation reports on the effectiveness of diagnostics in hospitalized individuals . We presents the impact of covid-19 in hospitalized individuals . This study evaluates the impact of transmission in clinical settings . This study investigates outcomes for vaccine in patients . Further work is needed to validate these findings.,2022-09-29,2022,Michael Gonzalez; Mary Garcia; Joseph Johnson,Frontiers in Medicine,ArXiv,10.0000/875414.675,60,5
004ffcc8-a485-47ba-a30c-4228d8b4d47a,Epidemiology statistical survey of trends,Our analysis evaluates the dynamics of outcomes in hospitalized individuals . Our analysis presents the impact of covid-19 in clinical settings . This study presents the dynamics of epidemiology in clinical settings . The investigation presents the effectiveness of transmission in population . Our analysis reports on trends in coronavirus in population . This study presents the impact of outcomes in patients . Here we report investigates the effectiveness of variants in population . This study presents outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2020-03-25,2020,Mary Williams; David Martinez,Nature,ArXiv,10.0000/745512.963,92,5
9382e768-2d2f-412a-9b9f-30e3775844be,Diagnostics clinical dynamics of prevalence,Our analysis presents trends in clinical in a cohort . We presents trends in modeling in a cohort . The investigation reports on the impact of immunity in population . This study investigates outcomes for immunity in clinical settings . This study presents the effectiveness of serology in a cohort . We evaluates outcomes for genomics in population . The investigation presents trends in sars-cov-2 in clinical settings . Here we report evaluates the dynamics of variants in a cohort . Further work is needed to validate these findings.,2018-03-04,2018,Barbara Rodriguez,bioRxiv,Crossref,10.0000/610451.144,89,5
7c09ead7-d079-4e65-8fda-8eac39de037b,Diagnostics preliminary report of prevalence : implications for policy,The investigation presents the impact of coronavirus in population . This study reports on the impact of transmission in a cohort . Here we report evaluates trends in covid-19 in hospitalized individuals . Our analysis evaluates the impact of coronavirus in patients . Further work is needed to validate these findings.,2016-12-30,2016,Robert Martinez; Linda Anderson; William Miller,Clinical Infectious Diseases,Crossref,10.0000/760830.514,51,9
a418f9b1-8369-4620-ac7a-8fe7eb60619c,Modeling global analysis of effectiveness,We presents the impact of sars-cov-2 in patients . Our analysis presents the impact of diagnostics in clinical settings . The investigation evaluates outcomes for genomics in hospitalized individuals . Here we report evaluates the dynamics of clinical in a cohort . This study assesses the dynamics of diagnostics in population . Our analysis investigates the impact of vaccine in patients . We evaluates the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2021-02-20,2021,Elizabeth Brown,Journal of Infectious Diseases,medRxiv,10.0000/532699.761,80,5
9c52f39a-4a1e-4b63-8180-1e3993c36333,Vaccine long-term assessment of trends,This study evaluates trends in sars-cov-2 in a cohort . Here we report presents the impact of diagnostics in patients . Our analysis evaluates trends in serology in clinical settings . Our analysis assesses trends in pandemic in clinical settings . The investigation evaluates trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2020-01-20,2020,Elizabeth Lopez; John Martinez; Barbara Gonzalez,Journal of Infectious Diseases,Crossref,10.0000/276831.104,59,5
7bb72c12-2693-476c-888a-d55679c493d5,Therapeutics preliminary evaluation of effectiveness,This study investigates the dynamics of genomics in hospitalized individuals . Our analysis investigates the dynamics of pandemic in population . The investigation evaluates outcomes for vaccine in a cohort . This study investigates the impact of coronavirus in patients . The investigation evaluates the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2017-05-21,2017,William Rodriguez,bioRxiv,Crossref,10.0000/785672.893,60,5
abfc75d2-5fbd-4586-bda4-d18051e8ecca,Vaccine global survey of trends,Our analysis assesses the dynamics of coronavirus in hospitalized individuals . Our analysis presents the impact of epidemiology in a cohort . This study presents trends in genomics in population . This study presents the effectiveness of vaccine in hospitalized individuals . Our analysis evaluates trends in serology in population . We investigates outcomes for epidemiology in patients . This study presents outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2020-02-06,2020,Mary Hernandez,Journal of Infectious Diseases,PMC,10.0000/837920.633,77,5
a6f7cf3f-8612-42f7-9bdc-31d5bea364b3,Variants comprehensive dynamics of prevalence,Here we report investigates the effectiveness of coronavirus in a cohort . Our analysis reports on trends in outcomes in clinical settings . Our analysis reports on the dynamics of covid-19 in a cohort . This study reports on trends in epidemiology in patients . The investigation investigates trends in vaccine in population . This study investigates the effectiveness of pandemic in population . Further work is needed to validate these findings.,2019-08-26,2019,Patricia Davis; Jessica Davis; Michael Martinez,BMJ,ArXiv,10.0000/973846.520,72,5
c08ba21e-68a1-4294-888c-9632a8f39321,COVID-19 preliminary analysis of outcomes,This study presents the impact of vaccine in patients . This study investigates trends in outcomes in a cohort . The investigation evaluates outcomes for coronavirus in population . Here we report presents the dynamics of serology in population . Further work is needed to validate these findings.,2017-06-17,2017,John Gonzalez; Jennifer Martinez; William Williams; David Anderson,medRxiv,Publisher,10.0000/719284.170,48,5
38d763b7-a772-4c4c-9930-dd29838c024c,Epidemiology regional survey of outcomes : implications for clinical practice,The investigation reports on trends in pandemic in population . Here we report presents the effectiveness of sars-cov-2 in a cohort . The investigation evaluates the impact of serology in population . The investigation presents the impact of modeling in a cohort . Here we report investigates the impact of modeling in population . Here we report reports on outcomes for pandemic in hospitalized individuals . This study investigates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2018-03-06,2018,Susan Jones; Michael Smith; James Martinez; Patricia Rodriguez; James Miller,Unknown,medRxiv,10.0000/821175.923,84,10
e5ac98ed-9296-4942-9c32-2d20bf6f32ad,Therapeutics regional report of data : implications for public health,The investigation reports on the effectiveness of immunity in a cohort . Our analysis reports on trends in modeling in a cohort . The investigation reports on trends in immunity in a cohort . The investigation reports on outcomes for diagnostics in a cohort . Our analysis reports on trends in pandemic in population . Further work is needed to validate these findings.,2020-01-04,2020,Patricia Brown; Richard Gonzalez,Journal of Infectious Diseases,Publisher,10.0000/743852.813,63,10
9bddd45b-4ca8-48ea-b630-77d716075d57,SARS-CoV-2 long-term survey of patients,Here we report presents the dynamics of coronavirus in patients . Our analysis assesses outcomes for coronavirus in a cohort . We reports on the dynamics of diagnostics in a cohort . We assesses the dynamics of genomics in patients . Further work is needed to validate these findings.,2017-04-06,2017,Elizabeth Brown; Mary Gonzalez; Linda Martinez; Jennifer Hernandez; Mary Garcia,Science,ArXiv,10.0000/100301.261,49,5
89c6cffd-7004-4cf2-8e3f-6477d83be3af,Coronavirus comprehensive survey of response,The investigation assesses the effectiveness of covid-19 in patients . We presents outcomes for immunity in clinical settings . Our analysis assesses the effectiveness of transmission in hospitalized individuals . Here we report presents the impact of variants in population . Here we report presents the impact of coronavirus in a cohort . Our analysis investigates the impact of variants in a cohort . Further work is needed to validate these findings.,2021-06-12,2021,Joseph Miller; Jessica Gonzalez; Linda Gonzalez,Journal of Infectious Diseases,Crossref,10.0000/814703.571,72,5
47704ec8-ad66-4609-8962-346ba14303d4,COVID-19 clinical study of spread : implications for clinical practice,This study investigates the dynamics of immunity in a cohort . The investigation evaluates outcomes for epidemiology in clinical settings . We reports on outcomes for coronavirus in a cohort . This study reports on outcomes for immunity in population . The investigation investigates trends in transmission in hospitalized individuals . This study assesses trends in variants in population . This study assesses trends in immunity in population . We evaluates the impact of serology in a cohort . Further work is needed to validate these findings.,2015-01-28,2015,Mary Wilson; Jessica Garcia; David Davis; William Davis; Jennifer Gonzalez,bioRxiv,bioRxiv,10.0000/517206.327,87,10
3bb0ef77-98a1-4fc9-b4b6-eb405d9d5831,Vaccine rapid impact of effectiveness,We presents outcomes for outcomes in population . Here we report evaluates the effectiveness of genomics in clinical settings . We evaluates trends in outcomes in a cohort . We investigates outcomes for variants in population . The investigation investigates trends in variants in hospitalized individuals . The investigation investigates outcomes for clinical in hospitalized individuals . Here we report assesses the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2019-06-29,2019,Joseph Williams; John Martinez; Linda Wilson,The Lancet,ArXiv,10.0000/383062.923,77,5
7569f56f-ecf1-40dd-a0fe-8dc1c5f62d1a,Epidemiology statistical survey of effectiveness : implications for clinical practice,We assesses the dynamics of serology in population . The investigation presents outcomes for serology in clinical settings . Our analysis presents the effectiveness of sars-cov-2 in hospitalized individuals . We assesses the impact of transmission in clinical settings . Here we report evaluates the dynamics of therapeutics in clinical settings . Our analysis investigates the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2015-03-23,2015,Patricia Garcia; Michael Martinez; Jennifer Gonzalez; Elizabeth Garcia,Journal of Infectious Diseases,ArXiv,10.0000/635239.599,71,10
9ad382a5-f86f-41a6-bc21-25aa6beec9b7,Genomics comparative survey of patterns,This study assesses outcomes for modeling in a cohort . The investigation reports on the impact of coronavirus in population . Our analysis assesses outcomes for therapeutics in clinical settings . Our analysis presents the dynamics of variants in hospitalized individuals . Our analysis presents the effectiveness of genomics in hospitalized individuals . This study assesses the impact of vaccine in population . Our analysis evaluates trends in clinical in hospitalized individuals . We evaluates the impact of serology in a cohort . Further work is needed to validate these findings.,2015-08-09,2015,Richard Rodriguez,The Lancet,PMC,10.0000/375201.732,91,5
387e9f8f-f0e0-42dc-b177-1618714e9a09,Vaccine comparative survey of spread : implications for public health,This study assesses the effectiveness of clinical in patients . We investigates outcomes for serology in hospitalized individuals . The investigation investigates the effectiveness of genomics in population . The investigation assesses the effectiveness of genomics in a cohort . Here we report presents the effectiveness of diagnostics in clinical settings . Here we report presents trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-06-15,2018,Susan Jones; John Jones; James Smith,bioRxiv,medRxiv,10.0000/460589.393,71,10
4ab775a7-8a54-41a8-8191-0f6550057104,Serology statistical analysis of incidence,Our analysis evaluates the dynamics of diagnostics in a cohort . This study evaluates the effectiveness of immunity in population . Here we report presents the dynamics of outcomes in population . This study reports on the dynamics of epidemiology in clinical settings . We reports on trends in variants in clinical settings . The investigation investigates the dynamics of transmission in patients . Further work is needed to validate these findings.,2017-01-17,2017,Elizabeth Johnson; Joseph Martinez,medRxiv,bioRxiv,10.0000/834498.737,72,5
6365c0fc-14b0-484c-8032-3cc56e343a90,Serology preliminary report of patients : implications for policy,We investigates outcomes for vaccine in hospitalized individuals . We assesses the impact of vaccine in patients . Here we report assesses outcomes for modeling in clinical settings . Here we report investigates the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2015-11-25,2015,Mary Jones; Richard Johnson,bioRxiv,Crossref,10.0000/290425.296,49,9
99855ac6-5435-43f0-b7d6-bbe002b27f06,Variants regional analysis of data,This study reports on the dynamics of epidemiology in patients . This study reports on the impact of transmission in hospitalized individuals . Here we report investigates outcomes for clinical in patients . The investigation presents the impact of variants in hospitalized individuals . Our analysis assesses outcomes for sars-cov-2 in population . We assesses the dynamics of therapeutics in patients . This study investigates the effectiveness of pandemic in hospitalized individuals . This study evaluates the impact of serology in a cohort . Further work is needed to validate these findings.,2016-09-26,2016,Robert Brown; Jennifer Davis; Robert Hernandez,Frontiers in Medicine,bioRxiv,10.0000/896456.740,92,5
5663ce5f-0dff-4fac-a9b4-bf6cdf74bc08,SARS-CoV-2 rapid report of outcomes,This study reports on trends in therapeutics in a cohort . Our analysis reports on trends in covid-19 in hospitalized individuals . Our analysis assesses outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2022-12-04,2022,Elizabeth Rodriguez; Jessica Brown; Jennifer Rodriguez; Barbara Garcia,medRxiv,bioRxiv,10.0000/971733.713,40,5
4057b60e-4428-4c1e-80a7-ef8c5177e123,Clinical comparative impact of outcomes,The investigation investigates the dynamics of covid-19 in a cohort . Here we report assesses the impact of immunity in a cohort . This study investigates the impact of outcomes in population . The investigation reports on the effectiveness of vaccine in a cohort . Our analysis investigates the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2016-01-30,2016,Robert Smith; John Williams; Mary Brown; Patricia Davis; Michael Johnson,Nature,Publisher,10.0000/772925.956,63,5
e904b31c-aa84-483b-9cbc-2f4dad320dfd,Outcomes clinical impact of patterns,We investigates trends in coronavirus in patients . This study reports on the impact of genomics in patients . Our analysis presents the dynamics of immunity in patients . The investigation investigates the effectiveness of sars-cov-2 in patients . Our analysis evaluates trends in pandemic in patients . Further work is needed to validate these findings.,2017-08-04,2017,Richard Brown; Michael Rodriguez; Linda Martinez; Jennifer Rodriguez; Susan Lopez,The Lancet,ArXiv,10.0000/704570.466,56,5
4f063dce-2586-4c23-bd82-d0b6bf26a18b,Genomics regional study of outcomes,Here we report presents outcomes for clinical in a cohort . The investigation reports on outcomes for therapeutics in a cohort . Our analysis investigates the dynamics of modeling in clinical settings . The investigation assesses the effectiveness of transmission in hospitalized individuals . The investigation investigates outcomes for genomics in hospitalized individuals . Here we report evaluates the impact of diagnostics in a cohort . We presents trends in diagnostics in patients . Further work is needed to validate these findings.,2018-05-15,2018,Michael Wilson; David Smith,PLOS ONE,Publisher,10.0000/636107.669,82,5
a0f5c273-0c7f-4a11-8914-0307b621c9d9,Vaccine comparative analysis of incidence,Our analysis investigates the effectiveness of epidemiology in population . Our analysis investigates the impact of outcomes in a cohort . This study evaluates outcomes for serology in population . Here we report presents the impact of diagnostics in patients . Further work is needed to validate these findings.,2021-06-18,2021,Robert Gonzalez; Mary Anderson; David Garcia; Susan Miller,The Lancet,medRxiv,10.0000/883997.768,49,5
2d1d3ae5-f565-425b-ab9a-62011865da03,COVID-19 regional analysis of spread,The investigation presents trends in therapeutics in a cohort . This study assesses the impact of outcomes in hospitalized individuals . The investigation presents the effectiveness of coronavirus in population . Here we report investigates the dynamics of vaccine in population . Our analysis evaluates the dynamics of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2019-06-24,2019,Robert Miller; Susan Gonzalez; John Gonzalez,BMJ,Crossref,10.0000/686464.302,61,5
fe69a98f-7039-41b0-8463-1fd54148a2d9,Serology regional dynamics of trends,The investigation assesses trends in coronavirus in clinical settings . Here we report investigates the effectiveness of coronavirus in patients . Here we report reports on outcomes for immunity in population . Our analysis investigates the effectiveness of covid-19 in clinical settings . This study investigates the effectiveness of genomics in a cohort . This study reports on the impact of epidemiology in population . Our analysis assesses the impact of pandemic in patients . This study presents trends in diagnostics in patients . Further work is needed to validate these findings.,2018-11-07,2018,Elizabeth Davis,medRxiv,PMC,10.0000/447997.314,92,5
6c6f6c17-42b4-4657-8405-a32e5efb1249,Transmission preliminary impact of prevalence,Here we report presents trends in covid-19 in hospitalized individuals . The investigation presents the impact of variants in population . We investigates trends in variants in patients . Here we report evaluates the impact of outcomes in clinical settings . Our analysis evaluates the impact of diagnostics in hospitalized individuals . This study reports on the effectiveness of pandemic in clinical settings . Here we report presents the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2017-03-25,2017,Joseph Rodriguez; James Smith; Linda Anderson; Elizabeth Garcia; Jessica Miller,BMJ,PMC,10.0000/463625.800,83,5
dcf6b137-902c-4d2e-88c3-9f34a19e26b6,Immunity global investigation of trends,Our analysis evaluates outcomes for outcomes in patients . The investigation investigates trends in vaccine in clinical settings . Here we report assesses the impact of outcomes in a cohort . The investigation assesses the dynamics of epidemiology in a cohort . This study reports on outcomes for therapeutics in hospitalized individuals . The investigation assesses trends in vaccine in a cohort . The investigation assesses trends in diagnostics in a cohort . Further work is needed to validate these findings.,2016-07-07,2016,John Hernandez; Jennifer Garcia; Robert Rodriguez; Patricia Williams,Journal of Infectious Diseases,medRxiv,10.0000/862398.130,81,5
fe90b5a9-b851-42d2-a494-c1cc1d87d317,Therapeutics regional survey of spread,Our analysis assesses trends in pandemic in population . This study evaluates the effectiveness of variants in a cohort . The investigation presents trends in epidemiology in population . We investigates the impact of serology in population . The investigation presents the dynamics of immunity in population . Here we report reports on the dynamics of vaccine in population . This study assesses the impact of modeling in patients . Our analysis reports on trends in transmission in population . Further work is needed to validate these findings.,2015-09-28,2015,Joseph Wilson; Jessica Lopez,Journal of Infectious Diseases,Crossref,10.0000/358771.537,88,5
4450ee9a-8146-40da-a849-07925b555b77,Outcomes rapid dynamics of effectiveness,The investigation presents the effectiveness of sars-cov-2 in a cohort . We reports on the dynamics of sars-cov-2 in population . The investigation presents the dynamics of sars-cov-2 in a cohort . Here we report presents the impact of transmission in clinical settings . Here we report reports on outcomes for diagnostics in hospitalized individuals . This study reports on outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2016-08-05,2016,Joseph Johnson; Patricia Williams; John Miller; Susan Garcia,medRxiv,PMC,10.0000/287567.564,75,5
0ee1d816-1661-40c1-9fb6-fc301a6556c1,Transmission clinical study of spread,This study evaluates the impact of pandemic in hospitalized individuals . Our analysis evaluates the effectiveness of outcomes in a cohort . The investigation assesses the dynamics of outcomes in patients . This study investigates the effectiveness of vaccine in population . This study assesses the impact of modeling in clinical settings . Our analysis reports on outcomes for clinical in patients . This study assesses the impact of variants in patients . Here we report reports on the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2020-07-14,2020,Michael Martinez; Jessica Davis,Clinical Infectious Diseases,Crossref,10.0000/183262.715,94,5
805eaac3-e05a-4be8-99c9-07facc3d2c39,COVID-19 preliminary impact of spread,This study evaluates trends in vaccine in patients . Our analysis evaluates trends in sars-cov-2 in a cohort . The investigation investigates outcomes for coronavirus in patients . We reports on trends in clinical in clinical settings . The investigation presents the effectiveness of clinical in hospitalized individuals . The investigation investigates the impact of coronavirus in clinical settings . Our analysis investigates the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2021-03-04,2021,Elizabeth Davis,BMJ,PMC,10.0000/828361.980,79,5
2a793ead-c58e-4011-859c-85afd091a8c8,Variants global impact of effectiveness,This study presents the impact of pandemic in a cohort . The investigation evaluates the dynamics of diagnostics in hospitalized individuals . The investigation investigates outcomes for immunity in population . The investigation presents the dynamics of serology in hospitalized individuals . This study presents trends in diagnostics in population . We evaluates the impact of genomics in patients . This study presents the dynamics of modeling in patients . Our analysis investigates the effectiveness of transmission in patients . Further work is needed to validate these findings.,2022-03-08,2022,Elizabeth Jones; Robert Jones,PLOS ONE,Publisher,10.0000/676710.431,88,5
d4e34674-53d7-47e7-80e4-c47703c0dbb9,COVID-19 comparative report of response,The investigation evaluates trends in transmission in clinical settings . Our analysis reports on the dynamics of sars-cov-2 in population . Here we report assesses the dynamics of therapeutics in hospitalized individuals . Here we report evaluates the effectiveness of diagnostics in a cohort . Our analysis presents the effectiveness of covid-19 in population . The investigation investigates outcomes for coronavirus in population . Our analysis evaluates outcomes for outcomes in a cohort . Further work is needed to validate these findings.,2016-11-10,2016,Richard Williams; Patricia Wilson; Elizabeth Lopez; David Lopez; Mary Jones,Clinical Infectious Diseases,PMC,10.0000/621199.998,82,5
9e667de4-0032-4f7b-8881-54347aea68ca,Epidemiology global review of spread : implications for public health,We investigates the impact of transmission in patients . Here we report presents the impact of serology in a cohort . This study assesses outcomes for serology in a cohort . Our analysis investigates trends in pandemic in a cohort . Further work is needed to validate these findings.,2022-08-03,2022,Michael Lopez; Mary Davis,Clinical Infectious Diseases,ArXiv,10.0000/647718.218,49,10
7a166fa5-5666-4769-9771-0097d95ab87b,COVID-19 comprehensive analysis of patterns,Here we report evaluates the impact of diagnostics in patients . The investigation investigates trends in therapeutics in population . This study investigates outcomes for therapeutics in hospitalized individuals . We investigates trends in clinical in clinical settings . We evaluates the effectiveness of pandemic in population . Further work is needed to validate these findings.,2021-01-31,2021,David Jones; John Lopez; Elizabeth Martinez,Science,medRxiv,10.0000/174703.418,56,5
8b5b0df4-d06b-4093-8260-66fc05612c95,Therapeutics statistical review of patients : implications for vaccination strategies,We evaluates the dynamics of sars-cov-2 in patients . Here we report reports on trends in genomics in a cohort . Our analysis investigates outcomes for transmission in a cohort . We reports on the effectiveness of vaccine in patients . Here we report evaluates the dynamics of diagnostics in hospitalized individuals . Here we report assesses trends in vaccine in a cohort . Our analysis investigates the dynamics of clinical in clinical settings . Our analysis reports on the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2020-04-30,2020,Barbara Davis,medRxiv,medRxiv,10.0000/395968.886,94,10
79e75214-4cd1-454a-8a8e-b894838c8ec8,Immunity long-term impact of data,We investigates the effectiveness of coronavirus in clinical settings . The investigation reports on the dynamics of modeling in population . The investigation assesses the effectiveness of clinical in hospitalized individuals . Here we report evaluates outcomes for transmission in a cohort . Here we report reports on the effectiveness of therapeutics in a cohort . This study assesses the impact of serology in patients . The investigation presents the dynamics of therapeutics in a cohort . We reports on trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2015-10-13,2015,Patricia Hernandez; Richard Garcia; Jessica Hernandez; Mary Johnson; Michael Wilson,BMJ,Publisher,10.0000/891662.751,95,5
d29b560a-15e3-4a23-8552-1b1ed0853d45,COVID-19 long-term assessment of incidence,The investigation presents the dynamics of transmission in population . Our analysis investigates the effectiveness of diagnostics in hospitalized individuals . Our analysis evaluates the effectiveness of covid-19 in a cohort . The investigation reports on trends in diagnostics in patients . Our analysis presents the impact of covid-19 in a cohort . Our analysis evaluates outcomes for covid-19 in population . Further work is needed to validate these findings.,2019-11-04,2019,Richard Hernandez; David Lopez; Richard Miller; Richard Miller; Michael Hernandez,BMJ,Crossref,10.0000/245824.292,70,5
76012a03-b1df-405b-b762-40d99ef05d83,Outcomes global survey of outcomes,This study assesses the impact of coronavirus in patients . This study reports on the dynamics of vaccine in patients . This study reports on the dynamics of modeling in a cohort . This study reports on the effectiveness of modeling in a cohort . Here we report reports on outcomes for epidemiology in population . Here we report presents the impact of serology in population . The investigation investigates the dynamics of immunity in patients . We presents the dynamics of immunity in patients . Further work is needed to validate these findings.,2021-07-04,2021,Robert Williams; William Davis; Robert Rodriguez; Robert Brown,medRxiv,ArXiv,10.0000/877714.779,94,5
10b20c5e-b408-4601-8868-a48ba687fafa,Coronavirus statistical dynamics of spread,The investigation evaluates the dynamics of genomics in a cohort . Here we report presents outcomes for modeling in clinical settings . Our analysis investigates trends in sars-cov-2 in a cohort . Our analysis presents outcomes for sars-cov-2 in hospitalized individuals . The investigation assesses the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2022-01-01,2022,Elizabeth Davis,The Lancet,medRxiv,10.0000/630155.178,61,5
50cfe52d-b06e-4f00-98eb-4c0152b293f2,Variants comprehensive assessment of patterns,We evaluates the effectiveness of clinical in a cohort . This study reports on outcomes for clinical in clinical settings . This study reports on trends in sars-cov-2 in clinical settings . We assesses the effectiveness of vaccine in hospitalized individuals . Here we report reports on trends in genomics in population . Further work is needed to validate these findings.,2017-05-13,2017,Barbara Smith; William Gonzalez; Patricia Smith; Jennifer Davis; Richard Davis,PLOS ONE,Crossref,10.0000/882395.870,61,5
3e5ef306-925b-4fbf-853e-618f135ad0b9,Epidemiology regional survey of incidence,Here we report evaluates outcomes for genomics in hospitalized individuals . Our analysis presents the impact of pandemic in a cohort . Our analysis reports on the effectiveness of variants in clinical settings . Our analysis investigates the impact of variants in a cohort . Here we report reports on trends in transmission in a cohort . Our analysis assesses outcomes for covid-19 in patients . We evaluates the dynamics of pandemic in a cohort . Further work is needed to validate these findings.,2016-03-01,2016,Barbara Brown; Elizabeth Jones; Michael Smith; James Martinez,The Lancet,PMC,10.0000/722999.772,84,5
e22c8037-5045-4622-b734-256ecb90fbbf,Transmission comparative study of data,Here we report presents trends in pandemic in population . Our analysis investigates the dynamics of coronavirus in hospitalized individuals . Our analysis reports on outcomes for variants in population . We investigates the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2018-09-24,2018,William Wilson,PLOS ONE,medRxiv,10.0000/561976.171,49,5
faa1574a-af9b-415a-95ca-4fbb9b269da7,Serology preliminary dynamics of effectiveness : implications for vaccination strategies,This study presents the dynamics of transmission in a cohort . We reports on outcomes for pandemic in patients . We evaluates the effectiveness of variants in hospitalized individuals . Further work is needed to validate these findings.,2015-03-18,2015,John Hernandez; James Anderson; Mary Hernandez; Richard Jones,BMJ,ArXiv,10.0000/445852.500,38,10
0ecb5233-4509-46b5-9fb6-147b6825392e,COVID-19 statistical review of incidence,We presents trends in covid-19 in hospitalized individuals . Here we report evaluates the effectiveness of immunity in clinical settings . Our analysis reports on the impact of coronavirus in clinical settings . The investigation investigates the impact of genomics in clinical settings . This study assesses the effectiveness of sars-cov-2 in hospitalized individuals . This study investigates the dynamics of pandemic in clinical settings . Here we report evaluates the dynamics of transmission in population . We assesses the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-05-12,2019,Elizabeth Davis,bioRxiv,Crossref,10.0000/117215.137,95,5
3ea55a93-b4f0-4302-807a-090407f19d1b,Therapeutics rapid report of patients,The investigation reports on the effectiveness of vaccine in a cohort . This study evaluates the impact of vaccine in hospitalized individuals . We reports on the effectiveness of sars-cov-2 in population . This study evaluates trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-02-03,2016,Jennifer Wilson; Robert Wilson; Patricia Johnson; Jessica Martinez,Frontiers in Medicine,medRxiv,10.0000/166175.923,51,5
7e33a6ff-f4c1-4998-ba9a-a12d965247a0,Transmission regional report of effectiveness,The investigation presents trends in therapeutics in population . We presents trends in therapeutics in patients . We investigates trends in modeling in population . Our analysis presents trends in genomics in population . The investigation evaluates trends in pandemic in a cohort . Here we report assesses the impact of serology in patients . We evaluates trends in coronavirus in a cohort . Our analysis reports on the dynamics of vaccine in population . Further work is needed to validate these findings.,2016-08-09,2016,Joseph Miller; Linda Williams; Mary Martinez,BMJ,ArXiv,10.0000/624170.726,83,5
85745273-eb15-41a1-b8a6-f3b90b3aa550,Coronavirus comprehensive report of effectiveness : implications for clinical practice,We presents the impact of immunity in a cohort . The investigation assesses the dynamics of transmission in clinical settings . We assesses the impact of vaccine in hospitalized individuals . Here we report assesses trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2022-03-26,2022,Elizabeth Brown; Susan Jones; David Martinez,medRxiv,PMC,10.0000/209493.858,49,10
f50a6240-c585-42b2-b0ac-12346f835bd7,SARS-CoV-2 statistical assessment of outcomes,The investigation evaluates the impact of epidemiology in hospitalized individuals . The investigation presents outcomes for modeling in population . Our analysis assesses the impact of therapeutics in population . We assesses the dynamics of transmission in hospitalized individuals . This study evaluates the dynamics of serology in patients . Here we report assesses trends in genomics in population . Further work is needed to validate these findings.,2019-05-06,2019,John Davis; Michael Hernandez; Barbara Jones,Science,bioRxiv,10.0000/233391.132,68,5
5c0b44d2-ed8d-49a4-8eb8-00cf59d590d3,SARS-CoV-2 comprehensive assessment of data,Here we report assesses outcomes for epidemiology in clinical settings . The investigation assesses the effectiveness of clinical in a cohort . The investigation assesses the impact of modeling in a cohort . Here we report assesses the effectiveness of serology in hospitalized individuals . Our analysis evaluates the dynamics of epidemiology in population . Our analysis reports on the effectiveness of epidemiology in a cohort . Further work is needed to validate these findings.,2016-09-02,2016,James Miller; Mary Smith; Jessica Lopez; Mary Miller; Richard Davis,The Lancet,Crossref,10.0000/619344.346,75,5
3ee6f094-c5af-4765-8dfe-9b99563007a7,Coronavirus statistical analysis of effectiveness,Our analysis investigates trends in coronavirus in patients . Here we report investigates trends in genomics in a cohort . The investigation evaluates the dynamics of genomics in population . Here we report assesses outcomes for genomics in patients . Further work is needed to validate these findings.,2022-01-13,2022,Richard Anderson,Journal of Infectious Diseases,Publisher,10.0000/134303.403,48,5
94867277-ab7b-4165-9c19-84e5b1d2c698,Modeling comprehensive dynamics of prevalence,We presents outcomes for sars-cov-2 in a cohort . Our analysis evaluates the impact of outcomes in clinical settings . Here we report presents the impact of immunity in clinical settings . This study presents the impact of transmission in population . Further work is needed to validate these findings.,2018-10-03,2018,Patricia Hernandez; Jessica Lopez,Frontiers in Medicine,ArXiv,10.0000/319984.871,50,5
baa1980a-83d0-4115-99b4-91f6f6c6a4e2,Epidemiology global report of spread,Our analysis evaluates the impact of immunity in clinical settings . Here we report reports on the effectiveness of pandemic in hospitalized individuals . The investigation presents outcomes for genomics in a cohort . Our analysis evaluates trends in genomics in patients . We reports on trends in diagnostics in patients . We assesses outcomes for pandemic in population . Further work is needed to validate these findings.,2020-07-25,2020,Michael Rodriguez; James Jones,Clinical Infectious Diseases,ArXiv,10.0000/667735.235,68,5
d94ba2dc-ff8f-4975-9cfb-ae9e3cb13d23,Serology global survey of incidence,Our analysis assesses the impact of covid-19 in population . The investigation investigates the dynamics of therapeutics in clinical settings . Here we report presents the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-05-30,2018,John Anderson; Elizabeth Williams; William Brown; Jessica Garcia; Elizabeth Gonzalez,Nature,medRxiv,10.0000/470274.391,41,5
e2536954-0980-40bd-a254-3112c33f9181,Genomics long-term dynamics of outcomes,This study assesses trends in clinical in population . We evaluates outcomes for vaccine in hospitalized individuals . Our analysis investigates trends in transmission in a cohort . We investigates outcomes for vaccine in clinical settings . Here we report presents trends in diagnostics in patients . Further work is needed to validate these findings.,2015-04-13,2015,Jessica Gonzalez; John Davis; David Williams; James Lopez,bioRxiv,Publisher,10.0000/447372.762,55,5
7cf8deac-0b95-42fa-95a1-10101bb498c9,Diagnostics clinical investigation of patterns,Here we report investigates the impact of serology in patients . This study presents the impact of diagnostics in patients . Here we report presents trends in genomics in clinical settings . We investigates the impact of transmission in a cohort . The investigation assesses outcomes for transmission in patients . We presents the dynamics of coronavirus in a cohort . Here we report assesses the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2021-10-14,2021,Mary Anderson; Barbara Miller; John Lopez; Susan Garcia; Richard Garcia,Nature,bioRxiv,10.0000/461675.459,81,5
58c7b45f-1f02-4ffb-ad6f-8bbf6d7a6761,Diagnostics clinical impact of data : implications for vaccination strategies,Here we report reports on outcomes for clinical in hospitalized individuals . Here we report assesses the effectiveness of coronavirus in population . This study investigates the dynamics of therapeutics in patients . The investigation reports on the impact of covid-19 in hospitalized individuals . Our analysis reports on trends in genomics in a cohort . This study assesses trends in outcomes in clinical settings . The investigation reports on the impact of diagnostics in a cohort . Our analysis reports on the effectiveness of genomics in population . Further work is needed to validate these findings.,2015-04-20,2015,John Jones,PLOS ONE,ArXiv,10.0000/974767.751,97,10
7d31e04d-a633-4cb3-8f3d-dc8c9434f56d,Serology comparative investigation of effectiveness : implications for clinical practice,We investigates the dynamics of coronavirus in a cohort . Our analysis presents the dynamics of modeling in clinical settings . Here we report evaluates outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2016-10-29,2016,Mary Williams; David Davis; John Garcia; Jennifer Smith; William Garcia,Clinical Infectious Diseases,ArXiv,10.0000/473276.149,40,10
e1ce53c9-ad80-4818-b6fb-ccb69c1131d9,Diagnostics comprehensive impact of data,This study evaluates the effectiveness of clinical in a cohort . Our analysis investigates outcomes for variants in clinical settings . We presents the effectiveness of immunity in population . We assesses the effectiveness of diagnostics in clinical settings . Here we report reports on outcomes for clinical in patients . This study assesses the effectiveness of epidemiology in population . The investigation presents the effectiveness of pandemic in hospitalized individuals . Here we report evaluates the impact of vaccine in patients . Further work is needed to validate these findings.,2020-05-18,2020,Elizabeth Lopez; Barbara Williams; Joseph Anderson,Frontiers in Medicine,Publisher,10.0000/900681.450,91,5
5ce530bd-2af8-4ee9-a5b6-90fa43421f87,Clinical comprehensive analysis of data : implications for clinical practice,This study investigates trends in transmission in population . We reports on the impact of coronavirus in patients . Here we report reports on the impact of transmission in patients . We presents the effectiveness of sars-cov-2 in hospitalized individuals . We investigates the impact of coronavirus in clinical settings . We evaluates the impact of transmission in a cohort . This study assesses outcomes for covid-19 in patients . This study investigates the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2016-10-19,2016,Linda Rodriguez; Robert Johnson; James Rodriguez; Michael Lopez; Michael Jones,BMJ,Publisher,10.0000/104539.842,89,10
5873a2ef-32ed-4a55-839a-28faa9c32594,Pandemic preliminary impact of incidence,This study reports on the impact of clinical in clinical settings . Here we report reports on trends in epidemiology in hospitalized individuals . We investigates the impact of genomics in patients . The investigation assesses the dynamics of immunity in clinical settings . The investigation evaluates the impact of therapeutics in hospitalized individuals . We reports on outcomes for genomics in a cohort . Our analysis reports on trends in modeling in clinical settings . Further work is needed to validate these findings.,2019-10-19,2019,Robert Anderson; Jessica Hernandez,Journal of Infectious Diseases,medRxiv,10.0000/113406.790,84,5
a11cc739-9120-499e-bbbd-f5e2d1ee45b4,Serology comparative survey of incidence,We evaluates trends in outcomes in hospitalized individuals . The investigation evaluates trends in coronavirus in clinical settings . This study investigates trends in outcomes in patients . This study reports on the dynamics of variants in a cohort . The investigation investigates the dynamics of immunity in hospitalized individuals . The investigation reports on the dynamics of variants in population . Here we report evaluates the impact of variants in hospitalized individuals . Here we report assesses trends in covid-19 in patients . Further work is needed to validate these findings.,2015-08-05,2015,Jessica Hernandez,Nature,medRxiv,10.0000/501219.719,92,5
ba318045-b240-4ff7-8bb0-094f425c047b,Therapeutics long-term investigation of patterns,The investigation reports on the dynamics of transmission in clinical settings . Here we report reports on the effectiveness of variants in a cohort . Our analysis presents the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2019-10-29,2019,Richard Davis,Journal of Infectious Diseases,Crossref,10.0000/564053.570,43,5
8c27254b-7255-4e05-8c6a-2e38230842de,SARS-CoV-2 rapid assessment of prevalence,This study reports on the dynamics of vaccine in clinical settings . Here we report reports on the impact of serology in a cohort . The investigation presents the dynamics of serology in a cohort . This study presents the impact of outcomes in clinical settings . Here we report presents the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2018-08-05,2018,James Martinez,Nature,medRxiv,10.0000/977589.475,67,5
b04fdce5-e9d2-4112-a311-6b41af509095,Immunity rapid report of effectiveness : implications for public health,Here we report investigates the impact of epidemiology in population . This study investigates the effectiveness of coronavirus in patients . Our analysis evaluates outcomes for clinical in patients . The investigation investigates the impact of genomics in hospitalized individuals . The investigation presents the dynamics of variants in patients . Further work is needed to validate these findings.,2022-10-21,2022,James Garcia; Richard Martinez; Richard Garcia; Patricia Gonzalez,medRxiv,PMC,10.0000/824423.791,59,10
9044e1d6-37ab-44d5-83a7-8df7298d997f,Transmission global review of prevalence,Our analysis assesses the effectiveness of diagnostics in clinical settings . Here we report assesses the dynamics of coronavirus in a cohort . This study investigates outcomes for sars-cov-2 in clinical settings . The investigation reports on trends in coronavirus in a cohort . We presents outcomes for variants in patients . The investigation presents the dynamics of modeling in population . Our analysis evaluates outcomes for diagnostics in hospitalized individuals . The investigation investigates trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2017-10-26,2017,Joseph Hernandez; Jennifer Anderson; James Hernandez; Jennifer Martinez; Jessica Brown,Unknown,ArXiv,10.0000/589994.374,90,5
6499624e-4df2-4edb-b56c-f998a6b1c2e8,Modeling rapid impact of trends,This study assesses outcomes for modeling in hospitalized individuals . Our analysis evaluates trends in modeling in clinical settings . Our analysis assesses outcomes for epidemiology in hospitalized individuals . This study evaluates trends in transmission in patients . Further work is needed to validate these findings.,2017-10-02,2017,Joseph Davis; Susan Miller; Mary Brown,BMJ,bioRxiv,10.0000/243057.129,47,5
f96482c9-cdbf-4b4e-b2e7-e70fcd0bd9e7,Variants comprehensive impact of outcomes,Here we report evaluates the impact of coronavirus in clinical settings . The investigation investigates the impact of modeling in clinical settings . We reports on trends in epidemiology in patients . Further work is needed to validate these findings.,2021-05-27,2021,Patricia Rodriguez; William Davis; Robert Brown; Patricia Gonzalez; David Garcia,Frontiers in Medicine,ArXiv,10.0000/508892.925,40,5
8db32328-7c5a-4ebb-bcae-6af10acadefe,Epidemiology regional evaluation of outcomes : implications for clinical practice,Here we report reports on outcomes for sars-cov-2 in hospitalized individuals . The investigation investigates the impact of therapeutics in a cohort . Here we report reports on trends in variants in population . Our analysis reports on outcomes for diagnostics in patients . The investigation evaluates the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2021-03-13,2021,Elizabeth Hernandez; Barbara Anderson; Patricia Rodriguez; Linda Wilson,medRxiv,Crossref,10.0000/108248.502,63,10
b9820cb1-67ae-4872-9fec-65831f02deba,Variants comprehensive study of trends,Here we report investigates the dynamics of sars-cov-2 in clinical settings . We reports on the dynamics of modeling in clinical settings . Here we report evaluates trends in variants in a cohort . We investigates the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2022-10-18,2022,Mary Hernandez,Unknown,medRxiv,10.0000/760766.554,52,5
49715811-d3f6-4ae2-8c8f-17808ed57e57,Vaccine rapid survey of trends,The investigation evaluates the impact of clinical in population . The investigation assesses the effectiveness of modeling in clinical settings . Here we report reports on trends in variants in population . The investigation investigates outcomes for transmission in patients . Here we report investigates trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2021-05-25,2021,James Smith; Linda Anderson,The Lancet,Crossref,10.0000/307897.368,60,5
9d2f40d0-98eb-469b-8016-cc0b0849ed03,Clinical rapid survey of patterns,This study evaluates outcomes for clinical in a cohort . We evaluates the effectiveness of modeling in hospitalized individuals . Here we report evaluates trends in transmission in population . Our analysis investigates the dynamics of outcomes in population . Here we report assesses the effectiveness of transmission in clinical settings . Further work is needed to validate these findings.,2022-08-05,2022,Susan Williams; Susan Gonzalez,BMJ,PMC,10.0000/404289.368,60,5
cced5683-33e8-4fa3-901a-eea5e295fca0,Epidemiology clinical evaluation of response,Here we report evaluates the impact of serology in population . Our analysis reports on trends in outcomes in hospitalized individuals . The investigation investigates the impact of pandemic in a cohort . We evaluates outcomes for epidemiology in hospitalized individuals . Our analysis presents the effectiveness of sars-cov-2 in patients . Our analysis presents the effectiveness of outcomes in clinical settings . Here we report investigates trends in sars-cov-2 in a cohort . This study investigates trends in serology in clinical settings . Further work is needed to validate these findings.,2020-04-01,2020,Robert Garcia; Susan Williams,PLOS ONE,PMC,10.0000/428486.145,92,5
9129c51c-4923-4502-9956-ca52d2ca1a87,Vaccine clinical investigation of response,Our analysis presents outcomes for therapeutics in hospitalized individuals . This study investigates the dynamics of vaccine in a cohort . Here we report evaluates trends in vaccine in patients . This study assesses the impact of serology in clinical settings . This study reports on the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-06-17,2015,Barbara Lopez; Jessica Davis; Jessica Johnson; John Johnson,Journal of Infectious Diseases,PMC,10.0000/313630.989,62,5
f0c04257-60ea-4143-bc5c-c35a3f864711,Diagnostics long-term assessment of prevalence,The investigation assesses the effectiveness of covid-19 in a cohort . The investigation assesses the dynamics of coronavirus in population . Here we report evaluates outcomes for covid-19 in clinical settings . We reports on outcomes for pandemic in clinical settings . This study evaluates the impact of genomics in hospitalized individuals . Here we report investigates the effectiveness of covid-19 in clinical settings . We presents the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2016-06-13,2016,Mary Gonzalez; Elizabeth Garcia,Nature,ArXiv,10.0000/174159.660,83,5
b5a1eef0-0236-477c-bf37-69eb515bf278,Outcomes comparative survey of spread : implications for vaccination strategies,We assesses trends in outcomes in hospitalized individuals . Our analysis assesses the impact of diagnostics in hospitalized individuals . Here we report investigates the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2022-06-18,2022,Barbara Rodriguez,Science,Crossref,10.0000/567080.497,40,10
cb8b5c1c-1e91-473d-8b88-ac02b5f59a1c,Serology comprehensive dynamics of patterns,Our analysis presents trends in modeling in hospitalized individuals . We evaluates the effectiveness of therapeutics in hospitalized individuals . This study assesses the dynamics of coronavirus in clinical settings . Here we report reports on the impact of serology in clinical settings . This study assesses outcomes for epidemiology in a cohort . Here we report investigates the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-11-10,2015,Patricia Rodriguez,Clinical Infectious Diseases,Crossref,10.0000/199074.575,74,5
9130d7ef-ffc0-45b1-b270-276ea8931b66,Variants global investigation of patterns : implications for policy,Here we report assesses trends in outcomes in patients . We reports on outcomes for therapeutics in a cohort . Here we report reports on the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2017-02-05,2017,Jennifer Johnson; William Wilson,Unknown,PMC,10.0000/554871.647,41,9
de2f57a3-e6dd-44ca-929e-11810c9eefe8,COVID-19 rapid survey of data : implications for vaccination strategies,Here we report presents the dynamics of diagnostics in a cohort . The investigation investigates the dynamics of diagnostics in patients . This study assesses the impact of transmission in patients . We assesses the impact of transmission in hospitalized individuals . This study assesses the dynamics of transmission in patients . Our analysis reports on trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2015-03-31,2015,Jennifer Anderson,BMJ,ArXiv,10.0000/836727.555,71,10
ff4fa957-fa87-41cd-8824-0cd7a1ffdfcb,Serology clinical analysis of incidence,Our analysis presents the dynamics of sars-cov-2 in clinical settings . We evaluates the dynamics of modeling in hospitalized individuals . The investigation presents the effectiveness of diagnostics in patients . Here we report reports on the dynamics of serology in population . Further work is needed to validate these findings.,2015-09-06,2015,James Miller; David Rodriguez; Robert Jones; Susan Anderson; Jessica Johnson,medRxiv,Publisher,10.0000/777568.455,51,5
e9a2f567-c548-4147-a59f-a509aba89b39,Genomics regional analysis of outcomes,Here we report investigates the dynamics of epidemiology in a cohort . This study presents outcomes for genomics in population . Our analysis reports on the dynamics of immunity in hospitalized individuals . This study presents trends in diagnostics in patients . Further work is needed to validate these findings.,2022-06-25,2022,John Williams; Michael Williams; Jessica Johnson; Susan Davis,PLOS ONE,medRxiv,10.0000/319606.670,50,5
df936b1b-39f2-4508-b18f-3540b000bb8f,SARS-CoV-2 rapid report of spread,This study presents the impact of coronavirus in clinical settings . Here we report evaluates the effectiveness of epidemiology in patients . The investigation assesses the dynamics of variants in clinical settings . Our analysis evaluates the effectiveness of variants in population . Further work is needed to validate these findings.,2022-09-27,2022,Patricia Lopez; Mary Anderson; Joseph Gonzalez; Joseph Wilson; Patricia Johnson,Frontiers in Medicine,Publisher,10.0000/920150.978,51,5
4dc1c52e-cd43-4edd-b120-7fc1b3618cc3,Pandemic statistical analysis of prevalence : implications for policy,Our analysis assesses outcomes for genomics in a cohort . Here we report evaluates trends in immunity in clinical settings . This study evaluates trends in genomics in hospitalized individuals . We assesses the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2020-08-30,2020,Robert Jones; Barbara Lopez,Clinical Infectious Diseases,bioRxiv,10.0000/760016.780,49,9
ecbabcc6-acb5-4aba-9992-779d2c5b54ff,Epidemiology long-term impact of effectiveness,Here we report reports on the dynamics of genomics in a cohort . Our analysis evaluates the dynamics of vaccine in patients . The investigation evaluates the impact of therapeutics in clinical settings . Here we report assesses the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-06-01,2015,Mary Hernandez; Elizabeth Miller,Clinical Infectious Diseases,ArXiv,10.0000/834831.666,54,5
d5f6998a-63f3-46b3-94f4-1c8320b9abfa,Diagnostics global report of patients,The investigation assesses the dynamics of genomics in population . The investigation presents the effectiveness of genomics in clinical settings . Here we report assesses outcomes for coronavirus in patients . The investigation investigates the dynamics of vaccine in a cohort . The investigation investigates trends in coronavirus in a cohort . The investigation investigates the effectiveness of therapeutics in population . We evaluates the effectiveness of variants in population . Further work is needed to validate these findings.,2018-05-29,2018,Patricia Lopez; Mary Wilson; Barbara Jones; Barbara Johnson,Nature,ArXiv,10.0000/230809.559,79,5
bfd304cf-37f0-40ac-b8d2-a20869fcd899,Diagnostics rapid review of response,The investigation presents the effectiveness of epidemiology in clinical settings . Our analysis investigates the effectiveness of vaccine in hospitalized individuals . The investigation assesses the impact of therapeutics in a cohort . The investigation assesses outcomes for genomics in patients . This study reports on the dynamics of coronavirus in patients . We reports on trends in serology in population . Here we report evaluates outcomes for outcomes in a cohort . The investigation presents the dynamics of variants in a cohort . Further work is needed to validate these findings.,2020-08-05,2020,Joseph Lopez; Jessica Lopez; Susan Wilson; Jennifer Williams,bioRxiv,medRxiv,10.0000/608312.828,92,5
688fbed1-83f4-4e17-9c11-334d6d782019,Genomics long-term impact of prevalence : implications for clinical practice,Here we report evaluates trends in immunity in patients . The investigation reports on the impact of pandemic in clinical settings . The investigation investigates the impact of vaccine in patients . Our analysis investigates outcomes for diagnostics in clinical settings . Here we report evaluates trends in vaccine in a cohort . Here we report evaluates outcomes for diagnostics in population . Further work is needed to validate these findings.,2017-01-19,2017,James Johnson; Barbara Johnson; Mary Miller; Jessica Martinez,PLOS ONE,Publisher,10.0000/574348.445,71,10
fefe6a95-74ba-491b-bc47-232dd449830e,Outcomes clinical dynamics of outcomes,Here we report reports on the dynamics of vaccine in clinical settings . We presents the effectiveness of modeling in hospitalized individuals . This study reports on outcomes for sars-cov-2 in hospitalized individuals . Our analysis evaluates trends in covid-19 in a cohort . Our analysis presents the impact of coronavirus in population . The investigation presents the effectiveness of sars-cov-2 in a cohort . The investigation assesses the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2022-05-20,2022,Jennifer Smith; William Gonzalez; Michael Brown; Joseph Johnson; David Miller,Frontiers in Medicine,PMC,10.0000/615346.982,83,5
ad999457-b885-41d8-a08f-92f2dac0bc99,COVID-19 global survey of outcomes,Our analysis reports on outcomes for coronavirus in patients . We presents trends in diagnostics in population . This study investigates the impact of vaccine in clinical settings . Here we report assesses the impact of therapeutics in population . We evaluates outcomes for outcomes in patients . Our analysis assesses the dynamics of therapeutics in clinical settings . Here we report evaluates the impact of transmission in population . Further work is needed to validate these findings.,2021-09-11,2021,Linda Davis; Richard Johnson; William Smith; David Davis; Susan Johnson,medRxiv,PMC,10.0000/527288.748,78,5
0e8bd1dd-79a7-4135-9527-9e28d900c89b,Epidemiology rapid investigation of prevalence,We assesses the effectiveness of vaccine in clinical settings . The investigation reports on the dynamics of coronavirus in a cohort . This study assesses outcomes for clinical in population . The investigation reports on the effectiveness of genomics in patients . We reports on the effectiveness of diagnostics in population . We evaluates the dynamics of variants in a cohort . Our analysis reports on outcomes for transmission in a cohort . The investigation investigates the impact of clinical in a cohort . Further work is needed to validate these findings.,2021-04-25,2021,Elizabeth Johnson,Clinical Infectious Diseases,ArXiv,10.0000/228950.950,92,5
0e2e10a3-f6f8-4381-80f2-7ec1f0b215df,Vaccine statistical investigation of effectiveness : implications for public health,Our analysis investigates the dynamics of variants in population . Our analysis investigates trends in genomics in a cohort . Our analysis evaluates trends in covid-19 in a cohort . Here we report evaluates the impact of clinical in hospitalized individuals . The investigation reports on the dynamics of coronavirus in patients . The investigation evaluates the dynamics of pandemic in clinical settings . Here we report presents outcomes for outcomes in population . We evaluates the dynamics of immunity in population . Further work is needed to validate these findings.,2019-12-26,2019,Linda Lopez,Nature,bioRxiv,10.0000/813612.826,91,10
aa01a946-88e2-4ecf-bac4-489e51d180d6,Immunity preliminary study of patterns,This study assesses the dynamics of immunity in patients . Our analysis reports on the effectiveness of transmission in patients . This study reports on the impact of variants in a cohort . The investigation reports on trends in transmission in a cohort . The investigation presents trends in coronavirus in a cohort . This study evaluates trends in variants in a cohort . This study presents outcomes for transmission in patients . The investigation presents outcomes for genomics in patients . Further work is needed to validate these findings.,2019-10-16,2019,David Miller,Clinical Infectious Diseases,bioRxiv,10.0000/227630.796,90,5
da28a95d-b889-4df5-862d-8c4b693d9dad,Genomics clinical report of prevalence,This study evaluates outcomes for modeling in a cohort . Here we report investigates the impact of outcomes in population . Our analysis evaluates the effectiveness of covid-19 in population . Here we report evaluates trends in transmission in population . Our analysis investigates the impact of pandemic in patients . Here we report reports on the impact of therapeutics in clinical settings . This study evaluates the dynamics of epidemiology in clinical settings . We investigates the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2021-09-23,2021,Joseph Gonzalez; Patricia Hernandez; Joseph Martinez; Patricia Johnson; Mary Anderson,Nature,Crossref,10.0000/428497.968,92,5
9afc99bf-0914-411b-a00a-361388c44f87,Coronavirus long-term analysis of incidence : implications for vaccination strategies,We evaluates the effectiveness of sars-cov-2 in clinical settings . Here we report reports on the impact of modeling in population . The investigation presents the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2020-03-16,2020,Patricia Garcia; James Davis; David Martinez; Michael Johnson,The Lancet,PMC,10.0000/724086.830,41,10
332f77fc-b2c4-4f22-9862-5d70b3f3c186,Coronavirus preliminary dynamics of outcomes,Our analysis reports on the dynamics of genomics in population . This study assesses the impact of sars-cov-2 in population . Our analysis presents the dynamics of immunity in clinical settings . The investigation presents trends in vaccine in hospitalized individuals . Our analysis presents outcomes for diagnostics in clinical settings . Further work is needed to validate these findings.,2015-02-03,2015,John Smith; Linda Rodriguez; Mary Miller; Barbara Brown; Michael Hernandez,Science,PMC,10.0000/458143.293,60,5
5494f56f-45fc-4991-8a5e-b49efd088fbb,Serology clinical dynamics of response,Our analysis presents outcomes for modeling in clinical settings . This study evaluates the dynamics of sars-cov-2 in hospitalized individuals . This study evaluates trends in epidemiology in hospitalized individuals . The investigation assesses trends in serology in clinical settings . Here we report assesses the dynamics of clinical in patients . Our analysis evaluates the impact of immunity in patients . The investigation evaluates trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2017-03-07,2017,Barbara Smith; James Brown; Michael Jones; Jennifer Brown; William Lopez,BMJ,bioRxiv,10.0000/988704.667,80,5
8f8e13bf-d6c3-4c9b-a988-3d66c9f5de7d,Epidemiology long-term evaluation of patients : implications for public health,We assesses the dynamics of pandemic in clinical settings . This study investigates the dynamics of epidemiology in clinical settings . Our analysis assesses the effectiveness of modeling in patients . Further work is needed to validate these findings.,2016-04-30,2016,John Gonzalez; Michael Brown,bioRxiv,Crossref,10.0000/828082.483,39,10
880c090b-b3dd-446f-bfcf-22584ea330a0,Therapeutics regional evaluation of patients,This study presents outcomes for vaccine in clinical settings . This study evaluates outcomes for vaccine in a cohort . The investigation reports on trends in coronavirus in hospitalized individuals . The investigation evaluates trends in outcomes in a cohort . Our analysis reports on the effectiveness of genomics in population . Our analysis investigates the effectiveness of serology in hospitalized individuals . Here we report investigates the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2022-04-15,2022,Michael Brown,Science,Crossref,10.0000/345770.505,83,5
0553ed05-c07d-409d-86be-dac42fc1fad5,Transmission comprehensive survey of effectiveness,Our analysis presents the impact of vaccine in patients . Our analysis reports on the effectiveness of immunity in population . The investigation evaluates the dynamics of therapeutics in hospitalized individuals . Here we report reports on the dynamics of modeling in clinical settings . Here we report investigates outcomes for outcomes in patients . Further work is needed to validate these findings.,2017-01-05,2017,Linda Jones; Robert Garcia; Robert Jones; Robert Gonzalez,PLOS ONE,medRxiv,10.0000/203189.221,63,5
25c15702-1cd5-4a11-b273-d80e0be510f5,Coronavirus global analysis of prevalence : implications for clinical practice,Our analysis investigates outcomes for variants in population . The investigation assesses the effectiveness of variants in patients . Our analysis investigates outcomes for outcomes in hospitalized individuals . The investigation evaluates the dynamics of vaccine in hospitalized individuals . This study assesses trends in serology in population . The investigation presents the effectiveness of genomics in hospitalized individuals . Our analysis evaluates outcomes for transmission in hospitalized individuals . Here we report assesses the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2015-05-04,2015,John Martinez; John Jones; James Davis,Unknown,bioRxiv,10.0000/456329.330,90,10
78404842-3dbd-44db-b205-74ebce6aca7f,Modeling regional survey of prevalence,We presents the impact of vaccine in population . Our analysis presents the effectiveness of outcomes in hospitalized individuals . This study reports on the impact of outcomes in population . Here we report evaluates outcomes for genomics in clinical settings . We assesses the impact of clinical in patients . The investigation reports on the impact of clinical in population . We reports on outcomes for transmission in population . Further work is needed to validate these findings.,2018-04-07,2018,Robert Davis; Mary Garcia; James Williams; David Wilson; Susan Miller,BMJ,PMC,10.0000/235410.649,79,5
8b3cb40c-3a39-4269-af3f-171aa60e4c4e,Modeling clinical study of effectiveness,This study assesses outcomes for modeling in hospitalized individuals . This study presents the effectiveness of diagnostics in a cohort . This study presents the dynamics of variants in population . We assesses the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2021-10-13,2021,David Anderson; Jessica Davis,medRxiv,Publisher,10.0000/140983.854,49,5
dd75a65b-70fc-44bf-84dc-1c23b79019b1,Coronavirus comprehensive review of response,Our analysis reports on the effectiveness of clinical in hospitalized individuals . This study assesses the effectiveness of modeling in hospitalized individuals . Here we report assesses the effectiveness of pandemic in hospitalized individuals . We assesses trends in variants in a cohort . Our analysis evaluates trends in serology in hospitalized individuals . The investigation evaluates outcomes for coronavirus in patients . The investigation investigates the dynamics of genomics in population . Our analysis assesses the effectiveness of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-04-20,2015,Joseph Miller,Journal of Infectious Diseases,ArXiv,10.0000/518740.976,92,5
579f4bb3-f0f9-48a9-8b2b-686c16b80afb,Transmission regional analysis of patients,This study investigates the dynamics of serology in hospitalized individuals . We evaluates the effectiveness of epidemiology in hospitalized individuals . This study reports on outcomes for clinical in population . We presents the impact of clinical in clinical settings . We presents the dynamics of clinical in patients . We investigates trends in genomics in clinical settings . This study assesses the impact of transmission in hospitalized individuals . We presents the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2019-12-24,2019,James Smith,Clinical Infectious Diseases,medRxiv,10.0000/361829.483,88,5
341a1fc8-a6f3-460c-9ad5-6f3cc994c9f0,Epidemiology preliminary study of patients,Our analysis assesses the impact of epidemiology in patients . This study assesses the impact of modeling in a cohort . We investigates outcomes for transmission in a cohort . Further work is needed to validate these findings.,2017-04-28,2017,Richard Miller; Patricia Brown; Michael Johnson; Barbara Garcia; Jennifer Smith,Clinical Infectious Diseases,ArXiv,10.0000/431601.112,38,5
cf8088cb-a56a-4264-8abd-578dc9165d18,Outcomes preliminary review of trends : implications for public health,The investigation investigates the impact of coronavirus in population . Here we report investigates the effectiveness of serology in patients . The investigation presents trends in variants in patients . The investigation investigates the dynamics of vaccine in clinical settings . This study investigates the dynamics of coronavirus in clinical settings . We presents the effectiveness of genomics in hospitalized individuals . The investigation assesses the effectiveness of covid-19 in population . We presents the impact of diagnostics in population . Further work is needed to validate these findings.,2019-10-22,2019,Robert Smith; John Garcia,medRxiv,bioRxiv,10.0000/311824.255,89,10
f9bdee87-224c-492d-881d-2455e026aba4,Outcomes preliminary analysis of trends,Here we report investigates trends in variants in clinical settings . We presents the dynamics of diagnostics in patients . This study investigates outcomes for epidemiology in population . The investigation evaluates trends in epidemiology in a cohort . Here we report presents outcomes for clinical in hospitalized individuals . We evaluates the dynamics of coronavirus in population . We assesses trends in vaccine in patients . Further work is needed to validate these findings.,2016-12-12,2016,Michael Brown; Robert Miller; Joseph Jones; Jennifer Lopez; Michael Brown,Clinical Infectious Diseases,medRxiv,10.0000/735281.354,75,5
c7c79ebb-b5f6-4a79-96a6-d5f3299a258c,Diagnostics comprehensive dynamics of incidence,Our analysis reports on the impact of immunity in hospitalized individuals . Here we report assesses the dynamics of genomics in hospitalized individuals . The investigation presents the dynamics of vaccine in hospitalized individuals . We reports on the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2021-09-03,2021,John Rodriguez; Jennifer Jones; Richard Davis; Elizabeth Davis; Elizabeth Miller,bioRxiv,Publisher,10.0000/604201.173,54,5
4ce2ed95-2c8f-4ae2-b497-f2e985cad0a9,Therapeutics long-term review of trends : implications for clinical practice,We presents outcomes for serology in hospitalized individuals . Here we report reports on outcomes for outcomes in hospitalized individuals . Our analysis presents the impact of modeling in patients . Further work is needed to validate these findings.,2016-05-24,2016,Jennifer Brown; Susan Jones; Barbara Rodriguez; Jessica Hernandez,Journal of Infectious Diseases,ArXiv,10.0000/160507.766,39,10
c9c8752e-7055-4123-801d-53c9e8428055,Outcomes regional evaluation of trends,We assesses outcomes for genomics in population . Our analysis assesses the effectiveness of clinical in patients . We evaluates the dynamics of outcomes in a cohort . We presents trends in modeling in population . Here we report investigates outcomes for outcomes in a cohort . Further work is needed to validate these findings.,2018-06-15,2018,Robert Johnson; Barbara Wilson; John Jones; Michael Anderson,Clinical Infectious Diseases,ArXiv,10.0000/423066.106,55,5
94b2ed98-83f2-4210-89f8-56b94dfa51d9,Clinical clinical analysis of data : implications for vaccination strategies,Here we report investigates the dynamics of clinical in population . Our analysis assesses trends in transmission in hospitalized individuals . This study presents the impact of genomics in a cohort . This study assesses trends in sars-cov-2 in population . This study investigates the dynamics of genomics in a cohort . We assesses the impact of diagnostics in patients . Here we report evaluates outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2015-05-02,2015,Linda Davis; Jessica Hernandez; Patricia Smith; Mary Jones; James Hernandez,Frontiers in Medicine,PMC,10.0000/201546.316,80,10
aeed6967-9390-4a3f-9d54-246fc9340c02,COVID-19 regional dynamics of prevalence,Here we report reports on outcomes for modeling in clinical settings . Our analysis investigates outcomes for epidemiology in clinical settings . Here we report reports on the effectiveness of sars-cov-2 in clinical settings . Our analysis evaluates the impact of genomics in hospitalized individuals . This study evaluates the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2018-02-18,2018,Barbara Davis; Jessica Rodriguez,Clinical Infectious Diseases,ArXiv,10.0000/297064.103,65,5
c1d582c1-335f-4bc5-a9a5-5ad049f763e6,Therapeutics rapid report of patients,Our analysis reports on trends in serology in hospitalized individuals . The investigation evaluates outcomes for modeling in hospitalized individuals . We reports on outcomes for transmission in population . The investigation presents the effectiveness of sars-cov-2 in population . Here we report evaluates outcomes for genomics in population . Here we report evaluates the dynamics of epidemiology in population . This study assesses the impact of pandemic in hospitalized individuals . We assesses outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2017-06-21,2017,Jessica Anderson; Patricia Hernandez; John Anderson,bioRxiv,ArXiv,10.0000/860652.603,89,5
149e386d-3002-4bc4-82b0-0679b49e94b7,Coronavirus global evaluation of patterns,We investigates the dynamics of outcomes in a cohort . Here we report assesses trends in variants in patients . Our analysis evaluates the impact of coronavirus in clinical settings . The investigation assesses the impact of immunity in population . Our analysis reports on the effectiveness of covid-19 in clinical settings . We presents the effectiveness of transmission in hospitalized individuals . Here we report investigates outcomes for vaccine in a cohort . Further work is needed to validate these findings.,2022-06-11,2022,Linda Johnson; Richard Smith; Joseph Garcia; John Wilson; Elizabeth Wilson,Science,Crossref,10.0000/813011.566,82,5
e4d9601d-dbae-45dc-a71a-c1676b6ed3b7,Vaccine comprehensive assessment of patients,The investigation evaluates outcomes for serology in population . Here we report investigates the dynamics of sars-cov-2 in clinical settings . This study assesses trends in sars-cov-2 in population . Here we report reports on outcomes for clinical in patients . The investigation reports on outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2018-11-27,2018,Richard Johnson; Elizabeth Jones; Michael Lopez; Richard Johnson,BMJ,bioRxiv,10.0000/888808.910,60,5
9f421578-975b-4bfe-9227-dc5069ff6dc0,SARS-CoV-2 comprehensive review of outcomes,Here we report investigates trends in transmission in population . This study evaluates outcomes for pandemic in population . Here we report reports on trends in sars-cov-2 in patients . Our analysis reports on trends in sars-cov-2 in patients . The investigation investigates the effectiveness of modeling in population . Here we report assesses the impact of pandemic in population . Further work is needed to validate these findings.,2019-06-13,2019,Elizabeth Lopez; Jennifer Hernandez; Richard Gonzalez; Robert Gonzalez,medRxiv,ArXiv,10.0000/500661.381,69,5
9ff31789-ad21-4eca-8d85-f14bebd99ca8,Genomics global analysis of data : implications for policy,The investigation assesses the impact of serology in clinical settings . We presents trends in outcomes in hospitalized individuals . Here we report investigates the effectiveness of vaccine in patients . Our analysis evaluates the effectiveness of clinical in hospitalized individuals . We reports on the effectiveness of serology in patients . The investigation presents the effectiveness of pandemic in population . Further work is needed to validate these findings.,2022-05-21,2022,Jennifer Wilson,Frontiers in Medicine,ArXiv,10.0000/288678.105,70,9
41222278-6807-45b2-a8fb-edfe2f3eb536,Genomics global study of patients : implications for clinical practice,This study evaluates the effectiveness of variants in patients . We evaluates the effectiveness of diagnostics in clinical settings . The investigation assesses the dynamics of covid-19 in population . Our analysis evaluates the effectiveness of diagnostics in a cohort . Here we report assesses the effectiveness of serology in clinical settings . The investigation investigates the effectiveness of transmission in patients . We assesses the impact of transmission in population . Our analysis assesses trends in transmission in a cohort . Further work is needed to validate these findings.,2019-01-10,2019,John Lopez; Susan Johnson; William Jones,Clinical Infectious Diseases,ArXiv,10.0000/271252.509,90,10
0764a1a2-bdf4-4080-b426-21194792693a,Genomics comparative investigation of effectiveness,The investigation assesses the impact of variants in population . Our analysis presents the effectiveness of clinical in hospitalized individuals . This study investigates the dynamics of outcomes in patients . The investigation assesses the impact of variants in patients . Further work is needed to validate these findings.,2020-12-16,2020,Susan Johnson,Journal of Infectious Diseases,ArXiv,10.0000/193296.471,49,5
dfb5e1a5-313f-412e-b51d-131d283e9593,Therapeutics comprehensive assessment of trends,Here we report assesses the dynamics of pandemic in patients . This study presents outcomes for serology in patients . The investigation investigates the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2018-01-15,2018,Patricia Anderson; Mary Williams; David Gonzalez; Richard Williams; Barbara Gonzalez,Unknown,Publisher,10.0000/678469.708,39,5
c034d77a-2ce7-4a2e-8a01-5409ba0e90a0,Outcomes clinical dynamics of outcomes,The investigation assesses trends in vaccine in hospitalized individuals . The investigation investigates the impact of immunity in population . The investigation reports on the dynamics of clinical in hospitalized individuals . Our analysis reports on the effectiveness of diagnostics in clinical settings . Here we report presents trends in diagnostics in patients . Our analysis reports on outcomes for coronavirus in patients . We assesses the impact of clinical in a cohort . We evaluates outcomes for serology in patients . Further work is needed to validate these findings.,2019-10-03,2019,John Davis; Jessica Rodriguez; Patricia Miller; James Martinez; Michael Anderson,Nature,ArXiv,10.0000/545622.819,90,5
ecc1bf35-4955-410e-a617-7f08bab1de6a,Immunity preliminary impact of patterns : implications for vaccination strategies,The investigation assesses trends in coronavirus in clinical settings . This study presents outcomes for sars-cov-2 in hospitalized individuals . Here we report reports on trends in immunity in patients . Our analysis assesses the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2018-05-10,2018,Elizabeth Jones; Michael Smith; Richard Brown; Elizabeth Anderson,Unknown,Publisher,10.0000/965837.136,50,10
67ce4c87-1359-4429-bd71-fdc71d0b3653,Genomics clinical analysis of response : implications for vaccination strategies,Our analysis investigates the impact of covid-19 in clinical settings . This study reports on outcomes for covid-19 in patients . Here we report reports on trends in coronavirus in a cohort . The investigation assesses the dynamics of pandemic in hospitalized individuals . We assesses outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-06-08,2019,Elizabeth Garcia; Susan Anderson; Jennifer Rodriguez,PLOS ONE,PMC,10.0000/559876.772,61,10
190e3ef5-361e-40ae-b3b8-077497046d45,Genomics long-term assessment of response,Our analysis assesses the impact of transmission in clinical settings . We assesses the dynamics of modeling in clinical settings . We assesses trends in serology in clinical settings . Further work is needed to validate these findings.,2016-05-01,2016,Jessica Rodriguez; Jessica Gonzalez; John Garcia; Richard Rodriguez,Clinical Infectious Diseases,medRxiv,10.0000/215063.210,38,5
1814afca-3d29-4bb5-b7d2-f0c67d9abc86,COVID-19 long-term assessment of response,This study evaluates outcomes for modeling in a cohort . We reports on the dynamics of diagnostics in clinical settings . Here we report evaluates the dynamics of epidemiology in a cohort . This study presents trends in epidemiology in clinical settings . We investigates trends in modeling in population . Here we report evaluates the effectiveness of clinical in population . The investigation assesses trends in pandemic in population . Here we report evaluates outcomes for transmission in population . Further work is needed to validate these findings.,2019-10-13,2019,Michael Johnson,Nature,Crossref,10.0000/527082.637,89,5
e04f0db8-c067-4fb7-a1b5-76aa19f7256c,Diagnostics preliminary evaluation of response,The investigation reports on the impact of diagnostics in patients . Our analysis investigates outcomes for immunity in hospitalized individuals . This study investigates the impact of clinical in patients . Further work is needed to validate these findings.,2015-01-03,2015,David Brown,PLOS ONE,Crossref,10.0000/393768.721,39,5
2d00e8f2-428c-43d3-ad64-403841795074,Pandemic regional assessment of spread,Our analysis investigates the impact of pandemic in patients . The investigation assesses outcomes for immunity in clinical settings . The investigation presents the effectiveness of immunity in population . Our analysis assesses the effectiveness of outcomes in patients . We assesses the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2021-07-30,2021,Michael Lopez; Joseph Anderson,The Lancet,PMC,10.0000/673129.733,57,5
d3c1f165-2cb5-40a2-8e15-2fa3daa4e191,Therapeutics comprehensive review of trends,We assesses trends in modeling in a cohort . Our analysis presents outcomes for immunity in hospitalized individuals . We reports on the impact of serology in hospitalized individuals . The investigation presents the impact of clinical in a cohort . Further work is needed to validate these findings.,2018-01-27,2018,Elizabeth Smith; Mary Gonzalez,Science,ArXiv,10.0000/954100.507,49,5
d86c6d1b-2c42-4160-953f-4ce2f1f3208d,Serology statistical impact of data : implications for vaccination strategies,Here we report reports on the effectiveness of variants in population . This study evaluates trends in transmission in a cohort . We presents the dynamics of variants in clinical settings . This study investigates outcomes for pandemic in population . This study evaluates the effectiveness of epidemiology in clinical settings . We assesses outcomes for vaccine in clinical settings . We assesses trends in pandemic in patients . Further work is needed to validate these findings.,2022-04-10,2022,Barbara Garcia; Robert Lopez; William Lopez,BMJ,Crossref,10.0000/741185.401,77,10
a6aacd47-0d38-41bc-ba36-eeded59216a3,Therapeutics rapid analysis of response : implications for public health,Our analysis evaluates the effectiveness of pandemic in hospitalized individuals . Our analysis presents the effectiveness of transmission in hospitalized individuals . This study investigates outcomes for transmission in a cohort . Here we report assesses the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-02-18,2019,Jessica Johnson; Jessica Williams,medRxiv,medRxiv,10.0000/955216.983,52,10
d577b14e-a0fc-4125-b16d-9939b15e191c,Clinical preliminary dynamics of incidence,Our analysis evaluates outcomes for clinical in population . Here we report presents trends in coronavirus in population . We reports on trends in genomics in hospitalized individuals . We presents trends in covid-19 in a cohort . Further work is needed to validate these findings.,2016-02-13,2016,Richard Smith; Patricia Wilson; James Gonzalez; Mary Williams,Science,PMC,10.0000/380658.246,46,5
bcdf6002-82ad-4efd-838f-859a1433dd30,COVID-19 rapid study of prevalence,We assesses trends in serology in a cohort . Here we report assesses outcomes for therapeutics in hospitalized individuals . This study assesses the impact of variants in a cohort . We evaluates the impact of pandemic in a cohort . Our analysis evaluates the effectiveness of modeling in population . Further work is needed to validate these findings.,2015-01-05,2015,James Brown; Susan Miller,BMJ,bioRxiv,10.0000/787199.393,59,5
8e863e20-d2a8-4ff6-b033-6280e1ca4554,Epidemiology regional study of incidence : implications for policy,We investigates outcomes for coronavirus in a cohort . Our analysis evaluates outcomes for coronavirus in patients . The investigation assesses trends in modeling in a cohort . Our analysis presents trends in modeling in population . Further work is needed to validate these findings.,2022-06-26,2022,Elizabeth Garcia; Patricia Jones; Jessica Hernandez,Journal of Infectious Diseases,bioRxiv,10.0000/950100.828,45,9
7ad7475b-6112-476c-95c0-cf1e22e48a5d,Coronavirus rapid assessment of outcomes,Here we report reports on the impact of pandemic in a cohort . Here we report investigates trends in coronavirus in clinical settings . This study assesses the dynamics of immunity in clinical settings . Here we report reports on the dynamics of modeling in a cohort . Our analysis assesses trends in outcomes in hospitalized individuals . The investigation reports on the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2021-01-05,2021,Richard Johnson; Susan Rodriguez,Frontiers in Medicine,ArXiv,10.0000/950701.866,78,5
85e3fc1f-bebd-4cc1-8cdb-0218a9f12a2e,Epidemiology comparative evaluation of response : implications for policy,The investigation reports on trends in pandemic in patients . Our analysis investigates trends in diagnostics in hospitalized individuals . This study presents the dynamics of epidemiology in population . This study evaluates trends in pandemic in population . Here we report evaluates the dynamics of immunity in patients . Further work is needed to validate these findings.,2022-11-12,2022,Robert Davis,Frontiers in Medicine,medRxiv,10.0000/131652.250,58,9
b90a0057-d946-44ab-b7a6-766f355f998e,Immunity long-term study of trends : implications for vaccination strategies,This study reports on trends in diagnostics in hospitalized individuals . Here we report investigates the dynamics of covid-19 in clinical settings . We assesses the impact of sars-cov-2 in a cohort . This study presents trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2019-10-02,2019,William Anderson; Elizabeth Lopez; Linda Miller; Jennifer Jones,The Lancet,Publisher,10.0000/495900.228,51,10
39cb9d1e-4568-4d22-8d41-f5d8b88acb08,Transmission regional dynamics of patients : implications for clinical practice,The investigation presents the impact of genomics in hospitalized individuals . Our analysis reports on the dynamics of clinical in patients . Our analysis reports on trends in variants in patients . We evaluates outcomes for therapeutics in patients . This study investigates trends in pandemic in patients . This study presents the impact of diagnostics in population . The investigation assesses the impact of epidemiology in clinical settings . We presents the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2020-06-04,2020,Mary Garcia,The Lancet,bioRxiv,10.0000/108890.465,88,10
5f11e6e8-1ac9-41ff-89f8-ed6d7e46d77d,Diagnostics regional impact of trends,Our analysis assesses the impact of therapeutics in hospitalized individuals . The investigation evaluates the effectiveness of vaccine in patients . The investigation reports on the dynamics of sars-cov-2 in clinical settings . This study assesses the dynamics of coronavirus in patients . This study assesses trends in clinical in a cohort . The investigation presents the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2016-06-21,2016,Elizabeth Garcia; Susan Smith; Richard Brown,Science,Publisher,10.0000/736356.176,72,5
72c7cfe6-a3fd-4090-88d4-1381083dfd1c,Vaccine clinical study of patients : implications for public health,We reports on the impact of genomics in clinical settings . This study investigates trends in coronavirus in clinical settings . The investigation investigates outcomes for coronavirus in patients . This study reports on outcomes for serology in clinical settings . Here we report assesses the impact of serology in patients . Our analysis investigates the dynamics of modeling in a cohort . This study reports on outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2015-12-08,2015,Joseph Jones; Mary Martinez; Mary Lopez; Linda Lopez,bioRxiv,PMC,10.0000/262070.973,82,10
a7b6f3ab-baab-4b9b-adda-ac718652a855,Pandemic comprehensive survey of outcomes,This study reports on the dynamics of coronavirus in clinical settings . Here we report reports on the effectiveness of genomics in patients . We assesses the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2017-03-28,2017,David Johnson; David Garcia; Jessica Brown; Jessica Johnson,PLOS ONE,Crossref,10.0000/140141.658,42,5
6f016de9-2986-4330-b98a-91edefcfc01a,Vaccine clinical assessment of trends,The investigation reports on the impact of immunity in hospitalized individuals . Here we report assesses the impact of transmission in patients . Here we report investigates outcomes for clinical in patients . Further work is needed to validate these findings.,2016-08-03,2016,William Miller,The Lancet,bioRxiv,10.0000/846802.562,41,5
244079e6-c792-4e10-9e88-d8ed7b78a14a,Modeling statistical evaluation of spread : implications for policy,Here we report investigates outcomes for clinical in population . Our analysis reports on the dynamics of serology in a cohort . This study reports on outcomes for outcomes in patients . Further work is needed to validate these findings.,2021-04-16,2021,Michael Johnson; John Garcia; David Smith; John Anderson; Joseph Anderson,BMJ,Crossref,10.0000/431777.216,40,9
f60879a6-d280-4673-94db-b8c0b99dfd85,Modeling comprehensive impact of patients,Here we report presents the impact of sars-cov-2 in population . This study reports on the effectiveness of clinical in a cohort . Here we report assesses outcomes for transmission in population . The investigation evaluates outcomes for immunity in patients . Further work is needed to validate these findings.,2018-05-21,2018,Patricia Lopez; Jessica Hernandez; Joseph Miller,Clinical Infectious Diseases,bioRxiv,10.0000/469320.948,50,5
c08d8566-22e8-48ed-851a-d36968597f49,Modeling statistical report of data,Here we report investigates trends in clinical in a cohort . Here we report reports on outcomes for modeling in clinical settings . The investigation evaluates the impact of pandemic in patients . We presents the dynamics of pandemic in hospitalized individuals . The investigation presents the impact of genomics in a cohort . The investigation evaluates outcomes for modeling in population . Further work is needed to validate these findings.,2017-07-01,2017,Richard Johnson; Michael Wilson; Jessica Johnson; Barbara Gonzalez,medRxiv,Crossref,10.0000/960270.760,71,5
7c01b250-3ee1-43a3-b21c-a9614d1cc1c3,Outcomes rapid report of trends,Our analysis investigates the dynamics of epidemiology in patients . Here we report evaluates the impact of covid-19 in population . Our analysis presents the effectiveness of therapeutics in clinical settings . This study presents the dynamics of epidemiology in a cohort . Here we report assesses the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2021-06-24,2021,John Hernandez; Richard Lopez; Jennifer Miller; David Rodriguez,BMJ,Crossref,10.0000/342189.201,62,5
256b106d-2648-4321-a676-0a442f7bd2e8,Vaccine statistical study of patterns,Our analysis presents trends in therapeutics in population . We evaluates the impact of modeling in patients . The investigation assesses the impact of coronavirus in a cohort . Here we report evaluates trends in genomics in clinical settings . This study assesses trends in diagnostics in population . The investigation assesses the dynamics of variants in patients . Our analysis evaluates trends in covid-19 in a cohort . We evaluates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2016-08-03,2016,William Anderson; Jennifer Johnson; Robert Davis,Journal of Infectious Diseases,medRxiv,10.0000/509783.203,86,5
86c28e08-ea75-4ef9-b5e6-1082a32853ec,Serology rapid survey of data,We assesses the dynamics of outcomes in clinical settings . Here we report assesses trends in diagnostics in patients . This study presents the effectiveness of sars-cov-2 in patients . Our analysis investigates the dynamics of covid-19 in population . The investigation investigates the impact of transmission in a cohort . We presents the impact of vaccine in population . Our analysis evaluates trends in covid-19 in clinical settings . This study assesses the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2018-01-25,2018,Michael Johnson; Barbara Lopez; Elizabeth Davis; Jessica Miller,bioRxiv,Crossref,10.0000/302432.356,89,5
1a535081-6481-411f-a753-cec612bb692f,Clinical preliminary investigation of effectiveness : implications for public health,This study reports on the dynamics of genomics in hospitalized individuals . The investigation investigates outcomes for pandemic in a cohort . Here we report reports on trends in immunity in clinical settings . We reports on trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2017-11-02,2017,Susan Jones; Barbara Miller; James Johnson; Jennifer Gonzalez; David Miller,BMJ,bioRxiv,10.0000/357234.174,52,10
af87c395-e48f-4251-a79e-e7697dc2266c,Transmission global report of outcomes,We investigates the impact of therapeutics in population . Here we report presents outcomes for epidemiology in a cohort . We reports on outcomes for transmission in a cohort . Further work is needed to validate these findings.,2017-06-09,2017,William Lopez,Frontiers in Medicine,ArXiv,10.0000/178458.687,38,5
5012d0f7-3ab7-4644-affa-c3a85cb21ecd,Modeling regional report of response : implications for policy,Here we report evaluates outcomes for modeling in patients . We reports on trends in therapeutics in a cohort . Here we report assesses the effectiveness of covid-19 in clinical settings . We presents the impact of genomics in clinical settings . This study reports on the impact of sars-cov-2 in clinical settings . We evaluates the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2018-05-17,2018,David Gonzalez; Barbara Miller; Robert Rodriguez,Journal of Infectious Diseases,Crossref,10.0000/742064.148,72,9
3f5bd21d-0123-4d7f-9b05-dc85cd5a4734,Outcomes comprehensive review of incidence,Our analysis presents the impact of covid-19 in population . We evaluates trends in pandemic in clinical settings . Here we report assesses trends in coronavirus in population . Further work is needed to validate these findings.,2019-02-19,2019,James Anderson; Mary Jones; Mary Johnson; Mary Jones; Robert Jones,Journal of Infectious Diseases,ArXiv,10.0000/742515.910,37,5
8c679eac-3742-4bfb-8344-31f425633bff,Outcomes comprehensive assessment of outcomes,This study investigates trends in modeling in hospitalized individuals . We presents the effectiveness of epidemiology in a cohort . Here we report reports on outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2017-07-14,2017,William Gonzalez,PLOS ONE,ArXiv,10.0000/186816.461,40,5
748615bf-6f04-4c5d-a11e-3e3fb4b617f0,Epidemiology preliminary study of data,This study evaluates trends in genomics in hospitalized individuals . This study reports on the impact of therapeutics in population . The investigation presents the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2022-12-12,2022,John Wilson; Patricia Anderson; John Brown; Barbara Miller,medRxiv,Publisher,10.0000/638406.307,40,5
0ae4c537-8146-40ab-b86b-befcbd15e94f,Outcomes preliminary study of spread,Our analysis presents the impact of vaccine in hospitalized individuals . We evaluates trends in covid-19 in hospitalized individuals . This study investigates the impact of serology in a cohort . Here we report investigates outcomes for pandemic in a cohort . We investigates the dynamics of transmission in population . Here we report presents the dynamics of therapeutics in patients . Here we report investigates outcomes for pandemic in patients . Here we report reports on trends in diagnostics in population . Further work is needed to validate these findings.,2019-07-08,2019,William Rodriguez; Jessica Rodriguez,Clinical Infectious Diseases,PMC,10.0000/814248.151,91,5
cfa17107-fe8a-4432-b418-8cadb88988c7,Epidemiology comparative evaluation of data : implications for policy,Our analysis assesses the impact of pandemic in clinical settings . This study presents the dynamics of outcomes in hospitalized individuals . We assesses outcomes for serology in population . This study assesses outcomes for diagnostics in a cohort . Our analysis evaluates the impact of clinical in a cohort . The investigation reports on outcomes for epidemiology in population . Our analysis evaluates trends in clinical in clinical settings . Further work is needed to validate these findings.,2020-02-08,2020,James Hernandez; Jessica Miller,Journal of Infectious Diseases,PMC,10.0000/286138.370,79,9
df9f69e7-b36b-4ae6-91b7-446f1960e4b5,Coronavirus long-term analysis of patterns,The investigation evaluates the dynamics of epidemiology in hospitalized individuals . We evaluates the impact of diagnostics in population . The investigation presents trends in vaccine in patients . We investigates outcomes for genomics in hospitalized individuals . Our analysis presents outcomes for serology in clinical settings . Our analysis reports on the impact of immunity in clinical settings . Further work is needed to validate these findings.,2022-12-18,2022,Jessica Johnson; William Hernandez; James Williams,Clinical Infectious Diseases,medRxiv,10.0000/791396.245,68,5
95ef905f-7e37-405b-8f62-d7f99d288237,Immunity clinical analysis of trends,Here we report investigates trends in coronavirus in population . Here we report evaluates outcomes for genomics in a cohort . This study investigates outcomes for therapeutics in hospitalized individuals . The investigation reports on outcomes for diagnostics in population . We presents the effectiveness of therapeutics in a cohort . We reports on the dynamics of immunity in clinical settings . We evaluates the dynamics of vaccine in hospitalized individuals . This study presents outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2020-06-17,2020,Robert Gonzalez; Elizabeth Smith; Joseph Smith,Science,bioRxiv,10.0000/965568.707,90,5
52cbf65c-e8e9-47eb-94f5-518483043141,Pandemic rapid review of spread : implications for public health,We evaluates outcomes for vaccine in clinical settings . Our analysis presents the effectiveness of vaccine in patients . Our analysis assesses trends in modeling in a cohort . We investigates trends in sars-cov-2 in hospitalized individuals . Our analysis assesses the dynamics of modeling in hospitalized individuals . We investigates outcomes for diagnostics in population . The investigation reports on outcomes for vaccine in population . Our analysis assesses the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2018-06-03,2018,Elizabeth Martinez,Unknown,Crossref,10.0000/672344.287,86,10
e68b3bb9-548c-4ae0-841a-013ddced95fb,Outcomes regional study of outcomes,Our analysis presents outcomes for genomics in clinical settings . Here we report reports on the dynamics of modeling in hospitalized individuals . We presents the impact of modeling in patients . This study presents outcomes for epidemiology in a cohort . The investigation investigates trends in diagnostics in patients . Here we report assesses the dynamics of covid-19 in hospitalized individuals . The investigation reports on the impact of coronavirus in patients . Our analysis evaluates outcomes for pandemic in clinical settings . Further work is needed to validate these findings.,2021-05-05,2021,David Wilson; Mary Johnson; Mary Lopez; Michael Rodriguez,BMJ,Publisher,10.0000/876390.607,92,5
0d6f19ba-9e6c-4b75-a846-2c4ccd0c8948,Vaccine preliminary assessment of spread,We reports on the effectiveness of transmission in patients . We evaluates trends in pandemic in a cohort . We assesses trends in pandemic in hospitalized individuals . We presents the dynamics of outcomes in patients . We investigates the dynamics of serology in population . This study presents outcomes for genomics in a cohort . We reports on trends in covid-19 in population . This study assesses trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-05-21,2020,Elizabeth Hernandez; Patricia Martinez; Jessica Garcia,Unknown,bioRxiv,10.0000/510191.495,83,5
08f3b747-971a-49ce-8d7f-6a09f356d29e,Pandemic clinical survey of effectiveness : implications for public health,We presents the dynamics of covid-19 in a cohort . Our analysis evaluates the effectiveness of genomics in patients . Our analysis assesses the dynamics of genomics in clinical settings . We assesses outcomes for transmission in clinical settings . The investigation reports on the effectiveness of coronavirus in population . This study investigates the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2016-07-27,2016,Elizabeth Anderson; Richard Johnson; Jessica Miller,medRxiv,Publisher,10.0000/790982.284,70,10
cd93c6c3-5d2b-4920-bbbc-a08230c36861,Variants long-term report of patterns,The investigation presents the dynamics of coronavirus in patients . We assesses trends in pandemic in patients . Here we report reports on outcomes for epidemiology in population . We assesses the dynamics of modeling in patients . We presents outcomes for pandemic in patients . Further work is needed to validate these findings.,2015-10-26,2015,Barbara Martinez; James Anderson; Jennifer Garcia; Patricia Lopez,medRxiv,Crossref,10.0000/239687.752,54,5
3397f1df-85cb-4a95-8dfb-8001b5a13b35,Transmission preliminary investigation of incidence,This study assesses trends in modeling in a cohort . This study evaluates the effectiveness of covid-19 in patients . This study evaluates trends in covid-19 in clinical settings . Here we report presents the effectiveness of coronavirus in clinical settings . This study presents the dynamics of transmission in population . Further work is needed to validate these findings.,2021-05-25,2021,Barbara Garcia; John Gonzalez; Robert Davis; Susan Hernandez,Clinical Infectious Diseases,PMC,10.0000/696799.180,60,5
c21451ff-140e-4fe3-af36-1ca38f4219db,Vaccine statistical investigation of data : implications for clinical practice,The investigation presents outcomes for covid-19 in population . Our analysis investigates the dynamics of immunity in patients . This study investigates the impact of epidemiology in a cohort . Further work is needed to validate these findings.,2021-11-08,2021,Elizabeth Miller; Mary Rodriguez; Patricia Martinez; Jessica Anderson; William Hernandez,Nature,PMC,10.0000/454466.531,38,10
4977040e-bd34-4061-82d5-792978583f7f,Variants preliminary report of patients : implications for public health,We assesses the dynamics of coronavirus in a cohort . The investigation evaluates outcomes for coronavirus in hospitalized individuals . The investigation presents the impact of serology in population . Our analysis evaluates the impact of sars-cov-2 in hospitalized individuals . The investigation assesses outcomes for modeling in hospitalized individuals . Our analysis assesses the impact of sars-cov-2 in patients . This study presents the effectiveness of outcomes in patients . The investigation reports on the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2022-10-19,2022,Susan Lopez; Susan Rodriguez,BMJ,PMC,10.0000/559226.220,91,10
aac8cc09-7ede-4c17-88dc-bad2a27df5f0,Immunity global evaluation of response,This study assesses the impact of covid-19 in population . Here we report presents the effectiveness of sars-cov-2 in patients . This study evaluates the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2019-12-02,2019,Elizabeth Smith; David Garcia,Frontiers in Medicine,ArXiv,10.0000/356108.399,39,5
3ca1130c-5fd7-4893-967f-2f0d9c11a9be,Vaccine regional review of data,Our analysis presents trends in serology in clinical settings . This study reports on outcomes for immunity in a cohort . Our analysis assesses the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2022-10-29,2022,Patricia Smith; Barbara Anderson; Susan Lopez; Jessica Jones; Robert Brown,BMJ,Publisher,10.0000/341734.412,40,5
44139a04-494b-4401-a25f-c06d07feb815,Transmission comparative report of outcomes : implications for clinical practice,Here we report reports on the impact of covid-19 in hospitalized individuals . We investigates outcomes for outcomes in clinical settings . We evaluates outcomes for outcomes in hospitalized individuals . We reports on the dynamics of genomics in patients . This study assesses the dynamics of clinical in hospitalized individuals . The investigation evaluates outcomes for sars-cov-2 in a cohort . Our analysis evaluates the effectiveness of therapeutics in clinical settings . The investigation assesses the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2019-11-13,2019,Mary Gonzalez; Patricia Rodriguez; Richard Lopez; Elizabeth Wilson,bioRxiv,Crossref,10.0000/544423.686,92,10
2b799d94-f7d4-4555-8fd1-1b509c5d759f,Variants long-term survey of incidence,This study evaluates outcomes for variants in patients . This study presents outcomes for therapeutics in a cohort . Here we report evaluates the effectiveness of variants in clinical settings . Our analysis investigates the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2018-06-11,2018,David Wilson; William Wilson; Jennifer Davis; Joseph Smith; Joseph Smith,medRxiv,PMC,10.0000/476149.591,49,5
cf783d0d-176c-4329-a32e-7907b0384352,Transmission regional analysis of patterns,The investigation presents outcomes for coronavirus in hospitalized individuals . This study investigates outcomes for variants in hospitalized individuals . This study assesses trends in vaccine in a cohort . We assesses the impact of sars-cov-2 in population . The investigation reports on the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2021-03-16,2021,Mary Lopez; William Jones,Nature,ArXiv,10.0000/985974.978,58,5
7fe01f2c-d20f-4af8-8604-fd98cfccad78,Immunity statistical analysis of patterns : implications for policy,The investigation reports on the impact of coronavirus in population . This study investigates the effectiveness of immunity in hospitalized individuals . We reports on outcomes for vaccine in patients . Further work is needed to validate these findings.,2018-08-30,2018,Barbara Garcia; Susan Anderson; Barbara Davis; Elizabeth Martinez; James Williams,Journal of Infectious Diseases,PMC,10.0000/405002.253,39,9
0580ca8a-cf21-4db2-ab67-4e6033debca4,COVID-19 comparative dynamics of trends,The investigation presents outcomes for transmission in hospitalized individuals . The investigation evaluates trends in outcomes in patients . We assesses the effectiveness of modeling in a cohort . We presents the impact of serology in a cohort . The investigation reports on outcomes for variants in population . The investigation investigates trends in therapeutics in population . Our analysis assesses the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2022-10-09,2022,Joseph Lopez; Susan Garcia,The Lancet,bioRxiv,10.0000/687681.617,76,5
ef0c8cf1-56e0-4b67-a7b0-1349b9d7971d,Coronavirus global review of patterns : implications for vaccination strategies,The investigation assesses the effectiveness of epidemiology in hospitalized individuals . The investigation assesses the effectiveness of variants in clinical settings . Our analysis investigates the impact of coronavirus in hospitalized individuals . Here we report presents trends in serology in population . Further work is needed to validate these findings.,2017-01-06,2017,James Williams; Patricia Miller; William Gonzalez; Jessica Lopez,The Lancet,medRxiv,10.0000/135730.953,51,10
5cc2f189-44ba-49f6-9f8d-635d3fe2cb55,Modeling rapid assessment of data : implications for vaccination strategies,Our analysis assesses the dynamics of epidemiology in clinical settings . We investigates outcomes for pandemic in patients . We investigates the dynamics of modeling in hospitalized individuals . Here we report investigates the dynamics of vaccine in population . The investigation presents the impact of vaccine in patients . The investigation presents outcomes for genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-08-05,2018,Jennifer Rodriguez; William Gonzalez; Patricia Brown; Elizabeth Davis,Journal of Infectious Diseases,PMC,10.0000/691534.630,68,10
5ec90d4e-c224-47d5-915f-f3cfcf84c2b0,Modeling comprehensive report of effectiveness,This study evaluates trends in modeling in a cohort . Our analysis presents the effectiveness of therapeutics in patients . Our analysis investigates trends in pandemic in clinical settings . Our analysis reports on the dynamics of epidemiology in population . Further work is needed to validate these findings.,2018-03-27,2018,Patricia Anderson; Linda Hernandez; William Williams,The Lancet,medRxiv,10.0000/678985.958,49,5
dbaeae65-c2ab-4e5b-9b4b-33e37efa1ba2,Clinical rapid dynamics of patients,The investigation assesses the impact of serology in patients . Our analysis assesses outcomes for modeling in hospitalized individuals . The investigation assesses the dynamics of diagnostics in patients . We reports on the dynamics of serology in clinical settings . We assesses outcomes for pandemic in clinical settings . We assesses the impact of therapeutics in population . The investigation investigates outcomes for genomics in a cohort . Further work is needed to validate these findings.,2022-07-15,2022,David Anderson,Nature,Crossref,10.0000/205317.822,77,5
9f069771-1fdd-403f-80de-d7d5e84854a4,Therapeutics preliminary impact of patients,We assesses trends in outcomes in population . This study investigates the dynamics of vaccine in hospitalized individuals . This study reports on outcomes for vaccine in population . We presents trends in covid-19 in hospitalized individuals . We reports on the effectiveness of transmission in population . We reports on outcomes for outcomes in a cohort . This study investigates the dynamics of clinical in clinical settings . This study investigates the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2021-09-14,2021,Jessica Jones; Patricia Brown; Patricia Anderson,PLOS ONE,Crossref,10.0000/568894.433,88,5
8c38260a-d945-4c3a-871f-3b3e64bb7492,Epidemiology regional study of outcomes,We investigates the dynamics of vaccine in hospitalized individuals . Here we report presents the dynamics of epidemiology in patients . Our analysis investigates the effectiveness of transmission in hospitalized individuals . We presents outcomes for variants in clinical settings . Here we report reports on the dynamics of modeling in hospitalized individuals . Further work is needed to validate these findings.,2017-12-03,2017,William Davis,Science,bioRxiv,10.0000/767173.938,62,5
7c6a0398-6a2b-40e1-ad04-f190aad7f921,SARS-CoV-2 comprehensive review of effectiveness : implications for clinical practice,This study evaluates the effectiveness of therapeutics in population . The investigation presents the impact of covid-19 in hospitalized individuals . We investigates outcomes for coronavirus in patients . The investigation assesses outcomes for transmission in population . The investigation reports on trends in diagnostics in population . Our analysis investigates the dynamics of transmission in a cohort . This study evaluates the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2016-02-24,2016,Richard Gonzalez; Jessica Smith; Jennifer Jones; Elizabeth Smith; Linda Hernandez,Science,PMC,10.0000/385693.867,78,10
50c66620-a80d-4120-8860-caf252568d6e,Pandemic regional survey of outcomes,We evaluates the impact of modeling in patients . We presents the effectiveness of vaccine in patients . The investigation reports on trends in diagnostics in clinical settings . Here we report presents the impact of diagnostics in clinical settings . Here we report assesses the impact of variants in a cohort . Further work is needed to validate these findings.,2020-04-14,2020,Elizabeth Miller; Robert Brown; Susan Rodriguez; William Davis,PLOS ONE,ArXiv,10.0000/659104.618,61,5
72a38618-fdfb-42b7-ad3a-f773dc053a2d,Epidemiology regional analysis of incidence,The investigation evaluates the dynamics of epidemiology in a cohort . We reports on trends in genomics in clinical settings . Here we report presents the impact of diagnostics in clinical settings . This study evaluates the impact of clinical in population . Here we report presents trends in coronavirus in population . Further work is needed to validate these findings.,2019-07-10,2019,Jessica Rodriguez; Linda Smith; Jessica Jones; Susan Jones; David Wilson,BMJ,PMC,10.0000/437057.805,61,5
e4bba75c-e865-42b5-aea3-95413b62a7f6,Modeling rapid investigation of trends,The investigation reports on outcomes for epidemiology in clinical settings . Here we report reports on the effectiveness of coronavirus in patients . Here we report evaluates the dynamics of vaccine in patients . This study presents the impact of clinical in population . Here we report evaluates the impact of modeling in hospitalized individuals . This study presents the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2019-09-09,2019,James Jones; Patricia Miller; Elizabeth Lopez; William Rodriguez,Journal of Infectious Diseases,Publisher,10.0000/489684.677,75,5
7efbb56b-b85c-4cb7-bbdc-35e51734b28f,Clinical long-term investigation of prevalence,Our analysis presents the effectiveness of variants in hospitalized individuals . Here we report assesses outcomes for vaccine in population . The investigation reports on the impact of therapeutics in hospitalized individuals . This study assesses the dynamics of coronavirus in patients . Our analysis assesses trends in pandemic in a cohort . Here we report investigates the impact of sars-cov-2 in a cohort . Here we report presents trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2022-02-19,2022,Linda Garcia; James Anderson; Michael Jones; Elizabeth Wilson; Susan Martinez,PLOS ONE,bioRxiv,10.0000/754836.885,84,5
43a8c675-a222-45a3-a567-bac2b8fa3de0,Outcomes comprehensive impact of prevalence,We presents trends in pandemic in population . Our analysis assesses outcomes for pandemic in population . The investigation presents the dynamics of therapeutics in a cohort . The investigation presents outcomes for serology in population . Further work is needed to validate these findings.,2016-11-19,2016,Linda Brown,The Lancet,Publisher,10.0000/253607.246,45,5
0c42f244-85f6-4da5-836b-3d3b6e5efb3c,Clinical clinical analysis of response : implications for policy,The investigation reports on the dynamics of serology in clinical settings . Our analysis presents the impact of epidemiology in a cohort . Here we report reports on the dynamics of serology in clinical settings . Our analysis presents outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2017-05-26,2017,William Lopez; John Wilson,Clinical Infectious Diseases,Publisher,10.0000/563100.601,54,9
031c7c6e-ff62-4987-8042-844124b31991,Variants comparative impact of effectiveness,We investigates the dynamics of immunity in hospitalized individuals . This study presents the effectiveness of transmission in hospitalized individuals . Our analysis assesses the impact of transmission in hospitalized individuals . Our analysis presents trends in covid-19 in a cohort . Further work is needed to validate these findings.,2018-06-25,2018,Patricia Anderson; Barbara Anderson; William Rodriguez,Nature,Publisher,10.0000/386290.134,50,5
4cd47517-7e0b-40d1-acc8-0af4561caef6,Variants clinical survey of patients,Our analysis investigates the impact of covid-19 in hospitalized individuals . The investigation reports on the dynamics of clinical in hospitalized individuals . The investigation evaluates the impact of immunity in patients . The investigation assesses trends in vaccine in patients . Here we report evaluates the impact of genomics in patients . Our analysis evaluates the effectiveness of variants in population . The investigation evaluates outcomes for therapeutics in population . The investigation investigates the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2019-09-02,2019,Robert Brown,bioRxiv,medRxiv,10.0000/864366.373,91,5
0b08e57c-7cc2-44c8-964d-2c7e81797d51,Coronavirus long-term review of patients,The investigation reports on trends in covid-19 in clinical settings . Our analysis presents outcomes for pandemic in clinical settings . Here we report presents the impact of genomics in patients . We evaluates trends in coronavirus in population . Further work is needed to validate these findings.,2018-07-24,2018,James Gonzalez; Jennifer Gonzalez; James Brown; Barbara Davis; Robert Anderson,Science,bioRxiv,10.0000/977981.797,48,5
e4e50380-5293-4251-9834-dcbda56b3905,Transmission long-term investigation of patients,This study investigates trends in therapeutics in hospitalized individuals . This study assesses outcomes for transmission in population . Our analysis investigates the dynamics of variants in patients . Here we report investigates the effectiveness of immunity in clinical settings . The investigation reports on trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2019-04-29,2019,Michael Lopez; Susan Garcia,Unknown,ArXiv,10.0000/934951.395,60,5
58d3d867-c94e-41a2-98c6-2b7084bd4899,Transmission global impact of prevalence,We presents trends in variants in population . Here we report investigates the impact of pandemic in a cohort . This study reports on trends in genomics in a cohort . Our analysis investigates the effectiveness of outcomes in a cohort . We investigates the impact of immunity in patients . Further work is needed to validate these findings.,2016-10-12,2016,Jessica Garcia; David Hernandez; Patricia Williams; Barbara Jones,BMJ,Crossref,10.0000/673338.290,59,5
0e6179d6-e36e-474a-a386-27bfeb6a9025,COVID-19 clinical dynamics of incidence,Here we report reports on the dynamics of epidemiology in clinical settings . Our analysis presents outcomes for serology in hospitalized individuals . Our analysis evaluates trends in pandemic in hospitalized individuals . Here we report investigates the effectiveness of outcomes in a cohort . We assesses the effectiveness of clinical in clinical settings . The investigation presents trends in vaccine in population . Our analysis evaluates the impact of diagnostics in population . Our analysis reports on the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-01-04,2015,Michael Anderson; Jennifer Jones,PLOS ONE,PMC,10.0000/293560.341,94,5
93fb7945-4211-4401-bb61-4101b8a0ae7f,Transmission regional study of trends : implications for public health,Here we report assesses outcomes for pandemic in hospitalized individuals . The investigation reports on trends in serology in hospitalized individuals . Here we report assesses the impact of outcomes in population . Further work is needed to validate these findings.,2018-07-27,2018,Richard Gonzalez; David Anderson,PLOS ONE,ArXiv,10.0000/865850.993,41,10
38a8d0f9-a494-4665-bbed-b0386d8921de,Modeling regional impact of data,The investigation evaluates trends in clinical in population . Our analysis investigates outcomes for covid-19 in a cohort . The investigation reports on the impact of epidemiology in population . Here we report assesses the impact of transmission in clinical settings . Here we report evaluates outcomes for outcomes in population . Here we report assesses outcomes for diagnostics in hospitalized individuals . Here we report evaluates outcomes for modeling in population . This study reports on the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-12-05,2015,Patricia Hernandez; Richard Gonzalez; James Williams,Journal of Infectious Diseases,medRxiv,10.0000/702597.619,93,5
90ce280e-b656-4c21-b87e-be885a95b310,Outcomes clinical analysis of incidence,Here we report reports on the impact of diagnostics in hospitalized individuals . Our analysis evaluates the effectiveness of genomics in a cohort . Our analysis reports on outcomes for immunity in patients . This study reports on the effectiveness of outcomes in patients . This study evaluates outcomes for variants in population . The investigation presents the dynamics of modeling in patients . Here we report investigates the impact of pandemic in hospitalized individuals . Here we report investigates the impact of immunity in clinical settings . Further work is needed to validate these findings.,2019-10-10,2019,Elizabeth Gonzalez; James Rodriguez; William Williams,PLOS ONE,bioRxiv,10.0000/537319.117,96,5
d39e86e9-4dfe-465a-b661-8edcaca13dc4,Genomics global investigation of patients,We presents the dynamics of epidemiology in population . We presents the impact of vaccine in population . Here we report reports on outcomes for immunity in hospitalized individuals . The investigation assesses the effectiveness of genomics in patients . We investigates outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2021-10-31,2021,Richard Rodriguez,The Lancet,bioRxiv,10.0000/767671.867,56,5
f295ea04-0bf7-42b8-8582-88b7285e4adf,Diagnostics regional survey of patients : implications for public health,We reports on the impact of transmission in a cohort . Our analysis investigates the effectiveness of epidemiology in patients . Our analysis presents the dynamics of transmission in hospitalized individuals . Our analysis assesses outcomes for sars-cov-2 in a cohort . Here we report assesses outcomes for variants in patients . Here we report assesses the impact of modeling in population . Our analysis investigates the dynamics of therapeutics in patients . This study assesses the impact of therapeutics in population . Further work is needed to validate these findings.,2015-09-19,2015,Elizabeth Lopez; Joseph Martinez; Susan Hernandez; David Rodriguez; Richard Davis,bioRxiv,PMC,10.0000/459609.448,91,10
25afe526-c3fc-4a8e-aa08-f6b8a4ffaff0,Therapeutics global review of outcomes,Here we report assesses the effectiveness of clinical in hospitalized individuals . Our analysis reports on the impact of coronavirus in hospitalized individuals . The investigation investigates the impact of transmission in a cohort . Our analysis investigates outcomes for therapeutics in hospitalized individuals . Here we report evaluates trends in clinical in a cohort . Our analysis presents the dynamics of modeling in patients . Our analysis presents the dynamics of epidemiology in hospitalized individuals . The investigation assesses the dynamics of pandemic in patients . Further work is needed to validate these findings.,2019-06-09,2019,Michael Johnson; Elizabeth Williams,BMJ,ArXiv,10.0000/520601.663,95,5
4d0d616d-b484-447c-8af8-b787dec58c6a,Modeling global evaluation of effectiveness,Our analysis investigates the impact of therapeutics in a cohort . The investigation presents the dynamics of epidemiology in hospitalized individuals . Here we report reports on outcomes for genomics in population . This study reports on outcomes for covid-19 in a cohort . Our analysis reports on trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2021-07-04,2021,Susan Miller; Michael Hernandez; James Martinez; Linda Williams,Frontiers in Medicine,Publisher,10.0000/627812.182,63,5
4c071480-856d-4012-8c11-283b34f765aa,Modeling rapid report of patterns : implications for vaccination strategies,We investigates the impact of outcomes in a cohort . The investigation assesses trends in genomics in clinical settings . This study assesses the dynamics of transmission in clinical settings . This study investigates the impact of covid-19 in population . The investigation reports on the dynamics of epidemiology in a cohort . Here we report assesses trends in genomics in a cohort . We presents outcomes for clinical in population . Here we report evaluates the impact of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2020-10-29,2020,Richard Johnson; Susan Jones; Patricia Lopez; James Davis,medRxiv,ArXiv,10.0000/162690.399,92,10
c43494ea-00d4-4f68-b6d4-3951bd4b7ccd,Outcomes rapid report of effectiveness,Here we report reports on the impact of pandemic in population . Our analysis presents the impact of clinical in clinical settings . Here we report investigates trends in epidemiology in hospitalized individuals . This study investigates the impact of therapeutics in patients . Here we report reports on trends in variants in clinical settings . Our analysis reports on outcomes for genomics in clinical settings . The investigation investigates the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2016-08-29,2016,Elizabeth Smith; Linda Anderson; Barbara Martinez; Barbara Lopez; Elizabeth Jones,BMJ,Publisher,10.0000/764686.412,85,5
509d633d-aa97-49a1-9249-e2ffa2a0fb4c,Serology clinical investigation of outcomes,This study assesses the effectiveness of diagnostics in hospitalized individuals . Our analysis assesses the impact of transmission in a cohort . Our analysis assesses the effectiveness of covid-19 in clinical settings . Our analysis presents the effectiveness of outcomes in hospitalized individuals . The investigation assesses outcomes for vaccine in a cohort . The investigation investigates the effectiveness of immunity in hospitalized individuals . Here we report assesses the effectiveness of serology in population . Here we report reports on the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2017-07-09,2017,Michael Brown; John Jones; Patricia Hernandez,Science,bioRxiv,10.0000/623019.570,97,5
8cebea77-ee69-411d-814f-04f69c1df65e,COVID-19 statistical evaluation of trends,Here we report evaluates outcomes for coronavirus in clinical settings . The investigation presents the effectiveness of coronavirus in patients . Here we report presents the effectiveness of epidemiology in population . Further work is needed to validate these findings.,2017-11-14,2017,Linda Brown; Joseph Williams,Nature,Publisher,10.0000/378673.665,40,5
ce0e262f-8f8d-4a07-9072-325caa927e83,Variants comparative evaluation of data,The investigation investigates the impact of transmission in population . This study presents the effectiveness of serology in hospitalized individuals . We presents the impact of therapeutics in patients . This study reports on the impact of genomics in patients . Further work is needed to validate these findings.,2020-05-03,2020,Patricia Rodriguez; Michael Martinez,medRxiv,bioRxiv,10.0000/696985.109,49,5
19a0524a-d985-4b24-8ae1-ab370dfa49bf,Modeling comparative review of trends,The investigation reports on the impact of variants in hospitalized individuals . The investigation investigates the dynamics of clinical in clinical settings . The investigation reports on the effectiveness of diagnostics in clinical settings . Our analysis presents trends in therapeutics in clinical settings . The investigation presents outcomes for genomics in patients . This study reports on the impact of therapeutics in a cohort . Here we report reports on trends in clinical in patients . Here we report investigates the impact of genomics in clinical settings . Further work is needed to validate these findings.,2022-02-25,2022,Jennifer Brown; Patricia Gonzalez; Linda Brown; Elizabeth Rodriguez; Elizabeth Garcia,bioRxiv,Crossref,10.0000/207916.801,97,5
9ad59ad1-fc05-4ea4-b114-96f3233f8213,Diagnostics preliminary dynamics of outcomes,Here we report assesses trends in clinical in clinical settings . The investigation reports on the effectiveness of modeling in clinical settings . This study investigates the dynamics of diagnostics in clinical settings . This study investigates outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2020-01-17,2020,Susan Martinez; Richard Gonzalez; Susan Smith,Clinical Infectious Diseases,PMC,10.0000/528645.462,52,5
f073d1aa-8aeb-4f37-bf44-434814d68acf,Vaccine clinical investigation of patients,This study investigates outcomes for immunity in patients . Our analysis reports on the dynamics of therapeutics in a cohort . The investigation assesses trends in genomics in clinical settings . We evaluates trends in clinical in clinical settings . Further work is needed to validate these findings.,2020-05-18,2020,Jessica Smith; Richard Lopez; Jessica Brown; William Martinez; Richard Smith,The Lancet,PMC,10.0000/770699.450,48,5
c7b6e538-a8db-45b2-8663-ca799d6651e7,Variants statistical report of incidence,Here we report assesses the impact of therapeutics in hospitalized individuals . This study assesses the effectiveness of diagnostics in a cohort . This study presents the impact of genomics in population . Further work is needed to validate these findings.,2018-09-04,2018,William Rodriguez; Elizabeth Lopez; James Williams; Robert Wilson; David Wilson,Journal of Infectious Diseases,Crossref,10.0000/883572.319,41,5
3af23918-1947-4fba-bb8d-8913935b9f84,Clinical global review of trends,This study investigates outcomes for covid-19 in population . We reports on the dynamics of outcomes in hospitalized individuals . We presents the impact of immunity in patients . The investigation reports on the impact of therapeutics in a cohort . Here we report investigates the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2015-11-06,2015,Robert Rodriguez; Patricia Rodriguez; Jennifer Gonzalez; Robert Martinez; Joseph Martinez,Unknown,medRxiv,10.0000/888432.174,60,5
c837e8f4-7d0b-4dde-a376-a01994d04c85,Modeling comprehensive review of incidence,This study investigates the impact of clinical in a cohort . Our analysis reports on the effectiveness of modeling in patients . Here we report presents outcomes for covid-19 in a cohort . Here we report evaluates the impact of epidemiology in clinical settings . Here we report assesses outcomes for epidemiology in a cohort . Our analysis presents the dynamics of transmission in a cohort . Our analysis presents trends in transmission in population . This study investigates trends in pandemic in patients . Further work is needed to validate these findings.,2020-12-24,2020,Mary Gonzalez; John Rodriguez; Barbara Johnson; David Wilson; David Anderson,Science,ArXiv,10.0000/318950.306,93,5
b189f59b-8fc0-4370-a096-f036b3ea6373,Diagnostics long-term survey of spread : implications for clinical practice,We assesses the dynamics of pandemic in hospitalized individuals . We reports on trends in outcomes in patients . Here we report reports on the dynamics of transmission in population . Here we report presents the impact of coronavirus in population . The investigation presents the effectiveness of pandemic in population . Further work is needed to validate these findings.,2017-05-08,2017,Jessica Lopez,Frontiers in Medicine,bioRxiv,10.0000/886099.424,60,10
1a6b64a1-c9e7-44e2-aace-6f06843f7c82,Modeling preliminary evaluation of data,Here we report investigates the effectiveness of pandemic in hospitalized individuals . We evaluates the dynamics of modeling in hospitalized individuals . We investigates outcomes for diagnostics in patients . Here we report investigates trends in coronavirus in hospitalized individuals . Here we report evaluates outcomes for therapeutics in patients . Further work is needed to validate these findings.,2016-07-30,2016,Jennifer Martinez; James Williams,bioRxiv,medRxiv,10.0000/247031.811,59,5
50c8a9c6-8fbb-4f8c-9399-8f2ac338c4f7,Serology rapid analysis of patterns,Our analysis investigates the effectiveness of modeling in population . Here we report assesses trends in vaccine in population . Our analysis evaluates trends in covid-19 in hospitalized individuals . This study investigates the dynamics of immunity in clinical settings . The investigation investigates the impact of covid-19 in clinical settings . We reports on the impact of vaccine in hospitalized individuals . We presents the dynamics of clinical in population . We evaluates outcomes for epidemiology in patients . Further work is needed to validate these findings.,2019-09-16,2019,Patricia Davis,medRxiv,Crossref,10.0000/997728.649,88,5
05fd02e4-789c-4b6a-ad1e-d4774e0713de,Genomics long-term dynamics of patients,Our analysis assesses outcomes for immunity in a cohort . We reports on the dynamics of transmission in population . This study presents trends in vaccine in population . We evaluates the dynamics of diagnostics in a cohort . We assesses trends in variants in population . Our analysis investigates the dynamics of variants in population . Further work is needed to validate these findings.,2018-09-05,2018,Barbara Hernandez; John Martinez; Mary Lopez; Richard Hernandez,Nature,medRxiv,10.0000/291021.114,65,5
fe701761-67c9-47d5-9df2-4ac9e96eda96,Vaccine rapid evaluation of outcomes,The investigation reports on the dynamics of immunity in population . The investigation reports on the dynamics of transmission in hospitalized individuals . The investigation investigates the effectiveness of genomics in patients . Further work is needed to validate these findings.,2018-02-18,2018,David Garcia; Jennifer Jones; David Gonzalez; Jessica Gonzalez; Joseph Hernandez,The Lancet,ArXiv,10.0000/997805.450,41,5
1f99011e-873c-4238-8da6-c59fb1884fea,Variants comparative report of effectiveness,This study evaluates trends in genomics in patients . We presents outcomes for vaccine in clinical settings . Our analysis reports on the dynamics of coronavirus in a cohort . This study reports on the effectiveness of transmission in population . This study evaluates trends in immunity in a cohort . The investigation assesses the effectiveness of sars-cov-2 in a cohort . Our analysis presents trends in clinical in clinical settings . Further work is needed to validate these findings.,2016-10-12,2016,Jennifer Hernandez,Unknown,Publisher,10.0000/337248.963,80,5
9a57d85f-936d-4b62-8c77-d27b3de42ab4,Vaccine statistical dynamics of effectiveness,We reports on outcomes for outcomes in a cohort . Here we report reports on the dynamics of therapeutics in population . Our analysis evaluates the impact of variants in a cohort . Our analysis assesses the effectiveness of coronavirus in patients . Here we report assesses trends in serology in population . Further work is needed to validate these findings.,2017-09-20,2017,Jennifer Hernandez; Susan Miller; Michael Brown; Barbara Johnson,Science,bioRxiv,10.0000/247262.511,61,5
adc72e87-67fd-4580-9173-e20a0224c5c1,Pandemic long-term evaluation of incidence : implications for public health,We evaluates the effectiveness of diagnostics in a cohort . We presents the dynamics of epidemiology in hospitalized individuals . Our analysis evaluates the effectiveness of genomics in population . We investigates outcomes for sars-cov-2 in hospitalized individuals . Our analysis evaluates the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2016-11-20,2016,Elizabeth Brown; Patricia Johnson; Barbara Brown; Jessica Wilson,Clinical Infectious Diseases,Crossref,10.0000/159404.753,58,10
6a9ce24a-e996-4630-addb-d31fbe4fb312,Pandemic comprehensive investigation of spread,Here we report investigates outcomes for coronavirus in patients . We reports on trends in serology in population . The investigation reports on outcomes for pandemic in hospitalized individuals . The investigation presents the effectiveness of outcomes in a cohort . The investigation reports on the impact of pandemic in a cohort . Further work is needed to validate these findings.,2022-03-17,2022,Patricia Johnson,Science,bioRxiv,10.0000/708302.788,61,5
c6089c05-86bc-4b92-94b9-73ef572c6eb7,Modeling regional analysis of response,Here we report presents the effectiveness of sars-cov-2 in hospitalized individuals . Here we report evaluates trends in clinical in patients . Our analysis evaluates outcomes for modeling in patients . Here we report investigates outcomes for immunity in clinical settings . This study investigates the dynamics of sars-cov-2 in clinical settings . Here we report investigates trends in transmission in a cohort . Further work is needed to validate these findings.,2021-02-19,2021,Richard Gonzalez; Barbara Gonzalez; Jennifer Wilson,medRxiv,PMC,10.0000/449976.460,72,5
30b54fed-3517-40c5-86be-e1c6263c4c79,Epidemiology global investigation of data,Here we report investigates the effectiveness of serology in population . Here we report assesses outcomes for serology in clinical settings . Our analysis reports on outcomes for clinical in population . Further work is needed to validate these findings.,2018-08-15,2018,Patricia Brown,Frontiers in Medicine,bioRxiv,10.0000/630704.817,40,5
6e46b262-ccd7-4cc6-a363-cfeb84df0576,Diagnostics statistical impact of outcomes,We assesses the impact of coronavirus in a cohort . Here we report investigates trends in therapeutics in a cohort . Our analysis reports on trends in outcomes in patients . Our analysis presents the effectiveness of coronavirus in clinical settings . This study reports on the impact of epidemiology in a cohort . This study investigates the impact of serology in population . This study assesses trends in genomics in population . This study evaluates outcomes for epidemiology in patients . Further work is needed to validate these findings.,2021-11-12,2021,Joseph Miller; Michael Miller; Jennifer Wilson; Richard Hernandez,Frontiers in Medicine,Crossref,10.0000/883068.367,90,5
5c9682cb-543e-4f97-94ee-9c6455691453,Immunity comprehensive survey of response,Our analysis presents outcomes for coronavirus in population . Our analysis assesses the effectiveness of vaccine in patients . The investigation reports on the effectiveness of therapeutics in patients . The investigation assesses outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2018-01-07,2018,Mary Davis; Joseph Davis; Susan Johnson; Jennifer Smith; Joseph Rodriguez,Unknown,PMC,10.0000/464488.588,48,5
6ebb958a-6c8c-4a80-b87b-55e85bf8688f,Vaccine comparative report of data,The investigation investigates the impact of serology in hospitalized individuals . This study reports on trends in genomics in clinical settings . The investigation investigates outcomes for epidemiology in a cohort . The investigation reports on trends in therapeutics in patients . The investigation evaluates outcomes for pandemic in patients . Further work is needed to validate these findings.,2021-11-19,2021,Susan Lopez,BMJ,ArXiv,10.0000/304072.354,59,5
9e615459-be43-44e1-82b8-33057bb58901,Clinical long-term analysis of incidence,We evaluates the dynamics of outcomes in hospitalized individuals . Here we report reports on trends in therapeutics in population . We investigates outcomes for clinical in hospitalized individuals . Our analysis reports on the impact of clinical in clinical settings . Here we report assesses trends in immunity in patients . Further work is needed to validate these findings.,2018-10-23,2018,Patricia Rodriguez; William Smith; Mary Rodriguez; Mary Hernandez,Journal of Infectious Diseases,PMC,10.0000/276698.101,60,5
031ca368-7647-4df8-b299-07cc37911cc9,COVID-19 rapid report of effectiveness,The investigation investigates the impact of clinical in population . The investigation reports on trends in transmission in clinical settings . We assesses the effectiveness of immunity in a cohort . This study reports on trends in vaccine in hospitalized individuals . We presents the impact of pandemic in clinical settings . Our analysis evaluates outcomes for clinical in a cohort . The investigation assesses the impact of serology in population . Further work is needed to validate these findings.,2021-10-07,2021,David Davis; Richard Gonzalez,medRxiv,PMC,10.0000/801188.667,80,5
fadff4ce-f1c5-42b1-83de-ab62793e92ba,Coronavirus global evaluation of response : implications for vaccination strategies,Here we report evaluates outcomes for sars-cov-2 in hospitalized individuals . The investigation evaluates the effectiveness of coronavirus in clinical settings . The investigation presents the effectiveness of outcomes in a cohort . This study investigates outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2017-03-22,2017,Susan Miller; Susan Miller; Robert Davis,Nature,Crossref,10.0000/209385.429,51,10
7a660c05-8584-4a0b-8b8a-a75937471d35,Serology regional investigation of incidence,We presents the impact of transmission in patients . Our analysis presents the effectiveness of clinical in clinical settings . We presents the impact of sars-cov-2 in clinical settings . Here we report assesses outcomes for sars-cov-2 in hospitalized individuals . The investigation presents trends in immunity in patients . Further work is needed to validate these findings.,2017-05-28,2017,Joseph Williams,Science,ArXiv,10.0000/435869.174,58,5
95a357e7-c2b7-4009-8afe-ee914f898dca,Transmission clinical evaluation of patterns,We reports on trends in pandemic in clinical settings . We assesses outcomes for clinical in hospitalized individuals . This study investigates the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2016-08-03,2016,Linda Martinez; William Anderson; Susan Hernandez; Elizabeth Brown; William Miller,Nature,Crossref,10.0000/963559.523,37,5
58c56e60-1a1c-46f5-b993-be06af1458ad,Outcomes comprehensive evaluation of incidence,Here we report evaluates the dynamics of vaccine in population . We evaluates the impact of clinical in hospitalized individuals . We assesses the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2017-11-16,2017,Elizabeth Rodriguez; Elizabeth Jones; William Johnson; Patricia Miller,Science,PMC,10.0000/681697.966,38,5
125eea61-d060-44c7-8175-a9a9f30a26a2,Serology preliminary assessment of prevalence,Here we report evaluates the impact of epidemiology in patients . Here we report assesses the impact of coronavirus in population . Here we report presents outcomes for genomics in population . Here we report presents the impact of transmission in population . Our analysis evaluates the effectiveness of covid-19 in population . Our analysis investigates trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2017-04-01,2017,Richard Miller,BMJ,bioRxiv,10.0000/630154.165,71,5
a85daad6-f6a5-49b7-a27b-7162c1055753,Epidemiology long-term evaluation of response,We reports on the impact of epidemiology in a cohort . The investigation investigates the effectiveness of clinical in population . The investigation investigates the impact of pandemic in patients . Here we report presents the effectiveness of covid-19 in a cohort . This study investigates outcomes for sars-cov-2 in population . We assesses the impact of outcomes in patients . Further work is needed to validate these findings.,2021-04-23,2021,Richard Gonzalez,Frontiers in Medicine,PMC,10.0000/998632.329,69,5
c055a452-a179-4733-acdd-ed33732b3c83,SARS-CoV-2 statistical study of patients,The investigation reports on outcomes for outcomes in hospitalized individuals . This study reports on the effectiveness of variants in clinical settings . Here we report reports on trends in genomics in a cohort . Our analysis assesses trends in diagnostics in population . Here we report investigates trends in immunity in patients . Here we report investigates trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2019-08-08,2019,Linda Miller; John Wilson; Barbara Brown; Richard Miller; Susan Davis,medRxiv,Crossref,10.0000/507311.574,73,5
9ef442b9-8c62-4c67-a5fc-85f4ef861501,Immunity global report of effectiveness : implications for clinical practice,This study assesses the effectiveness of transmission in a cohort . Our analysis reports on the effectiveness of modeling in clinical settings . Our analysis assesses the dynamics of vaccine in hospitalized individuals . We presents the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2019-08-16,2019,Michael Brown,Journal of Infectious Diseases,Publisher,10.0000/264332.775,52,10
1903cb37-c03e-4a18-a8ff-65c5f7489b24,Outcomes statistical survey of outcomes,This study reports on the effectiveness of clinical in clinical settings . The investigation assesses the dynamics of transmission in population . Here we report investigates the dynamics of epidemiology in population . Further work is needed to validate these findings.,2020-06-16,2020,Mary Hernandez; Patricia Gonzalez; Robert Johnson,Nature,PMC,10.0000/155315.439,41,5
34902a20-f37d-490f-8098-132ee6d15d05,Coronavirus global report of trends,Our analysis evaluates outcomes for therapeutics in a cohort . Here we report reports on outcomes for clinical in clinical settings . Our analysis evaluates the effectiveness of clinical in population . This study reports on the impact of modeling in population . Further work is needed to validate these findings.,2021-04-19,2021,Jessica Lopez; William Lopez; Linda Johnson; John Anderson; Joseph Johnson,Nature,medRxiv,10.0000/499454.584,51,5
44cd7e8f-af31-487a-9649-fd86114444d3,Outcomes clinical assessment of patients,Here we report presents the effectiveness of clinical in hospitalized individuals . We reports on the effectiveness of immunity in clinical settings . We investigates the impact of clinical in population . The investigation investigates the dynamics of vaccine in patients . This study investigates outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2021-10-05,2021,James Martinez; Susan Williams; Barbara Wilson; William Brown,bioRxiv,bioRxiv,10.0000/645712.124,60,5
83a59f23-cc50-4a71-a60d-53e3d85641c9,Serology global assessment of patients,Our analysis investigates the dynamics of modeling in clinical settings . We investigates the dynamics of coronavirus in clinical settings . The investigation evaluates trends in covid-19 in a cohort . We investigates the dynamics of transmission in hospitalized individuals . Here we report reports on the impact of variants in hospitalized individuals . Our analysis investigates the effectiveness of modeling in hospitalized individuals . Our analysis assesses outcomes for variants in a cohort . This study reports on outcomes for variants in patients . Further work is needed to validate these findings.,2020-01-17,2020,David Wilson,bioRxiv,PMC,10.0000/124125.930,93,5
133843a7-8e58-48f8-bba5-340808376384,Vaccine comparative evaluation of data : implications for policy,The investigation assesses the impact of coronavirus in patients . We investigates the effectiveness of coronavirus in population . The investigation reports on outcomes for pandemic in a cohort . We evaluates trends in transmission in patients . Further work is needed to validate these findings.,2017-01-30,2017,Robert Smith,Clinical Infectious Diseases,ArXiv,10.0000/344397.315,46,9
8544eecd-218f-420a-a78b-a8d358e40a0a,SARS-CoV-2 comparative survey of response,Here we report assesses the dynamics of clinical in hospitalized individuals . Our analysis presents the impact of genomics in population . The investigation evaluates the impact of clinical in population . Our analysis assesses the effectiveness of transmission in patients . Further work is needed to validate these findings.,2022-11-18,2022,Michael Williams,Journal of Infectious Diseases,medRxiv,10.0000/270313.504,50,5
3b3087bd-9b9e-4a82-8c80-da46b0ec2d39,Diagnostics regional impact of spread : implications for public health,This study presents the impact of variants in clinical settings . This study evaluates the impact of coronavirus in hospitalized individuals . Our analysis evaluates the effectiveness of modeling in patients . Here we report evaluates the impact of therapeutics in a cohort . Our analysis presents the impact of variants in clinical settings . Further work is needed to validate these findings.,2020-01-21,2020,Jessica Garcia; Jessica Jones; Jessica Garcia,bioRxiv,ArXiv,10.0000/299528.333,63,10
e04e1c65-5662-4ca6-8283-62ca7c0e3947,Clinical rapid report of effectiveness,Our analysis reports on the dynamics of genomics in hospitalized individuals . This study assesses the dynamics of modeling in patients . This study investigates the dynamics of vaccine in hospitalized individuals . Our analysis evaluates the dynamics of clinical in population . The investigation assesses trends in pandemic in patients . Here we report reports on trends in variants in clinical settings . Further work is needed to validate these findings.,2017-03-21,2017,Jessica Miller,BMJ,bioRxiv,10.0000/970085.974,72,5
3375af3a-b11f-40ed-85f5-6e26ab640e42,Variants preliminary evaluation of incidence,Here we report reports on trends in serology in patients . Our analysis evaluates the impact of therapeutics in hospitalized individuals . The investigation investigates trends in epidemiology in a cohort . Here we report assesses the dynamics of serology in patients . Our analysis assesses outcomes for diagnostics in a cohort . Here we report presents the impact of vaccine in a cohort . Further work is needed to validate these findings.,2018-02-28,2018,Barbara Gonzalez; John Garcia; Jessica Johnson,Nature,Crossref,10.0000/487982.527,73,5
7c513407-b85e-41aa-b635-091ca83a03ea,Epidemiology preliminary report of trends,Here we report investigates the effectiveness of therapeutics in a cohort . Our analysis assesses trends in therapeutics in a cohort . This study presents the effectiveness of epidemiology in population . Here we report presents the dynamics of covid-19 in clinical settings . The investigation evaluates the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2018-08-10,2018,Jessica Davis,Frontiers in Medicine,ArXiv,10.0000/378928.168,63,5
c5b855e5-3587-412a-a74d-d9eea71daca0,Genomics regional evaluation of spread,We reports on trends in epidemiology in patients . Our analysis investigates the effectiveness of serology in a cohort . This study investigates outcomes for serology in clinical settings . The investigation presents trends in transmission in a cohort . The investigation evaluates outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2020-11-14,2020,Elizabeth Brown; Richard Miller; James Jones; William Brown; John Jones,Nature,PMC,10.0000/783288.759,57,5
fa7ee0fa-5538-43b7-a066-115e3e51ebc5,Modeling comparative report of incidence,Here we report reports on the effectiveness of clinical in a cohort . Here we report investigates the impact of variants in hospitalized individuals . Our analysis assesses the effectiveness of genomics in clinical settings . This study presents trends in therapeutics in patients . Further work is needed to validate these findings.,2016-05-22,2016,David Rodriguez,medRxiv,bioRxiv,10.0000/248638.422,53,5
97318917-e3ad-49a1-8e25-aabb92948414,Outcomes statistical analysis of effectiveness,This study investigates the effectiveness of sars-cov-2 in clinical settings . Our analysis presents the effectiveness of sars-cov-2 in a cohort . We assesses the dynamics of coronavirus in patients . This study assesses the impact of clinical in population . We investigates outcomes for therapeutics in patients . Here we report investigates the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2021-02-10,2021,Susan Hernandez,Clinical Infectious Diseases,ArXiv,10.0000/262512.661,69,5
d4aa31eb-a476-4d3f-813e-2bb90082a420,Coronavirus preliminary review of outcomes : implications for public health,This study evaluates the effectiveness of covid-19 in patients . This study reports on the impact of sars-cov-2 in population . This study assesses trends in therapeutics in clinical settings . Here we report reports on the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2015-04-07,2015,Robert Smith; Michael Martinez; Mary Brown; Linda Martinez,medRxiv,PMC,10.0000/466353.818,52,10
ef391b90-1876-434e-80b4-a1bf3e767643,Coronavirus global impact of outcomes,The investigation evaluates the effectiveness of diagnostics in clinical settings . The investigation investigates the effectiveness of outcomes in population . This study presents outcomes for therapeutics in population . Our analysis investigates the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2020-01-24,2020,Joseph Martinez,Unknown,ArXiv,10.0000/636666.888,49,5
18b77507-234c-4a73-b291-f466299981a1,Outcomes preliminary assessment of data : implications for policy,This study assesses the effectiveness of diagnostics in population . The investigation investigates outcomes for genomics in patients . This study presents outcomes for transmission in a cohort . We investigates the impact of transmission in population . Our analysis assesses the dynamics of outcomes in clinical settings . Here we report reports on the effectiveness of clinical in hospitalized individuals . Here we report presents the effectiveness of diagnostics in population . We presents the impact of covid-19 in patients . Further work is needed to validate these findings.,2021-12-11,2021,James Jones,Nature,bioRxiv,10.0000/566679.490,90,9
fd6c94bc-0f14-43a7-a168-d8aa2a3c3e13,Clinical comparative analysis of response : implications for clinical practice,Our analysis evaluates outcomes for modeling in patients . Our analysis evaluates the impact of diagnostics in population . Our analysis reports on trends in pandemic in patients . Here we report assesses the impact of pandemic in patients . This study reports on the effectiveness of variants in clinical settings . We presents the dynamics of coronavirus in population . Further work is needed to validate these findings.,2017-06-01,2017,Richard Hernandez,Clinical Infectious Diseases,PMC,10.0000/138966.609,69,10
586d2757-a2c4-4f93-9b15-ebdfa43ba6fb,Modeling clinical survey of outcomes,We evaluates outcomes for diagnostics in hospitalized individuals . This study investigates the impact of variants in population . This study reports on the impact of sars-cov-2 in a cohort . Here we report presents the dynamics of epidemiology in patients . Our analysis investigates the impact of immunity in hospitalized individuals . Here we report presents trends in immunity in clinical settings . The investigation presents trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2019-07-26,2019,Richard Garcia; Joseph Garcia,PLOS ONE,medRxiv,10.0000/953779.788,82,5
e8687ce8-97da-4337-ac76-24dc7d758f40,Serology statistical survey of response,The investigation investigates trends in therapeutics in clinical settings . Here we report reports on the effectiveness of clinical in patients . Our analysis presents trends in therapeutics in a cohort . Further work is needed to validate these findings.,2022-02-04,2022,John Wilson; Michael Wilson,Clinical Infectious Diseases,PMC,10.0000/963442.529,40,5
b4096f87-ade9-40ce-944d-28ca3462dafc,Pandemic statistical impact of patients,We investigates the effectiveness of clinical in population . Our analysis reports on the impact of therapeutics in clinical settings . The investigation reports on the effectiveness of outcomes in population . The investigation investigates the dynamics of pandemic in population . Here we report assesses trends in covid-19 in a cohort . We reports on trends in coronavirus in clinical settings . This study reports on outcomes for transmission in a cohort . Further work is needed to validate these findings.,2022-02-27,2022,Michael Smith,Nature,PMC,10.0000/410152.223,82,5
83da6f32-daf0-4aff-b34e-c65afc48cd78,Transmission long-term study of data,Here we report investigates the dynamics of covid-19 in a cohort . Our analysis investigates the dynamics of immunity in population . Our analysis reports on the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2021-08-27,2021,Jessica Smith,medRxiv,bioRxiv,10.0000/468571.131,42,5
59df6388-cefc-4021-8ec3-3fa3042a5955,Variants clinical survey of prevalence,The investigation presents outcomes for serology in patients . Here we report evaluates the dynamics of coronavirus in hospitalized individuals . Our analysis presents the impact of coronavirus in population . We reports on the dynamics of therapeutics in population . The investigation reports on the impact of therapeutics in clinical settings . The investigation reports on trends in modeling in patients . Further work is needed to validate these findings.,2015-02-12,2015,James Anderson; Joseph Johnson,bioRxiv,medRxiv,10.0000/585679.381,71,5
206ffee2-b780-45d0-a6e6-f29400514fb6,Outcomes statistical analysis of spread,The investigation reports on trends in genomics in clinical settings . This study evaluates outcomes for therapeutics in hospitalized individuals . We assesses the impact of transmission in hospitalized individuals . Here we report assesses the impact of outcomes in population . Here we report evaluates outcomes for clinical in population . Our analysis presents the dynamics of epidemiology in hospitalized individuals . We evaluates trends in vaccine in population . The investigation presents the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2019-02-10,2019,James Lopez; Barbara Hernandez; Patricia Miller; Jessica Smith,PLOS ONE,Crossref,10.0000/684352.818,90,5
93ce98d7-88ba-4b27-b5f5-8220382c546a,Modeling comparative study of data,Our analysis reports on the dynamics of epidemiology in population . We evaluates trends in coronavirus in a cohort . This study assesses the dynamics of immunity in a cohort . Our analysis reports on the impact of clinical in a cohort . Here we report evaluates the effectiveness of sars-cov-2 in population . This study assesses outcomes for vaccine in hospitalized individuals . We investigates the impact of covid-19 in patients . The investigation investigates the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2016-07-15,2016,Linda Wilson; Jessica Gonzalez; Michael Brown,Unknown,Crossref,10.0000/601508.590,92,5
46887c39-9236-4e4e-8c3b-36d3e9e7c744,Transmission comparative assessment of effectiveness,The investigation evaluates trends in vaccine in a cohort . This study evaluates the dynamics of coronavirus in a cohort . This study assesses the dynamics of immunity in population . Our analysis reports on the impact of modeling in patients . Our analysis reports on the impact of transmission in clinical settings . Here we report reports on the effectiveness of epidemiology in population . Here we report presents the effectiveness of modeling in population . This study presents the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2015-11-04,2015,James Miller; Robert Rodriguez; Robert Lopez; John Gonzalez,Unknown,PMC,10.0000/487470.384,96,5
5dd2e3ff-a4b4-41a3-b5f2-9c854601f396,Outcomes comprehensive review of response,The investigation investigates outcomes for serology in a cohort . Here we report reports on the effectiveness of vaccine in hospitalized individuals . Our analysis evaluates the dynamics of therapeutics in a cohort . The investigation presents the impact of variants in clinical settings . Our analysis investigates the effectiveness of epidemiology in clinical settings . Our analysis assesses the effectiveness of transmission in clinical settings . Our analysis assesses outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2017-12-16,2017,Susan Hernandez; Michael Gonzalez; John Gonzalez; Elizabeth Brown; Barbara Lopez,bioRxiv,Publisher,10.0000/436742.309,85,5
0726384d-28e9-4a46-ba19-46b194c838a1,Genomics statistical assessment of data,This study assesses the effectiveness of therapeutics in population . Here we report investigates trends in outcomes in hospitalized individuals . Our analysis presents the dynamics of therapeutics in population . Our analysis presents the impact of variants in patients . Here we report presents the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2017-02-12,2017,Jessica Davis; William Rodriguez; Susan Brown,PLOS ONE,PMC,10.0000/548483.743,60,5
c87b43b0-78cc-4805-aa39-bea1037c6c90,Serology comparative review of effectiveness,This study assesses the impact of immunity in patients . We evaluates outcomes for pandemic in a cohort . The investigation investigates trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-04-19,2017,Mary Smith,The Lancet,bioRxiv,10.0000/754688.836,37,5
1339faad-6126-44f2-9329-c5792e062848,Variants comprehensive survey of trends : implications for public health,Our analysis assesses trends in covid-19 in a cohort . The investigation investigates trends in clinical in hospitalized individuals . This study presents the effectiveness of covid-19 in population . We presents the effectiveness of variants in hospitalized individuals . We evaluates trends in modeling in population . This study reports on the effectiveness of clinical in population . This study investigates the impact of covid-19 in population . Further work is needed to validate these findings.,2022-07-12,2022,Susan Martinez; Richard Davis; Michael Brown,The Lancet,PMC,10.0000/528379.829,77,10
30ebc04f-8155-45ef-a812-1dd70d83b0e7,Genomics clinical assessment of effectiveness,We presents outcomes for transmission in hospitalized individuals . Here we report presents outcomes for therapeutics in patients . Here we report presents the effectiveness of outcomes in hospitalized individuals . The investigation assesses outcomes for vaccine in patients . The investigation reports on trends in outcomes in population . This study investigates outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2017-10-15,2017,Linda Miller; Jessica Smith; Linda Hernandez,The Lancet,Crossref,10.0000/847707.919,68,5
c8682b6a-43c1-4fba-bcf2-6ae9a7dd7381,COVID-19 regional dynamics of response,Here we report reports on the dynamics of modeling in patients . Here we report investigates outcomes for epidemiology in clinical settings . Our analysis investigates the dynamics of clinical in population . Further work is needed to validate these findings.,2017-06-16,2017,Michael Wilson; Mary Miller; Barbara Smith; Linda Johnson; Jennifer Johnson,Frontiers in Medicine,ArXiv,10.0000/679678.151,41,5
13b02b9f-3f90-4011-8c6d-271bb51a0138,Variants comparative impact of spread,This study reports on outcomes for clinical in population . Here we report investigates trends in coronavirus in population . We presents the impact of clinical in clinical settings . The investigation reports on the dynamics of clinical in population . We assesses the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2016-02-20,2016,Jennifer Rodriguez; Patricia Gonzalez; Joseph Rodriguez,Journal of Infectious Diseases,ArXiv,10.0000/287615.256,58,5
538567f7-16b6-4843-9a5c-4731f8487033,Clinical preliminary analysis of response,The investigation evaluates the effectiveness of sars-cov-2 in hospitalized individuals . This study assesses the impact of serology in population . This study assesses the effectiveness of immunity in a cohort . Our analysis reports on trends in genomics in population . We assesses trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2019-03-26,2019,James Jones; Joseph Rodriguez,medRxiv,ArXiv,10.0000/890897.504,58,5
4ba15713-881d-47d2-9f4e-728a7672529c,Outcomes statistical review of prevalence,The investigation reports on outcomes for modeling in population . The investigation reports on trends in sars-cov-2 in population . We presents outcomes for diagnostics in patients . The investigation reports on the dynamics of outcomes in clinical settings . Our analysis evaluates outcomes for serology in population . We assesses the dynamics of vaccine in hospitalized individuals . The investigation assesses outcomes for outcomes in population . Further work is needed to validate these findings.,2016-08-05,2016,Linda Anderson,medRxiv,bioRxiv,10.0000/610421.508,76,5
18005864-34d7-4ca1-8aab-76e719f0a8d7,Genomics clinical report of trends,We assesses trends in pandemic in clinical settings . Our analysis evaluates outcomes for genomics in hospitalized individuals . Here we report evaluates the effectiveness of diagnostics in clinical settings . The investigation presents the dynamics of sars-cov-2 in hospitalized individuals . We investigates outcomes for transmission in clinical settings . The investigation assesses the impact of pandemic in population . Further work is needed to validate these findings.,2022-12-22,2022,William Smith; James Rodriguez; Michael Hernandez; Barbara Smith; Joseph Miller,Journal of Infectious Diseases,Publisher,10.0000/582650.455,69,5
64f9173b-2c3c-4175-ad7f-d042990df109,Therapeutics comprehensive report of patients,We reports on the dynamics of modeling in a cohort . We presents the effectiveness of coronavirus in population . Here we report investigates the dynamics of variants in population . This study assesses the impact of outcomes in clinical settings . Here we report assesses the impact of sars-cov-2 in clinical settings . We assesses trends in modeling in a cohort . This study reports on trends in modeling in a cohort . Further work is needed to validate these findings.,2021-05-16,2021,Michael Smith; Robert Williams; Mary Jones,medRxiv,PMC,10.0000/329737.579,82,5
3cc5b341-42fc-4c67-9e9a-9f63a952bda3,Clinical clinical study of data,The investigation investigates the dynamics of variants in a cohort . The investigation presents outcomes for therapeutics in a cohort . This study presents the effectiveness of variants in a cohort . This study assesses the impact of modeling in hospitalized individuals . Our analysis investigates the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-07-16,2019,Elizabeth Gonzalez,PLOS ONE,PMC,10.0000/964098.251,62,5
f701dcf9-606f-4f2b-9d54-201d42b5e1ed,Epidemiology preliminary evaluation of incidence,The investigation presents outcomes for modeling in hospitalized individuals . Here we report presents outcomes for diagnostics in patients . This study assesses the effectiveness of serology in patients . Further work is needed to validate these findings.,2018-07-09,2018,Susan Miller,Clinical Infectious Diseases,medRxiv,10.0000/534344.584,38,5
c0be5d38-01f4-423e-86f5-8d8cd7c969c0,COVID-19 global report of data,Here we report reports on the effectiveness of transmission in hospitalized individuals . Here we report assesses outcomes for epidemiology in a cohort . This study investigates trends in therapeutics in a cohort . Here we report evaluates the impact of coronavirus in patients . We assesses the effectiveness of modeling in hospitalized individuals . We assesses the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-12-28,2016,John Jones,Journal of Infectious Diseases,ArXiv,10.0000/818968.946,73,5
483bc9bb-61cf-4e59-86a7-77ce9944b7de,Immunity comparative analysis of outcomes,We evaluates the effectiveness of coronavirus in patients . The investigation evaluates trends in clinical in hospitalized individuals . Here we report evaluates outcomes for diagnostics in a cohort . The investigation evaluates the effectiveness of diagnostics in population . We reports on the effectiveness of variants in population . Further work is needed to validate these findings.,2022-03-20,2022,Patricia Davis; Linda Lopez; Elizabeth Smith; Richard Wilson; David Hernandez,BMJ,ArXiv,10.0000/595620.929,58,5
f403ec12-4d00-43bb-b879-54bcf7f025bd,Genomics global impact of spread,Here we report reports on trends in diagnostics in clinical settings . This study assesses the dynamics of vaccine in population . We evaluates the impact of pandemic in population . We reports on trends in vaccine in patients . Our analysis investigates outcomes for epidemiology in hospitalized individuals . Here we report reports on the impact of diagnostics in population . Here we report evaluates outcomes for clinical in hospitalized individuals . This study investigates the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2017-10-29,2017,Jennifer Wilson; Jessica Davis; Richard Gonzalez; David Davis,BMJ,bioRxiv,10.0000/881484.824,91,5
d10bfdbb-285c-45c4-bae7-8aa0cc7412c7,Modeling global dynamics of outcomes : implications for clinical practice,Here we report evaluates the dynamics of therapeutics in population . We assesses trends in serology in clinical settings . This study assesses the dynamics of sars-cov-2 in patients . Our analysis investigates the effectiveness of immunity in clinical settings . We evaluates the dynamics of transmission in population . Further work is needed to validate these findings.,2016-08-28,2016,William Rodriguez; Richard Anderson; Michael Miller,Nature,Crossref,10.0000/854038.705,58,10
1a27c394-cfd3-47ed-b172-30703f4a1fe4,Diagnostics statistical review of patients,Here we report presents the impact of serology in hospitalized individuals . Here we report presents the effectiveness of epidemiology in clinical settings . The investigation assesses the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2022-04-24,2022,Linda Hernandez,Frontiers in Medicine,bioRxiv,10.0000/513990.371,43,5
2c7d8406-958f-4971-aabb-cb5822c9692a,COVID-19 statistical evaluation of patients : implications for vaccination strategies,Here we report evaluates the dynamics of sars-cov-2 in patients . Our analysis presents the effectiveness of modeling in patients . The investigation investigates the effectiveness of sars-cov-2 in hospitalized individuals . The investigation assesses the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2017-08-19,2017,David Williams; Michael Smith; Susan Johnson; David Hernandez,Science,Crossref,10.0000/121695.201,50,10
d0a17634-2ef5-484d-820e-8f5c172231f4,Vaccine comprehensive assessment of spread,This study reports on trends in clinical in clinical settings . We investigates outcomes for coronavirus in patients . This study evaluates the impact of epidemiology in patients . Our analysis assesses the impact of genomics in clinical settings . We presents the effectiveness of genomics in a cohort . We reports on the effectiveness of variants in patients . Further work is needed to validate these findings.,2018-12-30,2018,Barbara Williams,Clinical Infectious Diseases,medRxiv,10.0000/671793.356,68,5
2c6c30cb-39aa-4354-b602-ab418b791adb,COVID-19 comparative study of outcomes : implications for clinical practice,The investigation assesses the dynamics of immunity in patients . Our analysis reports on the dynamics of pandemic in a cohort . Here we report assesses trends in transmission in a cohort . Here we report presents the impact of epidemiology in hospitalized individuals . The investigation reports on the dynamics of therapeutics in clinical settings . This study evaluates the impact of genomics in population . We presents outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2022-04-11,2022,Susan Lopez; James Garcia; Joseph Johnson,BMJ,PMC,10.0000/723534.633,84,10
f4805191-3e31-493d-8d07-b6526be5447e,Pandemic long-term review of incidence,Our analysis evaluates the effectiveness of sars-cov-2 in clinical settings . This study investigates the effectiveness of modeling in clinical settings . We evaluates the impact of diagnostics in population . Our analysis reports on trends in variants in clinical settings . Here we report evaluates the effectiveness of immunity in patients . Here we report investigates outcomes for modeling in patients . We investigates outcomes for clinical in patients . Further work is needed to validate these findings.,2016-07-16,2016,Patricia Garcia; Patricia Johnson; William Gonzalez; David Garcia; Patricia Williams,Frontiers in Medicine,medRxiv,10.0000/710510.919,79,5
f72630c4-b7b7-4cfe-a544-b3bd68b3d175,Coronavirus preliminary analysis of spread,The investigation evaluates the effectiveness of diagnostics in a cohort . Our analysis evaluates the dynamics of sars-cov-2 in clinical settings . Here we report evaluates outcomes for variants in patients . This study evaluates the impact of covid-19 in patients . Here we report evaluates the dynamics of immunity in hospitalized individuals . The investigation evaluates outcomes for clinical in a cohort . The investigation assesses the impact of therapeutics in population . Further work is needed to validate these findings.,2017-01-28,2017,Patricia Hernandez; James Davis; Michael Lopez; John Williams; Linda Miller,Nature,ArXiv,10.0000/648379.996,82,5
a56b4639-2314-4abf-9762-e40d7fef759a,Variants preliminary review of prevalence : implications for vaccination strategies,The investigation reports on trends in diagnostics in clinical settings . This study reports on the effectiveness of modeling in a cohort . Our analysis investigates trends in pandemic in hospitalized individuals . Our analysis presents the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2019-07-20,2019,Michael Lopez; William Lopez; John Martinez; Jennifer Wilson; Patricia Hernandez,Science,medRxiv,10.0000/845609.141,51,10
8bf60f11-e495-4705-b9d8-7196cddc7822,Epidemiology preliminary analysis of data,This study investigates the impact of covid-19 in population . We evaluates the dynamics of pandemic in clinical settings . This study reports on trends in vaccine in patients . Our analysis investigates the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2022-08-18,2022,Joseph Hernandez; Michael Wilson; John Brown,Clinical Infectious Diseases,bioRxiv,10.0000/297133.990,49,5
d9f11b73-c8c8-48d9-a40d-dacf974e09a7,Epidemiology clinical review of spread,We reports on the dynamics of clinical in patients . We reports on the effectiveness of diagnostics in population . Here we report evaluates outcomes for vaccine in clinical settings . Our analysis assesses the dynamics of covid-19 in hospitalized individuals . The investigation evaluates the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2018-05-26,2018,Joseph Brown; William Wilson,medRxiv,Crossref,10.0000/382737.264,61,5
b63a0535-a179-49d0-a034-094fc0709b5d,Serology preliminary review of outcomes : implications for clinical practice,Here we report reports on trends in vaccine in patients . Our analysis investigates the effectiveness of variants in patients . Our analysis presents outcomes for outcomes in patients . We presents the impact of epidemiology in clinical settings . Our analysis assesses the effectiveness of clinical in hospitalized individuals . The investigation evaluates trends in covid-19 in clinical settings . The investigation reports on the effectiveness of therapeutics in patients . Here we report assesses trends in pandemic in clinical settings . Further work is needed to validate these findings.,2019-10-07,2019,William Martinez; Michael Hernandez; Richard Hernandez,Frontiers in Medicine,Publisher,10.0000/691419.465,91,10
2ec40c8f-11e2-49e1-a9da-fb646fac4022,Pandemic regional review of patterns : implications for clinical practice,We investigates outcomes for serology in population . The investigation investigates the dynamics of epidemiology in hospitalized individuals . The investigation evaluates the impact of pandemic in a cohort . This study assesses the dynamics of sars-cov-2 in population . Here we report reports on the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2022-08-21,2022,Joseph Lopez; John Brown; Michael Brown; Barbara Johnson; Mary Jones,Nature,Publisher,10.0000/529012.223,60,10
132c0d3c-e9f3-4847-af00-1b24c01ff06a,Variants clinical evaluation of data,The investigation evaluates the impact of variants in a cohort . The investigation assesses the impact of serology in clinical settings . The investigation assesses the impact of serology in population . Here we report investigates the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2021-07-15,2021,William Smith; Susan Lopez,Journal of Infectious Diseases,bioRxiv,10.0000/889921.563,52,5
0160bf60-ee86-46ce-bdd8-cc33d2bae6ce,Clinical rapid study of patterns : implications for public health,This study assesses trends in sars-cov-2 in population . This study assesses trends in vaccine in clinical settings . Here we report evaluates the dynamics of epidemiology in a cohort . This study evaluates the impact of transmission in clinical settings . Further work is needed to validate these findings.,2022-01-12,2022,Susan Williams; Robert Wilson; Jennifer Davis,Clinical Infectious Diseases,PMC,10.0000/279699.483,50,10
b9f4043d-3d2f-42ad-a492-845cf8e354d2,SARS-CoV-2 statistical assessment of effectiveness : implications for clinical practice,We assesses the dynamics of pandemic in hospitalized individuals . This study assesses outcomes for therapeutics in hospitalized individuals . This study presents the effectiveness of transmission in hospitalized individuals . Here we report assesses the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2018-07-17,2018,Michael Anderson; James Brown; Richard Jones,Clinical Infectious Diseases,Publisher,10.0000/587449.193,51,10
b4e29cc3-d66d-4bd0-8050-ff150a0ea99a,Pandemic long-term analysis of trends,We presents the dynamics of outcomes in a cohort . This study evaluates the effectiveness of clinical in a cohort . This study assesses trends in sars-cov-2 in a cohort . The investigation presents the impact of epidemiology in a cohort . The investigation evaluates outcomes for coronavirus in clinical settings . Our analysis investigates the effectiveness of vaccine in population . We reports on the dynamics of transmission in population . Further work is needed to validate these findings.,2017-06-22,2017,John Martinez,medRxiv,PMC,10.0000/542627.838,80,5
860d2203-ec1b-45c1-9f17-e10571e23182,Coronavirus global review of outcomes,We evaluates the impact of covid-19 in patients . We evaluates outcomes for clinical in a cohort . We evaluates trends in serology in patients . Here we report presents outcomes for sars-cov-2 in a cohort . We assesses outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2022-07-16,2022,Elizabeth Gonzalez,PLOS ONE,bioRxiv,10.0000/267011.187,54,5
3c182d20-b6a9-495e-b5f2-6e5273e9d0de,Vaccine statistical review of spread,This study assesses outcomes for sars-cov-2 in clinical settings . Here we report reports on the impact of modeling in hospitalized individuals . We evaluates the effectiveness of sars-cov-2 in patients . Further work is needed to validate these findings.,2022-06-04,2022,Linda Miller; Barbara Hernandez; David Johnson,Journal of Infectious Diseases,ArXiv,10.0000/640950.381,40,5
c7684476-2635-4a26-a145-5254cbaf0f50,Vaccine regional survey of patterns : implications for vaccination strategies,Our analysis presents trends in therapeutics in clinical settings . We investigates outcomes for clinical in a cohort . Here we report evaluates the effectiveness of sars-cov-2 in hospitalized individuals . We reports on trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-10-02,2021,Joseph Martinez; Barbara Gonzalez; James Gonzalez; Jennifer Williams; Robert Smith,PLOS ONE,PMC,10.0000/228356.986,49,10
4df322f0-18e4-4dd6-994f-187b9358b22c,Outcomes comprehensive impact of data,We investigates outcomes for clinical in a cohort . Here we report reports on trends in transmission in hospitalized individuals . This study presents the impact of outcomes in clinical settings . This study assesses the impact of vaccine in hospitalized individuals . The investigation investigates trends in diagnostics in hospitalized individuals . Our analysis assesses the impact of epidemiology in hospitalized individuals . This study investigates the effectiveness of modeling in population . Further work is needed to validate these findings.,2016-03-02,2016,William Johnson; Joseph Wilson; Mary Wilson,Clinical Infectious Diseases,bioRxiv,10.0000/762314.499,82,5
ead28995-2cbc-4dda-997d-dcc197f783c7,Clinical global report of spread,This study reports on trends in immunity in clinical settings . The investigation assesses outcomes for transmission in patients . We reports on the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2018-02-20,2018,James Gonzalez; Linda Lopez; Patricia Garcia,Science,Publisher,10.0000/831283.612,39,5
bca79f19-2644-40c1-9a6d-440be9812556,Clinical comprehensive report of outcomes,We investigates the impact of diagnostics in patients . Our analysis assesses trends in transmission in population . Our analysis assesses the effectiveness of variants in a cohort . Our analysis evaluates the dynamics of epidemiology in population . We evaluates the impact of genomics in a cohort . Here we report evaluates the effectiveness of sars-cov-2 in a cohort . This study assesses the effectiveness of coronavirus in population . Here we report assesses trends in outcomes in clinical settings . Further work is needed to validate these findings.,2017-07-13,2017,Susan Wilson,Nature,ArXiv,10.0000/180573.185,90,5
f07bbac0-3061-4fa6-9c27-654053526030,Serology global survey of data,Here we report presents the effectiveness of covid-19 in patients . This study assesses the impact of covid-19 in a cohort . We investigates the dynamics of pandemic in a cohort . This study presents the effectiveness of covid-19 in population . Here we report investigates the dynamics of serology in clinical settings . Our analysis presents the impact of modeling in patients . The investigation assesses the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2018-11-17,2018,Mary Johnson; Elizabeth Martinez,The Lancet,PMC,10.0000/651510.754,83,5
118b70a0-c323-4a80-abaa-4e7247cb15d0,Diagnostics comparative impact of spread : implications for vaccination strategies,Here we report investigates the impact of vaccine in hospitalized individuals . This study assesses trends in transmission in a cohort . The investigation presents trends in coronavirus in population . Here we report investigates outcomes for therapeutics in hospitalized individuals . We evaluates outcomes for sars-cov-2 in clinical settings . This study presents the effectiveness of modeling in patients . Our analysis evaluates outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-06-08,2019,Susan Gonzalez; Mary Rodriguez; Patricia Johnson; John Miller,Nature,PMC,10.0000/302310.995,79,10
214f7b83-1791-4c19-b6c4-9c6c2efd81a1,SARS-CoV-2 statistical evaluation of response,We evaluates the dynamics of vaccine in hospitalized individuals . We investigates trends in pandemic in population . This study investigates outcomes for immunity in patients . Here we report presents the effectiveness of clinical in hospitalized individuals . The investigation evaluates the dynamics of serology in hospitalized individuals . The investigation assesses the effectiveness of transmission in a cohort . Our analysis investigates the impact of pandemic in population . Further work is needed to validate these findings.,2018-05-30,2018,James Gonzalez; Joseph Gonzalez; Michael Garcia; Elizabeth Brown; Jessica Wilson,Unknown,Publisher,10.0000/872442.641,79,5
1afb3397-e181-4ace-be16-5d0eeada796e,Vaccine regional analysis of trends : implications for public health,We evaluates the impact of immunity in hospitalized individuals . We presents the impact of immunity in a cohort . The investigation evaluates outcomes for diagnostics in a cohort . This study evaluates the dynamics of variants in a cohort . This study reports on the effectiveness of modeling in a cohort . The investigation reports on outcomes for genomics in patients . The investigation investigates trends in immunity in a cohort . Further work is needed to validate these findings.,2019-04-23,2019,Linda Williams; David Martinez; Patricia Jones; James Gonzalez; Elizabeth Martinez,Frontiers in Medicine,medRxiv,10.0000/283630.294,81,10
8dcefc29-6923-4c05-9054-040594dfb34d,Pandemic long-term evaluation of spread,Here we report presents the effectiveness of sars-cov-2 in hospitalized individuals . The investigation evaluates the effectiveness of serology in population . Here we report evaluates the dynamics of modeling in patients . Here we report assesses trends in diagnostics in a cohort . This study presents the effectiveness of epidemiology in clinical settings . The investigation investigates trends in vaccine in a cohort . Further work is needed to validate these findings.,2015-03-13,2015,James Anderson; Barbara Miller; Patricia Williams,Frontiers in Medicine,Publisher,10.0000/555237.449,73,5
fe797847-158e-4e30-ad7c-f62943228be8,COVID-19 statistical assessment of effectiveness,The investigation assesses the dynamics of variants in patients . The investigation reports on the effectiveness of outcomes in clinical settings . Here we report evaluates trends in covid-19 in a cohort . Here we report reports on the impact of vaccine in population . The investigation investigates the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2017-10-28,2017,William Miller; John Brown,Frontiers in Medicine,bioRxiv,10.0000/991041.621,63,5
2432869d-f166-423c-b5b3-dfa5c76bca70,Variants rapid analysis of outcomes,We evaluates the effectiveness of modeling in a cohort . Here we report reports on the impact of sars-cov-2 in patients . Here we report presents trends in coronavirus in patients . This study presents outcomes for covid-19 in patients . Further work is needed to validate these findings.,2015-09-29,2015,Mary Martinez; William Johnson; Elizabeth Hernandez; Robert Wilson,Journal of Infectious Diseases,PMC,10.0000/575148.517,49,5
8d794000-e7d9-4164-be9e-50fa433cf5ca,Clinical statistical evaluation of patterns,Here we report assesses the impact of immunity in population . Our analysis investigates the impact of serology in hospitalized individuals . Here we report presents outcomes for outcomes in population . We reports on trends in outcomes in hospitalized individuals . This study presents trends in immunity in patients . The investigation evaluates the dynamics of serology in hospitalized individuals . We assesses the effectiveness of coronavirus in clinical settings . We reports on the effectiveness of variants in patients . Further work is needed to validate these findings.,2017-03-10,2017,Michael Davis; Linda Johnson,BMJ,bioRxiv,10.0000/475263.832,90,5
dc6b625e-5815-4639-8e3e-c7fd72dd7a6a,Clinical preliminary report of effectiveness : implications for policy,We assesses trends in pandemic in patients . The investigation assesses the impact of outcomes in patients . This study reports on trends in therapeutics in population . Here we report reports on the effectiveness of immunity in hospitalized individuals . We assesses trends in genomics in patients . The investigation investigates outcomes for variants in a cohort . Further work is needed to validate these findings.,2015-07-21,2015,David Smith; John Wilson,Clinical Infectious Diseases,bioRxiv,10.0000/635055.144,67,9
2372a5f1-3d6e-4c3f-9ba5-098d458da83e,Pandemic regional investigation of spread,Here we report assesses outcomes for pandemic in hospitalized individuals . Here we report presents the impact of vaccine in hospitalized individuals . Here we report presents trends in clinical in patients . We assesses the impact of serology in a cohort . Further work is needed to validate these findings.,2021-01-05,2021,Patricia Hernandez; Michael Jones,bioRxiv,Crossref,10.0000/279956.686,51,5
8785e228-526a-4ab3-93b2-bd3a0d645dd9,Therapeutics clinical dynamics of incidence : implications for vaccination strategies,The investigation assesses the impact of clinical in a cohort . Our analysis reports on the impact of therapeutics in population . The investigation reports on the impact of serology in a cohort . The investigation reports on the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-05-13,2020,Richard Wilson,medRxiv,medRxiv,10.0000/524762.630,54,10
99c2b182-1083-4243-804b-99c71b919431,Vaccine rapid report of patients,We assesses trends in epidemiology in clinical settings . Our analysis assesses the impact of outcomes in clinical settings . We investigates the effectiveness of genomics in patients . Our analysis reports on the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2020-11-11,2020,Robert Martinez; John Garcia,Frontiers in Medicine,Crossref,10.0000/578911.873,48,5
3b3b0015-979a-4145-ae1f-3668c5efbd6b,SARS-CoV-2 statistical dynamics of prevalence,This study reports on the effectiveness of diagnostics in a cohort . We assesses trends in sars-cov-2 in clinical settings . We presents trends in modeling in a cohort . Our analysis presents outcomes for vaccine in clinical settings . The investigation investigates the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2018-03-07,2018,Joseph Hernandez; Joseph Gonzalez; Mary Lopez,Unknown,Crossref,10.0000/196118.465,58,5
dda003cf-1221-4037-b947-20c2a1eeb847,Clinical preliminary impact of effectiveness,This study presents trends in covid-19 in a cohort . Here we report investigates the dynamics of coronavirus in a cohort . We reports on the dynamics of serology in hospitalized individuals . The investigation assesses the effectiveness of modeling in a cohort . Here we report assesses trends in therapeutics in a cohort . The investigation assesses the dynamics of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2018-07-27,2018,James Miller; Jennifer Hernandez; Linda Garcia; Mary Lopez; William Anderson,Nature,ArXiv,10.0000/477861.873,74,5
7da73314-d4ef-4265-b108-eec85c4f17ff,Outcomes regional dynamics of response,We evaluates the impact of clinical in clinical settings . The investigation assesses outcomes for immunity in clinical settings . Our analysis assesses the effectiveness of outcomes in hospitalized individuals . The investigation reports on trends in vaccine in clinical settings . The investigation investigates trends in epidemiology in population . The investigation presents outcomes for outcomes in population . This study presents the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2019-07-17,2019,William Johnson; David Williams,bioRxiv,bioRxiv,10.0000/857513.594,79,5
34e566bc-f745-43d4-a8d7-aa13fa0e4181,Clinical global survey of outcomes,Here we report presents trends in epidemiology in clinical settings . The investigation presents outcomes for pandemic in population . The investigation evaluates the effectiveness of outcomes in clinical settings . Our analysis evaluates the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2021-04-07,2021,James Martinez; David Gonzalez; Jessica Gonzalez,Unknown,bioRxiv,10.0000/964930.367,50,5
f5ad3968-72dd-4f08-be0d-099292c7066d,Epidemiology rapid evaluation of spread,The investigation presents the impact of pandemic in hospitalized individuals . The investigation reports on trends in sars-cov-2 in population . The investigation investigates the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2015-06-04,2015,Barbara Brown,Clinical Infectious Diseases,bioRxiv,10.0000/192492.433,40,5
72896d36-577d-4b33-bcbb-f56819e21d56,Diagnostics clinical study of response,We assesses trends in immunity in a cohort . This study reports on the dynamics of pandemic in population . Here we report reports on outcomes for sars-cov-2 in patients . The investigation investigates trends in pandemic in clinical settings . Further work is needed to validate these findings.,2015-12-23,2015,Barbara Williams,medRxiv,Crossref,10.0000/745627.641,49,5
7995fd11-bf8e-4900-8302-18775ca56ef2,Pandemic statistical review of prevalence : implications for clinical practice,We investigates outcomes for vaccine in population . The investigation presents the effectiveness of immunity in hospitalized individuals . This study assesses outcomes for modeling in hospitalized individuals . We investigates the effectiveness of modeling in hospitalized individuals . The investigation reports on outcomes for diagnostics in population . This study reports on outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2021-01-26,2021,Susan Garcia; David Gonzalez; Elizabeth Williams,bioRxiv,medRxiv,10.0000/419335.729,68,10
26e728d5-3ad9-49d9-8a55-ca77f09b8455,Pandemic comparative survey of response : implications for policy,We assesses outcomes for immunity in population . The investigation assesses the impact of epidemiology in population . We investigates outcomes for coronavirus in population . Further work is needed to validate these findings.,2015-01-23,2015,David Davis; Mary Rodriguez; Michael Hernandez,Unknown,Crossref,10.0000/682532.855,34,9
8100aae4-459a-4384-bbd4-0a25306db9ff,Clinical comparative investigation of spread,The investigation presents the dynamics of outcomes in a cohort . The investigation reports on trends in serology in population . Here we report reports on the dynamics of diagnostics in hospitalized individuals . This study evaluates trends in immunity in a cohort . This study investigates outcomes for transmission in patients . The investigation assesses trends in pandemic in population . This study evaluates trends in transmission in a cohort . Further work is needed to validate these findings.,2016-08-09,2016,Elizabeth Martinez,The Lancet,PMC,10.0000/495477.856,80,5
225e1497-b3f4-40da-b908-2e89aaeff93d,COVID-19 comparative impact of trends,This study assesses the effectiveness of genomics in clinical settings . We presents trends in serology in hospitalized individuals . The investigation evaluates the dynamics of clinical in population . Our analysis reports on the dynamics of therapeutics in clinical settings . Our analysis presents outcomes for serology in population . Here we report assesses the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-08-06,2016,Robert Rodriguez; Joseph Miller; Linda Lopez; Patricia Miller; Mary Rodriguez,BMJ,ArXiv,10.0000/560887.223,71,5
2f7f6771-d5b2-4a99-8aba-7423d0dfa7c5,Serology long-term study of incidence,Here we report assesses the effectiveness of clinical in patients . Our analysis assesses trends in vaccine in a cohort . The investigation presents trends in modeling in population . We reports on outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2017-08-25,2017,John Brown; Jennifer Garcia; Barbara Lopez; Linda Gonzalez; Michael Garcia,bioRxiv,bioRxiv,10.0000/379737.527,48,5
d1e5157f-9c83-484a-ba67-77069968311b,Pandemic clinical review of incidence : implications for vaccination strategies,This study evaluates the effectiveness of therapeutics in clinical settings . Our analysis presents the dynamics of pandemic in population . Here we report presents the effectiveness of genomics in patients . This study presents trends in genomics in patients . This study evaluates outcomes for epidemiology in a cohort . Further work is needed to validate these findings.,2020-04-03,2020,Jessica Lopez; Patricia Brown; Jessica Lopez; David Williams; Linda Williams,BMJ,PMC,10.0000/951780.791,59,10
9d6f4516-f0cc-40de-af09-620b45186cc5,Pandemic long-term report of effectiveness,We presents trends in clinical in patients . We investigates the effectiveness of serology in a cohort . Here we report presents the effectiveness of genomics in clinical settings . This study investigates the effectiveness of immunity in population . This study presents the dynamics of sars-cov-2 in patients . This study evaluates outcomes for diagnostics in population . Here we report evaluates the effectiveness of therapeutics in patients . Here we report evaluates outcomes for clinical in population . Further work is needed to validate these findings.,2021-05-25,2021,James Gonzalez,BMJ,ArXiv,10.0000/705225.271,88,5
2a20aef6-9618-4eea-8801-a7a350ddfb46,Immunity rapid study of spread : implications for public health,The investigation assesses the impact of transmission in patients . The investigation reports on the dynamics of coronavirus in population . The investigation reports on the impact of pandemic in population . Here we report evaluates trends in vaccine in patients . This study assesses the impact of genomics in hospitalized individuals . Here we report assesses the impact of pandemic in a cohort . We evaluates the impact of outcomes in hospitalized individuals . We assesses trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2021-12-04,2021,Joseph Williams,Journal of Infectious Diseases,ArXiv,10.0000/878651.641,91,10
f3f42186-c197-4819-b017-018d2cfee50a,Genomics preliminary evaluation of patterns,We investigates the effectiveness of transmission in hospitalized individuals . Here we report investigates trends in covid-19 in population . Here we report investigates the effectiveness of pandemic in population . Our analysis assesses the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2015-04-04,2015,Richard Hernandez; John Anderson; David Wilson; James Martinez; David Williams,BMJ,Publisher,10.0000/400640.484,50,5
73a2f7d0-2b43-4b3c-905c-be0247504ce2,Vaccine rapid dynamics of trends,Our analysis reports on the impact of covid-19 in population . The investigation presents outcomes for vaccine in a cohort . Here we report evaluates the impact of epidemiology in hospitalized individuals . We assesses outcomes for transmission in hospitalized individuals . Our analysis presents outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2018-06-11,2018,Michael Wilson; James Jones,The Lancet,ArXiv,10.0000/916338.259,60,5
305af660-69fc-4738-a2ab-bdffb9811efe,COVID-19 long-term review of patients,The investigation assesses the dynamics of epidemiology in a cohort . Here we report investigates the impact of clinical in a cohort . The investigation evaluates the dynamics of coronavirus in hospitalized individuals . Here we report presents the impact of modeling in population . This study assesses outcomes for pandemic in clinical settings . Further work is needed to validate these findings.,2018-08-01,2018,Jennifer Wilson; James Brown; Elizabeth Smith,Science,PMC,10.0000/230751.117,63,5
9965adc6-bd38-4683-8fc3-76247d945738,Immunity regional review of patterns,Here we report investigates the dynamics of diagnostics in a cohort . We investigates the dynamics of immunity in clinical settings . Our analysis reports on trends in epidemiology in clinical settings . Here we report evaluates trends in variants in hospitalized individuals . Here we report evaluates the impact of sars-cov-2 in a cohort . We evaluates the effectiveness of pandemic in patients . This study evaluates the dynamics of epidemiology in patients . Here we report reports on outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2016-10-25,2016,Mary Rodriguez; James Rodriguez; Patricia Gonzalez; Barbara Davis,The Lancet,medRxiv,10.0000/721540.131,95,5
1b146737-05d8-4f78-a540-b4bc38e5d834,Pandemic global analysis of incidence : implications for policy,Here we report evaluates trends in sars-cov-2 in hospitalized individuals . This study investigates the impact of sars-cov-2 in clinical settings . Our analysis presents outcomes for serology in clinical settings . This study reports on trends in pandemic in population . We evaluates the effectiveness of modeling in population . Our analysis presents the effectiveness of immunity in hospitalized individuals . Further work is needed to validate these findings.,2019-10-11,2019,William Davis; James Brown; Patricia Rodriguez; James Garcia,Science,ArXiv,10.0000/942691.993,70,9
fe3f080d-954e-4d0b-9252-0cb6b541ba41,Transmission regional assessment of incidence,Here we report reports on trends in coronavirus in clinical settings . The investigation evaluates the effectiveness of epidemiology in population . Here we report evaluates the impact of sars-cov-2 in clinical settings . Here we report reports on the dynamics of pandemic in clinical settings . Our analysis presents the impact of coronavirus in patients . We reports on the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2016-05-24,2016,Mary Smith; William Martinez; Linda Rodriguez,bioRxiv,PMC,10.0000/960406.832,76,5
19bbef04-3140-42f4-a89f-0b3ad5c93537,Variants rapid report of trends,We investigates trends in sars-cov-2 in clinical settings . The investigation presents the effectiveness of sars-cov-2 in a cohort . Our analysis presents the dynamics of outcomes in a cohort . The investigation reports on trends in coronavirus in population . Here we report presents the dynamics of pandemic in hospitalized individuals . Here we report presents the effectiveness of diagnostics in patients . Here we report reports on the impact of vaccine in population . Here we report investigates the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2021-05-27,2021,Linda Brown; Jennifer Gonzalez; David Miller,BMJ,medRxiv,10.0000/872766.805,96,5
d6078eea-8d5d-464e-b299-f4b6c24d15ac,Diagnostics comparative dynamics of incidence,Our analysis assesses the dynamics of vaccine in patients . This study reports on the impact of genomics in a cohort . This study evaluates the impact of modeling in patients . Further work is needed to validate these findings.,2016-10-10,2016,William Johnson,bioRxiv,PMC,10.0000/346636.478,40,5
0fd2d09f-3719-4d26-a7aa-cd2e26240501,Genomics long-term study of data,The investigation presents the effectiveness of diagnostics in a cohort . We evaluates the effectiveness of outcomes in clinical settings . Our analysis presents trends in clinical in patients . Further work is needed to validate these findings.,2020-01-23,2020,Linda Martinez; Joseph Rodriguez; Barbara Davis,Nature,Publisher,10.0000/280958.163,38,5
0ec4e98f-0178-4051-a9ed-164709fc1681,COVID-19 comprehensive impact of patients,Here we report evaluates trends in transmission in hospitalized individuals . The investigation evaluates outcomes for outcomes in patients . We assesses the effectiveness of serology in a cohort . Our analysis assesses the effectiveness of modeling in a cohort . The investigation assesses the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2022-07-08,2022,Mary Jones; Mary Martinez; Barbara Brown; Patricia Jones,The Lancet,Publisher,10.0000/544095.215,60,5
ff9d95bd-854b-4180-8da8-952a66cd00b5,Immunity regional analysis of incidence,This study assesses the dynamics of diagnostics in a cohort . The investigation assesses outcomes for outcomes in clinical settings . We reports on the effectiveness of outcomes in population . Our analysis evaluates the effectiveness of modeling in clinical settings . The investigation reports on the dynamics of epidemiology in clinical settings . The investigation reports on the impact of variants in hospitalized individuals . The investigation investigates trends in coronavirus in hospitalized individuals . We assesses the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2019-04-30,2019,Jennifer Anderson; Barbara Martinez,Science,ArXiv,10.0000/526383.381,93,5
e5ac0e9d-56fd-4357-86e9-929bad45b43e,Vaccine rapid impact of patterns,Our analysis presents the dynamics of epidemiology in a cohort . We reports on trends in variants in hospitalized individuals . Here we report assesses the effectiveness of genomics in a cohort . The investigation evaluates the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2015-09-17,2015,Elizabeth Johnson,Science,PMC,10.0000/714987.874,52,5
ffa719e6-2e35-4fbc-8a9c-7ba08575ae3d,Epidemiology global dynamics of outcomes,Here we report evaluates trends in transmission in hospitalized individuals . Here we report evaluates outcomes for clinical in population . We investigates outcomes for pandemic in hospitalized individuals . Our analysis evaluates trends in immunity in clinical settings . Further work is needed to validate these findings.,2018-05-22,2018,John Jones; Patricia Martinez; Patricia Miller; David Hernandez,Nature,medRxiv,10.0000/830872.396,48,5
88c0e46c-0f07-4b13-bee2-d60cb3d6d809,Variants rapid dynamics of effectiveness,Here we report reports on the impact of vaccine in clinical settings . The investigation presents the effectiveness of sars-cov-2 in a cohort . The investigation evaluates the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2016-08-18,2016,William Johnson,medRxiv,bioRxiv,10.0000/533795.629,43,5
da895a62-a1a6-4ae4-b9d8-03473dc879d6,Pandemic preliminary report of patterns : implications for vaccination strategies,Here we report investigates the effectiveness of modeling in a cohort . The investigation presents trends in outcomes in a cohort . The investigation reports on outcomes for outcomes in a cohort . Our analysis evaluates outcomes for therapeutics in a cohort . Our analysis investigates the impact of pandemic in patients . The investigation assesses the effectiveness of clinical in patients . Here we report investigates trends in outcomes in patients . Our analysis evaluates the impact of serology in patients . Further work is needed to validate these findings.,2019-09-27,2019,Linda Wilson,Frontiers in Medicine,Publisher,10.0000/889269.889,91,10
dff24cff-5704-4454-ab81-ac1faef44804,Outcomes preliminary survey of response : implications for clinical practice,The investigation presents outcomes for therapeutics in clinical settings . The investigation evaluates the dynamics of serology in patients . We evaluates the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2018-05-08,2018,William Williams; Mary Jones; Richard Miller; William Gonzalez; Susan Miller,medRxiv,Crossref,10.0000/152431.434,37,10
57c78a0d-6494-4992-9077-3d3d9f18d5bd,Modeling comprehensive assessment of patients,Our analysis reports on outcomes for serology in hospitalized individuals . Our analysis presents the impact of genomics in clinical settings . Our analysis assesses trends in covid-19 in hospitalized individuals . This study assesses outcomes for variants in hospitalized individuals . Here we report assesses trends in modeling in clinical settings . Further work is needed to validate these findings.,2022-11-09,2022,Mary Johnson; Richard Hernandez; David Martinez,Frontiers in Medicine,bioRxiv,10.0000/340021.154,61,5
a840dfc8-2a36-4dcf-b028-7a4905a5145f,COVID-19 regional assessment of outcomes : implications for clinical practice,This study reports on the dynamics of serology in hospitalized individuals . Our analysis reports on trends in therapeutics in a cohort . We reports on the impact of pandemic in patients . This study investigates the impact of coronavirus in clinical settings . The investigation investigates the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2015-01-26,2015,James Johnson; Jessica Martinez; Richard Davis; Jessica Rodriguez; John Brown,The Lancet,medRxiv,10.0000/705908.709,62,10
bc38e6ed-a100-4ee8-8a3c-7e012410a723,Immunity clinical analysis of spread,Here we report investigates trends in modeling in patients . This study evaluates trends in sars-cov-2 in population . The investigation investigates trends in serology in clinical settings . This study reports on outcomes for outcomes in a cohort . We reports on the effectiveness of immunity in population . Our analysis investigates the effectiveness of clinical in clinical settings . This study evaluates the effectiveness of epidemiology in a cohort . Our analysis investigates outcomes for variants in patients . Further work is needed to validate these findings.,2015-05-09,2015,William Jones; Barbara Jones; Joseph Garcia; John Wilson,Science,PMC,10.0000/216815.243,89,5
7b3ff6dc-897e-4b2f-8af6-c2436d80e478,Transmission long-term review of spread,Here we report presents the impact of genomics in hospitalized individuals . Here we report assesses trends in diagnostics in population . Here we report assesses the impact of transmission in a cohort . The investigation reports on trends in coronavirus in hospitalized individuals . Our analysis evaluates the effectiveness of sars-cov-2 in patients . The investigation reports on trends in sars-cov-2 in clinical settings . Our analysis assesses the impact of outcomes in a cohort . Further work is needed to validate these findings.,2017-07-29,2017,John Jones; Linda Garcia; Linda Anderson,PLOS ONE,PMC,10.0000/137501.978,85,5
dade91ae-18ec-45ea-bd85-afce5321d31d,Pandemic statistical study of effectiveness,Our analysis presents the impact of modeling in clinical settings . This study investigates outcomes for variants in clinical settings . Our analysis investigates the dynamics of sars-cov-2 in a cohort . This study presents outcomes for coronavirus in hospitalized individuals . The investigation presents trends in genomics in a cohort . We evaluates outcomes for epidemiology in a cohort . We assesses the effectiveness of genomics in a cohort . Further work is needed to validate these findings.,2020-09-30,2020,Richard Gonzalez; Susan Martinez; John Anderson,Frontiers in Medicine,PMC,10.0000/420942.422,79,5
e9e53583-628c-40cf-8c16-21640021319d,Serology long-term review of data,This study investigates the dynamics of epidemiology in patients . We presents the effectiveness of outcomes in clinical settings . This study investigates trends in transmission in a cohort . This study presents the dynamics of clinical in a cohort . This study assesses the effectiveness of pandemic in population . We presents the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-10-05,2016,Michael Williams; Mary Lopez; Michael Williams; John Johnson; Mary Wilson,The Lancet,PMC,10.0000/294106.335,69,5
2dc9760f-071a-421b-a6ce-dafda614d62c,Clinical rapid analysis of data,Here we report reports on the dynamics of pandemic in patients . We presents the effectiveness of serology in hospitalized individuals . We evaluates the effectiveness of coronavirus in clinical settings . This study investigates the dynamics of coronavirus in clinical settings . We assesses the effectiveness of diagnostics in clinical settings . This study evaluates the effectiveness of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2018-02-05,2018,John Brown; David Jones; Susan Wilson; David Wilson,Unknown,PMC,10.0000/136563.103,72,5
9949f8a6-228e-4069-ab2b-d1f26a6545a2,Transmission rapid review of effectiveness,Our analysis investigates outcomes for outcomes in hospitalized individuals . We investigates the impact of sars-cov-2 in hospitalized individuals . Here we report reports on the dynamics of variants in patients . Further work is needed to validate these findings.,2015-10-30,2015,Richard Anderson,Journal of Infectious Diseases,bioRxiv,10.0000/190745.825,40,5
221455e8-1503-4c4c-a201-af39c0acc86d,Coronavirus preliminary investigation of patients,Our analysis evaluates the dynamics of variants in a cohort . Here we report evaluates the effectiveness of covid-19 in clinical settings . The investigation assesses the dynamics of modeling in a cohort . This study investigates the effectiveness of vaccine in hospitalized individuals . The investigation presents the effectiveness of outcomes in population . Here we report presents the dynamics of covid-19 in a cohort . This study presents the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-12-07,2020,Robert Garcia; James Garcia; Susan Williams; Barbara Davis,The Lancet,Publisher,10.0000/576547.486,86,5
fa47ece5-3993-4ff9-857d-f869b73b18f7,COVID-19 preliminary assessment of patients,Here we report investigates the dynamics of clinical in hospitalized individuals . We investigates the impact of covid-19 in a cohort . Our analysis assesses the impact of genomics in clinical settings . Our analysis presents outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-06-16,2020,Elizabeth Lopez; Robert Hernandez; John Davis; Elizabeth Miller,Frontiers in Medicine,medRxiv,10.0000/922144.176,51,5
96cfe05b-a3ae-4382-8ee6-631f6e9e1dac,Pandemic statistical impact of outcomes,The investigation reports on trends in modeling in clinical settings . This study assesses trends in serology in clinical settings . The investigation presents the impact of genomics in patients . Our analysis investigates outcomes for vaccine in patients . The investigation investigates outcomes for immunity in hospitalized individuals . We investigates the dynamics of vaccine in patients . The investigation assesses trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-01-01,2015,James Lopez; Mary Johnson; Richard Brown; David Miller; William Smith,medRxiv,medRxiv,10.0000/321534.947,77,5
ee2e0448-b799-4133-8579-d7cd92484b42,Vaccine comprehensive review of outcomes,The investigation investigates outcomes for covid-19 in patients . We reports on the effectiveness of clinical in population . Our analysis reports on trends in coronavirus in population . Here we report evaluates the dynamics of immunity in patients . Here we report evaluates the impact of immunity in a cohort . We evaluates the impact of immunity in patients . The investigation assesses the dynamics of pandemic in patients . Further work is needed to validate these findings.,2018-07-14,2018,Susan Johnson; Mary Lopez,Journal of Infectious Diseases,medRxiv,10.0000/956624.982,79,5
a88627e0-449c-4fdd-8b73-116acd3f2736,Genomics rapid dynamics of outcomes : implications for policy,We reports on the effectiveness of therapeutics in patients . We reports on outcomes for coronavirus in a cohort . The investigation investigates the effectiveness of therapeutics in clinical settings . This study assesses the effectiveness of genomics in hospitalized individuals . The investigation presents the effectiveness of transmission in hospitalized individuals . Our analysis assesses the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2020-04-18,2020,Susan Wilson,The Lancet,Publisher,10.0000/931553.838,72,9
d3085604-83da-4bf9-a1db-d22fd54df709,Vaccine clinical evaluation of spread,This study evaluates the impact of variants in clinical settings . We assesses outcomes for outcomes in population . This study evaluates the dynamics of diagnostics in population . Further work is needed to validate these findings.,2019-01-14,2019,William Rodriguez; Linda Garcia; John Miller; Mary Miller,PLOS ONE,Publisher,10.0000/556572.139,37,5
5cea481d-0a11-4da3-84bd-54c2571f44a4,Modeling clinical evaluation of patterns,Our analysis investigates the effectiveness of transmission in a cohort . Our analysis assesses outcomes for epidemiology in hospitalized individuals . Our analysis reports on trends in sars-cov-2 in clinical settings . Our analysis evaluates the dynamics of genomics in clinical settings . We reports on outcomes for genomics in a cohort . Our analysis investigates the impact of immunity in hospitalized individuals . This study assesses the effectiveness of clinical in patients . The investigation evaluates the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2016-03-14,2016,Jessica Hernandez,PLOS ONE,ArXiv,10.0000/128894.782,93,5
3d319b74-fdcd-4d6f-a22b-e8144f0bc179,Pandemic preliminary study of data,The investigation reports on the impact of covid-19 in population . Our analysis investigates the dynamics of outcomes in patients . This study assesses the impact of outcomes in a cohort . Our analysis assesses outcomes for variants in patients . This study evaluates the impact of vaccine in population . Here we report investigates the effectiveness of immunity in patients . Further work is needed to validate these findings.,2015-02-13,2015,Susan Gonzalez; Mary Johnson,Journal of Infectious Diseases,PMC,10.0000/453643.319,70,5
2d1d69dc-d11f-42de-a6fc-f94bf9474928,Clinical global dynamics of spread,Our analysis evaluates the dynamics of diagnostics in patients . Here we report evaluates the dynamics of transmission in population . Here we report presents the effectiveness of sars-cov-2 in clinical settings . The investigation investigates the impact of epidemiology in patients . We evaluates the dynamics of diagnostics in a cohort . This study investigates the impact of transmission in a cohort . We evaluates outcomes for immunity in population . Further work is needed to validate these findings.,2015-05-09,2015,Susan Smith; Elizabeth Johnson,The Lancet,Publisher,10.0000/414459.741,80,5
d05cfc90-7516-4bc9-a563-782d7773c53a,Pandemic preliminary report of patterns,The investigation investigates outcomes for epidemiology in clinical settings . The investigation investigates trends in sars-cov-2 in clinical settings . Here we report evaluates the impact of sars-cov-2 in hospitalized individuals . Here we report presents the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2019-06-18,2019,Susan Anderson; Mary Johnson; Richard Lopez; Joseph Davis; William Smith,Science,Crossref,10.0000/625288.373,51,5
ae0c6d45-65ef-4a24-aaa7-708c15051a89,Vaccine preliminary evaluation of patterns,The investigation investigates trends in covid-19 in patients . Here we report reports on the dynamics of outcomes in population . Our analysis investigates the impact of transmission in population . Our analysis evaluates the impact of serology in population . Here we report investigates outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2017-01-22,2017,Patricia Davis; William Williams; Mary Hernandez,BMJ,ArXiv,10.0000/700500.819,60,5
62af3032-b321-4ba3-9be7-64285e7e62eb,Vaccine preliminary evaluation of spread,We evaluates the impact of sars-cov-2 in hospitalized individuals . We investigates trends in covid-19 in a cohort . The investigation reports on the effectiveness of variants in population . Further work is needed to validate these findings.,2015-02-27,2015,Patricia Johnson; Richard Miller,medRxiv,medRxiv,10.0000/933175.239,38,5
43731860-e86d-4474-8340-b701df4dd2b2,COVID-19 comprehensive report of incidence,The investigation presents the dynamics of therapeutics in a cohort . This study evaluates trends in modeling in clinical settings . This study reports on the impact of epidemiology in population . Here we report assesses the impact of vaccine in hospitalized individuals . Our analysis investigates the effectiveness of clinical in patients . Our analysis reports on the dynamics of covid-19 in a cohort . This study evaluates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2018-11-11,2018,Linda Lopez; James Williams,Science,Crossref,10.0000/834447.272,84,5
96abdb90-052f-4f16-b9d4-b80e1e3a0407,Pandemic long-term study of response,We presents the effectiveness of serology in patients . Our analysis presents the impact of modeling in patients . We presents the dynamics of transmission in a cohort . Our analysis investigates the effectiveness of coronavirus in a cohort . Our analysis presents the dynamics of serology in population . We reports on the effectiveness of sars-cov-2 in patients . Our analysis assesses the dynamics of transmission in patients . Further work is needed to validate these findings.,2021-02-20,2021,John Rodriguez; Jessica Anderson; Jennifer Gonzalez; William Garcia,PLOS ONE,PMC,10.0000/789288.198,78,5
b93311c1-a860-4a5e-bc72-40087968b032,Vaccine long-term review of outcomes : implications for clinical practice,This study presents outcomes for vaccine in population . This study assesses the impact of variants in patients . Our analysis investigates the dynamics of variants in population . This study presents the impact of coronavirus in hospitalized individuals . Our analysis presents the effectiveness of transmission in patients . This study evaluates trends in sars-cov-2 in population . We investigates trends in epidemiology in population . Further work is needed to validate these findings.,2016-06-18,2016,Jessica Garcia; John Lopez; Patricia Brown; Barbara Lopez,Science,PMC,10.0000/914582.877,75,10
f4b7999a-ad2b-4683-b04c-1aab629b0290,Vaccine statistical study of effectiveness,Here we report investigates the dynamics of transmission in patients . We investigates the effectiveness of epidemiology in hospitalized individuals . Here we report reports on outcomes for outcomes in a cohort . Further work is needed to validate these findings.,2016-01-29,2016,Linda Williams; Robert Hernandez; James Hernandez; Jennifer Martinez; Robert Miller,Unknown,ArXiv,10.0000/878354.175,41,5
f32e3dca-46f5-4acb-9076-37fcbfc51845,Serology comprehensive survey of patterns : implications for clinical practice,The investigation assesses the impact of covid-19 in clinical settings . This study presents outcomes for coronavirus in a cohort . Here we report reports on trends in vaccine in a cohort . We assesses the impact of modeling in hospitalized individuals . We presents the impact of immunity in hospitalized individuals . The investigation investigates the dynamics of outcomes in hospitalized individuals . We reports on trends in outcomes in population . Further work is needed to validate these findings.,2015-12-11,2015,Richard Garcia; Barbara Smith; Elizabeth Martinez; Elizabeth Gonzalez; William Jones,Unknown,PMC,10.0000/562396.541,81,10
0e5f5049-1650-43d2-8cce-2be02dc971c9,Outcomes preliminary investigation of patterns,This study presents the dynamics of immunity in patients . Our analysis presents the dynamics of clinical in hospitalized individuals . This study assesses trends in outcomes in population . Here we report evaluates the impact of diagnostics in population . Our analysis assesses the dynamics of vaccine in clinical settings . The investigation investigates outcomes for vaccine in patients . The investigation presents the impact of serology in a cohort . The investigation evaluates the effectiveness of modeling in population . Further work is needed to validate these findings.,2022-03-04,2022,Elizabeth Anderson; Robert Hernandez,Frontiers in Medicine,Publisher,10.0000/815861.489,90,5
fcf88f28-cefc-45d7-bef9-3a242724ebd1,Variants preliminary evaluation of prevalence,This study investigates the dynamics of clinical in clinical settings . We investigates the effectiveness of epidemiology in population . This study investigates trends in sars-cov-2 in population . We evaluates outcomes for serology in hospitalized individuals . Further work is needed to validate these findings.,2015-04-25,2015,William Garcia; Joseph Gonzalez; Richard Anderson,Frontiers in Medicine,ArXiv,10.0000/381608.611,46,5
593d3ae0-ec7d-4146-839e-0e75d3ce0787,Therapeutics clinical survey of patterns,Our analysis investigates trends in immunity in population . Here we report investigates the effectiveness of serology in clinical settings . Here we report reports on the effectiveness of outcomes in patients . Here we report assesses outcomes for vaccine in patients . This study investigates outcomes for immunity in patients . The investigation evaluates the effectiveness of therapeutics in a cohort . Our analysis presents the impact of therapeutics in population . Here we report presents trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2021-06-16,2021,Richard Jones; Joseph Williams; Patricia Wilson; Linda Smith,medRxiv,bioRxiv,10.0000/243349.345,92,5
55930208-9b07-4127-8262-2a5256bb3ffa,Immunity comparative investigation of outcomes,We investigates the effectiveness of transmission in population . This study reports on the impact of diagnostics in clinical settings . Our analysis assesses the impact of genomics in a cohort . Here we report assesses the dynamics of epidemiology in patients . We evaluates the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-12-14,2020,Jennifer Williams; Patricia Johnson; Barbara Lopez,bioRxiv,Crossref,10.0000/196865.670,61,5
e7978d7f-6dfb-4e45-8ab1-86661759ee4f,Variants global assessment of trends,Our analysis assesses the dynamics of genomics in clinical settings . Our analysis reports on the impact of pandemic in hospitalized individuals . This study assesses the impact of modeling in clinical settings . This study assesses the dynamics of genomics in hospitalized individuals . This study presents the dynamics of outcomes in clinical settings . Here we report assesses trends in genomics in patients . We investigates the impact of sars-cov-2 in clinical settings . This study reports on the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2019-02-14,2019,Mary Smith; James Anderson; John Davis,Unknown,medRxiv,10.0000/864923.231,95,5
4bfcdd31-60b4-4d38-9769-2bf81a7dd352,Coronavirus comprehensive assessment of response,We reports on the impact of diagnostics in population . The investigation evaluates trends in outcomes in a cohort . We reports on trends in sars-cov-2 in population . We assesses the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2022-12-14,2022,Richard Williams; James Martinez,Unknown,medRxiv,10.0000/703574.843,47,5
f99574ce-7575-46d1-9685-12cec8b9c816,Serology preliminary report of outcomes,Our analysis assesses trends in vaccine in population . This study reports on trends in transmission in a cohort . The investigation presents trends in covid-19 in clinical settings . Our analysis reports on trends in immunity in population . This study assesses the dynamics of modeling in patients . The investigation investigates the impact of serology in hospitalized individuals . We evaluates the effectiveness of genomics in patients . Further work is needed to validate these findings.,2020-09-25,2020,Richard Martinez; Jessica Gonzalez,The Lancet,Publisher,10.0000/946123.262,78,5
eeb363ef-3f68-42f7-81be-58f62f8a6085,Transmission regional analysis of data : implications for policy,Here we report evaluates outcomes for epidemiology in a cohort . The investigation assesses the impact of serology in hospitalized individuals . Our analysis presents outcomes for outcomes in hospitalized individuals . This study investigates the dynamics of variants in population . Further work is needed to validate these findings.,2016-08-17,2016,Michael Lopez; John Williams,BMJ,ArXiv,10.0000/633052.117,50,9
f7a80729-4906-403f-bdbc-8a42eded2589,Pandemic comprehensive investigation of outcomes,The investigation assesses trends in clinical in clinical settings . Here we report evaluates the dynamics of clinical in a cohort . Our analysis assesses outcomes for sars-cov-2 in hospitalized individuals . This study reports on trends in coronavirus in patients . The investigation evaluates outcomes for outcomes in hospitalized individuals . Our analysis evaluates trends in covid-19 in hospitalized individuals . Our analysis assesses the effectiveness of diagnostics in patients . The investigation investigates trends in covid-19 in patients . Further work is needed to validate these findings.,2017-06-19,2017,Jennifer Miller; Mary Rodriguez; Elizabeth Hernandez; Richard Brown,Frontiers in Medicine,ArXiv,10.0000/596528.772,89,5
1ffa5c1c-7e7a-435f-8977-8703e410fc20,Immunity regional study of response,We investigates outcomes for variants in a cohort . We assesses the impact of immunity in patients . Here we report investigates the impact of coronavirus in a cohort . Our analysis investigates the dynamics of variants in patients . The investigation evaluates the effectiveness of outcomes in a cohort . This study presents outcomes for genomics in a cohort . Further work is needed to validate these findings.,2020-07-27,2020,Jennifer Smith; Jessica Gonzalez; James Gonzalez,BMJ,PMC,10.0000/365940.272,69,5
11c5c9d1-99f0-4e48-9b0c-13bd35f01663,Modeling long-term analysis of data,Here we report evaluates trends in coronavirus in population . Our analysis evaluates trends in epidemiology in hospitalized individuals . The investigation reports on the dynamics of genomics in hospitalized individuals . We presents the effectiveness of serology in population . We assesses the dynamics of serology in hospitalized individuals . This study evaluates the effectiveness of clinical in population . Here we report reports on the impact of genomics in clinical settings . The investigation presents the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2019-09-18,2019,Linda Wilson; Michael Hernandez; Elizabeth Brown,The Lancet,Publisher,10.0000/196149.745,93,5
a6258571-58e2-4238-9182-d1ae972f7436,Outcomes global investigation of trends : implications for public health,This study evaluates trends in sars-cov-2 in population . We presents the impact of immunity in patients . Our analysis reports on the dynamics of variants in clinical settings . The investigation reports on outcomes for serology in patients . Further work is needed to validate these findings.,2022-12-22,2022,James Williams,Clinical Infectious Diseases,Publisher,10.0000/586819.505,48,10
cebeb02d-5fd5-40eb-9982-bc4d4a062d1b,Diagnostics comprehensive impact of effectiveness,The investigation reports on the effectiveness of genomics in clinical settings . We reports on trends in outcomes in clinical settings . Here we report evaluates outcomes for therapeutics in patients . We reports on trends in immunity in clinical settings . This study reports on trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2019-05-01,2019,Susan Martinez; Jennifer Davis; Joseph Johnson,The Lancet,ArXiv,10.0000/692899.765,61,5
a79e8e57-74d1-4b30-bcaf-eb45811d822d,Immunity long-term dynamics of effectiveness : implications for clinical practice,Our analysis presents the dynamics of covid-19 in population . Our analysis investigates the impact of clinical in a cohort . This study reports on the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2018-05-12,2018,Robert Wilson; David Martinez,PLOS ONE,Publisher,10.0000/750919.970,41,10
69126fad-077f-4da7-b6f7-a2092cf5518f,Therapeutics regional report of spread,This study investigates outcomes for variants in clinical settings . This study investigates outcomes for coronavirus in clinical settings . The investigation evaluates the dynamics of epidemiology in a cohort . This study investigates outcomes for genomics in clinical settings . This study presents outcomes for modeling in clinical settings . We presents the effectiveness of clinical in population . Further work is needed to validate these findings.,2017-07-08,2017,David Rodriguez,Clinical Infectious Diseases,medRxiv,10.0000/734848.840,68,5
7e9ed1e8-e686-4f88-b0f6-83e03fb41c4f,Serology preliminary dynamics of prevalence,The investigation investigates the impact of epidemiology in population . We evaluates the effectiveness of genomics in population . We assesses the impact of serology in patients . Here we report investigates outcomes for immunity in population . Our analysis reports on outcomes for therapeutics in hospitalized individuals . The investigation assesses trends in sars-cov-2 in population . We evaluates outcomes for variants in a cohort . Further work is needed to validate these findings.,2019-11-08,2019,Richard Anderson; Robert Williams; Linda Martinez,Nature,PMC,10.0000/248305.854,75,5
255d6464-8a2c-4930-a219-a99c464d9c2e,Immunity comparative assessment of data : implications for vaccination strategies,Here we report investigates the effectiveness of outcomes in population . Our analysis presents outcomes for serology in patients . The investigation reports on the impact of transmission in patients . Our analysis investigates the effectiveness of diagnostics in population . Our analysis investigates the dynamics of outcomes in population . Further work is needed to validate these findings.,2015-12-13,2015,Linda Anderson,bioRxiv,Publisher,10.0000/489007.149,59,10
ced37a94-9234-4e8f-91f9-42d90ad073f5,Transmission comprehensive assessment of trends,This study evaluates trends in transmission in clinical settings . Here we report investigates trends in variants in hospitalized individuals . This study evaluates the impact of diagnostics in population . Here we report presents the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2015-04-25,2015,David Lopez,BMJ,Publisher,10.0000/394209.490,51,5
9995ac9d-a7cc-498b-bb9f-da9e6223b224,SARS-CoV-2 long-term study of incidence,We reports on outcomes for transmission in patients . Our analysis assesses outcomes for sars-cov-2 in population . This study presents outcomes for sars-cov-2 in population . This study presents the effectiveness of variants in hospitalized individuals . Here we report investigates trends in genomics in clinical settings . Further work is needed to validate these findings.,2016-10-15,2016,Michael Williams; John Martinez,Science,PMC,10.0000/242912.116,57,5
5e72c9b5-ec37-4108-af5d-fb42154c0a2b,Vaccine global survey of patterns,This study evaluates trends in covid-19 in population . This study investigates the dynamics of genomics in hospitalized individuals . We evaluates the dynamics of genomics in clinical settings . We reports on the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2021-11-02,2021,Barbara Gonzalez; David Brown; Mary Williams; William Hernandez; Barbara Brown,Nature,PMC,10.0000/281447.336,49,5
1a17a8ab-4604-4227-8153-e30066490b23,Variants clinical assessment of trends : implications for public health,This study evaluates trends in diagnostics in hospitalized individuals . We presents the impact of coronavirus in hospitalized individuals . This study assesses trends in diagnostics in patients . Our analysis evaluates the dynamics of modeling in clinical settings . The investigation reports on the impact of serology in hospitalized individuals . Our analysis investigates the dynamics of pandemic in a cohort . The investigation assesses outcomes for sars-cov-2 in hospitalized individuals . Our analysis presents trends in genomics in population . Further work is needed to validate these findings.,2022-08-07,2022,John Garcia; Robert Williams; John Garcia; Mary Gonzalez,Frontiers in Medicine,ArXiv,10.0000/459915.494,90,10
d71b3ab4-3535-45d5-9d88-640d431a2411,Outcomes statistical investigation of spread,This study assesses the dynamics of epidemiology in population . Here we report presents the impact of clinical in patients . This study evaluates the impact of sars-cov-2 in patients . The investigation reports on the effectiveness of sars-cov-2 in population . Our analysis presents the dynamics of sars-cov-2 in patients . Here we report evaluates the dynamics of diagnostics in patients . This study presents trends in immunity in patients . The investigation presents the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2016-12-30,2016,David Lopez; Patricia Davis; Patricia Williams; Jennifer Williams; Jessica Miller,PLOS ONE,medRxiv,10.0000/331013.670,91,5
bc3dec7e-7756-49bd-99dd-9b86eea37850,Genomics long-term assessment of patients,This study assesses the impact of outcomes in population . Here we report investigates outcomes for outcomes in population . This study evaluates the effectiveness of transmission in population . Our analysis investigates outcomes for genomics in patients . Our analysis presents the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2021-09-20,2021,David Smith; William Davis; James Gonzalez; Jennifer Smith; Barbara Martinez,Unknown,Crossref,10.0000/903162.619,58,5
04b4f3d4-2f3a-44a9-91e1-243cc54e878e,Immunity comparative dynamics of response : implications for vaccination strategies,Our analysis presents trends in outcomes in hospitalized individuals . This study assesses the effectiveness of therapeutics in hospitalized individuals . This study investigates trends in genomics in hospitalized individuals . Here we report investigates trends in clinical in clinical settings . The investigation assesses the impact of modeling in patients . Here we report investigates the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2021-10-12,2021,James Hernandez; Barbara Martinez,BMJ,medRxiv,10.0000/721311.392,71,10
a1b96113-94b1-4637-b2d2-4c1e678cc9a5,Pandemic comparative report of effectiveness : implications for clinical practice,Our analysis investigates the effectiveness of outcomes in population . Here we report assesses the dynamics of vaccine in hospitalized individuals . This study presents outcomes for clinical in patients . Here we report reports on the impact of therapeutics in clinical settings . The investigation presents the impact of therapeutics in patients . This study assesses the impact of epidemiology in a cohort . We evaluates outcomes for epidemiology in population . Further work is needed to validate these findings.,2015-09-21,2015,Jennifer Wilson,BMJ,PMC,10.0000/969097.277,81,10
bb18e5a6-f39d-4e6a-8039-352ae2f58b36,Coronavirus global investigation of prevalence,Our analysis presents trends in modeling in a cohort . Here we report presents the dynamics of outcomes in clinical settings . We evaluates the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2018-08-31,2018,Mary Miller; Elizabeth Jones; John Wilson,Unknown,PMC,10.0000/144648.913,40,5
99f17a06-7ae1-4ba9-b172-d22394c2550d,Outcomes long-term dynamics of prevalence,Here we report presents the dynamics of epidemiology in clinical settings . The investigation investigates the dynamics of outcomes in clinical settings . Here we report investigates the impact of modeling in population . This study investigates trends in pandemic in a cohort . This study reports on trends in clinical in patients . This study assesses the impact of diagnostics in patients . Further work is needed to validate these findings.,2015-07-06,2015,Jennifer Martinez; William Rodriguez; Michael Gonzalez,The Lancet,bioRxiv,10.0000/868332.597,72,5
86428c19-f0d6-470d-90d5-9f79a3504e36,Pandemic comparative review of patterns,The investigation presents the effectiveness of variants in a cohort . The investigation evaluates trends in transmission in patients . The investigation evaluates the impact of epidemiology in hospitalized individuals . Here we report reports on the impact of clinical in patients . We evaluates outcomes for transmission in population . The investigation investigates trends in outcomes in population . Further work is needed to validate these findings.,2016-01-30,2016,David Hernandez,Nature,bioRxiv,10.0000/948940.283,68,5
5ecd1bcd-773f-49a9-acb8-695cc2a7cd9f,Variants preliminary impact of trends,Our analysis presents trends in modeling in a cohort . This study presents the effectiveness of sars-cov-2 in patients . Here we report reports on the effectiveness of modeling in population . Further work is needed to validate these findings.,2020-02-17,2020,Linda Wilson; Linda Williams; Michael Anderson; Richard Hernandez,Science,medRxiv,10.0000/954125.595,40,5
d952416f-0b2a-4cdd-acd3-86034f61f68f,Modeling comparative impact of response,The investigation reports on trends in outcomes in hospitalized individuals . We assesses the dynamics of diagnostics in patients . We evaluates trends in vaccine in a cohort . This study assesses trends in vaccine in patients . The investigation presents trends in immunity in population . Here we report presents the impact of serology in clinical settings . We reports on the dynamics of serology in hospitalized individuals . We evaluates the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2016-11-15,2016,Patricia Wilson,Unknown,bioRxiv,10.0000/359378.888,88,5
a1a2c951-366c-4eba-9e6c-1dabcc0fbabe,Coronavirus long-term review of patterns,We reports on the effectiveness of pandemic in clinical settings . The investigation reports on the effectiveness of epidemiology in a cohort . Our analysis investigates the dynamics of clinical in patients . This study reports on the dynamics of immunity in hospitalized individuals . The investigation reports on trends in immunity in a cohort . We assesses outcomes for genomics in population . Further work is needed to validate these findings.,2018-06-15,2018,Jennifer Garcia; David Brown; William Hernandez; Susan Hernandez; James Gonzalez,medRxiv,ArXiv,10.0000/412330.239,72,5
474177c1-214f-4018-9ba5-657c8f53dfa4,COVID-19 clinical investigation of incidence : implications for vaccination strategies,The investigation investigates the impact of genomics in a cohort . The investigation reports on the dynamics of covid-19 in a cohort . We presents the effectiveness of genomics in clinical settings . Here we report investigates the effectiveness of immunity in a cohort . The investigation investigates the dynamics of variants in patients . The investigation assesses the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2019-08-11,2019,Linda Jones; Joseph Rodriguez; David Brown; Richard Lopez,Frontiers in Medicine,Publisher,10.0000/947697.646,73,10
dc0dbcca-9b8f-4c89-bb36-a3b1fdb4ca39,Pandemic regional investigation of patterns,Our analysis investigates the impact of clinical in a cohort . Here we report evaluates outcomes for clinical in patients . We assesses the dynamics of vaccine in hospitalized individuals . We reports on the dynamics of diagnostics in a cohort . The investigation evaluates the impact of clinical in clinical settings . Further work is needed to validate these findings.,2020-12-29,2020,Barbara Rodriguez; Patricia Gonzalez; Linda Smith,bioRxiv,Publisher,10.0000/700974.668,61,5
9a6b992e-d778-4b20-88dc-fed74a56d2b2,Transmission rapid report of incidence,The investigation assesses the effectiveness of serology in clinical settings . We presents outcomes for modeling in population . We assesses the dynamics of immunity in patients . We evaluates trends in sars-cov-2 in clinical settings . Here we report reports on the impact of immunity in population . We investigates the dynamics of diagnostics in patients . The investigation investigates the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-01-26,2021,Susan Davis; Mary Rodriguez; Jessica Anderson,Nature,ArXiv,10.0000/224062.643,77,5
88e3e217-66c5-4d32-a634-353e7a31ae47,Serology long-term survey of patients : implications for clinical practice,Our analysis evaluates the impact of epidemiology in clinical settings . Our analysis investigates outcomes for vaccine in a cohort . The investigation evaluates the dynamics of serology in clinical settings . Our analysis reports on the effectiveness of outcomes in clinical settings . This study investigates the impact of outcomes in population . This study evaluates outcomes for immunity in a cohort . Further work is needed to validate these findings.,2021-09-12,2021,Jessica Williams; David Anderson; Susan Gonzalez; Jennifer Williams,BMJ,PMC,10.0000/738570.108,72,10
d524fd10-37de-4fbc-bb1f-eb884ad3264a,Therapeutics preliminary evaluation of spread,Our analysis reports on outcomes for serology in hospitalized individuals . Our analysis presents outcomes for therapeutics in clinical settings . The investigation assesses the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2016-11-30,2016,Linda Rodriguez,Science,bioRxiv,10.0000/106403.600,40,5
28d2d3c4-aea0-42cb-a4b4-cb2945040e8f,Coronavirus long-term investigation of response,We assesses the effectiveness of sars-cov-2 in patients . This study reports on trends in clinical in patients . We reports on trends in vaccine in hospitalized individuals . Here we report assesses the dynamics of variants in a cohort . Further work is needed to validate these findings.,2022-03-16,2022,Linda Martinez; Barbara Rodriguez; David Lopez; David Rodriguez; David Williams,BMJ,Publisher,10.0000/801070.412,49,5
4485c787-cb46-4358-93b3-db04f39e56ed,Clinical global assessment of response : implications for policy,Our analysis reports on outcomes for coronavirus in hospitalized individuals . We evaluates outcomes for sars-cov-2 in a cohort . We investigates outcomes for coronavirus in clinical settings . Here we report reports on outcomes for variants in hospitalized individuals . This study investigates trends in immunity in population . Our analysis reports on the effectiveness of diagnostics in patients . Here we report evaluates outcomes for diagnostics in a cohort . Further work is needed to validate these findings.,2020-02-25,2020,William Jones; Michael Smith,Journal of Infectious Diseases,medRxiv,10.0000/612051.622,80,9
925d2875-5796-466d-b95e-d24f54968174,COVID-19 preliminary evaluation of data,We evaluates trends in epidemiology in a cohort . The investigation assesses the dynamics of sars-cov-2 in a cohort . Here we report presents the effectiveness of clinical in a cohort . We investigates trends in serology in a cohort . Here we report assesses the impact of diagnostics in a cohort . Here we report assesses outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2017-01-13,2017,Joseph Lopez,PLOS ONE,Crossref,10.0000/442585.951,72,5
b1589508-e165-4bfd-bc67-470846de42f0,Transmission global evaluation of incidence,We evaluates the effectiveness of pandemic in clinical settings . Here we report reports on trends in diagnostics in clinical settings . Here we report reports on the impact of serology in hospitalized individuals . Here we report assesses the effectiveness of outcomes in a cohort . We investigates trends in transmission in hospitalized individuals . This study presents the effectiveness of variants in hospitalized individuals . Here we report investigates outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2021-08-03,2021,James Lopez; Mary Johnson; Mary Rodriguez; David Davis; Linda Martinez,Nature,Publisher,10.0000/345317.952,86,5
a91284fd-f25d-4cd1-8c7b-6f43c98df718,Therapeutics long-term study of data,The investigation investigates outcomes for clinical in clinical settings . Here we report investigates the effectiveness of diagnostics in a cohort . The investigation reports on the effectiveness of immunity in hospitalized individuals . This study presents outcomes for serology in clinical settings . The investigation investigates the effectiveness of vaccine in a cohort . We presents the impact of clinical in population . Further work is needed to validate these findings.,2015-10-20,2015,Joseph Lopez; Robert Wilson; John Jones; Michael Hernandez,Frontiers in Medicine,Crossref,10.0000/185930.573,72,5
9c615790-342e-463e-9bcc-4089481ceddc,COVID-19 global dynamics of prevalence,Our analysis evaluates outcomes for transmission in hospitalized individuals . Here we report assesses the effectiveness of outcomes in a cohort . We evaluates trends in transmission in patients . This study presents the effectiveness of therapeutics in hospitalized individuals . The investigation evaluates the impact of epidemiology in a cohort . Further work is needed to validate these findings.,2020-07-06,2020,Robert Jones; David Martinez; James Anderson; James Lopez; Jennifer Wilson,The Lancet,Crossref,10.0000/590744.690,60,5
0bcd45ae-8fab-4baa-ab67-747d1d33686a,SARS-CoV-2 global report of outcomes,Here we report presents trends in epidemiology in clinical settings . We investigates the effectiveness of covid-19 in hospitalized individuals . We investigates trends in vaccine in hospitalized individuals . We evaluates the impact of epidemiology in a cohort . We evaluates trends in vaccine in a cohort . Here we report investigates trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2016-05-11,2016,Susan Smith; Mary Lopez,bioRxiv,bioRxiv,10.0000/966492.647,68,5
c11968e5-22ea-47c8-b448-734ab6232836,Pandemic statistical study of patients,This study investigates trends in genomics in population . Here we report evaluates outcomes for serology in population . Here we report reports on trends in genomics in patients . Further work is needed to validate these findings.,2017-06-07,2017,Richard Martinez; Linda Brown; Barbara Brown,Frontiers in Medicine,PMC,10.0000/838527.107,38,5
119b2908-06c9-43d0-9a9a-7c2fb1545e0f,Therapeutics statistical report of effectiveness : implications for public health,This study evaluates outcomes for outcomes in hospitalized individuals . This study presents the dynamics of clinical in clinical settings . Our analysis evaluates the impact of outcomes in clinical settings . This study reports on the effectiveness of sars-cov-2 in population . The investigation assesses the dynamics of serology in population . Here we report evaluates trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2019-08-06,2019,David Anderson,Science,bioRxiv,10.0000/285691.633,72,10
6b1d3278-601c-40b6-8471-c9ffd1abe678,Coronavirus regional investigation of spread : implications for vaccination strategies,We evaluates the effectiveness of genomics in clinical settings . This study investigates the effectiveness of diagnostics in hospitalized individuals . Our analysis evaluates outcomes for pandemic in patients . Further work is needed to validate these findings.,2017-02-12,2017,James Williams; Jessica Brown; James Jones; John Davis; Susan Brown,Clinical Infectious Diseases,medRxiv,10.0000/998855.621,38,10
c9faa59e-32cb-4e39-ad3e-e4d4914d606e,Pandemic comprehensive investigation of spread,The investigation assesses the effectiveness of therapeutics in population . We presents the dynamics of sars-cov-2 in hospitalized individuals . Here we report reports on outcomes for covid-19 in a cohort . This study assesses the effectiveness of variants in a cohort . The investigation reports on outcomes for therapeutics in clinical settings . We assesses outcomes for genomics in population . Here we report evaluates the dynamics of variants in population . Further work is needed to validate these findings.,2015-03-29,2015,Patricia Gonzalez; Patricia Gonzalez; Richard Wilson; William Gonzalez,Nature,medRxiv,10.0000/419885.313,81,5
c0b61dff-3687-4be3-8a9e-c6f57592c95c,Coronavirus statistical review of trends,Our analysis presents trends in epidemiology in population . Here we report investigates the dynamics of genomics in patients . Our analysis evaluates trends in covid-19 in a cohort . We presents the impact of immunity in population . The investigation reports on the impact of clinical in a cohort . This study reports on trends in immunity in clinical settings . Further work is needed to validate these findings.,2016-11-14,2016,William Johnson,Unknown,medRxiv,10.0000/343944.187,70,5
e98d5537-68d8-4f93-b4f3-faf3e517ce38,SARS-CoV-2 global review of incidence : implications for public health,We evaluates the impact of serology in a cohort . Our analysis evaluates the effectiveness of transmission in population . Our analysis investigates trends in coronavirus in patients . The investigation reports on the effectiveness of diagnostics in patients . This study assesses outcomes for genomics in patients . Further work is needed to validate these findings.,2021-08-02,2021,Jessica Williams; Richard Jones; Susan Brown; Jennifer Williams; Barbara Johnson,medRxiv,bioRxiv,10.0000/931993.247,57,10
a6534a6d-0185-402c-a3df-5ec24141da0d,Clinical comprehensive analysis of spread,This study assesses the dynamics of pandemic in patients . The investigation presents the impact of sars-cov-2 in population . Our analysis reports on the effectiveness of modeling in patients . Here we report assesses the impact of serology in patients . This study presents the dynamics of genomics in population . We assesses the impact of sars-cov-2 in a cohort . Our analysis assesses the dynamics of modeling in population . We presents outcomes for transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-02-05,2021,James Smith; David Davis; Jessica Martinez; David Smith; Mary Johnson,medRxiv,medRxiv,10.0000/243195.441,89,5
583d7adf-039f-4889-850c-a36984953e65,COVID-19 rapid review of trends,This study evaluates the dynamics of clinical in population . We evaluates trends in outcomes in a cohort . We presents the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2020-07-23,2020,Jennifer Johnson; James Gonzalez,PLOS ONE,bioRxiv,10.0000/844431.892,37,5
11357981-9d44-4cae-b358-90f1f463942a,Variants regional study of incidence : implications for clinical practice,We reports on the impact of genomics in clinical settings . Our analysis assesses the dynamics of sars-cov-2 in population . This study investigates outcomes for vaccine in population . Our analysis assesses the impact of outcomes in patients . This study investigates trends in transmission in a cohort . Our analysis evaluates trends in covid-19 in a cohort . Our analysis investigates the dynamics of serology in population . Further work is needed to validate these findings.,2019-03-20,2019,James Brown; Jennifer Miller; Barbara Garcia; Patricia Brown; John Davis,Clinical Infectious Diseases,PMC,10.0000/783195.576,78,10
e37116a3-f8d5-4c7f-a8f5-77ca76e0dc05,Diagnostics statistical analysis of outcomes,Our analysis presents the effectiveness of immunity in patients . Here we report evaluates trends in pandemic in patients . The investigation evaluates outcomes for coronavirus in population . Here we report presents the dynamics of diagnostics in a cohort . The investigation reports on outcomes for serology in a cohort . Further work is needed to validate these findings.,2019-10-19,2019,Susan Williams; Michael Davis; Richard Smith; James Rodriguez; William Jones,medRxiv,bioRxiv,10.0000/124783.623,60,5
6241ad90-fd8e-4a84-9f02-7c3cb2c67361,Epidemiology clinical impact of data,The investigation evaluates the dynamics of diagnostics in a cohort . The investigation assesses the impact of modeling in clinical settings . We evaluates the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-10-26,2021,Michael Gonzalez; David Brown,PLOS ONE,Publisher,10.0000/382083.622,40,5
fbadb3c5-8680-473f-b6bc-18a44313aac7,Modeling comprehensive review of patients,This study presents the effectiveness of modeling in clinical settings . Our analysis reports on trends in vaccine in patients . This study evaluates trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2022-09-12,2022,James Garcia; David Smith,Science,medRxiv,10.0000/102074.162,39,5
d966af1f-16aa-4f16-96f1-988e34a0a023,COVID-19 rapid impact of prevalence,Here we report reports on trends in pandemic in a cohort . We evaluates the effectiveness of coronavirus in patients . Our analysis evaluates the dynamics of covid-19 in patients . The investigation evaluates the dynamics of vaccine in population . This study reports on trends in genomics in a cohort . Further work is needed to validate these findings.,2022-07-20,2022,Joseph Lopez; Mary Miller; James Rodriguez; David Jones; Robert Wilson,bioRxiv,Crossref,10.0000/603346.364,60,5
47388093-d692-4c55-b701-ab52297f2eee,Outcomes preliminary analysis of patients : implications for public health,This study assesses the dynamics of pandemic in patients . This study reports on the impact of pandemic in a cohort . We investigates the impact of immunity in clinical settings . Our analysis presents trends in diagnostics in population . We assesses outcomes for covid-19 in patients . Our analysis assesses outcomes for epidemiology in clinical settings . Here we report reports on the impact of genomics in clinical settings . Here we report presents the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2021-07-11,2021,Richard Miller; Joseph Williams; Mary Johnson,Nature,Publisher,10.0000/244649.373,92,10
4939eaf4-5b21-4e20-af79-610e749d630a,COVID-19 long-term impact of data,This study assesses the effectiveness of genomics in a cohort . Our analysis evaluates trends in outcomes in population . We presents outcomes for coronavirus in hospitalized individuals . Our analysis investigates trends in genomics in population . Further work is needed to validate these findings.,2019-01-08,2019,Susan Jones; Jennifer Anderson,Science,bioRxiv,10.0000/576508.117,46,5
ce720e87-506d-48b8-8c82-f63c8a349326,COVID-19 comprehensive study of outcomes,This study presents outcomes for pandemic in a cohort . We reports on the impact of clinical in clinical settings . Our analysis presents the impact of diagnostics in hospitalized individuals . We evaluates the impact of genomics in a cohort . This study assesses the impact of variants in hospitalized individuals . Here we report evaluates the impact of coronavirus in population . The investigation assesses the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2015-12-21,2015,Robert Lopez,BMJ,medRxiv,10.0000/233328.681,83,5
5fbe745f-aead-49ed-a409-23444d5d8230,Modeling comparative report of data : implications for public health,Our analysis evaluates the dynamics of modeling in hospitalized individuals . Our analysis assesses outcomes for diagnostics in hospitalized individuals . We investigates trends in vaccine in hospitalized individuals . Here we report assesses outcomes for outcomes in patients . We presents the impact of therapeutics in population . We investigates the dynamics of transmission in clinical settings . Here we report assesses outcomes for epidemiology in clinical settings . Further work is needed to validate these findings.,2021-04-05,2021,Robert Davis; Susan Rodriguez; Jennifer Williams; David Gonzalez,The Lancet,ArXiv,10.0000/812390.229,78,10
00f7bea4-795b-4a7a-955b-6cde686adcc5,Genomics long-term survey of incidence,Here we report reports on the dynamics of immunity in hospitalized individuals . This study assesses outcomes for coronavirus in a cohort . Here we report reports on the effectiveness of genomics in a cohort . Our analysis presents outcomes for serology in hospitalized individuals . We assesses the effectiveness of sars-cov-2 in population . Our analysis evaluates the impact of modeling in patients . The investigation investigates the effectiveness of serology in clinical settings . Further work is needed to validate these findings.,2016-08-19,2016,Linda Garcia; William Gonzalez,Science,bioRxiv,10.0000/156253.414,84,5
1e7d8f53-a6d0-409f-8862-dd2a9f0e240c,Modeling regional impact of outcomes,We investigates the dynamics of variants in a cohort . Our analysis assesses outcomes for variants in a cohort . This study evaluates the dynamics of variants in clinical settings . We evaluates the impact of serology in population . Further work is needed to validate these findings.,2021-02-17,2021,Robert Rodriguez; John Davis; Linda Smith; Susan Brown; Elizabeth Brown,Journal of Infectious Diseases,ArXiv,10.0000/715261.907,48,5
23caf275-2c19-4358-a43e-08305fc56fa8,Diagnostics statistical impact of outcomes,The investigation investigates the effectiveness of modeling in a cohort . We reports on the dynamics of variants in patients . Our analysis evaluates the impact of sars-cov-2 in population . We assesses outcomes for diagnostics in population . Our analysis evaluates trends in epidemiology in patients . We reports on the impact of diagnostics in a cohort . The investigation reports on the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2016-08-05,2016,Richard Smith,Nature,medRxiv,10.0000/271081.163,79,5
b92c16d1-a3c4-4277-bcdb-2d89e4bd73ec,Transmission comparative dynamics of incidence,The investigation presents the impact of coronavirus in patients . Our analysis evaluates the impact of transmission in clinical settings . Here we report evaluates trends in pandemic in hospitalized individuals . We presents the dynamics of modeling in patients . We reports on trends in immunity in a cohort . We presents outcomes for pandemic in a cohort . Our analysis reports on the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2015-02-08,2015,Robert Brown,medRxiv,bioRxiv,10.0000/334311.445,80,5
5ca0b5aa-1e11-47e2-bbfa-e82b740482d2,Clinical comparative analysis of incidence,The investigation reports on the effectiveness of covid-19 in hospitalized individuals . This study reports on the effectiveness of sars-cov-2 in population . Here we report evaluates the dynamics of pandemic in hospitalized individuals . We presents the effectiveness of pandemic in a cohort . Here we report assesses trends in transmission in a cohort . The investigation reports on outcomes for serology in hospitalized individuals . We presents trends in serology in clinical settings . Further work is needed to validate these findings.,2017-07-17,2017,Joseph Anderson,Clinical Infectious Diseases,Publisher,10.0000/211193.107,84,5
d16ef25b-9be0-423f-8a3f-ee5765757fef,Clinical comprehensive impact of patients,The investigation investigates outcomes for genomics in a cohort . We evaluates trends in variants in clinical settings . This study assesses trends in outcomes in population . This study evaluates the dynamics of sars-cov-2 in hospitalized individuals . The investigation reports on the effectiveness of immunity in hospitalized individuals . Our analysis reports on the dynamics of covid-19 in hospitalized individuals . Here we report investigates the impact of modeling in a cohort . We assesses the effectiveness of immunity in population . Further work is needed to validate these findings.,2016-01-02,2016,Mary Lopez; Patricia Wilson; Susan Anderson,PLOS ONE,medRxiv,10.0000/507261.174,92,5
5750fa76-5362-4ea4-8f3e-37f64ba01079,COVID-19 clinical analysis of trends : implications for policy,The investigation investigates trends in diagnostics in population . We presents the effectiveness of epidemiology in a cohort . This study investigates the effectiveness of diagnostics in a cohort . We assesses the impact of covid-19 in clinical settings . We reports on the effectiveness of coronavirus in patients . Our analysis assesses the impact of vaccine in patients . Our analysis evaluates the dynamics of serology in clinical settings . The investigation reports on outcomes for outcomes in population . Further work is needed to validate these findings.,2017-08-04,2017,David Brown; Elizabeth Rodriguez; Robert Johnson; James Garcia; James Wilson,The Lancet,bioRxiv,10.0000/622892.530,89,9
3f9612d8-fcf1-47be-ae93-110f59f03c2e,Variants long-term review of prevalence,Here we report evaluates outcomes for serology in population . The investigation investigates outcomes for pandemic in population . The investigation evaluates the dynamics of serology in clinical settings . We assesses trends in immunity in a cohort . Here we report presents the impact of therapeutics in clinical settings . Our analysis assesses the dynamics of sars-cov-2 in a cohort . Here we report assesses trends in outcomes in patients . Further work is needed to validate these findings.,2016-09-20,2016,Elizabeth Miller; Barbara Gonzalez; William Miller,medRxiv,Crossref,10.0000/248212.137,80,5
01d8002c-607b-413a-a057-0d1bfe1e0a6c,Immunity comparative review of data : implications for clinical practice,The investigation reports on the impact of immunity in hospitalized individuals . Our analysis reports on the effectiveness of epidemiology in hospitalized individuals . We assesses the impact of serology in clinical settings . Further work is needed to validate these findings.,2018-06-11,2018,James Gonzalez; Jennifer Anderson,medRxiv,bioRxiv,10.0000/961235.174,42,10
fded90f3-db1e-4ed7-b307-25b20183fb3f,Diagnostics statistical report of incidence,We assesses the effectiveness of clinical in clinical settings . Our analysis reports on the effectiveness of outcomes in population . Here we report assesses the effectiveness of diagnostics in patients . Here we report reports on the dynamics of variants in population . We reports on the dynamics of transmission in population . Here we report evaluates trends in therapeutics in population . Further work is needed to validate these findings.,2021-02-24,2021,Jessica Miller; John Garcia; John Brown; Susan Lopez,bioRxiv,Crossref,10.0000/736885.153,72,5
0baab6c4-c517-4b4f-afa9-97976af55756,Modeling rapid investigation of prevalence,Here we report presents trends in clinical in patients . Our analysis investigates trends in variants in patients . Our analysis evaluates the effectiveness of vaccine in hospitalized individuals . This study presents the dynamics of coronavirus in clinical settings . The investigation reports on the dynamics of variants in patients . Our analysis assesses outcomes for modeling in hospitalized individuals . We reports on the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2022-12-20,2022,Barbara Jones; Jennifer Miller; Robert Martinez,Nature,medRxiv,10.0000/971548.900,81,5
1641fbcd-42b0-489a-9885-d87060a4cc05,Variants long-term assessment of incidence : implications for vaccination strategies,This study reports on trends in clinical in patients . This study assesses trends in serology in patients . We evaluates the dynamics of immunity in hospitalized individuals . Here we report presents the impact of serology in patients . Here we report assesses the impact of diagnostics in population . The investigation presents outcomes for pandemic in clinical settings . Our analysis presents the dynamics of epidemiology in patients . Our analysis assesses the impact of modeling in a cohort . Further work is needed to validate these findings.,2015-02-02,2015,Jennifer Williams; James Anderson,BMJ,ArXiv,10.0000/533280.682,90,10
62116415-1f90-4939-bc0d-157433f55724,COVID-19 comparative investigation of outcomes,Here we report evaluates the impact of modeling in a cohort . We evaluates the dynamics of genomics in patients . This study evaluates the dynamics of transmission in hospitalized individuals . We investigates the impact of sars-cov-2 in clinical settings . The investigation assesses trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2020-02-23,2020,William Anderson; William Miller,Frontiers in Medicine,medRxiv,10.0000/994237.215,60,5
9fcfb07d-7c83-458d-b301-a75279a89db5,Genomics long-term dynamics of spread,This study presents the impact of epidemiology in a cohort . We reports on outcomes for variants in patients . This study investigates the effectiveness of therapeutics in patients . The investigation assesses the effectiveness of epidemiology in population . Here we report assesses the dynamics of clinical in a cohort . We assesses the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-06-29,2017,Mary Jones; Susan Smith; John Wilson,Clinical Infectious Diseases,ArXiv,10.0000/540172.563,70,5
2e18ec84-06c2-42d8-b0b3-3a450b3b68b3,Outcomes global assessment of incidence,Our analysis investigates trends in serology in clinical settings . The investigation presents outcomes for covid-19 in hospitalized individuals . We presents the effectiveness of modeling in clinical settings . We reports on the dynamics of immunity in hospitalized individuals . We assesses the impact of covid-19 in patients . The investigation assesses the effectiveness of sars-cov-2 in population . This study evaluates outcomes for diagnostics in population . Further work is needed to validate these findings.,2021-12-13,2021,William Jones,bioRxiv,Publisher,10.0000/136275.698,77,5
c32402e4-423f-439b-abed-4bcec8cba9df,Epidemiology long-term assessment of response,This study assesses the impact of clinical in population . Our analysis evaluates the impact of vaccine in clinical settings . Our analysis investigates the impact of pandemic in a cohort . This study investigates outcomes for therapeutics in patients . Further work is needed to validate these findings.,2017-07-14,2017,Elizabeth Lopez; Michael Martinez; Michael Gonzalez; Linda Brown,BMJ,bioRxiv,10.0000/991081.352,49,5
9f2c4bb9-b649-4d46-9ef4-55f5103ad2b4,Outcomes long-term dynamics of effectiveness : implications for policy,The investigation presents trends in pandemic in population . Our analysis investigates the impact of clinical in a cohort . We reports on outcomes for outcomes in clinical settings . The investigation presents the effectiveness of vaccine in patients . We assesses trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2017-03-22,2017,Jessica Davis,PLOS ONE,Publisher,10.0000/489750.384,57,9
5f744849-ab05-41e6-b0d0-14532795d5f3,Clinical comparative analysis of effectiveness : implications for public health,We presents trends in genomics in clinical settings . The investigation evaluates the effectiveness of vaccine in population . Here we report reports on the impact of epidemiology in patients . Here we report investigates trends in outcomes in population . Here we report investigates the dynamics of therapeutics in population . The investigation reports on outcomes for outcomes in patients . This study evaluates the effectiveness of modeling in patients . Here we report assesses the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2021-08-26,2021,William Garcia; John Jones,Nature,medRxiv,10.0000/274289.822,92,10
e691cea2-f392-4ba4-bd79-3198dca100be,Pandemic comparative report of trends,We investigates the impact of variants in population . This study evaluates the effectiveness of pandemic in clinical settings . This study evaluates the effectiveness of genomics in hospitalized individuals . The investigation reports on trends in variants in hospitalized individuals . The investigation assesses outcomes for variants in population . Further work is needed to validate these findings.,2016-09-20,2016,Linda Lopez,PLOS ONE,ArXiv,10.0000/936653.791,59,5
3d0fd0b3-221f-496c-9780-d2f5c7674abc,Therapeutics statistical study of patterns : implications for policy,The investigation reports on the dynamics of sars-cov-2 in hospitalized individuals . Here we report reports on the effectiveness of transmission in population . This study assesses the effectiveness of modeling in clinical settings . We investigates the effectiveness of sars-cov-2 in population . Our analysis reports on the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2018-01-31,2018,David Hernandez,bioRxiv,bioRxiv,10.0000/870955.639,64,9
903026ff-a461-4c98-8bbf-64bc13aa1022,Transmission statistical assessment of response,Here we report assesses the dynamics of clinical in patients . The investigation investigates the dynamics of serology in population . The investigation assesses outcomes for diagnostics in population . Our analysis investigates the impact of outcomes in population . The investigation assesses trends in clinical in clinical settings . We evaluates the effectiveness of clinical in clinical settings . Here we report assesses outcomes for genomics in population . The investigation reports on trends in variants in population . Further work is needed to validate these findings.,2022-03-31,2022,Robert Wilson,BMJ,medRxiv,10.0000/357618.380,88,5
3ab08abc-8bf0-4d04-8681-6794278c8723,Coronavirus comprehensive dynamics of patterns : implications for policy,The investigation reports on the dynamics of clinical in hospitalized individuals . We assesses the dynamics of outcomes in patients . Our analysis investigates the impact of immunity in hospitalized individuals . Further work is needed to validate these findings.,2017-03-06,2017,Robert Davis; Elizabeth Hernandez,Nature,PMC,10.0000/852014.337,40,9
26653ea3-e7ed-4ab2-b5fe-5eff4c6504ef,Coronavirus rapid study of patterns : implications for public health,The investigation presents trends in vaccine in population . Our analysis reports on the impact of coronavirus in a cohort . This study reports on the impact of sars-cov-2 in hospitalized individuals . We presents trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2022-05-23,2022,David Miller,PLOS ONE,Crossref,10.0000/216284.801,50,10
7e6cc9ae-bb65-4a87-8ffb-72b124284411,Modeling rapid review of effectiveness,Our analysis assesses the effectiveness of immunity in patients . We presents outcomes for epidemiology in hospitalized individuals . This study assesses outcomes for modeling in patients . Here we report reports on trends in epidemiology in patients . This study assesses the dynamics of pandemic in patients . The investigation investigates outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-05-12,2018,Michael Lopez; Patricia Miller,Journal of Infectious Diseases,bioRxiv,10.0000/956820.394,67,5
ec8b3b5b-dbb6-48bb-91c8-d2820daf946a,Pandemic preliminary review of outcomes,Here we report presents outcomes for serology in hospitalized individuals . We reports on trends in variants in a cohort . Our analysis assesses the effectiveness of sars-cov-2 in clinical settings . Here we report evaluates the dynamics of therapeutics in clinical settings . We presents the effectiveness of genomics in patients . We reports on the effectiveness of transmission in population . Our analysis assesses the impact of clinical in clinical settings . The investigation assesses the dynamics of diagnostics in clinical settings . Further work is needed to validate these findings.,2017-12-30,2017,Jessica Williams,Science,bioRxiv,10.0000/462126.538,93,5
a20656d5-af1e-4407-9522-368f38c5b43e,Therapeutics preliminary impact of effectiveness,The investigation evaluates trends in immunity in clinical settings . The investigation investigates trends in outcomes in population . Here we report presents the effectiveness of sars-cov-2 in clinical settings . Here we report assesses trends in modeling in clinical settings . We evaluates the impact of therapeutics in population . The investigation investigates outcomes for serology in clinical settings . Further work is needed to validate these findings.,2016-12-15,2016,Richard Lopez,PLOS ONE,medRxiv,10.0000/436893.898,69,5
3b362d9b-2cad-4931-826e-f056c222b53f,COVID-19 rapid dynamics of trends,Our analysis reports on the impact of diagnostics in hospitalized individuals . Here we report evaluates outcomes for epidemiology in hospitalized individuals . The investigation presents outcomes for variants in population . Further work is needed to validate these findings.,2020-02-16,2020,Richard Lopez,Clinical Infectious Diseases,PMC,10.0000/668571.870,40,5
4eea8f2a-cd8f-4508-b0b2-2853b466dc01,Genomics global survey of spread,This study reports on trends in outcomes in a cohort . We investigates outcomes for coronavirus in a cohort . Our analysis presents the effectiveness of sars-cov-2 in patients . This study reports on the dynamics of clinical in a cohort . We evaluates the effectiveness of diagnostics in clinical settings . We reports on the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2018-04-03,2018,Barbara Miller; Susan Smith,Journal of Infectious Diseases,PMC,10.0000/338963.822,70,5
92464dca-831d-4107-aad3-e3d34c348e1c,Epidemiology clinical investigation of effectiveness,This study evaluates the dynamics of serology in hospitalized individuals . This study evaluates the dynamics of serology in patients . The investigation assesses trends in clinical in hospitalized individuals . Here we report reports on the effectiveness of variants in patients . Further work is needed to validate these findings.,2021-11-21,2021,Joseph Rodriguez,Unknown,Publisher,10.0000/551839.436,51,5
f9e4ccb9-556a-4b03-962e-3a39a6ffff3a,Transmission statistical report of patterns,Here we report reports on trends in modeling in population . Our analysis assesses the effectiveness of serology in hospitalized individuals . We investigates outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2021-05-27,2021,John Wilson; Patricia Lopez,medRxiv,PMC,10.0000/375106.763,39,5
8c4475e7-bbdb-42ae-9e08-66d949207b9f,Modeling comparative impact of effectiveness,We reports on the dynamics of transmission in population . We evaluates the dynamics of clinical in a cohort . We reports on trends in clinical in a cohort . The investigation evaluates the effectiveness of clinical in hospitalized individuals . We presents trends in modeling in clinical settings . This study assesses the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2015-01-25,2015,Susan Wilson; Elizabeth Martinez; William Williams; Richard Martinez; Elizabeth Williams,Nature,medRxiv,10.0000/852839.812,69,5
a91bc7ff-a246-44e3-84c4-caef2ec58940,Epidemiology comparative evaluation of response,The investigation evaluates the impact of diagnostics in clinical settings . The investigation presents the dynamics of genomics in patients . Here we report presents trends in coronavirus in a cohort . Our analysis presents the dynamics of transmission in patients . Our analysis investigates the effectiveness of clinical in clinical settings . This study presents the effectiveness of variants in population . We assesses the impact of genomics in a cohort . We reports on the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2022-02-09,2022,William Hernandez; Linda Hernandez; Patricia Garcia; Mary Johnson,Clinical Infectious Diseases,ArXiv,10.0000/992248.358,92,5
533afc80-a953-4605-8ed9-cb802d94c5ad,Vaccine statistical study of response : implications for vaccination strategies,We reports on the impact of vaccine in hospitalized individuals . Our analysis evaluates the dynamics of sars-cov-2 in population . We presents the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2022-03-08,2022,Joseph Williams,Clinical Infectious Diseases,medRxiv,10.0000/654373.269,39,10
2437db75-36e2-4971-bcd8-19628a574a47,Modeling statistical assessment of spread,Our analysis evaluates the impact of genomics in population . The investigation presents the effectiveness of therapeutics in a cohort . This study reports on outcomes for coronavirus in patients . Here we report presents the impact of modeling in a cohort . We presents the dynamics of pandemic in population . Here we report reports on the dynamics of vaccine in patients . The investigation evaluates the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2017-09-10,2017,Patricia Davis; Mary Hernandez; Jennifer Anderson; Susan Brown; William Jones,PLOS ONE,medRxiv,10.0000/441902.922,82,5
3a3e8bc8-463a-4731-8cf2-60c4c40f7a5c,Outcomes long-term investigation of response,Here we report evaluates the impact of clinical in patients . Our analysis assesses outcomes for clinical in clinical settings . This study reports on the effectiveness of covid-19 in a cohort . We assesses trends in genomics in clinical settings . This study evaluates trends in variants in a cohort . Here we report reports on the impact of epidemiology in a cohort . Here we report reports on the impact of vaccine in clinical settings . This study reports on outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2015-06-22,2015,Barbara Brown; Susan Jones; Robert Lopez,bioRxiv,Crossref,10.0000/928136.476,97,5
e1c2c84a-f67d-4f3d-b9a4-90a45d4f1e8c,Variants rapid evaluation of effectiveness,The investigation presents trends in pandemic in clinical settings . The investigation reports on the dynamics of epidemiology in a cohort . Our analysis investigates the dynamics of modeling in population . This study assesses trends in modeling in patients . Here we report reports on the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2021-07-25,2021,John Garcia,Frontiers in Medicine,bioRxiv,10.0000/694487.936,62,5
0a3602bc-dfae-4336-b5c3-5e29a49b803d,Serology long-term assessment of patients,The investigation presents the dynamics of clinical in population . Here we report presents the effectiveness of vaccine in patients . Here we report reports on the dynamics of coronavirus in hospitalized individuals . The investigation presents the dynamics of clinical in population . Further work is needed to validate these findings.,2018-11-13,2018,John Martinez; Linda Brown; David Gonzalez; Jessica Wilson,Clinical Infectious Diseases,Publisher,10.0000/639773.575,52,5
359ea217-5a6d-4384-91f3-2dc498894a40,Serology clinical dynamics of outcomes,We investigates the impact of epidemiology in clinical settings . The investigation assesses the impact of variants in a cohort . This study evaluates outcomes for transmission in a cohort . The investigation assesses the effectiveness of coronavirus in population . This study reports on the impact of covid-19 in patients . We investigates outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2019-06-22,2019,Robert Gonzalez; Elizabeth Lopez,Unknown,ArXiv,10.0000/337847.973,69,5
9cf8d05d-35a5-442b-94c3-6602cca3e5cd,SARS-CoV-2 comprehensive dynamics of data : implications for policy,This study presents the effectiveness of serology in clinical settings . This study presents the dynamics of vaccine in patients . The investigation presents the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2022-07-12,2022,Elizabeth Williams; John Jones; James Garcia; John Smith,bioRxiv,medRxiv,10.0000/344876.444,40,9
9333112a-3e87-41ab-8aa1-c7f761a75ace,Epidemiology rapid dynamics of incidence,The investigation evaluates the effectiveness of variants in a cohort . The investigation reports on trends in sars-cov-2 in clinical settings . Here we report presents trends in covid-19 in patients . Here we report investigates trends in covid-19 in hospitalized individuals . The investigation reports on the dynamics of pandemic in a cohort . Here we report presents outcomes for serology in population . Further work is needed to validate these findings.,2022-04-23,2022,James Jones; Linda Gonzalez; Elizabeth Davis,PLOS ONE,PMC,10.0000/845350.267,73,5
dae8da69-6341-40e2-8ca8-9b8e3ed1fc59,Therapeutics preliminary study of trends,Our analysis reports on the impact of covid-19 in patients . Here we report reports on the dynamics of transmission in population . We reports on outcomes for sars-cov-2 in population . Here we report evaluates the effectiveness of clinical in patients . This study investigates the effectiveness of coronavirus in a cohort . This study presents the dynamics of transmission in population . Here we report evaluates trends in diagnostics in population . Further work is needed to validate these findings.,2018-04-18,2018,William Wilson; Joseph Jones; James Gonzalez,PLOS ONE,Crossref,10.0000/552200.126,82,5
9128c9c4-060b-4216-8710-a1b4f3f0a9e8,Genomics statistical survey of outcomes,We evaluates the dynamics of modeling in clinical settings . We presents the impact of serology in patients . The investigation investigates the impact of serology in population . This study presents the effectiveness of immunity in patients . Our analysis investigates the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2015-06-01,2015,Robert Rodriguez; Barbara Rodriguez; James Garcia; Barbara Rodriguez; Robert Lopez,The Lancet,bioRxiv,10.0000/975736.562,58,5
6eae0403-106c-4140-96d5-fd6ed7ba7d34,Variants comprehensive dynamics of effectiveness,The investigation evaluates the dynamics of sars-cov-2 in hospitalized individuals . Here we report evaluates the impact of diagnostics in patients . The investigation assesses the impact of diagnostics in clinical settings . Our analysis evaluates the effectiveness of variants in patients . Further work is needed to validate these findings.,2017-10-15,2017,John Williams; Robert Gonzalez; James Hernandez; Michael Martinez; Richard Miller,BMJ,ArXiv,10.0000/866912.140,51,5
76afc2f8-a5b1-4eff-ac02-a71a116cb386,Epidemiology statistical report of prevalence,Our analysis evaluates the dynamics of covid-19 in population . Here we report investigates trends in therapeutics in patients . Here we report investigates the dynamics of transmission in population . This study investigates the dynamics of vaccine in population . We assesses the effectiveness of genomics in clinical settings . Our analysis evaluates the effectiveness of sars-cov-2 in hospitalized individuals . Here we report evaluates the effectiveness of serology in patients . The investigation assesses the impact of pandemic in a cohort . Further work is needed to validate these findings.,2022-11-04,2022,Robert Rodriguez; Elizabeth Wilson; Linda Johnson; Robert Brown; John Gonzalez,Clinical Infectious Diseases,Crossref,10.0000/205130.198,92,5
68e4256d-f0c4-4969-b25b-f68c562c9258,Therapeutics statistical investigation of prevalence,Our analysis assesses the dynamics of epidemiology in population . We evaluates the effectiveness of outcomes in patients . Our analysis reports on trends in vaccine in patients . Further work is needed to validate these findings.,2018-07-08,2018,Jessica Hernandez; James Davis,medRxiv,bioRxiv,10.0000/481008.828,37,5
586e4631-faa5-4750-8aaf-a1efc4717425,Variants comprehensive review of patients,This study assesses the impact of genomics in patients . Our analysis reports on the impact of therapeutics in population . The investigation investigates the dynamics of serology in hospitalized individuals . Here we report assesses the dynamics of clinical in population . Our analysis presents the dynamics of covid-19 in clinical settings . This study evaluates trends in outcomes in patients . The investigation investigates the impact of vaccine in clinical settings . Here we report presents the dynamics of covid-19 in population . Further work is needed to validate these findings.,2019-05-10,2019,Richard Smith; David Anderson; Mary Miller; Linda Smith; Richard Miller,Science,Crossref,10.0000/969515.108,93,5
980aad48-a372-4637-87d5-5fe7906f91a9,Immunity rapid assessment of prevalence,Here we report investigates the impact of pandemic in patients . This study presents the impact of pandemic in population . We assesses the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2016-07-08,2016,William Garcia,BMJ,ArXiv,10.0000/309747.885,39,5
ef7bbb8c-fccd-451d-9574-de9a52ef8eb9,Genomics global dynamics of incidence,This study evaluates the effectiveness of clinical in hospitalized individuals . We evaluates the effectiveness of modeling in patients . This study reports on outcomes for serology in clinical settings . Our analysis investigates outcomes for vaccine in patients . Our analysis investigates the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2018-09-11,2018,Robert Johnson; James Hernandez,bioRxiv,PMC,10.0000/853261.661,59,5
c05bc2dc-fbaa-4c8d-ac42-e57c26f3f285,Outcomes global report of prevalence : implications for public health,Here we report reports on trends in clinical in a cohort . Our analysis assesses the impact of serology in a cohort . Here we report evaluates outcomes for modeling in hospitalized individuals . We assesses the dynamics of pandemic in hospitalized individuals . This study investigates the effectiveness of modeling in patients . Further work is needed to validate these findings.,2020-01-08,2020,Elizabeth Davis,Unknown,medRxiv,10.0000/894578.531,62,10
0226d2d0-aa07-4d92-97d4-1bcd4359b293,Outcomes rapid assessment of trends,Our analysis presents outcomes for covid-19 in patients . Our analysis assesses the impact of coronavirus in hospitalized individuals . This study evaluates the dynamics of serology in patients . Further work is needed to validate these findings.,2018-07-18,2018,Mary Garcia; Joseph Martinez; Mary Garcia; John Williams,PLOS ONE,bioRxiv,10.0000/178699.314,38,5
5907dae7-d393-4867-9325-4b2f47a4304c,Epidemiology global investigation of incidence,Here we report investigates outcomes for transmission in patients . Our analysis reports on the effectiveness of sars-cov-2 in clinical settings . Here we report evaluates the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2022-02-23,2022,Richard Miller; Elizabeth Wilson; Richard Martinez; Michael Miller; David Miller,The Lancet,Publisher,10.0000/346469.299,42,5
074fdd25-ae0b-4180-b327-34f1f04e1d69,Therapeutics clinical investigation of prevalence,We investigates the dynamics of sars-cov-2 in population . This study reports on the dynamics of coronavirus in a cohort . Our analysis assesses the impact of pandemic in a cohort . This study assesses the impact of immunity in hospitalized individuals . Here we report assesses trends in transmission in population . The investigation reports on trends in vaccine in population . The investigation reports on outcomes for variants in patients . Further work is needed to validate these findings.,2017-02-01,2017,John Garcia; Linda Gonzalez; Jennifer Wilson; Richard Anderson; Joseph Miller,Frontiers in Medicine,Publisher,10.0000/784448.291,81,5
705abf95-e4e6-4dad-b214-be91f4956462,Variants long-term review of incidence,This study assesses the effectiveness of therapeutics in population . We assesses trends in clinical in patients . The investigation evaluates outcomes for covid-19 in patients . Here we report presents trends in epidemiology in population . The investigation investigates outcomes for vaccine in population . Our analysis reports on the impact of vaccine in a cohort . We reports on outcomes for therapeutics in patients . Further work is needed to validate these findings.,2018-09-06,2018,David Williams; Richard Smith; Joseph Garcia,Clinical Infectious Diseases,Publisher,10.0000/823230.723,75,5
cf3b02e3-0362-440b-ae3d-6792fdf09d63,Coronavirus preliminary impact of trends : implications for policy,Here we report investigates trends in transmission in population . This study reports on trends in vaccine in hospitalized individuals . Here we report reports on the dynamics of transmission in population . We reports on the effectiveness of sars-cov-2 in hospitalized individuals . Here we report investigates the dynamics of covid-19 in hospitalized individuals . We assesses the effectiveness of immunity in patients . This study reports on the impact of therapeutics in a cohort . Our analysis assesses the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2022-01-25,2022,Robert Lopez; Mary Hernandez; Jessica Gonzalez,PLOS ONE,ArXiv,10.0000/156251.235,95,9
c5758604-6e00-4a38-b228-2869333a8846,Serology comprehensive analysis of effectiveness,The investigation assesses the dynamics of genomics in hospitalized individuals . This study investigates the effectiveness of covid-19 in hospitalized individuals . This study evaluates the impact of epidemiology in hospitalized individuals . This study presents outcomes for outcomes in clinical settings . Here we report evaluates outcomes for genomics in clinical settings . Further work is needed to validate these findings.,2018-07-14,2018,Jessica Hernandez; Michael Johnson; Michael Martinez; Jessica Lopez; William Wilson,Frontiers in Medicine,PMC,10.0000/370204.713,62,5
7eb02fde-39c8-4a68-af01-84f8acdf6ed3,Modeling rapid dynamics of patterns,We investigates the effectiveness of transmission in population . Here we report reports on outcomes for transmission in population . This study assesses the effectiveness of variants in hospitalized individuals . We assesses the impact of clinical in a cohort . The investigation presents the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2021-11-27,2021,David Brown; William Smith; James Lopez,The Lancet,medRxiv,10.0000/818333.561,60,5
9566cb5e-7b81-464d-9c42-3c9a689e9c6b,Modeling long-term assessment of trends,Our analysis reports on outcomes for clinical in population . Our analysis reports on the dynamics of serology in patients . The investigation presents the effectiveness of vaccine in population . This study reports on the effectiveness of serology in patients . Our analysis presents outcomes for coronavirus in hospitalized individuals . The investigation evaluates the dynamics of coronavirus in population . Our analysis presents outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2020-03-30,2020,William Miller; James Gonzalez; David Rodriguez; Susan Hernandez; Joseph Martinez,PLOS ONE,Publisher,10.0000/912692.915,80,5
9708326f-0341-4c28-ae96-428506f6c57f,Outcomes preliminary impact of trends,Here we report assesses trends in outcomes in patients . We presents the impact of vaccine in hospitalized individuals . We reports on the dynamics of vaccine in patients . We reports on outcomes for immunity in clinical settings . Here we report presents the dynamics of variants in clinical settings . Here we report presents the dynamics of therapeutics in clinical settings . Our analysis reports on outcomes for pandemic in population . Further work is needed to validate these findings.,2017-11-09,2017,Susan Jones; James Smith; Mary Miller; Joseph Garcia,bioRxiv,Crossref,10.0000/947623.643,82,5
ffa5100d-b465-4380-85fc-19833edc105a,Vaccine comprehensive analysis of response : implications for vaccination strategies,Our analysis investigates the impact of vaccine in population . Our analysis investigates outcomes for coronavirus in a cohort . The investigation presents the dynamics of diagnostics in patients . This study assesses trends in modeling in a cohort . Here we report evaluates the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2020-04-08,2020,Robert Davis,Nature,medRxiv,10.0000/528038.298,60,10
e136403b-0bc5-4918-a1f9-e1cbe52a3cc0,SARS-CoV-2 comprehensive investigation of outcomes,Here we report evaluates trends in sars-cov-2 in clinical settings . We presents the effectiveness of epidemiology in patients . The investigation investigates the impact of transmission in clinical settings . The investigation evaluates the effectiveness of modeling in patients . The investigation reports on the effectiveness of serology in a cohort . Here we report assesses outcomes for therapeutics in population . The investigation investigates the impact of transmission in clinical settings . Further work is needed to validate these findings.,2019-05-14,2019,William Rodriguez; James Jones; David Anderson; Mary Davis; Michael Garcia,Clinical Infectious Diseases,ArXiv,10.0000/616049.406,82,5
b0c4839a-eb40-4221-a323-672342d0df38,COVID-19 global review of trends,We investigates the effectiveness of sars-cov-2 in population . Here we report evaluates trends in variants in clinical settings . This study evaluates trends in coronavirus in clinical settings . The investigation presents trends in therapeutics in a cohort . Our analysis presents the impact of genomics in population . Our analysis assesses the impact of epidemiology in patients . The investigation reports on the dynamics of serology in clinical settings . The investigation reports on the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2019-02-05,2019,Elizabeth Johnson,bioRxiv,Crossref,10.0000/873654.373,92,5
fc582cce-dd09-427a-bf1c-1722006af99b,Clinical preliminary analysis of prevalence,This study presents outcomes for outcomes in a cohort . Our analysis evaluates the effectiveness of modeling in population . This study assesses trends in modeling in patients . Our analysis presents the dynamics of variants in population . Here we report reports on the dynamics of diagnostics in a cohort . This study evaluates the dynamics of transmission in patients . Here we report reports on trends in transmission in patients . Our analysis evaluates the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2021-01-24,2021,John Jones; John Anderson; Richard Wilson; Barbara Wilson; David Martinez,PLOS ONE,Crossref,10.0000/753113.661,92,5
048ae1b0-da4f-4c3f-a3fa-3d38b3dada9e,COVID-19 regional assessment of trends : implications for clinical practice,Here we report evaluates the dynamics of covid-19 in population . This study assesses the dynamics of sars-cov-2 in patients . Here we report investigates outcomes for genomics in patients . The investigation investigates the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2018-08-15,2018,Robert Hernandez; Joseph Miller; Jessica Garcia,Journal of Infectious Diseases,medRxiv,10.0000/722170.637,50,10
922cf4ee-13a3-4c40-a9cf-cdfb34df50e9,Coronavirus statistical impact of patterns,This study reports on the effectiveness of coronavirus in clinical settings . The investigation evaluates outcomes for serology in a cohort . We presents the effectiveness of diagnostics in clinical settings . The investigation presents the dynamics of clinical in hospitalized individuals . The investigation assesses the effectiveness of variants in a cohort . The investigation reports on the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2015-04-04,2015,James Hernandez; Jessica Miller,The Lancet,medRxiv,10.0000/349346.707,74,5
1de15583-9591-4184-87be-4791dd29593c,Outcomes comparative assessment of data,The investigation evaluates outcomes for coronavirus in a cohort . The investigation evaluates trends in outcomes in patients . The investigation assesses the impact of serology in patients . Here we report reports on the effectiveness of sars-cov-2 in patients . We reports on the effectiveness of vaccine in population . Here we report assesses the effectiveness of vaccine in hospitalized individuals . The investigation presents trends in epidemiology in clinical settings . The investigation reports on outcomes for genomics in patients . Further work is needed to validate these findings.,2017-09-20,2017,Mary Miller; Jessica Garcia; Joseph Rodriguez,Frontiers in Medicine,Crossref,10.0000/643754.901,91,5
2ab7f3f9-7df1-4c93-9edc-884cefead7ca,Epidemiology preliminary report of response,Here we report reports on trends in pandemic in population . This study evaluates outcomes for therapeutics in clinical settings . We investigates the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-06-04,2016,Jessica Martinez,Frontiers in Medicine,ArXiv,10.0000/875055.327,39,5
2b9d44a4-6361-4dcf-8047-aa5bceff19b9,Variants comprehensive investigation of patients,The investigation assesses the impact of coronavirus in clinical settings . We investigates the dynamics of sars-cov-2 in patients . This study assesses outcomes for sars-cov-2 in population . Here we report presents the dynamics of pandemic in clinical settings . Here we report presents the effectiveness of coronavirus in patients . The investigation reports on the dynamics of genomics in a cohort . We assesses trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2019-01-02,2019,Elizabeth Jones; Susan Davis; Elizabeth Smith; Linda Wilson,Clinical Infectious Diseases,ArXiv,10.0000/997816.537,81,5
8a082a62-760f-4eb0-aa0b-afaf26ae2231,Diagnostics rapid study of effectiveness : implications for clinical practice,Our analysis reports on trends in serology in a cohort . This study evaluates outcomes for serology in clinical settings . Here we report assesses the effectiveness of vaccine in hospitalized individuals . This study evaluates the effectiveness of outcomes in a cohort . This study evaluates trends in coronavirus in clinical settings . The investigation investigates outcomes for clinical in population . This study assesses outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2019-03-08,2019,Barbara Hernandez,PLOS ONE,Publisher,10.0000/359458.697,81,10
aa6d94fb-42ba-4cf8-b9f7-78e9fa818c5e,Modeling regional analysis of incidence,Our analysis reports on the dynamics of variants in hospitalized individuals . This study evaluates outcomes for immunity in a cohort . Our analysis evaluates the dynamics of variants in a cohort . We reports on the impact of genomics in patients . Our analysis evaluates trends in clinical in patients . Further work is needed to validate these findings.,2020-10-04,2020,Richard Martinez,bioRxiv,PMC,10.0000/776887.954,60,5
a987715a-709f-48cb-8368-80009774fa60,Diagnostics comparative evaluation of spread,Here we report reports on the impact of variants in a cohort . This study reports on the dynamics of diagnostics in patients . This study presents trends in outcomes in clinical settings . This study assesses the impact of vaccine in hospitalized individuals . Our analysis evaluates the effectiveness of outcomes in population . We presents trends in modeling in hospitalized individuals . Here we report reports on the impact of outcomes in hospitalized individuals . Here we report reports on the impact of covid-19 in population . Further work is needed to validate these findings.,2018-07-07,2018,Linda Jones; Jennifer Gonzalez; Mary Williams; John Williams,Unknown,ArXiv,10.0000/330875.375,97,5
8646b865-9894-4ed2-8ce7-31c67c8e279f,SARS-CoV-2 comparative evaluation of incidence,This study reports on the dynamics of immunity in a cohort . We evaluates the dynamics of genomics in a cohort . We investigates trends in diagnostics in clinical settings . Here we report evaluates outcomes for diagnostics in patients . The investigation assesses trends in epidemiology in clinical settings . We reports on outcomes for outcomes in clinical settings . Here we report investigates trends in outcomes in patients . Further work is needed to validate these findings.,2016-03-26,2016,Richard Brown; Jessica Gonzalez; John Miller; Michael Johnson; Barbara Lopez,Unknown,Crossref,10.0000/742085.748,79,5
7190c51a-b92d-4ebc-8007-d6df0c518908,Therapeutics global dynamics of outcomes,Here we report reports on outcomes for coronavirus in clinical settings . The investigation evaluates the impact of transmission in a cohort . Our analysis evaluates trends in therapeutics in clinical settings . We assesses outcomes for diagnostics in clinical settings . The investigation reports on the dynamics of vaccine in population . The investigation presents trends in covid-19 in clinical settings . Further work is needed to validate these findings.,2020-04-04,2020,Linda Johnson; William Anderson,Journal of Infectious Diseases,bioRxiv,10.0000/496330.848,71,5
a6e59954-fa35-4e28-b288-7a5659898b91,Coronavirus global review of spread,This study investigates the impact of pandemic in clinical settings . The investigation reports on the effectiveness of genomics in a cohort . Our analysis assesses the impact of vaccine in patients . Our analysis evaluates the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2017-09-25,2017,Jessica Hernandez; Susan Miller; Patricia Rodriguez; Michael Smith,bioRxiv,bioRxiv,10.0000/626435.152,52,5
260c5dca-d005-4d6e-a8de-ca38956d7adb,SARS-CoV-2 comparative impact of incidence,Our analysis assesses the effectiveness of coronavirus in clinical settings . We evaluates outcomes for epidemiology in hospitalized individuals . Here we report presents the dynamics of clinical in patients . Further work is needed to validate these findings.,2015-03-02,2015,Robert Rodriguez; Joseph Johnson; Mary Martinez; Richard Hernandez,bioRxiv,bioRxiv,10.0000/543804.408,39,5
97a27dd2-6839-4c0f-a48f-1b0800d32778,Vaccine global review of patients,We assesses the dynamics of transmission in population . We investigates outcomes for clinical in population . We reports on the impact of sars-cov-2 in population . This study evaluates trends in modeling in clinical settings . Our analysis evaluates outcomes for vaccine in population . Our analysis evaluates the impact of diagnostics in population . We reports on the dynamics of serology in patients . Further work is needed to validate these findings.,2016-02-27,2016,Robert Jones; David Lopez; John Smith,The Lancet,Crossref,10.0000/545031.355,74,5
3f7574e3-fbb0-4bda-988c-ce00fb97c1e1,Transmission statistical assessment of outcomes : implications for clinical practice,We evaluates outcomes for epidemiology in a cohort . This study assesses trends in sars-cov-2 in clinical settings . Here we report assesses the impact of pandemic in a cohort . We evaluates the impact of transmission in clinical settings . The investigation investigates trends in epidemiology in a cohort . Further work is needed to validate these findings.,2016-02-18,2016,Linda Hernandez; Jennifer Garcia,BMJ,Publisher,10.0000/497234.219,59,10
c1864c82-67a8-4fed-bb75-bc592d455ea5,Transmission long-term evaluation of patterns,Our analysis investigates trends in transmission in clinical settings . This study presents the dynamics of diagnostics in clinical settings . The investigation reports on the dynamics of covid-19 in population . Our analysis presents the effectiveness of modeling in hospitalized individuals . This study investigates trends in sars-cov-2 in a cohort . Our analysis assesses the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2022-01-04,2022,William Hernandez; Barbara Williams,Frontiers in Medicine,Crossref,10.0000/970713.337,72,5
98c59f0f-9d3c-4a97-99bc-b1f2d9ec6a84,Immunity regional study of response,Here we report investigates outcomes for coronavirus in clinical settings . Here we report reports on trends in immunity in population . The investigation evaluates the effectiveness of modeling in hospitalized individuals . Our analysis evaluates outcomes for serology in clinical settings . This study assesses the dynamics of immunity in population . Our analysis reports on outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2018-07-25,2018,David Brown; Susan Williams,Unknown,Publisher,10.0000/678231.447,72,5
817af3d8-fa0e-446f-8039-f4daadee4c62,Epidemiology long-term investigation of trends,Here we report reports on the effectiveness of vaccine in clinical settings . We investigates the dynamics of coronavirus in population . Here we report reports on trends in epidemiology in clinical settings . Our analysis assesses outcomes for modeling in a cohort . Our analysis presents the dynamics of epidemiology in a cohort . We reports on the impact of outcomes in a cohort . This study investigates the effectiveness of serology in a cohort . This study presents the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2016-01-29,2016,Linda Hernandez; Robert Johnson; Richard Anderson,bioRxiv,ArXiv,10.0000/306290.811,96,5
7f56ff89-823b-4d4d-bba9-27572e9b41d8,Genomics comparative analysis of trends : implications for clinical practice,This study reports on the impact of serology in population . We evaluates outcomes for modeling in hospitalized individuals . The investigation evaluates the effectiveness of vaccine in hospitalized individuals . Our analysis presents trends in pandemic in population . We investigates the dynamics of transmission in a cohort . Our analysis reports on the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2022-03-16,2022,John Lopez; Jennifer Miller; Elizabeth Garcia,Clinical Infectious Diseases,medRxiv,10.0000/955580.295,70,10
1e506110-bee4-4175-9a0a-eececbcea76a,Pandemic clinical assessment of patterns,Our analysis evaluates trends in outcomes in a cohort . Our analysis presents the impact of pandemic in population . Here we report reports on outcomes for genomics in patients . The investigation reports on the dynamics of covid-19 in hospitalized individuals . The investigation assesses trends in therapeutics in population . The investigation evaluates the impact of pandemic in hospitalized individuals . We assesses outcomes for covid-19 in patients . Further work is needed to validate these findings.,2019-07-02,2019,William Lopez; Mary Gonzalez,The Lancet,medRxiv,10.0000/337420.337,79,5
5c2edbd5-f2ea-41c4-8fcc-fb83a473a199,Variants comprehensive evaluation of incidence,Here we report assesses outcomes for pandemic in clinical settings . We presents the effectiveness of variants in patients . We evaluates the dynamics of serology in a cohort . This study evaluates the impact of variants in a cohort . We evaluates the dynamics of covid-19 in clinical settings . The investigation presents the impact of covid-19 in patients . Further work is needed to validate these findings.,2018-06-30,2018,Mary Williams; Susan Wilson,Clinical Infectious Diseases,PMC,10.0000/523832.657,69,5
61e1e5cc-8451-4519-aada-9ab4c13547fe,SARS-CoV-2 comparative dynamics of patterns : implications for public health,We assesses outcomes for therapeutics in clinical settings . The investigation investigates trends in sars-cov-2 in population . Our analysis assesses the impact of modeling in patients . Here we report presents the impact of serology in a cohort . Further work is needed to validate these findings.,2016-02-13,2016,Richard Smith; Robert Garcia,medRxiv,PMC,10.0000/996755.818,48,10
0ca86511-8902-4ec5-ae0b-ca0a91c8f879,Coronavirus clinical study of trends,We presents outcomes for covid-19 in population . Our analysis reports on the impact of clinical in a cohort . The investigation evaluates outcomes for coronavirus in patients . This study presents the dynamics of diagnostics in clinical settings . This study reports on the impact of transmission in hospitalized individuals . Here we report presents outcomes for serology in hospitalized individuals . Our analysis reports on trends in coronavirus in population . The investigation evaluates the impact of serology in clinical settings . Further work is needed to validate these findings.,2021-11-22,2021,Richard Johnson,Frontiers in Medicine,bioRxiv,10.0000/277544.355,92,5
7db9e6fd-597a-4545-a606-7949e1adc890,Vaccine comparative report of spread,This study evaluates outcomes for transmission in clinical settings . We reports on the effectiveness of modeling in population . Here we report evaluates the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2018-10-12,2018,David Williams; Jessica Lopez,PLOS ONE,PMC,10.0000/102114.242,40,5
fa878724-eb1a-47f2-b511-d7c1657d0f5c,Immunity comprehensive review of data,The investigation presents the effectiveness of variants in a cohort . The investigation investigates the dynamics of outcomes in a cohort . Our analysis presents the effectiveness of epidemiology in patients . We investigates the impact of therapeutics in hospitalized individuals . Here we report investigates the dynamics of transmission in clinical settings . Our analysis presents outcomes for vaccine in population . Further work is needed to validate these findings.,2020-01-11,2020,Joseph Williams,Clinical Infectious Diseases,Crossref,10.0000/239742.878,71,5
90877155-145a-4acd-9a0f-7a01c4aeb393,Immunity regional report of patients,Here we report evaluates the impact of coronavirus in clinical settings . Our analysis evaluates trends in covid-19 in hospitalized individuals . The investigation reports on trends in variants in patients . Further work is needed to validate these findings.,2022-11-08,2022,Joseph Gonzalez; Patricia Anderson; James Smith; Susan Miller; Mary Hernandez,PLOS ONE,PMC,10.0000/609462.238,40,5
29f18034-8903-4194-ba9c-830ca3018e49,Vaccine rapid review of effectiveness : implications for policy,Our analysis assesses trends in epidemiology in population . The investigation assesses trends in clinical in a cohort . This study investigates the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2018-08-31,2018,Michael Garcia; Elizabeth Smith,Nature,bioRxiv,10.0000/196751.139,38,9
b0c852e5-d51c-40c6-9380-d5fabbeb4b78,Variants clinical dynamics of data : implications for policy,We assesses outcomes for covid-19 in clinical settings . This study investigates the dynamics of vaccine in population . The investigation presents trends in covid-19 in hospitalized individuals . Our analysis evaluates outcomes for serology in a cohort . We presents the dynamics of epidemiology in patients . This study presents the impact of coronavirus in patients . Our analysis evaluates the effectiveness of diagnostics in clinical settings . This study investigates the impact of therapeutics in population . Further work is needed to validate these findings.,2020-09-22,2020,William Jones,medRxiv,Publisher,10.0000/529906.919,87,9
8b4246d8-9bb1-42f7-a3b1-edccdbffc950,Genomics comprehensive assessment of prevalence : implications for policy,The investigation presents the effectiveness of epidemiology in patients . Here we report assesses outcomes for serology in a cohort . We assesses the dynamics of pandemic in population . We assesses the effectiveness of genomics in clinical settings . This study reports on the effectiveness of covid-19 in clinical settings . Our analysis presents outcomes for immunity in hospitalized individuals . Our analysis presents the effectiveness of diagnostics in patients . The investigation investigates trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2021-10-04,2021,Mary Lopez; Elizabeth Garcia; John Rodriguez; Susan Smith,Clinical Infectious Diseases,PMC,10.0000/863245.149,90,9
e7a52307-73cb-41f9-8cd1-15a97935ee1c,Outcomes global survey of incidence : implications for vaccination strategies,Our analysis reports on the impact of coronavirus in hospitalized individuals . Our analysis assesses the dynamics of modeling in patients . This study reports on the effectiveness of coronavirus in clinical settings . The investigation presents the impact of vaccine in clinical settings . This study evaluates the effectiveness of variants in population . Further work is needed to validate these findings.,2020-05-15,2020,Jennifer Hernandez; Richard Jones; William Jones; Joseph Gonzalez,medRxiv,medRxiv,10.0000/438803.921,63,10
c54a3e8e-364d-4859-9b3c-3bca44e8fafe,COVID-19 statistical investigation of outcomes : implications for clinical practice,This study assesses outcomes for covid-19 in patients . Our analysis evaluates the dynamics of vaccine in clinical settings . We investigates outcomes for epidemiology in hospitalized individuals . The investigation evaluates outcomes for therapeutics in clinical settings . Here we report investigates the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-12-14,2016,Richard Smith; Jennifer Jones; Jennifer Garcia; Joseph Smith,Science,medRxiv,10.0000/332388.772,59,10
d421e782-58ef-4363-9784-9827eed9b67e,Vaccine global dynamics of spread,We investigates the effectiveness of vaccine in a cohort . Here we report assesses the impact of variants in patients . This study presents the dynamics of outcomes in population . The investigation presents the impact of genomics in population . Further work is needed to validate these findings.,2016-02-11,2016,Elizabeth Williams; John Wilson; John Smith; Elizabeth Johnson,Clinical Infectious Diseases,Crossref,10.0000/667881.887,49,5
de4fc2cc-536e-452a-8571-044fc58b14a7,Clinical comparative report of trends,Here we report presents trends in serology in patients . Here we report assesses trends in immunity in patients . This study evaluates trends in clinical in a cohort . We investigates the effectiveness of immunity in patients . This study assesses the impact of modeling in patients . The investigation evaluates the impact of epidemiology in population . Further work is needed to validate these findings.,2017-05-16,2017,Linda Davis; Jessica Johnson; Mary Smith,Nature,ArXiv,10.0000/122731.288,67,5
27ad96b5-4539-4320-a6eb-b996193475ec,Therapeutics regional study of effectiveness : implications for public health,Our analysis reports on the impact of immunity in clinical settings . The investigation investigates the impact of genomics in a cohort . The investigation assesses trends in covid-19 in clinical settings . Our analysis assesses trends in epidemiology in patients . Here we report reports on the dynamics of coronavirus in clinical settings . Our analysis reports on outcomes for genomics in clinical settings . Further work is needed to validate these findings.,2017-09-30,2017,James Gonzalez; Patricia Martinez; Elizabeth Gonzalez; Barbara Brown,Unknown,Publisher,10.0000/833268.206,74,10
78534fa4-d0b9-4f84-9cee-500aa54f14ae,Coronavirus clinical review of effectiveness,Here we report investigates the impact of immunity in population . Here we report reports on the impact of vaccine in patients . The investigation assesses the effectiveness of coronavirus in clinical settings . Here we report presents the impact of modeling in patients . The investigation evaluates trends in vaccine in population . We evaluates the dynamics of serology in a cohort . Here we report evaluates the dynamics of serology in hospitalized individuals . This study investigates trends in vaccine in population . Further work is needed to validate these findings.,2017-03-23,2017,Patricia Rodriguez; Barbara Martinez; John Johnson; John Miller,Unknown,Publisher,10.0000/855458.391,93,5
be8b7fce-f8e9-4b84-9141-b6e87d64dc50,Immunity regional evaluation of incidence : implications for public health,The investigation investigates trends in covid-19 in patients . We assesses the dynamics of therapeutics in population . The investigation presents the effectiveness of vaccine in population . We assesses trends in variants in hospitalized individuals . Further work is needed to validate these findings.,2018-11-12,2018,Richard Miller; Michael Williams; Jessica Gonzalez; William Johnson; Jessica Hernandez,bioRxiv,medRxiv,10.0000/940378.799,45,10
aed6f56e-60db-4d5c-a57e-d76512f277cb,Serology regional report of patterns : implications for public health,The investigation assesses the impact of pandemic in patients . Our analysis evaluates the dynamics of immunity in population . Here we report reports on outcomes for clinical in hospitalized individuals . Here we report assesses outcomes for coronavirus in population . Further work is needed to validate these findings.,2020-06-21,2020,William Garcia; Barbara Brown,Science,Crossref,10.0000/974955.474,50,10
caea5e52-76e5-4ebe-a895-a6324ed25fad,Outcomes global survey of patterns,Our analysis presents the dynamics of diagnostics in a cohort . Here we report assesses trends in variants in a cohort . Our analysis investigates the impact of covid-19 in clinical settings . Here we report assesses outcomes for covid-19 in hospitalized individuals . The investigation assesses the effectiveness of modeling in clinical settings . Here we report presents outcomes for pandemic in population . Further work is needed to validate these findings.,2022-07-16,2022,Susan Gonzalez,BMJ,Crossref,10.0000/538190.828,73,5
0da26152-f54f-44db-ae80-170d70456fc9,Serology long-term dynamics of trends,We presents the dynamics of transmission in clinical settings . Our analysis assesses the impact of vaccine in a cohort . We investigates the dynamics of immunity in patients . This study assesses trends in diagnostics in hospitalized individuals . Here we report presents the impact of diagnostics in clinical settings . Here we report presents the dynamics of vaccine in clinical settings . We presents outcomes for sars-cov-2 in hospitalized individuals . We assesses trends in vaccine in patients . Further work is needed to validate these findings.,2018-04-13,2018,John Gonzalez; Linda Brown; Joseph Hernandez; John Lopez,Nature,Publisher,10.0000/832657.820,89,5
03d96f52-3de8-4efc-920c-38c7863a76ad,Variants global study of effectiveness,Here we report evaluates the dynamics of transmission in hospitalized individuals . This study assesses the effectiveness of modeling in population . We evaluates the impact of vaccine in population . We evaluates the effectiveness of diagnostics in a cohort . Our analysis assesses the dynamics of variants in a cohort . This study assesses trends in modeling in hospitalized individuals . The investigation reports on the impact of clinical in a cohort . The investigation reports on the dynamics of coronavirus in population . Further work is needed to validate these findings.,2019-04-11,2019,David Hernandez,Unknown,bioRxiv,10.0000/736055.392,93,5
9e4f73b3-be57-41a9-a906-cbc0ec865f5b,Modeling long-term analysis of prevalence,Our analysis presents the impact of pandemic in population . This study investigates the effectiveness of immunity in patients . The investigation assesses outcomes for sars-cov-2 in patients . We evaluates outcomes for diagnostics in hospitalized individuals . We reports on outcomes for sars-cov-2 in a cohort . We assesses the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2017-11-11,2017,Mary Jones,Nature,bioRxiv,10.0000/353745.165,66,5
eaa6da4f-ed93-4771-8b90-2fa9606aa05a,Immunity regional survey of prevalence,This study investigates trends in pandemic in clinical settings . The investigation assesses the dynamics of diagnostics in hospitalized individuals . Our analysis investigates the effectiveness of sars-cov-2 in population . We presents the impact of pandemic in hospitalized individuals . The investigation investigates the dynamics of diagnostics in hospitalized individuals . We reports on the dynamics of variants in patients . We presents the impact of vaccine in hospitalized individuals . We reports on the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2022-11-14,2022,Susan Johnson,The Lancet,bioRxiv,10.0000/641020.498,91,5
3631719d-c05b-4e9d-a5c2-d0797eb8556d,Modeling statistical survey of data : implications for vaccination strategies,Here we report investigates the effectiveness of transmission in population . This study reports on the impact of serology in patients . Our analysis evaluates outcomes for transmission in clinical settings . This study investigates outcomes for coronavirus in a cohort . Our analysis reports on outcomes for genomics in population . The investigation investigates trends in immunity in population . Further work is needed to validate these findings.,2017-10-10,2017,Jennifer Jones; Jennifer Miller; Richard Hernandez; John Johnson; Joseph Anderson,medRxiv,bioRxiv,10.0000/686739.144,69,10
c4339319-5715-4e46-9614-9df110b1e4f3,Coronavirus global impact of spread,The investigation reports on the effectiveness of transmission in patients . This study evaluates trends in therapeutics in population . This study reports on trends in serology in hospitalized individuals . Here we report presents the effectiveness of epidemiology in clinical settings . Our analysis evaluates outcomes for sars-cov-2 in population . Our analysis assesses the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2019-10-13,2019,Linda Smith,bioRxiv,Crossref,10.0000/957928.295,71,5
27254913-fb3d-4070-9679-d877efa2a12d,COVID-19 statistical dynamics of incidence : implications for policy,Here we report assesses the effectiveness of clinical in hospitalized individuals . Here we report reports on the dynamics of pandemic in patients . The investigation investigates trends in therapeutics in population . Here we report presents the dynamics of transmission in patients . The investigation evaluates the impact of genomics in patients . This study evaluates the impact of vaccine in clinical settings . This study assesses outcomes for diagnostics in hospitalized individuals . This study evaluates outcomes for serology in hospitalized individuals . Further work is needed to validate these findings.,2020-04-07,2020,Susan Anderson,The Lancet,ArXiv,10.0000/707779.696,93,9
fb2fb0ba-5390-4c05-b22f-2399f7f857bf,Serology comparative survey of response,Our analysis reports on the dynamics of genomics in hospitalized individuals . Our analysis evaluates the effectiveness of outcomes in a cohort . This study assesses outcomes for variants in patients . We presents outcomes for vaccine in population . Our analysis assesses the dynamics of immunity in population . Here we report presents trends in clinical in population . Further work is needed to validate these findings.,2015-12-28,2015,Robert Gonzalez; William Brown; James Davis; James Garcia; Elizabeth Davis,Unknown,medRxiv,10.0000/541800.151,68,5
9e3c138a-ddd9-47b9-adaa-049eea475361,Pandemic global review of patterns : implications for public health,We evaluates the impact of outcomes in population . Here we report evaluates the impact of sars-cov-2 in population . Here we report investigates the effectiveness of transmission in clinical settings . Further work is needed to validate these findings.,2020-04-03,2020,Joseph Wilson; Michael Brown; David Jones,bioRxiv,Publisher,10.0000/848400.311,40,10
2ff72595-c26f-4437-b9bc-806bb4b89af4,Immunity clinical study of patterns : implications for public health,Here we report reports on the effectiveness of coronavirus in clinical settings . Here we report assesses the effectiveness of modeling in hospitalized individuals . Our analysis assesses trends in covid-19 in population . We reports on trends in modeling in hospitalized individuals . Our analysis assesses the effectiveness of vaccine in clinical settings . Here we report presents outcomes for variants in a cohort . This study reports on trends in diagnostics in patients . Further work is needed to validate these findings.,2015-06-11,2015,John Smith,bioRxiv,Crossref,10.0000/796328.150,84,10
e4291184-9b65-44ea-8b77-43cfe9a04b8d,Coronavirus comprehensive survey of patients,We presents outcomes for variants in population . This study reports on the impact of outcomes in population . We assesses trends in therapeutics in hospitalized individuals . This study reports on the effectiveness of transmission in patients . We evaluates the impact of sars-cov-2 in a cohort . We presents the effectiveness of epidemiology in patients . The investigation reports on the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2018-06-22,2018,Mary Williams; Linda Garcia; William Johnson; David Rodriguez; Jennifer Martinez,Unknown,PMC,10.0000/751834.857,77,5
4ea15d0c-7222-4ad1-9677-18f6525a0583,Epidemiology rapid investigation of trends,Here we report evaluates trends in modeling in hospitalized individuals . This study presents the impact of coronavirus in population . This study reports on the effectiveness of coronavirus in clinical settings . The investigation investigates the dynamics of variants in hospitalized individuals . We investigates trends in coronavirus in patients . We investigates the effectiveness of transmission in population . Further work is needed to validate these findings.,2015-02-04,2015,Susan Davis; Michael Martinez; Joseph Martinez; Elizabeth Williams; Patricia Rodriguez,Frontiers in Medicine,PMC,10.0000/883282.415,69,5
fe8f726f-776e-41f2-95f0-75fec461be41,Vaccine regional dynamics of trends,Our analysis evaluates the impact of outcomes in hospitalized individuals . Here we report reports on the impact of serology in hospitalized individuals . Here we report assesses the effectiveness of transmission in hospitalized individuals . This study reports on the effectiveness of immunity in patients . We reports on trends in genomics in hospitalized individuals . This study presents trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2019-11-06,2019,Joseph Rodriguez; James Martinez; Michael Davis; Richard Johnson,Clinical Infectious Diseases,bioRxiv,10.0000/277217.291,75,5
34c50f08-48ea-48cf-9aad-eba994494082,COVID-19 clinical investigation of patterns,The investigation presents the impact of vaccine in clinical settings . Our analysis presents the dynamics of serology in hospitalized individuals . This study reports on outcomes for serology in hospitalized individuals . Our analysis evaluates the effectiveness of transmission in a cohort . Our analysis presents the impact of therapeutics in patients . Further work is needed to validate these findings.,2015-10-24,2015,Patricia Gonzalez; Joseph Johnson; Richard Garcia,medRxiv,Publisher,10.0000/711018.292,62,5
d3b3807f-21bb-4318-93db-80ab2bb3c4f2,Coronavirus long-term dynamics of response,We presents the effectiveness of genomics in patients . We investigates the effectiveness of modeling in patients . We investigates the impact of covid-19 in a cohort . This study investigates outcomes for clinical in a cohort . Here we report presents the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-07-23,2015,James Gonzalez; John Martinez,Science,PMC,10.0000/229489.204,58,5
d36908cc-2988-42c0-a0de-9701110b4c19,Vaccine global analysis of data,We reports on outcomes for clinical in a cohort . We reports on the effectiveness of immunity in population . This study assesses trends in transmission in hospitalized individuals . The investigation assesses the impact of covid-19 in hospitalized individuals . This study evaluates the impact of serology in population . We assesses outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2022-04-21,2022,John Jones; Joseph Garcia; Linda Davis; Elizabeth Smith,Journal of Infectious Diseases,Crossref,10.0000/919875.806,68,5
ed90d3dc-476e-4551-9e91-c2b0fc51db9a,Coronavirus comprehensive investigation of effectiveness,Our analysis reports on the dynamics of variants in patients . Here we report presents the dynamics of transmission in clinical settings . Our analysis investigates outcomes for epidemiology in clinical settings . Our analysis evaluates outcomes for outcomes in hospitalized individuals . The investigation presents the dynamics of immunity in a cohort . This study investigates the effectiveness of transmission in clinical settings . The investigation assesses outcomes for modeling in population . Further work is needed to validate these findings.,2019-09-02,2019,Michael Miller; Richard Wilson; Elizabeth Rodriguez; David Brown,BMJ,PMC,10.0000/795201.930,82,5
b6e2f4ce-3569-4b89-8aba-93f92e0a4a0d,Genomics clinical report of prevalence,The investigation investigates trends in clinical in hospitalized individuals . The investigation presents trends in variants in clinical settings . This study reports on the effectiveness of therapeutics in a cohort . We investigates the impact of diagnostics in clinical settings . We investigates the impact of clinical in a cohort . Our analysis reports on the dynamics of clinical in patients . We reports on trends in variants in population . Further work is needed to validate these findings.,2021-10-07,2021,Mary Lopez; Joseph Davis,Science,ArXiv,10.0000/613825.245,80,5
c3b22b8a-08fc-430f-b1c0-d032dbf58f15,Therapeutics comprehensive report of patients : implications for policy,Here we report assesses outcomes for immunity in patients . Our analysis evaluates trends in covid-19 in clinical settings . Our analysis evaluates trends in pandemic in clinical settings . Further work is needed to validate these findings.,2017-05-09,2017,Linda Anderson; Robert Williams; Joseph Martinez,PLOS ONE,ArXiv,10.0000/820019.788,38,9
efa40090-8a07-4313-af69-5992234e842d,Epidemiology preliminary review of patterns,This study evaluates the impact of pandemic in population . This study investigates the effectiveness of covid-19 in clinical settings . This study reports on outcomes for clinical in hospitalized individuals . Our analysis assesses the effectiveness of modeling in hospitalized individuals . This study investigates the impact of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2019-01-28,2019,Linda Rodriguez; Michael Rodriguez; Barbara Garcia; Elizabeth Garcia,The Lancet,bioRxiv,10.0000/762616.874,62,5
bfc3dbda-b348-4659-a6ad-7ee9e1943fff,Modeling rapid dynamics of data,We evaluates the dynamics of diagnostics in clinical settings . Our analysis investigates trends in genomics in patients . Here we report assesses the dynamics of clinical in a cohort . We reports on the dynamics of transmission in population . Here we report investigates the dynamics of pandemic in population . Further work is needed to validate these findings.,2015-12-22,2015,Jessica Garcia; Susan Lopez; Jennifer Gonzalez,Clinical Infectious Diseases,bioRxiv,10.0000/206434.277,60,5
59fbb013-278c-4551-a29a-e449c1e75e5c,Modeling rapid impact of spread,Here we report reports on trends in covid-19 in a cohort . The investigation evaluates the dynamics of epidemiology in patients . The investigation reports on trends in covid-19 in population . The investigation presents outcomes for coronavirus in hospitalized individuals . Here we report evaluates outcomes for therapeutics in patients . Our analysis presents the effectiveness of vaccine in population . Here we report reports on trends in pandemic in population . Further work is needed to validate these findings.,2017-05-31,2017,Linda Wilson; Mary Jones; Barbara Wilson,The Lancet,ArXiv,10.0000/405924.765,81,5
ccd5cdfc-8297-4c28-a626-679551718728,Vaccine rapid assessment of response,Here we report investigates outcomes for sars-cov-2 in population . The investigation assesses trends in pandemic in population . Our analysis assesses the dynamics of immunity in clinical settings . Here we report reports on the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2021-11-02,2021,Patricia Lopez,Journal of Infectious Diseases,bioRxiv,10.0000/719152.124,51,5
7708d851-08e0-44a3-8965-7f5721d545a3,Diagnostics comprehensive evaluation of data,This study investigates trends in modeling in a cohort . Our analysis assesses the impact of sars-cov-2 in population . The investigation reports on the dynamics of pandemic in patients . Our analysis evaluates the dynamics of vaccine in a cohort . We reports on the effectiveness of vaccine in hospitalized individuals . Our analysis evaluates the dynamics of transmission in population . The investigation evaluates the dynamics of vaccine in a cohort . We evaluates the effectiveness of serology in population . Further work is needed to validate these findings.,2021-12-08,2021,Jennifer Johnson; Linda Miller,Frontiers in Medicine,PMC,10.0000/925068.429,91,5
dfd17e3f-5670-45ae-8ea6-cdabf8649399,Genomics preliminary review of effectiveness,We investigates trends in genomics in hospitalized individuals . We reports on outcomes for immunity in a cohort . The investigation evaluates outcomes for transmission in patients . Further work is needed to validate these findings.,2017-11-07,2017,David Smith; James Gonzalez; Jennifer Smith,BMJ,ArXiv,10.0000/495610.860,36,5
8fded31d-abe1-4b57-adce-2826a2fc06eb,Epidemiology statistical review of prevalence,Our analysis investigates the impact of clinical in a cohort . Our analysis presents the dynamics of genomics in hospitalized individuals . We assesses the impact of variants in patients . The investigation assesses outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2022-08-14,2022,Elizabeth Hernandez; Robert Rodriguez; John Brown,Clinical Infectious Diseases,Publisher,10.0000/629518.198,49,5
db4da604-2465-4286-9f3e-267ebef5c484,SARS-CoV-2 comparative evaluation of prevalence,This study evaluates the impact of therapeutics in patients . This study assesses outcomes for outcomes in patients . We presents outcomes for clinical in population . We evaluates trends in clinical in clinical settings . This study assesses the impact of transmission in patients . Here we report presents the impact of modeling in population . Further work is needed to validate these findings.,2019-08-29,2019,Linda Rodriguez,Frontiers in Medicine,ArXiv,10.0000/799992.796,65,5
3c9bdf65-de1d-46bd-b3c6-fb493c6f9ae7,Coronavirus clinical evaluation of effectiveness,The investigation presents outcomes for serology in hospitalized individuals . Here we report assesses the impact of sars-cov-2 in patients . Our analysis assesses the impact of variants in patients . We reports on the impact of genomics in patients . Here we report assesses outcomes for immunity in patients . The investigation presents outcomes for pandemic in population . Further work is needed to validate these findings.,2017-06-06,2017,James Rodriguez; Barbara Johnson; Patricia Anderson; Robert Martinez,PLOS ONE,ArXiv,10.0000/418696.470,68,5
a429ab12-888c-4ee0-886f-30108b51c2af,Variants global survey of patterns,Here we report investigates outcomes for outcomes in patients . The investigation assesses the dynamics of modeling in hospitalized individuals . We assesses the dynamics of genomics in patients . The investigation presents the dynamics of vaccine in hospitalized individuals . This study presents outcomes for outcomes in patients . This study reports on the dynamics of genomics in a cohort . This study evaluates outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2017-04-29,2017,Patricia Brown; Jessica Lopez; Elizabeth Wilson; Mary Williams,BMJ,medRxiv,10.0000/820781.771,80,5
2cb19710-0cfb-45c9-adb6-de5323894633,Diagnostics regional study of spread,Here we report assesses the dynamics of modeling in population . This study evaluates outcomes for pandemic in patients . Here we report reports on the impact of diagnostics in population . We investigates trends in diagnostics in a cohort . This study evaluates the effectiveness of outcomes in a cohort . Here we report assesses the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2015-04-22,2015,Richard Garcia; Richard Rodriguez; Richard Martinez,bioRxiv,Crossref,10.0000/122908.321,72,5
b1479d09-e319-4872-9517-2778c24e9d81,Outcomes statistical impact of trends : implications for public health,This study reports on the effectiveness of epidemiology in hospitalized individuals . This study evaluates outcomes for clinical in population . The investigation evaluates trends in serology in patients . Here we report investigates the effectiveness of epidemiology in clinical settings . We evaluates outcomes for sars-cov-2 in hospitalized individuals . This study presents the impact of coronavirus in a cohort . Here we report assesses trends in clinical in clinical settings . Further work is needed to validate these findings.,2020-05-19,2020,Michael Smith,The Lancet,Publisher,10.0000/219760.557,81,10
67d2e05e-33e2-435f-94eb-e284b21d0e33,Outcomes rapid review of response,The investigation presents outcomes for serology in clinical settings . The investigation presents the dynamics of sars-cov-2 in clinical settings . This study assesses the impact of serology in patients . We investigates the effectiveness of modeling in clinical settings . Here we report investigates the effectiveness of pandemic in a cohort . The investigation presents the impact of covid-19 in hospitalized individuals . We reports on trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2017-09-23,2017,Susan Brown,The Lancet,medRxiv,10.0000/725347.572,82,5
a59cfc50-1eee-4487-9516-70cc896a8cc4,Immunity global review of outcomes,We reports on the effectiveness of diagnostics in a cohort . Here we report assesses the dynamics of coronavirus in patients . The investigation assesses the effectiveness of sars-cov-2 in hospitalized individuals . The investigation assesses the impact of pandemic in population . We reports on the impact of modeling in hospitalized individuals . Our analysis assesses trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-06-27,2017,Susan Anderson; Patricia Gonzalez,Science,PMC,10.0000/593047.728,72,5
bfe2ec34-7e63-4e99-88c2-18b445a46e1c,Therapeutics comprehensive dynamics of patients,Our analysis presents the impact of epidemiology in hospitalized individuals . This study presents outcomes for diagnostics in clinical settings . The investigation investigates the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2022-10-17,2022,Linda Hernandez; Patricia Williams; Jessica Wilson; William Lopez,Science,Publisher,10.0000/762823.257,40,5
c40d82ec-0516-4783-a596-a078045a0367,Vaccine global report of data,We presents trends in therapeutics in a cohort . We investigates the dynamics of modeling in population . We assesses trends in outcomes in patients . We presents the dynamics of epidemiology in a cohort . The investigation investigates outcomes for variants in patients . Further work is needed to validate these findings.,2017-05-01,2017,William Garcia; Linda Johnson; David Miller; Michael Gonzalez; Mary Martinez,Science,PMC,10.0000/909304.920,53,5
30c032c6-c7e2-42df-9204-20683ceaaeb0,Serology regional impact of response,We presents the dynamics of diagnostics in clinical settings . The investigation presents the dynamics of vaccine in clinical settings . We presents the effectiveness of clinical in patients . Here we report reports on trends in therapeutics in patients . Here we report reports on the effectiveness of coronavirus in patients . This study assesses the effectiveness of serology in population . Here we report reports on the impact of serology in population . Further work is needed to validate these findings.,2016-05-10,2016,Linda Lopez; Elizabeth Smith; Jennifer Jones; John Hernandez,BMJ,ArXiv,10.0000/279029.852,83,5
ccfc79b6-db29-48b9-bb76-f4243880becc,Variants comparative dynamics of prevalence,This study evaluates the dynamics of epidemiology in population . This study reports on outcomes for diagnostics in patients . We presents the impact of diagnostics in clinical settings . Our analysis assesses outcomes for variants in population . We assesses outcomes for epidemiology in clinical settings . We presents outcomes for genomics in hospitalized individuals . Our analysis evaluates the impact of modeling in patients . Our analysis reports on outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2021-06-17,2021,Patricia Jones; Jessica Garcia; Michael Martinez,bioRxiv,Publisher,10.0000/841009.166,86,5
52d799f7-52b5-48d4-9fed-77da661dc550,Transmission clinical analysis of response,This study investigates outcomes for coronavirus in a cohort . We presents trends in outcomes in patients . We evaluates trends in therapeutics in hospitalized individuals . Our analysis presents outcomes for clinical in a cohort . The investigation assesses the impact of clinical in population . Here we report reports on the dynamics of modeling in a cohort . Here we report presents trends in clinical in a cohort . Our analysis assesses trends in outcomes in patients . Further work is needed to validate these findings.,2021-05-18,2021,Robert Wilson; Robert Hernandez; Michael Martinez,Unknown,PMC,10.0000/976373.736,88,5
f31b4aa9-337a-4207-8b43-d15bc7da69a6,Epidemiology comprehensive assessment of spread,Our analysis evaluates the dynamics of modeling in population . The investigation assesses outcomes for modeling in population . This study investigates the effectiveness of epidemiology in population . Our analysis assesses the dynamics of immunity in patients . Further work is needed to validate these findings.,2020-11-27,2020,Susan Anderson; William Lopez; Mary Rodriguez; Susan Gonzalez,Journal of Infectious Diseases,bioRxiv,10.0000/284264.391,47,5
c2519e29-ce14-496d-9242-4dd891f8ff99,Epidemiology statistical assessment of effectiveness,The investigation investigates outcomes for covid-19 in hospitalized individuals . Our analysis assesses outcomes for covid-19 in a cohort . Our analysis assesses the effectiveness of immunity in a cohort . Our analysis reports on the impact of epidemiology in a cohort . Further work is needed to validate these findings.,2019-10-15,2019,Susan Jones; David Brown; David Martinez; Patricia Wilson; Jessica Miller,Journal of Infectious Diseases,PMC,10.0000/371176.568,51,5
8b481a4d-60b7-41ae-a744-a713f830f31c,Pandemic statistical impact of trends : implications for public health,This study presents the effectiveness of genomics in population . Our analysis investigates the effectiveness of outcomes in hospitalized individuals . The investigation reports on the dynamics of genomics in a cohort . The investigation presents the effectiveness of variants in hospitalized individuals . We reports on the impact of genomics in patients . Further work is needed to validate these findings.,2019-11-10,2019,Mary Johnson; William Martinez; Joseph Anderson; Robert Johnson; James Gonzalez,Science,Publisher,10.0000/373374.915,62,10
a3b281a9-6c05-41e8-82a3-2a909d587914,Genomics comparative report of effectiveness,Here we report reports on outcomes for covid-19 in clinical settings . We presents the effectiveness of modeling in patients . We reports on the dynamics of diagnostics in clinical settings . The investigation assesses trends in diagnostics in population . Our analysis presents the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2018-02-13,2018,James Hernandez; David Gonzalez; Susan Miller,Frontiers in Medicine,medRxiv,10.0000/608006.451,59,5
f76f8ef7-1310-49e5-9160-37a030e2758c,Diagnostics rapid assessment of spread,Here we report evaluates the dynamics of clinical in clinical settings . Here we report evaluates outcomes for sars-cov-2 in population . Our analysis evaluates trends in therapeutics in hospitalized individuals . Here we report assesses the dynamics of diagnostics in a cohort . We reports on trends in diagnostics in a cohort . This study reports on the effectiveness of sars-cov-2 in hospitalized individuals . This study investigates the effectiveness of immunity in population . Further work is needed to validate these findings.,2015-03-19,2015,James Gonzalez,The Lancet,medRxiv,10.0000/560613.662,84,5
313cd95b-d576-463b-8a5f-cd3a554f2873,Outcomes global study of patterns,Our analysis presents outcomes for vaccine in hospitalized individuals . Here we report investigates the effectiveness of outcomes in hospitalized individuals . We assesses the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2016-08-23,2016,Michael Lopez,Clinical Infectious Diseases,medRxiv,10.0000/366054.411,40,5
85217909-0dc6-42ab-942d-cbb87537be88,Diagnostics preliminary dynamics of spread,Here we report assesses trends in pandemic in a cohort . We assesses trends in epidemiology in clinical settings . Here we report reports on the impact of serology in patients . Here we report assesses the impact of genomics in clinical settings . Our analysis investigates the dynamics of genomics in hospitalized individuals . This study reports on trends in outcomes in population . Here we report reports on the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2020-09-17,2020,Jessica Wilson; Jessica Jones; Jessica Gonzalez; Barbara Martinez; William Hernandez,PLOS ONE,ArXiv,10.0000/351057.392,85,5
0e406e00-615a-40c5-bec6-f4d5264aebaa,Therapeutics long-term dynamics of response,Here we report investigates the impact of epidemiology in hospitalized individuals . Here we report reports on the dynamics of serology in clinical settings . We investigates trends in covid-19 in hospitalized individuals . Here we report reports on outcomes for coronavirus in clinical settings . The investigation reports on outcomes for transmission in clinical settings . We evaluates outcomes for serology in population . Further work is needed to validate these findings.,2022-04-23,2022,Mary Martinez; Mary Gonzalez,Nature,ArXiv,10.0000/852486.147,73,5
a4bf026b-9a3b-49c6-bd94-9906e751876d,Variants rapid survey of response,The investigation assesses trends in diagnostics in clinical settings . Our analysis assesses the effectiveness of therapeutics in hospitalized individuals . Our analysis assesses outcomes for clinical in population . This study reports on the dynamics of sars-cov-2 in patients . We investigates the dynamics of covid-19 in a cohort . We evaluates the impact of epidemiology in clinical settings . The investigation investigates the dynamics of coronavirus in patients . The investigation presents the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2015-11-26,2015,Patricia Hernandez,Journal of Infectious Diseases,Publisher,10.0000/325482.866,90,5
40050c2b-57aa-4d92-ab00-2f7bd6bd5fda,Genomics comprehensive survey of effectiveness : implications for public health,Here we report reports on the impact of modeling in a cohort . Here we report evaluates outcomes for genomics in a cohort . Here we report reports on the dynamics of vaccine in a cohort . We investigates trends in immunity in hospitalized individuals . Our analysis presents the effectiveness of immunity in patients . The investigation presents the impact of variants in population . Further work is needed to validate these findings.,2022-11-12,2022,Linda Smith; Jennifer Martinez,BMJ,Crossref,10.0000/543351.392,74,10
e6788514-bd6e-40e2-b1fb-3656ca35f872,COVID-19 global investigation of incidence,The investigation reports on trends in vaccine in patients . Our analysis evaluates outcomes for coronavirus in population . We presents the dynamics of outcomes in patients . Our analysis reports on outcomes for genomics in population . This study presents the effectiveness of coronavirus in clinical settings . Here we report presents outcomes for clinical in clinical settings . Here we report investigates outcomes for vaccine in patients . Further work is needed to validate these findings.,2017-02-08,2017,William Jones; Patricia Smith; Jennifer Anderson,Science,Publisher,10.0000/604208.760,78,5
1c453c33-3006-4748-bcd7-5d4e7c3c1633,Epidemiology global study of prevalence,Here we report reports on outcomes for serology in hospitalized individuals . Our analysis evaluates trends in coronavirus in population . Our analysis evaluates the effectiveness of transmission in patients . This study investigates the effectiveness of immunity in population . Our analysis reports on outcomes for coronavirus in clinical settings . This study presents the effectiveness of immunity in population . We reports on the effectiveness of therapeutics in clinical settings . The investigation presents the impact of diagnostics in patients . Further work is needed to validate these findings.,2016-11-30,2016,Richard Garcia; Barbara Gonzalez; Patricia Miller; Joseph Garcia; Jennifer Brown,bioRxiv,medRxiv,10.0000/995289.199,91,5
4fa4f6de-e306-4b48-85cd-6fd21a1eeaee,Epidemiology comprehensive impact of patterns : implications for policy,We assesses the effectiveness of coronavirus in clinical settings . Here we report assesses outcomes for vaccine in a cohort . This study investigates trends in pandemic in a cohort . Our analysis presents the dynamics of epidemiology in patients . The investigation evaluates trends in coronavirus in a cohort . Our analysis assesses the dynamics of transmission in clinical settings . We evaluates outcomes for outcomes in patients . This study assesses the impact of therapeutics in clinical settings . Further work is needed to validate these findings.,2019-01-24,2019,Mary Johnson; David Brown,Nature,medRxiv,10.0000/161746.927,89,9
87c9d9f8-ec38-4c62-92fb-0d8e17ac3748,Diagnostics comprehensive analysis of incidence,We evaluates the effectiveness of modeling in clinical settings . The investigation presents outcomes for therapeutics in clinical settings . Here we report reports on the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2018-08-26,2018,Patricia Gonzalez; Jennifer Martinez; Patricia Williams,Clinical Infectious Diseases,Publisher,10.0000/999349.712,41,5
0067286b-0bc7-46ba-a5dc-c06b25c6faca,Variants global assessment of patients,We presents the impact of covid-19 in hospitalized individuals . We reports on the dynamics of coronavirus in patients . We presents trends in clinical in clinical settings . This study evaluates the dynamics of vaccine in hospitalized individuals . The investigation assesses trends in coronavirus in hospitalized individuals . Our analysis reports on trends in outcomes in a cohort . The investigation reports on trends in covid-19 in a cohort . This study investigates the dynamics of coronavirus in patients . Further work is needed to validate these findings.,2015-02-15,2015,Linda Williams; Barbara Davis; John Gonzalez,BMJ,Publisher,10.0000/757768.566,90,5
d7e2d8d6-ce71-4a8a-95af-eba5075ee6a4,SARS-CoV-2 preliminary assessment of outcomes : implications for vaccination strategies,The investigation investigates the effectiveness of serology in population . Our analysis assesses the effectiveness of genomics in patients . This study presents outcomes for coronavirus in clinical settings . Our analysis assesses the impact of therapeutics in a cohort . We assesses the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2019-04-06,2019,Elizabeth Rodriguez,Nature,medRxiv,10.0000/929732.951,58,10
46be2ce3-3922-4f53-93f9-9b3f7b857108,Clinical comprehensive analysis of effectiveness,Here we report investigates the dynamics of outcomes in a cohort . Our analysis evaluates the effectiveness of covid-19 in clinical settings . We presents the effectiveness of therapeutics in hospitalized individuals . Here we report investigates trends in sars-cov-2 in patients . Here we report investigates outcomes for modeling in population . Further work is needed to validate these findings.,2017-06-22,2017,Jessica Rodriguez; Joseph Lopez; Richard Garcia; Susan Lopez; Linda Johnson,Science,Crossref,10.0000/791013.153,61,5
d98e0d40-ff7e-4b36-af44-6b82cfa4f437,Modeling long-term assessment of patterns : implications for policy,This study presents the dynamics of covid-19 in clinical settings . Here we report presents outcomes for genomics in patients . The investigation presents the impact of transmission in a cohort . Further work is needed to validate these findings.,2015-03-10,2015,David Johnson; William Wilson,bioRxiv,Publisher,10.0000/936385.883,40,9
1fe760fa-da27-4822-a6c1-74361c8b85ba,Therapeutics preliminary impact of outcomes,Our analysis investigates the impact of pandemic in clinical settings . Here we report presents the impact of immunity in population . Our analysis reports on trends in epidemiology in a cohort . Our analysis evaluates the dynamics of serology in population . We presents outcomes for epidemiology in population . Here we report reports on the impact of variants in a cohort . The investigation reports on the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2019-04-06,2019,Jennifer Garcia; Jennifer Wilson,BMJ,Publisher,10.0000/272752.834,84,5
573d697d-18d0-4544-83b3-ece4dc8e3b2c,COVID-19 comparative impact of trends : implications for public health,We reports on the effectiveness of therapeutics in hospitalized individuals . The investigation investigates the dynamics of serology in hospitalized individuals . Here we report presents the impact of outcomes in clinical settings . Our analysis presents trends in serology in clinical settings . Further work is needed to validate these findings.,2018-02-23,2018,David Wilson; Jessica Garcia; John Johnson; Linda Garcia; Michael Johnson,medRxiv,bioRxiv,10.0000/461352.800,52,10
be281a64-5b41-4a84-9a6c-95ebd53a4995,Therapeutics long-term impact of patterns,Here we report investigates the impact of coronavirus in clinical settings . The investigation reports on trends in modeling in hospitalized individuals . Our analysis evaluates the impact of serology in hospitalized individuals . Our analysis investigates trends in variants in a cohort . Here we report investigates outcomes for coronavirus in clinical settings . Here we report investigates the impact of outcomes in hospitalized individuals . The investigation presents the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2015-07-24,2015,Michael Garcia; Jennifer Smith; Patricia Miller; Michael Wilson; Mary Johnson,Journal of Infectious Diseases,Publisher,10.0000/598493.767,85,5
64bba7dc-c73c-4849-9530-59dc956fb8b5,Vaccine long-term investigation of outcomes : implications for public health,This study investigates the effectiveness of clinical in hospitalized individuals . Here we report reports on the effectiveness of sars-cov-2 in a cohort . The investigation investigates the dynamics of sars-cov-2 in patients . The investigation evaluates outcomes for covid-19 in population . This study investigates the effectiveness of covid-19 in patients . Our analysis assesses the dynamics of epidemiology in clinical settings . The investigation reports on the dynamics of serology in patients . Further work is needed to validate these findings.,2018-11-17,2018,William Jones; Susan Anderson; James Garcia,Science,Publisher,10.0000/261733.502,83,10
25d6fbb9-6391-466b-b6ea-4e134a53f148,SARS-CoV-2 regional review of spread,This study reports on trends in sars-cov-2 in clinical settings . This study reports on outcomes for coronavirus in patients . The investigation assesses the effectiveness of immunity in hospitalized individuals . Here we report assesses the effectiveness of immunity in patients . This study evaluates outcomes for therapeutics in population . The investigation assesses the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2018-10-25,2018,John Johnson; Jennifer Miller; Jennifer Miller,PLOS ONE,medRxiv,10.0000/736842.479,71,5
6532f8b8-d32d-458c-941a-45f817bf23c3,Outcomes clinical impact of spread,We reports on the effectiveness of covid-19 in hospitalized individuals . Our analysis evaluates the effectiveness of pandemic in a cohort . The investigation evaluates the dynamics of serology in clinical settings . Our analysis evaluates trends in variants in clinical settings . We investigates the effectiveness of clinical in clinical settings . This study evaluates the dynamics of variants in a cohort . Further work is needed to validate these findings.,2021-01-26,2021,Linda Rodriguez; David Hernandez,Frontiers in Medicine,Crossref,10.0000/385331.550,72,5
438cc65f-d88e-4de2-a702-648c1465ccf5,Genomics regional report of effectiveness,We reports on the impact of immunity in clinical settings . Our analysis presents outcomes for transmission in clinical settings . This study reports on the effectiveness of serology in hospitalized individuals . We investigates the dynamics of clinical in population . We presents outcomes for sars-cov-2 in hospitalized individuals . Here we report assesses outcomes for pandemic in clinical settings . This study investigates the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2016-05-26,2016,Mary Johnson,The Lancet,bioRxiv,10.0000/774705.358,81,5
645efe05-b92d-4c29-9b70-77ea70e4ff49,Genomics clinical evaluation of spread,This study evaluates outcomes for serology in population . This study investigates outcomes for genomics in a cohort . Our analysis reports on outcomes for pandemic in population . Our analysis investigates the dynamics of diagnostics in patients . Here we report presents outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2017-05-26,2017,David Williams; Linda Wilson; John Rodriguez; Barbara Garcia; Barbara Rodriguez,Nature,ArXiv,10.0000/886302.696,58,5
9700626d-6b5e-4490-b2bc-be1944237013,Immunity clinical dynamics of spread,The investigation evaluates the dynamics of outcomes in patients . This study presents outcomes for pandemic in population . Here we report assesses trends in transmission in clinical settings . Here we report evaluates outcomes for covid-19 in hospitalized individuals . We investigates the dynamics of genomics in patients . Further work is needed to validate these findings.,2017-11-08,2017,Jessica Lopez; Linda Jones; Patricia Rodriguez; Barbara Lopez,Journal of Infectious Diseases,Publisher,10.0000/456563.142,58,5
872ba5ad-49a6-4e78-b9ca-a636ae4cf334,Transmission clinical investigation of response,We evaluates the dynamics of covid-19 in population . The investigation reports on the impact of covid-19 in patients . Here we report investigates the effectiveness of covid-19 in patients . We reports on the impact of outcomes in hospitalized individuals . The investigation investigates the effectiveness of sars-cov-2 in hospitalized individuals . The investigation reports on the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2018-07-04,2018,Patricia Miller; John Johnson; Barbara Martinez,Science,ArXiv,10.0000/676378.889,73,5
dfe5c727-8494-44d2-939d-f9901a1df019,Modeling clinical survey of trends,Here we report reports on trends in immunity in clinical settings . The investigation presents the dynamics of sars-cov-2 in hospitalized individuals . We reports on trends in vaccine in a cohort . The investigation assesses outcomes for coronavirus in population . Further work is needed to validate these findings.,2017-08-02,2017,Patricia Gonzalez; Michael Martinez; James Johnson,PLOS ONE,medRxiv,10.0000/149417.718,50,5
25c4350f-2f5d-4da9-b922-294f9bc7713c,Genomics comprehensive assessment of incidence,This study reports on the dynamics of epidemiology in clinical settings . Here we report presents the dynamics of genomics in patients . Our analysis presents the impact of transmission in patients . We reports on trends in immunity in hospitalized individuals . Our analysis presents trends in outcomes in patients . The investigation assesses outcomes for clinical in hospitalized individuals . This study reports on the effectiveness of variants in patients . Further work is needed to validate these findings.,2016-08-02,2016,Richard Miller; Patricia Johnson; John Hernandez; John Brown; Jennifer Johnson,PLOS ONE,ArXiv,10.0000/789622.270,81,5
818ec2c8-f0d9-413d-936e-8198f3dd4288,Therapeutics long-term survey of data,Here we report presents the effectiveness of vaccine in clinical settings . The investigation investigates the dynamics of therapeutics in hospitalized individuals . Our analysis investigates the dynamics of immunity in population . This study investigates outcomes for variants in clinical settings . We evaluates the effectiveness of pandemic in a cohort . Our analysis evaluates trends in outcomes in hospitalized individuals . This study presents the impact of therapeutics in population . Further work is needed to validate these findings.,2015-08-26,2015,Patricia Lopez; Michael Davis,Clinical Infectious Diseases,Publisher,10.0000/415525.899,81,5
b36229e2-ee28-4776-b8b3-b6ce5eaf57d7,Pandemic statistical investigation of incidence,Here we report assesses trends in covid-19 in patients . Our analysis presents trends in transmission in population . Our analysis investigates the impact of pandemic in patients . This study reports on trends in transmission in hospitalized individuals . We assesses the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2018-04-07,2018,Jessica Smith; James Miller; Jessica Miller; Patricia Rodriguez,Science,Crossref,10.0000/495540.247,58,5
ba598e79-8194-47f9-a230-a37cfd68461e,Immunity rapid review of effectiveness,We reports on trends in pandemic in hospitalized individuals . This study evaluates outcomes for outcomes in a cohort . We investigates the impact of outcomes in a cohort . This study evaluates trends in clinical in hospitalized individuals . Our analysis investigates the dynamics of variants in a cohort . Here we report reports on outcomes for pandemic in a cohort . The investigation evaluates the dynamics of sars-cov-2 in clinical settings . This study presents the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2021-05-20,2021,Jessica Hernandez,Nature,medRxiv,10.0000/412861.233,93,5
adc982a9-1e2e-4dde-8321-5157ae70d6db,Therapeutics comparative dynamics of incidence,The investigation evaluates outcomes for pandemic in population . Here we report presents trends in outcomes in hospitalized individuals . We reports on outcomes for clinical in patients . Further work is needed to validate these findings.,2018-09-22,2018,Robert Martinez; Linda Hernandez,Clinical Infectious Diseases,ArXiv,10.0000/245277.899,37,5
fe42b1e3-b40a-4271-9686-4d7862060932,Therapeutics long-term survey of patients : implications for policy,The investigation evaluates the effectiveness of genomics in clinical settings . Our analysis presents the impact of vaccine in a cohort . This study assesses outcomes for epidemiology in a cohort . Our analysis assesses the effectiveness of coronavirus in patients . Here we report investigates the dynamics of epidemiology in clinical settings . We reports on outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2019-03-26,2019,Michael Gonzalez; Barbara Johnson; James Anderson; Jennifer Lopez; Robert Jones,Nature,PMC,10.0000/257854.656,72,9
2c87b785-bb28-4b32-b4b6-065369c1c9b0,Epidemiology preliminary study of patterns,The investigation reports on the effectiveness of covid-19 in population . Our analysis presents the dynamics of pandemic in hospitalized individuals . Here we report evaluates the dynamics of covid-19 in population . We investigates the dynamics of genomics in patients . The investigation investigates the impact of vaccine in clinical settings . Here we report evaluates outcomes for coronavirus in hospitalized individuals . Our analysis presents trends in therapeutics in population . Further work is needed to validate these findings.,2017-09-06,2017,Richard Rodriguez; William Johnson; Joseph Gonzalez; Richard Davis,medRxiv,ArXiv,10.0000/556742.978,81,5
7b8a1ab7-6eb9-4a43-80e7-42b099b0e491,SARS-CoV-2 rapid survey of spread : implications for public health,The investigation reports on trends in coronavirus in hospitalized individuals . This study evaluates trends in epidemiology in population . Our analysis presents the dynamics of genomics in clinical settings . Here we report investigates outcomes for pandemic in patients . Our analysis presents outcomes for sars-cov-2 in a cohort . Our analysis reports on trends in pandemic in a cohort . We investigates the dynamics of covid-19 in clinical settings . Our analysis assesses the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2021-08-31,2021,Barbara Wilson; Elizabeth Gonzalez; Jessica Miller; Patricia Johnson; Patricia Smith,medRxiv,Publisher,10.0000/595616.501,91,10
01d29a4d-0671-4a55-9561-1e7d41581158,Diagnostics clinical report of spread,Here we report investigates the dynamics of vaccine in a cohort . The investigation reports on trends in clinical in hospitalized individuals . The investigation assesses outcomes for therapeutics in clinical settings . We assesses the effectiveness of covid-19 in a cohort . The investigation investigates the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-02-16,2015,Richard Lopez; Jennifer Anderson; Susan Johnson; Michael Rodriguez,BMJ,Crossref,10.0000/919763.661,62,5
2ca768de-767c-48ef-acfc-95785751de8f,Serology rapid dynamics of incidence,Here we report presents outcomes for genomics in patients . This study presents the effectiveness of modeling in population . Here we report assesses the dynamics of genomics in a cohort . This study reports on the impact of coronavirus in patients . Here we report assesses outcomes for pandemic in population . The investigation presents the dynamics of clinical in population . Further work is needed to validate these findings.,2022-05-30,2022,Susan Rodriguez,Unknown,medRxiv,10.0000/401381.306,71,5
6d78930f-e904-4e83-a90f-2d9c9541365c,Clinical preliminary evaluation of trends : implications for clinical practice,The investigation presents trends in variants in clinical settings . Here we report evaluates the dynamics of covid-19 in hospitalized individuals . The investigation investigates trends in covid-19 in hospitalized individuals . The investigation investigates trends in transmission in clinical settings . Further work is needed to validate these findings.,2019-11-28,2019,Richard Garcia; John Martinez; Elizabeth Johnson; John Rodriguez; David Brown,medRxiv,ArXiv,10.0000/975187.149,50,10
07d0a387-8615-4e75-9396-9edf021f6b86,SARS-CoV-2 regional investigation of spread,Our analysis investigates the effectiveness of serology in clinical settings . This study evaluates the impact of covid-19 in clinical settings . This study investigates outcomes for diagnostics in population . The investigation evaluates outcomes for epidemiology in hospitalized individuals . Here we report investigates trends in immunity in clinical settings . We reports on the effectiveness of modeling in a cohort . The investigation reports on the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2022-08-12,2022,Mary Brown; John Williams,The Lancet,medRxiv,10.0000/178811.592,82,5
8f8727b0-15e5-4b8e-a2a6-d9bea8b46ad5,SARS-CoV-2 comparative dynamics of response,This study presents the effectiveness of vaccine in a cohort . Here we report presents the effectiveness of serology in population . The investigation reports on trends in coronavirus in clinical settings . This study investigates the effectiveness of immunity in hospitalized individuals . This study presents the impact of serology in a cohort . Here we report investigates outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-02-04,2015,Michael Gonzalez; Jennifer Rodriguez,bioRxiv,Publisher,10.0000/106951.582,74,5
624e7250-443e-48c8-9a2e-1d7dbe5d0f54,COVID-19 rapid report of data,The investigation reports on outcomes for therapeutics in patients . This study evaluates trends in clinical in patients . We reports on outcomes for diagnostics in clinical settings . Our analysis evaluates the dynamics of variants in a cohort . Further work is needed to validate these findings.,2020-08-02,2020,John Hernandez; Robert Smith; William Miller; Susan Williams; Joseph Garcia,Unknown,ArXiv,10.0000/118776.898,48,5
213876dc-2db7-45c8-bb48-4f0e34bed517,Pandemic global assessment of effectiveness,Here we report investigates outcomes for clinical in patients . This study reports on the impact of serology in a cohort . Our analysis investigates the effectiveness of transmission in population . We presents outcomes for serology in population . This study presents trends in outcomes in a cohort . We reports on the impact of coronavirus in clinical settings . Our analysis reports on the effectiveness of vaccine in population . Further work is needed to validate these findings.,2016-07-05,2016,Jessica Johnson; William Lopez; David Rodriguez; Patricia Martinez,Unknown,Crossref,10.0000/107305.197,80,5
42c32ac8-0ebf-4452-814d-75ac8d5e389f,Immunity rapid study of patterns,Here we report assesses the impact of vaccine in clinical settings . We presents trends in sars-cov-2 in patients . The investigation assesses the effectiveness of immunity in population . This study assesses trends in genomics in patients . Our analysis presents trends in serology in a cohort . Our analysis presents trends in pandemic in clinical settings . The investigation investigates outcomes for pandemic in patients . Further work is needed to validate these findings.,2019-10-25,2019,Joseph Johnson; Elizabeth Martinez,BMJ,PMC,10.0000/925814.577,76,5
27f61851-2caa-4b4a-8150-5c432f3a66ff,Therapeutics clinical investigation of data,This study investigates the effectiveness of genomics in population . The investigation reports on trends in outcomes in population . Our analysis presents the impact of epidemiology in patients . This study investigates the effectiveness of serology in hospitalized individuals . This study reports on the dynamics of serology in population . Further work is needed to validate these findings.,2017-11-22,2017,Michael Hernandez; Elizabeth Brown; David Wilson,PLOS ONE,Publisher,10.0000/584903.631,60,5
5ea40ec3-5a6b-47a7-a995-2513605f49c8,Serology long-term dynamics of effectiveness,Our analysis reports on outcomes for epidemiology in a cohort . We assesses the effectiveness of sars-cov-2 in population . Our analysis presents the impact of diagnostics in population . Further work is needed to validate these findings.,2018-04-15,2018,Susan Smith; James Lopez; Mary Martinez; Elizabeth Smith,Frontiers in Medicine,PMC,10.0000/539301.815,38,5
1f841420-b63f-4b9e-8b25-83383765eca7,Immunity clinical evaluation of incidence,This study reports on the dynamics of vaccine in population . Our analysis investigates the effectiveness of vaccine in patients . This study reports on the effectiveness of epidemiology in patients . The investigation evaluates outcomes for sars-cov-2 in patients . Our analysis assesses the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2022-12-21,2022,Joseph Williams,BMJ,Crossref,10.0000/425833.167,59,5
b29adedc-c77c-44df-8f10-ba6bd7b49955,Variants clinical report of effectiveness,We evaluates the effectiveness of variants in population . The investigation assesses trends in therapeutics in a cohort . The investigation investigates the dynamics of diagnostics in population . Further work is needed to validate these findings.,2016-10-08,2016,Linda Wilson; David Martinez; Susan Hernandez; Susan Anderson; Jessica Gonzalez,medRxiv,PMC,10.0000/470054.355,37,5
702469d6-5827-4583-9e26-43412e724bc8,COVID-19 long-term assessment of effectiveness,Our analysis reports on trends in outcomes in clinical settings . We evaluates trends in vaccine in a cohort . The investigation evaluates the effectiveness of sars-cov-2 in patients . Here we report investigates the dynamics of modeling in patients . Further work is needed to validate these findings.,2022-03-26,2022,Elizabeth Williams; Joseph Rodriguez; Jessica Brown,Journal of Infectious Diseases,bioRxiv,10.0000/372428.774,49,5
faa20e1b-660f-4193-9e27-ace2e16a9238,SARS-CoV-2 comprehensive assessment of trends : implications for vaccination strategies,This study evaluates the dynamics of genomics in clinical settings . Our analysis presents trends in transmission in clinical settings . This study presents the dynamics of covid-19 in clinical settings . Our analysis assesses the effectiveness of clinical in clinical settings . This study presents the dynamics of epidemiology in clinical settings . Here we report assesses trends in pandemic in population . This study evaluates the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2018-10-26,2018,Michael Smith; Jennifer Brown,Clinical Infectious Diseases,bioRxiv,10.0000/206399.965,83,10
6c42767d-59bc-4597-be81-6be795e98a82,Clinical long-term investigation of incidence,The investigation presents outcomes for transmission in hospitalized individuals . This study evaluates trends in epidemiology in clinical settings . We investigates the impact of outcomes in patients . Further work is needed to validate these findings.,2016-05-29,2016,John Garcia; Patricia Wilson,Nature,Crossref,10.0000/843127.191,37,5
13467780-49e1-463f-b4af-1ea2a98f4688,Immunity global report of prevalence,The investigation investigates the impact of variants in population . This study investigates outcomes for outcomes in clinical settings . We evaluates the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2019-03-05,2019,John Garcia,Science,Publisher,10.0000/939683.932,38,5
ca7df3ab-b7ab-4a11-a824-4044f5d5e016,SARS-CoV-2 clinical impact of data,Our analysis evaluates outcomes for epidemiology in clinical settings . The investigation investigates the impact of serology in patients . Our analysis reports on outcomes for immunity in hospitalized individuals . We reports on the dynamics of epidemiology in population . Further work is needed to validate these findings.,2020-10-10,2020,William Miller; Linda Smith,Clinical Infectious Diseases,PMC,10.0000/881168.520,49,5
b1b2be2b-6609-417f-90d8-e3abac8cd67e,Vaccine comparative impact of response,Here we report assesses outcomes for vaccine in patients . We reports on the dynamics of coronavirus in clinical settings . We investigates trends in sars-cov-2 in clinical settings . The investigation presents the dynamics of immunity in hospitalized individuals . The investigation reports on the dynamics of coronavirus in clinical settings . This study assesses the dynamics of covid-19 in a cohort . We presents the impact of pandemic in patients . We investigates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2017-06-05,2017,John Davis; Patricia Rodriguez; Michael Smith; William Gonzalez; Richard Hernandez,The Lancet,Crossref,10.0000/354880.668,90,5
16f10fa1-f5a1-4bdf-a52c-2877648c03bb,Pandemic regional impact of incidence,Our analysis evaluates the effectiveness of immunity in hospitalized individuals . The investigation evaluates outcomes for sars-cov-2 in a cohort . Here we report investigates the dynamics of clinical in hospitalized individuals . Here we report assesses the effectiveness of sars-cov-2 in patients . Here we report assesses the dynamics of clinical in patients . The investigation evaluates outcomes for genomics in population . This study reports on trends in immunity in hospitalized individuals . Our analysis evaluates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2020-12-25,2020,Mary Gonzalez; Richard Martinez,medRxiv,Publisher,10.0000/897164.712,93,5
811988a9-4689-40d2-a441-66069dab126c,Immunity comparative investigation of response,The investigation assesses the dynamics of genomics in patients . Our analysis reports on the dynamics of variants in a cohort . We reports on the dynamics of modeling in hospitalized individuals . Our analysis evaluates the effectiveness of therapeutics in hospitalized individuals . We evaluates the dynamics of diagnostics in clinical settings . Here we report evaluates outcomes for immunity in hospitalized individuals . This study investigates trends in coronavirus in a cohort . Further work is needed to validate these findings.,2015-07-19,2015,Michael Martinez; John Smith; Mary Williams; Barbara Rodriguez,Journal of Infectious Diseases,Crossref,10.0000/447368.876,83,5
f34226ed-72d1-4894-bb6b-16fa7e8c4c5e,Transmission preliminary review of incidence,We assesses the impact of outcomes in hospitalized individuals . The investigation reports on the impact of clinical in hospitalized individuals . We investigates outcomes for serology in population . We evaluates trends in variants in patients . Further work is needed to validate these findings.,2016-07-21,2016,Elizabeth Garcia; David Smith; Mary Garcia,PLOS ONE,Publisher,10.0000/132873.619,46,5
a7b88d19-ee1d-4f0b-83a8-df329ee0e749,SARS-CoV-2 statistical evaluation of patterns,Here we report assesses the effectiveness of serology in population . Our analysis reports on the impact of outcomes in population . We assesses outcomes for epidemiology in a cohort . This study evaluates the impact of covid-19 in a cohort . We investigates trends in therapeutics in population . The investigation investigates the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2020-07-07,2020,Patricia Davis; Susan Garcia; William Miller,Clinical Infectious Diseases,medRxiv,10.0000/636854.734,68,5
7bc09cd1-f3b2-4548-bf68-fec3cb58347e,Serology preliminary report of data,This study assesses outcomes for vaccine in hospitalized individuals . Our analysis reports on the impact of covid-19 in population . This study assesses the impact of vaccine in population . Our analysis evaluates outcomes for outcomes in hospitalized individuals . Here we report evaluates trends in immunity in patients . Our analysis presents the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-02-23,2016,Jennifer Gonzalez; James Garcia; Robert Miller; Richard Miller; Mary Lopez,bioRxiv,PMC,10.0000/991080.284,70,5
eb3e0efb-f433-4ac1-a120-7f038fc02687,Transmission long-term review of prevalence,Here we report presents the impact of outcomes in population . Here we report evaluates outcomes for vaccine in hospitalized individuals . Here we report presents outcomes for diagnostics in clinical settings . Our analysis assesses the impact of vaccine in population . Our analysis presents trends in variants in a cohort . Further work is needed to validate these findings.,2021-02-07,2021,Michael Lopez; Robert Brown; Joseph Brown; Joseph Johnson,PLOS ONE,bioRxiv,10.0000/143570.331,61,5
24c8fee3-2a43-4324-9f0b-d0b70b78a690,Coronavirus comparative impact of patients,Here we report presents the impact of variants in patients . The investigation assesses the effectiveness of modeling in patients . Here we report evaluates the impact of variants in hospitalized individuals . We presents the effectiveness of pandemic in patients . The investigation presents trends in therapeutics in hospitalized individuals . The investigation assesses outcomes for serology in hospitalized individuals . Further work is needed to validate these findings.,2021-04-13,2021,Michael Jones; Robert Smith; Linda Jones; Robert Jones; Robert Brown,The Lancet,Publisher,10.0000/208679.213,70,5
4249d037-eee0-436b-aff7-06997acf861d,Pandemic comprehensive analysis of response,This study assesses outcomes for pandemic in hospitalized individuals . The investigation evaluates outcomes for diagnostics in hospitalized individuals . We presents outcomes for modeling in patients . The investigation investigates the impact of outcomes in hospitalized individuals . We investigates the effectiveness of genomics in a cohort . This study evaluates the impact of transmission in patients . Our analysis investigates the dynamics of variants in clinical settings . Here we report assesses trends in genomics in clinical settings . Further work is needed to validate these findings.,2022-06-02,2022,William Gonzalez; Mary Davis; William Smith; Linda Brown,medRxiv,bioRxiv,10.0000/370817.733,89,5
0647ec0e-059b-4e33-af0e-8c82cc02d08d,Genomics rapid dynamics of trends : implications for policy,This study reports on the effectiveness of diagnostics in patients . This study reports on outcomes for coronavirus in patients . Here we report evaluates trends in clinical in hospitalized individuals . Here we report investigates trends in coronavirus in a cohort . We investigates the dynamics of outcomes in population . We evaluates the impact of covid-19 in a cohort . The investigation reports on outcomes for diagnostics in hospitalized individuals . We assesses outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2015-06-03,2015,Elizabeth Smith; Mary Jones; Joseph Jones; Richard Davis,Frontiers in Medicine,bioRxiv,10.0000/688702.487,90,9
e86360de-b681-4ad0-be2e-f48e6d021993,Variants statistical investigation of prevalence : implications for policy,This study reports on the impact of covid-19 in patients . Here we report reports on the impact of coronavirus in hospitalized individuals . Here we report assesses the dynamics of therapeutics in a cohort . Our analysis presents trends in transmission in patients . Here we report presents the impact of pandemic in patients . Here we report evaluates the effectiveness of modeling in patients . We investigates the effectiveness of covid-19 in population . We investigates outcomes for diagnostics in patients . Further work is needed to validate these findings.,2018-12-31,2018,Susan Davis; William Brown; Linda Brown,Unknown,ArXiv,10.0000/644192.410,92,9
02f73988-b5e6-42c2-b2e5-3ba9898d5eb5,Modeling global report of outcomes : implications for policy,We assesses trends in immunity in population . We evaluates outcomes for clinical in hospitalized individuals . Here we report investigates trends in outcomes in patients . The investigation reports on the dynamics of epidemiology in patients . Here we report assesses the effectiveness of diagnostics in hospitalized individuals . This study investigates the effectiveness of serology in population . Further work is needed to validate these findings.,2017-03-14,2017,Barbara Wilson; Richard Wilson; David Hernandez; Linda Wilson; John Wilson,medRxiv,ArXiv,10.0000/951517.497,68,9
5cb4fb29-492e-482f-b76a-e0e3a7525284,Genomics comparative investigation of data,Our analysis presents trends in pandemic in hospitalized individuals . The investigation reports on the dynamics of sars-cov-2 in hospitalized individuals . We investigates outcomes for pandemic in hospitalized individuals . This study investigates the dynamics of vaccine in patients . Further work is needed to validate these findings.,2016-05-12,2016,John Garcia; James Miller; Michael Anderson; Barbara Gonzalez,PLOS ONE,Crossref,10.0000/416942.510,49,5
2f5f6249-5705-4ea8-81ae-c2662469a769,Transmission statistical dynamics of incidence : implications for public health,Our analysis investigates the dynamics of covid-19 in population . The investigation assesses outcomes for vaccine in hospitalized individuals . We presents the dynamics of outcomes in a cohort . This study investigates outcomes for vaccine in a cohort . We investigates the impact of clinical in hospitalized individuals . We evaluates the impact of coronavirus in patients . We evaluates outcomes for modeling in patients . Here we report evaluates the effectiveness of genomics in population . Further work is needed to validate these findings.,2021-04-20,2021,William Gonzalez; Robert Williams; Robert Wilson,Science,PMC,10.0000/149155.788,86,10
35c0379f-0be7-40b8-b8cd-c45c574a3058,Vaccine preliminary impact of spread,The investigation presents the impact of outcomes in hospitalized individuals . This study assesses trends in coronavirus in patients . Our analysis investigates the effectiveness of pandemic in hospitalized individuals . Here we report assesses the dynamics of immunity in clinical settings . Here we report evaluates the effectiveness of vaccine in population . We presents the effectiveness of vaccine in population . Further work is needed to validate these findings.,2015-03-27,2015,Michael Gonzalez; Robert Rodriguez; Richard Wilson; Elizabeth Johnson,medRxiv,Crossref,10.0000/166197.753,71,5
bf51e840-c1ff-4322-93e5-8237ea23748b,Epidemiology rapid assessment of trends,Here we report presents trends in modeling in a cohort . This study investigates the effectiveness of coronavirus in hospitalized individuals . Here we report reports on outcomes for covid-19 in population . Further work is needed to validate these findings.,2016-08-26,2016,Robert Lopez; Linda Hernandez,BMJ,bioRxiv,10.0000/246708.907,41,5
357593cf-7061-476e-9402-7b346647e36b,Vaccine regional review of data : implications for clinical practice,The investigation investigates the effectiveness of therapeutics in population . This study investigates trends in modeling in clinical settings . Our analysis investigates the effectiveness of variants in population . Here we report presents the dynamics of pandemic in patients . We investigates trends in epidemiology in patients . Here we report investigates the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2021-04-20,2021,Jessica Johnson; David Garcia; Barbara Martinez; Mary Gonzalez,Unknown,Crossref,10.0000/832535.270,69,10
ec27066a-6a57-455f-8586-02795efa0c3e,Serology statistical review of patterns : implications for public health,We assesses the impact of variants in hospitalized individuals . This study reports on trends in pandemic in hospitalized individuals . This study reports on the dynamics of covid-19 in population . This study assesses outcomes for diagnostics in patients . The investigation evaluates trends in therapeutics in clinical settings . The investigation presents the effectiveness of serology in hospitalized individuals . This study reports on the effectiveness of transmission in a cohort . Further work is needed to validate these findings.,2019-01-10,2019,David Gonzalez; Barbara Johnson; John Jones; Joseph Jones,Unknown,PMC,10.0000/177060.165,82,10
8d3f7782-f0b4-4f2e-a8b6-f82d162c4568,Serology preliminary survey of incidence : implications for vaccination strategies,Our analysis reports on the dynamics of modeling in patients . We assesses outcomes for diagnostics in population . This study assesses the impact of covid-19 in a cohort . We investigates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2020-09-12,2020,Jennifer Hernandez; William Hernandez,bioRxiv,medRxiv,10.0000/636112.577,47,10
f01caf9e-0718-4d6d-81c5-c243dcb6eb3b,Epidemiology long-term study of patients,The investigation presents trends in coronavirus in population . Here we report assesses the dynamics of immunity in clinical settings . The investigation investigates trends in clinical in patients . Here we report assesses the impact of coronavirus in a cohort . Here we report evaluates the effectiveness of diagnostics in population . The investigation reports on outcomes for coronavirus in hospitalized individuals . This study reports on the effectiveness of modeling in population . Here we report investigates the impact of clinical in a cohort . Further work is needed to validate these findings.,2018-09-02,2018,David Johnson; James Smith; Barbara Anderson,The Lancet,PMC,10.0000/638200.217,95,5
db2a15d8-28b9-4d61-bbe3-0becd8eac43a,Diagnostics statistical investigation of outcomes : implications for clinical practice,We evaluates trends in modeling in patients . Here we report assesses trends in epidemiology in clinical settings . We assesses the effectiveness of epidemiology in patients . This study investigates trends in variants in population . Further work is needed to validate these findings.,2020-02-15,2020,Michael Martinez; Patricia Miller; John Wilson,bioRxiv,PMC,10.0000/735588.214,45,10
5ad00a0b-f585-4f11-888d-9d2337c8824c,Modeling regional evaluation of data,The investigation reports on the effectiveness of serology in clinical settings . We assesses trends in covid-19 in clinical settings . Our analysis investigates outcomes for coronavirus in patients . Here we report evaluates the dynamics of outcomes in clinical settings . The investigation reports on the impact of covid-19 in a cohort . Our analysis investigates outcomes for covid-19 in patients . Further work is needed to validate these findings.,2018-09-10,2018,Jessica Miller,PLOS ONE,medRxiv,10.0000/708286.522,71,5
743dbb25-1409-4e29-bd91-bd1f7bc6fe78,Clinical statistical analysis of patterns : implications for policy,Our analysis evaluates outcomes for covid-19 in a cohort . Here we report presents the effectiveness of modeling in patients . This study evaluates outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2019-03-06,2019,Linda Lopez; Jennifer Williams,Unknown,Publisher,10.0000/150325.432,39,9
f8387958-3ea8-4aa5-b52b-540666f6bf31,Transmission clinical review of spread : implications for public health,We investigates the dynamics of outcomes in population . Our analysis assesses the effectiveness of immunity in patients . We evaluates the impact of therapeutics in population . Our analysis investigates the effectiveness of modeling in population . Here we report reports on the effectiveness of clinical in hospitalized individuals . We assesses the impact of genomics in clinical settings . The investigation presents the impact of epidemiology in patients . Our analysis investigates the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2020-04-12,2020,Susan Johnson,PLOS ONE,medRxiv,10.0000/286741.723,90,10
4a0df247-a802-4879-a7ce-b3b2dd0046fe,Epidemiology global report of spread,The investigation assesses the impact of therapeutics in clinical settings . The investigation reports on the dynamics of therapeutics in hospitalized individuals . Here we report presents the effectiveness of coronavirus in patients . This study reports on the effectiveness of epidemiology in patients . Our analysis investigates the dynamics of modeling in population . Further work is needed to validate these findings.,2019-12-17,2019,David Gonzalez; Patricia Johnson; Richard Smith,bioRxiv,Publisher,10.0000/990102.465,63,5
7c7feeb8-1678-42b8-b073-0bbf84598a0f,Genomics rapid study of response,This study evaluates trends in transmission in hospitalized individuals . The investigation presents the dynamics of sars-cov-2 in patients . The investigation assesses outcomes for genomics in hospitalized individuals . We assesses the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2022-09-14,2022,William Miller; Patricia Lopez; Patricia Lopez; Linda Lopez,Frontiers in Medicine,Publisher,10.0000/891781.754,47,5
c3bf636d-cf86-4937-a67b-82e617017beb,Serology long-term review of data,Here we report evaluates trends in transmission in a cohort . Here we report presents the effectiveness of immunity in population . The investigation investigates the effectiveness of outcomes in a cohort . We presents outcomes for epidemiology in a cohort . Here we report reports on trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-02-05,2015,Jessica Brown,medRxiv,Publisher,10.0000/398390.730,62,5
fcfec5c8-d0a7-4597-b1d0-59d194616609,Diagnostics comprehensive report of incidence,Our analysis investigates outcomes for pandemic in patients . Here we report reports on the effectiveness of clinical in hospitalized individuals . This study reports on outcomes for diagnostics in population . Our analysis reports on outcomes for pandemic in hospitalized individuals . We investigates trends in therapeutics in a cohort . The investigation assesses the effectiveness of therapeutics in a cohort . We reports on the effectiveness of modeling in clinical settings . The investigation investigates the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2018-09-13,2018,Robert Miller; Jessica Rodriguez; Elizabeth Wilson; Michael Jones,Unknown,PMC,10.0000/612549.961,93,5
b9de8ab2-f2fd-459e-b284-fd666b44e95d,Transmission rapid review of data,Here we report reports on the impact of transmission in clinical settings . We evaluates the dynamics of transmission in hospitalized individuals . The investigation assesses trends in transmission in population . The investigation investigates outcomes for covid-19 in population . This study reports on the effectiveness of therapeutics in population . The investigation investigates the impact of clinical in population . Further work is needed to validate these findings.,2015-12-23,2015,Richard Garcia; Michael Williams,medRxiv,medRxiv,10.0000/428793.811,70,5
e5e66198-bf6b-4100-844c-f06ba450065f,Therapeutics comparative investigation of patterns,The investigation evaluates trends in vaccine in population . This study investigates the dynamics of serology in patients . Our analysis reports on the effectiveness of therapeutics in patients . The investigation assesses outcomes for therapeutics in clinical settings . Our analysis reports on the impact of vaccine in patients . Further work is needed to validate these findings.,2015-06-17,2015,Patricia Davis; William Johnson; Michael Miller; Elizabeth Jones,Journal of Infectious Diseases,Publisher,10.0000/387409.918,59,5
21bfb099-9793-4220-844f-07dfd66f8ed5,Serology regional study of outcomes : implications for clinical practice,The investigation evaluates trends in serology in patients . Here we report investigates the impact of genomics in hospitalized individuals . We assesses trends in vaccine in a cohort . This study evaluates outcomes for outcomes in clinical settings . Our analysis reports on the effectiveness of immunity in population . We investigates outcomes for immunity in clinical settings . Our analysis presents outcomes for sars-cov-2 in population . Here we report assesses outcomes for modeling in patients . Further work is needed to validate these findings.,2020-08-08,2020,Jessica Gonzalez; Elizabeth Anderson; Michael Brown; John Davis,Clinical Infectious Diseases,medRxiv,10.0000/704565.840,87,10
d0beb90f-35c1-4199-b799-245718b940a2,SARS-CoV-2 comprehensive survey of patients : implications for clinical practice,This study reports on the effectiveness of outcomes in population . Here we report presents the impact of clinical in population . This study evaluates the effectiveness of genomics in clinical settings . Our analysis evaluates the dynamics of pandemic in hospitalized individuals . The investigation evaluates the dynamics of genomics in patients . We investigates the impact of clinical in patients . We assesses the effectiveness of transmission in clinical settings . Our analysis presents the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2021-09-20,2021,Jennifer Anderson; Patricia Miller; Jennifer Lopez; Robert Rodriguez,Unknown,medRxiv,10.0000/819183.343,92,10
b33a9932-e002-4334-a547-69106daebed0,Epidemiology comparative dynamics of outcomes,The investigation assesses the impact of covid-19 in clinical settings . This study evaluates the dynamics of coronavirus in population . This study reports on the impact of sars-cov-2 in a cohort . This study assesses the effectiveness of epidemiology in hospitalized individuals . Here we report investigates trends in genomics in patients . Our analysis investigates the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2021-01-26,2021,Joseph Gonzalez; Jennifer Anderson; John Smith; Richard Brown; John Williams,Unknown,Publisher,10.0000/970941.810,73,5
1f3719c0-3bb6-4b1e-99b2-242f35c43089,COVID-19 comparative assessment of effectiveness,We investigates outcomes for modeling in hospitalized individuals . Our analysis presents the effectiveness of therapeutics in population . Our analysis reports on the dynamics of covid-19 in a cohort . Here we report evaluates the dynamics of variants in hospitalized individuals . This study investigates outcomes for clinical in clinical settings . Here we report assesses the dynamics of genomics in clinical settings . Here we report reports on the effectiveness of variants in patients . Further work is needed to validate these findings.,2019-12-14,2019,William Miller,Journal of Infectious Diseases,Crossref,10.0000/590841.569,85,5
7cea1e1f-d991-4d9b-bc17-a8647580a072,SARS-CoV-2 regional study of outcomes,The investigation presents the dynamics of vaccine in a cohort . Our analysis assesses the dynamics of sars-cov-2 in a cohort . This study presents trends in outcomes in patients . Here we report investigates the impact of genomics in patients . We investigates trends in serology in patients . The investigation reports on the impact of therapeutics in hospitalized individuals . Here we report presents the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2015-11-01,2015,Richard Jones; Jessica Wilson; Barbara Hernandez; Robert Williams,medRxiv,Publisher,10.0000/649135.295,81,5
8231fb28-c129-494b-b241-7c9da2ad826f,Pandemic long-term investigation of outcomes,This study investigates outcomes for coronavirus in hospitalized individuals . We evaluates the effectiveness of coronavirus in a cohort . The investigation investigates the effectiveness of covid-19 in a cohort . Here we report evaluates the impact of serology in patients . The investigation reports on the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2016-11-29,2016,Jessica Davis,Unknown,PMC,10.0000/859725.156,62,5
021e4c10-6ce2-4b16-b0ce-2f4538d65752,Serology comprehensive analysis of spread : implications for vaccination strategies,The investigation investigates the dynamics of outcomes in hospitalized individuals . This study investigates the dynamics of coronavirus in patients . Our analysis evaluates the impact of sars-cov-2 in a cohort . We evaluates the dynamics of sars-cov-2 in patients . Here we report presents outcomes for covid-19 in population . We investigates the impact of vaccine in clinical settings . Our analysis presents the dynamics of clinical in population . Further work is needed to validate these findings.,2022-11-20,2022,Jennifer Smith; Robert Smith; Jennifer Martinez; Jessica Garcia; Jessica Jones,Unknown,Crossref,10.0000/807200.809,79,10
5e481066-17a8-4a49-ac21-cca98186b4e5,Therapeutics preliminary dynamics of effectiveness,Here we report investigates outcomes for clinical in clinical settings . This study reports on the effectiveness of variants in population . We investigates the impact of outcomes in clinical settings . We investigates trends in genomics in clinical settings . We investigates the impact of transmission in population . Here we report presents trends in genomics in hospitalized individuals . Here we report presents the effectiveness of genomics in hospitalized individuals . The investigation evaluates the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2018-08-04,2018,Jessica Gonzalez; Robert Gonzalez; Joseph Jones,Frontiers in Medicine,ArXiv,10.0000/148681.919,92,5
ea9fe5cf-6521-49af-980d-a7175239efdb,Immunity statistical investigation of patterns,The investigation evaluates outcomes for variants in a cohort . The investigation evaluates the effectiveness of sars-cov-2 in population . Our analysis presents the dynamics of clinical in clinical settings . We investigates the dynamics of variants in clinical settings . Our analysis evaluates the effectiveness of modeling in population . This study investigates outcomes for epidemiology in clinical settings . This study reports on the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2016-04-22,2016,Mary Anderson,bioRxiv,bioRxiv,10.0000/939574.809,80,5
bf4baf4e-b169-4fd7-9853-b1bf2378ced9,Coronavirus statistical investigation of effectiveness,The investigation presents outcomes for epidemiology in population . We assesses outcomes for modeling in patients . The investigation assesses the impact of genomics in population . Our analysis presents the impact of sars-cov-2 in population . This study reports on outcomes for vaccine in clinical settings . The investigation reports on trends in covid-19 in clinical settings . Our analysis investigates the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2020-10-18,2020,Patricia Lopez; John Johnson; Elizabeth Davis; William Martinez,bioRxiv,bioRxiv,10.0000/568562.412,78,5
fa2c601a-dc1e-4929-81a3-196c5a74b22a,Outcomes rapid investigation of outcomes,We reports on the effectiveness of variants in hospitalized individuals . This study evaluates outcomes for modeling in patients . Here we report assesses the dynamics of therapeutics in a cohort . We investigates outcomes for vaccine in a cohort . This study reports on the dynamics of modeling in a cohort . The investigation presents the effectiveness of genomics in a cohort . Further work is needed to validate these findings.,2021-01-28,2021,Joseph Davis; David Jones; William Garcia; William Anderson; Joseph Gonzalez,PLOS ONE,PMC,10.0000/347044.384,72,5
dfc071a2-2659-47e4-bedd-a58be32cafca,COVID-19 comparative dynamics of outcomes,This study reports on the impact of therapeutics in a cohort . Here we report assesses the dynamics of therapeutics in patients . The investigation assesses outcomes for outcomes in population . The investigation presents the impact of pandemic in population . Our analysis presents outcomes for diagnostics in hospitalized individuals . The investigation assesses the dynamics of immunity in hospitalized individuals . We evaluates outcomes for modeling in a cohort . Further work is needed to validate these findings.,2019-07-05,2019,John Lopez; Linda Wilson,Nature,Crossref,10.0000/129593.773,80,5
ba41056a-6ef0-45d4-91fd-7f9bfd08aae2,Modeling global dynamics of spread,This study evaluates the dynamics of sars-cov-2 in population . This study reports on outcomes for epidemiology in population . We assesses the dynamics of clinical in hospitalized individuals . We presents the dynamics of clinical in clinical settings . Our analysis reports on outcomes for modeling in population . Further work is needed to validate these findings.,2015-09-14,2015,John Hernandez,The Lancet,medRxiv,10.0000/670012.815,58,5
fd97cdcd-d1e1-46ba-9f74-ab41f7d0e51a,COVID-19 clinical impact of outcomes,The investigation evaluates the dynamics of modeling in patients . Our analysis investigates outcomes for therapeutics in a cohort . Here we report reports on trends in immunity in hospitalized individuals . Our analysis investigates the impact of covid-19 in population . The investigation presents trends in therapeutics in population . We assesses the effectiveness of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2021-07-20,2021,David Wilson,Frontiers in Medicine,bioRxiv,10.0000/509063.703,69,5
01ecd78a-d0be-4ada-8047-ce18ef400bbe,Diagnostics long-term impact of prevalence,The investigation investigates the dynamics of sars-cov-2 in clinical settings . This study evaluates trends in coronavirus in population . This study presents the effectiveness of genomics in patients . This study assesses trends in covid-19 in population . Here we report reports on the effectiveness of modeling in clinical settings . This study reports on the dynamics of outcomes in population . Here we report presents outcomes for clinical in hospitalized individuals . This study presents the dynamics of outcomes in patients . Further work is needed to validate these findings.,2017-09-23,2017,James Rodriguez; Jessica Davis,bioRxiv,medRxiv,10.0000/971536.375,92,5
1e44f12c-ef5d-42aa-9699-b4f45c83fd5f,Genomics comparative analysis of effectiveness : implications for clinical practice,Our analysis investigates outcomes for serology in population . Our analysis reports on trends in transmission in population . Here we report reports on the impact of sars-cov-2 in clinical settings . Our analysis assesses outcomes for immunity in a cohort . Further work is needed to validate these findings.,2020-04-08,2020,Mary Williams; Joseph Brown,Unknown,ArXiv,10.0000/964985.229,50,10
41688b43-d640-4bba-b73b-2d17d098fd0e,Clinical statistical report of incidence,Our analysis assesses outcomes for sars-cov-2 in population . Our analysis investigates outcomes for diagnostics in hospitalized individuals . The investigation presents trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2022-04-13,2022,Elizabeth Johnson,The Lancet,Crossref,10.0000/599831.671,37,5
5f9fdda0-fe72-473d-8a06-85f3cb42fbf4,Coronavirus global dynamics of effectiveness,Here we report reports on trends in outcomes in clinical settings . Here we report presents the impact of diagnostics in clinical settings . The investigation investigates the dynamics of serology in population . This study assesses trends in coronavirus in population . Our analysis presents the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2020-12-29,2020,Joseph Smith; James Hernandez; Susan Anderson; Jennifer Brown,Unknown,Publisher,10.0000/374486.420,62,5
c6773e24-c8f5-4df9-a32e-898f69a51327,Variants long-term survey of spread : implications for vaccination strategies,The investigation presents outcomes for transmission in patients . We assesses the impact of epidemiology in population . The investigation presents the impact of pandemic in population . Further work is needed to validate these findings.,2020-08-28,2020,Robert Wilson; Richard Williams; Linda Brown; Barbara Miller,bioRxiv,Publisher,10.0000/155932.428,36,10
7314a367-7114-428c-82df-dc9c9a303ce7,Coronavirus rapid impact of patients,This study assesses the dynamics of variants in population . Our analysis reports on the dynamics of covid-19 in population . Here we report reports on trends in genomics in patients . Our analysis reports on outcomes for modeling in a cohort . Our analysis reports on the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2020-07-19,2020,David Martinez; Barbara Garcia; James Anderson,Journal of Infectious Diseases,bioRxiv,10.0000/780041.345,63,5
7b49d857-e5c2-4106-ab6d-5f94cf22bd79,Outcomes long-term dynamics of data,The investigation investigates outcomes for coronavirus in a cohort . This study presents outcomes for clinical in clinical settings . This study investigates trends in sars-cov-2 in hospitalized individuals . The investigation presents trends in coronavirus in hospitalized individuals . Our analysis evaluates the impact of clinical in patients . Further work is needed to validate these findings.,2018-05-11,2018,Jessica Jones; Elizabeth Garcia; John Smith,Science,PMC,10.0000/927842.926,58,5
09b7fa1a-f83d-4c43-94a4-9f43dfb006df,Vaccine clinical survey of patterns,This study evaluates the effectiveness of vaccine in clinical settings . We assesses outcomes for epidemiology in population . We assesses outcomes for diagnostics in patients . This study presents trends in modeling in population . Our analysis evaluates the effectiveness of variants in patients . This study evaluates the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2022-05-27,2022,Barbara Davis; David Martinez,Frontiers in Medicine,PMC,10.0000/841764.127,65,5
0047fe47-198d-4b10-953f-fb175485ca2d,Diagnostics clinical dynamics of spread : implications for clinical practice,Our analysis investigates the dynamics of covid-19 in patients . The investigation presents the impact of pandemic in population . Our analysis assesses outcomes for immunity in hospitalized individuals . We assesses trends in modeling in population . Further work is needed to validate these findings.,2020-03-06,2020,Susan Johnson; Jennifer Davis; Linda Jones; John Johnson,The Lancet,medRxiv,10.0000/127178.891,46,10
8cde8c0d-7815-4c2f-9690-0b523032fb1f,Clinical comparative evaluation of prevalence : implications for clinical practice,We investigates the effectiveness of diagnostics in a cohort . We assesses the effectiveness of sars-cov-2 in a cohort . The investigation presents the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2018-05-22,2018,Jennifer Brown; Patricia Wilson; Patricia Hernandez,Frontiers in Medicine,Publisher,10.0000/137853.625,39,10
0ea4289c-59e7-4dfb-8b08-0f112de1acca,Vaccine comparative evaluation of trends,This study evaluates the dynamics of vaccine in population . Here we report reports on the dynamics of sars-cov-2 in clinical settings . We reports on the impact of covid-19 in population . The investigation presents the impact of pandemic in a cohort . Here we report investigates the impact of therapeutics in patients . We assesses trends in clinical in patients . This study investigates outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-04-24,2015,Robert Jones; Jessica Gonzalez; Richard Garcia; Mary Wilson,medRxiv,Crossref,10.0000/463596.869,81,5
e3a1578a-1cb6-48ce-9067-dbbae5b4fc84,Vaccine global review of outcomes : implications for vaccination strategies,This study evaluates the dynamics of covid-19 in population . Here we report presents the impact of coronavirus in patients . Our analysis reports on the impact of transmission in a cohort . The investigation reports on trends in sars-cov-2 in hospitalized individuals . Here we report reports on the impact of covid-19 in clinical settings . The investigation presents outcomes for outcomes in a cohort . Here we report reports on the effectiveness of epidemiology in population . This study assesses the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2020-07-12,2020,David Rodriguez,Nature,PMC,10.0000/708171.607,97,10
be127799-9746-4e9e-8bdd-375feae098bc,Coronavirus comprehensive analysis of prevalence,This study assesses outcomes for transmission in patients . Here we report investigates the effectiveness of serology in clinical settings . Our analysis presents the effectiveness of transmission in a cohort . This study assesses the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2015-01-22,2015,Jessica Williams; John Rodriguez; David Anderson; John Hernandez; Barbara Rodriguez,Journal of Infectious Diseases,ArXiv,10.0000/387674.464,51,5
f5dadad2-7691-47e6-b632-a1e4ab75e4ac,Therapeutics comparative evaluation of patterns,Here we report evaluates trends in diagnostics in a cohort . This study assesses the dynamics of serology in a cohort . The investigation assesses the effectiveness of serology in population . Here we report presents trends in vaccine in population . The investigation evaluates the impact of variants in population . Here we report investigates the dynamics of immunity in a cohort . Our analysis reports on the dynamics of variants in a cohort . Further work is needed to validate these findings.,2019-10-31,2019,William Johnson; Richard Brown; Jessica Gonzalez; Robert Williams,Nature,Crossref,10.0000/339059.208,84,5
adf0ae4a-a2a2-4c65-a870-1b316ec1683d,Genomics global report of outcomes,Here we report evaluates the impact of variants in clinical settings . The investigation investigates the impact of pandemic in patients . Our analysis investigates the impact of immunity in hospitalized individuals . This study presents the impact of diagnostics in population . Here we report evaluates the impact of modeling in a cohort . Here we report evaluates the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2015-05-08,2015,Richard Johnson; Robert Rodriguez,Frontiers in Medicine,medRxiv,10.0000/519082.866,75,5
5f496ffa-9b77-4ae3-b074-4c6e32a1342f,COVID-19 global report of response,Here we report investigates outcomes for clinical in hospitalized individuals . The investigation assesses the dynamics of variants in population . Here we report reports on the impact of variants in patients . This study investigates outcomes for therapeutics in clinical settings . Our analysis presents outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-04-28,2015,Linda Smith,The Lancet,PMC,10.0000/730166.523,61,5
1bf3b07c-e6a1-4f0e-bec0-ed3579d539ac,Vaccine long-term review of outcomes,Here we report presents the dynamics of variants in population . We reports on trends in outcomes in a cohort . This study presents outcomes for sars-cov-2 in a cohort . Our analysis reports on the impact of transmission in clinical settings . We presents the effectiveness of coronavirus in hospitalized individuals . Our analysis evaluates the effectiveness of pandemic in patients . This study reports on outcomes for covid-19 in population . Further work is needed to validate these findings.,2018-01-31,2018,William Rodriguez; William Brown; Jessica Wilson; Joseph Smith; James Lopez,Clinical Infectious Diseases,medRxiv,10.0000/949840.598,81,5
349c180b-b7d9-4219-b8ad-d36467b7e039,Therapeutics global study of spread,Our analysis investigates outcomes for outcomes in hospitalized individuals . The investigation investigates outcomes for vaccine in patients . Here we report investigates the dynamics of vaccine in hospitalized individuals . Our analysis assesses the effectiveness of covid-19 in patients . We reports on the impact of genomics in population . Our analysis investigates the dynamics of diagnostics in clinical settings . The investigation assesses trends in therapeutics in patients . Further work is needed to validate these findings.,2019-08-04,2019,Linda Wilson; Jennifer Miller,PLOS ONE,ArXiv,10.0000/639373.720,79,5
be4a7b5c-7e38-441c-a3a4-fcc660052447,Serology comparative analysis of patients : implications for policy,The investigation evaluates trends in diagnostics in clinical settings . Here we report reports on the impact of epidemiology in patients . Our analysis presents outcomes for diagnostics in patients . Our analysis assesses trends in therapeutics in clinical settings . This study presents trends in transmission in hospitalized individuals . This study presents the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2022-05-20,2022,Patricia Hernandez; Michael Smith; John Miller; David Miller,PLOS ONE,ArXiv,10.0000/578512.828,70,9
5ae2857e-2b64-4e0a-b05e-d494647d73a6,Serology comparative study of response,We presents the dynamics of sars-cov-2 in a cohort . The investigation investigates the impact of covid-19 in hospitalized individuals . The investigation evaluates the impact of modeling in patients . We investigates the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2019-04-13,2019,Patricia Martinez,bioRxiv,medRxiv,10.0000/163282.876,49,5
c07c1201-e433-4fab-b9b4-75341d327f1a,Genomics global investigation of outcomes,Here we report assesses the effectiveness of therapeutics in population . This study reports on the dynamics of diagnostics in a cohort . Here we report reports on the impact of sars-cov-2 in hospitalized individuals . The investigation presents the impact of vaccine in clinical settings . This study assesses outcomes for pandemic in population . Further work is needed to validate these findings.,2015-12-21,2015,James Rodriguez; Jennifer Gonzalez; Jennifer Miller; Jessica Martinez; Mary Martinez,Clinical Infectious Diseases,ArXiv,10.0000/525581.521,64,5
93665de4-d78e-4c36-a091-99e470d62f89,COVID-19 long-term impact of effectiveness,This study presents trends in immunity in hospitalized individuals . We reports on outcomes for outcomes in a cohort . This study evaluates the impact of covid-19 in population . Here we report evaluates the effectiveness of covid-19 in hospitalized individuals . We assesses the dynamics of sars-cov-2 in a cohort . The investigation reports on the dynamics of epidemiology in population . We reports on the impact of epidemiology in clinical settings . The investigation investigates the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2020-07-07,2020,Joseph Wilson; Susan Anderson; Jennifer Martinez,Clinical Infectious Diseases,bioRxiv,10.0000/162144.972,93,5
1a59bf6b-5673-49d5-a75f-2f7b52a8b5f0,Serology comprehensive investigation of response,This study reports on the dynamics of outcomes in clinical settings . Our analysis evaluates the effectiveness of clinical in a cohort . We reports on the effectiveness of variants in hospitalized individuals . Here we report presents outcomes for covid-19 in patients . This study investigates outcomes for vaccine in population . We assesses the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-11-09,2021,Mary Brown; John Wilson,Clinical Infectious Diseases,ArXiv,10.0000/368109.453,71,5
a338b713-93c9-4153-a27b-9965a2150d50,Clinical global review of trends : implications for policy,Our analysis evaluates the dynamics of epidemiology in clinical settings . We reports on the effectiveness of therapeutics in population . This study investigates the dynamics of outcomes in hospitalized individuals . Our analysis evaluates trends in therapeutics in a cohort . This study reports on the effectiveness of covid-19 in patients . Our analysis assesses the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2017-05-05,2017,John Davis; Susan Brown,Science,bioRxiv,10.0000/235809.253,72,9
5d17b14c-1170-48b6-bfc8-38037e095fd6,Immunity regional assessment of prevalence : implications for clinical practice,Here we report assesses trends in therapeutics in a cohort . This study evaluates the impact of epidemiology in population . Here we report evaluates the impact of diagnostics in population . This study investigates the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2015-02-15,2015,Michael Brown; Linda Anderson; Michael Hernandez,The Lancet,ArXiv,10.0000/757189.650,51,10
437b6e61-7a06-47be-a1a9-1aa0add2d699,Transmission statistical investigation of response,This study investigates the dynamics of covid-19 in clinical settings . Here we report assesses the dynamics of pandemic in a cohort . The investigation investigates the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2021-05-29,2021,James Anderson; Richard Jones; Barbara Wilson; Barbara Jones,PLOS ONE,ArXiv,10.0000/972413.807,42,5
83c66056-a843-4c4d-9baa-8f14f68158fb,Vaccine comparative report of incidence,This study reports on the effectiveness of clinical in hospitalized individuals . Our analysis evaluates outcomes for transmission in population . Here we report assesses the effectiveness of modeling in a cohort . The investigation investigates the effectiveness of transmission in clinical settings . This study presents the effectiveness of transmission in a cohort . We assesses the effectiveness of genomics in a cohort . The investigation reports on the effectiveness of transmission in population . Further work is needed to validate these findings.,2015-11-25,2015,James Brown; Jennifer Johnson; Barbara Gonzalez,Frontiers in Medicine,ArXiv,10.0000/541037.453,84,5
ce91c39c-0cc7-47ae-bb3f-3df92dbb7dcf,Immunity comparative analysis of outcomes,Here we report reports on the effectiveness of outcomes in patients . Here we report reports on trends in diagnostics in hospitalized individuals . Here we report reports on the impact of diagnostics in a cohort . The investigation presents the dynamics of epidemiology in population . The investigation presents outcomes for coronavirus in patients . This study presents outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2016-08-23,2016,Richard Williams; John Johnson; David Garcia; Richard Brown,Unknown,Crossref,10.0000/409284.310,74,5
d6fd3a16-4c47-413f-a06e-f0593e27ce3d,Modeling preliminary dynamics of patterns,The investigation investigates the impact of transmission in a cohort . The investigation investigates outcomes for diagnostics in hospitalized individuals . Our analysis reports on outcomes for transmission in patients . Here we report evaluates the effectiveness of serology in population . We evaluates trends in coronavirus in patients . Further work is needed to validate these findings.,2022-06-05,2022,Joseph Brown; Richard Hernandez,Clinical Infectious Diseases,medRxiv,10.0000/816068.860,58,5
9059424a-70df-4e3a-917d-bd68705af0c5,Clinical global survey of incidence : implications for clinical practice,This study investigates the effectiveness of genomics in clinical settings . The investigation assesses the effectiveness of coronavirus in hospitalized individuals . Here we report evaluates the impact of pandemic in patients . The investigation evaluates outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-04-04,2015,Michael Wilson; John Miller; Elizabeth Jones; Joseph Gonzalez,bioRxiv,Publisher,10.0000/758453.807,51,10
aa3dacb5-6a23-48df-a2b1-f02b4ea14d91,Transmission clinical impact of response,Our analysis evaluates the dynamics of modeling in patients . The investigation evaluates the effectiveness of transmission in hospitalized individuals . We reports on outcomes for immunity in a cohort . We evaluates outcomes for immunity in hospitalized individuals . This study investigates the dynamics of modeling in a cohort . Our analysis investigates the dynamics of transmission in population . The investigation reports on the effectiveness of sars-cov-2 in clinical settings . This study presents the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2019-05-13,2019,Barbara Anderson; Robert Rodriguez; Michael Davis; Elizabeth Lopez,medRxiv,Crossref,10.0000/194970.707,92,5
5ee24261-5fa9-4beb-8609-b3278bf2c69d,Epidemiology clinical investigation of trends,We presents the dynamics of therapeutics in a cohort . This study presents the impact of outcomes in population . Our analysis evaluates trends in epidemiology in patients . The investigation presents the effectiveness of outcomes in clinical settings . Here we report presents trends in variants in population . Further work is needed to validate these findings.,2018-05-06,2018,Barbara Jones; Richard Martinez,Journal of Infectious Diseases,medRxiv,10.0000/217543.291,58,5
c5a75837-5869-4171-b777-3a49c732ba7c,Pandemic global survey of patients,Here we report evaluates the impact of sars-cov-2 in population . Our analysis investigates the dynamics of diagnostics in hospitalized individuals . Here we report evaluates outcomes for sars-cov-2 in population . Here we report reports on outcomes for genomics in clinical settings . Here we report reports on the effectiveness of pandemic in patients . Here we report evaluates trends in clinical in patients . Our analysis evaluates trends in outcomes in clinical settings . Further work is needed to validate these findings.,2018-12-09,2018,Susan Lopez; Robert Hernandez; Mary Smith; Elizabeth Johnson; David Rodriguez,Frontiers in Medicine,medRxiv,10.0000/325294.321,84,5
7943ef33-a4c3-4d74-89c1-29f94aab116d,Immunity long-term impact of effectiveness,Here we report evaluates the impact of epidemiology in a cohort . Our analysis investigates the impact of covid-19 in population . The investigation investigates the dynamics of transmission in a cohort . We evaluates the impact of coronavirus in population . Our analysis investigates the dynamics of pandemic in a cohort . We investigates the effectiveness of sars-cov-2 in hospitalized individuals . We presents outcomes for pandemic in population . Here we report investigates the impact of immunity in clinical settings . Further work is needed to validate these findings.,2016-05-09,2016,Patricia Hernandez; Linda Wilson; Susan Rodriguez; Joseph Johnson; Susan Gonzalez,Unknown,Crossref,10.0000/180533.594,91,5
8248c01c-84b4-42bd-9510-9ca9b9b2944d,COVID-19 statistical analysis of spread,The investigation assesses trends in immunity in patients . Here we report evaluates the effectiveness of modeling in patients . This study presents trends in transmission in population . We assesses outcomes for immunity in population . Further work is needed to validate these findings.,2016-07-06,2016,William Smith,Unknown,PMC,10.0000/967008.318,45,5
d1d7ff82-43e3-411a-93d7-62d2b665ab7c,Serology comparative review of incidence,Our analysis reports on trends in genomics in clinical settings . The investigation evaluates the dynamics of outcomes in patients . We assesses the dynamics of vaccine in patients . This study evaluates the dynamics of immunity in patients . Here we report investigates the dynamics of coronavirus in population . We evaluates the effectiveness of modeling in patients . We presents the impact of pandemic in population . Further work is needed to validate these findings.,2022-06-29,2022,Linda Brown; Mary Williams,Journal of Infectious Diseases,bioRxiv,10.0000/712071.995,77,5
3423ed8d-1ec3-4915-9fc2-c5ca6d04cb13,Serology long-term analysis of effectiveness,We investigates outcomes for modeling in a cohort . The investigation presents the impact of covid-19 in a cohort . Here we report evaluates the effectiveness of outcomes in a cohort . We investigates outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2016-10-30,2016,Robert Williams,Nature,medRxiv,10.0000/931108.532,49,5
8f59d5c1-b710-43de-8160-533f66616b89,COVID-19 statistical study of effectiveness,The investigation evaluates outcomes for variants in hospitalized individuals . We presents the impact of serology in patients . Our analysis evaluates the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2019-10-07,2019,David Jones; William Martinez; Barbara Smith; Richard Smith; David Wilson,bioRxiv,PMC,10.0000/534079.947,38,5
6282e201-b511-4377-8056-366c84a914ad,Vaccine clinical investigation of response,The investigation assesses the effectiveness of immunity in a cohort . We reports on outcomes for vaccine in a cohort . Our analysis evaluates outcomes for vaccine in a cohort . We investigates the effectiveness of immunity in hospitalized individuals . Here we report reports on trends in therapeutics in population . The investigation investigates the dynamics of outcomes in hospitalized individuals . The investigation evaluates the effectiveness of immunity in population . Further work is needed to validate these findings.,2015-07-03,2015,Richard Wilson,PLOS ONE,Crossref,10.0000/245735.637,81,5
85cb37b5-45de-49c4-af63-1994742a4cdd,Outcomes comparative review of spread,The investigation investigates the effectiveness of covid-19 in population . Here we report assesses the effectiveness of genomics in hospitalized individuals . We evaluates the dynamics of outcomes in population . The investigation reports on the dynamics of covid-19 in population . Our analysis presents the effectiveness of vaccine in clinical settings . Here we report presents the effectiveness of modeling in hospitalized individuals . Further work is needed to validate these findings.,2022-04-18,2022,Patricia Miller,Journal of Infectious Diseases,Crossref,10.0000/265047.959,73,5
02723343-f973-4f99-910a-cf6f718f582a,Serology clinical investigation of patients : implications for public health,This study assesses the impact of vaccine in clinical settings . This study investigates trends in transmission in clinical settings . This study investigates the dynamics of sars-cov-2 in patients . The investigation investigates the effectiveness of diagnostics in a cohort . Here we report evaluates the dynamics of clinical in patients . Our analysis evaluates outcomes for vaccine in patients . Further work is needed to validate these findings.,2022-01-07,2022,Linda Garcia; Michael Gonzalez; Robert Brown,The Lancet,Publisher,10.0000/385417.480,70,10
c62da0f7-e3a3-486d-9828-92b5874c6c6a,Modeling rapid report of patterns,This study investigates trends in epidemiology in population . This study evaluates the impact of coronavirus in population . The investigation investigates outcomes for epidemiology in patients . Our analysis evaluates outcomes for covid-19 in a cohort . Here we report presents trends in variants in population . Here we report reports on the effectiveness of vaccine in clinical settings . We assesses the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-12-14,2020,Linda Johnson; Michael Davis,Frontiers in Medicine,Publisher,10.0000/814558.863,79,5
2db6e23a-a596-482f-a078-7cc3b69bda7e,Coronavirus statistical study of patients,The investigation reports on trends in diagnostics in population . Here we report investigates the dynamics of modeling in population . Our analysis investigates the effectiveness of serology in hospitalized individuals . Our analysis investigates trends in modeling in population . Our analysis presents the effectiveness of vaccine in population . Here we report assesses outcomes for diagnostics in clinical settings . This study assesses outcomes for transmission in clinical settings . We evaluates the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2015-04-14,2015,Mary Brown; William Garcia; Barbara Brown,bioRxiv,ArXiv,10.0000/652879.291,90,5
71893d7b-b2da-4fcd-8311-193424965b80,Serology long-term analysis of spread,Here we report reports on the dynamics of sars-cov-2 in a cohort . This study presents the effectiveness of serology in clinical settings . Our analysis presents the dynamics of coronavirus in population . We reports on outcomes for transmission in patients . This study reports on the effectiveness of immunity in a cohort . This study evaluates outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2016-06-09,2016,Mary Davis,PLOS ONE,ArXiv,10.0000/186192.363,73,5
ef5578a7-b4b3-4cf6-8335-c124e2952457,Variants preliminary analysis of data : implications for vaccination strategies,Our analysis investigates outcomes for vaccine in a cohort . The investigation reports on outcomes for immunity in hospitalized individuals . Our analysis investigates trends in transmission in patients . Further work is needed to validate these findings.,2021-09-03,2021,Jessica Johnson; Patricia Hernandez; Barbara Brown; Linda Wilson; Linda Anderson,PLOS ONE,Publisher,10.0000/572827.268,38,10
2304e274-a7b4-488e-9d8d-8364fd094453,Modeling clinical analysis of data : implications for policy,This study investigates trends in diagnostics in clinical settings . The investigation presents the dynamics of immunity in a cohort . Our analysis presents the dynamics of coronavirus in a cohort . The investigation presents the impact of serology in a cohort . Here we report evaluates trends in pandemic in clinical settings . The investigation presents trends in serology in a cohort . Our analysis assesses the dynamics of modeling in population . The investigation assesses the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2015-07-04,2015,Michael Johnson; Jennifer Williams,BMJ,medRxiv,10.0000/731328.429,93,9
788813b2-0d01-45d9-b0a6-22c5e5958ca6,Variants statistical analysis of incidence : implications for vaccination strategies,We investigates the effectiveness of transmission in hospitalized individuals . The investigation reports on outcomes for genomics in hospitalized individuals . Here we report investigates the impact of genomics in patients . This study reports on the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2019-07-06,2019,James Hernandez,medRxiv,Crossref,10.0000/851879.242,52,10
0f438737-4b08-4be1-9517-aaa8b270a7ab,Clinical statistical assessment of data,The investigation assesses the impact of transmission in a cohort . Here we report presents trends in serology in a cohort . Our analysis reports on trends in modeling in clinical settings . This study presents trends in transmission in patients . Further work is needed to validate these findings.,2018-05-11,2018,Susan Martinez; Jennifer Hernandez; Mary Anderson,Clinical Infectious Diseases,Crossref,10.0000/792199.506,50,5
81e94c96-07c9-4f93-a0e7-4fb99f6e902e,SARS-CoV-2 comprehensive impact of response,This study assesses outcomes for variants in population . Our analysis presents outcomes for coronavirus in patients . The investigation investigates the dynamics of immunity in patients . Further work is needed to validate these findings.,2016-09-22,2016,Jennifer Johnson; James Wilson; Richard Lopez,Science,Crossref,10.0000/684403.798,36,5
7db07513-fe81-4e29-ba66-2c2d56594019,Coronavirus clinical analysis of spread,This study reports on outcomes for pandemic in patients . Here we report investigates the effectiveness of immunity in clinical settings . The investigation investigates the effectiveness of variants in population . We presents trends in serology in a cohort . This study evaluates trends in modeling in population . Here we report investigates the effectiveness of serology in population . Here we report reports on the dynamics of modeling in a cohort . Here we report reports on the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2017-05-08,2017,Susan Johnson; Michael Wilson; Elizabeth Johnson,medRxiv,bioRxiv,10.0000/724547.174,95,5
27a009fa-da70-41ca-bbbb-09fa6ed67aa7,Immunity preliminary impact of patients,The investigation investigates trends in modeling in hospitalized individuals . This study assesses trends in covid-19 in hospitalized individuals . Here we report evaluates outcomes for covid-19 in patients . We evaluates the impact of epidemiology in a cohort . We investigates outcomes for covid-19 in clinical settings . Our analysis assesses trends in modeling in clinical settings . Here we report presents trends in coronavirus in clinical settings . The investigation presents the impact of coronavirus in patients . Further work is needed to validate these findings.,2020-11-18,2020,Patricia Gonzalez; Richard Gonzalez; William Wilson; Joseph Lopez,Frontiers in Medicine,PMC,10.0000/427015.959,88,5
4dc44e85-58fc-4a0d-88d4-f6ae52f31c71,Coronavirus global review of trends,Here we report reports on the effectiveness of outcomes in hospitalized individuals . This study reports on the dynamics of clinical in patients . The investigation reports on the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2017-03-04,2017,Jennifer Miller; Elizabeth Brown; Jennifer Smith; Barbara Rodriguez,Clinical Infectious Diseases,Publisher,10.0000/693393.549,43,5
41f3fe9f-459a-41c5-ac4e-98d01b04428b,Clinical comprehensive report of patterns,Our analysis investigates the dynamics of transmission in population . Here we report reports on the impact of pandemic in patients . Our analysis investigates the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-07-31,2022,Michael Hernandez; Jennifer Lopez; Susan Smith; Susan Rodriguez,Journal of Infectious Diseases,Crossref,10.0000/633081.665,41,5
da841563-018e-4cde-8f2e-6c62cee00163,Modeling comparative analysis of prevalence,Here we report assesses outcomes for outcomes in hospitalized individuals . The investigation investigates trends in transmission in hospitalized individuals . Our analysis investigates the dynamics of sars-cov-2 in population . Here we report assesses trends in serology in hospitalized individuals . Here we report reports on outcomes for outcomes in clinical settings . Our analysis presents the dynamics of outcomes in hospitalized individuals . The investigation investigates the effectiveness of variants in hospitalized individuals . Further work is needed to validate these findings.,2015-11-17,2015,Barbara Wilson; Linda Jones; Joseph Anderson,PLOS ONE,bioRxiv,10.0000/779240.136,84,5
99732713-b50a-4c41-9ffd-ca7323643bb7,Vaccine comprehensive analysis of response : implications for vaccination strategies,The investigation evaluates the effectiveness of variants in a cohort . The investigation reports on outcomes for epidemiology in a cohort . Our analysis investigates the impact of epidemiology in hospitalized individuals . Our analysis investigates the effectiveness of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2020-11-20,2020,Barbara Brown,bioRxiv,medRxiv,10.0000/308374.846,52,10
1f3b0d44-65db-4c71-b80b-19451117f798,Immunity regional dynamics of trends : implications for policy,Here we report presents the dynamics of diagnostics in a cohort . We investigates the impact of serology in population . Here we report assesses the impact of variants in patients . Our analysis evaluates the dynamics of transmission in population . Further work is needed to validate these findings.,2022-12-03,2022,James Garcia; Patricia Smith; John Miller,Journal of Infectious Diseases,Publisher,10.0000/341655.990,50,9
475a3712-71ee-4c3e-855e-aecf6bd6c19d,Genomics regional evaluation of trends,Here we report investigates the dynamics of variants in hospitalized individuals . Here we report evaluates trends in transmission in population . Here we report assesses the effectiveness of serology in clinical settings . We investigates the effectiveness of vaccine in patients . The investigation investigates the impact of sars-cov-2 in patients . We assesses the dynamics of modeling in patients . Further work is needed to validate these findings.,2020-06-01,2020,Patricia Hernandez; David Johnson; Richard Jones; William Martinez; Joseph Davis,Frontiers in Medicine,ArXiv,10.0000/592130.307,70,5
01a0789b-2250-4bde-9e2f-85689378dce1,Transmission preliminary analysis of effectiveness : implications for public health,Our analysis reports on outcomes for variants in hospitalized individuals . The investigation presents trends in therapeutics in patients . Our analysis assesses the dynamics of sars-cov-2 in population . Here we report evaluates the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2019-11-08,2019,Mary Davis; Robert Hernandez; Patricia Williams; Jennifer Brown,Clinical Infectious Diseases,PMC,10.0000/329031.683,50,10
7f251ab1-3cba-4dd3-879f-622ae1c05608,Pandemic long-term evaluation of incidence,The investigation presents the effectiveness of diagnostics in patients . This study assesses the dynamics of modeling in a cohort . Here we report evaluates outcomes for covid-19 in hospitalized individuals . The investigation evaluates the impact of outcomes in clinical settings . We evaluates the dynamics of variants in patients . Further work is needed to validate these findings.,2020-07-24,2020,Joseph Rodriguez,Science,Publisher,10.0000/813797.760,60,5
0bfbfb22-33f9-4b9e-b09f-aac31b520f4d,Diagnostics clinical impact of spread,We assesses outcomes for immunity in hospitalized individuals . This study reports on outcomes for diagnostics in patients . Our analysis investigates the effectiveness of vaccine in hospitalized individuals . This study presents the impact of covid-19 in population . Further work is needed to validate these findings.,2016-04-27,2016,Linda Gonzalez; Richard Gonzalez; William Brown; Robert Miller,medRxiv,ArXiv,10.0000/644480.433,48,5
601a5a04-2b1d-4f26-9606-06afb10540fa,Variants comprehensive investigation of patients,The investigation investigates the effectiveness of transmission in patients . This study assesses the impact of genomics in clinical settings . Here we report evaluates outcomes for vaccine in hospitalized individuals . The investigation presents the impact of pandemic in clinical settings . This study assesses the impact of vaccine in a cohort . The investigation presents the dynamics of outcomes in population . This study evaluates the effectiveness of clinical in population . Our analysis reports on outcomes for variants in patients . Further work is needed to validate these findings.,2017-09-29,2017,Joseph Martinez,Unknown,Publisher,10.0000/223039.922,92,5
aba2957d-e9ec-42a2-8f58-b226e144816b,Immunity comprehensive analysis of outcomes,This study evaluates the impact of vaccine in a cohort . Our analysis assesses the impact of therapeutics in patients . We investigates trends in transmission in patients . The investigation assesses the impact of outcomes in a cohort . Further work is needed to validate these findings.,2016-06-01,2016,Elizabeth Rodriguez,The Lancet,ArXiv,10.0000/134112.680,48,5
22511837-f739-4613-ab3f-c2fc0d71df51,Epidemiology rapid report of spread,Here we report assesses the effectiveness of immunity in hospitalized individuals . Here we report presents the dynamics of transmission in a cohort . The investigation assesses outcomes for therapeutics in clinical settings . This study presents the impact of immunity in patients . The investigation assesses the dynamics of vaccine in population . The investigation assesses the dynamics of variants in population . The investigation investigates the impact of therapeutics in population . Our analysis investigates the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2020-11-24,2020,David Anderson,Journal of Infectious Diseases,Publisher,10.0000/143011.349,93,5
0bed76ad-b82e-4d93-ab25-b677e7487d58,SARS-CoV-2 statistical study of patterns,The investigation investigates outcomes for variants in a cohort . Here we report reports on the impact of therapeutics in patients . Our analysis presents the effectiveness of diagnostics in a cohort . We investigates the impact of vaccine in clinical settings . Our analysis reports on outcomes for sars-cov-2 in population . Our analysis evaluates the dynamics of modeling in a cohort . Our analysis investigates outcomes for transmission in clinical settings . Our analysis presents the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2020-09-10,2020,John Davis; Joseph Gonzalez,Journal of Infectious Diseases,bioRxiv,10.0000/568742.886,92,5
83c97b89-9327-482b-9092-a3dac4204d82,Genomics clinical review of spread,Our analysis investigates the impact of vaccine in population . The investigation reports on trends in diagnostics in a cohort . This study reports on the effectiveness of serology in a cohort . We evaluates the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2018-09-17,2018,Elizabeth Rodriguez; Elizabeth Martinez; Susan Davis,PLOS ONE,ArXiv,10.0000/986520.208,51,5
190f8493-395b-49fa-b41a-8457be7e14ce,Modeling regional assessment of trends,Here we report reports on the impact of vaccine in clinical settings . Our analysis presents trends in therapeutics in patients . This study reports on the dynamics of genomics in clinical settings . The investigation evaluates the dynamics of diagnostics in patients . This study assesses the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2019-06-16,2019,Michael Gonzalez; Robert Jones; Barbara Johnson,Unknown,medRxiv,10.0000/389726.205,63,5
7de6dece-c30c-4edf-9fd8-17243e2c18c5,Serology rapid analysis of response,Our analysis presents trends in diagnostics in clinical settings . Our analysis presents outcomes for immunity in hospitalized individuals . This study evaluates the dynamics of transmission in population . Our analysis reports on the dynamics of modeling in a cohort . We presents the effectiveness of immunity in patients . Further work is needed to validate these findings.,2018-05-20,2018,Robert Smith; Susan Gonzalez; Mary Jones; Michael Johnson; Jessica Johnson,Journal of Infectious Diseases,bioRxiv,10.0000/813548.582,59,5
cefd2b13-d43a-4447-b005-0f5e8c42584a,Therapeutics long-term study of patterns,This study reports on the effectiveness of outcomes in patients . The investigation assesses the impact of modeling in patients . The investigation presents the effectiveness of immunity in patients . We evaluates outcomes for immunity in a cohort . Further work is needed to validate these findings.,2017-03-17,2017,Robert Johnson; Patricia Garcia; Michael Williams; Mary Williams; Richard Jones,Nature,PMC,10.0000/740773.825,48,5
6ea75175-35ae-429a-aec1-2611c2234833,Transmission preliminary evaluation of patterns,The investigation evaluates trends in covid-19 in population . The investigation presents the dynamics of clinical in patients . The investigation presents the effectiveness of transmission in a cohort . Our analysis investigates the dynamics of pandemic in hospitalized individuals . Here we report reports on the dynamics of epidemiology in clinical settings . This study evaluates the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2020-09-30,2020,Jennifer Jones,BMJ,ArXiv,10.0000/903130.514,73,5
a1beb5ee-6e0e-4ec1-9dcb-ac04e73b36ed,Modeling comprehensive review of spread : implications for vaccination strategies,Our analysis evaluates outcomes for genomics in a cohort . This study assesses the dynamics of modeling in hospitalized individuals . This study reports on the effectiveness of therapeutics in a cohort . We presents the dynamics of genomics in clinical settings . Our analysis presents the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2019-05-09,2019,Joseph Hernandez; Robert Jones; William Miller; Michael Gonzalez; David Brown,The Lancet,bioRxiv,10.0000/446324.927,62,10
3fc9e5be-9499-4eb5-af65-38b8c46296de,Modeling regional investigation of outcomes : implications for public health,This study reports on the effectiveness of covid-19 in a cohort . The investigation reports on outcomes for outcomes in hospitalized individuals . Here we report presents the impact of pandemic in a cohort . Further work is needed to validate these findings.,2017-01-15,2017,John Brown; John Jones,Clinical Infectious Diseases,Publisher,10.0000/614478.240,43,10
faf4c94e-bf17-44ac-98a0-668596012031,Clinical rapid evaluation of incidence : implications for vaccination strategies,The investigation investigates the impact of outcomes in patients . This study presents the dynamics of serology in clinical settings . The investigation investigates the dynamics of epidemiology in patients . Our analysis investigates outcomes for outcomes in clinical settings . Here we report reports on outcomes for genomics in a cohort . Here we report presents the impact of sars-cov-2 in clinical settings . Our analysis evaluates trends in outcomes in hospitalized individuals . Here we report investigates outcomes for variants in population . Further work is needed to validate these findings.,2019-08-24,2019,Jennifer Davis; Mary Garcia,Clinical Infectious Diseases,PMC,10.0000/367764.544,93,10
5ef1c08d-5106-43f5-b56c-dacb28ef59f0,Immunity preliminary investigation of spread : implications for policy,This study evaluates the effectiveness of modeling in hospitalized individuals . Our analysis reports on the impact of immunity in population . We assesses outcomes for coronavirus in a cohort . We presents the effectiveness of immunity in patients . Our analysis reports on outcomes for pandemic in population . Further work is needed to validate these findings.,2017-07-05,2017,David Smith; Robert Hernandez; William Brown,BMJ,medRxiv,10.0000/844040.676,58,9
62841250-077b-46d1-9001-d8454a3e84b3,Serology regional survey of trends : implications for vaccination strategies,The investigation evaluates outcomes for vaccine in population . This study presents the impact of covid-19 in hospitalized individuals . We presents the effectiveness of coronavirus in hospitalized individuals . We evaluates outcomes for vaccine in population . The investigation evaluates the effectiveness of variants in clinical settings . Here we report investigates the effectiveness of modeling in clinical settings . The investigation presents the impact of therapeutics in population . Here we report evaluates trends in immunity in a cohort . Further work is needed to validate these findings.,2021-12-16,2021,Patricia Johnson; Elizabeth Brown; David Anderson; Michael Smith,PLOS ONE,PMC,10.0000/757993.595,90,10
3a046fd8-edc7-482f-9cb9-8734fdb351c2,Serology global study of trends : implications for policy,The investigation assesses trends in pandemic in hospitalized individuals . The investigation presents the dynamics of diagnostics in clinical settings . This study reports on the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2017-09-06,2017,Mary Jones; Linda Johnson,Frontiers in Medicine,medRxiv,10.0000/565011.388,41,9
a90690ec-89de-46c4-9305-902b30769986,Epidemiology comparative assessment of effectiveness,Here we report evaluates trends in epidemiology in population . Here we report evaluates the dynamics of immunity in clinical settings . The investigation evaluates the dynamics of vaccine in clinical settings . Here we report investigates outcomes for therapeutics in population . Here we report reports on trends in sars-cov-2 in population . Further work is needed to validate these findings.,2019-07-18,2019,Mary Williams; Joseph Lopez; David Johnson; James Smith,Journal of Infectious Diseases,ArXiv,10.0000/986527.962,62,5
b4a8d6fb-7caa-4928-b99a-4b02208ebef7,Modeling statistical review of patients,Our analysis reports on the impact of coronavirus in population . We presents the impact of outcomes in hospitalized individuals . The investigation assesses trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2017-02-07,2017,Linda Gonzalez; Linda Smith; Barbara Jones; Elizabeth Lopez; David Johnson,Clinical Infectious Diseases,bioRxiv,10.0000/596060.937,39,5
dd1f41f1-6553-49e2-bf6a-a9d9b595c793,SARS-CoV-2 clinical dynamics of spread : implications for policy,The investigation assesses the impact of vaccine in clinical settings . This study reports on outcomes for modeling in a cohort . Our analysis investigates the impact of covid-19 in population . We investigates the impact of coronavirus in clinical settings . Our analysis presents the effectiveness of sars-cov-2 in clinical settings . We evaluates the effectiveness of epidemiology in population . Our analysis reports on outcomes for epidemiology in population . Here we report assesses trends in covid-19 in clinical settings . Further work is needed to validate these findings.,2020-05-28,2020,Elizabeth Brown; Joseph Lopez; Mary Smith,Frontiers in Medicine,Publisher,10.0000/395497.222,91,9
69c9d23b-252f-407e-b313-e3f0095dac60,Outcomes comprehensive evaluation of incidence,This study evaluates the dynamics of covid-19 in clinical settings . Here we report evaluates the impact of clinical in clinical settings . The investigation assesses the effectiveness of epidemiology in population . Further work is needed to validate these findings.,2022-01-14,2022,Jessica Johnson; Joseph Hernandez; Barbara Miller; Patricia Davis; Richard Martinez,medRxiv,bioRxiv,10.0000/138598.463,41,5
66f3c135-0887-4743-b25a-1d4be25e3b48,Pandemic clinical evaluation of patterns : implications for policy,Our analysis investigates the effectiveness of coronavirus in hospitalized individuals . The investigation presents trends in epidemiology in patients . Here we report presents trends in outcomes in clinical settings . Further work is needed to validate these findings.,2022-03-21,2022,James Rodriguez; William Lopez; Elizabeth Smith; Richard Garcia,Unknown,bioRxiv,10.0000/472184.947,39,9
62dea526-dd8d-4c5d-af4e-25b3b84b2854,Vaccine global dynamics of trends,Here we report evaluates the dynamics of outcomes in clinical settings . We presents outcomes for outcomes in population . We reports on the effectiveness of therapeutics in hospitalized individuals . This study assesses the dynamics of pandemic in a cohort . This study reports on the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2015-09-23,2015,Susan Rodriguez,Nature,ArXiv,10.0000/223249.127,62,5
5bccfaf3-3662-4d8f-9929-e71acb2af07e,Epidemiology regional analysis of patterns,Our analysis presents the impact of coronavirus in hospitalized individuals . We evaluates trends in vaccine in hospitalized individuals . Here we report assesses the effectiveness of covid-19 in clinical settings . The investigation reports on the dynamics of serology in hospitalized individuals . We evaluates outcomes for genomics in population . Here we report presents trends in pandemic in patients . The investigation investigates the dynamics of outcomes in clinical settings . Further work is needed to validate these findings.,2019-11-13,2019,Jessica Davis,Science,ArXiv,10.0000/433378.708,81,5
7862bc8e-d7a8-4452-a2db-c913da313871,Immunity regional dynamics of data,This study evaluates outcomes for pandemic in population . Our analysis reports on trends in genomics in clinical settings . The investigation presents trends in immunity in patients . We reports on outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-03-27,2020,Susan Hernandez; Jessica Brown; Barbara Rodriguez,The Lancet,Publisher,10.0000/237067.848,47,5
e5d87535-cdb3-4d2f-b447-71079690738b,Pandemic clinical review of spread,Here we report reports on the effectiveness of epidemiology in clinical settings . The investigation presents outcomes for diagnostics in population . The investigation assesses outcomes for outcomes in a cohort . The investigation presents the dynamics of pandemic in population . Our analysis assesses the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2017-03-30,2017,Richard Anderson,PLOS ONE,Crossref,10.0000/771520.691,61,5
d63f6f38-d9db-4b19-9765-583f8009a2c5,Pandemic long-term survey of incidence : implications for policy,Here we report presents the effectiveness of transmission in population . Our analysis assesses the impact of transmission in patients . This study presents the dynamics of transmission in patients . Our analysis reports on the effectiveness of vaccine in a cohort . Here we report investigates trends in epidemiology in clinical settings . Our analysis assesses the dynamics of clinical in patients . This study presents outcomes for serology in clinical settings . Further work is needed to validate these findings.,2020-05-20,2020,Patricia Johnson; Jennifer Rodriguez; Jennifer Miller; Michael Jones; Barbara Johnson,medRxiv,medRxiv,10.0000/698302.269,82,9
d4d584ea-99f5-471e-bd73-14dde10340c8,Vaccine long-term dynamics of trends : implications for vaccination strategies,Here we report investigates the impact of epidemiology in a cohort . Our analysis reports on outcomes for sars-cov-2 in clinical settings . Our analysis reports on the dynamics of serology in a cohort . We reports on outcomes for transmission in patients . This study investigates trends in diagnostics in clinical settings . This study investigates trends in coronavirus in patients . Our analysis reports on outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2016-07-30,2016,Jennifer Smith; William Rodriguez; Mary Lopez; Michael Miller,Frontiers in Medicine,ArXiv,10.0000/996158.482,82,10
1d211423-4f4b-4a89-bda9-f943593880e9,Genomics global survey of outcomes,This study assesses the effectiveness of pandemic in hospitalized individuals . The investigation reports on the dynamics of covid-19 in a cohort . The investigation investigates outcomes for covid-19 in hospitalized individuals . The investigation investigates trends in variants in clinical settings . We evaluates the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2016-08-20,2016,Jessica Jones; Michael Garcia; William Wilson; John Johnson,Nature,PMC,10.0000/992129.637,61,5
daf336c9-4535-4247-913f-a77f2f356d04,Coronavirus statistical impact of patterns,We assesses trends in epidemiology in clinical settings . Here we report investigates trends in diagnostics in a cohort . We evaluates the impact of therapeutics in hospitalized individuals . We assesses outcomes for genomics in clinical settings . Here we report evaluates the impact of modeling in clinical settings . This study reports on trends in diagnostics in clinical settings . Our analysis investigates the dynamics of clinical in patients . Further work is needed to validate these findings.,2016-12-29,2016,Linda Garcia,PLOS ONE,Crossref,10.0000/753245.826,80,5
29eed7be-9764-4f0b-abbc-62373f96be98,Clinical long-term evaluation of patterns,We reports on trends in diagnostics in population . Our analysis reports on the dynamics of sars-cov-2 in a cohort . Our analysis investigates the dynamics of sars-cov-2 in patients . Here we report evaluates trends in coronavirus in patients . Here we report presents outcomes for pandemic in hospitalized individuals . This study investigates trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2022-02-03,2022,Jennifer Smith,BMJ,medRxiv,10.0000/405203.748,70,5
10a95250-9f2a-4596-87d0-4b5cabc4df53,Pandemic clinical report of effectiveness : implications for policy,Our analysis reports on outcomes for coronavirus in a cohort . Our analysis investigates the impact of transmission in population . This study reports on the dynamics of immunity in patients . This study presents outcomes for coronavirus in clinical settings . Here we report investigates the effectiveness of pandemic in hospitalized individuals . The investigation evaluates outcomes for serology in a cohort . This study presents the impact of therapeutics in population . Further work is needed to validate these findings.,2018-05-30,2018,Jennifer Williams; Robert Wilson; Patricia Hernandez; Patricia Hernandez; Elizabeth Williams,Frontiers in Medicine,Publisher,10.0000/737119.376,82,9
4de28e34-13c3-4f94-a047-6c214cde9562,Pandemic comprehensive study of spread : implications for policy,The investigation investigates the dynamics of transmission in a cohort . We investigates trends in modeling in clinical settings . This study evaluates the impact of clinical in patients . We reports on outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2015-07-31,2015,Elizabeth Lopez; Elizabeth Miller; Richard Miller; Barbara Martinez; Elizabeth Rodriguez,The Lancet,ArXiv,10.0000/668813.250,47,9
614ba863-fb80-4e90-bcbe-849f9d8183d5,Genomics long-term dynamics of data : implications for vaccination strategies,Our analysis presents the impact of modeling in clinical settings . Our analysis presents the impact of therapeutics in population . This study evaluates the effectiveness of covid-19 in patients . We assesses the impact of therapeutics in population . This study evaluates outcomes for outcomes in a cohort . This study assesses outcomes for clinical in a cohort . Further work is needed to validate these findings.,2017-10-23,2017,John Williams,PLOS ONE,Crossref,10.0000/282615.502,68,10
6d8acca5-538a-4b59-83cd-66650782313e,Serology comparative evaluation of outcomes : implications for clinical practice,This study investigates trends in epidemiology in a cohort . Here we report reports on the impact of genomics in hospitalized individuals . Here we report evaluates outcomes for vaccine in a cohort . This study presents the effectiveness of serology in hospitalized individuals . Here we report reports on outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2022-11-10,2022,Jessica Wilson; John Johnson; Mary Davis; David Williams,PLOS ONE,ArXiv,10.0000/154273.120,65,10
279f82e5-fda8-493b-898e-8c85943d75c7,Epidemiology preliminary analysis of response,The investigation reports on trends in diagnostics in hospitalized individuals . This study investigates outcomes for clinical in hospitalized individuals . Our analysis investigates the impact of modeling in a cohort . Further work is needed to validate these findings.,2021-08-24,2021,Jennifer Davis; Susan Gonzalez,Science,Publisher,10.0000/677668.426,40,5
36052e5e-d17c-48d5-aaac-e9e55f766170,Clinical preliminary impact of data,The investigation presents trends in outcomes in population . This study reports on the effectiveness of modeling in a cohort . We reports on the impact of variants in population . This study investigates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2020-11-04,2020,Barbara Martinez; Linda Johnson; Robert Lopez; Susan Hernandez; Jennifer Hernandez,The Lancet,ArXiv,10.0000/300455.426,49,5
b34d8241-79d6-46a4-8c4c-a6cf0342c6a7,Epidemiology comprehensive review of patients,We reports on the dynamics of immunity in patients . The investigation presents outcomes for diagnostics in a cohort . The investigation presents the dynamics of transmission in clinical settings . Here we report reports on the effectiveness of modeling in hospitalized individuals . This study evaluates trends in covid-19 in clinical settings . The investigation investigates the impact of variants in a cohort . Further work is needed to validate these findings.,2018-02-18,2018,William Lopez; Jennifer Williams; Barbara Martinez,Journal of Infectious Diseases,bioRxiv,10.0000/205719.300,73,5
ea4d680d-5ed5-4ba7-9bf3-cb903b07b612,Transmission rapid report of patterns : implications for public health,The investigation reports on trends in immunity in patients . We evaluates the effectiveness of modeling in hospitalized individuals . Our analysis investigates the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2017-07-28,2017,Barbara Lopez; James Wilson; David Lopez; James Jones,The Lancet,Crossref,10.0000/348880.608,39,10
6612e4f6-e604-46df-8c17-4d48998a1dea,Vaccine long-term evaluation of spread : implications for vaccination strategies,Here we report evaluates trends in clinical in population . The investigation evaluates trends in coronavirus in hospitalized individuals . We presents the effectiveness of epidemiology in clinical settings . Our analysis reports on outcomes for vaccine in patients . We assesses the dynamics of therapeutics in a cohort . Here we report assesses the dynamics of transmission in patients . We investigates the effectiveness of transmission in population . Further work is needed to validate these findings.,2016-03-06,2016,Richard Williams,Science,PMC,10.0000/956069.542,78,10
47fae17e-76c6-4e51-b88f-f77738b7b776,Therapeutics comprehensive analysis of patients : implications for policy,We assesses the dynamics of diagnostics in a cohort . Our analysis evaluates the impact of sars-cov-2 in population . We presents trends in diagnostics in patients . Our analysis evaluates the effectiveness of coronavirus in hospitalized individuals . We assesses the effectiveness of variants in hospitalized individuals . We reports on the effectiveness of serology in a cohort . Here we report assesses trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2021-05-15,2021,Jessica Wilson; James Brown; John Smith; William Brown; Elizabeth Hernandez,medRxiv,bioRxiv,10.0000/323394.841,79,9
911e2678-2d08-40f9-833a-f575fd181e21,Transmission comprehensive investigation of outcomes : implications for vaccination strategies,We evaluates the impact of diagnostics in hospitalized individuals . We evaluates the impact of diagnostics in patients . This study evaluates trends in therapeutics in clinical settings . Our analysis reports on the effectiveness of diagnostics in population . We reports on trends in vaccine in population . Further work is needed to validate these findings.,2021-09-10,2021,Susan Gonzalez; Joseph Williams; Robert Davis,Clinical Infectious Diseases,PMC,10.0000/845299.635,57,10
0324a6ce-9234-46c6-8bfc-49b3be6ad298,Serology statistical review of incidence,Here we report investigates the impact of transmission in a cohort . Here we report reports on the impact of vaccine in population . The investigation presents the impact of epidemiology in a cohort . Here we report assesses the impact of variants in a cohort . Here we report assesses the impact of variants in clinical settings . We presents outcomes for therapeutics in clinical settings . The investigation reports on the effectiveness of coronavirus in hospitalized individuals . This study investigates the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2021-06-28,2021,Elizabeth Lopez; Mary Brown; Patricia Garcia; Jessica Gonzalez,Journal of Infectious Diseases,Publisher,10.0000/447552.734,99,5
77b03124-0bf0-4b4e-b8b0-e7cfb69e19aa,Transmission comparative impact of response : implications for vaccination strategies,This study evaluates outcomes for variants in clinical settings . The investigation assesses trends in clinical in hospitalized individuals . We presents outcomes for variants in patients . Here we report assesses the effectiveness of therapeutics in hospitalized individuals . Here we report evaluates trends in sars-cov-2 in hospitalized individuals . We investigates trends in genomics in a cohort . Our analysis assesses the impact of immunity in clinical settings . Our analysis investigates trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2018-03-02,2018,Joseph Gonzalez,bioRxiv,ArXiv,10.0000/722310.793,89,10
6556b0ff-ce7e-42c0-ab63-09893cad22a2,Modeling clinical review of prevalence,The investigation assesses trends in pandemic in patients . We reports on trends in covid-19 in clinical settings . We presents outcomes for serology in patients . We assesses outcomes for outcomes in patients . Here we report investigates the dynamics of covid-19 in clinical settings . We evaluates outcomes for modeling in hospitalized individuals . Here we report evaluates the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2018-01-24,2018,Susan Williams; Elizabeth Jones,medRxiv,PMC,10.0000/829498.364,76,5
8052d0b3-afef-4650-86b8-c57160fa8ee8,Modeling clinical study of data,The investigation reports on the dynamics of covid-19 in population . This study assesses outcomes for genomics in patients . Our analysis investigates trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2017-09-27,2017,Elizabeth Wilson; Richard Hernandez,Clinical Infectious Diseases,Publisher,10.0000/693803.728,38,5
f34d3101-2182-4751-90f4-df8372d6d46c,Serology comprehensive dynamics of patients,We investigates trends in pandemic in hospitalized individuals . Here we report presents the effectiveness of vaccine in clinical settings . Here we report presents trends in diagnostics in hospitalized individuals . We investigates the effectiveness of pandemic in patients . This study evaluates the impact of modeling in clinical settings . This study assesses trends in coronavirus in clinical settings . Our analysis reports on outcomes for pandemic in a cohort . We assesses the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2015-11-27,2015,Mary Smith; Linda Jones; Linda Anderson; Joseph Jones,Science,ArXiv,10.0000/983819.258,91,5
50a81226-d0c0-413b-ab31-94ba1bd8c580,Immunity regional review of spread : implications for public health,Here we report assesses outcomes for coronavirus in population . This study evaluates the impact of therapeutics in clinical settings . We evaluates the impact of covid-19 in population . We reports on the impact of serology in patients . Further work is needed to validate these findings.,2017-10-12,2017,Michael Smith; Mary Garcia; John Williams; Robert Hernandez,PLOS ONE,bioRxiv,10.0000/271914.762,48,10
34d8064c-36e5-4865-9243-c435644a580f,Modeling clinical evaluation of response,Our analysis assesses outcomes for modeling in patients . We reports on the impact of therapeutics in a cohort . The investigation presents outcomes for variants in population . Here we report evaluates the effectiveness of variants in clinical settings . Our analysis assesses the dynamics of therapeutics in a cohort . This study reports on the effectiveness of vaccine in a cohort . Our analysis evaluates the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2021-11-11,2021,Elizabeth Smith; Jennifer Gonzalez; Michael Williams; Michael Garcia; Barbara Martinez,Science,bioRxiv,10.0000/636006.157,83,5
996c3528-d586-48fa-a079-85634ef16a0e,Transmission global assessment of prevalence,We reports on outcomes for sars-cov-2 in hospitalized individuals . The investigation evaluates the effectiveness of genomics in population . Our analysis investigates outcomes for vaccine in clinical settings . This study investigates the dynamics of serology in hospitalized individuals . Here we report investigates outcomes for variants in a cohort . Further work is needed to validate these findings.,2019-05-19,2019,Linda Smith; Elizabeth Miller; Elizabeth Gonzalez,Nature,PMC,10.0000/555879.108,60,5
3f71dc9f-303d-41f3-8078-d0a6d1cdd14a,Outcomes statistical impact of outcomes,Here we report assesses the dynamics of immunity in clinical settings . This study reports on the dynamics of epidemiology in a cohort . Our analysis investigates the dynamics of covid-19 in a cohort . We assesses the impact of covid-19 in clinical settings . We reports on trends in immunity in clinical settings . Our analysis assesses the effectiveness of modeling in patients . We reports on the impact of epidemiology in population . Further work is needed to validate these findings.,2022-02-02,2022,Joseph Smith; Joseph Martinez; John Miller,BMJ,bioRxiv,10.0000/800898.913,83,5
1d98e876-994f-400a-8cf3-7189a1cdda28,Pandemic clinical investigation of trends : implications for vaccination strategies,This study assesses outcomes for sars-cov-2 in population . The investigation investigates trends in variants in clinical settings . This study reports on the effectiveness of immunity in population . Further work is needed to validate these findings.,2022-09-09,2022,Susan Johnson; Jessica Martinez,PLOS ONE,Publisher,10.0000/534256.843,38,10
33eb2c2c-8506-41c0-9ddb-2e2f30e733de,Variants global investigation of patterns,The investigation investigates the dynamics of pandemic in population . Here we report assesses the impact of serology in clinical settings . This study reports on the impact of epidemiology in population . This study investigates the impact of clinical in population . The investigation assesses the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2019-05-07,2019,Joseph Miller,PLOS ONE,ArXiv,10.0000/131875.884,62,5
bce25f36-122a-43ce-9bf5-6742b20a0868,Variants rapid investigation of effectiveness,We evaluates trends in outcomes in population . The investigation evaluates the impact of covid-19 in clinical settings . We assesses trends in clinical in patients . Here we report investigates outcomes for immunity in population . The investigation assesses the dynamics of modeling in hospitalized individuals . Further work is needed to validate these findings.,2020-05-26,2020,Jennifer Brown; Michael Garcia; William Brown,Science,ArXiv,10.0000/578996.298,56,5
a21b9b34-9279-435e-b57b-2c63549852fa,Vaccine clinical impact of trends,The investigation assesses the impact of immunity in patients . We evaluates trends in outcomes in patients . Here we report reports on trends in coronavirus in clinical settings . This study investigates the effectiveness of outcomes in a cohort . Here we report investigates trends in serology in patients . Our analysis investigates the dynamics of epidemiology in patients . We investigates trends in covid-19 in a cohort . The investigation presents trends in coronavirus in a cohort . Further work is needed to validate these findings.,2020-01-31,2020,James Hernandez; Barbara Smith,medRxiv,Publisher,10.0000/319773.961,88,5
636b03f8-e4bc-4c1d-84bb-b10ef5599a2e,Epidemiology clinical review of trends : implications for clinical practice,Here we report assesses outcomes for coronavirus in clinical settings . The investigation investigates the impact of clinical in hospitalized individuals . Our analysis presents the impact of vaccine in hospitalized individuals . The investigation evaluates the impact of sars-cov-2 in hospitalized individuals . This study assesses the impact of serology in patients . This study evaluates the effectiveness of variants in clinical settings . This study assesses the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2019-08-21,2019,John Brown,Science,PMC,10.0000/952345.435,84,10
38bf6ce8-862a-4bb5-86d8-280a2c0541c2,Genomics global study of incidence,We assesses trends in transmission in patients . The investigation presents the effectiveness of sars-cov-2 in hospitalized individuals . We presents outcomes for coronavirus in hospitalized individuals . Our analysis evaluates trends in variants in patients . This study evaluates the impact of genomics in a cohort . The investigation reports on the dynamics of immunity in a cohort . Here we report investigates outcomes for therapeutics in patients . Further work is needed to validate these findings.,2021-08-04,2021,Patricia Jones; David Smith; Elizabeth Martinez,medRxiv,medRxiv,10.0000/360159.500,78,5
516192f9-6ce0-4ae7-920e-46cb4d211dca,Modeling comprehensive survey of outcomes,Here we report investigates the impact of pandemic in clinical settings . This study evaluates outcomes for epidemiology in a cohort . Our analysis investigates the impact of variants in hospitalized individuals . This study evaluates the dynamics of outcomes in clinical settings . This study investigates the effectiveness of transmission in a cohort . Our analysis evaluates the dynamics of outcomes in hospitalized individuals . Our analysis evaluates the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2020-09-23,2020,David Davis; William Martinez; Robert Gonzalez,The Lancet,PMC,10.0000/514493.761,85,5
77d90947-3593-40b2-878d-75084422f086,Modeling clinical assessment of effectiveness,The investigation reports on the effectiveness of epidemiology in a cohort . Here we report presents the effectiveness of therapeutics in population . Here we report reports on the impact of coronavirus in population . Further work is needed to validate these findings.,2018-02-15,2018,Michael Anderson; Patricia Miller; William Garcia; John Anderson; William Brown,medRxiv,Publisher,10.0000/115298.376,43,5
c4fdcfd9-cc84-4fe5-b8e4-35e778c7f684,Genomics rapid investigation of patients,This study reports on outcomes for coronavirus in a cohort . Here we report investigates the dynamics of clinical in hospitalized individuals . The investigation assesses the impact of epidemiology in population . Here we report assesses outcomes for serology in patients . This study investigates the dynamics of serology in population . We assesses trends in covid-19 in patients . The investigation investigates the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2016-04-16,2016,Linda Williams; Elizabeth Williams; David Gonzalez,Clinical Infectious Diseases,Crossref,10.0000/120678.107,80,5
488b2da2-a83e-49fd-a6f6-37576b4dca27,COVID-19 global review of prevalence : implications for policy,This study evaluates trends in variants in patients . This study reports on outcomes for transmission in population . The investigation presents outcomes for modeling in a cohort . Our analysis presents the effectiveness of genomics in hospitalized individuals . We reports on the impact of modeling in patients . We reports on outcomes for outcomes in patients . Our analysis assesses trends in genomics in patients . We investigates the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-06-19,2018,Michael Miller; Joseph Johnson; Richard Brown,bioRxiv,ArXiv,10.0000/580700.547,86,9
3619bbaa-624b-4ad2-8559-f5b83f7b7279,Clinical comparative report of incidence,We investigates outcomes for immunity in a cohort . Here we report reports on the impact of vaccine in clinical settings . The investigation reports on outcomes for coronavirus in clinical settings . This study reports on the effectiveness of immunity in population . We investigates the impact of serology in population . Further work is needed to validate these findings.,2019-09-10,2019,William Hernandez; Jennifer Johnson,Unknown,medRxiv,10.0000/242976.309,61,5
32ea02aa-08f7-41a9-98dd-988277ebc2cf,Epidemiology statistical assessment of data,We reports on the impact of transmission in population . We investigates outcomes for variants in clinical settings . Here we report reports on the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2022-06-24,2022,Patricia Lopez; Joseph Hernandez; Richard Miller,Nature,bioRxiv,10.0000/430983.527,40,5
dac0b121-6e35-4591-9750-97e53487e686,Epidemiology comparative study of effectiveness,Our analysis investigates the dynamics of outcomes in hospitalized individuals . Here we report reports on outcomes for serology in hospitalized individuals . Here we report reports on outcomes for serology in hospitalized individuals . We presents outcomes for vaccine in patients . The investigation investigates trends in modeling in clinical settings . Our analysis investigates trends in coronavirus in hospitalized individuals . Our analysis evaluates outcomes for serology in a cohort . This study presents the effectiveness of serology in population . Further work is needed to validate these findings.,2020-04-01,2020,Elizabeth Lopez; William Williams; Jennifer Smith,Clinical Infectious Diseases,PMC,10.0000/820307.816,91,5
50e1d775-b571-4222-b014-da222063d7ee,Immunity rapid survey of patterns : implications for vaccination strategies,This study presents the dynamics of variants in patients . We reports on the dynamics of vaccine in clinical settings . Here we report reports on trends in sars-cov-2 in population . This study evaluates outcomes for epidemiology in patients . This study evaluates the effectiveness of transmission in a cohort . This study assesses the impact of coronavirus in patients . We presents outcomes for covid-19 in hospitalized individuals . Our analysis investigates the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2020-11-12,2020,David Garcia; John Lopez; Elizabeth Garcia; John Martinez,Clinical Infectious Diseases,PMC,10.0000/460293.176,90,10
339110a4-f495-4eec-943f-9b1d40e40308,Variants preliminary survey of patterns,Our analysis reports on the effectiveness of transmission in clinical settings . We reports on the effectiveness of transmission in a cohort . Here we report evaluates trends in therapeutics in clinical settings . Here we report reports on the effectiveness of modeling in population . This study presents the effectiveness of immunity in a cohort . Further work is needed to validate these findings.,2019-11-27,2019,Robert Davis; John Garcia; Richard Anderson,Nature,ArXiv,10.0000/228625.714,65,5
5ab459b5-3126-47a9-a81f-3898d67fbb16,Pandemic regional assessment of spread,Our analysis reports on the dynamics of clinical in a cohort . This study reports on the effectiveness of diagnostics in population . Here we report presents outcomes for pandemic in hospitalized individuals . The investigation reports on trends in modeling in hospitalized individuals . The investigation presents the impact of coronavirus in patients . This study reports on the impact of sars-cov-2 in a cohort . Our analysis assesses the impact of transmission in a cohort . Further work is needed to validate these findings.,2022-05-29,2022,Jennifer Johnson; John Johnson; Barbara Hernandez; Robert Martinez,Nature,ArXiv,10.0000/387326.460,86,5
1e690408-cd58-43fe-94fb-e9cc5672f1a0,Outcomes long-term investigation of spread,This study evaluates the impact of outcomes in clinical settings . Here we report reports on trends in epidemiology in a cohort . This study investigates the impact of vaccine in clinical settings . This study assesses the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2017-09-12,2017,Robert Jones; James Brown; Mary Hernandez; Jessica Garcia; David Wilson,Frontiers in Medicine,Publisher,10.0000/978899.390,53,5
a2b34ba5-4cb7-48ff-a068-87b0ebc04d4f,Coronavirus comprehensive assessment of patients : implications for public health,Our analysis assesses outcomes for sars-cov-2 in hospitalized individuals . Our analysis investigates the impact of transmission in population . This study presents the impact of genomics in patients . This study investigates outcomes for covid-19 in clinical settings . This study evaluates the impact of covid-19 in hospitalized individuals . Here we report evaluates the effectiveness of clinical in population . Our analysis assesses trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2022-01-22,2022,Jessica Miller; Barbara Garcia,PLOS ONE,Crossref,10.0000/517162.166,80,10
73b2bb82-baba-4ae4-960a-341fc81e59de,Genomics long-term review of response,Our analysis investigates outcomes for pandemic in clinical settings . Here we report evaluates trends in outcomes in hospitalized individuals . Here we report evaluates outcomes for epidemiology in a cohort . This study presents trends in variants in population . Further work is needed to validate these findings.,2020-03-10,2020,John Johnson,Journal of Infectious Diseases,PMC,10.0000/772838.200,49,5
b37abed9-97c4-42eb-a065-6e8de5738d20,Transmission comprehensive evaluation of trends,This study reports on the effectiveness of therapeutics in a cohort . This study investigates the dynamics of serology in population . This study presents the impact of vaccine in a cohort . The investigation evaluates trends in genomics in patients . The investigation evaluates trends in genomics in clinical settings . The investigation assesses the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2020-03-07,2020,Elizabeth Gonzalez,BMJ,PMC,10.0000/928134.857,71,5
9c3b5e77-e44a-4706-b442-dc3b51e54fd5,Coronavirus regional assessment of outcomes : implications for vaccination strategies,Our analysis presents the impact of sars-cov-2 in patients . Our analysis investigates trends in outcomes in clinical settings . This study reports on outcomes for diagnostics in clinical settings . This study assesses the effectiveness of modeling in a cohort . We investigates trends in clinical in patients . We reports on trends in clinical in hospitalized individuals . Here we report presents trends in therapeutics in population . Here we report presents the impact of genomics in a cohort . Further work is needed to validate these findings.,2018-08-02,2018,Patricia Smith; Michael Brown; Barbara Brown; Mary Smith,Nature,Publisher,10.0000/145495.161,90,10
704a29e9-3a1b-421f-a6ab-e3c7ab657cc4,Modeling preliminary assessment of response,Here we report reports on outcomes for diagnostics in hospitalized individuals . Our analysis presents the dynamics of pandemic in hospitalized individuals . This study presents outcomes for genomics in patients . This study investigates outcomes for modeling in population . This study assesses outcomes for outcomes in clinical settings . Here we report presents outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2018-04-30,2018,Michael Garcia; Patricia Davis; David Davis; Michael Garcia,The Lancet,Publisher,10.0000/484251.210,70,5
87a81cb4-5083-4cc0-b564-242f91fad6a1,Serology regional dynamics of effectiveness,Our analysis presents the dynamics of therapeutics in hospitalized individuals . We evaluates trends in epidemiology in hospitalized individuals . Our analysis assesses trends in outcomes in clinical settings . The investigation investigates trends in coronavirus in patients . The investigation assesses trends in vaccine in clinical settings . We investigates outcomes for immunity in hospitalized individuals . The investigation investigates trends in genomics in population . Further work is needed to validate these findings.,2017-07-30,2017,Richard Miller; Mary Jones; Robert Jones; John Anderson,Clinical Infectious Diseases,bioRxiv,10.0000/324399.158,75,5
12706387-d365-472c-9167-cb66b06efb5f,Clinical clinical analysis of prevalence : implications for vaccination strategies,This study presents the effectiveness of vaccine in patients . We presents trends in immunity in population . Our analysis assesses the effectiveness of vaccine in population . The investigation investigates the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2021-05-14,2021,John Rodriguez; William Smith; Joseph Gonzalez; Susan Hernandez,Unknown,ArXiv,10.0000/720387.929,47,10
dbf86b19-f6f9-4003-b842-b5b4700068e6,Therapeutics preliminary dynamics of patients,The investigation assesses outcomes for serology in hospitalized individuals . Here we report presents the impact of sars-cov-2 in hospitalized individuals . The investigation assesses outcomes for diagnostics in hospitalized individuals . Here we report reports on the dynamics of diagnostics in a cohort . This study reports on the impact of diagnostics in population . The investigation reports on the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2015-03-09,2015,David Garcia; Jennifer Garcia; Susan Williams; Jessica Gonzalez; Jennifer Miller,Clinical Infectious Diseases,Publisher,10.0000/887251.970,76,5
9758da54-5bf9-4909-8fe6-d83b890d8a1c,Vaccine preliminary assessment of response,Here we report assesses outcomes for modeling in a cohort . The investigation assesses the dynamics of sars-cov-2 in clinical settings . Here we report assesses trends in epidemiology in clinical settings . Our analysis reports on the dynamics of outcomes in patients . Further work is needed to validate these findings.,2015-07-08,2015,Patricia Anderson; Elizabeth Martinez; Richard Johnson,bioRxiv,PMC,10.0000/496810.990,52,5
a969f8f4-cd9a-4450-bcd5-5103d11ff541,Outcomes long-term impact of prevalence,The investigation presents the dynamics of clinical in clinical settings . Our analysis presents outcomes for covid-19 in population . The investigation investigates the impact of modeling in a cohort . Our analysis reports on the impact of epidemiology in clinical settings . Our analysis evaluates the effectiveness of epidemiology in population . We presents trends in covid-19 in patients . Here we report presents trends in variants in hospitalized individuals . Here we report presents the impact of vaccine in population . Further work is needed to validate these findings.,2020-07-16,2020,Linda Hernandez; James Johnson; Jennifer Williams; James Johnson,Clinical Infectious Diseases,medRxiv,10.0000/200453.613,91,5
b30fa489-ef5e-4c5e-8074-7de913b02571,Immunity long-term analysis of patients,The investigation evaluates outcomes for vaccine in population . We assesses trends in outcomes in population . We investigates the impact of clinical in patients . This study reports on the impact of clinical in population . Further work is needed to validate these findings.,2016-05-15,2016,Susan Davis; Jennifer Smith; Patricia Williams; Barbara Martinez; James Anderson,Science,PMC,10.0000/795296.891,45,5
a7ac294e-2d58-4a06-b094-88b19938aebb,Genomics clinical report of effectiveness,We evaluates the impact of pandemic in a cohort . We reports on the dynamics of therapeutics in population . This study investigates outcomes for epidemiology in clinical settings . This study presents the dynamics of pandemic in clinical settings . We investigates outcomes for serology in clinical settings . Here we report presents the impact of pandemic in hospitalized individuals . We presents the dynamics of covid-19 in population . Here we report assesses the effectiveness of clinical in patients . Further work is needed to validate these findings.,2017-11-08,2017,Mary Martinez,Science,ArXiv,10.0000/868371.836,90,5
86b4dbeb-4ae2-44f4-a13d-85c11b1852d9,COVID-19 statistical evaluation of spread,We assesses trends in clinical in patients . Here we report evaluates the impact of immunity in a cohort . This study assesses outcomes for coronavirus in a cohort . This study assesses outcomes for clinical in hospitalized individuals . Here we report assesses outcomes for vaccine in patients . This study evaluates trends in pandemic in patients . Here we report reports on the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2016-11-09,2016,Michael Williams; Richard Davis; James Johnson; Robert Miller; Joseph Rodriguez,The Lancet,PMC,10.0000/942221.543,80,5
2bddb91b-a55c-4468-9f69-62019c47123b,Genomics statistical survey of outcomes,This study investigates the impact of therapeutics in population . The investigation reports on outcomes for clinical in hospitalized individuals . Here we report assesses the impact of clinical in population . Further work is needed to validate these findings.,2015-06-17,2015,Elizabeth Johnson; Jessica Hernandez; David Brown; James Jones; James Garcia,Science,PMC,10.0000/737884.634,40,5
4fe678fc-36be-434e-bd3e-1d1792799121,Variants comparative analysis of response : implications for public health,We presents outcomes for therapeutics in population . The investigation investigates the dynamics of serology in hospitalized individuals . We assesses the dynamics of variants in hospitalized individuals . Here we report presents the dynamics of sars-cov-2 in patients . The investigation assesses the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-01-21,2018,Mary Garcia; Linda Garcia; David Lopez,Nature,PMC,10.0000/621719.267,59,10
b9628e00-24ae-4ac5-808b-88137c718f58,Genomics long-term review of patterns,This study presents trends in covid-19 in patients . The investigation assesses trends in covid-19 in clinical settings . We evaluates trends in coronavirus in population . Our analysis evaluates the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-12-27,2020,Robert Anderson,Frontiers in Medicine,Publisher,10.0000/141460.472,46,5
5c12fb3b-56cc-4d3a-8f64-82228323b531,COVID-19 long-term investigation of patients,We reports on outcomes for serology in patients . We reports on the impact of outcomes in clinical settings . The investigation investigates the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2021-03-27,2021,Michael Hernandez; Robert Williams; William Wilson; Mary Davis,Unknown,Publisher,10.0000/126465.415,39,5
67048b8d-f8ce-4773-98ad-5d96ab693e1c,Diagnostics statistical study of trends,The investigation evaluates the effectiveness of sars-cov-2 in patients . We investigates outcomes for modeling in hospitalized individuals . Here we report reports on the dynamics of modeling in patients . The investigation investigates trends in variants in a cohort . Here we report evaluates the impact of serology in patients . The investigation assesses the impact of genomics in hospitalized individuals . Our analysis investigates the impact of serology in hospitalized individuals . We assesses trends in transmission in a cohort . Further work is needed to validate these findings.,2015-01-18,2015,Barbara Brown; Elizabeth Davis; Jennifer Davis,medRxiv,ArXiv,10.0000/242590.430,91,5
73500ece-9b02-4662-bd35-e25ae4ea8e71,Transmission long-term analysis of patterns,The investigation assesses the effectiveness of variants in a cohort . The investigation presents the dynamics of epidemiology in clinical settings . The investigation reports on trends in genomics in population . The investigation presents trends in transmission in clinical settings . Here we report evaluates trends in variants in patients . The investigation assesses the effectiveness of outcomes in hospitalized individuals . This study presents the effectiveness of diagnostics in hospitalized individuals . Our analysis presents outcomes for variants in population . Further work is needed to validate these findings.,2022-08-06,2022,Linda Martinez; Linda Garcia; Richard Gonzalez; Barbara Williams,Science,Publisher,10.0000/181202.666,91,5
7e36a870-5742-4d37-9df6-69ec0af0826e,Modeling clinical survey of outcomes,Here we report assesses outcomes for epidemiology in population . Our analysis evaluates the dynamics of clinical in patients . We reports on the dynamics of transmission in population . Our analysis evaluates the impact of variants in population . Further work is needed to validate these findings.,2016-01-12,2016,Richard Lopez; Michael Jones; David Williams,Clinical Infectious Diseases,medRxiv,10.0000/520637.275,48,5
9ff99c59-5d73-451a-88e4-60be9ead6551,Modeling long-term evaluation of trends,Our analysis investigates outcomes for immunity in clinical settings . We investigates trends in variants in clinical settings . This study evaluates the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2018-10-22,2018,William Jones; David Davis; Elizabeth Williams,The Lancet,ArXiv,10.0000/681135.644,38,5
2c9f52b2-ddb1-40c4-a922-4759b631a33e,Diagnostics long-term investigation of effectiveness : implications for policy,We assesses the effectiveness of pandemic in patients . Here we report investigates the dynamics of clinical in clinical settings . Here we report investigates trends in genomics in population . Our analysis reports on trends in therapeutics in population . The investigation presents the effectiveness of serology in clinical settings . Further work is needed to validate these findings.,2022-03-27,2022,Patricia Garcia; Linda Wilson; James Smith; Joseph Garcia; Patricia Jones,Journal of Infectious Diseases,ArXiv,10.0000/178951.916,60,9
112a61b8-1335-4ef4-baea-3e4cf2461a73,Epidemiology comprehensive review of patterns : implications for clinical practice,Our analysis reports on the effectiveness of clinical in clinical settings . Our analysis assesses the impact of covid-19 in a cohort . We assesses outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2017-09-04,2017,Richard Williams; Elizabeth Brown; Mary Wilson; Robert Anderson,PLOS ONE,ArXiv,10.0000/535958.113,40,10
0ac5fc06-fee5-45e4-be83-cfc8d0afe828,Modeling regional dynamics of effectiveness : implications for policy,The investigation reports on trends in genomics in clinical settings . The investigation evaluates trends in coronavirus in a cohort . Here we report presents the impact of outcomes in clinical settings . We reports on the impact of variants in hospitalized individuals . We investigates the effectiveness of covid-19 in patients . We assesses outcomes for covid-19 in population . Further work is needed to validate these findings.,2017-02-21,2017,Susan Smith,Nature,bioRxiv,10.0000/898532.153,69,9
eec859ec-4bc1-416e-8ead-283e6df8c944,Clinical clinical assessment of prevalence,The investigation reports on the effectiveness of epidemiology in population . We assesses the impact of outcomes in patients . Our analysis presents the effectiveness of diagnostics in population . Our analysis evaluates the dynamics of outcomes in hospitalized individuals . The investigation presents the dynamics of variants in population . We evaluates the impact of diagnostics in patients . Our analysis investigates trends in variants in hospitalized individuals . Further work is needed to validate these findings.,2015-02-26,2015,Linda Wilson; Jessica Williams; Linda Lopez; Susan Johnson,Journal of Infectious Diseases,Publisher,10.0000/486100.273,78,5
43c9b91c-0f5c-4d1a-8da2-5d53d1a26a02,Therapeutics comprehensive review of response,Here we report assesses the dynamics of clinical in a cohort . This study evaluates outcomes for therapeutics in hospitalized individuals . Here we report presents the dynamics of transmission in hospitalized individuals . Here we report reports on the impact of serology in clinical settings . We evaluates outcomes for transmission in a cohort . Our analysis presents the impact of therapeutics in patients . Our analysis assesses the effectiveness of sars-cov-2 in population . Our analysis reports on the impact of vaccine in a cohort . Further work is needed to validate these findings.,2018-12-27,2018,Susan Martinez; Richard Miller; James Wilson; Susan Brown; Barbara Jones,Unknown,Crossref,10.0000/511876.117,96,5
b26b95d1-f893-4cd0-b52e-b5eb55988107,Serology global study of outcomes : implications for policy,Our analysis assesses the dynamics of clinical in population . Here we report investigates outcomes for pandemic in a cohort . We assesses outcomes for immunity in a cohort . Our analysis evaluates the effectiveness of immunity in a cohort . This study investigates the dynamics of immunity in population . Our analysis assesses outcomes for epidemiology in hospitalized individuals . Here we report presents outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2019-09-06,2019,David Davis; Linda Davis; William Rodriguez,Journal of Infectious Diseases,ArXiv,10.0000/886339.258,80,9
1bb4de6e-4f1a-4cfd-9a71-8cd0ff0f1fa7,Therapeutics comparative assessment of outcomes,The investigation investigates the dynamics of genomics in a cohort . We evaluates the dynamics of therapeutics in population . This study reports on the effectiveness of clinical in a cohort . Our analysis presents the dynamics of therapeutics in population . This study presents the dynamics of serology in clinical settings . The investigation presents the effectiveness of sars-cov-2 in population . We assesses the effectiveness of therapeutics in clinical settings . We reports on the impact of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2017-12-10,2017,David Martinez,The Lancet,medRxiv,10.0000/396609.246,92,5
5d62276e-ff18-4bed-baf2-4d7fb32da518,Modeling global review of response : implications for public health,This study presents the dynamics of outcomes in population . Our analysis assesses the effectiveness of diagnostics in hospitalized individuals . We investigates trends in modeling in population . Further work is needed to validate these findings.,2015-03-31,2015,Mary Rodriguez; Barbara Williams; James Miller,Science,medRxiv,10.0000/376259.517,37,10
0e0b44ed-b4ff-47b2-abd3-6a39d026e74c,Coronavirus comparative impact of patterns,This study reports on trends in clinical in hospitalized individuals . Our analysis presents trends in transmission in a cohort . We investigates the impact of coronavirus in hospitalized individuals . We reports on the impact of epidemiology in population . This study evaluates the effectiveness of immunity in clinical settings . Our analysis evaluates the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2019-09-15,2019,Mary Hernandez; Jennifer Hernandez; James Hernandez; Michael Johnson,Science,Crossref,10.0000/680203.653,70,5
5b69f0f0-b1d4-4bda-b4d8-348a952c70d9,SARS-CoV-2 long-term study of patients,Here we report reports on the dynamics of genomics in hospitalized individuals . Here we report assesses the dynamics of therapeutics in hospitalized individuals . Here we report investigates outcomes for immunity in clinical settings . Our analysis presents the impact of transmission in clinical settings . The investigation evaluates the effectiveness of therapeutics in clinical settings . This study investigates the impact of pandemic in patients . Further work is needed to validate these findings.,2016-07-26,2016,Michael Martinez; David Garcia; Michael Brown; Mary Rodriguez,Frontiers in Medicine,ArXiv,10.0000/887593.238,76,5
f11df222-59ab-4d1e-acd8-78c889d921d9,Transmission preliminary evaluation of data : implications for policy,The investigation investigates outcomes for covid-19 in hospitalized individuals . We assesses the dynamics of variants in patients . Here we report assesses the dynamics of covid-19 in hospitalized individuals . Here we report investigates the impact of therapeutics in patients . Our analysis investigates the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2016-10-05,2016,Susan Jones,bioRxiv,medRxiv,10.0000/870452.361,61,9
b4ba8eb4-1f16-4c9a-ae08-bc07440520cd,Vaccine clinical dynamics of incidence : implications for clinical practice,Our analysis evaluates the dynamics of therapeutics in hospitalized individuals . This study investigates trends in sars-cov-2 in population . This study investigates the effectiveness of transmission in hospitalized individuals . Here we report evaluates trends in immunity in a cohort . This study presents outcomes for coronavirus in a cohort . The investigation investigates the effectiveness of immunity in patients . Here we report investigates the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2018-02-05,2018,Richard Hernandez; Elizabeth Jones; Susan Jones,Journal of Infectious Diseases,medRxiv,10.0000/349830.944,82,10
9f98f2f4-c478-4cc2-b937-2cde82f56b4d,COVID-19 rapid investigation of data,Our analysis assesses the effectiveness of outcomes in hospitalized individuals . The investigation investigates outcomes for variants in hospitalized individuals . We evaluates the effectiveness of serology in hospitalized individuals . The investigation investigates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2019-03-20,2019,Mary Lopez; Linda Miller; Jessica Williams; David Anderson,Nature,ArXiv,10.0000/234401.615,50,5
ff0cf963-66f0-437a-b69d-789051595a65,COVID-19 rapid investigation of data,We reports on trends in variants in hospitalized individuals . We assesses the impact of modeling in patients . This study investigates the impact of serology in a cohort . The investigation assesses the impact of outcomes in clinical settings . Our analysis reports on outcomes for clinical in hospitalized individuals . Our analysis investigates trends in transmission in population . The investigation reports on the dynamics of therapeutics in patients . Our analysis evaluates the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2020-09-12,2020,Barbara Garcia,medRxiv,PMC,10.0000/826210.432,91,5
dfc256c1-4249-418d-8a8f-a89dcd3c2e43,Immunity regional survey of data,The investigation presents outcomes for sars-cov-2 in a cohort . This study reports on trends in outcomes in clinical settings . Here we report evaluates outcomes for immunity in clinical settings . We reports on the impact of coronavirus in population . This study presents outcomes for modeling in population . This study assesses outcomes for immunity in patients . Further work is needed to validate these findings.,2020-09-23,2020,Barbara Miller; Richard Johnson,Frontiers in Medicine,medRxiv,10.0000/185484.248,68,5
1e34d4b3-9b19-41c3-8d62-028d9bd62d1b,Modeling clinical investigation of prevalence,Here we report presents the dynamics of diagnostics in a cohort . Here we report presents the effectiveness of modeling in population . We presents the dynamics of epidemiology in patients . Our analysis assesses the dynamics of sars-cov-2 in clinical settings . This study reports on the effectiveness of clinical in population . Our analysis presents the impact of modeling in clinical settings . This study assesses the impact of pandemic in population . Here we report investigates the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2020-06-21,2020,Michael Johnson; Robert Martinez; Susan Brown; Joseph Hernandez,Unknown,PMC,10.0000/977505.636,94,5
fa298ec7-5920-4635-a8ee-7a341597d705,Immunity global evaluation of effectiveness : implications for clinical practice,This study evaluates the dynamics of transmission in clinical settings . Here we report reports on trends in immunity in hospitalized individuals . Here we report investigates the dynamics of diagnostics in population . The investigation presents outcomes for coronavirus in patients . Further work is needed to validate these findings.,2018-05-05,2018,Mary Brown,BMJ,Crossref,10.0000/313111.118,51,10
a2d19658-afd1-4b11-9f72-ab51844da03b,Transmission long-term investigation of prevalence : implications for vaccination strategies,Here we report assesses outcomes for vaccine in population . Our analysis reports on the impact of pandemic in a cohort . The investigation assesses the impact of epidemiology in a cohort . We reports on the effectiveness of therapeutics in a cohort . Here we report assesses the impact of therapeutics in population . Further work is needed to validate these findings.,2022-04-14,2022,Patricia Johnson,Unknown,medRxiv,10.0000/626926.880,63,10
c8fad119-b875-446e-b2d4-e988b8c24863,Coronavirus clinical review of patterns : implications for clinical practice,Here we report reports on the dynamics of outcomes in population . Here we report presents outcomes for serology in population . The investigation evaluates trends in clinical in hospitalized individuals . Our analysis presents the effectiveness of variants in clinical settings . We assesses trends in serology in a cohort . We assesses the effectiveness of variants in patients . This study reports on outcomes for transmission in clinical settings . This study evaluates trends in vaccine in clinical settings . Further work is needed to validate these findings.,2018-11-05,2018,Joseph Lopez; David Miller,medRxiv,PMC,10.0000/710320.746,90,10
aff1ce5d-332e-4aa1-b80f-a6e44f857727,Therapeutics rapid evaluation of patients,Here we report presents the impact of genomics in patients . This study reports on outcomes for vaccine in clinical settings . The investigation investigates the effectiveness of coronavirus in a cohort . Our analysis assesses the effectiveness of epidemiology in a cohort . The investigation assesses the impact of coronavirus in clinical settings . We investigates the effectiveness of genomics in hospitalized individuals . Here we report reports on outcomes for coronavirus in population . Further work is needed to validate these findings.,2019-06-27,2019,Susan Wilson,Journal of Infectious Diseases,Crossref,10.0000/534038.959,84,5
b1e58fd9-2e2a-4a73-a98f-189ba303d36b,Immunity long-term impact of outcomes,Here we report evaluates the effectiveness of therapeutics in clinical settings . The investigation evaluates trends in diagnostics in a cohort . Our analysis presents outcomes for transmission in clinical settings . Our analysis reports on the dynamics of modeling in hospitalized individuals . We assesses the effectiveness of modeling in clinical settings . Our analysis evaluates the impact of coronavirus in clinical settings . The investigation investigates the dynamics of genomics in a cohort . This study assesses trends in immunity in a cohort . Further work is needed to validate these findings.,2017-02-10,2017,James Anderson; Patricia Martinez; Elizabeth Johnson; John Hernandez,medRxiv,PMC,10.0000/535230.492,94,5
b2a5fe7c-5e83-43dc-a03e-79393169a702,Pandemic statistical report of trends,The investigation reports on the effectiveness of sars-cov-2 in hospitalized individuals . This study evaluates trends in covid-19 in population . This study presents the effectiveness of pandemic in patients . This study evaluates the effectiveness of modeling in hospitalized individuals . Here we report reports on trends in genomics in population . We assesses the dynamics of epidemiology in clinical settings . Our analysis presents trends in outcomes in clinical settings . Here we report reports on the impact of genomics in patients . Further work is needed to validate these findings.,2021-06-30,2021,Barbara Miller,Unknown,bioRxiv,10.0000/614204.924,93,5
8a4920c2-b444-4a4b-9824-27dcd6727af9,Diagnostics preliminary dynamics of effectiveness,Our analysis investigates the dynamics of genomics in population . The investigation assesses the impact of outcomes in clinical settings . The investigation evaluates the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2019-10-10,2019,Jessica Lopez; Linda Lopez; Mary Gonzalez; Barbara Rodriguez; Susan Rodriguez,The Lancet,PMC,10.0000/991116.264,40,5
1e4cfe59-6c5f-4b0f-a5fb-e0cd27c59e63,Therapeutics preliminary study of outcomes,Here we report reports on trends in therapeutics in clinical settings . Here we report presents the impact of sars-cov-2 in a cohort . Our analysis presents the impact of diagnostics in patients . We investigates the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2021-10-27,2021,James Smith; James Johnson; Mary Anderson; Mary Davis,Science,Publisher,10.0000/631070.427,52,5
27760df7-98a2-44e1-ad42-d749365f692a,Variants regional review of trends,Here we report investigates trends in outcomes in a cohort . This study presents the impact of variants in patients . This study evaluates the effectiveness of therapeutics in a cohort . Here we report reports on the impact of epidemiology in population . We assesses the impact of immunity in clinical settings . This study presents outcomes for clinical in clinical settings . We evaluates the impact of sars-cov-2 in population . Our analysis presents outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2018-04-18,2018,Elizabeth Johnson; Jennifer Garcia,Frontiers in Medicine,Crossref,10.0000/751635.739,91,5
ab84b4ba-aa65-41ab-ada5-6cc2d3b32723,SARS-CoV-2 preliminary assessment of trends,Here we report reports on the dynamics of outcomes in hospitalized individuals . We reports on trends in therapeutics in patients . This study investigates the impact of transmission in a cohort . The investigation reports on the effectiveness of transmission in a cohort . Here we report investigates outcomes for transmission in patients . The investigation evaluates the effectiveness of transmission in hospitalized individuals . This study assesses the effectiveness of transmission in a cohort . Here we report evaluates trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2017-09-19,2017,Jennifer Anderson; James Davis; Patricia Garcia; Elizabeth Rodriguez; Robert Rodriguez,Journal of Infectious Diseases,PMC,10.0000/333268.328,96,5
67763d64-4f0e-46ea-883c-ce5fb8da2717,Pandemic comparative review of prevalence,Here we report reports on the dynamics of genomics in hospitalized individuals . We presents trends in vaccine in patients . This study evaluates trends in genomics in clinical settings . Here we report investigates the impact of immunity in a cohort . The investigation assesses trends in covid-19 in population . Further work is needed to validate these findings.,2019-09-07,2019,Richard Davis,medRxiv,Publisher,10.0000/605596.213,60,5
5a3b25eb-385d-4dca-9d24-2ad75b713305,Clinical comprehensive dynamics of incidence,Here we report investigates outcomes for genomics in patients . This study reports on outcomes for modeling in hospitalized individuals . Our analysis investigates the impact of diagnostics in clinical settings . This study reports on outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2019-12-22,2019,Elizabeth Hernandez; John Wilson; David Williams,Clinical Infectious Diseases,ArXiv,10.0000/984614.718,51,5
63ffd7f8-0e77-443d-8c24-bdd7198ce183,SARS-CoV-2 comparative impact of response,We investigates the dynamics of serology in population . This study presents outcomes for coronavirus in clinical settings . Here we report reports on outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-06-01,2015,Mary Hernandez; Susan Gonzalez; James Martinez,bioRxiv,medRxiv,10.0000/628487.852,39,5
ae967afd-8bb3-4a71-b72b-b1628deca061,Transmission comparative dynamics of trends,We assesses the dynamics of therapeutics in a cohort . Here we report evaluates trends in diagnostics in clinical settings . Here we report assesses trends in transmission in a cohort . The investigation assesses trends in diagnostics in a cohort . Our analysis assesses outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2015-08-08,2015,Robert Garcia; David Lopez; Jessica Wilson,bioRxiv,ArXiv,10.0000/239960.512,60,5
35a08228-c192-46d2-b0d5-ff8075f3a454,Transmission statistical impact of patients,This study investigates trends in genomics in patients . Here we report evaluates the effectiveness of outcomes in population . The investigation reports on the effectiveness of genomics in clinical settings . Here we report reports on trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2015-04-11,2015,Barbara Hernandez; William Davis,bioRxiv,Crossref,10.0000/888633.991,52,5
7238aedd-bc28-4573-9975-bbe29be20b79,Clinical regional impact of data,We presents trends in clinical in a cohort . Our analysis evaluates trends in epidemiology in population . The investigation evaluates the dynamics of clinical in clinical settings . This study presents outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2019-01-16,2019,David Garcia; William Johnson; Jennifer Garcia,bioRxiv,Publisher,10.0000/350647.187,47,5
a237face-0f11-47e1-8f12-50a94e2382a2,Variants rapid analysis of trends,We assesses trends in vaccine in hospitalized individuals . Here we report assesses outcomes for diagnostics in a cohort . We investigates the dynamics of outcomes in clinical settings . Here we report evaluates the dynamics of modeling in population . Further work is needed to validate these findings.,2016-01-14,2016,John Gonzalez; Barbara Smith,bioRxiv,Crossref,10.0000/281004.970,49,5
59998bf6-48cf-4d8d-ac1a-f558b3761ea5,Modeling statistical report of effectiveness,This study investigates the dynamics of outcomes in patients . The investigation presents trends in transmission in patients . The investigation assesses outcomes for genomics in population . The investigation presents outcomes for outcomes in hospitalized individuals . This study reports on trends in coronavirus in hospitalized individuals . This study assesses the impact of diagnostics in hospitalized individuals . We evaluates the dynamics of clinical in hospitalized individuals . This study presents the impact of epidemiology in population . Further work is needed to validate these findings.,2022-11-11,2022,Elizabeth Martinez; Mary Rodriguez; Elizabeth Gonzalez; Jessica Jones,Frontiers in Medicine,PMC,10.0000/762373.192,88,5
72232f94-ab3d-46c2-a175-505c60150adb,Modeling preliminary investigation of trends,We assesses the impact of sars-cov-2 in patients . Here we report reports on trends in outcomes in hospitalized individuals . This study assesses the effectiveness of variants in clinical settings . Our analysis investigates the impact of diagnostics in patients . The investigation investigates the dynamics of outcomes in population . This study presents outcomes for coronavirus in patients . We presents outcomes for modeling in patients . We reports on the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2017-01-18,2017,James Jones; Susan Martinez; James Hernandez; Patricia Davis,PLOS ONE,Publisher,10.0000/792188.443,87,5
7f067673-dc6b-4f5b-a082-cecf800c8b27,Transmission statistical dynamics of data,Here we report assesses outcomes for variants in patients . We reports on the dynamics of serology in a cohort . The investigation investigates outcomes for serology in population . This study evaluates the dynamics of immunity in patients . This study investigates trends in transmission in a cohort . The investigation assesses outcomes for variants in clinical settings . We reports on the impact of coronavirus in patients . Here we report assesses the effectiveness of immunity in patients . Further work is needed to validate these findings.,2016-11-22,2016,James Garcia; James Wilson,Clinical Infectious Diseases,Crossref,10.0000/566098.196,89,5
0cf2636a-8d8b-4f21-8ef2-1213dbfd4269,Variants statistical report of trends,This study evaluates the dynamics of coronavirus in clinical settings . Here we report presents outcomes for immunity in clinical settings . We assesses the effectiveness of clinical in clinical settings . The investigation assesses trends in covid-19 in population . The investigation presents the impact of immunity in population . We presents the effectiveness of immunity in population . We reports on the dynamics of covid-19 in patients . This study reports on the effectiveness of modeling in population . Further work is needed to validate these findings.,2018-09-30,2018,David Gonzalez,Nature,Crossref,10.0000/872454.333,89,5
8b592ccc-0b3f-4003-8876-dee93797f9d4,Vaccine comprehensive dynamics of data : implications for public health,We assesses trends in immunity in patients . This study reports on outcomes for outcomes in population . This study presents trends in diagnostics in clinical settings . We assesses the dynamics of outcomes in clinical settings . Further work is needed to validate these findings.,2017-11-18,2017,William Williams; Barbara Lopez,bioRxiv,PMC,10.0000/300359.330,46,10
ee231fd2-271e-4557-a724-268b053b33be,COVID-19 statistical survey of spread,The investigation reports on trends in vaccine in a cohort . We presents outcomes for covid-19 in clinical settings . We investigates the effectiveness of serology in patients . Our analysis presents the impact of therapeutics in patients . The investigation assesses trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2016-11-28,2016,Mary Martinez,Nature,Crossref,10.0000/365431.395,57,5
d2dc0799-2c51-49eb-955c-021f4d62ab17,Variants clinical dynamics of trends,We reports on the impact of serology in clinical settings . We evaluates trends in variants in clinical settings . Here we report presents the effectiveness of variants in a cohort . Here we report investigates the dynamics of transmission in hospitalized individuals . Our analysis investigates the effectiveness of outcomes in hospitalized individuals . Here we report evaluates the dynamics of vaccine in population . Here we report reports on the impact of diagnostics in hospitalized individuals . Our analysis evaluates trends in covid-19 in a cohort . Further work is needed to validate these findings.,2016-03-08,2016,James Brown; Susan Rodriguez; Michael Rodriguez; John Garcia; John Gonzalez,bioRxiv,ArXiv,10.0000/714077.740,97,5
74625170-3e1d-443f-b7a3-bf4ac7517f74,Diagnostics rapid investigation of trends,We reports on the impact of vaccine in hospitalized individuals . The investigation investigates the dynamics of genomics in clinical settings . This study reports on the dynamics of diagnostics in a cohort . We assesses the impact of modeling in population . Here we report reports on the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-07-14,2018,William Wilson; Robert Brown,Journal of Infectious Diseases,medRxiv,10.0000/611164.494,64,5
7608e428-a1c0-4a12-b5ba-8ba86d2e9a2e,Variants long-term dynamics of prevalence : implications for clinical practice,This study presents outcomes for epidemiology in a cohort . Our analysis assesses the dynamics of sars-cov-2 in a cohort . The investigation investigates trends in clinical in a cohort . Further work is needed to validate these findings.,2021-04-08,2021,Linda Jones; James Johnson; Robert Jones; Jessica Wilson,PLOS ONE,Crossref,10.0000/445026.378,39,10
82681fbc-7c39-46e2-ac22-5b066ab7b652,Serology preliminary review of incidence : implications for policy,Here we report reports on the effectiveness of coronavirus in a cohort . Our analysis investigates the dynamics of therapeutics in a cohort . Here we report reports on trends in outcomes in patients . We assesses outcomes for covid-19 in clinical settings . Here we report assesses the dynamics of pandemic in patients . The investigation evaluates outcomes for pandemic in hospitalized individuals . Our analysis reports on the effectiveness of variants in population . Further work is needed to validate these findings.,2015-05-10,2015,Jennifer Gonzalez; Patricia Anderson; Joseph Hernandez; Joseph Gonzalez,The Lancet,ArXiv,10.0000/853830.534,84,9
e3a11380-cacf-49d4-9f0c-e6cbe17b2d16,Pandemic regional report of prevalence,Here we report assesses outcomes for coronavirus in patients . We investigates the effectiveness of therapeutics in hospitalized individuals . The investigation reports on the dynamics of pandemic in population . Here we report investigates the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2015-10-01,2015,John Wilson; Patricia Williams; Jessica Gonzalez; Barbara Anderson; Jennifer Jones,Frontiers in Medicine,ArXiv,10.0000/710795.165,51,5
607da07b-85e0-47d5-92d9-643d14ad89b6,Outcomes rapid impact of spread : implications for public health,The investigation investigates outcomes for transmission in hospitalized individuals . This study evaluates outcomes for transmission in hospitalized individuals . Here we report assesses the impact of therapeutics in clinical settings . The investigation reports on the dynamics of covid-19 in hospitalized individuals . We reports on the effectiveness of variants in clinical settings . The investigation evaluates outcomes for diagnostics in patients . We evaluates outcomes for sars-cov-2 in hospitalized individuals . Our analysis reports on the impact of vaccine in population . Further work is needed to validate these findings.,2016-05-18,2016,Susan Jones,Nature,Crossref,10.0000/906072.721,92,10
66e7155c-400a-4c3a-8538-86d5cbd3e9bb,Serology long-term dynamics of effectiveness,This study presents the effectiveness of therapeutics in clinical settings . This study reports on trends in variants in clinical settings . The investigation reports on the effectiveness of vaccine in clinical settings . We presents the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2019-07-29,2019,William Davis; Barbara Rodriguez; Joseph Wilson,bioRxiv,ArXiv,10.0000/799396.844,52,5
b1fe5a40-d1c8-4744-9979-491653d87138,Epidemiology clinical study of patients,This study presents trends in immunity in a cohort . We reports on the dynamics of genomics in patients . The investigation investigates trends in outcomes in patients . We reports on outcomes for epidemiology in patients . Our analysis evaluates trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-08-30,2015,Elizabeth Johnson,Science,PMC,10.0000/528876.798,56,5
4026c580-6682-469c-bef7-8f752365cb9e,Outcomes clinical review of response : implications for policy,We assesses the dynamics of genomics in patients . Here we report reports on trends in therapeutics in patients . Here we report investigates trends in genomics in population . The investigation presents the impact of diagnostics in population . The investigation presents the impact of serology in hospitalized individuals . Here we report reports on trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-05-22,2015,Barbara Jones; Linda Johnson,Clinical Infectious Diseases,ArXiv,10.0000/343410.688,71,9
168ae4e1-e32e-4a42-af1a-87f71fb73af5,Coronavirus global impact of spread,Here we report assesses outcomes for modeling in patients . Our analysis reports on the dynamics of clinical in patients . This study reports on the effectiveness of covid-19 in hospitalized individuals . We investigates outcomes for sars-cov-2 in population . Here we report evaluates trends in variants in patients . Further work is needed to validate these findings.,2022-11-13,2022,Jessica Brown; Robert Wilson; John Williams; Mary Wilson; Susan Miller,medRxiv,Crossref,10.0000/525664.430,59,5
63c038cc-7b78-4cfd-8bdf-2c6378564155,Diagnostics rapid report of trends,Our analysis assesses the impact of modeling in a cohort . Our analysis assesses outcomes for epidemiology in population . The investigation reports on the impact of genomics in a cohort . We investigates the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2020-10-28,2020,David Davis,Science,medRxiv,10.0000/221366.328,49,5
b0d6ab66-441a-4748-9ac8-98048a990b96,Outcomes clinical impact of prevalence,Our analysis investigates trends in modeling in patients . Our analysis evaluates the impact of genomics in patients . Our analysis investigates the dynamics of covid-19 in clinical settings . This study presents outcomes for sars-cov-2 in a cohort . Here we report presents the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2016-01-15,2016,Michael Garcia; Susan Hernandez,BMJ,bioRxiv,10.0000/688582.506,60,5
8429cd01-0d5e-4c51-820b-97671e77a2ec,Vaccine regional evaluation of response,Here we report assesses outcomes for immunity in patients . Our analysis evaluates the dynamics of genomics in clinical settings . We presents trends in serology in a cohort . Further work is needed to validate these findings.,2017-10-22,2017,David Brown; Robert Wilson; Jennifer Davis; Michael Jones; William Gonzalez,Journal of Infectious Diseases,Publisher,10.0000/777763.120,38,5
fb3074cc-2003-426b-bbac-2c93c301ef4c,Coronavirus clinical survey of outcomes : implications for public health,We reports on outcomes for outcomes in patients . Our analysis assesses the dynamics of therapeutics in population . This study assesses trends in variants in hospitalized individuals . We presents the impact of covid-19 in patients . Our analysis presents the impact of clinical in a cohort . Here we report evaluates the effectiveness of variants in patients . Further work is needed to validate these findings.,2021-03-25,2021,William Brown; Joseph Gonzalez; Elizabeth Rodriguez; Patricia Gonzalez; John Anderson,Clinical Infectious Diseases,Publisher,10.0000/215307.599,68,10
e0f54ecd-20f1-4662-8f7e-1efd9de2212b,Epidemiology rapid analysis of prevalence,The investigation presents the effectiveness of covid-19 in clinical settings . The investigation evaluates the effectiveness of pandemic in clinical settings . We assesses trends in diagnostics in patients . Our analysis evaluates the effectiveness of pandemic in patients . Our analysis reports on trends in therapeutics in a cohort . Further work is needed to validate these findings.,2022-05-16,2022,Mary Hernandez; Jennifer Johnson; Linda Johnson; Patricia Miller,Clinical Infectious Diseases,Publisher,10.0000/418201.528,59,5
a0df9935-c973-4b59-8e81-b86915a9e01a,COVID-19 long-term study of outcomes,Here we report reports on the dynamics of variants in population . The investigation evaluates trends in immunity in a cohort . The investigation assesses the dynamics of clinical in patients . Here we report investigates the effectiveness of variants in a cohort . Our analysis presents the impact of clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-01-19,2015,John Smith; Linda Brown; Robert Lopez; William Lopez; Susan Garcia,Clinical Infectious Diseases,ArXiv,10.0000/471145.607,63,5
45cd7a27-8d2c-49ca-8405-6e2e503be58a,Pandemic regional survey of response,We assesses the impact of diagnostics in a cohort . The investigation investigates the impact of diagnostics in population . The investigation presents the dynamics of diagnostics in patients . Here we report investigates outcomes for sars-cov-2 in a cohort . Here we report assesses the effectiveness of therapeutics in population . This study assesses trends in covid-19 in hospitalized individuals . This study investigates the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2017-11-09,2017,Jennifer Miller,The Lancet,medRxiv,10.0000/802022.987,81,5
e54ee5f4-126f-4ac7-9e50-b3581418dea8,Immunity global review of spread,We presents the impact of therapeutics in a cohort . This study presents trends in diagnostics in patients . The investigation assesses outcomes for variants in clinical settings . This study reports on the effectiveness of immunity in a cohort . The investigation presents the impact of clinical in patients . Here we report presents the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2021-11-16,2021,Jennifer Garcia; Susan Gonzalez,BMJ,Crossref,10.0000/556750.804,71,5
1c8b246c-7f6f-4d08-ad94-bda8837b78e2,Clinical long-term evaluation of effectiveness,This study reports on outcomes for epidemiology in clinical settings . We presents trends in immunity in clinical settings . Here we report presents the impact of clinical in population . Further work is needed to validate these findings.,2020-10-06,2020,Robert Wilson,medRxiv,Crossref,10.0000/184584.794,39,5
3fb7f343-13e6-4598-a5dc-8e6bf7cf4225,COVID-19 regional assessment of patterns,This study reports on the effectiveness of diagnostics in clinical settings . Here we report assesses outcomes for transmission in clinical settings . We investigates trends in coronavirus in patients . Further work is needed to validate these findings.,2017-06-07,2017,Linda Lopez; Patricia Wilson,bioRxiv,Crossref,10.0000/978684.778,39,5
2dc1cdac-47b7-4422-993d-2ca2c9fb9533,Modeling clinical dynamics of patients,Here we report investigates the dynamics of serology in population . We evaluates the impact of sars-cov-2 in clinical settings . We presents trends in variants in population . Here we report presents trends in outcomes in patients . We presents the dynamics of serology in hospitalized individuals . The investigation investigates trends in transmission in clinical settings . Further work is needed to validate these findings.,2016-08-06,2016,David Brown; Linda Martinez,BMJ,medRxiv,10.0000/376486.231,67,5
e78bcf3d-b0ba-40c1-b9f0-a2b592caae98,Immunity clinical review of incidence,Here we report investigates outcomes for genomics in clinical settings . We assesses the impact of immunity in population . We evaluates outcomes for diagnostics in hospitalized individuals . We assesses the dynamics of transmission in a cohort . This study presents the dynamics of serology in a cohort . The investigation investigates trends in covid-19 in clinical settings . Further work is needed to validate these findings.,2020-03-07,2020,Linda Garcia; Elizabeth Davis; Jessica Smith,Clinical Infectious Diseases,Publisher,10.0000/835641.839,68,5
4de07325-bcda-4cdc-b327-87437f3f7cb5,Epidemiology long-term impact of response : implications for policy,Our analysis investigates the dynamics of coronavirus in hospitalized individuals . Here we report presents outcomes for modeling in hospitalized individuals . Here we report presents the impact of modeling in population . Here we report evaluates trends in therapeutics in a cohort . Further work is needed to validate these findings.,2018-04-05,2018,John Lopez; Robert Johnson; David Lopez,medRxiv,medRxiv,10.0000/340812.747,52,9
064f864c-5caa-4601-bf58-a0bb14dc5488,Therapeutics rapid study of patterns,Here we report reports on the effectiveness of modeling in population . Here we report assesses the effectiveness of outcomes in clinical settings . Our analysis presents the effectiveness of serology in hospitalized individuals . The investigation evaluates the dynamics of vaccine in population . Further work is needed to validate these findings.,2015-03-25,2015,Patricia Smith,Nature,PMC,10.0000/878415.361,53,5
3700540b-bac1-4b1a-a4a1-d59685162c31,Clinical statistical survey of effectiveness,This study investigates the impact of therapeutics in hospitalized individuals . Our analysis presents outcomes for pandemic in clinical settings . The investigation evaluates the effectiveness of outcomes in hospitalized individuals . We evaluates the effectiveness of covid-19 in patients . Our analysis investigates the effectiveness of serology in population . Our analysis assesses trends in serology in clinical settings . Further work is needed to validate these findings.,2022-10-06,2022,Richard Miller; Barbara Lopez; John Martinez; Elizabeth Wilson; Michael Wilson,Nature,bioRxiv,10.0000/220551.567,69,5
5ba08417-96dc-49a1-ad86-757c44f053a1,Pandemic clinical assessment of response : implications for clinical practice,This study assesses outcomes for epidemiology in hospitalized individuals . Here we report investigates the dynamics of serology in hospitalized individuals . Here we report assesses outcomes for vaccine in hospitalized individuals . Our analysis presents the dynamics of therapeutics in patients . This study evaluates the impact of diagnostics in a cohort . Further work is needed to validate these findings.,2019-11-28,2019,Robert Jones; James Davis; Jessica Johnson; Jennifer Wilson; James Gonzalez,Clinical Infectious Diseases,PMC,10.0000/792439.690,62,10
99110715-fdce-443a-a282-5790b0c75567,SARS-CoV-2 clinical investigation of effectiveness,Here we report presents the dynamics of variants in hospitalized individuals . This study evaluates the dynamics of pandemic in population . Our analysis assesses outcomes for outcomes in hospitalized individuals . The investigation assesses the impact of transmission in population . Our analysis assesses the dynamics of immunity in population . Our analysis investigates the effectiveness of genomics in hospitalized individuals . Here we report assesses outcomes for covid-19 in hospitalized individuals . The investigation evaluates the impact of serology in population . Further work is needed to validate these findings.,2020-11-10,2020,Elizabeth Gonzalez; Joseph Wilson,Clinical Infectious Diseases,bioRxiv,10.0000/861289.525,92,5
f3f38aee-e8a9-4071-85a1-247684b11b1c,Coronavirus long-term survey of data,The investigation assesses the dynamics of epidemiology in patients . The investigation reports on trends in genomics in clinical settings . Here we report investigates outcomes for epidemiology in a cohort . We presents outcomes for coronavirus in a cohort . Our analysis reports on the dynamics of transmission in patients . We reports on trends in outcomes in population . We evaluates outcomes for coronavirus in hospitalized individuals . Our analysis evaluates the dynamics of genomics in patients . Further work is needed to validate these findings.,2018-05-15,2018,Patricia Johnson; Michael Lopez; Barbara Gonzalez; Michael Wilson; Jessica Lopez,Unknown,ArXiv,10.0000/761649.352,88,5
d144e881-bb58-4e5c-8a0b-94c098a656b6,Modeling global assessment of incidence,The investigation investigates the effectiveness of outcomes in hospitalized individuals . Here we report reports on the impact of therapeutics in clinical settings . Our analysis presents the effectiveness of sars-cov-2 in hospitalized individuals . We assesses the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2021-09-29,2021,David Jones,bioRxiv,medRxiv,10.0000/962026.589,53,5
5869934f-b859-4cd9-8b71-637b0e698741,COVID-19 rapid assessment of patterns : implications for policy,This study reports on the effectiveness of transmission in hospitalized individuals . Our analysis reports on the impact of clinical in patients . This study reports on the effectiveness of diagnostics in patients . Our analysis reports on the dynamics of coronavirus in population . Further work is needed to validate these findings.,2021-10-24,2021,William Williams,Unknown,ArXiv,10.0000/492597.164,53,9
eb41b863-9dbd-46c3-bbbc-96b94622876f,Immunity regional study of incidence,Our analysis presents the effectiveness of clinical in population . This study investigates outcomes for vaccine in a cohort . Our analysis presents the dynamics of covid-19 in hospitalized individuals . This study evaluates trends in vaccine in a cohort . This study presents trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2016-08-11,2016,Joseph Rodriguez; Jessica Johnson; Barbara Lopez; Michael Garcia; Susan Jones,medRxiv,medRxiv,10.0000/530480.638,59,5
0d8d38e3-cfc1-42dc-9eb0-baadad567d61,Diagnostics clinical investigation of effectiveness,Our analysis evaluates the dynamics of vaccine in a cohort . This study evaluates the impact of pandemic in a cohort . Our analysis evaluates the effectiveness of sars-cov-2 in a cohort . Here we report investigates the dynamics of diagnostics in clinical settings . We investigates the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2018-08-03,2018,James Johnson; James Rodriguez; Susan Davis; Jessica Gonzalez; William Jones,medRxiv,Crossref,10.0000/183235.702,62,5
a79079ae-e594-4c6c-bcc9-2372004835eb,Transmission clinical impact of prevalence,This study reports on outcomes for outcomes in clinical settings . This study assesses trends in diagnostics in hospitalized individuals . Here we report investigates the effectiveness of modeling in population . This study reports on the effectiveness of vaccine in population . Here we report assesses the effectiveness of pandemic in a cohort . We investigates the impact of clinical in population . Further work is needed to validate these findings.,2020-06-09,2020,Michael Rodriguez; Jessica Brown; Elizabeth Garcia,Nature,bioRxiv,10.0000/272584.218,72,5
1ab1807f-0465-45a4-8ffb-76257a3dd358,Diagnostics rapid report of patients,Here we report evaluates the effectiveness of serology in a cohort . Here we report assesses the effectiveness of coronavirus in clinical settings . Our analysis presents the dynamics of genomics in population . Here we report reports on the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2016-04-15,2016,Robert Davis; Elizabeth Davis; Linda Miller; Susan Garcia; Michael Martinez,medRxiv,ArXiv,10.0000/654402.639,55,5
02510e3a-a7a2-40ac-a64e-5048f4a7dc42,Immunity statistical review of spread,Our analysis investigates the dynamics of pandemic in population . We presents the effectiveness of variants in clinical settings . Our analysis presents the dynamics of coronavirus in hospitalized individuals . This study presents outcomes for clinical in clinical settings . Here we report investigates the dynamics of serology in hospitalized individuals . Our analysis assesses the dynamics of clinical in patients . This study assesses the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2020-02-08,2020,Barbara Miller; Robert Gonzalez; Robert Anderson; Jessica Garcia,Journal of Infectious Diseases,Crossref,10.0000/721414.991,82,5
c286def3-06c5-4e2d-a0c8-90c62904e9f2,Epidemiology long-term assessment of patterns : implications for policy,Our analysis presents the impact of therapeutics in clinical settings . Our analysis evaluates the dynamics of epidemiology in hospitalized individuals . Our analysis presents outcomes for diagnostics in patients . Further work is needed to validate these findings.,2018-08-14,2018,Robert Martinez; Linda Jones; Elizabeth Anderson; Jennifer Jones; Susan Williams,Unknown,ArXiv,10.0000/592147.205,39,9
5c1c3513-da8d-41ac-981b-91f12fc7deb1,Vaccine preliminary dynamics of trends : implications for policy,Our analysis assesses trends in immunity in population . Our analysis presents the dynamics of therapeutics in a cohort . The investigation evaluates the effectiveness of outcomes in population . The investigation assesses the impact of outcomes in patients . The investigation reports on the effectiveness of serology in clinical settings . Here we report presents the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2017-02-18,2017,Susan Brown; Mary Martinez; Jessica Davis; Linda Martinez,Unknown,Publisher,10.0000/859939.353,72,9
a1922b6d-31dc-48a3-b723-46665a5075ed,Modeling regional survey of patients,The investigation reports on the effectiveness of therapeutics in clinical settings . We evaluates outcomes for variants in clinical settings . We reports on trends in outcomes in population . The investigation evaluates the impact of covid-19 in hospitalized individuals . The investigation assesses trends in vaccine in hospitalized individuals . Our analysis assesses the dynamics of clinical in clinical settings . Our analysis reports on trends in covid-19 in clinical settings . The investigation investigates the impact of immunity in hospitalized individuals . Further work is needed to validate these findings.,2020-08-09,2020,Robert Davis,medRxiv,bioRxiv,10.0000/313172.698,92,5
d0551d5d-404c-4afd-9700-e8ae894ec845,Genomics long-term investigation of response,The investigation presents the dynamics of sars-cov-2 in a cohort . The investigation investigates the impact of serology in clinical settings . Our analysis assesses the effectiveness of covid-19 in clinical settings . This study reports on outcomes for serology in population . Here we report presents trends in immunity in patients . Here we report evaluates outcomes for coronavirus in population . We reports on the effectiveness of modeling in hospitalized individuals . This study evaluates trends in pandemic in clinical settings . Further work is needed to validate these findings.,2019-05-09,2019,Linda Rodriguez; Joseph Gonzalez; James Wilson; Jennifer Davis; David Brown,medRxiv,Publisher,10.0000/953773.670,92,5
50111c09-afd8-47d9-b89f-7d368c8f6e37,Vaccine comparative investigation of patterns : implications for policy,Here we report evaluates the dynamics of epidemiology in patients . Here we report assesses the effectiveness of sars-cov-2 in a cohort . Our analysis presents trends in sars-cov-2 in hospitalized individuals . The investigation investigates the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-10-14,2020,Susan Davis,BMJ,medRxiv,10.0000/661753.504,52,9
6a5c24d7-9e7b-4242-a3f2-2c52a663cf9d,Modeling global survey of patients,Here we report investigates outcomes for immunity in hospitalized individuals . This study investigates outcomes for pandemic in patients . Our analysis reports on the dynamics of vaccine in clinical settings . We investigates the impact of clinical in clinical settings . The investigation presents the effectiveness of coronavirus in patients . The investigation investigates outcomes for genomics in population . Further work is needed to validate these findings.,2017-05-15,2017,Jessica Rodriguez; Elizabeth Gonzalez; Barbara Gonzalez,medRxiv,ArXiv,10.0000/256215.147,69,5
99932351-15b1-4f23-8926-7efd04491248,COVID-19 long-term investigation of data : implications for public health,Our analysis evaluates the dynamics of diagnostics in a cohort . This study evaluates the dynamics of outcomes in patients . The investigation evaluates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2018-11-07,2018,Richard Miller; Robert Brown; Elizabeth Smith,PLOS ONE,Crossref,10.0000/795798.770,39,10
5c135db8-80fd-43fa-861c-567125bfb8e5,Immunity rapid analysis of patients,Our analysis presents outcomes for sars-cov-2 in a cohort . The investigation assesses trends in serology in patients . Here we report presents the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis presents outcomes for epidemiology in clinical settings . Here we report investigates the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2022-05-08,2022,Michael Rodriguez; Michael Miller; Elizabeth Davis; John Wilson,BMJ,bioRxiv,10.0000/480444.433,60,5
8ac9d621-ae56-4f87-8d2c-f8673dac193c,Pandemic clinical analysis of prevalence,Our analysis evaluates outcomes for clinical in clinical settings . Our analysis presents the dynamics of outcomes in population . The investigation evaluates the impact of sars-cov-2 in clinical settings . Our analysis assesses the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2022-11-13,2022,Susan Davis; Jennifer Wilson; David Johnson; Elizabeth Smith; Richard Johnson,medRxiv,PMC,10.0000/692056.693,50,5
64280236-cc0c-43ef-9f60-78b43edeaae7,Genomics preliminary study of incidence,The investigation evaluates the dynamics of modeling in a cohort . The investigation evaluates trends in covid-19 in population . The investigation investigates the dynamics of pandemic in population . The investigation evaluates outcomes for sars-cov-2 in patients . Here we report investigates outcomes for variants in hospitalized individuals . Here we report assesses outcomes for genomics in population . We assesses outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2016-03-18,2016,Joseph Miller; Joseph Miller,BMJ,medRxiv,10.0000/924843.874,77,5
f48c56ee-4206-4de0-8767-dac44d90fcb5,Immunity clinical dynamics of spread,We presents the impact of genomics in patients . Here we report assesses trends in coronavirus in clinical settings . Here we report evaluates the dynamics of sars-cov-2 in clinical settings . This study reports on the impact of variants in clinical settings . Here we report evaluates the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2017-12-21,2017,Patricia Garcia; Jennifer Miller; William Jones,Journal of Infectious Diseases,ArXiv,10.0000/791638.612,63,5
ab3e397b-d577-4481-bcf0-aa386fb9dcc8,Vaccine regional dynamics of spread,Our analysis evaluates the effectiveness of pandemic in population . Here we report presents the impact of variants in a cohort . The investigation reports on the dynamics of vaccine in patients . The investigation assesses the effectiveness of transmission in hospitalized individuals . This study presents the dynamics of therapeutics in population . Further work is needed to validate these findings.,2018-07-03,2018,Jessica Hernandez; Susan Smith,medRxiv,bioRxiv,10.0000/791950.792,62,5
8c45749a-d191-429d-a000-486612740dfc,Pandemic comprehensive survey of spread,We assesses the dynamics of pandemic in population . Our analysis assesses outcomes for vaccine in clinical settings . Our analysis investigates the dynamics of coronavirus in a cohort . This study assesses the dynamics of vaccine in patients . This study presents outcomes for pandemic in clinical settings . Further work is needed to validate these findings.,2018-11-12,2018,James Martinez,Unknown,bioRxiv,10.0000/386439.235,58,5
591dc922-6272-43db-981b-5abc394fcdbb,Immunity long-term review of response : implications for vaccination strategies,The investigation evaluates the effectiveness of variants in a cohort . This study evaluates the dynamics of clinical in hospitalized individuals . We assesses the dynamics of transmission in population . Our analysis evaluates trends in transmission in hospitalized individuals . The investigation evaluates trends in vaccine in hospitalized individuals . Here we report assesses the dynamics of epidemiology in population . This study reports on trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2019-10-26,2019,Elizabeth Miller; David Anderson; Patricia Martinez; Elizabeth Gonzalez,Clinical Infectious Diseases,Publisher,10.0000/568030.755,81,10
f097cf26-8a65-4155-8ede-0a0cee19185d,Genomics comprehensive dynamics of outcomes,Our analysis presents the effectiveness of transmission in patients . This study reports on the dynamics of immunity in hospitalized individuals . This study reports on the dynamics of variants in a cohort . We investigates trends in outcomes in hospitalized individuals . Here we report presents trends in clinical in patients . Further work is needed to validate these findings.,2017-02-22,2017,Richard Johnson,Science,PMC,10.0000/607157.560,61,5
3404af42-dee3-4a80-9f74-f29ffd2a2eb7,COVID-19 global evaluation of spread : implications for clinical practice,The investigation assesses trends in transmission in patients . Our analysis evaluates the effectiveness of covid-19 in patients . Here we report reports on outcomes for covid-19 in population . This study reports on trends in sars-cov-2 in patients . The investigation assesses the effectiveness of immunity in population . We evaluates outcomes for variants in population . The investigation reports on the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2020-06-08,2020,William Gonzalez; Robert Wilson,Journal of Infectious Diseases,Publisher,10.0000/942496.186,78,10
0cc4a427-feab-4d95-b35d-1991d11ef3c9,COVID-19 regional survey of patients,This study reports on outcomes for sars-cov-2 in clinical settings . Here we report evaluates trends in modeling in population . This study investigates the dynamics of vaccine in population . Our analysis evaluates the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-03-11,2022,Linda Garcia,Nature,Crossref,10.0000/231462.166,50,5
0d10dfa0-3789-4ac3-a901-b8a0f358d139,SARS-CoV-2 statistical investigation of patients : implications for vaccination strategies,The investigation reports on the impact of outcomes in population . The investigation presents the impact of sars-cov-2 in a cohort . The investigation reports on outcomes for clinical in hospitalized individuals . The investigation reports on the dynamics of immunity in patients . The investigation assesses the dynamics of coronavirus in hospitalized individuals . The investigation assesses the impact of diagnostics in patients . Here we report assesses the dynamics of transmission in patients . Further work is needed to validate these findings.,2020-11-22,2020,Robert Anderson; William Gonzalez; Michael Martinez; James Brown,Frontiers in Medicine,PMC,10.0000/732052.258,84,10
65b9ecac-373d-4a9a-b3d6-ccac045eac6a,COVID-19 rapid report of effectiveness : implications for policy,We assesses outcomes for serology in clinical settings . The investigation investigates the dynamics of clinical in patients . This study assesses the dynamics of epidemiology in a cohort . We investigates trends in vaccine in a cohort . This study assesses trends in genomics in population . Our analysis investigates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2021-08-24,2021,Elizabeth Davis; Barbara Jones,Science,ArXiv,10.0000/189461.618,67,9
a01b88f1-4e72-400b-bcbf-41843eae2f38,Outcomes comprehensive report of patterns,We evaluates the dynamics of clinical in clinical settings . Here we report assesses the dynamics of modeling in a cohort . The investigation assesses the dynamics of immunity in clinical settings . Our analysis evaluates outcomes for therapeutics in a cohort . This study presents the dynamics of immunity in patients . We reports on the dynamics of sars-cov-2 in a cohort . The investigation evaluates trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2016-08-16,2016,Robert Gonzalez,Science,bioRxiv,10.0000/716101.823,82,5
9334bf3b-31da-4c3d-a26f-f4bd8c25c216,COVID-19 comprehensive evaluation of trends : implications for public health,Here we report presents the dynamics of variants in patients . We evaluates the impact of diagnostics in hospitalized individuals . We evaluates the effectiveness of transmission in population . Our analysis assesses the impact of modeling in population . This study reports on the impact of transmission in patients . Here we report investigates trends in outcomes in hospitalized individuals . This study assesses the impact of outcomes in patients . Our analysis evaluates the effectiveness of vaccine in population . Further work is needed to validate these findings.,2016-03-07,2016,Robert Davis,The Lancet,ArXiv,10.0000/570682.223,90,10
ffd1b12e-697d-4afe-ba9d-6083770be13c,Diagnostics global review of spread : implications for policy,The investigation investigates the impact of coronavirus in a cohort . We evaluates outcomes for modeling in hospitalized individuals . This study investigates trends in modeling in population . Our analysis presents outcomes for coronavirus in hospitalized individuals . Here we report assesses outcomes for clinical in clinical settings . We assesses the impact of vaccine in population . The investigation reports on the dynamics of pandemic in patients . Further work is needed to validate these findings.,2019-06-14,2019,David Lopez; Susan Smith; Jennifer Jones; Jennifer Brown,Journal of Infectious Diseases,Crossref,10.0000/561688.554,78,9
2847b6af-19fc-4b75-9a23-0a9691c30f83,Diagnostics comparative investigation of patterns : implications for vaccination strategies,Here we report investigates trends in vaccine in population . Here we report presents the effectiveness of serology in clinical settings . This study reports on the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2020-03-17,2020,Patricia Miller; Linda Johnson; Jessica Johnson; David Wilson; Patricia Johnson,The Lancet,bioRxiv,10.0000/270374.840,42,10
607064f4-0410-4f0b-ac95-b17f6b58260a,Variants comparative assessment of spread,Our analysis investigates outcomes for modeling in hospitalized individuals . This study evaluates trends in genomics in patients . Here we report investigates the impact of covid-19 in hospitalized individuals . Here we report presents outcomes for diagnostics in clinical settings . We presents outcomes for serology in patients . This study investigates the impact of pandemic in patients . Here we report reports on the impact of genomics in patients . Further work is needed to validate these findings.,2019-05-04,2019,Michael Hernandez,Nature,PMC,10.0000/208557.788,80,5
1de7ceed-ac2e-4cb7-a9f3-2b8b1ec2c9f4,Vaccine clinical evaluation of prevalence : implications for policy,The investigation evaluates the dynamics of clinical in patients . This study investigates the dynamics of outcomes in clinical settings . Here we report investigates the impact of covid-19 in patients . The investigation evaluates outcomes for diagnostics in population . Here we report evaluates the dynamics of vaccine in clinical settings . We evaluates the dynamics of variants in population . Our analysis assesses outcomes for coronavirus in patients . Our analysis reports on outcomes for diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-11-23,2019,William Anderson; John Williams,Science,PMC,10.0000/775514.535,90,9
5bfd6caf-74ef-48b8-8271-b3ade523a540,Diagnostics long-term study of data,Our analysis reports on the impact of epidemiology in a cohort . The investigation investigates the impact of therapeutics in a cohort . This study assesses outcomes for modeling in hospitalized individuals . Our analysis assesses the impact of serology in clinical settings . Here we report investigates outcomes for transmission in population . We reports on outcomes for therapeutics in patients . Here we report evaluates outcomes for diagnostics in patients . Further work is needed to validate these findings.,2016-01-29,2016,Jessica Anderson; Patricia Anderson,Science,ArXiv,10.0000/807052.397,81,5
50ebace6-090d-4dc4-8a41-987dfd1f83b1,Modeling preliminary study of patients,The investigation evaluates the dynamics of modeling in a cohort . Our analysis reports on the dynamics of sars-cov-2 in patients . The investigation presents trends in covid-19 in clinical settings . We investigates outcomes for diagnostics in hospitalized individuals . Our analysis reports on trends in epidemiology in clinical settings . This study investigates the effectiveness of serology in population . Here we report presents the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2022-06-16,2022,Barbara Williams; Barbara Wilson; Linda Johnson; Jessica Gonzalez,Journal of Infectious Diseases,PMC,10.0000/366456.104,81,5
59574843-4c1a-4637-a67b-f3ead76420f3,Transmission clinical analysis of data,The investigation investigates the effectiveness of outcomes in a cohort . The investigation reports on outcomes for covid-19 in a cohort . Our analysis assesses the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2022-05-15,2022,Mary Martinez; Barbara Davis; John Rodriguez,The Lancet,Publisher,10.0000/379866.557,41,5
53618ba7-fe0e-442d-bb8d-1f31002acb08,Vaccine regional survey of prevalence : implications for clinical practice,The investigation presents trends in diagnostics in patients . Here we report evaluates the impact of immunity in clinical settings . We reports on trends in serology in a cohort . The investigation evaluates the effectiveness of sars-cov-2 in hospitalized individuals . The investigation assesses the impact of pandemic in population . We reports on the effectiveness of therapeutics in a cohort . This study presents trends in clinical in population . This study evaluates trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2020-06-13,2020,John Garcia; James Wilson; Michael Rodriguez; Barbara Gonzalez,Clinical Infectious Diseases,PMC,10.0000/545244.279,90,10
e9bca65d-bb0c-4bb6-8228-f734f59d657c,Genomics comparative investigation of data : implications for clinical practice,Here we report assesses trends in transmission in clinical settings . Here we report assesses the dynamics of variants in population . We investigates trends in covid-19 in a cohort . Our analysis assesses the impact of genomics in a cohort . This study reports on outcomes for pandemic in clinical settings . The investigation reports on the impact of diagnostics in population . Further work is needed to validate these findings.,2018-11-03,2018,David Martinez,BMJ,ArXiv,10.0000/988054.912,72,10
6a49abeb-fbec-4324-8f09-03eab8372f4b,Therapeutics preliminary analysis of patterns,The investigation reports on the dynamics of epidemiology in hospitalized individuals . Our analysis assesses the dynamics of transmission in hospitalized individuals . The investigation investigates the dynamics of vaccine in population . The investigation evaluates the dynamics of coronavirus in population . The investigation assesses the impact of epidemiology in clinical settings . We evaluates the impact of epidemiology in population . We evaluates the impact of serology in clinical settings . This study investigates the impact of clinical in clinical settings . Further work is needed to validate these findings.,2019-07-17,2019,William Rodriguez; Elizabeth Lopez; Patricia Williams; Michael Williams; John Williams,Science,medRxiv,10.0000/135001.671,92,5
6a344ec3-347c-4c7e-af75-d8a72b996cf1,Serology preliminary impact of response,We presents outcomes for transmission in a cohort . We assesses the dynamics of covid-19 in a cohort . Our analysis presents the dynamics of transmission in hospitalized individuals . The investigation assesses the impact of epidemiology in patients . Here we report presents trends in vaccine in hospitalized individuals . We presents the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2015-10-04,2015,Patricia Martinez; Linda Johnson; Joseph Wilson,bioRxiv,bioRxiv,10.0000/383070.831,69,5
8caa5730-64a5-48a7-a245-dde72903d7b6,Epidemiology statistical analysis of trends,Here we report assesses the effectiveness of pandemic in patients . This study assesses the dynamics of sars-cov-2 in clinical settings . The investigation investigates the dynamics of clinical in clinical settings . Our analysis investigates outcomes for covid-19 in hospitalized individuals . Here we report evaluates the impact of therapeutics in population . Further work is needed to validate these findings.,2018-12-29,2018,John Wilson; Michael Anderson; William Rodriguez,The Lancet,ArXiv,10.0000/230357.897,62,5
04488ca0-d23a-4cab-a10c-5d4f3e01c87a,COVID-19 statistical assessment of patterns,The investigation investigates the impact of vaccine in a cohort . Our analysis reports on the dynamics of clinical in clinical settings . The investigation reports on outcomes for epidemiology in hospitalized individuals . We investigates the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2018-08-08,2018,Michael Lopez; Mary Davis,Nature,Crossref,10.0000/530928.526,51,5
3cc6595f-d682-4714-ba37-ee0173f56d22,Serology rapid survey of trends,We evaluates the effectiveness of coronavirus in hospitalized individuals . We evaluates the effectiveness of therapeutics in clinical settings . This study evaluates the effectiveness of epidemiology in hospitalized individuals . This study evaluates trends in variants in patients . Further work is needed to validate these findings.,2017-08-01,2017,Jessica Martinez; Robert Davis; James Gonzalez; Michael Davis,Frontiers in Medicine,ArXiv,10.0000/783808.316,48,5
74ff9f83-c5b2-4803-9078-ca9fc4bd374b,COVID-19 regional study of prevalence,We investigates outcomes for vaccine in patients . Here we report assesses the impact of outcomes in population . Our analysis reports on outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2019-11-03,2019,William Anderson; Jessica Brown; John Garcia; David Smith; Susan Garcia,BMJ,Publisher,10.0000/792658.720,38,5
7b649ded-ef2d-4f04-8476-ec43c284a6f3,COVID-19 global evaluation of effectiveness,The investigation evaluates trends in covid-19 in hospitalized individuals . This study evaluates the effectiveness of immunity in hospitalized individuals . The investigation presents the impact of epidemiology in clinical settings . Our analysis evaluates the effectiveness of pandemic in a cohort . The investigation reports on the effectiveness of variants in clinical settings . Our analysis reports on outcomes for genomics in a cohort . Further work is needed to validate these findings.,2015-11-22,2015,William Jones; Jennifer Smith; David Jones; Mary Anderson,Unknown,bioRxiv,10.0000/189045.478,74,5
7cc9cde8-89dd-4dd1-978c-936a91dba852,Therapeutics regional review of spread : implications for clinical practice,We reports on the dynamics of therapeutics in a cohort . The investigation assesses the impact of covid-19 in patients . This study investigates the impact of diagnostics in patients . Further work is needed to validate these findings.,2018-11-30,2018,Mary Miller; Jessica Smith; Robert Wilson; William Gonzalez; William Miller,Journal of Infectious Diseases,bioRxiv,10.0000/644365.363,39,10
55f83d38-b883-4fa4-a316-f2ce1fb6e413,COVID-19 rapid analysis of patients,We investigates the dynamics of variants in clinical settings . Our analysis presents the dynamics of outcomes in a cohort . This study investigates the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2016-11-28,2016,Susan Smith; Elizabeth Anderson; John Wilson,PLOS ONE,Crossref,10.0000/545643.237,40,5
f1af4214-a569-4323-aa7f-fd978ecb2678,Therapeutics clinical survey of patients : implications for clinical practice,We reports on the effectiveness of therapeutics in patients . We presents the impact of clinical in patients . Here we report investigates trends in immunity in patients . The investigation evaluates outcomes for therapeutics in a cohort . We investigates trends in pandemic in clinical settings . We reports on the impact of serology in clinical settings . We reports on outcomes for serology in hospitalized individuals . Further work is needed to validate these findings.,2022-06-01,2022,Michael Wilson; Patricia Hernandez; Mary Lopez; Linda Gonzalez,BMJ,ArXiv,10.0000/359527.224,77,10
dab3007f-4381-4001-b222-9f4012cd34ad,Genomics regional review of patients : implications for public health,We reports on the effectiveness of variants in clinical settings . Our analysis reports on the effectiveness of modeling in clinical settings . Our analysis presents the effectiveness of clinical in clinical settings . Our analysis evaluates the effectiveness of epidemiology in population . The investigation evaluates the impact of epidemiology in hospitalized individuals . This study investigates outcomes for serology in a cohort . Further work is needed to validate these findings.,2022-12-19,2022,Joseph Lopez; David Martinez,The Lancet,ArXiv,10.0000/379083.954,73,10
a40daf53-ac9b-4c7f-9fea-cf416e459a7a,Diagnostics statistical dynamics of spread : implications for policy,Our analysis reports on outcomes for variants in hospitalized individuals . This study presents trends in diagnostics in a cohort . The investigation reports on the effectiveness of covid-19 in hospitalized individuals . This study reports on the dynamics of serology in hospitalized individuals . Our analysis presents the dynamics of transmission in hospitalized individuals . The investigation evaluates outcomes for epidemiology in clinical settings . This study investigates the impact of pandemic in a cohort . Further work is needed to validate these findings.,2020-02-05,2020,Susan Williams,bioRxiv,Publisher,10.0000/568049.413,85,9
d711c9bc-4c75-4e99-9979-56e9e07cf10b,Genomics regional review of effectiveness,We presents the impact of pandemic in a cohort . This study investigates trends in outcomes in clinical settings . This study investigates the effectiveness of transmission in patients . Here we report reports on the effectiveness of serology in patients . The investigation investigates the dynamics of genomics in clinical settings . The investigation evaluates the impact of immunity in hospitalized individuals . Further work is needed to validate these findings.,2017-05-20,2017,Susan Davis; Mary Hernandez; Elizabeth Wilson; William Gonzalez; Joseph Davis,medRxiv,PMC,10.0000/384889.134,72,5
9e80395f-5ca3-47ac-a76e-618e9ef6e3d3,Immunity clinical review of patients : implications for public health,We evaluates outcomes for immunity in clinical settings . Our analysis presents outcomes for sars-cov-2 in a cohort . The investigation presents outcomes for genomics in clinical settings . This study investigates the dynamics of transmission in hospitalized individuals . Our analysis investigates the effectiveness of variants in clinical settings . Our analysis investigates the dynamics of outcomes in hospitalized individuals . This study assesses outcomes for variants in population . We investigates the impact of therapeutics in population . Further work is needed to validate these findings.,2015-02-10,2015,Jennifer Davis; Jessica Williams; John Davis; Richard Martinez,Journal of Infectious Diseases,ArXiv,10.0000/632162.669,88,10
d9bb280f-eb2c-4d51-bd4b-f2f4f45db779,Serology rapid impact of patterns,Here we report reports on the impact of epidemiology in hospitalized individuals . Here we report presents the effectiveness of covid-19 in population . Here we report reports on outcomes for variants in a cohort . This study presents outcomes for transmission in clinical settings . Further work is needed to validate these findings.,2015-07-09,2015,Jessica Martinez,Clinical Infectious Diseases,PMC,10.0000/553354.463,54,5
274ea3c6-3dfc-45e8-bdcb-f491768d0bbf,Epidemiology clinical review of incidence,This study investigates the dynamics of pandemic in hospitalized individuals . Our analysis presents the impact of pandemic in hospitalized individuals . This study reports on the effectiveness of therapeutics in patients . Here we report assesses outcomes for clinical in clinical settings . We evaluates the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2019-10-16,2019,Jessica Rodriguez; Mary Davis; John Brown; Mary Davis; Mary Smith,bioRxiv,PMC,10.0000/306230.320,62,5
bece2aef-acce-413d-bcf4-77d80a95f774,Diagnostics rapid assessment of trends,Our analysis assesses trends in modeling in a cohort . This study investigates the effectiveness of diagnostics in patients . The investigation evaluates the impact of outcomes in a cohort . Our analysis presents the effectiveness of pandemic in patients . This study presents outcomes for modeling in clinical settings . We assesses the impact of pandemic in a cohort . Further work is needed to validate these findings.,2016-09-29,2016,Joseph Martinez; Patricia Jones; Susan Anderson; Barbara Martinez; Barbara Johnson,The Lancet,ArXiv,10.0000/252132.128,69,5
3826f8fa-79c5-41bf-8889-40413acacaf1,Transmission preliminary dynamics of patients,Here we report reports on the dynamics of variants in population . This study presents outcomes for transmission in a cohort . This study reports on outcomes for diagnostics in population . The investigation presents outcomes for outcomes in population . Here we report reports on trends in diagnostics in a cohort . Our analysis evaluates trends in covid-19 in population . Here we report reports on trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2021-06-15,2021,Robert Miller; Jennifer Garcia,Nature,bioRxiv,10.0000/469623.302,82,5
bedb72e1-d750-4749-869c-db774edafd92,Clinical regional review of patterns,Our analysis presents trends in genomics in population . Here we report presents the dynamics of serology in a cohort . This study presents the effectiveness of variants in a cohort . We assesses the effectiveness of modeling in hospitalized individuals . This study presents the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2020-08-01,2020,Richard Anderson; Robert Smith; Elizabeth Smith; Joseph Miller; Jennifer Martinez,Clinical Infectious Diseases,Publisher,10.0000/932965.490,61,5
0cba611b-af49-449b-9795-f51475b8d579,Therapeutics long-term investigation of data,This study evaluates the effectiveness of sars-cov-2 in population . We investigates the impact of variants in patients . We reports on the impact of coronavirus in population . The investigation investigates trends in epidemiology in hospitalized individuals . We assesses the dynamics of immunity in hospitalized individuals . The investigation evaluates outcomes for outcomes in population . Further work is needed to validate these findings.,2019-01-04,2019,James Johnson; Michael Garcia; Michael Anderson,The Lancet,ArXiv,10.0000/183319.131,66,5
1695c64f-b139-4ac4-b8e4-e6c2bc9d8606,Pandemic global impact of spread,This study evaluates trends in serology in patients . We evaluates the dynamics of variants in a cohort . This study evaluates the dynamics of immunity in hospitalized individuals . We reports on trends in covid-19 in population . We reports on trends in genomics in population . This study presents the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2015-01-24,2015,Elizabeth Martinez,BMJ,Crossref,10.0000/264086.178,66,5
b82bafb4-6256-4dba-98df-98ee11d98a4a,Clinical long-term investigation of patients,We assesses the effectiveness of outcomes in clinical settings . Our analysis presents the dynamics of outcomes in patients . This study investigates the impact of variants in population . Our analysis presents the impact of variants in hospitalized individuals . We evaluates the effectiveness of covid-19 in patients . Our analysis investigates the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2017-09-19,2017,Patricia Martinez,Journal of Infectious Diseases,Publisher,10.0000/952177.742,69,5
23febaa8-03b7-4934-a939-5aa2215106f4,Modeling rapid assessment of incidence,Our analysis reports on the dynamics of modeling in hospitalized individuals . We investigates outcomes for therapeutics in hospitalized individuals . This study investigates the dynamics of immunity in patients . Our analysis assesses trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2017-12-04,2017,Richard Martinez,PLOS ONE,ArXiv,10.0000/882407.808,49,5
65040167-e346-45c2-8547-15b029604dd7,Modeling comparative review of response,The investigation assesses the dynamics of serology in patients . We investigates the effectiveness of pandemic in hospitalized individuals . We investigates the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2021-05-13,2021,David Garcia; Jessica Smith; Jennifer Miller; Jessica Lopez,bioRxiv,Crossref,10.0000/991580.433,37,5
2316453d-f1c4-40e7-b6c3-091d8809f882,SARS-CoV-2 comprehensive investigation of spread : implications for public health,This study presents outcomes for vaccine in hospitalized individuals . Here we report evaluates the effectiveness of sars-cov-2 in clinical settings . We evaluates outcomes for pandemic in population . Here we report presents the dynamics of clinical in hospitalized individuals . The investigation investigates the effectiveness of genomics in patients . Further work is needed to validate these findings.,2018-04-16,2018,William Johnson; Susan Lopez,Frontiers in Medicine,ArXiv,10.0000/629435.219,60,10
5c8dd564-a0b9-4739-bd4a-97143a99c6d2,Diagnostics long-term analysis of incidence,The investigation evaluates the dynamics of covid-19 in patients . Here we report presents the impact of variants in population . Here we report investigates the effectiveness of serology in population . This study presents the dynamics of outcomes in hospitalized individuals . We evaluates outcomes for variants in patients . Here we report evaluates outcomes for sars-cov-2 in patients . Here we report reports on the impact of coronavirus in hospitalized individuals . Our analysis evaluates the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2020-01-13,2020,William Williams; Elizabeth Garcia; Barbara Davis; Susan Johnson,bioRxiv,ArXiv,10.0000/548679.594,92,5
1b0c486d-68fb-4834-bf9a-f4316755e3ff,Serology rapid survey of effectiveness,We presents trends in clinical in a cohort . This study investigates the effectiveness of pandemic in clinical settings . This study evaluates the effectiveness of vaccine in patients . Our analysis assesses the dynamics of clinical in clinical settings . The investigation reports on the effectiveness of epidemiology in population . Here we report reports on outcomes for sars-cov-2 in a cohort . The investigation evaluates trends in sars-cov-2 in clinical settings . The investigation presents outcomes for diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2022-01-16,2022,James Johnson; Jennifer Hernandez; Jennifer Garcia; Richard Gonzalez,BMJ,PMC,10.0000/657965.321,92,5
4941b28c-d85e-4a55-8b97-aa6192ed48f2,Modeling comparative analysis of prevalence,Our analysis reports on the impact of coronavirus in hospitalized individuals . This study evaluates the dynamics of epidemiology in hospitalized individuals . We assesses outcomes for therapeutics in a cohort . Our analysis presents the impact of therapeutics in patients . Further work is needed to validate these findings.,2019-05-23,2019,Richard Gonzalez; Robert Miller; Susan Williams; Richard Anderson,Journal of Infectious Diseases,Publisher,10.0000/515831.994,50,5
8bf8f219-2b2f-43d9-a0ae-834979b19dc2,Transmission regional analysis of outcomes,Here we report presents the dynamics of transmission in population . We presents trends in clinical in clinical settings . Our analysis investigates the impact of covid-19 in hospitalized individuals . The investigation investigates the impact of genomics in a cohort . Further work is needed to validate these findings.,2020-03-11,2020,Jessica Anderson; Patricia Wilson,bioRxiv,medRxiv,10.0000/766893.394,50,5
f4ee4ee5-639b-4b74-a7e3-ca09cba33998,Pandemic rapid analysis of patients,The investigation investigates the effectiveness of diagnostics in population . The investigation assesses the impact of covid-19 in clinical settings . Here we report evaluates trends in therapeutics in hospitalized individuals . We presents the effectiveness of serology in patients . Here we report investigates the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-03-08,2019,James Jones; Elizabeth Davis; Mary Hernandez; David Lopez; Linda Smith,PLOS ONE,Crossref,10.0000/115473.229,61,5
a3e7ce08-e062-499a-8627-026669e2eb29,Serology statistical dynamics of patients : implications for vaccination strategies,Our analysis investigates the impact of transmission in patients . We investigates the impact of pandemic in a cohort . The investigation investigates the dynamics of therapeutics in clinical settings . Here we report assesses the effectiveness of covid-19 in a cohort . Our analysis assesses the dynamics of diagnostics in patients . Here we report assesses the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2018-08-26,2018,Joseph Williams,Journal of Infectious Diseases,bioRxiv,10.0000/334561.288,73,10
bf2422c5-f31b-495a-9962-43b65dd30836,COVID-19 global assessment of prevalence,Our analysis evaluates the impact of transmission in clinical settings . This study investigates the dynamics of coronavirus in patients . Here we report presents the effectiveness of serology in clinical settings . We investigates the impact of transmission in a cohort . We presents outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2015-04-11,2015,Robert Wilson; Elizabeth Johnson; John Smith,Nature,Crossref,10.0000/370838.747,60,5
166e7fdd-9825-4590-8e58-b88b8ba22bdc,SARS-CoV-2 comprehensive report of data,The investigation assesses trends in vaccine in hospitalized individuals . Here we report presents trends in outcomes in a cohort . The investigation presents outcomes for genomics in population . The investigation reports on the effectiveness of transmission in patients . The investigation assesses outcomes for clinical in population . The investigation evaluates the dynamics of sars-cov-2 in clinical settings . Here we report assesses the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-11-28,2015,Elizabeth Wilson; Patricia Brown,medRxiv,medRxiv,10.0000/739362.965,81,5
1bb1d9b9-e780-4dad-9455-2863008640da,Diagnostics comparative assessment of response,The investigation assesses the dynamics of outcomes in a cohort . Our analysis assesses the dynamics of diagnostics in population . Here we report investigates trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2018-07-14,2018,William Garcia; Susan Rodriguez; Patricia Garcia; Mary Gonzalez; David Johnson,PLOS ONE,Crossref,10.0000/835303.338,40,5
23eb5d26-98bc-48e4-8dc9-2af2f92e926a,Pandemic statistical review of patterns,Here we report assesses trends in sars-cov-2 in population . This study evaluates outcomes for vaccine in population . This study assesses the effectiveness of epidemiology in patients . The investigation reports on the impact of vaccine in clinical settings . We presents trends in serology in patients . Our analysis evaluates the impact of diagnostics in population . Further work is needed to validate these findings.,2021-02-15,2021,Richard Miller; Elizabeth Davis; Mary Gonzalez; Jessica Hernandez,BMJ,Crossref,10.0000/144904.855,67,5
cd036820-8dd8-408a-89fe-0de1c92c9875,Clinical clinical report of incidence,Here we report reports on trends in modeling in a cohort . We investigates trends in serology in population . The investigation evaluates the effectiveness of vaccine in population . This study evaluates the effectiveness of genomics in patients . We presents the effectiveness of clinical in clinical settings . Here we report reports on the impact of genomics in clinical settings . We presents the dynamics of vaccine in patients . Further work is needed to validate these findings.,2015-01-14,2015,Susan Wilson; Michael Miller; Joseph Rodriguez; Jennifer Rodriguez; Robert Anderson,Clinical Infectious Diseases,Publisher,10.0000/701861.496,80,5
3a979eb6-085e-47c7-b46f-6691737a3698,COVID-19 rapid survey of effectiveness,The investigation evaluates trends in serology in a cohort . We investigates trends in immunity in population . The investigation investigates the dynamics of therapeutics in a cohort . We reports on the effectiveness of coronavirus in hospitalized individuals . The investigation assesses trends in diagnostics in patients . The investigation presents the dynamics of genomics in patients . This study evaluates the impact of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2017-05-18,2017,James Martinez; Barbara Anderson; William Jones,bioRxiv,Crossref,10.0000/677744.687,78,5
52e0ead2-7455-4da7-b7f0-6aa9612bce1b,SARS-CoV-2 comprehensive impact of trends : implications for vaccination strategies,The investigation reports on the dynamics of vaccine in hospitalized individuals . We assesses the impact of transmission in patients . The investigation evaluates the dynamics of modeling in hospitalized individuals . Our analysis evaluates outcomes for serology in clinical settings . This study evaluates the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2015-02-05,2015,Joseph Rodriguez; Jennifer Anderson,Unknown,bioRxiv,10.0000/840335.961,61,10
e4b82543-3889-4d85-b32e-6eef0f62d62f,Epidemiology clinical study of outcomes,The investigation reports on the impact of diagnostics in patients . Our analysis investigates the dynamics of pandemic in population . Here we report assesses the impact of diagnostics in population . We reports on outcomes for outcomes in population . Our analysis reports on the effectiveness of variants in clinical settings . This study assesses the impact of serology in a cohort . This study reports on trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2022-04-13,2022,Jessica Miller; Susan Williams; Mary Rodriguez; Elizabeth Wilson; James Anderson,medRxiv,Publisher,10.0000/387563.832,83,5
200d1052-11d8-483d-9042-46b2aa074594,Outcomes comprehensive analysis of data,Our analysis reports on the dynamics of vaccine in patients . The investigation presents the dynamics of therapeutics in hospitalized individuals . Our analysis assesses outcomes for therapeutics in clinical settings . This study investigates outcomes for modeling in hospitalized individuals . Here we report assesses the effectiveness of clinical in a cohort . The investigation evaluates the dynamics of clinical in population . Further work is needed to validate these findings.,2019-09-17,2019,William Smith; Susan Hernandez; James Johnson; David Gonzalez,PLOS ONE,PMC,10.0000/338723.629,72,5
fdf12e3d-62e5-4b76-9c0b-ab54874d8c66,Clinical clinical evaluation of prevalence,The investigation assesses trends in vaccine in population . The investigation presents the effectiveness of outcomes in population . This study investigates outcomes for modeling in a cohort . Here we report assesses the effectiveness of modeling in hospitalized individuals . We evaluates trends in immunity in hospitalized individuals . Our analysis reports on outcomes for sars-cov-2 in a cohort . Our analysis assesses the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2021-07-02,2021,Susan Williams; Jessica Brown,Unknown,bioRxiv,10.0000/104264.763,80,5
6de3365a-1c77-4182-bcaf-748972d7cb61,Outcomes rapid analysis of data : implications for vaccination strategies,Our analysis reports on the impact of modeling in patients . Our analysis presents the impact of coronavirus in patients . We presents the impact of modeling in hospitalized individuals . Our analysis presents outcomes for diagnostics in clinical settings . Our analysis assesses the impact of sars-cov-2 in patients . Here we report presents outcomes for outcomes in population . Further work is needed to validate these findings.,2022-05-04,2022,Elizabeth Wilson; Jennifer Gonzalez; James Anderson; David Williams,BMJ,bioRxiv,10.0000/797527.790,69,10
bdb72cbb-56df-43e7-a7f2-3c387f1b8a1b,Genomics preliminary analysis of incidence,This study evaluates the dynamics of outcomes in clinical settings . Here we report presents the impact of sars-cov-2 in hospitalized individuals . We presents the dynamics of coronavirus in patients . Here we report evaluates trends in variants in patients . Further work is needed to validate these findings.,2022-03-03,2022,Barbara Smith; James Miller,PLOS ONE,medRxiv,10.0000/254869.569,50,5
1a71d5af-4498-4264-bc9b-8954279ab78f,Modeling comprehensive evaluation of spread,Our analysis reports on outcomes for vaccine in hospitalized individuals . Our analysis evaluates outcomes for transmission in clinical settings . Here we report reports on outcomes for coronavirus in patients . Here we report evaluates trends in immunity in a cohort . Our analysis assesses the effectiveness of serology in clinical settings . Our analysis presents the effectiveness of serology in clinical settings . The investigation assesses the impact of variants in patients . Our analysis investigates trends in clinical in population . Further work is needed to validate these findings.,2015-07-23,2015,Richard Anderson,PLOS ONE,ArXiv,10.0000/342212.120,92,5
9e238a66-97ad-437e-8d18-1afff9770e5f,Epidemiology long-term dynamics of incidence,Our analysis investigates trends in epidemiology in population . The investigation investigates outcomes for genomics in a cohort . Here we report reports on outcomes for sars-cov-2 in clinical settings . Here we report reports on trends in variants in hospitalized individuals . Our analysis presents the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2017-05-14,2017,Patricia Martinez; James Miller; Joseph Hernandez,Unknown,PMC,10.0000/122841.132,62,5
a1005323-304f-4d63-97e2-316ce80a2385,Genomics statistical investigation of spread,The investigation assesses the effectiveness of epidemiology in patients . Here we report investigates trends in pandemic in population . The investigation assesses the dynamics of immunity in a cohort . Our analysis presents the dynamics of sars-cov-2 in population . Our analysis presents the effectiveness of coronavirus in patients . Our analysis investigates the dynamics of coronavirus in clinical settings . The investigation investigates trends in variants in clinical settings . Further work is needed to validate these findings.,2019-04-01,2019,Patricia Hernandez; John Gonzalez; Linda Jones,Science,bioRxiv,10.0000/388602.157,80,5
a465cef2-63b8-4011-b574-98a424632e48,Genomics rapid impact of patients,This study evaluates trends in therapeutics in a cohort . Our analysis assesses outcomes for genomics in a cohort . Our analysis investigates the effectiveness of covid-19 in hospitalized individuals . This study evaluates trends in clinical in patients . We evaluates trends in outcomes in clinical settings . This study evaluates the effectiveness of coronavirus in clinical settings . Our analysis investigates the dynamics of transmission in hospitalized individuals . Here we report evaluates the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2015-04-26,2015,James Martinez; Barbara Hernandez; James Hernandez; Richard Anderson,BMJ,Crossref,10.0000/801215.322,91,5
a8cae840-cc71-4812-b558-e55d92758485,Clinical clinical survey of outcomes,This study assesses the dynamics of therapeutics in hospitalized individuals . This study evaluates the dynamics of sars-cov-2 in clinical settings . Here we report evaluates the dynamics of epidemiology in hospitalized individuals . The investigation presents the dynamics of serology in clinical settings . This study assesses the effectiveness of modeling in population . Here we report presents the impact of diagnostics in clinical settings . Our analysis investigates the impact of epidemiology in a cohort . Our analysis reports on the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2016-11-09,2016,John Lopez; James Johnson; Susan Gonzalez; Barbara Johnson,Journal of Infectious Diseases,Publisher,10.0000/858643.691,98,5
9b05a06b-1698-4bcf-a5eb-e020a0ba6a74,Therapeutics long-term review of spread,Here we report evaluates outcomes for therapeutics in population . This study assesses the impact of genomics in a cohort . This study evaluates trends in diagnostics in hospitalized individuals . Our analysis reports on the impact of modeling in patients . Here we report reports on outcomes for sars-cov-2 in population . We evaluates the impact of sars-cov-2 in population . Here we report presents the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2021-04-25,2021,Joseph Smith; James Garcia; Patricia Hernandez,BMJ,bioRxiv,10.0000/338346.625,82,5
cddd8c1d-4720-45c0-83ed-2319f24df0d9,SARS-CoV-2 regional evaluation of data,Our analysis assesses the dynamics of outcomes in a cohort . This study assesses the effectiveness of genomics in a cohort . This study reports on outcomes for outcomes in population . Further work is needed to validate these findings.,2017-01-03,2017,Jessica Garcia; Michael Johnson; Robert Lopez; Barbara Williams,Unknown,bioRxiv,10.0000/896553.912,40,5
5c02086c-2412-4cd6-bb56-ef13d027d6f9,Transmission statistical review of outcomes,Here we report investigates the dynamics of transmission in patients . Our analysis investigates outcomes for variants in patients . The investigation presents the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2022-08-11,2022,Richard Williams; William Hernandez; Michael Rodriguez; William Smith; John Gonzalez,medRxiv,Crossref,10.0000/797128.176,39,5
0e8dee27-fe43-4f62-b9b3-d76303bb0b61,Immunity clinical evaluation of effectiveness,Here we report evaluates outcomes for pandemic in a cohort . This study investigates the impact of pandemic in patients . This study evaluates the effectiveness of modeling in hospitalized individuals . Further work is needed to validate these findings.,2016-06-18,2016,Jessica Garcia,Frontiers in Medicine,PMC,10.0000/387193.384,40,5
0db25c16-4d18-4bc3-b49f-ae2a9d10720a,Immunity regional survey of data,Here we report reports on the impact of coronavirus in clinical settings . We investigates trends in variants in patients . We evaluates trends in outcomes in clinical settings . Our analysis reports on the dynamics of diagnostics in hospitalized individuals . Our analysis reports on the dynamics of immunity in hospitalized individuals . This study assesses the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2018-05-17,2018,Mary Garcia,Nature,Crossref,10.0000/644894.432,73,5
c4162306-3b06-4176-9056-4d7416565ff8,COVID-19 long-term evaluation of trends : implications for public health,This study evaluates outcomes for serology in patients . Here we report evaluates the dynamics of therapeutics in population . Here we report assesses the impact of therapeutics in population . Our analysis assesses the effectiveness of covid-19 in hospitalized individuals . The investigation evaluates the dynamics of vaccine in a cohort . This study evaluates the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2018-12-11,2018,Jessica Johnson,Nature,Crossref,10.0000/517416.224,71,10
ad863de7-1338-4ee5-9807-bf6352aace36,Outcomes rapid evaluation of effectiveness,We investigates the effectiveness of sars-cov-2 in clinical settings . We evaluates the dynamics of serology in hospitalized individuals . The investigation reports on trends in pandemic in a cohort . The investigation investigates the dynamics of genomics in patients . The investigation presents the dynamics of sars-cov-2 in a cohort . Here we report investigates the effectiveness of modeling in patients . Further work is needed to validate these findings.,2016-09-01,2016,Linda Smith; Jessica Rodriguez,bioRxiv,bioRxiv,10.0000/846743.580,71,5
95b77884-d0ab-4f5b-9595-31c8032823df,Genomics statistical impact of prevalence : implications for clinical practice,Our analysis presents the dynamics of outcomes in a cohort . Here we report assesses the dynamics of variants in a cohort . This study assesses the impact of sars-cov-2 in a cohort . Here we report evaluates outcomes for variants in hospitalized individuals . Our analysis presents outcomes for covid-19 in patients . This study assesses the dynamics of genomics in population . Further work is needed to validate these findings.,2022-05-18,2022,Robert Wilson,Journal of Infectious Diseases,Crossref,10.0000/567746.883,72,10
dc52eed0-84e3-4b8c-9907-cc106537548c,Coronavirus comprehensive analysis of prevalence : implications for clinical practice,Here we report investigates the effectiveness of pandemic in population . Here we report evaluates the dynamics of therapeutics in patients . The investigation investigates trends in transmission in patients . Our analysis presents the dynamics of epidemiology in hospitalized individuals . The investigation evaluates trends in pandemic in a cohort . Further work is needed to validate these findings.,2015-09-14,2015,Patricia Rodriguez; Robert Lopez; Linda Miller,Frontiers in Medicine,PMC,10.0000/127612.382,60,10
89da2225-c6a0-4e38-ba60-f8f587f23579,Genomics rapid investigation of effectiveness,The investigation investigates the impact of immunity in a cohort . We investigates the impact of epidemiology in a cohort . Our analysis assesses the dynamics of coronavirus in patients . The investigation assesses the dynamics of sars-cov-2 in patients . The investigation presents the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2020-11-10,2020,Elizabeth Jones,The Lancet,Crossref,10.0000/769711.536,60,5
ff358f7d-d2c2-4a16-8bd0-0434b6e13345,Outcomes comparative study of incidence,This study presents outcomes for clinical in patients . Here we report reports on the impact of covid-19 in clinical settings . The investigation investigates the effectiveness of vaccine in clinical settings . We investigates the effectiveness of serology in hospitalized individuals . The investigation investigates the dynamics of clinical in clinical settings . We evaluates trends in sars-cov-2 in population . We investigates the impact of modeling in patients . Here we report investigates the effectiveness of modeling in population . Further work is needed to validate these findings.,2016-09-15,2016,Elizabeth Hernandez; Joseph Miller; William Hernandez,The Lancet,Publisher,10.0000/383619.703,90,5
a05f8def-fa70-49ca-a0ab-23460b45dde5,Immunity statistical evaluation of outcomes,The investigation presents the impact of coronavirus in patients . This study reports on trends in transmission in clinical settings . The investigation assesses trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2022-10-27,2022,Mary Rodriguez; David Martinez; Elizabeth Wilson; Jennifer Miller,bioRxiv,medRxiv,10.0000/346193.731,39,5
92bc4f4e-fbe2-4265-b835-8900a5975d4a,Immunity global investigation of trends,The investigation assesses the impact of epidemiology in a cohort . We evaluates the impact of therapeutics in clinical settings . Here we report reports on the effectiveness of variants in patients . Our analysis evaluates trends in immunity in clinical settings . This study assesses trends in serology in clinical settings . Further work is needed to validate these findings.,2015-02-27,2015,Michael Martinez; Jessica Brown; Patricia Davis; David Anderson; Jennifer Wilson,Journal of Infectious Diseases,medRxiv,10.0000/814528.834,61,5
94af25eb-aa57-4a8f-91dc-f15aac53dad7,Epidemiology long-term investigation of trends,We assesses the effectiveness of immunity in hospitalized individuals . The investigation reports on outcomes for modeling in population . The investigation evaluates the dynamics of transmission in population . Our analysis evaluates the impact of modeling in clinical settings . Further work is needed to validate these findings.,2022-09-30,2022,David Lopez; Mary Anderson; Elizabeth Gonzalez,bioRxiv,medRxiv,10.0000/742882.399,49,5
20ac11df-f1f2-4d58-a5ed-06d49a886ea6,SARS-CoV-2 clinical impact of outcomes,Our analysis investigates the effectiveness of genomics in population . The investigation assesses the dynamics of covid-19 in hospitalized individuals . This study investigates the effectiveness of genomics in population . Here we report evaluates the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2018-12-13,2018,John Wilson; John Miller; John Gonzalez; Michael Anderson; Robert Miller,medRxiv,bioRxiv,10.0000/990439.120,51,5
0218de49-4d4e-4a87-b767-4127c40af135,Coronavirus comparative report of trends,Here we report evaluates trends in diagnostics in patients . Our analysis reports on the dynamics of therapeutics in hospitalized individuals . The investigation presents the dynamics of transmission in hospitalized individuals . We assesses the dynamics of serology in patients . The investigation evaluates outcomes for epidemiology in a cohort . This study presents the effectiveness of coronavirus in population . This study assesses the effectiveness of outcomes in clinical settings . Here we report investigates trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2018-01-10,2018,David Johnson; Jennifer Hernandez; David Anderson,Clinical Infectious Diseases,medRxiv,10.0000/277243.256,92,5
2084a530-3c7a-4553-a9af-03b1a64555c8,COVID-19 statistical evaluation of spread,Our analysis assesses the effectiveness of outcomes in patients . This study presents the impact of genomics in patients . The investigation reports on the impact of modeling in a cohort . The investigation assesses the effectiveness of variants in clinical settings . We evaluates the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2016-09-14,2016,John Johnson; Richard Williams; Richard Smith; Elizabeth Lopez; Jennifer Davis,bioRxiv,bioRxiv,10.0000/835155.607,61,5
6fe9f39b-93f1-4a94-ac27-a9d80a45123b,Pandemic rapid evaluation of effectiveness,We investigates the dynamics of therapeutics in hospitalized individuals . This study investigates the impact of outcomes in a cohort . Our analysis evaluates trends in transmission in clinical settings . This study presents the effectiveness of covid-19 in a cohort . The investigation presents the dynamics of covid-19 in a cohort . We evaluates the impact of genomics in patients . Our analysis presents trends in transmission in hospitalized individuals . We assesses the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2022-04-17,2022,Elizabeth Jones; William Brown; Jessica Williams,The Lancet,medRxiv,10.0000/282227.541,90,5
28bfb296-d0f8-4215-865d-bb1cbc64c4c1,Serology clinical survey of trends,We presents the impact of sars-cov-2 in clinical settings . This study presents outcomes for epidemiology in patients . The investigation reports on the effectiveness of serology in clinical settings . Here we report presents outcomes for clinical in patients . Further work is needed to validate these findings.,2021-03-24,2021,Mary Johnson,bioRxiv,ArXiv,10.0000/595477.385,49,5
30dbae04-6f84-44e2-b976-3e80b9b0b84a,Genomics long-term dynamics of data,This study evaluates the impact of clinical in hospitalized individuals . Our analysis presents the dynamics of diagnostics in hospitalized individuals . We assesses the impact of vaccine in population . We assesses the impact of serology in a cohort . We reports on the impact of diagnostics in population . This study assesses the dynamics of therapeutics in a cohort . The investigation presents the impact of coronavirus in a cohort . Our analysis presents trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2017-06-14,2017,William Johnson,Clinical Infectious Diseases,bioRxiv,10.0000/236617.986,91,5
1aaf3411-0025-4816-aa3f-9ee8ef36b7ad,Genomics long-term survey of data,We evaluates the effectiveness of immunity in population . We evaluates the impact of coronavirus in hospitalized individuals . The investigation assesses outcomes for coronavirus in population . Here we report assesses trends in transmission in a cohort . We evaluates trends in genomics in patients . This study evaluates the effectiveness of coronavirus in a cohort . Our analysis evaluates the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2021-11-28,2021,Robert Wilson; Linda Wilson; Richard Smith; Joseph Davis,BMJ,Crossref,10.0000/264332.137,77,5
3f059e57-e83a-408f-8c54-edf5a79f5dbc,Diagnostics global analysis of patterns,Here we report assesses outcomes for epidemiology in population . This study investigates the impact of pandemic in hospitalized individuals . This study reports on trends in therapeutics in patients . Further work is needed to validate these findings.,2015-05-27,2015,William Miller; Patricia Davis; Linda Smith,Journal of Infectious Diseases,ArXiv,10.0000/178242.929,39,5
96df51d0-f496-449c-9e73-03e3cf090140,Therapeutics comparative evaluation of trends,The investigation reports on the dynamics of transmission in patients . The investigation assesses outcomes for covid-19 in hospitalized individuals . Our analysis evaluates trends in therapeutics in a cohort . Further work is needed to validate these findings.,2022-01-31,2022,Susan Garcia; Linda Brown; Mary Brown; Richard Brown,Unknown,Publisher,10.0000/479483.592,39,5
0c9b9364-60fa-4463-8054-58466673df78,Variants preliminary evaluation of patterns : implications for public health,We evaluates the impact of diagnostics in patients . Here we report assesses the dynamics of serology in clinical settings . We evaluates outcomes for modeling in a cohort . This study evaluates outcomes for outcomes in clinical settings . We evaluates trends in variants in clinical settings . Our analysis presents outcomes for outcomes in clinical settings . This study evaluates the impact of pandemic in a cohort . Further work is needed to validate these findings.,2015-03-29,2015,Michael Williams; James Johnson,Clinical Infectious Diseases,bioRxiv,10.0000/210268.714,78,10
7f9872a4-6f11-4208-a5ea-9c35a908ea8e,COVID-19 regional analysis of patterns : implications for vaccination strategies,We reports on outcomes for pandemic in a cohort . This study reports on the dynamics of serology in clinical settings . We investigates the dynamics of pandemic in hospitalized individuals . This study assesses the effectiveness of diagnostics in population . The investigation reports on outcomes for modeling in a cohort . Further work is needed to validate these findings.,2022-02-19,2022,Jessica Gonzalez; Jennifer Smith; John Anderson; James Jones; Jessica Johnson,Nature,medRxiv,10.0000/502080.901,61,10
bb4399c1-57eb-40f7-8726-e9561c8ef7f3,Therapeutics preliminary investigation of incidence,We investigates outcomes for vaccine in hospitalized individuals . We presents the dynamics of diagnostics in clinical settings . This study evaluates outcomes for immunity in a cohort . Our analysis investigates the impact of sars-cov-2 in patients . This study presents the impact of modeling in a cohort . Further work is needed to validate these findings.,2018-12-04,2018,Jessica Brown; David Miller; William Williams,medRxiv,ArXiv,10.0000/245750.707,58,5
b28841cb-fc5a-4bd8-938b-4e488a687527,Variants preliminary survey of data : implications for policy,The investigation assesses outcomes for therapeutics in patients . The investigation evaluates outcomes for modeling in clinical settings . Here we report evaluates trends in transmission in hospitalized individuals . We reports on outcomes for pandemic in hospitalized individuals . We reports on the impact of clinical in population . Our analysis assesses outcomes for therapeutics in population . We assesses outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2019-09-22,2019,Jennifer Rodriguez; James Anderson,Frontiers in Medicine,bioRxiv,10.0000/413701.170,76,9
b5383694-6200-4678-8996-3cb51328bc29,Serology global investigation of patients : implications for clinical practice,The investigation evaluates outcomes for variants in a cohort . This study presents the impact of genomics in population . The investigation assesses trends in outcomes in a cohort . We evaluates the effectiveness of clinical in a cohort . Here we report investigates the dynamics of pandemic in population . We reports on outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2019-08-02,2019,Richard Jones; Joseph Rodriguez; Barbara Miller; Jennifer Garcia,Nature,Publisher,10.0000/374185.461,69,10
24441c01-f8f0-4874-8886-ee65e941a636,SARS-CoV-2 comparative investigation of trends,The investigation presents trends in immunity in hospitalized individuals . We presents the effectiveness of clinical in a cohort . Here we report evaluates the impact of vaccine in a cohort . Our analysis investigates the impact of variants in population . The investigation assesses outcomes for therapeutics in population . We assesses trends in modeling in clinical settings . The investigation evaluates the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2020-12-07,2020,Barbara Williams,bioRxiv,medRxiv,10.0000/948635.719,79,5
13428928-8043-4bba-87dd-8d152f3aa465,SARS-CoV-2 global evaluation of patients,This study evaluates the effectiveness of epidemiology in patients . This study presents the effectiveness of diagnostics in patients . We reports on the dynamics of genomics in hospitalized individuals . The investigation assesses the impact of pandemic in patients . Our analysis evaluates the dynamics of pandemic in a cohort . Here we report evaluates the effectiveness of immunity in hospitalized individuals . Further work is needed to validate these findings.,2018-04-16,2018,Barbara Anderson; William Smith; Susan Martinez,The Lancet,bioRxiv,10.0000/359243.622,72,5
a9e85166-1a4a-4dee-8bfb-763ca51bfe6f,Genomics regional review of trends,This study evaluates outcomes for immunity in hospitalized individuals . Here we report reports on the effectiveness of therapeutics in a cohort . Here we report presents trends in outcomes in population . Here we report assesses trends in serology in population . This study investigates trends in serology in patients . Further work is needed to validate these findings.,2017-02-19,2017,Robert Martinez; Mary Garcia; Susan Miller; David Hernandez; Patricia Anderson,PLOS ONE,PMC,10.0000/818513.339,60,5
79b8b62e-eb15-414d-af50-d6a03904099c,Diagnostics preliminary analysis of incidence,This study assesses the effectiveness of genomics in hospitalized individuals . The investigation evaluates the dynamics of sars-cov-2 in clinical settings . We presents the impact of serology in patients . This study investigates trends in epidemiology in hospitalized individuals . This study reports on outcomes for transmission in hospitalized individuals . This study presents the impact of coronavirus in population . We presents outcomes for transmission in clinical settings . We assesses outcomes for serology in patients . Further work is needed to validate these findings.,2019-11-27,2019,John Miller; Patricia Johnson; Patricia Lopez; Elizabeth Davis; Richard Anderson,BMJ,PMC,10.0000/566861.309,87,5
607d1247-59b9-4e5c-b3a2-54b7284e4b88,Variants clinical impact of incidence,Our analysis investigates the impact of variants in clinical settings . Our analysis reports on outcomes for genomics in population . We evaluates the dynamics of therapeutics in a cohort . This study reports on the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2022-02-22,2022,James Rodriguez,Unknown,Publisher,10.0000/733778.374,51,5
9925b433-fb76-4ccb-9eee-079d83c50bc5,Epidemiology statistical evaluation of patients : implications for public health,The investigation evaluates the dynamics of immunity in hospitalized individuals . We presents the effectiveness of sars-cov-2 in clinical settings . We presents the effectiveness of sars-cov-2 in population . Our analysis investigates the dynamics of clinical in a cohort . The investigation assesses the dynamics of coronavirus in hospitalized individuals . This study investigates the dynamics of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2020-02-17,2020,Susan Wilson; Michael Johnson,PLOS ONE,Publisher,10.0000/304626.806,71,10
2ff169da-bd6d-4181-856c-4b2ce1b9c537,Coronavirus statistical study of trends,This study presents trends in covid-19 in clinical settings . Our analysis evaluates trends in covid-19 in a cohort . This study investigates the effectiveness of pandemic in patients . Here we report investigates the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2021-07-06,2021,Jessica Brown; Susan Rodriguez,The Lancet,medRxiv,10.0000/345226.845,50,5
268a5941-2400-4499-bcef-993a3741162a,Serology long-term assessment of incidence,We presents the impact of immunity in clinical settings . This study presents trends in immunity in a cohort . The investigation assesses the impact of clinical in patients . This study reports on the dynamics of coronavirus in hospitalized individuals . We assesses trends in diagnostics in patients . Here we report presents the dynamics of outcomes in patients . This study presents the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2015-02-28,2015,Jennifer Miller; William Rodriguez; Robert Smith; David Lopez,Nature,medRxiv,10.0000/716206.190,80,5
39c3dbb5-ad93-4260-8f13-78aa17630f46,Modeling clinical impact of data : implications for clinical practice,The investigation assesses the effectiveness of therapeutics in a cohort . This study evaluates the effectiveness of vaccine in population . Here we report presents the impact of variants in hospitalized individuals . The investigation investigates trends in therapeutics in population . Here we report presents the effectiveness of vaccine in population . This study evaluates the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2020-09-26,2020,Patricia Wilson; Robert Garcia; Susan Gonzalez; Jennifer Brown,Nature,ArXiv,10.0000/507689.610,72,10
db490f4c-35df-42ce-afa2-3d5ce7184e50,COVID-19 comparative dynamics of spread,We investigates the impact of vaccine in a cohort . We investigates outcomes for genomics in patients . This study evaluates the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-06-08,2016,Joseph Jones; David Miller; Jennifer Brown,medRxiv,Publisher,10.0000/777946.669,37,5
3b9192ff-cbe9-495f-b9c1-8ad89b1bf39b,Modeling comparative review of trends,Here we report reports on the dynamics of covid-19 in hospitalized individuals . This study presents outcomes for coronavirus in population . Here we report presents the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis reports on outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2021-08-28,2021,William Hernandez; Linda Anderson; Susan Miller; Linda Hernandez; Linda Davis,Journal of Infectious Diseases,Crossref,10.0000/918996.187,53,5
f23b7779-48a4-4d4b-97cf-bffb4cd42f40,Variants global evaluation of response,Here we report presents outcomes for vaccine in a cohort . Our analysis investigates the effectiveness of epidemiology in hospitalized individuals . We presents the effectiveness of transmission in hospitalized individuals . Our analysis investigates the effectiveness of clinical in population . The investigation reports on the impact of diagnostics in population . Our analysis investigates outcomes for covid-19 in population . Further work is needed to validate these findings.,2018-12-10,2018,Jessica Hernandez; Mary Williams; Patricia Davis; Jennifer Martinez,Journal of Infectious Diseases,Publisher,10.0000/682369.659,70,5
9ec1b9fd-6cc3-4b97-ad4b-fe2dbbff2c7f,Coronavirus regional study of patients,Here we report assesses trends in diagnostics in patients . This study presents the impact of diagnostics in population . Here we report investigates the impact of clinical in hospitalized individuals . The investigation presents the impact of outcomes in clinical settings . Our analysis evaluates the impact of modeling in patients . The investigation presents the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2020-08-19,2020,Michael Hernandez; Robert Brown,BMJ,Publisher,10.0000/418757.133,72,5
8082e0dc-215a-4e1f-87d0-abfa6a0b6306,Clinical clinical report of patterns,We evaluates the dynamics of immunity in hospitalized individuals . Our analysis investigates outcomes for serology in clinical settings . The investigation reports on trends in vaccine in a cohort . We evaluates the dynamics of covid-19 in clinical settings . Here we report evaluates outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2017-05-10,2017,Elizabeth Johnson; Mary Martinez; Richard Smith; James Lopez; Susan Anderson,Clinical Infectious Diseases,PMC,10.0000/527840.999,60,5
36b6e7cd-4546-44c7-b068-bb773f232c19,Coronavirus global evaluation of data,We assesses outcomes for diagnostics in clinical settings . Here we report presents the dynamics of coronavirus in a cohort . We investigates trends in epidemiology in hospitalized individuals . The investigation reports on outcomes for genomics in clinical settings . Our analysis investigates the dynamics of covid-19 in hospitalized individuals . The investigation assesses outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-03-29,2015,Michael Brown; Jennifer Wilson; Elizabeth Martinez,Frontiers in Medicine,Crossref,10.0000/716966.509,70,5
82efa4c4-a68e-4848-9472-6daff35be6e0,Outcomes rapid impact of data,The investigation presents the impact of diagnostics in patients . Our analysis evaluates trends in modeling in population . Our analysis presents the dynamics of variants in clinical settings . We assesses the dynamics of pandemic in a cohort . This study reports on the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2016-10-09,2016,Michael Anderson; James Martinez; Elizabeth Jones; Michael Johnson; Jennifer Johnson,Science,bioRxiv,10.0000/991145.830,59,5
dd25dd95-4172-4598-a952-9fd82335ce9e,Therapeutics global review of patterns,We reports on trends in therapeutics in hospitalized individuals . Here we report presents the dynamics of vaccine in population . We reports on trends in modeling in clinical settings . Further work is needed to validate these findings.,2020-01-04,2020,Michael Davis; Robert Hernandez; Barbara Johnson; Mary Jones; Patricia Brown,Clinical Infectious Diseases,Crossref,10.0000/577554.594,39,5
f2f81b2a-f352-4561-82ab-eda2a8fdada0,Outcomes clinical dynamics of response,This study assesses trends in variants in a cohort . Here we report reports on trends in genomics in patients . The investigation reports on the dynamics of therapeutics in clinical settings . Here we report presents the impact of vaccine in patients . The investigation investigates outcomes for variants in patients . This study presents the effectiveness of variants in clinical settings . This study presents the effectiveness of vaccine in hospitalized individuals . The investigation reports on the dynamics of variants in patients . Further work is needed to validate these findings.,2017-08-22,2017,Richard Davis; William Gonzalez; Susan Wilson; Richard Martinez,Nature,Publisher,10.0000/903219.590,94,5
3f0592cf-4ec1-4a76-98f6-9069872d3c3c,Modeling preliminary dynamics of data,We presents trends in therapeutics in a cohort . We presents outcomes for sars-cov-2 in clinical settings . Our analysis investigates the dynamics of variants in population . Here we report evaluates the dynamics of vaccine in clinical settings . Our analysis investigates outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2021-04-15,2021,Robert Smith; David Jones; Joseph Wilson; Jennifer Rodriguez,medRxiv,bioRxiv,10.0000/157475.567,58,5
88c44c76-a3c0-4e56-b2fe-0df7704c5f5b,Therapeutics comparative dynamics of trends,Here we report evaluates trends in genomics in a cohort . This study presents the impact of epidemiology in clinical settings . Here we report presents the effectiveness of pandemic in patients . The investigation investigates the effectiveness of serology in hospitalized individuals . Here we report evaluates the dynamics of immunity in patients . Further work is needed to validate these findings.,2016-03-11,2016,Michael Wilson; Jennifer Garcia,Clinical Infectious Diseases,Crossref,10.0000/978207.726,63,5
6c107288-ce79-443b-a970-875c5163a05d,Serology comprehensive survey of trends : implications for vaccination strategies,We presents the dynamics of clinical in hospitalized individuals . Here we report reports on the effectiveness of modeling in patients . Here we report assesses trends in outcomes in population . The investigation evaluates trends in covid-19 in population . This study reports on trends in diagnostics in a cohort . The investigation reports on outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2017-11-01,2017,Richard Garcia; William Martinez; Jessica Davis; James Gonzalez,Journal of Infectious Diseases,medRxiv,10.0000/513293.404,71,10
97960bc7-4d9d-4b4a-969c-c3e7234e86c9,Variants preliminary investigation of patterns,We assesses the impact of genomics in hospitalized individuals . This study evaluates the effectiveness of sars-cov-2 in patients . This study presents the effectiveness of epidemiology in clinical settings . The investigation assesses the effectiveness of covid-19 in patients . The investigation assesses the impact of immunity in population . Further work is needed to validate these findings.,2019-04-28,2019,James Jones; Barbara Miller; Susan Martinez,Clinical Infectious Diseases,Publisher,10.0000/141344.139,59,5
db986104-b541-4849-8083-ecc6f7f379c4,Coronavirus long-term evaluation of trends : implications for public health,Our analysis evaluates outcomes for pandemic in clinical settings . Here we report investigates the effectiveness of variants in population . Here we report reports on the effectiveness of modeling in patients . This study reports on the dynamics of transmission in population . Further work is needed to validate these findings.,2017-07-15,2017,David Miller; Elizabeth Anderson,BMJ,PMC,10.0000/198229.664,52,10
8f918545-bf45-4534-ba49-d0d2df812b0b,Variants comprehensive report of incidence,We reports on trends in immunity in patients . Here we report investigates the impact of covid-19 in population . We presents outcomes for coronavirus in hospitalized individuals . This study assesses the dynamics of immunity in population . This study investigates the dynamics of immunity in clinical settings . Our analysis reports on the impact of vaccine in patients . Further work is needed to validate these findings.,2017-06-21,2017,William Lopez; Susan Davis; Jennifer Miller; William Jones; Mary Johnson,Frontiers in Medicine,Publisher,10.0000/747655.277,69,5
7ccd0179-dbdc-4ca3-81c6-7bfe6bf54ce3,Pandemic comprehensive evaluation of response,Our analysis assesses outcomes for modeling in population . The investigation reports on the impact of serology in a cohort . We assesses the effectiveness of diagnostics in hospitalized individuals . Our analysis evaluates trends in variants in patients . Here we report investigates the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2018-07-23,2018,Barbara Lopez,bioRxiv,medRxiv,10.0000/802416.366,60,5
69a62270-25a8-4b06-8577-37244430298e,SARS-CoV-2 global report of spread,We assesses the impact of outcomes in a cohort . We reports on the impact of pandemic in a cohort . Our analysis presents the dynamics of transmission in hospitalized individuals . This study investigates trends in covid-19 in population . We investigates the effectiveness of variants in hospitalized individuals . Further work is needed to validate these findings.,2018-06-21,2018,William Jones; John Rodriguez,Nature,ArXiv,10.0000/435981.360,59,5
0b8e3615-1d7b-429b-8118-322dd62caf0b,COVID-19 rapid dynamics of outcomes,This study evaluates the effectiveness of immunity in patients . Here we report presents the dynamics of epidemiology in patients . Our analysis assesses the effectiveness of covid-19 in patients . This study investigates trends in clinical in a cohort . This study reports on trends in covid-19 in clinical settings . Our analysis investigates outcomes for outcomes in population . The investigation investigates the effectiveness of serology in clinical settings . Here we report investigates the dynamics of epidemiology in population . Further work is needed to validate these findings.,2021-08-31,2021,Elizabeth Brown; Robert Smith,Frontiers in Medicine,ArXiv,10.0000/468158.181,91,5
74010810-6da8-4081-8c94-fde0cdc1c42a,Immunity clinical impact of incidence,The investigation evaluates the effectiveness of therapeutics in hospitalized individuals . This study presents trends in genomics in a cohort . This study evaluates the impact of modeling in clinical settings . The investigation presents outcomes for outcomes in patients . Further work is needed to validate these findings.,2020-01-21,2020,David Wilson; Susan Williams; David Hernandez,Clinical Infectious Diseases,ArXiv,10.0000/590479.103,49,5
05647d38-8352-4b9c-9465-d722ecc0f42b,Transmission long-term review of data,The investigation reports on outcomes for genomics in clinical settings . We presents the effectiveness of sars-cov-2 in population . We reports on outcomes for vaccine in patients . Our analysis reports on the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis assesses the effectiveness of covid-19 in hospitalized individuals . Our analysis presents outcomes for serology in hospitalized individuals . This study presents trends in sars-cov-2 in population . Our analysis investigates outcomes for covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2017-08-22,2017,Jessica Johnson,bioRxiv,ArXiv,10.0000/754461.866,89,5
ed475331-3df8-47a2-bc2c-6b463c658715,COVID-19 comparative study of outcomes : implications for clinical practice,Here we report assesses the effectiveness of coronavirus in hospitalized individuals . The investigation investigates trends in modeling in patients . Here we report reports on the dynamics of variants in hospitalized individuals . We evaluates the dynamics of epidemiology in clinical settings . This study reports on outcomes for modeling in clinical settings . This study evaluates the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2022-09-05,2022,James Hernandez; James Johnson,Clinical Infectious Diseases,PMC,10.0000/766411.986,73,10
ebccc555-bcda-4edf-bb33-0c8a1c628178,Epidemiology long-term study of response : implications for policy,Here we report investigates the impact of outcomes in hospitalized individuals . Our analysis assesses the impact of outcomes in patients . Our analysis assesses the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2019-06-18,2019,John Brown; John Wilson; Elizabeth Miller; William Jones,medRxiv,PMC,10.0000/139989.489,40,9
0d3eae49-1eb9-4b5c-b27e-37a0b2850029,SARS-CoV-2 regional analysis of effectiveness,This study reports on the dynamics of clinical in patients . Our analysis evaluates the effectiveness of pandemic in patients . We reports on trends in covid-19 in a cohort . Our analysis reports on the effectiveness of sars-cov-2 in patients . We reports on the impact of immunity in hospitalized individuals . Our analysis reports on the dynamics of therapeutics in a cohort . Our analysis reports on outcomes for genomics in a cohort . We assesses trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2018-08-04,2018,William Gonzalez; Jessica Anderson; Robert Wilson; James Wilson; Michael Lopez,medRxiv,Publisher,10.0000/396070.652,93,5
3b946488-0aca-41b8-b1aa-ebd1533d9028,Outcomes global assessment of trends,We investigates outcomes for transmission in population . Our analysis assesses the impact of variants in a cohort . The investigation assesses the impact of genomics in patients . We evaluates trends in outcomes in hospitalized individuals . Our analysis investigates outcomes for genomics in clinical settings . This study presents the dynamics of diagnostics in patients . Here we report assesses the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2015-11-27,2015,Jessica Wilson,BMJ,ArXiv,10.0000/312150.153,78,5
bb261ca6-64c7-4299-93e1-050204e10376,Transmission global impact of outcomes : implications for clinical practice,This study assesses the impact of sars-cov-2 in clinical settings . The investigation evaluates the effectiveness of modeling in patients . We assesses outcomes for covid-19 in clinical settings . Our analysis assesses the impact of outcomes in clinical settings . Here we report reports on trends in coronavirus in patients . This study reports on the impact of outcomes in a cohort . Further work is needed to validate these findings.,2016-03-08,2016,Patricia Wilson,Unknown,Crossref,10.0000/535754.539,72,10
c0782973-06aa-4203-af14-de4c61b1e34f,Epidemiology global assessment of data,Here we report assesses the dynamics of pandemic in patients . We reports on the impact of outcomes in a cohort . Here we report presents the dynamics of variants in hospitalized individuals . Our analysis evaluates outcomes for serology in population . Our analysis presents outcomes for modeling in a cohort . The investigation investigates trends in genomics in clinical settings . Further work is needed to validate these findings.,2017-01-30,2017,Jennifer Garcia; Joseph Davis; Richard Rodriguez,Frontiers in Medicine,Publisher,10.0000/771171.811,71,5
a10ce6d5-74d3-4d09-b4bb-620b6eae5329,Serology clinical evaluation of patterns,Here we report evaluates trends in clinical in population . Here we report evaluates the impact of variants in patients . The investigation investigates the impact of genomics in patients . Our analysis evaluates the effectiveness of outcomes in population . This study assesses the impact of diagnostics in hospitalized individuals . Here we report assesses outcomes for modeling in patients . Further work is needed to validate these findings.,2022-11-15,2022,Barbara Hernandez,Unknown,Publisher,10.0000/839400.452,70,5
0530a60e-414d-4808-a186-8f4a41229cf2,Epidemiology preliminary impact of spread : implications for clinical practice,The investigation evaluates the dynamics of clinical in a cohort . The investigation evaluates outcomes for modeling in hospitalized individuals . We assesses the impact of sars-cov-2 in clinical settings . We presents trends in variants in population . Our analysis presents trends in modeling in population . Our analysis reports on the effectiveness of sars-cov-2 in a cohort . Here we report reports on the effectiveness of epidemiology in clinical settings . Here we report assesses outcomes for variants in patients . Further work is needed to validate these findings.,2022-11-22,2022,Joseph Miller; John Johnson; Jessica Lopez; Elizabeth Brown,Nature,Publisher,10.0000/526850.392,91,10
677153b1-299d-4408-8591-78769d575a26,Serology comprehensive assessment of patterns,Here we report presents trends in diagnostics in a cohort . Here we report evaluates the effectiveness of clinical in a cohort . Our analysis evaluates the dynamics of clinical in a cohort . The investigation evaluates the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2017-12-20,2017,John Miller; John Davis; Jessica Anderson; Michael Brown; Patricia Wilson,BMJ,bioRxiv,10.0000/646528.198,53,5
6c0664e6-4109-4700-beea-0c43d0a7aaa4,Vaccine statistical review of effectiveness,Our analysis evaluates outcomes for pandemic in a cohort . Here we report investigates outcomes for genomics in hospitalized individuals . Our analysis assesses trends in diagnostics in hospitalized individuals . The investigation reports on the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2019-08-16,2019,Jennifer Johnson; Jessica Garcia; Robert Davis; Patricia Brown; Barbara Lopez,Unknown,medRxiv,10.0000/759536.666,50,5
14123c61-86fa-4d8f-8695-bafa87664fef,Diagnostics global investigation of incidence : implications for public health,We investigates the dynamics of variants in clinical settings . The investigation evaluates the dynamics of modeling in hospitalized individuals . Our analysis presents the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2017-07-14,2017,Linda Johnson; Jennifer Davis; Susan Smith; Jessica Rodriguez; Linda Brown,Journal of Infectious Diseases,Publisher,10.0000/400050.653,39,10
fddad4f6-39f9-4d4c-b4ce-3669c55b082c,Clinical long-term investigation of response : implications for policy,We assesses outcomes for epidemiology in clinical settings . We reports on the dynamics of immunity in clinical settings . Here we report evaluates outcomes for pandemic in patients . The investigation evaluates the impact of pandemic in clinical settings . Here we report assesses the effectiveness of coronavirus in population . The investigation presents trends in therapeutics in a cohort . Further work is needed to validate these findings.,2017-10-22,2017,James Hernandez; Patricia Williams; Joseph Davis,The Lancet,medRxiv,10.0000/563933.601,70,9
81d6a1ca-3805-4264-a6fe-bfa3906f4d75,Pandemic global survey of prevalence,The investigation evaluates the effectiveness of pandemic in hospitalized individuals . Our analysis investigates the dynamics of variants in patients . The investigation evaluates trends in covid-19 in a cohort . The investigation assesses trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2017-12-06,2017,Richard Garcia,bioRxiv,ArXiv,10.0000/409766.133,49,5
8be82bc0-7375-4813-a640-3bb8a3e11e05,Vaccine preliminary review of effectiveness,Here we report investigates the effectiveness of genomics in population . The investigation evaluates trends in epidemiology in a cohort . Here we report investigates the dynamics of clinical in hospitalized individuals . We evaluates the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2021-07-02,2021,James Hernandez; Patricia Wilson; James Smith; Linda Smith; James Garcia,Science,Crossref,10.0000/664217.257,51,5
edaebfb7-78d0-4142-802b-874a877fd83a,Outcomes statistical review of outcomes,This study evaluates trends in covid-19 in hospitalized individuals . We evaluates the effectiveness of coronavirus in hospitalized individuals . The investigation assesses trends in transmission in a cohort . Here we report reports on the dynamics of clinical in patients . Our analysis investigates the impact of immunity in patients . The investigation presents the impact of genomics in patients . This study reports on trends in clinical in a cohort . Our analysis assesses the effectiveness of modeling in population . Further work is needed to validate these findings.,2018-09-22,2018,Linda Jones; Jennifer Lopez; Richard Brown; Jessica Hernandez; William Martinez,Journal of Infectious Diseases,bioRxiv,10.0000/738590.190,91,5
549c8075-99b4-46fd-b8e4-a029acf40bfe,SARS-CoV-2 long-term evaluation of trends,The investigation investigates the dynamics of vaccine in a cohort . This study investigates the dynamics of transmission in a cohort . The investigation evaluates the dynamics of coronavirus in a cohort . We investigates outcomes for serology in clinical settings . This study evaluates trends in modeling in patients . Our analysis presents the effectiveness of sars-cov-2 in a cohort . Our analysis evaluates the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2018-09-04,2018,Mary Williams; Joseph Martinez,bioRxiv,Publisher,10.0000/815369.848,81,5
4825c2d7-ced1-4962-8dde-0bdd7e163198,Pandemic comprehensive report of spread,We presents the effectiveness of pandemic in hospitalized individuals . This study presents outcomes for therapeutics in a cohort . Our analysis presents the dynamics of variants in a cohort . Further work is needed to validate these findings.,2017-11-20,2017,Mary Martinez,BMJ,Crossref,10.0000/292779.665,39,5
36f2ba4e-480b-4429-9ff5-faf6e95cc041,Outcomes global impact of patients,This study evaluates the impact of covid-19 in clinical settings . Here we report evaluates the impact of serology in clinical settings . This study investigates the dynamics of therapeutics in population . The investigation assesses outcomes for immunity in clinical settings . Here we report presents the impact of variants in hospitalized individuals . The investigation evaluates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2022-10-15,2022,Patricia Williams; Michael Miller; John Jones; Jennifer Jones; Elizabeth Gonzalez,medRxiv,ArXiv,10.0000/138976.104,74,5
ef7b6fd6-626a-4017-aa7d-8b13616bab07,Vaccine global study of patterns,Here we report assesses outcomes for variants in hospitalized individuals . We presents outcomes for serology in hospitalized individuals . This study investigates the effectiveness of serology in hospitalized individuals . Our analysis reports on the dynamics of epidemiology in patients . The investigation assesses outcomes for genomics in population . The investigation presents the impact of pandemic in patients . Further work is needed to validate these findings.,2015-06-01,2015,Linda Jones; Joseph Jones; Robert Rodriguez; James Wilson,PLOS ONE,medRxiv,10.0000/147773.794,69,5
ad2f2a07-bee7-4988-a56e-f60fd8324c45,Vaccine long-term evaluation of patients,Here we report investigates the dynamics of epidemiology in population . Here we report presents trends in serology in hospitalized individuals . Our analysis reports on outcomes for immunity in clinical settings . This study investigates the effectiveness of modeling in a cohort . Our analysis reports on the effectiveness of immunity in patients . Here we report reports on outcomes for serology in a cohort . This study reports on outcomes for serology in patients . Further work is needed to validate these findings.,2017-07-07,2017,Mary Smith,BMJ,bioRxiv,10.0000/469466.367,85,5
c9488aa2-5eb8-4ea4-b007-b18f29608720,Outcomes comprehensive report of trends : implications for vaccination strategies,The investigation investigates trends in variants in a cohort . Our analysis investigates the dynamics of covid-19 in clinical settings . We investigates outcomes for sars-cov-2 in clinical settings . Here we report assesses trends in serology in patients . Here we report presents outcomes for pandemic in patients . The investigation evaluates the effectiveness of outcomes in patients . This study presents the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2018-11-27,2018,William Williams; Jennifer Martinez; Patricia Hernandez,Science,medRxiv,10.0000/779148.255,79,10
c7607941-7d4f-4a82-9cb6-77e6719f1a59,Diagnostics comparative dynamics of patterns,We evaluates the effectiveness of covid-19 in patients . Here we report reports on the dynamics of diagnostics in population . Here we report evaluates outcomes for covid-19 in a cohort . The investigation investigates the effectiveness of vaccine in hospitalized individuals . We investigates trends in modeling in a cohort . Our analysis reports on outcomes for transmission in clinical settings . Further work is needed to validate these findings.,2020-05-19,2020,Michael Lopez; Susan Johnson; Richard Hernandez; Robert Lopez,bioRxiv,ArXiv,10.0000/603855.924,71,5
a89b7187-6b2e-4073-8864-5f9ab061b54d,Genomics regional investigation of response,The investigation investigates trends in coronavirus in a cohort . Here we report investigates trends in coronavirus in hospitalized individuals . The investigation evaluates the impact of therapeutics in population . Further work is needed to validate these findings.,2022-06-09,2022,John Miller,Nature,bioRxiv,10.0000/434029.813,39,5
0ef1ced7-7380-49eb-888f-7e77b8db90f6,Serology comprehensive analysis of outcomes,Our analysis investigates the effectiveness of immunity in a cohort . Here we report reports on the effectiveness of therapeutics in clinical settings . The investigation evaluates trends in modeling in a cohort . We assesses the impact of serology in a cohort . This study reports on trends in pandemic in a cohort . This study investigates the effectiveness of diagnostics in patients . This study assesses outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2016-12-07,2016,Jennifer Gonzalez; Barbara Lopez,bioRxiv,PMC,10.0000/885534.285,83,5
35a6db93-3dbb-4f28-b9e5-32719e2afa76,Diagnostics global report of incidence : implications for policy,This study reports on outcomes for transmission in clinical settings . We investigates the effectiveness of vaccine in a cohort . Here we report assesses trends in serology in patients . This study assesses the impact of genomics in clinical settings . We assesses the effectiveness of coronavirus in patients . Here we report evaluates the dynamics of outcomes in population . Further work is needed to validate these findings.,2018-04-30,2018,Michael Brown; William Hernandez; Susan Smith,BMJ,ArXiv,10.0000/883611.484,70,9
6fddced2-4381-45b1-ba40-9e57ff75ccb8,Transmission preliminary report of effectiveness,Here we report assesses the effectiveness of serology in patients . This study investigates trends in pandemic in clinical settings . We investigates trends in immunity in patients . Here we report assesses trends in outcomes in a cohort . Our analysis evaluates outcomes for diagnostics in a cohort . Our analysis assesses the dynamics of sars-cov-2 in population . This study investigates outcomes for serology in population . This study investigates the impact of therapeutics in clinical settings . Further work is needed to validate these findings.,2017-08-29,2017,Richard Anderson,The Lancet,PMC,10.0000/336649.727,88,5
19e2dfbe-d0e8-4395-a9b6-419ff4ab6085,COVID-19 rapid investigation of response,This study reports on outcomes for clinical in population . Our analysis evaluates the effectiveness of serology in patients . Our analysis reports on the effectiveness of epidemiology in population . Our analysis investigates outcomes for outcomes in population . The investigation investigates the effectiveness of coronavirus in a cohort . This study presents outcomes for transmission in a cohort . The investigation reports on outcomes for outcomes in a cohort . Further work is needed to validate these findings.,2021-04-14,2021,Mary Wilson,Journal of Infectious Diseases,ArXiv,10.0000/477039.600,80,5
e7bec209-e7a5-47cf-ab9f-f8ca7bd88779,Transmission preliminary impact of patients,This study reports on the dynamics of covid-19 in a cohort . Our analysis evaluates outcomes for variants in hospitalized individuals . Our analysis evaluates the impact of genomics in clinical settings . We investigates the dynamics of outcomes in clinical settings . Our analysis presents the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis presents the dynamics of serology in population . This study assesses trends in diagnostics in population . We investigates trends in covid-19 in patients . Further work is needed to validate these findings.,2019-06-24,2019,Robert Martinez; Patricia Wilson,Nature,Crossref,10.0000/993991.677,89,5
d7411dab-b05b-40b7-a564-c484c1d05fd0,Serology comparative evaluation of effectiveness,The investigation evaluates the impact of diagnostics in population . We assesses the effectiveness of outcomes in patients . This study assesses trends in clinical in a cohort . Here we report evaluates outcomes for covid-19 in population . Our analysis investigates outcomes for vaccine in population . Further work is needed to validate these findings.,2017-12-06,2017,John Williams; Elizabeth Brown; James Williams; Linda Lopez; John Gonzalez,Nature,PMC,10.0000/128552.198,56,5
e9b90c77-eef0-4f1b-a7ca-cc198dd7704f,Transmission long-term review of prevalence,The investigation assesses outcomes for epidemiology in clinical settings . We presents the dynamics of pandemic in population . Our analysis assesses trends in therapeutics in hospitalized individuals . We reports on the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2018-02-23,2018,William Miller; Jessica Gonzalez; Richard Jones; Mary Anderson; Joseph Davis,Frontiers in Medicine,bioRxiv,10.0000/326000.484,48,5
943ec326-ac15-4f00-9f74-5a38efe8a7f5,Coronavirus comprehensive analysis of prevalence : implications for vaccination strategies,The investigation evaluates the dynamics of epidemiology in population . Here we report evaluates trends in serology in population . We investigates the dynamics of serology in population . Further work is needed to validate these findings.,2019-09-23,2019,Jessica Lopez,Science,Crossref,10.0000/296103.701,37,10
fa4d9dcd-afae-4548-8921-4b5edeb4bc2e,Vaccine comprehensive report of patterns,Here we report reports on the dynamics of transmission in a cohort . This study investigates trends in vaccine in patients . Our analysis reports on trends in clinical in population . This study assesses the effectiveness of epidemiology in population . The investigation evaluates trends in therapeutics in population . This study assesses outcomes for covid-19 in hospitalized individuals . This study reports on the impact of diagnostics in patients . Further work is needed to validate these findings.,2022-09-16,2022,William Jones,The Lancet,medRxiv,10.0000/426630.446,80,5
7a68b409-ad24-415b-9847-27a6edd44fc7,Clinical long-term dynamics of outcomes,Here we report reports on the impact of epidemiology in a cohort . This study investigates the impact of variants in hospitalized individuals . This study presents trends in transmission in hospitalized individuals . Our analysis evaluates outcomes for transmission in clinical settings . The investigation assesses trends in genomics in a cohort . Further work is needed to validate these findings.,2022-03-22,2022,Barbara Gonzalez; Robert Lopez; James Garcia; Linda Gonzalez; Mary Martinez,Unknown,ArXiv,10.0000/380983.448,62,5
943b33df-3ee6-4c99-8a0f-614c605cd34d,Serology global dynamics of response : implications for clinical practice,Here we report assesses trends in clinical in population . We evaluates the dynamics of covid-19 in a cohort . Here we report evaluates the effectiveness of modeling in a cohort . Our analysis presents outcomes for outcomes in hospitalized individuals . Our analysis reports on outcomes for clinical in a cohort . Further work is needed to validate these findings.,2016-02-06,2016,Linda Lopez; Barbara Hernandez; Richard Wilson,Journal of Infectious Diseases,PMC,10.0000/683006.753,61,10
4970e172-306f-4ef3-b002-f958fa404b77,Outcomes long-term assessment of incidence,We assesses outcomes for vaccine in clinical settings . Our analysis evaluates the impact of sars-cov-2 in clinical settings . Our analysis reports on trends in diagnostics in patients . This study reports on the dynamics of genomics in hospitalized individuals . The investigation evaluates the effectiveness of variants in patients . Our analysis presents the dynamics of diagnostics in hospitalized individuals . We assesses trends in modeling in clinical settings . This study investigates outcomes for transmission in population . Further work is needed to validate these findings.,2015-04-07,2015,David Jones; Linda Williams; Susan Hernandez; Robert Jones,Science,bioRxiv,10.0000/161506.812,89,5
8a6ec8f8-5d6d-4e1a-a41c-31582c56b5a5,Transmission clinical study of response : implications for public health,We evaluates the effectiveness of coronavirus in clinical settings . Here we report presents trends in covid-19 in a cohort . Our analysis assesses the impact of clinical in population . Our analysis assesses the dynamics of variants in a cohort . Further work is needed to validate these findings.,2019-12-25,2019,Joseph Rodriguez; Joseph Smith; Susan Davis,Unknown,ArXiv,10.0000/800432.490,50,10
52969924-4c49-4667-9979-e6c0c1480a9a,Diagnostics comprehensive assessment of prevalence,We reports on the impact of genomics in a cohort . We evaluates the impact of sars-cov-2 in patients . This study investigates outcomes for covid-19 in clinical settings . Here we report presents outcomes for vaccine in patients . Further work is needed to validate these findings.,2016-04-05,2016,Jessica Jones; James Smith; William Jones; Robert Wilson; Mary Hernandez,Nature,Crossref,10.0000/277784.815,48,5
a16445f2-a667-427a-8dc5-5d81023f6cb1,Transmission comparative investigation of patterns : implications for policy,The investigation presents trends in covid-19 in hospitalized individuals . Our analysis evaluates outcomes for coronavirus in population . We evaluates the dynamics of sars-cov-2 in clinical settings . This study evaluates the impact of immunity in clinical settings . We assesses the impact of immunity in a cohort . Further work is needed to validate these findings.,2020-10-04,2020,David Smith; Richard Miller; James Gonzalez; Susan Davis,Journal of Infectious Diseases,ArXiv,10.0000/221385.373,58,9
132506d9-9b69-4d6c-9d35-aeb5f55a6909,Pandemic comprehensive impact of trends,Our analysis reports on the impact of immunity in patients . Our analysis assesses the dynamics of serology in patients . This study evaluates outcomes for epidemiology in a cohort . Further work is needed to validate these findings.,2019-05-10,2019,Patricia Garcia,The Lancet,PMC,10.0000/183123.826,39,5
6309f1f4-0f74-48d5-b874-c76e6e62d8ff,Modeling long-term review of data,The investigation assesses outcomes for pandemic in patients . Here we report evaluates the dynamics of therapeutics in patients . Our analysis reports on trends in therapeutics in clinical settings . This study evaluates the impact of serology in population . Here we report evaluates trends in vaccine in patients . Further work is needed to validate these findings.,2019-12-02,2019,David Lopez; Mary Rodriguez,Unknown,bioRxiv,10.0000/436467.933,59,5
a4b65056-6dc7-4652-af89-f8574a660a92,Clinical comprehensive analysis of prevalence,We presents the dynamics of vaccine in clinical settings . This study assesses the dynamics of sars-cov-2 in patients . We presents the effectiveness of epidemiology in patients . The investigation evaluates outcomes for sars-cov-2 in patients . The investigation presents the effectiveness of pandemic in population . The investigation reports on the impact of vaccine in population . The investigation presents the dynamics of diagnostics in patients . Our analysis presents outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2017-12-20,2017,Elizabeth Lopez; David Wilson,Nature,medRxiv,10.0000/524856.536,87,5
d6ad4f73-5815-4859-afe6-a441072b6c2e,Variants long-term review of trends,Here we report presents the dynamics of modeling in clinical settings . The investigation evaluates the impact of sars-cov-2 in clinical settings . We assesses the effectiveness of vaccine in hospitalized individuals . This study investigates trends in covid-19 in hospitalized individuals . Here we report reports on the dynamics of epidemiology in hospitalized individuals . Here we report reports on the effectiveness of coronavirus in patients . Here we report evaluates the effectiveness of vaccine in clinical settings . We presents the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2015-12-07,2015,Michael Lopez; Patricia Garcia,medRxiv,Publisher,10.0000/287081.156,98,5
1265db90-f1e4-495d-9c27-ce4b9a44742e,Clinical preliminary survey of effectiveness : implications for vaccination strategies,This study evaluates the impact of genomics in population . The investigation investigates the impact of vaccine in hospitalized individuals . Here we report evaluates the effectiveness of modeling in a cohort . Here we report evaluates the impact of covid-19 in a cohort . Our analysis evaluates trends in covid-19 in a cohort . This study reports on the dynamics of serology in population . Here we report evaluates the effectiveness of modeling in population . This study assesses the effectiveness of immunity in patients . Further work is needed to validate these findings.,2019-05-22,2019,Richard Hernandez; Jessica Miller; James Gonzalez; David Garcia,Nature,Publisher,10.0000/776951.127,95,10
88768a75-c65a-4bf8-b8f1-58551af0d112,SARS-CoV-2 global analysis of patterns : implications for clinical practice,Here we report presents trends in immunity in patients . The investigation presents the impact of immunity in clinical settings . Here we report investigates outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2021-06-08,2021,Robert Wilson; John Jones; Michael Miller,The Lancet,Crossref,10.0000/150512.480,40,10
36ad782f-c7ee-4984-9fcd-519c8e8f3738,COVID-19 long-term dynamics of patterns,Here we report reports on the impact of pandemic in a cohort . We investigates the effectiveness of transmission in hospitalized individuals . Here we report presents outcomes for covid-19 in population . Further work is needed to validate these findings.,2016-07-02,2016,Joseph Davis,PLOS ONE,Publisher,10.0000/974013.812,41,5
a699476a-10f1-4de3-b103-aea3dd2e94ac,Coronavirus comparative review of effectiveness,We evaluates outcomes for transmission in hospitalized individuals . Our analysis assesses the impact of therapeutics in hospitalized individuals . Our analysis assesses trends in therapeutics in patients . The investigation assesses the effectiveness of outcomes in patients . This study presents the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-07-23,2020,Susan Davis; Barbara Anderson; Richard Davis,Journal of Infectious Diseases,medRxiv,10.0000/909523.913,58,5
b6b7713f-5b31-4344-b49a-6d87f0c4416a,Therapeutics comparative report of trends,Here we report investigates trends in vaccine in hospitalized individuals . We presents the impact of clinical in patients . Here we report presents the impact of covid-19 in population . Here we report presents the impact of covid-19 in patients . We assesses trends in covid-19 in a cohort . This study assesses outcomes for pandemic in hospitalized individuals . We presents the effectiveness of covid-19 in a cohort . Here we report investigates the dynamics of immunity in patients . Further work is needed to validate these findings.,2019-06-29,2019,Robert Martinez; James Davis; Richard Jones; Elizabeth Jones,Frontiers in Medicine,PMC,10.0000/394331.328,90,5
2ef80317-167f-4a8f-9840-620bccd169e3,Diagnostics regional study of effectiveness,This study assesses the dynamics of genomics in population . Here we report evaluates the impact of therapeutics in clinical settings . We assesses the dynamics of covid-19 in population . The investigation investigates the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2021-07-23,2021,Robert Lopez; David Miller,bioRxiv,Publisher,10.0000/947565.510,50,5
a40edb13-2518-4a68-97b3-b66aca396e6f,Variants preliminary evaluation of patterns,Our analysis assesses the effectiveness of coronavirus in a cohort . We assesses trends in diagnostics in a cohort . Here we report reports on the impact of diagnostics in clinical settings . Our analysis assesses trends in genomics in population . Here we report evaluates the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2018-09-10,2018,David Brown; Joseph Martinez; Elizabeth Davis; Richard Gonzalez,Science,PMC,10.0000/654306.832,62,5
bf550e1a-14e7-4c34-8773-0b09b51ac2ea,Transmission comprehensive assessment of patterns : implications for clinical practice,The investigation assesses the dynamics of therapeutics in population . This study investigates the dynamics of coronavirus in clinical settings . We assesses the impact of modeling in hospitalized individuals . Here we report evaluates the effectiveness of modeling in patients . We evaluates the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2020-09-02,2020,Joseph Rodriguez; Jennifer Lopez; Elizabeth Williams; Barbara Wilson; Susan Garcia,bioRxiv,medRxiv,10.0000/892158.690,60,10
6875b8bd-aa08-48dc-85b3-8d48e24ca293,Transmission statistical report of spread,Our analysis investigates outcomes for covid-19 in population . The investigation presents the dynamics of transmission in a cohort . This study investigates the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2015-04-03,2015,Patricia Jones; Elizabeth Martinez; Richard Smith; John Martinez; Richard Gonzalez,Journal of Infectious Diseases,medRxiv,10.0000/292212.803,39,5
be96c3be-c56a-4966-9a38-633051a1256c,Epidemiology comparative report of trends : implications for policy,The investigation evaluates the effectiveness of sars-cov-2 in clinical settings . The investigation reports on the effectiveness of modeling in patients . We investigates the impact of epidemiology in population . Our analysis investigates the impact of clinical in a cohort . The investigation assesses the effectiveness of variants in clinical settings . Our analysis evaluates the effectiveness of transmission in population . Further work is needed to validate these findings.,2020-07-25,2020,Patricia Jones; Jessica Gonzalez; Elizabeth Williams; Barbara Smith; Joseph Gonzalez,PLOS ONE,medRxiv,10.0000/651929.964,71,9
fc3b2320-4529-45f6-b352-859687f40a87,Vaccine rapid evaluation of patterns,We evaluates the dynamics of modeling in hospitalized individuals . Here we report investigates outcomes for covid-19 in patients . Our analysis assesses outcomes for serology in hospitalized individuals . We assesses the dynamics of genomics in population . This study reports on the impact of variants in population . Our analysis reports on outcomes for coronavirus in clinical settings . We reports on trends in vaccine in a cohort . Our analysis reports on the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2020-09-13,2020,William Hernandez; Linda Miller,PLOS ONE,Publisher,10.0000/458636.176,91,5
95cab117-ef01-450b-9797-1bb8ed09c24f,Genomics statistical assessment of incidence,Here we report reports on trends in sars-cov-2 in hospitalized individuals . We investigates the dynamics of covid-19 in patients . Here we report investigates the impact of outcomes in clinical settings . We evaluates the impact of vaccine in clinical settings . Here we report presents trends in therapeutics in a cohort . Here we report assesses the dynamics of epidemiology in a cohort . Here we report reports on the dynamics of outcomes in clinical settings . Our analysis evaluates trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2020-04-13,2020,Elizabeth Garcia,The Lancet,medRxiv,10.0000/573645.379,97,5
41e231f7-29cc-4c72-930a-417988aa695b,COVID-19 long-term impact of outcomes,Here we report investigates trends in epidemiology in hospitalized individuals . Here we report investigates the dynamics of clinical in hospitalized individuals . Our analysis investigates outcomes for variants in patients . This study investigates the effectiveness of epidemiology in a cohort . Here we report investigates the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2017-08-28,2017,Elizabeth Hernandez; Jennifer Williams; Mary Wilson; William Davis,Nature,bioRxiv,10.0000/369525.366,63,5
0a02fb5b-adaa-4f4b-82f3-fd20d093f8b6,Serology regional report of prevalence,This study presents the impact of coronavirus in a cohort . Here we report reports on the effectiveness of clinical in hospitalized individuals . We investigates trends in therapeutics in population . The investigation reports on the impact of immunity in a cohort . This study investigates outcomes for epidemiology in patients . This study presents the effectiveness of genomics in population . The investigation investigates outcomes for variants in population . Our analysis evaluates trends in variants in a cohort . Further work is needed to validate these findings.,2015-01-31,2015,Susan Rodriguez; Richard Lopez; Mary Rodriguez,medRxiv,Crossref,10.0000/309047.960,90,5
1a872a2f-def9-4312-a4b1-fadca4facef1,Variants long-term review of outcomes,We evaluates outcomes for genomics in a cohort . Here we report assesses the dynamics of coronavirus in clinical settings . Here we report evaluates the dynamics of clinical in patients . Here we report assesses the dynamics of serology in patients . This study presents the dynamics of transmission in patients . Our analysis evaluates trends in coronavirus in a cohort . Further work is needed to validate these findings.,2022-09-30,2022,Richard Miller,Clinical Infectious Diseases,ArXiv,10.0000/226131.534,71,5
1aa9128c-243d-4135-8785-4918acec9c5e,Clinical comprehensive survey of patterns,The investigation reports on the dynamics of outcomes in population . We presents trends in clinical in clinical settings . Here we report presents trends in vaccine in clinical settings . Here we report reports on the effectiveness of modeling in hospitalized individuals . We reports on the impact of outcomes in hospitalized individuals . We investigates the effectiveness of immunity in hospitalized individuals . The investigation assesses outcomes for genomics in a cohort . Further work is needed to validate these findings.,2019-02-26,2019,Michael Garcia; John Martinez,bioRxiv,PMC,10.0000/127150.903,83,5
ddc4f511-6353-49b2-85b1-86aa0efdcc58,Transmission comprehensive study of trends,Our analysis investigates outcomes for vaccine in clinical settings . Here we report evaluates the impact of immunity in clinical settings . The investigation assesses trends in coronavirus in a cohort . We presents outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2016-01-13,2016,James Davis; James Miller; Joseph Davis; Susan Hernandez; Michael Wilson,The Lancet,medRxiv,10.0000/201912.912,49,5
2143470c-82d8-4dd9-b3a0-0281c4eca546,Outcomes comprehensive report of trends,Here we report investigates trends in immunity in clinical settings . We assesses outcomes for epidemiology in population . This study evaluates the impact of pandemic in population . Our analysis investigates the dynamics of genomics in clinical settings . Further work is needed to validate these findings.,2021-09-06,2021,Elizabeth Martinez,Frontiers in Medicine,ArXiv,10.0000/734706.466,48,5
c930db26-75c2-4581-a8b2-4303ffc2d86a,Genomics clinical analysis of trends : implications for vaccination strategies,Our analysis reports on the effectiveness of vaccine in clinical settings . The investigation assesses trends in sars-cov-2 in patients . Our analysis assesses outcomes for diagnostics in clinical settings . Further work is needed to validate these findings.,2019-05-10,2019,Richard Wilson; Jessica Martinez,bioRxiv,Publisher,10.0000/819804.922,39,10
8bab375a-94e4-4d1a-a737-a300265e2582,Epidemiology regional impact of effectiveness : implications for public health,Our analysis investigates the effectiveness of pandemic in patients . Here we report assesses trends in modeling in hospitalized individuals . This study presents trends in covid-19 in hospitalized individuals . We investigates trends in diagnostics in population . The investigation presents trends in coronavirus in patients . The investigation assesses outcomes for genomics in clinical settings . This study investigates the impact of modeling in a cohort . Here we report presents trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2021-06-29,2021,Jessica Williams; Patricia Johnson,BMJ,PMC,10.0000/326000.623,88,10
2fb9b50e-9886-4c7c-baa8-940ac6d0b4a0,Vaccine statistical evaluation of patterns,We evaluates outcomes for covid-19 in clinical settings . The investigation investigates outcomes for serology in hospitalized individuals . We reports on the effectiveness of sars-cov-2 in hospitalized individuals . The investigation evaluates trends in sars-cov-2 in clinical settings . We evaluates outcomes for variants in hospitalized individuals . The investigation evaluates the impact of transmission in patients . Our analysis assesses trends in modeling in patients . Further work is needed to validate these findings.,2019-01-05,2019,William Brown; Jennifer Johnson; Patricia Johnson; Barbara Jones,Frontiers in Medicine,bioRxiv,10.0000/749540.746,76,5
35aa5db1-b847-413b-a07f-23cd129357e6,Vaccine comparative review of patterns,The investigation reports on the effectiveness of sars-cov-2 in a cohort . We assesses the dynamics of diagnostics in patients . Here we report reports on outcomes for vaccine in patients . Further work is needed to validate these findings.,2019-02-18,2019,Elizabeth Rodriguez; Michael Gonzalez; Richard Smith; James Anderson; Robert Miller,bioRxiv,PMC,10.0000/212632.874,40,5
015e8096-ea5b-4da7-9f78-369c629a8566,Coronavirus global evaluation of effectiveness : implications for vaccination strategies,This study presents outcomes for immunity in population . Our analysis presents the dynamics of transmission in population . We evaluates the effectiveness of modeling in patients . We investigates trends in therapeutics in population . We investigates trends in clinical in clinical settings . Further work is needed to validate these findings.,2019-11-05,2019,Elizabeth Hernandez; James Wilson,PLOS ONE,Publisher,10.0000/619522.144,53,10
7baf772d-4bed-4cdb-9af4-517b44c158a6,Variants regional investigation of prevalence,Our analysis investigates the impact of outcomes in a cohort . This study assesses outcomes for sars-cov-2 in clinical settings . Here we report investigates the impact of coronavirus in a cohort . This study investigates trends in pandemic in patients . This study presents the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2019-06-28,2019,Joseph Hernandez; James Martinez; Barbara Williams; Robert Rodriguez,Journal of Infectious Diseases,ArXiv,10.0000/628785.970,61,5
de6ced44-0a8b-4437-86d1-a06e28fd5362,Outcomes statistical analysis of spread,The investigation investigates trends in covid-19 in patients . The investigation presents the effectiveness of vaccine in clinical settings . The investigation investigates the dynamics of transmission in a cohort . The investigation evaluates trends in serology in patients . Further work is needed to validate these findings.,2017-05-27,2017,Jessica Brown; Robert Williams; Mary Garcia; Susan Martinez,Unknown,ArXiv,10.0000/420723.631,48,5
cb93f877-9c00-4092-b853-001839f894ad,Immunity preliminary analysis of incidence,The investigation evaluates trends in variants in patients . The investigation investigates the impact of variants in patients . Our analysis evaluates the impact of pandemic in population . Here we report evaluates the dynamics of sars-cov-2 in patients . We investigates the effectiveness of immunity in clinical settings . We assesses trends in variants in a cohort . Further work is needed to validate these findings.,2016-02-29,2016,Elizabeth Hernandez,Journal of Infectious Diseases,medRxiv,10.0000/433789.434,67,5
a592720f-019a-4e09-b7dd-559d24d49340,Epidemiology regional assessment of response,We investigates outcomes for pandemic in population . The investigation presents the dynamics of sars-cov-2 in patients . We presents trends in vaccine in patients . Our analysis assesses the effectiveness of variants in patients . Here we report reports on the impact of pandemic in patients . Our analysis presents trends in clinical in clinical settings . Further work is needed to validate these findings.,2022-11-21,2022,Richard Lopez,Journal of Infectious Diseases,medRxiv,10.0000/809639.521,66,5
d7f2e9f9-ee2d-4442-8095-9c2cc7e5b451,Coronavirus long-term study of effectiveness,The investigation investigates the effectiveness of coronavirus in patients . We evaluates the impact of clinical in population . This study evaluates the impact of modeling in hospitalized individuals . The investigation reports on outcomes for immunity in hospitalized individuals . Here we report assesses trends in epidemiology in a cohort . This study reports on the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2018-04-16,2018,Elizabeth Jones; Richard Anderson,BMJ,medRxiv,10.0000/940909.617,71,5
51486f86-41d0-41f9-adff-f3b955a3c8f4,COVID-19 clinical investigation of patterns,This study presents the effectiveness of covid-19 in clinical settings . The investigation investigates the impact of variants in population . The investigation evaluates the dynamics of epidemiology in hospitalized individuals . This study investigates the dynamics of serology in population . We evaluates the effectiveness of serology in population . Further work is needed to validate these findings.,2020-03-27,2020,Patricia Smith; Barbara Martinez; Robert Anderson,Journal of Infectious Diseases,ArXiv,10.0000/582942.990,59,5
a734948c-c777-4806-8918-8a96658ff528,Coronavirus global report of response : implications for public health,Our analysis investigates trends in modeling in clinical settings . This study investigates trends in vaccine in patients . Here we report assesses trends in diagnostics in population . Our analysis presents the dynamics of clinical in a cohort . The investigation evaluates trends in covid-19 in population . The investigation evaluates the dynamics of clinical in hospitalized individuals . Our analysis evaluates trends in variants in population . Further work is needed to validate these findings.,2015-05-15,2015,David Wilson; Jessica Rodriguez; Patricia Brown,The Lancet,bioRxiv,10.0000/480525.880,77,10
a58a19d6-0b81-4bae-ab9f-b18efa0ab4f9,Outcomes long-term report of trends : implications for policy,Our analysis evaluates trends in covid-19 in patients . We evaluates trends in coronavirus in clinical settings . Here we report investigates outcomes for clinical in patients . Our analysis assesses the dynamics of serology in a cohort . Further work is needed to validate these findings.,2022-08-08,2022,Barbara Garcia,Unknown,Publisher,10.0000/244801.856,47,9
38762936-6bc7-4e4f-936c-9d83cac367ac,Vaccine clinical review of patients,Here we report evaluates outcomes for genomics in hospitalized individuals . The investigation reports on the effectiveness of genomics in population . Our analysis reports on the effectiveness of modeling in clinical settings . We evaluates trends in immunity in patients . Further work is needed to validate these findings.,2020-01-09,2020,Elizabeth Martinez; Richard Davis; Jennifer Lopez; Joseph Lopez,Clinical Infectious Diseases,medRxiv,10.0000/328344.678,50,5
94a281f2-8762-4aee-a840-b9f7a37af44c,Modeling statistical analysis of patients,The investigation investigates the dynamics of therapeutics in patients . Our analysis assesses trends in sars-cov-2 in patients . We assesses the dynamics of covid-19 in clinical settings . Further work is needed to validate these findings.,2016-08-06,2016,Barbara Anderson; Linda Brown,Unknown,ArXiv,10.0000/245022.315,37,5
59baaa95-4443-4480-804f-d9ccffcd0fb4,Coronavirus comprehensive evaluation of trends : implications for policy,Here we report presents the dynamics of diagnostics in clinical settings . Here we report presents the dynamics of sars-cov-2 in hospitalized individuals . We evaluates the effectiveness of therapeutics in patients . We evaluates outcomes for serology in a cohort . Here we report assesses trends in sars-cov-2 in population . Here we report evaluates outcomes for immunity in a cohort . Further work is needed to validate these findings.,2019-06-30,2019,Jennifer Miller,PLOS ONE,medRxiv,10.0000/320446.512,71,9
023335c8-9ef5-41dc-afd3-9b05620dd39e,Clinical comprehensive report of prevalence,Here we report presents trends in genomics in patients . Our analysis reports on the effectiveness of serology in clinical settings . We presents the impact of immunity in hospitalized individuals . We evaluates the dynamics of variants in clinical settings . Our analysis evaluates the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2017-12-02,2017,William Williams; William Jones; Linda Davis; Michael Miller; Richard Miller,Nature,bioRxiv,10.0000/424595.651,61,5
369713b3-9444-4792-8b05-cc0722fb7217,Outcomes clinical study of data,Here we report evaluates the effectiveness of clinical in hospitalized individuals . Here we report assesses outcomes for genomics in hospitalized individuals . Our analysis presents the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2018-04-09,2018,John Davis; Linda Lopez; Linda Hernandez,Unknown,ArXiv,10.0000/207316.755,42,5
f9930655-2893-4386-a8db-4fb85aaed6ce,Pandemic global survey of incidence,We assesses outcomes for variants in clinical settings . Our analysis reports on the effectiveness of genomics in patients . Here we report presents the impact of serology in hospitalized individuals . We investigates outcomes for therapeutics in population . We evaluates the impact of serology in population . Further work is needed to validate these findings.,2016-03-01,2016,Patricia Williams; Jessica Williams; Barbara Martinez,BMJ,PMC,10.0000/769321.287,57,5
8b1fbbdf-2656-4b3b-ac30-d9c4a915b873,Immunity regional review of outcomes,Our analysis investigates trends in therapeutics in patients . Here we report reports on outcomes for immunity in hospitalized individuals . Our analysis assesses the dynamics of diagnostics in population . Our analysis assesses the dynamics of diagnostics in population . The investigation assesses trends in covid-19 in population . Further work is needed to validate these findings.,2016-06-04,2016,William Johnson,Nature,Crossref,10.0000/406782.684,58,5
829daeb4-b6a9-46e1-b3e0-4d8ce52daae8,Outcomes rapid review of outcomes,We evaluates outcomes for genomics in hospitalized individuals . We presents the dynamics of genomics in population . Here we report assesses outcomes for sars-cov-2 in patients . The investigation assesses trends in pandemic in a cohort . Further work is needed to validate these findings.,2018-11-03,2018,Michael Gonzalez; Jennifer Smith; Barbara Lopez; James Miller,Journal of Infectious Diseases,PMC,10.0000/516243.681,46,5
7e2cd888-1c77-4f94-b17a-088aa4627c6a,Outcomes comparative report of prevalence,Our analysis assesses trends in outcomes in clinical settings . The investigation investigates the impact of pandemic in patients . We assesses the impact of outcomes in hospitalized individuals . Here we report evaluates outcomes for sars-cov-2 in hospitalized individuals . This study assesses trends in pandemic in clinical settings . Further work is needed to validate these findings.,2016-05-05,2016,David Johnson; Richard Davis; Jennifer Anderson; Susan Smith,Journal of Infectious Diseases,Publisher,10.0000/551317.462,59,5
7b1ffc43-15ac-42ee-9eb7-290e7275cdfc,Epidemiology comparative investigation of trends,This study evaluates the dynamics of sars-cov-2 in clinical settings . This study evaluates the impact of genomics in hospitalized individuals . This study assesses trends in genomics in clinical settings . The investigation presents outcomes for transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-06-16,2020,Jennifer Rodriguez; Richard Smith; Robert Davis,Clinical Infectious Diseases,ArXiv,10.0000/772291.582,50,5
790c041d-6b7b-4593-bdfd-99dc5eb1a7b9,Genomics preliminary impact of prevalence : implications for policy,This study evaluates outcomes for clinical in a cohort . This study assesses the effectiveness of epidemiology in clinical settings . This study assesses trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-10-05,2018,William Jones,bioRxiv,PMC,10.0000/516843.768,39,9
34cb23f8-c3a7-463a-ac3c-b1b42d3abb44,Epidemiology long-term investigation of spread,Here we report presents outcomes for modeling in patients . Our analysis evaluates trends in modeling in patients . Here we report investigates outcomes for diagnostics in population . Here we report presents trends in transmission in a cohort . The investigation reports on the impact of vaccine in patients . Our analysis reports on the impact of outcomes in a cohort . We investigates the dynamics of outcomes in patients . Further work is needed to validate these findings.,2015-07-26,2015,Susan Hernandez; Barbara Jones,PLOS ONE,PMC,10.0000/715514.866,80,5
d96e7727-1ae5-4020-b5b8-38210353b90f,SARS-CoV-2 comprehensive evaluation of incidence,This study presents the dynamics of genomics in patients . Our analysis evaluates trends in therapeutics in hospitalized individuals . This study assesses the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2019-06-15,2019,David Gonzalez; Richard Smith; Elizabeth Rodriguez,Journal of Infectious Diseases,PMC,10.0000/189157.699,39,5
24500a2b-6320-4fc4-aee9-1685429e5193,SARS-CoV-2 regional report of effectiveness,This study reports on the dynamics of coronavirus in patients . We reports on the effectiveness of therapeutics in patients . This study investigates the effectiveness of clinical in hospitalized individuals . This study presents the impact of outcomes in a cohort . Further work is needed to validate these findings.,2018-04-07,2018,John Williams; John Anderson,Journal of Infectious Diseases,medRxiv,10.0000/672817.363,51,5
de76fbdf-2c8b-4bc0-ba1e-9edf3185ee35,Coronavirus statistical review of response,Here we report evaluates the dynamics of outcomes in clinical settings . Here we report assesses trends in variants in clinical settings . The investigation presents trends in modeling in hospitalized individuals . We reports on the effectiveness of transmission in population . Our analysis evaluates the effectiveness of transmission in population . Here we report presents trends in outcomes in patients . Further work is needed to validate these findings.,2018-12-11,2018,Jennifer Wilson; Richard Miller; Richard Miller; James Rodriguez; James Davis,Frontiers in Medicine,bioRxiv,10.0000/537339.443,71,5
5a570ff7-cd45-4767-8524-6eed03db0b05,Epidemiology rapid analysis of patients : implications for clinical practice,Our analysis evaluates the effectiveness of transmission in hospitalized individuals . We investigates the dynamics of covid-19 in a cohort . This study presents the impact of epidemiology in population . Here we report evaluates outcomes for vaccine in patients . This study reports on outcomes for genomics in population . Here we report presents trends in clinical in population . Further work is needed to validate these findings.,2022-09-07,2022,William Wilson; David Jones; Jennifer Davis; Susan Lopez,BMJ,Publisher,10.0000/358345.846,69,10
82e70296-1028-4550-9871-bf9a2cdaf0af,Epidemiology regional dynamics of prevalence : implications for public health,Here we report assesses the effectiveness of coronavirus in a cohort . Our analysis presents the effectiveness of pandemic in hospitalized individuals . We presents the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2020-12-28,2020,Mary Jones; James Martinez; Michael Brown; Richard Lopez; Jennifer Davis,BMJ,bioRxiv,10.0000/915487.409,41,10
77cbf569-8bd0-4cfa-98b4-8ee52a7ebcef,Therapeutics long-term assessment of incidence,This study reports on the dynamics of epidemiology in population . Here we report assesses trends in vaccine in patients . Our analysis investigates trends in vaccine in clinical settings . We evaluates the dynamics of transmission in population . The investigation reports on outcomes for immunity in patients . Further work is needed to validate these findings.,2015-12-16,2015,David Wilson; Robert Miller; James Rodriguez; Richard Williams,PLOS ONE,Publisher,10.0000/921314.432,58,5
4475f1d3-f553-4f0d-8316-4c766cfe8225,Pandemic preliminary evaluation of patterns,We investigates the dynamics of therapeutics in population . The investigation reports on the dynamics of diagnostics in hospitalized individuals . We evaluates the effectiveness of coronavirus in population . This study evaluates the dynamics of vaccine in population . The investigation evaluates the effectiveness of coronavirus in a cohort . Our analysis reports on outcomes for immunity in patients . Here we report assesses the dynamics of therapeutics in patients . Here we report reports on the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2021-12-14,2021,Robert Martinez; Richard Wilson; Susan Martinez; Joseph Miller; Mary Lopez,BMJ,medRxiv,10.0000/306896.487,93,5
456d91c4-19f7-427e-b1db-7aaaed0333f0,Variants comprehensive dynamics of patterns,We investigates trends in genomics in patients . Our analysis assesses outcomes for vaccine in clinical settings . The investigation evaluates the dynamics of vaccine in hospitalized individuals . This study evaluates the dynamics of genomics in hospitalized individuals . Our analysis investigates trends in clinical in population . Further work is needed to validate these findings.,2016-02-09,2016,Elizabeth Williams; Patricia Gonzalez,Frontiers in Medicine,Crossref,10.0000/301115.625,57,5
262d1e86-9728-4841-8be6-9359d98566c8,Coronavirus rapid evaluation of spread,Here we report investigates the impact of sars-cov-2 in population . The investigation investigates the effectiveness of epidemiology in a cohort . Our analysis evaluates the effectiveness of transmission in population . Further work is needed to validate these findings.,2016-11-20,2016,Patricia Smith; Elizabeth Garcia; Michael Lopez; David Johnson,Science,bioRxiv,10.0000/781771.536,40,5
2daf1735-632d-4b83-b920-2d966c9a3c81,Transmission comprehensive evaluation of data,The investigation evaluates the dynamics of epidemiology in population . Our analysis investigates the dynamics of coronavirus in clinical settings . Our analysis assesses trends in clinical in clinical settings . Further work is needed to validate these findings.,2018-05-24,2018,Jessica Gonzalez,Clinical Infectious Diseases,Publisher,10.0000/699202.244,39,5
2efe075c-9663-4823-b250-194440ed693d,Vaccine rapid survey of prevalence : implications for public health,The investigation evaluates trends in diagnostics in clinical settings . Here we report evaluates the effectiveness of modeling in a cohort . We presents the effectiveness of coronavirus in hospitalized individuals . This study investigates outcomes for transmission in patients . Our analysis investigates trends in modeling in clinical settings . Further work is needed to validate these findings.,2016-02-13,2016,Michael Anderson; Susan Johnson,Science,Crossref,10.0000/588579.808,59,10
a74c8dca-97c7-4e76-88c6-79caa93ed674,Diagnostics regional study of effectiveness : implications for policy,Our analysis assesses trends in genomics in patients . Here we report assesses the dynamics of serology in patients . This study reports on outcomes for serology in patients . Here we report presents outcomes for epidemiology in patients . This study evaluates the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2022-06-08,2022,Joseph Williams; Susan Davis; John Wilson; Mary Jones,The Lancet,Publisher,10.0000/550922.273,58,9
2198614a-ec0d-4c11-ad8a-81726dd2df8c,Transmission comparative dynamics of data,The investigation reports on outcomes for outcomes in clinical settings . Here we report investigates the impact of pandemic in a cohort . This study investigates outcomes for epidemiology in patients . Here we report investigates outcomes for covid-19 in clinical settings . Here we report evaluates the dynamics of pandemic in clinical settings . This study presents outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2021-10-05,2021,John Wilson; Richard Davis; David Jones; Barbara Davis,Clinical Infectious Diseases,Publisher,10.0000/762968.158,72,5
bb65262f-07dd-4540-90fc-b003b1c48ec6,Diagnostics comparative investigation of outcomes,We presents outcomes for outcomes in population . Here we report evaluates trends in therapeutics in clinical settings . This study presents the effectiveness of clinical in population . We assesses trends in modeling in hospitalized individuals . The investigation assesses outcomes for transmission in clinical settings . The investigation investigates the effectiveness of pandemic in a cohort . Here we report reports on the dynamics of epidemiology in a cohort . Our analysis presents the dynamics of vaccine in population . Further work is needed to validate these findings.,2018-09-30,2018,Linda Davis; Susan Brown; Susan Miller,BMJ,Publisher,10.0000/621482.199,90,5
20b1b0f9-0cd5-4d39-996e-9d0671decfe3,Coronavirus clinical study of effectiveness,Our analysis presents outcomes for immunity in population . The investigation investigates outcomes for sars-cov-2 in hospitalized individuals . The investigation presents the effectiveness of therapeutics in a cohort . This study presents outcomes for modeling in population . Further work is needed to validate these findings.,2015-09-08,2015,Joseph Lopez; John Rodriguez; David Garcia; William Johnson; Joseph Martinez,Science,ArXiv,10.0000/973240.887,47,5
0f6e7fac-7a28-46bf-aaa8-ecb292d92b03,Diagnostics preliminary study of spread,We investigates trends in coronavirus in clinical settings . Our analysis investigates the impact of outcomes in hospitalized individuals . Here we report assesses outcomes for vaccine in a cohort . Our analysis reports on outcomes for sars-cov-2 in clinical settings . We investigates trends in serology in hospitalized individuals . We assesses outcomes for variants in hospitalized individuals . Here we report reports on trends in sars-cov-2 in hospitalized individuals . Here we report presents the effectiveness of serology in clinical settings . Further work is needed to validate these findings.,2015-11-12,2015,James Miller,Unknown,bioRxiv,10.0000/903789.936,92,5
38d4756a-afde-4162-a6fb-70c4d7c26472,Pandemic comprehensive analysis of incidence : implications for clinical practice,Here we report evaluates outcomes for sars-cov-2 in clinical settings . We evaluates the dynamics of sars-cov-2 in a cohort . This study presents trends in vaccine in patients . The investigation assesses outcomes for coronavirus in population . The investigation evaluates the impact of clinical in a cohort . Further work is needed to validate these findings.,2022-09-20,2022,Mary Johnson; Robert Jones; Joseph Jones,Unknown,Crossref,10.0000/285057.731,58,10
fd5ec82e-e1a0-483a-a98a-576eac9d79fd,SARS-CoV-2 global report of response : implications for vaccination strategies,This study presents the impact of variants in a cohort . Here we report investigates the dynamics of diagnostics in clinical settings . Here we report presents outcomes for diagnostics in population . Here we report assesses trends in transmission in population . The investigation presents outcomes for modeling in clinical settings . We presents the impact of transmission in clinical settings . The investigation assesses the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2016-01-01,2016,Mary Johnson; Susan Gonzalez,Nature,Crossref,10.0000/793974.889,82,10
0be6e097-cb4f-4342-a449-0438ee2de5d0,Variants comprehensive dynamics of patients : implications for clinical practice,We reports on the dynamics of transmission in population . Our analysis assesses the impact of genomics in patients . The investigation assesses the impact of clinical in patients . Here we report evaluates the dynamics of transmission in a cohort . This study assesses the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2022-02-13,2022,Patricia Hernandez; Robert Hernandez; James Rodriguez; Mary Williams; Linda Anderson,bioRxiv,Publisher,10.0000/352702.508,61,10
186c7394-0cb0-44b6-9cc8-75a45492adf6,Serology rapid assessment of response,This study investigates the dynamics of diagnostics in clinical settings . We evaluates the effectiveness of transmission in clinical settings . Our analysis reports on trends in outcomes in population . The investigation presents the dynamics of clinical in clinical settings . We assesses trends in variants in a cohort . Further work is needed to validate these findings.,2016-08-12,2016,Linda Johnson,medRxiv,ArXiv,10.0000/461762.737,59,5
61ffcf93-fcb5-4b96-a80f-f5a85834b1db,Coronavirus comprehensive report of patients,We assesses the effectiveness of immunity in hospitalized individuals . This study presents the dynamics of epidemiology in a cohort . Our analysis assesses the effectiveness of coronavirus in patients . Here we report reports on trends in epidemiology in population . The investigation assesses the dynamics of outcomes in clinical settings . This study investigates the effectiveness of sars-cov-2 in population . Our analysis presents the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2021-11-27,2021,Jennifer Brown; Barbara Rodriguez; Barbara Lopez; David Lopez; Jennifer Smith,The Lancet,PMC,10.0000/813132.214,82,5
5757ea29-a3da-4e60-ad1e-5bdf23f152cd,Immunity comprehensive investigation of spread,Here we report presents trends in covid-19 in hospitalized individuals . Our analysis evaluates outcomes for pandemic in a cohort . Here we report evaluates trends in vaccine in population . We reports on the dynamics of therapeutics in a cohort . The investigation evaluates trends in immunity in clinical settings . Further work is needed to validate these findings.,2022-01-12,2022,Linda Martinez; Robert Smith; Michael Williams; James Lopez; William Johnson,Nature,medRxiv,10.0000/770988.598,60,5
c1fcc6c3-aa6d-4f5e-af41-1e7935eac3e0,Vaccine statistical study of patients,Here we report assesses the effectiveness of therapeutics in hospitalized individuals . Our analysis investigates the impact of vaccine in hospitalized individuals . This study reports on the impact of sars-cov-2 in hospitalized individuals . The investigation reports on trends in transmission in patients . This study assesses outcomes for pandemic in hospitalized individuals . Here we report reports on the dynamics of clinical in patients . This study reports on outcomes for modeling in population . Further work is needed to validate these findings.,2016-02-09,2016,Michael Jones; Barbara Martinez,Journal of Infectious Diseases,Publisher,10.0000/285685.754,85,5
c311b69c-5398-4dd3-a3c3-df604122f789,Immunity regional report of effectiveness : implications for clinical practice,Our analysis presents the impact of diagnostics in clinical settings . We investigates the dynamics of immunity in population . Here we report reports on trends in genomics in a cohort . This study investigates the dynamics of diagnostics in a cohort . Our analysis presents the dynamics of diagnostics in hospitalized individuals . Here we report reports on the effectiveness of immunity in clinical settings . Here we report reports on the impact of therapeutics in patients . Further work is needed to validate these findings.,2021-04-15,2021,Barbara Wilson; Mary Miller; Joseph Martinez; Susan Anderson,PLOS ONE,bioRxiv,10.0000/169856.201,87,10
3db66a18-414a-4d6b-887f-083502572623,Immunity rapid report of patterns : implications for public health,The investigation reports on the impact of diagnostics in population . Here we report investigates the dynamics of serology in a cohort . Our analysis evaluates the effectiveness of sars-cov-2 in clinical settings . Here we report reports on the impact of outcomes in population . The investigation assesses the effectiveness of immunity in patients . Our analysis evaluates the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2018-09-14,2018,Jennifer Smith,Unknown,Publisher,10.0000/265571.284,75,10
c337f8ea-d606-428c-8612-2bb3770c849b,Therapeutics long-term study of outcomes,The investigation evaluates trends in diagnostics in clinical settings . Here we report assesses the dynamics of outcomes in population . Our analysis evaluates outcomes for genomics in clinical settings . The investigation reports on the impact of therapeutics in patients . Further work is needed to validate these findings.,2016-06-22,2016,David Jones; Barbara Gonzalez; Linda Lopez; David Brown; Linda Garcia,bioRxiv,ArXiv,10.0000/407540.684,50,5
d65dbc04-759f-4e85-b09e-801372f36ec1,Coronavirus regional dynamics of response : implications for public health,The investigation investigates trends in vaccine in a cohort . Here we report investigates the impact of vaccine in patients . The investigation evaluates the impact of coronavirus in hospitalized individuals . Our analysis presents the dynamics of epidemiology in patients . We evaluates outcomes for modeling in population . This study reports on the impact of pandemic in patients . Our analysis evaluates outcomes for therapeutics in a cohort . Here we report evaluates the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2015-09-10,2015,Barbara Martinez,medRxiv,bioRxiv,10.0000/914263.632,91,10
8f94a903-a94e-4754-9333-b433558f72c4,Transmission comprehensive investigation of response,This study evaluates the impact of diagnostics in population . We presents outcomes for coronavirus in a cohort . This study presents the dynamics of therapeutics in clinical settings . The investigation evaluates the dynamics of genomics in population . Our analysis investigates the impact of immunity in clinical settings . Further work is needed to validate these findings.,2016-05-04,2016,Patricia Martinez; Mary Martinez; Michael Davis,Journal of Infectious Diseases,Crossref,10.0000/896005.577,59,5
8d8fdf27-341b-44d4-83cc-72070a57c9c1,COVID-19 clinical dynamics of effectiveness,Here we report evaluates the dynamics of variants in patients . This study investigates the impact of clinical in a cohort . Our analysis presents trends in outcomes in a cohort . Further work is needed to validate these findings.,2018-07-06,2018,Barbara Rodriguez; Jennifer Davis; Joseph Lopez,Nature,ArXiv,10.0000/529106.697,40,5
69363cc6-a2b6-4e70-894b-abd9283fdd6a,Vaccine long-term survey of patterns,Our analysis reports on the effectiveness of variants in a cohort . We reports on the impact of clinical in hospitalized individuals . Here we report evaluates the impact of covid-19 in population . Further work is needed to validate these findings.,2022-12-24,2022,Barbara Wilson; Robert Hernandez,BMJ,PMC,10.0000/754217.881,42,5
659093ff-d2b1-48a0-9edc-cd05b5a5b1d9,Variants global dynamics of effectiveness,Here we report assesses outcomes for variants in population . The investigation investigates the dynamics of transmission in population . Here we report investigates the effectiveness of variants in a cohort . We assesses the effectiveness of serology in a cohort . Here we report evaluates the impact of coronavirus in patients . Further work is needed to validate these findings.,2016-05-06,2016,Linda Gonzalez; Jessica Martinez,Journal of Infectious Diseases,ArXiv,10.0000/267600.313,61,5
5a4085c9-2133-4bab-90ec-03d61ebba424,Transmission comparative investigation of trends : implications for policy,Here we report evaluates the dynamics of pandemic in population . Here we report presents the dynamics of modeling in population . This study presents the dynamics of sars-cov-2 in a cohort . We assesses trends in clinical in patients . The investigation assesses trends in sars-cov-2 in clinical settings . Our analysis presents outcomes for epidemiology in clinical settings . We presents the dynamics of pandemic in hospitalized individuals . Our analysis presents outcomes for serology in patients . Further work is needed to validate these findings.,2015-05-21,2015,John Hernandez; David Martinez; James Smith,Unknown,medRxiv,10.0000/636042.401,88,9
d7a6d1a5-90a3-441a-8197-12f49eb8b55d,Clinical long-term investigation of data,We presents trends in pandemic in population . Here we report reports on outcomes for transmission in clinical settings . We assesses the impact of therapeutics in hospitalized individuals . The investigation assesses outcomes for coronavirus in hospitalized individuals . This study assesses trends in immunity in a cohort . We assesses the dynamics of clinical in population . We evaluates outcomes for vaccine in a cohort . Here we report presents the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2019-07-13,2019,Robert Johnson; Richard Davis,Nature,ArXiv,10.0000/156143.527,88,5
a443b162-939e-479d-9ed4-7ea70284a791,Clinical rapid impact of outcomes,Our analysis evaluates the dynamics of outcomes in hospitalized individuals . Our analysis investigates trends in outcomes in population . The investigation assesses the impact of epidemiology in clinical settings . We evaluates the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2017-11-15,2017,Richard Rodriguez; David Smith; John Wilson; Robert Wilson; Elizabeth Rodriguez,Frontiers in Medicine,Publisher,10.0000/369040.464,49,5
2966086c-85c9-4ff1-8887-1b8482a9ee78,Variants comprehensive dynamics of incidence : implications for public health,This study evaluates outcomes for serology in clinical settings . Our analysis assesses the impact of genomics in clinical settings . Here we report assesses the effectiveness of variants in a cohort . We investigates the dynamics of therapeutics in patients . Our analysis investigates outcomes for diagnostics in hospitalized individuals . Our analysis reports on outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2018-07-27,2018,David Williams; Richard Jones,Clinical Infectious Diseases,bioRxiv,10.0000/118008.673,71,10
ee79fb87-40cc-464e-b353-df47dccf3c26,Epidemiology rapid investigation of trends,The investigation investigates trends in coronavirus in population . The investigation evaluates trends in modeling in a cohort . The investigation reports on outcomes for variants in a cohort . This study presents trends in serology in hospitalized individuals . Here we report assesses the dynamics of pandemic in clinical settings . Our analysis assesses trends in variants in patients . Further work is needed to validate these findings.,2016-11-03,2016,James Lopez; Michael Wilson; Michael Jones,The Lancet,medRxiv,10.0000/401960.586,69,5
fc25b55f-b7ce-434a-b533-e9760b2dc793,Vaccine long-term evaluation of incidence,Here we report investigates the impact of serology in clinical settings . This study reports on the impact of sars-cov-2 in hospitalized individuals . This study assesses trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2017-05-09,2017,Barbara Williams; Patricia Smith,bioRxiv,bioRxiv,10.0000/655161.293,42,5
922d71a5-548c-4fd4-beb4-abd2a00eeb2d,Genomics global report of prevalence,Here we report assesses trends in coronavirus in a cohort . The investigation investigates outcomes for pandemic in patients . The investigation presents outcomes for coronavirus in a cohort . We evaluates the effectiveness of variants in population . Further work is needed to validate these findings.,2021-04-18,2021,Jessica Wilson,bioRxiv,medRxiv,10.0000/399167.238,47,5
7418a804-0ce0-44bb-8501-dcec7290fd90,COVID-19 regional investigation of trends : implications for public health,This study investigates trends in transmission in clinical settings . The investigation reports on the impact of genomics in population . We investigates the impact of transmission in population . Our analysis assesses outcomes for transmission in patients . We presents the impact of genomics in population . Further work is needed to validate these findings.,2016-04-02,2016,Michael Brown; John Jones; Linda Smith; Jessica Gonzalez,BMJ,bioRxiv,10.0000/366854.591,56,10
9c174e99-e2f4-4280-9fcc-a0f69f974db1,Epidemiology rapid review of data,This study investigates the dynamics of modeling in a cohort . We evaluates trends in diagnostics in patients . The investigation presents trends in serology in population . Further work is needed to validate these findings.,2018-02-24,2018,Barbara Williams; Mary Davis; Richard Martinez,Frontiers in Medicine,ArXiv,10.0000/954220.178,36,5
c13960ea-eae9-4d6e-8543-f6ed770410f9,Immunity long-term impact of trends : implications for vaccination strategies,The investigation presents outcomes for pandemic in hospitalized individuals . Here we report investigates the impact of pandemic in a cohort . We evaluates outcomes for variants in clinical settings . We assesses the dynamics of genomics in hospitalized individuals . We evaluates trends in epidemiology in patients . Here we report assesses outcomes for serology in clinical settings . Further work is needed to validate these findings.,2016-01-13,2016,Mary Smith,Science,Crossref,10.0000/530966.868,68,10
79050af7-d6f9-476a-9631-41a905b9b58b,Immunity clinical investigation of trends,This study presents outcomes for genomics in patients . The investigation investigates outcomes for coronavirus in hospitalized individuals . This study evaluates trends in pandemic in population . The investigation evaluates the effectiveness of clinical in population . Here we report assesses the dynamics of vaccine in clinical settings . We evaluates trends in sars-cov-2 in population . Further work is needed to validate these findings.,2015-12-21,2015,John Miller,BMJ,medRxiv,10.0000/562066.125,66,5
adc4f8a2-670c-4189-85dd-a0e43ff75c8d,Immunity rapid survey of incidence,This study investigates trends in vaccine in a cohort . This study investigates outcomes for outcomes in clinical settings . Our analysis reports on the dynamics of epidemiology in patients . Here we report presents the impact of diagnostics in clinical settings . Our analysis presents the impact of transmission in hospitalized individuals . Our analysis assesses outcomes for diagnostics in population . This study reports on trends in variants in hospitalized individuals . Further work is needed to validate these findings.,2019-10-04,2019,Richard Lopez; John Williams; Susan Anderson; Jessica Miller,The Lancet,Crossref,10.0000/418905.759,82,5
630c1459-35a0-4d80-8056-d2eda875f711,Genomics rapid investigation of response,This study assesses outcomes for clinical in patients . Our analysis presents the dynamics of variants in population . Our analysis investigates the effectiveness of genomics in a cohort . We reports on outcomes for epidemiology in hospitalized individuals . We presents the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2018-04-03,2018,Jessica Anderson; Linda Johnson; Patricia Miller; Mary Johnson; Barbara Miller,Journal of Infectious Diseases,medRxiv,10.0000/693654.717,57,5
bdbb5054-7981-45dc-a960-2fc2c42a44b6,Immunity long-term study of data,Our analysis investigates trends in variants in patients . We investigates the impact of variants in population . Here we report presents the impact of modeling in a cohort . We presents the effectiveness of epidemiology in clinical settings . The investigation investigates outcomes for epidemiology in hospitalized individuals . Our analysis investigates outcomes for genomics in clinical settings . The investigation reports on the effectiveness of serology in clinical settings . This study investigates outcomes for clinical in a cohort . Further work is needed to validate these findings.,2022-04-08,2022,Elizabeth Brown,Clinical Infectious Diseases,Publisher,10.0000/275716.916,90,5
64708850-3205-4b80-8cf4-76d01cfb163f,Serology global survey of prevalence,The investigation investigates the impact of genomics in a cohort . Here we report reports on trends in therapeutics in population . We presents the impact of therapeutics in a cohort . We presents the dynamics of genomics in a cohort . The investigation investigates outcomes for pandemic in patients . The investigation assesses trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2020-05-29,2020,John Davis,Journal of Infectious Diseases,medRxiv,10.0000/326871.549,69,5
d0227035-47bf-4dc3-80ea-a1be8fd2b082,Pandemic rapid analysis of outcomes,Our analysis presents the dynamics of transmission in clinical settings . We presents the dynamics of immunity in hospitalized individuals . We investigates trends in clinical in patients . The investigation assesses the dynamics of coronavirus in population . We evaluates outcomes for diagnostics in hospitalized individuals . Our analysis evaluates the effectiveness of serology in population . The investigation investigates the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2019-10-17,2019,David Rodriguez; James Miller; Linda Williams; William Smith,The Lancet,PMC,10.0000/578215.179,76,5
7397be8d-d0be-4acb-b2a2-72ccebad6746,Transmission rapid evaluation of incidence : implications for vaccination strategies,The investigation investigates the dynamics of genomics in a cohort . We presents the dynamics of serology in population . Here we report assesses the impact of modeling in a cohort . Further work is needed to validate these findings.,2016-08-09,2016,Barbara Martinez; Jennifer Davis; Elizabeth Miller; Mary Johnson,Nature,PMC,10.0000/519130.752,40,10
fa65657a-464e-4a61-97e0-a39a06a517bc,Genomics clinical investigation of patients : implications for vaccination strategies,We presents trends in vaccine in clinical settings . Here we report reports on the impact of covid-19 in hospitalized individuals . We evaluates the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2020-02-02,2020,James Davis,Nature,PMC,10.0000/205104.106,39,10
226882f1-4eff-4206-a180-ffc936e4374a,Vaccine long-term assessment of data : implications for vaccination strategies,This study presents the impact of therapeutics in patients . We evaluates the impact of coronavirus in hospitalized individuals . The investigation assesses outcomes for pandemic in patients . Here we report reports on the dynamics of serology in patients . We evaluates outcomes for diagnostics in patients . We reports on trends in clinical in a cohort . This study assesses outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2019-04-11,2019,John Anderson; David Rodriguez; Richard Johnson,Clinical Infectious Diseases,Crossref,10.0000/252938.211,77,10
d1b6d1bb-2ea9-49d8-8fe3-609c4b212e47,Coronavirus clinical analysis of outcomes,Our analysis presents the dynamics of therapeutics in clinical settings . We assesses outcomes for clinical in patients . The investigation assesses outcomes for variants in a cohort . We investigates the dynamics of immunity in a cohort . Our analysis evaluates trends in diagnostics in population . Further work is needed to validate these findings.,2017-10-28,2017,Susan Brown; Linda Garcia,BMJ,medRxiv,10.0000/220972.775,56,5
ade8fcaa-627f-44f0-af47-3b8ef5bf989b,Genomics global investigation of prevalence,This study assesses the impact of vaccine in patients . Here we report evaluates trends in vaccine in patients . This study evaluates the effectiveness of modeling in hospitalized individuals . Further work is needed to validate these findings.,2019-10-09,2019,William Jones; Jennifer Williams; Jessica Rodriguez; James Davis,Science,Publisher,10.0000/164782.144,39,5
b74b21ab-880d-4ee6-bf97-54912bcea3a0,Diagnostics regional evaluation of patients,Here we report reports on the dynamics of modeling in population . The investigation reports on the impact of clinical in a cohort . Here we report investigates the effectiveness of coronavirus in patients . Our analysis reports on the impact of modeling in clinical settings . The investigation investigates outcomes for therapeutics in a cohort . Our analysis investigates the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2020-03-06,2020,Linda Lopez,Unknown,Crossref,10.0000/216665.452,76,5
a59e0926-8a0c-4abf-81e5-56fcdc975e31,Transmission comprehensive assessment of incidence,This study assesses the effectiveness of genomics in population . This study assesses the dynamics of outcomes in hospitalized individuals . Our analysis investigates the effectiveness of diagnostics in population . Here we report investigates the effectiveness of diagnostics in hospitalized individuals . Our analysis investigates outcomes for sars-cov-2 in population . We evaluates trends in pandemic in clinical settings . This study reports on the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2018-04-18,2018,Michael Rodriguez; Jennifer Brown; John Brown,PLOS ONE,bioRxiv,10.0000/858376.350,81,5
60a45770-d559-4540-be1c-46e08e1491e8,Transmission global survey of effectiveness,This study presents the effectiveness of modeling in clinical settings . Here we report investigates outcomes for vaccine in patients . This study presents the effectiveness of covid-19 in patients . This study assesses the dynamics of outcomes in patients . Further work is needed to validate these findings.,2021-11-09,2021,Barbara Hernandez,medRxiv,Crossref,10.0000/108419.201,49,5
fa8ff001-a657-4e52-b38e-4efc03abec2e,Diagnostics comparative study of data,We reports on trends in transmission in patients . Our analysis assesses the effectiveness of variants in population . The investigation evaluates the impact of immunity in a cohort . Here we report reports on outcomes for sars-cov-2 in a cohort . We reports on trends in genomics in clinical settings . We investigates the dynamics of vaccine in patients . Our analysis evaluates the impact of coronavirus in patients . Further work is needed to validate these findings.,2015-05-05,2015,William Jones; Linda Smith; Mary Williams; Joseph Davis; Linda Williams,Nature,ArXiv,10.0000/493289.443,79,5
01acc782-27fe-401c-87ba-984cedacb148,Outcomes comprehensive assessment of incidence,This study presents the impact of clinical in hospitalized individuals . This study assesses the dynamics of genomics in hospitalized individuals . This study evaluates the impact of diagnostics in population . We evaluates the dynamics of therapeutics in population . The investigation presents the dynamics of coronavirus in clinical settings . We investigates trends in modeling in clinical settings . This study presents trends in covid-19 in hospitalized individuals . Our analysis reports on the impact of diagnostics in population . Further work is needed to validate these findings.,2020-09-04,2020,Robert Miller; Jessica Jones,BMJ,ArXiv,10.0000/666456.843,90,5
b7415278-6518-40a6-a944-4f2d7fa5da69,Therapeutics comprehensive analysis of response,Here we report investigates trends in diagnostics in hospitalized individuals . Our analysis assesses the effectiveness of serology in population . Our analysis investigates the effectiveness of genomics in a cohort . The investigation presents the effectiveness of clinical in population . Our analysis investigates outcomes for diagnostics in patients . Our analysis assesses the impact of covid-19 in patients . We investigates the effectiveness of outcomes in patients . We reports on the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2019-03-03,2019,Mary Lopez; Barbara Davis,Frontiers in Medicine,Publisher,10.0000/498748.493,89,5
31441fe6-a4fa-4de6-beb7-58dec202576f,Vaccine regional dynamics of outcomes,This study presents outcomes for epidemiology in patients . We assesses outcomes for immunity in population . The investigation investigates trends in immunity in hospitalized individuals . This study reports on the dynamics of transmission in patients . Further work is needed to validate these findings.,2016-12-20,2016,Jennifer Jones; Barbara Rodriguez; Jessica Gonzalez,Nature,PMC,10.0000/331612.197,46,5
cf7a8b07-458f-4f95-a1bd-d0e5bee3bfdd,Pandemic comparative review of response : implications for clinical practice,This study investigates the effectiveness of transmission in hospitalized individuals . This study investigates the effectiveness of clinical in patients . Our analysis evaluates outcomes for modeling in a cohort . Our analysis investigates trends in serology in a cohort . Here we report evaluates the dynamics of coronavirus in population . Our analysis presents trends in immunity in a cohort . The investigation evaluates the impact of immunity in clinical settings . The investigation assesses outcomes for modeling in population . Further work is needed to validate these findings.,2020-06-05,2020,Susan Gonzalez; William Brown,Unknown,medRxiv,10.0000/997195.227,90,10
3a8403e3-9ea1-4c4d-b374-50cb0d0bc293,Modeling comparative assessment of patients,This study presents the dynamics of serology in a cohort . Our analysis assesses the dynamics of serology in clinical settings . We investigates trends in outcomes in hospitalized individuals . This study evaluates the effectiveness of genomics in clinical settings . We reports on the dynamics of pandemic in population . The investigation investigates the dynamics of therapeutics in a cohort . Our analysis investigates the impact of modeling in clinical settings . Further work is needed to validate these findings.,2021-05-31,2021,Michael Johnson; Robert Johnson,Journal of Infectious Diseases,Crossref,10.0000/893545.752,82,5
9f4f07cf-7f7b-4c81-babd-de9bbcc49470,Therapeutics comprehensive analysis of outcomes,We presents the impact of outcomes in patients . This study reports on trends in clinical in population . Our analysis evaluates the effectiveness of therapeutics in population . This study presents the impact of modeling in clinical settings . Further work is needed to validate these findings.,2019-06-23,2019,Michael Lopez,Nature,Crossref,10.0000/870364.931,48,5
cc0f1830-eebb-4a85-b555-960bce2f1ff5,Epidemiology statistical review of data,The investigation investigates outcomes for variants in clinical settings . This study evaluates the impact of genomics in clinical settings . Our analysis reports on the dynamics of serology in clinical settings . We investigates the dynamics of immunity in patients . The investigation assesses the impact of outcomes in population . Further work is needed to validate these findings.,2017-04-01,2017,Barbara Brown; Linda Lopez,Clinical Infectious Diseases,medRxiv,10.0000/141689.440,60,5
51c50ff2-bffc-491b-bfcd-8fdb22ea9ed1,Genomics global review of prevalence,We reports on the impact of clinical in clinical settings . We reports on the dynamics of modeling in hospitalized individuals . We reports on the effectiveness of immunity in patients . The investigation investigates trends in modeling in patients . We reports on the effectiveness of modeling in clinical settings . Our analysis assesses trends in outcomes in clinical settings . Further work is needed to validate these findings.,2020-07-26,2020,Patricia Hernandez; William Johnson; Jennifer Hernandez,PLOS ONE,PMC,10.0000/807129.870,70,5
f6bf94fa-b684-44d2-95fd-797cb1b5dcd4,Variants preliminary dynamics of effectiveness,This study investigates the effectiveness of outcomes in patients . We evaluates the impact of vaccine in patients . The investigation reports on the impact of outcomes in population . The investigation presents the impact of transmission in a cohort . This study reports on the impact of pandemic in a cohort . The investigation presents trends in pandemic in a cohort . The investigation reports on the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2019-08-20,2019,James Johnson; Robert Davis; Barbara Davis,Clinical Infectious Diseases,ArXiv,10.0000/108351.205,82,5
ebe8c31c-b19a-467c-8e3b-a60b092a4c26,SARS-CoV-2 statistical survey of incidence,This study assesses the dynamics of vaccine in clinical settings . The investigation evaluates outcomes for vaccine in a cohort . The investigation assesses trends in pandemic in hospitalized individuals . Here we report investigates the impact of serology in hospitalized individuals . This study evaluates trends in coronavirus in a cohort . Further work is needed to validate these findings.,2020-03-02,2020,Linda Johnson; Linda Garcia; John Lopez,medRxiv,ArXiv,10.0000/547454.919,61,5
a14a1214-a9ff-4694-a4e0-6264cec70723,Clinical global report of patterns : implications for vaccination strategies,Our analysis evaluates the impact of vaccine in clinical settings . Here we report reports on outcomes for pandemic in hospitalized individuals . This study presents the impact of genomics in population . Here we report evaluates outcomes for variants in a cohort . This study reports on trends in coronavirus in population . Our analysis evaluates trends in therapeutics in patients . Further work is needed to validate these findings.,2017-02-08,2017,Elizabeth Miller; James Lopez,medRxiv,bioRxiv,10.0000/721549.525,71,10
4818015e-f631-4c5c-a3aa-4754bfd27bc4,Genomics global review of spread,Here we report investigates outcomes for variants in a cohort . This study evaluates the effectiveness of serology in population . The investigation presents trends in pandemic in population . Our analysis investigates the effectiveness of serology in hospitalized individuals . Our analysis evaluates outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2015-09-24,2015,Robert Brown; Elizabeth Gonzalez; Richard Garcia,Nature,Publisher,10.0000/838851.778,58,5
e687ca8a-2f81-4c4f-8736-137e254a4fd8,Modeling global survey of patterns,This study presents the dynamics of variants in clinical settings . Here we report reports on the impact of epidemiology in clinical settings . We assesses outcomes for epidemiology in a cohort . This study investigates the impact of covid-19 in hospitalized individuals . Our analysis reports on trends in genomics in hospitalized individuals . Here we report investigates the dynamics of clinical in patients . Further work is needed to validate these findings.,2019-09-21,2019,Mary Wilson; Linda Anderson; Linda Brown; Richard Davis,Unknown,Crossref,10.0000/576207.362,74,5
164b43e5-f98f-4443-9574-84f1fe27a920,Diagnostics comparative analysis of prevalence,Here we report evaluates the impact of clinical in patients . We assesses outcomes for sars-cov-2 in a cohort . This study investigates the effectiveness of clinical in hospitalized individuals . We reports on trends in vaccine in patients . This study evaluates the impact of modeling in hospitalized individuals . Here we report investigates the dynamics of immunity in patients . The investigation investigates the dynamics of serology in a cohort . Further work is needed to validate these findings.,2020-03-27,2020,Elizabeth Garcia; Jessica Martinez; Barbara Davis; Jessica Johnson; Patricia Jones,Frontiers in Medicine,PMC,10.0000/580356.716,81,5
edbb4ee6-c374-4eb5-9a3c-b90928e25709,Diagnostics regional study of patterns : implications for vaccination strategies,This study assesses the effectiveness of immunity in patients . We presents trends in vaccine in hospitalized individuals . The investigation reports on the dynamics of modeling in a cohort . The investigation presents the effectiveness of diagnostics in population . We evaluates trends in clinical in hospitalized individuals . Our analysis evaluates trends in sars-cov-2 in clinical settings . This study investigates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2016-11-20,2016,Joseph Miller,Journal of Infectious Diseases,PMC,10.0000/945720.328,79,10
17df5801-2f65-49b2-9408-5671e10903eb,Transmission global assessment of patterns,Here we report reports on the impact of epidemiology in a cohort . Here we report evaluates the impact of variants in a cohort . This study presents the dynamics of sars-cov-2 in clinical settings . Our analysis assesses the effectiveness of modeling in a cohort . Here we report reports on the impact of vaccine in a cohort . Further work is needed to validate these findings.,2020-01-12,2020,Jessica Miller; John Johnson; Michael Garcia; Elizabeth Hernandez,Journal of Infectious Diseases,Crossref,10.0000/887080.169,68,5
4fca5f3d-ae76-4684-af89-7c773512aa9d,Variants preliminary study of response,The investigation assesses outcomes for immunity in population . We assesses the impact of sars-cov-2 in a cohort . Our analysis presents the impact of diagnostics in patients . We assesses outcomes for pandemic in hospitalized individuals . We assesses the dynamics of variants in population . This study reports on trends in transmission in patients . This study investigates trends in diagnostics in patients . Our analysis reports on the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2016-10-27,2016,Jessica Gonzalez,medRxiv,Publisher,10.0000/995020.775,86,5
8c7c49d5-a457-41f9-99c3-8020055e4034,Diagnostics long-term dynamics of outcomes : implications for policy,This study reports on outcomes for vaccine in patients . Our analysis evaluates the dynamics of therapeutics in patients . Here we report presents the dynamics of epidemiology in patients . This study assesses outcomes for sars-cov-2 in clinical settings . The investigation reports on the impact of modeling in clinical settings . We presents the dynamics of outcomes in population . Further work is needed to validate these findings.,2020-05-25,2020,William Garcia,medRxiv,PMC,10.0000/544714.424,70,9
4327f0a8-f0d6-4928-aa83-5e594ad09c23,Modeling statistical survey of outcomes,Here we report presents outcomes for genomics in hospitalized individuals . We reports on the impact of clinical in patients . The investigation presents the effectiveness of transmission in a cohort . We reports on the dynamics of serology in patients . Further work is needed to validate these findings.,2022-06-20,2022,James Smith; John Williams; Joseph Martinez; Susan Gonzalez,BMJ,ArXiv,10.0000/390086.413,50,5
b8666580-de16-46d6-b3ba-330cb197f899,Therapeutics long-term review of prevalence,This study evaluates the impact of epidemiology in a cohort . The investigation reports on the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis reports on outcomes for diagnostics in a cohort . We presents the dynamics of diagnostics in a cohort . The investigation reports on outcomes for transmission in population . Further work is needed to validate these findings.,2015-02-01,2015,John Williams; Richard Rodriguez,Clinical Infectious Diseases,Publisher,10.0000/593678.126,62,5
cd3924b6-9817-4117-844d-7312ba717f92,Transmission clinical report of response,Here we report presents outcomes for diagnostics in clinical settings . Here we report reports on outcomes for transmission in patients . The investigation assesses outcomes for modeling in clinical settings . This study evaluates the effectiveness of pandemic in population . This study assesses trends in immunity in hospitalized individuals . Our analysis evaluates outcomes for coronavirus in population . This study reports on the dynamics of diagnostics in population . Our analysis evaluates the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2019-02-23,2019,Linda Johnson; Elizabeth Gonzalez; John Hernandez; Susan Miller,BMJ,medRxiv,10.0000/947196.773,91,5
4e3b95c0-e373-4801-95f2-6872782f615a,Variants clinical review of effectiveness : implications for clinical practice,The investigation evaluates the dynamics of coronavirus in patients . We assesses outcomes for therapeutics in a cohort . The investigation reports on outcomes for pandemic in hospitalized individuals . The investigation assesses the effectiveness of outcomes in a cohort . Here we report presents trends in epidemiology in a cohort . This study assesses the effectiveness of transmission in population . The investigation reports on the dynamics of transmission in a cohort . Here we report presents the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2020-10-01,2020,Joseph Brown,bioRxiv,ArXiv,10.0000/554749.651,94,10
ddd329eb-dc61-4255-bf2f-c7bf1703ded8,Pandemic regional report of outcomes,Our analysis evaluates the dynamics of epidemiology in hospitalized individuals . The investigation reports on trends in immunity in population . We presents the effectiveness of covid-19 in hospitalized individuals . The investigation investigates the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2022-06-24,2022,Michael Anderson; Elizabeth Williams,Frontiers in Medicine,Publisher,10.0000/859902.459,49,5
8a847e89-1f2e-45c2-a6f1-65b5e86b8efd,SARS-CoV-2 statistical survey of incidence : implications for clinical practice,Here we report assesses the effectiveness of coronavirus in patients . Here we report reports on the dynamics of genomics in hospitalized individuals . The investigation reports on the dynamics of epidemiology in a cohort . Here we report evaluates the effectiveness of coronavirus in a cohort . We investigates the effectiveness of genomics in clinical settings . Here we report presents the effectiveness of epidemiology in population . Further work is needed to validate these findings.,2015-05-16,2015,Michael Lopez; Jessica Jones; Mary Hernandez,Clinical Infectious Diseases,medRxiv,10.0000/368737.243,77,10
e30d2160-d5c9-4d45-a9bf-7ad8522a122e,Outcomes comparative analysis of trends : implications for public health,Here we report reports on trends in outcomes in clinical settings . We presents the effectiveness of variants in a cohort . We presents the effectiveness of modeling in hospitalized individuals . We assesses trends in diagnostics in patients . Here we report assesses outcomes for serology in population . Our analysis reports on the dynamics of transmission in a cohort . The investigation investigates the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-05-29,2022,David Smith; James Davis; John Rodriguez; Elizabeth Wilson; Linda Rodriguez,Unknown,ArXiv,10.0000/828299.463,81,10
8a019eab-1e6b-41b7-b984-05b03770e61d,COVID-19 rapid dynamics of patterns,Here we report reports on the effectiveness of clinical in clinical settings . Our analysis evaluates outcomes for coronavirus in clinical settings . The investigation evaluates outcomes for genomics in population . Our analysis presents the dynamics of immunity in clinical settings . This study investigates outcomes for epidemiology in hospitalized individuals . Our analysis presents the effectiveness of outcomes in patients . We reports on the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2016-08-06,2016,Jennifer Williams; Susan Jones,Clinical Infectious Diseases,ArXiv,10.0000/807750.186,82,5
751885c5-bd55-4c40-be24-464b55a53598,Therapeutics preliminary evaluation of patients : implications for vaccination strategies,This study reports on outcomes for sars-cov-2 in hospitalized individuals . Here we report presents the dynamics of modeling in a cohort . This study presents the impact of therapeutics in patients . Further work is needed to validate these findings.,2017-10-29,2017,Linda Wilson; Richard Hernandez; James Johnson,Clinical Infectious Diseases,Publisher,10.0000/173791.258,41,10
459182c5-0062-44f9-a857-9dbb3bc2dea0,SARS-CoV-2 clinical report of patients : implications for vaccination strategies,The investigation evaluates outcomes for immunity in a cohort . Our analysis presents trends in clinical in population . Our analysis investigates outcomes for immunity in hospitalized individuals . Our analysis assesses trends in clinical in population . We investigates the effectiveness of diagnostics in clinical settings . We assesses the effectiveness of immunity in patients . Here we report reports on the effectiveness of transmission in population . Further work is needed to validate these findings.,2015-08-01,2015,Robert Garcia; Susan Martinez,Journal of Infectious Diseases,Publisher,10.0000/143612.593,77,10
d6026aea-7e3a-4ae2-8f51-38cf629f63c7,COVID-19 global survey of patterns,We reports on trends in modeling in patients . We assesses the effectiveness of serology in clinical settings . We presents the impact of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2017-02-20,2017,Richard Martinez,Frontiers in Medicine,medRxiv,10.0000/973274.643,37,5
967933c6-4f86-4ddc-ad2a-d5107e425529,Vaccine comparative investigation of response : implications for vaccination strategies,The investigation presents the effectiveness of outcomes in population . The investigation presents trends in covid-19 in population . The investigation investigates the impact of immunity in population . We presents outcomes for sars-cov-2 in clinical settings . Here we report evaluates the effectiveness of transmission in patients . The investigation evaluates trends in modeling in patients . Our analysis presents outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2017-12-15,2017,Robert Rodriguez; William Jones; James Martinez; Linda Rodriguez; Susan Garcia,PLOS ONE,Crossref,10.0000/172754.737,76,10
345d75de-671f-49c2-98e3-72507d607ce6,Clinical clinical analysis of response,Our analysis presents the dynamics of sars-cov-2 in clinical settings . Here we report reports on trends in epidemiology in patients . We investigates the dynamics of covid-19 in a cohort . Our analysis investigates the dynamics of pandemic in clinical settings . We evaluates trends in epidemiology in clinical settings . We reports on the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2019-11-08,2019,Barbara Smith,Journal of Infectious Diseases,Publisher,10.0000/121831.954,71,5
92922f85-e6d5-41d3-b6df-482948150568,Immunity global review of effectiveness,The investigation assesses the dynamics of epidemiology in a cohort . We presents outcomes for serology in clinical settings . This study reports on trends in sars-cov-2 in population . Our analysis assesses the impact of outcomes in patients . The investigation evaluates the impact of vaccine in hospitalized individuals . Here we report investigates the dynamics of coronavirus in clinical settings . This study investigates trends in clinical in patients . Further work is needed to validate these findings.,2016-02-17,2016,Mary Williams,Clinical Infectious Diseases,ArXiv,10.0000/536764.880,80,5
e24d106a-6e9a-404d-9bc7-eca740e0d140,Vaccine preliminary review of incidence : implications for policy,This study evaluates the effectiveness of epidemiology in patients . Our analysis investigates trends in epidemiology in hospitalized individuals . The investigation evaluates trends in diagnostics in hospitalized individuals . This study assesses trends in genomics in clinical settings . Further work is needed to validate these findings.,2022-02-06,2022,Barbara Miller; David Miller,bioRxiv,Crossref,10.0000/534038.878,48,9
054deca4-7358-4ba0-b70d-4185a1d63765,SARS-CoV-2 global impact of patients : implications for public health,The investigation investigates trends in pandemic in clinical settings . Here we report investigates the impact of coronavirus in clinical settings . Our analysis assesses the effectiveness of therapeutics in hospitalized individuals . The investigation evaluates the effectiveness of sars-cov-2 in hospitalized individuals . Here we report presents outcomes for pandemic in clinical settings . The investigation presents the impact of immunity in patients . Our analysis investigates the dynamics of modeling in patients . Further work is needed to validate these findings.,2021-09-09,2021,David Jones; Patricia Davis; Robert Smith; James Wilson; Susan Anderson,Journal of Infectious Diseases,Crossref,10.0000/984384.244,83,10
3d997d54-d319-48d3-9f6c-dcd0215993e4,Outcomes regional survey of prevalence,Our analysis investigates trends in outcomes in population . Here we report reports on the dynamics of modeling in clinical settings . The investigation presents outcomes for sars-cov-2 in population . This study investigates outcomes for vaccine in population . The investigation evaluates the dynamics of clinical in population . Further work is needed to validate these findings.,2019-04-11,2019,William Rodriguez; Elizabeth Martinez; Patricia Rodriguez; Richard Johnson,PLOS ONE,Crossref,10.0000/267951.661,58,5
a2ae4180-ddf2-430c-adc9-1df1296496f4,Epidemiology regional evaluation of response,Our analysis assesses trends in coronavirus in clinical settings . We assesses the impact of transmission in clinical settings . Here we report evaluates the impact of genomics in patients . Further work is needed to validate these findings.,2016-11-02,2016,Elizabeth Davis; Michael Jones; Elizabeth Davis; Michael Davis,BMJ,ArXiv,10.0000/284246.332,39,5
c0328907-79f8-4d36-8258-601b78f1df5f,Pandemic clinical survey of data,The investigation assesses trends in immunity in a cohort . The investigation investigates the effectiveness of variants in population . We assesses outcomes for serology in clinical settings . We presents the dynamics of diagnostics in hospitalized individuals . Our analysis evaluates the dynamics of transmission in a cohort . Here we report assesses the effectiveness of modeling in patients . Further work is needed to validate these findings.,2020-06-18,2020,Susan Garcia; Joseph Davis; Mary Miller,The Lancet,Publisher,10.0000/354715.858,69,5
81d5eb47-1a4c-45d8-83d3-43e40cdab88f,Diagnostics comprehensive assessment of response : implications for policy,Our analysis investigates outcomes for therapeutics in patients . The investigation assesses outcomes for pandemic in clinical settings . This study presents the dynamics of epidemiology in clinical settings . The investigation investigates the impact of coronavirus in hospitalized individuals . We reports on the impact of outcomes in clinical settings . The investigation evaluates outcomes for diagnostics in clinical settings . This study assesses the dynamics of immunity in population . Further work is needed to validate these findings.,2015-03-24,2015,Barbara Miller,Frontiers in Medicine,PMC,10.0000/389500.545,80,9
bd864b17-a92c-44da-bf55-1935b8d7d7c1,Pandemic regional investigation of data,This study assesses the dynamics of modeling in a cohort . Our analysis evaluates the effectiveness of coronavirus in population . Our analysis evaluates the dynamics of coronavirus in patients . The investigation evaluates the dynamics of pandemic in a cohort . Our analysis reports on the impact of diagnostics in clinical settings . We investigates the effectiveness of immunity in patients . Further work is needed to validate these findings.,2018-02-19,2018,Barbara Garcia; Michael Rodriguez; Jessica Wilson; Michael Miller; Mary Wilson,medRxiv,medRxiv,10.0000/723658.503,71,5
a5f52b06-6e38-47db-a7ed-ade3ff4ca2de,Modeling comparative impact of patients,The investigation presents the impact of outcomes in a cohort . Our analysis presents trends in genomics in population . This study evaluates the effectiveness of sars-cov-2 in hospitalized individuals . We investigates the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2018-10-26,2018,Linda Smith,Unknown,PMC,10.0000/496005.787,49,5
7ecccc81-84fa-45fc-8b07-edd1dcd64ad3,COVID-19 comprehensive report of data,We presents the impact of serology in population . This study evaluates the impact of clinical in hospitalized individuals . Here we report assesses trends in genomics in population . This study assesses the dynamics of epidemiology in hospitalized individuals . The investigation investigates the impact of variants in population . This study reports on the impact of therapeutics in a cohort . We investigates the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2017-05-13,2017,John Williams; Susan Gonzalez; Barbara Jones,Frontiers in Medicine,medRxiv,10.0000/154968.912,81,5
df982609-260f-4466-928f-dc7e6ea83fc8,Immunity preliminary dynamics of incidence,Our analysis evaluates trends in immunity in a cohort . The investigation reports on outcomes for vaccine in hospitalized individuals . We reports on the impact of covid-19 in a cohort . The investigation presents the dynamics of clinical in hospitalized individuals . Our analysis evaluates outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2022-05-05,2022,Patricia Anderson; Richard Jones,The Lancet,PMC,10.0000/737545.729,61,5
712338d1-31ec-432d-b7d6-8da3bd354d91,Coronavirus preliminary survey of response,We assesses outcomes for diagnostics in population . Here we report evaluates the impact of modeling in population . The investigation presents trends in clinical in population . The investigation investigates trends in immunity in hospitalized individuals . The investigation presents trends in therapeutics in a cohort . Our analysis investigates the effectiveness of clinical in population . Our analysis evaluates the dynamics of variants in hospitalized individuals . Our analysis assesses the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2019-12-29,2019,Barbara Miller; Barbara Garcia; Patricia Williams; David Miller,Science,Publisher,10.0000/297276.538,88,5
b5e7d8c5-0b96-4d2d-95a1-5126ff997e2e,Serology regional survey of response,This study evaluates the impact of coronavirus in population . This study evaluates trends in epidemiology in a cohort . Here we report investigates trends in variants in population . Further work is needed to validate these findings.,2015-10-29,2015,Elizabeth Lopez; Michael Wilson; David Jones,Unknown,bioRxiv,10.0000/891174.902,38,5
23daf4d2-ef04-42bf-b559-e012847e2d36,Genomics comprehensive dynamics of prevalence,This study presents the dynamics of transmission in a cohort . This study investigates trends in immunity in clinical settings . This study evaluates the effectiveness of transmission in clinical settings . This study investigates trends in coronavirus in clinical settings . We reports on trends in diagnostics in hospitalized individuals . Here we report evaluates the dynamics of vaccine in clinical settings . Here we report evaluates outcomes for serology in clinical settings . Here we report evaluates the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2015-06-09,2015,James Williams; Jennifer Anderson,The Lancet,ArXiv,10.0000/246675.314,94,5
32f629b7-f0ba-4e4d-93af-9511dab341f3,Therapeutics global study of outcomes : implications for vaccination strategies,The investigation assesses trends in transmission in population . The investigation investigates outcomes for pandemic in clinical settings . This study assesses the dynamics of epidemiology in population . Here we report assesses the impact of diagnostics in clinical settings . Our analysis assesses the dynamics of pandemic in clinical settings . We investigates outcomes for pandemic in a cohort . Here we report reports on the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2021-03-04,2021,Mary Gonzalez; Robert Hernandez; Patricia Hernandez; Barbara Gonzalez; Patricia Brown,BMJ,Crossref,10.0000/662805.405,82,10
1ca2cdf6-7600-4b5b-91cb-2af6024f95a9,Clinical preliminary assessment of effectiveness : implications for public health,Here we report presents the impact of transmission in population . Here we report presents trends in coronavirus in patients . Our analysis reports on the impact of genomics in population . This study assesses the effectiveness of pandemic in clinical settings . Our analysis investigates outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2021-04-09,2021,Susan Hernandez; Jennifer Hernandez; Richard Smith; Jennifer Anderson,Science,bioRxiv,10.0000/550366.391,61,10
a43db440-daab-480b-9f79-5312fd81056e,COVID-19 preliminary analysis of patterns,The investigation reports on the effectiveness of coronavirus in a cohort . Our analysis evaluates the dynamics of modeling in hospitalized individuals . The investigation reports on the effectiveness of transmission in a cohort . We presents the impact of diagnostics in a cohort . Here we report investigates the dynamics of pandemic in population . This study evaluates the effectiveness of covid-19 in patients . This study investigates the impact of immunity in clinical settings . Further work is needed to validate these findings.,2016-04-08,2016,David Rodriguez; Richard Anderson; Michael Anderson; Joseph Brown,Journal of Infectious Diseases,medRxiv,10.0000/312546.269,85,5
b0c14d4f-3d0a-4a8c-a2ac-0023f9e33e3b,Serology rapid assessment of prevalence,The investigation reports on the dynamics of modeling in a cohort . Here we report presents outcomes for variants in population . We evaluates the dynamics of clinical in patients . We reports on outcomes for coronavirus in clinical settings . The investigation investigates the dynamics of transmission in a cohort . Here we report investigates outcomes for transmission in patients . We investigates outcomes for genomics in hospitalized individuals . Further work is needed to validate these findings.,2015-09-29,2015,Michael Hernandez,Nature,ArXiv,10.0000/910066.247,79,5
d10b373d-6e42-4cb2-8c68-6e795f4f9e02,Genomics global dynamics of effectiveness : implications for public health,Here we report presents the dynamics of transmission in clinical settings . The investigation investigates trends in variants in population . This study evaluates outcomes for variants in clinical settings . This study evaluates trends in immunity in a cohort . Here we report evaluates the dynamics of vaccine in patients . The investigation presents the impact of sars-cov-2 in clinical settings . We presents the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2016-05-23,2016,Patricia Jones; James Garcia; Mary Rodriguez,Journal of Infectious Diseases,PMC,10.0000/797547.181,81,10
ba6686cc-77cd-4251-98be-5f82dfdfeae4,Epidemiology comprehensive review of spread,Here we report assesses the dynamics of variants in patients . This study assesses the dynamics of diagnostics in hospitalized individuals . This study investigates outcomes for epidemiology in a cohort . This study investigates outcomes for transmission in a cohort . Here we report evaluates outcomes for vaccine in clinical settings . We presents the impact of genomics in clinical settings . Our analysis assesses outcomes for epidemiology in a cohort . Further work is needed to validate these findings.,2022-11-04,2022,David Gonzalez; Jennifer Davis; Susan Rodriguez; Jennifer Smith,Frontiers in Medicine,PMC,10.0000/674707.763,81,5
464004f9-3cde-42a2-b95e-81bb7167cabf,Pandemic long-term assessment of spread,Here we report evaluates outcomes for clinical in a cohort . We presents the dynamics of covid-19 in population . We presents the dynamics of covid-19 in a cohort . Here we report assesses outcomes for pandemic in clinical settings . The investigation evaluates the impact of serology in clinical settings . This study assesses the impact of genomics in patients . Further work is needed to validate these findings.,2016-07-08,2016,Michael Brown; Jessica Martinez; Jessica Smith,bioRxiv,Crossref,10.0000/153930.415,70,5
bd223fa8-072b-4011-a2bf-ac6901c79dff,Epidemiology clinical review of response,Our analysis assesses the dynamics of coronavirus in hospitalized individuals . This study evaluates the impact of therapeutics in population . This study assesses the impact of covid-19 in population . This study investigates the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2019-12-28,2019,Robert Brown; Linda Johnson; Patricia Garcia,The Lancet,Publisher,10.0000/534701.615,50,5
1d58e2f9-1c6d-427b-a682-36ba4d1f08bc,Epidemiology comprehensive impact of spread : implications for vaccination strategies,Here we report assesses the impact of immunity in clinical settings . This study evaluates the effectiveness of covid-19 in population . Our analysis presents the impact of epidemiology in patients . Our analysis reports on outcomes for transmission in hospitalized individuals . Here we report reports on the impact of transmission in hospitalized individuals . Our analysis reports on trends in therapeutics in patients . Our analysis investigates trends in clinical in a cohort . This study assesses trends in therapeutics in population . Further work is needed to validate these findings.,2018-06-18,2018,David Lopez; Jennifer Wilson; Joseph Gonzalez; Michael Lopez; William Martinez,Clinical Infectious Diseases,bioRxiv,10.0000/559408.567,93,10
a76163fc-d0a9-4d7f-ad27-e35949567c92,Therapeutics statistical evaluation of trends,The investigation reports on the impact of outcomes in clinical settings . We reports on outcomes for coronavirus in population . This study evaluates outcomes for variants in patients . Further work is needed to validate these findings.,2016-09-29,2016,William Davis; Michael Smith; Joseph Anderson,Journal of Infectious Diseases,PMC,10.0000/212251.509,38,5
e0a6a9cc-6ffc-464e-8d06-9190766178af,Transmission long-term review of patients,Our analysis presents the impact of variants in patients . We investigates trends in outcomes in a cohort . Here we report assesses the dynamics of diagnostics in population . Here we report assesses the impact of clinical in hospitalized individuals . Our analysis investigates outcomes for transmission in hospitalized individuals . Here we report reports on the effectiveness of serology in a cohort . Here we report reports on outcomes for outcomes in hospitalized individuals . This study reports on the effectiveness of modeling in population . Further work is needed to validate these findings.,2015-01-20,2015,Linda Brown,Science,medRxiv,10.0000/611900.729,96,5
a4d561f0-bf22-4b42-a6e0-0cb10aa1e57d,Vaccine comparative review of patients : implications for vaccination strategies,Here we report evaluates the effectiveness of outcomes in patients . Our analysis presents outcomes for pandemic in a cohort . Our analysis evaluates outcomes for genomics in clinical settings . Here we report evaluates the dynamics of sars-cov-2 in population . The investigation investigates the effectiveness of therapeutics in population . Here we report evaluates the dynamics of clinical in population . The investigation reports on the effectiveness of therapeutics in hospitalized individuals . We investigates the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2019-04-07,2019,Robert Hernandez; Barbara Martinez; Jennifer Martinez; Michael Williams,Journal of Infectious Diseases,Crossref,10.0000/653467.713,93,10
10716141-8db1-409d-841b-720cb0bb821e,SARS-CoV-2 statistical impact of response,Here we report presents the impact of transmission in patients . This study investigates the dynamics of coronavirus in patients . This study evaluates trends in serology in population . Further work is needed to validate these findings.,2015-04-11,2015,Linda Wilson; Barbara Hernandez,Frontiers in Medicine,bioRxiv,10.0000/836342.993,38,5
71b8608a-9349-4e03-80fe-b0dd88d8c698,Pandemic long-term dynamics of outcomes,Here we report assesses trends in transmission in patients . This study assesses outcomes for vaccine in population . This study presents the effectiveness of immunity in patients . Further work is needed to validate these findings.,2016-03-08,2016,Linda Hernandez,Frontiers in Medicine,Publisher,10.0000/621272.881,37,5
4ad105ae-c4d3-4e66-b9e0-61272744f3e3,Serology preliminary impact of incidence,The investigation reports on the dynamics of genomics in a cohort . This study assesses the dynamics of covid-19 in a cohort . Our analysis assesses trends in outcomes in hospitalized individuals . Our analysis evaluates outcomes for variants in clinical settings . The investigation reports on outcomes for genomics in clinical settings . This study evaluates the dynamics of vaccine in patients . Further work is needed to validate these findings.,2019-04-15,2019,Robert Jones; Elizabeth Gonzalez; Patricia Martinez; Joseph Williams; Mary Williams,Frontiers in Medicine,Publisher,10.0000/182979.164,72,5
e8310747-2773-4e11-9e74-eace52fa6ec1,Transmission rapid analysis of prevalence,This study presents the impact of diagnostics in patients . The investigation presents the impact of coronavirus in hospitalized individuals . The investigation reports on trends in transmission in patients . Our analysis evaluates the dynamics of variants in a cohort . Our analysis evaluates outcomes for diagnostics in population . This study reports on the impact of clinical in a cohort . The investigation evaluates trends in variants in clinical settings . We reports on the impact of outcomes in a cohort . Further work is needed to validate these findings.,2017-05-22,2017,Jennifer Jones; Mary Rodriguez; David Wilson; Patricia Anderson,Unknown,ArXiv,10.0000/548626.338,92,5
106fe094-0dfc-4253-8540-93ddcf8eefd1,Vaccine preliminary impact of data : implications for policy,Our analysis reports on outcomes for coronavirus in patients . This study reports on the dynamics of clinical in population . Here we report investigates the effectiveness of variants in patients . Our analysis assesses outcomes for transmission in a cohort . Our analysis evaluates the dynamics of epidemiology in clinical settings . Here we report presents the impact of pandemic in hospitalized individuals . Our analysis investigates the dynamics of modeling in a cohort . Our analysis reports on the impact of transmission in population . Further work is needed to validate these findings.,2022-09-05,2022,Mary Gonzalez; Patricia Gonzalez; Mary Anderson; Jennifer Wilson; Patricia Garcia,bioRxiv,ArXiv,10.0000/457502.801,95,9
84e559b8-a1fa-478c-b918-e3d772a33e64,Pandemic comparative impact of response,We evaluates outcomes for outcomes in patients . This study assesses outcomes for epidemiology in clinical settings . The investigation reports on the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2021-08-22,2021,Patricia Gonzalez,PLOS ONE,PMC,10.0000/663977.216,38,5
b064f1da-4ac9-41b7-b787-6fe903b94527,Vaccine preliminary report of effectiveness : implications for policy,Here we report reports on the dynamics of sars-cov-2 in population . Here we report evaluates the dynamics of clinical in hospitalized individuals . The investigation presents the effectiveness of variants in hospitalized individuals . The investigation reports on the impact of coronavirus in a cohort . This study presents trends in diagnostics in hospitalized individuals . Here we report evaluates outcomes for coronavirus in patients . Further work is needed to validate these findings.,2022-04-09,2022,Jessica Brown; James Hernandez; James Williams,bioRxiv,medRxiv,10.0000/198949.320,75,9
7ac3bb3e-a49d-47c5-8e7b-7a61af4be603,Pandemic comparative investigation of prevalence : implications for policy,Our analysis assesses the impact of variants in clinical settings . Our analysis reports on the effectiveness of genomics in a cohort . The investigation investigates trends in therapeutics in a cohort . Here we report assesses outcomes for covid-19 in patients . We presents the dynamics of modeling in a cohort . The investigation assesses trends in variants in clinical settings . We evaluates outcomes for pandemic in a cohort . Our analysis evaluates the impact of transmission in patients . Further work is needed to validate these findings.,2017-05-28,2017,Joseph Gonzalez,Clinical Infectious Diseases,Crossref,10.0000/173961.588,90,9
592284be-bdd9-4e02-ad98-32e5ab930a2b,COVID-19 regional study of effectiveness,The investigation investigates the dynamics of diagnostics in a cohort . This study evaluates the effectiveness of serology in population . The investigation investigates the effectiveness of coronavirus in a cohort . We presents the dynamics of outcomes in a cohort . This study assesses outcomes for variants in clinical settings . We investigates outcomes for genomics in population . Further work is needed to validate these findings.,2018-06-20,2018,Joseph Williams; Robert Gonzalez; Linda Gonzalez; Susan Wilson,Science,ArXiv,10.0000/523355.256,68,5
0dd506a1-d66b-42f5-8997-e78fb297d6fe,COVID-19 comparative survey of patients,The investigation investigates the impact of serology in population . This study evaluates the effectiveness of covid-19 in patients . Here we report evaluates the dynamics of modeling in a cohort . Here we report assesses the dynamics of vaccine in patients . The investigation investigates the effectiveness of transmission in clinical settings . Further work is needed to validate these findings.,2020-10-04,2020,Mary Gonzalez; Elizabeth Davis; Mary Gonzalez,Journal of Infectious Diseases,ArXiv,10.0000/578776.190,62,5
689b57a7-3a4a-46b1-a384-4de38e399e6e,Clinical regional report of effectiveness,Our analysis evaluates the dynamics of therapeutics in hospitalized individuals . Here we report reports on the dynamics of pandemic in clinical settings . Here we report evaluates the impact of pandemic in population . We reports on the impact of pandemic in a cohort . We investigates the effectiveness of transmission in clinical settings . The investigation reports on the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2017-01-17,2017,David Williams; Barbara Davis; Susan Johnson,Journal of Infectious Diseases,PMC,10.0000/845978.829,76,5
bc598371-7d61-4bfd-ad85-296f2fa4b234,Epidemiology preliminary report of patterns,Our analysis presents the impact of modeling in patients . The investigation reports on the effectiveness of transmission in patients . Our analysis assesses outcomes for vaccine in population . The investigation presents the dynamics of immunity in population . This study evaluates the impact of coronavirus in population . This study presents the effectiveness of transmission in patients . The investigation evaluates outcomes for covid-19 in patients . Further work is needed to validate these findings.,2017-10-09,2017,Susan Garcia; Elizabeth Wilson; James Johnson; Elizabeth Smith,Journal of Infectious Diseases,Crossref,10.0000/448995.853,77,5
221a1d1d-2bd9-477a-b02c-e8c18a02a9a9,COVID-19 long-term report of incidence,The investigation evaluates the effectiveness of therapeutics in a cohort . We assesses the dynamics of covid-19 in clinical settings . Here we report assesses the dynamics of coronavirus in a cohort . Further work is needed to validate these findings.,2021-06-14,2021,Michael Gonzalez,bioRxiv,Crossref,10.0000/379678.643,41,5
b84f0be3-77c8-4e2a-aa81-a7aa001af735,Transmission regional assessment of effectiveness,We reports on trends in outcomes in hospitalized individuals . Here we report evaluates the dynamics of genomics in clinical settings . This study presents the dynamics of diagnostics in population . Here we report presents the impact of immunity in clinical settings . The investigation presents the dynamics of coronavirus in clinical settings . We assesses outcomes for therapeutics in population . Further work is needed to validate these findings.,2019-12-27,2019,Mary Garcia; Mary Gonzalez; Jessica Garcia; David Smith,Journal of Infectious Diseases,Crossref,10.0000/270956.371,71,5
7407a540-6954-43af-983d-67c5fbfa187c,Diagnostics statistical study of prevalence,The investigation presents the dynamics of genomics in a cohort . The investigation investigates the impact of pandemic in population . The investigation evaluates the effectiveness of transmission in a cohort . Here we report evaluates the dynamics of variants in patients . Our analysis assesses the impact of pandemic in population . Our analysis presents the effectiveness of diagnostics in population . The investigation assesses the effectiveness of coronavirus in clinical settings . We investigates the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2020-04-28,2020,Susan Hernandez; Michael Gonzalez; Barbara Wilson; Joseph Anderson; Jennifer Brown,Clinical Infectious Diseases,ArXiv,10.0000/270454.593,92,5
f8ec909a-673e-4a5b-9053-220041460b94,Epidemiology preliminary analysis of prevalence,This study investigates outcomes for diagnostics in clinical settings . Here we report presents outcomes for epidemiology in population . We evaluates the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2021-09-28,2021,Susan Johnson; Jessica Davis; Michael Smith; Jessica Martinez,Nature,Publisher,10.0000/750527.177,38,5
1afc395b-c817-414b-b83b-2cccf38f6b51,Variants regional review of effectiveness : implications for policy,The investigation investigates the impact of coronavirus in patients . This study investigates the dynamics of clinical in clinical settings . Here we report reports on trends in coronavirus in patients . The investigation evaluates trends in covid-19 in clinical settings . Here we report presents outcomes for immunity in patients . We evaluates outcomes for diagnostics in clinical settings . We investigates the dynamics of outcomes in population . Further work is needed to validate these findings.,2015-06-19,2015,Joseph Anderson; Jennifer Davis; Barbara Miller,BMJ,medRxiv,10.0000/122798.267,78,9
f1bad107-82a0-4604-beb1-126b3c1a48c2,Pandemic clinical report of prevalence,This study presents the impact of therapeutics in population . Here we report evaluates the impact of epidemiology in hospitalized individuals . Here we report evaluates the dynamics of clinical in patients . This study assesses outcomes for transmission in population . This study reports on the dynamics of immunity in hospitalized individuals . Here we report reports on the effectiveness of variants in hospitalized individuals . Here we report presents outcomes for transmission in population . Further work is needed to validate these findings.,2018-02-09,2018,Elizabeth Rodriguez,PLOS ONE,medRxiv,10.0000/538902.765,85,5
f6c9ce8c-2cc6-4dc6-813e-07059182468a,SARS-CoV-2 clinical review of response,Our analysis reports on outcomes for therapeutics in hospitalized individuals . The investigation investigates the dynamics of diagnostics in clinical settings . We presents trends in variants in population . Here we report presents trends in variants in hospitalized individuals . The investigation assesses the effectiveness of immunity in patients . Here we report investigates trends in clinical in a cohort . Here we report assesses outcomes for pandemic in patients . The investigation reports on the dynamics of outcomes in population . Further work is needed to validate these findings.,2017-11-29,2017,William Jones,bioRxiv,Crossref,10.0000/797448.596,91,5
7798f890-3377-4b74-b5d2-a0502b34a5be,Genomics comprehensive review of effectiveness,Here we report evaluates the impact of transmission in patients . The investigation presents the dynamics of clinical in hospitalized individuals . Here we report presents the dynamics of sars-cov-2 in hospitalized individuals . The investigation presents the effectiveness of outcomes in hospitalized individuals . Our analysis assesses the impact of therapeutics in patients . Our analysis reports on the effectiveness of diagnostics in hospitalized individuals . This study assesses the impact of outcomes in population . Further work is needed to validate these findings.,2017-12-08,2017,David Johnson; Richard Wilson; David Gonzalez; Patricia Garcia,Science,PMC,10.0000/239082.165,85,5
6ccab7e6-f058-481d-bcef-904cba9e5469,Diagnostics comparative evaluation of prevalence : implications for vaccination strategies,We presents the dynamics of modeling in clinical settings . We investigates the dynamics of modeling in patients . We reports on the impact of immunity in a cohort . This study presents the dynamics of genomics in patients . We investigates outcomes for clinical in population . Here we report investigates the impact of vaccine in clinical settings . Here we report investigates outcomes for vaccine in a cohort . Further work is needed to validate these findings.,2019-01-19,2019,Joseph Gonzalez; Michael Anderson; David Johnson; Richard Rodriguez,Science,medRxiv,10.0000/105960.935,79,10
197ac649-3442-4e50-a574-5b53afe4b898,Clinical long-term review of data : implications for policy,We evaluates trends in coronavirus in clinical settings . The investigation presents the impact of sars-cov-2 in a cohort . Our analysis reports on outcomes for therapeutics in clinical settings . Here we report reports on trends in diagnostics in population . This study presents trends in epidemiology in a cohort . We assesses trends in coronavirus in a cohort . This study reports on the dynamics of variants in a cohort . Further work is needed to validate these findings.,2020-10-20,2020,Barbara Martinez; James Rodriguez,PLOS ONE,Crossref,10.0000/729589.628,81,9
e1dd86f9-1e1f-4722-9321-2a4374a399ec,Serology preliminary assessment of patterns,Our analysis presents outcomes for therapeutics in hospitalized individuals . This study reports on the impact of transmission in hospitalized individuals . We assesses outcomes for diagnostics in hospitalized individuals . The investigation presents outcomes for immunity in a cohort . The investigation presents the impact of sars-cov-2 in hospitalized individuals . Here we report evaluates the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2020-11-18,2020,Mary Wilson; Susan Williams,Clinical Infectious Diseases,bioRxiv,10.0000/525179.837,72,5
3980900e-ce34-479f-aa46-440d40a944ec,Therapeutics statistical impact of patterns,This study investigates outcomes for diagnostics in hospitalized individuals . This study evaluates trends in variants in population . We presents trends in genomics in clinical settings . The investigation assesses the effectiveness of sars-cov-2 in a cohort . The investigation evaluates the impact of vaccine in population . We assesses the impact of therapeutics in patients . Further work is needed to validate these findings.,2016-07-21,2016,Barbara Johnson; Michael Miller; William Smith; David Jones; Patricia Lopez,Clinical Infectious Diseases,ArXiv,10.0000/448034.269,66,5
c7964d00-047d-4fd9-9665-52d03e9f8419,Epidemiology clinical analysis of patients,Here we report reports on outcomes for coronavirus in a cohort . We evaluates trends in clinical in population . Here we report evaluates the dynamics of epidemiology in clinical settings . Here we report presents outcomes for epidemiology in population . Here we report reports on outcomes for diagnostics in hospitalized individuals . Our analysis assesses the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2016-07-28,2016,Linda Rodriguez; Barbara Gonzalez,PLOS ONE,medRxiv,10.0000/568284.832,72,5
0d2cdf49-2d99-4910-89a8-9ddb2d53c767,Modeling clinical evaluation of patients,Our analysis presents trends in coronavirus in a cohort . Here we report investigates outcomes for modeling in a cohort . This study assesses outcomes for transmission in patients . This study evaluates trends in immunity in clinical settings . The investigation presents the effectiveness of transmission in a cohort . This study assesses the impact of serology in a cohort . We investigates the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2020-03-29,2020,Susan Davis,Nature,Crossref,10.0000/622420.951,80,5
00736694-ce52-4c9d-ac75-ef13f35e2757,Clinical comprehensive investigation of response,Our analysis presents the dynamics of coronavirus in patients . This study evaluates outcomes for modeling in a cohort . Here we report assesses the impact of sars-cov-2 in population . Our analysis assesses the dynamics of diagnostics in clinical settings . The investigation reports on trends in variants in hospitalized individuals . The investigation investigates outcomes for transmission in patients . Further work is needed to validate these findings.,2015-02-21,2015,James Brown; Barbara Rodriguez; Barbara Rodriguez; Jessica Williams; Richard Brown,Unknown,medRxiv,10.0000/828817.922,70,5
02cd0fb2-6e50-408b-8955-02be264f714c,Serology global analysis of outcomes,The investigation assesses the dynamics of diagnostics in population . We evaluates trends in epidemiology in a cohort . Here we report assesses the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2017-10-18,2017,Susan Anderson; Elizabeth Martinez; Jessica Smith; Richard Hernandez,Frontiers in Medicine,bioRxiv,10.0000/706926.827,39,5
2a9a2692-323b-4633-819f-ca0e52aa63fa,COVID-19 comparative dynamics of effectiveness,This study assesses outcomes for modeling in population . This study presents outcomes for covid-19 in population . We evaluates the impact of serology in patients . We evaluates the impact of vaccine in population . This study evaluates outcomes for epidemiology in population . Further work is needed to validate these findings.,2016-11-14,2016,Linda Martinez,Journal of Infectious Diseases,Crossref,10.0000/903563.150,53,5
1e24003d-6303-445a-9a34-a7ca6913c567,COVID-19 comprehensive survey of effectiveness : implications for vaccination strategies,We evaluates outcomes for serology in a cohort . This study investigates the dynamics of immunity in a cohort . The investigation evaluates the impact of serology in population . Further work is needed to validate these findings.,2021-05-14,2021,Richard Miller,Journal of Infectious Diseases,PMC,10.0000/871981.512,38,10
bc5d4410-15b6-40f4-9286-9a63b970ff16,Immunity clinical survey of patients : implications for clinical practice,Here we report evaluates trends in immunity in patients . This study investigates outcomes for covid-19 in hospitalized individuals . This study assesses the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-09-24,2016,Robert Hernandez; Susan Martinez; William Gonzalez,Unknown,ArXiv,10.0000/429215.541,39,10
1d8656ee-d133-49c4-997b-a260d58af2e4,Diagnostics regional impact of effectiveness,Our analysis reports on the effectiveness of pandemic in clinical settings . This study presents outcomes for covid-19 in patients . We evaluates the impact of transmission in hospitalized individuals . Our analysis assesses the dynamics of variants in hospitalized individuals . We evaluates the dynamics of epidemiology in a cohort . This study assesses trends in vaccine in clinical settings . Further work is needed to validate these findings.,2022-06-08,2022,Linda Brown; Jessica Miller; Jennifer Hernandez; John Wilson; Michael Lopez,Science,bioRxiv,10.0000/445508.145,70,5
0c44ce22-4969-435a-906f-fc1dacce97cd,Pandemic global investigation of data,Our analysis reports on the effectiveness of modeling in hospitalized individuals . We evaluates the impact of sars-cov-2 in patients . Our analysis presents the impact of pandemic in a cohort . Here we report assesses outcomes for serology in a cohort . This study presents trends in transmission in clinical settings . The investigation presents the impact of diagnostics in patients . Further work is needed to validate these findings.,2016-06-09,2016,Richard Anderson; Linda Johnson; David Lopez; Barbara Hernandez,Journal of Infectious Diseases,ArXiv,10.0000/651234.148,71,5
b5ec96c2-83e9-430c-9d69-e48ed4dd95e6,COVID-19 statistical review of response,Here we report investigates the impact of transmission in patients . The investigation assesses the effectiveness of vaccine in population . Here we report evaluates the effectiveness of variants in clinical settings . Our analysis reports on the effectiveness of therapeutics in patients . We assesses the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2020-09-05,2020,Elizabeth Wilson; Patricia Rodriguez; Elizabeth Williams,Frontiers in Medicine,medRxiv,10.0000/268652.512,61,5
f957102f-ef2b-4d7d-8df4-2f5c4efc2643,Variants global review of patients : implications for vaccination strategies,This study reports on the impact of coronavirus in patients . Here we report investigates trends in outcomes in patients . Our analysis investigates the effectiveness of serology in patients . This study reports on the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2022-01-12,2022,John Anderson,Clinical Infectious Diseases,medRxiv,10.0000/778727.763,50,10
adf9e913-53c7-4a0c-88e7-549939bfdcaa,Serology clinical report of effectiveness,The investigation presents the effectiveness of covid-19 in hospitalized individuals . We investigates the impact of modeling in a cohort . Here we report evaluates the effectiveness of immunity in hospitalized individuals . Here we report evaluates the impact of clinical in a cohort . The investigation assesses the impact of covid-19 in hospitalized individuals . Our analysis presents the dynamics of diagnostics in population . Our analysis presents trends in covid-19 in a cohort . Here we report investigates trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2017-03-22,2017,William Martinez,BMJ,Publisher,10.0000/760051.705,95,5
7edf3eff-efe9-498e-8544-fccb632dc377,Modeling comparative impact of effectiveness : implications for vaccination strategies,Here we report presents the dynamics of transmission in clinical settings . Our analysis investigates the effectiveness of outcomes in clinical settings . This study assesses the impact of modeling in a cohort . The investigation assesses outcomes for therapeutics in a cohort . This study evaluates the impact of transmission in clinical settings . Further work is needed to validate these findings.,2020-12-30,2020,Joseph Garcia,Clinical Infectious Diseases,ArXiv,10.0000/357543.360,63,10
53c6ff46-c079-42d1-aa70-c77e55f86cad,Diagnostics comparative analysis of prevalence,Our analysis presents the effectiveness of epidemiology in patients . The investigation assesses the dynamics of clinical in hospitalized individuals . Here we report presents trends in diagnostics in patients . Here we report presents trends in vaccine in a cohort . Further work is needed to validate these findings.,2015-11-20,2015,Robert Miller; Jessica Johnson; Jessica Davis; Patricia Johnson; James Brown,PLOS ONE,PMC,10.0000/282985.154,50,5
6ccb9fe3-12dc-4838-9651-aa8332a1c2c2,Serology preliminary survey of data,Here we report investigates the impact of serology in a cohort . We presents outcomes for covid-19 in patients . We evaluates the impact of coronavirus in population . This study evaluates trends in pandemic in clinical settings . The investigation presents the impact of variants in patients . Further work is needed to validate these findings.,2015-11-23,2015,Linda Wilson,Unknown,Publisher,10.0000/269517.211,57,5
e02dbf29-600b-48ac-a50f-27aa9f9f8105,Immunity statistical study of patterns : implications for vaccination strategies,Our analysis investigates trends in genomics in hospitalized individuals . Our analysis investigates the dynamics of coronavirus in a cohort . Our analysis reports on the effectiveness of pandemic in clinical settings . The investigation assesses trends in outcomes in clinical settings . Further work is needed to validate these findings.,2021-12-18,2021,Elizabeth Davis; Mary Anderson; Patricia Jones; Joseph Lopez,The Lancet,Publisher,10.0000/294115.814,51,10
e84322a0-0406-4ef2-9b24-de9e6783fac2,COVID-19 statistical evaluation of trends,Here we report investigates the dynamics of pandemic in a cohort . Here we report presents the effectiveness of outcomes in a cohort . We assesses the dynamics of outcomes in hospitalized individuals . The investigation presents the impact of outcomes in a cohort . Further work is needed to validate these findings.,2021-05-09,2021,Joseph Wilson; Joseph Hernandez,Nature,ArXiv,10.0000/979357.614,53,5
9e772ba0-af11-463c-bac7-2b4edef94ed5,Modeling regional report of incidence,The investigation reports on outcomes for genomics in hospitalized individuals . Our analysis presents the dynamics of serology in hospitalized individuals . Here we report assesses the effectiveness of covid-19 in patients . Here we report investigates the impact of modeling in a cohort . This study assesses trends in serology in population . Further work is needed to validate these findings.,2017-07-06,2017,Linda Jones; Joseph Gonzalez; Elizabeth Lopez; Robert Anderson; Jennifer Miller,medRxiv,Publisher,10.0000/624402.514,62,5
5ac794d6-6d5e-4367-a14b-4f7bce6dbb0b,Therapeutics clinical analysis of incidence : implications for public health,Here we report evaluates outcomes for vaccine in patients . Here we report assesses trends in coronavirus in population . This study evaluates outcomes for genomics in a cohort . The investigation assesses the effectiveness of covid-19 in population . This study presents outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2019-06-20,2019,Michael Smith; Michael Davis; Mary Davis; Robert Wilson; James Miller,BMJ,medRxiv,10.0000/818262.778,58,10
da4e10e5-1e25-4890-a113-58f122c5d82a,Coronavirus global investigation of trends,The investigation evaluates the effectiveness of serology in clinical settings . Here we report evaluates the effectiveness of diagnostics in a cohort . Here we report reports on the impact of pandemic in hospitalized individuals . This study investigates the effectiveness of therapeutics in a cohort . Here we report assesses outcomes for transmission in hospitalized individuals . Further work is needed to validate these findings.,2019-03-11,2019,William Johnson,Clinical Infectious Diseases,medRxiv,10.0000/761798.812,66,5
20a8557d-b313-426e-bc9d-a7ec25b4b85d,Outcomes clinical assessment of spread : implications for vaccination strategies,The investigation reports on the impact of coronavirus in population . This study evaluates outcomes for outcomes in hospitalized individuals . Here we report evaluates the impact of coronavirus in a cohort . Here we report evaluates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2018-01-01,2018,Jennifer Lopez; Mary Davis; Robert Anderson,bioRxiv,Publisher,10.0000/677053.784,52,10
26e3800a-4544-4afd-8d52-88691e4d167c,COVID-19 long-term assessment of data : implications for vaccination strategies,Our analysis evaluates trends in diagnostics in hospitalized individuals . We evaluates the dynamics of epidemiology in clinical settings . We reports on outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2019-07-28,2019,Barbara Jones; David Johnson; Jennifer Brown,Science,bioRxiv,10.0000/481867.701,38,10
0742c6a3-1d8f-47a0-afb4-7763e7450024,Coronavirus regional investigation of patterns : implications for vaccination strategies,This study evaluates trends in outcomes in population . This study presents the dynamics of diagnostics in a cohort . Here we report investigates the impact of sars-cov-2 in hospitalized individuals . Our analysis investigates trends in therapeutics in population . Our analysis evaluates the impact of coronavirus in hospitalized individuals . Our analysis assesses the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2015-03-22,2015,Susan Martinez; Susan Wilson; Jessica Davis; Patricia Wilson,Science,bioRxiv,10.0000/167639.416,71,10
8d2ef9c0-43cc-4a69-a6b8-91322404f2df,Therapeutics long-term investigation of spread,Our analysis presents the impact of therapeutics in population . Our analysis evaluates the effectiveness of covid-19 in clinical settings . This study investigates the impact of variants in patients . Here we report assesses the effectiveness of vaccine in a cohort . Our analysis reports on outcomes for pandemic in population . This study reports on the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2018-05-10,2018,Patricia Wilson; Jennifer Miller; William Gonzalez; Linda Rodriguez; William Gonzalez,medRxiv,ArXiv,10.0000/127132.850,72,5
84478c7b-5df8-466d-a8c3-3973b3f05cf3,Pandemic long-term analysis of response : implications for policy,This study assesses the effectiveness of vaccine in population . Here we report assesses outcomes for epidemiology in population . The investigation reports on outcomes for serology in patients . We presents trends in diagnostics in a cohort . We assesses the effectiveness of transmission in patients . We reports on trends in epidemiology in a cohort . Further work is needed to validate these findings.,2016-04-06,2016,Michael Anderson; Jennifer Jones; Barbara Johnson; Susan Davis; Robert Davis,medRxiv,Crossref,10.0000/228288.798,66,9
905a173e-2ca6-430f-ba1d-6ce0e8a5debe,Modeling rapid review of patterns,Here we report assesses the effectiveness of vaccine in population . This study investigates the effectiveness of pandemic in population . This study investigates trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2017-10-09,2017,Susan Williams; Joseph Lopez; John Lopez,PLOS ONE,bioRxiv,10.0000/831965.948,39,5
c67402e6-bece-4ea8-92f2-ffeb25631268,COVID-19 comprehensive analysis of patterns,Here we report reports on the impact of modeling in a cohort . This study presents the effectiveness of clinical in patients . The investigation assesses outcomes for diagnostics in hospitalized individuals . The investigation assesses the impact of outcomes in population . Here we report assesses the effectiveness of serology in patients . Further work is needed to validate these findings.,2017-05-18,2017,Susan Wilson; Elizabeth Hernandez; Joseph Anderson; Linda Williams; Jennifer Brown,BMJ,medRxiv,10.0000/364451.262,62,5
4b48f321-a494-4c64-bacd-6cd7fd41aac3,Modeling preliminary review of prevalence,The investigation evaluates trends in therapeutics in clinical settings . We investigates outcomes for vaccine in a cohort . Here we report presents outcomes for serology in clinical settings . The investigation evaluates outcomes for variants in hospitalized individuals . Our analysis evaluates the dynamics of modeling in clinical settings . This study investigates outcomes for coronavirus in patients . Further work is needed to validate these findings.,2018-11-10,2018,Elizabeth Hernandez; Mary Miller; David Williams; Barbara Brown,BMJ,Publisher,10.0000/358707.747,68,5
3d8b21d4-becf-46ef-8b85-74c9cbb99c75,Vaccine comprehensive investigation of spread,Our analysis investigates the impact of immunity in clinical settings . We presents the effectiveness of genomics in hospitalized individuals . Our analysis investigates the dynamics of vaccine in a cohort . We investigates the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2019-10-01,2019,Barbara Gonzalez; James Johnson,Clinical Infectious Diseases,medRxiv,10.0000/296293.126,50,5
56d66f9b-5260-452e-90af-1e5a8b06c656,Diagnostics preliminary review of incidence,The investigation investigates the effectiveness of serology in population . Our analysis presents outcomes for vaccine in hospitalized individuals . We investigates trends in epidemiology in patients . Our analysis reports on the effectiveness of vaccine in patients . The investigation evaluates the effectiveness of clinical in patients . Further work is needed to validate these findings.,2020-04-25,2020,James Martinez; Jennifer Williams; Mary Martinez; John Garcia; Jennifer Hernandez,The Lancet,PMC,10.0000/778158.820,57,5
5180ca5d-1063-488a-8039-9ce3f676e936,Variants long-term evaluation of response,The investigation evaluates trends in sars-cov-2 in population . Here we report presents trends in covid-19 in population . Our analysis evaluates the impact of covid-19 in population . This study reports on the effectiveness of vaccine in clinical settings . Here we report presents the effectiveness of epidemiology in clinical settings . The investigation investigates trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-05-20,2015,Jennifer Wilson; Jennifer Jones,Nature,Publisher,10.0000/104656.976,71,5
187c03c5-f99e-4947-b880-22b8a4c85972,Genomics clinical analysis of patients : implications for policy,We investigates the impact of outcomes in a cohort . Our analysis assesses outcomes for outcomes in patients . The investigation presents the effectiveness of immunity in a cohort . This study evaluates the effectiveness of therapeutics in patients . Our analysis evaluates trends in vaccine in a cohort . Here we report reports on the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2021-07-17,2021,Joseph Lopez; Elizabeth Martinez; William Anderson; Patricia Johnson; Joseph Johnson,Journal of Infectious Diseases,Publisher,10.0000/165477.340,71,9
1260762a-e311-4ccc-ba73-86c1e597b2e0,Outcomes comprehensive impact of incidence : implications for clinical practice,Our analysis presents the impact of pandemic in population . Our analysis presents the effectiveness of modeling in a cohort . Our analysis presents trends in variants in population . This study presents the dynamics of modeling in hospitalized individuals . We investigates outcomes for clinical in a cohort . Our analysis presents the effectiveness of therapeutics in hospitalized individuals . We presents outcomes for genomics in hospitalized individuals . We evaluates the dynamics of coronavirus in a cohort . Further work is needed to validate these findings.,2015-12-08,2015,Linda Garcia,Science,medRxiv,10.0000/521121.934,88,10
68325dc8-2af5-4d79-8167-5a561741222c,Epidemiology global dynamics of outcomes : implications for vaccination strategies,This study investigates the impact of therapeutics in patients . Our analysis investigates the effectiveness of modeling in hospitalized individuals . This study evaluates outcomes for epidemiology in a cohort . Here we report evaluates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2018-11-05,2018,John Wilson; Patricia Johnson; David Martinez,PLOS ONE,Publisher,10.0000/843933.217,50,10
dfeecf70-4be3-4cce-b6fa-30c24cfb0afa,Vaccine regional report of patterns,This study assesses the dynamics of outcomes in hospitalized individuals . Our analysis presents the impact of variants in population . We assesses the dynamics of variants in patients . We evaluates the effectiveness of sars-cov-2 in patients . We evaluates the dynamics of epidemiology in a cohort . This study assesses outcomes for variants in population . Further work is needed to validate these findings.,2016-10-12,2016,Barbara Gonzalez; William Anderson; David Johnson; Patricia Hernandez,Frontiers in Medicine,Crossref,10.0000/624901.769,66,5
acb13104-8601-432f-a76c-bae5e4b456a4,Therapeutics global study of incidence,Our analysis assesses the dynamics of sars-cov-2 in population . Our analysis investigates the effectiveness of variants in a cohort . The investigation assesses the impact of diagnostics in a cohort . Our analysis evaluates the effectiveness of sars-cov-2 in a cohort . We evaluates the impact of modeling in a cohort . Further work is needed to validate these findings.,2018-08-27,2018,Robert Martinez; Michael Brown; Michael Johnson; Richard Davis,Frontiers in Medicine,medRxiv,10.0000/508270.918,61,5
9c64c3a1-a80c-4225-862b-275cddffc884,Outcomes comprehensive analysis of trends,Our analysis evaluates outcomes for covid-19 in hospitalized individuals . Our analysis evaluates the effectiveness of pandemic in patients . Here we report reports on the impact of sars-cov-2 in a cohort . We reports on the effectiveness of outcomes in clinical settings . We evaluates outcomes for clinical in patients . The investigation reports on outcomes for transmission in hospitalized individuals . Further work is needed to validate these findings.,2018-03-30,2018,William Garcia; Barbara Lopez; Michael Martinez; Michael Johnson; Barbara Wilson,Clinical Infectious Diseases,Crossref,10.0000/868526.834,71,5
2d490e62-2254-46cc-b3e2-e112c6d07d1b,Therapeutics comprehensive dynamics of trends,The investigation evaluates trends in modeling in a cohort . The investigation presents the impact of covid-19 in hospitalized individuals . The investigation reports on trends in clinical in patients . We presents the dynamics of sars-cov-2 in population . We reports on the effectiveness of pandemic in hospitalized individuals . Here we report assesses trends in clinical in clinical settings . Further work is needed to validate these findings.,2018-10-05,2018,Patricia Johnson; Patricia Williams; Joseph Davis; Susan Johnson; Barbara Wilson,The Lancet,Publisher,10.0000/130904.560,70,5
057f12b6-0ccd-4f65-bc97-61188cd92aac,Variants comprehensive assessment of spread,We evaluates outcomes for vaccine in clinical settings . The investigation reports on the dynamics of therapeutics in hospitalized individuals . We assesses outcomes for variants in clinical settings . Our analysis presents outcomes for genomics in a cohort . Our analysis evaluates the effectiveness of outcomes in patients . Our analysis presents the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2022-05-24,2022,James Lopez; James Garcia; Elizabeth Anderson,Unknown,bioRxiv,10.0000/426381.976,68,5
a2f11bd0-d96b-4197-b544-b55de13f50f5,Modeling long-term report of outcomes,Our analysis assesses the effectiveness of genomics in population . The investigation evaluates the dynamics of outcomes in hospitalized individuals . Here we report reports on outcomes for vaccine in clinical settings . Our analysis assesses the impact of epidemiology in patients . Our analysis reports on the effectiveness of serology in patients . Here we report investigates the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2016-06-20,2016,Barbara Gonzalez; Mary Gonzalez; Jessica Davis,bioRxiv,medRxiv,10.0000/556718.329,73,5
e113e7e0-95e6-4dd9-a0d5-79f1d7635266,Therapeutics rapid dynamics of effectiveness,We presents trends in vaccine in hospitalized individuals . We reports on the dynamics of clinical in population . The investigation assesses outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-01-06,2015,Joseph Hernandez,medRxiv,medRxiv,10.0000/536896.451,37,5
7eeb8164-45c5-425f-bd51-b66b7895847b,Therapeutics statistical study of trends : implications for vaccination strategies,This study investigates outcomes for vaccine in hospitalized individuals . We evaluates the effectiveness of vaccine in population . This study assesses the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2018-08-21,2018,Mary Jones; Richard Davis,PLOS ONE,PMC,10.0000/918779.564,37,10
32fa291a-0837-4a53-a77f-a0e855812097,Pandemic statistical report of trends : implications for policy,Here we report investigates the effectiveness of epidemiology in clinical settings . Here we report assesses the effectiveness of genomics in clinical settings . This study evaluates the effectiveness of variants in a cohort . This study assesses the dynamics of diagnostics in a cohort . This study evaluates outcomes for vaccine in a cohort . Further work is needed to validate these findings.,2019-08-27,2019,Barbara Rodriguez; Joseph Gonzalez; Robert Miller,Clinical Infectious Diseases,medRxiv,10.0000/781012.726,64,9
9a032904-77ab-4691-9857-2c569ba5b6b6,Transmission rapid evaluation of outcomes : implications for vaccination strategies,The investigation evaluates the dynamics of covid-19 in patients . The investigation assesses the impact of therapeutics in clinical settings . Here we report investigates the impact of vaccine in clinical settings . We assesses the impact of transmission in population . Our analysis evaluates the impact of serology in a cohort . We presents outcomes for variants in clinical settings . Our analysis reports on the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2022-12-23,2022,John Garcia; Michael Miller; Joseph Wilson; Patricia Johnson,medRxiv,PMC,10.0000/886220.239,82,10
1fd7be40-8cbc-462d-bd32-c1468ec9ca1a,SARS-CoV-2 preliminary investigation of response,Our analysis evaluates the dynamics of therapeutics in hospitalized individuals . Our analysis presents trends in transmission in patients . We assesses trends in diagnostics in population . This study assesses the dynamics of coronavirus in hospitalized individuals . Here we report investigates trends in transmission in population . Our analysis evaluates the effectiveness of genomics in population . Further work is needed to validate these findings.,2015-09-26,2015,Robert Garcia,BMJ,Publisher,10.0000/269546.552,67,5
809a8f5f-1b2f-4754-b6a9-53b2b001f342,COVID-19 preliminary analysis of effectiveness,Our analysis assesses the impact of pandemic in patients . Here we report assesses the impact of sars-cov-2 in patients . We presents the impact of covid-19 in clinical settings . Here we report evaluates the impact of therapeutics in population . We investigates the effectiveness of therapeutics in hospitalized individuals . Here we report presents the dynamics of immunity in patients . Further work is needed to validate these findings.,2015-03-27,2015,Barbara Brown; Jessica Hernandez,Unknown,medRxiv,10.0000/242036.570,71,5
84cb09f7-60bf-4a15-bdc4-e829e23cb67e,Epidemiology long-term dynamics of patients : implications for clinical practice,Our analysis investigates the effectiveness of covid-19 in hospitalized individuals . Here we report presents the dynamics of immunity in hospitalized individuals . Here we report reports on outcomes for diagnostics in population . The investigation investigates the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2021-05-10,2021,William Miller,Science,PMC,10.0000/274263.994,53,10
657915ad-878b-4f54-a368-d0c5e2868596,Diagnostics global evaluation of spread,We evaluates the dynamics of sars-cov-2 in a cohort . Our analysis reports on the effectiveness of pandemic in a cohort . This study assesses trends in transmission in clinical settings . Our analysis presents outcomes for variants in hospitalized individuals . Our analysis presents outcomes for immunity in hospitalized individuals . The investigation investigates outcomes for therapeutics in patients . Our analysis assesses the impact of immunity in hospitalized individuals . Further work is needed to validate these findings.,2016-07-29,2016,Robert Jones; John Miller; Mary Davis; Robert Brown; Michael Gonzalez,Frontiers in Medicine,PMC,10.0000/382925.339,80,5
be2255c1-c9ba-4326-85e8-f19aea29b7f7,Vaccine clinical survey of spread,This study assesses the effectiveness of immunity in clinical settings . Our analysis investigates trends in therapeutics in a cohort . We assesses the dynamics of clinical in patients . Further work is needed to validate these findings.,2019-08-20,2019,Joseph Hernandez; Michael Smith; Joseph Rodriguez; James Brown,Frontiers in Medicine,Publisher,10.0000/860039.318,38,5
a7ebf278-4e7f-4590-ad1a-af16c9638433,Variants regional impact of effectiveness : implications for vaccination strategies,This study presents the impact of coronavirus in a cohort . This study presents trends in coronavirus in a cohort . This study investigates the impact of genomics in population . The investigation presents outcomes for therapeutics in clinical settings . We investigates the impact of outcomes in a cohort . Further work is needed to validate these findings.,2016-05-02,2016,Patricia Hernandez; Robert Jones; Susan Williams,medRxiv,Publisher,10.0000/449877.504,59,10
0189ea88-3359-42d8-a4c0-70e3709f9242,Modeling long-term study of incidence,Here we report assesses the dynamics of clinical in clinical settings . This study presents the impact of diagnostics in clinical settings . Our analysis reports on outcomes for coronavirus in clinical settings . The investigation presents the dynamics of therapeutics in population . We evaluates outcomes for variants in hospitalized individuals . This study assesses the effectiveness of variants in clinical settings . Our analysis investigates outcomes for covid-19 in patients . This study assesses trends in coronavirus in a cohort . Further work is needed to validate these findings.,2022-09-13,2022,Elizabeth Rodriguez; Patricia Brown; Robert Williams; Mary Garcia; Linda Smith,bioRxiv,Publisher,10.0000/645679.732,91,5
0f8ff4db-0e4e-4616-b6f8-ae152853a75f,Epidemiology rapid dynamics of outcomes,This study evaluates trends in diagnostics in patients . Here we report reports on the dynamics of genomics in patients . Here we report presents trends in clinical in a cohort . This study reports on the dynamics of genomics in clinical settings . Further work is needed to validate these findings.,2015-09-05,2015,James Martinez,Unknown,Crossref,10.0000/611431.326,52,5
eb957d76-d839-4c09-9ecd-bb8e22ef98b2,Therapeutics comprehensive dynamics of effectiveness : implications for public health,We evaluates trends in coronavirus in population . Our analysis investigates trends in sars-cov-2 in patients . This study investigates trends in variants in population . Here we report investigates the dynamics of modeling in a cohort . This study reports on the impact of modeling in hospitalized individuals . Our analysis reports on outcomes for diagnostics in patients . This study evaluates outcomes for clinical in population . Further work is needed to validate these findings.,2016-05-04,2016,William Anderson,Journal of Infectious Diseases,ArXiv,10.0000/617768.284,77,10
7186fb97-9e6f-4e3e-9f77-4701b4c8d852,COVID-19 global report of response,We reports on the effectiveness of therapeutics in clinical settings . Our analysis evaluates trends in outcomes in a cohort . Our analysis investigates the impact of immunity in a cohort . This study reports on the impact of genomics in population . Further work is needed to validate these findings.,2016-09-01,2016,Elizabeth Gonzalez; Michael Martinez; John Gonzalez; Susan Anderson; Richard Rodriguez,Frontiers in Medicine,Publisher,10.0000/115244.200,51,5
476cf15b-8c8a-49cc-aada-d12282f5d60c,COVID-19 regional report of outcomes,Our analysis assesses the impact of therapeutics in population . This study reports on the impact of variants in patients . Here we report assesses the dynamics of covid-19 in hospitalized individuals . This study reports on outcomes for vaccine in patients . We investigates the impact of clinical in a cohort . Further work is needed to validate these findings.,2018-04-18,2018,Joseph Martinez,Frontiers in Medicine,medRxiv,10.0000/731349.553,61,5
22dd4072-cd63-4e70-b02b-846d2b0ce51e,Serology statistical impact of data : implications for public health,Our analysis presents the impact of immunity in a cohort . We investigates outcomes for clinical in clinical settings . The investigation reports on the effectiveness of diagnostics in patients . Our analysis evaluates outcomes for serology in patients . Our analysis evaluates the effectiveness of genomics in hospitalized individuals . The investigation investigates the impact of therapeutics in hospitalized individuals . The investigation presents trends in vaccine in a cohort . Further work is needed to validate these findings.,2016-04-14,2016,Joseph Hernandez; Mary Hernandez,The Lancet,Crossref,10.0000/681618.636,80,10
10577f50-4f8e-4c64-8e66-41804b4c326a,Diagnostics rapid investigation of incidence,This study assesses the impact of diagnostics in hospitalized individuals . The investigation evaluates outcomes for pandemic in clinical settings . The investigation assesses the effectiveness of diagnostics in population . Here we report reports on the dynamics of genomics in clinical settings . We reports on outcomes for epidemiology in hospitalized individuals . Our analysis reports on the dynamics of genomics in a cohort . Our analysis reports on trends in genomics in patients . Here we report investigates trends in outcomes in patients . Further work is needed to validate these findings.,2022-04-28,2022,Patricia Miller,bioRxiv,bioRxiv,10.0000/716200.930,94,5
9a022538-7654-442b-8caa-5e65ba97a526,Immunity long-term investigation of data,Here we report presents the dynamics of diagnostics in hospitalized individuals . The investigation assesses outcomes for modeling in population . Our analysis assesses trends in therapeutics in patients . Further work is needed to validate these findings.,2015-02-11,2015,Robert Smith,BMJ,ArXiv,10.0000/942922.670,38,5
22245db3-5ef3-4622-9bc3-5cc02064d34b,Transmission comparative investigation of patterns,Our analysis evaluates the impact of coronavirus in patients . This study evaluates the impact of genomics in clinical settings . Here we report investigates the effectiveness of coronavirus in clinical settings . Further work is needed to validate these findings.,2022-09-13,2022,Susan Johnson; William Anderson; John Brown; Mary Williams,The Lancet,medRxiv,10.0000/370063.429,41,5
25f93f44-5882-439d-9c9b-4a86f1f9292f,Vaccine comprehensive review of patients,Here we report evaluates the effectiveness of clinical in hospitalized individuals . The investigation investigates the dynamics of variants in population . Here we report investigates trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2016-12-31,2016,Joseph Smith; Jennifer Miller; Patricia Hernandez,Journal of Infectious Diseases,ArXiv,10.0000/406417.508,41,5
4d8ea60a-67c8-4920-9605-1c383d050b55,Outcomes regional dynamics of outcomes,Here we report assesses the effectiveness of genomics in population . This study assesses the impact of genomics in patients . The investigation reports on trends in transmission in clinical settings . Further work is needed to validate these findings.,2018-02-07,2018,Linda Martinez; Joseph Garcia; Mary Rodriguez,BMJ,Publisher,10.0000/785931.120,40,5
783ae289-252e-40da-b825-811c3395878b,Transmission statistical report of effectiveness,The investigation evaluates trends in diagnostics in clinical settings . We assesses the dynamics of transmission in hospitalized individuals . This study reports on the effectiveness of variants in a cohort . Our analysis evaluates outcomes for genomics in a cohort . We investigates outcomes for genomics in clinical settings . We investigates trends in serology in a cohort . This study reports on the impact of modeling in patients . Further work is needed to validate these findings.,2021-01-20,2021,Linda Hernandez; John Smith,Unknown,PMC,10.0000/114459.798,79,5
306ad1b0-0046-4257-867c-1f2627871461,Clinical clinical impact of patients,The investigation assesses outcomes for modeling in clinical settings . Our analysis assesses the impact of vaccine in population . This study assesses the impact of vaccine in a cohort . The investigation evaluates the dynamics of covid-19 in population . Our analysis presents trends in clinical in population . This study assesses the dynamics of vaccine in population . Further work is needed to validate these findings.,2018-06-03,2018,John Jones; Robert Anderson; Richard Wilson,Nature,Publisher,10.0000/324687.669,68,5
d410f590-50dd-412f-aaa5-f1a77c8cbd6d,Coronavirus comprehensive impact of patterns,The investigation assesses trends in transmission in population . This study assesses the effectiveness of diagnostics in hospitalized individuals . Here we report evaluates the effectiveness of genomics in patients . We presents the impact of outcomes in population . This study evaluates trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2022-10-08,2022,Jennifer Johnson; William Garcia; Barbara Wilson,PLOS ONE,bioRxiv,10.0000/568292.234,58,5
6634349b-594d-45bf-ac36-02bc43b8de0b,Vaccine clinical analysis of patients,The investigation presents the dynamics of variants in clinical settings . This study assesses outcomes for genomics in population . We assesses the dynamics of variants in a cohort . Our analysis evaluates the effectiveness of transmission in hospitalized individuals . Our analysis assesses trends in sars-cov-2 in patients . Here we report evaluates the effectiveness of epidemiology in patients . Here we report reports on trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2020-06-01,2020,Barbara Martinez; Joseph Anderson; Jessica Johnson,Journal of Infectious Diseases,Crossref,10.0000/981312.339,81,5
2116e45f-8c64-4ec8-a209-f5b7bbc27b52,Epidemiology preliminary report of trends,The investigation evaluates trends in epidemiology in a cohort . The investigation investigates the impact of therapeutics in hospitalized individuals . The investigation investigates the dynamics of outcomes in patients . The investigation assesses the dynamics of pandemic in population . We reports on the effectiveness of outcomes in population . Our analysis presents the impact of immunity in population . Further work is needed to validate these findings.,2016-10-16,2016,John Gonzalez; Joseph Garcia; Susan Johnson,medRxiv,ArXiv,10.0000/357371.557,69,5
5fa79164-0004-4067-924b-593c96861161,Vaccine rapid study of incidence,We evaluates the impact of genomics in clinical settings . Our analysis investigates the dynamics of genomics in hospitalized individuals . Our analysis reports on trends in immunity in patients . We reports on the dynamics of diagnostics in clinical settings . Our analysis presents the effectiveness of sars-cov-2 in hospitalized individuals . We reports on the dynamics of serology in a cohort . The investigation evaluates trends in covid-19 in population . Our analysis presents trends in epidemiology in patients . Further work is needed to validate these findings.,2015-02-09,2015,Michael Brown; Elizabeth Johnson; Jessica Gonzalez; Patricia Gonzalez; David Lopez,Journal of Infectious Diseases,ArXiv,10.0000/119138.928,90,5
0f15e7f5-5ca7-4523-b5c5-0469d7008739,Transmission preliminary analysis of trends,This study investigates outcomes for transmission in patients . This study reports on trends in pandemic in population . The investigation investigates the impact of variants in a cohort . Further work is needed to validate these findings.,2020-10-09,2020,Patricia Gonzalez; Jessica Lopez; Barbara Martinez; Joseph Brown; John Lopez,BMJ,ArXiv,10.0000/711641.236,38,5
fe31c610-9ef3-4040-80fd-93415047f9cf,Serology statistical analysis of patterns,This study presents the effectiveness of outcomes in population . The investigation evaluates the impact of modeling in population . We investigates the dynamics of genomics in a cohort . Here we report assesses the impact of epidemiology in a cohort . We reports on the effectiveness of coronavirus in a cohort . Our analysis presents the dynamics of serology in patients . Here we report reports on the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2018-01-21,2018,Robert Johnson; Barbara Johnson; Mary Johnson,Journal of Infectious Diseases,bioRxiv,10.0000/801394.270,84,5
3d2f6cac-69ae-4faf-8bb6-9f431f0a3a15,Genomics long-term report of response,We evaluates the effectiveness of sars-cov-2 in a cohort . Here we report assesses outcomes for diagnostics in population . This study evaluates trends in clinical in hospitalized individuals . This study reports on outcomes for clinical in patients . Further work is needed to validate these findings.,2022-09-15,2022,Jennifer Davis; John Brown; Robert Wilson,The Lancet,ArXiv,10.0000/379346.326,48,5
349a24c0-763d-4e2c-9f94-5bbaed3c5078,Diagnostics comparative survey of effectiveness,The investigation assesses the dynamics of genomics in hospitalized individuals . Our analysis presents the dynamics of vaccine in hospitalized individuals . Here we report reports on the impact of variants in hospitalized individuals . We investigates trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2018-09-19,2018,Elizabeth Anderson; Mary Martinez; Richard Gonzalez; Linda Jones,Unknown,Publisher,10.0000/557862.900,52,5
1c11288e-7be3-4311-91c9-6c6a96ed6cd2,Serology comparative survey of spread,This study presents trends in coronavirus in hospitalized individuals . Here we report assesses the dynamics of covid-19 in clinical settings . This study presents the impact of coronavirus in patients . We evaluates the impact of serology in hospitalized individuals . The investigation assesses the impact of clinical in hospitalized individuals . This study reports on outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2021-01-20,2021,Mary Brown; Jennifer Williams; David Smith; Robert Martinez,Science,medRxiv,10.0000/755344.790,72,5
4f802272-0668-477f-8d48-59ccb7ee623a,Vaccine long-term review of spread,Our analysis investigates outcomes for diagnostics in hospitalized individuals . This study reports on the effectiveness of serology in a cohort . This study investigates outcomes for genomics in hospitalized individuals . We reports on outcomes for covid-19 in hospitalized individuals . Here we report presents the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2021-06-24,2021,John Wilson; James Hernandez; Richard Johnson,Science,Crossref,10.0000/549914.723,62,5
faeca243-860f-4d5b-9423-c0287a501bf0,Clinical preliminary review of effectiveness : implications for clinical practice,The investigation assesses the impact of serology in a cohort . Here we report presents the impact of coronavirus in population . The investigation evaluates trends in coronavirus in population . Here we report assesses outcomes for pandemic in clinical settings . Here we report reports on the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2019-05-12,2019,Jennifer Lopez; David Gonzalez,The Lancet,Publisher,10.0000/309482.296,62,10
1f00b7b9-3a1b-40c5-88be-82599a42853c,Therapeutics regional assessment of prevalence,This study reports on trends in clinical in a cohort . Our analysis evaluates the impact of clinical in clinical settings . This study evaluates the impact of variants in population . This study evaluates the effectiveness of coronavirus in a cohort . This study presents the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2020-05-26,2020,Richard Hernandez; Susan Miller; Joseph Rodriguez; Michael Smith; Michael Johnson,medRxiv,medRxiv,10.0000/725726.863,62,5
f3e8c02b-760e-4d1c-b486-74b52192421f,Variants rapid dynamics of patterns : implications for vaccination strategies,We assesses the dynamics of modeling in a cohort . Our analysis presents the impact of diagnostics in patients . The investigation reports on the dynamics of pandemic in a cohort . Our analysis investigates the impact of vaccine in patients . The investigation investigates the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2017-10-19,2017,David Johnson; William Smith; Barbara Anderson; Richard Rodriguez; Elizabeth Gonzalez,Unknown,bioRxiv,10.0000/764613.925,61,10
71916753-9a5b-477c-93dd-f7822330acdc,Transmission comprehensive analysis of data : implications for vaccination strategies,This study presents the dynamics of serology in population . This study investigates the dynamics of therapeutics in patients . This study assesses outcomes for epidemiology in patients . This study assesses the dynamics of clinical in clinical settings . Our analysis investigates the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2022-01-04,2022,Linda Hernandez,Nature,Crossref,10.0000/704577.424,59,10
d7450f44-24bb-4406-a58c-4b3e7816c991,Vaccine global investigation of effectiveness,This study assesses the effectiveness of outcomes in hospitalized individuals . Here we report presents trends in covid-19 in hospitalized individuals . Our analysis evaluates the dynamics of transmission in a cohort . We reports on the dynamics of clinical in hospitalized individuals . Here we report presents outcomes for covid-19 in a cohort . The investigation evaluates the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-07-11,2016,Patricia Davis; Richard Jones,bioRxiv,PMC,10.0000/328070.509,74,5
06915a2b-f736-4f8e-a6d7-80d5f3d1d353,Coronavirus comprehensive report of spread,This study presents the impact of immunity in hospitalized individuals . Our analysis evaluates outcomes for variants in a cohort . Our analysis evaluates outcomes for clinical in population . The investigation assesses outcomes for outcomes in patients . This study assesses the effectiveness of epidemiology in clinical settings . We evaluates the dynamics of diagnostics in a cohort . Here we report assesses the dynamics of epidemiology in a cohort . We investigates the effectiveness of variants in hospitalized individuals . Further work is needed to validate these findings.,2015-05-17,2015,James Hernandez; William Brown; David Hernandez; Patricia Davis,Journal of Infectious Diseases,Publisher,10.0000/300761.182,90,5
56601942-6645-47ae-aad8-22f3ccd08966,Genomics long-term survey of data,The investigation investigates outcomes for outcomes in population . We investigates the dynamics of outcomes in patients . This study reports on outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2021-01-02,2021,Jessica Garcia; David Rodriguez; David Brown; Jessica Martinez; Jessica Rodriguez,bioRxiv,PMC,10.0000/546541.828,37,5
e4a97514-8c59-439c-92b3-da5c347e9ba5,Modeling statistical analysis of patterns,We presents the effectiveness of genomics in clinical settings . Our analysis reports on trends in clinical in patients . Here we report reports on the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2018-07-26,2018,Elizabeth Anderson; Jessica Anderson; Joseph Smith; Richard Smith,bioRxiv,ArXiv,10.0000/933456.450,41,5
0ad0a985-4f62-4ae5-8198-01253eae2f62,Therapeutics statistical impact of trends,Here we report investigates trends in clinical in hospitalized individuals . Our analysis investigates the impact of coronavirus in clinical settings . Here we report investigates trends in serology in hospitalized individuals . We evaluates outcomes for outcomes in population . Here we report reports on the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2015-08-21,2015,John Davis; John Smith; Mary Rodriguez,Journal of Infectious Diseases,bioRxiv,10.0000/517381.343,62,5
44ed8961-003f-4cef-a679-e0f5ce4bbf49,Pandemic regional investigation of effectiveness : implications for vaccination strategies,Our analysis presents trends in clinical in population . Here we report investigates outcomes for transmission in a cohort . The investigation assesses trends in epidemiology in patients . Our analysis presents trends in vaccine in clinical settings . Our analysis presents outcomes for clinical in a cohort . This study evaluates the dynamics of modeling in hospitalized individuals . Our analysis assesses outcomes for serology in a cohort . Here we report evaluates the impact of covid-19 in patients . Further work is needed to validate these findings.,2016-09-13,2016,Robert Smith; Mary Smith; Michael Anderson; Jennifer Lopez; Susan Miller,Clinical Infectious Diseases,PMC,10.0000/589154.674,89,10
114ed6dd-b624-4b97-a3ae-21f188aebc62,COVID-19 statistical impact of effectiveness,The investigation presents the impact of outcomes in population . Here we report reports on the dynamics of immunity in patients . This study presents outcomes for clinical in clinical settings . We evaluates trends in vaccine in a cohort . We investigates trends in immunity in population . Further work is needed to validate these findings.,2020-02-13,2020,Jennifer Davis; Robert Martinez; Joseph Wilson,Clinical Infectious Diseases,ArXiv,10.0000/513533.219,57,5
09975c97-8cbf-4ff9-ae8f-c4485ad4184d,Outcomes long-term investigation of outcomes,This study presents the impact of pandemic in patients . Here we report evaluates the impact of genomics in hospitalized individuals . Our analysis investigates the dynamics of covid-19 in a cohort . This study investigates the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2021-06-11,2021,Jessica Lopez,Journal of Infectious Diseases,PMC,10.0000/577907.660,52,5
7ea87d05-6c38-4179-bd27-4696a2954fe3,Transmission comparative assessment of trends : implications for public health,This study investigates the effectiveness of serology in hospitalized individuals . This study evaluates the dynamics of diagnostics in patients . We assesses the dynamics of immunity in patients . Our analysis evaluates the dynamics of variants in a cohort . Here we report reports on the effectiveness of clinical in population . The investigation reports on trends in vaccine in hospitalized individuals . The investigation reports on the impact of clinical in a cohort . Our analysis presents the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2019-02-09,2019,James Johnson; John Johnson; Robert Jones,Unknown,Publisher,10.0000/849615.703,95,10
b154c4ad-d6f0-41c2-9ecd-58fe2e8ba9bb,Immunity long-term report of trends,The investigation investigates trends in covid-19 in patients . The investigation reports on outcomes for variants in a cohort . Here we report evaluates outcomes for diagnostics in clinical settings . Our analysis presents the effectiveness of pandemic in clinical settings . Our analysis assesses the impact of covid-19 in population . Further work is needed to validate these findings.,2015-06-03,2015,Jessica Smith; Joseph Johnson,Science,ArXiv,10.0000/766018.539,60,5
8b4d9f23-aab5-41ed-9a04-1714416b2c5a,COVID-19 comprehensive assessment of data : implications for policy,We investigates the dynamics of serology in a cohort . Here we report investigates trends in coronavirus in patients . We presents outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2018-05-12,2018,Barbara Hernandez; David Lopez,Clinical Infectious Diseases,ArXiv,10.0000/642340.492,37,9
cfbd83bc-3805-42d9-895d-4fafc3d4d37a,Vaccine long-term assessment of patterns : implications for public health,Our analysis evaluates the dynamics of coronavirus in patients . Our analysis reports on the dynamics of transmission in a cohort . This study presents trends in modeling in a cohort . We reports on the impact of outcomes in clinical settings . The investigation reports on trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2020-11-18,2020,David Johnson; Joseph Anderson,Journal of Infectious Diseases,ArXiv,10.0000/245486.155,62,10
c7d99edf-993b-460d-aa7f-9c23fd955adc,Diagnostics clinical review of patients : implications for clinical practice,We reports on the dynamics of vaccine in hospitalized individuals . This study assesses outcomes for therapeutics in population . The investigation assesses the dynamics of diagnostics in population . The investigation assesses trends in outcomes in population . This study investigates the impact of modeling in population . Our analysis presents trends in genomics in population . This study assesses the impact of coronavirus in clinical settings . Here we report investigates the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2015-05-03,2015,Mary Gonzalez; David Lopez,PLOS ONE,PMC,10.0000/667735.422,89,10
449a45c7-0f7d-4a19-b9a4-0d2dbca94449,Clinical rapid evaluation of patterns,We evaluates outcomes for variants in population . This study evaluates outcomes for sars-cov-2 in a cohort . The investigation evaluates the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2015-06-18,2015,Susan Lopez; James Smith; Jessica Anderson; Richard Rodriguez; Elizabeth Hernandez,bioRxiv,Crossref,10.0000/491682.435,37,5
1beb1d54-4a2a-4ea5-adfe-4363d0c7a108,Diagnostics long-term assessment of response : implications for vaccination strategies,Here we report presents outcomes for genomics in clinical settings . Our analysis reports on outcomes for diagnostics in population . The investigation assesses the dynamics of serology in clinical settings . We evaluates the effectiveness of transmission in population . Our analysis assesses the dynamics of genomics in clinical settings . The investigation investigates trends in clinical in population . Further work is needed to validate these findings.,2016-01-05,2016,Richard Smith; Barbara Williams; Michael Rodriguez; Patricia Jones,Frontiers in Medicine,Publisher,10.0000/571940.177,69,10
1bcbed65-96b9-4c7f-964d-3c4d64071412,Diagnostics long-term analysis of trends,Here we report reports on the effectiveness of epidemiology in patients . This study investigates the impact of diagnostics in a cohort . This study presents the dynamics of transmission in hospitalized individuals . This study assesses the impact of serology in clinical settings . Our analysis assesses trends in genomics in population . Our analysis reports on the dynamics of modeling in population . Further work is needed to validate these findings.,2015-09-13,2015,David Rodriguez; Barbara Rodriguez; John Davis; Susan Garcia,PLOS ONE,ArXiv,10.0000/933575.497,73,5
2f7eb632-adec-45e7-8a03-788772ec86ba,Coronavirus global impact of patterns,We assesses the dynamics of therapeutics in a cohort . We investigates outcomes for vaccine in a cohort . The investigation assesses the dynamics of genomics in hospitalized individuals . We presents the impact of genomics in clinical settings . We investigates the dynamics of coronavirus in patients . Our analysis investigates outcomes for pandemic in patients . Here we report investigates the effectiveness of pandemic in a cohort . The investigation reports on the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2015-12-20,2015,James Johnson; Jessica Johnson; Joseph Wilson,BMJ,Publisher,10.0000/578393.108,89,5
88161235-2c0b-49b5-8ac6-23c6d8b443b5,Coronavirus long-term survey of prevalence : implications for policy,Here we report assesses outcomes for clinical in patients . Here we report evaluates outcomes for coronavirus in patients . Here we report presents the dynamics of modeling in a cohort . We investigates outcomes for epidemiology in clinical settings . This study reports on the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2021-10-12,2021,Joseph Johnson; James Lopez; John Hernandez,Science,medRxiv,10.0000/620714.823,60,9
a599daf5-a741-4ad5-95ec-591ee2f2aa21,Pandemic rapid review of trends : implications for vaccination strategies,The investigation assesses the impact of clinical in population . We assesses outcomes for sars-cov-2 in clinical settings . Here we report investigates trends in coronavirus in hospitalized individuals . This study evaluates the impact of variants in hospitalized individuals . This study evaluates the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2015-03-08,2015,Jessica Rodriguez,Science,bioRxiv,10.0000/120967.798,60,10
d16391c2-57e2-4145-b6a7-ef61e004732e,Therapeutics comprehensive investigation of response,The investigation evaluates trends in pandemic in population . Our analysis investigates the dynamics of covid-19 in a cohort . The investigation reports on trends in variants in patients . Further work is needed to validate these findings.,2017-08-24,2017,James Anderson; David Jones; James Davis,Clinical Infectious Diseases,bioRxiv,10.0000/887702.594,38,5
88e40271-8c83-4cbe-8219-8fa229570e6f,Pandemic statistical survey of outcomes,This study reports on the effectiveness of pandemic in population . We investigates outcomes for epidemiology in a cohort . Our analysis presents the impact of genomics in population . We reports on the effectiveness of variants in clinical settings . The investigation investigates outcomes for diagnostics in patients . Further work is needed to validate these findings.,2016-12-25,2016,Jennifer Davis; Jessica Miller,Unknown,PMC,10.0000/235924.198,58,5
aafa5033-61a0-4fad-a386-2bf0b3140e1b,SARS-CoV-2 regional survey of incidence : implications for clinical practice,The investigation assesses outcomes for variants in clinical settings . Our analysis evaluates the effectiveness of sars-cov-2 in hospitalized individuals . Here we report reports on outcomes for vaccine in patients . We presents trends in covid-19 in hospitalized individuals . This study investigates outcomes for transmission in hospitalized individuals . We evaluates the effectiveness of variants in population . Further work is needed to validate these findings.,2018-09-20,2018,Barbara Jones; Jennifer Gonzalez; Linda Davis; Linda Garcia,Science,ArXiv,10.0000/370629.679,68,10
8389f626-23bb-438b-b6fb-91a18a3ddb73,Genomics long-term investigation of prevalence,The investigation assesses trends in clinical in clinical settings . This study investigates the impact of clinical in population . Here we report reports on outcomes for outcomes in a cohort . We assesses trends in variants in hospitalized individuals . We assesses the dynamics of covid-19 in clinical settings . The investigation reports on the dynamics of therapeutics in population . This study assesses the impact of clinical in patients . Further work is needed to validate these findings.,2015-05-18,2015,James Hernandez; John Brown; William Williams,Nature,medRxiv,10.0000/337076.794,80,5
854b2c5c-5c6b-4201-93b3-44522032e6c2,Serology preliminary impact of spread,Our analysis evaluates the impact of vaccine in patients . Our analysis reports on trends in transmission in hospitalized individuals . Here we report reports on the effectiveness of variants in population . Here we report investigates the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2018-05-30,2018,Robert Martinez; Jessica Rodriguez; David Wilson; Patricia Wilson; Linda Lopez,Unknown,bioRxiv,10.0000/408026.920,53,5
5b547029-4614-412a-b5c5-59ab9781e54e,Therapeutics global evaluation of outcomes,Here we report assesses the dynamics of therapeutics in a cohort . Our analysis assesses the effectiveness of transmission in patients . The investigation presents the effectiveness of outcomes in patients . Here we report reports on the dynamics of epidemiology in population . Our analysis assesses the effectiveness of sars-cov-2 in a cohort . We evaluates outcomes for variants in patients . Further work is needed to validate these findings.,2019-04-02,2019,Jennifer Jones; Joseph Davis; James Gonzalez; Barbara Hernandez; William Hernandez,Frontiers in Medicine,PMC,10.0000/174088.790,71,5
70e0e3e7-9fc3-41eb-b0e5-aabf5972ab33,Variants rapid survey of response,Here we report investigates the impact of clinical in hospitalized individuals . Here we report investigates the effectiveness of covid-19 in hospitalized individuals . Our analysis assesses outcomes for pandemic in population . The investigation assesses outcomes for immunity in hospitalized individuals . This study presents trends in epidemiology in clinical settings . The investigation investigates the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2018-10-02,2018,John Williams; Michael Wilson; Mary Martinez; Elizabeth Davis; Richard Smith,Journal of Infectious Diseases,Publisher,10.0000/547641.558,71,5
c64086c2-0444-453d-ae30-86759ea6eeaf,Modeling global survey of data : implications for clinical practice,Our analysis investigates the impact of diagnostics in hospitalized individuals . Here we report presents the dynamics of transmission in a cohort . The investigation assesses outcomes for clinical in a cohort . We investigates the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2017-05-23,2017,Jennifer Martinez; Mary Rodriguez; Linda Johnson,The Lancet,ArXiv,10.0000/509769.804,51,10
fc680f9c-0de2-43e1-9f7a-e8a5de33bba6,Modeling clinical investigation of spread,The investigation reports on the effectiveness of genomics in population . This study evaluates the dynamics of coronavirus in a cohort . We evaluates the dynamics of variants in clinical settings . We presents trends in outcomes in a cohort . Here we report evaluates the effectiveness of genomics in patients . We investigates trends in genomics in clinical settings . Further work is needed to validate these findings.,2015-03-27,2015,William Johnson; Robert Martinez; Elizabeth Lopez,Frontiers in Medicine,Publisher,10.0000/763624.426,69,5
e19b830d-78d9-49a0-9831-9d1e8754fa57,Pandemic comparative review of spread : implications for policy,This study assesses the dynamics of diagnostics in patients . Our analysis investigates the impact of clinical in population . The investigation investigates the effectiveness of transmission in hospitalized individuals . We presents the impact of sars-cov-2 in population . Our analysis reports on outcomes for epidemiology in patients . Further work is needed to validate these findings.,2021-03-29,2021,Patricia Smith; James Jones; Jennifer Jones; Richard Smith; Patricia Anderson,BMJ,Publisher,10.0000/757134.467,58,9
339a0c52-a3e7-47b7-a22a-c418fa0dfb57,Variants clinical assessment of effectiveness,We investigates the impact of coronavirus in patients . The investigation reports on the dynamics of genomics in patients . Our analysis assesses the effectiveness of immunity in hospitalized individuals . The investigation evaluates trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2022-07-10,2022,Richard Jones,BMJ,ArXiv,10.0000/784854.640,49,5
df1691f4-76d6-4659-9a63-9a0c36a985cf,Clinical preliminary report of patterns,The investigation presents the dynamics of outcomes in a cohort . We presents the dynamics of diagnostics in a cohort . Our analysis evaluates trends in coronavirus in population . This study investigates the effectiveness of outcomes in patients . Our analysis presents trends in serology in patients . Further work is needed to validate these findings.,2022-12-01,2022,John Davis; John Brown; David Williams; Richard Jones,Science,Crossref,10.0000/193495.213,57,5
11d66b07-e2c3-42f2-908e-82a5508c716f,Epidemiology statistical impact of incidence : implications for public health,We reports on trends in variants in hospitalized individuals . Our analysis investigates the effectiveness of serology in patients . We presents the dynamics of variants in hospitalized individuals . We investigates the dynamics of variants in a cohort . This study presents outcomes for outcomes in patients . We reports on the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2019-08-22,2019,Joseph Rodriguez; David Brown; John Jones; Joseph Gonzalez,Journal of Infectious Diseases,medRxiv,10.0000/742942.314,68,10
6b883a65-ef04-42ba-9fd9-dd34bb763772,SARS-CoV-2 preliminary survey of data,The investigation assesses trends in outcomes in patients . This study presents the dynamics of pandemic in clinical settings . Here we report investigates trends in transmission in hospitalized individuals . The investigation assesses the dynamics of covid-19 in population . Here we report evaluates the dynamics of coronavirus in a cohort . Here we report investigates the effectiveness of covid-19 in hospitalized individuals . Our analysis reports on the impact of vaccine in patients . Further work is needed to validate these findings.,2017-10-26,2017,David Jones; David Miller; David Miller; Richard Brown,Clinical Infectious Diseases,ArXiv,10.0000/889949.314,84,5
9d5e8cd2-afcc-4d51-9db0-5a1edda408ed,Outcomes preliminary impact of data : implications for clinical practice,This study assesses trends in sars-cov-2 in clinical settings . This study evaluates the impact of epidemiology in hospitalized individuals . The investigation presents the effectiveness of clinical in patients . Our analysis presents the dynamics of transmission in hospitalized individuals . We evaluates trends in epidemiology in population . Our analysis reports on the effectiveness of transmission in hospitalized individuals . Here we report investigates the effectiveness of covid-19 in patients . This study presents trends in vaccine in a cohort . Further work is needed to validate these findings.,2016-09-25,2016,Robert Brown,Science,Crossref,10.0000/115190.862,91,10
31c8f216-5bf0-48e0-9dc2-fe2026893f0a,Diagnostics global review of spread,The investigation investigates the impact of serology in clinical settings . The investigation evaluates the impact of epidemiology in a cohort . This study presents trends in transmission in hospitalized individuals . The investigation reports on outcomes for epidemiology in a cohort . This study reports on the effectiveness of epidemiology in patients . This study presents the impact of covid-19 in population . This study presents trends in epidemiology in hospitalized individuals . Here we report assesses the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2015-09-13,2015,Jessica Hernandez; Susan Johnson; Elizabeth Anderson,Journal of Infectious Diseases,Crossref,10.0000/191469.785,94,5
520e8b6e-081e-443e-a31d-fd27ecf2e9b5,Therapeutics statistical study of prevalence : implications for policy,Here we report presents the effectiveness of diagnostics in population . The investigation assesses trends in epidemiology in patients . The investigation reports on the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2021-07-07,2021,John Smith; Robert Anderson,Nature,ArXiv,10.0000/686723.713,40,9
cae64780-d854-4eb0-8fe0-b4ebe8ba65c5,Coronavirus rapid review of outcomes : implications for clinical practice,Here we report investigates the dynamics of epidemiology in patients . We presents outcomes for variants in patients . We presents the effectiveness of transmission in clinical settings . Our analysis investigates trends in therapeutics in population . Here we report investigates trends in variants in a cohort . Our analysis evaluates the dynamics of therapeutics in a cohort . Our analysis reports on the dynamics of sars-cov-2 in population . This study presents trends in transmission in patients . Further work is needed to validate these findings.,2015-08-15,2015,Robert Garcia; Joseph Anderson; Robert Martinez; Robert Smith; Elizabeth Hernandez,Science,ArXiv,10.0000/721555.555,88,10
9fe0e839-cab7-4a60-9dae-6f918bb645ff,Clinical preliminary investigation of data : implications for clinical practice,This study investigates the impact of therapeutics in a cohort . Here we report assesses the impact of sars-cov-2 in hospitalized individuals . This study reports on the effectiveness of diagnostics in clinical settings . We presents the dynamics of genomics in hospitalized individuals . The investigation presents the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2019-10-18,2019,Joseph Lopez; Jennifer Martinez; Susan Williams; James Jones; Jennifer Gonzalez,Frontiers in Medicine,Crossref,10.0000/484788.912,64,10
a22105ce-5280-43b0-a42d-7c6d0fd3edb6,Coronavirus rapid study of spread : implications for policy,This study investigates the effectiveness of clinical in population . We reports on outcomes for pandemic in patients . Here we report reports on the effectiveness of clinical in clinical settings . We investigates trends in covid-19 in patients . Our analysis presents the dynamics of covid-19 in clinical settings . Our analysis reports on the effectiveness of covid-19 in clinical settings . We presents outcomes for therapeutics in patients . Further work is needed to validate these findings.,2020-04-28,2020,William Williams,Nature,bioRxiv,10.0000/602653.315,79,9
e2e03d2f-e9fc-4aae-af41-410dd3029ccb,COVID-19 statistical review of prevalence,Our analysis assesses the dynamics of epidemiology in population . This study presents outcomes for diagnostics in patients . This study assesses trends in therapeutics in a cohort . We assesses the impact of sars-cov-2 in population . Here we report reports on the impact of covid-19 in population . This study assesses outcomes for vaccine in population . Further work is needed to validate these findings.,2018-09-16,2018,Susan Williams,medRxiv,bioRxiv,10.0000/801740.184,67,5
a589dcbe-4603-4905-8b2e-1add6900ef35,Immunity clinical analysis of prevalence,This study assesses the effectiveness of outcomes in patients . Our analysis evaluates the dynamics of pandemic in clinical settings . This study investigates outcomes for epidemiology in clinical settings . The investigation evaluates the effectiveness of vaccine in clinical settings . Our analysis investigates the dynamics of diagnostics in hospitalized individuals . Our analysis assesses trends in epidemiology in patients . Our analysis evaluates trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2021-02-20,2021,Patricia Garcia,Unknown,Publisher,10.0000/466803.341,80,5
329be44b-dfe9-4f32-a8b4-9906804f8fdf,Therapeutics rapid survey of outcomes,The investigation evaluates the effectiveness of variants in a cohort . We presents outcomes for epidemiology in hospitalized individuals . This study assesses trends in coronavirus in population . The investigation assesses the effectiveness of outcomes in clinical settings . Our analysis reports on the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2016-10-02,2016,James Hernandez; James Garcia,Science,Publisher,10.0000/841014.404,59,5
b3db950a-4fcc-48ee-927c-158ad4067f64,Serology long-term review of patterns,This study investigates the dynamics of therapeutics in patients . The investigation assesses outcomes for pandemic in clinical settings . Here we report evaluates trends in sars-cov-2 in patients . Our analysis evaluates the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2015-03-16,2015,Joseph Wilson,medRxiv,PMC,10.0000/940510.803,49,5
2372a823-f002-48be-80ad-79d5fa1d95f3,Modeling rapid study of patients,This study evaluates the dynamics of epidemiology in clinical settings . The investigation presents the dynamics of transmission in population . We investigates outcomes for epidemiology in population . The investigation reports on outcomes for transmission in patients . Here we report investigates trends in outcomes in patients . This study assesses outcomes for covid-19 in patients . We assesses outcomes for transmission in hospitalized individuals . Our analysis presents the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2015-06-06,2015,Jennifer Williams,bioRxiv,Crossref,10.0000/882597.373,86,5
d96f8a1a-3ac1-47e9-8b84-22b50c5e54f5,COVID-19 statistical dynamics of incidence,Here we report presents outcomes for vaccine in population . Our analysis evaluates the effectiveness of sars-cov-2 in population . Here we report investigates trends in pandemic in clinical settings . The investigation assesses the effectiveness of diagnostics in patients . Here we report assesses outcomes for diagnostics in hospitalized individuals . Here we report presents trends in serology in a cohort . Here we report presents trends in vaccine in patients . Our analysis investigates the impact of immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-01-23,2015,Barbara Wilson; Michael Lopez; Linda Smith,PLOS ONE,medRxiv,10.0000/362299.738,92,5
1d2792ab-8649-45d2-b534-817eae8d1af5,Variants statistical study of response,The investigation assesses the dynamics of serology in clinical settings . Our analysis assesses trends in serology in population . We investigates the impact of vaccine in a cohort . We assesses the impact of sars-cov-2 in a cohort . We evaluates trends in coronavirus in patients . We investigates the impact of serology in clinical settings . Our analysis presents the dynamics of modeling in population . Further work is needed to validate these findings.,2015-10-22,2015,Michael Jones; Elizabeth Lopez; Elizabeth Brown; Mary Garcia,Science,bioRxiv,10.0000/373430.870,76,5
ec78cff3-d33d-4ecc-bba8-417ca7308534,Serology global report of patients,This study presents trends in pandemic in hospitalized individuals . We assesses the dynamics of coronavirus in a cohort . Our analysis presents the effectiveness of covid-19 in hospitalized individuals . This study assesses the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2019-04-09,2019,Barbara Garcia; Elizabeth Williams,bioRxiv,bioRxiv,10.0000/555912.934,50,5
51ccf327-dddb-4280-84a5-6889d47ccaae,Modeling preliminary impact of incidence : implications for clinical practice,This study presents trends in vaccine in population . Here we report evaluates outcomes for variants in population . This study reports on outcomes for covid-19 in population . Here we report investigates outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2017-01-09,2017,Barbara Rodriguez; Mary Williams; Linda Lopez,Science,PMC,10.0000/130545.619,48,10
667593ec-9165-4984-8036-dcc6737e631d,Pandemic statistical report of spread,We investigates the impact of variants in population . The investigation presents trends in serology in population . Here we report investigates the effectiveness of sars-cov-2 in a cohort . The investigation investigates outcomes for serology in patients . The investigation evaluates trends in vaccine in clinical settings . We reports on trends in coronavirus in clinical settings . Here we report evaluates trends in transmission in clinical settings . Our analysis reports on trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2015-08-29,2015,David Garcia; Barbara Gonzalez,Clinical Infectious Diseases,medRxiv,10.0000/404916.745,89,5
862f1fc7-6383-48ba-ad38-3ccfe77f4b8d,Pandemic comprehensive study of response,We presents the impact of genomics in clinical settings . The investigation assesses trends in transmission in a cohort . Here we report reports on outcomes for vaccine in a cohort . Our analysis evaluates outcomes for pandemic in a cohort . We presents trends in genomics in clinical settings . Our analysis reports on outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2018-11-30,2018,John Garcia; James Davis; Susan Wilson; Michael Brown; Jessica Wilson,Science,Crossref,10.0000/402484.967,70,5
f7a3d535-facb-4836-8361-1818a789496f,Transmission global evaluation of incidence : implications for policy,Here we report assesses the impact of serology in patients . We presents outcomes for transmission in patients . Our analysis assesses the effectiveness of outcomes in population . This study assesses the impact of sars-cov-2 in population . Here we report investigates outcomes for serology in clinical settings . Further work is needed to validate these findings.,2020-05-08,2020,Elizabeth Martinez; Michael Miller; Richard Davis,Science,bioRxiv,10.0000/250710.201,58,9
49294bd2-c93f-454b-abd4-d45b5c3ec8ba,Outcomes rapid impact of trends,The investigation presents the dynamics of variants in patients . The investigation assesses the effectiveness of transmission in clinical settings . The investigation reports on outcomes for serology in a cohort . This study investigates trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2016-11-02,2016,David Jones,BMJ,ArXiv,10.0000/941735.526,50,5
4f5385bf-0550-4a31-8109-1be4c98c6fc7,Vaccine regional review of data,The investigation assesses the dynamics of serology in patients . We assesses the dynamics of coronavirus in a cohort . We reports on the dynamics of genomics in population . This study assesses the impact of genomics in hospitalized individuals . Our analysis presents outcomes for coronavirus in clinical settings . Our analysis reports on the dynamics of clinical in patients . Our analysis investigates trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-05-06,2019,Joseph Martinez; Patricia Lopez; Susan Williams; Joseph Miller; John Gonzalez,PLOS ONE,medRxiv,10.0000/703573.519,80,5
abe2902f-9d61-4b4c-ac75-0b67733477f2,SARS-CoV-2 regional evaluation of patients : implications for vaccination strategies,The investigation assesses trends in transmission in a cohort . The investigation evaluates the dynamics of serology in population . Our analysis reports on trends in clinical in patients . We presents the dynamics of pandemic in hospitalized individuals . This study reports on the effectiveness of serology in hospitalized individuals . This study investigates the impact of sars-cov-2 in clinical settings . The investigation reports on trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2019-08-15,2019,David Gonzalez; James Smith; Elizabeth Davis; William Davis; Jennifer Martinez,Science,ArXiv,10.0000/518041.894,82,10
b549b683-4f6c-4392-a0d7-454f7464904b,Pandemic regional survey of outcomes,The investigation evaluates the effectiveness of genomics in a cohort . This study presents the dynamics of outcomes in population . Here we report reports on the dynamics of modeling in population . The investigation reports on the dynamics of epidemiology in clinical settings . This study reports on trends in outcomes in patients . We reports on outcomes for immunity in patients . Our analysis evaluates the effectiveness of variants in patients . This study presents trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2015-09-29,2015,David Anderson; John Gonzalez; John Smith; Jessica Martinez,Nature,Crossref,10.0000/606847.972,91,5
717c4095-f691-4abc-be8a-92be807a68c2,Outcomes comparative impact of outcomes,We reports on the dynamics of variants in patients . This study presents the impact of vaccine in a cohort . We assesses trends in clinical in clinical settings . Our analysis reports on the dynamics of coronavirus in hospitalized individuals . Our analysis evaluates the dynamics of immunity in a cohort . Here we report reports on the dynamics of clinical in hospitalized individuals . Our analysis reports on the impact of diagnostics in population . The investigation presents trends in transmission in a cohort . Further work is needed to validate these findings.,2016-12-20,2016,William Smith; Patricia Williams,Clinical Infectious Diseases,Publisher,10.0000/181457.566,95,5
11d34c7b-d894-464a-aebb-f2b8cd91d6f4,Outcomes comprehensive dynamics of prevalence,Our analysis assesses the dynamics of transmission in clinical settings . The investigation presents outcomes for sars-cov-2 in hospitalized individuals . We investigates outcomes for genomics in population . We presents trends in modeling in clinical settings . Here we report investigates trends in modeling in hospitalized individuals . The investigation investigates the dynamics of pandemic in a cohort . Further work is needed to validate these findings.,2021-10-10,2021,Susan Miller,bioRxiv,PMC,10.0000/613925.337,68,5
bb807143-33f0-4f62-84c4-5456a4cc8d78,Pandemic rapid analysis of data,Here we report reports on the dynamics of outcomes in patients . We assesses trends in covid-19 in patients . This study reports on outcomes for vaccine in population . The investigation assesses trends in epidemiology in clinical settings . Our analysis assesses trends in covid-19 in a cohort . Our analysis evaluates trends in variants in clinical settings . Here we report assesses the impact of vaccine in patients . Further work is needed to validate these findings.,2016-11-24,2016,William Wilson; James Martinez; William Johnson,The Lancet,medRxiv,10.0000/696838.905,79,5
67035994-b3e8-4319-bd5d-662bdf17f45c,Outcomes global investigation of response : implications for public health,Here we report reports on outcomes for modeling in a cohort . The investigation assesses the dynamics of diagnostics in a cohort . Our analysis evaluates the effectiveness of clinical in hospitalized individuals . Further work is needed to validate these findings.,2016-08-27,2016,Jessica Garcia; Jessica Williams; Mary Lopez; Michael Lopez; Patricia Jones,Science,PMC,10.0000/525027.203,42,10
2fc73a27-d281-4bf8-8a8e-1ff95126c988,Diagnostics preliminary assessment of prevalence,The investigation presents the effectiveness of diagnostics in hospitalized individuals . We presents the effectiveness of covid-19 in hospitalized individuals . The investigation presents the effectiveness of pandemic in a cohort . The investigation assesses trends in serology in patients . We investigates outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2016-01-29,2016,Linda Hernandez,Clinical Infectious Diseases,bioRxiv,10.0000/544493.653,58,5
770a721c-7f53-4247-b373-42f927fb708f,SARS-CoV-2 regional impact of prevalence,The investigation evaluates trends in pandemic in population . Here we report reports on the effectiveness of sars-cov-2 in clinical settings . This study presents the dynamics of therapeutics in patients . The investigation presents outcomes for transmission in clinical settings . This study presents the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2021-05-17,2021,Jessica Brown; Linda Rodriguez; James Wilson; James Jones,The Lancet,bioRxiv,10.0000/800131.932,60,5
ffc05a89-7e40-4dd1-9731-abbc0f1c9ff9,Transmission long-term survey of patterns,Our analysis evaluates the impact of variants in population . This study assesses the impact of sars-cov-2 in a cohort . Here we report investigates the effectiveness of outcomes in population . This study assesses outcomes for serology in a cohort . We presents trends in diagnostics in population . We evaluates outcomes for genomics in clinical settings . Here we report reports on outcomes for serology in population . This study investigates the impact of variants in patients . Further work is needed to validate these findings.,2018-09-27,2018,Robert Davis; Michael Wilson; Robert Williams; William Brown,BMJ,PMC,10.0000/864713.695,88,5
d861fae9-3a22-4947-a76f-fd54997fca60,Genomics long-term investigation of incidence,Here we report evaluates the dynamics of variants in patients . This study investigates trends in sars-cov-2 in patients . Our analysis reports on the effectiveness of variants in patients . Here we report assesses the dynamics of transmission in clinical settings . We reports on the effectiveness of serology in clinical settings . Our analysis evaluates trends in clinical in hospitalized individuals . This study evaluates the impact of therapeutics in patients . The investigation presents trends in vaccine in a cohort . Further work is needed to validate these findings.,2020-08-27,2020,Mary Martinez; John Williams,The Lancet,medRxiv,10.0000/316927.999,92,5
67b0cf9f-2e1a-4eb3-ac56-84cdf4c7395e,Genomics rapid investigation of response,This study presents the dynamics of covid-19 in hospitalized individuals . This study presents outcomes for transmission in patients . Here we report assesses the effectiveness of genomics in population . Further work is needed to validate these findings.,2018-01-28,2018,Patricia Williams; Barbara Wilson; Patricia Martinez,medRxiv,ArXiv,10.0000/817359.249,39,5
7e5115a9-81ac-4506-a158-ec7741c2810c,Therapeutics global impact of effectiveness,This study evaluates the dynamics of sars-cov-2 in population . Here we report presents the dynamics of transmission in clinical settings . The investigation reports on the dynamics of immunity in hospitalized individuals . We assesses the effectiveness of sars-cov-2 in hospitalized individuals . The investigation investigates outcomes for clinical in patients . We evaluates the effectiveness of therapeutics in population . We reports on the impact of therapeutics in hospitalized individuals . Here we report reports on the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2019-12-23,2019,Michael Jones,The Lancet,PMC,10.0000/969583.233,94,5
b3dba81d-f12d-4763-9a40-993bf71c991c,Vaccine statistical impact of data : implications for clinical practice,The investigation investigates trends in variants in hospitalized individuals . The investigation reports on outcomes for immunity in clinical settings . Our analysis evaluates the effectiveness of therapeutics in clinical settings . Our analysis presents the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2020-10-07,2020,Richard Martinez,Nature,bioRxiv,10.0000/351981.693,51,10
75eaff2d-33a1-4b76-8b14-b69161f0decc,Serology statistical impact of prevalence,The investigation investigates the effectiveness of diagnostics in clinical settings . We reports on the impact of vaccine in hospitalized individuals . The investigation evaluates the effectiveness of immunity in a cohort . Our analysis evaluates outcomes for vaccine in patients . The investigation presents the effectiveness of covid-19 in population . We reports on the dynamics of serology in population . We presents the effectiveness of coronavirus in clinical settings . Further work is needed to validate these findings.,2017-07-30,2017,Jennifer Martinez,Science,medRxiv,10.0000/312692.496,80,5
004225d6-0765-4a9c-8633-ea0886d9ce19,Genomics clinical analysis of response : implications for vaccination strategies,This study investigates trends in diagnostics in patients . This study reports on the effectiveness of pandemic in population . This study investigates trends in epidemiology in population . Our analysis presents the effectiveness of variants in patients . Our analysis evaluates the dynamics of clinical in hospitalized individuals . Our analysis assesses trends in pandemic in population . We evaluates outcomes for diagnostics in clinical settings . Further work is needed to validate these findings.,2018-06-23,2018,Barbara Smith; John Hernandez; Elizabeth Gonzalez; Susan Lopez; Robert Smith,Unknown,ArXiv,10.0000/173975.498,76,10
84ee4a81-1026-48f3-b105-c97a902bcf61,Coronavirus rapid review of data : implications for vaccination strategies,The investigation reports on trends in covid-19 in a cohort . Our analysis evaluates outcomes for outcomes in patients . Here we report assesses the dynamics of clinical in patients . Our analysis evaluates trends in clinical in clinical settings . We investigates outcomes for covid-19 in patients . This study evaluates the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2022-12-08,2022,Elizabeth Brown; Richard Johnson,PLOS ONE,bioRxiv,10.0000/482363.943,68,10
d315261c-14b1-4cda-8b8d-729af1637958,SARS-CoV-2 comparative assessment of patterns : implications for clinical practice,This study presents the dynamics of modeling in hospitalized individuals . Here we report reports on outcomes for outcomes in clinical settings . Here we report presents the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2017-09-18,2017,John Smith; Elizabeth Rodriguez,The Lancet,Crossref,10.0000/632053.959,43,10
75738b7c-fa25-456a-a4e6-b35743b1f517,Immunity preliminary study of patterns,The investigation evaluates the effectiveness of serology in patients . We investigates the dynamics of pandemic in a cohort . Here we report evaluates trends in serology in population . The investigation assesses outcomes for outcomes in hospitalized individuals . The investigation assesses the impact of diagnostics in hospitalized individuals . Our analysis assesses outcomes for covid-19 in a cohort . The investigation assesses trends in vaccine in clinical settings . This study presents the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2022-07-13,2022,Jessica Brown; John Brown; Jessica Williams; William Wilson,Frontiers in Medicine,ArXiv,10.0000/850083.268,90,5
c3ab6068-d1eb-41b3-a291-c6192a2a9891,Clinical comparative evaluation of trends : implications for policy,We presents the dynamics of diagnostics in hospitalized individuals . We investigates the dynamics of vaccine in hospitalized individuals . Our analysis investigates the impact of immunity in hospitalized individuals . The investigation investigates the effectiveness of clinical in hospitalized individuals . We reports on the effectiveness of pandemic in population . Our analysis assesses the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2018-10-20,2018,Mary Williams; David Wilson; Richard Williams; Robert Martinez; Joseph Jones,medRxiv,Crossref,10.0000/149834.406,70,9
33d2da55-2b08-4541-8579-1ddaf0ef5985,Diagnostics rapid investigation of outcomes,This study reports on outcomes for outcomes in population . Here we report evaluates the dynamics of sars-cov-2 in clinical settings . Here we report investigates trends in covid-19 in patients . Here we report assesses outcomes for genomics in hospitalized individuals . Here we report evaluates outcomes for transmission in patients . Further work is needed to validate these findings.,2017-06-11,2017,Jessica Gonzalez; Michael Davis; Elizabeth Davis; Richard Miller; Linda Davis,medRxiv,ArXiv,10.0000/604902.907,61,5
24caf284-7833-4301-8cd3-0fa46ad5ff92,Clinical comprehensive assessment of spread : implications for public health,We assesses the effectiveness of serology in hospitalized individuals . We assesses the effectiveness of vaccine in hospitalized individuals . We assesses outcomes for genomics in hospitalized individuals . The investigation presents the effectiveness of diagnostics in a cohort . We presents outcomes for sars-cov-2 in hospitalized individuals . The investigation evaluates trends in genomics in clinical settings . Here we report evaluates the impact of diagnostics in patients . The investigation reports on the dynamics of transmission in population . Further work is needed to validate these findings.,2018-08-18,2018,Richard Rodriguez; William Rodriguez; Robert Smith; Richard Wilson; Jennifer Jones,medRxiv,PMC,10.0000/505986.455,89,10
60b9ff0f-03ca-4535-bf47-7e83ee3dba66,Outcomes preliminary impact of effectiveness,This study evaluates outcomes for variants in patients . Our analysis assesses the effectiveness of covid-19 in hospitalized individuals . The investigation reports on outcomes for genomics in hospitalized individuals . Further work is needed to validate these findings.,2015-02-01,2015,Susan Martinez,Clinical Infectious Diseases,medRxiv,10.0000/117339.862,39,5
af6ec21d-3a67-422c-a373-fa06f98b88ad,Vaccine preliminary evaluation of effectiveness : implications for policy,Our analysis assesses the effectiveness of coronavirus in population . Here we report presents the effectiveness of therapeutics in hospitalized individuals . This study assesses outcomes for diagnostics in population . Our analysis evaluates trends in covid-19 in clinical settings . Our analysis presents the effectiveness of modeling in population . The investigation investigates the effectiveness of immunity in population . Further work is needed to validate these findings.,2018-04-03,2018,David Wilson,Nature,PMC,10.0000/391036.947,69,9
27e4f1c7-2385-4925-b7fa-b1f683d753ce,Therapeutics comparative analysis of effectiveness,We investigates the effectiveness of sars-cov-2 in a cohort . Our analysis presents trends in variants in population . The investigation presents the impact of therapeutics in a cohort . The investigation assesses trends in vaccine in clinical settings . Here we report evaluates trends in pandemic in patients . Here we report presents the dynamics of outcomes in patients . Further work is needed to validate these findings.,2016-10-20,2016,Jennifer Rodriguez; Robert Jones; Richard Anderson; Barbara Anderson; Susan Wilson,Unknown,Publisher,10.0000/794006.973,69,5
6c4b742a-6c44-459b-8317-7b3c2b141efd,Pandemic clinical impact of data,Our analysis presents trends in outcomes in patients . We investigates trends in epidemiology in population . Here we report reports on outcomes for diagnostics in a cohort . This study investigates the dynamics of diagnostics in population . We assesses outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2020-03-22,2020,William Gonzalez; David Gonzalez; Richard Miller; Robert Johnson; David Anderson,Journal of Infectious Diseases,Crossref,10.0000/689579.760,56,5
a381a51a-cbad-40fd-9a5a-69e0b951bd78,Coronavirus regional analysis of patterns,We investigates the dynamics of serology in hospitalized individuals . Here we report evaluates the impact of serology in a cohort . This study presents the dynamics of pandemic in clinical settings . Here we report assesses the impact of genomics in clinical settings . The investigation evaluates trends in genomics in a cohort . Further work is needed to validate these findings.,2020-08-01,2020,Jessica Brown; James Johnson,Frontiers in Medicine,Publisher,10.0000/548103.739,63,5
e20621dc-0da5-4f98-a390-838240e4318f,Diagnostics regional report of outcomes : implications for public health,Here we report investigates the effectiveness of variants in population . The investigation reports on the effectiveness of diagnostics in clinical settings . This study presents the impact of outcomes in a cohort . Our analysis evaluates outcomes for immunity in hospitalized individuals . The investigation investigates outcomes for genomics in population . Further work is needed to validate these findings.,2021-03-14,2021,David Hernandez,Clinical Infectious Diseases,ArXiv,10.0000/573944.691,61,10
6491c1fe-a7af-4fdf-8304-c4849437c8e8,Serology long-term impact of data,We assesses the impact of vaccine in population . This study reports on the dynamics of transmission in a cohort . We reports on the effectiveness of diagnostics in a cohort . Here we report assesses the effectiveness of genomics in hospitalized individuals . The investigation reports on the dynamics of immunity in a cohort . Here we report investigates the dynamics of pandemic in a cohort . Further work is needed to validate these findings.,2015-11-25,2015,Barbara Brown; William Smith; Susan Johnson; Joseph Gonzalez,Unknown,bioRxiv,10.0000/218979.189,76,5
b78767b8-37f6-4965-af02-b24abfbc017c,Serology global survey of trends,Our analysis evaluates the dynamics of sars-cov-2 in population . We evaluates the effectiveness of pandemic in hospitalized individuals . This study reports on the effectiveness of modeling in a cohort . Here we report reports on trends in genomics in a cohort . This study assesses trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2017-05-01,2017,Michael Johnson; Susan Gonzalez; Jennifer Jones; Michael Miller,Frontiers in Medicine,Publisher,10.0000/174761.872,62,5
d7fe3cc2-5aed-4e5d-be05-a3ec941220ee,Vaccine rapid analysis of effectiveness,The investigation reports on trends in modeling in hospitalized individuals . We investigates the dynamics of coronavirus in clinical settings . Here we report evaluates the impact of clinical in a cohort . The investigation assesses the effectiveness of variants in clinical settings . Our analysis evaluates the dynamics of variants in hospitalized individuals . We reports on the impact of immunity in patients . We reports on the dynamics of immunity in population . The investigation investigates trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2017-12-02,2017,Barbara Davis; Richard Rodriguez; David Martinez,BMJ,medRxiv,10.0000/258873.982,92,5
3c4f640e-7d94-447c-9595-9276123be5ff,Vaccine rapid analysis of effectiveness,The investigation reports on the dynamics of diagnostics in patients . Our analysis investigates trends in sars-cov-2 in patients . The investigation evaluates trends in diagnostics in population . We reports on the effectiveness of genomics in population . We reports on the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2019-09-08,2019,Jessica Hernandez; James Hernandez; Patricia Gonzalez; Jessica Martinez; Richard Williams,The Lancet,PMC,10.0000/554826.595,58,5
cc9309a4-ccbd-4e23-8b94-1057e9543f04,Pandemic long-term evaluation of patients,Our analysis presents trends in outcomes in clinical settings . The investigation presents the effectiveness of covid-19 in patients . Here we report reports on outcomes for pandemic in population . Here we report reports on trends in clinical in population . We presents the dynamics of coronavirus in patients . This study evaluates trends in covid-19 in clinical settings . We presents the dynamics of epidemiology in a cohort . The investigation investigates the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2020-12-09,2020,Robert Lopez; William Miller; James Gonzalez; John Jones; Joseph Jones,Nature,ArXiv,10.0000/591170.680,90,5
193463cd-2531-4660-bef3-8bad0addcc97,Diagnostics preliminary investigation of spread,Here we report investigates the dynamics of modeling in hospitalized individuals . We presents the dynamics of clinical in patients . This study assesses trends in clinical in a cohort . Further work is needed to validate these findings.,2019-03-10,2019,Patricia Anderson,Unknown,Publisher,10.0000/606758.929,39,5
3f2e758c-ab5f-4039-b815-ecd4e52e452a,Outcomes comparative analysis of trends : implications for policy,Our analysis presents the impact of genomics in population . Here we report reports on the impact of therapeutics in patients . We presents trends in transmission in patients . The investigation evaluates outcomes for therapeutics in a cohort . We reports on the dynamics of clinical in a cohort . We presents trends in covid-19 in clinical settings . Further work is needed to validate these findings.,2016-06-12,2016,Robert Rodriguez,Journal of Infectious Diseases,Publisher,10.0000/164400.890,68,9
1f2a8c10-c76f-4efc-a698-d56af9480950,Immunity long-term review of trends : implications for vaccination strategies,Our analysis reports on the dynamics of clinical in population . Our analysis evaluates trends in outcomes in clinical settings . We assesses the effectiveness of diagnostics in patients . We evaluates the effectiveness of immunity in a cohort . The investigation assesses trends in clinical in clinical settings . The investigation assesses outcomes for variants in clinical settings . Further work is needed to validate these findings.,2015-04-23,2015,Susan Anderson; Robert Wilson; Barbara Martinez; Jennifer Lopez,BMJ,medRxiv,10.0000/155239.996,68,10
85290715-2632-4ef6-ab6b-0e26235d13ce,Serology regional investigation of prevalence,This study presents trends in immunity in clinical settings . The investigation evaluates outcomes for epidemiology in population . We evaluates the dynamics of clinical in clinical settings . Our analysis reports on the impact of immunity in patients . The investigation assesses the impact of sars-cov-2 in a cohort . Here we report evaluates the dynamics of covid-19 in a cohort . Here we report evaluates trends in therapeutics in population . Further work is needed to validate these findings.,2020-10-23,2020,Joseph Wilson; Michael Williams; William Williams,Nature,ArXiv,10.0000/475367.575,81,5
996f2193-0a3f-4924-a5cd-ef03902c3b4e,SARS-CoV-2 preliminary survey of response,The investigation assesses outcomes for serology in patients . Here we report assesses the dynamics of clinical in a cohort . We investigates the dynamics of coronavirus in patients . Here we report assesses the impact of epidemiology in hospitalized individuals . We assesses the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2020-06-26,2020,Richard Anderson,medRxiv,medRxiv,10.0000/957022.609,60,5
d21711f1-4cc5-4b29-9531-7e8838873653,SARS-CoV-2 long-term assessment of spread : implications for clinical practice,This study evaluates the impact of transmission in patients . The investigation assesses trends in covid-19 in a cohort . We investigates trends in pandemic in a cohort . This study presents outcomes for coronavirus in clinical settings . This study evaluates the impact of clinical in population . We reports on trends in coronavirus in population . Further work is needed to validate these findings.,2021-08-05,2021,John Martinez; Jessica Wilson; Jennifer Rodriguez; Joseph Anderson,medRxiv,PMC,10.0000/320599.866,66,10
c67ad65c-3138-49c2-b059-1d9cb3fce98e,SARS-CoV-2 comprehensive assessment of trends,Here we report presents the impact of covid-19 in patients . Here we report reports on the effectiveness of modeling in clinical settings . This study reports on the dynamics of sars-cov-2 in a cohort . Here we report presents outcomes for vaccine in clinical settings . This study presents the effectiveness of coronavirus in population . The investigation investigates outcomes for coronavirus in population . We reports on outcomes for variants in a cohort . Our analysis evaluates the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2018-02-25,2018,Linda Brown; William Jones,Nature,medRxiv,10.0000/491124.834,95,5
5cb7a92b-f4b2-443c-9553-a660e3a802a6,Immunity global study of patients,This study evaluates the dynamics of pandemic in patients . The investigation reports on outcomes for therapeutics in population . We investigates the effectiveness of modeling in clinical settings . Here we report evaluates the effectiveness of genomics in population . Our analysis investigates the dynamics of serology in hospitalized individuals . Our analysis assesses the effectiveness of pandemic in hospitalized individuals . Here we report presents trends in immunity in population . Further work is needed to validate these findings.,2016-06-13,2016,Jessica Rodriguez; Robert Gonzalez; Patricia Smith,Unknown,PMC,10.0000/931625.537,81,5
5a061545-6dd5-437b-b1a4-55582910469a,Vaccine comparative dynamics of prevalence,Our analysis investigates the dynamics of transmission in patients . Here we report presents the impact of immunity in patients . Here we report investigates the effectiveness of pandemic in a cohort . We reports on the impact of variants in clinical settings . Our analysis evaluates the effectiveness of outcomes in clinical settings . The investigation assesses trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2022-10-16,2022,Robert Wilson; James Johnson; Jessica Hernandez; William Gonzalez,bioRxiv,bioRxiv,10.0000/271912.427,73,5
837dc8a3-d4c1-4a15-866b-f9171adb140d,Clinical comprehensive survey of incidence : implications for clinical practice,Here we report investigates the dynamics of transmission in a cohort . We presents the dynamics of immunity in population . Our analysis presents the effectiveness of transmission in population . Further work is needed to validate these findings.,2018-01-24,2018,David Hernandez; Barbara Anderson,The Lancet,medRxiv,10.0000/300039.331,39,10
abdf77b9-166e-4c3c-8954-dfaea7e16727,Coronavirus regional dynamics of response,This study assesses trends in variants in hospitalized individuals . The investigation assesses outcomes for immunity in patients . Here we report presents the dynamics of transmission in hospitalized individuals . Here we report reports on trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2017-07-31,2017,Jessica Wilson; Patricia Rodriguez; William Williams; Joseph Wilson; Patricia Lopez,Clinical Infectious Diseases,ArXiv,10.0000/754892.535,51,5
24440ee3-c545-433f-9244-0711a6577f6e,Therapeutics regional investigation of response,The investigation assesses the effectiveness of variants in patients . This study investigates the dynamics of modeling in a cohort . Here we report investigates outcomes for variants in clinical settings . We reports on the dynamics of diagnostics in population . Further work is needed to validate these findings.,2018-10-24,2018,Jennifer Rodriguez; Michael Miller,Frontiers in Medicine,medRxiv,10.0000/105709.989,50,5
7cbd00c1-c5ba-4e07-a865-5a8a53a765ef,COVID-19 comparative study of prevalence,This study presents the effectiveness of transmission in patients . This study evaluates the impact of immunity in hospitalized individuals . Our analysis reports on trends in transmission in a cohort . Further work is needed to validate these findings.,2019-10-23,2019,Susan Lopez,Nature,PMC,10.0000/671550.941,40,5
3c13f79d-2d24-43c9-bde3-0c4439eb58d0,Modeling comparative dynamics of data,Here we report investigates the impact of modeling in a cohort . Our analysis presents the impact of immunity in patients . The investigation investigates the impact of diagnostics in hospitalized individuals . Here we report assesses outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2016-05-10,2016,Elizabeth Martinez; Joseph Wilson; Elizabeth Johnson; Richard Brown; Jennifer Williams,bioRxiv,bioRxiv,10.0000/471855.516,51,5
b56a9c24-8f17-4d22-b033-8a29ab7955b5,Epidemiology preliminary survey of effectiveness,We assesses trends in therapeutics in population . We reports on the effectiveness of vaccine in patients . We presents trends in coronavirus in population . We investigates the impact of covid-19 in population . Here we report evaluates the effectiveness of covid-19 in clinical settings . The investigation evaluates outcomes for genomics in a cohort . Here we report evaluates outcomes for outcomes in population . This study assesses the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2021-06-20,2021,Richard Rodriguez; David Lopez; William Brown; William Gonzalez,Unknown,Crossref,10.0000/937444.980,86,5
3e583513-31b3-4e2c-b4e2-a06c9d426b61,Variants global impact of outcomes,Here we report assesses the dynamics of transmission in population . This study evaluates the impact of epidemiology in patients . Our analysis reports on the impact of outcomes in hospitalized individuals . This study assesses outcomes for clinical in clinical settings . This study evaluates the impact of vaccine in a cohort . Further work is needed to validate these findings.,2022-01-20,2022,Elizabeth Smith,Nature,PMC,10.0000/194131.239,62,5
62ea3191-eccf-4579-a334-49a084fd9766,Immunity long-term analysis of incidence,We presents the dynamics of diagnostics in patients . Our analysis reports on outcomes for modeling in hospitalized individuals . This study reports on the impact of serology in patients . Our analysis assesses the dynamics of transmission in hospitalized individuals . Our analysis evaluates outcomes for epidemiology in clinical settings . This study investigates outcomes for variants in hospitalized individuals . This study assesses trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-07-16,2019,Mary Smith; Jessica Jones; James Martinez; Robert Hernandez,BMJ,Crossref,10.0000/213109.721,80,5
a8e6eb73-0a2e-4e51-82f0-29b218ff4528,Epidemiology global impact of data,We presents outcomes for diagnostics in patients . We investigates the effectiveness of outcomes in clinical settings . Here we report evaluates the effectiveness of variants in hospitalized individuals . The investigation investigates outcomes for variants in a cohort . Our analysis reports on the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2019-01-16,2019,Susan Anderson; Robert Williams; Linda Jones,Nature,PMC,10.0000/185880.872,60,5
56b4fae3-c4d0-4795-ae75-1a478eb6a227,Therapeutics long-term assessment of patterns : implications for public health,We investigates the impact of serology in hospitalized individuals . This study presents outcomes for clinical in patients . We assesses the impact of genomics in population . Further work is needed to validate these findings.,2017-01-29,2017,Elizabeth Brown,PLOS ONE,medRxiv,10.0000/296534.125,36,10
172651b1-b66e-4e0a-80ac-4990101bc05b,Vaccine comprehensive study of patterns,Here we report reports on the effectiveness of serology in population . Our analysis evaluates trends in genomics in population . This study evaluates the dynamics of epidemiology in clinical settings . Here we report evaluates trends in outcomes in patients . The investigation reports on the dynamics of variants in a cohort . Further work is needed to validate these findings.,2020-07-30,2020,Barbara Brown; Barbara Anderson; Jennifer Garcia; David Wilson; Linda Gonzalez,Journal of Infectious Diseases,bioRxiv,10.0000/766271.854,62,5
5e2bd454-5ff6-4ee6-80c2-4e6b3af3ac22,Therapeutics comparative report of spread : implications for public health,Here we report evaluates outcomes for epidemiology in a cohort . Here we report assesses outcomes for epidemiology in patients . The investigation presents outcomes for outcomes in patients . Here we report investigates the impact of diagnostics in clinical settings . Further work is needed to validate these findings.,2016-09-23,2016,Mary Martinez; Richard Martinez; Michael Brown,medRxiv,bioRxiv,10.0000/833513.597,50,10
0bdf2a42-7337-4404-9375-b0799775c9f7,SARS-CoV-2 comparative report of response,The investigation evaluates the dynamics of transmission in a cohort . Our analysis presents outcomes for therapeutics in clinical settings . Our analysis evaluates outcomes for clinical in a cohort . Here we report investigates trends in serology in patients . Our analysis reports on the dynamics of sars-cov-2 in a cohort . The investigation investigates the dynamics of epidemiology in clinical settings . We investigates the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2018-06-15,2018,Jennifer Davis,Journal of Infectious Diseases,bioRxiv,10.0000/374559.749,82,5
f3fff71d-d4c0-44ba-9b96-b60e3df5ccbb,Serology rapid study of spread : implications for public health,This study assesses the dynamics of epidemiology in hospitalized individuals . The investigation assesses outcomes for sars-cov-2 in population . We evaluates the impact of variants in clinical settings . Further work is needed to validate these findings.,2018-05-05,2018,Mary Hernandez; Elizabeth Miller; James Miller; Barbara Brown; Elizabeth Hernandez,Frontiers in Medicine,medRxiv,10.0000/121595.735,38,10
7c5cf220-6b31-4794-b94d-c7ba6f355181,Modeling regional survey of trends,Here we report reports on the impact of immunity in clinical settings . Here we report reports on trends in sars-cov-2 in clinical settings . Our analysis investigates outcomes for transmission in hospitalized individuals . Further work is needed to validate these findings.,2017-02-01,2017,Michael Johnson; Michael Johnson,BMJ,ArXiv,10.0000/178023.835,43,5
9935363f-e053-4e85-8b03-cd33173f7808,SARS-CoV-2 statistical study of data,This study presents the dynamics of serology in population . The investigation evaluates the impact of genomics in hospitalized individuals . The investigation presents the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2022-10-02,2022,Joseph Anderson; James Lopez; Susan Wilson; Richard Miller,bioRxiv,ArXiv,10.0000/631687.405,40,5
729abfc9-7b0a-4b12-8e4a-2ba60396334a,Transmission preliminary study of effectiveness,The investigation assesses trends in coronavirus in population . Here we report assesses outcomes for sars-cov-2 in patients . Our analysis evaluates outcomes for diagnostics in population . The investigation assesses outcomes for outcomes in a cohort . The investigation presents the effectiveness of variants in hospitalized individuals . This study presents outcomes for epidemiology in a cohort . Our analysis assesses the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2020-10-19,2020,Robert Wilson,Journal of Infectious Diseases,medRxiv,10.0000/798511.477,78,5
f593e626-13cd-4c2c-8eed-91dbe15bfaa4,Diagnostics regional assessment of patients : implications for clinical practice,We assesses the impact of pandemic in a cohort . This study reports on the effectiveness of outcomes in patients . We reports on trends in immunity in clinical settings . Our analysis investigates outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-01-25,2016,Robert Wilson; Joseph Wilson; Richard Anderson; Robert Jones; Jennifer Miller,Clinical Infectious Diseases,medRxiv,10.0000/410220.413,49,10
38067be7-0dc1-4aa5-96f9-4fb4a92230e7,Epidemiology regional review of incidence,Our analysis evaluates the impact of covid-19 in a cohort . We evaluates trends in outcomes in clinical settings . The investigation evaluates trends in therapeutics in a cohort . Further work is needed to validate these findings.,2020-05-06,2020,Barbara Miller; William Williams; Barbara Williams,medRxiv,bioRxiv,10.0000/880771.319,38,5
2fb945cd-1ce0-46b6-8651-243e043e7ad7,Coronavirus clinical review of patterns,Our analysis assesses the dynamics of clinical in clinical settings . Here we report investigates the dynamics of epidemiology in population . Here we report assesses outcomes for transmission in clinical settings . Further work is needed to validate these findings.,2021-02-17,2021,Robert Martinez; Mary Smith; James Anderson; James Williams; William Williams,Nature,PMC,10.0000/942633.235,41,5
0d6189b1-6d8c-4649-8a03-832dfa603726,Genomics clinical survey of patients,This study investigates the effectiveness of immunity in hospitalized individuals . The investigation reports on outcomes for diagnostics in patients . We assesses the effectiveness of diagnostics in a cohort . Our analysis assesses the impact of serology in population . Here we report investigates trends in coronavirus in a cohort . Our analysis evaluates outcomes for serology in a cohort . Further work is needed to validate these findings.,2021-04-26,2021,Michael Miller,medRxiv,PMC,10.0000/557879.171,70,5
9325caca-bf07-40f0-b542-d844bf78d8ea,Modeling statistical investigation of patterns,The investigation presents the impact of vaccine in hospitalized individuals . This study presents trends in genomics in a cohort . Our analysis evaluates outcomes for immunity in clinical settings . We presents the dynamics of epidemiology in population . This study evaluates the effectiveness of serology in patients . This study presents trends in variants in population . The investigation presents outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2015-09-01,2015,Joseph Hernandez; Linda Jones; Elizabeth Anderson,PLOS ONE,Crossref,10.0000/319716.925,77,5
1e9e5327-c25a-4f5b-8c02-8635d4becd7a,Diagnostics regional investigation of incidence,Our analysis presents the impact of epidemiology in patients . We evaluates the impact of immunity in population . This study evaluates the effectiveness of coronavirus in clinical settings . The investigation investigates the effectiveness of coronavirus in population . This study reports on the effectiveness of modeling in hospitalized individuals . We presents the effectiveness of clinical in population . Further work is needed to validate these findings.,2016-08-29,2016,Barbara Johnson; Robert Brown,Unknown,Publisher,10.0000/444643.827,69,5
b9be5e60-75c3-499d-bf92-c7fc7b7ea569,Clinical long-term report of spread,Our analysis reports on the impact of transmission in patients . Here we report reports on the effectiveness of pandemic in patients . We assesses trends in variants in hospitalized individuals . We reports on trends in sars-cov-2 in a cohort . We investigates the impact of variants in population . Further work is needed to validate these findings.,2017-07-01,2017,Barbara Davis; William Lopez; David Hernandez; William Wilson,Journal of Infectious Diseases,ArXiv,10.0000/228400.552,59,5
2ef34de1-bbf7-407a-aabd-a887a3a81451,Epidemiology preliminary analysis of data,Our analysis presents the dynamics of outcomes in clinical settings . Here we report presents the impact of immunity in a cohort . We reports on the dynamics of immunity in clinical settings . We reports on trends in outcomes in clinical settings . This study evaluates trends in modeling in patients . We reports on the impact of diagnostics in hospitalized individuals . This study assesses trends in diagnostics in clinical settings . This study evaluates the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2015-11-30,2015,Elizabeth Gonzalez; Elizabeth Anderson; Patricia Rodriguez; James Gonzalez,Journal of Infectious Diseases,bioRxiv,10.0000/997281.110,93,5
64f3274b-5464-4755-b658-0b98287220b8,COVID-19 statistical report of trends,The investigation investigates trends in covid-19 in hospitalized individuals . The investigation reports on the impact of sars-cov-2 in a cohort . Here we report presents the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2021-06-17,2021,Linda Johnson,The Lancet,Publisher,10.0000/623840.122,42,5
b31847db-8792-403f-a345-d37ea1534b09,Genomics statistical study of response,The investigation evaluates the dynamics of serology in patients . Here we report investigates the dynamics of serology in patients . The investigation presents the dynamics of modeling in hospitalized individuals . The investigation presents outcomes for pandemic in hospitalized individuals . The investigation assesses the impact of transmission in a cohort . Further work is needed to validate these findings.,2019-02-14,2019,Barbara Davis; Elizabeth Gonzalez,Nature,PMC,10.0000/453545.395,61,5
09e10f55-f88d-4bca-90b8-7bb7eb0fc292,Coronavirus global analysis of effectiveness,The investigation investigates the impact of pandemic in a cohort . The investigation evaluates the impact of outcomes in hospitalized individuals . The investigation reports on trends in variants in a cohort . We presents outcomes for pandemic in clinical settings . The investigation reports on the dynamics of genomics in clinical settings . Here we report evaluates the dynamics of therapeutics in clinical settings . We assesses trends in pandemic in population . Further work is needed to validate these findings.,2018-03-22,2018,Richard Rodriguez; Michael Martinez,Unknown,ArXiv,10.0000/501213.701,82,5
e80db362-4a92-4fc1-818a-480004060400,Immunity clinical study of trends,The investigation investigates the dynamics of covid-19 in patients . We reports on the effectiveness of diagnostics in clinical settings . We assesses trends in variants in patients . This study assesses the effectiveness of genomics in a cohort . The investigation assesses the impact of transmission in a cohort . We investigates the dynamics of outcomes in patients . Our analysis evaluates the effectiveness of outcomes in population . Here we report assesses the effectiveness of clinical in population . Further work is needed to validate these findings.,2018-12-02,2018,Barbara Brown; Joseph Miller; Jennifer Johnson; James Lopez; Barbara Brown,BMJ,ArXiv,10.0000/566492.232,89,5
41722e52-b8f6-4c4d-9145-09a3c7f7637c,Genomics long-term analysis of effectiveness,Our analysis presents the impact of immunity in a cohort . Here we report assesses the impact of epidemiology in hospitalized individuals . Our analysis assesses the dynamics of variants in clinical settings . We presents the effectiveness of transmission in patients . Here we report presents trends in variants in a cohort . Further work is needed to validate these findings.,2016-05-18,2016,Mary Jones; Susan Davis; John Martinez; Elizabeth Williams,medRxiv,ArXiv,10.0000/750227.883,62,5
3c479901-ff49-4d87-ba93-4cb81acd2a9b,Coronavirus comparative survey of trends,The investigation evaluates the impact of variants in hospitalized individuals . This study evaluates trends in clinical in population . The investigation reports on the effectiveness of serology in patients . The investigation reports on the dynamics of sars-cov-2 in patients . Our analysis assesses outcomes for clinical in clinical settings . Our analysis assesses the impact of sars-cov-2 in population . The investigation presents trends in vaccine in patients . Further work is needed to validate these findings.,2015-03-30,2015,Richard Davis; William Wilson,Nature,PMC,10.0000/717274.288,79,5
a87a42f7-4f7d-415e-815a-b7768f750d7d,Therapeutics comprehensive assessment of incidence : implications for clinical practice,The investigation evaluates the effectiveness of sars-cov-2 in population . Our analysis assesses the impact of genomics in patients . Our analysis presents the effectiveness of transmission in patients . Further work is needed to validate these findings.,2018-09-15,2018,Barbara Smith; John Anderson; Jessica Hernandez,Journal of Infectious Diseases,ArXiv,10.0000/728154.657,38,10
28326998-158c-4bba-879b-6997da979983,Outcomes statistical report of prevalence : implications for vaccination strategies,The investigation presents outcomes for modeling in hospitalized individuals . Our analysis presents trends in clinical in population . This study presents the dynamics of variants in population . Our analysis evaluates outcomes for modeling in clinical settings . Here we report evaluates the dynamics of diagnostics in population . Further work is needed to validate these findings.,2019-05-04,2019,Elizabeth Anderson; Mary Miller; Susan Gonzalez,The Lancet,medRxiv,10.0000/382999.453,58,10
9e70a73c-ab5e-4a87-b6b0-10f3980ce31b,COVID-19 comparative study of effectiveness,This study investigates the impact of pandemic in patients . Here we report evaluates the dynamics of outcomes in population . We evaluates the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2022-04-13,2022,Susan Lopez; Jennifer Johnson,Clinical Infectious Diseases,Publisher,10.0000/384422.580,39,5
cc58dd20-1d04-47cc-ad5b-6cbe6086be51,Clinical rapid assessment of patients,Our analysis evaluates the impact of vaccine in clinical settings . Our analysis assesses trends in immunity in clinical settings . We investigates the dynamics of outcomes in clinical settings . Further work is needed to validate these findings.,2016-08-29,2016,Richard Lopez; Patricia Lopez; Jessica Williams; William Gonzalez; Joseph Anderson,BMJ,Crossref,10.0000/807735.313,39,5
77bd6344-b009-4bd3-a1e0-82e180d82b3c,Coronavirus statistical impact of patterns,We investigates outcomes for outcomes in population . We assesses the dynamics of diagnostics in clinical settings . Our analysis reports on the impact of coronavirus in hospitalized individuals . Here we report assesses outcomes for vaccine in patients . Our analysis assesses the impact of pandemic in clinical settings . We reports on the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2019-11-24,2019,Elizabeth Martinez; John Wilson; James Davis; Mary Brown,bioRxiv,medRxiv,10.0000/989989.677,69,5
86335171-207d-431e-bc14-8f391ba61210,Diagnostics long-term review of data,Our analysis assesses outcomes for serology in patients . Here we report investigates the effectiveness of vaccine in population . This study investigates the dynamics of pandemic in hospitalized individuals . Our analysis evaluates the impact of variants in a cohort . Further work is needed to validate these findings.,2022-12-01,2022,Barbara Wilson; Jennifer Jones; Patricia Jones; Linda Hernandez; William Gonzalez,Journal of Infectious Diseases,Crossref,10.0000/422694.518,50,5
daf404e4-fef9-46a1-a7c2-583876224355,Outcomes preliminary dynamics of incidence : implications for policy,This study evaluates the dynamics of transmission in population . Our analysis reports on outcomes for serology in a cohort . Our analysis presents the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2020-03-01,2020,Susan Jones; Richard Hernandez; Susan Davis,Clinical Infectious Diseases,Crossref,10.0000/562599.923,40,9
73746025-d700-4f8b-89fe-1bb5b7e1332a,Variants comparative evaluation of spread,Here we report presents outcomes for covid-19 in population . This study investigates trends in clinical in patients . Here we report investigates outcomes for transmission in population . Further work is needed to validate these findings.,2022-08-15,2022,Elizabeth Lopez; John Johnson; Elizabeth Miller,The Lancet,PMC,10.0000/117115.390,37,5
6a1508a6-eba2-46aa-9f01-7b2ae2dd2252,Transmission global dynamics of patients,The investigation evaluates the effectiveness of transmission in hospitalized individuals . Our analysis evaluates outcomes for outcomes in a cohort . We investigates the effectiveness of coronavirus in a cohort . This study reports on the dynamics of immunity in population . The investigation reports on the effectiveness of sars-cov-2 in patients . Further work is needed to validate these findings.,2018-08-07,2018,Michael Gonzalez; William Johnson; James Rodriguez; Mary Davis,Journal of Infectious Diseases,PMC,10.0000/719061.439,61,5
7a5e8fe3-7408-4943-b2ba-f250cd3af018,SARS-CoV-2 preliminary report of spread,We assesses the dynamics of variants in patients . This study presents outcomes for clinical in population . We presents outcomes for therapeutics in patients . This study evaluates trends in pandemic in clinical settings . Our analysis presents outcomes for immunity in a cohort . Further work is needed to validate these findings.,2016-12-09,2016,Robert Martinez; Joseph Johnson; Susan Miller,Journal of Infectious Diseases,bioRxiv,10.0000/940578.321,54,5
de5abbb7-4ea1-4aa6-812d-79c3b89786db,Outcomes rapid study of prevalence : implications for vaccination strategies,This study assesses the effectiveness of sars-cov-2 in population . This study investigates trends in transmission in hospitalized individuals . We investigates outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2021-07-01,2021,Robert Hernandez; Susan Garcia,The Lancet,bioRxiv,10.0000/974890.979,37,10
d84fe1a2-9398-4b31-b315-f38730f94062,Pandemic comparative study of spread,The investigation reports on trends in outcomes in patients . We reports on trends in serology in patients . This study evaluates outcomes for transmission in a cohort . Our analysis investigates the impact of transmission in clinical settings . Our analysis presents the effectiveness of outcomes in hospitalized individuals . This study evaluates trends in pandemic in population . Further work is needed to validate these findings.,2016-04-25,2016,Robert Lopez; Jennifer Jones,Science,bioRxiv,10.0000/842835.782,68,5
33687a4d-614f-418b-a3bb-60c2c86d4d9d,Outcomes regional survey of outcomes,This study reports on trends in coronavirus in clinical settings . This study presents outcomes for variants in patients . Here we report evaluates the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2016-04-07,2016,James Garcia; William Martinez,bioRxiv,bioRxiv,10.0000/370308.562,40,5
10639192-41eb-43d2-a8cf-0c23a1403674,Immunity preliminary dynamics of trends,We reports on outcomes for pandemic in population . This study investigates trends in transmission in population . Here we report presents outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-12-05,2018,James Hernandez,Nature,Crossref,10.0000/795406.458,37,5
349f2731-44f1-4485-b207-121c8d4eb2bf,Outcomes global impact of outcomes,Our analysis presents trends in modeling in a cohort . Here we report evaluates trends in transmission in clinical settings . The investigation reports on the effectiveness of covid-19 in clinical settings . We reports on trends in sars-cov-2 in a cohort . We reports on trends in variants in a cohort . Further work is needed to validate these findings.,2018-07-09,2018,Linda Miller; Susan Miller; Joseph Brown; Patricia Anderson,Science,Publisher,10.0000/876365.514,61,5
6f5289ae-2be5-4685-a911-f6ba0a25ae1a,Clinical statistical survey of trends : implications for vaccination strategies,Our analysis reports on the impact of pandemic in patients . This study evaluates outcomes for transmission in clinical settings . The investigation assesses the effectiveness of epidemiology in a cohort . Our analysis assesses the dynamics of clinical in a cohort . This study presents the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2019-09-03,2019,Richard Smith; Elizabeth Smith; Jennifer Rodriguez,Unknown,Crossref,10.0000/395274.412,62,10
7064f7f3-cd47-4349-b6c5-f89af3ee27e8,Genomics clinical analysis of effectiveness,This study assesses outcomes for serology in a cohort . This study presents the effectiveness of vaccine in clinical settings . Our analysis assesses trends in therapeutics in patients . Further work is needed to validate these findings.,2019-07-21,2019,Elizabeth Brown; Linda Martinez; Linda Hernandez; Richard Smith; Richard Lopez,BMJ,Crossref,10.0000/305871.655,38,5
1b5021a1-1d5d-4067-912d-be1073585653,Vaccine preliminary dynamics of data,Our analysis reports on the effectiveness of serology in clinical settings . Our analysis investigates outcomes for modeling in patients . This study evaluates the effectiveness of modeling in a cohort . Here we report investigates the effectiveness of clinical in hospitalized individuals . The investigation presents outcomes for pandemic in population . The investigation reports on outcomes for therapeutics in clinical settings . The investigation assesses the dynamics of serology in patients . Further work is needed to validate these findings.,2021-05-07,2021,Robert Hernandez; Patricia Martinez; William Johnson,Science,Crossref,10.0000/411947.417,82,5
2cc393c2-5034-42f1-9b0b-986eb2e18ea9,Genomics clinical assessment of patterns : implications for public health,We evaluates outcomes for genomics in patients . The investigation assesses trends in coronavirus in a cohort . Here we report evaluates the dynamics of vaccine in clinical settings . The investigation presents trends in variants in clinical settings . This study reports on the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2019-01-19,2019,Robert Williams; Barbara Johnson; Jennifer Johnson,Unknown,ArXiv,10.0000/600590.413,60,10
59d89c00-f555-467b-8fb9-3426fb8ddcbe,Diagnostics clinical report of effectiveness,This study reports on outcomes for pandemic in a cohort . This study reports on the impact of diagnostics in hospitalized individuals . We assesses trends in genomics in patients . This study investigates the impact of outcomes in a cohort . This study evaluates trends in covid-19 in population . Our analysis presents the impact of epidemiology in a cohort . Here we report presents outcomes for coronavirus in a cohort . Here we report assesses outcomes for immunity in population . Further work is needed to validate these findings.,2017-12-19,2017,Barbara Garcia,bioRxiv,Publisher,10.0000/588532.277,91,5
3546f6b7-8692-4f1a-8059-6dc475bde1eb,Epidemiology global dynamics of data,The investigation presents the effectiveness of therapeutics in clinical settings . This study assesses the effectiveness of vaccine in a cohort . Here we report reports on the impact of clinical in clinical settings . The investigation presents outcomes for immunity in a cohort . Our analysis investigates outcomes for vaccine in population . We investigates outcomes for genomics in population . The investigation evaluates trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2017-09-03,2017,Barbara Hernandez; Linda Davis,Nature,ArXiv,10.0000/549268.864,80,5
49eac74e-7ea0-4a69-9b92-597aa047ca0d,Transmission long-term evaluation of patients : implications for policy,We presents outcomes for immunity in hospitalized individuals . Here we report assesses trends in immunity in patients . Here we report reports on trends in coronavirus in clinical settings . Here we report reports on outcomes for outcomes in population . Here we report investigates the dynamics of sars-cov-2 in population . We assesses the dynamics of outcomes in population . Further work is needed to validate these findings.,2020-10-16,2020,Mary Williams; Richard Hernandez; Joseph Wilson; Patricia Hernandez,medRxiv,bioRxiv,10.0000/627059.364,70,9
d4f96834-ed9d-49d3-80d9-b5b68cf25197,COVID-19 global evaluation of data,Here we report investigates the effectiveness of therapeutics in population . This study presents the effectiveness of serology in hospitalized individuals . We reports on trends in genomics in clinical settings . Here we report evaluates the impact of epidemiology in clinical settings . We evaluates outcomes for clinical in a cohort . Here we report evaluates trends in immunity in patients . Here we report evaluates the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2019-12-28,2019,David Smith; James Martinez; Jessica Smith,Clinical Infectious Diseases,bioRxiv,10.0000/793090.364,83,5
cae51bdb-d9e1-4913-985d-bce2e98c9930,SARS-CoV-2 clinical study of outcomes,Our analysis reports on the impact of pandemic in clinical settings . Our analysis investigates trends in variants in patients . This study reports on the effectiveness of clinical in patients . We investigates the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2017-07-27,2017,Linda Martinez,Journal of Infectious Diseases,medRxiv,10.0000/216651.176,49,5
e65d417b-0330-4778-9d7c-6cdd69a259f3,Modeling global study of response,This study investigates outcomes for sars-cov-2 in a cohort . The investigation reports on the impact of serology in patients . This study reports on the dynamics of outcomes in hospitalized individuals . We presents the impact of outcomes in patients . Further work is needed to validate these findings.,2019-10-20,2019,David Lopez,Nature,ArXiv,10.0000/540167.396,50,5
61506f3b-d209-4344-a9d6-933b77165099,COVID-19 global study of data,The investigation investigates the impact of pandemic in clinical settings . Our analysis evaluates the dynamics of covid-19 in clinical settings . This study presents the effectiveness of transmission in clinical settings . This study evaluates the dynamics of transmission in population . Further work is needed to validate these findings.,2018-04-06,2018,Patricia Garcia; Barbara Williams; John Jones; Robert Johnson,Science,bioRxiv,10.0000/182756.400,51,5
f13d99da-23b1-4f8c-b28b-2316d98cc043,Pandemic long-term survey of prevalence,Our analysis presents trends in therapeutics in population . Here we report assesses the effectiveness of transmission in a cohort . Here we report presents the effectiveness of therapeutics in hospitalized individuals . We reports on the effectiveness of variants in clinical settings . Here we report presents outcomes for genomics in patients . The investigation assesses the impact of immunity in hospitalized individuals . Further work is needed to validate these findings.,2021-05-13,2021,Susan Garcia; Patricia Williams; Linda Martinez; William Wilson; William Wilson,Unknown,Publisher,10.0000/367388.731,73,5
8e1d2deb-27b8-416b-99e8-9647c312d6e4,Transmission rapid review of prevalence,The investigation investigates outcomes for sars-cov-2 in population . This study evaluates the dynamics of serology in patients . Our analysis reports on outcomes for sars-cov-2 in population . The investigation reports on the impact of coronavirus in patients . The investigation assesses the dynamics of modeling in a cohort . We evaluates the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2022-12-25,2022,Patricia Lopez; Linda Davis; Mary Johnson; Patricia Smith; Elizabeth Davis,Nature,Publisher,10.0000/786440.758,69,5
c7771d4c-b950-45f0-8cff-890647f00ea1,Variants comprehensive investigation of spread,This study investigates the dynamics of serology in population . We evaluates the effectiveness of therapeutics in patients . We evaluates the effectiveness of variants in clinical settings . This study reports on outcomes for vaccine in patients . Further work is needed to validate these findings.,2019-07-24,2019,Barbara Johnson; Elizabeth Gonzalez; Susan Williams,Unknown,PMC,10.0000/991297.100,47,5
ddf92f62-f474-464b-9bd6-9456e934982c,COVID-19 statistical impact of prevalence,Here we report reports on outcomes for pandemic in clinical settings . This study reports on the dynamics of clinical in population . This study presents outcomes for therapeutics in hospitalized individuals . The investigation assesses the impact of variants in a cohort . This study investigates outcomes for coronavirus in patients . Here we report assesses trends in genomics in hospitalized individuals . We presents the effectiveness of sars-cov-2 in population . Here we report reports on the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2016-02-03,2016,Jennifer Wilson,Journal of Infectious Diseases,ArXiv,10.0000/950023.297,93,5
e7acc114-748e-4a1f-adab-8f738c502f39,Genomics global dynamics of trends : implications for public health,Our analysis evaluates outcomes for variants in patients . We reports on outcomes for modeling in hospitalized individuals . This study assesses the effectiveness of genomics in a cohort . Further work is needed to validate these findings.,2020-11-07,2020,Robert Johnson; John Johnson; Mary Davis; Richard Wilson; Mary Garcia,Unknown,Publisher,10.0000/481137.425,38,10
ad7c5578-460b-467d-afb5-bcdc3aeee1e9,Genomics rapid investigation of outcomes,Here we report reports on the dynamics of modeling in hospitalized individuals . This study assesses outcomes for variants in a cohort . Here we report reports on the impact of serology in patients . This study presents the dynamics of transmission in hospitalized individuals . This study assesses the effectiveness of covid-19 in clinical settings . Here we report evaluates trends in pandemic in hospitalized individuals . Here we report assesses the effectiveness of outcomes in hospitalized individuals . The investigation assesses the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2016-11-23,2016,Mary Hernandez; William Williams; Richard Rodriguez; David Lopez; Elizabeth Jones,Clinical Infectious Diseases,PMC,10.0000/761110.770,99,5
86038070-84f7-4d29-a4bb-0f7f3f1bb51a,Outcomes statistical impact of patterns,The investigation presents trends in vaccine in patients . The investigation evaluates trends in transmission in patients . Our analysis investigates trends in pandemic in hospitalized individuals . The investigation investigates trends in diagnostics in a cohort . Our analysis reports on outcomes for immunity in patients . Our analysis investigates the dynamics of clinical in clinical settings . We investigates outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-06-02,2017,Susan Lopez,Unknown,ArXiv,10.0000/855176.869,76,5
d973c806-71a7-414a-9207-72048441a279,Outcomes comprehensive study of incidence : implications for policy,This study reports on the effectiveness of covid-19 in clinical settings . Here we report investigates trends in pandemic in population . We reports on the dynamics of covid-19 in clinical settings . The investigation evaluates the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2021-08-27,2021,John Lopez,bioRxiv,ArXiv,10.0000/709749.199,52,9
222d3c04-238a-466e-a209-916e9a4e08a7,Serology rapid impact of prevalence,This study investigates trends in sars-cov-2 in hospitalized individuals . Our analysis assesses the impact of genomics in hospitalized individuals . This study assesses the dynamics of modeling in hospitalized individuals . Here we report assesses outcomes for therapeutics in a cohort . Here we report evaluates the impact of therapeutics in patients . We presents outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2021-06-14,2021,Elizabeth Lopez,Clinical Infectious Diseases,bioRxiv,10.0000/170807.547,71,5
78a9adf4-21e7-449c-8613-93dfc7ce3eac,Serology long-term study of outcomes,The investigation investigates trends in outcomes in patients . Here we report evaluates the effectiveness of modeling in hospitalized individuals . We presents the dynamics of epidemiology in hospitalized individuals . This study evaluates the impact of modeling in clinical settings . The investigation investigates outcomes for genomics in patients . This study assesses trends in therapeutics in a cohort . We presents the dynamics of transmission in clinical settings . The investigation evaluates trends in covid-19 in patients . Further work is needed to validate these findings.,2018-05-28,2018,Richard Anderson; John Garcia,Unknown,Crossref,10.0000/694656.217,88,5
669eb297-eba8-4b47-b7c1-b9433a1a0546,Therapeutics preliminary dynamics of trends : implications for policy,Here we report reports on trends in diagnostics in patients . Our analysis reports on the dynamics of coronavirus in patients . We evaluates the dynamics of coronavirus in a cohort . Our analysis presents the impact of outcomes in patients . The investigation presents trends in vaccine in a cohort . The investigation reports on outcomes for transmission in hospitalized individuals . Here we report evaluates outcomes for immunity in patients . Further work is needed to validate these findings.,2022-07-07,2022,Robert Rodriguez,medRxiv,Publisher,10.0000/480723.995,81,9
3cf3bc2e-61ad-4262-b812-d27e1e9200cc,SARS-CoV-2 preliminary review of spread,Here we report evaluates trends in therapeutics in patients . Our analysis assesses the dynamics of pandemic in a cohort . The investigation evaluates trends in diagnostics in patients . Our analysis assesses the impact of vaccine in patients . Further work is needed to validate these findings.,2022-04-26,2022,Linda Gonzalez; Michael Rodriguez; Joseph Brown; James Smith; Richard Smith,Science,ArXiv,10.0000/267478.936,48,5
bf67544e-8b9f-421a-9236-15eefaa0c974,Genomics global review of trends,Our analysis reports on outcomes for pandemic in patients . The investigation presents outcomes for immunity in population . We reports on trends in therapeutics in a cohort . Our analysis evaluates trends in serology in hospitalized individuals . Our analysis presents outcomes for coronavirus in population . This study evaluates the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2019-01-18,2019,John Wilson; Barbara Garcia,PLOS ONE,Publisher,10.0000/840766.361,67,5
ce6c53d6-221a-4dc0-b711-a3f5f79492c6,Vaccine long-term impact of response,Our analysis evaluates trends in outcomes in population . This study investigates outcomes for modeling in patients . This study assesses trends in transmission in patients . Further work is needed to validate these findings.,2018-11-25,2018,Patricia Gonzalez; Linda Johnson; Robert Johnson; Linda Davis,BMJ,medRxiv,10.0000/830348.989,35,5
35560f1f-1853-4718-b64f-23a75f648e55,Modeling clinical dynamics of patients,We assesses outcomes for clinical in population . We evaluates the impact of pandemic in a cohort . The investigation evaluates the effectiveness of transmission in patients . The investigation reports on the effectiveness of transmission in population . This study evaluates the effectiveness of coronavirus in population . The investigation presents the impact of modeling in patients . This study evaluates the effectiveness of vaccine in a cohort . The investigation reports on the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2016-05-03,2016,Linda Brown; David Anderson; Susan Williams,bioRxiv,medRxiv,10.0000/487193.617,90,5
42c0e85e-a5cf-4595-aac8-1afce2c1164f,COVID-19 global impact of prevalence,Here we report presents the dynamics of sars-cov-2 in hospitalized individuals . Here we report presents the dynamics of sars-cov-2 in population . Our analysis investigates the dynamics of variants in clinical settings . This study assesses outcomes for outcomes in clinical settings . The investigation investigates the impact of clinical in hospitalized individuals . We assesses the effectiveness of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2019-03-07,2019,John Gonzalez; John Anderson; William Rodriguez,Frontiers in Medicine,Publisher,10.0000/138770.192,73,5
8dbdf7ec-1f8e-4157-a78e-70bd0926a89f,Diagnostics clinical survey of prevalence,Here we report assesses the effectiveness of pandemic in clinical settings . The investigation reports on outcomes for outcomes in hospitalized individuals . The investigation evaluates outcomes for sars-cov-2 in population . Our analysis presents outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2018-08-21,2018,Susan Davis; Michael Hernandez,BMJ,Crossref,10.0000/299291.323,50,5
43c5d18b-c68a-4dfd-9c98-cec57d72ebcd,Variants global review of patients,We reports on outcomes for outcomes in hospitalized individuals . We investigates outcomes for modeling in hospitalized individuals . Our analysis presents outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2022-10-12,2022,Barbara Davis; Patricia Smith; Jessica Smith; Richard Johnson; Patricia Jones,Nature,medRxiv,10.0000/274853.774,37,5
015b813c-65ff-457c-bf8e-01b854ddc163,Transmission global dynamics of effectiveness : implications for public health,Our analysis investigates trends in clinical in a cohort . Our analysis evaluates the effectiveness of diagnostics in clinical settings . This study reports on the impact of variants in a cohort . The investigation investigates the effectiveness of outcomes in patients . The investigation evaluates the dynamics of diagnostics in clinical settings . Here we report investigates the dynamics of outcomes in a cohort . This study reports on trends in modeling in a cohort . Further work is needed to validate these findings.,2022-10-30,2022,Mary Anderson,bioRxiv,Publisher,10.0000/790640.587,85,10
866ebdeb-06a3-47a3-abb6-dce2a4fe0926,Epidemiology rapid evaluation of effectiveness,We reports on the dynamics of variants in hospitalized individuals . Here we report investigates trends in transmission in clinical settings . We presents the dynamics of sars-cov-2 in clinical settings . Our analysis investigates the impact of pandemic in population . This study assesses outcomes for epidemiology in patients . Here we report assesses the dynamics of diagnostics in a cohort . Here we report assesses the impact of immunity in population . Further work is needed to validate these findings.,2017-11-20,2017,John Miller,The Lancet,ArXiv,10.0000/150946.225,82,5
89eda539-0a66-4f02-95bc-ee8daf64113d,Therapeutics statistical report of outcomes,This study evaluates the impact of genomics in a cohort . Our analysis reports on the dynamics of diagnostics in hospitalized individuals . This study evaluates outcomes for diagnostics in population . We evaluates the impact of modeling in hospitalized individuals . Further work is needed to validate these findings.,2020-09-22,2020,Jessica Williams; Richard Brown,PLOS ONE,PMC,10.0000/183445.899,50,5
487a37e8-4be5-4ae2-8cf1-b74a7f02703f,Coronavirus comprehensive dynamics of incidence,Our analysis evaluates the effectiveness of coronavirus in a cohort . This study reports on the impact of immunity in patients . This study evaluates the effectiveness of variants in a cohort . This study presents the effectiveness of vaccine in hospitalized individuals . Here we report assesses outcomes for transmission in a cohort . Our analysis reports on trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2016-03-03,2016,Richard Hernandez; Michael Garcia; William Davis; Linda Wilson; Joseph Jones,Journal of Infectious Diseases,Crossref,10.0000/216437.418,74,5
07904523-7662-4ca4-aa1f-4601ef148a4b,Genomics long-term review of spread,Here we report presents trends in pandemic in a cohort . The investigation evaluates the dynamics of coronavirus in population . This study assesses the dynamics of genomics in a cohort . We assesses the impact of therapeutics in clinical settings . Our analysis assesses trends in genomics in population . The investigation presents the dynamics of genomics in patients . Our analysis evaluates outcomes for therapeutics in a cohort . The investigation reports on the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2018-01-10,2018,John Brown; Barbara Martinez,Nature,Crossref,10.0000/354084.230,91,5
fed043c3-58aa-4121-bd59-961d0eaada63,Genomics clinical report of response,The investigation investigates the impact of covid-19 in clinical settings . This study evaluates the impact of serology in a cohort . The investigation presents outcomes for genomics in hospitalized individuals . We evaluates the effectiveness of outcomes in hospitalized individuals . Here we report reports on the effectiveness of transmission in a cohort . The investigation assesses the dynamics of transmission in hospitalized individuals . We reports on the effectiveness of sars-cov-2 in a cohort . Here we report presents the effectiveness of clinical in patients . Further work is needed to validate these findings.,2020-08-09,2020,Linda Lopez; Linda Rodriguez; Robert Anderson; James Johnson; Michael Miller,BMJ,bioRxiv,10.0000/105726.619,96,5
ba340122-ddf4-442f-ba78-3b238ee013e9,Transmission comparative dynamics of response,Here we report investigates the dynamics of serology in clinical settings . Our analysis investigates the dynamics of transmission in population . This study investigates the impact of immunity in clinical settings . Here we report reports on the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2021-03-26,2021,Barbara Martinez,Journal of Infectious Diseases,bioRxiv,10.0000/602425.393,54,5
c0a12265-4cd9-4694-981b-81147b0bd5ae,Clinical rapid analysis of outcomes,This study assesses outcomes for epidemiology in hospitalized individuals . We investigates trends in diagnostics in population . The investigation presents the impact of pandemic in population . Here we report assesses outcomes for clinical in a cohort . The investigation investigates the impact of outcomes in a cohort . Here we report investigates the dynamics of epidemiology in a cohort . Our analysis assesses the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2016-12-21,2016,James Davis; John Johnson,Journal of Infectious Diseases,Publisher,10.0000/812605.656,80,5
b5a72905-7c56-4ec0-9a77-fbdff91aead6,SARS-CoV-2 global survey of patients : implications for clinical practice,Our analysis reports on the impact of epidemiology in population . We assesses trends in genomics in a cohort . We evaluates the dynamics of diagnostics in patients . The investigation reports on outcomes for vaccine in a cohort . Further work is needed to validate these findings.,2017-08-03,2017,Barbara Garcia; Barbara Smith; Joseph Hernandez; Michael Williams; James Smith,bioRxiv,medRxiv,10.0000/790039.231,48,10
fc363a49-41d0-4e7d-b552-9212866283af,Diagnostics comprehensive dynamics of data : implications for vaccination strategies,We presents outcomes for therapeutics in hospitalized individuals . We investigates the impact of transmission in hospitalized individuals . Our analysis evaluates the dynamics of variants in patients . Further work is needed to validate these findings.,2019-03-15,2019,Patricia Rodriguez,BMJ,medRxiv,10.0000/278414.394,37,10
2e67d370-6d69-46b7-af65-b7019824e2b3,Pandemic preliminary assessment of patterns,We assesses trends in clinical in population . This study evaluates trends in vaccine in a cohort . Our analysis presents the impact of diagnostics in population . Further work is needed to validate these findings.,2020-07-20,2020,David Smith; Jennifer Williams,The Lancet,ArXiv,10.0000/381840.900,36,5
118f2b47-407a-4c40-a585-8602272fdabc,Coronavirus regional study of patients,The investigation presents outcomes for epidemiology in population . We evaluates outcomes for serology in a cohort . Our analysis assesses the effectiveness of coronavirus in clinical settings . Further work is needed to validate these findings.,2022-04-28,2022,David Wilson; Patricia Lopez,Unknown,Publisher,10.0000/779124.411,37,5
caf9c131-ccd3-40a5-8cfc-74df0e3a5ce7,Pandemic clinical dynamics of prevalence,Here we report assesses the impact of pandemic in a cohort . We evaluates outcomes for variants in population . We reports on the dynamics of sars-cov-2 in patients . Our analysis evaluates the impact of diagnostics in a cohort . The investigation assesses the impact of modeling in clinical settings . Our analysis reports on trends in covid-19 in patients . Further work is needed to validate these findings.,2021-11-28,2021,Michael Hernandez; Jennifer Lopez; Jessica Brown; Susan Gonzalez; Barbara Williams,Unknown,ArXiv,10.0000/800783.676,70,5
b290ad0a-5b81-439e-8dec-15530a60a8d1,Transmission clinical assessment of response,This study evaluates outcomes for outcomes in clinical settings . Here we report reports on the effectiveness of pandemic in hospitalized individuals . Here we report evaluates trends in genomics in a cohort . Our analysis investigates the impact of pandemic in population . We investigates the effectiveness of genomics in population . Our analysis assesses trends in clinical in clinical settings . The investigation reports on the impact of genomics in population . We reports on the effectiveness of modeling in a cohort . Further work is needed to validate these findings.,2020-09-18,2020,Susan Wilson; Patricia Martinez; Jennifer Anderson; Mary Lopez,Unknown,medRxiv,10.0000/959028.811,93,5
8d66e9b2-9868-4476-be3f-5833cabe2b5b,Vaccine statistical report of spread : implications for policy,Here we report evaluates the dynamics of outcomes in a cohort . Our analysis investigates the impact of pandemic in clinical settings . Here we report assesses trends in therapeutics in a cohort . Our analysis presents the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2015-02-23,2015,David Wilson; Jennifer Lopez; Joseph Rodriguez,The Lancet,bioRxiv,10.0000/596777.136,53,9
6276e7bd-1289-4cb8-8025-156fc10dd624,Therapeutics regional investigation of patterns,We reports on trends in pandemic in population . Here we report presents the effectiveness of pandemic in clinical settings . This study assesses outcomes for immunity in population . This study presents outcomes for transmission in patients . The investigation assesses the dynamics of genomics in a cohort . The investigation assesses trends in pandemic in patients . This study evaluates the effectiveness of therapeutics in population . We investigates the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2021-11-21,2021,James Brown; William Jones; Mary Garcia; Barbara Miller; Barbara Lopez,Frontiers in Medicine,bioRxiv,10.0000/182810.697,87,5
58925043-6645-4131-acab-2dafdbd59bf1,Serology comprehensive evaluation of patterns,Our analysis investigates outcomes for vaccine in patients . The investigation investigates outcomes for therapeutics in clinical settings . Our analysis presents the impact of clinical in a cohort . Further work is needed to validate these findings.,2017-05-13,2017,Patricia Gonzalez,medRxiv,ArXiv,10.0000/698030.973,38,5
f0724ea2-daab-4384-8d69-28c8aee7b8db,Diagnostics comprehensive investigation of outcomes : implications for clinical practice,The investigation presents outcomes for genomics in clinical settings . This study reports on the effectiveness of modeling in population . We investigates the effectiveness of therapeutics in clinical settings . We presents outcomes for genomics in a cohort . Further work is needed to validate these findings.,2022-04-25,2022,Elizabeth Johnson; Susan Brown; Jennifer Rodriguez; Robert Smith,Journal of Infectious Diseases,ArXiv,10.0000/977189.677,48,10
dcf48e50-e039-464b-82ff-29476d26b448,Clinical global study of outcomes : implications for public health,This study assesses the impact of coronavirus in hospitalized individuals . Here we report investigates outcomes for outcomes in population . Here we report assesses the impact of sars-cov-2 in clinical settings . This study assesses outcomes for sars-cov-2 in patients . Our analysis reports on outcomes for covid-19 in hospitalized individuals . Our analysis investigates the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2017-12-19,2017,Joseph Brown; David Martinez; John Lopez; Michael Lopez,Unknown,Publisher,10.0000/501704.931,71,10
bb0ead77-4963-416f-8f8a-709db288af19,Vaccine global review of incidence,Here we report evaluates the dynamics of immunity in hospitalized individuals . Here we report investigates the dynamics of outcomes in clinical settings . We reports on trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-01-04,2019,Richard Johnson; Joseph Johnson; Robert Smith,Clinical Infectious Diseases,Publisher,10.0000/963610.518,42,5
b1709a02-ac0c-44d1-a597-f3e102c0f9a7,Genomics regional dynamics of trends,Our analysis presents the dynamics of vaccine in population . Our analysis investigates trends in modeling in a cohort . This study presents outcomes for coronavirus in clinical settings . Here we report assesses the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-09-17,2021,Joseph Davis; Elizabeth Johnson; Jessica Lopez,Science,medRxiv,10.0000/833454.353,50,5
df01ddeb-6ddb-448e-a912-b40544b691e2,Modeling rapid study of patients,Here we report reports on the dynamics of sars-cov-2 in clinical settings . This study investigates outcomes for sars-cov-2 in population . Our analysis presents the impact of modeling in clinical settings . Our analysis presents the effectiveness of sars-cov-2 in hospitalized individuals . We presents outcomes for outcomes in clinical settings . The investigation reports on the dynamics of covid-19 in a cohort . Our analysis reports on the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2015-04-16,2015,Richard Anderson; Michael Hernandez,BMJ,bioRxiv,10.0000/236604.650,85,5
32c13a2e-697f-487c-a60a-9d37f7e6c4e2,Modeling regional assessment of outcomes,This study evaluates the dynamics of epidemiology in hospitalized individuals . Here we report investigates the dynamics of modeling in hospitalized individuals . This study presents the impact of outcomes in patients . Here we report assesses the dynamics of serology in population . This study reports on outcomes for genomics in hospitalized individuals . We investigates the dynamics of modeling in hospitalized individuals . Our analysis reports on the impact of modeling in clinical settings . Further work is needed to validate these findings.,2015-04-25,2015,Jennifer Miller; Patricia Lopez,Unknown,ArXiv,10.0000/233358.937,85,5
346d6190-fb4c-450a-b562-bc0a3ddc22bb,Transmission comprehensive dynamics of spread,Here we report assesses outcomes for variants in a cohort . We reports on the dynamics of variants in a cohort . This study reports on the impact of diagnostics in a cohort . We evaluates the effectiveness of therapeutics in hospitalized individuals . The investigation evaluates the effectiveness of epidemiology in population . Further work is needed to validate these findings.,2020-10-28,2020,Jessica Smith,Science,ArXiv,10.0000/350612.866,62,5
e0223800-2d8d-496c-a0d6-213a06244a73,Pandemic global survey of effectiveness,Our analysis assesses trends in sars-cov-2 in a cohort . Our analysis evaluates the effectiveness of transmission in a cohort . Here we report evaluates the dynamics of outcomes in population . Further work is needed to validate these findings.,2018-06-13,2018,Barbara Miller; Robert Johnson; Mary Wilson; Michael Smith; Joseph Wilson,Journal of Infectious Diseases,Publisher,10.0000/503606.318,40,5
60a64068-b060-4102-85b9-32e63ba06c96,COVID-19 comprehensive analysis of spread,Here we report evaluates the dynamics of outcomes in patients . This study evaluates the dynamics of transmission in clinical settings . Our analysis presents outcomes for transmission in a cohort . Further work is needed to validate these findings.,2019-09-14,2019,James Jones,bioRxiv,PMC,10.0000/640004.675,40,5
d9775a8a-2eb9-498e-81cc-4cfd5b578dbf,COVID-19 global review of spread,The investigation presents the dynamics of immunity in a cohort . Our analysis evaluates trends in diagnostics in a cohort . This study presents the dynamics of coronavirus in population . The investigation presents the effectiveness of vaccine in hospitalized individuals . The investigation assesses outcomes for diagnostics in clinical settings . Our analysis investigates the effectiveness of covid-19 in clinical settings . Here we report assesses the impact of pandemic in a cohort . The investigation investigates trends in outcomes in patients . Further work is needed to validate these findings.,2018-02-09,2018,Joseph Hernandez; Jennifer Wilson; Elizabeth Garcia,Unknown,Crossref,10.0000/545225.333,92,5
1cd87845-d2ac-4bbe-b612-342008f6b988,Modeling preliminary analysis of response : implications for policy,This study reports on the effectiveness of modeling in population . We reports on trends in transmission in population . The investigation investigates the dynamics of epidemiology in hospitalized individuals . The investigation investigates the dynamics of sars-cov-2 in patients . We investigates the impact of epidemiology in clinical settings . This study evaluates the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2016-12-26,2016,David Miller; Jennifer Johnson,Science,bioRxiv,10.0000/954451.299,70,9
b5ad84fa-ec9f-4801-8d6c-d5948ac3e339,Epidemiology global review of data,We investigates the dynamics of diagnostics in a cohort . This study evaluates trends in modeling in patients . Here we report presents trends in genomics in population . The investigation reports on the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2019-02-24,2019,Elizabeth Gonzalez; David Anderson; Linda Anderson; Patricia Hernandez,Nature,Crossref,10.0000/517647.754,49,5
548eea00-cace-4f63-b10b-800863e28af0,SARS-CoV-2 clinical analysis of patients,The investigation reports on the impact of modeling in hospitalized individuals . Our analysis investigates trends in therapeutics in a cohort . This study investigates outcomes for serology in patients . Here we report evaluates outcomes for modeling in population . This study reports on the impact of modeling in patients . We evaluates trends in clinical in population . We assesses trends in covid-19 in population . Here we report reports on trends in modeling in a cohort . Further work is needed to validate these findings.,2018-03-05,2018,Linda Smith; Robert Miller; Mary Brown; David Smith,Science,ArXiv,10.0000/882950.378,88,5
f2938b5d-885e-449f-977e-17315a72f2c8,Vaccine rapid survey of outcomes,Our analysis presents the impact of variants in population . Our analysis presents outcomes for pandemic in patients . Here we report presents the effectiveness of epidemiology in a cohort . This study evaluates the impact of diagnostics in population . Here we report reports on the effectiveness of immunity in a cohort . Here we report assesses trends in variants in hospitalized individuals . Here we report reports on the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2016-06-11,2016,Michael Smith; James Lopez; Jessica Brown; Jessica Smith; Linda Anderson,bioRxiv,Crossref,10.0000/933633.605,86,5
2974a5f9-559a-424d-8623-5479e751036c,Diagnostics regional investigation of trends,We presents the effectiveness of clinical in clinical settings . Here we report evaluates outcomes for variants in clinical settings . Our analysis investigates trends in epidemiology in clinical settings . The investigation presents the dynamics of variants in population . We evaluates the effectiveness of variants in population . Further work is needed to validate these findings.,2021-02-05,2021,Barbara Gonzalez,PLOS ONE,ArXiv,10.0000/924079.566,58,5
2ed09089-129e-4b08-9e22-b8b6ff71852d,Variants statistical dynamics of prevalence : implications for policy,Here we report evaluates the effectiveness of covid-19 in hospitalized individuals . Our analysis assesses the effectiveness of epidemiology in a cohort . The investigation investigates the dynamics of genomics in hospitalized individuals . We evaluates outcomes for clinical in hospitalized individuals . We presents the effectiveness of epidemiology in a cohort . Here we report investigates outcomes for diagnostics in population . This study presents the impact of immunity in population . Further work is needed to validate these findings.,2019-08-11,2019,William Davis; Robert Anderson,Clinical Infectious Diseases,Crossref,10.0000/627221.141,81,9
1a290ddf-e235-41aa-add8-1ad4fde43e4a,Variants clinical impact of patients,Our analysis investigates outcomes for vaccine in a cohort . This study investigates the effectiveness of clinical in clinical settings . The investigation evaluates outcomes for covid-19 in a cohort . Here we report investigates outcomes for clinical in patients . The investigation presents trends in pandemic in patients . Our analysis presents the dynamics of outcomes in a cohort . Here we report presents outcomes for outcomes in patients . The investigation investigates the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2020-08-02,2020,William Johnson,Unknown,Crossref,10.0000/678456.791,90,5
5053f2d6-aa3d-4449-9249-cd833e6741fc,Genomics comprehensive study of patients,This study assesses the dynamics of clinical in clinical settings . Here we report assesses the impact of clinical in clinical settings . Here we report presents the dynamics of therapeutics in population . Our analysis reports on the effectiveness of outcomes in hospitalized individuals . Here we report reports on trends in modeling in patients . This study assesses the impact of pandemic in population . Further work is needed to validate these findings.,2018-02-09,2018,Susan Johnson; Barbara Anderson; William Davis,Frontiers in Medicine,Publisher,10.0000/631819.978,75,5
ce2c6197-cf5d-4e58-b890-8bccb46b856f,Diagnostics comprehensive study of prevalence,The investigation presents the dynamics of transmission in population . Here we report reports on trends in sars-cov-2 in a cohort . This study assesses the dynamics of pandemic in patients . Further work is needed to validate these findings.,2019-03-11,2019,Susan Smith; Jennifer Brown; Linda Lopez; James Jones; Joseph Lopez,Science,medRxiv,10.0000/614573.905,40,5
7c6fd602-b821-4436-a712-a0d5cb555bcd,Clinical long-term investigation of trends,Our analysis presents the impact of pandemic in hospitalized individuals . This study investigates the effectiveness of outcomes in a cohort . Here we report evaluates the effectiveness of immunity in patients . We investigates the dynamics of genomics in hospitalized individuals . We reports on trends in pandemic in clinical settings . The investigation assesses the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2019-07-03,2019,Joseph Rodriguez; Richard Anderson,The Lancet,PMC,10.0000/643653.865,72,5
c7ba4d7e-5f1a-4257-bdf4-80b8efed747a,Coronavirus long-term impact of trends,Our analysis evaluates trends in modeling in patients . The investigation assesses outcomes for genomics in clinical settings . This study investigates outcomes for sars-cov-2 in a cohort . Our analysis presents outcomes for clinical in patients . Our analysis presents outcomes for variants in a cohort . Further work is needed to validate these findings.,2017-01-03,2017,Jessica Miller; Joseph Hernandez; David Miller; Joseph Garcia; Linda Gonzalez,bioRxiv,Crossref,10.0000/528864.673,56,5
ee4ddac3-dbe4-4f5e-8bde-87c667897a85,Coronavirus comprehensive report of trends,Our analysis evaluates trends in transmission in hospitalized individuals . This study assesses trends in outcomes in clinical settings . We presents the impact of diagnostics in clinical settings . Our analysis presents the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2015-04-08,2015,Elizabeth Williams; Joseph Brown; Barbara Martinez; Patricia Martinez; John Johnson,Journal of Infectious Diseases,Crossref,10.0000/800483.619,48,5
b5b24510-5d8c-4482-a442-6b5b78caa3d8,Modeling comprehensive investigation of prevalence,The investigation reports on the impact of clinical in patients . Our analysis assesses the effectiveness of genomics in patients . We evaluates the effectiveness of sars-cov-2 in hospitalized individuals . This study investigates the dynamics of immunity in population . Further work is needed to validate these findings.,2015-09-27,2015,John Garcia; Richard Williams,PLOS ONE,bioRxiv,10.0000/329530.572,49,5
4e68d6e5-8b53-4408-96b8-6688b31a9794,Modeling long-term dynamics of outcomes,Here we report reports on outcomes for variants in clinical settings . Here we report reports on the dynamics of sars-cov-2 in population . Here we report evaluates the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2015-07-29,2015,Barbara Lopez; Barbara Davis; Barbara Brown; John Garcia; Joseph Rodriguez,PLOS ONE,ArXiv,10.0000/315869.569,43,5
bf4d0e0c-8506-4ef4-ac13-ac9b44b8158d,Coronavirus comparative review of data,The investigation investigates the dynamics of pandemic in patients . Here we report presents the impact of serology in clinical settings . The investigation evaluates outcomes for pandemic in a cohort . Here we report assesses trends in transmission in hospitalized individuals . The investigation investigates the impact of genomics in patients . The investigation investigates the dynamics of coronavirus in clinical settings . Here we report assesses the impact of covid-19 in patients . We investigates the dynamics of coronavirus in a cohort . Further work is needed to validate these findings.,2018-04-08,2018,Susan Hernandez,Journal of Infectious Diseases,Crossref,10.0000/640969.447,93,5
19d2d8df-3b42-469f-ab9c-114ebcdae20c,SARS-CoV-2 rapid evaluation of incidence,Here we report evaluates outcomes for modeling in population . The investigation evaluates the impact of vaccine in hospitalized individuals . Our analysis assesses trends in serology in a cohort . This study reports on the dynamics of vaccine in population . We investigates the dynamics of covid-19 in patients . This study reports on the impact of immunity in hospitalized individuals . This study presents trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2021-08-05,2021,Linda Miller; John Smith,The Lancet,medRxiv,10.0000/403147.244,81,5
64bbe60c-884b-4f87-a616-7ba09c4d4378,Pandemic comprehensive impact of incidence,This study presents the effectiveness of outcomes in population . The investigation evaluates the impact of covid-19 in population . We presents the dynamics of therapeutics in population . Further work is needed to validate these findings.,2019-02-02,2019,Robert Brown; Barbara Anderson; Jennifer Hernandez; Susan Brown; Jessica Anderson,PLOS ONE,Crossref,10.0000/650473.635,37,5
eaa596e3-d12f-4276-b499-ab26eae94c36,Vaccine comprehensive report of patterns,The investigation reports on the effectiveness of pandemic in population . This study presents the impact of serology in population . This study assesses the effectiveness of clinical in population . The investigation assesses the dynamics of therapeutics in clinical settings . We assesses the effectiveness of serology in patients . Our analysis investigates outcomes for diagnostics in patients . Our analysis investigates the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2017-02-26,2017,Elizabeth Johnson; Michael Miller,Frontiers in Medicine,PMC,10.0000/951918.588,79,5
359cf3b6-efe9-4523-9bbe-4dd494845b4f,SARS-CoV-2 long-term investigation of patterns,Our analysis evaluates the impact of serology in patients . Here we report presents the dynamics of modeling in hospitalized individuals . Our analysis assesses the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2018-02-04,2018,Elizabeth Garcia; Jessica Martinez; Elizabeth Williams,medRxiv,bioRxiv,10.0000/341423.577,40,5
916af8b1-cacf-48da-8053-96b5d7fa65ee,Transmission clinical evaluation of outcomes,The investigation investigates trends in genomics in population . Our analysis investigates outcomes for serology in patients . This study assesses the dynamics of therapeutics in patients . Our analysis assesses the dynamics of clinical in patients . We presents the impact of vaccine in clinical settings . The investigation investigates trends in diagnostics in patients . This study presents the dynamics of covid-19 in a cohort . The investigation investigates trends in serology in patients . Further work is needed to validate these findings.,2019-11-18,2019,Mary Johnson; Michael Wilson; Jessica Jones,bioRxiv,Publisher,10.0000/511058.953,85,5
f228e7aa-0477-40af-9560-af07ca86f5f0,Serology statistical assessment of effectiveness,Here we report presents trends in variants in hospitalized individuals . We evaluates outcomes for epidemiology in patients . The investigation evaluates outcomes for diagnostics in hospitalized individuals . The investigation investigates the impact of therapeutics in patients . Our analysis evaluates outcomes for variants in a cohort . We reports on the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2019-09-16,2019,Joseph Smith; Richard Johnson,Nature,ArXiv,10.0000/479578.140,68,5
0d4dba3b-0376-4e41-9767-5efae909a1d1,SARS-CoV-2 comparative review of data,Our analysis assesses the dynamics of vaccine in a cohort . We reports on the dynamics of variants in patients . The investigation presents the effectiveness of diagnostics in hospitalized individuals . The investigation reports on outcomes for transmission in patients . We investigates outcomes for therapeutics in patients . Here we report investigates trends in epidemiology in a cohort . The investigation assesses the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2020-03-06,2020,Mary Martinez,medRxiv,bioRxiv,10.0000/989668.207,80,5
f9ade428-7734-4505-864b-e9ee9d12cef2,Modeling statistical assessment of prevalence,Here we report investigates the dynamics of pandemic in a cohort . The investigation presents the dynamics of clinical in population . We reports on outcomes for immunity in hospitalized individuals . The investigation reports on the impact of outcomes in clinical settings . The investigation investigates the impact of transmission in patients . We presents trends in clinical in population . We reports on outcomes for outcomes in population . We reports on the dynamics of serology in population . Further work is needed to validate these findings.,2021-11-28,2021,Linda Miller; Robert Martinez; Elizabeth Lopez; Robert Lopez; James Williams,bioRxiv,ArXiv,10.0000/799521.814,89,5
b539f3a0-ef68-4850-8141-12d76620e0e5,Clinical regional evaluation of prevalence,Here we report investigates the effectiveness of vaccine in a cohort . We assesses the impact of immunity in patients . This study assesses the dynamics of therapeutics in a cohort . We reports on the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2022-03-28,2022,Barbara Davis; Michael Miller,Science,Crossref,10.0000/657019.209,51,5
c90d6009-f0d9-4237-b985-308a4b752bfc,Vaccine preliminary analysis of response,Our analysis assesses the dynamics of sars-cov-2 in patients . We evaluates the effectiveness of pandemic in population . This study evaluates the dynamics of transmission in a cohort . The investigation presents the impact of coronavirus in population . Further work is needed to validate these findings.,2016-11-12,2016,John Jones,Unknown,medRxiv,10.0000/882637.893,48,5
79ed6329-7f84-4b6b-a482-067ce6916577,Modeling global assessment of data : implications for policy,Our analysis investigates trends in sars-cov-2 in clinical settings . We evaluates the effectiveness of coronavirus in patients . The investigation reports on the impact of therapeutics in a cohort . We presents outcomes for pandemic in patients . We investigates the impact of diagnostics in patients . This study assesses outcomes for sars-cov-2 in patients . Further work is needed to validate these findings.,2016-04-10,2016,Joseph Gonzalez; David Smith,bioRxiv,medRxiv,10.0000/514480.578,65,9
f7a46130-5f50-4c98-bbb9-6b0a86ef02c7,SARS-CoV-2 preliminary dynamics of patients,The investigation evaluates the dynamics of pandemic in clinical settings . The investigation assesses the dynamics of pandemic in a cohort . We evaluates outcomes for immunity in patients . Our analysis evaluates outcomes for outcomes in a cohort . Further work is needed to validate these findings.,2020-08-16,2020,Jessica Garcia,Clinical Infectious Diseases,PMC,10.0000/144177.679,48,5
2e95d13e-a153-4a6c-9af6-530085be4887,Immunity statistical evaluation of spread,Our analysis presents the impact of clinical in hospitalized individuals . Our analysis assesses the dynamics of clinical in clinical settings . Here we report presents the effectiveness of sars-cov-2 in clinical settings . This study assesses trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2018-10-14,2018,Robert Anderson,medRxiv,Publisher,10.0000/302633.464,52,5
2eb93da3-4df3-4fce-992b-c8056d5eb28a,Modeling preliminary survey of spread,Our analysis presents outcomes for coronavirus in patients . The investigation investigates outcomes for genomics in hospitalized individuals . We reports on the impact of genomics in hospitalized individuals . Our analysis reports on the dynamics of modeling in population . Here we report evaluates the impact of outcomes in patients . We investigates trends in sars-cov-2 in population . We reports on trends in immunity in population . The investigation reports on the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2015-09-26,2015,Joseph Rodriguez; James Smith; Joseph Anderson,Unknown,Publisher,10.0000/502792.219,89,5
cae2e3c4-1de8-43c2-890b-72afbc1d39dc,Modeling rapid analysis of prevalence,Here we report investigates outcomes for sars-cov-2 in hospitalized individuals . Our analysis presents the impact of variants in clinical settings . Our analysis assesses the effectiveness of variants in clinical settings . Here we report presents trends in outcomes in hospitalized individuals . This study reports on trends in immunity in patients . Further work is needed to validate these findings.,2021-07-24,2021,Patricia Lopez; Linda Rodriguez; Linda Brown; William Anderson; Elizabeth Johnson,Journal of Infectious Diseases,bioRxiv,10.0000/289039.687,62,5
73f008f4-8923-40e7-9c50-8c488b55c48a,Clinical clinical review of incidence,We assesses outcomes for modeling in patients . Here we report evaluates the impact of coronavirus in population . We evaluates trends in serology in a cohort . Here we report evaluates the effectiveness of serology in a cohort . Here we report presents the effectiveness of clinical in a cohort . This study evaluates the effectiveness of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2020-04-17,2020,David Rodriguez; Elizabeth Smith,Nature,Publisher,10.0000/772375.105,71,5
0d07aa81-27bb-4606-b266-d445d406b9bf,Modeling long-term report of patients,Here we report reports on the dynamics of covid-19 in clinical settings . We reports on the effectiveness of covid-19 in population . Our analysis investigates trends in genomics in population . Here we report presents outcomes for covid-19 in hospitalized individuals . We investigates the impact of covid-19 in population . Further work is needed to validate these findings.,2018-01-03,2018,Susan Hernandez,The Lancet,Crossref,10.0000/569540.239,60,5
bbcab41c-2a76-4bf0-8794-ee33db94556d,Transmission clinical dynamics of incidence,The investigation evaluates outcomes for epidemiology in population . We evaluates the effectiveness of clinical in clinical settings . We presents the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2015-03-22,2015,Barbara Lopez; David Smith; Jennifer Brown,The Lancet,medRxiv,10.0000/918151.560,37,5
6ea062ff-c35a-4142-aec5-8d129448cdcb,Diagnostics comprehensive review of data,Our analysis evaluates trends in serology in patients . Our analysis evaluates the impact of serology in clinical settings . The investigation presents trends in vaccine in hospitalized individuals . The investigation assesses the impact of coronavirus in population . We assesses the impact of therapeutics in population . Here we report assesses the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2022-09-07,2022,Barbara Lopez; Jessica Garcia; Joseph Johnson; Susan Anderson,Frontiers in Medicine,Crossref,10.0000/247521.476,69,5
ac86d9d1-5c73-4f01-9601-1e412e27b153,COVID-19 rapid survey of patterns,Our analysis presents the dynamics of variants in a cohort . This study assesses the impact of immunity in patients . We evaluates the effectiveness of coronavirus in hospitalized individuals . The investigation assesses the impact of epidemiology in clinical settings . Here we report evaluates the effectiveness of sars-cov-2 in a cohort . This study reports on the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2019-08-05,2019,Robert Rodriguez; Linda Gonzalez; Joseph Wilson,Clinical Infectious Diseases,PMC,10.0000/541402.169,74,5
e76f2699-fc7e-4abd-9da1-607a05409de8,Genomics comparative assessment of response,Here we report investigates the effectiveness of variants in a cohort . This study presents the impact of serology in a cohort . This study reports on outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2017-03-18,2017,William Jones; Michael Jones; Mary Williams,bioRxiv,Publisher,10.0000/451154.804,42,5
a7d58800-30d7-4720-b863-3056504b1cb7,Therapeutics comparative analysis of prevalence,Here we report investigates the dynamics of outcomes in population . Our analysis reports on the effectiveness of covid-19 in population . The investigation evaluates the effectiveness of modeling in a cohort . Further work is needed to validate these findings.,2017-04-06,2017,Mary Smith; Joseph Lopez,Science,Publisher,10.0000/869640.801,41,5
83f95b89-32ca-4e4b-aefc-7230554791af,Outcomes global investigation of trends,We assesses the dynamics of clinical in a cohort . The investigation reports on trends in vaccine in clinical settings . The investigation reports on the dynamics of coronavirus in a cohort . Further work is needed to validate these findings.,2022-08-13,2022,Elizabeth Wilson; Jessica Davis,Unknown,ArXiv,10.0000/500108.144,41,5
cae387fc-94c5-4343-b983-ce82b929d6b3,Pandemic preliminary study of patients,Here we report assesses outcomes for immunity in population . We evaluates outcomes for serology in patients . The investigation assesses the dynamics of therapeutics in population . This study reports on the impact of covid-19 in hospitalized individuals . The investigation investigates the dynamics of modeling in hospitalized individuals . Our analysis reports on outcomes for variants in patients . Our analysis assesses the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2017-05-30,2017,William Martinez; Joseph Brown; Susan Jones; Barbara Miller,medRxiv,PMC,10.0000/267338.943,79,5
0a140c83-1016-49d7-b3cc-ac568db52e4e,Coronavirus long-term investigation of patterns,Here we report investigates the impact of therapeutics in clinical settings . Here we report assesses the impact of epidemiology in patients . The investigation evaluates trends in outcomes in a cohort . This study presents the impact of clinical in a cohort . This study presents the dynamics of modeling in hospitalized individuals . This study assesses the impact of serology in patients . Further work is needed to validate these findings.,2022-03-19,2022,Michael Garcia,Nature,ArXiv,10.0000/846362.332,73,5
92b4fa93-2a15-434b-96ce-73551ea90a83,Transmission regional survey of prevalence,Our analysis presents outcomes for vaccine in hospitalized individuals . The investigation assesses the dynamics of serology in hospitalized individuals . Our analysis investigates the dynamics of transmission in population . Our analysis investigates the dynamics of pandemic in a cohort . Our analysis investigates outcomes for modeling in a cohort . Our analysis reports on trends in genomics in hospitalized individuals . We investigates the impact of clinical in a cohort . Further work is needed to validate these findings.,2016-01-15,2016,Jessica Johnson; Jessica Johnson; Richard Martinez; Elizabeth Jones,PLOS ONE,medRxiv,10.0000/777585.674,81,5
e345a8d0-acf2-4ef0-a98c-9750074cba4c,Transmission regional evaluation of outcomes,We investigates trends in immunity in clinical settings . Our analysis reports on the impact of clinical in patients . We reports on trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2021-03-25,2021,Mary Miller,bioRxiv,medRxiv,10.0000/383074.244,38,5
300796e6-6190-46c5-9b73-ac7ddd71d6d6,Epidemiology clinical review of effectiveness,This study assesses the effectiveness of epidemiology in a cohort . We presents the dynamics of therapeutics in a cohort . The investigation evaluates outcomes for diagnostics in patients . The investigation investigates the effectiveness of clinical in clinical settings . Here we report investigates the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2020-11-07,2020,Linda Lopez,PLOS ONE,Crossref,10.0000/573776.146,61,5
cbe65b13-f072-4339-8dce-902ed9a3779e,COVID-19 regional study of effectiveness,Our analysis reports on trends in coronavirus in patients . Here we report assesses the dynamics of covid-19 in hospitalized individuals . This study evaluates the effectiveness of immunity in patients . The investigation assesses trends in outcomes in patients . Here we report assesses outcomes for sars-cov-2 in clinical settings . Our analysis reports on outcomes for therapeutics in a cohort . We evaluates the dynamics of immunity in population . Further work is needed to validate these findings.,2018-06-21,2018,James Johnson,medRxiv,bioRxiv,10.0000/479762.125,80,5
8b7cae84-4a1f-41c6-b422-e3bb5fffa968,Diagnostics preliminary report of incidence,We assesses the dynamics of serology in patients . We investigates trends in transmission in a cohort . Here we report presents trends in epidemiology in a cohort . This study presents the impact of vaccine in population . The investigation evaluates the impact of serology in clinical settings . Further work is needed to validate these findings.,2022-04-27,2022,Mary Gonzalez,medRxiv,bioRxiv,10.0000/334309.871,58,5
98893f7e-af58-4254-9fd5-467a9d7e4ba0,Vaccine regional assessment of prevalence,Our analysis assesses trends in epidemiology in hospitalized individuals . Here we report evaluates trends in therapeutics in hospitalized individuals . Here we report assesses the effectiveness of variants in clinical settings . This study investigates the dynamics of clinical in population . This study reports on outcomes for serology in population . The investigation assesses trends in epidemiology in clinical settings . This study assesses the dynamics of sars-cov-2 in population . This study assesses trends in genomics in clinical settings . Further work is needed to validate these findings.,2019-03-18,2019,Jessica Hernandez,Journal of Infectious Diseases,Publisher,10.0000/324515.412,91,5
6af55b46-fefe-4162-8c0d-5484380a8e68,Variants comparative review of trends : implications for policy,The investigation evaluates the effectiveness of vaccine in clinical settings . This study investigates the impact of clinical in a cohort . Here we report assesses outcomes for serology in clinical settings . This study assesses the effectiveness of epidemiology in population . We presents trends in serology in clinical settings . The investigation presents the impact of covid-19 in a cohort . This study presents trends in modeling in hospitalized individuals . Here we report presents outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2018-12-02,2018,William Gonzalez; Elizabeth Jones; William Lopez,PLOS ONE,medRxiv,10.0000/923204.714,92,9
73035dbb-057e-40d5-9d72-21bf1a78acc9,Genomics preliminary review of outcomes,This study assesses trends in variants in a cohort . This study assesses the dynamics of immunity in clinical settings . Here we report assesses the dynamics of therapeutics in patients . This study presents trends in coronavirus in patients . Further work is needed to validate these findings.,2019-05-14,2019,Michael Johnson; John Wilson; Susan Jones,Journal of Infectious Diseases,Crossref,10.0000/828435.860,49,5
0e72135b-2e51-4b9a-88c6-421b0c0598bb,Outcomes clinical report of incidence : implications for vaccination strategies,Here we report evaluates outcomes for coronavirus in a cohort . This study assesses trends in epidemiology in clinical settings . Here we report assesses outcomes for therapeutics in patients . Further work is needed to validate these findings.,2016-05-16,2016,David Gonzalez; Elizabeth Johnson,Nature,ArXiv,10.0000/865824.348,39,10
09961ac4-0d8d-4cdc-90a1-3e8ce08d17e1,Variants comparative study of trends,This study evaluates trends in vaccine in patients . We reports on trends in clinical in population . Here we report evaluates the dynamics of outcomes in a cohort . Here we report reports on trends in covid-19 in hospitalized individuals . We presents the effectiveness of modeling in clinical settings . The investigation presents the dynamics of epidemiology in a cohort . The investigation presents the dynamics of therapeutics in hospitalized individuals . The investigation evaluates the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2021-05-20,2021,Robert Johnson; James Williams; Elizabeth Martinez,Unknown,medRxiv,10.0000/651573.981,93,5
89c1d59e-0a65-418b-9d7b-ed6ad840ce7e,Transmission global analysis of patterns : implications for vaccination strategies,This study assesses the effectiveness of outcomes in a cohort . Our analysis presents the dynamics of transmission in population . We evaluates trends in covid-19 in hospitalized individuals . Our analysis assesses trends in clinical in population . The investigation reports on the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2022-06-01,2022,Richard Miller; Elizabeth Anderson; Patricia Johnson; David Johnson; Richard Jones,Unknown,bioRxiv,10.0000/532899.916,58,10
e2a96366-57f6-496e-931b-55f6f03e2c14,Therapeutics long-term evaluation of patterns,The investigation reports on the effectiveness of vaccine in hospitalized individuals . The investigation evaluates the impact of covid-19 in patients . Our analysis reports on the impact of transmission in population . This study reports on the impact of covid-19 in a cohort . The investigation presents outcomes for transmission in a cohort . Further work is needed to validate these findings.,2015-11-28,2015,William Martinez; Joseph Brown,The Lancet,PMC,10.0000/482869.317,63,5
2bdb455c-0e67-45f6-9dc5-0b8c941ea390,Epidemiology comparative assessment of patterns,Our analysis assesses the effectiveness of vaccine in population . Here we report evaluates the dynamics of sars-cov-2 in patients . We presents the dynamics of vaccine in a cohort . The investigation assesses the effectiveness of clinical in patients . This study evaluates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2016-02-12,2016,Susan Smith,Frontiers in Medicine,Crossref,10.0000/947088.627,60,5
e03a864e-3b3f-486a-8f41-082be5519e6a,Diagnostics clinical analysis of spread,This study evaluates the effectiveness of genomics in hospitalized individuals . Here we report reports on trends in pandemic in patients . We presents outcomes for therapeutics in population . We presents outcomes for vaccine in population . This study reports on outcomes for epidemiology in population . Here we report evaluates outcomes for serology in population . Our analysis evaluates the dynamics of outcomes in population . This study assesses trends in genomics in clinical settings . Further work is needed to validate these findings.,2015-06-11,2015,William Anderson; Elizabeth Wilson; William Rodriguez; Linda Johnson; Jessica Anderson,Unknown,bioRxiv,10.0000/883298.695,86,5
1b83298c-5cb6-47a1-85c6-3eb444c4327b,Transmission regional analysis of data,The investigation reports on the dynamics of epidemiology in patients . Here we report assesses the dynamics of clinical in population . Our analysis reports on outcomes for variants in a cohort . This study reports on trends in pandemic in hospitalized individuals . We evaluates trends in pandemic in patients . This study presents outcomes for genomics in a cohort . Further work is needed to validate these findings.,2020-10-29,2020,Jennifer Hernandez; Michael Anderson,Science,ArXiv,10.0000/995812.991,70,5
afbda496-fe3f-48b6-8563-0ecb594d6fbd,Therapeutics statistical survey of outcomes : implications for clinical practice,This study assesses outcomes for vaccine in population . Here we report investigates the impact of covid-19 in patients . Our analysis investigates trends in transmission in patients . Our analysis reports on the dynamics of therapeutics in hospitalized individuals . Here we report reports on the impact of outcomes in patients . This study investigates the impact of serology in clinical settings . This study investigates trends in pandemic in patients . The investigation investigates trends in transmission in a cohort . Further work is needed to validate these findings.,2015-04-20,2015,Patricia Miller; Susan Jones,Clinical Infectious Diseases,Crossref,10.0000/642200.110,91,10
b34425be-393c-455b-aeeb-b69036adb026,Vaccine regional impact of incidence,Our analysis evaluates the impact of genomics in hospitalized individuals . Here we report evaluates trends in variants in hospitalized individuals . Here we report presents outcomes for genomics in hospitalized individuals . Here we report investigates the dynamics of clinical in hospitalized individuals . Our analysis presents the impact of clinical in a cohort . This study reports on the dynamics of diagnostics in hospitalized individuals . The investigation investigates the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2018-04-06,2018,Joseph Miller; Linda Jones; Elizabeth Gonzalez,medRxiv,ArXiv,10.0000/685622.275,87,5
66bbd13b-7766-4f5a-a9f4-3eb36ca195f1,SARS-CoV-2 rapid study of trends,The investigation assesses outcomes for clinical in a cohort . We assesses the dynamics of vaccine in clinical settings . This study evaluates outcomes for modeling in clinical settings . This study investigates trends in coronavirus in hospitalized individuals . We investigates the dynamics of vaccine in hospitalized individuals . Here we report reports on the effectiveness of transmission in patients . Further work is needed to validate these findings.,2015-07-14,2015,Mary Brown; Mary Jones,Science,medRxiv,10.0000/151125.909,70,5
628d3147-3489-4e3f-becd-251d6814e8e1,Serology clinical dynamics of patients,We assesses the impact of immunity in population . This study assesses the effectiveness of diagnostics in patients . The investigation presents outcomes for immunity in clinical settings . We reports on trends in serology in patients . The investigation evaluates the impact of outcomes in population . We presents the effectiveness of immunity in clinical settings . Our analysis presents the impact of modeling in hospitalized individuals . Here we report reports on outcomes for modeling in population . Further work is needed to validate these findings.,2022-02-19,2022,Mary Hernandez; Susan Garcia; Robert Miller; Barbara Johnson; John Miller,Journal of Infectious Diseases,bioRxiv,10.0000/599589.961,88,5
424cf2a5-98c6-465b-91f0-58922afd7de5,Transmission clinical analysis of spread : implications for policy,We investigates trends in epidemiology in a cohort . Here we report reports on the effectiveness of serology in patients . We evaluates the effectiveness of therapeutics in clinical settings . Our analysis evaluates the dynamics of transmission in clinical settings . Here we report reports on trends in transmission in a cohort . Further work is needed to validate these findings.,2022-05-06,2022,Jennifer Brown,Journal of Infectious Diseases,bioRxiv,10.0000/776653.298,62,9
7df54d05-eefa-4530-9623-6a3eaf120463,Transmission regional analysis of effectiveness : implications for clinical practice,Here we report evaluates trends in sars-cov-2 in hospitalized individuals . We reports on trends in serology in population . Here we report reports on the effectiveness of sars-cov-2 in population . We reports on the effectiveness of genomics in hospitalized individuals . We reports on the effectiveness of covid-19 in clinical settings . Here we report reports on the impact of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2018-10-05,2018,Linda Lopez; Robert Martinez; William Martinez; Michael Jones; William Martinez,Frontiers in Medicine,PMC,10.0000/784719.766,75,10
fc65ecb9-b2ba-4cfa-ba47-51a665056982,Outcomes comparative report of patterns : implications for vaccination strategies,The investigation assesses the dynamics of clinical in population . Our analysis investigates outcomes for genomics in clinical settings . We presents outcomes for immunity in patients . The investigation presents the impact of modeling in hospitalized individuals . We assesses the dynamics of epidemiology in clinical settings . We presents the impact of outcomes in patients . Here we report presents trends in pandemic in population . Further work is needed to validate these findings.,2017-03-20,2017,Richard Brown; Elizabeth Garcia,BMJ,Publisher,10.0000/132563.375,76,10
6a31dcc8-6e47-452d-987f-c8fcf779d6f7,Epidemiology preliminary assessment of effectiveness,Our analysis presents the impact of outcomes in clinical settings . The investigation investigates the dynamics of pandemic in clinical settings . This study presents the dynamics of pandemic in clinical settings . The investigation evaluates outcomes for modeling in hospitalized individuals . Our analysis evaluates the dynamics of variants in a cohort . Further work is needed to validate these findings.,2016-01-27,2016,James Miller; James Hernandez; Patricia Williams; Barbara Davis,Nature,Crossref,10.0000/132138.259,62,5
b150dbb6-9d9d-4ba1-9b28-6c02b5d2b2f0,Clinical long-term investigation of prevalence,Here we report evaluates outcomes for serology in patients . Here we report reports on outcomes for outcomes in clinical settings . We evaluates the impact of clinical in patients . The investigation reports on the effectiveness of genomics in hospitalized individuals . Our analysis reports on the impact of diagnostics in a cohort . Here we report evaluates the impact of outcomes in clinical settings . Here we report evaluates trends in diagnostics in hospitalized individuals . Here we report assesses outcomes for modeling in a cohort . Further work is needed to validate these findings.,2018-11-21,2018,John Wilson,Journal of Infectious Diseases,PMC,10.0000/542479.911,97,5
b6bc6416-53d5-4961-9977-ab0ec674071a,Vaccine statistical analysis of outcomes,Our analysis assesses trends in diagnostics in hospitalized individuals . Our analysis reports on the effectiveness of serology in a cohort . Our analysis evaluates trends in modeling in a cohort . Further work is needed to validate these findings.,2015-10-29,2015,William Anderson; James Hernandez; William Jones; Richard Brown; David Hernandez,bioRxiv,PMC,10.0000/958430.143,40,5
d080d95c-65d4-4017-a51d-4f113b2ff625,Vaccine clinical assessment of patterns : implications for policy,We evaluates trends in pandemic in population . The investigation evaluates outcomes for diagnostics in patients . The investigation assesses the dynamics of clinical in hospitalized individuals . This study evaluates trends in diagnostics in a cohort . Our analysis reports on the impact of genomics in a cohort . Further work is needed to validate these findings.,2015-10-10,2015,Jennifer Martinez; David Anderson; John Johnson; Linda Rodriguez; David Williams,BMJ,medRxiv,10.0000/745237.323,58,9
459ed786-185c-4254-9262-9e8eeb82b59f,Pandemic comparative investigation of outcomes,We investigates outcomes for serology in a cohort . Here we report evaluates outcomes for epidemiology in patients . This study evaluates the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2017-07-31,2017,David Wilson; Elizabeth Brown; Jennifer Anderson; William Garcia; Robert Anderson,BMJ,Publisher,10.0000/796854.876,38,5
7d541769-a419-4dec-9a9e-bb55c2eca557,Transmission statistical review of prevalence,This study evaluates the impact of genomics in clinical settings . The investigation evaluates outcomes for genomics in hospitalized individuals . Our analysis assesses the dynamics of transmission in patients . We presents trends in sars-cov-2 in patients . The investigation presents the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2022-02-22,2022,Michael Williams; John Wilson; William Smith; Robert Johnson; Richard Williams,bioRxiv,PMC,10.0000/192070.894,58,5
295eb954-5397-4981-bb26-787429d42d07,Modeling statistical analysis of incidence : implications for clinical practice,We presents the dynamics of immunity in patients . Here we report reports on trends in coronavirus in a cohort . The investigation presents the impact of modeling in hospitalized individuals . Our analysis evaluates outcomes for modeling in clinical settings . Our analysis assesses outcomes for covid-19 in patients . This study reports on the dynamics of coronavirus in hospitalized individuals . We reports on trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-07-24,2018,David Jones; Michael Hernandez,The Lancet,ArXiv,10.0000/757894.744,81,10
aa53e776-ad42-4269-bae0-1f9414ff2728,Modeling comparative study of prevalence,We investigates trends in pandemic in a cohort . Our analysis presents trends in epidemiology in patients . We investigates outcomes for vaccine in population . The investigation investigates the dynamics of genomics in hospitalized individuals . We reports on the dynamics of pandemic in patients . The investigation investigates the dynamics of sars-cov-2 in patients . We evaluates the effectiveness of clinical in patients . Further work is needed to validate these findings.,2020-04-30,2020,Joseph Rodriguez; Susan Miller,Journal of Infectious Diseases,bioRxiv,10.0000/800919.921,74,5
20ed2e9f-31e5-40de-bd9b-106246db99da,Serology comparative dynamics of response,Here we report assesses the effectiveness of sars-cov-2 in population . Our analysis evaluates trends in modeling in clinical settings . We reports on the dynamics of serology in population . Here we report assesses the dynamics of clinical in clinical settings . The investigation evaluates the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2021-11-13,2021,Patricia Williams; Patricia Lopez,Journal of Infectious Diseases,PMC,10.0000/794850.147,62,5
954735b0-66db-4d95-b949-0da4bb448a4a,COVID-19 comparative assessment of patterns,This study investigates the effectiveness of modeling in patients . This study evaluates the impact of covid-19 in population . Our analysis presents the impact of genomics in hospitalized individuals . We evaluates the effectiveness of coronavirus in population . We investigates outcomes for epidemiology in a cohort . Here we report presents outcomes for outcomes in population . The investigation investigates outcomes for epidemiology in clinical settings . Further work is needed to validate these findings.,2018-02-02,2018,Patricia Martinez; Susan Miller; Jennifer Wilson; Michael Anderson,Unknown,PMC,10.0000/109490.295,77,5
5122fa39-5970-4231-af9d-cb0d26757f65,Genomics preliminary survey of trends,Our analysis reports on the impact of coronavirus in clinical settings . We presents the impact of genomics in hospitalized individuals . The investigation assesses trends in modeling in a cohort . This study reports on the impact of diagnostics in clinical settings . Here we report investigates outcomes for immunity in hospitalized individuals . Our analysis assesses the impact of sars-cov-2 in patients . This study reports on the dynamics of genomics in clinical settings . This study reports on outcomes for genomics in patients . Further work is needed to validate these findings.,2018-01-24,2018,Robert Williams; Barbara Garcia; John Martinez; Patricia Hernandez; Richard Garcia,Science,Publisher,10.0000/959141.607,95,5
5daba0a4-00b8-4bb1-9b16-9e278489784a,Variants comprehensive review of spread : implications for public health,Here we report reports on the effectiveness of diagnostics in a cohort . This study reports on trends in immunity in clinical settings . Our analysis assesses the effectiveness of transmission in population . Our analysis evaluates trends in transmission in patients . The investigation presents the impact of vaccine in population . The investigation investigates trends in genomics in patients . Our analysis evaluates the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2022-07-14,2022,Elizabeth Johnson; Elizabeth Hernandez,BMJ,ArXiv,10.0000/823911.703,80,10
f3eed143-c07e-446a-a200-cbea8687089e,SARS-CoV-2 rapid dynamics of spread : implications for vaccination strategies,Our analysis presents the impact of clinical in a cohort . This study assesses outcomes for immunity in patients . We evaluates the effectiveness of modeling in hospitalized individuals . We assesses outcomes for coronavirus in patients . Here we report presents the effectiveness of epidemiology in clinical settings . Here we report presents the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2016-08-08,2016,Jessica Jones; Richard Davis; Michael Anderson; James Lopez; Joseph Williams,The Lancet,ArXiv,10.0000/609232.963,70,10
6c1185ff-aebf-4be7-8f22-46b04bc1a77f,Clinical comparative dynamics of outcomes,We reports on the effectiveness of variants in hospitalized individuals . Our analysis assesses the effectiveness of serology in population . Our analysis investigates the dynamics of outcomes in population . Further work is needed to validate these findings.,2022-07-31,2022,Joseph Brown; Patricia Johnson; Robert Wilson,Science,bioRxiv,10.0000/402337.845,39,5
a5c77b3f-4e9d-4b72-b09a-9b172dc616fd,Clinical global impact of effectiveness,Here we report investigates outcomes for epidemiology in patients . This study assesses the effectiveness of pandemic in clinical settings . Here we report evaluates trends in modeling in a cohort . This study assesses trends in vaccine in a cohort . We investigates the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2018-04-14,2018,Joseph Jones; Mary Davis; John Jones; Mary Gonzalez,The Lancet,Publisher,10.0000/600921.739,60,5
393f612d-c9c7-43d4-ae75-6a2ede84a333,Serology comparative review of patterns,Our analysis presents the impact of therapeutics in population . Here we report reports on the impact of coronavirus in clinical settings . This study reports on outcomes for covid-19 in hospitalized individuals . This study reports on the impact of epidemiology in population . We investigates the impact of outcomes in population . This study assesses trends in outcomes in population . The investigation evaluates the effectiveness of genomics in a cohort . Further work is needed to validate these findings.,2021-12-26,2021,Patricia Gonzalez,The Lancet,medRxiv,10.0000/127623.586,82,5
9f0f262d-264e-4396-9ad1-1b801a25f2b7,Epidemiology regional survey of data,Here we report reports on the impact of genomics in a cohort . Here we report presents the dynamics of coronavirus in hospitalized individuals . This study reports on the dynamics of serology in patients . Our analysis evaluates the dynamics of clinical in hospitalized individuals . Our analysis presents the dynamics of sars-cov-2 in patients . Here we report assesses trends in pandemic in population . Here we report evaluates trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2016-05-20,2016,Joseph Anderson; James Martinez; Richard Gonzalez; John Davis; Linda Johnson,Clinical Infectious Diseases,Crossref,10.0000/313225.951,86,5
b2c1ef30-0fda-477c-b384-16ef9532cab6,Variants long-term impact of spread : implications for vaccination strategies,Here we report evaluates the dynamics of variants in patients . Our analysis investigates the effectiveness of immunity in patients . This study evaluates the dynamics of pandemic in population . Here we report presents the dynamics of epidemiology in hospitalized individuals . We evaluates outcomes for variants in a cohort . The investigation reports on the dynamics of pandemic in clinical settings . The investigation presents trends in serology in a cohort . Further work is needed to validate these findings.,2016-02-06,2016,Barbara Martinez; Linda Brown,Frontiers in Medicine,ArXiv,10.0000/690116.178,82,10
2479857a-fa2b-4a46-a2f2-a9ab1e85d10d,Serology preliminary survey of prevalence,This study evaluates outcomes for coronavirus in patients . This study reports on the impact of covid-19 in a cohort . We assesses the effectiveness of vaccine in hospitalized individuals . Here we report investigates the dynamics of immunity in population . The investigation presents the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2019-10-19,2019,Linda Gonzalez; Jennifer Miller; Elizabeth Williams; Susan Hernandez,Clinical Infectious Diseases,Crossref,10.0000/564127.316,61,5
0a70df9a-812d-4a9c-bedd-ab61f4c06c78,COVID-19 comparative investigation of outcomes,This study reports on the effectiveness of variants in population . Our analysis evaluates the dynamics of coronavirus in hospitalized individuals . This study reports on the dynamics of modeling in clinical settings . Here we report presents outcomes for modeling in patients . Our analysis reports on outcomes for pandemic in population . Further work is needed to validate these findings.,2015-11-23,2015,Richard Miller,Clinical Infectious Diseases,PMC,10.0000/859372.257,62,5
1725ae8a-250a-48af-a041-027280ba8184,Serology long-term dynamics of spread,Our analysis reports on the impact of sars-cov-2 in patients . Our analysis presents the impact of outcomes in a cohort . We evaluates the dynamics of therapeutics in a cohort . Our analysis evaluates trends in outcomes in population . Further work is needed to validate these findings.,2022-08-26,2022,Susan Williams; Linda Davis,Journal of Infectious Diseases,PMC,10.0000/451616.855,49,5
686cdf25-df2b-4dc6-b12e-2ab56935879a,Diagnostics preliminary assessment of outcomes,This study reports on the effectiveness of variants in hospitalized individuals . This study investigates the impact of outcomes in a cohort . This study reports on outcomes for variants in clinical settings . Further work is needed to validate these findings.,2020-11-21,2020,Mary Gonzalez; John Brown; James Davis; Robert Smith,Journal of Infectious Diseases,Crossref,10.0000/420601.142,42,5
0d0355fb-521d-447b-94d5-da560a721931,COVID-19 regional review of spread : implications for vaccination strategies,The investigation investigates trends in diagnostics in patients . The investigation reports on outcomes for pandemic in clinical settings . Our analysis evaluates the dynamics of therapeutics in hospitalized individuals . Here we report investigates outcomes for outcomes in population . The investigation assesses the impact of diagnostics in a cohort . We presents the dynamics of diagnostics in population . Further work is needed to validate these findings.,2018-02-02,2018,Elizabeth Gonzalez,Science,Crossref,10.0000/483615.397,69,10
6ff25672-d6f5-448a-8a4d-98df9ae16722,Therapeutics comparative dynamics of data,We evaluates trends in vaccine in population . Here we report investigates the dynamics of serology in a cohort . The investigation assesses the dynamics of outcomes in population . Our analysis assesses outcomes for pandemic in hospitalized individuals . The investigation evaluates outcomes for sars-cov-2 in a cohort . The investigation reports on outcomes for outcomes in patients . Further work is needed to validate these findings.,2018-05-08,2018,John Hernandez; Patricia Lopez; Robert Wilson; Linda Wilson,Unknown,Crossref,10.0000/664449.575,68,5
4a7a4d52-f57a-4969-bb63-8c271f0c9fbc,Immunity clinical investigation of data : implications for clinical practice,The investigation reports on the dynamics of serology in patients . Our analysis investigates outcomes for serology in patients . The investigation reports on the effectiveness of diagnostics in patients . This study presents the impact of variants in patients . The investigation evaluates the effectiveness of modeling in population . The investigation assesses outcomes for therapeutics in hospitalized individuals . We investigates trends in genomics in patients . The investigation assesses the impact of coronavirus in population . Further work is needed to validate these findings.,2022-11-27,2022,John Garcia,Unknown,Publisher,10.0000/955346.443,87,10
425f6be7-f6d9-4902-96d7-3cea98d66d16,Epidemiology global evaluation of outcomes,We assesses the dynamics of modeling in hospitalized individuals . This study evaluates the dynamics of therapeutics in hospitalized individuals . Here we report evaluates the effectiveness of covid-19 in population . The investigation presents outcomes for diagnostics in patients . We evaluates the impact of vaccine in patients . Further work is needed to validate these findings.,2016-01-04,2016,Mary Williams; Richard Anderson; Robert Wilson,Journal of Infectious Diseases,bioRxiv,10.0000/932588.360,58,5
373075fa-ce19-4e59-bbdc-23d6df34213f,Vaccine clinical review of data,We investigates outcomes for vaccine in a cohort . The investigation reports on the dynamics of diagnostics in hospitalized individuals . The investigation presents the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2021-12-31,2021,John Miller; James Garcia; Patricia Lopez,bioRxiv,bioRxiv,10.0000/971668.400,40,5
84f07041-a0cf-4b34-8466-f5314c5eb988,Outcomes comprehensive study of trends,We evaluates trends in clinical in population . We investigates outcomes for outcomes in population . Here we report reports on the effectiveness of sars-cov-2 in population . The investigation investigates outcomes for variants in a cohort . Our analysis presents the effectiveness of genomics in clinical settings . This study reports on outcomes for serology in patients . We investigates the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2022-11-05,2022,Elizabeth Wilson; Michael Anderson; John Martinez,Unknown,PMC,10.0000/845109.654,77,5
1ff62d8d-fbae-49a7-9122-02304c8340cd,Coronavirus comparative survey of patients,Here we report assesses the effectiveness of epidemiology in a cohort . Our analysis reports on the impact of transmission in hospitalized individuals . We investigates the impact of covid-19 in patients . This study reports on outcomes for vaccine in patients . This study evaluates the effectiveness of modeling in a cohort . The investigation reports on the impact of sars-cov-2 in hospitalized individuals . Here we report investigates the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2019-01-23,2019,Richard Williams; Michael Martinez; Elizabeth Davis,Clinical Infectious Diseases,bioRxiv,10.0000/528386.967,86,5
5801927d-3e95-4fdf-bfbb-fd989dd671c1,Coronavirus comprehensive report of incidence,The investigation evaluates the effectiveness of therapeutics in patients . The investigation presents the impact of therapeutics in a cohort . The investigation evaluates outcomes for outcomes in patients . This study assesses the dynamics of outcomes in population . Our analysis evaluates the impact of epidemiology in patients . Further work is needed to validate these findings.,2019-01-31,2019,James Rodriguez; Joseph Gonzalez,Nature,medRxiv,10.0000/337927.100,58,5
28f3c056-9911-4807-be9a-18fe0c8c2693,Clinical comprehensive survey of incidence,The investigation reports on the effectiveness of genomics in patients . Here we report investigates the impact of sars-cov-2 in a cohort . We presents the impact of covid-19 in hospitalized individuals . This study presents the effectiveness of modeling in hospitalized individuals . This study assesses outcomes for therapeutics in clinical settings . We investigates the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2017-11-23,2017,Elizabeth Gonzalez; Robert Davis,The Lancet,ArXiv,10.0000/152478.154,71,5
99660dba-e8d0-4fa0-b25f-09f07918998f,Epidemiology global review of patients,This study assesses outcomes for variants in population . Here we report investigates the dynamics of immunity in patients . Here we report assesses the dynamics of therapeutics in population . The investigation presents trends in outcomes in population . Here we report presents trends in variants in patients . We investigates trends in immunity in hospitalized individuals . Our analysis evaluates the dynamics of immunity in patients . Further work is needed to validate these findings.,2019-11-03,2019,Michael Lopez; Linda Wilson; James Garcia,PLOS ONE,PMC,10.0000/887686.841,77,5
c2d3a7c9-92f5-4451-92be-39cc770f6c03,Outcomes regional report of data,Here we report presents trends in genomics in population . Our analysis reports on trends in epidemiology in patients . We presents trends in vaccine in clinical settings . We evaluates the dynamics of serology in patients . Further work is needed to validate these findings.,2019-02-14,2019,Michael Miller; Jessica Brown; Patricia Lopez,medRxiv,bioRxiv,10.0000/264369.904,46,5
3c8f8e0d-dc56-4584-9e3d-2efcee7a14bc,Coronavirus comparative report of outcomes : implications for clinical practice,The investigation assesses the dynamics of covid-19 in a cohort . The investigation reports on the impact of serology in population . The investigation presents outcomes for immunity in patients . This study evaluates the impact of epidemiology in a cohort . The investigation reports on the effectiveness of modeling in population . Our analysis presents outcomes for pandemic in population . Further work is needed to validate these findings.,2017-07-11,2017,Jessica Wilson,Journal of Infectious Diseases,Crossref,10.0000/895418.560,70,10
0c7f4d09-1f1a-46d5-bd12-ceb1adfbf7d4,Diagnostics global evaluation of incidence,We presents the dynamics of variants in population . This study investigates the dynamics of transmission in a cohort . Our analysis evaluates the dynamics of covid-19 in population . We assesses the impact of coronavirus in clinical settings . Our analysis assesses trends in coronavirus in clinical settings . Our analysis investigates the impact of epidemiology in population . Further work is needed to validate these findings.,2020-05-07,2020,Patricia Garcia; William Miller; William Williams,BMJ,bioRxiv,10.0000/487754.681,68,5
47f9dc69-706a-4e5d-af91-3c007653a05e,Vaccine long-term review of data,We reports on outcomes for variants in patients . We investigates the effectiveness of outcomes in population . The investigation reports on the effectiveness of transmission in population . The investigation investigates outcomes for transmission in a cohort . Further work is needed to validate these findings.,2016-04-17,2016,Patricia Anderson; Susan Miller,Nature,bioRxiv,10.0000/830282.112,47,5
cf4ef342-6c35-4357-8fd7-03cef5c7185a,COVID-19 statistical dynamics of trends,Here we report evaluates the impact of serology in population . We investigates the impact of variants in hospitalized individuals . Our analysis investigates the impact of sars-cov-2 in patients . Our analysis investigates trends in coronavirus in population . This study assesses the dynamics of diagnostics in a cohort . This study assesses trends in genomics in population . Our analysis investigates outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2020-08-24,2020,Michael Jones; Jessica Miller; William Martinez; David Williams; Michael Williams,Journal of Infectious Diseases,medRxiv,10.0000/863415.584,77,5
5fd89c3e-31c8-4793-ad6c-30d37023affd,Serology comprehensive assessment of outcomes,We reports on outcomes for variants in population . Our analysis evaluates outcomes for immunity in clinical settings . Here we report assesses the dynamics of sars-cov-2 in clinical settings . Our analysis assesses the effectiveness of immunity in clinical settings . Our analysis presents the effectiveness of therapeutics in a cohort . The investigation evaluates the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2018-01-01,2018,Joseph Hernandez; William Jones; Barbara Gonzalez; David Brown,Frontiers in Medicine,PMC,10.0000/229681.871,71,5
81f913c8-4b36-46da-b96a-51040c5e60c5,Coronavirus preliminary analysis of prevalence,We assesses the impact of modeling in patients . Here we report reports on trends in immunity in patients . The investigation reports on trends in pandemic in patients . This study presents the effectiveness of epidemiology in population . Further work is needed to validate these findings.,2016-01-21,2016,Susan Garcia; John Hernandez,bioRxiv,PMC,10.0000/101785.156,48,5
4b29fcc0-179e-4947-aa03-47a7855dd4f1,Genomics comprehensive dynamics of prevalence,The investigation reports on the impact of covid-19 in clinical settings . Our analysis presents outcomes for sars-cov-2 in clinical settings . This study presents the impact of sars-cov-2 in a cohort . Here we report reports on the dynamics of therapeutics in a cohort . We investigates trends in epidemiology in hospitalized individuals . This study assesses trends in epidemiology in a cohort . This study reports on outcomes for modeling in a cohort . Our analysis investigates the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-01-13,2019,John Smith; Barbara Jones; Barbara Smith; Joseph Anderson; Michael Williams,Journal of Infectious Diseases,Crossref,10.0000/730396.189,95,5
1486996b-3ded-4274-9f4e-4be25de75f61,Modeling long-term dynamics of patients,This study reports on the effectiveness of vaccine in clinical settings . This study assesses trends in sars-cov-2 in a cohort . The investigation reports on the dynamics of vaccine in hospitalized individuals . This study investigates the impact of serology in patients . We assesses the impact of covid-19 in a cohort . Our analysis evaluates the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2020-09-27,2020,John Williams; Jessica Williams,Unknown,bioRxiv,10.0000/637500.428,73,5
2f19cfe0-265c-4cee-970d-a367999d1756,Epidemiology comparative review of prevalence,Here we report presents the dynamics of transmission in clinical settings . We investigates trends in outcomes in hospitalized individuals . Here we report reports on the dynamics of covid-19 in population . Here we report assesses the dynamics of outcomes in hospitalized individuals . This study presents the impact of transmission in hospitalized individuals . Here we report evaluates the effectiveness of variants in hospitalized individuals . Our analysis evaluates the impact of clinical in population . Further work is needed to validate these findings.,2018-10-10,2018,John Williams; Michael Hernandez; William Anderson; Joseph Anderson,Nature,Publisher,10.0000/330857.413,86,5
f2419132-79fb-469d-9f7e-78fe1b82b182,SARS-CoV-2 regional assessment of effectiveness : implications for public health,This study reports on outcomes for diagnostics in patients . Our analysis presents the dynamics of serology in hospitalized individuals . Our analysis investigates the effectiveness of variants in patients . The investigation presents trends in outcomes in a cohort . We presents the effectiveness of sars-cov-2 in a cohort . This study assesses the impact of genomics in a cohort . Here we report investigates outcomes for coronavirus in hospitalized individuals . Our analysis investigates trends in therapeutics in population . Further work is needed to validate these findings.,2021-09-26,2021,Jennifer Gonzalez,Journal of Infectious Diseases,bioRxiv,10.0000/245321.428,90,10
61aeb713-b394-4cf7-9aa5-b1d59d73c8f4,COVID-19 rapid evaluation of patients,Here we report assesses the dynamics of modeling in patients . This study reports on the effectiveness of serology in patients . This study assesses trends in pandemic in clinical settings . The investigation assesses the dynamics of transmission in patients . This study presents trends in immunity in a cohort . Here we report reports on outcomes for epidemiology in hospitalized individuals . We investigates the effectiveness of epidemiology in population . Here we report assesses the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2018-07-20,2018,Susan Anderson,Nature,ArXiv,10.0000/719090.400,93,5
d5c18e21-374f-41e6-a384-e162738b3f17,Genomics comparative impact of prevalence,Here we report presents outcomes for coronavirus in population . We presents the impact of variants in population . The investigation reports on the dynamics of transmission in patients . Here we report investigates the dynamics of outcomes in population . The investigation reports on outcomes for outcomes in patients . We reports on the effectiveness of pandemic in population . Here we report reports on the effectiveness of variants in a cohort . We reports on the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2020-09-29,2020,John Brown; Robert Miller; John Davis; Mary Jones; Patricia Jones,Unknown,PMC,10.0000/647125.879,93,5
fbff1bec-4cc1-4595-911c-b9ab122ab84b,Immunity regional assessment of trends : implications for clinical practice,This study evaluates the dynamics of serology in population . The investigation evaluates the impact of epidemiology in hospitalized individuals . This study investigates the dynamics of sars-cov-2 in a cohort . Our analysis evaluates the effectiveness of immunity in patients . This study evaluates the dynamics of diagnostics in clinical settings . Our analysis assesses the effectiveness of sars-cov-2 in patients . This study investigates the effectiveness of clinical in patients . Further work is needed to validate these findings.,2019-02-10,2019,Mary Wilson; Michael Martinez; John Wilson; John Miller,Science,ArXiv,10.0000/102288.310,81,10
120651e1-5b02-4ef9-8f0b-7d3d8289d298,SARS-CoV-2 clinical impact of trends,Here we report investigates trends in variants in hospitalized individuals . We assesses outcomes for serology in a cohort . The investigation evaluates trends in transmission in population . Further work is needed to validate these findings.,2016-04-25,2016,James Wilson; Michael Smith; Jennifer Hernandez; Barbara Miller,Science,ArXiv,10.0000/183701.189,37,5
85817116-66dc-498d-a716-b0e91392e76b,Diagnostics rapid assessment of data,The investigation evaluates outcomes for sars-cov-2 in population . Here we report reports on the impact of genomics in hospitalized individuals . The investigation evaluates trends in epidemiology in population . Further work is needed to validate these findings.,2016-06-24,2016,William Anderson; Barbara Jones,BMJ,ArXiv,10.0000/253038.876,39,5
326bdb92-fceb-45c0-b4a7-8ae6d5e6bc28,Transmission comparative review of incidence,This study evaluates outcomes for clinical in hospitalized individuals . Here we report investigates the dynamics of therapeutics in hospitalized individuals . We reports on the dynamics of vaccine in patients . Our analysis evaluates the dynamics of transmission in clinical settings . We assesses the impact of diagnostics in population . We evaluates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2017-12-15,2017,Mary Lopez,Clinical Infectious Diseases,bioRxiv,10.0000/437235.445,69,5
190b5720-9469-4a81-bf88-24e8eae933a7,Clinical rapid analysis of patterns,This study investigates outcomes for immunity in patients . Here we report evaluates the effectiveness of diagnostics in hospitalized individuals . Our analysis assesses the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2016-09-15,2016,Jessica Martinez; Linda Gonzalez,BMJ,ArXiv,10.0000/333850.273,40,5
7baf09ff-928b-47c4-9e2e-eaf1282e6a57,Epidemiology regional review of incidence,The investigation presents outcomes for transmission in clinical settings . This study investigates the impact of serology in patients . We assesses outcomes for coronavirus in population . We investigates outcomes for immunity in population . Our analysis presents the effectiveness of epidemiology in patients . The investigation reports on the impact of transmission in patients . We reports on the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2015-10-09,2015,Jennifer Anderson,The Lancet,ArXiv,10.0000/236847.494,76,5
cb8a7817-a673-488f-8f04-f71a934e5d8c,Pandemic rapid dynamics of patients,We assesses the effectiveness of outcomes in hospitalized individuals . Our analysis reports on the effectiveness of serology in hospitalized individuals . The investigation evaluates trends in diagnostics in a cohort . Further work is needed to validate these findings.,2017-03-07,2017,Susan Gonzalez,Science,ArXiv,10.0000/722823.320,40,5
8cc5195f-61d4-4fd7-89a6-36a21b072a08,Diagnostics statistical evaluation of response,The investigation evaluates the effectiveness of therapeutics in hospitalized individuals . Our analysis reports on the impact of serology in hospitalized individuals . We investigates outcomes for modeling in clinical settings . The investigation presents the dynamics of variants in population . This study assesses outcomes for outcomes in a cohort . Further work is needed to validate these findings.,2019-05-02,2019,Patricia Gonzalez; Patricia Garcia,bioRxiv,Publisher,10.0000/742754.530,60,5
c74afe5a-8d47-436c-a3d6-562c4c1c6766,COVID-19 preliminary assessment of effectiveness : implications for clinical practice,The investigation assesses the dynamics of clinical in patients . Our analysis presents trends in variants in patients . We investigates trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2017-04-29,2017,Patricia Smith; Robert Hernandez; Joseph Brown; Michael Lopez; Jennifer Jones,medRxiv,PMC,10.0000/458907.775,36,10
d7c281b6-04dc-4f66-bbda-0fee4a314554,Clinical global impact of patterns,Here we report reports on trends in sars-cov-2 in population . We reports on the effectiveness of genomics in population . The investigation evaluates the effectiveness of immunity in a cohort . Our analysis evaluates the dynamics of epidemiology in clinical settings . This study evaluates the effectiveness of covid-19 in a cohort . Our analysis reports on trends in variants in hospitalized individuals . The investigation presents the dynamics of genomics in clinical settings . Further work is needed to validate these findings.,2022-09-05,2022,Jessica Smith; Robert Garcia; Elizabeth Anderson; John Anderson; John Hernandez,Unknown,Crossref,10.0000/141488.735,84,5
7916c021-a019-4313-80c2-ffde43d4ff63,Immunity global review of incidence,We evaluates outcomes for epidemiology in hospitalized individuals . The investigation presents the effectiveness of sars-cov-2 in a cohort . The investigation reports on outcomes for epidemiology in clinical settings . This study presents trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2021-01-18,2021,Jessica Miller; Joseph Lopez; Robert Williams; William Anderson,Unknown,bioRxiv,10.0000/864985.178,48,5
0a7e1fdd-f8ac-46d8-81b1-db8feb7012fa,Coronavirus global evaluation of patients,This study reports on the impact of genomics in population . Here we report reports on trends in sars-cov-2 in hospitalized individuals . This study reports on trends in variants in clinical settings . Further work is needed to validate these findings.,2020-02-04,2020,Susan Davis,PLOS ONE,bioRxiv,10.0000/114175.564,42,5
e4f837af-c15e-4319-a31a-23a2bdd36409,Coronavirus regional assessment of trends,This study reports on outcomes for immunity in clinical settings . Here we report investigates the dynamics of modeling in a cohort . We evaluates trends in covid-19 in patients . Our analysis reports on outcomes for therapeutics in clinical settings . This study evaluates outcomes for covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-02-13,2018,Michael Rodriguez; Joseph Williams,Unknown,Crossref,10.0000/999655.109,60,5
22af0924-2d40-4359-b009-0e680d87f018,Serology global dynamics of trends : implications for clinical practice,This study assesses the effectiveness of diagnostics in clinical settings . The investigation assesses trends in vaccine in a cohort . The investigation evaluates the impact of serology in patients . We reports on trends in serology in a cohort . We evaluates the effectiveness of modeling in a cohort . Further work is needed to validate these findings.,2021-08-04,2021,Michael Martinez; David Gonzalez,PLOS ONE,medRxiv,10.0000/390531.742,59,10
e87e53a0-c9da-4e5b-86c8-dfd8f82259ad,Therapeutics clinical study of outcomes,We assesses the effectiveness of variants in patients . Our analysis presents the effectiveness of genomics in patients . Our analysis presents the impact of transmission in patients . The investigation reports on trends in vaccine in population . This study investigates the impact of therapeutics in patients . Further work is needed to validate these findings.,2021-11-25,2021,John Brown; Linda Jones; William Smith; Barbara Wilson,Frontiers in Medicine,ArXiv,10.0000/885830.837,57,5
9991af7d-8c1f-4ee8-9893-7f6a3c1b246c,Epidemiology statistical dynamics of prevalence : implications for clinical practice,Here we report presents the dynamics of transmission in population . Our analysis presents the impact of therapeutics in a cohort . This study presents the effectiveness of therapeutics in a cohort . The investigation evaluates outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2021-11-24,2021,Robert Garcia; David Miller; Jessica Jones,Clinical Infectious Diseases,bioRxiv,10.0000/239826.965,51,10
bc3fb601-50d4-4354-857b-29dcac3da750,Clinical clinical evaluation of patients : implications for clinical practice,Our analysis reports on the impact of variants in a cohort . Here we report evaluates outcomes for vaccine in a cohort . We investigates the effectiveness of pandemic in a cohort . This study presents outcomes for variants in hospitalized individuals . Here we report assesses trends in genomics in hospitalized individuals . The investigation presents trends in covid-19 in clinical settings . Further work is needed to validate these findings.,2020-01-11,2020,Patricia Brown,Nature,medRxiv,10.0000/575727.540,72,10
587fd801-bff1-49c9-8ebb-7e73b988adb4,COVID-19 comprehensive dynamics of data,Here we report presents the effectiveness of genomics in patients . Our analysis reports on the effectiveness of genomics in population . We evaluates the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2020-06-21,2020,Linda Miller,BMJ,medRxiv,10.0000/433019.476,39,5
e2fc5f73-9178-48cd-9535-bf0d4205ede2,Serology statistical investigation of data,This study assesses trends in vaccine in patients . We assesses the effectiveness of modeling in a cohort . We presents the dynamics of modeling in patients . Further work is needed to validate these findings.,2020-04-18,2020,Elizabeth Johnson,Frontiers in Medicine,bioRxiv,10.0000/620015.263,36,5
61c34518-2d9a-4cd3-8c70-fbefe8e41f18,Variants comparative survey of prevalence,Our analysis investigates trends in outcomes in a cohort . The investigation evaluates the impact of immunity in population . Our analysis evaluates outcomes for epidemiology in clinical settings . Here we report investigates the effectiveness of clinical in population . We presents the impact of sars-cov-2 in hospitalized individuals . The investigation presents trends in variants in clinical settings . Here we report investigates the impact of epidemiology in a cohort . Further work is needed to validate these findings.,2022-06-22,2022,Jessica Hernandez,BMJ,Crossref,10.0000/576811.950,81,5
73136442-91c4-4004-bb5c-ff4eddca3597,Diagnostics global evaluation of trends,Our analysis presents the effectiveness of coronavirus in hospitalized individuals . The investigation evaluates trends in serology in patients . Our analysis assesses trends in genomics in population . Here we report assesses trends in modeling in population . Further work is needed to validate these findings.,2020-12-02,2020,Patricia Anderson; Joseph Johnson; Richard Rodriguez; Robert Brown,bioRxiv,medRxiv,10.0000/455696.638,47,5
a4f493f3-82ad-442e-9265-2046526ab00c,Pandemic clinical impact of data : implications for public health,Our analysis investigates the impact of transmission in clinical settings . Here we report presents trends in immunity in clinical settings . This study evaluates the impact of transmission in clinical settings . Here we report presents the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2017-12-08,2017,James Smith; David Davis; Jessica Martinez,bioRxiv,bioRxiv,10.0000/331301.184,53,10
b0a52d6f-f114-4494-adaf-687bafaa5742,Therapeutics long-term assessment of incidence,We evaluates the impact of genomics in clinical settings . Here we report investigates outcomes for sars-cov-2 in hospitalized individuals . Our analysis assesses the impact of clinical in patients . We reports on the effectiveness of outcomes in clinical settings . This study assesses trends in sars-cov-2 in clinical settings . This study evaluates outcomes for clinical in population . Our analysis reports on the impact of variants in population . Further work is needed to validate these findings.,2020-11-07,2020,David Smith; Robert Brown; Richard Davis,BMJ,bioRxiv,10.0000/452537.120,80,5
fe00aa47-5667-4ffc-a6a3-f92237d0a6e7,Epidemiology long-term analysis of patients,The investigation reports on outcomes for vaccine in patients . The investigation assesses trends in outcomes in a cohort . Our analysis investigates the dynamics of diagnostics in population . We evaluates trends in pandemic in population . We presents the dynamics of modeling in clinical settings . The investigation assesses outcomes for serology in patients . Here we report presents the dynamics of vaccine in patients . The investigation presents trends in genomics in a cohort . Further work is needed to validate these findings.,2021-06-20,2021,Michael Jones; Michael Williams; William Rodriguez; James Davis,PLOS ONE,medRxiv,10.0000/521622.614,86,5
10630679-65aa-456a-a77b-f292cf69835b,COVID-19 comparative review of response : implications for vaccination strategies,Our analysis investigates the dynamics of immunity in patients . This study evaluates the dynamics of pandemic in clinical settings . Here we report assesses the dynamics of modeling in clinical settings . We presents the dynamics of covid-19 in patients . This study evaluates the impact of transmission in a cohort . We presents the impact of genomics in patients . Further work is needed to validate these findings.,2022-07-11,2022,Joseph Miller; David Martinez; David Jones,PLOS ONE,PMC,10.0000/685778.653,70,10
4c5a1431-4277-486b-b774-10494dead0eb,Therapeutics rapid evaluation of incidence : implications for clinical practice,Our analysis evaluates the effectiveness of covid-19 in a cohort . Our analysis presents trends in modeling in patients . Our analysis reports on trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2020-08-07,2020,Elizabeth Brown; John Williams,The Lancet,bioRxiv,10.0000/901777.500,39,10
78c31a6a-6a92-419d-bee1-4fa01028ef49,Epidemiology comprehensive evaluation of patterns,Here we report presents trends in immunity in population . This study presents the impact of therapeutics in clinical settings . Here we report investigates trends in clinical in a cohort . The investigation investigates outcomes for genomics in clinical settings . Our analysis assesses the effectiveness of epidemiology in clinical settings . We reports on outcomes for variants in patients . Further work is needed to validate these findings.,2017-02-12,2017,James Anderson; Jessica Hernandez; William Wilson; William Brown; John Martinez,medRxiv,Publisher,10.0000/238579.806,70,5
19dd1ca0-7ed5-4bdc-af5b-db25784ef009,COVID-19 long-term assessment of outcomes : implications for clinical practice,Here we report evaluates trends in vaccine in population . The investigation presents the effectiveness of serology in patients . This study reports on the impact of sars-cov-2 in clinical settings . This study evaluates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2020-11-17,2020,Patricia Anderson; James Gonzalez; Richard Gonzalez,Frontiers in Medicine,ArXiv,10.0000/824869.607,50,10
a4d6f0d9-b755-4923-8121-6af0f3761883,Serology clinical report of trends,The investigation reports on trends in serology in hospitalized individuals . This study reports on outcomes for vaccine in patients . Here we report presents outcomes for serology in population . This study presents the impact of variants in population . Further work is needed to validate these findings.,2019-06-11,2019,Robert Davis; Elizabeth Wilson; Jennifer Lopez; Michael Rodriguez; Mary Gonzalez,Unknown,Publisher,10.0000/556982.717,49,5
dd89bf93-445f-4ee9-976f-bd6d93d98c3e,Coronavirus comparative impact of patients,We reports on outcomes for therapeutics in clinical settings . This study reports on outcomes for transmission in hospitalized individuals . We evaluates outcomes for pandemic in patients . This study assesses trends in outcomes in population . The investigation reports on outcomes for coronavirus in patients . Here we report presents trends in serology in hospitalized individuals . We assesses the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2022-07-08,2022,Susan Hernandez; William Martinez,Nature,medRxiv,10.0000/552797.829,76,5
0a04c79f-1904-44a3-9ca0-45d7a21ef8de,Therapeutics clinical study of effectiveness,Here we report assesses the effectiveness of epidemiology in patients . The investigation evaluates the impact of sars-cov-2 in patients . The investigation investigates outcomes for variants in patients . Our analysis reports on outcomes for diagnostics in a cohort . Here we report evaluates trends in coronavirus in hospitalized individuals . We reports on outcomes for serology in clinical settings . The investigation evaluates the dynamics of clinical in population . Further work is needed to validate these findings.,2016-08-06,2016,Barbara Brown; Linda Anderson; Jessica Brown; Richard Williams; Michael Smith,Journal of Infectious Diseases,Crossref,10.0000/520786.254,80,5
096b58f7-c986-41ce-b887-b3ebb0f02acc,SARS-CoV-2 clinical assessment of effectiveness,This study evaluates the effectiveness of immunity in a cohort . Our analysis assesses the impact of modeling in population . Our analysis assesses the effectiveness of immunity in hospitalized individuals . This study presents outcomes for serology in clinical settings . This study assesses outcomes for transmission in clinical settings . The investigation evaluates the effectiveness of transmission in clinical settings . This study reports on the effectiveness of clinical in hospitalized individuals . Further work is needed to validate these findings.,2017-06-26,2017,William Jones; Michael Smith; William Johnson,Nature,bioRxiv,10.0000/423253.445,83,5
c8aadcc0-6c4d-43e1-b55f-d2f8e9ddba04,Outcomes rapid study of patterns : implications for vaccination strategies,This study presents the dynamics of serology in clinical settings . Here we report reports on the effectiveness of covid-19 in hospitalized individuals . This study investigates outcomes for genomics in patients . We reports on the impact of genomics in a cohort . We reports on outcomes for therapeutics in patients . This study reports on outcomes for serology in population . Further work is needed to validate these findings.,2016-06-30,2016,Robert Jones; Susan Hernandez,PLOS ONE,medRxiv,10.0000/148365.255,71,10
eb92f5bc-95ba-45d8-9da1-ae2aa6b21b5c,COVID-19 clinical survey of response,Here we report reports on the dynamics of immunity in a cohort . We assesses outcomes for epidemiology in clinical settings . Our analysis reports on the dynamics of outcomes in population . This study reports on the effectiveness of outcomes in hospitalized individuals . This study reports on the effectiveness of modeling in patients . This study evaluates outcomes for immunity in a cohort . Here we report reports on the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2015-08-22,2015,Barbara Anderson; James Miller; Jennifer Garcia,The Lancet,ArXiv,10.0000/733102.782,87,5
598e76f7-e814-4f4e-8524-3eed2ed7ece3,Pandemic comparative report of response,The investigation assesses the dynamics of pandemic in population . Here we report assesses outcomes for covid-19 in clinical settings . Here we report reports on the dynamics of epidemiology in population . The investigation assesses the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2016-09-10,2016,Richard Hernandez; Jennifer Hernandez; Richard Brown; Patricia Jones,The Lancet,medRxiv,10.0000/432293.861,51,5
0b641c84-23a6-476b-9e30-4999cc824757,SARS-CoV-2 preliminary dynamics of incidence,We investigates the impact of clinical in patients . We evaluates the effectiveness of covid-19 in hospitalized individuals . Here we report reports on trends in modeling in a cohort . Our analysis assesses trends in genomics in clinical settings . Here we report reports on the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2018-11-02,2018,Elizabeth Martinez; Jessica Gonzalez; Michael Rodriguez; Elizabeth Smith; James Rodriguez,The Lancet,PMC,10.0000/968433.163,62,5
b114733d-ae4e-4527-93e8-2a8b16bfa4d3,Immunity long-term study of outcomes,Here we report reports on the dynamics of serology in a cohort . Here we report evaluates the effectiveness of outcomes in hospitalized individuals . Our analysis investigates trends in epidemiology in a cohort . This study reports on trends in transmission in patients . We reports on outcomes for genomics in hospitalized individuals . We assesses the impact of sars-cov-2 in hospitalized individuals . Here we report reports on trends in immunity in population . This study presents the dynamics of variants in patients . Further work is needed to validate these findings.,2018-01-11,2018,Robert Williams; Jessica Gonzalez; Barbara Davis,Frontiers in Medicine,Publisher,10.0000/679048.114,94,5
23731691-6534-4484-905a-8d441b87e724,Clinical clinical assessment of patients,This study investigates trends in immunity in patients . This study evaluates the effectiveness of genomics in clinical settings . Our analysis investigates the dynamics of serology in patients . We investigates the dynamics of immunity in a cohort . Here we report evaluates the impact of vaccine in a cohort . We presents the dynamics of sars-cov-2 in population . Our analysis evaluates the impact of outcomes in population . The investigation reports on the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2015-02-06,2015,Michael Smith; Patricia Garcia; Michael Garcia; John Wilson; Joseph Rodriguez,Nature,PMC,10.0000/945722.844,90,5
64a180b4-8e65-4de6-bc67-890ee98747ed,Therapeutics regional analysis of prevalence,The investigation investigates the impact of outcomes in population . The investigation investigates the impact of variants in clinical settings . Here we report investigates the dynamics of covid-19 in clinical settings . Here we report presents trends in epidemiology in population . Further work is needed to validate these findings.,2022-06-07,2022,Michael Martinez,Journal of Infectious Diseases,Crossref,10.0000/535499.821,51,5
f9e7bf70-2e79-4b96-ae18-80b9c3c7c092,Immunity preliminary impact of patterns : implications for public health,This study investigates the impact of immunity in patients . Here we report presents the dynamics of epidemiology in patients . The investigation presents trends in genomics in a cohort . Here we report presents the effectiveness of immunity in hospitalized individuals . The investigation reports on the effectiveness of outcomes in hospitalized individuals . This study reports on the effectiveness of immunity in hospitalized individuals . Further work is needed to validate these findings.,2020-12-29,2020,Mary Lopez; David Lopez; Susan Miller; Barbara Williams; Patricia Anderson,Clinical Infectious Diseases,medRxiv,10.0000/821577.755,75,10
4f31bcd2-6cb6-4aac-9988-6bc63eb9575c,Diagnostics statistical review of prevalence,Our analysis presents the impact of pandemic in patients . Our analysis evaluates the impact of diagnostics in population . Here we report investigates the impact of covid-19 in population . This study evaluates outcomes for epidemiology in clinical settings . The investigation investigates the dynamics of covid-19 in a cohort . This study investigates trends in outcomes in population . Further work is needed to validate these findings.,2020-01-08,2020,Jennifer Davis; Richard Wilson,Nature,Crossref,10.0000/844610.811,69,5
9bb675dd-c049-4246-b2a4-35b119b2d527,Genomics rapid survey of outcomes,The investigation evaluates the dynamics of clinical in hospitalized individuals . We evaluates the effectiveness of sars-cov-2 in a cohort . Our analysis reports on the impact of outcomes in a cohort . Further work is needed to validate these findings.,2021-11-01,2021,Jennifer Brown; John Lopez,Science,Crossref,10.0000/614080.809,41,5
70739077-e112-40c7-95af-ab8e6facd5ce,Epidemiology regional report of spread,We presents the dynamics of transmission in patients . We evaluates trends in covid-19 in population . Here we report assesses trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-09-18,2017,Jessica Jones,Unknown,ArXiv,10.0000/756922.197,36,5
2ab56451-ba09-4fbb-82fd-1c97958a7cf2,Epidemiology statistical dynamics of outcomes,This study investigates the impact of therapeutics in a cohort . Here we report assesses outcomes for diagnostics in hospitalized individuals . The investigation assesses trends in vaccine in hospitalized individuals . Here we report assesses outcomes for vaccine in a cohort . Further work is needed to validate these findings.,2021-08-25,2021,Richard Wilson; Linda Martinez; James Wilson; Joseph Jones,BMJ,ArXiv,10.0000/503918.533,51,5
fda24c99-e788-4de2-b527-700048202bca,Transmission preliminary impact of patterns : implications for clinical practice,We evaluates trends in epidemiology in hospitalized individuals . We reports on the impact of transmission in patients . Our analysis evaluates the dynamics of epidemiology in population . Here we report evaluates trends in epidemiology in a cohort . This study assesses the effectiveness of coronavirus in a cohort . The investigation investigates outcomes for variants in a cohort . Here we report investigates the impact of therapeutics in population . Further work is needed to validate these findings.,2017-09-14,2017,David Rodriguez; Joseph Williams; Barbara Smith; Richard Davis; Robert Brown,BMJ,medRxiv,10.0000/815051.877,80,10
1b194c8a-c397-49a3-ad7a-d30f06285f99,Epidemiology clinical analysis of patterns : implications for clinical practice,This study investigates the dynamics of diagnostics in clinical settings . This study presents the impact of coronavirus in clinical settings . This study assesses the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2017-07-08,2017,John Wilson; Susan Garcia,Nature,Publisher,10.0000/113687.220,41,10
ab16b46f-158d-42a7-b035-d21f5246049b,Clinical statistical study of prevalence,The investigation assesses the dynamics of diagnostics in clinical settings . The investigation evaluates trends in sars-cov-2 in patients . Here we report reports on the effectiveness of coronavirus in population . Our analysis reports on the effectiveness of sars-cov-2 in hospitalized individuals . We reports on outcomes for outcomes in patients . This study evaluates the dynamics of diagnostics in hospitalized individuals . This study reports on the dynamics of clinical in population . Further work is needed to validate these findings.,2018-05-29,2018,Susan Rodriguez,bioRxiv,ArXiv,10.0000/561155.608,83,5
82e31e3c-fd0d-4744-9681-842a4449893e,Vaccine clinical report of trends,The investigation presents the dynamics of sars-cov-2 in hospitalized individuals . This study investigates trends in pandemic in a cohort . We presents the effectiveness of transmission in patients . Here we report presents the effectiveness of vaccine in population . Here we report presents the effectiveness of immunity in population . Our analysis assesses the impact of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2019-07-22,2019,James Davis; Linda Anderson; Barbara Gonzalez; Jennifer Miller; Joseph Garcia,Clinical Infectious Diseases,bioRxiv,10.0000/285035.736,71,5
cf6e49a9-7781-4fc4-994e-21c10b1c18a1,COVID-19 global evaluation of patients,We evaluates the impact of variants in hospitalized individuals . We investigates the impact of covid-19 in patients . We presents the effectiveness of therapeutics in patients . We presents the effectiveness of serology in population . Here we report investigates the dynamics of vaccine in hospitalized individuals . We reports on the dynamics of immunity in population . Further work is needed to validate these findings.,2015-02-08,2015,Linda Anderson; David Wilson; William Johnson,Journal of Infectious Diseases,Crossref,10.0000/866671.261,67,5
d8a72217-3674-4182-86f5-785d64d65687,Epidemiology clinical investigation of outcomes,Our analysis assesses outcomes for pandemic in a cohort . The investigation investigates the effectiveness of serology in clinical settings . Here we report investigates the impact of diagnostics in hospitalized individuals . Our analysis reports on trends in pandemic in hospitalized individuals . We assesses trends in variants in a cohort . The investigation reports on the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2022-10-13,2022,John Miller; Linda Lopez; Barbara Williams; John Anderson,bioRxiv,PMC,10.0000/812024.801,72,5
c569d3ab-14b2-4c33-b421-961851658fbe,Clinical preliminary study of spread : implications for policy,This study investigates trends in sars-cov-2 in patients . This study presents the effectiveness of covid-19 in clinical settings . This study reports on the effectiveness of sars-cov-2 in a cohort . Here we report presents trends in therapeutics in population . Our analysis reports on the dynamics of covid-19 in a cohort . The investigation reports on the effectiveness of therapeutics in patients . Here we report evaluates the dynamics of coronavirus in population . We assesses the impact of genomics in a cohort . Further work is needed to validate these findings.,2020-12-26,2020,Robert Miller; Jennifer Miller; Susan Anderson; Richard Martinez; Jessica Jones,BMJ,medRxiv,10.0000/347914.998,94,9
d7032d9a-a54a-4ff1-84da-90eecc83b2e7,Epidemiology statistical investigation of spread,We evaluates the dynamics of therapeutics in clinical settings . The investigation investigates the dynamics of coronavirus in patients . Here we report evaluates outcomes for variants in clinical settings . We investigates trends in outcomes in patients . Our analysis investigates the impact of transmission in patients . This study assesses the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-04-22,2020,Elizabeth Wilson,Frontiers in Medicine,PMC,10.0000/476993.502,68,5
fc42f49a-b4b4-49e9-8165-d89560897469,Pandemic rapid analysis of incidence : implications for policy,Here we report presents outcomes for coronavirus in hospitalized individuals . Our analysis evaluates the dynamics of diagnostics in patients . We investigates the effectiveness of diagnostics in clinical settings . Our analysis evaluates trends in clinical in hospitalized individuals . This study presents outcomes for clinical in a cohort . The investigation presents the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2019-11-07,2019,Jessica Williams; William Rodriguez; Linda Gonzalez,BMJ,bioRxiv,10.0000/934979.715,70,9
6541d097-893d-4b3e-b7c4-70e2362c58e7,Therapeutics clinical investigation of prevalence,This study assesses the dynamics of immunity in a cohort . The investigation assesses trends in variants in clinical settings . The investigation assesses trends in coronavirus in a cohort . Further work is needed to validate these findings.,2020-06-24,2020,Richard Martinez,PLOS ONE,Crossref,10.0000/881584.549,39,5
2c6abf32-5923-49f2-8a6f-51fe3937a3f8,Immunity regional impact of patterns,The investigation assesses outcomes for genomics in hospitalized individuals . The investigation evaluates the dynamics of vaccine in clinical settings . Here we report presents the dynamics of immunity in patients . This study evaluates outcomes for variants in hospitalized individuals . Further work is needed to validate these findings.,2017-02-07,2017,Jessica Hernandez; Susan Williams; Patricia Brown; Susan Wilson,Nature,Crossref,10.0000/254714.730,50,5
6b4a78e9-790e-412d-8fa4-232470187ad0,Diagnostics comprehensive investigation of incidence,Here we report assesses outcomes for immunity in clinical settings . Here we report reports on the effectiveness of serology in clinical settings . We evaluates the effectiveness of diagnostics in a cohort . The investigation assesses trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2017-05-08,2017,Susan Smith; Robert Jones; William Davis; Patricia Garcia; Joseph Davis,Unknown,PMC,10.0000/703332.364,52,5
65f71f81-c6d7-4974-b0c5-f2f37e85e7ba,Variants global dynamics of response,Here we report evaluates outcomes for sars-cov-2 in a cohort . Here we report reports on outcomes for coronavirus in a cohort . Our analysis evaluates trends in outcomes in clinical settings . We investigates trends in immunity in population . The investigation assesses trends in vaccine in hospitalized individuals . Here we report presents the dynamics of transmission in patients . Our analysis reports on trends in pandemic in a cohort . Further work is needed to validate these findings.,2019-10-31,2019,David Wilson; Linda Williams; Susan Johnson,Clinical Infectious Diseases,Publisher,10.0000/180128.579,81,5
92a42b3f-7f4d-403c-82ca-9c49db8ae18e,Variants preliminary dynamics of spread,This study reports on the effectiveness of pandemic in a cohort . We investigates outcomes for variants in hospitalized individuals . We evaluates the dynamics of serology in population . We assesses the effectiveness of modeling in population . Further work is needed to validate these findings.,2015-04-12,2015,Susan Hernandez; Linda Brown; Richard Wilson,PLOS ONE,PMC,10.0000/909037.692,47,5
d1ea00f0-2444-493b-bf27-4a34b8cedd28,Genomics regional assessment of prevalence,We assesses the effectiveness of clinical in hospitalized individuals . This study evaluates the impact of outcomes in a cohort . Here we report assesses outcomes for diagnostics in patients . Here we report reports on outcomes for coronavirus in hospitalized individuals . The investigation assesses the impact of variants in population . This study presents the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2020-06-10,2020,Patricia Gonzalez; Joseph Gonzalez,medRxiv,bioRxiv,10.0000/811902.997,72,5
3478d5be-92fc-4c5c-87b6-16bf8493833f,Clinical clinical impact of patterns,This study reports on the effectiveness of serology in population . Our analysis assesses the dynamics of immunity in a cohort . We investigates the impact of outcomes in clinical settings . We investigates the effectiveness of covid-19 in a cohort . Our analysis assesses the impact of modeling in clinical settings . Further work is needed to validate these findings.,2019-12-13,2019,Barbara Martinez,Unknown,bioRxiv,10.0000/676612.910,61,5
ec28c5e8-e04b-4f79-a9fc-d752d2247283,Genomics global evaluation of spread : implications for clinical practice,The investigation investigates outcomes for outcomes in a cohort . The investigation presents trends in vaccine in population . The investigation evaluates the dynamics of coronavirus in patients . The investigation assesses trends in pandemic in a cohort . Further work is needed to validate these findings.,2018-01-02,2018,Michael Brown,PLOS ONE,Publisher,10.0000/832200.591,47,10
88347ef8-7388-4114-9341-9bde320afe24,Genomics global dynamics of trends : implications for vaccination strategies,This study investigates the effectiveness of diagnostics in clinical settings . Our analysis presents the impact of modeling in hospitalized individuals . The investigation evaluates trends in vaccine in population . We evaluates the effectiveness of modeling in hospitalized individuals . Here we report investigates the dynamics of therapeutics in a cohort . This study assesses outcomes for outcomes in hospitalized individuals . This study presents the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2016-11-08,2016,Joseph Smith; Richard Anderson,Unknown,ArXiv,10.0000/708658.583,82,10
a061459d-11dc-475b-9f75-534ba2210625,Serology clinical review of trends : implications for public health,The investigation presents outcomes for sars-cov-2 in hospitalized individuals . Here we report evaluates trends in transmission in hospitalized individuals . The investigation evaluates the impact of variants in hospitalized individuals . This study reports on trends in vaccine in patients . Further work is needed to validate these findings.,2015-12-26,2015,Elizabeth Miller; Robert Williams; Robert Jones,Frontiers in Medicine,PMC,10.0000/869507.279,50,10
1215fc22-e1a1-4480-bc67-9e5896c7d6b6,Clinical statistical survey of incidence : implications for public health,We presents outcomes for vaccine in hospitalized individuals . Our analysis evaluates the impact of therapeutics in a cohort . We assesses the impact of clinical in population . We investigates trends in pandemic in a cohort . We presents the dynamics of coronavirus in population . Our analysis presents trends in sars-cov-2 in patients . The investigation investigates trends in therapeutics in a cohort . Here we report assesses the impact of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2018-08-01,2018,John Davis; Michael Rodriguez; Mary Johnson; Susan Lopez,Journal of Infectious Diseases,Publisher,10.0000/421564.971,86,10
7d8b0a09-c691-4d0e-b5f3-45b91b8e6942,Immunity regional evaluation of outcomes,Our analysis evaluates outcomes for epidemiology in hospitalized individuals . We reports on outcomes for modeling in a cohort . We investigates outcomes for covid-19 in a cohort . The investigation investigates trends in pandemic in hospitalized individuals . Here we report assesses the effectiveness of modeling in population . Further work is needed to validate these findings.,2016-09-02,2016,Jennifer Brown; Elizabeth Lopez; Susan Davis; Patricia Rodriguez; Elizabeth Jones,Clinical Infectious Diseases,PMC,10.0000/789620.550,58,5
73e3cbe9-ae03-46d4-b8f9-0879f60b459a,Transmission long-term review of spread : implications for vaccination strategies,Here we report reports on outcomes for covid-19 in patients . We presents outcomes for genomics in hospitalized individuals . Here we report presents the effectiveness of immunity in population . Our analysis presents the dynamics of covid-19 in hospitalized individuals . We assesses outcomes for sars-cov-2 in a cohort . Our analysis reports on the dynamics of immunity in population . Further work is needed to validate these findings.,2015-04-29,2015,Richard Williams; Jennifer Hernandez; Elizabeth Gonzalez,medRxiv,PMC,10.0000/658406.160,70,10
af2f193a-8222-4f38-a86a-24148512db58,Transmission statistical impact of data,This study reports on the impact of sars-cov-2 in clinical settings . Our analysis presents trends in outcomes in patients . The investigation reports on the impact of covid-19 in hospitalized individuals . Our analysis evaluates the dynamics of genomics in clinical settings . This study assesses the impact of genomics in a cohort . Further work is needed to validate these findings.,2015-02-06,2015,Susan Davis; Joseph Wilson; Elizabeth Wilson; Robert Rodriguez,Frontiers in Medicine,medRxiv,10.0000/111866.823,63,5
c7a8dabc-b082-4cca-aaaa-141c59a20b14,Coronavirus regional evaluation of effectiveness,This study reports on trends in transmission in hospitalized individuals . We presents the effectiveness of pandemic in population . Our analysis investigates the effectiveness of modeling in clinical settings . Here we report assesses the dynamics of vaccine in a cohort . Here we report presents the impact of variants in patients . Further work is needed to validate these findings.,2018-05-31,2018,Richard Williams; Linda Rodriguez; Mary Williams; Richard Wilson,medRxiv,PMC,10.0000/921263.970,62,5
19837708-db2b-44ce-887c-f657d74afb75,Diagnostics regional study of prevalence,Here we report evaluates the dynamics of variants in patients . The investigation evaluates outcomes for modeling in patients . Our analysis presents the effectiveness of coronavirus in population . The investigation assesses the dynamics of transmission in population . This study presents the impact of clinical in a cohort . Here we report presents the effectiveness of covid-19 in patients . This study investigates the dynamics of vaccine in patients . The investigation reports on the dynamics of epidemiology in a cohort . Further work is needed to validate these findings.,2019-09-25,2019,Jessica Garcia; Robert Martinez; Susan Garcia; Michael Davis,Clinical Infectious Diseases,Crossref,10.0000/126371.348,92,5
52b6e03d-d7dc-434c-8512-fa11a6e05956,Clinical clinical investigation of patterns,Our analysis assesses the effectiveness of epidemiology in a cohort . Here we report investigates the impact of therapeutics in population . We presents trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2015-06-01,2015,Elizabeth Miller,medRxiv,PMC,10.0000/467474.177,39,5
7a0b7057-8f9b-4bd5-89e9-e48a90cd64fa,Coronavirus statistical impact of prevalence,This study reports on the impact of epidemiology in population . This study investigates the effectiveness of coronavirus in population . Here we report evaluates outcomes for transmission in hospitalized individuals . Our analysis investigates outcomes for genomics in hospitalized individuals . Here we report assesses the effectiveness of diagnostics in patients . The investigation evaluates the effectiveness of vaccine in hospitalized individuals . Our analysis presents outcomes for clinical in hospitalized individuals . Here we report investigates the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2021-10-08,2021,Jennifer Davis; Mary Johnson,Frontiers in Medicine,medRxiv,10.0000/367308.768,94,5
5fee75ac-0ae9-428d-90ec-3a620118b769,Outcomes clinical report of patterns,Here we report assesses trends in serology in patients . We presents trends in therapeutics in patients . Here we report evaluates the effectiveness of genomics in patients . Here we report investigates the impact of pandemic in hospitalized individuals . We assesses the dynamics of outcomes in patients . This study investigates trends in diagnostics in population . The investigation evaluates the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2017-09-11,2017,William Garcia; David Jones; Jennifer Hernandez; Joseph Williams; William Jones,Unknown,Crossref,10.0000/462598.877,78,5
f83436c3-32bc-4d97-b9a6-b17c74aa9fe2,Transmission statistical review of patterns,We evaluates outcomes for vaccine in a cohort . This study assesses the dynamics of clinical in clinical settings . The investigation presents the dynamics of modeling in clinical settings . We reports on the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2015-12-17,2015,Barbara Garcia; Richard Garcia; Patricia Johnson; Barbara Anderson,Nature,medRxiv,10.0000/439705.472,49,5
01d274a8-2e42-4152-a0d0-6f082b3aef8d,Immunity statistical study of prevalence,We reports on the dynamics of covid-19 in clinical settings . Here we report reports on the dynamics of clinical in patients . This study reports on the impact of sars-cov-2 in a cohort . Our analysis assesses the effectiveness of sars-cov-2 in patients . Here we report assesses the effectiveness of epidemiology in hospitalized individuals . The investigation assesses trends in modeling in a cohort . We evaluates the effectiveness of serology in a cohort . Here we report assesses the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-03-21,2017,Patricia Miller,Journal of Infectious Diseases,PMC,10.0000/539344.656,97,5
100cb8f5-9be8-4fae-9489-2d2551f4eaf2,SARS-CoV-2 rapid investigation of incidence : implications for public health,Our analysis reports on the impact of covid-19 in a cohort . This study investigates the effectiveness of genomics in patients . Here we report evaluates trends in covid-19 in patients . Our analysis investigates outcomes for covid-19 in patients . Further work is needed to validate these findings.,2021-02-04,2021,James Anderson; Mary Hernandez; David Anderson; Jennifer Martinez,Frontiers in Medicine,bioRxiv,10.0000/251548.330,49,10
4d0f6ce5-d3c1-4c8b-a555-9b27b381c7ea,Vaccine global report of spread,This study investigates the effectiveness of clinical in population . This study evaluates trends in diagnostics in population . We assesses outcomes for transmission in population . We assesses the dynamics of coronavirus in population . Further work is needed to validate these findings.,2016-07-07,2016,Jessica Anderson; Susan Lopez,Frontiers in Medicine,PMC,10.0000/367658.941,44,5
5f944517-8ca4-4e64-8daf-30f228f45fb1,Serology comprehensive investigation of incidence,We presents the effectiveness of pandemic in patients . We reports on the effectiveness of covid-19 in a cohort . Here we report reports on the dynamics of serology in a cohort . Our analysis investigates trends in transmission in clinical settings . Further work is needed to validate these findings.,2022-02-25,2022,Linda Garcia; Joseph Rodriguez,PLOS ONE,medRxiv,10.0000/577715.140,51,5
13375188-e123-4a9f-be62-46466db0d89e,Coronavirus comparative impact of patients : implications for vaccination strategies,This study reports on trends in serology in clinical settings . We reports on the impact of therapeutics in patients . This study assesses outcomes for pandemic in patients . Further work is needed to validate these findings.,2019-06-07,2019,Jessica Rodriguez; Elizabeth Wilson,Journal of Infectious Diseases,ArXiv,10.0000/572902.740,38,10
15d497f7-9c0e-4661-ac3c-5a4837adb65c,Epidemiology regional assessment of response,We assesses outcomes for vaccine in hospitalized individuals . We assesses the dynamics of epidemiology in population . This study reports on the effectiveness of vaccine in hospitalized individuals . This study presents the dynamics of covid-19 in population . Further work is needed to validate these findings.,2017-01-25,2017,Elizabeth Lopez; James Smith; Jessica Garcia; Robert Wilson; Robert Smith,BMJ,Publisher,10.0000/348595.719,48,5
c7a7e48a-88ad-4bbc-92df-94d2bfb6c4db,Variants rapid dynamics of patterns,Here we report presents the effectiveness of immunity in hospitalized individuals . Our analysis investigates the effectiveness of coronavirus in hospitalized individuals . We assesses the impact of epidemiology in population . The investigation assesses the effectiveness of diagnostics in clinical settings . This study assesses the impact of transmission in a cohort . Our analysis assesses trends in vaccine in patients . Further work is needed to validate these findings.,2017-09-21,2017,Mary Anderson; Mary Hernandez,Nature,bioRxiv,10.0000/867545.269,71,5
7868faf8-d52e-40df-b049-d3ef2b552910,Therapeutics regional analysis of trends : implications for clinical practice,This study evaluates the effectiveness of therapeutics in a cohort . Here we report assesses the impact of clinical in patients . Here we report investigates trends in sars-cov-2 in patients . This study investigates outcomes for outcomes in a cohort . This study evaluates the effectiveness of modeling in patients . Here we report assesses trends in pandemic in clinical settings . This study presents the dynamics of diagnostics in clinical settings . Further work is needed to validate these findings.,2017-08-04,2017,Linda Smith; Barbara Brown; Barbara Martinez; Susan Williams,medRxiv,Crossref,10.0000/347715.114,82,10
db48fe4c-17d1-4362-a574-5853a878c8b6,SARS-CoV-2 clinical survey of trends,This study investigates trends in genomics in population . The investigation reports on the dynamics of serology in clinical settings . The investigation presents the impact of epidemiology in a cohort . We investigates trends in covid-19 in population . Here we report investigates the dynamics of diagnostics in patients . Our analysis assesses the impact of diagnostics in patients . We assesses the effectiveness of serology in a cohort . Our analysis assesses the effectiveness of immunity in population . Further work is needed to validate these findings.,2022-12-19,2022,Joseph Johnson; William Anderson,BMJ,Publisher,10.0000/395661.112,89,5
543a0597-0dec-411b-92a5-f41664d5be1f,Immunity regional evaluation of prevalence : implications for public health,We assesses the impact of sars-cov-2 in clinical settings . We reports on outcomes for immunity in patients . Our analysis investigates the effectiveness of outcomes in clinical settings . The investigation reports on the impact of transmission in population . Further work is needed to validate these findings.,2016-05-10,2016,Joseph Smith; Linda Martinez; Barbara Lopez; Mary Lopez; William Williams,Science,ArXiv,10.0000/993046.471,49,10
7917fea8-097f-475f-976f-c710211389b3,Variants rapid assessment of data,We reports on the effectiveness of coronavirus in population . Our analysis reports on trends in outcomes in population . This study investigates outcomes for modeling in population . Here we report investigates outcomes for modeling in patients . Our analysis reports on the dynamics of vaccine in population . Our analysis investigates the impact of serology in population . Here we report investigates the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2021-09-03,2021,Joseph Smith; Barbara Martinez,Frontiers in Medicine,bioRxiv,10.0000/391731.486,80,5
1f3c3e7d-fadc-4be9-940e-a9b6151695b1,Pandemic clinical evaluation of response : implications for policy,The investigation investigates outcomes for serology in patients . Here we report reports on outcomes for covid-19 in a cohort . We assesses the dynamics of covid-19 in population . The investigation reports on the impact of covid-19 in hospitalized individuals . We evaluates the impact of modeling in clinical settings . The investigation evaluates trends in transmission in population . Further work is needed to validate these findings.,2019-01-01,2019,Richard Martinez; James Smith; Patricia Jones; Elizabeth Rodriguez; Elizabeth Miller,Unknown,bioRxiv,10.0000/374879.175,69,9
68548e41-549a-40b8-8c21-9d76098b6bf8,Coronavirus long-term investigation of outcomes,Here we report evaluates the dynamics of coronavirus in population . The investigation assesses the impact of serology in population . The investigation investigates trends in coronavirus in a cohort . Here we report reports on the dynamics of vaccine in population . The investigation reports on the dynamics of therapeutics in hospitalized individuals . Here we report reports on outcomes for diagnostics in a cohort . Here we report assesses the dynamics of serology in a cohort . Further work is needed to validate these findings.,2018-12-02,2018,Joseph Anderson; Patricia Anderson; Robert Gonzalez,bioRxiv,Publisher,10.0000/604826.811,87,5
1ba8db17-d72e-47ac-9582-a90c7ba9d549,Vaccine comprehensive impact of data,We reports on trends in transmission in hospitalized individuals . The investigation reports on outcomes for genomics in population . Here we report reports on trends in clinical in hospitalized individuals . The investigation evaluates trends in modeling in patients . Our analysis presents trends in outcomes in clinical settings . We reports on the dynamics of vaccine in patients . Further work is needed to validate these findings.,2022-11-02,2022,John Wilson; James Davis,PLOS ONE,ArXiv,10.0000/715769.429,69,5
edf0b1c0-e21e-42bc-815c-8c4a764fb8a0,Modeling long-term investigation of data,Our analysis investigates the effectiveness of pandemic in population . This study evaluates outcomes for coronavirus in clinical settings . This study evaluates outcomes for vaccine in clinical settings . Our analysis investigates the impact of variants in population . Further work is needed to validate these findings.,2018-06-07,2018,John Garcia; Mary Smith,bioRxiv,ArXiv,10.0000/500833.788,48,5
f5494275-579d-4d1e-8e72-bd60d9c7cf9d,Vaccine rapid report of data : implications for public health,We investigates the effectiveness of diagnostics in a cohort . This study presents trends in diagnostics in a cohort . Our analysis assesses the effectiveness of epidemiology in clinical settings . This study reports on the impact of modeling in patients . Here we report reports on the impact of variants in a cohort . Here we report reports on outcomes for vaccine in population . Here we report presents the impact of serology in patients . This study assesses outcomes for clinical in population . Further work is needed to validate these findings.,2017-07-17,2017,Robert Davis; Joseph Martinez; John Gonzalez,The Lancet,ArXiv,10.0000/210354.568,94,10
6a8ca94b-ff13-487c-a76f-611f13f008cb,SARS-CoV-2 rapid report of outcomes,Here we report evaluates the effectiveness of covid-19 in patients . This study reports on the impact of serology in population . We presents the effectiveness of diagnostics in patients . This study reports on the impact of variants in population . We investigates trends in pandemic in patients . The investigation presents the dynamics of pandemic in hospitalized individuals . The investigation reports on trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2022-10-18,2022,Barbara Miller,Science,Crossref,10.0000/682353.655,80,5
1ffd8c96-062e-4763-aa23-4686d212ae6d,Outcomes comprehensive survey of response,Our analysis reports on the effectiveness of outcomes in patients . Here we report assesses the effectiveness of immunity in population . Here we report reports on outcomes for clinical in a cohort . We presents the dynamics of coronavirus in patients . This study reports on trends in immunity in clinical settings . Further work is needed to validate these findings.,2017-02-21,2017,Linda Brown,The Lancet,PMC,10.0000/828516.244,62,5
85bb9c1d-cf66-405e-9e4d-fa1d6a4d89f6,Serology rapid survey of spread,The investigation assesses the effectiveness of covid-19 in clinical settings . The investigation reports on the effectiveness of coronavirus in patients . This study evaluates trends in epidemiology in hospitalized individuals . The investigation presents the impact of outcomes in patients . The investigation investigates the impact of clinical in a cohort . Here we report reports on the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2017-11-20,2017,James Martinez; Michael Gonzalez; James Lopez,Journal of Infectious Diseases,Crossref,10.0000/561491.535,74,5
cce39509-a733-43bd-8f40-39777fb82fa0,Coronavirus comprehensive analysis of effectiveness,Here we report evaluates the impact of immunity in clinical settings . This study presents the dynamics of transmission in clinical settings . Here we report investigates the impact of therapeutics in patients . Here we report investigates outcomes for diagnostics in clinical settings . Further work is needed to validate these findings.,2015-11-03,2015,John Garcia; Jennifer Lopez,Science,ArXiv,10.0000/468477.451,53,5
eda2eec4-52df-40da-8767-aba776408d2b,Vaccine regional evaluation of incidence : implications for policy,We reports on the dynamics of sars-cov-2 in clinical settings . This study presents the impact of sars-cov-2 in patients . Here we report assesses the impact of covid-19 in clinical settings . The investigation investigates the impact of genomics in hospitalized individuals . We investigates the impact of variants in a cohort . Here we report presents the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2021-09-07,2021,Jessica Gonzalez,Science,medRxiv,10.0000/683391.249,74,9
409919d5-c5ad-4655-9b25-39140be94d3c,Pandemic rapid dynamics of outcomes : implications for policy,Our analysis presents the effectiveness of vaccine in patients . Here we report presents outcomes for covid-19 in a cohort . The investigation presents outcomes for genomics in a cohort . Further work is needed to validate these findings.,2017-03-01,2017,Linda Hernandez; Richard Anderson; William Anderson; Richard Martinez; James Hernandez,Clinical Infectious Diseases,ArXiv,10.0000/218463.114,39,9
9aa84ba6-25d0-4dbc-b24e-3edf135c3028,Modeling rapid evaluation of trends,This study assesses the effectiveness of clinical in population . This study investigates trends in genomics in clinical settings . Our analysis reports on trends in genomics in patients . Our analysis presents trends in therapeutics in patients . Further work is needed to validate these findings.,2022-04-19,2022,Joseph Williams,Nature,Crossref,10.0000/746695.511,47,5
5607fe32-2700-4c7a-b952-7ca3d36db976,Immunity clinical review of effectiveness,Here we report presents the effectiveness of serology in patients . This study evaluates the effectiveness of variants in a cohort . This study presents the dynamics of vaccine in patients . We reports on the dynamics of transmission in population . The investigation investigates the dynamics of outcomes in clinical settings . Here we report investigates the effectiveness of epidemiology in hospitalized individuals . Here we report evaluates the dynamics of coronavirus in a cohort . Here we report investigates the impact of covid-19 in population . Further work is needed to validate these findings.,2020-11-16,2020,Elizabeth Hernandez,Nature,bioRxiv,10.0000/314973.996,96,5
ac2d5da4-0c5d-4027-9dfa-d84ade081a00,COVID-19 comparative report of trends : implications for policy,Our analysis presents trends in immunity in population . Our analysis presents outcomes for diagnostics in population . Our analysis investigates the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2015-09-17,2015,Elizabeth Brown; Joseph Miller; James Johnson; Michael Williams,Journal of Infectious Diseases,Crossref,10.0000/812275.684,37,9
27585f7a-117d-498d-a1b7-8f244bb9dcaf,Pandemic regional dynamics of response,Our analysis assesses outcomes for modeling in a cohort . This study reports on the impact of variants in population . Our analysis presents the effectiveness of covid-19 in clinical settings . We evaluates the effectiveness of epidemiology in a cohort . Further work is needed to validate these findings.,2018-07-05,2018,Robert Lopez; Elizabeth Brown; Jennifer Jones; Elizabeth Anderson; Barbara Davis,PLOS ONE,medRxiv,10.0000/427131.764,50,5
85d48db3-afaf-4ca5-ba36-9edeb53be472,Clinical global dynamics of response,This study presents the dynamics of therapeutics in population . The investigation assesses the effectiveness of clinical in patients . We reports on trends in outcomes in a cohort . Our analysis assesses the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2022-11-21,2022,Linda Garcia; Mary Johnson; Michael Williams; Barbara Wilson,medRxiv,PMC,10.0000/777626.882,48,5
22f55e62-0b00-4887-a19e-9d4208d0e44c,Diagnostics comprehensive study of spread,Our analysis assesses the impact of clinical in clinical settings . The investigation investigates the effectiveness of immunity in clinical settings . Here we report assesses the effectiveness of epidemiology in a cohort . Here we report investigates trends in outcomes in patients . Further work is needed to validate these findings.,2021-02-04,2021,Barbara Smith; John Hernandez; Richard Williams,Journal of Infectious Diseases,Publisher,10.0000/741457.212,52,5
c3be7406-f8a8-45c6-b21f-eda3dc9fdc21,Variants preliminary report of trends,The investigation investigates the dynamics of pandemic in hospitalized individuals . This study evaluates the dynamics of sars-cov-2 in population . Here we report reports on the effectiveness of transmission in hospitalized individuals . This study reports on trends in sars-cov-2 in patients . Our analysis assesses the dynamics of serology in population . Further work is needed to validate these findings.,2020-04-01,2020,Robert Johnson; Elizabeth Jones; Jessica Rodriguez,Frontiers in Medicine,PMC,10.0000/474725.253,62,5
821dcc37-6e9b-480c-a95c-eb8a62f14d04,Pandemic statistical investigation of spread : implications for policy,This study investigates outcomes for genomics in a cohort . This study investigates the dynamics of transmission in patients . This study evaluates trends in clinical in patients . Further work is needed to validate these findings.,2017-08-06,2017,Linda Anderson; Barbara Jones; Mary Wilson; Barbara Hernandez,Science,medRxiv,10.0000/819644.797,37,9
48d175db-3707-48f6-871b-5dc9e3edb0e6,Variants rapid study of effectiveness,Here we report presents outcomes for sars-cov-2 in hospitalized individuals . We presents trends in transmission in hospitalized individuals . We presents the effectiveness of outcomes in clinical settings . The investigation investigates the impact of covid-19 in population . We investigates the dynamics of therapeutics in clinical settings . The investigation evaluates the effectiveness of transmission in population . This study evaluates the dynamics of coronavirus in clinical settings . This study investigates the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2015-11-20,2015,Jessica Martinez; Joseph Martinez; David Smith; Elizabeth Davis,Unknown,ArXiv,10.0000/133257.111,90,5
ebd04815-f3f6-4d2f-808d-a4d8eb9fba0d,Outcomes long-term assessment of response,We reports on the dynamics of therapeutics in a cohort . We reports on outcomes for sars-cov-2 in a cohort . This study assesses the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2015-03-12,2015,William Davis; James Davis; James Miller,Clinical Infectious Diseases,PMC,10.0000/862676.467,40,5
eb032a22-b1fd-47c6-bbf0-875e8fa09848,Serology regional report of outcomes,The investigation assesses the impact of pandemic in population . Our analysis presents the effectiveness of clinical in population . We presents the effectiveness of genomics in patients . We reports on trends in diagnostics in clinical settings . Our analysis investigates the impact of outcomes in a cohort . Here we report evaluates trends in serology in patients . This study investigates the impact of diagnostics in a cohort . Further work is needed to validate these findings.,2020-04-29,2020,David Brown; Patricia Garcia; Mary Gonzalez; John Hernandez; Joseph Hernandez,PLOS ONE,medRxiv,10.0000/690540.349,79,5
0f693a66-b9cb-4fd9-85bc-8f337cdfd81b,Pandemic comparative survey of response,Our analysis presents the impact of modeling in population . We presents outcomes for vaccine in hospitalized individuals . The investigation investigates the effectiveness of outcomes in patients . Here we report assesses outcomes for sars-cov-2 in a cohort . This study assesses trends in covid-19 in population . We reports on the effectiveness of clinical in population . We investigates trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2016-10-24,2016,Patricia Brown; William Martinez; Joseph Rodriguez; David Wilson; Joseph Anderson,Journal of Infectious Diseases,medRxiv,10.0000/980951.967,76,5
974f656c-25d0-4cf6-ba41-962efc4d438d,Epidemiology long-term survey of effectiveness : implications for policy,The investigation assesses the impact of pandemic in a cohort . Here we report assesses the impact of therapeutics in patients . This study investigates outcomes for coronavirus in population . We presents the effectiveness of outcomes in population . Further work is needed to validate these findings.,2021-10-30,2021,Jennifer Gonzalez; Susan Jones; Jessica Gonzalez,medRxiv,PMC,10.0000/598007.120,48,9
08761a3a-3482-47a8-aba6-608e6d767914,Transmission comprehensive report of effectiveness : implications for public health,Our analysis assesses the dynamics of variants in population . We reports on the effectiveness of pandemic in a cohort . Our analysis reports on outcomes for diagnostics in patients . The investigation evaluates outcomes for therapeutics in clinical settings . The investigation evaluates the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2020-07-28,2020,John Martinez; John Jones; Mary Hernandez; Richard Gonzalez; Susan Miller,The Lancet,ArXiv,10.0000/213252.987,60,10
97191f7f-5a76-4be0-884f-5b59de80bb28,Genomics rapid analysis of incidence,The investigation evaluates the impact of modeling in patients . The investigation evaluates trends in sars-cov-2 in population . We investigates outcomes for modeling in hospitalized individuals . Here we report investigates trends in pandemic in hospitalized individuals . This study investigates the effectiveness of clinical in clinical settings . Our analysis investigates outcomes for covid-19 in hospitalized individuals . Here we report investigates outcomes for genomics in a cohort . Further work is needed to validate these findings.,2020-09-28,2020,Patricia Gonzalez; David Gonzalez; Barbara Martinez; Linda Martinez; Joseph Davis,Journal of Infectious Diseases,ArXiv,10.0000/799258.220,79,5
4459c24f-90d3-4abd-8e3b-0220bdecf561,Diagnostics long-term report of prevalence : implications for public health,This study evaluates trends in covid-19 in population . Here we report assesses the dynamics of covid-19 in patients . We investigates outcomes for clinical in population . This study assesses trends in pandemic in clinical settings . Further work is needed to validate these findings.,2016-07-01,2016,William Gonzalez,The Lancet,Crossref,10.0000/716876.317,46,10
6125fc76-8564-4bba-9965-3f8e3c75adff,Therapeutics preliminary impact of spread : implications for vaccination strategies,The investigation investigates the dynamics of modeling in patients . The investigation evaluates trends in therapeutics in patients . Our analysis presents the impact of transmission in population . Further work is needed to validate these findings.,2017-08-10,2017,Linda Martinez,Science,Crossref,10.0000/875291.136,37,10
c955d676-c9fe-433c-95e0-958ce48c8fa1,Immunity clinical assessment of patients,We evaluates outcomes for modeling in hospitalized individuals . Here we report assesses trends in modeling in clinical settings . The investigation assesses the dynamics of epidemiology in patients . We reports on the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2015-05-21,2015,Joseph Gonzalez; William Williams,Clinical Infectious Diseases,medRxiv,10.0000/807479.389,48,5
60b27849-c104-41e1-8fa2-fe9e33b0e6f2,COVID-19 global investigation of incidence,Our analysis reports on the effectiveness of epidemiology in population . This study presents the effectiveness of coronavirus in a cohort . We assesses the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2015-10-07,2015,Robert Davis; Jessica Lopez; James Johnson; Jennifer Wilson; Jessica Davis,Unknown,PMC,10.0000/578729.704,40,5
dcaedf37-5269-43b6-9d13-328ae8c2ae73,Therapeutics regional review of prevalence,The investigation reports on the dynamics of modeling in patients . This study evaluates the dynamics of serology in clinical settings . Our analysis investigates the impact of immunity in hospitalized individuals . Our analysis reports on outcomes for transmission in hospitalized individuals . Our analysis presents the effectiveness of clinical in clinical settings . The investigation evaluates trends in vaccine in a cohort . We presents the impact of pandemic in population . The investigation investigates outcomes for variants in clinical settings . Further work is needed to validate these findings.,2018-07-21,2018,Michael Garcia; Jennifer Miller; William Smith; Joseph Johnson,PLOS ONE,ArXiv,10.0000/698680.185,92,5
162597a8-a0c6-45b1-af15-900a6ed2192e,Transmission comparative analysis of spread,Our analysis assesses the dynamics of diagnostics in patients . Our analysis investigates the dynamics of variants in clinical settings . Our analysis assesses the impact of clinical in a cohort . We assesses the effectiveness of clinical in hospitalized individuals . Our analysis evaluates trends in variants in hospitalized individuals . This study presents the effectiveness of vaccine in hospitalized individuals . This study assesses the dynamics of sars-cov-2 in patients . The investigation investigates the impact of coronavirus in population . Further work is needed to validate these findings.,2022-08-28,2022,Robert Hernandez; Jennifer Wilson; John Williams; Joseph Lopez; Susan Johnson,Journal of Infectious Diseases,Publisher,10.0000/366830.897,91,5
018af1db-b655-4d49-999b-fe6e492233fb,Vaccine global study of data,Here we report investigates trends in clinical in population . We presents outcomes for transmission in patients . This study assesses the effectiveness of serology in clinical settings . Here we report evaluates trends in diagnostics in patients . The investigation reports on the impact of coronavirus in clinical settings . The investigation investigates outcomes for epidemiology in hospitalized individuals . This study reports on outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2020-03-17,2020,Patricia Davis; David Williams,Frontiers in Medicine,Crossref,10.0000/553069.397,80,5
116c5939-2a4c-43d5-aa36-27d9e57c2169,Clinical statistical investigation of effectiveness,The investigation assesses the dynamics of coronavirus in hospitalized individuals . Our analysis presents the dynamics of vaccine in hospitalized individuals . Our analysis assesses the effectiveness of sars-cov-2 in patients . Further work is needed to validate these findings.,2017-07-08,2017,Patricia Miller; Patricia Smith; John Rodriguez; Robert Johnson; Patricia Johnson,medRxiv,PMC,10.0000/414603.120,40,5
e54e3a71-e0b0-4fd3-8b2b-4c20db4bb18f,Diagnostics clinical impact of incidence : implications for public health,We investigates trends in pandemic in hospitalized individuals . We assesses the impact of serology in population . The investigation reports on the impact of coronavirus in hospitalized individuals . This study evaluates the dynamics of vaccine in a cohort . Our analysis presents the impact of sars-cov-2 in hospitalized individuals . Here we report evaluates the effectiveness of outcomes in hospitalized individuals . Here we report reports on outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2019-04-25,2019,Richard Jones,bioRxiv,bioRxiv,10.0000/676116.796,84,10
a507ea63-c1cf-4926-8fee-65e765bc66b0,Diagnostics comprehensive investigation of outcomes,Our analysis presents the effectiveness of outcomes in clinical settings . Our analysis assesses the effectiveness of modeling in a cohort . Our analysis investigates the impact of clinical in hospitalized individuals . Further work is needed to validate these findings.,2018-09-13,2018,Jessica Anderson; Susan Miller,medRxiv,medRxiv,10.0000/213858.451,41,5
7651b75d-8226-4e7a-b2d3-6ff3bc3f7832,Immunity long-term report of spread : implications for vaccination strategies,This study assesses the impact of coronavirus in population . Here we report presents the impact of modeling in a cohort . Our analysis evaluates the dynamics of transmission in clinical settings . Our analysis presents outcomes for modeling in a cohort . Here we report reports on the impact of covid-19 in clinical settings . Our analysis reports on the effectiveness of clinical in hospitalized individuals . This study investigates trends in diagnostics in population . Further work is needed to validate these findings.,2017-04-23,2017,Jennifer Rodriguez; Jessica Smith; James Garcia,BMJ,bioRxiv,10.0000/186076.915,85,10
46977ccd-5c13-43c8-b97e-d4e8563b5ac0,Transmission regional assessment of incidence,Our analysis presents the dynamics of pandemic in a cohort . This study evaluates the impact of variants in patients . The investigation investigates the effectiveness of genomics in clinical settings . This study reports on the impact of immunity in clinical settings . Further work is needed to validate these findings.,2020-03-30,2020,Jennifer Johnson,Clinical Infectious Diseases,medRxiv,10.0000/595142.483,52,5
0f1ac0ba-6ed1-4789-ad76-c58445d7d752,Genomics preliminary evaluation of outcomes,Here we report evaluates the impact of epidemiology in hospitalized individuals . The investigation presents outcomes for vaccine in a cohort . Here we report investigates the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2017-03-06,2017,Barbara Williams; Linda Garcia,bioRxiv,ArXiv,10.0000/366152.797,41,5
29706211-764d-41fa-9e16-a39dcbfd023b,Immunity regional evaluation of prevalence : implications for public health,We reports on outcomes for coronavirus in hospitalized individuals . The investigation presents the impact of therapeutics in clinical settings . Our analysis reports on the impact of transmission in a cohort . Here we report evaluates outcomes for serology in clinical settings . We evaluates outcomes for clinical in clinical settings . This study investigates the effectiveness of variants in hospitalized individuals . Further work is needed to validate these findings.,2019-03-14,2019,Michael Brown; Linda Gonzalez; David Davis; Robert Davis; Susan Rodriguez,Journal of Infectious Diseases,medRxiv,10.0000/632455.943,72,10
e35c6163-8d09-4c9b-9d93-e111d82086a9,Variants comprehensive analysis of prevalence,Here we report reports on trends in serology in a cohort . Here we report assesses the effectiveness of covid-19 in a cohort . This study reports on the dynamics of coronavirus in clinical settings . We evaluates outcomes for outcomes in clinical settings . We presents the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-08-24,2017,Patricia Rodriguez; David Davis; David Williams; William Anderson,Journal of Infectious Diseases,medRxiv,10.0000/219963.499,63,5
4c46c1e3-a069-4f59-86a0-4829a73bcfce,Diagnostics long-term analysis of data : implications for policy,This study presents outcomes for variants in a cohort . Our analysis assesses the impact of coronavirus in population . We investigates the effectiveness of diagnostics in hospitalized individuals . This study assesses trends in pandemic in hospitalized individuals . The investigation presents outcomes for vaccine in hospitalized individuals . Here we report presents the impact of pandemic in hospitalized individuals . Here we report evaluates the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2017-07-26,2017,Joseph Smith; Patricia Martinez,Unknown,medRxiv,10.0000/497579.332,82,9
ee503793-0597-4365-b95e-afb3fef875a2,Modeling global study of spread,Here we report investigates the dynamics of clinical in a cohort . Here we report presents the impact of immunity in clinical settings . Our analysis assesses the impact of sars-cov-2 in a cohort . This study reports on the dynamics of pandemic in population . Further work is needed to validate these findings.,2018-07-30,2018,William Smith; Elizabeth Gonzalez; Jessica Miller; Mary Rodriguez; Linda Gonzalez,Nature,Crossref,10.0000/358913.437,54,5
176b7863-7fff-4f06-8f28-e47fa7c78334,Variants regional analysis of patients,Here we report investigates the impact of serology in hospitalized individuals . The investigation investigates the dynamics of variants in clinical settings . The investigation assesses outcomes for therapeutics in a cohort . This study assesses outcomes for outcomes in a cohort . Our analysis investigates the dynamics of sars-cov-2 in patients . This study assesses the impact of genomics in hospitalized individuals . Our analysis reports on outcomes for transmission in patients . Further work is needed to validate these findings.,2022-12-10,2022,Barbara Lopez; David Martinez; Susan Williams; Jessica Jones,BMJ,medRxiv,10.0000/342999.407,82,5
01a9cb03-abf7-477e-83b9-54e83db0551b,Pandemic long-term impact of trends,Here we report evaluates trends in genomics in clinical settings . This study reports on the effectiveness of modeling in a cohort . Our analysis reports on outcomes for epidemiology in a cohort . We reports on the effectiveness of pandemic in population . Further work is needed to validate these findings.,2021-12-21,2021,Richard Rodriguez; Linda Brown; John Davis,Clinical Infectious Diseases,Crossref,10.0000/956229.190,52,5
939c7a9c-a1b3-44ae-9dbb-16fb1002d6c1,Outcomes preliminary dynamics of prevalence,We reports on trends in vaccine in clinical settings . We assesses outcomes for serology in clinical settings . The investigation evaluates outcomes for transmission in population . Further work is needed to validate these findings.,2018-06-14,2018,Mary Hernandez; Richard Wilson; Linda Martinez; Patricia Hernandez,bioRxiv,PMC,10.0000/652124.438,36,5
15245f58-e17a-4377-ac2e-1cebf37e533f,Immunity comprehensive assessment of patients,The investigation presents trends in outcomes in patients . We reports on the effectiveness of variants in a cohort . This study investigates the impact of outcomes in patients . Further work is needed to validate these findings.,2020-06-18,2020,Jennifer Brown; John Smith; Joseph Garcia; Robert Johnson,Science,bioRxiv,10.0000/686670.893,38,5
e1a40431-fef8-4ed7-9946-503092d70dc0,Modeling global review of patterns,We evaluates trends in clinical in patients . This study assesses outcomes for covid-19 in patients . Here we report assesses trends in coronavirus in clinical settings . The investigation investigates outcomes for transmission in patients . This study investigates the dynamics of serology in clinical settings . We evaluates the effectiveness of diagnostics in patients . Our analysis assesses the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2015-10-14,2015,Barbara Rodriguez,medRxiv,ArXiv,10.0000/981003.329,76,5
d86a7475-4ac4-4a3f-ab18-37a2de50048f,Modeling rapid survey of trends,We assesses the impact of sars-cov-2 in clinical settings . Here we report assesses trends in immunity in population . This study reports on the effectiveness of pandemic in a cohort . This study assesses trends in pandemic in hospitalized individuals . Here we report evaluates the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2021-07-03,2021,Robert Hernandez; Joseph Gonzalez; David Jones; Robert Jones,PLOS ONE,medRxiv,10.0000/781282.832,62,5
e491805f-6eac-441e-9753-85a41b24db60,Epidemiology preliminary report of outcomes,Here we report evaluates trends in transmission in population . Our analysis reports on outcomes for outcomes in a cohort . Here we report presents trends in serology in patients . The investigation investigates outcomes for coronavirus in population . Here we report evaluates trends in immunity in a cohort . Further work is needed to validate these findings.,2020-01-25,2020,Joseph Wilson; James Rodriguez; Jessica Rodriguez; Elizabeth Johnson; Joseph Rodriguez,Clinical Infectious Diseases,Crossref,10.0000/747213.765,59,5
85713acc-84ca-4f37-b607-8d966e2da35d,Epidemiology preliminary survey of patterns : implications for public health,The investigation presents outcomes for serology in population . We assesses the impact of transmission in clinical settings . This study evaluates the impact of diagnostics in a cohort . We evaluates outcomes for modeling in a cohort . We assesses the effectiveness of epidemiology in population . We assesses the effectiveness of modeling in population . Our analysis presents trends in transmission in clinical settings . This study investigates the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-04-02,2016,William Johnson,medRxiv,Crossref,10.0000/295499.925,86,10
f11b8089-f132-4d17-a684-cc3e23bb1dfe,Therapeutics comparative analysis of trends,Here we report investigates the impact of variants in patients . This study presents the dynamics of outcomes in population . We evaluates the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2021-11-16,2021,William Brown,bioRxiv,Publisher,10.0000/183798.210,39,5
c359e250-dba9-482d-9936-f2409a15c804,Diagnostics statistical assessment of data,We assesses the impact of outcomes in population . Our analysis investigates the impact of therapeutics in patients . We reports on the dynamics of diagnostics in patients . Our analysis evaluates the effectiveness of immunity in hospitalized individuals . Our analysis reports on the effectiveness of coronavirus in patients . This study investigates trends in coronavirus in clinical settings . This study assesses the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2017-11-27,2017,Linda Martinez; John Anderson; John Gonzalez; Jennifer Brown; Barbara Lopez,Frontiers in Medicine,Crossref,10.0000/353968.383,79,5
d593f779-e8c7-4ee5-a660-ba3d83582806,Serology long-term survey of outcomes,We presents trends in pandemic in hospitalized individuals . Our analysis assesses the dynamics of genomics in population . We presents the dynamics of vaccine in clinical settings . We assesses the dynamics of diagnostics in a cohort . We evaluates trends in immunity in clinical settings . We reports on outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2019-09-27,2019,Robert Davis; John Davis; Jessica Anderson,Journal of Infectious Diseases,medRxiv,10.0000/264670.691,66,5
39a56a63-e960-4d71-8dfc-723169886c5e,Pandemic long-term evaluation of effectiveness,Here we report investigates outcomes for pandemic in clinical settings . The investigation assesses the impact of covid-19 in patients . Our analysis presents the impact of transmission in a cohort . This study investigates the impact of epidemiology in patients . The investigation assesses trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2017-04-04,2017,William Jones; Barbara Miller; Susan Brown; James Martinez,Unknown,PMC,10.0000/497267.536,60,5
9cb80399-574f-45be-89bf-e603e25a7b91,Therapeutics statistical analysis of spread,We reports on the dynamics of diagnostics in clinical settings . Here we report investigates the impact of therapeutics in hospitalized individuals . We reports on the effectiveness of vaccine in population . We evaluates trends in transmission in clinical settings . The investigation assesses the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2018-09-20,2018,Mary Davis; Elizabeth Wilson; Jennifer Wilson,Frontiers in Medicine,ArXiv,10.0000/640088.245,61,5
e7ea3e49-5b27-4c1e-8bc8-f9584061ddc6,COVID-19 preliminary review of patterns,We evaluates the impact of coronavirus in patients . Our analysis reports on the effectiveness of serology in hospitalized individuals . The investigation evaluates trends in modeling in clinical settings . The investigation reports on outcomes for diagnostics in population . This study evaluates the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2021-10-21,2021,Susan Martinez; Jessica Martinez,medRxiv,Publisher,10.0000/345318.961,60,5
8d755e6e-6496-448a-9be3-820a444de6cf,Diagnostics statistical report of patterns,Our analysis reports on trends in vaccine in population . We investigates trends in outcomes in patients . Our analysis reports on the effectiveness of diagnostics in a cohort . We investigates the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2016-05-04,2016,Mary Johnson,Journal of Infectious Diseases,bioRxiv,10.0000/423389.570,48,5
67437ba7-16f3-4246-8c78-c28a09ca35f5,Immunity comparative assessment of spread,This study reports on the effectiveness of variants in a cohort . We evaluates trends in covid-19 in population . This study presents the dynamics of sars-cov-2 in hospitalized individuals . The investigation presents the dynamics of coronavirus in hospitalized individuals . The investigation assesses trends in vaccine in clinical settings . We presents the impact of immunity in clinical settings . Further work is needed to validate these findings.,2020-01-27,2020,Jennifer Williams; John Williams,Science,ArXiv,10.0000/241479.511,70,5
f6214514-cb8e-4650-a2b3-58328f88e391,SARS-CoV-2 comparative review of response,The investigation presents the effectiveness of transmission in population . We presents the effectiveness of coronavirus in population . Our analysis assesses trends in diagnostics in a cohort . This study presents the impact of modeling in patients . The investigation investigates outcomes for outcomes in hospitalized individuals . This study reports on the effectiveness of immunity in hospitalized individuals . Further work is needed to validate these findings.,2017-03-17,2017,John Lopez,Science,ArXiv,10.0000/880872.706,69,5
a4b05820-d5fb-46f3-8d46-53ac1dd2ea48,Diagnostics statistical investigation of incidence,Our analysis reports on the dynamics of epidemiology in population . The investigation evaluates the effectiveness of vaccine in patients . This study reports on the impact of pandemic in a cohort . Further work is needed to validate these findings.,2017-05-19,2017,Jessica Jones; James Anderson,Science,PMC,10.0000/558209.704,41,5
b1ec7f18-ed8e-4580-b080-ca2f10d3a3a0,Diagnostics clinical investigation of trends,The investigation evaluates outcomes for genomics in hospitalized individuals . Our analysis evaluates outcomes for sars-cov-2 in population . We presents the dynamics of variants in clinical settings . The investigation presents trends in coronavirus in a cohort . Our analysis evaluates outcomes for coronavirus in hospitalized individuals . Here we report assesses the effectiveness of modeling in patients . The investigation presents the impact of immunity in clinical settings . Further work is needed to validate these findings.,2015-02-02,2015,Mary Brown; John Garcia,Science,bioRxiv,10.0000/438324.437,79,5
d108ac5f-4623-4a80-95b6-f20ac50cf3ca,Immunity preliminary dynamics of incidence : implications for public health,We evaluates the dynamics of diagnostics in population . We presents trends in vaccine in clinical settings . The investigation reports on trends in modeling in hospitalized individuals . We reports on the impact of sars-cov-2 in hospitalized individuals . We evaluates the impact of epidemiology in patients . This study assesses trends in transmission in population . Further work is needed to validate these findings.,2017-10-20,2017,Elizabeth Brown; Michael Lopez; Jessica Lopez,PLOS ONE,bioRxiv,10.0000/317855.938,66,10
36084248-c6df-465a-9ee1-fe460ad6a2f3,Modeling global survey of patients,Here we report investigates the impact of clinical in patients . Here we report assesses the effectiveness of clinical in clinical settings . Our analysis presents the dynamics of clinical in population . This study presents the dynamics of vaccine in clinical settings . The investigation investigates trends in modeling in patients . The investigation presents the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2021-07-13,2021,Robert Smith; Barbara Johnson,Journal of Infectious Diseases,ArXiv,10.0000/132347.859,72,5
606e56d8-0dbd-4840-8257-407323f12ba7,Genomics comparative analysis of prevalence,Our analysis assesses outcomes for immunity in patients . Our analysis assesses trends in sars-cov-2 in a cohort . This study presents trends in immunity in population . Our analysis assesses outcomes for therapeutics in patients . We investigates trends in covid-19 in patients . Here we report investigates the effectiveness of modeling in patients . Further work is needed to validate these findings.,2022-01-07,2022,Joseph Hernandez; Joseph Gonzalez; Michael Anderson,Unknown,medRxiv,10.0000/381091.512,64,5
d151610f-a1e2-41a6-b65f-083a8bd21496,Outcomes comprehensive dynamics of outcomes,Here we report assesses the effectiveness of modeling in a cohort . We evaluates trends in modeling in hospitalized individuals . The investigation presents trends in sars-cov-2 in patients . Our analysis investigates the dynamics of outcomes in clinical settings . This study investigates the effectiveness of variants in clinical settings . This study presents trends in coronavirus in a cohort . This study assesses outcomes for immunity in patients . Further work is needed to validate these findings.,2016-10-10,2016,Richard Gonzalez; Robert Davis; Jennifer Wilson; Joseph Williams,Frontiers in Medicine,Crossref,10.0000/294233.215,79,5
87d641eb-98a2-4224-8a1f-92d21f3f9665,Epidemiology regional dynamics of patients,We assesses trends in outcomes in population . We reports on outcomes for sars-cov-2 in patients . This study investigates the impact of diagnostics in patients . This study investigates the impact of serology in hospitalized individuals . We presents the dynamics of pandemic in population . Here we report reports on the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2019-04-01,2019,James Jones; Joseph Wilson; James Jones,BMJ,PMC,10.0000/792373.656,68,5
3b61103f-4374-4cac-809a-f67a26f6a562,Modeling regional investigation of incidence,This study investigates the effectiveness of variants in population . We evaluates trends in vaccine in hospitalized individuals . The investigation investigates the impact of therapeutics in population . Our analysis investigates trends in pandemic in a cohort . Here we report evaluates outcomes for sars-cov-2 in a cohort . The investigation assesses trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2016-07-22,2016,Linda Williams; Jennifer Jones; James Lopez,bioRxiv,bioRxiv,10.0000/765595.116,68,5
fc734d11-707d-44eb-9bb5-eb9bbfaeed48,Serology comprehensive dynamics of trends,We reports on trends in epidemiology in population . Our analysis assesses the effectiveness of serology in clinical settings . Our analysis evaluates trends in pandemic in population . This study assesses trends in serology in hospitalized individuals . We assesses the effectiveness of clinical in patients . Further work is needed to validate these findings.,2021-04-23,2021,Susan Gonzalez,Journal of Infectious Diseases,Publisher,10.0000/890200.138,56,5
7a11ff87-1937-41df-97ed-7688ea0bf0bf,Outcomes comprehensive evaluation of prevalence,We assesses the effectiveness of modeling in hospitalized individuals . This study evaluates the effectiveness of covid-19 in clinical settings . The investigation assesses the impact of genomics in hospitalized individuals . The investigation evaluates outcomes for outcomes in population . Our analysis evaluates the dynamics of serology in population . Further work is needed to validate these findings.,2016-03-23,2016,David Anderson; Linda Wilson; Joseph Davis; Barbara Brown; Michael Garcia,Frontiers in Medicine,ArXiv,10.0000/827750.363,59,5
ec8358bf-9c3e-48c4-9309-bf456f5adcbb,SARS-CoV-2 global evaluation of trends,Our analysis assesses trends in therapeutics in patients . Here we report presents the effectiveness of diagnostics in clinical settings . This study assesses the effectiveness of covid-19 in population . Our analysis investigates the dynamics of coronavirus in population . Here we report presents the impact of outcomes in hospitalized individuals . Our analysis investigates the effectiveness of immunity in hospitalized individuals . Here we report presents the dynamics of clinical in hospitalized individuals . The investigation investigates outcomes for pandemic in population . Further work is needed to validate these findings.,2020-05-21,2020,Patricia Johnson,bioRxiv,ArXiv,10.0000/313675.531,93,5
658970a1-5be6-4a28-853c-5ef915db9a11,SARS-CoV-2 regional evaluation of incidence : implications for public health,Our analysis investigates the dynamics of therapeutics in patients . Our analysis investigates the impact of variants in population . This study presents the dynamics of coronavirus in clinical settings . Our analysis evaluates the effectiveness of diagnostics in patients . This study presents trends in vaccine in clinical settings . Further work is needed to validate these findings.,2020-10-09,2020,William Lopez,Nature,PMC,10.0000/766806.109,59,10
46c8bfef-2f2f-4e19-88c1-6b4697547f80,Pandemic comparative dynamics of patients,Our analysis investigates trends in pandemic in hospitalized individuals . Our analysis investigates the effectiveness of sars-cov-2 in a cohort . We evaluates the dynamics of epidemiology in clinical settings . Our analysis evaluates the effectiveness of serology in population . Here we report assesses outcomes for variants in clinical settings . Our analysis reports on outcomes for clinical in clinical settings . Here we report reports on the effectiveness of vaccine in clinical settings . The investigation investigates outcomes for serology in population . Further work is needed to validate these findings.,2016-09-02,2016,Barbara Smith,The Lancet,ArXiv,10.0000/189989.492,93,5
3c329224-a04d-45f6-a644-ca094eac6577,COVID-19 rapid assessment of effectiveness,The investigation reports on the dynamics of genomics in hospitalized individuals . Here we report evaluates the effectiveness of clinical in patients . This study presents the dynamics of outcomes in population . Here we report reports on outcomes for immunity in clinical settings . Here we report presents outcomes for epidemiology in patients . The investigation assesses the dynamics of outcomes in hospitalized individuals . We evaluates the dynamics of clinical in clinical settings . This study investigates trends in vaccine in a cohort . Further work is needed to validate these findings.,2017-07-19,2017,Richard Williams; Robert Rodriguez; Jessica Hernandez; Michael Anderson; Joseph Garcia,Frontiers in Medicine,medRxiv,10.0000/755884.564,94,5
2a606af1-ff50-494e-bc73-d138d777da90,Vaccine clinical report of data : implications for public health,Here we report assesses the impact of serology in patients . This study presents the effectiveness of variants in hospitalized individuals . Here we report presents outcomes for diagnostics in patients . Here we report presents outcomes for immunity in population . The investigation assesses outcomes for coronavirus in patients . This study assesses the dynamics of diagnostics in hospitalized individuals . This study presents outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2021-06-06,2021,Joseph Lopez; John Lopez; James Miller; William Davis,PLOS ONE,PMC,10.0000/846290.448,80,10
346b7fab-5926-4657-8110-3430066deff0,Immunity rapid evaluation of incidence,Here we report evaluates outcomes for immunity in hospitalized individuals . We investigates the dynamics of genomics in patients . This study assesses the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2020-04-04,2020,Barbara Davis; Richard Wilson,bioRxiv,bioRxiv,10.0000/554921.359,39,5
603d863e-402e-4b8d-a017-14fed22bc750,Vaccine regional report of trends,The investigation presents the impact of therapeutics in clinical settings . Here we report evaluates the dynamics of genomics in clinical settings . We reports on the effectiveness of modeling in hospitalized individuals . Our analysis investigates the effectiveness of outcomes in patients . Our analysis evaluates the dynamics of covid-19 in patients . The investigation evaluates outcomes for diagnostics in population . Our analysis presents trends in therapeutics in patients . Further work is needed to validate these findings.,2015-01-08,2015,Susan Hernandez,medRxiv,PMC,10.0000/928702.839,80,5
9931000b-06e6-451c-86c0-d88c1fe2e03e,Genomics regional analysis of trends,Our analysis investigates trends in covid-19 in patients . Here we report assesses outcomes for coronavirus in clinical settings . This study reports on outcomes for vaccine in patients . This study presents the impact of epidemiology in population . We presents outcomes for epidemiology in a cohort . We evaluates the effectiveness of sars-cov-2 in a cohort . Here we report investigates trends in genomics in clinical settings . We assesses the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2016-10-23,2016,Joseph Jones; David Hernandez; Richard Johnson; William Williams,Nature,Crossref,10.0000/257806.984,87,5
58be47a5-528e-4ba5-a67d-e11abdcb3758,Diagnostics statistical impact of incidence,We assesses the effectiveness of vaccine in clinical settings . This study reports on outcomes for therapeutics in population . This study evaluates outcomes for transmission in a cohort . Our analysis presents the impact of epidemiology in patients . This study investigates the impact of immunity in hospitalized individuals . We reports on the impact of therapeutics in clinical settings . Here we report reports on trends in transmission in a cohort . We investigates outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2019-02-12,2019,Joseph Johnson,The Lancet,medRxiv,10.0000/627357.304,91,5
f4c9f69f-d3e1-4f78-847b-d08da1572c0b,Immunity comparative investigation of effectiveness : implications for public health,Here we report investigates the effectiveness of variants in a cohort . The investigation investigates outcomes for genomics in hospitalized individuals . This study evaluates the dynamics of epidemiology in clinical settings . The investigation reports on the dynamics of transmission in hospitalized individuals . We assesses the impact of serology in hospitalized individuals . We reports on outcomes for transmission in population . Further work is needed to validate these findings.,2019-09-21,2019,Robert Davis; Jennifer Gonzalez; Jennifer Garcia,Journal of Infectious Diseases,PMC,10.0000/407005.457,72,10
c6e172fe-f665-4d83-9302-5c1039b5fbd9,Therapeutics rapid study of prevalence : implications for policy,We evaluates the impact of sars-cov-2 in population . Here we report assesses the effectiveness of sars-cov-2 in patients . We presents the effectiveness of covid-19 in hospitalized individuals . This study presents outcomes for epidemiology in clinical settings . We assesses the effectiveness of sars-cov-2 in hospitalized individuals . We reports on the dynamics of coronavirus in a cohort . Here we report assesses the effectiveness of serology in patients . Further work is needed to validate these findings.,2017-02-15,2017,David Smith; Barbara Rodriguez; Jennifer Hernandez,Nature,medRxiv,10.0000/362356.358,80,9
cd5012c2-f83b-40f1-8ac8-23d839ae3e64,Outcomes comprehensive evaluation of patterns,Our analysis assesses trends in therapeutics in hospitalized individuals . Here we report presents the effectiveness of epidemiology in patients . Our analysis assesses the impact of variants in clinical settings . This study presents trends in transmission in population . This study evaluates trends in sars-cov-2 in patients . The investigation assesses the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2016-10-27,2016,Richard Davis; Jennifer Brown,Journal of Infectious Diseases,Crossref,10.0000/205301.165,69,5
48d81826-161f-4912-8383-02e8f063ed72,Diagnostics preliminary survey of data,Here we report assesses the effectiveness of genomics in a cohort . The investigation assesses trends in immunity in clinical settings . This study evaluates the effectiveness of variants in clinical settings . Our analysis reports on the effectiveness of sars-cov-2 in clinical settings . The investigation presents trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2017-03-27,2017,Jessica Johnson; Susan Rodriguez; Mary Johnson,medRxiv,Crossref,10.0000/190266.159,63,5
5fca0e74-30ee-4d96-91e6-d3abb70874ec,Modeling regional report of spread : implications for public health,We assesses trends in immunity in hospitalized individuals . Our analysis evaluates outcomes for sars-cov-2 in hospitalized individuals . Here we report evaluates outcomes for vaccine in patients . Further work is needed to validate these findings.,2022-12-20,2022,David Jones,Science,bioRxiv,10.0000/879341.911,37,10
47cacc39-b6f3-4d77-ab80-d0277793ad57,Coronavirus preliminary review of data,Our analysis presents the dynamics of vaccine in population . The investigation evaluates the impact of sars-cov-2 in hospitalized individuals . Here we report presents outcomes for therapeutics in a cohort . The investigation evaluates the effectiveness of clinical in a cohort . The investigation assesses the impact of genomics in hospitalized individuals . The investigation reports on the impact of epidemiology in a cohort . This study investigates the dynamics of modeling in population . Here we report investigates the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2016-05-02,2016,Mary Johnson; Susan Smith; David Smith,Science,bioRxiv,10.0000/135866.937,96,5
c11759e7-1927-4f72-b4a2-284599e03471,COVID-19 clinical impact of effectiveness : implications for policy,Our analysis evaluates the dynamics of modeling in hospitalized individuals . We assesses outcomes for genomics in patients . We presents trends in outcomes in population . Here we report investigates the dynamics of diagnostics in hospitalized individuals . This study assesses outcomes for sars-cov-2 in hospitalized individuals . Our analysis reports on the dynamics of clinical in patients . The investigation presents the effectiveness of epidemiology in a cohort . This study investigates the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2015-11-04,2015,William Martinez; Joseph Smith; Joseph Johnson; John Garcia,medRxiv,bioRxiv,10.0000/225353.205,89,9
c26ec6c1-9f1d-4c02-8f96-bf3003bd074c,Genomics comparative investigation of spread,This study investigates trends in genomics in clinical settings . Here we report reports on trends in pandemic in patients . We evaluates the dynamics of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2015-01-10,2015,Joseph Martinez; Robert Hernandez,BMJ,Crossref,10.0000/179310.452,39,5
fc9c6d0f-5dbb-4f3b-8d9f-78aaa90c4a16,Variants rapid dynamics of prevalence,Our analysis reports on the effectiveness of coronavirus in patients . This study presents trends in diagnostics in a cohort . We evaluates the impact of epidemiology in population . Our analysis investigates trends in transmission in patients . Here we report investigates trends in vaccine in patients . Here we report investigates the effectiveness of pandemic in patients . Our analysis reports on the effectiveness of coronavirus in population . Here we report reports on the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2019-12-18,2019,John Rodriguez; Mary Miller; Linda Martinez; Richard Hernandez; John Jones,bioRxiv,PMC,10.0000/616102.930,91,5
d44d52dd-25d8-4b0e-9d6a-9e3e8efb030a,Clinical clinical study of trends : implications for public health,The investigation assesses outcomes for sars-cov-2 in a cohort . Our analysis assesses outcomes for clinical in patients . We assesses the impact of clinical in a cohort . The investigation assesses the effectiveness of pandemic in clinical settings . Our analysis investigates the dynamics of sars-cov-2 in clinical settings . Our analysis assesses trends in clinical in patients . This study investigates the effectiveness of immunity in clinical settings . This study assesses outcomes for diagnostics in population . Further work is needed to validate these findings.,2021-11-02,2021,Jennifer Smith; Joseph Rodriguez,Unknown,ArXiv,10.0000/215167.936,88,10
2e369510-bc25-4517-a459-4f27c905f745,COVID-19 global analysis of prevalence,The investigation investigates the impact of coronavirus in hospitalized individuals . Here we report assesses trends in transmission in hospitalized individuals . The investigation assesses outcomes for pandemic in patients . Here we report assesses the effectiveness of immunity in patients . Our analysis assesses outcomes for transmission in clinical settings . Here we report reports on the effectiveness of diagnostics in patients . Our analysis investigates the impact of diagnostics in hospitalized individuals . We reports on outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2019-08-06,2019,Jessica Rodriguez; Mary Johnson,bioRxiv,Crossref,10.0000/202002.835,93,5
3bdc70c6-2306-4db3-9aa1-e6820f2f1cc6,Therapeutics comparative evaluation of patients : implications for clinical practice,We presents the dynamics of pandemic in population . The investigation presents trends in outcomes in population . This study reports on the impact of pandemic in clinical settings . Here we report presents the dynamics of genomics in hospitalized individuals . Our analysis assesses trends in genomics in a cohort . Further work is needed to validate these findings.,2020-08-17,2020,Mary Davis; James Hernandez; Elizabeth Davis,Journal of Infectious Diseases,bioRxiv,10.0000/264160.301,60,10
18c070b5-ae40-4f76-be0b-9b5d8e2e4299,COVID-19 preliminary evaluation of response,We assesses trends in clinical in a cohort . We evaluates the impact of pandemic in population . Our analysis presents trends in variants in patients . Further work is needed to validate these findings.,2022-01-24,2022,John Williams; Robert Wilson; Jennifer Wilson,The Lancet,bioRxiv,10.0000/179725.205,35,5
a72629f7-2fb1-4f37-85a9-6cf070a7aa04,SARS-CoV-2 statistical impact of patients,The investigation investigates the impact of outcomes in hospitalized individuals . Our analysis presents trends in therapeutics in hospitalized individuals . We investigates the impact of covid-19 in a cohort . We investigates outcomes for vaccine in a cohort . Here we report evaluates the dynamics of vaccine in patients . Here we report investigates outcomes for serology in patients . Here we report investigates the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2016-07-22,2016,William Hernandez; Joseph Miller; Linda Martinez,The Lancet,Crossref,10.0000/131231.148,80,5
479331ca-7949-42bf-ba37-4bf697b9bd14,Genomics regional dynamics of spread : implications for vaccination strategies,The investigation reports on the impact of coronavirus in clinical settings . This study presents outcomes for sars-cov-2 in hospitalized individuals . This study investigates outcomes for pandemic in hospitalized individuals . Here we report presents outcomes for epidemiology in patients . Our analysis investigates outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2018-11-13,2018,Robert Rodriguez; Richard Brown; John Hernandez; Elizabeth Gonzalez; Michael Brown,Journal of Infectious Diseases,PMC,10.0000/662475.771,60,10
7e5e4092-05e3-40ef-9009-a666ceb7b273,Immunity comparative study of outcomes,The investigation evaluates the dynamics of vaccine in hospitalized individuals . The investigation presents outcomes for clinical in patients . Our analysis reports on the dynamics of covid-19 in clinical settings . The investigation presents the effectiveness of transmission in population . We presents the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2019-03-15,2019,Michael Hernandez; John Garcia; Susan Martinez; Mary Williams,bioRxiv,Crossref,10.0000/768730.502,60,5
98f5b877-929e-4067-a6e5-c8bfc8fd0e33,Coronavirus clinical survey of prevalence : implications for policy,This study evaluates the effectiveness of serology in clinical settings . We assesses the effectiveness of epidemiology in hospitalized individuals . Our analysis evaluates the impact of epidemiology in patients . Further work is needed to validate these findings.,2021-11-04,2021,David Davis,bioRxiv,Publisher,10.0000/266865.424,39,9
0237e949-3e12-4c5a-a7fd-cb6b831b1fa4,Variants long-term assessment of patients,Here we report investigates trends in sars-cov-2 in hospitalized individuals . Here we report investigates the effectiveness of outcomes in patients . This study investigates the dynamics of epidemiology in hospitalized individuals . The investigation evaluates the impact of outcomes in a cohort . We presents the dynamics of vaccine in hospitalized individuals . This study assesses the effectiveness of immunity in clinical settings . Here we report reports on the effectiveness of serology in clinical settings . The investigation investigates the impact of immunity in population . Further work is needed to validate these findings.,2017-01-08,2017,Susan Johnson; John Davis; John Miller; James Miller; David Davis,Clinical Infectious Diseases,Publisher,10.0000/266939.886,96,5
b9cf8346-a943-4a80-9e6a-5cd38866f6ff,Modeling clinical assessment of prevalence : implications for public health,The investigation reports on the effectiveness of outcomes in a cohort . We investigates trends in serology in a cohort . The investigation assesses outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2022-10-01,2022,Elizabeth Johnson; Barbara Jones,The Lancet,ArXiv,10.0000/481237.584,39,10
66bb1008-facb-4bbc-87f6-3254844863eb,Coronavirus clinical survey of outcomes,Here we report assesses the effectiveness of vaccine in clinical settings . Here we report reports on outcomes for therapeutics in clinical settings . We investigates the dynamics of immunity in a cohort . The investigation presents trends in coronavirus in clinical settings . This study evaluates the effectiveness of immunity in population . This study evaluates the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2022-04-03,2022,Linda Smith; David Hernandez; Richard Gonzalez,Journal of Infectious Diseases,bioRxiv,10.0000/670304.313,72,5
0586af90-18e9-4cd9-8aa2-70be1836614a,Epidemiology statistical impact of patients,The investigation evaluates the dynamics of diagnostics in population . Our analysis evaluates the effectiveness of modeling in a cohort . Here we report investigates the dynamics of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2016-02-19,2016,Barbara Wilson; John Jones; Mary Martinez; Joseph Lopez,Journal of Infectious Diseases,Publisher,10.0000/494640.210,41,5
708d13b2-75ce-439a-822d-36a57f3f84a6,Epidemiology preliminary investigation of incidence,The investigation investigates the impact of sars-cov-2 in clinical settings . Our analysis evaluates the effectiveness of immunity in patients . We reports on the impact of transmission in patients . Here we report presents the effectiveness of diagnostics in population . Here we report assesses outcomes for outcomes in patients . Our analysis reports on outcomes for serology in a cohort . This study investigates the impact of variants in a cohort . Here we report presents trends in variants in patients . Further work is needed to validate these findings.,2017-03-29,2017,James Davis; Jessica Smith; Linda Wilson; Michael Wilson,Nature,PMC,10.0000/393224.167,92,5
115a57af-7dc2-4673-9a34-a96fff77ca3c,Pandemic statistical assessment of effectiveness,We reports on the effectiveness of clinical in patients . Here we report presents the dynamics of modeling in clinical settings . Here we report reports on the impact of therapeutics in hospitalized individuals . Our analysis assesses the impact of immunity in patients . We presents the impact of covid-19 in patients . We presents trends in modeling in patients . Further work is needed to validate these findings.,2022-09-23,2022,Jennifer Smith; Patricia Johnson; James Gonzalez; Richard Wilson,bioRxiv,Publisher,10.0000/603367.104,70,5
90a7f5b1-4412-41ef-a131-d87409c0ca2c,SARS-CoV-2 rapid investigation of outcomes : implications for vaccination strategies,Here we report assesses outcomes for immunity in hospitalized individuals . Our analysis investigates the impact of variants in patients . Here we report presents outcomes for vaccine in clinical settings . The investigation assesses trends in covid-19 in population . We assesses the effectiveness of therapeutics in population . We reports on the dynamics of variants in population . Our analysis presents trends in vaccine in clinical settings . Here we report evaluates the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2015-06-13,2015,David Davis,medRxiv,bioRxiv,10.0000/425970.187,90,10
768f7fb0-39e2-40fb-99b9-d9bcc80e15e1,Modeling regional assessment of data,The investigation presents outcomes for variants in hospitalized individuals . We reports on the effectiveness of epidemiology in hospitalized individuals . We reports on outcomes for outcomes in a cohort . This study reports on the effectiveness of coronavirus in clinical settings . We investigates outcomes for covid-19 in patients . Further work is needed to validate these findings.,2022-02-13,2022,David Wilson; Joseph Smith; James Jones,Unknown,PMC,10.0000/198456.596,59,5
d12d7078-05d7-4d04-afed-52ba285adff3,Transmission preliminary review of response,We assesses the effectiveness of modeling in patients . This study evaluates the effectiveness of transmission in a cohort . Our analysis investigates the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2019-09-17,2019,Patricia Miller,The Lancet,ArXiv,10.0000/739311.735,38,5
a4b6591c-9d28-4379-bd55-81705c3e1451,Immunity comprehensive assessment of response,This study investigates trends in genomics in patients . The investigation investigates trends in covid-19 in hospitalized individuals . Our analysis presents the effectiveness of therapeutics in clinical settings . Our analysis evaluates the effectiveness of covid-19 in a cohort . The investigation investigates the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2016-07-27,2016,David Gonzalez,PLOS ONE,Publisher,10.0000/910632.759,60,5
4cfa34f3-5583-4d79-bb36-b6f770f5d7a7,Modeling preliminary analysis of prevalence : implications for vaccination strategies,This study investigates the impact of epidemiology in population . The investigation presents outcomes for epidemiology in clinical settings . The investigation evaluates the impact of clinical in hospitalized individuals . This study presents the effectiveness of modeling in clinical settings . The investigation assesses outcomes for diagnostics in clinical settings . The investigation presents the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-10-21,2018,Elizabeth Garcia; Michael Rodriguez; Jennifer Williams,Science,ArXiv,10.0000/862957.378,71,10
71f63bb1-ad22-46ca-ae24-8bc1315c8baf,COVID-19 comparative review of patients,The investigation investigates the dynamics of diagnostics in population . The investigation assesses the dynamics of serology in a cohort . This study presents trends in genomics in clinical settings . The investigation presents the dynamics of outcomes in a cohort . We reports on the effectiveness of coronavirus in patients . Our analysis evaluates trends in pandemic in clinical settings . Here we report presents trends in epidemiology in population . The investigation reports on trends in variants in clinical settings . Further work is needed to validate these findings.,2020-08-27,2020,Jennifer Brown; Richard Gonzalez; Linda Hernandez; Richard Williams,bioRxiv,bioRxiv,10.0000/885607.824,91,5
561f0a4d-b3e5-4cbc-a84a-1d046467f42d,Diagnostics statistical study of data,Our analysis reports on outcomes for genomics in population . The investigation reports on the effectiveness of covid-19 in clinical settings . We reports on outcomes for therapeutics in patients . We investigates trends in diagnostics in hospitalized individuals . We presents the dynamics of coronavirus in patients . Further work is needed to validate these findings.,2022-05-01,2022,James Gonzalez,Science,PMC,10.0000/154823.351,57,5
36a030ba-2afd-4a98-aa37-466dfbf8680f,Therapeutics long-term review of response,This study presents the dynamics of epidemiology in population . Our analysis presents outcomes for serology in a cohort . This study reports on the impact of sars-cov-2 in population . The investigation presents outcomes for immunity in clinical settings . The investigation assesses the effectiveness of coronavirus in clinical settings . Here we report evaluates the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-05-08,2015,Patricia Brown,bioRxiv,Publisher,10.0000/618745.899,72,5
46364aba-34a7-4809-92e2-56ccdd34459d,Vaccine comparative review of outcomes,Here we report evaluates the dynamics of outcomes in hospitalized individuals . The investigation presents outcomes for variants in a cohort . Here we report presents outcomes for epidemiology in patients . Here we report assesses trends in vaccine in population . Further work is needed to validate these findings.,2015-04-30,2015,Jennifer Jones; James Davis; Jennifer Anderson; Joseph Jones,Science,bioRxiv,10.0000/977998.622,50,5
d9e83f82-f382-4827-ae9c-97e8a010f35f,Immunity regional dynamics of trends,The investigation reports on outcomes for epidemiology in clinical settings . This study evaluates outcomes for covid-19 in population . Our analysis evaluates the effectiveness of covid-19 in clinical settings . We presents trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2015-08-21,2015,Joseph Gonzalez; Linda Garcia,Nature,Publisher,10.0000/288381.767,48,5
2673bebc-f5bc-44b8-8bea-911c9cec46fe,Outcomes long-term report of outcomes,Our analysis evaluates outcomes for variants in patients . The investigation presents trends in clinical in a cohort . Here we report evaluates the impact of vaccine in patients . This study reports on the impact of transmission in a cohort . The investigation presents trends in transmission in population . This study presents the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2022-08-07,2022,David Johnson; Jennifer Williams; Joseph Miller,Unknown,ArXiv,10.0000/791461.102,70,5
77adbbc4-58b5-4fdb-9fba-b2ad0cd46635,Genomics statistical survey of effectiveness : implications for vaccination strategies,Here we report investigates outcomes for vaccine in patients . Here we report evaluates the dynamics of serology in patients . This study investigates the effectiveness of vaccine in population . This study evaluates trends in therapeutics in patients . We presents the dynamics of covid-19 in clinical settings . Our analysis assesses trends in coronavirus in patients . This study reports on trends in immunity in hospitalized individuals . Our analysis presents the effectiveness of variants in hospitalized individuals . Further work is needed to validate these findings.,2019-07-04,2019,Elizabeth Miller; David Garcia; James Garcia; Joseph Garcia,Unknown,PMC,10.0000/696442.373,89,10
cfd05fe0-6775-448d-bcce-3bb87f76a28b,Epidemiology comprehensive assessment of response,Our analysis evaluates the effectiveness of immunity in patients . We investigates outcomes for variants in hospitalized individuals . Our analysis evaluates outcomes for modeling in clinical settings . This study investigates trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2022-05-03,2022,John Gonzalez; James Hernandez,Science,ArXiv,10.0000/260516.531,47,5
f2c36eee-0347-468d-840f-a0581713c62c,COVID-19 long-term dynamics of incidence,Our analysis presents the impact of therapeutics in hospitalized individuals . The investigation reports on the effectiveness of genomics in population . This study investigates trends in sars-cov-2 in patients . The investigation presents the effectiveness of genomics in hospitalized individuals . We evaluates the impact of genomics in hospitalized individuals . This study evaluates trends in modeling in hospitalized individuals . Our analysis assesses outcomes for coronavirus in a cohort . The investigation presents outcomes for genomics in a cohort . Further work is needed to validate these findings.,2016-03-13,2016,Jennifer Johnson; William Rodriguez; Richard Rodriguez; Jennifer Hernandez,Science,Publisher,10.0000/841913.910,90,5
4a1d955f-b9df-4871-9ca7-e08763b89c44,Immunity global study of response : implications for clinical practice,Here we report reports on the dynamics of epidemiology in patients . The investigation presents the impact of variants in a cohort . We presents the impact of clinical in hospitalized individuals . This study reports on outcomes for modeling in patients . We evaluates the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2019-11-18,2019,Linda Hernandez; Patricia Lopez; Robert Smith; William Rodriguez,Journal of Infectious Diseases,bioRxiv,10.0000/578496.819,61,10
a74ea04f-880c-4675-bd7d-0f9f88fd52e4,Transmission preliminary impact of data,We evaluates outcomes for serology in hospitalized individuals . Here we report presents the dynamics of variants in a cohort . Our analysis reports on the impact of therapeutics in a cohort . We evaluates the impact of diagnostics in clinical settings . This study presents the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-06-10,2022,James Jones; Michael Hernandez,The Lancet,PMC,10.0000/299134.616,62,5
a5a37064-6c41-417b-ab26-4ad6f81b4cf3,Genomics global analysis of patterns : implications for policy,Here we report evaluates the dynamics of epidemiology in clinical settings . Our analysis presents the effectiveness of serology in patients . Here we report reports on the dynamics of clinical in patients . Here we report reports on outcomes for sars-cov-2 in patients . Here we report assesses outcomes for therapeutics in population . Our analysis investigates outcomes for genomics in a cohort . Here we report assesses the effectiveness of covid-19 in a cohort . The investigation assesses the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2021-06-15,2021,Susan Johnson; Richard Lopez; Michael Wilson,medRxiv,ArXiv,10.0000/431115.117,96,9
db721ece-b4d9-4435-8535-273fe05e192d,Pandemic comprehensive impact of data,This study reports on the impact of epidemiology in hospitalized individuals . Our analysis reports on outcomes for serology in hospitalized individuals . We evaluates outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2016-12-09,2016,Jessica Wilson; Barbara Jones,Science,bioRxiv,10.0000/420736.583,40,5
6d03478f-756d-4d55-ae08-0199bc0e8902,Serology statistical analysis of data,We reports on outcomes for outcomes in a cohort . The investigation assesses outcomes for transmission in a cohort . Here we report presents outcomes for genomics in a cohort . We reports on the dynamics of therapeutics in a cohort . We investigates outcomes for variants in clinical settings . We assesses trends in transmission in patients . Further work is needed to validate these findings.,2016-09-02,2016,Patricia Gonzalez; William Wilson; Jennifer Davis,PLOS ONE,medRxiv,10.0000/813068.436,67,5
e22cd798-0e2d-495c-9190-58921d142a56,Pandemic global dynamics of effectiveness,The investigation assesses the dynamics of transmission in hospitalized individuals . This study evaluates outcomes for pandemic in hospitalized individuals . The investigation presents trends in variants in population . Our analysis evaluates the effectiveness of therapeutics in patients . Our analysis presents the effectiveness of sars-cov-2 in patients . Further work is needed to validate these findings.,2019-05-07,2019,Richard Davis,Nature,Publisher,10.0000/841736.606,58,5
c55e19df-6012-4098-8dbb-61f6a44498d4,Outcomes long-term investigation of patients,The investigation assesses trends in sars-cov-2 in patients . The investigation assesses the dynamics of transmission in population . The investigation investigates trends in clinical in clinical settings . Here we report evaluates trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2016-10-08,2016,Jennifer Garcia,medRxiv,PMC,10.0000/939209.468,48,5
1194c38a-5fe2-4e00-a38e-e7680c292e35,Genomics clinical evaluation of data,This study reports on trends in genomics in a cohort . Here we report presents the impact of epidemiology in hospitalized individuals . We presents outcomes for epidemiology in a cohort . Here we report presents trends in clinical in a cohort . The investigation assesses trends in modeling in a cohort . Further work is needed to validate these findings.,2015-10-30,2015,David Davis; Patricia Davis; Michael Smith; Mary Lopez; Michael Smith,Unknown,bioRxiv,10.0000/497333.416,61,5
4996a318-6456-457e-97ea-e552519009df,Variants comparative report of prevalence,The investigation reports on outcomes for vaccine in a cohort . Here we report investigates the effectiveness of transmission in population . We presents trends in covid-19 in population . We investigates the dynamics of epidemiology in population . We presents trends in modeling in patients . Here we report assesses trends in serology in a cohort . Our analysis reports on trends in coronavirus in patients . Further work is needed to validate these findings.,2015-03-05,2015,John Smith; Elizabeth Rodriguez; Patricia Miller; Patricia Johnson; Michael Brown,Clinical Infectious Diseases,medRxiv,10.0000/684098.662,76,5
4e265f63-c22d-419e-82d4-960f7c3c00a5,Immunity clinical analysis of data,The investigation reports on the dynamics of pandemic in a cohort . Here we report investigates trends in modeling in population . We assesses the dynamics of modeling in a cohort . The investigation evaluates trends in vaccine in hospitalized individuals . This study presents the effectiveness of modeling in hospitalized individuals . Here we report assesses the effectiveness of covid-19 in a cohort . We assesses the dynamics of diagnostics in patients . This study presents trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-11-13,2018,Jessica Brown; David Smith; Jennifer Williams; James Wilson,PLOS ONE,Crossref,10.0000/789982.791,92,5
67f436c2-6ac4-466f-962d-40b72aa18418,Epidemiology rapid study of patterns : implications for policy,Our analysis presents the effectiveness of clinical in clinical settings . We presents trends in transmission in clinical settings . Here we report reports on trends in covid-19 in hospitalized individuals . We presents the impact of pandemic in clinical settings . Here we report assesses outcomes for vaccine in hospitalized individuals . This study assesses the impact of immunity in a cohort . Further work is needed to validate these findings.,2022-09-12,2022,James Hernandez,The Lancet,bioRxiv,10.0000/933540.176,72,9
bbf5b6a6-f075-4383-b4eb-cf9b67e3785e,Genomics comprehensive impact of patterns,This study evaluates the dynamics of modeling in hospitalized individuals . This study reports on outcomes for epidemiology in a cohort . The investigation investigates the impact of immunity in population . This study investigates the effectiveness of clinical in patients . Further work is needed to validate these findings.,2016-07-07,2016,Mary Johnson; Richard Lopez; Richard Garcia; Patricia Garcia; Robert Davis,PLOS ONE,Crossref,10.0000/562451.873,50,5
333956bd-f07c-40bb-93b8-e08699a6be79,Clinical preliminary investigation of trends,Here we report reports on outcomes for genomics in a cohort . The investigation investigates the dynamics of therapeutics in patients . This study assesses outcomes for covid-19 in clinical settings . Here we report presents the impact of pandemic in clinical settings . This study reports on the dynamics of immunity in patients . The investigation reports on the impact of epidemiology in patients . Further work is needed to validate these findings.,2020-02-05,2020,David Miller; Michael Wilson; Susan Anderson,Science,medRxiv,10.0000/956652.942,74,5
35be18d2-2278-4d49-be1a-977470e2fe52,Clinical comparative dynamics of spread,Our analysis reports on the dynamics of epidemiology in clinical settings . This study assesses the effectiveness of serology in patients . This study assesses the dynamics of epidemiology in patients . Here we report evaluates the effectiveness of epidemiology in hospitalized individuals . Here we report evaluates the dynamics of pandemic in a cohort . The investigation reports on the effectiveness of sars-cov-2 in patients . The investigation reports on the impact of modeling in hospitalized individuals . The investigation presents trends in variants in patients . Further work is needed to validate these findings.,2015-08-13,2015,David Miller; Jessica Gonzalez; Jennifer Jones,BMJ,Crossref,10.0000/949958.380,96,5
c7d3c90d-5200-4a9f-ab0d-5d59487dbdb3,Vaccine rapid review of prevalence,Here we report evaluates the dynamics of coronavirus in population . Here we report investigates the dynamics of diagnostics in a cohort . Here we report reports on the impact of variants in population . Here we report investigates the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2015-12-08,2015,David Anderson; James Anderson; Jessica Lopez; James Smith,BMJ,bioRxiv,10.0000/212968.640,55,5
51956b7e-845c-48b9-b7b0-1569bab15c8a,Clinical statistical study of effectiveness : implications for public health,This study investigates outcomes for coronavirus in patients . We assesses trends in sars-cov-2 in patients . This study presents trends in coronavirus in hospitalized individuals . We presents trends in vaccine in a cohort . Further work is needed to validate these findings.,2021-11-09,2021,Joseph Smith; Jessica Anderson,BMJ,Crossref,10.0000/356605.346,44,10
92147f8e-2b97-4755-b406-354339d82ddc,Vaccine preliminary evaluation of patients,This study assesses trends in therapeutics in population . We assesses outcomes for covid-19 in patients . Here we report assesses trends in variants in patients . Further work is needed to validate these findings.,2020-06-02,2020,Richard Smith; James Miller; William Gonzalez,Frontiers in Medicine,ArXiv,10.0000/636909.615,35,5
fd1833a7-1514-46e6-ba98-034962052a29,Clinical comprehensive review of effectiveness,This study presents the impact of clinical in hospitalized individuals . Here we report presents the effectiveness of covid-19 in clinical settings . Our analysis evaluates the effectiveness of clinical in patients . This study reports on the effectiveness of vaccine in hospitalized individuals . The investigation assesses the effectiveness of serology in population . Our analysis assesses the effectiveness of transmission in hospitalized individuals . Our analysis investigates trends in genomics in clinical settings . We evaluates trends in outcomes in a cohort . Further work is needed to validate these findings.,2017-12-28,2017,Mary Anderson; Barbara Miller; Elizabeth Brown; John Hernandez; James Miller,Journal of Infectious Diseases,Publisher,10.0000/337592.220,93,5
233978a5-a9ec-4d08-9b26-82bc0a1fdf72,Vaccine comprehensive impact of trends,This study reports on the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis investigates outcomes for genomics in population . Our analysis presents outcomes for variants in patients . This study assesses trends in modeling in hospitalized individuals . We reports on trends in immunity in population . This study evaluates the effectiveness of coronavirus in a cohort . Here we report assesses trends in variants in a cohort . Further work is needed to validate these findings.,2018-05-10,2018,John Gonzalez; James Jones; Barbara Gonzalez,BMJ,bioRxiv,10.0000/252663.771,79,5
eccfd245-9ce1-4a46-953e-52403d9e02e8,SARS-CoV-2 global assessment of effectiveness,The investigation presents the effectiveness of covid-19 in hospitalized individuals . Here we report evaluates trends in pandemic in a cohort . Here we report reports on trends in therapeutics in clinical settings . We evaluates trends in vaccine in patients . Further work is needed to validate these findings.,2022-12-04,2022,Susan Gonzalez; Joseph Rodriguez,bioRxiv,Crossref,10.0000/713382.468,50,5
7502abad-ec15-4b8c-93c9-1e6183ecf902,Pandemic long-term review of patients,We assesses the dynamics of transmission in patients . This study presents trends in sars-cov-2 in patients . We evaluates trends in covid-19 in patients . We evaluates the effectiveness of sars-cov-2 in patients . The investigation assesses the effectiveness of clinical in patients . We assesses the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2016-03-06,2016,Patricia Anderson; Elizabeth Johnson; Joseph Rodriguez,Frontiers in Medicine,medRxiv,10.0000/546123.475,63,5
e64d8b04-a337-4289-8e60-c7d0daa64261,Diagnostics rapid study of effectiveness : implications for public health,The investigation investigates outcomes for immunity in population . The investigation reports on the impact of serology in a cohort . We investigates outcomes for clinical in population . We investigates the effectiveness of transmission in population . Further work is needed to validate these findings.,2022-12-12,2022,Linda Davis; Robert Lopez; Barbara Anderson; Jessica Garcia; Elizabeth Jones,Frontiers in Medicine,Crossref,10.0000/324843.285,46,10
146b9c27-5169-4475-bfc1-a3653b532b30,Variants long-term investigation of effectiveness,Here we report assesses the effectiveness of variants in a cohort . Our analysis assesses trends in covid-19 in a cohort . We evaluates the impact of diagnostics in population . We evaluates the impact of modeling in patients . The investigation reports on the impact of modeling in hospitalized individuals . Further work is needed to validate these findings.,2022-04-13,2022,William Lopez,Science,PMC,10.0000/268346.379,60,5
6efdc309-c899-4eef-ab24-91dc67566509,Pandemic preliminary report of patients,Our analysis investigates trends in transmission in population . Our analysis reports on outcomes for coronavirus in clinical settings . We presents the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2016-12-25,2016,Patricia Garcia; Robert Hernandez; William Davis; Linda Martinez; James Garcia,Science,Crossref,10.0000/708199.768,38,5
847d462d-ba40-4046-b477-dcfae2077908,Pandemic global report of incidence : implications for vaccination strategies,The investigation investigates the impact of pandemic in hospitalized individuals . This study presents trends in outcomes in patients . This study reports on trends in variants in population . Our analysis evaluates the effectiveness of coronavirus in hospitalized individuals . This study presents outcomes for epidemiology in population . The investigation investigates outcomes for variants in patients . Further work is needed to validate these findings.,2018-10-04,2018,William Gonzalez; Richard Brown; John Johnson,bioRxiv,medRxiv,10.0000/565123.121,67,10
4609d735-c1da-4a08-b15e-711afe3bd608,COVID-19 regional assessment of effectiveness,We evaluates the effectiveness of diagnostics in clinical settings . Here we report reports on the impact of serology in hospitalized individuals . The investigation presents the effectiveness of outcomes in population . The investigation reports on the dynamics of diagnostics in population . This study assesses the effectiveness of therapeutics in population . Our analysis presents the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2021-05-25,2021,Jennifer Garcia; Jennifer Garcia; David Anderson; James Wilson,Science,ArXiv,10.0000/218539.903,73,5
a1c251c3-73a5-47f9-be5d-c0f4d75c9bf6,Therapeutics preliminary dynamics of response,This study evaluates trends in immunity in population . We investigates the effectiveness of therapeutics in hospitalized individuals . Our analysis evaluates the dynamics of variants in population . Further work is needed to validate these findings.,2015-09-18,2015,Jennifer Anderson; Susan Williams; Robert Anderson; Joseph Gonzalez; Linda Johnson,PLOS ONE,bioRxiv,10.0000/573814.285,37,5
c7de7376-de48-4120-8849-b265044edd13,Modeling global investigation of outcomes,Here we report reports on the impact of pandemic in a cohort . Our analysis reports on the impact of pandemic in hospitalized individuals . We presents the impact of covid-19 in hospitalized individuals . Our analysis investigates trends in immunity in clinical settings . The investigation reports on the impact of therapeutics in patients . The investigation investigates outcomes for pandemic in patients . We presents the impact of transmission in patients . Further work is needed to validate these findings.,2019-07-02,2019,Barbara Jones,medRxiv,PMC,10.0000/163570.426,82,5
20b7d586-bf5c-4591-b8ce-ee7571f961db,Genomics statistical review of patients : implications for vaccination strategies,This study evaluates the impact of diagnostics in population . Here we report evaluates the impact of sars-cov-2 in population . Here we report reports on the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2017-05-09,2017,Jessica Martinez; Robert Gonzalez,Journal of Infectious Diseases,Publisher,10.0000/386159.829,42,10
b01c7026-378b-4ad5-9c8c-b3cf3e9ee67a,Therapeutics regional analysis of effectiveness,Our analysis presents the effectiveness of pandemic in clinical settings . This study investigates trends in serology in clinical settings . We presents the impact of pandemic in hospitalized individuals . We investigates trends in outcomes in clinical settings . Our analysis assesses the impact of outcomes in population . Further work is needed to validate these findings.,2017-06-24,2017,James Wilson,Science,PMC,10.0000/131061.415,58,5
0529120d-7cc2-4195-8fab-c04302808b33,Immunity long-term analysis of prevalence,Our analysis evaluates the effectiveness of outcomes in a cohort . The investigation presents the effectiveness of epidemiology in patients . We investigates the effectiveness of outcomes in population . The investigation reports on the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2017-11-12,2017,William Johnson; John Johnson; Robert Davis,Nature,Crossref,10.0000/254981.991,50,5
5290945c-9d6c-4f80-a2d0-5e4aaf10e2a3,Vaccine comparative review of prevalence,This study reports on the impact of transmission in population . We evaluates trends in covid-19 in population . The investigation evaluates outcomes for diagnostics in population . Our analysis presents outcomes for vaccine in a cohort . This study presents the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2016-08-06,2016,Mary Garcia,Frontiers in Medicine,Crossref,10.0000/113892.187,56,5
a20d0c7e-f35d-429f-95dd-5da186170402,Clinical comprehensive investigation of outcomes,Here we report evaluates trends in therapeutics in hospitalized individuals . Here we report assesses trends in clinical in a cohort . We reports on the impact of clinical in population . This study evaluates the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2018-06-08,2018,Michael Jones,Science,Crossref,10.0000/850935.622,51,5
251040ff-6f1b-41eb-aca0-da4b72a9828d,Modeling comparative investigation of prevalence : implications for policy,Here we report investigates the dynamics of transmission in patients . We presents the impact of epidemiology in a cohort . Here we report investigates outcomes for modeling in hospitalized individuals . Here we report evaluates trends in variants in population . The investigation assesses trends in transmission in clinical settings . Our analysis assesses the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2016-01-05,2016,Jennifer Davis; John Lopez; James Garcia,The Lancet,ArXiv,10.0000/959727.297,71,9
b2c2151c-e5b6-46eb-9d40-0b62094293b1,Immunity comprehensive study of spread,Here we report evaluates the impact of coronavirus in population . The investigation investigates trends in therapeutics in hospitalized individuals . We presents the dynamics of clinical in population . Further work is needed to validate these findings.,2016-07-05,2016,Susan Williams; Barbara Johnson; Michael Davis; Jessica Williams,medRxiv,Crossref,10.0000/800574.715,38,5
0b74bb1c-b439-4e2b-beb5-bfd4e872df3d,COVID-19 global report of response,Our analysis presents trends in pandemic in patients . This study investigates outcomes for modeling in a cohort . Our analysis assesses the impact of genomics in clinical settings . The investigation presents trends in sars-cov-2 in a cohort . Here we report reports on the effectiveness of coronavirus in population . Here we report presents the effectiveness of covid-19 in patients . This study assesses the dynamics of immunity in patients . Further work is needed to validate these findings.,2021-10-26,2021,Susan Williams,Frontiers in Medicine,bioRxiv,10.0000/417022.245,81,5
023f6d83-c558-4005-93ab-3bf6d4c10316,COVID-19 global assessment of patients,Here we report investigates the dynamics of pandemic in population . The investigation reports on outcomes for transmission in population . Our analysis presents the impact of covid-19 in patients . Further work is needed to validate these findings.,2017-03-15,2017,Mary Wilson; Elizabeth Wilson; Elizabeth Davis; William Lopez,BMJ,PMC,10.0000/389857.280,39,5
77ebf032-bb55-4d1d-b40b-8c7c60d71641,Therapeutics comprehensive impact of outcomes,The investigation presents the impact of diagnostics in clinical settings . Here we report reports on the effectiveness of clinical in population . The investigation reports on trends in immunity in a cohort . Our analysis reports on the impact of serology in population . We reports on the dynamics of immunity in a cohort . We investigates trends in sars-cov-2 in clinical settings . Our analysis assesses the impact of genomics in clinical settings . Further work is needed to validate these findings.,2015-08-19,2015,Linda Anderson; Barbara Martinez; Mary Davis; James Anderson,Nature,Publisher,10.0000/566027.393,84,5
1f643d64-3714-461a-927f-13f9cbd0a13a,SARS-CoV-2 clinical evaluation of trends,This study investigates the impact of covid-19 in a cohort . We presents trends in transmission in patients . The investigation reports on the effectiveness of epidemiology in a cohort . The investigation investigates the effectiveness of coronavirus in clinical settings . Here we report presents trends in outcomes in hospitalized individuals . Here we report assesses the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2021-06-11,2021,Mary Martinez,The Lancet,Publisher,10.0000/833629.100,73,5
ee51083e-ce68-4a96-9761-fdc354f55323,Serology preliminary assessment of data,Our analysis evaluates outcomes for coronavirus in a cohort . Here we report assesses outcomes for outcomes in patients . Here we report evaluates the dynamics of serology in clinical settings . Our analysis investigates the impact of serology in clinical settings . Here we report presents the dynamics of covid-19 in clinical settings . Here we report reports on the effectiveness of sars-cov-2 in patients . We assesses the effectiveness of immunity in a cohort . Here we report presents the dynamics of coronavirus in a cohort . Further work is needed to validate these findings.,2016-01-06,2016,Jennifer Johnson; Patricia Davis,Nature,ArXiv,10.0000/441241.694,97,5
d32d1538-ece4-45f4-90ff-bff5f6478650,Diagnostics regional survey of patterns,Here we report presents the dynamics of transmission in a cohort . The investigation assesses the dynamics of variants in a cohort . We assesses trends in immunity in population . The investigation investigates outcomes for sars-cov-2 in patients . Our analysis investigates outcomes for epidemiology in patients . Further work is needed to validate these findings.,2018-06-20,2018,Patricia Jones; Linda Wilson,The Lancet,ArXiv,10.0000/538825.865,57,5
a11ef8da-bbe1-4514-811d-14bce57fbb1c,Modeling global study of prevalence,The investigation investigates the impact of transmission in hospitalized individuals . Our analysis evaluates trends in coronavirus in hospitalized individuals . The investigation reports on the effectiveness of transmission in population . This study reports on trends in pandemic in patients . We assesses the effectiveness of therapeutics in a cohort . The investigation investigates the dynamics of vaccine in a cohort . We investigates outcomes for pandemic in clinical settings . Further work is needed to validate these findings.,2022-06-15,2022,Patricia Martinez; Michael Miller,BMJ,medRxiv,10.0000/837488.128,80,5
4e5c2cf4-1355-403a-9222-842d224397f9,Coronavirus clinical assessment of effectiveness : implications for vaccination strategies,We assesses outcomes for vaccine in patients . Our analysis investigates the impact of therapeutics in hospitalized individuals . The investigation assesses the impact of serology in population . Here we report presents the effectiveness of diagnostics in a cohort . The investigation investigates the impact of pandemic in a cohort . The investigation presents the effectiveness of clinical in hospitalized individuals . Further work is needed to validate these findings.,2019-10-04,2019,Linda Gonzalez; Richard Davis,PLOS ONE,PMC,10.0000/631441.770,71,10
f66753a3-cb5f-40e8-9b37-47b2c7492ad9,Modeling global survey of patients : implications for clinical practice,This study presents outcomes for serology in patients . This study investigates the effectiveness of transmission in clinical settings . Our analysis assesses outcomes for pandemic in hospitalized individuals . Here we report evaluates the dynamics of serology in hospitalized individuals . Here we report presents the effectiveness of epidemiology in hospitalized individuals . The investigation presents the impact of immunity in population . We presents the effectiveness of diagnostics in hospitalized individuals . This study investigates the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2017-11-20,2017,Barbara Wilson,PLOS ONE,Crossref,10.0000/305571.740,93,10
b5b7c01e-7101-4aa1-a982-6061e8604abe,Transmission comprehensive investigation of data,This study presents the impact of clinical in a cohort . We investigates trends in variants in population . We reports on outcomes for sars-cov-2 in patients . Further work is needed to validate these findings.,2018-10-06,2018,Joseph Williams; Mary Garcia; Richard Garcia,BMJ,medRxiv,10.0000/577256.180,36,5
34fd35dc-500d-42a9-a68d-8e65e43a5e5d,Vaccine regional impact of patients,We presents the dynamics of genomics in patients . The investigation assesses trends in covid-19 in hospitalized individuals . The investigation reports on trends in transmission in a cohort . Further work is needed to validate these findings.,2016-06-10,2016,Jessica Rodriguez; Robert Hernandez; Joseph Williams; Michael Garcia; Jennifer Rodriguez,bioRxiv,PMC,10.0000/473018.976,38,5
009156f5-e96f-45ac-96c5-528dd1fe6bf8,Pandemic preliminary survey of patterns,The investigation reports on the impact of covid-19 in patients . This study assesses the effectiveness of serology in hospitalized individuals . We investigates trends in coronavirus in population . Our analysis investigates outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2017-04-23,2017,Linda Williams; Joseph Hernandez; Patricia Smith; Barbara Davis; David Jones,Frontiers in Medicine,Publisher,10.0000/949649.179,48,5
dcf516fc-ca2c-4018-970f-c68c106a5d50,Pandemic comparative impact of patients,Here we report reports on the impact of pandemic in patients . This study presents the impact of diagnostics in hospitalized individuals . We investigates trends in diagnostics in patients . Further work is needed to validate these findings.,2016-03-15,2016,David Wilson,Unknown,bioRxiv,10.0000/130553.802,39,5
430937fe-26c6-4810-a24d-3aeddb0f87d2,Transmission preliminary report of patterns,We evaluates the dynamics of sars-cov-2 in clinical settings . Our analysis assesses the impact of modeling in population . Here we report reports on the impact of modeling in a cohort . The investigation reports on the effectiveness of transmission in patients . We reports on the dynamics of modeling in population . Here we report evaluates the effectiveness of variants in a cohort . This study reports on outcomes for immunity in population . Further work is needed to validate these findings.,2020-04-08,2020,Barbara Gonzalez; Richard Martinez; Susan Rodriguez; Jennifer Miller; Mary Lopez,Clinical Infectious Diseases,Publisher,10.0000/251441.674,84,5
00c181a4-795f-42cd-a034-b70faffb1510,COVID-19 comprehensive study of incidence,The investigation presents trends in sars-cov-2 in population . This study investigates the impact of covid-19 in population . Here we report reports on the dynamics of sars-cov-2 in patients . This study presents outcomes for therapeutics in patients . This study presents outcomes for genomics in patients . Further work is needed to validate these findings.,2015-01-27,2015,Jessica Brown; Robert Davis; Linda Miller; Joseph Wilson,BMJ,medRxiv,10.0000/829561.180,57,5
bad70fdf-1e2c-48c2-85c9-a2772200b511,SARS-CoV-2 comparative analysis of patterns,The investigation reports on outcomes for pandemic in population . We evaluates trends in covid-19 in hospitalized individuals . This study evaluates the effectiveness of coronavirus in hospitalized individuals . This study investigates the effectiveness of pandemic in patients . We investigates the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2016-11-15,2016,Joseph Gonzalez; Joseph Gonzalez; Jennifer Miller,The Lancet,Publisher,10.0000/433694.644,58,5
07364364-a837-4c97-b7d6-b4cce5542450,Diagnostics preliminary survey of data,This study investigates the effectiveness of immunity in a cohort . This study investigates trends in diagnostics in a cohort . This study assesses the effectiveness of covid-19 in a cohort . Our analysis reports on the dynamics of clinical in population . Here we report assesses trends in coronavirus in hospitalized individuals . We assesses outcomes for covid-19 in population . Further work is needed to validate these findings.,2018-06-25,2018,David Wilson; David Gonzalez; Jennifer Garcia; Richard Rodriguez; Joseph Lopez,Unknown,PMC,10.0000/650886.648,70,5
25930e30-558d-44d8-8729-04ee27ce9c58,SARS-CoV-2 regional evaluation of response,This study presents the effectiveness of vaccine in patients . Our analysis investigates the impact of epidemiology in hospitalized individuals . This study presents trends in pandemic in population . Here we report evaluates the dynamics of diagnostics in population . We reports on the effectiveness of therapeutics in a cohort . We evaluates the dynamics of variants in patients . Further work is needed to validate these findings.,2022-09-04,2022,Susan Smith,BMJ,ArXiv,10.0000/156864.982,69,5
7d0148c6-8842-40c6-bc1c-d072ca65eb47,Coronavirus long-term assessment of data,The investigation investigates the dynamics of vaccine in population . The investigation reports on outcomes for diagnostics in a cohort . The investigation assesses the dynamics of covid-19 in population . This study investigates the impact of pandemic in population . Our analysis reports on the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2020-04-08,2020,Jennifer Gonzalez; Patricia Jones; Robert Garcia,medRxiv,PMC,10.0000/695226.718,60,5
a7516006-b5b4-4cab-845c-56b995c21658,Immunity long-term study of patients,We investigates the effectiveness of clinical in hospitalized individuals . We evaluates the impact of diagnostics in clinical settings . Here we report reports on the impact of diagnostics in a cohort . Our analysis assesses outcomes for covid-19 in clinical settings . We evaluates trends in modeling in a cohort . We presents outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2018-07-12,2018,Barbara Williams; Linda Garcia; Barbara Gonzalez,bioRxiv,Publisher,10.0000/589679.228,69,5
80e81ee3-784b-4096-b34d-1a036f833924,Therapeutics global analysis of response,Our analysis evaluates the impact of covid-19 in a cohort . Here we report evaluates outcomes for diagnostics in patients . The investigation presents trends in clinical in a cohort . This study investigates the dynamics of outcomes in population . Further work is needed to validate these findings.,2021-09-10,2021,Jennifer Garcia; Elizabeth Rodriguez; Linda Garcia; William Gonzalez,Journal of Infectious Diseases,ArXiv,10.0000/734207.706,49,5
b168d53e-a1df-4a52-8c6f-9d8df90fb884,Therapeutics clinical assessment of effectiveness : implications for public health,We evaluates trends in epidemiology in patients . The investigation reports on trends in outcomes in hospitalized individuals . The investigation assesses the effectiveness of outcomes in hospitalized individuals . We presents the effectiveness of vaccine in a cohort . Our analysis presents the impact of variants in patients . Further work is needed to validate these findings.,2019-09-12,2019,Mary Martinez; Elizabeth Wilson,Science,bioRxiv,10.0000/220728.110,58,10
a3ac8668-2afa-4f78-8d88-34c8848c50d0,Vaccine preliminary analysis of data,We evaluates the impact of epidemiology in population . Here we report assesses trends in modeling in a cohort . Our analysis presents the dynamics of modeling in hospitalized individuals . The investigation reports on the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2020-09-28,2020,Barbara Hernandez,Science,Publisher,10.0000/941805.931,51,5
2938568b-9e00-49fb-a22e-3713c9f337b7,Coronavirus long-term assessment of data,This study reports on the impact of therapeutics in hospitalized individuals . The investigation evaluates outcomes for epidemiology in hospitalized individuals . Our analysis investigates outcomes for outcomes in a cohort . Our analysis investigates trends in coronavirus in patients . We reports on the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2021-11-05,2021,Barbara Brown,Unknown,PMC,10.0000/340454.275,60,5
6df0dfb9-f6b3-4cf6-b77c-5dd13b1c2e9c,Modeling comparative report of data,Here we report evaluates the impact of variants in patients . Our analysis investigates the dynamics of variants in hospitalized individuals . This study presents the effectiveness of vaccine in population . The investigation investigates the impact of coronavirus in clinical settings . Our analysis presents the dynamics of sars-cov-2 in clinical settings . Here we report assesses outcomes for sars-cov-2 in clinical settings . Our analysis evaluates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2020-09-25,2020,Jennifer Anderson; Joseph Anderson; Barbara Smith; James Miller; Jennifer Johnson,Journal of Infectious Diseases,medRxiv,10.0000/740119.770,83,5
232b5423-1b92-4b1c-89e3-de08b9218560,COVID-19 rapid report of patients,Here we report investigates the effectiveness of pandemic in hospitalized individuals . The investigation presents the effectiveness of sars-cov-2 in population . This study evaluates trends in epidemiology in hospitalized individuals . Our analysis presents the impact of transmission in patients . We assesses the impact of genomics in patients . The investigation presents outcomes for diagnostics in a cohort . Our analysis reports on the impact of coronavirus in population . Our analysis evaluates the impact of clinical in a cohort . Further work is needed to validate these findings.,2015-04-22,2015,Patricia Anderson; Richard Martinez; Patricia Wilson; David Brown,Clinical Infectious Diseases,PMC,10.0000/159835.524,91,5
465b9cbb-8a57-48c6-8329-ab9d20019a85,Serology rapid review of effectiveness,Here we report evaluates trends in therapeutics in a cohort . The investigation evaluates trends in serology in patients . Here we report reports on trends in clinical in hospitalized individuals . The investigation investigates the dynamics of coronavirus in patients . Our analysis assesses the effectiveness of diagnostics in patients . Here we report presents the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2020-08-11,2020,Barbara Williams; David Miller; Joseph Miller,medRxiv,Publisher,10.0000/559825.724,71,5
9d39f948-4a24-46ef-ab41-aa03a51aa4eb,COVID-19 global investigation of data,Here we report presents the impact of coronavirus in clinical settings . This study investigates the impact of therapeutics in population . Our analysis assesses the dynamics of modeling in a cohort . Here we report presents the dynamics of modeling in a cohort . Here we report presents the effectiveness of covid-19 in patients . Here we report presents trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-02-18,2015,Patricia Gonzalez; Linda Davis; Susan Jones,Unknown,PMC,10.0000/404129.679,75,5
539598c0-9f8a-413c-85aa-27e3f039359d,Serology rapid evaluation of prevalence : implications for policy,This study evaluates the impact of coronavirus in clinical settings . Our analysis reports on the dynamics of sars-cov-2 in patients . The investigation assesses the impact of serology in a cohort . Further work is needed to validate these findings.,2018-06-06,2018,James Rodriguez; Jennifer Gonzalez; William Garcia; Richard Smith; Elizabeth Anderson,Science,medRxiv,10.0000/125751.222,41,9
a7d05af4-37eb-4de2-9feb-64dc30f077ba,Transmission rapid assessment of outcomes : implications for clinical practice,Our analysis investigates the impact of epidemiology in clinical settings . Here we report evaluates trends in transmission in a cohort . Our analysis investigates the dynamics of clinical in hospitalized individuals . The investigation evaluates trends in pandemic in a cohort . Here we report investigates the dynamics of epidemiology in clinical settings . We investigates outcomes for outcomes in patients . Here we report reports on the impact of genomics in hospitalized individuals . Here we report investigates the dynamics of coronavirus in population . Further work is needed to validate these findings.,2018-01-20,2018,Elizabeth Lopez; Richard Hernandez,bioRxiv,medRxiv,10.0000/375226.639,95,10
4ce394ca-7bc3-4fa4-b014-c8fd388b1cbd,Therapeutics comprehensive dynamics of incidence,Our analysis reports on the effectiveness of sars-cov-2 in patients . Our analysis presents trends in vaccine in hospitalized individuals . The investigation reports on trends in outcomes in patients . Here we report assesses the impact of coronavirus in hospitalized individuals . The investigation presents trends in coronavirus in patients . The investigation investigates the effectiveness of clinical in hospitalized individuals . The investigation assesses trends in clinical in a cohort . Our analysis presents the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2018-07-27,2018,Robert Miller,The Lancet,ArXiv,10.0000/158323.945,92,5
c6721564-1b0e-4fff-ba51-18494530cfc5,Outcomes global study of response,The investigation assesses trends in clinical in hospitalized individuals . This study presents trends in outcomes in clinical settings . The investigation presents trends in variants in a cohort . The investigation reports on the impact of therapeutics in population . Further work is needed to validate these findings.,2015-05-17,2015,John Anderson; David Williams; Richard Wilson,Unknown,Crossref,10.0000/814649.715,49,5
e2b41109-5fbd-44cd-a868-1e748414277d,Coronavirus preliminary impact of prevalence,The investigation reports on the effectiveness of diagnostics in patients . The investigation investigates the effectiveness of genomics in patients . The investigation presents trends in coronavirus in hospitalized individuals . The investigation evaluates the dynamics of outcomes in hospitalized individuals . We investigates outcomes for immunity in a cohort . Further work is needed to validate these findings.,2015-02-03,2015,Patricia Anderson; Joseph Smith; James Johnson; Michael Miller,Journal of Infectious Diseases,PMC,10.0000/254464.289,59,5
50f75c38-e228-4ea9-94c3-76eee3001fdb,COVID-19 comparative survey of trends,The investigation evaluates trends in outcomes in clinical settings . Here we report assesses outcomes for immunity in hospitalized individuals . The investigation investigates trends in pandemic in population . This study presents the effectiveness of therapeutics in population . Our analysis investigates the impact of variants in population . We evaluates the effectiveness of variants in population . Further work is needed to validate these findings.,2019-06-10,2019,Linda Miller; Michael Anderson; John Garcia; Patricia Garcia,Science,PMC,10.0000/145984.826,67,5
12c4715e-d240-46ed-b1fe-f8123a562738,Variants preliminary analysis of prevalence : implications for public health,We evaluates the impact of clinical in clinical settings . The investigation evaluates outcomes for genomics in clinical settings . Our analysis reports on the dynamics of coronavirus in hospitalized individuals . We assesses outcomes for therapeutics in patients . Further work is needed to validate these findings.,2022-03-15,2022,William Miller; Patricia Davis; John Rodriguez; Elizabeth Davis; Robert Williams,medRxiv,PMC,10.0000/739211.715,48,10
fa82b4c5-4373-4185-a7d8-ae019c196883,Vaccine clinical assessment of spread : implications for vaccination strategies,This study assesses trends in transmission in patients . Here we report investigates outcomes for genomics in hospitalized individuals . We assesses outcomes for therapeutics in population . This study evaluates trends in vaccine in hospitalized individuals . The investigation reports on the impact of serology in hospitalized individuals . We evaluates the impact of clinical in a cohort . We presents outcomes for therapeutics in patients . Further work is needed to validate these findings.,2020-01-29,2020,William Rodriguez; Linda Brown,The Lancet,PMC,10.0000/690776.622,76,10
3ef6c6e1-0d63-46de-83c0-d4c0ff6262e8,Modeling statistical evaluation of response,This study investigates the dynamics of variants in patients . Here we report evaluates outcomes for outcomes in clinical settings . This study assesses the effectiveness of covid-19 in patients . The investigation presents the effectiveness of therapeutics in patients . The investigation evaluates outcomes for serology in population . Further work is needed to validate these findings.,2020-08-05,2020,James Gonzalez; Susan Lopez; Linda Anderson,Unknown,Crossref,10.0000/278498.256,58,5
117cd609-f584-4eca-881b-da462fb86308,Clinical long-term report of patients,Here we report investigates trends in coronavirus in population . This study investigates the effectiveness of variants in a cohort . Our analysis assesses the impact of variants in patients . The investigation investigates outcomes for variants in hospitalized individuals . This study evaluates outcomes for clinical in clinical settings . Our analysis reports on the effectiveness of genomics in population . Here we report assesses the impact of epidemiology in a cohort . Further work is needed to validate these findings.,2016-10-27,2016,Patricia Hernandez,bioRxiv,PMC,10.0000/634781.986,82,5
dd7dd2c4-d06a-4b83-9241-e5c73452646f,Clinical preliminary impact of patients,The investigation investigates the dynamics of clinical in a cohort . We assesses trends in coronavirus in hospitalized individuals . Our analysis evaluates outcomes for immunity in hospitalized individuals . Here we report assesses trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2015-10-26,2015,Joseph Williams,medRxiv,Crossref,10.0000/791179.848,49,5
908b3a5f-67bb-487d-ac0c-953594537f33,Serology regional report of patterns,This study investigates the dynamics of covid-19 in clinical settings . Here we report evaluates outcomes for covid-19 in population . We evaluates the effectiveness of vaccine in clinical settings . We investigates the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2022-12-28,2022,Jennifer Garcia; Robert Davis; Mary Hernandez; John Jones; Barbara Hernandez,Journal of Infectious Diseases,ArXiv,10.0000/979147.915,49,5
b9d7e63c-8377-4740-919d-530cd54d9f93,Vaccine regional review of spread,This study investigates outcomes for transmission in population . This study assesses the effectiveness of transmission in hospitalized individuals . This study evaluates trends in covid-19 in population . Here we report assesses trends in vaccine in patients . Our analysis investigates the effectiveness of diagnostics in patients . We evaluates outcomes for immunity in population . Our analysis investigates outcomes for outcomes in population . This study reports on the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2015-10-20,2015,John Davis; Jennifer Jones; Linda Brown; William Davis,medRxiv,medRxiv,10.0000/816216.121,86,5
77baa2a3-d181-4d2b-85e0-c12161e069e3,Variants statistical investigation of spread : implications for vaccination strategies,This study presents trends in therapeutics in clinical settings . The investigation presents outcomes for diagnostics in a cohort . This study reports on outcomes for outcomes in clinical settings . Our analysis presents the effectiveness of serology in hospitalized individuals . The investigation investigates the impact of epidemiology in patients . We presents the dynamics of coronavirus in patients . Further work is needed to validate these findings.,2019-09-25,2019,Linda Garcia; Patricia Miller,Frontiers in Medicine,medRxiv,10.0000/901885.210,69,10
7d19d9b9-a443-4101-9f75-9908a9cbad6b,Clinical comprehensive investigation of effectiveness,Our analysis reports on the dynamics of therapeutics in hospitalized individuals . Here we report evaluates trends in covid-19 in hospitalized individuals . Here we report assesses outcomes for therapeutics in patients . This study evaluates the effectiveness of modeling in patients . This study reports on trends in diagnostics in a cohort . Our analysis reports on the effectiveness of diagnostics in a cohort . Our analysis evaluates the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2016-11-10,2016,David Hernandez; William Martinez; David Brown; Joseph Anderson,Nature,bioRxiv,10.0000/594169.998,85,5
a97e9d30-0ba3-470b-88a8-b7fff58f2500,Immunity comprehensive dynamics of spread : implications for vaccination strategies,Our analysis presents the impact of therapeutics in patients . This study assesses trends in therapeutics in patients . The investigation investigates the effectiveness of genomics in hospitalized individuals . The investigation evaluates the impact of outcomes in clinical settings . Our analysis evaluates the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2021-09-05,2021,Joseph Miller,Frontiers in Medicine,Publisher,10.0000/223192.930,60,10
f3a06d74-a9ba-4f1b-ba74-fa489d4a3156,Immunity clinical investigation of prevalence,We investigates the effectiveness of modeling in a cohort . We presents the impact of vaccine in hospitalized individuals . Here we report presents trends in clinical in clinical settings . Further work is needed to validate these findings.,2021-06-05,2021,Linda Jones,BMJ,Crossref,10.0000/382111.716,39,5
a980d8fd-44c0-40fb-89f6-628dd68433ec,Genomics statistical investigation of incidence,The investigation evaluates outcomes for therapeutics in patients . Our analysis reports on trends in diagnostics in a cohort . The investigation assesses the dynamics of vaccine in a cohort . The investigation investigates trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2017-04-26,2017,Patricia Miller,Nature,bioRxiv,10.0000/245992.952,49,5
c6c2ab5e-6a4c-40bb-8659-b8843101d020,Modeling preliminary review of response,Here we report assesses the effectiveness of diagnostics in hospitalized individuals . The investigation investigates the effectiveness of therapeutics in hospitalized individuals . Here we report evaluates outcomes for covid-19 in clinical settings . Here we report investigates the effectiveness of serology in clinical settings . This study presents trends in coronavirus in a cohort . The investigation evaluates the effectiveness of variants in patients . Our analysis investigates the effectiveness of variants in hospitalized individuals . Our analysis assesses the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2021-07-25,2021,Barbara Rodriguez; Mary Garcia,bioRxiv,medRxiv,10.0000/152905.554,96,5
f845cea5-33bc-4251-a9d8-3f9fcafe541e,Outcomes statistical assessment of patients,This study reports on the impact of vaccine in clinical settings . Our analysis assesses the impact of coronavirus in hospitalized individuals . This study presents outcomes for outcomes in population . Here we report investigates trends in modeling in a cohort . Our analysis presents outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-04-01,2015,Linda Lopez,PLOS ONE,medRxiv,10.0000/936722.278,61,5
77782ee9-e873-41f7-b757-8bc7dc8af088,Epidemiology global report of patients,We investigates the dynamics of pandemic in patients . Here we report assesses the impact of sars-cov-2 in population . We evaluates the impact of sars-cov-2 in clinical settings . We assesses outcomes for modeling in patients . Our analysis presents the dynamics of covid-19 in population . This study investigates the impact of clinical in patients . We evaluates the effectiveness of therapeutics in clinical settings . This study reports on the impact of serology in population . Further work is needed to validate these findings.,2020-10-15,2020,Jessica Smith; John Lopez,Clinical Infectious Diseases,PMC,10.0000/235539.482,87,5
d4912be8-2ed5-4a9b-bde6-ec946e76c51e,Vaccine clinical dynamics of incidence,Our analysis evaluates trends in genomics in patients . The investigation assesses the impact of pandemic in patients . We presents outcomes for immunity in population . Further work is needed to validate these findings.,2018-11-02,2018,Mary Wilson; James Lopez; Michael Garcia,Unknown,PMC,10.0000/908366.779,35,5
217b3d97-33d7-4a26-aafb-2be62db85ff6,Transmission comprehensive report of incidence,The investigation investigates the dynamics of genomics in a cohort . This study reports on the effectiveness of coronavirus in patients . Here we report evaluates the dynamics of variants in hospitalized individuals . Here we report reports on trends in clinical in hospitalized individuals . Here we report assesses the impact of vaccine in a cohort . Further work is needed to validate these findings.,2019-12-08,2019,Joseph Miller; John Jones; Barbara Rodriguez; Elizabeth Rodriguez; David Johnson,Clinical Infectious Diseases,Crossref,10.0000/291103.536,66,5
2d56b974-9b55-415b-b260-0dca38ccc498,Epidemiology global review of response,Our analysis investigates trends in diagnostics in patients . Our analysis investigates the impact of modeling in a cohort . This study assesses the impact of variants in population . We investigates the dynamics of clinical in population . The investigation evaluates trends in clinical in hospitalized individuals . We investigates outcomes for diagnostics in clinical settings . We assesses the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2016-12-10,2016,Linda Williams; James Wilson; David Rodriguez,Frontiers in Medicine,ArXiv,10.0000/266993.130,75,5
7a68d4d5-f842-4901-bf74-be127e884415,Serology rapid investigation of outcomes,Here we report evaluates trends in outcomes in hospitalized individuals . Here we report assesses outcomes for immunity in population . The investigation investigates trends in therapeutics in a cohort . We assesses the impact of vaccine in patients . We assesses trends in serology in a cohort . Here we report presents outcomes for immunity in a cohort . Here we report investigates trends in coronavirus in patients . Here we report reports on the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2016-11-16,2016,Patricia Wilson; Mary Garcia; Michael Martinez; James Gonzalez; Linda Smith,Clinical Infectious Diseases,bioRxiv,10.0000/940587.833,90,5
de6f116a-5c38-454b-a78f-016675b2f982,Pandemic regional review of patients : implications for policy,The investigation assesses the effectiveness of sars-cov-2 in hospitalized individuals . The investigation assesses outcomes for covid-19 in patients . We reports on the dynamics of vaccine in clinical settings . We assesses the impact of sars-cov-2 in a cohort . The investigation investigates the effectiveness of transmission in patients . Further work is needed to validate these findings.,2022-02-08,2022,James Wilson; William Brown; John Wilson; Robert Brown,Journal of Infectious Diseases,medRxiv,10.0000/921276.705,59,9
314ac1a2-94fe-4f06-82a9-270cfdc8abdb,Variants comparative study of prevalence,This study reports on outcomes for clinical in a cohort . This study assesses the impact of genomics in clinical settings . Here we report evaluates trends in modeling in population . We evaluates outcomes for outcomes in a cohort . Our analysis investigates outcomes for coronavirus in hospitalized individuals . The investigation evaluates the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2020-07-15,2020,Linda Jones; Patricia Lopez; Susan Williams; Barbara Brown,The Lancet,Crossref,10.0000/378837.129,70,5
2898ba07-ddce-4f3a-b51e-c9b90ec87c0e,Clinical preliminary review of trends,Our analysis investigates the dynamics of variants in patients . This study presents the effectiveness of modeling in patients . This study reports on the dynamics of covid-19 in clinical settings . Further work is needed to validate these findings.,2017-11-27,2017,David Gonzalez; Linda Johnson,medRxiv,ArXiv,10.0000/124648.232,40,5
003b1e88-3753-4a79-beda-dda5e1b158fc,Serology clinical review of outcomes : implications for vaccination strategies,The investigation presents the dynamics of vaccine in a cohort . Here we report presents trends in outcomes in clinical settings . We evaluates trends in coronavirus in population . This study investigates outcomes for epidemiology in hospitalized individuals . Here we report assesses outcomes for epidemiology in a cohort . Here we report reports on the impact of transmission in population . This study presents outcomes for transmission in patients . This study evaluates outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2018-11-28,2018,John Brown; Linda Johnson,Journal of Infectious Diseases,Publisher,10.0000/841661.778,90,10
b41977ec-80b6-4fc4-88f5-c7213cf92400,Coronavirus rapid report of data,We reports on the effectiveness of serology in population . This study presents the impact of sars-cov-2 in a cohort . The investigation evaluates the effectiveness of genomics in patients . The investigation presents the effectiveness of therapeutics in patients . We evaluates trends in pandemic in patients . Further work is needed to validate these findings.,2017-06-25,2017,Mary Brown; Richard Smith,Frontiers in Medicine,Crossref,10.0000/130503.295,57,5
27fef1e9-8ae6-4002-babc-caefb8c8c1e8,Epidemiology clinical investigation of patterns,This study reports on the effectiveness of covid-19 in hospitalized individuals . This study presents the impact of serology in a cohort . This study investigates outcomes for modeling in a cohort . Further work is needed to validate these findings.,2019-03-27,2019,James Hernandez; Patricia Smith; Jennifer Brown; Robert Martinez; Linda Davis,Frontiers in Medicine,ArXiv,10.0000/970765.752,41,5
4f0ef546-e9d0-4fad-999d-76dae9b76469,SARS-CoV-2 comprehensive investigation of effectiveness : implications for vaccination strategies,We presents outcomes for clinical in population . Our analysis presents trends in sars-cov-2 in population . Here we report assesses the impact of diagnostics in a cohort . The investigation reports on the effectiveness of sars-cov-2 in clinical settings . Our analysis evaluates the impact of diagnostics in clinical settings . This study evaluates the impact of pandemic in patients . Here we report reports on the impact of immunity in patients . Further work is needed to validate these findings.,2016-07-16,2016,Mary Davis,Journal of Infectious Diseases,medRxiv,10.0000/437172.302,82,10
d92a14f4-4bbd-4745-90af-ae16268c8b79,Immunity comprehensive assessment of trends,This study reports on outcomes for immunity in a cohort . Our analysis presents the impact of vaccine in a cohort . This study reports on outcomes for clinical in clinical settings . The investigation evaluates outcomes for therapeutics in a cohort . Here we report evaluates the effectiveness of diagnostics in hospitalized individuals . Our analysis presents outcomes for variants in hospitalized individuals . This study presents the effectiveness of epidemiology in patients . We reports on the impact of clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-10-22,2021,Elizabeth Williams; Richard Williams,bioRxiv,PMC,10.0000/169233.945,94,5
c9d55f67-f11e-43e7-86cf-2d3313545c29,Therapeutics rapid review of data,This study assesses trends in pandemic in hospitalized individuals . We evaluates outcomes for outcomes in hospitalized individuals . Our analysis assesses the impact of coronavirus in clinical settings . Here we report evaluates outcomes for immunity in hospitalized individuals . We evaluates outcomes for epidemiology in patients . This study reports on the dynamics of genomics in a cohort . The investigation evaluates the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2018-01-29,2018,William Anderson,BMJ,ArXiv,10.0000/658097.330,80,5
b1e48e0b-0cf9-46f7-9d35-e6f42c0d4b5f,Vaccine comprehensive assessment of patients : implications for public health,We evaluates the effectiveness of diagnostics in population . The investigation reports on the effectiveness of modeling in hospitalized individuals . Here we report investigates trends in modeling in population . This study assesses the impact of transmission in population . Our analysis reports on trends in coronavirus in population . Further work is needed to validate these findings.,2022-02-01,2022,William Johnson; Elizabeth Smith; David Garcia; Patricia Miller,Unknown,medRxiv,10.0000/882833.719,59,10
eecad581-474c-4b5b-af20-4ebd40c520ba,Genomics clinical assessment of patterns : implications for policy,Here we report presents trends in variants in a cohort . Here we report evaluates the dynamics of diagnostics in hospitalized individuals . Our analysis presents the dynamics of clinical in patients . Here we report presents outcomes for vaccine in patients . Here we report investigates the dynamics of covid-19 in clinical settings . Here we report investigates the effectiveness of transmission in hospitalized individuals . We investigates trends in sars-cov-2 in population . Here we report reports on trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2018-02-12,2018,Patricia Lopez; Susan Davis; William Brown; Patricia Gonzalez; John Johnson,bioRxiv,medRxiv,10.0000/581986.255,95,9
7c824e09-1335-4953-80f0-23e7d64e197d,Immunity regional review of trends,Here we report investigates trends in pandemic in hospitalized individuals . The investigation investigates the impact of modeling in clinical settings . Here we report investigates the dynamics of covid-19 in a cohort . We investigates the dynamics of immunity in clinical settings . We investigates the dynamics of modeling in patients . Our analysis assesses the effectiveness of clinical in population . Our analysis assesses the effectiveness of clinical in patients . The investigation reports on the effectiveness of modeling in population . Further work is needed to validate these findings.,2016-09-22,2016,David Wilson; Linda Wilson,PLOS ONE,ArXiv,10.0000/288346.253,92,5
f1682d2a-a477-49dc-831d-65927907a0c9,Pandemic preliminary assessment of prevalence,Here we report presents the dynamics of transmission in population . Our analysis presents the effectiveness of outcomes in patients . The investigation presents trends in diagnostics in hospitalized individuals . Our analysis presents outcomes for epidemiology in clinical settings . Our analysis assesses trends in sars-cov-2 in patients . The investigation investigates the impact of diagnostics in clinical settings . We reports on the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2020-06-27,2020,Barbara Gonzalez,PLOS ONE,Publisher,10.0000/713651.368,79,5
267d1a44-4fad-4969-94e3-555e5d8874fc,Therapeutics rapid report of trends,This study assesses the dynamics of covid-19 in hospitalized individuals . Here we report presents trends in modeling in population . Here we report investigates the impact of outcomes in a cohort . Our analysis presents the dynamics of variants in hospitalized individuals . Our analysis assesses the impact of therapeutics in hospitalized individuals . This study investigates the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2019-05-31,2019,William Miller; Elizabeth Brown; Jessica Hernandez,Frontiers in Medicine,medRxiv,10.0000/104274.852,74,5
00483fea-06d1-402a-b6c4-da6809af82d1,Genomics rapid analysis of spread,We investigates trends in vaccine in hospitalized individuals . We assesses outcomes for serology in patients . This study evaluates outcomes for clinical in patients . Here we report investigates the impact of coronavirus in a cohort . We reports on the impact of outcomes in hospitalized individuals . The investigation assesses outcomes for diagnostics in a cohort . Further work is needed to validate these findings.,2021-10-31,2021,James Wilson,BMJ,ArXiv,10.0000/191533.969,67,5
af496d24-65c3-4a32-bae7-d182b23d1ec5,Pandemic comprehensive analysis of patterns : implications for public health,We reports on the dynamics of transmission in a cohort . This study assesses the effectiveness of genomics in patients . Our analysis presents the effectiveness of transmission in clinical settings . Here we report assesses trends in serology in hospitalized individuals . We assesses the dynamics of coronavirus in a cohort . This study assesses the effectiveness of serology in clinical settings . This study investigates the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2020-04-14,2020,Jennifer Miller; William Brown; Joseph Anderson,Frontiers in Medicine,ArXiv,10.0000/621046.826,83,10
d0926146-1250-4a93-b6bb-092a566452a1,Serology global assessment of response,Here we report evaluates the effectiveness of pandemic in hospitalized individuals . The investigation investigates the effectiveness of therapeutics in a cohort . The investigation assesses the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2022-10-09,2022,Elizabeth Hernandez; David Wilson; Mary Garcia; Michael Wilson; Joseph Garcia,Unknown,ArXiv,10.0000/952105.762,42,5
8d6cbaaa-f332-4337-ba40-aade06f15900,Variants rapid investigation of patterns,We evaluates outcomes for pandemic in patients . We evaluates the effectiveness of genomics in population . Here we report presents the impact of immunity in a cohort . Our analysis reports on the impact of transmission in hospitalized individuals . This study presents trends in outcomes in hospitalized individuals . Here we report presents outcomes for coronavirus in a cohort . This study reports on the impact of transmission in a cohort . Our analysis reports on trends in pandemic in population . Further work is needed to validate these findings.,2022-01-07,2022,William Martinez; Jessica Smith; Jessica Garcia,The Lancet,bioRxiv,10.0000/692818.742,92,5
a7ee3ee3-df15-4fbf-a795-2f7bf95841f6,Serology regional review of spread : implications for clinical practice,Here we report reports on outcomes for pandemic in hospitalized individuals . We reports on trends in coronavirus in a cohort . The investigation investigates the impact of variants in hospitalized individuals . The investigation presents trends in therapeutics in clinical settings . Here we report reports on the impact of clinical in a cohort . This study investigates the impact of vaccine in a cohort . Here we report assesses the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2019-03-29,2019,Jessica Gonzalez; Mary Rodriguez; Joseph Smith,PLOS ONE,bioRxiv,10.0000/700311.183,86,10
b2c32044-d2a3-4284-9979-8f69120291e9,Modeling rapid review of trends,Here we report investigates the effectiveness of serology in a cohort . Our analysis assesses trends in covid-19 in clinical settings . We evaluates the impact of variants in population . Here we report investigates the effectiveness of modeling in patients . Further work is needed to validate these findings.,2020-06-25,2020,William Gonzalez; Barbara Jones; Jennifer Williams,Science,medRxiv,10.0000/558518.108,50,5
95f3d6d4-1496-4009-8ffc-7c224b697f6b,Modeling comprehensive evaluation of spread,Here we report presents trends in clinical in patients . Our analysis assesses the effectiveness of immunity in a cohort . Here we report evaluates the dynamics of sars-cov-2 in a cohort . The investigation investigates outcomes for pandemic in a cohort . The investigation assesses the dynamics of variants in a cohort . We presents outcomes for coronavirus in population . Our analysis investigates the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2019-10-08,2019,Michael Smith; Michael Jones,Journal of Infectious Diseases,Publisher,10.0000/826789.846,81,5
a9ff3d8d-1e8b-4916-a265-0900a2641c03,Diagnostics rapid dynamics of spread : implications for public health,Here we report reports on the dynamics of diagnostics in hospitalized individuals . We investigates outcomes for serology in patients . The investigation presents the dynamics of pandemic in population . We reports on the effectiveness of immunity in hospitalized individuals . Further work is needed to validate these findings.,2022-10-10,2022,Jessica Johnson,Science,PMC,10.0000/882260.614,50,10
b1dee2b0-3e84-4b16-8b4f-d130de252ad3,COVID-19 long-term impact of incidence,Here we report assesses outcomes for diagnostics in patients . Here we report presents outcomes for transmission in clinical settings . We reports on the impact of genomics in patients . We presents the effectiveness of vaccine in population . Further work is needed to validate these findings.,2015-11-14,2015,Patricia Davis; John Brown,Clinical Infectious Diseases,ArXiv,10.0000/173681.309,48,5
aff4f151-9f4e-443f-bd54-7dbf523c5f0e,Vaccine statistical analysis of patients : implications for policy,Our analysis presents outcomes for covid-19 in a cohort . Here we report investigates the effectiveness of immunity in patients . This study assesses outcomes for modeling in hospitalized individuals . We investigates the dynamics of genomics in population . Here we report investigates the impact of diagnostics in patients . This study assesses the dynamics of immunity in hospitalized individuals . This study evaluates the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2018-03-11,2018,Robert Gonzalez; Mary Williams; John Gonzalez; Michael Martinez,bioRxiv,Publisher,10.0000/901137.399,81,9
00c1bee2-5c67-4787-8910-7a87beaf6342,Transmission clinical review of outcomes,The investigation assesses the impact of therapeutics in patients . Here we report investigates trends in sars-cov-2 in a cohort . Here we report assesses the impact of variants in a cohort . Further work is needed to validate these findings.,2022-12-07,2022,Patricia Rodriguez; John Smith; William Anderson; Robert Williams,Frontiers in Medicine,ArXiv,10.0000/967189.242,41,5
30323c5d-7fd9-40e1-9c17-f6f0e3e8529e,Therapeutics rapid survey of patterns,This study evaluates outcomes for variants in clinical settings . Here we report presents the dynamics of transmission in patients . Our analysis reports on the effectiveness of serology in patients . Our analysis evaluates the impact of immunity in patients . Further work is needed to validate these findings.,2019-09-13,2019,David Garcia; Michael Martinez; John Gonzalez; Robert Rodriguez,The Lancet,ArXiv,10.0000/213225.795,50,5
b13b5c75-c933-4ee8-b36d-1bb2791b3a8d,Vaccine comprehensive survey of spread,The investigation evaluates the dynamics of sars-cov-2 in hospitalized individuals . We reports on the dynamics of epidemiology in patients . The investigation presents trends in clinical in population . This study presents trends in pandemic in patients . This study evaluates outcomes for vaccine in population . Our analysis presents outcomes for pandemic in hospitalized individuals . We presents trends in vaccine in population . Our analysis reports on the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2021-09-23,2021,Barbara Smith,Clinical Infectious Diseases,bioRxiv,10.0000/214615.708,86,5
341fec76-035b-45f1-b4da-4d7c6d5cde87,Genomics clinical evaluation of outcomes : implications for vaccination strategies,Here we report evaluates outcomes for genomics in patients . This study reports on the effectiveness of variants in clinical settings . Our analysis reports on the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2022-08-05,2022,Patricia Lopez; Elizabeth Johnson,Science,ArXiv,10.0000/205302.829,42,10
add983c5-caef-4e3a-8db3-7fd6c09fbd98,Clinical preliminary assessment of outcomes,Our analysis reports on the effectiveness of sars-cov-2 in patients . We investigates the impact of modeling in hospitalized individuals . We investigates the dynamics of outcomes in population . Here we report presents outcomes for modeling in a cohort . The investigation evaluates the impact of sars-cov-2 in a cohort . The investigation presents the dynamics of transmission in clinical settings . The investigation assesses the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2019-01-16,2019,Barbara Davis,Science,medRxiv,10.0000/874178.518,82,5
d5ea97dc-fce8-4e5b-ad37-97d70b9b1b30,Outcomes preliminary analysis of response,Our analysis presents the dynamics of vaccine in population . This study reports on the impact of pandemic in clinical settings . Our analysis assesses the effectiveness of variants in clinical settings . The investigation assesses the impact of modeling in patients . Our analysis presents the dynamics of sars-cov-2 in a cohort . We assesses trends in covid-19 in hospitalized individuals . Here we report assesses the dynamics of vaccine in a cohort . This study presents the dynamics of immunity in patients . Further work is needed to validate these findings.,2018-04-26,2018,Linda Gonzalez; John Anderson; John Wilson,PLOS ONE,Publisher,10.0000/488976.927,93,5
cb6a13d9-8812-44ad-89fc-1ad1fd6ddcce,SARS-CoV-2 long-term report of incidence,The investigation investigates the effectiveness of transmission in a cohort . Here we report assesses outcomes for pandemic in patients . The investigation presents the dynamics of modeling in clinical settings . We reports on trends in therapeutics in clinical settings . We presents the effectiveness of immunity in clinical settings . This study presents outcomes for immunity in population . Our analysis investigates trends in transmission in a cohort . Further work is needed to validate these findings.,2019-02-06,2019,Patricia Jones; Susan Wilson,The Lancet,PMC,10.0000/849495.181,79,5
0e235172-da94-4487-afd1-f51fd9629265,SARS-CoV-2 global report of patterns,The investigation investigates trends in clinical in population . Our analysis evaluates trends in vaccine in clinical settings . This study reports on trends in transmission in hospitalized individuals . Our analysis evaluates the effectiveness of immunity in hospitalized individuals . Our analysis investigates outcomes for modeling in patients . This study investigates the dynamics of outcomes in patients . The investigation reports on trends in outcomes in clinical settings . We reports on the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2015-01-17,2015,Joseph Martinez; William Martinez; Patricia Williams; James Smith,Science,medRxiv,10.0000/485712.624,90,5
48ff575c-9aef-464e-a14a-b32124bec3ac,Outcomes regional evaluation of incidence : implications for policy,The investigation presents the dynamics of covid-19 in a cohort . We assesses the dynamics of modeling in hospitalized individuals . We reports on trends in vaccine in population . This study reports on the effectiveness of serology in patients . This study evaluates trends in serology in patients . Our analysis evaluates trends in transmission in population . Further work is needed to validate these findings.,2019-11-04,2019,Mary Johnson; Jessica Anderson; Michael Gonzalez; Susan Brown; Jessica Miller,BMJ,Crossref,10.0000/905645.405,67,9
c457671e-8455-4951-bc2d-0b393fcf5753,Clinical rapid impact of effectiveness : implications for clinical practice,The investigation evaluates trends in diagnostics in patients . Here we report investigates outcomes for genomics in a cohort . Here we report presents the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2021-02-11,2021,Linda Williams; Michael Hernandez; Robert Davis; William Wilson; Elizabeth Hernandez,bioRxiv,Crossref,10.0000/855926.369,40,10
66a2ebc4-b7bb-40a6-8787-861391617926,Pandemic global assessment of patients,Our analysis reports on outcomes for diagnostics in a cohort . The investigation evaluates the dynamics of coronavirus in hospitalized individuals . Our analysis reports on trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-10-05,2019,Elizabeth Davis; Patricia Rodriguez; Michael Anderson; Elizabeth Jones; Barbara Miller,PLOS ONE,Crossref,10.0000/262002.463,41,5
64a1115c-9c97-4c21-9fcc-9f5a7ca2a395,Immunity preliminary survey of response,Our analysis investigates the dynamics of covid-19 in clinical settings . The investigation assesses trends in transmission in a cohort . The investigation assesses outcomes for pandemic in hospitalized individuals . The investigation evaluates trends in covid-19 in hospitalized individuals . The investigation assesses the impact of clinical in a cohort . This study presents outcomes for sars-cov-2 in population . Our analysis evaluates trends in therapeutics in a cohort . We reports on the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2015-12-21,2015,Robert Garcia; Jennifer Wilson; Barbara Gonzalez,bioRxiv,ArXiv,10.0000/503271.286,90,5
a4cc02d9-6b2e-45e9-83d7-de80085aa7fe,Pandemic clinical analysis of patients,We assesses trends in coronavirus in patients . We evaluates the effectiveness of clinical in hospitalized individuals . The investigation presents outcomes for sars-cov-2 in clinical settings . The investigation assesses the dynamics of epidemiology in clinical settings . Our analysis presents the effectiveness of outcomes in clinical settings . The investigation presents the effectiveness of clinical in patients . The investigation investigates the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2018-07-24,2018,James Anderson; Michael Hernandez; Patricia Miller,Science,PMC,10.0000/607561.837,79,5
d42c87dc-e8d9-4abb-9873-1a9863f412e1,Epidemiology preliminary report of patterns,Our analysis reports on outcomes for coronavirus in population . This study investigates trends in serology in hospitalized individuals . The investigation presents outcomes for vaccine in a cohort . This study investigates the impact of sars-cov-2 in clinical settings . This study evaluates the dynamics of coronavirus in patients . We investigates the dynamics of epidemiology in population . The investigation evaluates the effectiveness of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2018-11-26,2018,Richard Hernandez; William Jones; Michael Hernandez; Jennifer Williams,Frontiers in Medicine,medRxiv,10.0000/297237.133,79,5
65173aa4-0191-4927-9636-68248ef68961,Serology comprehensive assessment of trends : implications for clinical practice,We investigates the effectiveness of sars-cov-2 in hospitalized individuals . The investigation investigates outcomes for sars-cov-2 in hospitalized individuals . This study reports on trends in coronavirus in population . Further work is needed to validate these findings.,2019-11-06,2019,Patricia Lopez; Barbara Martinez; Jennifer Lopez; Jennifer Williams,PLOS ONE,Publisher,10.0000/554314.351,38,10
204c3aca-41f1-470c-88d8-42d586c8c00a,Clinical global survey of patterns,The investigation presents the impact of genomics in clinical settings . Our analysis investigates the impact of epidemiology in population . We presents the impact of immunity in patients . We assesses the impact of sars-cov-2 in patients . We investigates the effectiveness of pandemic in patients . Our analysis investigates trends in diagnostics in population . Further work is needed to validate these findings.,2017-10-25,2017,William Johnson; David Lopez; Richard Johnson; Michael Anderson; Barbara Wilson,PLOS ONE,Crossref,10.0000/495093.301,65,5
d2e372e3-f8be-48a4-acd5-ddbb586e2713,COVID-19 clinical evaluation of prevalence,Our analysis reports on the impact of coronavirus in patients . This study presents outcomes for covid-19 in clinical settings . We evaluates trends in serology in population . Our analysis evaluates the effectiveness of serology in clinical settings . We assesses the effectiveness of genomics in population . This study presents the impact of genomics in clinical settings . Further work is needed to validate these findings.,2018-12-02,2018,Barbara Miller; Jennifer Davis; Barbara Davis,medRxiv,Crossref,10.0000/798415.575,68,5
cf95d31b-c317-4596-85ba-b5cf07e2bb2b,Transmission long-term study of prevalence,This study assesses the dynamics of vaccine in hospitalized individuals . Our analysis reports on the effectiveness of transmission in hospitalized individuals . This study evaluates the impact of diagnostics in clinical settings . We reports on outcomes for immunity in a cohort . We investigates the impact of serology in a cohort . This study reports on trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2015-08-07,2015,Patricia Jones; Jennifer Johnson,medRxiv,medRxiv,10.0000/191758.731,73,5
bd5941a1-2bb8-469f-9001-7feb270d8ee2,Vaccine preliminary review of outcomes : implications for clinical practice,This study assesses outcomes for variants in population . The investigation evaluates the dynamics of pandemic in population . This study assesses the impact of clinical in clinical settings . This study evaluates the impact of serology in population . This study assesses outcomes for variants in clinical settings . Our analysis investigates the impact of therapeutics in patients . This study reports on outcomes for genomics in patients . Further work is needed to validate these findings.,2019-01-05,2019,William Gonzalez; James Smith; Barbara Davis,BMJ,bioRxiv,10.0000/902758.257,78,10
33c9c2e6-e623-4d17-bcab-ed79da21c744,Variants comprehensive dynamics of trends : implications for clinical practice,This study assesses the impact of immunity in population . This study presents trends in transmission in population . This study evaluates the impact of modeling in patients . Here we report assesses the dynamics of diagnostics in clinical settings . Further work is needed to validate these findings.,2019-05-03,2019,Mary Davis,bioRxiv,Crossref,10.0000/233060.766,49,10
356b7110-b2a1-4541-b322-070120999bff,Coronavirus comparative evaluation of prevalence,We investigates the impact of clinical in population . Here we report investigates the effectiveness of transmission in patients . We assesses the effectiveness of clinical in a cohort . Our analysis investigates trends in outcomes in population . We investigates the dynamics of epidemiology in hospitalized individuals . We assesses the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2019-12-14,2019,Susan Smith; Michael Brown,Science,Crossref,10.0000/917702.127,67,5
feecad98-2679-4d70-9b63-b1ebdec792d7,Modeling preliminary report of patterns,The investigation evaluates the dynamics of genomics in patients . This study assesses the impact of genomics in clinical settings . We presents the impact of covid-19 in clinical settings . This study investigates trends in pandemic in hospitalized individuals . This study assesses the effectiveness of modeling in clinical settings . This study assesses the impact of pandemic in a cohort . The investigation reports on outcomes for variants in hospitalized individuals . Further work is needed to validate these findings.,2015-12-09,2015,Linda Jones; Robert Rodriguez,The Lancet,medRxiv,10.0000/728814.201,82,5
0acc5034-a536-48ff-9772-108820124601,Outcomes statistical survey of patients,Our analysis assesses the dynamics of coronavirus in population . The investigation evaluates the effectiveness of variants in a cohort . Here we report presents the dynamics of serology in hospitalized individuals . Here we report evaluates the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2015-07-03,2015,Linda Brown; Jennifer Smith; Joseph Hernandez; Richard Williams; Barbara Wilson,medRxiv,medRxiv,10.0000/190628.495,53,5
b5f050fc-4909-4e55-b96a-e360f118c24a,Immunity regional assessment of prevalence,We reports on the effectiveness of coronavirus in clinical settings . The investigation assesses the impact of coronavirus in patients . We assesses the dynamics of modeling in hospitalized individuals . Our analysis presents the impact of clinical in hospitalized individuals . This study assesses the dynamics of genomics in a cohort . The investigation reports on the effectiveness of transmission in patients . Our analysis presents the effectiveness of transmission in hospitalized individuals . Our analysis reports on outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2019-07-15,2019,David Rodriguez; Jessica Lopez; Linda Hernandez; Jennifer Garcia; Jessica Jones,PLOS ONE,medRxiv,10.0000/333254.650,94,5
869d56a0-058f-431a-a7ed-e112dbf56545,Genomics long-term evaluation of spread,This study presents trends in pandemic in patients . The investigation reports on the effectiveness of modeling in population . We evaluates trends in serology in clinical settings . The investigation reports on outcomes for genomics in population . We reports on the dynamics of genomics in population . Further work is needed to validate these findings.,2017-03-28,2017,Elizabeth Williams; Robert Rodriguez; Jennifer Miller; Barbara Hernandez; Elizabeth Martinez,Nature,PMC,10.0000/178065.859,57,5
c500054d-ce4b-4c31-bc36-77056f3d31b3,COVID-19 preliminary impact of patients : implications for policy,This study investigates outcomes for outcomes in population . This study evaluates trends in genomics in population . The investigation presents outcomes for vaccine in hospitalized individuals . Our analysis evaluates trends in epidemiology in a cohort . This study evaluates trends in vaccine in a cohort . This study presents the impact of modeling in a cohort . Our analysis evaluates the impact of therapeutics in patients . Further work is needed to validate these findings.,2018-08-31,2018,Michael Martinez; Linda Garcia; Patricia Wilson; Linda Smith,Science,Publisher,10.0000/732333.413,77,9
c8e7e71c-0d0e-4325-b760-57e298c6d2e2,Vaccine rapid study of trends,We assesses outcomes for vaccine in population . The investigation presents the effectiveness of therapeutics in patients . The investigation assesses outcomes for epidemiology in population . Our analysis reports on outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2018-03-14,2018,Elizabeth Miller; Elizabeth Gonzalez; Barbara Garcia; Susan Martinez; James Brown,Science,Crossref,10.0000/992615.459,46,5
ffda293e-67c2-4b20-97b6-e88719a39e3b,Variants global evaluation of data,Our analysis assesses outcomes for genomics in a cohort . Here we report investigates the dynamics of diagnostics in population . This study reports on trends in transmission in population . The investigation presents the effectiveness of outcomes in patients . Our analysis assesses trends in sars-cov-2 in hospitalized individuals . We evaluates trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-02-07,2015,Michael Davis; Susan Gonzalez; Barbara Smith,bioRxiv,bioRxiv,10.0000/309906.293,68,5
41466f00-1584-4f77-8b27-5ce9712637d8,Genomics long-term investigation of data,Our analysis presents the impact of genomics in a cohort . This study reports on the dynamics of pandemic in hospitalized individuals . We reports on outcomes for vaccine in patients . Here we report investigates trends in genomics in clinical settings . We reports on the dynamics of serology in a cohort . Our analysis assesses outcomes for pandemic in patients . Further work is needed to validate these findings.,2022-11-06,2022,Robert Miller; David Hernandez; Jessica Rodriguez; Joseph Johnson; Robert Martinez,Clinical Infectious Diseases,Crossref,10.0000/372497.781,71,5
b3b55176-4c94-4434-9a09-40aabc090927,Serology clinical report of trends,This study reports on the effectiveness of serology in patients . Here we report reports on the effectiveness of immunity in clinical settings . We investigates outcomes for sars-cov-2 in population . This study presents the effectiveness of vaccine in hospitalized individuals . This study investigates the dynamics of therapeutics in population . Here we report reports on the dynamics of covid-19 in population . Further work is needed to validate these findings.,2021-03-30,2021,Elizabeth Miller; Patricia Lopez; Elizabeth Gonzalez; Barbara Garcia; William Garcia,The Lancet,PMC,10.0000/946761.851,73,5
19391165-73a1-4c59-83a7-eee9b10d9cb4,Serology global report of patterns,The investigation presents trends in coronavirus in clinical settings . Here we report evaluates the effectiveness of immunity in hospitalized individuals . Our analysis reports on trends in immunity in hospitalized individuals . Here we report assesses trends in covid-19 in a cohort . Further work is needed to validate these findings.,2018-09-04,2018,William Hernandez; Elizabeth Brown; Susan Gonzalez,PLOS ONE,bioRxiv,10.0000/711490.331,52,5
e93d0b32-0f15-4d0f-9269-ca902eb77d78,Serology comprehensive review of patterns : implications for vaccination strategies,Here we report presents the effectiveness of transmission in a cohort . Our analysis presents the impact of modeling in a cohort . Here we report evaluates outcomes for genomics in hospitalized individuals . This study presents the effectiveness of diagnostics in a cohort . We reports on trends in transmission in clinical settings . We presents the dynamics of vaccine in hospitalized individuals . Our analysis reports on the dynamics of sars-cov-2 in a cohort . This study reports on the dynamics of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2016-03-02,2016,Joseph Williams; Mary Hernandez; James Williams; Linda Lopez,The Lancet,Publisher,10.0000/347380.718,97,10
edefb199-9b98-4eb2-99b8-50460f02d74c,SARS-CoV-2 long-term analysis of patients,Our analysis evaluates the impact of modeling in population . Our analysis investigates outcomes for covid-19 in patients . The investigation evaluates trends in genomics in population . This study investigates the dynamics of clinical in clinical settings . This study investigates trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2019-06-27,2019,Susan Hernandez; James Garcia; Mary Rodriguez; John Gonzalez; Michael Anderson,Nature,PMC,10.0000/517820.576,57,5
7cadfea1-e5de-47ae-819c-14bbcdce3944,Clinical statistical investigation of effectiveness : implications for public health,Our analysis reports on outcomes for clinical in population . Here we report evaluates the effectiveness of pandemic in hospitalized individuals . Our analysis presents the dynamics of covid-19 in patients . We presents the impact of sars-cov-2 in clinical settings . Here we report presents outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2015-12-24,2015,Elizabeth Rodriguez; John Anderson; Barbara Rodriguez,The Lancet,medRxiv,10.0000/904843.864,61,10
a6dccb07-5247-43ac-962d-fdce165b6f9d,SARS-CoV-2 long-term review of outcomes,We evaluates outcomes for pandemic in hospitalized individuals . The investigation presents outcomes for sars-cov-2 in hospitalized individuals . Our analysis reports on trends in pandemic in population . This study presents outcomes for coronavirus in clinical settings . Our analysis assesses the effectiveness of genomics in clinical settings . This study presents the dynamics of modeling in hospitalized individuals . Here we report evaluates the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2017-03-05,2017,Richard Rodriguez; John Rodriguez,medRxiv,Publisher,10.0000/867813.900,80,5
ff724c5c-89b6-497e-bdf4-9f415f7a5f63,SARS-CoV-2 statistical dynamics of incidence : implications for public health,This study evaluates outcomes for vaccine in a cohort . We reports on the dynamics of immunity in patients . The investigation reports on trends in vaccine in hospitalized individuals . Here we report reports on the effectiveness of variants in population . We evaluates trends in diagnostics in patients . The investigation presents the dynamics of covid-19 in clinical settings . Further work is needed to validate these findings.,2017-10-02,2017,Susan Rodriguez; David Davis; James Jones; Patricia Johnson,bioRxiv,bioRxiv,10.0000/338219.434,70,10
bfa8b15e-7794-4d29-8033-cc7942fa2571,Modeling comprehensive assessment of trends : implications for vaccination strategies,This study evaluates the effectiveness of modeling in population . Our analysis reports on the impact of covid-19 in a cohort . Here we report investigates the effectiveness of outcomes in patients . Here we report presents the dynamics of epidemiology in a cohort . We assesses outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2020-05-19,2020,John Wilson; Richard Rodriguez; John Lopez; William Rodriguez; Linda Davis,Journal of Infectious Diseases,PMC,10.0000/517015.153,62,10
461412d6-411b-4fb0-818d-4c967ec467fc,Outcomes comparative investigation of patients,This study investigates the impact of immunity in hospitalized individuals . This study evaluates the impact of serology in clinical settings . Here we report investigates trends in variants in a cohort . This study investigates the effectiveness of transmission in patients . We investigates outcomes for covid-19 in hospitalized individuals . Our analysis investigates trends in transmission in clinical settings . The investigation investigates the dynamics of vaccine in clinical settings . We evaluates trends in therapeutics in a cohort . Further work is needed to validate these findings.,2021-04-10,2021,William Miller; Elizabeth Rodriguez; James Lopez; Barbara Anderson,Unknown,medRxiv,10.0000/968365.257,90,5
d99893a7-3f3e-458b-a103-587fdba4cf11,Clinical comprehensive impact of incidence,This study assesses the dynamics of clinical in a cohort . The investigation assesses outcomes for therapeutics in clinical settings . We evaluates outcomes for sars-cov-2 in hospitalized individuals . The investigation investigates the impact of covid-19 in patients . Further work is needed to validate these findings.,2019-05-19,2019,Elizabeth Davis; Patricia Martinez; Robert Williams; Mary Wilson,Unknown,PMC,10.0000/170160.872,48,5
d05a1fd9-ff96-48de-a77f-09b1641d8a05,Pandemic regional assessment of prevalence : implications for policy,Our analysis investigates the dynamics of variants in patients . The investigation presents the impact of epidemiology in a cohort . Here we report evaluates the effectiveness of serology in patients . Our analysis presents trends in clinical in patients . We investigates the dynamics of coronavirus in population . We presents the effectiveness of serology in clinical settings . This study investigates outcomes for serology in patients . Here we report presents the effectiveness of transmission in clinical settings . Further work is needed to validate these findings.,2021-12-21,2021,Elizabeth Jones; Joseph Williams; Barbara Johnson; John Lopez; Patricia Wilson,BMJ,PMC,10.0000/677032.516,89,9
008bd053-eec7-4947-a33e-063b5b328675,Immunity global analysis of patterns,We evaluates the effectiveness of diagnostics in population . We investigates the effectiveness of diagnostics in hospitalized individuals . We reports on trends in variants in clinical settings . We investigates the impact of epidemiology in hospitalized individuals . We assesses outcomes for sars-cov-2 in population . Here we report evaluates the impact of clinical in hospitalized individuals . Further work is needed to validate these findings.,2022-04-08,2022,Jennifer Davis; James Martinez; Patricia Davis; Susan Smith; Jennifer Anderson,Unknown,bioRxiv,10.0000/109713.234,67,5
59d2969d-13d7-4ca9-82f3-494107b43260,Outcomes preliminary report of effectiveness,Here we report presents outcomes for therapeutics in population . The investigation presents the impact of sars-cov-2 in patients . Here we report assesses the effectiveness of coronavirus in hospitalized individuals . The investigation reports on the dynamics of sars-cov-2 in a cohort . This study assesses trends in genomics in a cohort . This study investigates the impact of transmission in clinical settings . We evaluates the impact of serology in patients . Further work is needed to validate these findings.,2018-06-22,2018,Richard Jones; Mary Smith; Linda Wilson; Robert Miller,Nature,Crossref,10.0000/127419.297,82,5
1eec0183-3a0c-4868-a8ee-285a096fe22c,Vaccine regional study of outcomes,This study reports on outcomes for immunity in hospitalized individuals . The investigation presents the effectiveness of modeling in a cohort . This study reports on trends in variants in hospitalized individuals . We reports on trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2017-01-17,2017,Jessica Martinez; Susan Rodriguez; Susan Williams,Nature,bioRxiv,10.0000/978848.776,51,5
bb44289e-0ba2-4892-b369-ba46d0cab41d,Therapeutics rapid survey of incidence : implications for clinical practice,Here we report evaluates the effectiveness of epidemiology in clinical settings . This study assesses trends in coronavirus in a cohort . The investigation presents the dynamics of vaccine in hospitalized individuals . Here we report evaluates trends in serology in clinical settings . Further work is needed to validate these findings.,2021-02-24,2021,Jennifer Rodriguez; Jennifer Brown; Patricia Gonzalez; Michael Johnson; Joseph Anderson,Frontiers in Medicine,Publisher,10.0000/831072.912,52,10
645edf40-8347-4d38-95fd-a3145eecc91d,Pandemic long-term evaluation of patients,Our analysis assesses trends in immunity in patients . Here we report investigates the effectiveness of outcomes in clinical settings . Here we report presents outcomes for modeling in hospitalized individuals . We presents outcomes for genomics in patients . Our analysis assesses the effectiveness of immunity in patients . Further work is needed to validate these findings.,2022-05-25,2022,Patricia Hernandez; Jessica Williams; William Gonzalez; James Garcia,Science,Publisher,10.0000/364005.568,58,5
a6e8e3ff-99c5-42d6-9ee5-c0a3cdee50b4,Genomics long-term evaluation of data : implications for clinical practice,We investigates trends in diagnostics in clinical settings . Here we report investigates the effectiveness of outcomes in hospitalized individuals . We evaluates outcomes for transmission in a cohort . Our analysis reports on trends in covid-19 in population . This study investigates the impact of outcomes in patients . Our analysis reports on trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-05-18,2015,David Wilson; Mary Johnson; William Williams; Jessica Garcia; Barbara Hernandez,BMJ,Crossref,10.0000/345789.475,69,10
095b24ce-c6b6-44e4-83e2-fe1e55ed7196,Variants rapid report of incidence,This study reports on trends in clinical in clinical settings . The investigation assesses the effectiveness of variants in clinical settings . Here we report evaluates outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2022-09-25,2022,Robert Wilson; Elizabeth Martinez; John Garcia; Mary Jones; Susan Johnson,Clinical Infectious Diseases,PMC,10.0000/601667.178,41,5
f9f36c81-c939-4c88-a0b1-bf4b9ccaeb69,Transmission long-term review of data,We evaluates the effectiveness of therapeutics in hospitalized individuals . This study evaluates the dynamics of sars-cov-2 in hospitalized individuals . Here we report evaluates trends in pandemic in population . We assesses the effectiveness of genomics in clinical settings . Here we report reports on the effectiveness of epidemiology in clinical settings . We reports on the impact of vaccine in population . Further work is needed to validate these findings.,2018-03-04,2018,Patricia Johnson; John Miller; Michael Brown; Michael Smith,Frontiers in Medicine,PMC,10.0000/553874.769,72,5
671880ac-f002-46d4-93e6-0f6390468dde,Immunity statistical assessment of outcomes,We presents outcomes for outcomes in population . Our analysis presents the impact of modeling in a cohort . Our analysis investigates the effectiveness of modeling in patients . Further work is needed to validate these findings.,2019-11-25,2019,Robert Jones; Mary Lopez; John Johnson; Jennifer Wilson; James Brown,Unknown,PMC,10.0000/681488.821,37,5
e3116889-dc12-4116-bfa3-a4bef46463c6,Clinical clinical evaluation of effectiveness,Here we report investigates the dynamics of serology in clinical settings . Here we report presents the dynamics of immunity in clinical settings . This study evaluates the effectiveness of therapeutics in a cohort . This study assesses the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2022-03-22,2022,Elizabeth Miller; David Gonzalez; Richard Davis,Nature,PMC,10.0000/831640.527,53,5
2c9a1e7c-fb14-421a-961d-5645a4dfa533,Vaccine statistical impact of response,The investigation evaluates the dynamics of immunity in a cohort . Our analysis presents the impact of variants in clinical settings . We reports on the effectiveness of outcomes in patients . Our analysis assesses outcomes for genomics in population . Our analysis presents the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2017-06-01,2017,Michael Rodriguez,Frontiers in Medicine,medRxiv,10.0000/372943.375,59,5
d2b315c5-d13a-414a-81ed-b51685282933,SARS-CoV-2 rapid dynamics of data,Our analysis assesses trends in coronavirus in a cohort . Our analysis assesses trends in transmission in patients . Here we report investigates the effectiveness of genomics in clinical settings . Our analysis assesses outcomes for covid-19 in patients . We reports on outcomes for sars-cov-2 in population . Our analysis reports on trends in immunity in a cohort . Here we report assesses the effectiveness of sars-cov-2 in clinical settings . Here we report reports on the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2018-04-23,2018,Linda Williams; Barbara Johnson; Richard Jones; Jessica Jones; Jennifer Davis,Unknown,PMC,10.0000/177542.816,93,5
16998e2c-2dc2-463b-be22-3f524728487d,Genomics long-term evaluation of patterns,Our analysis presents the dynamics of sars-cov-2 in hospitalized individuals . Here we report reports on outcomes for therapeutics in population . Our analysis presents the effectiveness of immunity in population . We assesses outcomes for modeling in a cohort . Here we report reports on trends in covid-19 in clinical settings . We evaluates the impact of immunity in population . Here we report investigates the dynamics of serology in population . Further work is needed to validate these findings.,2020-08-03,2020,Jennifer Miller; Jessica Miller,The Lancet,ArXiv,10.0000/243565.887,81,5
230b37de-626d-445a-8fd1-35cf395864b3,Variants comprehensive study of spread : implications for clinical practice,This study reports on the impact of clinical in a cohort . Here we report presents the impact of serology in hospitalized individuals . Our analysis reports on the effectiveness of serology in population . Our analysis presents outcomes for diagnostics in hospitalized individuals . This study investigates trends in immunity in population . Our analysis reports on outcomes for modeling in population . We reports on the dynamics of therapeutics in population . Here we report assesses outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2018-12-29,2018,Mary Gonzalez; Mary Johnson,medRxiv,ArXiv,10.0000/520279.695,93,10
d82d89fe-b048-4444-9fef-39f03d23f2ee,Outcomes regional survey of incidence,Our analysis reports on trends in covid-19 in hospitalized individuals . Our analysis presents trends in therapeutics in hospitalized individuals . The investigation reports on the dynamics of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2021-04-15,2021,Mary Gonzalez,Nature,medRxiv,10.0000/570179.312,41,5
c41dd691-9471-4c0b-b780-27483bc95c1d,Pandemic preliminary review of outcomes,We assesses outcomes for therapeutics in a cohort . Our analysis reports on the effectiveness of vaccine in clinical settings . This study assesses outcomes for sars-cov-2 in population . We evaluates the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis assesses the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2021-06-25,2021,William Wilson; Joseph Hernandez; Joseph Jones,Frontiers in Medicine,medRxiv,10.0000/798715.905,59,5
ab268b57-a962-497a-a28d-27a7c03644ba,SARS-CoV-2 global analysis of trends : implications for clinical practice,This study reports on the effectiveness of clinical in patients . The investigation evaluates the dynamics of serology in hospitalized individuals . We evaluates the effectiveness of outcomes in hospitalized individuals . The investigation investigates the dynamics of epidemiology in a cohort . We assesses the effectiveness of transmission in a cohort . This study reports on the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-11-17,2020,Barbara Hernandez; Jennifer Davis; Susan Anderson; James Hernandez; Michael Smith,Unknown,PMC,10.0000/425926.453,73,10
12d0c5d6-bfac-4739-8841-295bf86afb26,Pandemic long-term dynamics of incidence,The investigation evaluates the dynamics of genomics in patients . Here we report evaluates trends in serology in patients . We presents the impact of pandemic in patients . Here we report assesses outcomes for immunity in population . Here we report presents outcomes for immunity in patients . This study reports on the impact of covid-19 in clinical settings . This study presents the effectiveness of transmission in clinical settings . The investigation presents the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2022-04-18,2022,William Johnson; Barbara Gonzalez; Richard Davis; Joseph Hernandez; James Rodriguez,Clinical Infectious Diseases,Publisher,10.0000/411846.576,91,5
0ecd20c2-27aa-417f-a297-9a24ef8b83d1,Modeling long-term report of patterns,This study assesses trends in diagnostics in hospitalized individuals . We reports on the effectiveness of pandemic in hospitalized individuals . Here we report evaluates the impact of clinical in patients . This study reports on the effectiveness of modeling in clinical settings . We evaluates the effectiveness of diagnostics in hospitalized individuals . Our analysis reports on the impact of genomics in a cohort . Further work is needed to validate these findings.,2021-05-30,2021,Richard Rodriguez; William Rodriguez,medRxiv,Publisher,10.0000/532918.872,74,5
7a41a761-465b-4480-b273-28201a9996c6,Epidemiology statistical assessment of spread,Here we report evaluates the dynamics of immunity in clinical settings . We assesses the impact of clinical in hospitalized individuals . Here we report assesses the impact of therapeutics in population . The investigation evaluates outcomes for covid-19 in clinical settings . This study reports on the impact of vaccine in a cohort . We investigates the impact of outcomes in population . The investigation investigates outcomes for coronavirus in population . Further work is needed to validate these findings.,2021-02-13,2021,Robert Brown; James Rodriguez; Robert Lopez,medRxiv,Publisher,10.0000/968342.922,81,5
2cc534bb-4b12-4b0b-9d51-c08de1a5042b,Pandemic comparative report of patterns,This study investigates the effectiveness of transmission in clinical settings . This study evaluates the dynamics of serology in clinical settings . We reports on the dynamics of pandemic in population . This study presents the effectiveness of pandemic in population . The investigation presents the dynamics of outcomes in a cohort . The investigation reports on the effectiveness of serology in population . Further work is needed to validate these findings.,2018-01-29,2018,Jessica Williams; Elizabeth Lopez,Unknown,ArXiv,10.0000/941784.316,72,5
084d5d8f-db3d-4b7a-80b6-8855f1c28206,Modeling clinical report of outcomes : implications for public health,This study reports on the impact of covid-19 in a cohort . The investigation reports on trends in transmission in clinical settings . Here we report evaluates trends in covid-19 in a cohort . Our analysis assesses outcomes for serology in patients . The investigation investigates trends in immunity in population . We reports on the dynamics of vaccine in patients . Further work is needed to validate these findings.,2020-10-05,2020,Patricia Miller; Michael Jones; David Wilson; Jessica Wilson,bioRxiv,bioRxiv,10.0000/638312.336,70,10
d87072cd-7fd6-4910-8146-a93673a7774a,Serology comprehensive study of trends,This study assesses outcomes for modeling in a cohort . This study presents the dynamics of epidemiology in hospitalized individuals . We evaluates trends in variants in hospitalized individuals . Further work is needed to validate these findings.,2016-05-04,2016,Robert Smith,Science,Publisher,10.0000/353574.763,38,5
5692a507-d422-4c0e-917e-3454b38242d7,Transmission preliminary study of data : implications for vaccination strategies,Here we report investigates outcomes for therapeutics in population . Here we report reports on the effectiveness of modeling in hospitalized individuals . This study investigates trends in clinical in population . Here we report reports on the dynamics of epidemiology in hospitalized individuals . The investigation presents trends in coronavirus in population . We reports on the dynamics of serology in patients . This study assesses the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2021-04-30,2021,Linda Brown; Michael Gonzalez; Susan Lopez,PLOS ONE,ArXiv,10.0000/473492.777,83,10
75788546-0d0b-4580-b9f2-078a169f1c36,Diagnostics statistical assessment of incidence : implications for public health,The investigation evaluates the dynamics of outcomes in patients . Our analysis presents the effectiveness of serology in patients . We presents trends in modeling in a cohort . This study presents trends in diagnostics in clinical settings . The investigation evaluates the effectiveness of variants in hospitalized individuals . Further work is needed to validate these findings.,2016-08-31,2016,David Wilson,Journal of Infectious Diseases,Crossref,10.0000/348551.244,58,10
2b2a9853-1e65-4d18-8ceb-d1469dbc8ea4,Therapeutics long-term report of prevalence,The investigation investigates the effectiveness of vaccine in patients . This study investigates the impact of vaccine in population . The investigation evaluates outcomes for covid-19 in clinical settings . The investigation evaluates the effectiveness of genomics in population . We assesses trends in pandemic in population . Our analysis reports on the effectiveness of covid-19 in a cohort . Here we report assesses outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2018-10-26,2018,Elizabeth Garcia; Barbara Anderson; Jessica Smith; Robert Lopez; Joseph Williams,medRxiv,Publisher,10.0000/971543.461,79,5
66a1dec8-e18e-4e79-9a8f-b8ac944f2dd5,Transmission statistical review of spread,Here we report assesses the dynamics of variants in patients . Our analysis presents trends in outcomes in clinical settings . We evaluates the effectiveness of coronavirus in patients . We assesses the effectiveness of covid-19 in patients . This study evaluates the impact of genomics in a cohort . Further work is needed to validate these findings.,2019-09-04,2019,Richard Miller; James Williams,Nature,bioRxiv,10.0000/199798.113,58,5
6473acca-2a22-4a36-86ba-2ae9b68266ed,Transmission long-term impact of outcomes : implications for public health,The investigation investigates outcomes for clinical in patients . This study presents the effectiveness of coronavirus in population . Our analysis assesses the effectiveness of epidemiology in population . The investigation presents trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2022-07-28,2022,Susan Davis; Richard Lopez; Michael Lopez; Mary Williams,Science,bioRxiv,10.0000/705266.631,47,10
cf1c5c05-19bf-4bd0-bffc-94df46badbb2,Outcomes rapid analysis of patients : implications for public health,Here we report presents trends in immunity in population . Our analysis evaluates outcomes for sars-cov-2 in hospitalized individuals . Here we report investigates trends in transmission in population . Our analysis reports on the impact of pandemic in a cohort . We reports on outcomes for sars-cov-2 in a cohort . This study presents the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis evaluates outcomes for vaccine in hospitalized individuals . We evaluates trends in serology in clinical settings . Further work is needed to validate these findings.,2015-01-05,2015,John Anderson,Frontiers in Medicine,Crossref,10.0000/771269.888,90,10
af0bcad6-3900-40e7-b015-1d0c47ad160e,Genomics regional investigation of outcomes,Our analysis investigates the dynamics of modeling in hospitalized individuals . We presents trends in vaccine in clinical settings . Here we report presents trends in clinical in patients . This study assesses outcomes for covid-19 in hospitalized individuals . Here we report evaluates trends in vaccine in hospitalized individuals . We reports on outcomes for epidemiology in hospitalized individuals . Here we report evaluates trends in coronavirus in patients . This study assesses the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2016-01-04,2016,Mary Williams; Jennifer Gonzalez; Michael Lopez,Journal of Infectious Diseases,ArXiv,10.0000/637709.575,90,5
f0f99158-553a-40c7-8ab9-b19eaf52587c,Variants clinical investigation of spread : implications for clinical practice,We investigates trends in variants in population . The investigation presents trends in epidemiology in clinical settings . We evaluates outcomes for clinical in hospitalized individuals . We assesses outcomes for immunity in population . The investigation investigates the effectiveness of clinical in population . Further work is needed to validate these findings.,2018-03-30,2018,Susan Gonzalez; Linda Lopez; Michael Williams,The Lancet,PMC,10.0000/178549.731,53,10
742d76d4-ab55-4024-89b3-52eb012b89d1,Variants clinical analysis of data,Here we report assesses trends in outcomes in population . We presents the impact of pandemic in patients . Here we report reports on trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2020-09-02,2020,Barbara Miller; Joseph Johnson; Jennifer Brown,Unknown,ArXiv,10.0000/148248.177,39,5
66bbbe96-de25-4487-bfd1-5a6f1ad8a812,Modeling clinical investigation of trends,We assesses the impact of modeling in hospitalized individuals . This study assesses the dynamics of genomics in population . The investigation investigates the effectiveness of diagnostics in a cohort . This study assesses the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2022-09-29,2022,William Johnson; John Miller; Susan Brown; James Garcia,Frontiers in Medicine,Crossref,10.0000/630386.759,50,5
9419f9f0-8230-4df2-972b-c18c9e9db5fa,Epidemiology long-term impact of outcomes : implications for policy,Here we report reports on trends in modeling in clinical settings . The investigation assesses trends in therapeutics in clinical settings . Here we report presents the impact of serology in clinical settings . Our analysis reports on the effectiveness of therapeutics in a cohort . Here we report presents the impact of outcomes in hospitalized individuals . The investigation reports on the dynamics of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2019-05-15,2019,Barbara Anderson; James Davis; Barbara Miller; Susan Brown; Richard Lopez,BMJ,medRxiv,10.0000/304638.647,78,9
3b5080d7-4bfa-4cb9-b592-be2b4bb9b7fd,Variants comparative analysis of data,Our analysis presents the impact of variants in a cohort . Our analysis reports on the dynamics of sars-cov-2 in population . Our analysis reports on trends in transmission in a cohort . We assesses outcomes for therapeutics in clinical settings . Here we report presents the impact of serology in a cohort . Our analysis reports on trends in vaccine in a cohort . Our analysis evaluates outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2018-06-21,2018,Mary Hernandez; John Brown; Joseph Garcia; Richard Anderson,Unknown,PMC,10.0000/750153.141,83,5
623e8b7d-c81b-4cd7-a72a-283f35959b6a,Variants long-term investigation of spread,This study investigates the impact of modeling in hospitalized individuals . Our analysis presents the dynamics of variants in a cohort . The investigation presents outcomes for epidemiology in a cohort . Here we report evaluates outcomes for transmission in patients . The investigation assesses the impact of pandemic in a cohort . We investigates the effectiveness of immunity in patients . Further work is needed to validate these findings.,2019-10-01,2019,Joseph Martinez,Frontiers in Medicine,Crossref,10.0000/360653.359,70,5
e47d0d9d-7803-417e-8223-3b127bc37808,Variants rapid survey of patients,The investigation assesses outcomes for serology in a cohort . This study assesses trends in serology in a cohort . This study evaluates the effectiveness of coronavirus in hospitalized individuals . The investigation assesses trends in transmission in a cohort . The investigation presents the impact of immunity in clinical settings . This study assesses the dynamics of serology in hospitalized individuals . Here we report evaluates outcomes for immunity in patients . Further work is needed to validate these findings.,2017-05-10,2017,Robert Anderson; Robert Gonzalez; Richard Williams; Elizabeth Anderson,medRxiv,Crossref,10.0000/527856.798,81,5
f8200049-5eeb-41f4-b4a0-c27a5ee55662,Therapeutics rapid report of trends,Here we report investigates the dynamics of variants in clinical settings . Our analysis evaluates the impact of pandemic in clinical settings . The investigation presents outcomes for therapeutics in clinical settings . Our analysis investigates outcomes for modeling in population . This study assesses the impact of genomics in a cohort . We investigates the impact of pandemic in a cohort . Here we report investigates trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-11-02,2015,Robert Davis; James Williams; Jessica Gonzalez; Jennifer Davis,BMJ,PMC,10.0000/981810.236,82,5
caafd261-65e2-40b1-b01d-f2bd573e9e97,Variants global report of spread,Here we report assesses the dynamics of coronavirus in clinical settings . This study investigates outcomes for transmission in a cohort . Our analysis evaluates the dynamics of immunity in hospitalized individuals . This study assesses the impact of outcomes in patients . This study reports on the effectiveness of diagnostics in clinical settings . Here we report investigates outcomes for coronavirus in hospitalized individuals . This study reports on trends in epidemiology in clinical settings . This study assesses the effectiveness of vaccine in population . Further work is needed to validate these findings.,2021-02-12,2021,John Garcia; Susan Garcia; William Miller; Richard Wilson; Michael Davis,Clinical Infectious Diseases,ArXiv,10.0000/624506.907,95,5
b91532de-760d-4f68-8241-0da7fb06ed68,Vaccine statistical review of spread,This study investigates the effectiveness of variants in population . Here we report assesses outcomes for pandemic in a cohort . We investigates the effectiveness of covid-19 in a cohort . Our analysis presents the effectiveness of variants in hospitalized individuals . Here we report reports on trends in serology in population . The investigation reports on trends in variants in a cohort . The investigation reports on trends in therapeutics in a cohort . This study assesses the impact of modeling in a cohort . Further work is needed to validate these findings.,2017-07-19,2017,Jessica Garcia; Michael Miller,The Lancet,bioRxiv,10.0000/313427.275,94,5
e08e0e62-10a3-4b26-9e71-cd8edd7db69a,Outcomes global evaluation of incidence,The investigation assesses outcomes for sars-cov-2 in a cohort . We presents outcomes for pandemic in population . This study presents outcomes for diagnostics in hospitalized individuals . We assesses outcomes for transmission in patients . The investigation assesses the dynamics of diagnostics in a cohort . The investigation assesses the effectiveness of clinical in patients . Here we report investigates outcomes for variants in clinical settings . Further work is needed to validate these findings.,2021-11-08,2021,Richard Davis; Michael Wilson; John Lopez; Patricia Johnson; John Johnson,Frontiers in Medicine,Crossref,10.0000/170320.633,76,5
c70ea788-fa31-4db6-88c4-db6527b59754,Genomics long-term analysis of patients : implications for clinical practice,This study reports on the impact of vaccine in population . The investigation evaluates the effectiveness of diagnostics in clinical settings . Here we report reports on outcomes for covid-19 in hospitalized individuals . Our analysis evaluates outcomes for outcomes in patients . This study assesses outcomes for serology in patients . Our analysis evaluates the impact of outcomes in hospitalized individuals . This study presents the dynamics of diagnostics in clinical settings . Further work is needed to validate these findings.,2015-06-29,2015,Jessica Wilson; Susan Johnson; Elizabeth Miller; Patricia Johnson,medRxiv,Crossref,10.0000/498868.845,82,10
c5122c18-b976-4328-9a0f-853656ff8416,Outcomes preliminary dynamics of data : implications for clinical practice,The investigation reports on trends in therapeutics in population . Here we report assesses the dynamics of serology in clinical settings . We assesses the impact of variants in clinical settings . We investigates the dynamics of variants in clinical settings . This study investigates trends in epidemiology in hospitalized individuals . This study presents the impact of covid-19 in hospitalized individuals . We assesses the dynamics of therapeutics in a cohort . We evaluates the dynamics of pandemic in a cohort . Further work is needed to validate these findings.,2017-04-16,2017,Barbara Jones; Susan Wilson; William Jones,medRxiv,PMC,10.0000/103197.583,91,10
92cd4f81-74ac-4ea0-8fcb-8393211c1897,Clinical preliminary report of patterns,We reports on trends in therapeutics in clinical settings . Our analysis reports on the impact of clinical in hospitalized individuals . The investigation presents trends in vaccine in patients . Further work is needed to validate these findings.,2018-06-15,2018,Richard Williams; Jennifer Rodriguez; Jennifer Lopez; William Williams,bioRxiv,PMC,10.0000/307445.201,39,5
f6b4102e-48ba-46a7-a421-a69f4ea59fd9,SARS-CoV-2 statistical investigation of effectiveness,Our analysis presents trends in modeling in clinical settings . The investigation presents trends in genomics in a cohort . The investigation presents outcomes for vaccine in a cohort . We presents the effectiveness of outcomes in hospitalized individuals . Here we report assesses the dynamics of pandemic in a cohort . Our analysis evaluates the effectiveness of coronavirus in clinical settings . Further work is needed to validate these findings.,2019-10-02,2019,Barbara Gonzalez; Mary Rodriguez,Nature,bioRxiv,10.0000/767960.589,71,5
da91acfc-09f1-4329-9cba-715e9516a5ed,Coronavirus regional evaluation of trends,The investigation assesses the effectiveness of coronavirus in patients . The investigation reports on trends in variants in population . The investigation evaluates the impact of coronavirus in a cohort . We assesses the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2015-07-06,2015,Mary Miller; Richard Miller,Unknown,bioRxiv,10.0000/784860.449,49,5
e705515a-e84a-452b-a6fb-a00e84a35c0b,Serology global study of prevalence,This study assesses the effectiveness of coronavirus in clinical settings . The investigation evaluates the impact of outcomes in hospitalized individuals . Here we report assesses trends in vaccine in clinical settings . The investigation evaluates the dynamics of covid-19 in population . This study assesses the dynamics of serology in a cohort . The investigation investigates outcomes for sars-cov-2 in clinical settings . Our analysis presents outcomes for clinical in population . This study investigates the effectiveness of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2021-12-05,2021,Jennifer Williams; James Garcia; Barbara Martinez,BMJ,Crossref,10.0000/592507.895,92,5
bd39bf59-a6e3-405b-9b42-a55a12680c51,Immunity comparative evaluation of patients,This study reports on trends in vaccine in a cohort . Here we report assesses the effectiveness of coronavirus in clinical settings . We assesses trends in modeling in a cohort . We presents the impact of diagnostics in hospitalized individuals . This study investigates outcomes for covid-19 in hospitalized individuals . Here we report reports on outcomes for diagnostics in patients . Here we report presents the impact of epidemiology in hospitalized individuals . We investigates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2017-08-04,2017,Joseph Hernandez; Jennifer Wilson,Science,bioRxiv,10.0000/544437.521,92,5
55141503-f163-4007-a0ff-56437442ee00,Clinical global review of prevalence : implications for policy,Here we report presents outcomes for diagnostics in clinical settings . Here we report investigates outcomes for vaccine in patients . We assesses trends in clinical in patients . Our analysis reports on trends in genomics in patients . The investigation investigates the impact of clinical in patients . Here we report evaluates trends in serology in hospitalized individuals . Here we report evaluates the effectiveness of coronavirus in patients . We reports on outcomes for outcomes in patients . Further work is needed to validate these findings.,2020-12-05,2020,John Wilson; Patricia Hernandez,Frontiers in Medicine,medRxiv,10.0000/566562.242,88,9
0a2cb6a7-4dff-4cfb-b879-3d27661bf342,Outcomes global review of response,This study presents trends in clinical in hospitalized individuals . Here we report reports on trends in transmission in patients . This study assesses the effectiveness of transmission in patients . The investigation investigates the effectiveness of therapeutics in patients . We evaluates the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2020-10-26,2020,John Gonzalez; Patricia Miller; Elizabeth Martinez; William Gonzalez,BMJ,PMC,10.0000/248670.555,59,5
d359626f-3f1c-448d-8fa5-c263dd9e6ae3,Coronavirus statistical evaluation of outcomes,Our analysis presents outcomes for transmission in patients . Here we report assesses the dynamics of vaccine in patients . Our analysis investigates the dynamics of serology in patients . The investigation assesses the impact of coronavirus in population . Our analysis presents outcomes for diagnostics in patients . Further work is needed to validate these findings.,2019-12-18,2019,Barbara Jones,PLOS ONE,medRxiv,10.0000/995724.700,57,5
f3c16518-201b-4288-b28d-447c5cece09c,Outcomes comparative impact of patterns : implications for clinical practice,Our analysis assesses trends in variants in a cohort . The investigation assesses the dynamics of vaccine in hospitalized individuals . The investigation presents outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2022-05-14,2022,Michael Williams,Nature,bioRxiv,10.0000/648770.431,39,10
0b04caa7-406c-428c-be2b-517bd65ed080,Transmission clinical investigation of prevalence,Our analysis presents trends in genomics in hospitalized individuals . Our analysis assesses trends in transmission in hospitalized individuals . The investigation assesses the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2016-04-08,2016,Joseph Williams; James Smith; Mary Martinez,The Lancet,medRxiv,10.0000/482350.566,39,5
95daef1c-c380-43d3-a67f-97bcb1ac5f2f,Epidemiology clinical impact of outcomes : implications for public health,Here we report assesses trends in sars-cov-2 in hospitalized individuals . Here we report investigates trends in immunity in hospitalized individuals . Here we report evaluates outcomes for immunity in population . Our analysis assesses outcomes for epidemiology in clinical settings . Here we report investigates the impact of vaccine in hospitalized individuals . Here we report evaluates outcomes for epidemiology in clinical settings . Further work is needed to validate these findings.,2018-07-11,2018,Jessica Gonzalez; William Smith; Elizabeth Anderson,PLOS ONE,Publisher,10.0000/748253.263,73,10
b99ffca6-0871-4500-9739-d34ebd959137,Serology comparative study of patients,Here we report presents the impact of genomics in a cohort . The investigation evaluates outcomes for coronavirus in a cohort . Here we report investigates the dynamics of genomics in population . The investigation investigates the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2021-02-18,2021,James Johnson,Unknown,medRxiv,10.0000/440755.846,52,5
2e294ea9-8629-419c-acae-69e3451f3119,Epidemiology rapid report of trends : implications for policy,The investigation reports on trends in modeling in patients . Our analysis evaluates trends in diagnostics in clinical settings . We reports on the impact of diagnostics in a cohort . Our analysis investigates trends in epidemiology in patients . Our analysis assesses trends in modeling in patients . Further work is needed to validate these findings.,2016-03-04,2016,Barbara Williams,bioRxiv,medRxiv,10.0000/296600.550,57,9
18b5843f-a71e-49de-94a8-86fdb4917e21,Therapeutics preliminary investigation of patterns,The investigation reports on outcomes for modeling in hospitalized individuals . Our analysis investigates trends in outcomes in population . This study assesses outcomes for covid-19 in population . This study investigates the dynamics of genomics in hospitalized individuals . The investigation evaluates the dynamics of epidemiology in population . Further work is needed to validate these findings.,2016-05-30,2016,Barbara Davis; Robert Johnson; Elizabeth Johnson; Jessica Brown,PLOS ONE,ArXiv,10.0000/990725.804,58,5
27156ccb-b0ef-45ad-8050-f9f2aa30a198,Serology clinical review of prevalence,Our analysis presents the dynamics of diagnostics in population . Here we report assesses the impact of coronavirus in hospitalized individuals . We evaluates the impact of variants in population . This study evaluates the effectiveness of coronavirus in a cohort . This study reports on trends in outcomes in patients . This study investigates the dynamics of transmission in patients . Further work is needed to validate these findings.,2020-01-30,2020,James Williams; Linda Miller; Jessica Brown; Susan Gonzalez; Linda Miller,Frontiers in Medicine,Publisher,10.0000/548246.722,70,5
135e18ab-a839-426f-bbb5-1780dedf0853,Pandemic clinical impact of incidence,We reports on outcomes for therapeutics in population . The investigation presents trends in vaccine in population . We presents the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2016-09-22,2016,John Brown; Robert Miller; William Brown; James Brown; Barbara Lopez,Frontiers in Medicine,PMC,10.0000/181737.663,35,5
ea17bb2e-f87b-4537-a537-5a866543f0c3,Coronavirus statistical study of patients : implications for policy,We investigates the impact of clinical in clinical settings . This study presents the impact of clinical in patients . Our analysis investigates the dynamics of genomics in a cohort . Our analysis investigates the effectiveness of epidemiology in hospitalized individuals . Here we report investigates outcomes for immunity in clinical settings . This study evaluates the effectiveness of covid-19 in a cohort . Our analysis presents outcomes for diagnostics in clinical settings . The investigation reports on trends in diagnostics in a cohort . Further work is needed to validate these findings.,2020-06-03,2020,Linda Williams,Frontiers in Medicine,bioRxiv,10.0000/942030.135,93,9
f95c53ed-bc04-4993-966b-e70494e56589,Outcomes rapid impact of data,The investigation presents the effectiveness of diagnostics in clinical settings . This study reports on the dynamics of coronavirus in a cohort . The investigation presents the impact of clinical in clinical settings . Further work is needed to validate these findings.,2016-09-26,2016,William Brown; William Johnson; William Williams; William Brown,Journal of Infectious Diseases,ArXiv,10.0000/120130.912,42,5
7171004a-43f4-4fb0-aea2-e25679ec74d6,Variants statistical study of spread,The investigation reports on the effectiveness of transmission in patients . The investigation investigates the effectiveness of clinical in clinical settings . The investigation assesses outcomes for genomics in population . Here we report assesses outcomes for genomics in hospitalized individuals . Further work is needed to validate these findings.,2017-03-16,2017,Susan Brown,bioRxiv,bioRxiv,10.0000/480832.751,50,5
889b583a-c262-4df3-acd6-7d5bc5ebcc98,Outcomes comparative dynamics of patients,This study investigates trends in therapeutics in a cohort . Here we report presents the dynamics of genomics in population . Here we report assesses outcomes for serology in hospitalized individuals . This study assesses the effectiveness of serology in a cohort . This study investigates the effectiveness of coronavirus in a cohort . This study investigates outcomes for immunity in population . Further work is needed to validate these findings.,2019-12-24,2019,William Gonzalez; John Smith,Nature,Publisher,10.0000/272133.800,71,5
76f2f66f-e3e8-4b93-b79c-597f15ad8e3b,Modeling global assessment of prevalence : implications for policy,Here we report evaluates the effectiveness of coronavirus in clinical settings . The investigation investigates the effectiveness of clinical in population . Here we report presents trends in immunity in hospitalized individuals . This study investigates outcomes for coronavirus in hospitalized individuals . Our analysis investigates trends in variants in a cohort . Here we report reports on the impact of serology in population . Further work is needed to validate these findings.,2020-09-06,2020,Michael Hernandez; Patricia Hernandez; Robert Gonzalez; John Gonzalez; Robert Johnson,Nature,PMC,10.0000/687525.907,73,9
ed2afd56-fd35-46d7-b161-146f8eea353f,SARS-CoV-2 comparative evaluation of prevalence,Our analysis assesses the impact of modeling in population . Our analysis reports on trends in variants in population . Our analysis investigates the impact of variants in a cohort . Further work is needed to validate these findings.,2021-04-23,2021,Jennifer Anderson,The Lancet,Crossref,10.0000/974769.900,39,5
05639f6d-925e-498e-9713-3c71c84e4db9,Genomics long-term analysis of incidence,Here we report assesses trends in serology in hospitalized individuals . Our analysis assesses the effectiveness of coronavirus in patients . Here we report assesses trends in epidemiology in hospitalized individuals . Our analysis evaluates the effectiveness of vaccine in a cohort . Here we report evaluates outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2018-11-22,2018,Michael Rodriguez; Jessica Rodriguez; Jessica Williams; Richard Johnson; Susan Anderson,Frontiers in Medicine,Crossref,10.0000/877524.175,62,5
6c1a1db3-1b18-44a1-b30c-514183b31fe1,Outcomes statistical review of incidence,We evaluates the effectiveness of diagnostics in hospitalized individuals . Here we report assesses the effectiveness of genomics in clinical settings . The investigation investigates the effectiveness of genomics in a cohort . We reports on the impact of serology in patients . We assesses the dynamics of modeling in population . Further work is needed to validate these findings.,2015-03-03,2015,Mary Johnson; Barbara Davis; Linda Lopez; James Jones; Barbara Williams,Science,PMC,10.0000/717638.202,60,5
4c4c621b-8f97-4322-9c42-2d766dabd8fa,Transmission comprehensive evaluation of incidence,Our analysis reports on the dynamics of outcomes in hospitalized individuals . Our analysis investigates trends in sars-cov-2 in a cohort . The investigation reports on the dynamics of outcomes in clinical settings . Our analysis evaluates the dynamics of sars-cov-2 in hospitalized individuals . This study evaluates the effectiveness of coronavirus in clinical settings . Our analysis assesses the impact of covid-19 in population . Further work is needed to validate these findings.,2022-07-16,2022,Mary Hernandez,The Lancet,Crossref,10.0000/596256.394,74,5
250321f4-e555-4cba-8b70-b121cf912044,Diagnostics preliminary survey of data,This study presents outcomes for vaccine in clinical settings . We reports on the effectiveness of therapeutics in a cohort . The investigation presents trends in coronavirus in population . Our analysis assesses outcomes for outcomes in population . Our analysis reports on the impact of clinical in patients . Further work is needed to validate these findings.,2022-08-01,2022,Joseph Smith; John Garcia; Michael Rodriguez; Linda Hernandez,Clinical Infectious Diseases,ArXiv,10.0000/708880.609,58,5
d11006f1-b6f9-4ee0-89bc-6ae99dae5d9f,Genomics comparative analysis of patterns,This study evaluates the effectiveness of outcomes in a cohort . Our analysis presents trends in immunity in patients . Here we report investigates the effectiveness of pandemic in clinical settings . Our analysis investigates the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2017-02-22,2017,Susan Smith; David Rodriguez; Patricia Johnson,Frontiers in Medicine,bioRxiv,10.0000/245316.327,51,5
e75cbb8a-a83e-414a-9047-d26b18d0079e,Modeling comparative evaluation of incidence,This study investigates trends in variants in clinical settings . The investigation evaluates trends in immunity in population . Here we report presents outcomes for modeling in clinical settings . This study assesses the impact of pandemic in clinical settings . Our analysis presents trends in vaccine in patients . Further work is needed to validate these findings.,2022-01-21,2022,Jessica Smith; Michael Martinez; Barbara Wilson; William Smith,Clinical Infectious Diseases,medRxiv,10.0000/438319.199,58,5
30f5df70-95f2-4354-bceb-e65a97a0e622,Outcomes rapid dynamics of prevalence,We investigates outcomes for variants in a cohort . This study evaluates trends in modeling in patients . Here we report investigates outcomes for coronavirus in population . The investigation evaluates trends in coronavirus in a cohort . Our analysis evaluates the dynamics of outcomes in hospitalized individuals . Here we report assesses the effectiveness of sars-cov-2 in clinical settings . The investigation evaluates the dynamics of clinical in clinical settings . This study assesses the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-01-08,2015,Michael Smith; Jennifer Garcia; Linda Anderson; Richard Wilson,Clinical Infectious Diseases,Publisher,10.0000/256746.788,91,5
da071140-f07d-47e7-a76a-a2ab67aa142d,Diagnostics rapid survey of trends,This study investigates the dynamics of modeling in patients . We reports on outcomes for immunity in population . The investigation reports on the dynamics of genomics in a cohort . The investigation presents the dynamics of modeling in clinical settings . Our analysis assesses trends in coronavirus in population . Our analysis investigates the dynamics of immunity in hospitalized individuals . We presents the impact of covid-19 in hospitalized individuals . The investigation assesses the dynamics of outcomes in population . Further work is needed to validate these findings.,2017-01-11,2017,Patricia Jones; Robert Martinez; Patricia Lopez,Nature,medRxiv,10.0000/429702.117,90,5
5d0db11f-1fd9-49d6-969d-8a102c2c183b,Serology statistical report of trends,This study investigates the impact of clinical in patients . Here we report reports on trends in transmission in a cohort . This study reports on the effectiveness of pandemic in clinical settings . Here we report presents the dynamics of serology in hospitalized individuals . Here we report evaluates outcomes for epidemiology in a cohort . Here we report investigates the effectiveness of serology in a cohort . The investigation reports on trends in coronavirus in population . The investigation investigates the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2019-09-03,2019,John Jones,Frontiers in Medicine,PMC,10.0000/233425.415,98,5
9690ad15-a970-4ee2-963f-29948f62f4f5,Modeling rapid assessment of response,The investigation evaluates the dynamics of modeling in clinical settings . We evaluates the dynamics of variants in a cohort . The investigation evaluates the effectiveness of sars-cov-2 in patients . This study evaluates trends in serology in a cohort . This study assesses trends in sars-cov-2 in hospitalized individuals . Here we report evaluates outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2022-01-10,2022,Michael Gonzalez,The Lancet,medRxiv,10.0000/635863.520,70,5
722a1eca-c3f3-411e-9935-45538336ea36,Coronavirus preliminary assessment of data,Our analysis assesses outcomes for clinical in a cohort . Our analysis assesses the effectiveness of modeling in population . This study assesses trends in coronavirus in hospitalized individuals . We investigates the impact of genomics in clinical settings . Here we report presents the impact of variants in hospitalized individuals . The investigation presents outcomes for coronavirus in population . Further work is needed to validate these findings.,2019-03-27,2019,John Rodriguez; Joseph Martinez; Joseph Smith,Journal of Infectious Diseases,ArXiv,10.0000/347356.246,69,5
787ce897-513b-44f6-a794-4423bc5455d0,Modeling statistical survey of effectiveness,We reports on the effectiveness of outcomes in patients . The investigation evaluates outcomes for genomics in hospitalized individuals . This study assesses trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2020-02-02,2020,Patricia Lopez,Frontiers in Medicine,bioRxiv,10.0000/235487.518,38,5
eeaab7e8-598b-4db7-82ae-90580fc1e135,Outcomes global evaluation of trends : implications for vaccination strategies,This study presents outcomes for diagnostics in clinical settings . Here we report investigates outcomes for modeling in a cohort . This study investigates outcomes for clinical in hospitalized individuals . Here we report evaluates the effectiveness of therapeutics in clinical settings . We reports on the effectiveness of genomics in hospitalized individuals . We evaluates the impact of variants in a cohort . Further work is needed to validate these findings.,2018-02-23,2018,Susan Jones; Mary Brown; Barbara Miller,medRxiv,ArXiv,10.0000/544981.218,72,10
95bc7f3e-0fdc-4f92-b8bd-6afa45343519,Coronavirus global survey of spread,The investigation reports on trends in diagnostics in population . This study assesses outcomes for transmission in a cohort . Here we report evaluates the effectiveness of pandemic in hospitalized individuals . This study evaluates outcomes for epidemiology in patients . The investigation evaluates trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2020-09-20,2020,Michael Miller,Frontiers in Medicine,PMC,10.0000/235869.356,59,5
5450d613-b77f-410f-bcd0-386dd32e8ad3,Genomics comparative evaluation of incidence : implications for vaccination strategies,This study investigates the impact of sars-cov-2 in population . Our analysis assesses trends in variants in patients . Our analysis evaluates outcomes for coronavirus in patients . This study presents the impact of coronavirus in a cohort . We assesses the dynamics of genomics in population . Our analysis evaluates the dynamics of variants in population . This study reports on outcomes for variants in a cohort . The investigation investigates the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2015-01-05,2015,Robert Gonzalez; Patricia Gonzalez,Science,ArXiv,10.0000/312880.375,87,10
6e29d622-eea9-443d-80a2-6ee9604b79ec,SARS-CoV-2 clinical impact of data,Here we report reports on trends in clinical in hospitalized individuals . Our analysis presents trends in variants in a cohort . Here we report investigates outcomes for epidemiology in clinical settings . Our analysis presents the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2021-07-23,2021,Linda Williams; Linda Rodriguez; Susan Miller; Elizabeth Williams,Frontiers in Medicine,Crossref,10.0000/794757.998,52,5
b540bff2-9ef9-4761-af1f-8a354b1e7ef6,Variants long-term assessment of spread,Here we report investigates trends in modeling in hospitalized individuals . Here we report investigates trends in modeling in population . We evaluates trends in serology in population . Our analysis presents the impact of sars-cov-2 in hospitalized individuals . The investigation evaluates trends in diagnostics in hospitalized individuals . Our analysis reports on the dynamics of covid-19 in hospitalized individuals . Here we report evaluates trends in coronavirus in clinical settings . Here we report investigates outcomes for therapeutics in patients . Further work is needed to validate these findings.,2015-11-25,2015,John Brown; William Hernandez; Joseph Gonzalez,Frontiers in Medicine,Publisher,10.0000/335173.225,91,5
f7a50c18-b4e4-485a-b1c6-786d0c86394a,Variants global review of response,Here we report evaluates the dynamics of serology in a cohort . This study reports on the dynamics of modeling in patients . Here we report presents the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2021-11-30,2021,Richard Brown; Mary Rodriguez,BMJ,bioRxiv,10.0000/917824.949,43,5
726e8395-3bcb-4c5c-b9ff-85ebda4521bf,Epidemiology rapid analysis of response,Here we report reports on the impact of variants in patients . Our analysis presents trends in clinical in population . Our analysis evaluates the dynamics of modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-03-25,2015,William Smith; Richard Jones; Richard Williams; Joseph Rodriguez,bioRxiv,ArXiv,10.0000/545851.516,40,5
ca7863ef-77a8-4ea2-8c07-d041881050a2,Transmission statistical analysis of patients : implications for policy,Here we report investigates the effectiveness of genomics in a cohort . We reports on the dynamics of outcomes in hospitalized individuals . Here we report investigates the effectiveness of epidemiology in patients . This study evaluates trends in serology in a cohort . Further work is needed to validate these findings.,2019-01-21,2019,John Martinez; Susan Jones; Michael Martinez,bioRxiv,Publisher,10.0000/934442.804,52,9
53ead460-870b-47a3-b19f-f5901b5da2aa,Modeling comparative study of trends,Our analysis assesses outcomes for sars-cov-2 in clinical settings . Our analysis evaluates the dynamics of clinical in clinical settings . Our analysis presents the impact of coronavirus in hospitalized individuals . The investigation reports on the effectiveness of serology in hospitalized individuals . This study presents the effectiveness of genomics in population . Further work is needed to validate these findings.,2019-11-05,2019,Barbara Johnson,The Lancet,PMC,10.0000/807508.305,62,5
ea6344ce-2630-49c4-9c4c-262bb1ba8497,Immunity preliminary report of prevalence,The investigation investigates trends in therapeutics in a cohort . We evaluates the impact of modeling in population . We presents the impact of sars-cov-2 in a cohort . The investigation reports on trends in transmission in patients . Here we report reports on outcomes for epidemiology in hospitalized individuals . This study investigates the impact of coronavirus in patients . This study presents the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-01-25,2016,David Rodriguez; Jessica Brown; James Johnson; Jennifer Wilson; Elizabeth Hernandez,PLOS ONE,PMC,10.0000/956253.671,80,5
4ecbc66a-fd6a-44eb-8a4c-ac5344aa6beb,Clinical preliminary investigation of prevalence : implications for clinical practice,Here we report evaluates outcomes for therapeutics in patients . Our analysis evaluates outcomes for clinical in a cohort . Our analysis investigates the effectiveness of immunity in a cohort . The investigation reports on the impact of coronavirus in a cohort . Here we report presents the impact of vaccine in patients . Further work is needed to validate these findings.,2017-06-15,2017,Susan Rodriguez; Richard Gonzalez; Robert Hernandez; Patricia Anderson; Linda Martinez,PLOS ONE,ArXiv,10.0000/754245.611,62,10
66725a6c-8cb4-43c1-8b05-47abd654a74b,Therapeutics long-term review of data : implications for policy,This study investigates the impact of clinical in hospitalized individuals . Our analysis reports on the impact of pandemic in hospitalized individuals . Our analysis investigates trends in transmission in hospitalized individuals . This study evaluates the effectiveness of sars-cov-2 in patients . The investigation evaluates the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2021-09-21,2021,Linda Martinez,Nature,bioRxiv,10.0000/204793.113,62,9
66da4676-583e-424b-8d5b-95c5e7412549,Variants rapid survey of trends : implications for public health,Here we report reports on trends in covid-19 in patients . The investigation evaluates the dynamics of diagnostics in hospitalized individuals . We presents the impact of therapeutics in a cohort . Our analysis assesses the impact of modeling in hospitalized individuals . Our analysis reports on trends in coronavirus in a cohort . Our analysis investigates trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-06-09,2016,James Brown,Clinical Infectious Diseases,PMC,10.0000/851377.497,72,10
cdbda22c-70ec-4378-b8d3-83f39ec4b5d4,Therapeutics comprehensive evaluation of prevalence,This study reports on trends in clinical in hospitalized individuals . This study assesses the dynamics of modeling in population . Our analysis investigates the effectiveness of outcomes in population . Further work is needed to validate these findings.,2019-11-11,2019,Barbara Wilson; Michael Garcia,BMJ,ArXiv,10.0000/973002.780,39,5
e9e7047e-d39e-4255-853f-caf5dbdac6fb,Clinical clinical review of spread,Here we report reports on the dynamics of modeling in patients . The investigation reports on outcomes for diagnostics in clinical settings . The investigation assesses outcomes for variants in clinical settings . Further work is needed to validate these findings.,2021-06-17,2021,Robert Davis; Susan Jones; Jennifer Jones,Frontiers in Medicine,medRxiv,10.0000/291579.591,41,5
e12df842-931c-412c-af30-89ade0797446,Epidemiology statistical investigation of prevalence,Here we report reports on the impact of covid-19 in patients . Our analysis presents outcomes for vaccine in hospitalized individuals . We reports on the effectiveness of sars-cov-2 in a cohort . Here we report evaluates trends in coronavirus in a cohort . Here we report assesses the effectiveness of immunity in a cohort . We assesses the impact of clinical in patients . Here we report investigates the dynamics of covid-19 in population . Further work is needed to validate these findings.,2020-11-29,2020,Michael Miller; Barbara Davis; Susan Smith; Robert Garcia; James Jones,Science,Publisher,10.0000/325642.868,84,5
2bd4cd6e-6827-4dc3-93fa-9b98923edee2,Coronavirus statistical survey of patterns,We investigates outcomes for modeling in clinical settings . This study evaluates the dynamics of serology in population . We reports on the effectiveness of sars-cov-2 in population . The investigation assesses the dynamics of epidemiology in a cohort . The investigation evaluates the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2020-05-17,2020,Elizabeth Davis; Richard Martinez; Michael Smith; Elizabeth Anderson,Journal of Infectious Diseases,PMC,10.0000/138610.828,58,5
60937a1d-eade-416d-8939-0a8534bce7b9,Immunity statistical evaluation of incidence,The investigation presents the dynamics of sars-cov-2 in patients . Our analysis investigates trends in immunity in patients . The investigation presents the dynamics of sars-cov-2 in clinical settings . Our analysis evaluates the dynamics of serology in a cohort . The investigation investigates trends in immunity in patients . Further work is needed to validate these findings.,2021-10-19,2021,Robert Jones,Frontiers in Medicine,ArXiv,10.0000/848696.890,58,5
03132903-3699-47fb-8e08-51cd25b4aaa6,Transmission global analysis of outcomes,This study presents the dynamics of sars-cov-2 in clinical settings . The investigation reports on trends in covid-19 in hospitalized individuals . Here we report reports on the effectiveness of pandemic in patients . The investigation presents the impact of epidemiology in patients . Our analysis reports on outcomes for variants in patients . Further work is needed to validate these findings.,2015-03-23,2015,Michael Johnson,Clinical Infectious Diseases,Publisher,10.0000/735018.499,62,5
65ad12fd-72c0-435b-815f-74ec9808a9a8,Vaccine comparative evaluation of patterns : implications for policy,Our analysis evaluates outcomes for vaccine in clinical settings . This study assesses the effectiveness of variants in population . The investigation assesses the effectiveness of diagnostics in patients . Here we report investigates outcomes for transmission in population . The investigation investigates outcomes for clinical in clinical settings . Here we report presents the effectiveness of variants in patients . Further work is needed to validate these findings.,2021-10-06,2021,Michael Garcia; Joseph Johnson; Jennifer Anderson; Barbara Brown,Science,medRxiv,10.0000/311929.883,69,9
6e5fb9a3-087e-4b34-b995-5752308a9b4c,Pandemic global study of outcomes : implications for public health,The investigation reports on the effectiveness of serology in patients . The investigation reports on outcomes for outcomes in hospitalized individuals . Our analysis evaluates the effectiveness of covid-19 in hospitalized individuals . We investigates trends in therapeutics in hospitalized individuals . This study evaluates the impact of vaccine in population . Further work is needed to validate these findings.,2017-01-17,2017,Patricia Johnson,Journal of Infectious Diseases,PMC,10.0000/644133.291,60,10
86029c1b-4c4d-49ee-ae7c-9175107fb552,Diagnostics statistical survey of data,We reports on trends in immunity in clinical settings . Our analysis reports on the effectiveness of variants in patients . Our analysis investigates the dynamics of diagnostics in hospitalized individuals . This study investigates outcomes for genomics in a cohort . Our analysis reports on the dynamics of serology in patients . Further work is needed to validate these findings.,2019-05-02,2019,Elizabeth Anderson; William Davis,medRxiv,Publisher,10.0000/680635.557,61,5
974a8337-fa1e-4818-b661-0af6f3c09fa5,Epidemiology preliminary study of data,Here we report investigates trends in sars-cov-2 in clinical settings . Our analysis assesses the dynamics of sars-cov-2 in hospitalized individuals . Our analysis reports on the impact of transmission in patients . Our analysis assesses the effectiveness of modeling in a cohort . This study reports on the impact of vaccine in a cohort . Further work is needed to validate these findings.,2016-11-24,2016,Linda Smith; Joseph Hernandez; Barbara Smith; William Davis,Journal of Infectious Diseases,Crossref,10.0000/858822.161,64,5
58ba7e6e-5f04-41a9-8597-f5a7f1f10267,Genomics comprehensive study of spread,Our analysis investigates the impact of pandemic in patients . Our analysis presents outcomes for epidemiology in patients . The investigation investigates the dynamics of coronavirus in a cohort . Here we report investigates the impact of outcomes in clinical settings . Our analysis reports on the effectiveness of therapeutics in a cohort . The investigation investigates outcomes for transmission in a cohort . Further work is needed to validate these findings.,2020-03-08,2020,Jennifer Wilson; Robert Lopez; James Rodriguez; Jessica Anderson,PLOS ONE,Publisher,10.0000/905537.463,72,5
1033d0ea-6ae3-4a37-8e27-b74101fbf0a8,Diagnostics long-term analysis of prevalence,The investigation evaluates trends in therapeutics in patients . The investigation evaluates outcomes for serology in hospitalized individuals . We presents the dynamics of serology in population . We presents outcomes for outcomes in population . Here we report assesses trends in clinical in clinical settings . Further work is needed to validate these findings.,2015-12-21,2015,Robert Brown; Elizabeth Hernandez; Mary Johnson,medRxiv,bioRxiv,10.0000/735896.782,55,5
6dc97550-ebd1-44ad-ba14-12a4def0032d,Genomics comparative evaluation of effectiveness,Our analysis investigates the impact of therapeutics in patients . The investigation evaluates the dynamics of variants in a cohort . Here we report reports on trends in serology in a cohort . Here we report investigates the impact of genomics in a cohort . Further work is needed to validate these findings.,2017-05-02,2017,Barbara Anderson; John Garcia; John Hernandez; Joseph Wilson; Elizabeth Hernandez,medRxiv,PMC,10.0000/394349.878,53,5
b20a0295-24a4-4b68-a6dd-e89637561931,Outcomes global review of data,Here we report reports on the impact of immunity in hospitalized individuals . The investigation reports on trends in epidemiology in patients . Here we report evaluates the effectiveness of coronavirus in a cohort . This study evaluates the effectiveness of transmission in a cohort . Further work is needed to validate these findings.,2016-11-23,2016,Susan Brown; Barbara Garcia; Linda Williams; David Rodriguez; Jessica Anderson,bioRxiv,Publisher,10.0000/620842.115,54,5
c070008b-86ea-4064-9925-17176fc4f374,Vaccine long-term study of outcomes,Our analysis reports on outcomes for pandemic in hospitalized individuals . We reports on the dynamics of variants in clinical settings . The investigation investigates the effectiveness of transmission in patients . Here we report investigates the impact of transmission in a cohort . The investigation evaluates outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2022-10-19,2022,John Rodriguez; Jessica Jones,Science,ArXiv,10.0000/369593.595,62,5
e32a9475-966a-4ba3-b4f7-979253ccf0a3,Outcomes long-term dynamics of effectiveness : implications for vaccination strategies,This study presents the dynamics of sars-cov-2 in a cohort . This study presents the effectiveness of vaccine in patients . Here we report reports on trends in vaccine in clinical settings . Further work is needed to validate these findings.,2015-10-25,2015,Barbara Miller; Jessica Brown; Susan Rodriguez; James Garcia,Clinical Infectious Diseases,PMC,10.0000/108608.490,41,10
def24d03-3c95-4769-a15e-4d24865c5f1a,Clinical comparative review of response,The investigation assesses trends in epidemiology in a cohort . This study assesses the impact of vaccine in clinical settings . Here we report reports on the dynamics of serology in hospitalized individuals . This study reports on the effectiveness of covid-19 in patients . The investigation investigates trends in variants in a cohort . Our analysis evaluates outcomes for outcomes in a cohort . Further work is needed to validate these findings.,2021-03-08,2021,Michael Wilson,BMJ,medRxiv,10.0000/800483.165,73,5
11c7e469-72cf-432c-8bd5-dca05920938a,Clinical comprehensive dynamics of response,This study presents the effectiveness of covid-19 in population . This study investigates trends in modeling in patients . Our analysis investigates trends in covid-19 in clinical settings . We investigates the effectiveness of therapeutics in population . Here we report reports on the effectiveness of epidemiology in clinical settings . We investigates the dynamics of modeling in clinical settings . We investigates the dynamics of epidemiology in a cohort . This study presents trends in epidemiology in population . Further work is needed to validate these findings.,2019-08-19,2019,Mary Rodriguez; Richard Miller; Michael Lopez; Robert Garcia,BMJ,ArXiv,10.0000/609718.200,88,5
1671a49e-abd7-41c0-966d-55966f70e550,Genomics clinical survey of incidence,This study evaluates trends in therapeutics in hospitalized individuals . Here we report evaluates the effectiveness of variants in clinical settings . Here we report presents the dynamics of immunity in clinical settings . We evaluates outcomes for serology in a cohort . Here we report assesses the dynamics of vaccine in clinical settings . Here we report presents the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2016-05-10,2016,John Martinez; Richard Rodriguez; Robert Martinez; John Rodriguez,The Lancet,PMC,10.0000/630750.560,75,5
496664c1-4ab2-4eb5-82b3-8c98a1ae11dd,Pandemic clinical survey of prevalence : implications for policy,Here we report investigates the effectiveness of outcomes in a cohort . We assesses trends in modeling in population . Our analysis reports on the impact of variants in patients . We assesses the dynamics of epidemiology in patients . Here we report reports on the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-01-21,2015,Linda Garcia,medRxiv,Publisher,10.0000/389281.227,61,9
e266cbae-b14f-4f25-bcbf-7d88cce82b01,Genomics rapid impact of incidence : implications for public health,We reports on outcomes for covid-19 in clinical settings . Here we report presents outcomes for serology in clinical settings . Our analysis investigates trends in outcomes in hospitalized individuals . Here we report reports on outcomes for coronavirus in clinical settings . Our analysis reports on the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2015-07-31,2015,William Garcia; Robert Davis; William Anderson; Michael Anderson,bioRxiv,Publisher,10.0000/839111.177,63,10
1bb6d9e1-761a-486c-a377-d55b50ba98b6,COVID-19 comprehensive analysis of patients,This study presents outcomes for variants in clinical settings . This study assesses trends in coronavirus in hospitalized individuals . The investigation investigates the impact of therapeutics in patients . Here we report reports on the impact of serology in clinical settings . The investigation reports on trends in coronavirus in population . Here we report investigates trends in outcomes in population . Further work is needed to validate these findings.,2016-03-11,2016,Jessica Miller; William Smith; Michael Martinez; Linda Williams; Joseph Lopez,BMJ,Crossref,10.0000/830244.750,71,5
bcda9383-aabe-411f-8084-ad140aa552ef,Immunity comparative investigation of outcomes : implications for public health,Our analysis reports on the effectiveness of coronavirus in hospitalized individuals . The investigation presents the dynamics of immunity in clinical settings . This study evaluates the effectiveness of outcomes in population . We reports on the dynamics of modeling in a cohort . Our analysis assesses the impact of genomics in patients . Further work is needed to validate these findings.,2015-02-16,2015,Patricia Gonzalez,bioRxiv,Publisher,10.0000/999463.679,62,10
f80138b7-2b3d-4795-b2cb-c165e05407b4,Variants clinical report of incidence,This study evaluates the effectiveness of covid-19 in a cohort . We reports on trends in outcomes in patients . This study evaluates the effectiveness of modeling in population . The investigation reports on the effectiveness of modeling in patients . Our analysis investigates the impact of serology in clinical settings . Here we report evaluates the dynamics of pandemic in a cohort . Further work is needed to validate these findings.,2019-03-16,2019,Richard Rodriguez,bioRxiv,ArXiv,10.0000/952701.528,72,5
6ff7c9e6-047e-42ac-ac28-f1d21ce20ba8,Clinical rapid investigation of trends,The investigation presents the impact of therapeutics in a cohort . We investigates the impact of covid-19 in a cohort . The investigation assesses the dynamics of therapeutics in population . Our analysis reports on outcomes for modeling in a cohort . We reports on the effectiveness of clinical in population . The investigation investigates outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2020-12-13,2020,Michael Jones; James Garcia; Joseph Johnson; Joseph Martinez,bioRxiv,bioRxiv,10.0000/577039.450,70,5
c9c508cf-da9a-4fdc-bda9-fa0476138177,Transmission comprehensive survey of trends,Our analysis assesses the impact of clinical in clinical settings . The investigation evaluates trends in vaccine in clinical settings . We reports on trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2020-02-08,2020,Joseph Martinez; Richard Gonzalez,Clinical Infectious Diseases,bioRxiv,10.0000/173868.939,39,5
7e7f3a3f-f265-40ad-90fb-cba4ce5d5f7e,COVID-19 rapid study of outcomes,Our analysis investigates the effectiveness of clinical in patients . Here we report assesses the impact of covid-19 in a cohort . This study reports on the impact of covid-19 in clinical settings . This study reports on the dynamics of therapeutics in patients . The investigation reports on outcomes for vaccine in a cohort . Our analysis investigates outcomes for diagnostics in patients . Here we report investigates the effectiveness of serology in hospitalized individuals . Here we report presents the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2021-05-25,2021,Michael Williams,Science,ArXiv,10.0000/651350.405,97,5
84f35314-0896-4014-b1cd-32270cacb124,Pandemic global analysis of patients : implications for public health,The investigation reports on the effectiveness of transmission in clinical settings . Our analysis evaluates the effectiveness of transmission in population . We presents the effectiveness of epidemiology in hospitalized individuals . Our analysis presents outcomes for therapeutics in population . This study reports on the dynamics of clinical in hospitalized individuals . Our analysis assesses the dynamics of genomics in patients . Our analysis reports on the effectiveness of epidemiology in hospitalized individuals . We assesses the effectiveness of serology in population . Further work is needed to validate these findings.,2019-05-21,2019,Patricia Davis; Jennifer Martinez,Science,ArXiv,10.0000/878517.176,92,10
5ab8c98b-102e-4de0-9d83-3e8d44310433,Variants comprehensive impact of incidence,The investigation investigates the dynamics of outcomes in a cohort . This study assesses outcomes for serology in population . Here we report evaluates outcomes for diagnostics in a cohort . We presents trends in immunity in population . This study presents the impact of epidemiology in a cohort . We presents the effectiveness of covid-19 in population . Our analysis assesses outcomes for vaccine in population . Our analysis presents outcomes for genomics in patients . Further work is needed to validate these findings.,2016-08-23,2016,Elizabeth Martinez; Jessica Davis; Jessica Hernandez,BMJ,Crossref,10.0000/637872.466,85,5
b4ff56fb-abe7-41e0-85d9-dd9783c08d9d,Modeling global report of patients,This study presents outcomes for epidemiology in patients . Our analysis investigates trends in diagnostics in population . Our analysis reports on outcomes for immunity in population . This study evaluates trends in diagnostics in a cohort . We investigates trends in epidemiology in patients . The investigation investigates outcomes for epidemiology in hospitalized individuals . The investigation assesses the dynamics of clinical in clinical settings . The investigation investigates outcomes for transmission in a cohort . Further work is needed to validate these findings.,2022-01-10,2022,Jennifer Johnson; Elizabeth Martinez; Barbara Davis,Unknown,Publisher,10.0000/450137.588,85,5
42eb60d2-8ddf-4e78-80a4-edd8c55b8f2d,Outcomes clinical survey of patients,Our analysis evaluates the impact of pandemic in clinical settings . This study assesses the impact of therapeutics in clinical settings . The investigation presents the impact of epidemiology in hospitalized individuals . This study evaluates the dynamics of genomics in a cohort . Our analysis investigates the impact of immunity in patients . Further work is needed to validate these findings.,2019-02-08,2019,John Rodriguez; Richard Lopez; Mary Davis; William Rodriguez,Journal of Infectious Diseases,medRxiv,10.0000/694320.622,62,5
7b44b208-0b65-420c-9255-959649ca9f05,Outcomes clinical report of response,The investigation assesses the effectiveness of clinical in clinical settings . Here we report assesses the impact of coronavirus in hospitalized individuals . This study reports on outcomes for immunity in population . Our analysis presents the effectiveness of epidemiology in a cohort . Further work is needed to validate these findings.,2018-06-25,2018,David Martinez; Richard Williams,Science,Crossref,10.0000/407344.205,52,5
3239736d-d08f-41c6-8344-e0fa911fc2a2,Coronavirus comparative assessment of data : implications for public health,We reports on the dynamics of transmission in hospitalized individuals . Our analysis presents the dynamics of modeling in population . This study evaluates trends in pandemic in clinical settings . Further work is needed to validate these findings.,2018-01-05,2018,John Brown; Linda Hernandez; William Hernandez,medRxiv,bioRxiv,10.0000/665630.377,39,10
449128f4-718a-4565-9499-4f5c95721135,Transmission clinical investigation of patients : implications for vaccination strategies,The investigation evaluates the dynamics of vaccine in patients . The investigation assesses trends in genomics in clinical settings . We investigates the effectiveness of therapeutics in clinical settings . This study assesses the impact of variants in clinical settings . We investigates trends in diagnostics in hospitalized individuals . The investigation reports on trends in serology in patients . We presents the effectiveness of outcomes in clinical settings . We assesses outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2021-01-16,2021,Robert Martinez; Robert Johnson; Patricia Gonzalez; John Martinez; Robert Martinez,medRxiv,bioRxiv,10.0000/252233.538,87,10
23ae93eb-08af-4bb6-ab78-1e13252cfd17,Variants comparative study of data,This study investigates the dynamics of outcomes in patients . This study presents the impact of covid-19 in patients . This study evaluates the dynamics of pandemic in a cohort . Here we report evaluates the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2019-08-31,2019,Robert Brown; William Davis,Frontiers in Medicine,medRxiv,10.0000/211465.888,50,5
3d78266e-fc0b-4060-aa82-0e71b806434a,SARS-CoV-2 preliminary assessment of prevalence,We reports on the impact of therapeutics in hospitalized individuals . We reports on the dynamics of pandemic in clinical settings . The investigation presents the effectiveness of coronavirus in clinical settings . This study assesses the impact of pandemic in patients . Here we report assesses outcomes for immunity in a cohort . This study evaluates the impact of modeling in population . We assesses the effectiveness of pandemic in hospitalized individuals . The investigation investigates the impact of variants in a cohort . Further work is needed to validate these findings.,2019-03-20,2019,Susan Garcia; James Rodriguez,bioRxiv,medRxiv,10.0000/750698.106,93,5
8c36a0e5-bebd-4e6f-aa60-2b35c068322a,Transmission comparative study of prevalence,We presents the impact of outcomes in hospitalized individuals . Here we report reports on outcomes for sars-cov-2 in a cohort . Our analysis reports on trends in variants in clinical settings . Our analysis investigates trends in coronavirus in patients . The investigation evaluates outcomes for vaccine in a cohort . The investigation investigates the dynamics of therapeutics in a cohort . Our analysis evaluates trends in serology in a cohort . Further work is needed to validate these findings.,2020-06-07,2020,Jessica Garcia; William Gonzalez,Journal of Infectious Diseases,Publisher,10.0000/972181.182,81,5
38fb1f91-1f29-4d5d-8cd7-b65e83901f70,Diagnostics preliminary analysis of outcomes : implications for public health,The investigation presents the effectiveness of vaccine in hospitalized individuals . Our analysis reports on the dynamics of clinical in patients . Here we report reports on the effectiveness of therapeutics in clinical settings . Our analysis reports on the dynamics of covid-19 in clinical settings . The investigation reports on the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2019-05-09,2019,James Williams; Richard Jones,Nature,Publisher,10.0000/232596.196,67,10
6d012e39-360e-4dd1-86ae-c91f8727f3d2,Variants global impact of patients,The investigation presents the dynamics of epidemiology in patients . The investigation presents the dynamics of pandemic in a cohort . Here we report presents the effectiveness of clinical in population . Our analysis evaluates the effectiveness of modeling in patients . The investigation investigates the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2018-09-25,2018,David Garcia,bioRxiv,PMC,10.0000/413801.778,60,5
c8e2d217-a7f4-4e8f-9ed1-aae1f8f06995,Genomics comparative assessment of outcomes,Here we report investigates trends in sars-cov-2 in a cohort . We investigates the effectiveness of variants in a cohort . We assesses the effectiveness of pandemic in patients . Our analysis evaluates the impact of sars-cov-2 in a cohort . Here we report presents trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-10-13,2016,Elizabeth Anderson; Mary Lopez; Elizabeth Smith,Frontiers in Medicine,medRxiv,10.0000/971782.354,60,5
65606213-4c02-4932-b2e4-b0533cb9db3a,Genomics preliminary assessment of effectiveness : implications for policy,This study presents the dynamics of clinical in population . The investigation presents outcomes for outcomes in clinical settings . Here we report reports on outcomes for diagnostics in a cohort . Here we report assesses the impact of vaccine in hospitalized individuals . This study reports on the effectiveness of therapeutics in a cohort . We evaluates the impact of variants in a cohort . The investigation evaluates the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2022-07-09,2022,Robert Miller; Barbara Anderson; Patricia Johnson,Clinical Infectious Diseases,ArXiv,10.0000/305683.736,85,9
9013f347-9f99-4e87-a051-6483441dd2fa,Transmission comparative dynamics of incidence : implications for clinical practice,The investigation reports on the effectiveness of epidemiology in a cohort . Here we report reports on the dynamics of sars-cov-2 in clinical settings . This study investigates the impact of therapeutics in population . Further work is needed to validate these findings.,2021-07-20,2021,Linda Smith,Clinical Infectious Diseases,Publisher,10.0000/482575.531,43,10
cba6eeeb-c8d1-430f-9b61-23ab3bb0518e,Diagnostics global dynamics of incidence,We investigates outcomes for pandemic in a cohort . Here we report assesses the dynamics of immunity in patients . Our analysis presents outcomes for diagnostics in population . Our analysis investigates the effectiveness of clinical in patients . This study evaluates trends in diagnostics in a cohort . This study evaluates trends in variants in hospitalized individuals . This study assesses the effectiveness of epidemiology in population . The investigation evaluates trends in genomics in population . Further work is needed to validate these findings.,2018-08-17,2018,William Johnson; Patricia Davis,Science,Crossref,10.0000/975874.175,86,5
e869a41d-6790-4820-907c-c55522bbadd3,Genomics statistical investigation of response,The investigation reports on trends in therapeutics in hospitalized individuals . Our analysis assesses trends in pandemic in patients . Here we report investigates the dynamics of outcomes in patients . We investigates trends in modeling in patients . Here we report investigates trends in epidemiology in a cohort . Further work is needed to validate these findings.,2021-01-30,2021,Mary Martinez; James Davis; Barbara Smith; Elizabeth Gonzalez; Linda Lopez,Science,PMC,10.0000/483814.861,58,5
cc5acd23-e2ad-46db-bfc6-2745683c2f37,Serology rapid investigation of effectiveness : implications for policy,The investigation assesses trends in outcomes in a cohort . The investigation assesses the impact of pandemic in patients . Here we report evaluates the dynamics of variants in patients . Here we report reports on the effectiveness of coronavirus in population . Our analysis reports on the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2016-04-10,2016,Joseph Gonzalez; Jennifer Lopez; Patricia Rodriguez; Linda Wilson; Robert Lopez,Clinical Infectious Diseases,PMC,10.0000/632668.649,62,9
55806633-8046-4652-a10d-91d72faf9613,Genomics comprehensive report of trends,Here we report presents the dynamics of transmission in a cohort . Our analysis presents outcomes for genomics in hospitalized individuals . This study reports on the dynamics of immunity in patients . This study investigates outcomes for sars-cov-2 in clinical settings . This study assesses trends in therapeutics in clinical settings . Here we report investigates the effectiveness of serology in clinical settings . The investigation presents the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2019-12-23,2019,Elizabeth Williams,BMJ,PMC,10.0000/268108.410,84,5
c48a158c-3e59-40fd-b5d1-2ec7490a32b2,Variants global impact of patterns : implications for clinical practice,Here we report evaluates trends in variants in patients . This study investigates the impact of serology in a cohort . The investigation reports on the effectiveness of therapeutics in a cohort . This study presents the dynamics of modeling in hospitalized individuals . We investigates the effectiveness of coronavirus in hospitalized individuals . The investigation reports on the effectiveness of covid-19 in patients . Our analysis presents the effectiveness of therapeutics in patients . We evaluates the impact of variants in population . Further work is needed to validate these findings.,2019-01-15,2019,Susan Jones; James Garcia,The Lancet,Crossref,10.0000/744499.440,92,10
e841f266-faa2-4091-a10a-bf01dfb14be6,Vaccine comparative dynamics of data,The investigation investigates trends in pandemic in clinical settings . Here we report assesses the impact of serology in clinical settings . The investigation evaluates the dynamics of serology in hospitalized individuals . Here we report investigates the impact of sars-cov-2 in hospitalized individuals . This study evaluates trends in clinical in population . Further work is needed to validate these findings.,2018-11-03,2018,Barbara Gonzalez; Joseph Anderson; John Lopez; Jennifer Rodriguez; David Hernandez,Frontiers in Medicine,Crossref,10.0000/207794.244,62,5
ea884f36-90d1-4154-8882-7e3beadebe98,Pandemic global review of prevalence,Our analysis presents the dynamics of sars-cov-2 in clinical settings . The investigation presents the dynamics of therapeutics in patients . The investigation investigates trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-10-06,2022,Jennifer Johnson; Joseph Davis; Richard Davis; Joseph Davis; Robert Anderson,medRxiv,bioRxiv,10.0000/731694.906,39,5
6aeaa394-4f8e-4c72-a81d-05a1a4e9687e,Epidemiology rapid analysis of effectiveness : implications for vaccination strategies,The investigation presents outcomes for diagnostics in clinical settings . Our analysis evaluates the dynamics of sars-cov-2 in population . We assesses the dynamics of serology in population . This study presents the impact of pandemic in clinical settings . The investigation investigates trends in sars-cov-2 in patients . This study evaluates trends in variants in a cohort . Further work is needed to validate these findings.,2020-05-09,2020,Jennifer Williams; Jessica Jones; Michael Garcia,BMJ,bioRxiv,10.0000/837560.219,67,10
caedbe04-3e9c-46f8-93e9-fc88aa2bacbb,Diagnostics preliminary dynamics of prevalence,We evaluates outcomes for covid-19 in hospitalized individuals . Our analysis investigates the effectiveness of sars-cov-2 in patients . The investigation assesses the dynamics of modeling in population . Further work is needed to validate these findings.,2020-01-16,2020,Richard Williams; Jennifer Gonzalez; David Smith; Elizabeth Williams; William Lopez,Unknown,PMC,10.0000/420575.463,37,5
d7183217-a65c-4e26-a851-8d0cea4e770b,Clinical comparative investigation of trends,We investigates the impact of modeling in population . The investigation presents the dynamics of diagnostics in hospitalized individuals . Our analysis presents outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2019-06-02,2019,Richard Johnson; William Smith; Michael Gonzalez,Journal of Infectious Diseases,bioRxiv,10.0000/781241.369,38,5
30705716-a434-4a35-b348-494d36e463d0,COVID-19 regional analysis of patients,This study investigates the effectiveness of serology in clinical settings . The investigation reports on the effectiveness of serology in patients . This study evaluates the impact of modeling in a cohort . The investigation assesses outcomes for genomics in hospitalized individuals . Further work is needed to validate these findings.,2017-09-29,2017,Joseph Anderson; Michael Hernandez; William Johnson; Jennifer Wilson; Joseph Smith,bioRxiv,ArXiv,10.0000/354315.399,51,5
7b52e2f4-e66c-4a3d-940c-37ce082c366e,Immunity clinical evaluation of patients,We assesses outcomes for vaccine in a cohort . Here we report investigates the dynamics of epidemiology in a cohort . Here we report assesses trends in diagnostics in patients . Further work is needed to validate these findings.,2020-01-14,2020,James Garcia; Mary Jones,Clinical Infectious Diseases,bioRxiv,10.0000/564223.659,39,5
c73e28e1-5bcc-4c42-961b-0e8c05c6412e,Variants regional survey of effectiveness : implications for vaccination strategies,This study evaluates trends in diagnostics in patients . We assesses trends in outcomes in clinical settings . This study reports on trends in epidemiology in a cohort . Further work is needed to validate these findings.,2020-01-15,2020,Barbara Smith; Linda Davis; Barbara Williams; Linda Brown; Barbara Garcia,Unknown,bioRxiv,10.0000/755334.724,37,10
46edcb33-ad05-47b2-900d-b367ec6f0160,Clinical rapid impact of effectiveness,We evaluates the effectiveness of epidemiology in population . Our analysis investigates trends in modeling in clinical settings . The investigation evaluates outcomes for epidemiology in population . Here we report reports on trends in therapeutics in hospitalized individuals . The investigation investigates the impact of variants in population . Further work is needed to validate these findings.,2017-05-25,2017,Mary Jones; David Garcia; Patricia Brown; Patricia Wilson,Science,Publisher,10.0000/368334.326,58,5
47fbf1f6-1537-48c5-9ba8-ee7bfd923b17,Modeling regional study of data : implications for public health,Here we report reports on outcomes for covid-19 in population . The investigation reports on outcomes for covid-19 in patients . We evaluates the impact of pandemic in a cohort . Our analysis evaluates outcomes for clinical in a cohort . Our analysis presents the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2020-12-30,2020,Patricia Smith; Joseph Martinez,The Lancet,ArXiv,10.0000/142059.618,59,10
6d03dc82-d016-4533-8381-2bbbda49df06,Serology clinical dynamics of prevalence,Here we report investigates outcomes for modeling in population . Our analysis reports on trends in genomics in population . The investigation assesses the impact of sars-cov-2 in a cohort . This study evaluates the dynamics of transmission in population . The investigation reports on the impact of modeling in patients . This study assesses trends in genomics in clinical settings . This study evaluates the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2019-12-14,2019,Mary Gonzalez,Journal of Infectious Diseases,ArXiv,10.0000/127331.959,81,5
e22bbace-ae63-4f09-bc84-974e348c8376,Coronavirus statistical evaluation of outcomes,We assesses the impact of transmission in a cohort . This study evaluates the effectiveness of epidemiology in population . The investigation assesses trends in diagnostics in hospitalized individuals . This study assesses the dynamics of variants in population . Our analysis evaluates the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2018-02-17,2018,Barbara Martinez; Patricia Jones,PLOS ONE,Crossref,10.0000/350428.662,59,5
571d94e1-dd43-4830-8f81-61da04d92dd1,Transmission preliminary evaluation of effectiveness,Here we report reports on trends in covid-19 in a cohort . The investigation investigates the dynamics of covid-19 in clinical settings . This study investigates outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2022-02-01,2022,Jessica Wilson; Joseph Gonzalez; Patricia Smith,Nature,medRxiv,10.0000/566261.448,41,5
5f749639-eb5d-48a0-977b-5884ce60aea7,Serology statistical dynamics of prevalence,Here we report reports on the effectiveness of pandemic in patients . Here we report investigates the effectiveness of sars-cov-2 in population . Our analysis presents trends in modeling in hospitalized individuals . Our analysis assesses the dynamics of serology in hospitalized individuals . This study evaluates the dynamics of clinical in a cohort . Here we report assesses the dynamics of immunity in hospitalized individuals . This study evaluates the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2016-03-14,2016,Robert Gonzalez; Linda Brown,bioRxiv,Crossref,10.0000/891933.161,86,5
53d69f3e-9848-4a55-8474-6890f2e4b53a,Genomics long-term review of spread,This study assesses trends in vaccine in clinical settings . Our analysis investigates the dynamics of epidemiology in a cohort . Here we report assesses the effectiveness of vaccine in hospitalized individuals . Here we report presents the impact of serology in hospitalized individuals . The investigation reports on trends in transmission in patients . This study investigates the impact of therapeutics in a cohort . The investigation investigates outcomes for modeling in hospitalized individuals . The investigation investigates the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2016-03-12,2016,Jessica Garcia; Richard Martinez; Elizabeth Gonzalez; Barbara Hernandez,Clinical Infectious Diseases,bioRxiv,10.0000/781252.674,95,5
f1acf4cc-4b3e-4394-97f0-bed8e6a8dd91,Epidemiology rapid dynamics of prevalence,The investigation evaluates outcomes for therapeutics in patients . Here we report investigates the impact of transmission in population . Our analysis reports on trends in modeling in clinical settings . Further work is needed to validate these findings.,2022-08-11,2022,Barbara Lopez,Frontiers in Medicine,bioRxiv,10.0000/434543.192,39,5
ec9224ec-56d6-4c27-9dd3-0cdfefe14a0a,Diagnostics global review of outcomes,This study presents the impact of outcomes in patients . Our analysis presents the dynamics of sars-cov-2 in clinical settings . This study reports on the dynamics of coronavirus in hospitalized individuals . The investigation reports on the dynamics of coronavirus in a cohort . Here we report reports on the dynamics of epidemiology in patients . Our analysis presents the impact of vaccine in clinical settings . Here we report presents outcomes for modeling in patients . Our analysis evaluates trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2018-10-09,2018,David Davis,BMJ,PMC,10.0000/288460.357,96,5
2d886352-8cf2-4cdb-9055-d1f99560d48d,Pandemic rapid report of trends,This study presents the dynamics of epidemiology in a cohort . Our analysis reports on the effectiveness of sars-cov-2 in clinical settings . This study reports on trends in immunity in hospitalized individuals . Here we report investigates outcomes for pandemic in a cohort . We evaluates the impact of serology in patients . Here we report presents trends in pandemic in patients . Further work is needed to validate these findings.,2020-05-08,2020,William Brown; Susan Smith; Richard Davis; Barbara Williams,PLOS ONE,Crossref,10.0000/825104.812,72,5
f85d0734-9ed7-4987-96f7-ce31dbe9e7e7,Immunity rapid review of data : implications for vaccination strategies,This study investigates the effectiveness of serology in patients . This study assesses trends in serology in clinical settings . Our analysis assesses the effectiveness of covid-19 in patients . Our analysis reports on the dynamics of diagnostics in patients . The investigation assesses the effectiveness of diagnostics in population . We investigates the impact of variants in clinical settings . The investigation assesses the effectiveness of coronavirus in hospitalized individuals . This study evaluates the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2022-08-07,2022,Joseph Martinez; Jessica Gonzalez; Mary Jones; Patricia Gonzalez,Journal of Infectious Diseases,Crossref,10.0000/365547.235,91,10
48f7acc6-2f65-455e-93ac-2da73efa3984,Variants preliminary assessment of data,The investigation reports on the dynamics of vaccine in a cohort . This study reports on trends in sars-cov-2 in hospitalized individuals . This study presents trends in genomics in patients . Here we report assesses outcomes for therapeutics in hospitalized individuals . Here we report investigates the effectiveness of diagnostics in a cohort . The investigation evaluates the impact of serology in clinical settings . The investigation presents trends in genomics in clinical settings . Here we report presents trends in serology in patients . Further work is needed to validate these findings.,2022-12-29,2022,Barbara Garcia; Michael Lopez; Robert Miller; Richard Gonzalez; Barbara Smith,PLOS ONE,medRxiv,10.0000/412346.961,94,5
60a2178d-f9f7-4f4a-9a77-a69fa63ba48d,Variants statistical investigation of effectiveness,We reports on the dynamics of coronavirus in hospitalized individuals . This study assesses the impact of clinical in clinical settings . The investigation assesses the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2022-09-23,2022,Mary Williams; Jessica Williams,Journal of Infectious Diseases,Crossref,10.0000/452683.269,40,5
1a00c98e-fa08-4894-8770-8f3fd9a52f97,Clinical regional assessment of response,This study evaluates outcomes for clinical in population . The investigation assesses the impact of pandemic in patients . Here we report presents the dynamics of immunity in patients . Our analysis investigates the impact of immunity in clinical settings . The investigation evaluates trends in diagnostics in a cohort . Here we report reports on the effectiveness of sars-cov-2 in patients . We investigates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2017-12-31,2017,Joseph Davis; James Hernandez,The Lancet,bioRxiv,10.0000/326614.625,80,5
04193913-7e49-46c2-92c6-568a2916dab9,Clinical rapid investigation of spread,The investigation investigates trends in coronavirus in patients . We evaluates the dynamics of clinical in patients . Here we report reports on the impact of immunity in hospitalized individuals . Here we report assesses the effectiveness of serology in clinical settings . This study assesses trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2019-02-03,2019,Michael Wilson; John Martinez; Elizabeth Miller; James Johnson,BMJ,ArXiv,10.0000/637623.948,61,5
b9a82451-26e5-4931-8f74-8eb8b1c14326,Variants global assessment of patterns,This study assesses the effectiveness of variants in hospitalized individuals . This study reports on the effectiveness of serology in patients . Here we report assesses the dynamics of covid-19 in a cohort . Here we report assesses trends in transmission in a cohort . We reports on the effectiveness of serology in clinical settings . We reports on the effectiveness of epidemiology in a cohort . The investigation reports on outcomes for immunity in a cohort . Further work is needed to validate these findings.,2021-10-23,2021,Patricia Hernandez; Michael Wilson; David Jones; Richard Lopez; Richard Hernandez,Journal of Infectious Diseases,medRxiv,10.0000/245732.632,86,5
7df57684-e8c6-450d-9404-15d7bc51815f,Genomics global evaluation of trends,Here we report presents the effectiveness of modeling in patients . We evaluates trends in therapeutics in hospitalized individuals . The investigation presents trends in genomics in hospitalized individuals . The investigation presents the dynamics of coronavirus in clinical settings . Here we report presents the effectiveness of outcomes in population . This study reports on the dynamics of therapeutics in clinical settings . We investigates outcomes for immunity in patients . The investigation assesses outcomes for variants in patients . Further work is needed to validate these findings.,2017-05-01,2017,John Rodriguez; David Garcia; Elizabeth Jones; William Davis,Frontiers in Medicine,medRxiv,10.0000/657343.841,89,5
fcbd36c3-1dc9-4e0a-a94e-49e6d11aafb7,Serology rapid dynamics of outcomes,Here we report presents the effectiveness of pandemic in population . We evaluates the effectiveness of therapeutics in a cohort . The investigation investigates trends in transmission in a cohort . This study presents outcomes for genomics in a cohort . Here we report investigates the impact of immunity in population . Our analysis reports on trends in sars-cov-2 in a cohort . We evaluates the impact of sars-cov-2 in population . The investigation evaluates the impact of genomics in clinical settings . Further work is needed to validate these findings.,2016-03-26,2016,Susan Hernandez; Mary Smith,Frontiers in Medicine,PMC,10.0000/155759.328,91,5
c5fe8b8c-843d-4089-980d-6225c79c50be,Coronavirus long-term impact of patients,This study presents the effectiveness of diagnostics in clinical settings . Here we report investigates the dynamics of clinical in population . Here we report presents the dynamics of diagnostics in patients . Here we report reports on trends in outcomes in population . We presents the dynamics of epidemiology in clinical settings . Our analysis investigates outcomes for diagnostics in hospitalized individuals . We reports on the impact of serology in a cohort . We investigates outcomes for covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-04-06,2016,Jessica Martinez; James Johnson,The Lancet,Crossref,10.0000/846554.536,92,5
63baf8e5-2c3d-488f-9711-25706428c1db,Vaccine comparative report of prevalence,We investigates outcomes for sars-cov-2 in population . This study evaluates outcomes for vaccine in population . Our analysis assesses outcomes for transmission in population . This study evaluates the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2022-08-29,2022,Elizabeth Martinez; Linda Martinez; Robert Gonzalez; Mary Smith,The Lancet,PMC,10.0000/236978.624,44,5
2b8334dc-87a6-41ec-a27c-7347cb57347c,Variants rapid study of incidence : implications for clinical practice,Our analysis reports on the dynamics of serology in a cohort . Our analysis assesses the dynamics of sars-cov-2 in a cohort . This study reports on the effectiveness of coronavirus in clinical settings . Our analysis assesses trends in clinical in a cohort . We presents the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2021-06-25,2021,Robert Davis,Nature,ArXiv,10.0000/118174.219,63,10
679a7d61-1f2f-4f99-99e0-ba3be4d508d3,Immunity comparative dynamics of incidence,Our analysis investigates trends in variants in hospitalized individuals . The investigation assesses the impact of genomics in population . The investigation presents the impact of diagnostics in clinical settings . Our analysis evaluates outcomes for modeling in clinical settings . This study evaluates trends in variants in clinical settings . Here we report investigates trends in therapeutics in a cohort . Further work is needed to validate these findings.,2019-02-23,2019,David Williams; Jennifer Gonzalez,PLOS ONE,medRxiv,10.0000/828264.153,70,5
d41f059a-cd6c-4ced-90fd-d58d9cb28132,COVID-19 comprehensive assessment of response,Our analysis assesses trends in coronavirus in population . Here we report presents the impact of serology in hospitalized individuals . This study assesses outcomes for variants in patients . Our analysis reports on trends in transmission in population . Here we report presents the effectiveness of diagnostics in clinical settings . The investigation assesses the impact of therapeutics in patients . Here we report presents the effectiveness of serology in clinical settings . The investigation investigates trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2016-11-16,2016,John Gonzalez; Barbara Martinez; Jessica Miller,PLOS ONE,PMC,10.0000/897020.955,92,5
185b7584-6f7b-46dc-a2ae-e28470816eac,SARS-CoV-2 regional dynamics of effectiveness,We evaluates the dynamics of diagnostics in clinical settings . This study assesses the dynamics of covid-19 in patients . Our analysis evaluates outcomes for immunity in patients . We investigates the impact of genomics in hospitalized individuals . Our analysis reports on the effectiveness of outcomes in patients . This study assesses outcomes for genomics in hospitalized individuals . Here we report assesses the dynamics of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-12-16,2015,Susan Brown,BMJ,medRxiv,10.0000/506806.890,80,5
8604e23b-d4f7-490f-a071-cfde39b417c6,Clinical global evaluation of incidence,We reports on the impact of pandemic in population . We reports on the effectiveness of genomics in a cohort . We assesses trends in vaccine in population . We reports on outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2019-07-03,2019,Robert Wilson; Jessica Smith; David Rodriguez,Nature,medRxiv,10.0000/158033.594,47,5
17d1d593-b32f-4805-afad-9027b128eb60,Pandemic comprehensive survey of patients : implications for public health,Here we report assesses outcomes for diagnostics in patients . We evaluates trends in serology in population . We assesses the impact of sars-cov-2 in clinical settings . We presents the dynamics of coronavirus in clinical settings . Here we report presents the impact of covid-19 in hospitalized individuals . Here we report investigates trends in vaccine in hospitalized individuals . This study evaluates outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2017-06-19,2017,John Hernandez; John Jones; William Wilson; Jennifer Martinez; David Johnson,Journal of Infectious Diseases,medRxiv,10.0000/672906.404,79,10
477b30d1-9181-4ae3-87bd-22cf3cb9ecd7,Pandemic rapid assessment of spread : implications for vaccination strategies,This study reports on the impact of outcomes in hospitalized individuals . Our analysis investigates trends in pandemic in patients . This study evaluates the effectiveness of modeling in population . Here we report reports on outcomes for sars-cov-2 in patients . The investigation investigates trends in clinical in a cohort . Further work is needed to validate these findings.,2019-01-06,2019,Jennifer Smith; Elizabeth Gonzalez,Science,medRxiv,10.0000/842256.108,60,10
e8f5358f-cadb-4ab1-8a96-0cd192585f9e,COVID-19 regional assessment of trends : implications for public health,Our analysis reports on the effectiveness of vaccine in hospitalized individuals . Here we report assesses outcomes for immunity in hospitalized individuals . This study investigates the dynamics of therapeutics in population . Further work is needed to validate these findings.,2019-11-08,2019,Elizabeth Martinez; Linda Anderson; David Lopez; Robert Martinez,Frontiers in Medicine,PMC,10.0000/571811.552,41,10
65b41a56-3637-4e03-9ab4-ddaeff06a3c1,Epidemiology clinical survey of effectiveness : implications for clinical practice,The investigation assesses the dynamics of serology in population . Our analysis investigates the dynamics of diagnostics in clinical settings . We investigates trends in outcomes in hospitalized individuals . We presents the dynamics of sars-cov-2 in clinical settings . The investigation presents the effectiveness of variants in patients . Further work is needed to validate these findings.,2022-02-21,2022,Barbara Johnson,PLOS ONE,Publisher,10.0000/546328.659,58,10
f65b7b61-5ea1-452e-bf4b-89387c1458f0,Genomics preliminary survey of prevalence,The investigation investigates outcomes for outcomes in patients . The investigation presents the impact of epidemiology in clinical settings . The investigation assesses the impact of outcomes in hospitalized individuals . Our analysis investigates the impact of transmission in patients . We presents trends in clinical in a cohort . Our analysis reports on trends in genomics in a cohort . Here we report assesses the dynamics of serology in a cohort . The investigation presents the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2021-07-27,2021,Jennifer Williams; Michael Johnson; William Williams; Patricia Johnson,Unknown,medRxiv,10.0000/446502.347,91,5
4845c458-f5ff-4dee-a3c8-7f657de360ad,Variants rapid investigation of spread,We reports on trends in coronavirus in patients . We assesses outcomes for outcomes in hospitalized individuals . Here we report presents outcomes for modeling in patients . We assesses the effectiveness of transmission in clinical settings . This study evaluates the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2017-06-06,2017,David Martinez; Jessica Gonzalez,Journal of Infectious Diseases,Crossref,10.0000/597258.615,57,5
65aae9ec-ff0b-41ad-aa2a-1bc542db0d8e,Serology clinical survey of data : implications for vaccination strategies,We investigates the effectiveness of clinical in clinical settings . We evaluates the impact of modeling in a cohort . We evaluates outcomes for coronavirus in a cohort . We assesses the dynamics of modeling in population . We reports on the dynamics of modeling in patients . Further work is needed to validate these findings.,2015-01-29,2015,Mary Johnson; Robert Lopez,medRxiv,bioRxiv,10.0000/483824.216,56,10
0f4a35df-5fc3-40a4-bc8d-1bc7b537bec9,Epidemiology comprehensive review of incidence : implications for policy,We evaluates the dynamics of sars-cov-2 in patients . This study evaluates the effectiveness of therapeutics in a cohort . Here we report assesses the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2016-04-16,2016,William Garcia; Barbara Garcia,The Lancet,Publisher,10.0000/484751.165,40,9
0371c310-42ea-43b0-8196-cc98e8d45bd4,Epidemiology long-term assessment of outcomes,We presents the effectiveness of covid-19 in patients . Here we report evaluates outcomes for modeling in a cohort . Our analysis presents the impact of variants in clinical settings . Here we report presents the effectiveness of variants in hospitalized individuals . We investigates trends in immunity in patients . Further work is needed to validate these findings.,2016-12-19,2016,Mary Jones,Journal of Infectious Diseases,ArXiv,10.0000/960351.226,59,5
2939cd94-7277-4ccd-ad07-185992b50a13,Therapeutics statistical assessment of prevalence,Our analysis reports on the effectiveness of immunity in a cohort . Here we report presents the dynamics of variants in clinical settings . This study evaluates trends in genomics in a cohort . The investigation evaluates the impact of genomics in clinical settings . Our analysis reports on the impact of therapeutics in patients . This study evaluates outcomes for variants in patients . Further work is needed to validate these findings.,2018-01-03,2018,Michael Gonzalez; Elizabeth Garcia; Joseph Miller; John Anderson; David Jones,The Lancet,medRxiv,10.0000/909865.825,73,5
bb24d004-d46f-4c52-9320-da5eb5562b35,Clinical comparative investigation of effectiveness : implications for vaccination strategies,The investigation evaluates the effectiveness of diagnostics in population . The investigation assesses the effectiveness of immunity in hospitalized individuals . The investigation investigates the dynamics of modeling in clinical settings . We investigates outcomes for serology in hospitalized individuals . Here we report investigates outcomes for therapeutics in population . We assesses the effectiveness of modeling in hospitalized individuals . Further work is needed to validate these findings.,2020-11-01,2020,Michael Miller; Jennifer Anderson,Unknown,Crossref,10.0000/885246.760,69,10
18e5745d-801e-4e66-9942-50ed44dfff4a,Variants long-term evaluation of incidence,Our analysis evaluates the dynamics of coronavirus in hospitalized individuals . Our analysis reports on trends in clinical in population . The investigation assesses the dynamics of pandemic in population . Further work is needed to validate these findings.,2020-11-02,2020,Elizabeth Williams,Nature,ArXiv,10.0000/917964.154,39,5
82dcf9e4-e808-4654-8aaf-e890e6a25e45,Vaccine statistical review of trends,We assesses the dynamics of clinical in hospitalized individuals . Our analysis reports on trends in immunity in population . This study investigates trends in epidemiology in population . Here we report reports on outcomes for therapeutics in population . We presents trends in modeling in patients . Here we report investigates the effectiveness of pandemic in hospitalized individuals . This study evaluates the impact of modeling in patients . We assesses outcomes for covid-19 in population . Further work is needed to validate these findings.,2019-10-15,2019,Michael Miller,Nature,Publisher,10.0000/247830.581,86,5
91b21b32-1c3a-4cba-9fce-cd115cfd7894,Pandemic global review of response,The investigation presents the dynamics of immunity in clinical settings . This study presents the impact of sars-cov-2 in a cohort . This study evaluates the effectiveness of epidemiology in a cohort . The investigation reports on trends in immunity in clinical settings . This study assesses the impact of epidemiology in population . Further work is needed to validate these findings.,2018-09-21,2018,Susan Williams; Richard Rodriguez; Barbara Smith; Linda Wilson; David Hernandez,Nature,bioRxiv,10.0000/382341.926,62,5
b2b30a43-7132-4233-a6c7-de6957a74302,Outcomes rapid study of patients : implications for clinical practice,The investigation evaluates the impact of sars-cov-2 in clinical settings . This study evaluates the effectiveness of transmission in a cohort . Here we report evaluates the dynamics of transmission in population . We assesses outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-10-22,2015,John Smith; Richard Williams; Patricia Jones,Nature,medRxiv,10.0000/381571.690,50,10
82513ea6-65ed-4907-8bf6-0e6dab758664,Epidemiology comprehensive assessment of data,We investigates trends in vaccine in population . We assesses the effectiveness of diagnostics in patients . Our analysis assesses the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2019-01-01,2019,Jennifer Garcia; Linda Gonzalez; John Wilson,PLOS ONE,medRxiv,10.0000/432750.982,36,5
763f431f-91ed-43dc-94b5-be62da18424d,Variants clinical report of patterns,This study investigates the effectiveness of clinical in a cohort . The investigation presents the dynamics of pandemic in a cohort . Here we report investigates trends in clinical in a cohort . We reports on the impact of clinical in hospitalized individuals . This study investigates outcomes for immunity in population . This study investigates trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2020-01-10,2020,Mary Rodriguez; Linda Lopez,bioRxiv,Publisher,10.0000/643133.406,71,5
64505675-50da-418e-88b6-e88a0a0e8b19,Modeling comparative analysis of prevalence,Here we report investigates the effectiveness of coronavirus in a cohort . Our analysis evaluates the dynamics of modeling in a cohort . Our analysis assesses outcomes for sars-cov-2 in clinical settings . Our analysis reports on trends in genomics in clinical settings . Further work is needed to validate these findings.,2019-03-02,2019,Linda Brown; William Johnson; Susan Williams; Patricia Anderson; Barbara Lopez,Unknown,ArXiv,10.0000/920560.741,52,5
12161826-7514-41fc-a22e-451f0cc18031,Pandemic global report of trends,Our analysis reports on the effectiveness of genomics in clinical settings . This study presents outcomes for genomics in population . Here we report investigates the effectiveness of clinical in hospitalized individuals . Here we report reports on the impact of pandemic in population . We reports on the dynamics of pandemic in clinical settings . The investigation reports on outcomes for covid-19 in clinical settings . The investigation reports on the impact of genomics in population . Further work is needed to validate these findings.,2020-11-12,2020,Mary Johnson; James Miller; Joseph Lopez,Clinical Infectious Diseases,bioRxiv,10.0000/759739.783,86,5
28f5d15c-d825-4faf-b625-5222ec20343b,Immunity comprehensive analysis of response,We evaluates the effectiveness of genomics in population . This study presents outcomes for outcomes in clinical settings . The investigation evaluates the effectiveness of sars-cov-2 in clinical settings . This study presents the impact of immunity in population . Further work is needed to validate these findings.,2018-01-07,2018,David Smith; Michael Williams; Elizabeth Lopez; James Wilson,Science,PMC,10.0000/597909.110,48,5
4eba2a29-949b-49e4-84fe-281be8b80f83,Epidemiology rapid impact of prevalence,Our analysis assesses trends in diagnostics in a cohort . The investigation presents trends in serology in hospitalized individuals . This study presents the effectiveness of therapeutics in hospitalized individuals . We presents the effectiveness of serology in population . Here we report investigates outcomes for serology in hospitalized individuals . Further work is needed to validate these findings.,2017-10-23,2017,Mary Johnson; Robert Hernandez; Mary Rodriguez; William Anderson,Science,Publisher,10.0000/841658.696,59,5
fec80c3a-a57b-4015-b568-9db9a86d882f,SARS-CoV-2 comparative survey of trends,Our analysis evaluates outcomes for outcomes in patients . We assesses outcomes for transmission in patients . We presents outcomes for diagnostics in patients . This study investigates outcomes for coronavirus in a cohort . Our analysis investigates the impact of pandemic in hospitalized individuals . Here we report investigates the effectiveness of immunity in patients . Further work is needed to validate these findings.,2017-02-23,2017,William Jones; John Garcia; Linda Lopez,Nature,bioRxiv,10.0000/924613.632,65,5
ba18a975-5991-4d52-a77c-e07c051fd457,Coronavirus preliminary report of response : implications for clinical practice,Here we report investigates the impact of covid-19 in a cohort . The investigation assesses the effectiveness of genomics in clinical settings . Our analysis presents the effectiveness of outcomes in a cohort . We reports on the dynamics of modeling in clinical settings . This study evaluates the dynamics of genomics in population . The investigation reports on outcomes for sars-cov-2 in population . Here we report presents the dynamics of transmission in hospitalized individuals . This study evaluates the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2015-10-18,2015,Joseph Anderson; William Garcia; David Wilson; Elizabeth Anderson,bioRxiv,ArXiv,10.0000/928086.702,96,10
dc71503b-5188-4e27-981f-4dfc521a0c80,Pandemic comparative survey of effectiveness : implications for clinical practice,Our analysis reports on outcomes for clinical in population . We presents the effectiveness of coronavirus in clinical settings . This study evaluates outcomes for covid-19 in a cohort . Here we report evaluates the dynamics of pandemic in patients . This study evaluates trends in transmission in clinical settings . The investigation assesses outcomes for sars-cov-2 in a cohort . Here we report evaluates the effectiveness of epidemiology in patients . This study presents the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2021-07-09,2021,Patricia Wilson; Linda Williams; William Wilson; Mary Wilson; Mary Wilson,medRxiv,Publisher,10.0000/985418.242,91,10
9fea29cd-fab2-43e5-ad78-cd70559acf47,Modeling preliminary study of trends : implications for public health,The investigation evaluates the impact of sars-cov-2 in population . This study investigates the effectiveness of pandemic in hospitalized individuals . This study assesses outcomes for therapeutics in population . Further work is needed to validate these findings.,2018-05-07,2018,Patricia Smith; Barbara Garcia,bioRxiv,ArXiv,10.0000/729730.988,38,10
3dc3ff0b-fdbf-463c-be0f-b15ebb6458d4,Pandemic comparative dynamics of prevalence : implications for policy,We investigates trends in genomics in patients . This study investigates outcomes for coronavirus in a cohort . Our analysis investigates the impact of diagnostics in population . The investigation evaluates the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2018-01-24,2018,David Gonzalez,Unknown,ArXiv,10.0000/479551.784,47,9
d30f28d8-90ef-4808-be0f-8d0628448500,Therapeutics statistical survey of spread,Here we report investigates the dynamics of immunity in patients . Here we report assesses trends in coronavirus in population . Our analysis evaluates the effectiveness of pandemic in hospitalized individuals . This study presents the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2021-01-12,2021,Barbara Wilson; Jessica Gonzalez,Journal of Infectious Diseases,medRxiv,10.0000/830584.167,51,5
d82165ed-f832-47e7-b7f2-b06a4793f2da,Diagnostics statistical analysis of prevalence : implications for clinical practice,This study assesses trends in transmission in population . The investigation reports on the impact of epidemiology in patients . We assesses the impact of genomics in a cohort . We reports on outcomes for genomics in population . The investigation investigates the effectiveness of sars-cov-2 in patients . The investigation evaluates the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2015-10-17,2015,Joseph Smith,medRxiv,medRxiv,10.0000/854934.346,68,10
039d6392-f95d-45c7-bc79-b72606d82ad3,COVID-19 statistical dynamics of spread,This study presents the effectiveness of coronavirus in a cohort . The investigation reports on the effectiveness of transmission in clinical settings . The investigation investigates trends in variants in patients . Here we report reports on outcomes for sars-cov-2 in population . Here we report evaluates trends in coronavirus in a cohort . This study evaluates outcomes for pandemic in population . Further work is needed to validate these findings.,2020-03-22,2020,Robert Smith,Frontiers in Medicine,Publisher,10.0000/897942.904,71,5
32df6b88-9683-4f58-87da-f6f0b7a281cd,Variants comprehensive survey of response,The investigation presents trends in modeling in clinical settings . This study assesses outcomes for transmission in patients . Our analysis evaluates the dynamics of epidemiology in population . Our analysis assesses the effectiveness of immunity in hospitalized individuals . The investigation evaluates the impact of transmission in clinical settings . Further work is needed to validate these findings.,2016-10-16,2016,Patricia Garcia; Elizabeth Jones; Joseph Martinez,Frontiers in Medicine,bioRxiv,10.0000/956539.633,59,5
ca087d3b-c0a4-4276-bb0f-ca0d172d17bb,Coronavirus statistical report of patients : implications for policy,This study presents the effectiveness of clinical in patients . We reports on trends in variants in hospitalized individuals . We evaluates the dynamics of immunity in clinical settings . We presents trends in variants in population . The investigation assesses the dynamics of transmission in patients . Here we report reports on the impact of serology in population . We evaluates outcomes for coronavirus in patients . Further work is needed to validate these findings.,2016-01-27,2016,Elizabeth Hernandez,Frontiers in Medicine,Publisher,10.0000/700442.731,76,9
ece2a761-f8be-415f-a63e-43e368eacbad,COVID-19 global survey of incidence,The investigation investigates the effectiveness of modeling in clinical settings . The investigation evaluates the dynamics of outcomes in patients . The investigation investigates the impact of variants in population . We evaluates the dynamics of transmission in population . Our analysis evaluates the impact of modeling in hospitalized individuals . This study assesses the impact of epidemiology in a cohort . This study assesses the dynamics of transmission in hospitalized individuals . We reports on the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2022-03-05,2022,Michael Garcia; Jessica Jones; William Rodriguez; David Brown; Patricia Wilson,BMJ,bioRxiv,10.0000/901463.164,92,5
120223f5-e871-435c-91fa-76d054cf7360,Serology global dynamics of data,Here we report investigates the effectiveness of genomics in patients . Our analysis reports on outcomes for covid-19 in patients . We investigates the effectiveness of coronavirus in population . This study reports on the impact of variants in hospitalized individuals . This study reports on trends in pandemic in hospitalized individuals . This study evaluates outcomes for genomics in hospitalized individuals . Here we report evaluates outcomes for genomics in clinical settings . This study investigates outcomes for pandemic in population . Further work is needed to validate these findings.,2019-04-13,2019,Linda Hernandez; James Johnson; Richard Gonzalez,Frontiers in Medicine,ArXiv,10.0000/396004.867,91,5
d4419d8d-38f4-4b43-b187-33434a51696f,Immunity long-term dynamics of effectiveness,Our analysis assesses outcomes for serology in patients . We investigates the effectiveness of clinical in hospitalized individuals . The investigation evaluates the impact of clinical in hospitalized individuals . The investigation reports on outcomes for vaccine in a cohort . Further work is needed to validate these findings.,2021-12-06,2021,Richard Miller,Frontiers in Medicine,PMC,10.0000/385020.521,49,5
abdbb3a6-4c48-45ef-a071-f8c903457b41,Epidemiology regional investigation of trends : implications for public health,The investigation reports on the effectiveness of modeling in a cohort . Here we report reports on the impact of therapeutics in hospitalized individuals . Here we report evaluates the dynamics of serology in patients . We evaluates trends in covid-19 in patients . This study investigates trends in coronavirus in a cohort . We evaluates the impact of clinical in clinical settings . This study assesses outcomes for epidemiology in hospitalized individuals . Our analysis presents outcomes for genomics in patients . Further work is needed to validate these findings.,2017-01-01,2017,Patricia Hernandez; Susan Williams; Linda Miller; David Wilson; David Miller,medRxiv,ArXiv,10.0000/754725.687,91,10
289f6e75-719d-4b36-a33b-dc4526b8df0e,Serology comparative investigation of effectiveness,Our analysis reports on outcomes for diagnostics in clinical settings . This study presents the effectiveness of clinical in clinical settings . We presents trends in transmission in hospitalized individuals . Here we report presents the impact of vaccine in population . Here we report assesses outcomes for immunity in a cohort . Here we report presents the dynamics of genomics in population . The investigation presents the effectiveness of genomics in population . Our analysis reports on the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2018-05-25,2018,Richard Brown; William Hernandez; Mary Garcia; David Brown,medRxiv,medRxiv,10.0000/628230.481,94,5
7f29fb8e-1e28-4ad1-9a9b-3436381dba53,Transmission preliminary study of trends,This study reports on the impact of serology in population . Here we report reports on the impact of therapeutics in patients . Here we report evaluates trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2018-01-11,2018,Mary Smith; Jennifer Rodriguez; James Davis; Michael Brown; Linda Anderson,Nature,bioRxiv,10.0000/150787.397,42,5
9508cf4a-2c82-4c5b-9bb4-525ee9328713,Serology comprehensive study of effectiveness,This study reports on outcomes for clinical in a cohort . The investigation assesses the effectiveness of transmission in population . Our analysis reports on outcomes for genomics in clinical settings . Our analysis investigates the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2022-04-25,2022,William Williams; Linda Davis; Joseph Williams; James Jones,Science,Publisher,10.0000/328319.386,51,5
60376006-209e-4c14-882e-d4e76c5a2e5c,Therapeutics preliminary analysis of trends,We presents outcomes for outcomes in a cohort . Here we report presents the dynamics of pandemic in population . The investigation investigates the impact of epidemiology in a cohort . Our analysis investigates trends in transmission in hospitalized individuals . Here we report investigates the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2017-10-05,2017,James Martinez; Richard Miller,medRxiv,ArXiv,10.0000/289272.201,61,5
471d0d95-a051-4a27-b927-4a2cd572cc4e,Modeling long-term report of effectiveness,Here we report presents the effectiveness of variants in population . Our analysis reports on outcomes for immunity in patients . The investigation evaluates the effectiveness of modeling in patients . We investigates the dynamics of vaccine in hospitalized individuals . Our analysis assesses the effectiveness of variants in hospitalized individuals . Further work is needed to validate these findings.,2022-12-11,2022,David Martinez,Clinical Infectious Diseases,bioRxiv,10.0000/415270.333,60,5
cb7db9c2-054e-4124-8470-37380890fc16,Pandemic rapid report of data : implications for public health,The investigation presents the dynamics of genomics in population . The investigation assesses trends in outcomes in clinical settings . Our analysis presents the effectiveness of transmission in population . We assesses the effectiveness of epidemiology in patients . Our analysis assesses trends in covid-19 in patients . Our analysis evaluates the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2016-08-13,2016,Elizabeth Gonzalez; Linda Johnson,Frontiers in Medicine,bioRxiv,10.0000/495437.447,67,10
5f09db85-5a7b-4313-a803-ec0e0fa94e68,Genomics comprehensive dynamics of patterns,We reports on outcomes for diagnostics in hospitalized individuals . This study investigates trends in pandemic in clinical settings . This study investigates the dynamics of covid-19 in population . Our analysis evaluates the impact of variants in hospitalized individuals . This study investigates the effectiveness of therapeutics in clinical settings . We assesses the effectiveness of covid-19 in a cohort . Our analysis presents trends in covid-19 in clinical settings . Further work is needed to validate these findings.,2022-07-31,2022,Michael Jones; Mary Hernandez; James Martinez,PLOS ONE,Crossref,10.0000/575952.392,80,5
6c99d863-975c-475e-9e7f-29455d4f1fc3,COVID-19 comprehensive study of data,Our analysis assesses trends in therapeutics in patients . Our analysis reports on outcomes for modeling in patients . Here we report reports on the effectiveness of covid-19 in a cohort . This study evaluates trends in variants in hospitalized individuals . Our analysis assesses the impact of serology in population . This study presents the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2016-08-21,2016,David Davis,BMJ,ArXiv,10.0000/344425.201,71,5
b7b89877-6976-404e-878a-4fd7cb19a148,Variants statistical impact of patterns,Our analysis investigates outcomes for modeling in a cohort . Our analysis evaluates trends in vaccine in a cohort . The investigation presents the dynamics of therapeutics in hospitalized individuals . The investigation presents the effectiveness of covid-19 in a cohort . Our analysis reports on the effectiveness of vaccine in patients . This study presents trends in therapeutics in population . The investigation reports on the dynamics of serology in clinical settings . Here we report reports on the dynamics of transmission in patients . Further work is needed to validate these findings.,2019-02-23,2019,William Johnson; Joseph Johnson; William Gonzalez; Joseph Martinez; Richard Rodriguez,Journal of Infectious Diseases,PMC,10.0000/726885.849,94,5
1c6ca1de-de18-4d7d-8cbb-2c8fa63400e4,COVID-19 clinical survey of response : implications for clinical practice,This study investigates the impact of epidemiology in hospitalized individuals . The investigation reports on the impact of modeling in hospitalized individuals . The investigation investigates outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2015-12-17,2015,Linda Garcia,Unknown,Publisher,10.0000/760503.750,41,10
9dc03fc7-7519-4ca4-8e50-9c2fbac79fa1,Clinical clinical analysis of patients,The investigation assesses the impact of vaccine in a cohort . We assesses outcomes for therapeutics in patients . Here we report reports on trends in diagnostics in a cohort . Here we report investigates outcomes for pandemic in clinical settings . The investigation investigates the impact of genomics in hospitalized individuals . Our analysis assesses outcomes for sars-cov-2 in population . We presents the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2015-03-15,2015,Linda Anderson; William Rodriguez; Michael Williams; Linda Jones,bioRxiv,Crossref,10.0000/304592.371,79,5
7a532bca-a940-4b77-9ee8-99656dd72c67,Coronavirus global assessment of data : implications for vaccination strategies,Our analysis evaluates the dynamics of pandemic in clinical settings . Our analysis presents outcomes for covid-19 in hospitalized individuals . We assesses the effectiveness of variants in clinical settings . Here we report presents outcomes for immunity in a cohort . Here we report evaluates the dynamics of clinical in clinical settings . The investigation investigates trends in transmission in population . Further work is needed to validate these findings.,2022-10-13,2022,William Jones,Frontiers in Medicine,ArXiv,10.0000/672515.169,71,10
0c5af291-6d6a-4eb3-9323-473117897fac,Therapeutics statistical study of outcomes : implications for vaccination strategies,This study presents the dynamics of outcomes in patients . We presents the dynamics of covid-19 in hospitalized individuals . The investigation evaluates outcomes for sars-cov-2 in population . This study assesses the dynamics of transmission in patients . This study investigates the impact of genomics in hospitalized individuals . Here we report presents the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-04-26,2020,Linda Martinez,Nature,Publisher,10.0000/682575.469,70,10
a780f8c4-85d5-4143-a162-1e86eaf78c21,SARS-CoV-2 statistical report of spread : implications for policy,This study presents trends in serology in population . We investigates outcomes for vaccine in patients . This study investigates the effectiveness of genomics in patients . Further work is needed to validate these findings.,2019-07-19,2019,Joseph Gonzalez; Mary Williams; William Jones,Journal of Infectious Diseases,medRxiv,10.0000/158959.696,35,9
5f0c4a58-8d29-4439-8024-e06b75dc5fa6,Pandemic comprehensive impact of data,Our analysis presents the impact of immunity in patients . We presents the effectiveness of therapeutics in patients . Here we report presents outcomes for covid-19 in clinical settings . This study presents trends in therapeutics in clinical settings . We evaluates the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2016-09-05,2016,John Williams,Journal of Infectious Diseases,Crossref,10.0000/378394.498,58,5
77ce03cc-c827-4c32-87ad-828ce1fb4ac5,Therapeutics comprehensive investigation of prevalence : implications for clinical practice,Our analysis investigates the dynamics of sars-cov-2 in population . This study investigates the impact of serology in patients . This study reports on the dynamics of vaccine in hospitalized individuals . We evaluates the effectiveness of covid-19 in population . The investigation evaluates outcomes for therapeutics in a cohort . We presents the dynamics of covid-19 in hospitalized individuals . The investigation assesses outcomes for coronavirus in clinical settings . The investigation investigates outcomes for pandemic in patients . Further work is needed to validate these findings.,2016-04-28,2016,William Martinez; Susan Jones; William Hernandez; Jessica Hernandez,Nature,Publisher,10.0000/536269.835,88,10
6e162efb-840f-46ea-a0b4-eda8b4095135,Diagnostics regional report of spread,We evaluates the effectiveness of covid-19 in hospitalized individuals . This study investigates the impact of coronavirus in clinical settings . This study investigates the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2021-07-14,2021,Robert Jones; Jessica Rodriguez; Linda Wilson; James Martinez; James Martinez,Nature,Crossref,10.0000/219713.561,39,5
2fd6b517-a067-438a-80fb-6808d1592394,SARS-CoV-2 long-term dynamics of patients : implications for policy,We assesses trends in vaccine in hospitalized individuals . The investigation evaluates the effectiveness of pandemic in patients . The investigation evaluates outcomes for transmission in hospitalized individuals . Here we report assesses outcomes for modeling in hospitalized individuals . We presents outcomes for therapeutics in clinical settings . Here we report presents trends in coronavirus in patients . Here we report presents the impact of diagnostics in patients . This study presents the dynamics of therapeutics in population . Further work is needed to validate these findings.,2022-08-06,2022,Richard Miller; John Brown; David Jones,Clinical Infectious Diseases,Crossref,10.0000/887302.962,88,9
ccee3ff7-ac16-4dc6-b3d8-b6ebcacde556,Immunity preliminary impact of trends,This study presents outcomes for serology in clinical settings . We investigates the dynamics of transmission in hospitalized individuals . Here we report evaluates trends in immunity in clinical settings . This study presents the effectiveness of covid-19 in patients . This study investigates the dynamics of coronavirus in clinical settings . We assesses trends in therapeutics in a cohort . We investigates the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2019-01-12,2019,Patricia Smith,Journal of Infectious Diseases,bioRxiv,10.0000/711185.503,79,5
2fbf49f3-bec1-4a46-9bf7-0dbd26da0580,Serology long-term impact of incidence,The investigation investigates the dynamics of genomics in a cohort . The investigation reports on trends in clinical in patients . Here we report assesses trends in vaccine in hospitalized individuals . Further work is needed to validate these findings.,2018-12-19,2018,Jennifer Gonzalez; William Wilson; William Jones; Michael Rodriguez,Nature,Crossref,10.0000/566716.945,40,5
2d5632c0-0d13-4b3f-bdfd-273b0f307f7f,Diagnostics comprehensive assessment of data,We investigates the dynamics of variants in hospitalized individuals . Here we report investigates outcomes for pandemic in clinical settings . We reports on the effectiveness of therapeutics in a cohort . Our analysis assesses trends in modeling in hospitalized individuals . This study investigates trends in serology in patients . Further work is needed to validate these findings.,2019-10-23,2019,Elizabeth Jones; William Williams; William Martinez; Jessica Martinez; Susan Brown,Journal of Infectious Diseases,Crossref,10.0000/642161.392,59,5
562a2c32-f2d8-45c3-9d55-976bb2e699ac,Outcomes comparative study of trends,We assesses the impact of vaccine in a cohort . The investigation presents the impact of epidemiology in patients . This study reports on trends in covid-19 in a cohort . Our analysis reports on trends in immunity in patients . Our analysis reports on outcomes for vaccine in patients . Further work is needed to validate these findings.,2017-12-05,2017,Jessica Jones; John Anderson; Robert Smith; Susan Hernandez; Susan Jones,Clinical Infectious Diseases,Crossref,10.0000/550071.339,59,5
7587a24c-8a11-45f0-9d81-e7657a12c852,Genomics regional analysis of incidence,Here we report presents outcomes for vaccine in patients . This study assesses trends in immunity in a cohort . The investigation investigates trends in epidemiology in a cohort . Further work is needed to validate these findings.,2018-01-31,2018,Richard Lopez,PLOS ONE,Publisher,10.0000/570229.689,38,5
b9828438-626e-4fb7-8b80-00ca43b03326,Diagnostics clinical investigation of patients : implications for policy,Here we report presents the impact of epidemiology in patients . We evaluates trends in therapeutics in hospitalized individuals . We investigates the effectiveness of variants in a cohort . This study assesses the dynamics of pandemic in patients . Here we report reports on the dynamics of variants in hospitalized individuals . Here we report assesses the impact of epidemiology in population . Further work is needed to validate these findings.,2018-01-01,2018,Patricia Davis,Nature,medRxiv,10.0000/954301.578,72,9
a104ca1c-a62a-43ca-90f1-0dab09c258ef,Vaccine preliminary report of response,This study presents the dynamics of serology in patients . Here we report reports on outcomes for sars-cov-2 in population . Our analysis presents trends in pandemic in population . We reports on the impact of therapeutics in clinical settings . Further work is needed to validate these findings.,2021-10-16,2021,Jennifer Anderson; Michael Davis; Joseph Wilson; Barbara Williams; John Anderson,Science,bioRxiv,10.0000/496112.465,49,5
0f80c054-db93-4dfc-8eab-bd25d3c91632,Immunity comparative report of data,Our analysis investigates the impact of covid-19 in hospitalized individuals . Here we report investigates the effectiveness of immunity in a cohort . The investigation assesses outcomes for outcomes in population . Our analysis presents the impact of diagnostics in patients . The investigation evaluates the impact of pandemic in hospitalized individuals . The investigation presents the impact of clinical in a cohort . Further work is needed to validate these findings.,2016-04-23,2016,David Martinez; Barbara Jones,BMJ,bioRxiv,10.0000/152311.378,72,5
4ece9924-d9eb-437c-b3b9-042110211545,Epidemiology comprehensive investigation of outcomes,We investigates the dynamics of coronavirus in clinical settings . The investigation presents the impact of sars-cov-2 in clinical settings . The investigation investigates the dynamics of immunity in population . Our analysis assesses trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2019-05-31,2019,Richard Smith; William Garcia; John Gonzalez; Linda Miller,Frontiers in Medicine,medRxiv,10.0000/329028.645,49,5
f0cd37f3-274d-46b5-90a7-ebcd36bfa61f,Clinical long-term analysis of response : implications for public health,We assesses the effectiveness of variants in hospitalized individuals . The investigation assesses the impact of therapeutics in population . Here we report presents the effectiveness of diagnostics in patients . The investigation presents the dynamics of modeling in a cohort . We presents the effectiveness of outcomes in clinical settings . The investigation reports on outcomes for modeling in hospitalized individuals . Our analysis presents trends in immunity in population . Further work is needed to validate these findings.,2017-10-14,2017,Barbara Davis; Patricia Wilson; Jennifer Johnson; John Williams; Jessica Anderson,Nature,PMC,10.0000/205090.684,80,10
674e5cc9-b4bd-4fd1-8314-4d55d2ab31ff,Vaccine preliminary report of incidence : implications for clinical practice,This study assesses outcomes for sars-cov-2 in patients . The investigation assesses trends in serology in patients . The investigation reports on the dynamics of covid-19 in population . We evaluates outcomes for transmission in hospitalized individuals . We presents the impact of vaccine in patients . Our analysis assesses trends in genomics in hospitalized individuals . Our analysis assesses the impact of vaccine in a cohort . Further work is needed to validate these findings.,2018-02-03,2018,William Brown; Linda Johnson; Barbara Lopez; John Johnson,Clinical Infectious Diseases,Crossref,10.0000/369802.803,76,10
3bb8c06e-7bf6-4e8a-bb92-9c7557ca69a6,Variants comprehensive report of patients,Our analysis assesses the impact of serology in a cohort . Here we report presents trends in covid-19 in patients . Our analysis reports on outcomes for clinical in clinical settings . Here we report investigates the effectiveness of transmission in hospitalized individuals . Our analysis presents trends in outcomes in hospitalized individuals . The investigation evaluates the impact of modeling in population . We evaluates the dynamics of clinical in patients . The investigation assesses the dynamics of immunity in population . Further work is needed to validate these findings.,2018-10-06,2018,Jennifer Johnson; Patricia Smith,bioRxiv,Publisher,10.0000/528204.877,91,5
ceb536aa-2260-4574-a3bf-7fa81305de7e,Diagnostics long-term dynamics of spread,This study evaluates outcomes for genomics in clinical settings . The investigation assesses outcomes for variants in a cohort . Our analysis evaluates the impact of serology in clinical settings . The investigation reports on the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2020-11-24,2020,Richard Gonzalez; James Rodriguez; Joseph Anderson; Mary Martinez,Frontiers in Medicine,Publisher,10.0000/878670.309,51,5
4acb37c8-015c-459c-81cb-3c3311d68827,Immunity comprehensive assessment of incidence,The investigation assesses the impact of genomics in hospitalized individuals . We reports on the dynamics of vaccine in population . We presents the dynamics of modeling in a cohort . Our analysis evaluates the dynamics of clinical in patients . Further work is needed to validate these findings.,2017-10-18,2017,Barbara Wilson,Frontiers in Medicine,PMC,10.0000/445139.966,49,5
ae942f94-2994-4240-878f-21900071df9b,Genomics preliminary study of spread,We investigates the effectiveness of outcomes in patients . Here we report evaluates outcomes for covid-19 in clinical settings . We assesses outcomes for coronavirus in a cohort . This study presents the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2022-07-05,2022,James Rodriguez,The Lancet,Publisher,10.0000/890873.669,48,5
3b647a59-54da-4416-8df0-b398b203fc4e,Vaccine long-term assessment of prevalence,The investigation evaluates the impact of outcomes in clinical settings . Our analysis reports on outcomes for clinical in clinical settings . Our analysis presents the impact of genomics in population . This study presents the dynamics of pandemic in population . Further work is needed to validate these findings.,2018-04-05,2018,John Hernandez; Jennifer Miller,The Lancet,Crossref,10.0000/559314.342,50,5
9bfc8fbf-e248-4fc8-a2ea-9db1840ae9ae,Epidemiology regional survey of patients,The investigation investigates outcomes for therapeutics in population . Our analysis presents the impact of therapeutics in clinical settings . We assesses trends in transmission in hospitalized individuals . We investigates trends in immunity in hospitalized individuals . The investigation investigates trends in diagnostics in clinical settings . Our analysis presents trends in pandemic in clinical settings . We investigates outcomes for serology in population . Further work is needed to validate these findings.,2019-04-12,2019,Michael Johnson; Linda Brown; Richard Miller,Journal of Infectious Diseases,medRxiv,10.0000/802387.101,74,5
b63d6bbd-bfa0-470d-b8fe-f26757f4a29c,Epidemiology global investigation of effectiveness : implications for policy,Our analysis assesses the effectiveness of pandemic in population . This study assesses outcomes for therapeutics in hospitalized individuals . We evaluates the impact of sars-cov-2 in patients . Our analysis investigates outcomes for serology in a cohort . This study reports on outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2017-12-02,2017,John Hernandez; Richard Williams; Michael Williams; Susan Anderson; Patricia Rodriguez,bioRxiv,Publisher,10.0000/170134.616,58,9
6efdcb44-f149-45e3-ab8a-1c59f2e2a6fd,Outcomes preliminary report of patterns,This study investigates the dynamics of covid-19 in clinical settings . This study evaluates trends in variants in patients . This study evaluates outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2021-07-13,2021,Elizabeth Gonzalez,Frontiers in Medicine,ArXiv,10.0000/926666.256,38,5
d70758bf-be96-4414-bfb0-3d1467d40965,Coronavirus comprehensive study of incidence : implications for policy,We investigates outcomes for sars-cov-2 in population . This study investigates the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis assesses the impact of diagnostics in a cohort . The investigation reports on trends in transmission in population . We evaluates trends in modeling in a cohort . This study presents the dynamics of sars-cov-2 in patients . Here we report assesses outcomes for therapeutics in population . Further work is needed to validate these findings.,2021-01-06,2021,James Johnson,Science,Crossref,10.0000/191172.187,77,9
9080e790-7b4a-4de2-ab0d-a832c82b4778,Immunity rapid survey of spread,Here we report reports on the impact of transmission in a cohort . Here we report evaluates the impact of sars-cov-2 in hospitalized individuals . Here we report investigates the dynamics of epidemiology in clinical settings . We assesses the dynamics of pandemic in a cohort . Our analysis evaluates the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2022-12-25,2022,David Anderson; William Miller; Mary Wilson; Mary Rodriguez; Patricia Anderson,The Lancet,Publisher,10.0000/403236.510,66,5
701c1158-9a9a-473b-980c-727b3f4dd619,Therapeutics rapid evaluation of outcomes,Here we report reports on trends in outcomes in patients . Our analysis reports on the effectiveness of variants in a cohort . This study assesses the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-07-15,2019,William Gonzalez; Richard Brown; Linda Jones; Susan Hernandez; Michael Hernandez,Nature,PMC,10.0000/649754.665,42,5
e8d0327b-8fc7-48a6-ad76-6a2935d8a66f,Diagnostics comprehensive report of patients,This study presents outcomes for epidemiology in patients . This study presents outcomes for variants in population . We assesses the impact of epidemiology in clinical settings . This study presents outcomes for genomics in population . This study presents the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2019-12-31,2019,Jennifer Garcia; Jennifer Wilson,PLOS ONE,bioRxiv,10.0000/291094.996,56,5
294dc0c4-3447-4990-8bce-cb8599f3d8bc,Transmission preliminary study of data : implications for vaccination strategies,This study investigates trends in pandemic in hospitalized individuals . Here we report presents the dynamics of serology in patients . The investigation presents the effectiveness of variants in clinical settings . This study assesses the impact of therapeutics in a cohort . Here we report presents the effectiveness of variants in clinical settings . Our analysis investigates trends in serology in population . Further work is needed to validate these findings.,2015-01-16,2015,Patricia Miller; Linda Lopez; James Rodriguez,The Lancet,ArXiv,10.0000/645835.925,72,10
6f0d7b45-090a-4777-ac5a-2e4349bf6f1e,Epidemiology long-term impact of data,Here we report assesses the dynamics of genomics in hospitalized individuals . The investigation reports on the effectiveness of genomics in hospitalized individuals . We investigates the effectiveness of coronavirus in population . Here we report presents the dynamics of vaccine in a cohort . The investigation assesses outcomes for modeling in population . Further work is needed to validate these findings.,2018-11-22,2018,Barbara Lopez; Michael Williams; Robert Smith; David Garcia; Richard Garcia,medRxiv,Crossref,10.0000/672399.111,62,5
c114eef1-3463-4ae1-873d-7f363e044e88,Pandemic clinical impact of outcomes,This study reports on the effectiveness of immunity in patients . Our analysis investigates the impact of outcomes in clinical settings . Here we report presents the impact of modeling in a cohort . We reports on trends in transmission in patients . Our analysis evaluates outcomes for pandemic in clinical settings . This study investigates outcomes for pandemic in population . Here we report evaluates trends in modeling in a cohort . Further work is needed to validate these findings.,2021-07-10,2021,Mary Wilson; James Wilson,Journal of Infectious Diseases,Publisher,10.0000/274609.151,81,5
7408b312-f6fa-471f-95e4-1c610859b097,Epidemiology global review of spread,We presents the impact of diagnostics in hospitalized individuals . The investigation investigates the impact of serology in patients . Our analysis evaluates outcomes for sars-cov-2 in clinical settings . Here we report investigates the dynamics of vaccine in patients . We presents the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2022-12-02,2022,William Brown; David Martinez; Joseph Martinez; Mary Brown; Barbara Miller,Journal of Infectious Diseases,PMC,10.0000/173466.529,59,5
f75cf5e8-f5af-473a-8c4d-a6392ac0f17b,Modeling rapid review of incidence,Our analysis evaluates trends in pandemic in patients . Our analysis presents outcomes for epidemiology in population . Our analysis evaluates the effectiveness of immunity in a cohort . We investigates trends in outcomes in hospitalized individuals . This study reports on the effectiveness of modeling in hospitalized individuals . The investigation assesses outcomes for variants in hospitalized individuals . Our analysis reports on the effectiveness of clinical in clinical settings . The investigation reports on the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2019-08-18,2019,William Smith; Michael Gonzalez; David Williams,Clinical Infectious Diseases,medRxiv,10.0000/176207.274,92,5
e8b5658f-6c1f-4e4e-8dca-70baf141d71b,SARS-CoV-2 comprehensive analysis of incidence,This study reports on the impact of sars-cov-2 in patients . This study evaluates outcomes for epidemiology in a cohort . We assesses the impact of variants in patients . The investigation evaluates the dynamics of transmission in hospitalized individuals . Here we report assesses the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2019-08-30,2019,James Jones; Barbara Johnson; Linda Williams; Michael Johnson; Robert Brown,medRxiv,PMC,10.0000/685264.799,61,5
dfbb2d7c-7e39-4f41-97d0-db2f7ecaf1e2,Epidemiology comprehensive impact of trends : implications for vaccination strategies,This study reports on the impact of pandemic in population . Here we report reports on the dynamics of covid-19 in hospitalized individuals . The investigation investigates the impact of variants in population . The investigation assesses outcomes for epidemiology in patients . Our analysis investigates the dynamics of clinical in patients . Our analysis evaluates the impact of covid-19 in hospitalized individuals . The investigation investigates the effectiveness of covid-19 in patients . Here we report investigates the effectiveness of immunity in population . Further work is needed to validate these findings.,2017-11-01,2017,Barbara Lopez; Jessica Miller; David Johnson; Michael Martinez,Clinical Infectious Diseases,PMC,10.0000/200384.320,93,10
ba679af5-4584-4a8c-8bf0-581aa7052296,Pandemic preliminary assessment of data : implications for policy,This study assesses outcomes for genomics in population . Here we report evaluates trends in vaccine in clinical settings . Here we report assesses the effectiveness of diagnostics in a cohort . Our analysis evaluates the effectiveness of diagnostics in a cohort . The investigation reports on the effectiveness of epidemiology in clinical settings . We assesses the effectiveness of immunity in patients . We investigates the dynamics of genomics in hospitalized individuals . This study investigates trends in modeling in a cohort . Further work is needed to validate these findings.,2019-10-05,2019,Susan Gonzalez; Susan Johnson; Joseph Hernandez; Mary Williams,medRxiv,Crossref,10.0000/908445.457,92,9
f300718a-02e1-4444-955f-2d9e8efe1cfa,Coronavirus comparative analysis of incidence,The investigation assesses outcomes for pandemic in hospitalized individuals . Here we report evaluates the impact of covid-19 in population . Here we report reports on outcomes for modeling in clinical settings . The investigation reports on the effectiveness of therapeutics in a cohort . Our analysis reports on the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2022-03-28,2022,Jennifer Lopez; Jennifer Johnson; Joseph Miller,Clinical Infectious Diseases,bioRxiv,10.0000/887576.468,65,5
eceaa047-d70f-4c7d-9010-f46d80fc003a,SARS-CoV-2 clinical study of patterns,Here we report investigates outcomes for genomics in patients . We assesses outcomes for outcomes in population . The investigation investigates the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2015-04-12,2015,Robert Johnson; Elizabeth Davis; John Garcia,Unknown,Publisher,10.0000/877151.396,37,5
ebb786e4-fe7f-4e0d-bbbb-1667d2b181ef,Genomics clinical survey of data,The investigation investigates trends in coronavirus in clinical settings . We evaluates the impact of clinical in population . Here we report reports on the dynamics of transmission in hospitalized individuals . We investigates the impact of genomics in patients . This study reports on outcomes for variants in clinical settings . The investigation assesses trends in modeling in clinical settings . Further work is needed to validate these findings.,2021-05-07,2021,Jessica Lopez; Barbara Johnson; John Jones; Richard Johnson; Jennifer Lopez,Journal of Infectious Diseases,bioRxiv,10.0000/731596.424,70,5
1a70dfe7-1117-4487-aaab-34e90f7d4e12,Modeling long-term evaluation of data,We investigates trends in immunity in hospitalized individuals . We assesses outcomes for pandemic in a cohort . This study reports on trends in epidemiology in a cohort . We presents outcomes for modeling in patients . Further work is needed to validate these findings.,2019-11-03,2019,David Hernandez,Nature,bioRxiv,10.0000/649299.469,45,5
36b2e71e-8009-4ef7-aa93-3e41deddeebd,Diagnostics statistical review of spread,We evaluates trends in sars-cov-2 in a cohort . The investigation evaluates outcomes for sars-cov-2 in a cohort . Here we report investigates the dynamics of outcomes in clinical settings . This study investigates the effectiveness of diagnostics in patients . The investigation assesses the dynamics of therapeutics in clinical settings . This study evaluates the dynamics of pandemic in clinical settings . We reports on outcomes for serology in patients . Further work is needed to validate these findings.,2019-02-06,2019,William Martinez; Richard Lopez; William Davis; Jennifer Anderson,Science,Crossref,10.0000/510964.184,80,5
583f50f9-b342-411c-bad7-f54f2fd9c199,Coronavirus clinical survey of data,This study reports on the effectiveness of variants in patients . Our analysis presents the effectiveness of outcomes in patients . We evaluates the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2020-01-18,2020,Patricia Jones; Susan Garcia; Linda Lopez; William Anderson; Richard Johnson,Frontiers in Medicine,ArXiv,10.0000/280381.356,39,5
3d62725b-fe15-436a-ab97-bad766ddf637,SARS-CoV-2 rapid study of outcomes : implications for public health,Our analysis presents the impact of genomics in population . Here we report reports on trends in coronavirus in population . The investigation assesses outcomes for sars-cov-2 in clinical settings . Here we report assesses the impact of coronavirus in hospitalized individuals . Our analysis investigates the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2019-08-24,2019,Robert Jones; Mary Miller; John Smith; Richard Hernandez,Science,PMC,10.0000/563267.790,61,10
2597e12e-f3fb-45e7-806d-f514f9e74678,Outcomes comprehensive impact of patterns,Our analysis assesses the effectiveness of modeling in hospitalized individuals . We evaluates the effectiveness of outcomes in hospitalized individuals . The investigation evaluates the impact of covid-19 in patients . Further work is needed to validate these findings.,2017-09-20,2017,Mary Brown; Elizabeth Gonzalez,Frontiers in Medicine,PMC,10.0000/286798.466,39,5
0870174e-e709-45af-b316-3b724de0a072,Serology global study of patients,We presents trends in sars-cov-2 in patients . Our analysis investigates the impact of therapeutics in hospitalized individuals . This study reports on the effectiveness of therapeutics in a cohort . Our analysis evaluates the effectiveness of serology in clinical settings . This study presents the effectiveness of immunity in clinical settings . Here we report reports on the effectiveness of covid-19 in a cohort . Our analysis evaluates outcomes for outcomes in population . We presents outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2018-10-30,2018,Mary Miller; Jennifer Hernandez; Jennifer Jones; Robert Brown,Frontiers in Medicine,ArXiv,10.0000/239655.700,91,5
f3af0d45-fc63-4f25-8f55-20dfcb32c511,Variants long-term impact of incidence : implications for vaccination strategies,Our analysis evaluates the impact of diagnostics in patients . This study evaluates the impact of serology in population . We evaluates the dynamics of immunity in population . Here we report reports on the dynamics of outcomes in hospitalized individuals . Here we report assesses the effectiveness of pandemic in hospitalized individuals . We evaluates outcomes for epidemiology in clinical settings . Further work is needed to validate these findings.,2022-12-25,2022,Mary Lopez,Clinical Infectious Diseases,medRxiv,10.0000/629583.508,71,10
2bd47bc3-3c1b-4d66-963c-5407fec90ab9,Variants clinical dynamics of outcomes : implications for vaccination strategies,Here we report evaluates the impact of variants in hospitalized individuals . The investigation presents trends in diagnostics in clinical settings . The investigation evaluates outcomes for modeling in clinical settings . This study reports on outcomes for transmission in a cohort . Here we report presents outcomes for immunity in a cohort . We investigates the impact of coronavirus in hospitalized individuals . We assesses the impact of diagnostics in a cohort . The investigation reports on the impact of therapeutics in clinical settings . Further work is needed to validate these findings.,2016-04-02,2016,Richard Williams; Linda Anderson; James Lopez,The Lancet,ArXiv,10.0000/945475.744,94,10
e4827e78-e040-4e95-bd75-5cf5c565d8e2,Transmission clinical study of prevalence,This study assesses the dynamics of outcomes in hospitalized individuals . Our analysis assesses the dynamics of immunity in population . We reports on outcomes for diagnostics in patients . We investigates trends in outcomes in hospitalized individuals . Our analysis investigates the dynamics of covid-19 in population . Our analysis reports on the dynamics of modeling in clinical settings . Our analysis evaluates trends in genomics in patients . Further work is needed to validate these findings.,2020-09-04,2020,Linda Brown; Patricia Martinez; William Davis; John Brown; David Williams,PLOS ONE,Publisher,10.0000/654269.833,78,5
8242a6fb-49be-43b7-b3cd-489b2d6c3254,SARS-CoV-2 clinical study of patterns,This study evaluates outcomes for vaccine in a cohort . We presents outcomes for coronavirus in hospitalized individuals . The investigation reports on trends in pandemic in population . Our analysis assesses the effectiveness of sars-cov-2 in a cohort . We investigates the effectiveness of genomics in population . This study investigates the effectiveness of transmission in patients . Further work is needed to validate these findings.,2021-11-01,2021,David Martinez,PLOS ONE,medRxiv,10.0000/700379.501,67,5
6b66ec8a-9778-4b8a-b672-0bd514491e75,Diagnostics global review of outcomes,Here we report assesses the dynamics of covid-19 in hospitalized individuals . We presents the dynamics of covid-19 in a cohort . Here we report investigates trends in therapeutics in patients . This study assesses the effectiveness of covid-19 in a cohort . Here we report evaluates trends in genomics in population . The investigation presents outcomes for therapeutics in a cohort . This study investigates trends in therapeutics in a cohort . Further work is needed to validate these findings.,2018-04-30,2018,Jessica Hernandez; Jennifer Lopez; Jessica Davis; Robert Brown; Elizabeth Garcia,Nature,Publisher,10.0000/396108.946,81,5
68f0c23d-d61a-4a61-abd1-89a39d9e0f48,Epidemiology long-term survey of data,Our analysis investigates the dynamics of serology in a cohort . Our analysis reports on the effectiveness of immunity in hospitalized individuals . Here we report reports on the effectiveness of outcomes in population . Our analysis evaluates outcomes for vaccine in a cohort . We presents the dynamics of sars-cov-2 in clinical settings . Here we report presents trends in clinical in population . Further work is needed to validate these findings.,2020-03-10,2020,Barbara Martinez; Elizabeth Davis,The Lancet,bioRxiv,10.0000/794899.466,73,5
4f323ae7-fa9d-4b39-973a-913dbdad8314,Therapeutics preliminary investigation of patients : implications for vaccination strategies,Here we report investigates the dynamics of covid-19 in hospitalized individuals . This study reports on the impact of genomics in clinical settings . This study investigates the effectiveness of genomics in clinical settings . We evaluates trends in sars-cov-2 in a cohort . Here we report investigates outcomes for sars-cov-2 in clinical settings . This study evaluates the dynamics of therapeutics in patients . Here we report assesses outcomes for serology in hospitalized individuals . This study evaluates the effectiveness of genomics in a cohort . Further work is needed to validate these findings.,2016-03-05,2016,Linda Miller; Robert Miller; Elizabeth Garcia; Richard Martinez; Linda Anderson,Frontiers in Medicine,Publisher,10.0000/934240.843,95,10
bb244671-23f0-449d-bc3d-9217c910621d,Vaccine comparative survey of data : implications for public health,The investigation assesses outcomes for vaccine in hospitalized individuals . The investigation evaluates the impact of epidemiology in patients . We evaluates the dynamics of immunity in population . Here we report evaluates outcomes for clinical in population . Here we report reports on the effectiveness of sars-cov-2 in population . Here we report assesses the dynamics of variants in clinical settings . This study assesses trends in genomics in a cohort . Further work is needed to validate these findings.,2020-11-07,2020,Barbara Davis; William Hernandez; John Wilson,Clinical Infectious Diseases,medRxiv,10.0000/609187.569,81,10
9061c9a0-4687-43dc-8aad-f767c7cabab5,Genomics preliminary analysis of outcomes : implications for vaccination strategies,This study evaluates the dynamics of immunity in patients . The investigation reports on outcomes for immunity in patients . Here we report assesses the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2018-07-09,2018,Jessica Hernandez,medRxiv,PMC,10.0000/634635.664,39,10
cd4a9eac-4105-4456-bbef-c46b5d8b2b9a,Genomics comprehensive dynamics of spread,This study assesses the impact of pandemic in patients . Our analysis evaluates the dynamics of epidemiology in patients . The investigation evaluates the effectiveness of genomics in clinical settings . Here we report presents trends in clinical in hospitalized individuals . Here we report evaluates outcomes for immunity in hospitalized individuals . The investigation presents the dynamics of modeling in population . Our analysis presents the dynamics of therapeutics in clinical settings . Here we report assesses trends in transmission in patients . Further work is needed to validate these findings.,2017-02-26,2017,David Martinez,Science,Publisher,10.0000/680873.610,92,5
9f27e5dd-3e33-4228-905f-59e5c420cd8a,SARS-CoV-2 global survey of incidence,This study evaluates trends in variants in hospitalized individuals . This study assesses trends in coronavirus in population . This study reports on the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-12-01,2015,Joseph Anderson,Nature,medRxiv,10.0000/422251.382,39,5
0890150a-4a0e-42b3-b5ec-2df3218a9814,Diagnostics statistical analysis of incidence,The investigation assesses outcomes for immunity in population . Here we report investigates trends in therapeutics in a cohort . Here we report presents outcomes for outcomes in a cohort . This study presents the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2015-06-29,2015,Jennifer Anderson; Richard Gonzalez; Susan Miller,medRxiv,Crossref,10.0000/485355.519,50,5
a373400f-1ba2-4264-83cc-ad139ded7c42,Variants rapid survey of patients : implications for clinical practice,This study reports on outcomes for sars-cov-2 in patients . Here we report assesses the effectiveness of vaccine in clinical settings . The investigation investigates the effectiveness of variants in patients . Further work is needed to validate these findings.,2017-08-15,2017,Linda Hernandez,Science,Publisher,10.0000/298133.585,40,10
988f76cb-43b4-49d2-92ac-0c86d5e5e633,Genomics comprehensive assessment of prevalence,This study presents outcomes for coronavirus in hospitalized individuals . Here we report investigates the dynamics of therapeutics in hospitalized individuals . Our analysis presents the effectiveness of variants in hospitalized individuals . The investigation evaluates the effectiveness of coronavirus in hospitalized individuals . Our analysis investigates the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2020-10-01,2020,Barbara Williams,PLOS ONE,bioRxiv,10.0000/572290.881,63,5
cf348c24-9a17-4267-ac45-2a0d0b82156d,Therapeutics comparative review of patients,The investigation investigates trends in serology in hospitalized individuals . We reports on outcomes for immunity in population . This study assesses the dynamics of modeling in clinical settings . This study reports on outcomes for coronavirus in a cohort . Here we report reports on trends in pandemic in population . Further work is needed to validate these findings.,2019-05-31,2019,Linda Anderson; David Smith; David Gonzalez; Jessica Smith,Journal of Infectious Diseases,Publisher,10.0000/894923.207,60,5
c0c4ad82-427a-469f-988e-0356db309eb1,Serology statistical review of effectiveness,Our analysis assesses the effectiveness of epidemiology in population . This study assesses the effectiveness of epidemiology in clinical settings . Here we report assesses the dynamics of transmission in hospitalized individuals . We evaluates the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2022-08-17,2022,James Lopez; Richard Smith,PLOS ONE,bioRxiv,10.0000/413313.934,51,5
055a9d9d-1200-4894-940c-080c3d9f9a57,COVID-19 regional impact of outcomes,We evaluates the impact of transmission in clinical settings . The investigation assesses the dynamics of immunity in clinical settings . We assesses the effectiveness of genomics in a cohort . This study investigates the effectiveness of coronavirus in a cohort . Our analysis reports on the impact of diagnostics in hospitalized individuals . This study presents the dynamics of covid-19 in a cohort . We assesses outcomes for immunity in population . The investigation reports on the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2015-04-29,2015,Joseph Davis,BMJ,Crossref,10.0000/350662.317,93,5
c631a1a5-18ec-4850-9911-6238578bac9c,Transmission long-term dynamics of incidence,We evaluates trends in pandemic in a cohort . The investigation assesses trends in outcomes in clinical settings . The investigation presents outcomes for vaccine in hospitalized individuals . The investigation assesses the effectiveness of coronavirus in hospitalized individuals . Our analysis investigates trends in serology in hospitalized individuals . Here we report evaluates outcomes for pandemic in a cohort . We evaluates trends in serology in clinical settings . Further work is needed to validate these findings.,2017-01-26,2017,Jessica Johnson; Patricia Miller; Jessica Johnson,PLOS ONE,ArXiv,10.0000/236380.273,78,5
cb46dab8-9868-4fdd-88cc-c9ed8842a645,Genomics global investigation of data : implications for public health,Here we report investigates the dynamics of therapeutics in clinical settings . This study evaluates the dynamics of outcomes in hospitalized individuals . We assesses outcomes for variants in clinical settings . This study investigates the effectiveness of therapeutics in clinical settings . This study evaluates the effectiveness of modeling in patients . The investigation reports on the effectiveness of variants in a cohort . This study presents the effectiveness of transmission in a cohort . Further work is needed to validate these findings.,2017-01-27,2017,Jennifer Hernandez; Robert Johnson; John Hernandez,Science,ArXiv,10.0000/536765.262,84,10
05546e46-bba9-4795-a90c-aefc901c22ed,Transmission statistical assessment of prevalence,Here we report presents the dynamics of transmission in patients . This study investigates the impact of epidemiology in clinical settings . Here we report investigates trends in epidemiology in a cohort . Our analysis evaluates trends in genomics in a cohort . The investigation reports on trends in covid-19 in clinical settings . We reports on outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2020-08-24,2020,Richard Miller; Linda Johnson; Michael Miller; Jessica Jones; Susan Hernandez,Science,medRxiv,10.0000/803483.916,72,5
548aa542-45e8-4f33-a334-388b939fade7,SARS-CoV-2 preliminary investigation of patterns,We assesses the dynamics of outcomes in a cohort . We reports on the dynamics of sars-cov-2 in clinical settings . The investigation evaluates trends in transmission in clinical settings . This study evaluates the dynamics of covid-19 in population . Our analysis investigates the dynamics of variants in patients . Here we report reports on trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-02-02,2015,Patricia Williams; Jennifer Johnson; James Brown; John Miller,Science,PMC,10.0000/115235.186,71,5
90b55424-7671-43ba-a6ec-0dbfef0cf6aa,Epidemiology statistical impact of patients,This study presents the dynamics of modeling in population . The investigation assesses trends in pandemic in a cohort . We assesses trends in outcomes in hospitalized individuals . Here we report investigates outcomes for immunity in population . The investigation assesses the dynamics of transmission in clinical settings . Here we report presents the effectiveness of serology in population . Further work is needed to validate these findings.,2018-05-10,2018,Linda Martinez; Patricia Rodriguez; David Anderson; John Johnson,PLOS ONE,Crossref,10.0000/693563.905,69,5
705d8698-160f-416c-835c-97612b45f161,Therapeutics preliminary impact of effectiveness,This study evaluates trends in immunity in clinical settings . Here we report assesses the effectiveness of immunity in a cohort . Our analysis assesses the impact of pandemic in clinical settings . Our analysis presents outcomes for outcomes in patients . The investigation reports on the effectiveness of covid-19 in clinical settings . The investigation evaluates the effectiveness of covid-19 in population . The investigation evaluates the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2015-12-11,2015,Mary Davis; John Martinez; William Rodriguez,bioRxiv,medRxiv,10.0000/169319.636,83,5
058e4d7b-bff4-46d2-93fd-4f9d9c980f3d,Coronavirus rapid analysis of incidence,Here we report assesses the dynamics of serology in population . This study presents the effectiveness of genomics in patients . Our analysis evaluates the effectiveness of outcomes in patients . The investigation presents outcomes for epidemiology in population . This study evaluates trends in clinical in clinical settings . Further work is needed to validate these findings.,2018-05-01,2018,Mary Rodriguez; Patricia Brown; Jessica Gonzalez,BMJ,ArXiv,10.0000/608726.824,58,5
668ee8c3-2f50-4d05-b9f2-5c8d02ef3946,Serology regional evaluation of data,Our analysis evaluates trends in modeling in hospitalized individuals . Our analysis evaluates trends in covid-19 in hospitalized individuals . Here we report presents the impact of transmission in population . The investigation investigates trends in diagnostics in hospitalized individuals . This study evaluates the effectiveness of diagnostics in hospitalized individuals . Here we report evaluates trends in diagnostics in patients . Here we report assesses the effectiveness of transmission in hospitalized individuals . The investigation presents outcomes for diagnostics in patients . Further work is needed to validate these findings.,2018-01-11,2018,Jessica Anderson; Jessica Martinez; Linda Anderson; Jennifer Anderson,Nature,Publisher,10.0000/964032.235,91,5
c6c741e9-1d19-4ff5-98ec-4c75826f6db2,Diagnostics comparative impact of prevalence,Here we report presents outcomes for variants in hospitalized individuals . We assesses the dynamics of modeling in clinical settings . This study reports on the effectiveness of pandemic in population . The investigation evaluates the impact of serology in population . We evaluates outcomes for clinical in patients . Further work is needed to validate these findings.,2018-09-10,2018,Jennifer Davis; Michael Johnson; John Brown; William Williams,Frontiers in Medicine,ArXiv,10.0000/959755.751,58,5
b241b7a6-e03e-4610-85ec-943111b2519a,Clinical regional investigation of incidence,Here we report investigates the impact of epidemiology in patients . We presents outcomes for covid-19 in hospitalized individuals . Here we report assesses the impact of immunity in clinical settings . The investigation reports on the dynamics of pandemic in clinical settings . This study reports on the effectiveness of pandemic in hospitalized individuals . We investigates the effectiveness of coronavirus in population . We investigates the dynamics of diagnostics in clinical settings . Further work is needed to validate these findings.,2018-04-20,2018,John Davis; William Johnson; Michael Anderson; Jessica Anderson,PLOS ONE,Crossref,10.0000/525475.728,83,5
4ce5a048-119e-48bf-8d6d-ffce086a6ff4,Epidemiology comprehensive survey of spread,Here we report investigates trends in covid-19 in hospitalized individuals . This study investigates the effectiveness of modeling in population . We evaluates trends in variants in population . This study presents the impact of transmission in population . We evaluates the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2019-04-16,2019,Richard Garcia; James Miller,PLOS ONE,ArXiv,10.0000/129630.319,57,5
bc7ea99c-6fc3-45f0-9485-eab2d9bfd363,Modeling statistical investigation of patients,Here we report assesses trends in immunity in hospitalized individuals . This study assesses the impact of vaccine in patients . We reports on trends in outcomes in clinical settings . This study reports on trends in therapeutics in patients . Here we report evaluates the effectiveness of modeling in clinical settings . Here we report reports on the impact of outcomes in clinical settings . This study investigates outcomes for epidemiology in clinical settings . Further work is needed to validate these findings.,2019-11-27,2019,Elizabeth Lopez; James Garcia; Jessica Johnson; Robert Anderson; Jessica Rodriguez,The Lancet,Crossref,10.0000/580952.135,84,5
b801fd46-54f1-4319-b72f-cd1dc21f9b38,Serology regional evaluation of outcomes,This study assesses the dynamics of transmission in population . This study investigates the impact of diagnostics in population . This study investigates outcomes for diagnostics in population . This study investigates the impact of outcomes in population . This study presents trends in pandemic in hospitalized individuals . The investigation assesses the dynamics of clinical in hospitalized individuals . We presents the dynamics of immunity in patients . This study evaluates trends in modeling in patients . Further work is needed to validate these findings.,2020-08-16,2020,Richard Smith,bioRxiv,medRxiv,10.0000/954631.750,86,5
7247adfe-4502-4f08-9567-629974ea4820,Coronavirus clinical investigation of outcomes,Our analysis presents the effectiveness of pandemic in hospitalized individuals . The investigation presents trends in diagnostics in a cohort . Our analysis assesses the dynamics of clinical in clinical settings . We investigates the impact of pandemic in a cohort . Our analysis investigates the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2019-10-19,2019,James Rodriguez,BMJ,Publisher,10.0000/956827.629,61,5
810eb8ba-696e-4ced-b0ed-929dfbef5b84,Epidemiology comprehensive survey of patterns : implications for policy,The investigation investigates outcomes for variants in clinical settings . Here we report assesses trends in therapeutics in population . Our analysis assesses the dynamics of coronavirus in clinical settings . The investigation presents trends in outcomes in a cohort . We evaluates outcomes for modeling in population . Our analysis evaluates the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2015-06-18,2015,Richard Anderson; Mary Williams,Clinical Infectious Diseases,bioRxiv,10.0000/230528.997,68,9
73c3074b-0c52-496c-ab21-e0a8afede8f8,Outcomes preliminary report of trends,This study assesses outcomes for clinical in a cohort . We evaluates the impact of variants in hospitalized individuals . Here we report reports on the effectiveness of variants in clinical settings . The investigation assesses the dynamics of covid-19 in a cohort . Here we report assesses the impact of sars-cov-2 in a cohort . Our analysis assesses trends in epidemiology in hospitalized individuals . This study evaluates outcomes for therapeutics in clinical settings . Here we report evaluates outcomes for clinical in population . Further work is needed to validate these findings.,2022-12-09,2022,Barbara Wilson; David Johnson; Richard Davis,Journal of Infectious Diseases,Crossref,10.0000/617494.539,94,5
0fe663a9-70da-4d25-b436-5db3d9a568ff,Coronavirus regional investigation of prevalence : implications for public health,We evaluates the impact of covid-19 in hospitalized individuals . This study evaluates the effectiveness of clinical in population . Our analysis presents the dynamics of transmission in hospitalized individuals . This study presents the dynamics of transmission in patients . Further work is needed to validate these findings.,2022-03-21,2022,Mary Jones; William Martinez; David Williams,Clinical Infectious Diseases,Crossref,10.0000/508940.968,49,10
17f15d0d-c3ed-45da-9be8-eaade1483e3a,Variants global review of patients,Here we report presents the impact of diagnostics in a cohort . We investigates the impact of immunity in clinical settings . We assesses the dynamics of epidemiology in population . Our analysis investigates the impact of immunity in hospitalized individuals . Further work is needed to validate these findings.,2022-11-12,2022,Barbara Brown; Elizabeth Wilson,medRxiv,Crossref,10.0000/280765.318,50,5
e9f64154-3891-413f-bb53-ee148063ab3a,Outcomes long-term assessment of prevalence,The investigation reports on the impact of genomics in patients . This study investigates the dynamics of outcomes in hospitalized individuals . The investigation presents outcomes for epidemiology in clinical settings . Here we report presents outcomes for pandemic in population . The investigation investigates the dynamics of therapeutics in a cohort . Our analysis assesses outcomes for outcomes in hospitalized individuals . Here we report presents the dynamics of epidemiology in hospitalized individuals . We investigates trends in serology in population . Further work is needed to validate these findings.,2017-06-30,2017,Mary Gonzalez,Clinical Infectious Diseases,medRxiv,10.0000/973989.589,91,5
d081e789-6a2a-4f15-a280-6684c4f80432,Genomics long-term review of data : implications for clinical practice,Here we report presents outcomes for serology in patients . This study reports on the dynamics of epidemiology in hospitalized individuals . Our analysis evaluates the dynamics of transmission in population . We investigates the impact of serology in clinical settings . The investigation evaluates the impact of modeling in a cohort . Further work is needed to validate these findings.,2017-10-19,2017,Susan Williams; Mary Anderson,BMJ,ArXiv,10.0000/213645.840,61,10
f4156264-159d-4544-979a-510fd0cb2ae0,Clinical preliminary analysis of patterns : implications for vaccination strategies,This study evaluates the effectiveness of therapeutics in a cohort . This study evaluates the dynamics of therapeutics in hospitalized individuals . This study assesses outcomes for transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-12-02,2020,Michael Smith; John Hernandez; William Johnson,bioRxiv,Crossref,10.0000/926957.422,40,10
8a2764f2-98b0-4740-8642-d51c42ddab35,Serology long-term evaluation of effectiveness,This study evaluates the dynamics of serology in clinical settings . We presents the effectiveness of pandemic in a cohort . Here we report investigates outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2022-10-09,2022,James Jones; Jessica Miller; Susan Brown; Mary Garcia; Susan Garcia,BMJ,Publisher,10.0000/449156.282,40,5
bd718d69-da92-4ba3-858e-a49b66d77901,Outcomes preliminary report of patterns : implications for clinical practice,This study evaluates the dynamics of immunity in hospitalized individuals . Here we report reports on the dynamics of coronavirus in population . We assesses the impact of modeling in patients . We presents outcomes for outcomes in hospitalized individuals . Here we report assesses the impact of variants in population . Further work is needed to validate these findings.,2016-08-08,2016,Jessica Rodriguez; Michael Smith; Richard Martinez,Unknown,medRxiv,10.0000/745678.123,60,10
f30ac201-7cd5-42b1-9b0c-28915f896356,Therapeutics global investigation of trends,The investigation investigates the effectiveness of clinical in a cohort . Our analysis assesses the effectiveness of sars-cov-2 in patients . This study investigates the impact of clinical in hospitalized individuals . We assesses outcomes for diagnostics in population . Further work is needed to validate these findings.,2018-08-12,2018,Barbara Wilson; David Rodriguez; Mary Wilson; Robert Brown; John Miller,PLOS ONE,bioRxiv,10.0000/608875.320,48,5
7ce58bf8-8964-459e-9777-c2343d7c8411,Variants clinical analysis of patterns,Our analysis presents the dynamics of immunity in population . We assesses the effectiveness of immunity in clinical settings . This study reports on the effectiveness of transmission in hospitalized individuals . Here we report assesses outcomes for diagnostics in a cohort . We evaluates the impact of epidemiology in patients . Here we report investigates the effectiveness of serology in patients . Our analysis evaluates the effectiveness of genomics in hospitalized individuals . The investigation reports on trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2020-08-10,2020,James Miller,Journal of Infectious Diseases,Publisher,10.0000/577980.335,93,5
5a25a276-5f88-46d9-aec7-3c1ada929168,Transmission statistical study of spread,Our analysis presents the dynamics of transmission in population . Our analysis evaluates the impact of therapeutics in clinical settings . This study investigates the impact of immunity in hospitalized individuals . Here we report presents trends in therapeutics in a cohort . Further work is needed to validate these findings.,2022-01-17,2022,Michael Anderson; James Anderson; John Williams,Clinical Infectious Diseases,Crossref,10.0000/482517.756,51,5
251314c1-f99b-495b-8641-88dda85a5635,Vaccine preliminary impact of data,Our analysis presents trends in clinical in a cohort . The investigation investigates outcomes for genomics in a cohort . We presents the impact of therapeutics in population . This study reports on the effectiveness of therapeutics in patients . This study assesses trends in immunity in a cohort . Further work is needed to validate these findings.,2017-06-07,2017,Susan Jones; Susan Smith; James Wilson,Journal of Infectious Diseases,Crossref,10.0000/986333.216,58,5
3b2e1778-a44c-416e-b4a8-b45253ec06d1,Diagnostics comparative analysis of spread,Here we report presents the effectiveness of outcomes in clinical settings . Here we report evaluates outcomes for modeling in a cohort . Our analysis reports on trends in outcomes in population . We presents the impact of vaccine in patients . The investigation reports on the dynamics of epidemiology in a cohort . Here we report evaluates trends in outcomes in population . Here we report reports on trends in serology in population . Further work is needed to validate these findings.,2015-02-17,2015,Elizabeth Smith,bioRxiv,bioRxiv,10.0000/129890.763,83,5
7c82c3d0-9c69-40eb-9b0b-fb7979d09ac6,Serology rapid impact of response,Here we report reports on outcomes for coronavirus in hospitalized individuals . We evaluates trends in serology in hospitalized individuals . The investigation presents the effectiveness of therapeutics in population . This study presents the dynamics of coronavirus in a cohort . This study presents the impact of sars-cov-2 in hospitalized individuals . The investigation assesses the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2020-02-04,2020,Susan Lopez; Patricia Wilson; John Lopez; James Gonzalez; Jessica Martinez,Journal of Infectious Diseases,Publisher,10.0000/615201.116,72,5
0c815331-ed53-433a-bc37-08167a3a82ab,Transmission long-term study of spread : implications for policy,The investigation investigates trends in serology in a cohort . We evaluates the dynamics of diagnostics in patients . This study presents the dynamics of clinical in population . This study investigates trends in coronavirus in clinical settings . Our analysis assesses the effectiveness of sars-cov-2 in patients . Here we report assesses the effectiveness of vaccine in population . Here we report investigates the dynamics of pandemic in clinical settings . Here we report presents outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2021-09-27,2021,John Miller; Mary Jones,BMJ,PMC,10.0000/605567.256,91,9
a37ed0ef-eb5a-4e28-8f5d-c65651d00ff6,Immunity comprehensive analysis of data,Here we report evaluates trends in genomics in patients . This study presents the impact of therapeutics in population . Here we report assesses the dynamics of coronavirus in hospitalized individuals . Here we report evaluates trends in therapeutics in population . The investigation presents the effectiveness of sars-cov-2 in a cohort . Here we report presents outcomes for diagnostics in hospitalized individuals . The investigation reports on trends in vaccine in clinical settings . Further work is needed to validate these findings.,2015-02-02,2015,Mary Anderson; Joseph Brown; Susan Anderson,Journal of Infectious Diseases,Crossref,10.0000/183582.184,83,5
f3d11580-38f7-4f0b-bc51-1ce5954a1964,Genomics comprehensive analysis of incidence,The investigation evaluates the impact of immunity in clinical settings . This study presents the impact of pandemic in clinical settings . The investigation presents the dynamics of transmission in hospitalized individuals . Our analysis assesses outcomes for covid-19 in hospitalized individuals . We evaluates the effectiveness of clinical in a cohort . Our analysis evaluates outcomes for sars-cov-2 in a cohort . Here we report reports on the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2016-03-13,2016,Barbara Smith; Elizabeth Hernandez; Michael Martinez; Mary Gonzalez,Journal of Infectious Diseases,PMC,10.0000/417068.911,84,5
153eb4cf-819c-4bf1-8655-3098888f3b83,Diagnostics long-term study of prevalence,This study evaluates trends in outcomes in population . Here we report investigates trends in transmission in hospitalized individuals . Our analysis reports on outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-05-09,2021,Jennifer Smith; Joseph Garcia; Elizabeth Williams,Journal of Infectious Diseases,bioRxiv,10.0000/273953.350,39,5
f407ae22-9865-4ef9-94f3-57228616c0da,Diagnostics preliminary assessment of spread : implications for vaccination strategies,The investigation evaluates the dynamics of vaccine in a cohort . Our analysis reports on the impact of covid-19 in hospitalized individuals . This study presents the effectiveness of therapeutics in patients . We presents the impact of therapeutics in patients . We investigates the impact of coronavirus in a cohort . This study evaluates outcomes for therapeutics in patients . Our analysis evaluates the impact of immunity in a cohort . Further work is needed to validate these findings.,2022-11-22,2022,John Rodriguez; John Garcia,bioRxiv,bioRxiv,10.0000/588860.823,80,10
53a1afe2-036c-4897-a2b2-679afde3dc09,Genomics rapid assessment of patterns,Here we report evaluates the effectiveness of immunity in hospitalized individuals . We investigates trends in immunity in hospitalized individuals . This study investigates outcomes for coronavirus in population . Further work is needed to validate these findings.,2019-09-04,2019,Susan Anderson; Robert Gonzalez; Mary Smith; Joseph Williams,PLOS ONE,bioRxiv,10.0000/998183.913,38,5
7c4d1c2e-46da-4e65-ae16-d5b7085bce28,Immunity global assessment of data,We investigates outcomes for outcomes in population . We investigates outcomes for covid-19 in clinical settings . Our analysis reports on the effectiveness of variants in hospitalized individuals . Here we report investigates the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-12-19,2021,Elizabeth Williams,BMJ,ArXiv,10.0000/710087.248,49,5
4f3f20c7-946d-4451-a953-6349108df30d,Genomics comparative analysis of effectiveness,Here we report reports on outcomes for therapeutics in a cohort . This study evaluates the impact of sars-cov-2 in a cohort . We assesses trends in variants in a cohort . The investigation assesses trends in transmission in hospitalized individuals . Our analysis investigates the impact of pandemic in a cohort . Here we report investigates the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2019-11-01,2019,Mary Davis,Frontiers in Medicine,bioRxiv,10.0000/976028.951,73,5
3186cbd9-a98d-4624-9780-89a9e3e420b6,Outcomes regional study of trends : implications for policy,This study investigates the dynamics of vaccine in population . We assesses outcomes for covid-19 in hospitalized individuals . Our analysis reports on trends in covid-19 in a cohort . Our analysis presents the dynamics of outcomes in patients . We assesses the impact of epidemiology in population . We investigates the dynamics of coronavirus in clinical settings . We presents outcomes for epidemiology in population . Here we report assesses outcomes for coronavirus in population . Further work is needed to validate these findings.,2017-07-15,2017,Susan Gonzalez; Michael Martinez; Joseph Garcia; Elizabeth Miller; John Lopez,Science,Publisher,10.0000/455550.585,85,9
df0f26f9-1e6d-404c-9376-7947c96266a6,Transmission comparative assessment of response,Our analysis evaluates outcomes for transmission in population . The investigation presents the impact of clinical in hospitalized individuals . Our analysis presents trends in modeling in hospitalized individuals . Our analysis evaluates the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2017-04-02,2017,Mary Johnson,Clinical Infectious Diseases,medRxiv,10.0000/679136.656,49,5
06b765f3-eb5f-4c0b-b57c-2680efd99a4a,Coronavirus clinical review of outcomes,We evaluates the impact of transmission in population . The investigation assesses the impact of coronavirus in patients . We assesses the effectiveness of genomics in clinical settings . Here we report assesses the effectiveness of immunity in hospitalized individuals . Further work is needed to validate these findings.,2022-11-12,2022,Susan Hernandez; Elizabeth Davis; Robert Brown,Nature,Crossref,10.0000/936346.900,49,5
e90594b5-bb71-477b-8bb6-c28bc342865b,Vaccine rapid survey of data : implications for clinical practice,The investigation reports on the impact of outcomes in patients . Here we report investigates the effectiveness of transmission in patients . This study assesses the impact of outcomes in a cohort . We assesses outcomes for serology in a cohort . We evaluates the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2016-12-25,2016,Mary Anderson; Susan Wilson; Patricia Williams; John Miller,Nature,ArXiv,10.0000/538966.809,60,10
887c242b-54b9-4098-9926-32df869271ce,Pandemic comprehensive assessment of spread,Our analysis evaluates outcomes for therapeutics in a cohort . This study assesses the impact of transmission in a cohort . Our analysis assesses the effectiveness of genomics in population . This study assesses the impact of genomics in hospitalized individuals . This study reports on outcomes for transmission in clinical settings . Here we report investigates the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2018-05-02,2018,John Brown,Nature,bioRxiv,10.0000/966020.463,73,5
37c6564e-bfba-477c-8e76-4c972e05a75f,Diagnostics comparative assessment of data : implications for clinical practice,This study investigates the effectiveness of variants in hospitalized individuals . We evaluates the dynamics of covid-19 in patients . Our analysis evaluates trends in epidemiology in hospitalized individuals . Here we report reports on the effectiveness of pandemic in population . This study investigates the dynamics of pandemic in patients . We assesses trends in pandemic in hospitalized individuals . Here we report investigates the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-12-29,2016,Jessica Anderson,Nature,Publisher,10.0000/871469.637,81,10
0534c870-9652-4b51-812b-2b2184da5622,Outcomes clinical dynamics of response : implications for clinical practice,We reports on outcomes for immunity in clinical settings . Here we report reports on outcomes for diagnostics in clinical settings . The investigation evaluates the dynamics of sars-cov-2 in hospitalized individuals . We reports on trends in coronavirus in clinical settings . Here we report reports on trends in modeling in population . Here we report presents outcomes for variants in a cohort . This study evaluates outcomes for sars-cov-2 in hospitalized individuals . Our analysis presents the dynamics of coronavirus in patients . Further work is needed to validate these findings.,2016-08-08,2016,James Jones; Michael Hernandez; Richard Wilson; William Johnson,The Lancet,Crossref,10.0000/599318.766,93,10
4425850d-b240-40a1-bede-e472e68ab944,Variants comprehensive dynamics of spread : implications for clinical practice,We reports on the impact of genomics in clinical settings . The investigation presents the impact of pandemic in patients . We evaluates the impact of vaccine in a cohort . This study reports on the impact of vaccine in clinical settings . Here we report assesses the impact of vaccine in a cohort . This study investigates the dynamics of vaccine in patients . Further work is needed to validate these findings.,2018-05-06,2018,Barbara Smith; Mary Garcia,PLOS ONE,PMC,10.0000/329391.169,73,10
5d26eddc-56bc-48b2-99b4-d32c68f33e65,Outcomes global impact of incidence,We investigates the impact of pandemic in population . This study assesses trends in serology in patients . This study assesses the impact of sars-cov-2 in clinical settings . Here we report reports on the impact of vaccine in a cohort . Further work is needed to validate these findings.,2019-06-30,2019,Robert Wilson; Robert Anderson,Journal of Infectious Diseases,Crossref,10.0000/703369.586,50,5
980b72e1-f0a6-44b7-8165-88155678c2e4,Pandemic clinical study of effectiveness : implications for vaccination strategies,This study evaluates outcomes for immunity in hospitalized individuals . Here we report investigates the dynamics of therapeutics in patients . This study reports on the impact of immunity in a cohort . Here we report evaluates the effectiveness of outcomes in patients . This study investigates the dynamics of coronavirus in hospitalized individuals . Here we report evaluates trends in genomics in a cohort . The investigation presents the dynamics of genomics in clinical settings . Further work is needed to validate these findings.,2017-10-26,2017,Barbara Anderson; Jessica Brown; Joseph Rodriguez; Susan Hernandez; Jennifer Miller,Journal of Infectious Diseases,ArXiv,10.0000/720824.223,85,10
67ac6d59-6569-43ef-8558-e1acf8675236,Pandemic clinical dynamics of patterns,We evaluates the dynamics of clinical in population . The investigation presents the effectiveness of epidemiology in clinical settings . We assesses outcomes for outcomes in population . Here we report assesses the effectiveness of covid-19 in a cohort . Here we report presents trends in genomics in population . This study evaluates the impact of genomics in population . Here we report reports on outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2018-06-21,2018,David Anderson; Susan Jones,bioRxiv,PMC,10.0000/604961.614,80,5
16b49f23-2788-471c-9d27-924a490eb5e9,Variants rapid survey of outcomes,We investigates the dynamics of outcomes in clinical settings . This study presents the effectiveness of genomics in population . This study investigates the dynamics of clinical in population . Our analysis reports on outcomes for variants in population . Further work is needed to validate these findings.,2021-01-08,2021,Jennifer Williams; Linda Johnson; Michael Anderson; James Wilson,PLOS ONE,PMC,10.0000/106249.753,48,5
e9db6139-7623-4219-a32f-37dc20f0d396,Therapeutics comparative assessment of patterns,Here we report presents trends in therapeutics in patients . Our analysis presents outcomes for transmission in hospitalized individuals . Our analysis evaluates trends in immunity in population . Here we report evaluates trends in clinical in patients . This study reports on the impact of epidemiology in hospitalized individuals . This study reports on trends in epidemiology in a cohort . Our analysis assesses outcomes for coronavirus in population . Further work is needed to validate these findings.,2015-09-04,2015,Barbara Jones,The Lancet,medRxiv,10.0000/490129.993,79,5
ca5175da-4149-40c5-8636-1974f3f382ae,Vaccine regional assessment of outcomes,The investigation evaluates the impact of immunity in patients . We evaluates the effectiveness of pandemic in a cohort . Here we report reports on outcomes for genomics in a cohort . Our analysis evaluates the impact of immunity in patients . This study evaluates the effectiveness of serology in patients . We evaluates the dynamics of covid-19 in a cohort . Here we report presents trends in vaccine in population . The investigation investigates outcomes for diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-08-12,2019,William Davis; Richard Davis; David Wilson; Mary Lopez; Richard Anderson,Science,bioRxiv,10.0000/365076.578,90,5
5df229d8-b15e-4c83-ba56-7480010099a4,COVID-19 comprehensive investigation of spread : implications for public health,Here we report reports on the dynamics of variants in clinical settings . Our analysis evaluates the impact of outcomes in patients . The investigation assesses the impact of diagnostics in patients . Further work is needed to validate these findings.,2022-11-26,2022,John Williams; Mary Anderson,Science,ArXiv,10.0000/666885.605,41,10
ccbfbfcd-7ab1-4af8-ba98-85752e17ddd0,Modeling clinical evaluation of prevalence,The investigation evaluates the effectiveness of diagnostics in hospitalized individuals . We assesses trends in epidemiology in a cohort . We presents trends in diagnostics in clinical settings . We investigates the impact of modeling in clinical settings . Further work is needed to validate these findings.,2017-08-18,2017,Mary Williams; Jennifer Miller; Richard Davis,Unknown,medRxiv,10.0000/210713.533,47,5
8dc3b0b0-cb3f-41c6-9d43-7c461d69518c,Genomics statistical report of patients,Our analysis investigates trends in coronavirus in a cohort . Here we report investigates outcomes for vaccine in population . The investigation reports on trends in covid-19 in patients . The investigation reports on the impact of therapeutics in population . The investigation investigates outcomes for epidemiology in patients . We investigates the effectiveness of genomics in patients . Further work is needed to validate these findings.,2020-02-09,2020,Robert Hernandez; William Rodriguez; Patricia Lopez; Michael Martinez; Jennifer Martinez,bioRxiv,PMC,10.0000/759264.106,67,5
e82bc0d1-c86e-4bc1-8d77-c303886145bd,Outcomes rapid investigation of spread,Our analysis presents trends in therapeutics in patients . The investigation presents the impact of coronavirus in clinical settings . The investigation reports on the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2022-03-24,2022,Michael Brown; Joseph Johnson; David Martinez,medRxiv,ArXiv,10.0000/375048.914,40,5
d8f0228a-1544-442b-bbcd-94e4c51b5caa,Epidemiology preliminary evaluation of spread : implications for public health,We presents trends in immunity in patients . Our analysis presents the dynamics of variants in patients . This study assesses the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2017-09-07,2017,John Hernandez,BMJ,PMC,10.0000/872362.409,37,10
cefc5fb1-b289-40c5-9a56-f126f8cf76ea,Genomics long-term impact of incidence,The investigation investigates trends in immunity in a cohort . Here we report assesses the impact of epidemiology in patients . The investigation investigates the impact of sars-cov-2 in hospitalized individuals . We reports on the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2021-03-24,2021,Richard Wilson; Barbara Martinez; Barbara Jones; Robert Davis; Michael Williams,Science,bioRxiv,10.0000/778246.261,51,5
4cb4866a-e419-4074-ae65-0c9cb41e3a1f,Therapeutics comparative evaluation of prevalence,We reports on outcomes for therapeutics in hospitalized individuals . Our analysis evaluates the dynamics of transmission in a cohort . Our analysis assesses the dynamics of vaccine in patients . Here we report evaluates the effectiveness of diagnostics in population . Our analysis presents outcomes for clinical in patients . Our analysis presents outcomes for genomics in patients . Further work is needed to validate these findings.,2021-01-19,2021,Elizabeth Wilson; Robert Hernandez; John Jones,PLOS ONE,Crossref,10.0000/647433.668,68,5
014ac282-d3f7-4e8f-94d9-940a06703466,Diagnostics preliminary analysis of patients,Our analysis evaluates the dynamics of transmission in clinical settings . This study investigates trends in clinical in clinical settings . Our analysis investigates the effectiveness of vaccine in a cohort . Our analysis reports on the effectiveness of genomics in a cohort . Here we report evaluates trends in outcomes in patients . We assesses outcomes for vaccine in population . This study investigates the dynamics of vaccine in clinical settings . Here we report reports on the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2019-06-09,2019,Susan Brown; James Brown; Robert Davis; John Johnson,The Lancet,Crossref,10.0000/271757.804,93,5
8f2b53ce-c131-44ec-bac3-fb13d1977ecd,Diagnostics comprehensive assessment of data,The investigation reports on the impact of genomics in hospitalized individuals . We evaluates the impact of diagnostics in patients . The investigation assesses the effectiveness of transmission in hospitalized individuals . Here we report reports on the dynamics of outcomes in population . Here we report evaluates the effectiveness of therapeutics in clinical settings . The investigation presents trends in serology in patients . We assesses outcomes for therapeutics in a cohort . Our analysis investigates trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2022-01-22,2022,Jessica Brown; Elizabeth Johnson; Joseph Jones; James Jones; Jessica Johnson,Journal of Infectious Diseases,Publisher,10.0000/244957.682,92,5
121143ec-67ea-418c-9884-ae4eb8058d8d,Pandemic long-term study of trends,Our analysis presents the effectiveness of serology in patients . Our analysis assesses trends in sars-cov-2 in a cohort . We investigates the dynamics of sars-cov-2 in patients . The investigation presents the effectiveness of modeling in clinical settings . Here we report reports on trends in transmission in clinical settings . Our analysis presents the effectiveness of variants in patients . Here we report evaluates the dynamics of therapeutics in population . Our analysis reports on the dynamics of epidemiology in a cohort . Further work is needed to validate these findings.,2021-10-27,2021,James Williams; James Smith; David Williams,Frontiers in Medicine,bioRxiv,10.0000/517373.920,93,5
5f76fafb-6ed0-4315-8b24-b35adb472ee6,Variants long-term survey of outcomes,Our analysis presents the dynamics of pandemic in population . Our analysis reports on the dynamics of coronavirus in clinical settings . Our analysis evaluates the impact of pandemic in population . The investigation presents the impact of coronavirus in clinical settings . This study investigates the impact of clinical in clinical settings . Our analysis assesses the effectiveness of covid-19 in hospitalized individuals . Here we report reports on trends in clinical in clinical settings . This study assesses the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2021-05-07,2021,Elizabeth Hernandez; Jennifer Williams; Linda Johnson,Nature,PMC,10.0000/282476.867,96,5
40ec3dba-2d32-4aaf-a657-5a73c3aed886,Therapeutics comparative assessment of prevalence : implications for vaccination strategies,Here we report presents the impact of sars-cov-2 in population . We assesses trends in variants in population . Here we report presents trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2019-06-03,2019,John Anderson; William Johnson,bioRxiv,PMC,10.0000/639023.190,38,10
21f2ee21-acfc-47fa-9546-6acd5877296a,Variants clinical impact of spread,Our analysis assesses trends in immunity in a cohort . The investigation assesses the effectiveness of covid-19 in population . We assesses outcomes for transmission in a cohort . Further work is needed to validate these findings.,2020-04-15,2020,Robert Davis,Clinical Infectious Diseases,Publisher,10.0000/315518.212,37,5
523b6799-f5a8-4ab0-a63e-67638270a055,Diagnostics rapid assessment of incidence,We presents trends in transmission in population . Here we report assesses the effectiveness of genomics in clinical settings . Our analysis presents trends in immunity in clinical settings . We reports on trends in diagnostics in population . We investigates the dynamics of modeling in population . This study evaluates the impact of coronavirus in population . We investigates the impact of variants in clinical settings . Further work is needed to validate these findings.,2022-11-28,2022,William Williams; Joseph Anderson; Jessica Rodriguez; Barbara Davis; Robert Smith,The Lancet,medRxiv,10.0000/572853.879,76,5
e488df8a-bf6f-4b85-b2ee-a4cc0f0265c2,Transmission clinical impact of effectiveness,Here we report reports on the effectiveness of immunity in patients . Our analysis evaluates the effectiveness of covid-19 in a cohort . Here we report evaluates the impact of epidemiology in patients . Further work is needed to validate these findings.,2019-03-03,2019,Mary Miller,BMJ,ArXiv,10.0000/942705.560,42,5
058396fb-110a-4a5a-983b-e82b64c39016,Clinical clinical investigation of data : implications for clinical practice,This study assesses outcomes for clinical in population . This study assesses trends in sars-cov-2 in a cohort . Here we report evaluates the impact of clinical in hospitalized individuals . The investigation assesses the impact of epidemiology in population . Further work is needed to validate these findings.,2018-01-01,2018,Michael Davis; William Lopez,Science,Crossref,10.0000/854448.938,49,10
cb9bc271-3870-4550-9569-b76786d77be8,Vaccine long-term evaluation of patterns,Here we report evaluates the impact of outcomes in hospitalized individuals . This study presents outcomes for transmission in a cohort . Here we report assesses outcomes for vaccine in population . Here we report presents trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2016-10-06,2016,Mary Davis; David Gonzalez; John Williams; Joseph Davis; David Rodriguez,bioRxiv,Publisher,10.0000/573234.224,51,5
7096fda6-9d69-4e28-a180-19435020bf7c,Diagnostics preliminary survey of response : implications for clinical practice,Here we report presents the dynamics of sars-cov-2 in population . This study presents the effectiveness of diagnostics in patients . Our analysis investigates the dynamics of immunity in hospitalized individuals . Our analysis presents outcomes for epidemiology in hospitalized individuals . Here we report presents trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2021-12-26,2021,Barbara Miller; Patricia Lopez; John Lopez,The Lancet,PMC,10.0000/597505.442,61,10
7f4f732f-760f-4524-bcf2-7f9c1a3ccab9,Serology comparative impact of prevalence : implications for vaccination strategies,We reports on the impact of coronavirus in population . Here we report assesses outcomes for epidemiology in patients . We investigates the dynamics of immunity in population . This study presents the dynamics of clinical in a cohort . We reports on outcomes for epidemiology in clinical settings . The investigation investigates the effectiveness of clinical in hospitalized individuals . We reports on the effectiveness of vaccine in patients . This study assesses the effectiveness of immunity in patients . Further work is needed to validate these findings.,2019-04-12,2019,Michael Gonzalez; Patricia Rodriguez; William Martinez; Linda Jones,The Lancet,medRxiv,10.0000/412246.479,89,10
0094a893-6424-4523-a3b8-37266a2a2b2c,Serology rapid impact of data,Our analysis assesses outcomes for transmission in population . Here we report investigates the dynamics of variants in clinical settings . Our analysis assesses the impact of immunity in population . Here we report reports on the impact of epidemiology in a cohort . We evaluates outcomes for modeling in population . Our analysis reports on outcomes for epidemiology in a cohort . Further work is needed to validate these findings.,2016-09-20,2016,John Garcia; Jessica Rodriguez; Barbara Jones; Barbara Gonzalez; Barbara Garcia,Nature,bioRxiv,10.0000/978542.211,71,5
2f2afda5-7b64-4cbd-b689-e9ed80bad768,Therapeutics statistical review of patterns,Our analysis presents the impact of outcomes in patients . Here we report reports on the effectiveness of clinical in clinical settings . Our analysis presents trends in vaccine in population . Further work is needed to validate these findings.,2015-12-23,2015,John Smith; David Anderson; Mary Jones; Richard Rodriguez; Elizabeth Wilson,Nature,Publisher,10.0000/824885.690,40,5
23886671-0ee0-4a80-84a4-c350a493be46,Diagnostics rapid dynamics of spread,Our analysis reports on outcomes for serology in a cohort . Here we report presents the dynamics of vaccine in hospitalized individuals . The investigation reports on trends in diagnostics in clinical settings . The investigation assesses the impact of diagnostics in patients . Further work is needed to validate these findings.,2021-06-23,2021,Joseph Johnson,PLOS ONE,Crossref,10.0000/283342.550,52,5
cc421dfd-5f65-4812-9b73-0bb0d9826bdb,SARS-CoV-2 preliminary dynamics of trends,The investigation presents trends in therapeutics in population . This study reports on trends in vaccine in a cohort . Here we report reports on the dynamics of therapeutics in patients . Here we report assesses the dynamics of transmission in population . Our analysis investigates outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-03-24,2016,Elizabeth Garcia; Richard Williams; Michael Martinez; Robert Brown; Richard Davis,medRxiv,bioRxiv,10.0000/354508.362,61,5
97320109-b2ba-4ac1-9145-9d1e2336c73c,Pandemic comprehensive survey of incidence : implications for policy,Here we report investigates outcomes for clinical in hospitalized individuals . This study investigates trends in covid-19 in patients . This study assesses outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-07-30,2021,Richard Jones; Barbara Martinez; Elizabeth Jones,Journal of Infectious Diseases,PMC,10.0000/105001.408,38,9
15b2b48b-5948-46da-8e14-b3d65c6d4b90,COVID-19 comparative review of incidence,Here we report investigates trends in sars-cov-2 in patients . This study investigates the effectiveness of variants in patients . We investigates trends in clinical in hospitalized individuals . Our analysis investigates the impact of variants in patients . We presents the dynamics of serology in population . Our analysis evaluates trends in covid-19 in clinical settings . Further work is needed to validate these findings.,2022-10-02,2022,Susan Garcia; Jessica Anderson; Joseph Gonzalez,PLOS ONE,ArXiv,10.0000/957916.849,66,5
62050975-b0e6-4ccc-a00c-4efb6b5dc8d3,Genomics regional impact of response,This study assesses the effectiveness of modeling in population . This study reports on trends in coronavirus in patients . This study presents the effectiveness of clinical in a cohort . The investigation presents trends in covid-19 in clinical settings . We reports on the effectiveness of transmission in hospitalized individuals . Here we report presents the dynamics of covid-19 in a cohort . Here we report assesses trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2020-07-26,2020,William Martinez; Linda Johnson; Jessica Lopez,PLOS ONE,medRxiv,10.0000/502192.257,83,5
b918a288-40e8-4e9d-be0a-64017289478e,Serology comparative investigation of data,Here we report assesses trends in vaccine in a cohort . This study evaluates outcomes for modeling in hospitalized individuals . The investigation assesses the effectiveness of therapeutics in population . Here we report presents trends in pandemic in clinical settings . The investigation reports on trends in epidemiology in clinical settings . We assesses the impact of outcomes in clinical settings . Here we report reports on the dynamics of pandemic in a cohort . This study investigates trends in modeling in population . Further work is needed to validate these findings.,2018-05-21,2018,John Martinez; Jennifer Williams; William Brown; John Williams; Joseph Gonzalez,The Lancet,PMC,10.0000/434247.231,93,5
bf8ab70a-c54c-4527-a56c-a98238a4c29f,Transmission global review of prevalence : implications for policy,We assesses the impact of immunity in clinical settings . We investigates the effectiveness of vaccine in hospitalized individuals . The investigation presents the impact of variants in patients . Our analysis evaluates the effectiveness of modeling in a cohort . We investigates the dynamics of epidemiology in a cohort . We investigates the impact of covid-19 in clinical settings . Our analysis investigates trends in immunity in population . Further work is needed to validate these findings.,2019-08-05,2019,William Miller; Mary Miller; Jessica Martinez,BMJ,Crossref,10.0000/627500.660,78,9
c5d7513b-0433-4ba7-a49f-1a4f05122f16,Epidemiology preliminary investigation of response,The investigation reports on the effectiveness of modeling in population . We presents outcomes for outcomes in hospitalized individuals . Our analysis investigates the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2019-07-01,2019,Jessica Rodriguez; Patricia Brown; Linda Martinez,Nature,PMC,10.0000/602282.407,39,5
eca6e037-617c-4c8a-9ce0-7cea2263e1ce,Modeling long-term impact of effectiveness,We investigates the impact of modeling in a cohort . This study investigates the effectiveness of serology in hospitalized individuals . Here we report reports on trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-10-30,2015,Susan Anderson; William Hernandez; Mary Garcia; Linda Davis; Susan Davis,Nature,ArXiv,10.0000/367047.184,41,5
02ca38d6-1677-4808-b9df-1f11b6128868,Therapeutics comparative analysis of effectiveness : implications for clinical practice,Our analysis assesses the impact of outcomes in patients . Our analysis reports on the effectiveness of epidemiology in clinical settings . We assesses the impact of diagnostics in a cohort . The investigation investigates the impact of variants in clinical settings . Here we report presents outcomes for outcomes in patients . Our analysis reports on the impact of serology in population . Here we report reports on the impact of pandemic in a cohort . The investigation assesses outcomes for clinical in patients . Further work is needed to validate these findings.,2018-07-28,2018,Jennifer Garcia,Science,medRxiv,10.0000/244209.108,94,10
82857b97-01c9-4b67-bf14-c1d467174de4,Outcomes comparative dynamics of spread,Here we report assesses the dynamics of pandemic in clinical settings . Our analysis assesses the impact of diagnostics in patients . This study evaluates the effectiveness of clinical in patients . Further work is needed to validate these findings.,2022-11-03,2022,John Hernandez,bioRxiv,medRxiv,10.0000/849086.366,40,5
07064c09-289b-4024-9ef7-22ef7811fb47,Modeling preliminary report of response,Here we report investigates outcomes for transmission in hospitalized individuals . This study presents outcomes for diagnostics in patients . This study investigates trends in pandemic in patients . We reports on the effectiveness of genomics in population . Here we report reports on outcomes for variants in patients . The investigation evaluates the impact of variants in population . The investigation reports on outcomes for clinical in hospitalized individuals . The investigation investigates the impact of modeling in patients . Further work is needed to validate these findings.,2018-07-21,2018,Mary Wilson; Mary Martinez,Nature,bioRxiv,10.0000/689697.873,89,5
45c9b10b-2b03-4237-ace1-2d90015d4a5e,Variants statistical study of trends,The investigation investigates the dynamics of therapeutics in hospitalized individuals . Our analysis reports on the dynamics of outcomes in population . This study evaluates the effectiveness of covid-19 in population . Our analysis investigates trends in genomics in population . We reports on the dynamics of modeling in a cohort . The investigation reports on outcomes for pandemic in clinical settings . Here we report investigates the dynamics of covid-19 in hospitalized individuals . This study investigates the impact of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2021-02-17,2021,Mary Johnson; Joseph Lopez,PLOS ONE,bioRxiv,10.0000/419206.543,94,5
b065c2f3-e79d-48af-a701-54f3349e7d74,Outcomes regional assessment of effectiveness,The investigation reports on trends in covid-19 in patients . This study assesses the impact of immunity in hospitalized individuals . Here we report assesses the dynamics of serology in a cohort . Our analysis investigates trends in outcomes in patients . Here we report investigates the effectiveness of outcomes in population . We presents the dynamics of modeling in clinical settings . The investigation presents the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2016-04-08,2016,Barbara Anderson; Patricia Hernandez,The Lancet,medRxiv,10.0000/339011.733,82,5
c9c08c4d-8347-4627-b996-dee3a239f3fb,Serology clinical assessment of incidence,The investigation investigates the impact of outcomes in a cohort . Our analysis evaluates the dynamics of coronavirus in clinical settings . Here we report assesses the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2019-08-19,2019,Mary Miller,BMJ,ArXiv,10.0000/666976.293,42,5
898d3312-b742-4286-9fc4-c32f8ec25c9d,Outcomes rapid analysis of effectiveness,We reports on the effectiveness of covid-19 in population . We investigates the impact of epidemiology in hospitalized individuals . Our analysis presents trends in modeling in patients . Further work is needed to validate these findings.,2022-03-21,2022,Susan Jones; Mary Jones,Nature,Crossref,10.0000/710590.660,37,5
ad92d5cd-b83d-4354-95db-ed3fed4b9678,Clinical rapid survey of trends,Our analysis evaluates the dynamics of serology in a cohort . This study reports on outcomes for clinical in patients . Here we report evaluates trends in coronavirus in patients . Further work is needed to validate these findings.,2017-03-14,2017,Joseph Anderson; Patricia Gonzalez; Jennifer Wilson; Joseph Smith; Linda Martinez,medRxiv,ArXiv,10.0000/216122.835,39,5
be73cdb5-6386-45c2-97e7-98a6c3cc002e,Therapeutics preliminary investigation of prevalence,We assesses outcomes for sars-cov-2 in a cohort . This study presents the dynamics of immunity in hospitalized individuals . We assesses outcomes for immunity in clinical settings . This study assesses outcomes for serology in hospitalized individuals . Our analysis evaluates the impact of genomics in clinical settings . Our analysis presents the impact of diagnostics in population . Further work is needed to validate these findings.,2017-01-29,2017,William Davis; Robert Anderson,Frontiers in Medicine,ArXiv,10.0000/158298.449,68,5
b17710fd-9f2d-4505-ba7c-eb514687bbe6,Genomics comprehensive study of incidence,This study evaluates outcomes for diagnostics in clinical settings . We presents the effectiveness of serology in clinical settings . We presents trends in modeling in patients . The investigation presents the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2016-08-16,2016,Patricia Jones; Joseph Johnson; James Miller; David Lopez,Clinical Infectious Diseases,medRxiv,10.0000/440344.958,47,5
04248648-5ed4-4a0e-96b3-ba8f2db4a67d,Coronavirus comprehensive survey of response,This study reports on the effectiveness of outcomes in population . We reports on the dynamics of genomics in patients . The investigation evaluates trends in covid-19 in hospitalized individuals . We assesses the impact of clinical in hospitalized individuals . The investigation assesses outcomes for clinical in population . We presents the dynamics of modeling in patients . We investigates the effectiveness of serology in clinical settings . Further work is needed to validate these findings.,2021-07-25,2021,Elizabeth Wilson; Barbara Anderson; Linda Johnson; Patricia Smith; John Anderson,Frontiers in Medicine,PMC,10.0000/316487.511,77,5
b2d2778d-c0f2-4ea2-b47b-7c7e9f071715,Outcomes statistical investigation of patients,Our analysis evaluates the effectiveness of epidemiology in a cohort . Here we report reports on trends in pandemic in a cohort . Here we report presents the effectiveness of genomics in a cohort . We evaluates the impact of transmission in population . Here we report presents outcomes for clinical in patients . We reports on trends in modeling in patients . Further work is needed to validate these findings.,2016-06-08,2016,John Jones; James Rodriguez; Jennifer Hernandez; Richard Wilson,Nature,medRxiv,10.0000/965840.904,71,5
44dfb950-75f7-4b95-8cda-2532c99cd33f,Outcomes long-term investigation of patterns,The investigation reports on trends in diagnostics in a cohort . Our analysis presents the impact of modeling in a cohort . Our analysis assesses the impact of vaccine in patients . This study assesses the impact of therapeutics in clinical settings . We assesses the effectiveness of transmission in a cohort . Our analysis evaluates trends in genomics in a cohort . Here we report evaluates trends in therapeutics in clinical settings . The investigation evaluates outcomes for serology in clinical settings . Further work is needed to validate these findings.,2016-04-06,2016,James Wilson; William Jones; Elizabeth Gonzalez,Journal of Infectious Diseases,ArXiv,10.0000/316076.603,92,5
687c2774-3f2c-40ff-b7a6-c080e142ade5,Outcomes rapid analysis of effectiveness,This study evaluates the dynamics of outcomes in clinical settings . Our analysis reports on trends in coronavirus in population . Here we report evaluates trends in genomics in patients . Here we report investigates the impact of epidemiology in population . Further work is needed to validate these findings.,2018-01-04,2018,Joseph Hernandez; Michael Garcia; Joseph Smith; Mary Gonzalez; Mary Gonzalez,medRxiv,PMC,10.0000/198731.997,50,5
182ad3ee-bfb9-4f8a-8ded-65d2b8f35ca6,Modeling comparative review of spread : implications for vaccination strategies,Here we report evaluates outcomes for genomics in population . We investigates the dynamics of covid-19 in patients . We investigates the dynamics of immunity in hospitalized individuals . Our analysis assesses the impact of diagnostics in population . We evaluates the dynamics of coronavirus in patients . We reports on outcomes for transmission in a cohort . Our analysis assesses the dynamics of genomics in population . Further work is needed to validate these findings.,2021-02-14,2021,Jessica Gonzalez; David Rodriguez,Unknown,bioRxiv,10.0000/946173.439,76,10
54ad7445-ec34-4f7b-b0b6-c0b9aa8ac3da,Pandemic long-term assessment of spread,The investigation presents the dynamics of sars-cov-2 in a cohort . This study investigates the dynamics of genomics in clinical settings . Our analysis presents outcomes for modeling in a cohort . We presents trends in outcomes in population . Here we report reports on trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2020-01-19,2020,William Williams,medRxiv,Publisher,10.0000/573869.554,60,5
4a5ea025-3551-49fb-8068-eda81b64dcd2,Pandemic comparative assessment of incidence,Here we report evaluates trends in pandemic in hospitalized individuals . The investigation presents the effectiveness of pandemic in population . The investigation presents the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-09-26,2020,David Miller; Richard Garcia; Joseph Williams,Nature,PMC,10.0000/572341.823,40,5
85b06c4a-fd17-441e-89f6-bb45c2bceb9b,Coronavirus long-term analysis of prevalence,This study assesses outcomes for pandemic in population . Our analysis investigates the effectiveness of modeling in patients . We assesses trends in diagnostics in a cohort . Our analysis assesses the dynamics of pandemic in a cohort . Further work is needed to validate these findings.,2015-08-24,2015,Jessica Gonzalez; Joseph Wilson; Susan Davis; Elizabeth Martinez; Susan Davis,The Lancet,Publisher,10.0000/852528.819,47,5
551ea841-61da-431d-8ac6-29c486370a16,Variants clinical study of outcomes,The investigation assesses the dynamics of sars-cov-2 in patients . The investigation evaluates the impact of pandemic in hospitalized individuals . Our analysis assesses the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2018-03-07,2018,Jennifer Rodriguez; Elizabeth Smith; Richard Johnson; Richard Hernandez,Science,ArXiv,10.0000/292977.825,40,5
51b8c858-6a57-4304-bdf6-cd03f7b2bcb8,Transmission regional review of incidence,Here we report assesses the effectiveness of immunity in clinical settings . We reports on the impact of diagnostics in a cohort . The investigation evaluates the effectiveness of pandemic in hospitalized individuals . This study evaluates outcomes for vaccine in a cohort . This study presents trends in epidemiology in patients . Our analysis evaluates the impact of diagnostics in hospitalized individuals . The investigation reports on the impact of immunity in hospitalized individuals . We assesses trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2019-10-25,2019,Robert Anderson; David Garcia; Barbara Miller; David Smith,PLOS ONE,ArXiv,10.0000/501632.552,93,5
4fe008a1-9287-4e8a-ba21-40a39618e198,Outcomes global report of patients,We investigates the dynamics of vaccine in population . Here we report investigates the dynamics of diagnostics in a cohort . This study evaluates the effectiveness of vaccine in a cohort . We reports on the dynamics of serology in patients . Our analysis reports on trends in transmission in clinical settings . We evaluates the effectiveness of clinical in population . Further work is needed to validate these findings.,2016-11-30,2016,Elizabeth Gonzalez; David Rodriguez; Patricia Martinez,Journal of Infectious Diseases,ArXiv,10.0000/289042.998,70,5
2561394d-42b9-4700-affb-983e91cb1aba,Genomics clinical study of data,Our analysis evaluates the dynamics of modeling in hospitalized individuals . The investigation presents trends in epidemiology in clinical settings . Our analysis evaluates trends in immunity in population . Further work is needed to validate these findings.,2016-12-27,2016,Barbara Martinez; John Brown; Barbara Johnson; Elizabeth Smith,Science,Publisher,10.0000/165195.725,38,5
b0113a14-d321-4717-8e36-6b362becbabf,Serology statistical review of prevalence,Our analysis investigates trends in therapeutics in population . The investigation assesses the effectiveness of outcomes in hospitalized individuals . Our analysis reports on the impact of modeling in population . Here we report reports on the effectiveness of variants in population . This study presents outcomes for therapeutics in hospitalized individuals . Our analysis assesses trends in epidemiology in patients . Our analysis investigates the effectiveness of sars-cov-2 in a cohort . We reports on trends in vaccine in clinical settings . Further work is needed to validate these findings.,2020-10-13,2020,Michael Lopez,Frontiers in Medicine,ArXiv,10.0000/614197.235,91,5
40e177d8-d7aa-4d08-a3b9-5f2e9a8bd602,Serology statistical study of patterns,This study reports on outcomes for therapeutics in hospitalized individuals . The investigation evaluates the dynamics of therapeutics in hospitalized individuals . The investigation investigates the impact of coronavirus in population . Here we report reports on trends in vaccine in patients . Further work is needed to validate these findings.,2019-10-13,2019,Michael Miller; James Miller,Clinical Infectious Diseases,PMC,10.0000/292108.585,51,5
9da023a7-2354-4436-ba36-bb3dbbe6c135,Therapeutics comprehensive report of spread,This study assesses the dynamics of covid-19 in clinical settings . This study evaluates the effectiveness of coronavirus in hospitalized individuals . The investigation investigates the dynamics of genomics in population . This study evaluates the dynamics of diagnostics in clinical settings . Our analysis presents the effectiveness of transmission in patients . Further work is needed to validate these findings.,2022-09-18,2022,Patricia Anderson; John Williams; James Miller,Science,Publisher,10.0000/559204.160,61,5
cc0d099b-3c00-4085-8351-9f12de85f067,Genomics statistical study of response,We presents the impact of outcomes in a cohort . Here we report reports on outcomes for vaccine in clinical settings . Here we report investigates the dynamics of variants in patients . Our analysis reports on outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2019-04-20,2019,Michael Johnson; Susan Lopez; Elizabeth Rodriguez; Barbara Martinez,Science,bioRxiv,10.0000/342246.517,52,5
d818cce4-b1db-4726-bfd4-64a8fd176bfb,Pandemic rapid evaluation of prevalence,Here we report evaluates the dynamics of variants in clinical settings . Our analysis reports on the effectiveness of covid-19 in population . We evaluates outcomes for transmission in population . We reports on outcomes for covid-19 in patients . Here we report presents the dynamics of immunity in a cohort . The investigation evaluates outcomes for genomics in hospitalized individuals . Our analysis evaluates the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2020-05-12,2020,Linda Wilson; Michael Davis; Joseph Rodriguez,Journal of Infectious Diseases,Crossref,10.0000/816510.128,80,5
707dee52-d1c5-4fc3-9b9c-6986f01269f4,Variants clinical analysis of incidence,We evaluates outcomes for vaccine in clinical settings . This study reports on the dynamics of immunity in a cohort . Our analysis assesses outcomes for pandemic in patients . Here we report investigates outcomes for epidemiology in patients . This study assesses the impact of pandemic in clinical settings . We evaluates the effectiveness of variants in patients . Further work is needed to validate these findings.,2021-03-25,2021,Elizabeth Williams; John Brown; Barbara Martinez; Susan Smith,Journal of Infectious Diseases,medRxiv,10.0000/827818.960,68,5
fb599fb0-d399-4b39-b812-b0d79dda75c3,Modeling long-term investigation of prevalence,Our analysis presents trends in diagnostics in a cohort . Here we report evaluates trends in modeling in population . Our analysis assesses the dynamics of genomics in population . Our analysis assesses the dynamics of coronavirus in clinical settings . We presents trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2017-09-21,2017,Jennifer Martinez,Nature,PMC,10.0000/438991.896,58,5
10daa83c-8e57-49bd-9e01-08f7b4947ae1,Variants comprehensive analysis of data,We investigates trends in therapeutics in patients . This study evaluates the impact of outcomes in clinical settings . Here we report investigates the impact of serology in population . Further work is needed to validate these findings.,2016-01-25,2016,David Rodriguez; Mary Martinez,Frontiers in Medicine,bioRxiv,10.0000/841306.806,38,5
9d1aa272-ca05-43f5-8092-62dff5f0a4f8,Therapeutics regional review of outcomes,Here we report presents the impact of coronavirus in patients . We investigates the impact of variants in clinical settings . We reports on outcomes for sars-cov-2 in hospitalized individuals . Our analysis reports on trends in immunity in patients . We investigates the impact of pandemic in a cohort . We presents outcomes for immunity in population . The investigation assesses the impact of transmission in a cohort . The investigation investigates outcomes for genomics in patients . Further work is needed to validate these findings.,2022-08-16,2022,Elizabeth Brown; Susan Garcia; David Brown; John Brown,BMJ,Crossref,10.0000/340116.299,87,5
777b6c43-2aa8-4b45-bf3d-a55815414c75,Genomics comparative impact of patients,We assesses trends in modeling in hospitalized individuals . Our analysis assesses the effectiveness of clinical in hospitalized individuals . Our analysis presents the impact of epidemiology in patients . This study assesses outcomes for transmission in patients . Our analysis presents the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2022-08-05,2022,Elizabeth Hernandez; Robert Lopez; Michael Williams,BMJ,ArXiv,10.0000/159865.946,58,5
10da4893-d6d0-4e61-a922-c5c09347e29c,Serology comparative analysis of prevalence,Our analysis reports on outcomes for vaccine in a cohort . Our analysis presents the effectiveness of pandemic in clinical settings . The investigation evaluates the dynamics of coronavirus in a cohort . This study presents trends in clinical in patients . Further work is needed to validate these findings.,2017-11-25,2017,Richard Jones; William Lopez,medRxiv,ArXiv,10.0000/900645.528,50,5
9e4dc27f-169b-48cf-a449-74445ff8ee46,Variants comparative review of trends : implications for public health,We presents the effectiveness of serology in a cohort . This study investigates the dynamics of pandemic in a cohort . The investigation investigates outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2017-09-22,2017,David Gonzalez; John Jones; Linda Wilson,Clinical Infectious Diseases,Publisher,10.0000/105154.182,39,10
ebf60997-663a-4ca8-b714-2b6dd6f30308,Serology rapid impact of trends,Here we report evaluates the impact of variants in patients . The investigation investigates trends in clinical in patients . Here we report investigates the dynamics of immunity in patients . Our analysis reports on the effectiveness of immunity in clinical settings . Here we report evaluates the dynamics of outcomes in a cohort . This study assesses the impact of diagnostics in clinical settings . Here we report reports on the impact of pandemic in patients . Further work is needed to validate these findings.,2016-09-12,2016,Barbara Johnson; Elizabeth Jones,Clinical Infectious Diseases,bioRxiv,10.0000/667730.404,86,5
4495830a-7655-47c5-b264-b03f4eff9bc7,Coronavirus preliminary assessment of effectiveness,We reports on the effectiveness of epidemiology in population . The investigation investigates the effectiveness of outcomes in clinical settings . This study reports on the impact of therapeutics in hospitalized individuals . We evaluates the dynamics of epidemiology in a cohort . Our analysis assesses the dynamics of outcomes in clinical settings . We evaluates trends in vaccine in hospitalized individuals . Our analysis reports on trends in coronavirus in a cohort . The investigation reports on outcomes for covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-07-20,2016,Barbara Williams,Unknown,Crossref,10.0000/356315.868,93,5
f7ef2955-e1a8-4809-9658-cdbb570ed8c1,Coronavirus statistical report of response,Our analysis investigates the dynamics of pandemic in hospitalized individuals . Our analysis assesses the dynamics of coronavirus in clinical settings . This study assesses the impact of genomics in a cohort . The investigation assesses the dynamics of epidemiology in patients . Here we report assesses trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-03-20,2015,Michael Jones; Jennifer Smith; John Miller,Science,bioRxiv,10.0000/762659.730,62,5
e3a6be76-6d47-4e3d-a10b-a8494de27a9a,Outcomes rapid review of patients,Our analysis evaluates the effectiveness of diagnostics in patients . This study evaluates the impact of epidemiology in patients . Our analysis investigates trends in transmission in patients . Here we report evaluates outcomes for epidemiology in a cohort . We presents trends in sars-cov-2 in population . This study assesses the dynamics of serology in a cohort . Here we report investigates outcomes for transmission in a cohort . Further work is needed to validate these findings.,2022-08-19,2022,Jennifer Smith,Frontiers in Medicine,ArXiv,10.0000/776678.972,78,5
9486bbf9-4790-471d-8f21-cf038cd39518,Vaccine preliminary review of data,This study investigates outcomes for covid-19 in hospitalized individuals . We presents the effectiveness of epidemiology in patients . The investigation reports on outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2019-04-19,2019,Robert Garcia,Unknown,PMC,10.0000/123807.413,38,5
11a7ba49-734e-4c0d-ab5c-a32787c2ce88,Epidemiology statistical report of outcomes,We investigates the impact of transmission in population . Here we report evaluates outcomes for epidemiology in a cohort . We reports on the effectiveness of transmission in patients . This study assesses trends in pandemic in patients . We presents trends in serology in a cohort . The investigation evaluates trends in immunity in hospitalized individuals . Our analysis reports on trends in immunity in a cohort . Further work is needed to validate these findings.,2020-06-20,2020,Michael Hernandez; Robert Wilson,BMJ,ArXiv,10.0000/299394.532,77,5
f085a1fc-4346-4e63-af73-dddfc3dd2931,Clinical clinical report of effectiveness,The investigation reports on outcomes for serology in patients . Our analysis presents outcomes for genomics in clinical settings . Here we report presents trends in epidemiology in hospitalized individuals . Here we report evaluates the impact of serology in a cohort . Our analysis assesses outcomes for epidemiology in population . Here we report presents the impact of variants in a cohort . The investigation evaluates the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2017-05-06,2017,John Anderson,BMJ,Publisher,10.0000/901910.492,83,5
51fe59cd-4bcb-4e4b-87d2-5dd231c576a7,Transmission global study of outcomes,Our analysis assesses outcomes for modeling in population . Our analysis investigates trends in coronavirus in population . We reports on the effectiveness of covid-19 in a cohort . We reports on the effectiveness of transmission in a cohort . Here we report presents the impact of outcomes in a cohort . This study presents the dynamics of covid-19 in patients . Here we report reports on trends in therapeutics in a cohort . The investigation reports on trends in pandemic in clinical settings . Further work is needed to validate these findings.,2021-09-24,2021,Richard Anderson; Robert Wilson,PLOS ONE,medRxiv,10.0000/474361.165,93,5
39fcf864-b30f-4512-838c-69f357abff11,Diagnostics statistical survey of incidence,The investigation assesses the dynamics of transmission in population . This study evaluates the effectiveness of epidemiology in population . This study presents trends in diagnostics in hospitalized individuals . Here we report evaluates the effectiveness of transmission in hospitalized individuals . This study assesses the effectiveness of clinical in patients . We investigates outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2020-08-05,2020,Jennifer Smith; Patricia Lopez; Susan Smith,Science,ArXiv,10.0000/250736.216,69,5
b083bfa9-f09d-4f6f-b70f-5f2f8d32b32d,Diagnostics comprehensive survey of response,The investigation presents the dynamics of sars-cov-2 in hospitalized individuals . Our analysis assesses trends in serology in population . We investigates trends in coronavirus in clinical settings . We assesses the impact of variants in clinical settings . Our analysis reports on the dynamics of diagnostics in clinical settings . Our analysis reports on the dynamics of vaccine in patients . We presents the impact of immunity in patients . Further work is needed to validate these findings.,2022-06-14,2022,Mary Jones; Barbara Rodriguez; Barbara Jones; John Rodriguez; David Williams,Science,PMC,10.0000/441155.651,79,5
461ade61-12e8-4ff1-8f02-25e775d0d45c,Transmission long-term assessment of spread,Our analysis presents the dynamics of transmission in a cohort . Here we report reports on the dynamics of coronavirus in hospitalized individuals . We evaluates the impact of genomics in a cohort . Our analysis investigates the impact of immunity in clinical settings . The investigation presents the impact of immunity in hospitalized individuals . The investigation investigates the dynamics of coronavirus in a cohort . Our analysis reports on trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-10-27,2020,William Anderson; James Gonzalez; John Lopez; Richard Lopez; Richard Hernandez,medRxiv,ArXiv,10.0000/523991.420,86,5
1ef09d79-3e08-4474-95db-3c8c099a80d4,Variants preliminary impact of prevalence,We investigates trends in transmission in clinical settings . This study assesses the dynamics of therapeutics in a cohort . The investigation assesses the dynamics of modeling in a cohort . The investigation evaluates outcomes for covid-19 in a cohort . The investigation investigates the impact of sars-cov-2 in population . The investigation presents the effectiveness of sars-cov-2 in hospitalized individuals . Here we report reports on outcomes for vaccine in a cohort . Further work is needed to validate these findings.,2015-08-04,2015,John Davis; Linda Garcia; Susan Davis; Elizabeth Williams,bioRxiv,PMC,10.0000/854856.447,82,5
0526ba12-0415-4c1d-b473-124de9453385,Modeling comparative report of patients,We presents the impact of epidemiology in hospitalized individuals . We assesses the effectiveness of epidemiology in hospitalized individuals . The investigation evaluates the impact of covid-19 in population . Here we report assesses the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2022-02-15,2022,Linda Garcia; Elizabeth Anderson; William Hernandez; Robert Jones; Linda Davis,BMJ,bioRxiv,10.0000/725462.618,50,5
20752e7b-2fc2-4a2c-b058-03100f60e803,Variants comprehensive study of patterns : implications for clinical practice,Our analysis evaluates trends in serology in clinical settings . The investigation investigates the impact of modeling in patients . Here we report reports on the effectiveness of epidemiology in hospitalized individuals . We assesses the effectiveness of transmission in a cohort . Here we report presents the dynamics of modeling in hospitalized individuals . We assesses trends in transmission in hospitalized individuals . This study presents trends in clinical in patients . Further work is needed to validate these findings.,2017-05-06,2017,Joseph Anderson,Journal of Infectious Diseases,PMC,10.0000/861627.757,81,10
bcb1acb4-861e-4a59-b13b-29e59fb754f5,Immunity clinical analysis of outcomes,We reports on the effectiveness of sars-cov-2 in population . The investigation presents the impact of genomics in a cohort . We assesses the impact of outcomes in patients . Our analysis presents the impact of pandemic in a cohort . The investigation assesses the dynamics of therapeutics in patients . We assesses the effectiveness of coronavirus in clinical settings . Further work is needed to validate these findings.,2019-04-05,2019,Michael Wilson; Elizabeth Brown; William Anderson; Joseph Johnson; Patricia Brown,Journal of Infectious Diseases,ArXiv,10.0000/213694.298,69,5
7feac444-1984-4f4b-953a-8bc431c901b3,Immunity long-term review of spread,Here we report assesses the impact of vaccine in hospitalized individuals . The investigation presents trends in genomics in patients . Our analysis reports on the impact of variants in patients . Further work is needed to validate these findings.,2019-07-15,2019,Jennifer Gonzalez; Elizabeth Wilson; Jessica Johnson; Patricia Williams; Linda Garcia,The Lancet,Crossref,10.0000/339932.446,40,5
f436df87-5149-46a9-bf92-1e0a84b99f92,Therapeutics clinical assessment of spread,The investigation assesses the dynamics of outcomes in population . We assesses the impact of sars-cov-2 in a cohort . Our analysis investigates the dynamics of sars-cov-2 in clinical settings . The investigation presents the impact of serology in hospitalized individuals . Our analysis investigates the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2020-01-15,2020,Joseph Garcia; John Brown; Patricia Miller; David Rodriguez,Clinical Infectious Diseases,bioRxiv,10.0000/582114.146,60,5
b168f0e4-6b42-468f-97ca-264808e2ce1d,Clinical regional analysis of data,We investigates the dynamics of variants in population . Here we report presents outcomes for outcomes in a cohort . We investigates outcomes for outcomes in population . Our analysis investigates the impact of therapeutics in population . We investigates trends in modeling in population . Here we report reports on trends in immunity in population . The investigation assesses the effectiveness of coronavirus in clinical settings . Further work is needed to validate these findings.,2019-11-17,2019,Susan Rodriguez; Barbara Johnson; John Wilson; Richard Gonzalez; Jessica Brown,Frontiers in Medicine,PMC,10.0000/865902.638,76,5
81dcc9b0-fdd8-4026-b350-04df0157bf97,Modeling comprehensive evaluation of prevalence,Our analysis evaluates trends in immunity in clinical settings . This study presents outcomes for sars-cov-2 in patients . This study investigates trends in vaccine in clinical settings . Our analysis investigates the dynamics of modeling in a cohort . The investigation assesses trends in therapeutics in patients . Here we report reports on the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2017-02-08,2017,Susan Miller; Joseph Brown; Joseph Rodriguez; Susan Lopez; Richard Davis,The Lancet,Publisher,10.0000/851319.567,70,5
9a1ae955-8cb5-493c-8236-07ae154ae8e2,Pandemic preliminary assessment of patients,This study assesses the dynamics of serology in hospitalized individuals . This study assesses the dynamics of outcomes in hospitalized individuals . This study assesses trends in transmission in population . The investigation evaluates the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2020-12-07,2020,Robert Martinez,Journal of Infectious Diseases,bioRxiv,10.0000/594282.556,50,5
02db7644-13f7-4878-8316-fb5c72f77e3d,Diagnostics comprehensive review of effectiveness,We presents the impact of pandemic in hospitalized individuals . The investigation assesses the impact of covid-19 in a cohort . The investigation assesses the impact of vaccine in clinical settings . Our analysis evaluates the impact of diagnostics in a cohort . Here we report presents the dynamics of sars-cov-2 in a cohort . The investigation assesses the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2016-05-28,2016,Jennifer Davis; Mary Smith,BMJ,Crossref,10.0000/196861.543,74,5
fcd0fa98-ff4c-4014-8c01-2ae4241e9cc1,Modeling global evaluation of spread : implications for public health,Here we report investigates the dynamics of covid-19 in patients . We investigates outcomes for pandemic in hospitalized individuals . Here we report evaluates the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2021-05-15,2021,Richard Garcia; Linda Smith; Linda Anderson; Susan Miller; Elizabeth Anderson,The Lancet,Crossref,10.0000/492560.116,40,10
8cd0c4a1-bffd-40a5-97d1-6f99a3815abc,Serology regional report of effectiveness,The investigation investigates the dynamics of immunity in patients . Here we report evaluates outcomes for immunity in population . This study investigates the impact of variants in a cohort . We evaluates the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2017-05-20,2017,James Jones; Mary Smith; William Lopez; Elizabeth Jones; Patricia Wilson,bioRxiv,PMC,10.0000/922049.572,49,5
d6103fc5-65a7-4051-82b1-56b3183420a7,Modeling preliminary report of patients,Here we report evaluates the impact of outcomes in clinical settings . The investigation reports on the effectiveness of clinical in population . This study reports on the effectiveness of vaccine in patients . Here we report assesses the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2019-06-01,2019,Susan Martinez; Jessica Williams; Mary Anderson; Mary Miller; William Brown,Unknown,ArXiv,10.0000/913439.673,54,5
eca84480-aa6d-408f-9ae8-bf0ee4c34c45,Diagnostics long-term impact of outcomes : implications for vaccination strategies,The investigation evaluates the dynamics of epidemiology in a cohort . The investigation presents the effectiveness of genomics in patients . Our analysis assesses the dynamics of outcomes in a cohort . This study reports on trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2020-10-19,2020,Richard Wilson; Patricia Jones; John Garcia; David Jones,BMJ,bioRxiv,10.0000/787576.906,51,10
e3bf7653-49fa-4b6f-99e4-b1cf568d0829,Therapeutics global dynamics of patterns : implications for public health,This study assesses the effectiveness of serology in hospitalized individuals . Our analysis reports on outcomes for vaccine in clinical settings . We presents trends in variants in patients . Our analysis presents outcomes for transmission in a cohort . This study reports on the dynamics of sars-cov-2 in clinical settings . Our analysis assesses the dynamics of clinical in a cohort . We investigates the effectiveness of immunity in patients . Here we report evaluates the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2020-08-25,2020,Elizabeth Davis; William Williams; Mary Garcia,medRxiv,Publisher,10.0000/709127.465,92,10
c1232bf0-81b1-46a8-88e7-07656b551893,Variants long-term dynamics of response,The investigation reports on the dynamics of clinical in hospitalized individuals . The investigation reports on the impact of pandemic in population . This study presents the impact of therapeutics in patients . The investigation assesses trends in therapeutics in patients . Our analysis assesses outcomes for immunity in population . Further work is needed to validate these findings.,2022-01-20,2022,Richard Rodriguez; Michael Garcia; Patricia Johnson; Mary Lopez; Michael Wilson,Unknown,bioRxiv,10.0000/947156.979,59,5
ea54df0a-e69f-4f5c-9f9c-5eecbfee02b0,Transmission clinical report of effectiveness : implications for public health,The investigation investigates trends in coronavirus in a cohort . This study investigates outcomes for modeling in clinical settings . This study presents trends in serology in hospitalized individuals . The investigation assesses trends in outcomes in a cohort . We assesses the impact of variants in population . Our analysis assesses the impact of variants in population . Further work is needed to validate these findings.,2018-06-30,2018,Linda Lopez; Joseph Wilson; Susan Rodriguez; William Anderson; William Martinez,Nature,PMC,10.0000/114518.484,67,10
9fee5cf8-f408-43d2-8d5f-4f2b452d263c,SARS-CoV-2 preliminary assessment of outcomes,The investigation presents the effectiveness of transmission in patients . Our analysis investigates the dynamics of modeling in population . Our analysis assesses the effectiveness of clinical in clinical settings . We reports on outcomes for outcomes in clinical settings . This study evaluates the impact of transmission in a cohort . Our analysis investigates the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2022-12-13,2022,Barbara Johnson; Barbara Williams; David Miller; Richard Williams,bioRxiv,Publisher,10.0000/430460.991,71,5
20d7b2ef-9f76-4e16-bec9-ed84516ef28b,Vaccine global evaluation of patients : implications for policy,Here we report assesses the effectiveness of covid-19 in clinical settings . Here we report reports on the dynamics of serology in a cohort . This study presents the impact of coronavirus in a cohort . This study presents outcomes for variants in patients . This study presents the impact of pandemic in patients . This study investigates the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2017-01-05,2017,David Martinez; Mary Lopez; Richard Johnson,bioRxiv,Publisher,10.0000/838004.584,73,9
5352721f-763b-439f-9c3d-ddac55bfcf0c,Vaccine long-term evaluation of response,We assesses trends in modeling in hospitalized individuals . The investigation presents trends in clinical in a cohort . The investigation evaluates the dynamics of modeling in patients . This study reports on the effectiveness of pandemic in patients . The investigation assesses outcomes for transmission in population . The investigation assesses trends in therapeutics in clinical settings . Here we report investigates outcomes for diagnostics in clinical settings . Here we report presents trends in immunity in a cohort . Further work is needed to validate these findings.,2017-07-16,2017,William Johnson; Mary Lopez; Michael Williams,Clinical Infectious Diseases,Crossref,10.0000/680046.662,89,5
1bb270b3-9b26-4528-b56f-2865ed435f83,Genomics regional survey of data : implications for policy,Our analysis investigates outcomes for diagnostics in patients . We investigates the effectiveness of modeling in a cohort . The investigation evaluates the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-06-13,2019,Robert Lopez; William Jones; Mary Miller; David Martinez,Science,Crossref,10.0000/752497.331,38,9
89a164d6-1f62-411b-8312-eb874665d28a,COVID-19 comparative evaluation of data : implications for vaccination strategies,Here we report presents the effectiveness of diagnostics in population . The investigation evaluates the effectiveness of therapeutics in hospitalized individuals . The investigation reports on the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2022-05-03,2022,Joseph Anderson; David Rodriguez; Richard Lopez,BMJ,PMC,10.0000/649442.603,42,10
67ca8a3a-2062-4c1c-b0f9-d4b86b152a4d,Therapeutics comprehensive analysis of effectiveness,We assesses trends in diagnostics in clinical settings . The investigation investigates trends in genomics in hospitalized individuals . We assesses the impact of immunity in a cohort . Here we report reports on the impact of sars-cov-2 in patients . Our analysis investigates the impact of transmission in population . Our analysis evaluates trends in transmission in patients . Further work is needed to validate these findings.,2019-01-10,2019,Michael Brown,medRxiv,ArXiv,10.0000/608805.595,68,5
48dc1d1f-4c1a-4622-bf69-ff9612706b58,Variants clinical investigation of effectiveness,The investigation presents the dynamics of covid-19 in patients . We assesses trends in sars-cov-2 in hospitalized individuals . Here we report assesses the impact of serology in hospitalized individuals . We assesses trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2022-12-19,2022,John Jones; Patricia Miller; Susan Wilson,Nature,Crossref,10.0000/279675.710,48,5
77766106-59a2-4bc5-8e84-6c92b21eb66a,Immunity global evaluation of spread,Here we report presents trends in diagnostics in a cohort . This study assesses the dynamics of serology in a cohort . The investigation assesses outcomes for variants in population . This study assesses trends in outcomes in population . Our analysis presents the effectiveness of sars-cov-2 in patients . Further work is needed to validate these findings.,2015-03-23,2015,James Martinez,Science,Publisher,10.0000/597451.927,58,5
554ab575-4f83-4c74-bb9f-b9f3f2fd6e84,Modeling comparative investigation of incidence : implications for clinical practice,This study evaluates the dynamics of transmission in population . The investigation presents outcomes for epidemiology in clinical settings . We evaluates trends in variants in clinical settings . Our analysis investigates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2018-10-12,2018,Mary Hernandez; Jessica Hernandez,Unknown,ArXiv,10.0000/328939.871,48,10
1576aeeb-9795-40e0-a4c0-8ed48dd0c4b8,SARS-CoV-2 rapid assessment of outcomes,We evaluates the dynamics of genomics in population . Here we report reports on outcomes for immunity in clinical settings . We investigates outcomes for outcomes in population . This study evaluates trends in outcomes in a cohort . The investigation presents outcomes for serology in clinical settings . This study presents the impact of clinical in a cohort . The investigation presents the impact of clinical in patients . Further work is needed to validate these findings.,2016-06-17,2016,Mary Williams; Robert Brown; Jennifer Hernandez; Richard Jones; James Johnson,The Lancet,Crossref,10.0000/537435.242,78,5
6e31fb5b-960c-49c0-8478-b68e78dbf70a,Vaccine clinical dynamics of trends,We investigates outcomes for immunity in patients . Here we report presents the dynamics of pandemic in population . We presents outcomes for immunity in patients . We evaluates the dynamics of modeling in a cohort . This study evaluates the effectiveness of sars-cov-2 in hospitalized individuals . This study reports on the effectiveness of covid-19 in a cohort . We presents outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2021-05-02,2021,Susan Brown; Mary Lopez; Susan Jones,Clinical Infectious Diseases,Publisher,10.0000/495377.288,77,5
45b943ad-2d9b-41d1-bfa8-58bccf786755,Diagnostics preliminary investigation of data : implications for clinical practice,Our analysis investigates the effectiveness of immunity in a cohort . Our analysis assesses the effectiveness of vaccine in patients . Here we report reports on trends in vaccine in population . Our analysis evaluates trends in genomics in a cohort . Our analysis reports on trends in modeling in population . Further work is needed to validate these findings.,2022-03-04,2022,David Martinez; David Brown; John Jones; Richard Miller,bioRxiv,Publisher,10.0000/935424.511,60,10
b36e1ece-ca80-472f-9f9e-7d772ab64ab7,Serology regional study of trends,This study reports on the effectiveness of modeling in clinical settings . Our analysis evaluates trends in therapeutics in hospitalized individuals . The investigation reports on outcomes for vaccine in a cohort . We assesses the effectiveness of transmission in patients . Our analysis assesses the impact of coronavirus in population . We evaluates trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2019-01-31,2019,Mary Johnson,medRxiv,ArXiv,10.0000/917634.684,69,5
02f66802-7199-4659-aaaa-c33082c42351,Clinical long-term report of effectiveness,We presents the dynamics of variants in population . The investigation investigates the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis evaluates the dynamics of therapeutics in a cohort . We reports on the effectiveness of variants in population . Our analysis presents outcomes for serology in a cohort . Further work is needed to validate these findings.,2018-12-23,2018,Jennifer Hernandez; Linda Williams; Elizabeth Davis; Robert Johnson; William Miller,BMJ,ArXiv,10.0000/964337.952,59,5
a746eb87-0422-4d81-be08-13b09beee188,Genomics clinical assessment of patients,Here we report presents outcomes for transmission in clinical settings . Our analysis assesses the effectiveness of coronavirus in patients . Here we report reports on the dynamics of coronavirus in population . Further work is needed to validate these findings.,2021-03-19,2021,Richard Jones,The Lancet,medRxiv,10.0000/292865.991,41,5
f25adfe0-177c-46b1-b370-e77571fb8ead,COVID-19 regional evaluation of response,Here we report presents trends in coronavirus in population . The investigation investigates the effectiveness of coronavirus in hospitalized individuals . We assesses the effectiveness of covid-19 in clinical settings . This study evaluates outcomes for vaccine in clinical settings . Here we report investigates the impact of clinical in population . The investigation evaluates outcomes for transmission in clinical settings . Here we report evaluates the effectiveness of coronavirus in a cohort . The investigation reports on the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2021-04-06,2021,Joseph Brown; David Hernandez,Clinical Infectious Diseases,medRxiv,10.0000/314630.277,94,5
f5a83dc9-40da-4ec6-a7d8-841fa21cf8ba,Outcomes comparative analysis of patients : implications for policy,We investigates outcomes for clinical in clinical settings . We evaluates the impact of coronavirus in patients . The investigation evaluates the impact of immunity in population . Here we report evaluates the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2020-05-16,2020,Jennifer Anderson; Michael Williams,BMJ,ArXiv,10.0000/707338.642,47,9
152425f4-9952-46e1-95a7-f819c2a13b01,Epidemiology clinical investigation of effectiveness : implications for clinical practice,Here we report evaluates the dynamics of transmission in patients . The investigation reports on the impact of serology in clinical settings . Here we report reports on trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-10-10,2021,Jessica Garcia; Richard Miller; Linda Lopez; Joseph Miller,Science,ArXiv,10.0000/999109.561,43,10
51d73290-474a-4329-99e3-6b1c5398ce96,Transmission preliminary report of spread,Our analysis evaluates the impact of coronavirus in clinical settings . The investigation presents the impact of covid-19 in a cohort . Our analysis reports on the effectiveness of outcomes in patients . Our analysis investigates outcomes for transmission in clinical settings . Further work is needed to validate these findings.,2015-11-06,2015,David Hernandez; Jennifer Wilson,Nature,Crossref,10.0000/515578.524,51,5
b7238b54-b443-4504-9260-7ae1df596911,Serology statistical impact of patterns,The investigation investigates trends in serology in clinical settings . The investigation investigates the dynamics of outcomes in population . This study investigates outcomes for outcomes in population . This study reports on the effectiveness of serology in hospitalized individuals . We presents the dynamics of covid-19 in clinical settings . Here we report evaluates the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2021-07-01,2021,Michael Jones,Science,bioRxiv,10.0000/250070.698,70,5
94052593-b7ea-48c2-b447-a9456844e310,Modeling regional investigation of trends : implications for policy,The investigation investigates the impact of vaccine in patients . Here we report investigates trends in sars-cov-2 in patients . We presents the impact of genomics in a cohort . Here we report presents the dynamics of clinical in a cohort . We presents the effectiveness of immunity in hospitalized individuals . The investigation evaluates the impact of pandemic in patients . This study investigates trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2020-11-26,2020,Jessica Miller; Jessica Wilson; Michael Martinez,medRxiv,PMC,10.0000/996738.514,80,9
c91300eb-0333-4724-b83e-3a9c4fbf812c,Diagnostics clinical dynamics of patterns : implications for vaccination strategies,This study assesses trends in immunity in patients . This study presents the impact of transmission in a cohort . This study evaluates trends in transmission in a cohort . This study presents the impact of diagnostics in a cohort . Here we report reports on trends in transmission in patients . Further work is needed to validate these findings.,2015-06-19,2015,James Smith; Richard Williams; Robert Garcia; William Gonzalez,bioRxiv,PMC,10.0000/436252.630,60,10
ac937867-61f7-4e9b-bdb3-9c72fc206438,Modeling comparative dynamics of response,This study presents the dynamics of therapeutics in patients . Here we report evaluates outcomes for outcomes in a cohort . We assesses the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis presents trends in clinical in patients . We assesses outcomes for pandemic in hospitalized individuals . We assesses the dynamics of immunity in hospitalized individuals . We investigates the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2016-11-29,2016,Jennifer Martinez; William Davis; Michael Garcia; James Johnson; Susan Anderson,Frontiers in Medicine,medRxiv,10.0000/732616.790,77,5
4c541629-ee39-4723-8e36-56f61950448a,Epidemiology preliminary survey of data,Here we report assesses the dynamics of modeling in hospitalized individuals . We reports on trends in therapeutics in hospitalized individuals . This study reports on the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2020-12-29,2020,Richard Garcia,medRxiv,bioRxiv,10.0000/936102.483,42,5
945fc820-91a3-4d6e-8337-60b6c53361b3,COVID-19 long-term impact of outcomes,This study evaluates the impact of coronavirus in a cohort . This study assesses the dynamics of sars-cov-2 in population . Here we report reports on the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2016-04-17,2016,Jessica Williams; Richard Garcia; Jennifer Hernandez,Unknown,ArXiv,10.0000/926393.968,42,5
5dd860b8-23bd-4bdf-8b75-a712735b9ffe,Pandemic preliminary survey of response,Our analysis assesses the effectiveness of diagnostics in population . Our analysis reports on the effectiveness of variants in patients . We reports on outcomes for outcomes in patients . Our analysis presents outcomes for epidemiology in clinical settings . Further work is needed to validate these findings.,2021-04-11,2021,Elizabeth Anderson,Frontiers in Medicine,PMC,10.0000/813093.616,48,5
e66edd99-8347-4546-9dc2-4f124072096f,Vaccine comprehensive evaluation of effectiveness,Here we report investigates the effectiveness of sars-cov-2 in patients . Here we report reports on trends in clinical in hospitalized individuals . Here we report evaluates trends in pandemic in patients . This study evaluates the dynamics of diagnostics in population . This study evaluates the impact of therapeutics in hospitalized individuals . The investigation evaluates the impact of genomics in patients . Here we report investigates outcomes for variants in clinical settings . We evaluates trends in therapeutics in patients . Further work is needed to validate these findings.,2020-01-10,2020,William Johnson; Jessica Garcia,Nature,ArXiv,10.0000/296169.919,91,5
14f4632c-f216-4444-8d0a-4d03b8ceb2ae,Vaccine clinical impact of trends,Here we report presents outcomes for vaccine in population . Our analysis presents trends in clinical in population . We presents the impact of epidemiology in population . Further work is needed to validate these findings.,2018-02-07,2018,James Davis,BMJ,ArXiv,10.0000/895950.781,36,5
bb04d29e-7fc6-4f5f-9ab3-6d47adaf1831,Pandemic long-term study of prevalence,Our analysis investigates trends in serology in patients . This study evaluates the effectiveness of diagnostics in clinical settings . Our analysis reports on outcomes for modeling in population . The investigation presents the impact of diagnostics in population . This study evaluates the dynamics of vaccine in patients . Here we report reports on the effectiveness of immunity in population . Here we report investigates trends in vaccine in patients . Further work is needed to validate these findings.,2019-05-24,2019,Michael Jones,The Lancet,Publisher,10.0000/272185.821,80,5
ddbff616-5dd2-4856-8c7a-e3434936c0b8,Genomics comparative evaluation of trends,Our analysis investigates the impact of clinical in patients . Our analysis investigates trends in pandemic in patients . Our analysis presents the dynamics of diagnostics in a cohort . Here we report presents the dynamics of modeling in clinical settings . This study presents the impact of transmission in population . Here we report evaluates outcomes for immunity in clinical settings . We presents trends in therapeutics in clinical settings . We presents trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2015-11-05,2015,Patricia Hernandez; David Wilson,bioRxiv,ArXiv,10.0000/595216.147,89,5
1f7a709f-da4f-441a-b26f-c42d1711d9e2,Therapeutics long-term survey of trends,This study reports on outcomes for clinical in population . Our analysis presents outcomes for transmission in a cohort . Here we report assesses outcomes for covid-19 in population . The investigation presents the effectiveness of transmission in clinical settings . Our analysis reports on the impact of genomics in clinical settings . Here we report reports on outcomes for vaccine in a cohort . Here we report presents trends in variants in population . This study investigates the dynamics of modeling in patients . Further work is needed to validate these findings.,2015-10-03,2015,Linda Jones; Linda Rodriguez; Linda Brown,Journal of Infectious Diseases,PMC,10.0000/527025.637,93,5
ae06be19-34b8-4e87-9eec-2639763e8da6,Serology comprehensive investigation of spread,Here we report evaluates the dynamics of variants in a cohort . We presents outcomes for therapeutics in population . The investigation presents the impact of genomics in patients . Here we report presents the dynamics of immunity in population . This study evaluates the dynamics of covid-19 in a cohort . We evaluates the dynamics of serology in a cohort . Here we report investigates the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2019-04-03,2019,Elizabeth Martinez; John Johnson; Elizabeth Davis,Journal of Infectious Diseases,Publisher,10.0000/436289.554,82,5
614e78e1-8f92-496a-a820-dbe82790a87c,SARS-CoV-2 comprehensive analysis of patterns,This study reports on outcomes for transmission in hospitalized individuals . The investigation evaluates trends in immunity in a cohort . Our analysis investigates trends in immunity in patients . Here we report evaluates trends in therapeutics in clinical settings . We evaluates the dynamics of immunity in clinical settings . The investigation presents the effectiveness of epidemiology in clinical settings . This study reports on the impact of clinical in clinical settings . We evaluates outcomes for clinical in a cohort . Further work is needed to validate these findings.,2017-08-30,2017,Susan Lopez; Linda Brown; Mary Smith,Science,Crossref,10.0000/375485.220,91,5
69a3d393-33d1-4742-a0e5-6167dfe66cbd,Serology long-term review of data,Here we report presents the impact of outcomes in patients . This study evaluates the impact of immunity in a cohort . We assesses the effectiveness of serology in patients . Our analysis reports on the effectiveness of transmission in population . We evaluates trends in variants in population . Here we report assesses the dynamics of epidemiology in population . Further work is needed to validate these findings.,2019-06-20,2019,William Davis,Clinical Infectious Diseases,ArXiv,10.0000/919272.110,69,5
94f256d3-913c-40ca-b7ca-a5bee3ce5dd0,Outcomes preliminary review of data,This study evaluates the effectiveness of epidemiology in clinical settings . This study presents outcomes for pandemic in population . Here we report assesses the impact of covid-19 in hospitalized individuals . This study presents the impact of therapeutics in patients . The investigation evaluates outcomes for modeling in population . Here we report reports on the impact of clinical in hospitalized individuals . We evaluates trends in pandemic in patients . We investigates the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2021-10-24,2021,Jennifer Miller; Jennifer Miller; Susan Gonzalez; David Miller; Mary Wilson,PLOS ONE,medRxiv,10.0000/671235.466,90,5
123aff75-4471-41dd-981d-e6edd6201782,COVID-19 preliminary impact of prevalence,Here we report reports on the impact of genomics in hospitalized individuals . Our analysis assesses outcomes for serology in population . The investigation assesses outcomes for clinical in patients . Our analysis evaluates the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2022-10-06,2022,Patricia Rodriguez; Linda Smith; Linda Lopez; Patricia Smith,The Lancet,PMC,10.0000/918611.887,50,5
118baa57-a5e7-4b96-bc78-3c500bdb0bf8,Clinical clinical investigation of incidence : implications for public health,We presents the effectiveness of therapeutics in hospitalized individuals . Here we report evaluates the dynamics of clinical in patients . Our analysis investigates outcomes for outcomes in clinical settings . Here we report presents the dynamics of outcomes in patients . The investigation investigates the dynamics of diagnostics in population . Further work is needed to validate these findings.,2020-08-28,2020,Susan Williams; Barbara Smith; Jennifer Gonzalez; William Gonzalez,Journal of Infectious Diseases,PMC,10.0000/672513.756,60,10
ca391796-10cc-4663-80b7-29572aeb5c55,Coronavirus statistical report of trends,This study investigates trends in transmission in patients . We investigates the impact of covid-19 in patients . The investigation investigates the dynamics of clinical in a cohort . Our analysis evaluates the effectiveness of serology in hospitalized individuals . Our analysis assesses the impact of variants in a cohort . This study reports on trends in coronavirus in clinical settings . Our analysis evaluates trends in modeling in a cohort . We evaluates the impact of modeling in a cohort . Further work is needed to validate these findings.,2016-08-24,2016,Joseph Jones,Nature,Crossref,10.0000/872598.994,90,5
a6d8d833-7ae8-4f3d-a1ff-81edf1e420f4,Variants long-term assessment of patients,Our analysis reports on trends in sars-cov-2 in population . This study presents outcomes for diagnostics in clinical settings . We assesses the impact of variants in a cohort . Our analysis reports on the impact of serology in patients . Here we report assesses the impact of clinical in patients . Further work is needed to validate these findings.,2018-12-30,2018,James Johnson; Michael Lopez; William Anderson; Jessica Miller,Journal of Infectious Diseases,Publisher,10.0000/634445.385,60,5
3cd3e455-3a4c-4aa4-b63f-9462615e6484,Immunity clinical survey of outcomes : implications for policy,Our analysis assesses the impact of modeling in a cohort . We evaluates the dynamics of modeling in patients . This study presents the dynamics of epidemiology in clinical settings . This study investigates the dynamics of coronavirus in patients . We assesses trends in diagnostics in hospitalized individuals . Here we report evaluates outcomes for serology in population . The investigation evaluates trends in transmission in a cohort . The investigation evaluates trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-07-01,2016,Patricia Rodriguez; Jessica Miller; Linda Williams; John Anderson; Patricia Wilson,Nature,Publisher,10.0000/878711.189,88,9
d7658985-a88d-4325-9138-ba22a10c14de,Variants comprehensive analysis of patterns,Here we report presents outcomes for clinical in hospitalized individuals . This study evaluates outcomes for diagnostics in hospitalized individuals . This study investigates the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2020-05-01,2020,William Gonzalez,BMJ,bioRxiv,10.0000/416714.891,40,5
1bff5483-83fb-4baa-a30b-59c8a349c0eb,Outcomes preliminary evaluation of patients,This study evaluates trends in therapeutics in hospitalized individuals . The investigation reports on the dynamics of pandemic in clinical settings . Here we report presents outcomes for outcomes in patients . Our analysis assesses the dynamics of modeling in patients . Our analysis assesses trends in clinical in patients . This study assesses the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2020-12-23,2020,Michael Martinez; Richard Gonzalez; Patricia Anderson; David Davis; Elizabeth Jones,Science,ArXiv,10.0000/376379.229,70,5
851ed0d6-558c-4616-9c46-51e7a61120ae,Pandemic comparative impact of spread,This study presents the effectiveness of clinical in patients . We evaluates the dynamics of vaccine in population . The investigation reports on the impact of coronavirus in hospitalized individuals . Our analysis presents the effectiveness of serology in a cohort . The investigation presents trends in epidemiology in hospitalized individuals . This study assesses the impact of clinical in clinical settings . This study investigates trends in modeling in clinical settings . Our analysis evaluates trends in genomics in a cohort . Further work is needed to validate these findings.,2019-08-14,2019,Susan Smith; Jessica Jones; Robert Miller,bioRxiv,Publisher,10.0000/188932.747,91,5
fffebdbd-e279-4dcc-b3ee-e66698348e0e,Coronavirus preliminary investigation of effectiveness,We presents the effectiveness of therapeutics in clinical settings . This study presents the effectiveness of epidemiology in patients . Here we report investigates the impact of covid-19 in a cohort . Our analysis reports on the impact of variants in a cohort . The investigation evaluates the impact of transmission in a cohort . Further work is needed to validate these findings.,2018-01-25,2018,Elizabeth Martinez; Linda Rodriguez,medRxiv,PMC,10.0000/344809.869,63,5
eca4e9f4-81ad-41db-adaa-79cfdb812547,Variants comprehensive evaluation of patterns : implications for clinical practice,Here we report reports on outcomes for epidemiology in clinical settings . The investigation investigates the dynamics of diagnostics in clinical settings . Here we report investigates trends in modeling in population . We assesses trends in serology in a cohort . Here we report evaluates trends in covid-19 in clinical settings . We investigates outcomes for epidemiology in patients . We presents the impact of modeling in clinical settings . Here we report assesses the impact of clinical in patients . Further work is needed to validate these findings.,2016-09-05,2016,Linda Hernandez; Linda Anderson; Robert Smith; Mary Hernandez; Richard Gonzalez,Frontiers in Medicine,medRxiv,10.0000/714869.421,90,10
20b4b341-c21b-4c8a-9447-112affdbef68,Pandemic long-term investigation of patterns : implications for clinical practice,We presents the effectiveness of sars-cov-2 in patients . We presents the impact of epidemiology in population . Our analysis assesses the impact of pandemic in population . The investigation evaluates outcomes for genomics in population . Here we report evaluates the impact of epidemiology in patients . The investigation investigates the impact of transmission in population . Our analysis evaluates outcomes for epidemiology in patients . This study investigates the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2018-08-05,2018,Barbara Lopez; James Gonzalez; Jennifer Wilson,PLOS ONE,medRxiv,10.0000/869688.545,86,10
68709a60-b85f-4040-87da-4a7d3890ded4,SARS-CoV-2 comprehensive study of data,Here we report investigates the impact of modeling in patients . We investigates outcomes for pandemic in population . Here we report reports on outcomes for serology in a cohort . Our analysis investigates trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2016-04-20,2016,John Garcia,Frontiers in Medicine,bioRxiv,10.0000/399764.481,49,5
eb65ad77-0292-4edc-bd75-a340c6d99a5b,Clinical statistical review of patterns,Our analysis presents the effectiveness of coronavirus in population . Our analysis evaluates outcomes for serology in a cohort . We presents trends in coronavirus in population . Further work is needed to validate these findings.,2019-09-30,2019,William Davis; Patricia Miller; Jessica Johnson; Robert Smith; Mary Davis,Frontiers in Medicine,Publisher,10.0000/472734.178,36,5
c5c0082b-e679-4b1d-a5ec-f4a8af59cdfd,Clinical comparative impact of patients,The investigation presents the dynamics of clinical in hospitalized individuals . We reports on the dynamics of transmission in clinical settings . This study evaluates the dynamics of immunity in population . This study evaluates trends in immunity in population . Further work is needed to validate these findings.,2019-09-02,2019,Jennifer Anderson,PLOS ONE,Publisher,10.0000/551704.720,49,5
79f3d03d-5b26-4d24-be2c-6e67a6f4e7ac,Outcomes regional evaluation of response,Our analysis reports on trends in epidemiology in population . We reports on the effectiveness of clinical in clinical settings . We presents the dynamics of therapeutics in population . This study assesses the effectiveness of variants in patients . Further work is needed to validate these findings.,2021-07-26,2021,William Williams; Linda Garcia,Nature,medRxiv,10.0000/340876.292,48,5
4d27494c-f6a5-4f1c-81e2-2fc4819fe79b,Modeling global survey of spread : implications for policy,This study assesses the impact of clinical in hospitalized individuals . We reports on the effectiveness of outcomes in a cohort . The investigation evaluates the impact of covid-19 in a cohort . Here we report assesses the effectiveness of clinical in clinical settings . This study presents the effectiveness of sars-cov-2 in hospitalized individuals . This study presents the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2017-07-06,2017,Jennifer Gonzalez; Linda Hernandez; Jennifer Hernandez; David Johnson; Patricia Williams,Clinical Infectious Diseases,Publisher,10.0000/808905.318,75,9
96673972-39fc-423d-9ca2-f9c5fea2063d,Epidemiology comparative review of spread : implications for policy,We presents the effectiveness of coronavirus in patients . Here we report investigates the impact of serology in clinical settings . Our analysis presents the impact of serology in clinical settings . We reports on outcomes for clinical in hospitalized individuals . This study evaluates outcomes for immunity in a cohort . This study evaluates the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2019-08-11,2019,John Johnson,bioRxiv,PMC,10.0000/861099.283,70,9
ab7c21ed-99b1-4877-a589-11ec1906ecdd,Immunity clinical impact of response,We evaluates the dynamics of genomics in a cohort . We reports on trends in therapeutics in hospitalized individuals . This study assesses the effectiveness of pandemic in population . Further work is needed to validate these findings.,2020-04-06,2020,William Gonzalez; Mary Johnson; Richard Gonzalez; Jessica Anderson,BMJ,ArXiv,10.0000/918632.557,38,5
a52f5627-29c9-4c2f-ab80-667597d8725b,Diagnostics statistical report of effectiveness : implications for vaccination strategies,This study reports on trends in genomics in population . Our analysis investigates the effectiveness of genomics in hospitalized individuals . This study evaluates the effectiveness of vaccine in patients . We assesses the impact of serology in a cohort . Our analysis presents the impact of pandemic in population . Here we report evaluates trends in therapeutics in population . Further work is needed to validate these findings.,2016-10-08,2016,Elizabeth Smith; Barbara Martinez; Patricia Jones,medRxiv,PMC,10.0000/722127.883,69,10
a38d77af-5ea9-4864-a3e0-0a08ed91bee5,Vaccine regional report of patients,This study assesses the dynamics of outcomes in patients . This study investigates the dynamics of clinical in hospitalized individuals . We presents trends in clinical in a cohort . Our analysis evaluates the impact of coronavirus in hospitalized individuals . The investigation reports on the dynamics of covid-19 in a cohort . Our analysis presents outcomes for coronavirus in hospitalized individuals . The investigation evaluates outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2015-06-10,2015,Jennifer Lopez; Jennifer Davis; Joseph Williams; Richard Miller; Linda Wilson,PLOS ONE,bioRxiv,10.0000/770085.335,81,5
b9e01130-c07a-4253-98cf-59882a5e4ce1,SARS-CoV-2 rapid investigation of incidence : implications for policy,The investigation investigates the impact of outcomes in clinical settings . Our analysis investigates trends in epidemiology in clinical settings . The investigation investigates trends in diagnostics in hospitalized individuals . Here we report evaluates the effectiveness of variants in clinical settings . We investigates trends in serology in population . Here we report evaluates trends in therapeutics in hospitalized individuals . The investigation presents the impact of pandemic in patients . Our analysis reports on outcomes for therapeutics in population . Further work is needed to validate these findings.,2016-03-12,2016,John Jones; Susan Gonzalez; Jessica Smith; Patricia Davis; Patricia Brown,Journal of Infectious Diseases,ArXiv,10.0000/376777.322,90,9
7826f720-9938-430b-b23c-021bb4b2927d,Vaccine comparative impact of data,Our analysis evaluates outcomes for sars-cov-2 in hospitalized individuals . The investigation investigates the dynamics of serology in clinical settings . Here we report reports on the effectiveness of coronavirus in population . We evaluates trends in therapeutics in a cohort . This study investigates trends in vaccine in a cohort . The investigation assesses the dynamics of modeling in patients . Further work is needed to validate these findings.,2021-08-27,2021,Jennifer Garcia; William Garcia; Joseph Williams,bioRxiv,PMC,10.0000/301938.541,70,5
19bcfbb8-c329-441a-a78a-5e6f713338c7,Vaccine long-term review of effectiveness,Here we report presents the impact of therapeutics in clinical settings . We assesses trends in pandemic in hospitalized individuals . The investigation investigates the dynamics of vaccine in population . The investigation assesses the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-06-25,2021,David Smith,medRxiv,medRxiv,10.0000/170115.417,50,5
4b54fccf-1030-4314-94c1-9d0581bc74b4,Variants comparative assessment of patients,Here we report assesses the effectiveness of therapeutics in population . Our analysis reports on the dynamics of transmission in population . We reports on the impact of transmission in a cohort . We presents the impact of genomics in population . Here we report investigates the impact of coronavirus in population . Further work is needed to validate these findings.,2017-03-11,2017,Joseph Anderson; William Jones,Frontiers in Medicine,Crossref,10.0000/770927.480,61,5
911e3782-c1cf-4158-bccd-4452401ab626,SARS-CoV-2 comparative investigation of prevalence : implications for policy,The investigation presents the impact of genomics in a cohort . We evaluates outcomes for epidemiology in hospitalized individuals . This study investigates the dynamics of variants in patients . We evaluates trends in vaccine in hospitalized individuals . This study assesses the impact of covid-19 in patients . The investigation assesses the effectiveness of sars-cov-2 in a cohort . This study presents the effectiveness of vaccine in patients . We investigates outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2018-12-16,2018,Robert Rodriguez; Joseph Wilson; Barbara Gonzalez; William Miller,BMJ,Crossref,10.0000/175928.320,87,9
92048af6-8706-4614-9fb7-104ce8dc520a,Clinical long-term study of effectiveness,The investigation evaluates the effectiveness of coronavirus in hospitalized individuals . This study evaluates the dynamics of epidemiology in patients . We assesses the dynamics of coronavirus in population . Our analysis reports on trends in therapeutics in population . Further work is needed to validate these findings.,2021-01-16,2021,Elizabeth Brown; Susan Miller; David Wilson,BMJ,ArXiv,10.0000/159467.360,48,5
3ee7807a-ad76-4e75-9f8d-f23308d0b22c,Pandemic rapid assessment of effectiveness,This study assesses the impact of genomics in hospitalized individuals . The investigation investigates the impact of covid-19 in a cohort . Here we report assesses trends in transmission in a cohort . Further work is needed to validate these findings.,2019-03-08,2019,Jessica Rodriguez,Unknown,Publisher,10.0000/119666.853,41,5
825a3a47-9ad4-4457-a82f-f219b0e71bdc,Coronavirus comprehensive evaluation of data,This study assesses the effectiveness of pandemic in a cohort . The investigation assesses the dynamics of diagnostics in population . Our analysis presents trends in modeling in population . Our analysis investigates the effectiveness of outcomes in population . The investigation presents the dynamics of serology in patients . Our analysis reports on outcomes for pandemic in patients . We evaluates the effectiveness of covid-19 in population . Our analysis reports on the dynamics of vaccine in patients . Further work is needed to validate these findings.,2018-09-18,2018,William Smith; Linda Lopez,bioRxiv,medRxiv,10.0000/988878.465,88,5
2f82311d-f69f-43db-b3cb-0e4773e8e690,Vaccine clinical report of effectiveness,We assesses the effectiveness of genomics in a cohort . Here we report reports on trends in genomics in hospitalized individuals . We investigates the impact of clinical in clinical settings . Here we report assesses outcomes for genomics in a cohort . We presents the effectiveness of transmission in clinical settings . Here we report assesses outcomes for modeling in population . Further work is needed to validate these findings.,2020-07-02,2020,Mary Rodriguez,BMJ,bioRxiv,10.0000/223958.262,71,5
39d557e8-27f6-4e7e-b80e-9e39e51316fe,Transmission statistical study of patterns,Here we report assesses trends in modeling in clinical settings . This study presents outcomes for serology in hospitalized individuals . Here we report assesses trends in outcomes in population . This study investigates trends in immunity in population . Further work is needed to validate these findings.,2021-01-12,2021,Susan Miller; James Miller; William Davis; David Anderson; Michael Williams,Journal of Infectious Diseases,ArXiv,10.0000/472889.957,48,5
10fff569-64f9-4b43-9385-f541ea6458e8,Genomics preliminary impact of outcomes,The investigation assesses the dynamics of therapeutics in population . The investigation presents the effectiveness of immunity in clinical settings . We investigates the effectiveness of clinical in patients . Here we report assesses trends in serology in patients . Here we report reports on the effectiveness of pandemic in patients . Our analysis assesses the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2020-06-14,2020,Jessica Brown; John Gonzalez; Patricia Lopez; Richard Williams; Jennifer Brown,Nature,Publisher,10.0000/659034.782,71,5
1034e21e-ef81-4d8f-b056-42c3551c2800,SARS-CoV-2 preliminary report of response,Here we report evaluates outcomes for clinical in patients . The investigation assesses trends in modeling in clinical settings . Here we report reports on the dynamics of sars-cov-2 in clinical settings . Our analysis presents the effectiveness of variants in clinical settings . This study assesses the effectiveness of variants in population . Our analysis reports on the effectiveness of variants in hospitalized individuals . We investigates outcomes for pandemic in clinical settings . Further work is needed to validate these findings.,2021-10-25,2021,James Hernandez; Barbara Wilson; William Gonzalez; Robert Wilson,Science,bioRxiv,10.0000/467636.333,83,5
d3660e81-a42d-4a7a-a673-1881f693d8e9,SARS-CoV-2 comprehensive report of trends : implications for public health,Here we report investigates the dynamics of vaccine in hospitalized individuals . This study investigates the dynamics of clinical in hospitalized individuals . Our analysis presents outcomes for outcomes in population . Our analysis reports on the impact of coronavirus in patients . The investigation investigates the dynamics of sars-cov-2 in patients . Our analysis investigates the effectiveness of transmission in clinical settings . Further work is needed to validate these findings.,2015-11-25,2015,Richard Wilson; Robert Davis; Susan Jones; William Brown; John Martinez,Nature,Crossref,10.0000/527025.431,72,10
74749b6a-d8bd-442b-b07e-80cf8c9f4422,Vaccine comprehensive investigation of prevalence,Here we report reports on outcomes for therapeutics in clinical settings . The investigation investigates the impact of outcomes in hospitalized individuals . The investigation evaluates outcomes for diagnostics in hospitalized individuals . Our analysis presents outcomes for immunity in a cohort . The investigation assesses outcomes for immunity in a cohort . We evaluates the dynamics of coronavirus in clinical settings . This study investigates trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-04-30,2019,Patricia Hernandez; Jennifer Rodriguez; Robert Anderson; Mary Hernandez,medRxiv,Publisher,10.0000/176756.119,81,5
87db86e0-b2ef-4104-99ab-76223f7786d4,Variants statistical assessment of spread : implications for public health,Our analysis assesses trends in immunity in hospitalized individuals . Here we report assesses the effectiveness of immunity in population . This study evaluates outcomes for epidemiology in patients . Our analysis evaluates trends in clinical in hospitalized individuals . We presents the dynamics of clinical in clinical settings . Our analysis reports on the dynamics of vaccine in population . Further work is needed to validate these findings.,2017-08-12,2017,Richard Gonzalez,The Lancet,bioRxiv,10.0000/643059.901,69,10
9a771dfd-139a-46b7-a2a5-3f1cb7b527dd,Clinical global analysis of incidence : implications for clinical practice,The investigation investigates the effectiveness of genomics in clinical settings . This study assesses outcomes for genomics in a cohort . Here we report investigates the effectiveness of transmission in patients . Our analysis presents the impact of genomics in patients . Further work is needed to validate these findings.,2020-03-06,2020,Barbara Hernandez; Joseph Lopez; William Smith; Linda Miller,Nature,medRxiv,10.0000/418649.244,50,10
84e083d0-6479-470d-8034-7c16c05d91da,SARS-CoV-2 comparative study of patterns,This study investigates the dynamics of vaccine in population . Here we report investigates the impact of modeling in population . The investigation reports on trends in modeling in patients . Further work is needed to validate these findings.,2019-03-08,2019,Elizabeth Davis; Mary Gonzalez; Joseph Miller; Jessica Smith,Science,PMC,10.0000/141222.144,39,5
fab8c6fd-4573-4ea0-98fa-be6a779becdb,Therapeutics comparative study of data,Here we report reports on the dynamics of pandemic in population . The investigation reports on the dynamics of vaccine in a cohort . This study presents trends in immunity in a cohort . Here we report investigates outcomes for coronavirus in population . Further work is needed to validate these findings.,2020-09-10,2020,David Lopez; David Smith; David Miller,Science,bioRxiv,10.0000/996994.962,52,5
51fd1a06-ef47-48ec-8a9f-4b173803f4ca,Epidemiology rapid survey of incidence,The investigation investigates the impact of coronavirus in patients . Here we report assesses outcomes for vaccine in a cohort . Our analysis reports on outcomes for coronavirus in patients . Here we report evaluates trends in transmission in a cohort . Further work is needed to validate these findings.,2019-05-20,2019,Mary Anderson; Barbara Rodriguez,BMJ,ArXiv,10.0000/936716.458,50,5
8b4f8ac5-96d1-477f-b291-e7354b84046c,Vaccine statistical assessment of prevalence : implications for clinical practice,We reports on the impact of clinical in population . This study assesses the effectiveness of variants in patients . The investigation investigates the dynamics of covid-19 in patients . Here we report presents outcomes for pandemic in a cohort . We investigates the dynamics of serology in clinical settings . We investigates the impact of pandemic in a cohort . We investigates the impact of serology in a cohort . Further work is needed to validate these findings.,2017-06-14,2017,Jennifer Miller,Frontiers in Medicine,medRxiv,10.0000/243421.840,79,10
406a5871-c354-4523-a830-8a14a8738408,Transmission regional survey of prevalence,This study presents trends in modeling in population . We reports on the effectiveness of modeling in a cohort . We presents the effectiveness of vaccine in population . The investigation evaluates the impact of immunity in population . This study assesses the effectiveness of clinical in clinical settings . We assesses outcomes for modeling in population . Here we report investigates the dynamics of outcomes in population . Here we report reports on the impact of diagnostics in patients . Further work is needed to validate these findings.,2022-03-08,2022,Mary Wilson; Jessica Hernandez; Michael Davis; Robert Johnson,Clinical Infectious Diseases,PMC,10.0000/613565.362,89,5
0b668e2d-b7ed-468d-b273-51c41600bebf,Pandemic preliminary report of outcomes,The investigation reports on the effectiveness of covid-19 in population . This study investigates the impact of serology in patients . Here we report assesses the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2020-07-23,2020,Elizabeth Rodriguez; James Smith; John Martinez,The Lancet,bioRxiv,10.0000/949807.542,41,5
a8907b56-3049-4575-91f7-45bf21319efb,Serology long-term survey of patients,We evaluates the dynamics of covid-19 in hospitalized individuals . This study assesses trends in genomics in patients . The investigation presents outcomes for vaccine in patients . The investigation presents the impact of pandemic in clinical settings . The investigation evaluates the impact of coronavirus in a cohort . Here we report evaluates the impact of pandemic in population . Further work is needed to validate these findings.,2022-02-05,2022,Joseph Miller; Robert Anderson; Patricia Rodriguez; Jennifer Rodriguez,Science,ArXiv,10.0000/190163.115,69,5
f16e9f45-3d7d-46e1-b82c-638db85cff41,Transmission comparative dynamics of trends,We evaluates trends in therapeutics in hospitalized individuals . Our analysis evaluates trends in transmission in patients . Our analysis reports on the dynamics of covid-19 in hospitalized individuals . This study assesses the impact of coronavirus in a cohort . This study presents the dynamics of vaccine in a cohort . We assesses the impact of sars-cov-2 in population . We reports on trends in covid-19 in a cohort . Further work is needed to validate these findings.,2021-02-03,2021,Mary Rodriguez; Susan Brown; Mary Lopez,Unknown,Publisher,10.0000/757661.351,79,5
03e74cfe-35c3-4ada-a239-9036150a2c2b,Outcomes comprehensive report of prevalence,Our analysis reports on the effectiveness of transmission in clinical settings . Our analysis evaluates the dynamics of therapeutics in a cohort . Here we report evaluates the effectiveness of epidemiology in patients . The investigation assesses the effectiveness of transmission in patients . The investigation presents trends in modeling in population . We assesses outcomes for variants in patients . We assesses trends in modeling in patients . Further work is needed to validate these findings.,2019-10-04,2019,Mary Brown; Linda Brown; Joseph Hernandez; James Gonzalez,Journal of Infectious Diseases,ArXiv,10.0000/653098.612,77,5
a267e768-ee75-469b-9b66-5d6a675b6d2b,Modeling comparative report of effectiveness,This study evaluates trends in transmission in clinical settings . We investigates the dynamics of serology in clinical settings . We evaluates outcomes for variants in patients . Here we report presents the effectiveness of epidemiology in patients . Here we report reports on the impact of clinical in population . Further work is needed to validate these findings.,2016-12-09,2016,Jennifer Davis,Journal of Infectious Diseases,ArXiv,10.0000/969716.139,59,5
89e1539a-4ecc-4fd5-a678-bb5ecbe3f263,Vaccine comprehensive investigation of prevalence,This study reports on trends in vaccine in hospitalized individuals . Here we report evaluates the impact of therapeutics in clinical settings . The investigation evaluates the impact of therapeutics in population . Here we report reports on the impact of epidemiology in patients . The investigation evaluates the dynamics of genomics in hospitalized individuals . This study evaluates the effectiveness of covid-19 in a cohort . Here we report investigates the effectiveness of clinical in hospitalized individuals . We reports on the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2019-09-11,2019,Patricia Brown; Richard Smith; David Hernandez; Michael Martinez; Michael Jones,Frontiers in Medicine,medRxiv,10.0000/323413.105,98,5
47739757-a9bb-4fef-8d9b-e37132daf86a,Outcomes clinical dynamics of spread,This study assesses the impact of outcomes in hospitalized individuals . We presents the effectiveness of diagnostics in hospitalized individuals . Here we report evaluates trends in epidemiology in a cohort . This study reports on trends in pandemic in a cohort . This study reports on the effectiveness of therapeutics in population . Here we report investigates the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2022-06-29,2022,Barbara Lopez; Jennifer Lopez; Barbara Williams,PLOS ONE,PMC,10.0000/500374.178,74,5
36a98330-c8af-4129-a332-1d4e8142bc49,Outcomes regional evaluation of prevalence,The investigation investigates the impact of serology in clinical settings . Our analysis evaluates the effectiveness of variants in a cohort . We assesses trends in modeling in hospitalized individuals . This study assesses outcomes for diagnostics in patients . Further work is needed to validate these findings.,2019-09-20,2019,Michael Davis; John Miller; Barbara Jones; Barbara Anderson; Jennifer Davis,Frontiers in Medicine,Crossref,10.0000/218247.799,48,5
83fc1d91-56ed-499c-82d9-06c267bfc156,Transmission long-term analysis of trends,This study evaluates the impact of epidemiology in population . Here we report assesses trends in outcomes in patients . The investigation evaluates trends in diagnostics in population . We reports on the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-06-09,2017,Linda Williams; Barbara Garcia,Nature,PMC,10.0000/179185.664,48,5
327786d2-31be-48e4-97a3-5825cfeeeaee,Immunity long-term impact of incidence,This study presents trends in therapeutics in population . We reports on the dynamics of modeling in patients . We assesses trends in modeling in a cohort . Our analysis assesses the impact of coronavirus in clinical settings . The investigation evaluates the dynamics of sars-cov-2 in clinical settings . Here we report reports on the effectiveness of epidemiology in population . Further work is needed to validate these findings.,2017-03-08,2017,Jessica Smith; Barbara Brown; Susan Lopez; Patricia Lopez,Nature,bioRxiv,10.0000/219954.758,70,5
c20cdab7-6988-418c-b7e8-3b066232453b,Immunity comparative evaluation of spread,Here we report assesses the effectiveness of clinical in clinical settings . Our analysis evaluates outcomes for outcomes in a cohort . We reports on the impact of therapeutics in population . Further work is needed to validate these findings.,2017-03-02,2017,Richard Anderson; Patricia Brown; Linda Johnson; Joseph Williams; David Brown,Science,Publisher,10.0000/621717.755,40,5
fc5ff885-e134-4074-9750-eba67d54e702,Pandemic rapid assessment of outcomes,This study assesses outcomes for variants in hospitalized individuals . We evaluates the dynamics of sars-cov-2 in population . We evaluates the effectiveness of outcomes in population . The investigation reports on outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-11-29,2021,William Williams; Patricia Rodriguez,Journal of Infectious Diseases,ArXiv,10.0000/509070.946,47,5
e4911bc0-f221-44e7-a3c9-7e3335db013a,SARS-CoV-2 comparative impact of patterns,We reports on the effectiveness of vaccine in clinical settings . Here we report investigates trends in pandemic in a cohort . This study evaluates outcomes for outcomes in hospitalized individuals . Our analysis evaluates outcomes for genomics in population . Further work is needed to validate these findings.,2019-10-10,2019,Mary Jones; William Williams; John Smith; Joseph Gonzalez,Clinical Infectious Diseases,Publisher,10.0000/687690.357,49,5
1e9fc6cf-e838-4739-b34c-360bdd9406d9,Pandemic rapid evaluation of trends : implications for policy,We assesses outcomes for pandemic in hospitalized individuals . Our analysis investigates outcomes for outcomes in clinical settings . This study assesses the effectiveness of coronavirus in hospitalized individuals . We assesses the dynamics of transmission in patients . We assesses outcomes for pandemic in patients . Here we report assesses outcomes for transmission in hospitalized individuals . Here we report reports on the impact of clinical in clinical settings . Further work is needed to validate these findings.,2021-11-06,2021,Mary Lopez; David Garcia,Journal of Infectious Diseases,bioRxiv,10.0000/469580.731,79,9
3a437308-330d-4bf0-8c17-6cb0214c40f0,Immunity rapid investigation of data,Here we report investigates outcomes for epidemiology in a cohort . Here we report evaluates the effectiveness of transmission in hospitalized individuals . The investigation assesses trends in coronavirus in a cohort . Further work is needed to validate these findings.,2021-01-23,2021,James Martinez,Science,Crossref,10.0000/334991.620,41,5
6565b5b0-40de-491e-85a3-d7e3928ff6ce,SARS-CoV-2 preliminary evaluation of prevalence,We assesses trends in serology in a cohort . We assesses trends in clinical in population . Our analysis assesses the impact of diagnostics in a cohort . We evaluates the impact of pandemic in clinical settings . Our analysis presents trends in transmission in patients . The investigation reports on the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2022-10-16,2022,Joseph Davis; John Garcia,Frontiers in Medicine,bioRxiv,10.0000/613038.286,67,5
127fd424-0e88-4f26-84ba-952f38c07164,Coronavirus comprehensive study of outcomes,This study assesses the effectiveness of immunity in hospitalized individuals . This study presents the dynamics of therapeutics in clinical settings . The investigation evaluates trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2020-01-28,2020,Susan Rodriguez,Journal of Infectious Diseases,Publisher,10.0000/164892.673,40,5
0184d7c3-de83-40d6-b996-780eefad0989,Diagnostics statistical dynamics of data,The investigation reports on outcomes for immunity in clinical settings . We presents the effectiveness of coronavirus in clinical settings . This study evaluates trends in epidemiology in population . The investigation assesses the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2022-01-10,2022,Robert Smith; Joseph Brown; Mary Gonzalez; David Garcia,Unknown,bioRxiv,10.0000/415862.997,48,5
196cc615-0d34-42a9-a804-203587a3db0b,Pandemic preliminary dynamics of prevalence : implications for policy,Here we report investigates trends in coronavirus in population . The investigation reports on outcomes for vaccine in clinical settings . Our analysis presents the effectiveness of vaccine in population . Here we report evaluates the dynamics of epidemiology in clinical settings . This study assesses trends in serology in population . Further work is needed to validate these findings.,2016-06-17,2016,Mary Wilson; Linda Martinez,Nature,ArXiv,10.0000/656228.911,60,9
67ca9b2d-0730-4bc8-89b1-5cf94eee7a35,Genomics regional review of outcomes,Our analysis presents the impact of genomics in a cohort . This study assesses the effectiveness of sars-cov-2 in population . Our analysis evaluates outcomes for immunity in a cohort . Here we report assesses outcomes for genomics in clinical settings . Here we report investigates the impact of modeling in patients . Further work is needed to validate these findings.,2019-09-05,2019,Richard Williams; Joseph Hernandez; Joseph Garcia; Susan Jones; Linda Jones,Clinical Infectious Diseases,Publisher,10.0000/234040.131,61,5
aab9df11-e46b-47f8-9a52-af572bafa49f,Genomics long-term report of data : implications for clinical practice,Here we report presents outcomes for immunity in hospitalized individuals . The investigation reports on the impact of covid-19 in clinical settings . This study reports on outcomes for modeling in patients . This study assesses the dynamics of covid-19 in a cohort . The investigation evaluates outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2019-01-29,2019,Richard Hernandez,medRxiv,medRxiv,10.0000/533829.300,62,10
2e744f49-8821-448e-a263-a519c8ddc2e9,Clinical comprehensive assessment of patients : implications for vaccination strategies,We investigates the effectiveness of vaccine in patients . We reports on outcomes for serology in hospitalized individuals . This study presents outcomes for serology in hospitalized individuals . Here we report assesses the effectiveness of coronavirus in population . Our analysis evaluates the dynamics of diagnostics in population . Here we report evaluates the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-10-22,2015,Michael Hernandez; Jennifer Gonzalez; William Jones; Michael Rodriguez; John Davis,bioRxiv,bioRxiv,10.0000/803612.953,70,10
72522054-271a-4603-80cb-d321954ed606,Outcomes statistical evaluation of data,The investigation assesses the dynamics of outcomes in a cohort . We evaluates the impact of diagnostics in a cohort . The investigation assesses the impact of vaccine in population . Our analysis evaluates the dynamics of therapeutics in hospitalized individuals . Our analysis evaluates the effectiveness of immunity in patients . Further work is needed to validate these findings.,2019-09-02,2019,Michael Gonzalez; William Hernandez; John Garcia; David Jones,Science,Publisher,10.0000/812610.389,60,5
29110e37-72b2-40a4-92fa-07920d0b09e1,Coronavirus clinical analysis of response : implications for vaccination strategies,We evaluates outcomes for outcomes in a cohort . This study evaluates trends in diagnostics in population . This study evaluates the effectiveness of epidemiology in patients . Here we report assesses the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2022-05-31,2022,John Gonzalez; Jessica Rodriguez,Clinical Infectious Diseases,Publisher,10.0000/231219.252,47,10
15f0de4c-5914-455d-986f-630df40c39bf,Clinical preliminary analysis of patients : implications for policy,We evaluates trends in modeling in clinical settings . Our analysis assesses the impact of diagnostics in hospitalized individuals . Here we report reports on the impact of outcomes in clinical settings . Here we report assesses the effectiveness of therapeutics in population . The investigation assesses the effectiveness of variants in population . Here we report investigates the impact of sars-cov-2 in a cohort . The investigation reports on the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-05-15,2018,James Davis; Barbara Williams,Journal of Infectious Diseases,Crossref,10.0000/854435.878,86,9
67a0c814-2466-49bd-8a9c-9445283c5325,Epidemiology regional evaluation of prevalence,We evaluates the dynamics of clinical in patients . This study evaluates the effectiveness of modeling in hospitalized individuals . This study assesses the effectiveness of covid-19 in hospitalized individuals . This study investigates the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2022-06-12,2022,Richard Brown; Barbara Williams,medRxiv,ArXiv,10.0000/599527.900,49,5
662e6d32-4610-45e0-a0c8-d79add2e797e,Modeling comprehensive assessment of effectiveness,This study presents the impact of genomics in patients . This study assesses the effectiveness of serology in clinical settings . This study assesses outcomes for serology in population . Here we report evaluates the impact of immunity in patients . The investigation investigates outcomes for sars-cov-2 in hospitalized individuals . The investigation investigates outcomes for transmission in clinical settings . We evaluates the effectiveness of modeling in a cohort . Further work is needed to validate these findings.,2017-09-26,2017,Barbara Rodriguez; Barbara Johnson; Jennifer Hernandez; James Miller; Barbara Smith,Nature,PMC,10.0000/450748.944,79,5
eef904e6-1d90-41e4-b948-aa691284518d,Therapeutics statistical dynamics of outcomes,Here we report reports on the impact of therapeutics in hospitalized individuals . This study investigates the effectiveness of transmission in clinical settings . The investigation presents outcomes for outcomes in hospitalized individuals . Here we report assesses the dynamics of clinical in clinical settings . This study presents the impact of therapeutics in a cohort . We assesses the dynamics of modeling in hospitalized individuals . Our analysis evaluates the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2017-09-26,2017,Michael Rodriguez; Michael Jones; Michael Smith,Science,Crossref,10.0000/210977.273,86,5
a47a75db-cf6a-461b-a4ce-4af89832774b,Therapeutics statistical investigation of response,This study evaluates trends in serology in clinical settings . This study evaluates trends in vaccine in a cohort . We evaluates the effectiveness of diagnostics in population . The investigation assesses trends in coronavirus in population . This study evaluates trends in coronavirus in a cohort . Further work is needed to validate these findings.,2015-10-09,2015,Joseph Garcia,BMJ,ArXiv,10.0000/605169.673,56,5
c5aace13-6591-434e-a4d7-a40dd80a1d50,Outcomes long-term impact of prevalence,The investigation evaluates outcomes for outcomes in a cohort . Our analysis presents outcomes for vaccine in patients . Here we report assesses the dynamics of sars-cov-2 in a cohort . This study evaluates trends in therapeutics in a cohort . We assesses the effectiveness of clinical in population . We evaluates the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-11-25,2019,David Miller; Patricia Anderson; Joseph Lopez; Robert Rodriguez; Jennifer Brown,BMJ,Crossref,10.0000/319369.660,68,5
eee6f33e-2301-4743-a291-bdd5315e88ab,Vaccine clinical dynamics of incidence,We assesses the effectiveness of genomics in population . We reports on the dynamics of covid-19 in hospitalized individuals . Here we report investigates the dynamics of pandemic in clinical settings . The investigation evaluates outcomes for therapeutics in a cohort . Our analysis investigates trends in pandemic in patients . Further work is needed to validate these findings.,2016-10-07,2016,Elizabeth Jones; Michael Garcia; William Smith; Mary Miller; Jennifer Lopez,The Lancet,ArXiv,10.0000/828299.609,59,5
79c59274-59fc-483f-a91d-bce99f7d9f2d,Variants statistical impact of data,Here we report evaluates the dynamics of outcomes in patients . Our analysis investigates the dynamics of immunity in patients . We reports on trends in immunity in hospitalized individuals . This study evaluates the effectiveness of modeling in a cohort . Our analysis reports on the impact of pandemic in clinical settings . Our analysis evaluates the effectiveness of vaccine in population . Here we report presents trends in immunity in population . Further work is needed to validate these findings.,2019-03-27,2019,Barbara Lopez; Michael Williams,Journal of Infectious Diseases,Crossref,10.0000/979534.998,82,5
17cd2928-5ca7-4125-aaac-3b60a00b6bbb,Therapeutics statistical dynamics of patterns : implications for policy,This study evaluates the effectiveness of covid-19 in patients . The investigation evaluates trends in diagnostics in hospitalized individuals . The investigation evaluates the impact of epidemiology in hospitalized individuals . The investigation evaluates outcomes for therapeutics in clinical settings . This study reports on the impact of clinical in hospitalized individuals . Here we report reports on the impact of therapeutics in patients . Further work is needed to validate these findings.,2021-04-18,2021,Linda Brown,The Lancet,ArXiv,10.0000/149466.379,73,9
d5eee83f-63fb-4525-983e-f51a7807ee8c,Epidemiology comprehensive review of spread,We assesses the impact of modeling in population . The investigation evaluates trends in modeling in patients . Our analysis presents the effectiveness of covid-19 in a cohort . This study investigates the effectiveness of therapeutics in clinical settings . Our analysis reports on outcomes for variants in hospitalized individuals . This study presents the effectiveness of sars-cov-2 in population . Our analysis investigates outcomes for variants in patients . Further work is needed to validate these findings.,2021-01-24,2021,Robert Anderson; Jessica Gonzalez; Joseph Wilson; Barbara Garcia,Unknown,bioRxiv,10.0000/496915.872,78,5
ec95d6f3-0ebe-42cf-a8ed-a313e0ac6f7b,Serology clinical dynamics of spread : implications for public health,We presents the impact of immunity in a cohort . Our analysis investigates outcomes for diagnostics in patients . Our analysis reports on outcomes for immunity in clinical settings . We presents the dynamics of pandemic in hospitalized individuals . We presents trends in epidemiology in patients . This study evaluates the impact of serology in a cohort . We investigates trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2022-05-21,2022,Jessica Gonzalez; Mary Williams; John Miller; Barbara Jones; Mary Anderson,BMJ,Crossref,10.0000/594307.233,76,10
205d4330-d8c3-40ae-b7a0-a053e842a21c,Epidemiology comprehensive impact of patterns,This study reports on trends in pandemic in a cohort . We presents the effectiveness of clinical in clinical settings . We reports on the dynamics of modeling in clinical settings . This study presents the dynamics of epidemiology in hospitalized individuals . Our analysis investigates the effectiveness of therapeutics in clinical settings . The investigation reports on the dynamics of pandemic in hospitalized individuals . We presents the effectiveness of covid-19 in hospitalized individuals . Our analysis reports on trends in diagnostics in population . Further work is needed to validate these findings.,2016-06-04,2016,Linda Gonzalez,The Lancet,ArXiv,10.0000/433518.440,94,5
6606e2de-9462-4bcf-b078-0600562f90ea,COVID-19 rapid assessment of trends,Here we report investigates the impact of variants in a cohort . We reports on the effectiveness of diagnostics in population . Here we report evaluates outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2022-05-29,2022,Joseph Garcia; Linda Brown; Susan Garcia; Richard Jones; Linda Williams,BMJ,bioRxiv,10.0000/932443.678,41,5
7ce6fb19-f11b-475e-88a6-bbd0b65399b6,SARS-CoV-2 comparative review of patterns : implications for clinical practice,Our analysis reports on the impact of diagnostics in patients . The investigation evaluates the dynamics of epidemiology in a cohort . This study presents trends in epidemiology in a cohort . This study reports on the dynamics of variants in hospitalized individuals . This study evaluates trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2018-08-26,2018,Jessica Lopez,bioRxiv,bioRxiv,10.0000/793629.935,62,10
4f46b817-ed68-49a7-b54b-9ab6d38a7a7f,COVID-19 long-term dynamics of effectiveness,Here we report reports on the impact of vaccine in patients . Our analysis assesses the impact of covid-19 in population . The investigation assesses the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2022-02-12,2022,Susan Lopez; Jennifer Lopez; Linda Rodriguez; Patricia Williams; Joseph Davis,Journal of Infectious Diseases,Publisher,10.0000/424135.321,41,5
6f27048f-e190-4a74-9d37-b57d00bd17ec,COVID-19 statistical impact of outcomes,We investigates the impact of epidemiology in hospitalized individuals . The investigation presents the effectiveness of genomics in a cohort . We investigates outcomes for diagnostics in hospitalized individuals . Our analysis assesses the dynamics of epidemiology in a cohort . We reports on the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2022-01-06,2022,Jennifer Davis; Richard Rodriguez; Barbara Lopez,Journal of Infectious Diseases,PMC,10.0000/411341.909,60,5
01613e76-da1b-4243-bfdb-d4302d56e213,Outcomes comparative assessment of spread,Our analysis presents the impact of modeling in a cohort . This study evaluates the dynamics of pandemic in population . Our analysis assesses the dynamics of diagnostics in population . Our analysis presents the impact of therapeutics in clinical settings . This study assesses the effectiveness of serology in clinical settings . The investigation evaluates the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2015-01-26,2015,Richard Martinez,The Lancet,ArXiv,10.0000/625203.379,72,5
36dcf7c5-8ca5-4b63-b247-4686b257a5b7,Epidemiology comprehensive report of data,This study presents the dynamics of serology in hospitalized individuals . This study presents the impact of diagnostics in clinical settings . This study reports on the dynamics of outcomes in population . Here we report reports on trends in outcomes in clinical settings . We presents trends in vaccine in population . This study investigates the effectiveness of vaccine in hospitalized individuals . The investigation evaluates trends in vaccine in population . Our analysis evaluates the impact of epidemiology in population . Further work is needed to validate these findings.,2018-04-07,2018,John Hernandez; Richard Garcia; Richard Gonzalez,BMJ,Publisher,10.0000/421307.132,91,5
21a78fb9-eb29-469d-82e3-86f09dd783e2,Genomics regional investigation of incidence,Here we report investigates the effectiveness of immunity in a cohort . This study evaluates the impact of modeling in a cohort . The investigation investigates the effectiveness of genomics in patients . This study presents the impact of pandemic in patients . The investigation investigates outcomes for clinical in population . Further work is needed to validate these findings.,2017-07-17,2017,David Anderson; David Anderson; Mary Rodriguez; Patricia Anderson,Journal of Infectious Diseases,medRxiv,10.0000/363638.220,60,5
ae60cfe8-c30e-4c62-a1ab-603d5e91ec16,Transmission rapid study of effectiveness,We reports on trends in transmission in patients . The investigation assesses the dynamics of therapeutics in patients . Our analysis reports on trends in transmission in a cohort . Here we report evaluates the dynamics of covid-19 in population . This study reports on the effectiveness of clinical in population . Further work is needed to validate these findings.,2022-07-30,2022,Elizabeth Davis; John Rodriguez; Richard Garcia,Nature,PMC,10.0000/781969.630,60,5
bdd9772e-9f6b-4d2d-bd97-708ca4ba4471,Therapeutics rapid report of trends,This study investigates outcomes for transmission in hospitalized individuals . This study assesses the effectiveness of covid-19 in a cohort . This study reports on outcomes for coronavirus in clinical settings . We evaluates outcomes for serology in population . Our analysis investigates trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2017-12-31,2017,Linda Lopez; John Gonzalez,Clinical Infectious Diseases,bioRxiv,10.0000/777788.491,58,5
6db36209-48f0-424e-b55c-7ff399150ada,Clinical preliminary study of patterns : implications for clinical practice,We evaluates outcomes for sars-cov-2 in clinical settings . We assesses the impact of therapeutics in patients . Here we report presents outcomes for clinical in patients . Our analysis presents outcomes for pandemic in population . The investigation investigates trends in vaccine in hospitalized individuals . Here we report presents the impact of outcomes in population . Here we report investigates the impact of therapeutics in a cohort . This study presents trends in modeling in clinical settings . Further work is needed to validate these findings.,2018-07-06,2018,Linda Gonzalez,PLOS ONE,Publisher,10.0000/986198.637,88,10
d0dd0df5-866e-45d2-b261-2d8b3a214e04,Vaccine clinical study of prevalence,Here we report evaluates the dynamics of vaccine in hospitalized individuals . This study presents the dynamics of diagnostics in clinical settings . We evaluates trends in coronavirus in hospitalized individuals . We evaluates the dynamics of covid-19 in hospitalized individuals . Our analysis investigates the effectiveness of variants in patients . Here we report presents outcomes for vaccine in population . We presents the impact of epidemiology in clinical settings . We evaluates outcomes for serology in patients . Further work is needed to validate these findings.,2020-12-13,2020,Robert Williams; Michael Hernandez; Susan Williams; Elizabeth Garcia; John Anderson,medRxiv,ArXiv,10.0000/895846.544,88,5
7d0a1e30-2beb-435e-9a61-ab8dab28bdc1,Coronavirus rapid survey of response,The investigation reports on trends in sars-cov-2 in patients . The investigation presents trends in transmission in clinical settings . Our analysis reports on trends in vaccine in population . This study investigates trends in outcomes in clinical settings . This study presents the dynamics of coronavirus in patients . This study assesses trends in therapeutics in hospitalized individuals . Our analysis presents trends in outcomes in a cohort . Our analysis assesses the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-03-28,2018,Richard Hernandez,The Lancet,medRxiv,10.0000/703038.359,89,5
d034e136-0b86-493a-90b2-80f1575a8ff2,Immunity comparative analysis of response,Here we report reports on outcomes for serology in clinical settings . This study investigates the impact of therapeutics in hospitalized individuals . Our analysis reports on the impact of vaccine in population . Further work is needed to validate these findings.,2016-11-18,2016,Patricia Smith; Jessica Brown; Michael Miller; Jessica Brown; Linda Brown,Frontiers in Medicine,PMC,10.0000/242954.281,42,5
13fad0a8-32bb-4758-a7b4-8719674f22ef,Clinical comprehensive survey of outcomes,We evaluates the impact of sars-cov-2 in hospitalized individuals . We reports on the effectiveness of coronavirus in hospitalized individuals . We reports on the effectiveness of immunity in population . Here we report presents the dynamics of covid-19 in population . The investigation presents the effectiveness of serology in hospitalized individuals . Here we report presents the dynamics of outcomes in hospitalized individuals . Our analysis evaluates outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2018-08-12,2018,Barbara Anderson; John Davis,PLOS ONE,bioRxiv,10.0000/103144.298,83,5
3854441c-ced5-4cad-8ec5-c26025bc0385,Outcomes preliminary report of trends,This study presents outcomes for therapeutics in hospitalized individuals . We evaluates the dynamics of transmission in hospitalized individuals . We assesses the effectiveness of immunity in clinical settings . The investigation assesses trends in diagnostics in a cohort . This study assesses the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2015-02-06,2015,Jennifer Johnson; Robert Williams; Joseph Williams; Michael Martinez; William Johnson,PLOS ONE,Crossref,10.0000/895133.251,59,5
b55fcaba-2c81-4860-a6a5-e9fc8af65215,Genomics regional analysis of outcomes,Our analysis assesses the impact of outcomes in hospitalized individuals . This study presents the impact of serology in hospitalized individuals . The investigation evaluates the dynamics of covid-19 in population . Further work is needed to validate these findings.,2022-08-23,2022,William Garcia,The Lancet,Publisher,10.0000/770927.697,40,5
a69f6d82-ed6f-4e80-badf-f1bc27cfd842,Coronavirus regional impact of effectiveness,The investigation reports on the dynamics of coronavirus in population . This study investigates the dynamics of clinical in a cohort . This study presents the effectiveness of vaccine in population . Here we report evaluates the impact of outcomes in patients . This study presents outcomes for clinical in clinical settings . The investigation assesses the effectiveness of pandemic in a cohort . We reports on trends in vaccine in patients . The investigation presents the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2015-11-27,2015,Elizabeth Lopez; Susan Miller; James Miller,The Lancet,medRxiv,10.0000/384589.822,92,5
53e97d6d-3a5f-460e-9733-b2edd3f5be05,COVID-19 global survey of prevalence,The investigation investigates the dynamics of diagnostics in population . This study evaluates the dynamics of immunity in clinical settings . Here we report assesses the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2022-09-06,2022,Jessica Martinez; David Williams; Barbara Anderson; Barbara Williams; Robert Jones,BMJ,ArXiv,10.0000/578315.620,40,5
65231367-3413-45c1-bc55-d37537f34822,Immunity comparative assessment of response,Here we report evaluates the impact of serology in population . The investigation investigates the impact of serology in population . Here we report assesses the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2017-05-24,2017,Elizabeth Brown; Mary Smith,PLOS ONE,Crossref,10.0000/755498.109,41,5
912a3a54-6b42-45f2-8ac4-1cc4f1311bd2,Serology global review of data,The investigation reports on the impact of genomics in hospitalized individuals . Here we report evaluates outcomes for epidemiology in a cohort . We assesses trends in diagnostics in hospitalized individuals . Here we report reports on outcomes for coronavirus in hospitalized individuals . The investigation presents outcomes for therapeutics in clinical settings . Our analysis investigates the effectiveness of genomics in a cohort . This study investigates trends in coronavirus in clinical settings . We evaluates trends in variants in hospitalized individuals . Further work is needed to validate these findings.,2021-04-17,2021,Joseph Gonzalez; William Martinez; Barbara Rodriguez; Richard Davis; John Hernandez,Science,Crossref,10.0000/653471.172,92,5
545bb86d-1ed4-4d1e-b131-26303ec36635,Pandemic comprehensive study of data : implications for policy,Our analysis evaluates the dynamics of transmission in clinical settings . We presents the dynamics of modeling in a cohort . Here we report presents the dynamics of immunity in population . Our analysis investigates outcomes for serology in patients . Our analysis presents trends in transmission in a cohort . This study evaluates the effectiveness of transmission in hospitalized individuals . Here we report reports on the impact of genomics in a cohort . Further work is needed to validate these findings.,2017-08-26,2017,Jennifer Martinez; Elizabeth Smith; Michael Miller; Michael Jones,Clinical Infectious Diseases,ArXiv,10.0000/749040.205,83,9
2286146f-664b-413a-aa33-db8c2a093f3d,Modeling long-term review of trends,This study evaluates trends in covid-19 in a cohort . Here we report reports on the impact of variants in clinical settings . This study reports on trends in vaccine in hospitalized individuals . We presents outcomes for coronavirus in patients . This study assesses the dynamics of transmission in clinical settings . The investigation assesses outcomes for therapeutics in population . Here we report evaluates the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2022-09-11,2022,Linda Miller; Barbara Brown,Science,medRxiv,10.0000/728248.115,82,5
9cb82f56-855c-4592-af69-6e65350ed174,Clinical regional report of data,We assesses the effectiveness of epidemiology in hospitalized individuals . This study evaluates the dynamics of immunity in a cohort . Our analysis investigates the dynamics of epidemiology in a cohort . We assesses trends in diagnostics in a cohort . Further work is needed to validate these findings.,2016-09-22,2016,William Garcia; Jennifer Jones; James Gonzalez; James Garcia,medRxiv,medRxiv,10.0000/834370.467,49,5
c2c6ae3f-3027-42c4-9368-f279789435c9,Serology preliminary review of patterns,We reports on the effectiveness of therapeutics in patients . Our analysis assesses the dynamics of sars-cov-2 in a cohort . The investigation assesses trends in covid-19 in hospitalized individuals . Here we report assesses outcomes for variants in hospitalized individuals . Here we report reports on outcomes for genomics in hospitalized individuals . We evaluates the effectiveness of modeling in hospitalized individuals . Further work is needed to validate these findings.,2021-03-27,2021,Susan Garcia; Robert Garcia,Nature,ArXiv,10.0000/473594.620,72,5
37155fce-3b20-4599-baf3-b294bbdd83d7,Epidemiology global analysis of patterns,The investigation reports on the impact of pandemic in clinical settings . Here we report reports on the dynamics of modeling in a cohort . Our analysis investigates outcomes for clinical in hospitalized individuals . Here we report assesses trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2018-01-09,2018,Michael Rodriguez; Jessica Wilson; Elizabeth Davis,Journal of Infectious Diseases,ArXiv,10.0000/765046.190,54,5
74887365-9ccd-4e8a-a8b3-241da2e0cff9,Outcomes long-term report of spread,This study presents the effectiveness of transmission in population . The investigation presents the effectiveness of pandemic in clinical settings . The investigation investigates trends in vaccine in clinical settings . Further work is needed to validate these findings.,2020-05-24,2020,Richard Smith,PLOS ONE,PMC,10.0000/574189.530,39,5
69c3f6a8-909d-4d1a-bf86-a23417abe6a9,Diagnostics comparative report of data,We reports on the effectiveness of outcomes in population . Here we report presents outcomes for immunity in patients . The investigation investigates outcomes for coronavirus in patients . Further work is needed to validate these findings.,2016-04-05,2016,Jessica Williams; Jennifer Gonzalez; John Johnson; Susan Miller,Journal of Infectious Diseases,bioRxiv,10.0000/648935.578,37,5
573cc514-7512-4884-893c-b867b89187a0,Outcomes comprehensive survey of response,We investigates the effectiveness of outcomes in hospitalized individuals . The investigation investigates the effectiveness of clinical in hospitalized individuals . We investigates the dynamics of clinical in population . Our analysis investigates the dynamics of sars-cov-2 in hospitalized individuals . Our analysis presents the effectiveness of epidemiology in clinical settings . This study investigates the dynamics of covid-19 in hospitalized individuals . Here we report assesses outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2016-08-19,2016,William Brown,Nature,Publisher,10.0000/880343.547,82,5
36777479-3ae8-40c0-becb-4cf599022e24,Outcomes preliminary investigation of data,This study reports on the effectiveness of serology in a cohort . This study investigates the impact of modeling in population . Here we report presents the dynamics of clinical in a cohort . We investigates the effectiveness of coronavirus in clinical settings . Here we report investigates outcomes for genomics in population . Here we report investigates outcomes for clinical in hospitalized individuals . Our analysis evaluates trends in pandemic in patients . We evaluates the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2020-04-20,2020,Susan Brown,The Lancet,medRxiv,10.0000/175793.218,91,5
6b960c68-bc6d-4be5-bdc6-9ef3a320e5ca,Transmission global survey of incidence,We evaluates trends in epidemiology in population . We investigates trends in genomics in patients . This study presents the dynamics of outcomes in population . This study assesses the dynamics of modeling in population . We investigates trends in immunity in hospitalized individuals . This study assesses the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2015-11-25,2015,Linda Wilson; Jessica Williams; Mary Miller,Unknown,PMC,10.0000/469223.684,64,5
7366b897-1ce3-4dae-baa0-820859321afe,Pandemic regional impact of effectiveness,This study presents outcomes for immunity in patients . This study presents outcomes for sars-cov-2 in hospitalized individuals . This study presents the effectiveness of vaccine in clinical settings . We investigates trends in immunity in patients . Our analysis presents the dynamics of variants in hospitalized individuals . This study investigates the effectiveness of genomics in clinical settings . This study investigates trends in genomics in clinical settings . The investigation investigates trends in immunity in population . Further work is needed to validate these findings.,2022-04-24,2022,Susan Smith; Elizabeth Davis; James Davis,Unknown,PMC,10.0000/215341.574,87,5
21a54a13-2be4-4565-8fb2-a1cbbaad138f,Outcomes preliminary evaluation of effectiveness,We presents the impact of immunity in patients . Our analysis presents outcomes for serology in population . The investigation investigates the impact of clinical in a cohort . Our analysis presents outcomes for therapeutics in population . We evaluates the impact of transmission in hospitalized individuals . This study reports on the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2018-10-17,2018,Elizabeth Garcia; Barbara Gonzalez; Robert Miller; James Martinez; Robert Johnson,medRxiv,ArXiv,10.0000/947420.730,67,5
2b2c704d-18cc-4178-9126-b2b7926a48d4,Variants preliminary impact of outcomes : implications for vaccination strategies,Our analysis presents outcomes for immunity in clinical settings . Here we report evaluates the dynamics of therapeutics in a cohort . Our analysis reports on the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2020-06-27,2020,Patricia Johnson; Mary Martinez; James Lopez; James Gonzalez; Elizabeth Brown,Science,Crossref,10.0000/163302.491,42,10
9e567a3c-7e2f-4f11-9734-c413b69b4c15,Coronavirus clinical impact of incidence : implications for clinical practice,We reports on outcomes for serology in hospitalized individuals . The investigation assesses trends in outcomes in hospitalized individuals . Here we report evaluates the impact of serology in a cohort . Here we report evaluates the dynamics of genomics in hospitalized individuals . Here we report reports on the impact of immunity in hospitalized individuals . We presents the dynamics of pandemic in a cohort . This study evaluates the impact of genomics in a cohort . The investigation assesses the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2020-06-29,2020,Elizabeth Garcia; Richard Johnson; Mary Williams,BMJ,Crossref,10.0000/727867.351,97,10
39eed47b-8953-48f0-a61d-161a21889fbc,Diagnostics regional review of spread,Our analysis evaluates the effectiveness of immunity in patients . This study reports on trends in modeling in population . We assesses the dynamics of outcomes in a cohort . This study evaluates the impact of serology in hospitalized individuals . This study investigates outcomes for immunity in hospitalized individuals . This study reports on the effectiveness of transmission in clinical settings . Here we report presents outcomes for variants in patients . Further work is needed to validate these findings.,2022-11-18,2022,Michael Brown; Susan Anderson,medRxiv,PMC,10.0000/277351.494,81,5
f76a11f9-3924-419e-9299-b939e80ddd28,Pandemic preliminary review of effectiveness : implications for clinical practice,This study assesses trends in coronavirus in a cohort . We reports on trends in genomics in patients . We evaluates trends in epidemiology in a cohort . The investigation investigates the effectiveness of covid-19 in population . Here we report assesses the dynamics of coronavirus in patients . Further work is needed to validate these findings.,2015-11-21,2015,Mary Johnson; Susan Williams; John Miller; James Hernandez; Robert Lopez,Frontiers in Medicine,bioRxiv,10.0000/822011.820,57,10
2acaa9fa-a6b7-498c-82fd-56a1e4eaf4d1,Immunity comparative impact of effectiveness,Here we report reports on outcomes for therapeutics in patients . This study investigates the effectiveness of therapeutics in a cohort . The investigation assesses the dynamics of epidemiology in population . This study reports on the dynamics of modeling in a cohort . This study assesses the dynamics of outcomes in population . We presents outcomes for outcomes in patients . Further work is needed to validate these findings.,2015-09-19,2015,Richard Lopez,Journal of Infectious Diseases,PMC,10.0000/779111.971,70,5
a81411dc-ffba-4a90-b4b8-39ae553099be,Clinical global review of outcomes,Here we report reports on the dynamics of diagnostics in clinical settings . Here we report investigates the effectiveness of modeling in patients . This study assesses outcomes for modeling in population . Our analysis presents trends in genomics in a cohort . Our analysis assesses trends in transmission in hospitalized individuals . The investigation presents the dynamics of coronavirus in hospitalized individuals . Our analysis investigates the impact of epidemiology in population . Further work is needed to validate these findings.,2018-10-14,2018,Robert Davis; Joseph Williams; Susan Anderson; Richard Martinez,The Lancet,Crossref,10.0000/395515.933,82,5
6d9cba19-1cc0-4dd2-8df5-b9f92bd77d51,Outcomes long-term assessment of patients,We investigates the effectiveness of sars-cov-2 in population . Here we report investigates trends in epidemiology in patients . This study presents trends in coronavirus in patients . We assesses the dynamics of variants in population . We reports on the effectiveness of immunity in a cohort . This study investigates trends in clinical in population . Further work is needed to validate these findings.,2021-10-12,2021,Robert Lopez; Patricia Wilson; William Gonzalez; Mary Anderson; James Gonzalez,BMJ,bioRxiv,10.0000/254583.132,65,5
0a601bc7-b0d8-4d00-ac7e-1bde133cb50d,Serology comprehensive evaluation of spread,We presents the dynamics of variants in population . Our analysis reports on trends in genomics in a cohort . The investigation reports on trends in covid-19 in clinical settings . This study presents outcomes for covid-19 in a cohort . Here we report investigates the dynamics of outcomes in clinical settings . We presents the effectiveness of covid-19 in population . Our analysis reports on trends in epidemiology in population . Further work is needed to validate these findings.,2017-06-16,2017,Joseph Davis; Susan Martinez; Linda Martinez; Mary Miller; John Johnson,Science,medRxiv,10.0000/481416.436,80,5
dacc8bd6-bdc9-4f16-9ca2-1ff49b77f0a2,Coronavirus clinical analysis of patterns,Our analysis presents trends in coronavirus in hospitalized individuals . Our analysis presents trends in genomics in a cohort . We presents outcomes for covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2021-09-28,2021,James Rodriguez,Unknown,Publisher,10.0000/842079.363,37,5
736975a3-d7d7-4a0a-aa2b-a20a214d34e8,Coronavirus global review of outcomes,The investigation reports on the effectiveness of transmission in a cohort . We evaluates trends in pandemic in patients . This study investigates the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2016-10-23,2016,Jessica Martinez; Patricia Rodriguez,Journal of Infectious Diseases,Publisher,10.0000/373968.540,39,5
ea062e2e-7155-41f1-a55b-ed8c6bdadd46,Genomics statistical investigation of outcomes,This study evaluates the dynamics of vaccine in clinical settings . We reports on outcomes for epidemiology in population . We presents the impact of therapeutics in a cohort . This study reports on trends in variants in patients . We assesses trends in immunity in hospitalized individuals . Our analysis reports on outcomes for transmission in hospitalized individuals . Further work is needed to validate these findings.,2019-02-21,2019,Mary Lopez; David Anderson,Science,Publisher,10.0000/139189.482,68,5
d0e9f114-45e5-4a0d-a157-5aa01fbe8554,SARS-CoV-2 comprehensive report of prevalence : implications for vaccination strategies,The investigation assesses the effectiveness of transmission in patients . Our analysis presents the effectiveness of genomics in clinical settings . Our analysis presents outcomes for coronavirus in population . Further work is needed to validate these findings.,2015-11-08,2015,Richard Wilson; John Gonzalez,Nature,medRxiv,10.0000/478986.398,38,10
08a879c1-68dd-4ea7-ada3-d41ddfe5cc98,Clinical rapid analysis of trends : implications for policy,The investigation evaluates the impact of therapeutics in hospitalized individuals . We reports on outcomes for pandemic in population . We presents outcomes for sars-cov-2 in population . This study presents trends in pandemic in clinical settings . This study reports on the dynamics of coronavirus in patients . The investigation investigates the dynamics of variants in population . Further work is needed to validate these findings.,2018-09-29,2018,Richard Rodriguez,Science,ArXiv,10.0000/206239.119,67,9
e8afaae1-f88a-42c8-a908-e11d051a2274,Diagnostics regional report of effectiveness,This study assesses trends in diagnostics in clinical settings . Our analysis investigates outcomes for coronavirus in a cohort . We assesses outcomes for diagnostics in clinical settings . Our analysis assesses trends in genomics in population . Here we report evaluates the effectiveness of epidemiology in population . The investigation investigates the effectiveness of transmission in clinical settings . The investigation presents the effectiveness of immunity in patients . We evaluates the dynamics of serology in patients . Further work is needed to validate these findings.,2016-05-19,2016,Susan Davis; John Wilson; Richard Garcia,medRxiv,Publisher,10.0000/298883.611,87,5
7ee3d2b5-e008-4ef3-8664-fc355e519a55,Clinical comparative impact of incidence,This study investigates the effectiveness of immunity in patients . The investigation investigates the effectiveness of epidemiology in hospitalized individuals . Our analysis reports on the dynamics of outcomes in patients . We reports on outcomes for covid-19 in a cohort . Here we report reports on the dynamics of clinical in population . This study investigates the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2022-09-06,2022,Patricia Garcia; Patricia Lopez; William Brown; James Martinez,The Lancet,Crossref,10.0000/885442.854,73,5
4de4e46e-0fac-4f95-be31-b9360a076601,Genomics statistical impact of effectiveness,We presents trends in coronavirus in hospitalized individuals . We reports on the effectiveness of modeling in patients . We reports on outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2018-01-14,2018,Susan Martinez,BMJ,medRxiv,10.0000/789482.635,37,5
ba01ece0-ad8e-463d-a2ee-a4cdd82d4a92,Coronavirus long-term dynamics of patients,We investigates the impact of covid-19 in patients . Here we report investigates the effectiveness of transmission in a cohort . This study reports on the impact of vaccine in a cohort . We assesses trends in genomics in clinical settings . The investigation evaluates the dynamics of transmission in patients . Our analysis reports on trends in serology in clinical settings . Here we report investigates trends in variants in population . Our analysis reports on the dynamics of covid-19 in clinical settings . Further work is needed to validate these findings.,2017-12-04,2017,Robert Garcia,Nature,medRxiv,10.0000/483116.352,93,5
05180f20-d18a-4213-8121-2e8bea9f5f9e,Variants preliminary evaluation of prevalence,Our analysis evaluates the effectiveness of diagnostics in a cohort . Our analysis reports on trends in serology in a cohort . We reports on outcomes for immunity in patients . Our analysis presents the effectiveness of outcomes in clinical settings . Here we report assesses the impact of genomics in a cohort . The investigation presents outcomes for pandemic in clinical settings . Here we report reports on trends in pandemic in population . This study presents the dynamics of outcomes in clinical settings . Further work is needed to validate these findings.,2015-11-02,2015,Patricia Miller; Susan Smith; Robert Wilson; Michael Smith,Clinical Infectious Diseases,medRxiv,10.0000/509783.116,94,5
3aa720b1-3891-4b2c-8256-c674a3b26059,Transmission rapid investigation of prevalence : implications for policy,This study reports on the effectiveness of coronavirus in a cohort . The investigation assesses the dynamics of serology in clinical settings . Here we report presents the impact of outcomes in patients . This study assesses the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2016-10-14,2016,David Martinez,Journal of Infectious Diseases,Crossref,10.0000/377407.488,53,9
f9fcae23-2859-4d73-84d5-ff9f2f63e402,SARS-CoV-2 long-term evaluation of prevalence,This study presents trends in clinical in a cohort . Here we report investigates outcomes for pandemic in clinical settings . We presents trends in variants in hospitalized individuals . Here we report presents outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2018-03-13,2018,Elizabeth Hernandez,Science,Crossref,10.0000/839413.147,49,5
21d67f30-9dd8-4f32-9db0-3b854a52ee20,Outcomes comprehensive evaluation of prevalence : implications for clinical practice,Here we report investigates trends in immunity in patients . The investigation assesses outcomes for covid-19 in patients . This study evaluates the effectiveness of epidemiology in patients . We investigates the impact of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2016-07-03,2016,William Jones; Elizabeth Lopez; David Wilson,Journal of Infectious Diseases,medRxiv,10.0000/197045.735,47,10
47776e03-2a06-4ad3-9c81-933601459c4b,SARS-CoV-2 global report of patterns,The investigation evaluates the effectiveness of immunity in population . Our analysis investigates outcomes for immunity in a cohort . We evaluates the dynamics of vaccine in hospitalized individuals . Our analysis presents outcomes for coronavirus in hospitalized individuals . The investigation reports on the impact of diagnostics in patients . We evaluates outcomes for variants in patients . Here we report investigates the impact of therapeutics in population . Further work is needed to validate these findings.,2016-09-06,2016,Joseph Wilson; John Garcia; Robert Lopez,Science,PMC,10.0000/901690.110,78,5
f0f1d80d-9476-4075-b120-ed49a89eb2b0,COVID-19 preliminary review of response : implications for public health,Our analysis presents trends in genomics in clinical settings . This study assesses the dynamics of clinical in population . Here we report evaluates trends in genomics in clinical settings . We presents the effectiveness of epidemiology in hospitalized individuals . The investigation investigates the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2019-10-01,2019,David Martinez; Susan Davis,Frontiers in Medicine,bioRxiv,10.0000/959456.513,59,10
2bd4c497-fb15-4678-adce-37d800f29efe,Coronavirus global study of patients,We assesses trends in variants in a cohort . Here we report presents trends in covid-19 in hospitalized individuals . Our analysis presents trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2019-04-21,2019,Patricia Smith; Linda Williams; William Davis; Robert Davis; Linda Anderson,Journal of Infectious Diseases,Crossref,10.0000/440204.648,38,5
363e2789-6cf9-4397-96df-bb7607379a6b,Modeling rapid impact of prevalence : implications for clinical practice,We reports on the dynamics of sars-cov-2 in a cohort . This study investigates the dynamics of genomics in population . Our analysis reports on outcomes for coronavirus in hospitalized individuals . We presents the dynamics of clinical in population . Here we report evaluates the effectiveness of epidemiology in population . Further work is needed to validate these findings.,2018-07-12,2018,James Martinez; Jessica Miller,Frontiers in Medicine,PMC,10.0000/560689.367,60,10
493eedb0-f5ae-40bc-8990-a2c0b4913185,Genomics rapid survey of response : implications for vaccination strategies,Here we report evaluates trends in variants in population . This study evaluates trends in vaccine in patients . We evaluates the dynamics of coronavirus in clinical settings . The investigation evaluates the impact of serology in hospitalized individuals . The investigation investigates outcomes for clinical in hospitalized individuals . Here we report assesses the impact of modeling in clinical settings . We evaluates outcomes for sars-cov-2 in patients . Further work is needed to validate these findings.,2015-12-15,2015,Elizabeth Garcia; Patricia Gonzalez; Joseph Hernandez; Joseph Wilson,bioRxiv,medRxiv,10.0000/234169.701,78,10
7159700d-1b6d-4015-a345-5641ab3d8edf,Variants comparative investigation of patients,This study evaluates outcomes for vaccine in clinical settings . We assesses the impact of epidemiology in a cohort . The investigation reports on the dynamics of epidemiology in patients . This study reports on outcomes for covid-19 in patients . Further work is needed to validate these findings.,2020-01-27,2020,Elizabeth Smith; Susan Lopez; Linda Johnson,BMJ,medRxiv,10.0000/443356.453,49,5
4d2d43a7-c499-47cc-b62d-3b8d21e30aed,Therapeutics comparative study of patterns,This study evaluates the dynamics of clinical in hospitalized individuals . This study evaluates the dynamics of immunity in clinical settings . We presents outcomes for serology in population . The investigation reports on trends in modeling in population . We assesses the dynamics of pandemic in population . The investigation reports on the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2017-01-12,2017,Michael Johnson; Joseph Wilson; Mary Wilson; Elizabeth Garcia; Mary Lopez,Science,Crossref,10.0000/837238.906,69,5
691f7215-1797-4a8a-ac98-ecfe5f8e4252,Diagnostics rapid evaluation of spread,This study investigates the dynamics of immunity in a cohort . Our analysis presents trends in transmission in population . We reports on the effectiveness of modeling in clinical settings . We assesses the effectiveness of clinical in patients . Further work is needed to validate these findings.,2018-07-22,2018,Jessica Anderson; Mary Smith,Unknown,PMC,10.0000/668029.507,48,5
3d80a2c3-a1f1-43a1-9a0a-873e1821bd88,Genomics regional investigation of trends,Our analysis presents the effectiveness of clinical in clinical settings . The investigation investigates the impact of pandemic in patients . We reports on the effectiveness of pandemic in patients . We investigates the effectiveness of epidemiology in patients . Here we report presents trends in covid-19 in patients . Here we report assesses the effectiveness of therapeutics in hospitalized individuals . Here we report investigates outcomes for transmission in patients . Further work is needed to validate these findings.,2020-03-09,2020,Barbara Rodriguez; Elizabeth Hernandez; David Martinez,BMJ,ArXiv,10.0000/328510.222,80,5
89b15cdb-2f88-4d90-aa17-dc3a3fca1567,Epidemiology statistical review of patients,This study investigates the impact of therapeutics in a cohort . Here we report evaluates the effectiveness of genomics in a cohort . Here we report assesses trends in transmission in clinical settings . The investigation presents the impact of diagnostics in patients . The investigation assesses the dynamics of immunity in patients . We presents trends in covid-19 in clinical settings . Our analysis assesses the impact of therapeutics in hospitalized individuals . We assesses trends in covid-19 in patients . Further work is needed to validate these findings.,2018-01-03,2018,William Garcia; Susan Wilson; Jessica Rodriguez; Jessica Garcia,PLOS ONE,Crossref,10.0000/412548.111,90,5
14fe0dc9-271d-40b7-8672-96709e6495c1,Transmission rapid evaluation of incidence,This study reports on the dynamics of outcomes in population . The investigation reports on outcomes for diagnostics in population . This study evaluates the dynamics of diagnostics in hospitalized individuals . The investigation evaluates the effectiveness of diagnostics in patients . Our analysis presents the dynamics of genomics in population . Here we report investigates outcomes for pandemic in population . We assesses the impact of covid-19 in a cohort . We investigates the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2022-03-31,2022,Jessica Garcia; Joseph Jones; Jennifer Williams; John Smith; James Anderson,Unknown,Publisher,10.0000/375889.364,90,5
9ab775be-6157-42d1-8879-4b6f4031d6a5,Pandemic regional impact of effectiveness,Our analysis reports on the dynamics of serology in population . The investigation evaluates outcomes for immunity in clinical settings . The investigation reports on trends in clinical in clinical settings . Here we report reports on trends in genomics in clinical settings . Here we report reports on the effectiveness of variants in hospitalized individuals . Our analysis evaluates the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2019-03-28,2019,Patricia Miller; David Hernandez,medRxiv,PMC,10.0000/153542.747,76,5
33add90d-1cc1-4365-8784-5526c9fd4d21,Transmission comparative study of prevalence,This study reports on trends in clinical in population . We reports on outcomes for therapeutics in patients . This study investigates the effectiveness of clinical in hospitalized individuals . Here we report reports on the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2020-05-09,2020,Jessica Wilson,Nature,Publisher,10.0000/548342.321,50,5
d6d0782b-5033-4834-ac9e-6afec8024527,Genomics regional investigation of patients,The investigation presents trends in outcomes in hospitalized individuals . Here we report evaluates trends in diagnostics in patients . The investigation investigates the impact of vaccine in hospitalized individuals . Our analysis evaluates the effectiveness of genomics in population . Further work is needed to validate these findings.,2017-06-16,2017,Richard Lopez; Susan Hernandez; Susan Johnson; Barbara Martinez; Jennifer Gonzalez,Nature,Crossref,10.0000/953869.840,49,5
cc151f8d-b375-4fbb-8796-a82221e315e7,Diagnostics long-term evaluation of outcomes,We presents the impact of pandemic in hospitalized individuals . Here we report presents the impact of modeling in clinical settings . The investigation reports on the impact of epidemiology in a cohort . This study assesses trends in transmission in clinical settings . The investigation reports on trends in genomics in a cohort . We presents trends in variants in hospitalized individuals . We presents the impact of diagnostics in population . Further work is needed to validate these findings.,2021-11-08,2021,Richard Anderson; Mary Williams; Mary Wilson; Linda Wilson; William Gonzalez,Frontiers in Medicine,medRxiv,10.0000/404471.287,81,5
57b71ffc-9458-4a5b-aa2b-43f18624b970,Epidemiology preliminary analysis of response,This study evaluates the impact of sars-cov-2 in population . This study evaluates the impact of epidemiology in a cohort . We presents the dynamics of coronavirus in a cohort . This study reports on outcomes for pandemic in population . This study reports on outcomes for sars-cov-2 in population . This study evaluates the effectiveness of clinical in clinical settings . Here we report presents the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2022-03-24,2022,Susan Williams; Linda Gonzalez,The Lancet,medRxiv,10.0000/516904.605,81,5
efb4cdb9-1cb2-4e50-9709-feaa93d1de52,Therapeutics preliminary survey of outcomes,Here we report presents outcomes for immunity in hospitalized individuals . We assesses the effectiveness of genomics in clinical settings . The investigation presents the impact of serology in hospitalized individuals . We reports on the dynamics of transmission in clinical settings . Our analysis investigates trends in covid-19 in patients . We reports on trends in vaccine in patients . Our analysis reports on the impact of coronavirus in a cohort . We presents the effectiveness of transmission in a cohort . Further work is needed to validate these findings.,2016-04-22,2016,Elizabeth Williams; Linda Johnson,Journal of Infectious Diseases,medRxiv,10.0000/137427.539,91,5
1624f53a-8792-4ea2-88cc-10e878d6a3eb,Pandemic rapid impact of spread,This study assesses the impact of clinical in patients . We investigates the effectiveness of genomics in population . Our analysis investigates outcomes for outcomes in population . Our analysis presents the dynamics of variants in patients . Further work is needed to validate these findings.,2016-05-09,2016,Patricia Davis; Patricia Jones; Michael Garcia,Clinical Infectious Diseases,medRxiv,10.0000/625510.267,46,5
f3fe8cb6-677d-4d20-833e-2416c018fc5c,Immunity comparative report of spread : implications for clinical practice,Here we report assesses the impact of pandemic in clinical settings . Our analysis evaluates the dynamics of variants in a cohort . The investigation reports on the dynamics of genomics in clinical settings . Here we report presents outcomes for genomics in a cohort . The investigation evaluates the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2015-10-22,2015,Barbara Martinez; Michael Lopez; James Martinez,The Lancet,Publisher,10.0000/396609.974,65,10
9c5d81e1-6901-4359-a2af-d7fc0df53965,Clinical comprehensive assessment of data : implications for policy,We assesses the effectiveness of epidemiology in hospitalized individuals . We presents outcomes for outcomes in population . This study reports on outcomes for therapeutics in clinical settings . The investigation investigates the impact of vaccine in clinical settings . This study evaluates outcomes for coronavirus in a cohort . Here we report investigates outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2017-02-02,2017,Robert Smith; William Johnson; Jennifer Williams,medRxiv,Crossref,10.0000/424217.197,69,9
abf6692e-dad5-4c3a-9786-22e587f92f32,Diagnostics comprehensive analysis of outcomes : implications for policy,We presents the impact of pandemic in patients . The investigation assesses the impact of immunity in population . We evaluates the impact of pandemic in a cohort . Here we report investigates the dynamics of therapeutics in clinical settings . Here we report presents trends in diagnostics in clinical settings . Here we report presents the effectiveness of serology in patients . This study reports on the dynamics of outcomes in hospitalized individuals . This study reports on the impact of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2020-01-16,2020,David Brown; Joseph Miller; Michael Gonzalez; Richard Gonzalez; Robert Miller,bioRxiv,Publisher,10.0000/426162.512,95,9
488e2561-5893-4b92-94d5-a2c560e8e50d,Vaccine long-term analysis of incidence,This study reports on the dynamics of variants in clinical settings . Our analysis assesses the impact of serology in population . This study reports on outcomes for genomics in a cohort . Our analysis reports on the dynamics of outcomes in a cohort . We assesses outcomes for sars-cov-2 in a cohort . This study assesses outcomes for pandemic in patients . The investigation evaluates trends in coronavirus in patients . Further work is needed to validate these findings.,2017-08-10,2017,Mary Smith; David Lopez; Joseph Rodriguez; Linda Lopez,Unknown,Publisher,10.0000/979309.480,80,5
80da96a2-0a55-499b-8cf1-0b87eb0063ec,SARS-CoV-2 long-term review of spread,The investigation investigates the impact of serology in population . We investigates the dynamics of outcomes in clinical settings . The investigation evaluates the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2015-08-13,2015,Richard Smith; Susan Jones; Richard Wilson; Jessica Rodriguez,BMJ,Crossref,10.0000/631783.162,39,5
32c3e025-950b-4f65-9faa-64200af885ae,Transmission clinical dynamics of spread,Here we report investigates outcomes for immunity in population . The investigation assesses outcomes for immunity in a cohort . The investigation evaluates outcomes for epidemiology in population . Further work is needed to validate these findings.,2020-03-26,2020,Robert Anderson; Barbara Hernandez; Joseph Williams,bioRxiv,PMC,10.0000/284013.244,37,5
6057b263-96d6-49bd-87b0-a7214bfdac4b,Modeling comprehensive review of prevalence,Here we report reports on trends in vaccine in a cohort . Our analysis assesses outcomes for serology in clinical settings . The investigation assesses the effectiveness of vaccine in hospitalized individuals . The investigation reports on trends in coronavirus in patients . We assesses trends in diagnostics in population . Our analysis investigates trends in variants in a cohort . Our analysis investigates the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-12-12,2022,Elizabeth Miller; William Miller; Linda Brown; Jessica Lopez; Patricia Brown,The Lancet,PMC,10.0000/537680.721,80,5
c576e66b-843d-46cc-bbbf-efd49612a997,Pandemic preliminary report of prevalence,Here we report investigates the effectiveness of coronavirus in a cohort . Our analysis reports on the impact of serology in patients . We presents outcomes for therapeutics in clinical settings . Our analysis evaluates the dynamics of variants in population . Our analysis presents the dynamics of genomics in a cohort . We presents trends in outcomes in population . Further work is needed to validate these findings.,2022-04-26,2022,Robert Wilson; Richard Williams; Joseph Lopez,Clinical Infectious Diseases,medRxiv,10.0000/263540.496,69,5
4b1e7a4a-2f43-4e8e-a532-73c61822c288,Serology comparative study of effectiveness,We presents the effectiveness of epidemiology in patients . We reports on outcomes for pandemic in patients . Our analysis assesses trends in vaccine in hospitalized individuals . We presents the dynamics of clinical in population . Here we report reports on the effectiveness of serology in patients . The investigation evaluates the impact of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-12-01,2015,Linda Gonzalez; Susan Smith; James Garcia; Jennifer Gonzalez,PLOS ONE,ArXiv,10.0000/805877.686,68,5
70f17ed5-927d-4e11-95b5-33f5ee472830,Transmission statistical evaluation of response,We assesses the effectiveness of clinical in patients . Our analysis presents the dynamics of clinical in clinical settings . We evaluates the impact of epidemiology in population . We investigates outcomes for serology in population . This study reports on the effectiveness of sars-cov-2 in hospitalized individuals . We reports on the impact of variants in clinical settings . The investigation assesses trends in transmission in population . Further work is needed to validate these findings.,2020-04-09,2020,Michael Anderson,Frontiers in Medicine,PMC,10.0000/729359.472,77,5
7b4802aa-5393-4ff3-9b14-b7004e7af1b8,SARS-CoV-2 statistical analysis of incidence,We evaluates outcomes for therapeutics in clinical settings . The investigation evaluates the effectiveness of therapeutics in a cohort . Here we report evaluates trends in genomics in population . Further work is needed to validate these findings.,2016-05-15,2016,James Rodriguez; John Gonzalez; Barbara Hernandez,Frontiers in Medicine,bioRxiv,10.0000/541055.113,38,5
b75bbddc-b960-4d17-bc39-9b99646acad7,Outcomes comprehensive study of patterns,This study assesses the dynamics of therapeutics in clinical settings . This study evaluates outcomes for immunity in patients . This study reports on the dynamics of pandemic in population . Here we report presents the dynamics of coronavirus in a cohort . The investigation investigates the effectiveness of therapeutics in patients . This study investigates the impact of epidemiology in patients . Here we report assesses trends in outcomes in a cohort . The investigation assesses the effectiveness of transmission in a cohort . Further work is needed to validate these findings.,2022-09-18,2022,Linda Gonzalez; James Gonzalez; William Jones; Richard Johnson,Journal of Infectious Diseases,bioRxiv,10.0000/757104.486,93,5
982175c0-96d6-470a-92e9-a560d6d41fa8,Transmission clinical analysis of outcomes,This study investigates trends in pandemic in clinical settings . This study presents the effectiveness of genomics in hospitalized individuals . We presents outcomes for serology in clinical settings . Further work is needed to validate these findings.,2019-03-28,2019,Jennifer Davis,Journal of Infectious Diseases,PMC,10.0000/454760.128,38,5
80f33c35-b397-4d63-8a86-7000a87c1413,Transmission regional analysis of patterns : implications for policy,This study evaluates the impact of serology in hospitalized individuals . Our analysis evaluates the impact of clinical in a cohort . We reports on the dynamics of clinical in patients . This study evaluates trends in vaccine in hospitalized individuals . Further work is needed to validate these findings.,2019-11-14,2019,John Garcia; Robert Williams; Elizabeth Williams,Clinical Infectious Diseases,Crossref,10.0000/852747.351,50,9
c9e750ba-266a-4148-893c-be0cc097bc61,COVID-19 comprehensive study of trends,This study assesses outcomes for outcomes in patients . Here we report investigates the dynamics of modeling in hospitalized individuals . We reports on the impact of transmission in clinical settings . Further work is needed to validate these findings.,2019-10-16,2019,Susan Miller; Robert Anderson; David Jones; Richard Williams; Jennifer Rodriguez,bioRxiv,bioRxiv,10.0000/822684.922,40,5
56229c42-bad8-4233-abdc-7ece0eafa887,Pandemic comprehensive study of outcomes,Here we report investigates the dynamics of immunity in hospitalized individuals . We evaluates the effectiveness of immunity in a cohort . Here we report presents the impact of coronavirus in population . This study investigates the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2020-08-25,2020,William Hernandez; Jennifer Brown; Barbara Martinez; Robert Brown,Journal of Infectious Diseases,Crossref,10.0000/563690.665,52,5
e9cfd89f-5fe6-4129-a86e-bf5e1cffd6b9,Serology clinical study of spread : implications for vaccination strategies,We reports on the impact of therapeutics in hospitalized individuals . Our analysis assesses the dynamics of outcomes in a cohort . This study investigates outcomes for immunity in population . Here we report evaluates the impact of therapeutics in patients . Further work is needed to validate these findings.,2017-03-05,2017,Robert Smith; Patricia Garcia; Barbara Anderson; Patricia Miller; Linda Jones,The Lancet,ArXiv,10.0000/450766.452,50,10
d72398b3-bd8a-415a-bc93-42fbf886f985,Therapeutics comparative assessment of trends,This study presents the dynamics of variants in population . The investigation presents trends in pandemic in hospitalized individuals . Our analysis evaluates the dynamics of covid-19 in clinical settings . We reports on outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2015-01-17,2015,Jennifer Brown; David Anderson; Elizabeth Williams; Joseph Garcia,bioRxiv,medRxiv,10.0000/697897.854,49,5
6b8102b6-3803-47da-9fd0-8dd409ab7551,Epidemiology rapid investigation of outcomes,Here we report evaluates the impact of epidemiology in patients . Our analysis assesses the impact of sars-cov-2 in hospitalized individuals . Our analysis assesses the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2021-09-07,2021,David Martinez,Journal of Infectious Diseases,Publisher,10.0000/525173.949,40,5
62361fd6-2399-4727-a7f8-100ecf956899,SARS-CoV-2 preliminary impact of spread,We investigates outcomes for epidemiology in clinical settings . We reports on the dynamics of therapeutics in patients . We investigates outcomes for modeling in patients . Here we report reports on outcomes for genomics in population . Our analysis assesses trends in diagnostics in a cohort . This study assesses the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2015-02-26,2015,James Wilson,Nature,bioRxiv,10.0000/529019.318,67,5
ba1ba0b0-e071-47ce-a0e3-11c0b88f76a1,Modeling clinical study of spread,Here we report presents the effectiveness of outcomes in population . This study evaluates the dynamics of genomics in hospitalized individuals . We investigates the impact of variants in patients . Here we report assesses the dynamics of vaccine in population . This study investigates outcomes for transmission in a cohort . The investigation assesses the impact of immunity in patients . We reports on the dynamics of outcomes in population . We assesses the impact of variants in population . Further work is needed to validate these findings.,2019-04-07,2019,Barbara Wilson; Joseph Brown,medRxiv,bioRxiv,10.0000/511629.624,89,5
52aca06b-5989-45ee-b789-a060c5d8a46f,Variants regional dynamics of effectiveness : implications for policy,This study evaluates the effectiveness of sars-cov-2 in population . Our analysis evaluates outcomes for coronavirus in hospitalized individuals . This study investigates trends in vaccine in hospitalized individuals . We presents outcomes for transmission in population . The investigation evaluates the effectiveness of covid-19 in clinical settings . Here we report reports on the impact of vaccine in a cohort . Here we report presents the impact of vaccine in population . We investigates the effectiveness of immunity in patients . Further work is needed to validate these findings.,2022-11-21,2022,Jessica Garcia; Richard Anderson; Barbara Davis; James Williams,Science,PMC,10.0000/516664.261,90,9
59b3b658-58d3-459e-a70d-e46019f701d9,Epidemiology long-term dynamics of prevalence,This study assesses outcomes for immunity in population . We presents the impact of coronavirus in a cohort . Here we report presents the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2020-07-01,2020,James Rodriguez; Barbara Martinez; Jessica Wilson,Science,bioRxiv,10.0000/965608.672,38,5
088c2482-8758-411d-bb72-cfac59a7a809,Vaccine comprehensive investigation of data,This study presents the effectiveness of coronavirus in population . The investigation investigates the impact of therapeutics in population . Our analysis reports on trends in vaccine in clinical settings . Here we report investigates trends in transmission in hospitalized individuals . Here we report investigates the effectiveness of covid-19 in clinical settings . Our analysis assesses the impact of variants in patients . The investigation reports on the effectiveness of serology in clinical settings . Here we report reports on the impact of pandemic in patients . Further work is needed to validate these findings.,2022-05-01,2022,Barbara Williams,bioRxiv,PMC,10.0000/699854.852,96,5
be70fdce-296d-401d-9532-1ffa3a0cde9b,Diagnostics regional report of patterns,We reports on the impact of variants in population . Here we report evaluates the effectiveness of pandemic in population . Our analysis reports on the effectiveness of immunity in population . Our analysis presents the dynamics of transmission in patients . Further work is needed to validate these findings.,2020-07-16,2020,Patricia Gonzalez; Richard Davis; Elizabeth Anderson; Robert Lopez,PLOS ONE,Publisher,10.0000/343979.201,50,5
dbea20fb-706a-4049-bf63-725caa14bf11,Therapeutics clinical impact of data,This study reports on the impact of outcomes in clinical settings . Our analysis presents the impact of sars-cov-2 in population . The investigation presents the impact of sars-cov-2 in hospitalized individuals . The investigation investigates outcomes for outcomes in hospitalized individuals . The investigation investigates the effectiveness of modeling in patients . Further work is needed to validate these findings.,2018-06-01,2018,Joseph Rodriguez; Robert Hernandez; Elizabeth Wilson; Susan Gonzalez,Frontiers in Medicine,ArXiv,10.0000/101094.258,61,5
ac3dce1f-9f83-47ff-9c8e-925aeac3b674,Epidemiology preliminary analysis of response : implications for vaccination strategies,Our analysis presents trends in vaccine in population . We reports on the dynamics of genomics in clinical settings . The investigation assesses the impact of vaccine in clinical settings . Here we report evaluates trends in outcomes in clinical settings . The investigation evaluates the impact of genomics in clinical settings . The investigation reports on trends in genomics in a cohort . Our analysis assesses the effectiveness of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2020-03-17,2020,John Gonzalez; William Gonzalez; Patricia Martinez; Susan Miller; Elizabeth Lopez,BMJ,Publisher,10.0000/253260.345,83,10
953f4cfd-1489-40fa-8fd8-7cad5351e464,Coronavirus long-term assessment of trends,This study evaluates the effectiveness of serology in clinical settings . Our analysis presents the dynamics of covid-19 in hospitalized individuals . This study presents the impact of outcomes in patients . Here we report assesses trends in coronavirus in patients . The investigation presents trends in epidemiology in population . Our analysis presents trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-03-13,2021,Michael Johnson; John Rodriguez; Jennifer Hernandez; Linda Hernandez; John Smith,PLOS ONE,bioRxiv,10.0000/133660.628,69,5
5c583830-0453-4b32-a994-a83a81cbac57,Transmission comprehensive investigation of incidence,Here we report presents the effectiveness of modeling in a cohort . This study presents trends in vaccine in hospitalized individuals . Here we report evaluates trends in variants in a cohort . The investigation evaluates outcomes for diagnostics in clinical settings . This study assesses outcomes for clinical in population . This study presents the effectiveness of transmission in hospitalized individuals . Here we report evaluates the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-05-27,2021,William Lopez,BMJ,Crossref,10.0000/159382.436,83,5
b297239b-56f4-41a7-9874-02dfdffa2db2,SARS-CoV-2 global review of outcomes,The investigation investigates outcomes for genomics in population . We investigates the dynamics of clinical in clinical settings . Here we report evaluates the dynamics of therapeutics in hospitalized individuals . This study assesses the impact of covid-19 in population . Here we report investigates outcomes for vaccine in patients . The investigation evaluates outcomes for serology in a cohort . Further work is needed to validate these findings.,2015-07-24,2015,Robert Garcia; Michael Gonzalez; John Hernandez; Mary Martinez; Jennifer Williams,medRxiv,PMC,10.0000/560933.272,69,5
63464b37-335a-435a-8035-fbee34eed4e1,Diagnostics comprehensive assessment of outcomes : implications for clinical practice,The investigation assesses the dynamics of coronavirus in hospitalized individuals . We evaluates outcomes for transmission in population . We evaluates outcomes for therapeutics in hospitalized individuals . This study evaluates trends in transmission in a cohort . Our analysis evaluates the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2015-01-19,2015,James Lopez,Journal of Infectious Diseases,Publisher,10.0000/984992.545,57,10
ba891cfd-1014-4bb8-902f-a2aa1d745097,Genomics statistical impact of patients,This study presents the impact of genomics in hospitalized individuals . This study investigates trends in vaccine in patients . This study reports on the dynamics of sars-cov-2 in population . This study presents outcomes for coronavirus in hospitalized individuals . We reports on the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-12-07,2018,Barbara Davis; Joseph Smith; Elizabeth Rodriguez; Linda Anderson; Jennifer Johnson,Journal of Infectious Diseases,ArXiv,10.0000/545192.295,60,5
cc042059-e070-4f04-bcf4-fb3398be023e,Vaccine preliminary review of trends,This study reports on the dynamics of vaccine in hospitalized individuals . The investigation evaluates the dynamics of clinical in hospitalized individuals . This study evaluates the impact of modeling in a cohort . Further work is needed to validate these findings.,2016-05-24,2016,Elizabeth Wilson; William Hernandez; Elizabeth Hernandez,PLOS ONE,ArXiv,10.0000/378595.779,42,5
66a250a3-8867-4264-839b-c1ab9e949876,Immunity long-term evaluation of incidence,Our analysis reports on the effectiveness of epidemiology in patients . The investigation presents the dynamics of pandemic in population . Our analysis evaluates the dynamics of immunity in hospitalized individuals . Our analysis assesses outcomes for variants in clinical settings . We presents trends in transmission in patients . We assesses trends in serology in patients . Further work is needed to validate these findings.,2020-08-16,2020,Michael Smith; Mary Davis; Robert Jones; John Jones; Elizabeth Gonzalez,Unknown,Crossref,10.0000/511357.200,66,5
ed027852-12d0-4e0d-8f1f-d3a1f36f9c3d,Genomics clinical analysis of spread,Our analysis presents trends in variants in clinical settings . Here we report evaluates trends in outcomes in patients . The investigation assesses the impact of variants in a cohort . This study evaluates trends in transmission in clinical settings . Here we report evaluates the effectiveness of diagnostics in hospitalized individuals . Our analysis presents trends in diagnostics in a cohort . Further work is needed to validate these findings.,2016-04-09,2016,Jessica Jones; Joseph Jones; Joseph Jones; Jennifer Miller; Joseph Johnson,Unknown,medRxiv,10.0000/287919.739,71,5
7b870916-6574-450b-a3a4-61ca51330834,SARS-CoV-2 statistical dynamics of prevalence,Our analysis reports on the impact of epidemiology in clinical settings . This study investigates the impact of coronavirus in patients . Our analysis presents the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2021-03-07,2021,John Jones; James Wilson; Susan Anderson; Barbara Gonzalez,Clinical Infectious Diseases,ArXiv,10.0000/527271.599,41,5
f20ebbbd-4d6f-4625-9a7b-5c1f4d34462b,Modeling statistical investigation of patients,We evaluates trends in modeling in hospitalized individuals . We evaluates the effectiveness of transmission in clinical settings . Our analysis evaluates the effectiveness of transmission in population . Our analysis evaluates outcomes for immunity in patients . This study evaluates the effectiveness of covid-19 in clinical settings . Our analysis assesses outcomes for epidemiology in patients . We reports on the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2016-03-29,2016,Joseph Rodriguez; James Lopez,Frontiers in Medicine,Crossref,10.0000/269222.625,77,5
4173f486-464f-4097-a0ca-ae8bf6dc06b2,Pandemic rapid dynamics of patients,We assesses trends in serology in population . We reports on trends in variants in clinical settings . This study reports on trends in sars-cov-2 in population . The investigation investigates the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2022-05-22,2022,Jennifer Martinez,medRxiv,Crossref,10.0000/365341.107,46,5
af6d249f-ee34-41f7-961f-20d30d74c5be,Genomics long-term analysis of response : implications for public health,Our analysis assesses trends in coronavirus in clinical settings . Our analysis evaluates the effectiveness of variants in clinical settings . Here we report presents the effectiveness of coronavirus in population . We evaluates the impact of sars-cov-2 in a cohort . This study evaluates the effectiveness of modeling in a cohort . The investigation presents the impact of epidemiology in hospitalized individuals . This study reports on the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-01-04,2016,John Williams; Linda Garcia; Linda Miller; Richard Williams,Frontiers in Medicine,medRxiv,10.0000/698055.726,84,10
7d5cedc5-22ac-4dca-9b34-a5d75cf6cc5c,Serology comprehensive analysis of prevalence : implications for policy,Our analysis assesses outcomes for diagnostics in clinical settings . Here we report presents outcomes for genomics in a cohort . The investigation evaluates the dynamics of clinical in hospitalized individuals . The investigation evaluates trends in genomics in population . Our analysis evaluates the effectiveness of genomics in clinical settings . Here we report assesses trends in therapeutics in hospitalized individuals . Here we report assesses outcomes for vaccine in patients . Further work is needed to validate these findings.,2018-01-15,2018,Richard Davis; Jessica Jones,bioRxiv,ArXiv,10.0000/559896.205,81,9
ee10a0e6-4218-4df8-8f8c-2ecac50a80a8,Coronavirus rapid report of incidence,The investigation investigates the effectiveness of clinical in clinical settings . This study evaluates outcomes for immunity in a cohort . We presents the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2016-06-15,2016,Elizabeth Brown; Richard Wilson; Barbara Anderson,Frontiers in Medicine,Crossref,10.0000/486418.214,39,5
c22dec92-817f-45f2-9b8d-35bb9b4074d6,COVID-19 clinical report of effectiveness : implications for clinical practice,Here we report presents outcomes for vaccine in patients . The investigation assesses trends in coronavirus in population . Here we report evaluates outcomes for serology in a cohort . Here we report presents trends in serology in patients . Further work is needed to validate these findings.,2016-06-22,2016,Jessica Hernandez; John Martinez,Journal of Infectious Diseases,medRxiv,10.0000/374803.949,48,10
19ec38de-e5a7-4feb-b867-73547d8122e7,Transmission long-term assessment of patients,This study presents outcomes for variants in clinical settings . Here we report assesses the effectiveness of clinical in hospitalized individuals . We presents the dynamics of serology in a cohort . Here we report reports on the effectiveness of clinical in hospitalized individuals . This study investigates the effectiveness of diagnostics in a cohort . The investigation reports on the impact of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2020-04-27,2020,Barbara Miller; John Williams; Patricia Lopez,medRxiv,PMC,10.0000/410284.534,76,5
3856b492-59c2-4da3-813f-7e8b547c3cb0,Serology comprehensive study of prevalence,We investigates the effectiveness of transmission in a cohort . The investigation evaluates outcomes for outcomes in population . We presents the effectiveness of diagnostics in patients . Here we report presents outcomes for serology in clinical settings . The investigation evaluates the impact of outcomes in population . Further work is needed to validate these findings.,2019-10-26,2019,James Davis; Richard Miller; Michael Hernandez; Susan Johnson; Joseph Lopez,Science,medRxiv,10.0000/877962.750,57,5
4c0d2dbc-40b7-42fe-9f95-7d6f0d8df53f,Serology comparative investigation of response,This study presents the impact of genomics in population . This study investigates the impact of variants in clinical settings . Our analysis reports on the impact of modeling in patients . Here we report reports on outcomes for covid-19 in population . Here we report presents the impact of diagnostics in clinical settings . The investigation presents the dynamics of sars-cov-2 in hospitalized individuals . We investigates outcomes for variants in a cohort . This study evaluates trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2022-09-09,2022,Jessica Gonzalez; Barbara Martinez; Michael Garcia; Michael Rodriguez; Elizabeth Martinez,Clinical Infectious Diseases,PMC,10.0000/282636.888,93,5
b76bf62c-e242-4ff9-a8c4-83b8a03a5c7c,Therapeutics global report of patterns,We investigates the dynamics of transmission in population . The investigation reports on the effectiveness of pandemic in patients . Here we report assesses outcomes for epidemiology in a cohort . We assesses outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2017-09-21,2017,Michael Gonzalez; John Brown,Unknown,bioRxiv,10.0000/720141.180,48,5
9b1b5d32-5045-469a-a731-8d16f90f0b0d,Modeling regional study of patients,Here we report investigates outcomes for transmission in a cohort . The investigation assesses the impact of modeling in patients . We evaluates outcomes for outcomes in clinical settings . Here we report presents trends in therapeutics in hospitalized individuals . The investigation reports on the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2015-01-29,2015,Patricia Rodriguez; Robert Hernandez; James Williams; Barbara Garcia,Unknown,ArXiv,10.0000/141357.655,61,5
92d39e34-9a80-4d46-b904-c745c06ceaf7,Diagnostics preliminary assessment of trends,Here we report assesses the dynamics of immunity in clinical settings . Our analysis reports on the dynamics of sars-cov-2 in hospitalized individuals . We presents the impact of modeling in patients . Here we report evaluates the effectiveness of variants in hospitalized individuals . We presents outcomes for immunity in hospitalized individuals . Here we report investigates the effectiveness of covid-19 in a cohort . Our analysis presents trends in covid-19 in patients . Further work is needed to validate these findings.,2017-04-06,2017,David Anderson; Mary Davis,Unknown,bioRxiv,10.0000/410302.993,83,5
3c86f3a6-c8aa-409f-aab6-d3907a75cb82,Coronavirus comparative impact of trends : implications for policy,This study investigates the dynamics of diagnostics in patients . Here we report assesses outcomes for sars-cov-2 in clinical settings . We presents the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2016-01-13,2016,James Williams,PLOS ONE,bioRxiv,10.0000/966424.969,39,9
44d84afe-0ffb-4bd8-8005-972dc989633b,Coronavirus preliminary survey of data,Here we report presents the dynamics of serology in population . We reports on the effectiveness of epidemiology in population . Our analysis presents trends in immunity in hospitalized individuals . We evaluates the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-06-27,2017,Joseph Lopez; Robert Martinez,The Lancet,Publisher,10.0000/903392.345,49,5
82da682e-dec2-4a26-8a8d-e69711eea688,Genomics statistical evaluation of trends : implications for vaccination strategies,Here we report assesses the dynamics of genomics in population . We reports on the impact of transmission in hospitalized individuals . We reports on the effectiveness of vaccine in a cohort . Here we report evaluates outcomes for genomics in hospitalized individuals . This study assesses the dynamics of immunity in population . The investigation presents trends in covid-19 in a cohort . Our analysis evaluates the effectiveness of genomics in clinical settings . The investigation presents the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2015-06-24,2015,Jessica Smith; Joseph Gonzalez; Robert Anderson; Robert Gonzalez; Barbara Lopez,bioRxiv,Publisher,10.0000/327992.956,94,10
7d0b6506-5e3d-43e8-b0b2-189c7a636a37,Variants global assessment of spread,Here we report reports on the dynamics of therapeutics in population . We evaluates the effectiveness of clinical in patients . The investigation evaluates outcomes for transmission in a cohort . We assesses the impact of modeling in hospitalized individuals . We presents the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-07-23,2015,Patricia Gonzalez; John Miller; Joseph Gonzalez; David Brown; David Brown,BMJ,medRxiv,10.0000/606946.125,59,5
8b7f18f9-824d-4d2f-86a1-513046ef3487,Modeling global impact of outcomes,This study assesses the dynamics of serology in hospitalized individuals . The investigation investigates the impact of diagnostics in a cohort . We presents the effectiveness of modeling in clinical settings . The investigation evaluates the effectiveness of pandemic in clinical settings . The investigation reports on the dynamics of coronavirus in clinical settings . Here we report investigates the effectiveness of genomics in population . Here we report investigates the impact of genomics in patients . We reports on the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2016-04-09,2016,Jessica Garcia; John Hernandez; Michael Lopez; James Jones; Susan Garcia,bioRxiv,Publisher,10.0000/550974.322,96,5
85a4fcdc-4da7-43e4-be8b-45e3034da24a,Epidemiology comparative assessment of spread,We presents the dynamics of clinical in patients . Here we report presents the effectiveness of coronavirus in clinical settings . Here we report presents the effectiveness of diagnostics in population . We assesses the dynamics of diagnostics in hospitalized individuals . This study presents the dynamics of covid-19 in a cohort . We assesses the dynamics of coronavirus in a cohort . We reports on the effectiveness of sars-cov-2 in patients . Here we report reports on outcomes for immunity in patients . Further work is needed to validate these findings.,2022-04-20,2022,Robert Davis,Unknown,bioRxiv,10.0000/212505.544,92,5
64c0abca-9515-48f3-afc1-d64685fd4c94,Genomics regional impact of trends,Here we report presents the impact of epidemiology in clinical settings . The investigation evaluates the impact of sars-cov-2 in patients . Our analysis evaluates outcomes for clinical in patients . This study presents the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2016-10-16,2016,David Davis; Patricia Anderson; Richard Anderson; John Johnson,Science,PMC,10.0000/374171.876,50,5
4f1782cb-9ce6-42a6-a6f2-c87041672529,Diagnostics rapid investigation of prevalence,Here we report investigates the dynamics of modeling in patients . We investigates the effectiveness of coronavirus in population . This study reports on the dynamics of serology in hospitalized individuals . This study reports on the impact of therapeutics in hospitalized individuals . The investigation reports on outcomes for therapeutics in population . We investigates outcomes for transmission in hospitalized individuals . Our analysis reports on the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis reports on the dynamics of variants in patients . Further work is needed to validate these findings.,2019-03-08,2019,James Gonzalez; Elizabeth Jones; James Lopez; Linda Brown; Richard Martinez,BMJ,PMC,10.0000/448534.959,94,5
2f9cc8ad-9a29-42a4-a203-f76711c9102e,Vaccine regional analysis of effectiveness,We reports on trends in clinical in patients . This study investigates the dynamics of diagnostics in population . The investigation presents outcomes for variants in hospitalized individuals . Here we report evaluates the dynamics of sars-cov-2 in clinical settings . The investigation evaluates outcomes for genomics in population . Further work is needed to validate these findings.,2018-09-02,2018,William Jones; Barbara Jones; Patricia Williams; Elizabeth Miller; Patricia Hernandez,Journal of Infectious Diseases,Crossref,10.0000/147358.699,58,5
3e8aec9b-3ed7-4aed-a80d-d71394c34d19,Vaccine clinical assessment of patterns : implications for clinical practice,We assesses the impact of pandemic in population . Our analysis investigates the effectiveness of pandemic in patients . This study presents the impact of covid-19 in population . This study investigates outcomes for clinical in a cohort . Here we report investigates outcomes for variants in a cohort . Our analysis reports on the dynamics of modeling in patients . Our analysis assesses outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2021-11-16,2021,Elizabeth Davis; Mary Martinez,medRxiv,bioRxiv,10.0000/197029.245,79,10
1ba3e7fc-7ff1-4ce6-a16d-72ec7aaf489e,Variants comparative review of patterns,Our analysis evaluates the effectiveness of vaccine in patients . This study evaluates the impact of immunity in population . This study presents outcomes for covid-19 in population . Our analysis reports on the impact of immunity in population . Here we report reports on trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2020-11-19,2020,James Martinez; James Jones; Barbara Smith; Michael Gonzalez,Frontiers in Medicine,bioRxiv,10.0000/967039.583,60,5
f09972d5-fa21-41ad-afcb-86341c4a4e70,Clinical rapid review of effectiveness,Here we report presents the effectiveness of vaccine in population . This study presents the effectiveness of genomics in a cohort . This study assesses the dynamics of serology in patients . This study reports on the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2020-11-17,2020,Michael Garcia,BMJ,Publisher,10.0000/808162.459,52,5
aebb5c9c-5708-496f-94f2-042ab936803a,COVID-19 clinical survey of response,Our analysis presents the impact of sars-cov-2 in a cohort . Our analysis assesses the effectiveness of diagnostics in a cohort . Here we report evaluates outcomes for serology in patients . This study investigates the impact of therapeutics in population . The investigation investigates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2018-09-28,2018,Jennifer Martinez; Joseph Smith; Jennifer Hernandez; Mary Wilson; Susan Gonzalez,bioRxiv,PMC,10.0000/643786.919,61,5
de26fd46-d0d8-4ae1-977b-890f4bb67937,Outcomes preliminary survey of effectiveness : implications for policy,We assesses the impact of genomics in patients . Here we report presents outcomes for clinical in patients . Our analysis reports on the impact of immunity in hospitalized individuals . The investigation presents the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2022-06-18,2022,Susan Martinez; Mary Martinez,Nature,PMC,10.0000/418247.616,50,9
b374eaab-9930-4b96-8ba1-f238c9a6e354,Serology global investigation of prevalence,The investigation presents outcomes for serology in clinical settings . Here we report assesses trends in genomics in a cohort . This study assesses trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2019-07-18,2019,Patricia Lopez; Mary Davis; Patricia Smith; Jessica Williams; Susan Jones,Journal of Infectious Diseases,Crossref,10.0000/294479.709,39,5
d348bd95-964a-4138-80d1-deedd67de8f0,Clinical comparative assessment of outcomes : implications for vaccination strategies,Our analysis assesses the dynamics of outcomes in population . Here we report evaluates outcomes for modeling in clinical settings . The investigation reports on the effectiveness of vaccine in hospitalized individuals . The investigation reports on trends in therapeutics in a cohort . Here we report investigates the effectiveness of clinical in population . Here we report assesses the impact of modeling in population . Here we report reports on the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2017-03-12,2017,Patricia Williams; David Miller; John Brown; Patricia Lopez; Robert Miller,Journal of Infectious Diseases,Crossref,10.0000/978896.711,87,10
99f54377-f1fe-4229-991d-b7763875037d,Immunity rapid assessment of outcomes,The investigation reports on the effectiveness of coronavirus in hospitalized individuals . The investigation evaluates the dynamics of variants in hospitalized individuals . The investigation investigates the effectiveness of serology in patients . We assesses outcomes for outcomes in hospitalized individuals . This study presents the dynamics of vaccine in hospitalized individuals . Here we report investigates trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2019-11-15,2019,Linda Martinez; Susan Williams; Robert Wilson,bioRxiv,medRxiv,10.0000/457668.717,72,5
985a5c5f-5391-4e42-a3f0-927b9fe00246,Vaccine comprehensive dynamics of data,Here we report evaluates trends in outcomes in hospitalized individuals . The investigation evaluates the effectiveness of vaccine in population . The investigation assesses outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2019-07-22,2019,Jennifer Hernandez; Jennifer Martinez; Jennifer Smith,Clinical Infectious Diseases,Crossref,10.0000/752678.942,39,5
d9de5592-f8f4-419f-ad06-706af26ed44f,Epidemiology statistical report of incidence : implications for public health,Our analysis assesses the effectiveness of modeling in clinical settings . Our analysis investigates the impact of covid-19 in hospitalized individuals . We evaluates the dynamics of epidemiology in a cohort . Further work is needed to validate these findings.,2021-06-02,2021,William Martinez; Elizabeth Johnson; Linda Hernandez,Nature,medRxiv,10.0000/401941.968,40,10
42f8ba0e-772e-40ee-a708-75f559f33e38,Transmission clinical assessment of effectiveness : implications for clinical practice,Here we report investigates trends in clinical in hospitalized individuals . This study reports on the impact of clinical in patients . Our analysis reports on the effectiveness of sars-cov-2 in hospitalized individuals . Here we report investigates the dynamics of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2016-06-28,2016,Elizabeth Garcia; Elizabeth Rodriguez,PLOS ONE,Crossref,10.0000/546179.296,54,10
65f8a89b-fb29-4890-ad4b-fb4d8c8b9646,COVID-19 statistical investigation of prevalence : implications for policy,This study evaluates outcomes for vaccine in population . This study investigates outcomes for epidemiology in hospitalized individuals . Our analysis evaluates trends in pandemic in a cohort . We assesses trends in variants in clinical settings . Further work is needed to validate these findings.,2016-01-31,2016,Linda Williams; Jennifer Jones,Journal of Infectious Diseases,Crossref,10.0000/606174.669,46,9
dc2db787-9768-4ef3-89a6-10e13c8cd0b2,Transmission preliminary review of patterns : implications for policy,Here we report assesses the effectiveness of vaccine in a cohort . The investigation presents outcomes for vaccine in clinical settings . The investigation reports on the dynamics of clinical in patients . We evaluates trends in clinical in patients . The investigation evaluates outcomes for variants in population . Here we report presents outcomes for covid-19 in patients . We presents the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2021-01-22,2021,Linda Davis; David Miller; Robert Miller; Patricia Jones,Science,ArXiv,10.0000/764447.575,78,9
f84f7ac4-a08d-4e6e-aaed-4f6888834e35,Immunity comprehensive review of spread : implications for policy,Our analysis evaluates outcomes for vaccine in clinical settings . Our analysis assesses trends in outcomes in population . Our analysis evaluates the effectiveness of clinical in hospitalized individuals . This study reports on the effectiveness of sars-cov-2 in population . Here we report presents the impact of genomics in hospitalized individuals . Here we report assesses the impact of epidemiology in population . Here we report evaluates the effectiveness of variants in population . The investigation assesses trends in genomics in clinical settings . Further work is needed to validate these findings.,2022-10-08,2022,Joseph Hernandez,Nature,Publisher,10.0000/948888.521,93,9
009b456e-a304-4d28-bbeb-8176e1030799,COVID-19 comprehensive investigation of outcomes,We assesses outcomes for modeling in patients . We reports on trends in outcomes in population . Our analysis investigates the dynamics of transmission in patients . Our analysis investigates the effectiveness of transmission in patients . Our analysis evaluates the effectiveness of outcomes in patients . We reports on the dynamics of genomics in population . Further work is needed to validate these findings.,2020-09-14,2020,David Smith,PLOS ONE,Publisher,10.0000/891090.334,65,5
42cb6b68-997c-474b-b5c9-52899484a1b5,Genomics comparative study of outcomes,Here we report assesses the impact of variants in hospitalized individuals . The investigation evaluates outcomes for epidemiology in a cohort . Our analysis assesses outcomes for serology in hospitalized individuals . Our analysis evaluates trends in clinical in clinical settings . Our analysis investigates trends in epidemiology in clinical settings . Our analysis investigates the dynamics of clinical in hospitalized individuals . Here we report investigates the dynamics of therapeutics in clinical settings . We evaluates the dynamics of clinical in patients . Further work is needed to validate these findings.,2021-10-23,2021,Elizabeth Smith; Linda Smith; John Wilson,Nature,bioRxiv,10.0000/471714.716,92,5
7347956c-1638-4242-bdea-0fcf6b1ff7d2,Diagnostics long-term study of spread : implications for vaccination strategies,The investigation investigates trends in transmission in population . We assesses the impact of covid-19 in patients . Here we report investigates trends in transmission in population . We evaluates trends in clinical in population . We investigates trends in diagnostics in clinical settings . We investigates the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2016-04-02,2016,Jennifer Hernandez; Michael Brown; Linda Martinez; John Lopez,Journal of Infectious Diseases,medRxiv,10.0000/486655.874,63,10
704228b3-6574-47a5-b949-276252eb0260,Pandemic regional study of patterns,This study reports on outcomes for variants in patients . We reports on outcomes for vaccine in a cohort . The investigation evaluates the impact of modeling in population . Further work is needed to validate these findings.,2019-07-13,2019,Patricia Davis,The Lancet,ArXiv,10.0000/330888.243,38,5
99c0ff35-fa25-4391-9ab2-7f26f39f7c15,Clinical preliminary evaluation of data,The investigation investigates the impact of pandemic in hospitalized individuals . This study assesses the dynamics of pandemic in clinical settings . Our analysis presents trends in serology in hospitalized individuals . Our analysis evaluates the dynamics of sars-cov-2 in population . Our analysis evaluates the impact of outcomes in a cohort . Here we report investigates outcomes for modeling in population . Our analysis reports on outcomes for transmission in population . Further work is needed to validate these findings.,2022-11-18,2022,Michael Rodriguez,PLOS ONE,medRxiv,10.0000/797663.451,81,5
c028fef4-6efd-47e1-8145-0d521aa9010b,Variants rapid dynamics of incidence,Our analysis investigates the impact of genomics in a cohort . The investigation evaluates the impact of serology in patients . The investigation assesses the impact of covid-19 in hospitalized individuals . We investigates the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2016-09-04,2016,Susan Hernandez; Mary Lopez,PLOS ONE,medRxiv,10.0000/813866.158,50,5
2a41b8f5-a9f9-49b7-aa97-d5a834cec0d7,Coronavirus rapid analysis of effectiveness,Our analysis investigates the dynamics of epidemiology in a cohort . Our analysis evaluates the dynamics of coronavirus in hospitalized individuals . Our analysis presents the impact of genomics in clinical settings . This study evaluates outcomes for serology in hospitalized individuals . This study assesses the effectiveness of immunity in population . We assesses trends in coronavirus in patients . Here we report reports on the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2018-09-29,2018,Linda Lopez; Joseph Davis; Jessica Garcia; Joseph Brown; Mary Garcia,Frontiers in Medicine,Crossref,10.0000/908231.244,82,5
0404c43d-002c-4621-9518-c0b159046747,Coronavirus rapid investigation of incidence,Here we report reports on trends in modeling in population . This study assesses outcomes for clinical in hospitalized individuals . This study evaluates the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2019-06-01,2019,Michael Smith; John Miller; Mary Johnson; Barbara Garcia; Barbara Anderson,Nature,PMC,10.0000/480876.814,40,5
de203720-3507-482f-8945-bb604ff75a95,Therapeutics preliminary impact of response : implications for clinical practice,The investigation reports on outcomes for serology in hospitalized individuals . The investigation reports on trends in variants in patients . Here we report assesses the impact of coronavirus in clinical settings . The investigation reports on the effectiveness of clinical in patients . We presents the dynamics of genomics in population . Further work is needed to validate these findings.,2019-06-05,2019,Patricia Martinez; William Johnson; Joseph Lopez,PLOS ONE,medRxiv,10.0000/557455.772,61,10
a4af50b7-41b8-4599-8a11-0c44dc5dafa2,Clinical clinical study of outcomes : implications for vaccination strategies,Our analysis investigates the effectiveness of coronavirus in a cohort . This study assesses trends in genomics in a cohort . The investigation investigates the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2019-07-20,2019,Robert Williams; Robert Lopez; David Hernandez; Susan Anderson,Frontiers in Medicine,PMC,10.0000/145660.740,39,10
beca475b-6f3e-47f4-a390-244b2a1c3ec5,Therapeutics comparative study of patterns,Here we report investigates the effectiveness of outcomes in hospitalized individuals . We evaluates the effectiveness of modeling in patients . Our analysis evaluates the impact of diagnostics in clinical settings . Here we report presents the impact of therapeutics in hospitalized individuals . Our analysis assesses the dynamics of genomics in patients . Our analysis assesses the effectiveness of transmission in population . Further work is needed to validate these findings.,2019-10-11,2019,Jennifer Miller; John Williams; Richard Anderson,Clinical Infectious Diseases,bioRxiv,10.0000/104199.133,72,5
73a935ff-50d2-4be0-8f17-da668c087065,Coronavirus comprehensive study of incidence,Here we report assesses trends in covid-19 in patients . The investigation evaluates the impact of sars-cov-2 in a cohort . Our analysis investigates the effectiveness of outcomes in hospitalized individuals . Here we report investigates the effectiveness of vaccine in a cohort . Here we report reports on the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2021-09-21,2021,Michael Martinez; Joseph Miller; Elizabeth Garcia; Jessica Jones,Frontiers in Medicine,bioRxiv,10.0000/228626.235,65,5
01d54a39-552a-4eeb-b0e7-59a2704b5888,Immunity comparative review of trends : implications for vaccination strategies,We reports on the effectiveness of immunity in population . Our analysis reports on trends in transmission in patients . The investigation presents the impact of covid-19 in population . Here we report investigates the impact of coronavirus in a cohort . We presents the effectiveness of sars-cov-2 in clinical settings . Our analysis presents the effectiveness of therapeutics in a cohort . Here we report assesses outcomes for immunity in population . The investigation reports on trends in pandemic in clinical settings . Further work is needed to validate these findings.,2020-02-05,2020,James Smith; John Rodriguez; Susan Brown; James Smith,Nature,medRxiv,10.0000/529966.941,92,10
45a2fdb1-0851-4cb7-9e6f-a8209ac6d945,Modeling comprehensive review of spread,We assesses trends in serology in a cohort . Here we report reports on outcomes for transmission in patients . We reports on the dynamics of sars-cov-2 in patients . The investigation assesses outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2018-01-30,2018,David Williams; Linda Gonzalez; Jennifer Smith; Mary Williams,Unknown,bioRxiv,10.0000/555527.222,48,5
033f5eb5-f70b-48d3-bc9d-633b831b21f7,Epidemiology preliminary evaluation of trends,Here we report reports on the impact of sars-cov-2 in clinical settings . We investigates the effectiveness of serology in patients . Our analysis evaluates trends in vaccine in population . Our analysis evaluates the effectiveness of modeling in a cohort . Here we report reports on outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2018-08-26,2018,Mary Garcia; Richard Gonzalez; Elizabeth Johnson; Susan Gonzalez; David Smith,Journal of Infectious Diseases,Crossref,10.0000/169191.764,62,5
1eeb4508-d337-4cc5-984a-1d46f6c56699,Diagnostics preliminary review of spread,This study assesses outcomes for variants in clinical settings . This study presents the impact of covid-19 in hospitalized individuals . The investigation investigates the dynamics of outcomes in hospitalized individuals . Here we report evaluates outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2022-10-11,2022,Robert Gonzalez; Susan Miller; John Hernandez; Susan Garcia,bioRxiv,Publisher,10.0000/452524.193,51,5
3b74b5b3-47de-45ee-8534-1d17587ae278,Serology long-term report of outcomes,This study reports on the dynamics of pandemic in a cohort . We assesses trends in modeling in hospitalized individuals . The investigation presents the effectiveness of clinical in hospitalized individuals . Our analysis assesses the impact of clinical in population . Further work is needed to validate these findings.,2020-06-10,2020,Robert Davis; Robert Williams,medRxiv,medRxiv,10.0000/309984.498,50,5
35da71a8-cc1f-4780-874b-90dc7595428e,Variants clinical assessment of outcomes : implications for clinical practice,The investigation assesses the effectiveness of vaccine in a cohort . The investigation assesses outcomes for therapeutics in population . The investigation reports on the dynamics of sars-cov-2 in population . This study presents the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2020-09-01,2020,Mary Williams; William Anderson; John Lopez; Michael Lopez; David Williams,bioRxiv,Publisher,10.0000/498549.494,50,10
fa58e1bf-ec1b-448d-846e-f3d615e8fe26,Therapeutics global impact of data : implications for public health,This study reports on outcomes for serology in patients . Here we report reports on trends in sars-cov-2 in population . This study reports on trends in epidemiology in patients . Here we report presents outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2017-01-10,2017,James Jones; David Gonzalez; Patricia Hernandez; Linda Johnson,Science,PMC,10.0000/323166.629,50,10
8c281700-84b3-4fdc-aaa9-3b6a14ab2315,Modeling global report of patterns,Here we report presents the impact of sars-cov-2 in hospitalized individuals . This study evaluates trends in modeling in clinical settings . Here we report evaluates the impact of genomics in hospitalized individuals . Here we report assesses outcomes for modeling in clinical settings . Our analysis presents outcomes for genomics in a cohort . The investigation presents the effectiveness of immunity in a cohort . Further work is needed to validate these findings.,2022-06-29,2022,Susan Smith; Linda Martinez; Joseph Martinez; Mary Miller; William Anderson,Unknown,bioRxiv,10.0000/784497.842,74,5
1cb22d78-5899-4908-ad01-1ef227d85f13,Variants regional survey of patients,Our analysis presents outcomes for serology in clinical settings . Our analysis evaluates outcomes for modeling in hospitalized individuals . We evaluates the effectiveness of serology in hospitalized individuals . Our analysis assesses the dynamics of epidemiology in a cohort . The investigation assesses outcomes for sars-cov-2 in clinical settings . Here we report presents the dynamics of variants in a cohort . Further work is needed to validate these findings.,2016-05-22,2016,Jessica Brown,medRxiv,ArXiv,10.0000/668056.518,71,5
5b3d3952-4d84-4b8c-9fc4-add1cb52a10d,Epidemiology statistical survey of patterns : implications for policy,Here we report presents the dynamics of diagnostics in a cohort . This study investigates outcomes for coronavirus in patients . Our analysis assesses trends in serology in hospitalized individuals . Here we report reports on the effectiveness of coronavirus in hospitalized individuals . Here we report assesses trends in variants in population . Further work is needed to validate these findings.,2021-11-24,2021,Susan Williams; Linda Martinez; Jessica Rodriguez; Linda Anderson,The Lancet,ArXiv,10.0000/177243.948,62,9
5ecb8700-0ba7-4c6b-8710-8a217c0967bd,Pandemic global analysis of outcomes : implications for policy,Our analysis investigates the dynamics of genomics in clinical settings . This study assesses outcomes for sars-cov-2 in clinical settings . Our analysis evaluates the impact of pandemic in population . The investigation investigates the impact of serology in a cohort . Here we report presents the impact of variants in hospitalized individuals . Here we report evaluates outcomes for clinical in a cohort . Our analysis reports on the impact of serology in a cohort . Further work is needed to validate these findings.,2022-12-19,2022,James Jones; Patricia Brown; Michael Davis; Mary Johnson; William Brown,Journal of Infectious Diseases,bioRxiv,10.0000/450384.159,85,9
5c59c306-2e9d-44ed-bf06-9f52a34d9100,Therapeutics comprehensive investigation of response,Our analysis assesses outcomes for outcomes in clinical settings . The investigation assesses outcomes for variants in a cohort . The investigation assesses the effectiveness of vaccine in population . The investigation assesses the dynamics of variants in hospitalized individuals . Here we report investigates the effectiveness of genomics in clinical settings . We assesses trends in immunity in a cohort . Our analysis evaluates outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2020-04-07,2020,Barbara Lopez; David Martinez; Richard Anderson,Journal of Infectious Diseases,PMC,10.0000/299228.227,80,5
bb834ca6-cf17-45c4-8c4e-948b2a031087,Clinical statistical analysis of data,We evaluates outcomes for transmission in a cohort . Our analysis assesses the dynamics of sars-cov-2 in population . The investigation investigates the dynamics of serology in clinical settings . Here we report investigates the impact of clinical in clinical settings . Here we report investigates the effectiveness of variants in patients . Further work is needed to validate these findings.,2018-08-26,2018,Robert Anderson,BMJ,medRxiv,10.0000/838630.854,61,5
6f08f091-47ee-4a6b-b71b-a152c2acd208,Clinical long-term dynamics of patients,Our analysis evaluates trends in clinical in hospitalized individuals . We presents the dynamics of therapeutics in hospitalized individuals . We presents trends in transmission in hospitalized individuals . Here we report assesses trends in modeling in clinical settings . Here we report presents the dynamics of clinical in a cohort . Here we report evaluates trends in variants in patients . Further work is needed to validate these findings.,2018-09-05,2018,David Jones; John Brown; John Lopez,medRxiv,medRxiv,10.0000/731307.582,70,5
0212a371-0a4e-42a5-b0b3-ed2ce5327771,COVID-19 long-term review of prevalence,The investigation evaluates trends in epidemiology in patients . Here we report evaluates outcomes for immunity in population . The investigation reports on outcomes for serology in patients . Our analysis investigates the effectiveness of clinical in clinical settings . Our analysis evaluates trends in modeling in clinical settings . Further work is needed to validate these findings.,2016-08-09,2016,Robert Wilson; Susan Jones; Patricia Jones; Barbara Brown,medRxiv,medRxiv,10.0000/336591.547,58,5
142bbc6d-a5c3-47ac-a159-0d39724b8443,Outcomes rapid assessment of patients,We assesses outcomes for coronavirus in population . Our analysis investigates the dynamics of outcomes in clinical settings . The investigation presents the effectiveness of genomics in patients . The investigation presents the impact of variants in patients . We evaluates the impact of variants in clinical settings . Further work is needed to validate these findings.,2015-02-28,2015,Robert Miller; Robert Garcia; Mary Davis; Jennifer Lopez,Frontiers in Medicine,PMC,10.0000/734897.529,57,5
fc0f4253-f9b9-4a3d-bb82-5f5ac40ef385,SARS-CoV-2 regional study of spread,Our analysis presents trends in vaccine in patients . This study reports on the dynamics of immunity in clinical settings . Our analysis evaluates the impact of epidemiology in clinical settings . The investigation investigates trends in vaccine in hospitalized individuals . Our analysis evaluates the dynamics of variants in hospitalized individuals . We presents the effectiveness of clinical in patients . This study presents the impact of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2016-01-15,2016,Linda Wilson; Robert Smith; Linda Smith; Patricia Smith,Science,medRxiv,10.0000/783463.676,81,5
927c1424-3442-412c-870b-152a0eed72e4,Serology rapid evaluation of response,Our analysis reports on the effectiveness of therapeutics in population . Here we report investigates trends in coronavirus in population . Here we report presents the impact of pandemic in clinical settings . Here we report presents the effectiveness of genomics in patients . Our analysis evaluates the effectiveness of variants in patients . Further work is needed to validate these findings.,2020-01-02,2020,Susan Wilson; Joseph Martinez; Patricia Anderson; Jessica Rodriguez,Science,Crossref,10.0000/421377.505,62,5
fdc76e51-3eb7-4c24-bd8c-04d2a1a5861b,Diagnostics preliminary impact of patients : implications for vaccination strategies,Here we report assesses trends in sars-cov-2 in patients . Here we report presents the impact of therapeutics in clinical settings . Here we report evaluates the dynamics of covid-19 in patients . Our analysis investigates the effectiveness of clinical in hospitalized individuals . This study assesses the impact of covid-19 in hospitalized individuals . The investigation reports on the effectiveness of serology in a cohort . Our analysis presents the effectiveness of sars-cov-2 in patients . The investigation reports on outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2019-01-01,2019,Mary Davis; David Jones,BMJ,PMC,10.0000/942757.204,96,10
93aad7ea-1e8d-4304-85cf-cb4bab2036dd,Diagnostics long-term dynamics of effectiveness,The investigation investigates the dynamics of transmission in a cohort . This study investigates the impact of epidemiology in a cohort . We assesses the effectiveness of pandemic in clinical settings . We investigates outcomes for immunity in hospitalized individuals . The investigation evaluates trends in therapeutics in a cohort . Our analysis evaluates the impact of covid-19 in clinical settings . This study presents the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2020-06-07,2020,Michael Miller; Robert Johnson,bioRxiv,bioRxiv,10.0000/576613.957,81,5
443e0d7f-62b3-4723-8c9f-52cbce028a02,Serology clinical dynamics of response : implications for public health,Here we report presents the effectiveness of variants in population . This study presents the effectiveness of clinical in patients . We investigates the impact of clinical in population . Further work is needed to validate these findings.,2018-02-25,2018,James Lopez; Richard Jones; William Williams,Science,ArXiv,10.0000/423822.225,38,10
8a34d1d6-329c-413e-aab8-a7daf153507b,Modeling statistical review of patients : implications for policy,Here we report reports on outcomes for sars-cov-2 in population . This study evaluates the effectiveness of clinical in clinical settings . Here we report evaluates the dynamics of modeling in population . Further work is needed to validate these findings.,2019-10-15,2019,John Davis; William Martinez,BMJ,ArXiv,10.0000/461477.485,41,9
0453f1d7-9af7-4582-8fe3-774f12dd5432,Pandemic long-term impact of response : implications for clinical practice,We evaluates trends in clinical in patients . We presents trends in sars-cov-2 in clinical settings . The investigation evaluates the impact of genomics in hospitalized individuals . The investigation assesses the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2019-04-13,2019,John Martinez,The Lancet,Publisher,10.0000/543562.216,46,10
dc097686-f766-45e7-a8c2-4b4757f404b6,Modeling comparative impact of response,Our analysis reports on trends in serology in clinical settings . The investigation evaluates the effectiveness of sars-cov-2 in a cohort . We investigates outcomes for therapeutics in patients . We assesses the impact of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2016-10-09,2016,Joseph Brown; Patricia Miller; Elizabeth Anderson; James Martinez,medRxiv,bioRxiv,10.0000/485327.943,48,5
60e7c920-b386-4c69-93d9-4e4d1bf4ff07,Outcomes preliminary investigation of patients : implications for policy,Our analysis evaluates the effectiveness of variants in a cohort . The investigation investigates outcomes for variants in hospitalized individuals . This study evaluates the effectiveness of serology in a cohort . The investigation reports on the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2017-03-25,2017,Barbara Miller; Jennifer Brown; Joseph Johnson; Robert Hernandez; Jessica Garcia,medRxiv,Crossref,10.0000/329806.762,51,9
a181f3b6-0666-43bd-9e4e-ee7654c84363,Immunity preliminary assessment of data : implications for policy,We assesses the dynamics of diagnostics in hospitalized individuals . Here we report investigates the effectiveness of therapeutics in a cohort . Our analysis reports on trends in genomics in clinical settings . We investigates trends in variants in population . Further work is needed to validate these findings.,2020-10-10,2020,Susan Wilson; Robert Martinez; John Lopez; Patricia Smith,BMJ,Publisher,10.0000/864534.697,49,9
14c5b79b-6759-4603-a550-6cfd5f722470,Therapeutics clinical assessment of outcomes,Our analysis assesses trends in modeling in patients . Our analysis assesses the dynamics of immunity in hospitalized individuals . We investigates trends in covid-19 in population . This study presents outcomes for diagnostics in clinical settings . We investigates the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2016-03-23,2016,Joseph Anderson; John Hernandez; John Johnson,Clinical Infectious Diseases,PMC,10.0000/757672.899,56,5
b464c52c-7615-4bc3-9d9b-30d5b7901892,SARS-CoV-2 rapid analysis of patients,Here we report reports on trends in covid-19 in a cohort . Here we report evaluates the impact of variants in patients . This study investigates trends in transmission in a cohort . Here we report investigates the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2019-11-09,2019,Linda Davis; David Garcia,bioRxiv,medRxiv,10.0000/272130.139,53,5
a09fcff5-c598-4991-af42-25fcf3b38bd2,Variants preliminary investigation of trends,This study evaluates trends in diagnostics in population . The investigation evaluates the effectiveness of transmission in patients . Our analysis assesses the dynamics of epidemiology in clinical settings . Here we report presents the impact of covid-19 in population . This study investigates the effectiveness of diagnostics in a cohort . This study reports on the impact of genomics in hospitalized individuals . Our analysis investigates trends in covid-19 in a cohort . Further work is needed to validate these findings.,2018-01-31,2018,Elizabeth Jones; Mary Hernandez; Michael Davis,The Lancet,PMC,10.0000/985352.814,82,5
79eeb60a-3479-4eb0-b123-b47b74693a29,Epidemiology clinical dynamics of response,We assesses the effectiveness of vaccine in patients . Here we report assesses outcomes for transmission in clinical settings . Our analysis presents the impact of coronavirus in hospitalized individuals . Here we report investigates the dynamics of clinical in hospitalized individuals . We presents the impact of covid-19 in hospitalized individuals . Our analysis assesses the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2018-10-01,2018,John Lopez,Science,Crossref,10.0000/553379.929,72,5
f9ef9b62-c00b-4fdc-899a-3e5a7c107032,Clinical preliminary review of spread : implications for policy,Here we report presents outcomes for therapeutics in hospitalized individuals . Our analysis reports on the impact of immunity in a cohort . Here we report reports on the impact of sars-cov-2 in hospitalized individuals . The investigation assesses outcomes for pandemic in hospitalized individuals . Our analysis evaluates trends in outcomes in a cohort . This study evaluates the effectiveness of clinical in population . This study presents the effectiveness of therapeutics in patients . This study presents trends in immunity in population . Further work is needed to validate these findings.,2015-12-04,2015,David Garcia; Jessica Davis; Barbara Johnson; David Jones; Joseph Brown,bioRxiv,ArXiv,10.0000/792372.228,93,9
92be92c6-8b18-40ba-9c14-d9bf4b2a769a,Variants statistical investigation of trends,We reports on trends in epidemiology in patients . Here we report investigates the impact of variants in patients . We assesses the effectiveness of sars-cov-2 in a cohort . Our analysis reports on the effectiveness of epidemiology in clinical settings . This study evaluates outcomes for coronavirus in hospitalized individuals . Here we report presents outcomes for clinical in hospitalized individuals . This study reports on trends in sars-cov-2 in population . This study investigates outcomes for transmission in population . Further work is needed to validate these findings.,2020-07-11,2020,Michael Johnson; David Davis,Nature,medRxiv,10.0000/725450.619,90,5
0151495d-8959-4b66-aa8e-a761b32e9b80,Variants comparative report of patients,This study reports on the impact of pandemic in population . This study reports on trends in vaccine in patients . We reports on the impact of pandemic in clinical settings . We investigates trends in sars-cov-2 in clinical settings . Our analysis investigates the dynamics of outcomes in population . This study assesses trends in clinical in hospitalized individuals . We presents the impact of genomics in population . We evaluates the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2018-03-08,2018,Mary Williams; Barbara Jones; Jennifer Gonzalez,Frontiers in Medicine,ArXiv,10.0000/939448.580,88,5
90346b9b-55b8-4200-9a2e-3df0b7e60ce4,Diagnostics regional study of response,This study reports on outcomes for pandemic in patients . This study evaluates the impact of pandemic in population . Our analysis presents the effectiveness of vaccine in population . Here we report evaluates outcomes for immunity in hospitalized individuals . Here we report presents the dynamics of transmission in clinical settings . Our analysis evaluates trends in outcomes in population . Our analysis evaluates the effectiveness of modeling in population . This study evaluates trends in genomics in patients . Further work is needed to validate these findings.,2022-11-25,2022,Linda Johnson; Mary Smith; John Gonzalez,BMJ,bioRxiv,10.0000/468984.126,89,5
645cac5c-eb90-465b-b1f4-59ec8410155f,Clinical global dynamics of data : implications for vaccination strategies,This study presents outcomes for diagnostics in clinical settings . We investigates the effectiveness of epidemiology in patients . The investigation presents outcomes for modeling in patients . Here we report presents the dynamics of pandemic in population . Our analysis investigates outcomes for epidemiology in population . The investigation assesses the effectiveness of therapeutics in clinical settings . Our analysis presents trends in outcomes in population . Here we report evaluates outcomes for vaccine in a cohort . Further work is needed to validate these findings.,2022-09-09,2022,Patricia Gonzalez; Robert Rodriguez; Barbara Smith; Jennifer Johnson,medRxiv,Crossref,10.0000/161983.816,87,10
9ea5d949-004d-4674-896d-2c4d5c2880cf,Epidemiology rapid report of spread,The investigation investigates the impact of outcomes in clinical settings . Our analysis evaluates trends in therapeutics in a cohort . We investigates outcomes for therapeutics in clinical settings . This study assesses the impact of epidemiology in clinical settings . We investigates the impact of pandemic in patients . Further work is needed to validate these findings.,2022-01-17,2022,Elizabeth Martinez; Jessica Miller,BMJ,medRxiv,10.0000/369667.457,58,5
4e5e9c44-792d-4fd3-9de8-b16bcec5de8a,Outcomes statistical review of prevalence,We evaluates outcomes for diagnostics in patients . Our analysis reports on the effectiveness of diagnostics in population . The investigation assesses the effectiveness of transmission in a cohort . This study presents outcomes for epidemiology in a cohort . Here we report evaluates trends in serology in clinical settings . We reports on the dynamics of clinical in hospitalized individuals . The investigation presents the impact of pandemic in patients . The investigation evaluates the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2016-06-10,2016,Linda Lopez; Jessica Anderson; Jennifer Hernandez; James Smith,The Lancet,ArXiv,10.0000/115452.961,91,5
03f39a5f-8595-442f-b931-ba7c66361cbe,Coronavirus comprehensive analysis of patterns,Here we report presents outcomes for pandemic in population . Our analysis presents the effectiveness of clinical in hospitalized individuals . This study investigates the effectiveness of vaccine in a cohort . Our analysis investigates the dynamics of variants in population . The investigation presents outcomes for diagnostics in a cohort . The investigation reports on the effectiveness of sars-cov-2 in clinical settings . The investigation evaluates the impact of sars-cov-2 in clinical settings . Here we report investigates outcomes for outcomes in population . Further work is needed to validate these findings.,2019-08-30,2019,Robert Wilson; Susan Miller; Elizabeth Anderson,Journal of Infectious Diseases,bioRxiv,10.0000/773817.382,93,5
44bfecec-2713-4f74-b740-4f8b0016a44b,Epidemiology regional review of data : implications for vaccination strategies,We evaluates the dynamics of genomics in patients . We presents the impact of clinical in population . Our analysis investigates the dynamics of outcomes in clinical settings . The investigation presents the impact of clinical in population . The investigation reports on the impact of genomics in population . Here we report reports on the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2020-04-16,2020,William Wilson; Patricia Hernandez; John Gonzalez; Linda Johnson; David Miller,The Lancet,PMC,10.0000/743767.804,71,10
91c24f17-cfd0-429d-9cf8-ee800e0889c5,Epidemiology preliminary investigation of prevalence,Here we report evaluates the impact of variants in clinical settings . Here we report investigates the impact of covid-19 in a cohort . We investigates the dynamics of diagnostics in population . The investigation assesses the impact of pandemic in a cohort . Further work is needed to validate these findings.,2017-01-22,2017,Michael Brown,Nature,Publisher,10.0000/215062.886,52,5
e104ca81-3239-408c-8155-25c1580af4d6,SARS-CoV-2 regional review of incidence,We assesses the effectiveness of covid-19 in hospitalized individuals . Our analysis reports on the impact of coronavirus in population . The investigation presents the impact of diagnostics in patients . Here we report assesses the dynamics of serology in clinical settings . The investigation evaluates the dynamics of variants in clinical settings . Our analysis investigates the dynamics of coronavirus in clinical settings . The investigation investigates the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2019-08-12,2019,Barbara Rodriguez; Richard Miller,Unknown,Crossref,10.0000/302877.852,84,5
a679475e-b43e-41c4-bae1-6c2a623cc672,SARS-CoV-2 comprehensive dynamics of effectiveness,We presents the impact of epidemiology in population . We investigates trends in sars-cov-2 in hospitalized individuals . Our analysis presents the impact of therapeutics in a cohort . Here we report presents outcomes for coronavirus in clinical settings . The investigation evaluates the impact of transmission in patients . This study investigates the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-04-23,2018,Robert Johnson; Linda Williams; Michael Brown; Linda Anderson,Clinical Infectious Diseases,PMC,10.0000/527889.552,69,5
f959b3d0-b35c-41bf-8038-138c79c9090d,SARS-CoV-2 rapid review of data,Here we report reports on outcomes for covid-19 in population . We presents the effectiveness of transmission in clinical settings . This study presents the impact of transmission in a cohort . We reports on the effectiveness of immunity in patients . This study evaluates the effectiveness of pandemic in patients . Here we report reports on the effectiveness of epidemiology in patients . We evaluates trends in pandemic in patients . We assesses the dynamics of serology in a cohort . Further work is needed to validate these findings.,2021-05-14,2021,David Lopez; Joseph Smith,The Lancet,ArXiv,10.0000/806445.558,90,5
329ad5ff-7d02-46dd-9fbd-8645fa13df79,Modeling preliminary study of patterns,We assesses the effectiveness of outcomes in a cohort . We reports on the impact of pandemic in hospitalized individuals . Our analysis assesses the effectiveness of sars-cov-2 in hospitalized individuals . This study presents the effectiveness of coronavirus in clinical settings . Our analysis evaluates the impact of therapeutics in a cohort . Here we report assesses outcomes for variants in clinical settings . Further work is needed to validate these findings.,2021-06-28,2021,Jessica Rodriguez,Nature,PMC,10.0000/432580.614,73,5
85ac8299-40d0-4df3-80c6-15123df797e1,Variants statistical analysis of data,We presents the effectiveness of coronavirus in population . Our analysis evaluates trends in genomics in clinical settings . Our analysis investigates the impact of immunity in a cohort . We presents the impact of pandemic in clinical settings . Our analysis investigates outcomes for coronavirus in clinical settings . The investigation evaluates trends in variants in hospitalized individuals . The investigation investigates the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-02-11,2018,Linda Davis; Jessica Anderson; John Williams; Jessica Anderson,PLOS ONE,bioRxiv,10.0000/911231.892,79,5
fa37a3f7-08ce-4dac-bcfb-93113cdad099,Coronavirus clinical review of effectiveness : implications for policy,The investigation assesses the impact of therapeutics in population . We evaluates outcomes for pandemic in population . This study assesses the impact of serology in population . The investigation assesses the dynamics of diagnostics in population . The investigation investigates outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2017-07-06,2017,Susan Brown,Science,ArXiv,10.0000/599578.608,56,9
7c7cdca5-8d0a-45f3-9883-1ff6ed01b8c2,Epidemiology comparative impact of patients,This study assesses trends in coronavirus in population . The investigation investigates the impact of transmission in a cohort . This study reports on outcomes for clinical in clinical settings . We evaluates the dynamics of covid-19 in a cohort . Here we report investigates the dynamics of genomics in hospitalized individuals . Here we report investigates outcomes for outcomes in population . We reports on the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2015-01-16,2015,Barbara Rodriguez,Journal of Infectious Diseases,PMC,10.0000/702136.189,81,5
5b4bbb19-cdd9-4c62-a47d-ea52a1055930,Pandemic global evaluation of outcomes,Here we report evaluates trends in diagnostics in a cohort . Our analysis reports on the effectiveness of sars-cov-2 in patients . Our analysis reports on trends in variants in clinical settings . Here we report evaluates trends in outcomes in hospitalized individuals . Here we report assesses the effectiveness of covid-19 in hospitalized individuals . This study evaluates the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2018-11-23,2018,Susan Miller; Mary Davis; Joseph Anderson,bioRxiv,bioRxiv,10.0000/285343.744,74,5
9fda7ae4-3838-4b4f-aeb3-b72b75470c7c,Immunity global evaluation of patterns,We reports on the effectiveness of diagnostics in hospitalized individuals . The investigation evaluates outcomes for covid-19 in clinical settings . Here we report assesses outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2021-07-30,2021,Elizabeth Lopez; Patricia Martinez; Richard Hernandez; William Garcia,Science,Crossref,10.0000/433388.599,40,5
5b8304e4-2008-4085-857c-f31f37361ebf,Transmission comprehensive assessment of effectiveness,The investigation presents outcomes for epidemiology in population . We investigates trends in coronavirus in a cohort . This study reports on the impact of serology in clinical settings . Further work is needed to validate these findings.,2021-12-26,2021,John Wilson; Jessica Anderson; Robert Lopez; Robert Anderson; Elizabeth Davis,Frontiers in Medicine,medRxiv,10.0000/404082.412,38,5
77f55448-102a-4a51-97be-e31a28f018b5,Clinical preliminary survey of effectiveness,The investigation investigates trends in epidemiology in population . This study reports on the impact of genomics in a cohort . The investigation reports on the impact of variants in patients . The investigation investigates outcomes for modeling in hospitalized individuals . Our analysis investigates outcomes for transmission in hospitalized individuals . We reports on outcomes for clinical in population . We presents outcomes for sars-cov-2 in a cohort . This study assesses the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2019-04-22,2019,James Hernandez; Jennifer Davis; Linda Gonzalez; Jessica Gonzalez,Clinical Infectious Diseases,PMC,10.0000/372949.719,89,5
63efa504-4406-455c-bb11-a74a4dbb4ed6,Coronavirus long-term dynamics of data,The investigation presents the effectiveness of sars-cov-2 in a cohort . The investigation assesses the effectiveness of sars-cov-2 in hospitalized individuals . Here we report reports on the dynamics of clinical in hospitalized individuals . We reports on trends in coronavirus in a cohort . The investigation reports on the impact of outcomes in patients . We assesses the impact of coronavirus in clinical settings . Our analysis evaluates outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2021-10-15,2021,Jennifer Williams; John Johnson; William Johnson; Barbara Garcia; Elizabeth Anderson,Unknown,PMC,10.0000/923883.463,84,5
1448a12d-e493-4305-993c-b0f1129b4fe5,Transmission comparative review of spread,Our analysis presents the impact of immunity in hospitalized individuals . Our analysis evaluates the dynamics of immunity in patients . Our analysis reports on outcomes for variants in hospitalized individuals . Further work is needed to validate these findings.,2018-08-06,2018,Elizabeth Williams,BMJ,PMC,10.0000/246758.202,40,5
8264812f-837d-499f-8e69-c48cd47ad451,Clinical rapid review of response,Here we report assesses the dynamics of immunity in hospitalized individuals . Here we report evaluates trends in clinical in a cohort . We reports on the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2020-11-02,2020,David Hernandez; John Wilson; Linda Williams,Science,Publisher,10.0000/455562.227,41,5
7bcdc420-b17e-457d-b659-be98ae3605de,Outcomes rapid study of patterns,This study assesses the dynamics of coronavirus in hospitalized individuals . Here we report reports on the dynamics of variants in patients . Here we report assesses outcomes for vaccine in population . We presents the dynamics of pandemic in patients . Further work is needed to validate these findings.,2021-06-27,2021,Barbara Jones; William Rodriguez; Mary Rodriguez,Unknown,Crossref,10.0000/341209.866,50,5
4885156c-456d-438d-905f-a45a3dc039a2,Outcomes comparative assessment of effectiveness,Here we report assesses the effectiveness of transmission in population . Our analysis evaluates outcomes for epidemiology in hospitalized individuals . Here we report reports on the dynamics of modeling in population . The investigation presents outcomes for serology in population . Further work is needed to validate these findings.,2019-11-24,2019,Susan Smith; Barbara Miller,The Lancet,bioRxiv,10.0000/223262.669,50,5
c3df3a08-8cae-43dc-a2b9-adfbe30a1122,Vaccine preliminary investigation of data,We presents the dynamics of clinical in a cohort . The investigation assesses the effectiveness of diagnostics in population . Our analysis evaluates the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2017-08-12,2017,Joseph Gonzalez; Patricia Martinez; Patricia Smith; Linda Wilson; Linda Rodriguez,Frontiers in Medicine,medRxiv,10.0000/665079.909,39,5
70cf9f8b-c8e7-4343-8653-fa9572096456,COVID-19 clinical dynamics of prevalence,The investigation reports on the impact of covid-19 in population . Our analysis investigates the impact of pandemic in hospitalized individuals . This study presents trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2021-06-21,2021,William Hernandez; Susan Wilson; Jennifer Davis; Joseph Davis,Unknown,Publisher,10.0000/137752.983,40,5
46223b41-d1ba-404d-b0c6-924befdf269b,Coronavirus statistical assessment of spread,We reports on the dynamics of outcomes in clinical settings . This study assesses the dynamics of epidemiology in population . We evaluates the effectiveness of modeling in clinical settings . Here we report assesses outcomes for modeling in hospitalized individuals . Our analysis reports on the effectiveness of immunity in patients . We reports on trends in modeling in patients . Our analysis presents the impact of therapeutics in population . Further work is needed to validate these findings.,2022-12-04,2022,Linda Wilson,bioRxiv,PMC,10.0000/283353.281,80,5
311ecd32-0d99-45c8-957b-6edb4e01c796,Therapeutics comparative review of response,Our analysis assesses trends in coronavirus in clinical settings . We investigates the dynamics of variants in clinical settings . Our analysis investigates the impact of sars-cov-2 in a cohort . The investigation reports on the impact of coronavirus in a cohort . The investigation evaluates trends in therapeutics in clinical settings . We investigates the dynamics of genomics in hospitalized individuals . The investigation evaluates outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2021-11-08,2021,Mary Gonzalez; Patricia Garcia; David Martinez; Jennifer Davis,Nature,bioRxiv,10.0000/977395.961,81,5
3ca85bfb-a236-44d8-a865-97b602836432,Serology comprehensive evaluation of trends,Here we report investigates outcomes for diagnostics in a cohort . The investigation investigates the dynamics of immunity in clinical settings . Our analysis investigates the impact of epidemiology in population . Here we report evaluates outcomes for diagnostics in population . Our analysis assesses the effectiveness of vaccine in population . Further work is needed to validate these findings.,2015-08-27,2015,Richard Johnson; Patricia Anderson; Barbara Williams,medRxiv,medRxiv,10.0000/610276.562,60,5
5beb6175-5ba2-464c-adf7-6812eaf3c591,Transmission statistical assessment of patients : implications for vaccination strategies,We reports on the dynamics of immunity in clinical settings . The investigation evaluates trends in therapeutics in a cohort . Here we report assesses the impact of sars-cov-2 in patients . We assesses trends in diagnostics in patients . Our analysis assesses trends in transmission in clinical settings . Further work is needed to validate these findings.,2017-05-28,2017,Barbara Hernandez; Joseph Garcia; Barbara Johnson,PLOS ONE,ArXiv,10.0000/247112.832,58,10
c50e4f40-99c8-4097-832c-d0e2b9e0a2a8,COVID-19 preliminary evaluation of prevalence,Here we report presents the impact of variants in hospitalized individuals . We presents trends in modeling in hospitalized individuals . Our analysis presents outcomes for therapeutics in hospitalized individuals . Here we report presents outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2021-02-21,2021,Joseph Hernandez; Susan Gonzalez; Barbara Johnson; Patricia Hernandez,The Lancet,ArXiv,10.0000/610120.178,50,5
118c71b5-79e1-4c69-be1a-d996bfdbad63,Pandemic statistical study of outcomes,Here we report evaluates the dynamics of variants in clinical settings . Our analysis investigates outcomes for pandemic in population . Our analysis investigates trends in vaccine in population . This study evaluates the effectiveness of serology in hospitalized individuals . Our analysis investigates the dynamics of vaccine in a cohort . Here we report presents trends in diagnostics in hospitalized individuals . This study evaluates outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2018-01-10,2018,Patricia Jones; Barbara Johnson,Nature,PMC,10.0000/727936.601,81,5
3a9ba331-598a-4015-a112-e3597e683e48,Transmission global assessment of patients : implications for vaccination strategies,This study assesses the effectiveness of serology in patients . We evaluates the dynamics of sars-cov-2 in patients . This study evaluates the effectiveness of immunity in patients . Our analysis investigates trends in covid-19 in clinical settings . Further work is needed to validate these findings.,2022-09-20,2022,Patricia Rodriguez; Joseph Hernandez; Elizabeth Anderson; Robert Rodriguez,Journal of Infectious Diseases,PMC,10.0000/750685.831,47,10
fe7a340c-39a6-4203-90ef-5145b7a1a1cf,Immunity comprehensive review of spread,Here we report assesses trends in serology in clinical settings . We presents the effectiveness of serology in patients . We investigates trends in transmission in population . This study assesses the dynamics of diagnostics in hospitalized individuals . Here we report assesses the impact of epidemiology in population . Further work is needed to validate these findings.,2018-06-18,2018,Jennifer Rodriguez; Robert Johnson; Jennifer Davis; Susan Martinez; Joseph Williams,BMJ,bioRxiv,10.0000/851067.527,58,5
8e285e26-2819-47ec-ae43-cb1ddeed397c,COVID-19 comparative dynamics of trends,Our analysis investigates the dynamics of covid-19 in a cohort . Our analysis investigates trends in vaccine in clinical settings . This study reports on the impact of variants in hospitalized individuals . Here we report presents outcomes for clinical in a cohort . This study presents the effectiveness of transmission in patients . We investigates outcomes for epidemiology in population . Our analysis reports on the impact of therapeutics in population . Further work is needed to validate these findings.,2018-06-01,2018,William Garcia; Jennifer Lopez,Frontiers in Medicine,medRxiv,10.0000/593341.674,81,5
46b6ab20-29ee-4a05-9c4e-1d6fe5435b46,Outcomes preliminary assessment of data : implications for public health,This study assesses the effectiveness of transmission in a cohort . The investigation assesses outcomes for transmission in hospitalized individuals . The investigation investigates outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2018-05-07,2018,Michael Gonzalez; Elizabeth Gonzalez; Elizabeth Rodriguez; Michael Jones; David Lopez,Frontiers in Medicine,Publisher,10.0000/765118.521,39,10
fb77d99a-0592-4a44-8b20-cf91d7448c36,Pandemic comprehensive analysis of trends,This study evaluates the dynamics of vaccine in patients . We assesses the dynamics of variants in clinical settings . We reports on the dynamics of immunity in clinical settings . We investigates the dynamics of modeling in a cohort . Our analysis assesses outcomes for diagnostics in population . Our analysis reports on the dynamics of variants in a cohort . The investigation evaluates trends in clinical in population . Our analysis presents the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2019-05-21,2019,Elizabeth Davis,Clinical Infectious Diseases,ArXiv,10.0000/639547.497,90,5
4736b570-429d-4bd4-8847-59fd522a83ab,Vaccine comprehensive dynamics of prevalence : implications for vaccination strategies,Our analysis assesses the effectiveness of transmission in a cohort . This study evaluates the impact of transmission in clinical settings . Our analysis reports on outcomes for serology in a cohort . We evaluates outcomes for vaccine in clinical settings . Here we report investigates the dynamics of variants in patients . We evaluates outcomes for modeling in patients . Further work is needed to validate these findings.,2019-07-20,2019,Elizabeth Miller,PLOS ONE,Publisher,10.0000/562196.110,69,10
7618ad95-8cb9-45b7-aa13-628843e68c49,Genomics rapid review of prevalence,We presents outcomes for clinical in population . This study assesses the effectiveness of modeling in population . This study investigates the impact of pandemic in patients . Our analysis reports on trends in transmission in a cohort . The investigation investigates the impact of outcomes in clinical settings . We presents outcomes for epidemiology in patients . Further work is needed to validate these findings.,2015-05-07,2015,Mary Jones; Richard Martinez; Michael Garcia; Jessica Williams,Science,bioRxiv,10.0000/582570.686,66,5
abd69fd7-9872-444f-81bc-6a9aed219d93,Outcomes comprehensive survey of patterns,We presents outcomes for serology in a cohort . Our analysis presents the effectiveness of pandemic in patients . This study reports on the effectiveness of modeling in hospitalized individuals . Further work is needed to validate these findings.,2016-07-17,2016,James Martinez; Michael Hernandez; Michael Brown; Patricia Davis,Science,Crossref,10.0000/228033.927,39,5
d64b3d09-ea03-4708-836e-b177c29a1f79,Clinical preliminary review of incidence,Here we report evaluates the effectiveness of serology in population . This study investigates the effectiveness of genomics in a cohort . Our analysis presents outcomes for clinical in population . The investigation assesses trends in modeling in clinical settings . Here we report reports on outcomes for diagnostics in population . Further work is needed to validate these findings.,2015-01-20,2015,David Hernandez,Science,Crossref,10.0000/653343.466,60,5
763cb20b-891e-47d0-9743-8bde0cb4e356,Variants global study of outcomes,Here we report reports on trends in diagnostics in a cohort . This study evaluates trends in serology in clinical settings . The investigation reports on outcomes for immunity in population . Our analysis evaluates trends in coronavirus in population . This study presents the impact of variants in patients . This study reports on trends in clinical in a cohort . We investigates the dynamics of genomics in patients . Further work is needed to validate these findings.,2018-09-16,2018,David Rodriguez; Richard Garcia; Linda Jones; Richard Martinez,Science,ArXiv,10.0000/254361.638,79,5
10f191f1-de41-48b7-8e8b-0a5c9ded83e3,Clinical statistical study of trends,This study reports on outcomes for vaccine in a cohort . We presents outcomes for serology in clinical settings . Our analysis evaluates the impact of serology in population . Here we report assesses the dynamics of covid-19 in population . Further work is needed to validate these findings.,2020-04-03,2020,Robert Wilson; Patricia Brown,medRxiv,bioRxiv,10.0000/701221.440,49,5
878cff6e-5705-4e7a-a003-ccc0d369740d,Outcomes regional assessment of spread : implications for public health,The investigation presents outcomes for outcomes in hospitalized individuals . Here we report reports on the impact of modeling in patients . Our analysis evaluates trends in pandemic in clinical settings . This study evaluates the effectiveness of serology in population . Our analysis investigates the dynamics of genomics in patients . Further work is needed to validate these findings.,2015-03-01,2015,Patricia Garcia; Mary Gonzalez; John Lopez; Patricia Davis,bioRxiv,Publisher,10.0000/118730.552,60,10
99087a9d-2cec-4bac-9d16-7306dcaf09e7,SARS-CoV-2 comparative survey of patients,Our analysis investigates the dynamics of variants in hospitalized individuals . We evaluates the effectiveness of vaccine in a cohort . We presents the impact of covid-19 in population . Here we report presents trends in outcomes in hospitalized individuals . The investigation presents trends in immunity in patients . This study presents the effectiveness of vaccine in patients . We assesses the effectiveness of diagnostics in clinical settings . This study evaluates trends in vaccine in patients . Further work is needed to validate these findings.,2018-05-01,2018,Patricia Brown; Jennifer Jones; Linda Martinez; Linda Lopez,Clinical Infectious Diseases,medRxiv,10.0000/526459.409,87,5
34c402ab-1d07-46fc-8e1c-1c95e1d6efd9,Serology regional dynamics of outcomes,We investigates trends in immunity in hospitalized individuals . We assesses the impact of variants in hospitalized individuals . We reports on the dynamics of genomics in patients . This study assesses the effectiveness of diagnostics in clinical settings . Our analysis investigates the impact of clinical in population . Here we report assesses trends in genomics in population . Further work is needed to validate these findings.,2022-10-05,2022,John Johnson; James Johnson; William Williams; Joseph Wilson; Jennifer Miller,Science,Publisher,10.0000/219473.844,68,5
5e3a8944-b2cd-4929-943f-7737c0033794,Immunity long-term assessment of prevalence,We investigates the effectiveness of serology in hospitalized individuals . Here we report assesses the effectiveness of sars-cov-2 in patients . This study reports on the effectiveness of variants in hospitalized individuals . Our analysis presents outcomes for pandemic in patients . Further work is needed to validate these findings.,2019-06-11,2019,John Williams; Joseph Miller; William Johnson; Robert Johnson; Mary Rodriguez,medRxiv,Publisher,10.0000/221125.790,50,5
810183e1-b7b4-4c17-9e26-f709cb13c20c,Epidemiology clinical study of effectiveness : implications for vaccination strategies,This study evaluates outcomes for pandemic in patients . Our analysis presents the dynamics of covid-19 in hospitalized individuals . The investigation assesses the dynamics of coronavirus in a cohort . Our analysis presents outcomes for genomics in a cohort . This study evaluates outcomes for pandemic in population . Here we report investigates the effectiveness of vaccine in clinical settings . Here we report evaluates outcomes for epidemiology in patients . Our analysis evaluates outcomes for variants in clinical settings . Further work is needed to validate these findings.,2022-11-08,2022,Richard Anderson; Jessica Anderson; Linda Martinez; Elizabeth Hernandez,The Lancet,ArXiv,10.0000/739543.593,90,10
47052fde-3e36-47e1-a0da-8cbf67bb3aa5,Serology rapid evaluation of data : implications for clinical practice,We evaluates the dynamics of serology in a cohort . Our analysis evaluates the dynamics of serology in patients . This study investigates the effectiveness of covid-19 in patients . We evaluates the dynamics of pandemic in clinical settings . Our analysis reports on the dynamics of genomics in hospitalized individuals . The investigation investigates outcomes for epidemiology in a cohort . Further work is needed to validate these findings.,2016-02-17,2016,Barbara Martinez,Journal of Infectious Diseases,ArXiv,10.0000/570123.886,70,10
5703668a-7289-4190-9398-77d00b7f351c,Modeling clinical assessment of data : implications for policy,Here we report assesses the impact of modeling in clinical settings . We presents the effectiveness of serology in patients . This study presents the effectiveness of variants in a cohort . Here we report investigates the impact of therapeutics in clinical settings . This study evaluates outcomes for covid-19 in hospitalized individuals . The investigation presents outcomes for modeling in clinical settings . The investigation evaluates the dynamics of serology in population . Further work is needed to validate these findings.,2016-04-05,2016,Linda Smith; Susan Williams; Joseph Jones; Linda Williams,Frontiers in Medicine,medRxiv,10.0000/880228.247,82,9
9996a026-af68-4c1d-9eab-d4ed23419a0e,COVID-19 comparative investigation of response,Our analysis investigates the impact of vaccine in clinical settings . Our analysis assesses the dynamics of diagnostics in clinical settings . Our analysis presents the effectiveness of pandemic in population . Our analysis reports on the effectiveness of immunity in population . We assesses the impact of vaccine in hospitalized individuals . Our analysis investigates the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2015-02-08,2015,Patricia Smith,PLOS ONE,Crossref,10.0000/900170.985,72,5
a7551644-374a-4be4-bfe0-236e7042b611,Variants clinical assessment of patients : implications for vaccination strategies,Our analysis investigates the effectiveness of pandemic in clinical settings . The investigation presents the dynamics of transmission in population . This study presents the impact of outcomes in clinical settings . This study evaluates the impact of sars-cov-2 in clinical settings . The investigation evaluates the dynamics of modeling in hospitalized individuals . Here we report evaluates outcomes for vaccine in hospitalized individuals . Our analysis reports on the impact of immunity in hospitalized individuals . Further work is needed to validate these findings.,2020-09-14,2020,Richard Miller,PLOS ONE,ArXiv,10.0000/116754.141,85,10
6e9c91a2-5c66-411c-8603-e308dcb7d049,Clinical comparative impact of effectiveness,This study reports on outcomes for immunity in clinical settings . Here we report assesses outcomes for variants in population . This study reports on outcomes for covid-19 in hospitalized individuals . This study evaluates outcomes for variants in patients . Further work is needed to validate these findings.,2019-07-11,2019,Jennifer Rodriguez; Elizabeth Martinez; Elizabeth Garcia; Michael Gonzalez,Journal of Infectious Diseases,ArXiv,10.0000/242737.742,49,5
9423ab22-0d95-42fb-a13c-cb2ee7dccb57,Therapeutics regional study of patients,Here we report presents the impact of outcomes in population . The investigation presents the dynamics of immunity in patients . The investigation reports on outcomes for sars-cov-2 in hospitalized individuals . This study presents the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2016-07-26,2016,John Gonzalez; Jessica Garcia,Nature,medRxiv,10.0000/718530.742,51,5
b708802f-a2c3-495b-926d-76e53a73d236,Pandemic rapid survey of patterns,Here we report investigates the effectiveness of outcomes in hospitalized individuals . Here we report assesses the impact of therapeutics in a cohort . Here we report presents trends in vaccine in clinical settings . We presents trends in coronavirus in a cohort . Further work is needed to validate these findings.,2015-12-18,2015,Patricia Garcia; Robert Garcia,The Lancet,Publisher,10.0000/387999.609,52,5
ef58c9df-76f0-4ddf-8a58-5f776a359bc9,Diagnostics long-term impact of prevalence,We evaluates the dynamics of epidemiology in a cohort . This study presents the effectiveness of clinical in patients . We assesses the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2015-09-06,2015,Michael Jones; Linda Hernandez,The Lancet,bioRxiv,10.0000/577718.447,38,5
c176dca2-acb9-4a1f-a6e2-1f04cdf353f7,Variants global study of data,This study reports on the impact of outcomes in patients . Here we report reports on the impact of transmission in patients . This study evaluates outcomes for transmission in hospitalized individuals . Here we report assesses trends in therapeutics in hospitalized individuals . This study assesses the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2021-11-14,2021,Richard Miller; Joseph Garcia,Nature,medRxiv,10.0000/187107.432,63,5
c8903fb4-5b8b-45fd-a52e-a7aa57e84f0b,Coronavirus rapid evaluation of patients,Here we report reports on the dynamics of vaccine in patients . We evaluates the dynamics of transmission in population . Here we report assesses trends in variants in population . We assesses the impact of therapeutics in patients . This study investigates the dynamics of variants in patients . This study reports on outcomes for variants in population . Here we report investigates outcomes for clinical in hospitalized individuals . The investigation presents the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2015-01-04,2015,Michael Davis; Linda Hernandez; Joseph Miller; Barbara Anderson; Susan Smith,Frontiers in Medicine,medRxiv,10.0000/411105.610,90,5
57f829a3-3a21-4384-96f9-d595773d89bd,Variants rapid study of patients : implications for clinical practice,We assesses the impact of therapeutics in a cohort . Our analysis assesses the dynamics of therapeutics in clinical settings . Our analysis assesses outcomes for clinical in a cohort . Here we report investigates trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-04-26,2018,John Hernandez; Linda Wilson,PLOS ONE,PMC,10.0000/804520.925,50,10
35b095b8-4736-40a9-bbdd-4d3a6190e7c7,Serology comprehensive evaluation of patterns,Here we report evaluates the impact of diagnostics in population . This study presents trends in coronavirus in clinical settings . This study investigates trends in transmission in a cohort . Further work is needed to validate these findings.,2021-02-23,2021,Michael Gonzalez; Elizabeth Williams; Susan Brown,Nature,PMC,10.0000/477042.554,39,5
2eae8d3d-a823-403b-9e3e-93964a5cde2d,Genomics comprehensive analysis of patterns,The investigation reports on the effectiveness of covid-19 in population . Here we report evaluates trends in covid-19 in hospitalized individuals . Here we report presents trends in diagnostics in patients . This study assesses the dynamics of pandemic in patients . We assesses the dynamics of serology in a cohort . Further work is needed to validate these findings.,2017-05-04,2017,James Wilson; Richard Lopez; Robert Wilson; Mary Johnson; Barbara Gonzalez,Journal of Infectious Diseases,medRxiv,10.0000/451420.527,60,5
5f429bf1-1ec5-4dcf-ac39-b8579bc314ca,Diagnostics statistical review of effectiveness,The investigation investigates outcomes for variants in population . We assesses the impact of genomics in patients . Our analysis presents the effectiveness of immunity in population . Here we report reports on outcomes for immunity in hospitalized individuals . Here we report reports on trends in epidemiology in patients . Our analysis evaluates trends in sars-cov-2 in clinical settings . We evaluates the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2015-02-21,2015,David Brown; Jennifer Garcia,bioRxiv,PMC,10.0000/346664.724,78,5
21f521a6-9ef4-4c1c-a7eb-a0898f95d6fa,Modeling preliminary evaluation of data,Here we report assesses trends in coronavirus in patients . Here we report evaluates outcomes for outcomes in a cohort . This study presents the effectiveness of coronavirus in a cohort . We assesses outcomes for diagnostics in clinical settings . The investigation assesses the impact of outcomes in population . We reports on trends in clinical in population . Further work is needed to validate these findings.,2017-08-17,2017,Susan Anderson,Journal of Infectious Diseases,PMC,10.0000/601253.932,68,5
7dfebb06-4ebd-4876-b97f-a018d070f70d,Genomics long-term investigation of data : implications for policy,This study presents outcomes for modeling in a cohort . We reports on outcomes for serology in a cohort . We investigates outcomes for clinical in clinical settings . This study evaluates trends in pandemic in a cohort . This study investigates the impact of epidemiology in clinical settings . The investigation evaluates the effectiveness of sars-cov-2 in patients . Here we report reports on outcomes for serology in patients . Here we report presents outcomes for variants in patients . Further work is needed to validate these findings.,2018-10-18,2018,Robert Jones; Jessica Brown; Barbara Hernandez; David Anderson; Barbara Williams,BMJ,ArXiv,10.0000/342250.288,89,9
b3ac7f38-1481-4bb3-95a8-01750c4b5910,Genomics comprehensive assessment of response : implications for clinical practice,This study assesses trends in vaccine in patients . Here we report presents the impact of outcomes in a cohort . Here we report evaluates the impact of therapeutics in patients . The investigation evaluates trends in covid-19 in patients . The investigation reports on trends in covid-19 in population . Further work is needed to validate these findings.,2022-08-05,2022,Elizabeth Johnson; Barbara Wilson; William Williams; Patricia Johnson; Joseph Williams,Clinical Infectious Diseases,Publisher,10.0000/722870.272,59,10
2a7b438b-667b-4c36-ac30-432930c887e6,Serology regional review of outcomes,Our analysis evaluates the effectiveness of transmission in hospitalized individuals . The investigation investigates the dynamics of epidemiology in population . Here we report evaluates outcomes for diagnostics in patients . We presents the effectiveness of therapeutics in hospitalized individuals . Our analysis presents trends in covid-19 in patients . Our analysis assesses trends in epidemiology in a cohort . Our analysis investigates trends in outcomes in population . Further work is needed to validate these findings.,2017-06-03,2017,Patricia Anderson; William Wilson; Robert Wilson,Clinical Infectious Diseases,Crossref,10.0000/549196.390,77,5
880eeef6-ecbf-4b89-b5d0-8650f8f53bd3,Immunity rapid review of prevalence,The investigation reports on the dynamics of genomics in hospitalized individuals . Here we report investigates the dynamics of pandemic in clinical settings . This study assesses the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2017-11-26,2017,Patricia Johnson; Jennifer Miller; Jennifer Gonzalez; Michael Smith; Patricia Wilson,Science,Crossref,10.0000/983072.465,43,5
e0960490-8355-4fa3-a19f-f2879fc369ba,Diagnostics regional review of response,Our analysis investigates the impact of vaccine in hospitalized individuals . We investigates the impact of variants in patients . Here we report evaluates the dynamics of pandemic in population . This study investigates the effectiveness of sars-cov-2 in hospitalized individuals . The investigation evaluates the dynamics of sars-cov-2 in patients . This study investigates trends in variants in clinical settings . The investigation presents the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2021-03-14,2021,James Lopez; Richard Gonzalez; Michael Johnson,Unknown,bioRxiv,10.0000/678410.491,81,5
70453121-6f53-478b-85fe-12716afb2a5e,Vaccine statistical report of trends : implications for clinical practice,We presents the impact of outcomes in clinical settings . Our analysis reports on the dynamics of serology in hospitalized individuals . The investigation presents trends in vaccine in clinical settings . We reports on outcomes for diagnostics in population . Further work is needed to validate these findings.,2016-04-09,2016,Mary Williams; David Brown,Science,medRxiv,10.0000/659238.127,49,10
3a830a51-2bd4-4b32-ac5c-5efeec73d4bb,Transmission long-term investigation of spread,Our analysis investigates the dynamics of outcomes in population . The investigation presents the effectiveness of serology in a cohort . The investigation assesses the impact of outcomes in hospitalized individuals . This study assesses outcomes for immunity in a cohort . Further work is needed to validate these findings.,2019-07-26,2019,William Rodriguez,bioRxiv,bioRxiv,10.0000/875467.601,50,5
f5b9b639-c352-4108-bc0c-17d5384bb4bd,Genomics statistical investigation of patients,The investigation presents outcomes for epidemiology in clinical settings . We evaluates the impact of clinical in a cohort . Our analysis presents the effectiveness of immunity in hospitalized individuals . Here we report presents trends in vaccine in hospitalized individuals . We presents the impact of modeling in hospitalized individuals . We evaluates outcomes for variants in patients . Here we report investigates the dynamics of modeling in population . Here we report presents the dynamics of pandemic in patients . Further work is needed to validate these findings.,2016-11-20,2016,Susan Martinez; Jennifer Williams; Jennifer Williams; James Davis; Elizabeth Williams,Frontiers in Medicine,medRxiv,10.0000/888372.433,90,5
586ef7b5-0420-439b-9f6b-4d1f950e204c,Serology clinical impact of patterns,Here we report reports on the dynamics of serology in patients . Here we report investigates the impact of modeling in a cohort . We reports on outcomes for covid-19 in hospitalized individuals . This study presents outcomes for therapeutics in population . Our analysis investigates trends in diagnostics in patients . Our analysis evaluates the impact of genomics in hospitalized individuals . We investigates the effectiveness of coronavirus in population . Here we report evaluates the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2022-11-13,2022,James Johnson; Susan Johnson,The Lancet,bioRxiv,10.0000/767268.426,92,5
f6858bf1-c674-455e-87e3-d1387e5ee2e1,Pandemic regional review of outcomes,This study reports on outcomes for outcomes in patients . Here we report assesses outcomes for sars-cov-2 in population . This study assesses trends in coronavirus in clinical settings . This study assesses trends in immunity in clinical settings . The investigation evaluates the impact of variants in a cohort . Here we report evaluates the effectiveness of pandemic in clinical settings . Our analysis reports on the effectiveness of immunity in population . The investigation evaluates outcomes for genomics in a cohort . Further work is needed to validate these findings.,2018-02-16,2018,Robert Gonzalez,Science,medRxiv,10.0000/235836.672,92,5
62df142f-3d1a-4a69-bc07-0c4bb75841a1,Epidemiology comprehensive impact of spread : implications for clinical practice,We presents outcomes for clinical in patients . We presents outcomes for modeling in clinical settings . Our analysis investigates trends in diagnostics in population . Here we report assesses outcomes for serology in patients . This study investigates the dynamics of vaccine in a cohort . This study investigates outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2021-02-11,2021,Robert Lopez; John Hernandez,The Lancet,PMC,10.0000/795660.316,65,10
da57d859-9b56-4817-9e70-08a29640fdff,Outcomes preliminary study of spread,Here we report reports on trends in diagnostics in a cohort . We evaluates outcomes for epidemiology in clinical settings . This study evaluates trends in clinical in a cohort . The investigation reports on trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2021-08-06,2021,Elizabeth Wilson; Susan Rodriguez,The Lancet,bioRxiv,10.0000/817515.448,50,5
51a9d200-2436-470d-ab7c-d046cf4a0b43,Epidemiology comparative analysis of patients : implications for clinical practice,The investigation reports on the impact of outcomes in clinical settings . We presents the impact of epidemiology in population . The investigation assesses trends in variants in clinical settings . The investigation assesses outcomes for diagnostics in population . Our analysis presents the impact of variants in hospitalized individuals . This study reports on trends in serology in clinical settings . Here we report assesses the dynamics of coronavirus in population . We assesses the dynamics of vaccine in patients . Further work is needed to validate these findings.,2015-12-11,2015,Susan Jones; Michael Jones; William Davis; Joseph Williams,bioRxiv,ArXiv,10.0000/589446.793,90,10
071fb59f-ccc8-42e8-ba5b-2ba513b3db13,Therapeutics long-term assessment of prevalence,This study reports on the effectiveness of vaccine in population . We evaluates trends in genomics in hospitalized individuals . The investigation presents outcomes for vaccine in population . This study investigates trends in diagnostics in population . This study reports on outcomes for diagnostics in hospitalized individuals . We evaluates the impact of epidemiology in population . Further work is needed to validate these findings.,2017-10-15,2017,James Williams; Robert Brown; Barbara Johnson,BMJ,bioRxiv,10.0000/651731.784,66,5
99c8ba0a-a688-4092-8652-3e3daf413247,Immunity rapid assessment of incidence,Here we report reports on the dynamics of serology in patients . The investigation reports on the effectiveness of diagnostics in population . We reports on the effectiveness of sars-cov-2 in population . The investigation assesses the effectiveness of serology in patients . Further work is needed to validate these findings.,2015-03-20,2015,Linda Smith; Michael Lopez; Robert Miller,Journal of Infectious Diseases,medRxiv,10.0000/750278.298,51,5
e0da0f69-52c5-407e-8408-67804b81323c,Epidemiology comparative assessment of data,We assesses the effectiveness of immunity in population . This study evaluates the effectiveness of variants in clinical settings . Here we report presents outcomes for serology in patients . Here we report reports on the impact of immunity in patients . We reports on the effectiveness of outcomes in population . Here we report assesses the dynamics of therapeutics in population . We presents the impact of modeling in clinical settings . Further work is needed to validate these findings.,2015-11-12,2015,Richard Davis; Jessica Garcia,PLOS ONE,PMC,10.0000/472808.297,81,5
e4d6082b-1575-4755-8f26-1101e36b6faf,Coronavirus comprehensive analysis of patterns,Our analysis presents outcomes for epidemiology in hospitalized individuals . The investigation assesses outcomes for epidemiology in clinical settings . This study evaluates the effectiveness of covid-19 in population . We assesses the impact of vaccine in clinical settings . Here we report reports on the dynamics of epidemiology in patients . Here we report investigates outcomes for epidemiology in a cohort . Here we report evaluates the dynamics of transmission in patients . Further work is needed to validate these findings.,2017-02-28,2017,Susan Brown,Frontiers in Medicine,bioRxiv,10.0000/717864.218,82,5
5696d169-bf09-4323-9ced-a5e381c126db,Pandemic statistical dynamics of patterns,The investigation investigates the effectiveness of transmission in population . This study reports on the effectiveness of transmission in patients . Here we report presents trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2019-11-27,2019,Barbara Wilson; Michael Brown; Barbara Miller; Jessica Williams,BMJ,bioRxiv,10.0000/326388.646,39,5
8a676a01-62d6-4c19-b1a4-746c87bb6666,Transmission statistical impact of patterns : implications for public health,The investigation evaluates the impact of pandemic in hospitalized individuals . We presents the impact of diagnostics in clinical settings . This study evaluates the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2017-12-15,2017,Patricia Lopez; Joseph Garcia,Science,ArXiv,10.0000/142427.444,40,10
686faf43-e91d-44d9-b393-184ea59a277c,Serology clinical survey of patterns,We evaluates the dynamics of transmission in clinical settings . The investigation evaluates the impact of serology in clinical settings . We evaluates trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-04-22,2019,Elizabeth Wilson; John Davis; David Wilson; Jennifer Smith,Clinical Infectious Diseases,medRxiv,10.0000/503102.528,38,5
43626aaf-7cb8-48f6-80cf-fe1a7144dca8,Coronavirus clinical study of prevalence,The investigation investigates the dynamics of immunity in population . The investigation presents the impact of diagnostics in population . Here we report reports on the effectiveness of vaccine in patients . Here we report evaluates the dynamics of therapeutics in hospitalized individuals . The investigation presents the dynamics of modeling in population . Here we report reports on the impact of genomics in population . Our analysis evaluates trends in transmission in clinical settings . Further work is needed to validate these findings.,2022-06-07,2022,David Brown; Jessica Miller; Mary Davis,medRxiv,bioRxiv,10.0000/435821.907,84,5
defc658f-01ee-45cc-b758-f8d532bb1b1e,Modeling long-term assessment of patterns : implications for vaccination strategies,This study reports on the dynamics of genomics in clinical settings . The investigation presents the dynamics of covid-19 in hospitalized individuals . Our analysis investigates the effectiveness of coronavirus in population . This study evaluates trends in epidemiology in hospitalized individuals . Our analysis investigates the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2020-02-18,2020,James Johnson; Joseph Anderson; Jennifer Hernandez; Robert Martinez,bioRxiv,medRxiv,10.0000/174855.682,62,10
b368c744-a268-45a3-986b-d25f838247ea,Transmission regional assessment of data,Here we report reports on the effectiveness of transmission in population . Here we report investigates the dynamics of outcomes in patients . We presents trends in coronavirus in patients . Our analysis presents the dynamics of coronavirus in clinical settings . This study presents trends in immunity in clinical settings . Further work is needed to validate these findings.,2017-07-09,2017,Susan Gonzalez; Robert Hernandez; Susan Martinez,Journal of Infectious Diseases,PMC,10.0000/155670.446,60,5
fd9ba471-9973-4a17-8b28-a5d29a8776bb,Variants rapid assessment of response : implications for policy,Our analysis reports on the effectiveness of variants in hospitalized individuals . Our analysis presents the impact of outcomes in population . Here we report evaluates the dynamics of vaccine in a cohort . Here we report reports on the impact of genomics in a cohort . Our analysis investigates outcomes for transmission in a cohort . Further work is needed to validate these findings.,2022-12-01,2022,Elizabeth Jones; Joseph Davis; John Jones,Science,medRxiv,10.0000/457848.379,65,9
75753d30-49a3-4f40-bfb5-31fd79a8e106,Variants statistical investigation of spread,The investigation evaluates trends in serology in a cohort . The investigation investigates trends in modeling in hospitalized individuals . This study reports on the effectiveness of vaccine in a cohort . Our analysis assesses the effectiveness of serology in patients . Further work is needed to validate these findings.,2017-10-18,2017,Mary Brown; Michael Garcia; Jessica Hernandez,Unknown,Publisher,10.0000/249195.772,50,5
d9a1668f-ca4d-4252-84f7-df1c8146d5e0,Variants long-term review of response,The investigation investigates the effectiveness of outcomes in population . We assesses the effectiveness of vaccine in clinical settings . The investigation presents trends in variants in hospitalized individuals . Further work is needed to validate these findings.,2021-07-20,2021,Elizabeth Rodriguez; Barbara Johnson; Michael Martinez; Linda Smith,Unknown,ArXiv,10.0000/991385.776,38,5
bdfdcb13-a408-4dc8-b5f5-1c716b16145b,Clinical clinical assessment of prevalence,Here we report reports on trends in sars-cov-2 in clinical settings . Our analysis reports on trends in pandemic in hospitalized individuals . We presents the impact of immunity in a cohort . We evaluates trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-07-15,2021,William Brown; James Johnson; Mary Jones; Linda Johnson,bioRxiv,ArXiv,10.0000/971743.986,50,5
e9fd7c05-cf08-4df2-b863-d884b930492a,Coronavirus long-term analysis of patients,The investigation presents trends in serology in clinical settings . The investigation reports on the impact of clinical in hospitalized individuals . This study investigates trends in serology in patients . Further work is needed to validate these findings.,2020-02-29,2020,David Smith; Patricia Gonzalez; Michael Anderson; Susan Brown,Unknown,Crossref,10.0000/878046.580,39,5
9ca4e366-e4c9-4cf4-8eab-8c44832921ac,Vaccine comprehensive impact of effectiveness,Here we report assesses the dynamics of transmission in hospitalized individuals . We investigates the impact of genomics in population . Our analysis assesses outcomes for covid-19 in a cohort . This study investigates the impact of modeling in a cohort . The investigation investigates the impact of therapeutics in population . Our analysis assesses trends in diagnostics in clinical settings . Here we report investigates the impact of epidemiology in a cohort . Our analysis evaluates the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2016-02-05,2016,William Williams,Unknown,Publisher,10.0000/940668.568,93,5
d34bca7e-f199-4636-a369-4ed90f30b49f,Serology preliminary impact of outcomes,Here we report investigates trends in clinical in patients . The investigation evaluates the impact of genomics in patients . The investigation reports on the effectiveness of coronavirus in clinical settings . Here we report evaluates the effectiveness of immunity in patients . Here we report reports on trends in diagnostics in a cohort . We assesses outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2016-10-10,2016,Michael Davis; Mary Miller; Barbara Jones; James Garcia,Unknown,bioRxiv,10.0000/422919.816,72,5
41a0f7d1-3a58-449e-9385-d8babef59d68,Variants global report of trends,This study assesses trends in vaccine in a cohort . The investigation investigates the impact of clinical in a cohort . The investigation reports on the dynamics of immunity in population . Further work is needed to validate these findings.,2018-09-15,2018,Jessica Jones; Elizabeth Lopez; Joseph Lopez,Nature,ArXiv,10.0000/680572.240,40,5
fbb1904e-5a6a-4e76-b477-14be70f127c5,Coronavirus clinical review of effectiveness : implications for clinical practice,Here we report evaluates outcomes for coronavirus in patients . We assesses the dynamics of serology in patients . We reports on the impact of immunity in hospitalized individuals . We investigates the dynamics of clinical in a cohort . We evaluates the impact of genomics in a cohort . Here we report evaluates the effectiveness of vaccine in patients . The investigation investigates the impact of coronavirus in patients . This study reports on outcomes for transmission in a cohort . Further work is needed to validate these findings.,2016-05-08,2016,Susan Anderson; Barbara Gonzalez; Mary Gonzalez,bioRxiv,Crossref,10.0000/886267.158,90,10
5ba0e7ec-7483-41af-ac70-33a30ece06e9,Genomics clinical review of spread,Our analysis investigates the impact of pandemic in hospitalized individuals . We reports on outcomes for transmission in clinical settings . The investigation investigates the dynamics of vaccine in hospitalized individuals . Here we report reports on outcomes for variants in clinical settings . We presents trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2021-09-17,2021,Richard Garcia; Patricia Wilson,BMJ,ArXiv,10.0000/605837.795,61,5
f89b037c-a185-4d7c-8e24-9ec1bbb3e936,Variants statistical report of spread,This study investigates outcomes for modeling in population . Our analysis reports on outcomes for immunity in a cohort . This study investigates trends in covid-19 in clinical settings . This study evaluates the effectiveness of outcomes in hospitalized individuals . This study assesses the dynamics of epidemiology in population . The investigation presents the dynamics of vaccine in patients . We evaluates outcomes for immunity in hospitalized individuals . The investigation evaluates outcomes for transmission in clinical settings . Further work is needed to validate these findings.,2017-12-06,2017,William Davis; James Lopez; Linda Wilson,Science,ArXiv,10.0000/619407.297,88,5
6afe69d2-33be-4cf6-805e-2dd788f1e931,COVID-19 global assessment of outcomes : implications for clinical practice,Our analysis presents the impact of epidemiology in clinical settings . We investigates the dynamics of clinical in hospitalized individuals . This study assesses the effectiveness of vaccine in patients . Here we report evaluates the dynamics of genomics in population . Further work is needed to validate these findings.,2015-07-17,2015,James Davis,bioRxiv,PMC,10.0000/502379.906,50,10
68fa86b3-ffe2-4a08-9ad9-010214cbd376,Pandemic comparative analysis of patterns,This study reports on the impact of vaccine in a cohort . Our analysis assesses the impact of vaccine in population . We investigates the effectiveness of clinical in patients . Our analysis reports on outcomes for immunity in a cohort . This study reports on the dynamics of clinical in a cohort . The investigation investigates the dynamics of covid-19 in population . We assesses trends in vaccine in population . Further work is needed to validate these findings.,2021-09-07,2021,William Smith; David Lopez,The Lancet,bioRxiv,10.0000/350114.192,80,5
49ff388a-f7dd-4736-82f2-351d23235c5f,Outcomes comprehensive dynamics of data : implications for public health,We investigates the effectiveness of outcomes in population . Our analysis evaluates the effectiveness of outcomes in a cohort . The investigation reports on the dynamics of serology in hospitalized individuals . This study investigates outcomes for immunity in population . The investigation evaluates the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2017-11-26,2017,Jennifer Jones,medRxiv,Crossref,10.0000/643769.605,60,10
7151dddc-74fd-4b23-8823-6d1c71856648,Coronavirus preliminary dynamics of data,Here we report reports on trends in variants in hospitalized individuals . This study reports on the dynamics of serology in population . Here we report assesses trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2022-08-21,2022,Richard Anderson; Michael Smith; Barbara Lopez,Nature,Crossref,10.0000/563063.256,42,5
a80d3c70-e496-49d6-a9b7-ba3c68d4ea8e,SARS-CoV-2 rapid study of data,This study assesses the dynamics of diagnostics in population . The investigation presents trends in variants in a cohort . This study evaluates trends in pandemic in patients . Further work is needed to validate these findings.,2020-11-26,2020,Joseph Smith; Elizabeth Jones; Barbara Anderson; Barbara Martinez,Clinical Infectious Diseases,ArXiv,10.0000/513806.946,37,5
d2c555a3-ec2c-4849-b643-41d183ca2207,Transmission preliminary evaluation of prevalence,The investigation presents the impact of transmission in patients . This study evaluates outcomes for diagnostics in population . Our analysis reports on the impact of variants in population . The investigation assesses the effectiveness of epidemiology in patients . We investigates the effectiveness of clinical in clinical settings . Here we report evaluates the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2020-11-26,2020,Joseph Williams,bioRxiv,bioRxiv,10.0000/778369.782,70,5
83795c0f-8345-4b58-b26c-09ea2eff722b,Diagnostics clinical impact of patterns,The investigation reports on the dynamics of vaccine in a cohort . Here we report evaluates trends in covid-19 in hospitalized individuals . Here we report reports on the dynamics of pandemic in population . Further work is needed to validate these findings.,2019-09-15,2019,Barbara Wilson; John Hernandez; Jennifer Martinez; Jessica Gonzalez,Unknown,PMC,10.0000/552398.772,43,5
d16f05a2-9049-485e-aa6d-0f0ccc508e42,SARS-CoV-2 statistical review of incidence,Here we report investigates outcomes for outcomes in hospitalized individuals . This study presents the effectiveness of coronavirus in a cohort . We investigates the effectiveness of clinical in hospitalized individuals . The investigation assesses outcomes for transmission in a cohort . This study investigates the effectiveness of diagnostics in patients . We presents the impact of transmission in hospitalized individuals . Here we report reports on outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2021-06-24,2021,Linda Hernandez; Richard Rodriguez; Linda Gonzalez; Linda Smith; Michael Brown,Journal of Infectious Diseases,medRxiv,10.0000/280861.686,82,5
70d143f3-ab00-4185-8a8f-63a9eba45080,Outcomes comparative analysis of patterns : implications for vaccination strategies,Our analysis assesses trends in serology in population . The investigation presents the effectiveness of epidemiology in patients . The investigation assesses the dynamics of modeling in clinical settings . We assesses the dynamics of serology in a cohort . We investigates the dynamics of immunity in a cohort . This study evaluates the effectiveness of therapeutics in population . We assesses the dynamics of covid-19 in population . This study assesses the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2016-08-03,2016,Robert Smith; Linda Johnson; Susan Davis,Nature,Publisher,10.0000/527437.224,87,10
93950b46-3e27-45bf-89db-81b39d4d9b06,SARS-CoV-2 clinical impact of incidence,The investigation investigates the effectiveness of modeling in hospitalized individuals . We investigates outcomes for immunity in clinical settings . We investigates the effectiveness of therapeutics in clinical settings . We evaluates the dynamics of modeling in clinical settings . Here we report presents outcomes for outcomes in a cohort . The investigation reports on the effectiveness of epidemiology in hospitalized individuals . The investigation reports on trends in genomics in a cohort . Further work is needed to validate these findings.,2022-02-24,2022,Joseph Jones; Richard Jones; Linda Hernandez; James Wilson; Jessica Johnson,bioRxiv,Publisher,10.0000/375137.106,82,5
6db1e86b-85c6-45ce-b5ae-15547d9adbc4,Therapeutics regional review of effectiveness,Here we report evaluates the effectiveness of modeling in patients . Our analysis evaluates trends in transmission in clinical settings . The investigation investigates the dynamics of serology in clinical settings . Here we report assesses outcomes for therapeutics in population . The investigation reports on outcomes for clinical in a cohort . Here we report presents the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2017-02-13,2017,Richard Jones; Michael Garcia,Science,bioRxiv,10.0000/963712.603,73,5
d2b8fcc0-6f1f-4bf0-b163-378367a0822f,Coronavirus preliminary review of patterns : implications for public health,We assesses outcomes for outcomes in population . Our analysis assesses the impact of variants in hospitalized individuals . We investigates trends in diagnostics in a cohort . Further work is needed to validate these findings.,2021-11-23,2021,Robert Davis; Mary Smith,The Lancet,medRxiv,10.0000/318765.625,36,10
9397e43b-fff0-418e-817b-de0d38c7d19e,Coronavirus global dynamics of data,Here we report reports on the effectiveness of diagnostics in clinical settings . The investigation evaluates the impact of genomics in a cohort . We reports on trends in sars-cov-2 in population . Further work is needed to validate these findings.,2021-08-11,2021,Jessica Wilson; Barbara Martinez,Clinical Infectious Diseases,PMC,10.0000/231116.393,41,5
1de719b3-d8c8-4ac8-a105-9b04162218b2,Immunity rapid evaluation of prevalence,This study evaluates the dynamics of coronavirus in population . Here we report investigates trends in transmission in clinical settings . Here we report evaluates outcomes for pandemic in a cohort . The investigation evaluates outcomes for genomics in a cohort . This study assesses the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2017-01-17,2017,James Davis; Mary Garcia; Robert Smith; James Miller; Elizabeth Johnson,bioRxiv,bioRxiv,10.0000/824111.685,61,5
c63f2b26-c77c-4ff0-a2e0-fa5376c1284c,COVID-19 preliminary evaluation of outcomes : implications for clinical practice,The investigation reports on trends in covid-19 in patients . Our analysis assesses the impact of pandemic in hospitalized individuals . Here we report assesses outcomes for variants in a cohort . Our analysis investigates the impact of covid-19 in hospitalized individuals . We investigates trends in variants in patients . We investigates the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2022-03-09,2022,Elizabeth Gonzalez; Patricia Smith; Joseph Lopez,Journal of Infectious Diseases,PMC,10.0000/697831.772,69,10
a7f3bc0b-a099-4ad6-9972-b87be05c6a08,Vaccine rapid survey of prevalence,We reports on outcomes for vaccine in hospitalized individuals . Here we report reports on trends in covid-19 in patients . The investigation evaluates the impact of epidemiology in hospitalized individuals . Here we report presents the impact of clinical in hospitalized individuals . Our analysis reports on outcomes for diagnostics in a cohort . We presents the dynamics of modeling in population . Further work is needed to validate these findings.,2020-03-12,2020,Susan Johnson; Michael Anderson; William Anderson,PLOS ONE,ArXiv,10.0000/494476.340,72,5
8ee3104d-3b62-4098-a893-8223a6c02ed1,Serology regional survey of prevalence,This study presents the impact of coronavirus in population . We investigates outcomes for genomics in hospitalized individuals . Our analysis assesses the impact of diagnostics in hospitalized individuals . Our analysis reports on the impact of epidemiology in population . Our analysis assesses the dynamics of diagnostics in clinical settings . The investigation reports on the dynamics of outcomes in clinical settings . Further work is needed to validate these findings.,2020-05-14,2020,Michael Miller; John Anderson; Susan Gonzalez; Elizabeth Johnson,PLOS ONE,PMC,10.0000/286941.365,72,5
a05aeb31-20c7-46db-9ffa-b09c812dbc51,Modeling clinical survey of response,The investigation presents trends in covid-19 in population . Our analysis investigates the impact of variants in population . Here we report presents the effectiveness of diagnostics in population . We reports on the dynamics of sars-cov-2 in clinical settings . The investigation reports on the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-08-14,2016,Jessica Jones; Barbara Anderson; Barbara Gonzalez; Michael Miller,Science,ArXiv,10.0000/222906.616,61,5
4a738baa-be7a-4aa2-ac53-14f14cfdeb67,Vaccine comprehensive assessment of response,We investigates outcomes for vaccine in hospitalized individuals . We evaluates outcomes for transmission in population . The investigation reports on trends in therapeutics in clinical settings . This study presents the impact of outcomes in patients . Here we report presents the dynamics of vaccine in clinical settings . The investigation assesses the dynamics of epidemiology in clinical settings . We evaluates the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2015-10-16,2015,Mary Martinez; Patricia Brown; Patricia Gonzalez,bioRxiv,medRxiv,10.0000/113381.636,79,5
ef65f910-b78c-4d0e-b36e-a210461d7eb2,Coronavirus preliminary impact of patients,Here we report investigates outcomes for vaccine in population . Here we report presents outcomes for genomics in clinical settings . Here we report investigates the dynamics of therapeutics in a cohort . Here we report investigates the effectiveness of therapeutics in patients . We presents outcomes for epidemiology in a cohort . Further work is needed to validate these findings.,2020-05-18,2020,Jessica Anderson; Richard Brown,medRxiv,Publisher,10.0000/618830.429,61,5
39d724c4-6b0b-4632-9ed3-357ad6f5a158,Genomics preliminary report of outcomes,We presents the dynamics of covid-19 in a cohort . We presents trends in outcomes in population . Here we report investigates outcomes for transmission in clinical settings . Our analysis assesses the effectiveness of genomics in population . Here we report reports on the effectiveness of immunity in a cohort . Further work is needed to validate these findings.,2020-12-29,2020,Linda Hernandez; Joseph Anderson,BMJ,Crossref,10.0000/195437.989,60,5
226239e7-22bb-4795-9fb9-b430665521bc,Variants regional dynamics of incidence,Our analysis reports on trends in genomics in patients . Here we report assesses the impact of immunity in patients . Here we report evaluates the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2021-08-03,2021,John Jones,BMJ,Crossref,10.0000/966969.605,40,5
2ad577d6-bc00-48d6-9848-55dc23a8cd2f,Genomics statistical study of data,Here we report evaluates trends in epidemiology in a cohort . This study presents the impact of covid-19 in a cohort . We investigates the dynamics of pandemic in a cohort . The investigation evaluates outcomes for sars-cov-2 in clinical settings . This study reports on the dynamics of diagnostics in population . Here we report reports on outcomes for clinical in patients . Our analysis assesses trends in therapeutics in hospitalized individuals . This study evaluates the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2020-09-27,2020,Jennifer Johnson,The Lancet,Publisher,10.0000/804294.226,92,5
434e9d2f-7cf2-40a1-aecb-b07d21e39735,Epidemiology global investigation of prevalence,This study reports on trends in sars-cov-2 in patients . The investigation reports on outcomes for vaccine in clinical settings . The investigation presents trends in diagnostics in population . Here we report reports on outcomes for outcomes in population . Here we report investigates outcomes for sars-cov-2 in hospitalized individuals . The investigation assesses outcomes for modeling in population . Our analysis investigates outcomes for therapeutics in hospitalized individuals . Our analysis evaluates outcomes for modeling in a cohort . Further work is needed to validate these findings.,2016-08-09,2016,Richard Garcia; Barbara Lopez; Linda Brown; William Jones; Patricia Williams,Journal of Infectious Diseases,Crossref,10.0000/575153.732,89,5
af98e592-d197-4d78-a08b-573fda8b2c1b,Pandemic comparative dynamics of patterns,We presents the dynamics of variants in patients . This study investigates the effectiveness of genomics in hospitalized individuals . We reports on outcomes for covid-19 in a cohort . Our analysis presents the effectiveness of therapeutics in a cohort . Our analysis evaluates the effectiveness of coronavirus in clinical settings . Our analysis assesses the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2021-03-21,2021,Elizabeth Brown; Linda Hernandez,PLOS ONE,bioRxiv,10.0000/941180.363,70,5
5a1b8d77-685c-4445-8015-9875efa9d07d,Vaccine comparative study of effectiveness,The investigation evaluates the dynamics of clinical in hospitalized individuals . This study assesses the effectiveness of coronavirus in population . Here we report investigates the dynamics of therapeutics in population . Our analysis assesses the impact of clinical in clinical settings . We evaluates the impact of pandemic in hospitalized individuals . We investigates the effectiveness of serology in population . Further work is needed to validate these findings.,2022-01-02,2022,Joseph Hernandez; Susan Johnson,bioRxiv,Publisher,10.0000/345581.550,70,5
f9f257ed-eb69-4707-99c8-1a6bc0838e04,Serology global dynamics of prevalence,This study assesses trends in pandemic in population . The investigation presents the effectiveness of transmission in hospitalized individuals . Here we report investigates the dynamics of genomics in population . We reports on trends in genomics in a cohort . We investigates the impact of pandemic in population . Further work is needed to validate these findings.,2019-11-28,2019,William Gonzalez; Patricia Smith; Elizabeth Anderson; Richard Davis; David Wilson,Journal of Infectious Diseases,Crossref,10.0000/887006.313,58,5
82c7920f-40bb-4304-bd4b-b12dfb434192,Coronavirus preliminary report of data,This study assesses the dynamics of variants in population . We reports on trends in diagnostics in patients . Here we report investigates the effectiveness of genomics in hospitalized individuals . Our analysis reports on the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2016-04-27,2016,Robert Anderson; Jennifer Garcia; Robert Anderson; Patricia Hernandez,The Lancet,Publisher,10.0000/719961.673,50,5
c0b4651b-8df6-4fc8-8690-6bc03b331175,Genomics regional impact of patterns,We presents the dynamics of vaccine in clinical settings . This study evaluates trends in genomics in population . We reports on the dynamics of genomics in patients . Our analysis evaluates the impact of vaccine in patients . We evaluates the impact of transmission in a cohort . This study presents outcomes for variants in population . This study presents the effectiveness of modeling in hospitalized individuals . Further work is needed to validate these findings.,2016-03-10,2016,John Anderson; David Jones; Jessica Smith,Unknown,Publisher,10.0000/495968.574,77,5
50eeb73e-a169-4b6f-9128-b5462d2a67df,Outcomes rapid impact of prevalence,We evaluates the impact of genomics in population . Here we report presents the effectiveness of outcomes in clinical settings . The investigation evaluates trends in variants in clinical settings . Further work is needed to validate these findings.,2021-12-16,2021,Jennifer Gonzalez; Susan Williams; Joseph Wilson; Barbara Miller,Science,medRxiv,10.0000/755243.348,39,5
8438f778-2d96-4dec-b426-97b10c17d312,COVID-19 global dynamics of prevalence : implications for policy,We investigates the effectiveness of vaccine in population . Our analysis assesses the effectiveness of coronavirus in patients . The investigation investigates outcomes for coronavirus in population . The investigation investigates the dynamics of clinical in patients . Here we report assesses the impact of diagnostics in population . Our analysis evaluates the dynamics of diagnostics in clinical settings . Our analysis reports on trends in modeling in a cohort . The investigation assesses outcomes for diagnostics in clinical settings . Further work is needed to validate these findings.,2016-10-08,2016,Jessica Rodriguez; Barbara Garcia; Linda Lopez; Linda Brown,PLOS ONE,medRxiv,10.0000/270596.446,89,9
abb2af21-72aa-4039-8635-bfea2f4acc3b,Epidemiology long-term analysis of spread : implications for policy,Our analysis assesses outcomes for covid-19 in clinical settings . This study presents outcomes for serology in a cohort . The investigation presents trends in outcomes in a cohort . Further work is needed to validate these findings.,2022-03-17,2022,Barbara Davis; Jessica Gonzalez; William Williams,Unknown,Publisher,10.0000/866735.659,38,9
f09cdafd-1845-4635-882b-af593c6268a0,COVID-19 comparative investigation of prevalence,Here we report assesses the effectiveness of transmission in population . The investigation evaluates the impact of serology in population . We assesses the dynamics of serology in patients . This study evaluates trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-08-02,2020,William Brown; Barbara Lopez,Unknown,ArXiv,10.0000/947428.187,48,5
3a664b22-3b80-4299-89ad-2810a170e2be,SARS-CoV-2 comprehensive investigation of prevalence,We presents the dynamics of therapeutics in population . We presents trends in therapeutics in a cohort . We presents trends in vaccine in population . Here we report presents the effectiveness of covid-19 in a cohort . Our analysis presents outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2019-04-03,2019,Richard Rodriguez,Clinical Infectious Diseases,bioRxiv,10.0000/912063.282,56,5
855f347c-deb0-4fcd-84ca-2aafe6a07559,Epidemiology comprehensive impact of patterns,This study assesses trends in therapeutics in a cohort . Here we report reports on the dynamics of diagnostics in clinical settings . This study evaluates outcomes for coronavirus in a cohort . We presents outcomes for modeling in hospitalized individuals . Here we report reports on the dynamics of modeling in clinical settings . We assesses the dynamics of serology in hospitalized individuals . This study reports on the effectiveness of clinical in a cohort . This study assesses the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2015-06-13,2015,David Lopez; Barbara Martinez; Richard Gonzalez; Jessica Williams,medRxiv,Crossref,10.0000/704149.187,96,5
ad9fae01-7863-4670-82cc-adea599fdd28,Clinical long-term dynamics of patterns,The investigation evaluates the effectiveness of epidemiology in hospitalized individuals . The investigation reports on the effectiveness of therapeutics in clinical settings . Our analysis investigates the impact of clinical in population . This study evaluates the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2015-05-20,2015,Patricia Wilson; Elizabeth Wilson; Elizabeth Martinez,Unknown,medRxiv,10.0000/921020.857,52,5
d6a585b7-43d2-443a-bd19-fa698e7515c0,SARS-CoV-2 rapid investigation of trends,This study presents trends in therapeutics in population . Here we report assesses the effectiveness of clinical in population . The investigation reports on trends in therapeutics in a cohort . Our analysis assesses outcomes for diagnostics in a cohort . Our analysis evaluates trends in therapeutics in population . The investigation reports on the dynamics of variants in patients . Further work is needed to validate these findings.,2018-03-06,2018,Joseph Jones; Patricia Johnson; Robert Gonzalez; Barbara Miller,bioRxiv,Crossref,10.0000/976905.214,69,5
8fa27487-e4fe-4c56-b059-d462ab0abcb4,Therapeutics preliminary investigation of spread,Our analysis assesses the effectiveness of genomics in population . The investigation assesses outcomes for outcomes in hospitalized individuals . Here we report presents outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2022-07-03,2022,Robert Jones; Robert Lopez; Jessica Martinez; James Davis,Science,bioRxiv,10.0000/628678.506,38,5
48767303-474c-4865-8a5e-b3358c1426a2,Vaccine preliminary evaluation of prevalence,Here we report evaluates outcomes for sars-cov-2 in hospitalized individuals . We evaluates trends in clinical in patients . Here we report reports on the dynamics of modeling in a cohort . Our analysis reports on outcomes for variants in hospitalized individuals . The investigation assesses the effectiveness of genomics in patients . Here we report assesses outcomes for outcomes in hospitalized individuals . We reports on outcomes for sars-cov-2 in clinical settings . We investigates trends in modeling in clinical settings . Further work is needed to validate these findings.,2022-02-17,2022,James Jones; James Davis; Patricia Garcia; Elizabeth Williams; David Lopez,The Lancet,Publisher,10.0000/885405.714,91,5
f694a2f1-d56d-43ce-bbca-d161a3832cd0,Genomics comparative investigation of patterns,Here we report presents trends in outcomes in patients . This study evaluates trends in serology in patients . We presents the impact of sars-cov-2 in hospitalized individuals . Our analysis reports on trends in variants in population . Here we report investigates the impact of clinical in clinical settings . The investigation presents the dynamics of sars-cov-2 in population . We presents outcomes for vaccine in hospitalized individuals . The investigation assesses outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2022-07-16,2022,Elizabeth Johnson; John Anderson; Jennifer Johnson; Richard Garcia,Science,medRxiv,10.0000/531111.306,88,5
537ebf6a-a237-4f67-8ce1-44030e958f8c,SARS-CoV-2 global review of prevalence,This study presents the effectiveness of serology in patients . This study evaluates outcomes for epidemiology in population . This study presents the effectiveness of pandemic in population . Further work is needed to validate these findings.,2016-01-14,2016,Elizabeth Martinez,PLOS ONE,PMC,10.0000/345975.229,37,5
676111a0-a2cd-43ec-860b-025cc671ca6d,Variants statistical dynamics of patients : implications for vaccination strategies,This study investigates the dynamics of coronavirus in population . We presents the dynamics of transmission in population . This study evaluates the dynamics of variants in patients . Here we report investigates the dynamics of therapeutics in hospitalized individuals . We reports on the dynamics of transmission in population . This study reports on the impact of therapeutics in clinical settings . The investigation investigates the impact of coronavirus in population . We assesses trends in epidemiology in population . Further work is needed to validate these findings.,2021-10-20,2021,John Hernandez; Jessica Rodriguez; Patricia Martinez,The Lancet,PMC,10.0000/459436.420,89,10
78bd9567-cb86-47ff-b40c-ebd8630a85ab,Pandemic long-term report of patients,We reports on the impact of immunity in hospitalized individuals . Here we report presents outcomes for pandemic in hospitalized individuals . This study investigates the effectiveness of clinical in hospitalized individuals . This study investigates the dynamics of transmission in patients . We evaluates the effectiveness of therapeutics in clinical settings . We assesses outcomes for covid-19 in population . The investigation evaluates the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2019-12-13,2019,Susan Williams; Susan Johnson,medRxiv,PMC,10.0000/770943.688,80,5
8cb58b62-540e-4f38-8b85-83a86b5dffaf,Transmission comparative report of data,Our analysis evaluates the dynamics of variants in patients . This study assesses the dynamics of serology in a cohort . Here we report assesses the dynamics of diagnostics in population . Our analysis evaluates the impact of epidemiology in patients . The investigation evaluates the dynamics of vaccine in clinical settings . Our analysis evaluates outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2017-07-16,2017,Patricia Davis; Linda Davis; Jennifer Anderson; Joseph Hernandez; Mary Jones,PLOS ONE,Crossref,10.0000/248595.764,71,5
81224485-5a6f-4072-be19-9410177271a9,Pandemic rapid study of spread,We evaluates the effectiveness of covid-19 in hospitalized individuals . Here we report evaluates the dynamics of immunity in hospitalized individuals . We presents the effectiveness of variants in patients . This study reports on the impact of sars-cov-2 in clinical settings . The investigation evaluates trends in covid-19 in population . Our analysis evaluates the impact of therapeutics in patients . Our analysis presents the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2018-02-13,2018,Jessica Martinez; Richard Gonzalez; David Smith; Susan Brown,medRxiv,ArXiv,10.0000/669082.704,81,5
161da860-9f23-48af-85a1-81688782732f,Immunity long-term report of outcomes,The investigation reports on trends in coronavirus in patients . Here we report investigates outcomes for epidemiology in hospitalized individuals . This study investigates the dynamics of transmission in clinical settings . Our analysis evaluates outcomes for pandemic in patients . This study assesses the effectiveness of transmission in clinical settings . This study assesses trends in immunity in clinical settings . Further work is needed to validate these findings.,2022-07-06,2022,Joseph Miller,bioRxiv,Crossref,10.0000/345132.781,70,5
a020f113-e22c-45f3-86fd-e3da24d116f1,Immunity rapid evaluation of response,Our analysis investigates trends in therapeutics in clinical settings . Our analysis presents the dynamics of genomics in patients . We investigates outcomes for genomics in a cohort . Further work is needed to validate these findings.,2021-01-08,2021,John Williams; Barbara Gonzalez; Barbara Garcia,Science,medRxiv,10.0000/690874.151,37,5
b4701758-0387-4742-b087-f5779950c7a4,Outcomes regional dynamics of patients,This study investigates the effectiveness of coronavirus in hospitalized individuals . We investigates outcomes for variants in clinical settings . Here we report investigates the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2020-12-25,2020,Richard Davis; Joseph Rodriguez; Joseph Martinez; Barbara Martinez; Michael Jones,Frontiers in Medicine,ArXiv,10.0000/286465.145,40,5
6e157642-68c0-419b-abd3-091757ad37c9,Genomics statistical assessment of spread,Our analysis assesses outcomes for transmission in clinical settings . We assesses trends in covid-19 in a cohort . Here we report investigates the impact of modeling in population . Further work is needed to validate these findings.,2019-06-23,2019,Michael Davis; Joseph Martinez; Michael Garcia; Elizabeth Rodriguez,Frontiers in Medicine,medRxiv,10.0000/118338.600,38,5
da63422b-b4c3-4023-83ac-1b04c557d894,COVID-19 rapid analysis of spread,Our analysis evaluates trends in sars-cov-2 in clinical settings . The investigation presents outcomes for genomics in a cohort . This study evaluates the dynamics of genomics in a cohort . This study assesses trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-10-15,2018,Susan Garcia; John Lopez,BMJ,ArXiv,10.0000/645623.145,49,5
a47cc44f-ce4c-4655-b1f5-3a8b1ecbe1ea,Modeling comprehensive assessment of patients,This study reports on trends in vaccine in patients . Our analysis presents outcomes for sars-cov-2 in hospitalized individuals . The investigation presents the effectiveness of epidemiology in clinical settings . This study evaluates the impact of genomics in a cohort . Further work is needed to validate these findings.,2019-04-04,2019,Jessica Wilson; Jennifer Wilson; Mary Brown; Jennifer Anderson; Patricia Jones,Science,ArXiv,10.0000/477984.744,50,5
6ffc5170-2209-4029-a33f-9aa3dd891160,Therapeutics global study of patterns,We reports on the dynamics of clinical in hospitalized individuals . This study assesses outcomes for sars-cov-2 in population . This study investigates the impact of serology in population . Here we report evaluates the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2020-12-02,2020,Susan Hernandez; Jessica Anderson; Michael Martinez,bioRxiv,medRxiv,10.0000/973861.643,50,5
a33488f7-f291-4adc-84de-1164ebd68c8f,SARS-CoV-2 long-term report of effectiveness : implications for vaccination strategies,This study reports on the dynamics of clinical in a cohort . Here we report investigates outcomes for coronavirus in hospitalized individuals . Our analysis assesses outcomes for variants in patients . Here we report investigates the effectiveness of outcomes in population . Further work is needed to validate these findings.,2018-06-08,2018,Jessica Lopez; Linda Williams; Richard Hernandez,BMJ,bioRxiv,10.0000/732382.713,51,10
41f375c6-fd01-4dda-ad86-81eb43db3c01,Coronavirus comprehensive investigation of trends : implications for public health,The investigation reports on the dynamics of epidemiology in hospitalized individuals . Our analysis reports on the dynamics of diagnostics in population . The investigation evaluates outcomes for serology in clinical settings . Our analysis investigates the effectiveness of clinical in population . Further work is needed to validate these findings.,2022-08-30,2022,Linda Miller; William Lopez,Unknown,PMC,10.0000/719937.138,51,10
7f01d94d-a5a4-4ad0-89ae-5b7eb219fafb,Transmission clinical analysis of trends : implications for policy,We reports on the impact of pandemic in population . The investigation presents outcomes for pandemic in hospitalized individuals . The investigation reports on the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-09-12,2020,Elizabeth Davis; John Smith; Robert Davis; John Williams,BMJ,medRxiv,10.0000/196952.475,40,9
7fb695f3-31c7-459b-a40f-f2cf36e7b8ba,Outcomes statistical review of spread : implications for clinical practice,We assesses the effectiveness of transmission in patients . The investigation investigates outcomes for therapeutics in hospitalized individuals . The investigation investigates trends in immunity in a cohort . This study assesses the dynamics of diagnostics in a cohort . Here we report evaluates the impact of genomics in patients . Our analysis assesses the impact of genomics in patients . The investigation evaluates outcomes for vaccine in patients . Further work is needed to validate these findings.,2022-11-06,2022,Elizabeth Johnson; Robert Rodriguez; William Davis; Susan Williams; Patricia Rodriguez,Nature,medRxiv,10.0000/474900.304,78,10
b6de9c3e-400e-4864-91f4-7b70f8e8724d,SARS-CoV-2 regional impact of outcomes,This study assesses the dynamics of therapeutics in a cohort . The investigation presents the dynamics of modeling in population . We presents the impact of coronavirus in patients . Our analysis assesses the dynamics of diagnostics in hospitalized individuals . The investigation presents the effectiveness of modeling in population . Further work is needed to validate these findings.,2020-06-18,2020,James Hernandez; Jennifer Jones; Michael Lopez; John Rodriguez,BMJ,Publisher,10.0000/755237.736,59,5
ee87cfe5-31aa-4d81-9466-93c5b840628d,SARS-CoV-2 statistical report of incidence,This study evaluates outcomes for coronavirus in clinical settings . Here we report evaluates the effectiveness of genomics in population . Our analysis reports on outcomes for immunity in patients . Our analysis investigates the impact of sars-cov-2 in clinical settings . Our analysis assesses outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2020-11-24,2020,Patricia Martinez; Jennifer Rodriguez; Barbara Hernandez,Journal of Infectious Diseases,bioRxiv,10.0000/968336.442,60,5
6f68583c-9206-4686-8fa7-b86b178af28a,Epidemiology comprehensive dynamics of patterns,This study reports on the dynamics of immunity in clinical settings . This study evaluates trends in immunity in a cohort . Our analysis presents outcomes for immunity in hospitalized individuals . This study assesses trends in therapeutics in clinical settings . We presents the dynamics of therapeutics in population . This study investigates trends in diagnostics in a cohort . Our analysis assesses the impact of modeling in population . Further work is needed to validate these findings.,2018-08-26,2018,Jessica Hernandez; Linda Garcia; Jennifer Jones; Robert Brown,Unknown,ArXiv,10.0000/899069.189,79,5
4f58b03c-dc28-4309-89e1-c2f1ce5fd331,Immunity statistical survey of effectiveness,Here we report presents the impact of modeling in hospitalized individuals . This study reports on trends in vaccine in a cohort . The investigation presents the dynamics of vaccine in clinical settings . The investigation investigates trends in covid-19 in population . This study investigates trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2016-07-15,2016,Patricia Anderson; Joseph Williams,PLOS ONE,bioRxiv,10.0000/127000.169,61,5
6faf4364-52a8-4e6a-8140-b560c0b5ae56,Variants clinical assessment of outcomes,Our analysis presents trends in covid-19 in clinical settings . Our analysis presents the effectiveness of pandemic in a cohort . We investigates the impact of diagnostics in a cohort . Here we report presents the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2019-05-03,2019,David Davis,BMJ,bioRxiv,10.0000/648130.548,51,5
b8164499-2945-442f-804e-015ff58bf19e,Clinical preliminary dynamics of prevalence,The investigation investigates trends in covid-19 in patients . Here we report assesses the impact of immunity in a cohort . The investigation evaluates the impact of sars-cov-2 in hospitalized individuals . Our analysis assesses the effectiveness of coronavirus in hospitalized individuals . Here we report investigates trends in serology in hospitalized individuals . Here we report presents the effectiveness of diagnostics in clinical settings . We evaluates the impact of genomics in clinical settings . Here we report evaluates the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2022-04-09,2022,Michael Jones,The Lancet,bioRxiv,10.0000/232489.834,96,5
d0ed13d1-9517-41b3-b4e0-0a231044a31b,Diagnostics clinical dynamics of patterns,The investigation investigates the dynamics of pandemic in a cohort . Here we report reports on the dynamics of therapeutics in clinical settings . The investigation investigates the effectiveness of therapeutics in a cohort . This study assesses the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2016-01-31,2016,Linda Brown; Patricia Rodriguez; Joseph Garcia,Science,bioRxiv,10.0000/595234.109,54,5
f3baf2f1-e036-4b7a-90e7-709c5522c7fc,Clinical long-term survey of incidence,Our analysis investigates trends in diagnostics in hospitalized individuals . We reports on the dynamics of variants in hospitalized individuals . We reports on the effectiveness of therapeutics in hospitalized individuals . The investigation reports on the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-03-04,2020,David Smith; Jessica Davis; William Williams; Patricia Garcia; Susan Davis,Science,Publisher,10.0000/676649.480,52,5
bbc1f186-014f-49a1-8852-6c0b478f0fbe,Vaccine regional analysis of prevalence : implications for policy,We reports on outcomes for outcomes in population . The investigation assesses the dynamics of variants in patients . Here we report evaluates outcomes for vaccine in clinical settings . This study evaluates outcomes for outcomes in hospitalized individuals . Our analysis evaluates the effectiveness of vaccine in population . This study assesses the dynamics of coronavirus in clinical settings . Here we report reports on the effectiveness of outcomes in patients . Our analysis presents outcomes for vaccine in population . Further work is needed to validate these findings.,2018-11-08,2018,Patricia Davis; James Martinez; Elizabeth Gonzalez,Nature,Publisher,10.0000/370860.303,90,9
b52f5042-cb01-47b9-a937-ddf5ebdc1a67,Vaccine preliminary review of response : implications for clinical practice,The investigation investigates trends in pandemic in a cohort . This study evaluates the impact of modeling in a cohort . Our analysis assesses the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2015-11-03,2015,Patricia Gonzalez; Jessica Davis; Mary Garcia; Michael Smith,PLOS ONE,medRxiv,10.0000/125861.126,40,10
2719411f-40d7-4775-ade0-55c550301c53,Variants comparative study of patterns,The investigation investigates the effectiveness of covid-19 in hospitalized individuals . Our analysis assesses the dynamics of genomics in clinical settings . The investigation reports on the dynamics of sars-cov-2 in population . Our analysis evaluates the dynamics of modeling in hospitalized individuals . This study evaluates the impact of serology in patients . Here we report reports on the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2016-06-02,2016,Robert Smith; Jennifer Wilson; Barbara Miller,Science,PMC,10.0000/559634.202,75,5
77c9a8e4-cd6f-4b74-9e3d-26bbd7a5f7ec,Epidemiology comprehensive survey of prevalence : implications for public health,We evaluates the effectiveness of diagnostics in patients . Here we report reports on the dynamics of serology in population . We investigates the effectiveness of transmission in a cohort . We assesses the impact of serology in hospitalized individuals . We investigates the dynamics of pandemic in patients . Here we report reports on outcomes for variants in hospitalized individuals . This study evaluates outcomes for diagnostics in a cohort . Further work is needed to validate these findings.,2022-03-14,2022,William Davis; James Johnson,The Lancet,ArXiv,10.0000/886589.960,80,10
4f7af86e-4a1a-4080-a252-02596559b6b2,Therapeutics comprehensive impact of patterns : implications for policy,Our analysis reports on the effectiveness of sars-cov-2 in patients . This study assesses outcomes for vaccine in a cohort . We investigates the dynamics of immunity in a cohort . Here we report investigates the impact of variants in patients . Our analysis assesses trends in vaccine in clinical settings . Further work is needed to validate these findings.,2019-06-08,2019,Susan Lopez; John Garcia,BMJ,Crossref,10.0000/596973.452,60,9
68b0247e-38ad-4dee-a66c-9c34284522b2,Transmission comprehensive dynamics of patients,The investigation reports on the impact of coronavirus in population . Here we report investigates trends in genomics in patients . We evaluates the effectiveness of genomics in patients . The investigation evaluates the dynamics of pandemic in a cohort . Here we report presents the impact of variants in patients . The investigation investigates trends in outcomes in clinical settings . Our analysis investigates the impact of genomics in population . This study presents the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2020-01-10,2020,Robert Davis; Michael Johnson; John Davis,PLOS ONE,medRxiv,10.0000/701322.899,91,5
47082544-a2c8-4f95-ac18-cae760e8b2df,Pandemic rapid analysis of spread : implications for policy,Here we report assesses the impact of sars-cov-2 in patients . We investigates the effectiveness of diagnostics in population . Our analysis reports on the effectiveness of sars-cov-2 in patients . This study evaluates trends in transmission in population . Our analysis assesses outcomes for coronavirus in population . We reports on outcomes for pandemic in patients . This study assesses the effectiveness of variants in population . Further work is needed to validate these findings.,2022-08-26,2022,Susan Jones; John Smith; James Martinez; Barbara Williams; Richard Martinez,BMJ,PMC,10.0000/522390.694,76,9
43772618-b1b5-4400-ab50-7bf29b0c5544,Vaccine clinical report of trends,This study investigates the impact of diagnostics in a cohort . Our analysis investigates outcomes for immunity in patients . This study investigates the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2019-06-05,2019,Patricia Jones,Clinical Infectious Diseases,medRxiv,10.0000/169294.407,39,5
c86e04ee-6372-4b88-b121-8d1963d6f66e,Diagnostics global survey of patterns,Our analysis presents the impact of diagnostics in patients . Our analysis presents trends in outcomes in hospitalized individuals . The investigation investigates the impact of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2016-10-24,2016,William Garcia; John Garcia; Linda Johnson,BMJ,PMC,10.0000/667872.334,39,5
c0c757fd-0073-4327-a1bb-a1c85e09c764,Coronavirus regional investigation of trends : implications for policy,The investigation evaluates the dynamics of sars-cov-2 in clinical settings . Our analysis investigates outcomes for clinical in patients . The investigation presents the impact of variants in hospitalized individuals . Here we report investigates outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2020-12-23,2020,Patricia Smith; Jessica Miller; Susan Wilson,Nature,Publisher,10.0000/729633.525,50,9
7da90b9a-ed40-4e47-be12-b388a905b6e6,SARS-CoV-2 regional survey of effectiveness,This study evaluates the dynamics of outcomes in clinical settings . The investigation investigates the dynamics of covid-19 in hospitalized individuals . Our analysis assesses the dynamics of therapeutics in population . The investigation assesses the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2019-01-22,2019,James Miller; Richard Gonzalez; Susan Hernandez; Michael Miller; Robert Lopez,Nature,PMC,10.0000/196990.579,51,5
ac2f0e19-24fe-4502-9821-c7997ca8a9a5,Coronavirus long-term report of patients,We reports on trends in serology in clinical settings . Here we report investigates outcomes for epidemiology in patients . Our analysis investigates trends in modeling in clinical settings . We investigates the impact of variants in population . Our analysis reports on trends in pandemic in a cohort . We presents trends in diagnostics in clinical settings . This study reports on the impact of serology in clinical settings . Our analysis assesses the effectiveness of clinical in hospitalized individuals . Further work is needed to validate these findings.,2019-07-22,2019,Linda Johnson,medRxiv,ArXiv,10.0000/454689.135,90,5
4278ca07-a9f2-4ba2-9838-89e5c2776068,COVID-19 statistical analysis of patients,We investigates the impact of sars-cov-2 in population . Here we report presents outcomes for transmission in population . We assesses trends in clinical in clinical settings . Further work is needed to validate these findings.,2018-10-15,2018,James Anderson; Richard Wilson; Barbara Wilson; Mary Anderson,Frontiers in Medicine,ArXiv,10.0000/408701.976,36,5
7726b191-0847-433a-8e41-6a993462e7ac,COVID-19 comprehensive impact of patterns,The investigation assesses the dynamics of diagnostics in clinical settings . The investigation assesses the effectiveness of epidemiology in patients . This study assesses the dynamics of coronavirus in a cohort . This study investigates the impact of pandemic in hospitalized individuals . Our analysis reports on outcomes for epidemiology in patients . Here we report assesses the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2016-12-24,2016,John Jones; Linda Smith,bioRxiv,medRxiv,10.0000/534675.888,73,5
69b4c0ec-699b-434c-9f84-7ef28fcef094,Epidemiology long-term investigation of effectiveness,This study assesses the effectiveness of epidemiology in clinical settings . The investigation assesses outcomes for genomics in patients . We investigates the impact of genomics in population . The investigation reports on the effectiveness of covid-19 in a cohort . Here we report evaluates trends in pandemic in hospitalized individuals . Our analysis reports on the effectiveness of coronavirus in clinical settings . The investigation reports on the effectiveness of modeling in patients . Further work is needed to validate these findings.,2015-04-03,2015,Robert Martinez; Elizabeth Miller; Patricia Davis; Michael Williams,Clinical Infectious Diseases,Publisher,10.0000/679838.552,83,5
e0717899-0c4b-4035-9959-6cca184e51b7,Outcomes regional investigation of patterns : implications for clinical practice,We investigates outcomes for epidemiology in population . Our analysis reports on the effectiveness of variants in clinical settings . Here we report evaluates trends in genomics in clinical settings . The investigation evaluates the impact of pandemic in clinical settings . Our analysis reports on the dynamics of clinical in population . This study presents the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-09-28,2021,Barbara Smith; Elizabeth Lopez; Mary Gonzalez; Robert Martinez,bioRxiv,bioRxiv,10.0000/666962.877,72,10
c9400d48-752e-464e-941c-402852bd58f4,Diagnostics comprehensive dynamics of patients,Our analysis presents the dynamics of vaccine in population . The investigation investigates outcomes for covid-19 in hospitalized individuals . Here we report presents trends in outcomes in population . Here we report assesses outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2017-07-26,2017,Michael Brown; William Davis; John Garcia,Journal of Infectious Diseases,Crossref,10.0000/989084.750,49,5
3dd38208-2b5a-4684-987d-1c0a876ef23e,SARS-CoV-2 preliminary analysis of outcomes : implications for policy,Here we report presents the impact of vaccine in a cohort . Our analysis assesses outcomes for serology in patients . Here we report investigates outcomes for diagnostics in clinical settings . The investigation evaluates trends in immunity in patients . Our analysis evaluates the dynamics of coronavirus in a cohort . Further work is needed to validate these findings.,2020-12-12,2020,Elizabeth Davis,The Lancet,Crossref,10.0000/767606.638,60,9
d869770e-11ad-44e6-8591-38cf037b9405,Outcomes comparative report of effectiveness,Our analysis investigates trends in therapeutics in clinical settings . We reports on the impact of variants in population . Here we report presents trends in clinical in patients . Here we report evaluates the dynamics of clinical in patients . The investigation assesses the impact of immunity in a cohort . We reports on the dynamics of immunity in a cohort . This study investigates the dynamics of modeling in hospitalized individuals . This study investigates the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2022-12-20,2022,James Jones,medRxiv,Crossref,10.0000/717788.397,93,5
007a94de-c3b3-46db-a94c-26ada66aea95,Coronavirus regional dynamics of effectiveness,Here we report reports on the effectiveness of pandemic in hospitalized individuals . Here we report reports on outcomes for genomics in hospitalized individuals . Here we report presents the dynamics of modeling in a cohort . We investigates trends in outcomes in hospitalized individuals . This study reports on trends in transmission in population . This study investigates the impact of clinical in patients . Further work is needed to validate these findings.,2021-10-22,2021,Elizabeth Lopez,PLOS ONE,Publisher,10.0000/776763.716,74,5
d4ab6cd7-88de-42e6-9919-664be1d358a5,Outcomes global dynamics of prevalence,We presents outcomes for sars-cov-2 in patients . We assesses the dynamics of therapeutics in clinical settings . We presents the dynamics of transmission in patients . Further work is needed to validate these findings.,2020-12-29,2020,Barbara Hernandez; William Anderson; Susan Hernandez,Journal of Infectious Diseases,medRxiv,10.0000/642482.494,35,5
ca03e48c-0b2c-46cb-aa59-248911673652,Immunity comparative report of prevalence,The investigation investigates outcomes for coronavirus in clinical settings . We reports on trends in covid-19 in patients . This study investigates trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-09-05,2015,Patricia Brown; Patricia Brown; James Wilson; William Miller,Frontiers in Medicine,medRxiv,10.0000/524886.719,37,5
aa2de874-2c2f-4e57-b917-ce5467b1be58,Modeling long-term analysis of data,We assesses the effectiveness of vaccine in clinical settings . We evaluates outcomes for covid-19 in clinical settings . Our analysis presents the effectiveness of outcomes in a cohort . Here we report assesses the dynamics of diagnostics in population . Further work is needed to validate these findings.,2015-01-20,2015,Joseph Lopez; Linda Gonzalez; Barbara Johnson; John Hernandez,medRxiv,Crossref,10.0000/830410.188,49,5
3234a44d-4d07-45bb-99de-d8e4c3bded40,Clinical statistical survey of trends,We investigates the impact of immunity in clinical settings . Here we report presents outcomes for clinical in a cohort . Here we report assesses the effectiveness of epidemiology in clinical settings . Our analysis investigates outcomes for therapeutics in population . Our analysis investigates trends in outcomes in a cohort . Here we report reports on trends in epidemiology in population . Further work is needed to validate these findings.,2022-10-22,2022,Elizabeth Johnson; Robert Rodriguez; Michael Gonzalez; William Wilson,Unknown,Crossref,10.0000/941008.804,71,5
b2cecb6e-ff20-47af-b842-a61500eaca49,SARS-CoV-2 rapid assessment of response : implications for public health,Here we report presents the effectiveness of immunity in a cohort . Here we report evaluates the effectiveness of therapeutics in population . The investigation reports on the dynamics of clinical in population . Our analysis assesses the effectiveness of diagnostics in patients . Here we report evaluates the effectiveness of covid-19 in patients . Here we report investigates the effectiveness of serology in hospitalized individuals . We investigates the impact of genomics in population . Our analysis presents the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2018-04-27,2018,Elizabeth Lopez,Science,Publisher,10.0000/869810.532,95,10
5c0eecc9-6b18-4293-939f-dcdc1da3bd8c,Variants clinical analysis of trends : implications for policy,We presents the impact of variants in clinical settings . We investigates trends in covid-19 in a cohort . We assesses the effectiveness of outcomes in a cohort . This study presents the dynamics of outcomes in patients . Further work is needed to validate these findings.,2017-11-10,2017,Linda Garcia; Mary Garcia; David Gonzalez,Unknown,PMC,10.0000/389008.250,47,9
69053cff-9bfc-4ba0-a1f0-bf6078dbd96a,Variants regional study of incidence,The investigation assesses the dynamics of outcomes in patients . This study reports on the effectiveness of genomics in hospitalized individuals . This study reports on the dynamics of genomics in population . This study reports on outcomes for genomics in a cohort . Our analysis assesses trends in serology in population . Here we report reports on the impact of pandemic in clinical settings . The investigation presents the effectiveness of covid-19 in population . We evaluates trends in modeling in clinical settings . Further work is needed to validate these findings.,2018-04-30,2018,Michael Hernandez; Barbara Martinez; Robert Hernandez; David Martinez; Susan Brown,Nature,Publisher,10.0000/713339.435,93,5
a27d76d3-e84a-473a-a56a-fabe7fad434e,Genomics statistical review of data,Our analysis evaluates outcomes for therapeutics in population . We reports on the impact of transmission in patients . We investigates outcomes for transmission in patients . This study evaluates outcomes for vaccine in population . This study reports on trends in immunity in hospitalized individuals . Our analysis investigates trends in transmission in hospitalized individuals . Here we report evaluates the impact of pandemic in a cohort . Our analysis evaluates outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2018-02-19,2018,Robert Wilson; John Jones; Linda Gonzalez; Robert Williams; Joseph Garcia,Journal of Infectious Diseases,ArXiv,10.0000/576838.476,87,5
57a4ac79-df92-467e-a65e-f59bce387c17,Outcomes clinical dynamics of trends,Here we report evaluates the dynamics of outcomes in hospitalized individuals . We assesses the effectiveness of genomics in a cohort . The investigation reports on the effectiveness of variants in population . This study presents outcomes for variants in clinical settings . The investigation presents the effectiveness of therapeutics in clinical settings . Here we report presents the dynamics of therapeutics in patients . Our analysis presents outcomes for modeling in a cohort . We evaluates the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2020-01-07,2020,Barbara Davis; Jessica Johnson; Patricia Hernandez,Frontiers in Medicine,medRxiv,10.0000/320674.613,93,5
9040b1cb-0230-4572-93db-caa3c75920ef,Transmission comparative impact of trends,The investigation investigates the effectiveness of outcomes in hospitalized individuals . This study presents the effectiveness of coronavirus in clinical settings . We assesses the dynamics of therapeutics in a cohort . Our analysis reports on trends in variants in clinical settings . Our analysis assesses the impact of sars-cov-2 in clinical settings . Here we report reports on the dynamics of clinical in clinical settings . This study assesses the dynamics of variants in patients . Further work is needed to validate these findings.,2022-01-29,2022,Richard Lopez; Jennifer Smith; Robert Martinez; Jennifer Smith,Unknown,bioRxiv,10.0000/621298.623,85,5
dde67e7f-5028-4ad1-bbea-5fd3ad9d7dfa,Immunity comprehensive assessment of outcomes,This study investigates the impact of coronavirus in population . Our analysis presents the effectiveness of serology in hospitalized individuals . This study assesses trends in outcomes in clinical settings . This study evaluates outcomes for pandemic in population . The investigation reports on the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2017-10-20,2017,David Hernandez,The Lancet,PMC,10.0000/433628.138,59,5
dc8b59b0-927d-4fb9-9be5-b885af3c95ac,Diagnostics clinical review of outcomes,We assesses the effectiveness of clinical in a cohort . This study presents trends in epidemiology in population . We investigates the impact of diagnostics in clinical settings . The investigation evaluates the impact of vaccine in hospitalized individuals . Our analysis presents the effectiveness of serology in clinical settings . Further work is needed to validate these findings.,2016-06-02,2016,Michael Miller; Patricia Miller; Richard Miller,BMJ,Publisher,10.0000/748739.998,59,5
fde80cbc-65ee-4979-9453-50610f4143fa,COVID-19 regional dynamics of effectiveness,We assesses the impact of genomics in a cohort . Here we report assesses the dynamics of vaccine in population . We assesses the impact of coronavirus in hospitalized individuals . This study assesses the dynamics of epidemiology in a cohort . Further work is needed to validate these findings.,2018-01-29,2018,Elizabeth Hernandez; Jennifer Johnson,BMJ,PMC,10.0000/547037.261,50,5
dcabd166-5632-4125-af20-ff8992b33bd5,Therapeutics global assessment of prevalence,The investigation assesses trends in genomics in patients . We presents the impact of therapeutics in clinical settings . Our analysis investigates the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2016-03-26,2016,Jessica Martinez; Linda Davis,PLOS ONE,medRxiv,10.0000/578266.738,38,5
fac6dab3-288a-4d63-aeeb-61d319676c24,Pandemic global evaluation of trends,We assesses trends in variants in a cohort . The investigation reports on the dynamics of covid-19 in a cohort . Here we report investigates the dynamics of outcomes in population . Our analysis investigates the dynamics of coronavirus in a cohort . Further work is needed to validate these findings.,2015-02-27,2015,Patricia Garcia; Linda Martinez,Nature,bioRxiv,10.0000/430909.877,51,5
58e19e85-d9e2-4796-ad58-b1bbac3d81c2,Vaccine clinical impact of patterns : implications for clinical practice,Here we report evaluates trends in diagnostics in clinical settings . The investigation reports on outcomes for coronavirus in patients . We reports on the dynamics of outcomes in clinical settings . Further work is needed to validate these findings.,2016-11-19,2016,Michael Lopez; Jennifer Miller; David Wilson,PLOS ONE,ArXiv,10.0000/874305.801,40,10
602b315b-e146-41b7-bff4-7bd057cb0df2,Transmission comprehensive survey of incidence,This study investigates trends in serology in population . This study evaluates trends in clinical in hospitalized individuals . We evaluates trends in epidemiology in a cohort . Further work is needed to validate these findings.,2018-01-12,2018,Susan Anderson; James Johnson; Linda Hernandez; Jessica Jones,medRxiv,Publisher,10.0000/358599.277,36,5
a109f16a-6e4a-4fc7-93c2-130bb87622e7,Variants preliminary report of outcomes,This study investigates the effectiveness of outcomes in population . The investigation reports on the dynamics of transmission in clinical settings . Here we report investigates the effectiveness of clinical in a cohort . Our analysis evaluates the dynamics of transmission in hospitalized individuals . We reports on the effectiveness of epidemiology in a cohort . This study evaluates outcomes for transmission in population . This study reports on outcomes for genomics in hospitalized individuals . Here we report evaluates the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2020-12-17,2020,Michael Wilson; Michael Jones; Jennifer Martinez; Patricia Lopez,Science,Publisher,10.0000/743995.929,96,5
e1ec7612-2583-46d2-b705-455507eec3f9,Diagnostics comparative dynamics of patterns,The investigation reports on the impact of clinical in hospitalized individuals . The investigation reports on outcomes for immunity in hospitalized individuals . We presents the impact of serology in clinical settings . We presents the dynamics of coronavirus in clinical settings . We investigates outcomes for sars-cov-2 in population . The investigation reports on trends in diagnostics in hospitalized individuals . Our analysis investigates the effectiveness of clinical in patients . Further work is needed to validate these findings.,2019-04-26,2019,John Wilson,Journal of Infectious Diseases,medRxiv,10.0000/256232.401,80,5
2365d051-0fd6-4c4f-9e25-70dc86eba049,SARS-CoV-2 clinical investigation of trends,The investigation investigates outcomes for modeling in clinical settings . Here we report assesses the dynamics of coronavirus in hospitalized individuals . This study reports on the dynamics of serology in patients . Here we report reports on the impact of serology in patients . This study presents trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2022-12-29,2022,John Lopez; Joseph Jones; Jessica Miller; Barbara Gonzalez,medRxiv,bioRxiv,10.0000/929717.185,63,5
4366720c-beb5-430b-9905-aaa4a0796ca1,Pandemic rapid assessment of patients,This study presents trends in transmission in population . The investigation investigates the dynamics of clinical in clinical settings . We assesses the impact of transmission in population . Further work is needed to validate these findings.,2020-01-28,2020,Barbara Davis; Elizabeth Smith,Frontiers in Medicine,PMC,10.0000/250582.500,37,5
8faa5c63-21d0-4b75-8773-4755e4bbf750,Epidemiology statistical analysis of patients : implications for policy,Here we report evaluates the effectiveness of sars-cov-2 in hospitalized individuals . The investigation presents the impact of covid-19 in patients . We investigates trends in variants in population . We reports on trends in variants in patients . Further work is needed to validate these findings.,2021-04-10,2021,Patricia Martinez; Jessica Jones; David Martinez; Patricia Rodriguez; Barbara Davis,Unknown,bioRxiv,10.0000/768185.413,47,9
9afadd9c-d589-4656-9e4b-9a7b50572ed1,Vaccine comparative investigation of incidence,The investigation investigates the impact of vaccine in population . The investigation evaluates outcomes for clinical in hospitalized individuals . This study evaluates outcomes for covid-19 in a cohort . We investigates trends in vaccine in population . Here we report evaluates the dynamics of transmission in hospitalized individuals . Our analysis assesses outcomes for pandemic in clinical settings . This study reports on the effectiveness of clinical in population . We evaluates outcomes for clinical in patients . Further work is needed to validate these findings.,2022-11-09,2022,Jennifer Davis; Elizabeth Gonzalez; Robert Smith; William Jones; Linda Lopez,Nature,Publisher,10.0000/410480.587,87,5
701a5bb0-6818-4813-8730-7341b89ca9c1,Diagnostics global study of patterns,This study investigates the effectiveness of variants in population . Here we report investigates the effectiveness of pandemic in clinical settings . The investigation evaluates the impact of serology in patients . Our analysis presents the effectiveness of epidemiology in a cohort . The investigation presents the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2019-06-20,2019,Susan Anderson; Richard Williams,Science,Publisher,10.0000/463799.340,62,5
0b071d28-6114-4e68-93fd-b05a79cabc93,Diagnostics rapid assessment of data,This study reports on the dynamics of transmission in clinical settings . We assesses trends in genomics in patients . Here we report presents trends in coronavirus in hospitalized individuals . Our analysis investigates trends in transmission in patients . Our analysis investigates trends in clinical in patients . Our analysis presents the impact of coronavirus in clinical settings . The investigation assesses trends in sars-cov-2 in population . The investigation reports on the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2018-06-24,2018,Susan Smith; Mary Miller,BMJ,PMC,10.0000/198193.971,89,5
a021cae5-9a45-418b-8e77-bcf6f4b2f26d,Epidemiology preliminary report of incidence,We reports on outcomes for epidemiology in hospitalized individuals . The investigation assesses the effectiveness of clinical in hospitalized individuals . The investigation investigates trends in transmission in clinical settings . Further work is needed to validate these findings.,2017-10-19,2017,James Rodriguez,medRxiv,medRxiv,10.0000/180157.768,39,5
0240b4af-d6ab-4657-8201-93433408c4a0,Vaccine statistical analysis of incidence : implications for vaccination strategies,Here we report presents trends in immunity in patients . This study presents the effectiveness of genomics in patients . Here we report reports on the impact of diagnostics in clinical settings . Further work is needed to validate these findings.,2018-06-29,2018,Barbara Smith; Barbara Miller; Patricia Anderson,medRxiv,PMC,10.0000/480821.798,41,10
b34f4499-4133-46c0-b720-861186af7726,Modeling comprehensive analysis of effectiveness,This study presents the dynamics of genomics in patients . We reports on trends in modeling in population . Our analysis reports on the impact of pandemic in population . We presents the dynamics of diagnostics in hospitalized individuals . Here we report presents the effectiveness of serology in clinical settings . This study assesses outcomes for clinical in clinical settings . This study investigates trends in variants in a cohort . Here we report reports on the effectiveness of genomics in a cohort . Further work is needed to validate these findings.,2015-12-08,2015,Jessica Garcia,Nature,Publisher,10.0000/221242.745,93,5
e242021d-f775-4287-9208-8fb739baa8fe,Outcomes clinical review of patterns,We assesses trends in clinical in clinical settings . Our analysis assesses the effectiveness of therapeutics in population . This study assesses the impact of clinical in a cohort . We presents the effectiveness of coronavirus in population . The investigation investigates trends in immunity in clinical settings . Further work is needed to validate these findings.,2015-10-17,2015,Susan Hernandez,Nature,Crossref,10.0000/910087.830,57,5
e06f711c-5cc0-41a1-984d-ffee9d2e2a20,Modeling comprehensive review of data,This study assesses the dynamics of immunity in patients . Our analysis evaluates the dynamics of diagnostics in a cohort . This study evaluates the impact of sars-cov-2 in clinical settings . The investigation evaluates trends in coronavirus in patients . Further work is needed to validate these findings.,2018-01-10,2018,Jessica Miller; Michael Rodriguez; David Lopez,bioRxiv,PMC,10.0000/443711.684,49,5
1b1b3dac-8882-4488-be89-34e5745a8c71,SARS-CoV-2 preliminary evaluation of spread : implications for policy,Our analysis evaluates the effectiveness of sars-cov-2 in a cohort . The investigation reports on the impact of genomics in patients . This study investigates the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2018-09-23,2018,Jennifer Jones; Michael Johnson; Richard Brown,BMJ,bioRxiv,10.0000/373462.852,41,9
401c31a5-b864-43a5-8cd0-82cb072454c1,SARS-CoV-2 comprehensive evaluation of effectiveness,This study assesses the effectiveness of genomics in patients . We investigates the impact of clinical in clinical settings . This study investigates the impact of modeling in hospitalized individuals . Further work is needed to validate these findings.,2020-01-12,2020,Robert Rodriguez; David Jones; Linda Rodriguez; Robert Hernandez; Robert Hernandez,Journal of Infectious Diseases,PMC,10.0000/599640.396,39,5
2492ccca-8fab-465f-9ae9-08bfdebbe6bf,Clinical rapid dynamics of data,The investigation presents the dynamics of immunity in population . This study reports on the effectiveness of outcomes in population . We investigates the dynamics of outcomes in population . This study presents the effectiveness of therapeutics in a cohort . This study investigates the impact of serology in clinical settings . Here we report reports on the impact of epidemiology in patients . This study reports on the effectiveness of diagnostics in population . This study reports on the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2018-02-14,2018,Jennifer Rodriguez; Richard Johnson,PLOS ONE,Publisher,10.0000/274425.692,94,5
6d1fa23d-b84e-459a-9e0f-25ac49bbb2d9,Coronavirus clinical report of outcomes,The investigation reports on the effectiveness of outcomes in patients . The investigation investigates the impact of clinical in a cohort . The investigation reports on the impact of transmission in population . Here we report assesses the dynamics of transmission in hospitalized individuals . Our analysis assesses outcomes for diagnostics in hospitalized individuals . The investigation reports on the impact of epidemiology in population . We investigates the impact of variants in clinical settings . Further work is needed to validate these findings.,2015-06-07,2015,Richard Hernandez; William Johnson,Frontiers in Medicine,medRxiv,10.0000/343280.403,84,5
459ef9cf-46ff-4790-9d47-acad9f269094,Transmission statistical report of effectiveness,The investigation evaluates the dynamics of therapeutics in population . Our analysis evaluates trends in serology in hospitalized individuals . Here we report reports on outcomes for therapeutics in patients . This study assesses the dynamics of modeling in hospitalized individuals . Further work is needed to validate these findings.,2018-07-15,2018,William Jones; Jennifer Hernandez,Clinical Infectious Diseases,ArXiv,10.0000/760664.812,50,5
4833cd3a-4130-4de1-8a91-de7a8412f95f,Vaccine comparative report of spread : implications for public health,We investigates the impact of serology in patients . We reports on the impact of clinical in population . This study presents trends in coronavirus in a cohort . Our analysis assesses the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2015-02-03,2015,Elizabeth Wilson; Jennifer Davis; Jennifer Hernandez; Jennifer Rodriguez,bioRxiv,PMC,10.0000/734650.743,47,10
bc23c7e6-6a3b-49ed-a4a5-99cb602e72ba,Outcomes statistical analysis of incidence,This study presents trends in vaccine in hospitalized individuals . This study assesses outcomes for covid-19 in population . The investigation reports on the effectiveness of vaccine in hospitalized individuals . Here we report evaluates the effectiveness of epidemiology in a cohort . The investigation evaluates trends in diagnostics in a cohort . The investigation investigates trends in sars-cov-2 in clinical settings . Here we report assesses the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2020-04-15,2020,Barbara Smith,BMJ,Crossref,10.0000/332194.275,83,5
76b4004d-bacf-4485-8505-58d8cd875f68,Vaccine long-term investigation of trends : implications for public health,The investigation evaluates the impact of immunity in a cohort . Our analysis presents trends in therapeutics in population . The investigation investigates the dynamics of pandemic in a cohort . Our analysis reports on the effectiveness of diagnostics in a cohort . The investigation assesses the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2019-10-24,2019,Susan Wilson; Barbara Hernandez,Nature,Crossref,10.0000/527073.368,62,10
a01f3770-5181-4972-888b-c4f316efe1a6,Transmission clinical assessment of trends,We assesses the dynamics of covid-19 in a cohort . Our analysis presents outcomes for diagnostics in clinical settings . Our analysis evaluates outcomes for pandemic in patients . Here we report presents the effectiveness of serology in hospitalized individuals . The investigation assesses the impact of variants in patients . Our analysis presents outcomes for immunity in a cohort . This study evaluates the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2016-07-27,2016,Michael Smith; John Martinez; William Garcia; Jessica Rodriguez,PLOS ONE,Publisher,10.0000/352882.142,80,5
4b58b2f1-c151-4346-84be-afa278206d29,Variants long-term study of effectiveness,We investigates trends in covid-19 in patients . We presents the impact of pandemic in a cohort . Here we report reports on the dynamics of immunity in patients . Here we report evaluates the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2019-10-27,2019,William Williams; John Johnson,medRxiv,bioRxiv,10.0000/928774.710,50,5
efddd0e4-0fa9-4524-a0bf-040577da7454,SARS-CoV-2 preliminary dynamics of patients : implications for public health,We assesses the effectiveness of diagnostics in clinical settings . This study reports on trends in vaccine in hospitalized individuals . This study reports on the dynamics of epidemiology in clinical settings . This study evaluates trends in therapeutics in clinical settings . Our analysis investigates trends in serology in hospitalized individuals . Our analysis investigates outcomes for transmission in hospitalized individuals . We reports on the effectiveness of immunity in clinical settings . Our analysis presents outcomes for modeling in patients . Further work is needed to validate these findings.,2016-05-01,2016,Elizabeth Martinez; Barbara Smith; James Miller,Nature,PMC,10.0000/879272.137,91,10
fa6a0338-6480-4ac1-bfcd-284f5b438a98,Clinical long-term report of prevalence,Our analysis reports on the impact of transmission in population . The investigation reports on the dynamics of covid-19 in clinical settings . Here we report investigates outcomes for vaccine in a cohort . Here we report reports on the effectiveness of vaccine in clinical settings . The investigation presents outcomes for epidemiology in clinical settings . The investigation presents the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2016-06-01,2016,Mary Davis; Joseph Brown; Elizabeth Anderson; David Lopez; Patricia Brown,Nature,medRxiv,10.0000/442521.517,76,5
b0c69c83-6822-4e74-953f-3f2d60defebb,Vaccine regional analysis of prevalence : implications for public health,This study presents the effectiveness of variants in clinical settings . We presents the dynamics of vaccine in hospitalized individuals . The investigation investigates the dynamics of diagnostics in a cohort . Our analysis assesses trends in sars-cov-2 in patients . Our analysis evaluates the dynamics of vaccine in hospitalized individuals . We reports on trends in immunity in a cohort . This study assesses trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2020-08-08,2020,David Davis; Richard Lopez; Linda Miller; James Johnson,bioRxiv,Crossref,10.0000/964920.239,80,10
b77675f1-bde5-4d2e-a66e-9c826507b573,Coronavirus long-term dynamics of effectiveness : implications for public health,The investigation presents the dynamics of variants in patients . We reports on trends in epidemiology in clinical settings . Our analysis reports on the effectiveness of immunity in patients . This study presents the effectiveness of diagnostics in clinical settings . The investigation presents the impact of clinical in hospitalized individuals . We evaluates trends in immunity in clinical settings . Further work is needed to validate these findings.,2021-01-12,2021,Barbara Davis; David Williams; John Davis; Robert Rodriguez; Barbara Gonzalez,The Lancet,ArXiv,10.0000/773125.637,70,10
f3e97eeb-1504-42be-b16b-7ee414e7b430,Outcomes comparative dynamics of response,Here we report evaluates outcomes for pandemic in clinical settings . Here we report presents outcomes for therapeutics in population . Our analysis assesses the impact of vaccine in population . We assesses trends in pandemic in clinical settings . We reports on outcomes for pandemic in population . Our analysis presents trends in diagnostics in hospitalized individuals . The investigation evaluates trends in sars-cov-2 in a cohort . Our analysis assesses the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2022-09-05,2022,Joseph Rodriguez,PLOS ONE,medRxiv,10.0000/683598.728,88,5
8aad1af1-39a3-4d7e-9a78-73f28aa25800,Variants statistical review of patterns,Our analysis investigates the effectiveness of diagnostics in hospitalized individuals . We assesses trends in outcomes in patients . This study presents the impact of coronavirus in clinical settings . Our analysis reports on the dynamics of transmission in patients . Here we report investigates the dynamics of covid-19 in population . Further work is needed to validate these findings.,2017-01-30,2017,Robert Anderson; Mary Miller; Joseph Brown; Richard Anderson,Clinical Infectious Diseases,Publisher,10.0000/332325.284,60,5
0477af7f-53ca-4e5e-ad03-8cc59621bb90,Modeling long-term impact of patients,This study assesses the effectiveness of pandemic in population . Our analysis presents the effectiveness of diagnostics in clinical settings . We investigates trends in therapeutics in population . Here we report evaluates outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2019-08-03,2019,Linda Martinez; Barbara Brown; Joseph Jones; Richard Jones,PLOS ONE,PMC,10.0000/907064.168,48,5
a0529164-cb95-45f9-836b-d9992574cdfb,Transmission preliminary dynamics of incidence : implications for policy,Here we report investigates outcomes for genomics in clinical settings . This study evaluates the dynamics of epidemiology in patients . The investigation evaluates the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2015-05-23,2015,David Miller; Michael Smith,Unknown,Crossref,10.0000/618388.293,40,9
b15e2388-d119-40f0-a425-8aad8dd8ea70,Vaccine comprehensive review of effectiveness,Our analysis assesses the effectiveness of modeling in population . We reports on trends in coronavirus in clinical settings . This study presents trends in pandemic in patients . We presents the effectiveness of genomics in population . Here we report presents the impact of immunity in hospitalized individuals . Our analysis presents the effectiveness of vaccine in clinical settings . The investigation assesses the dynamics of transmission in population . The investigation evaluates outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2022-03-04,2022,John Anderson; Jennifer Brown; David Johnson; Linda Wilson,BMJ,Publisher,10.0000/912552.722,89,5
91ab4b47-89a5-479f-8c10-e1cb7373eb6c,Diagnostics preliminary evaluation of incidence,This study presents the dynamics of genomics in patients . This study reports on the dynamics of vaccine in population . This study assesses trends in pandemic in hospitalized individuals . Here we report presents the dynamics of genomics in hospitalized individuals . The investigation presents the impact of clinical in patients . We reports on outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2016-01-24,2016,Linda Anderson; Barbara Wilson; Patricia Lopez,medRxiv,ArXiv,10.0000/408089.541,71,5
92599d75-5417-4593-bf33-ab1590caf7d1,Transmission clinical assessment of patterns : implications for clinical practice,We evaluates the dynamics of immunity in a cohort . This study reports on the impact of covid-19 in clinical settings . Here we report reports on trends in epidemiology in patients . Here we report assesses trends in variants in hospitalized individuals . Our analysis presents outcomes for sars-cov-2 in hospitalized individuals . We presents trends in immunity in population . The investigation assesses trends in therapeutics in population . The investigation assesses the impact of therapeutics in patients . Further work is needed to validate these findings.,2021-04-12,2021,Patricia Gonzalez; Mary Wilson,PLOS ONE,bioRxiv,10.0000/929611.256,89,10
2ab52ed9-5363-4b2c-9674-bbe1748143f9,Epidemiology statistical report of patterns : implications for policy,The investigation investigates the impact of serology in clinical settings . The investigation evaluates trends in variants in clinical settings . Here we report reports on trends in coronavirus in population . Our analysis presents the effectiveness of genomics in a cohort . We evaluates the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2017-03-01,2017,Barbara Martinez; Jessica Johnson; Barbara Rodriguez; Richard Martinez; Elizabeth Lopez,Unknown,bioRxiv,10.0000/804809.648,61,9
04e55628-93b1-445a-ade9-bc7ce3d6bc22,Pandemic long-term analysis of spread : implications for policy,The investigation assesses the dynamics of immunity in a cohort . The investigation investigates outcomes for vaccine in population . Here we report assesses the dynamics of pandemic in a cohort . We assesses outcomes for vaccine in a cohort . The investigation evaluates trends in serology in population . This study assesses the impact of sars-cov-2 in population . We evaluates trends in immunity in clinical settings . Further work is needed to validate these findings.,2016-07-26,2016,Barbara Gonzalez; Jennifer Garcia; David Smith; Joseph Hernandez,BMJ,Crossref,10.0000/358706.712,77,9
2244bb03-654a-434e-983e-3d728d0a1e8c,Diagnostics comparative survey of prevalence,This study evaluates trends in coronavirus in population . This study presents trends in clinical in clinical settings . Here we report investigates outcomes for immunity in population . We investigates the effectiveness of genomics in a cohort . This study presents outcomes for therapeutics in clinical settings . We presents the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2019-07-01,2019,Richard Martinez; Elizabeth Johnson; Robert Wilson; Michael Martinez,Science,Publisher,10.0000/303098.628,67,5
b1c9c63c-d240-4022-a203-d95c97cc7f0f,Pandemic preliminary impact of patients : implications for clinical practice,Here we report investigates the effectiveness of transmission in population . We evaluates outcomes for epidemiology in clinical settings . We investigates the effectiveness of variants in population . Further work is needed to validate these findings.,2016-09-26,2016,Robert Johnson; Patricia Williams; John Smith; Jessica Gonzalez; Mary Davis,bioRxiv,medRxiv,10.0000/381530.926,37,10
4481d648-a50a-41f9-aa51-ec37722a050e,Serology preliminary survey of spread,Here we report reports on the effectiveness of epidemiology in population . This study assesses the effectiveness of covid-19 in hospitalized individuals . Our analysis evaluates trends in clinical in clinical settings . Here we report investigates trends in modeling in a cohort . We assesses trends in variants in hospitalized individuals . Further work is needed to validate these findings.,2021-05-12,2021,Elizabeth Rodriguez; Richard Rodriguez; William Wilson; Barbara Jones,Frontiers in Medicine,Publisher,10.0000/347758.661,61,5
fe2c609e-c60b-430f-a205-0c92290d789f,Variants clinical analysis of patients : implications for clinical practice,Here we report investigates the dynamics of epidemiology in patients . This study assesses outcomes for diagnostics in a cohort . This study reports on the impact of immunity in population . This study assesses the dynamics of pandemic in a cohort . This study reports on the effectiveness of coronavirus in clinical settings . Our analysis investigates the effectiveness of pandemic in population . Further work is needed to validate these findings.,2017-03-01,2017,Linda Brown; Barbara Hernandez; Joseph Gonzalez,Frontiers in Medicine,Crossref,10.0000/181895.744,73,10
0a09b77d-c44c-4086-bbb5-4df084ffab65,Clinical long-term review of response : implications for public health,This study investigates the impact of diagnostics in a cohort . This study assesses the dynamics of coronavirus in clinical settings . Our analysis evaluates the effectiveness of serology in hospitalized individuals . We assesses the effectiveness of variants in population . Here we report assesses trends in pandemic in clinical settings . Further work is needed to validate these findings.,2020-05-08,2020,Susan Williams,The Lancet,Crossref,10.0000/693599.729,61,10
8896ad9d-331d-4bd2-ab01-067ece0e473b,Epidemiology preliminary survey of patients,This study evaluates the dynamics of sars-cov-2 in population . Our analysis reports on the dynamics of therapeutics in population . We assesses the effectiveness of outcomes in patients . Here we report presents trends in serology in population . Here we report evaluates trends in epidemiology in a cohort . Further work is needed to validate these findings.,2016-05-03,2016,Mary Jones; Linda Johnson,The Lancet,medRxiv,10.0000/265218.751,59,5
d11fbd7a-bd35-48a0-bde7-867c6ed1b82a,Pandemic statistical report of spread,This study reports on outcomes for pandemic in clinical settings . This study reports on the dynamics of genomics in patients . The investigation assesses the impact of outcomes in clinical settings . We reports on outcomes for diagnostics in a cohort . Here we report assesses the dynamics of covid-19 in patients . This study reports on the effectiveness of sars-cov-2 in hospitalized individuals . We assesses trends in outcomes in clinical settings . Further work is needed to validate these findings.,2022-04-24,2022,Mary Davis; Barbara Wilson; Robert Hernandez,Clinical Infectious Diseases,ArXiv,10.0000/910585.153,83,5
32087f8e-9e0f-4ee1-a939-eb81aa377c2f,Diagnostics preliminary survey of outcomes,The investigation assesses trends in immunity in hospitalized individuals . We assesses trends in modeling in a cohort . This study assesses the effectiveness of therapeutics in a cohort . The investigation evaluates the dynamics of genomics in population . Further work is needed to validate these findings.,2021-05-21,2021,David Gonzalez; Joseph Lopez; Barbara Wilson; Richard Williams; John Davis,BMJ,PMC,10.0000/173594.170,48,5
5c55bd75-4697-4640-b174-1c04df1694a8,Epidemiology comparative investigation of spread,We investigates trends in outcomes in population . Our analysis presents the impact of diagnostics in population . We evaluates trends in variants in a cohort . This study assesses the effectiveness of variants in hospitalized individuals . We presents the impact of vaccine in a cohort . The investigation presents the effectiveness of coronavirus in a cohort . Here we report investigates the effectiveness of coronavirus in population . We evaluates the impact of transmission in population . Further work is needed to validate these findings.,2021-02-13,2021,Linda Hernandez; John Smith; Richard Smith; Jessica Gonzalez; David Wilson,BMJ,medRxiv,10.0000/337790.219,87,5
7b872eda-d94d-4b33-b2e8-12c64373f17d,Diagnostics rapid impact of outcomes,We presents the effectiveness of pandemic in clinical settings . Here we report reports on outcomes for diagnostics in a cohort . We presents the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2021-11-12,2021,David Lopez; Patricia Miller,BMJ,Publisher,10.0000/499297.216,40,5
2f673574-2659-4740-9156-4b161e95a439,Therapeutics comparative study of outcomes,Our analysis evaluates the impact of therapeutics in clinical settings . The investigation investigates the effectiveness of serology in a cohort . This study assesses outcomes for clinical in a cohort . We investigates the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2019-01-04,2019,Patricia Lopez; Jessica Brown,bioRxiv,bioRxiv,10.0000/227986.351,50,5
79b3ec03-d960-4029-abba-6743f139145d,Pandemic clinical report of outcomes,Here we report reports on the effectiveness of serology in patients . We presents the impact of serology in a cohort . The investigation presents outcomes for transmission in patients . Further work is needed to validate these findings.,2015-03-10,2015,Robert Anderson; Elizabeth Hernandez; Richard Brown; Richard Garcia; David Rodriguez,Frontiers in Medicine,bioRxiv,10.0000/134981.854,39,5
f0ca7aec-b1c0-4d6d-a023-fb9e4d4b865e,Genomics long-term investigation of effectiveness,The investigation presents trends in modeling in population . This study assesses outcomes for variants in population . The investigation investigates outcomes for transmission in a cohort . The investigation assesses the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2021-03-30,2021,Michael Garcia; Susan Wilson,Journal of Infectious Diseases,Crossref,10.0000/269598.448,47,5
dd702028-8274-4e32-a304-8adcbdc75f20,Diagnostics preliminary investigation of patients : implications for policy,The investigation assesses outcomes for sars-cov-2 in clinical settings . The investigation evaluates trends in therapeutics in a cohort . We evaluates the dynamics of sars-cov-2 in hospitalized individuals . This study reports on outcomes for clinical in clinical settings . Our analysis evaluates the impact of serology in a cohort . Here we report presents the effectiveness of pandemic in population . Further work is needed to validate these findings.,2015-11-13,2015,Michael Jones; Jennifer Wilson; Robert Garcia,The Lancet,Publisher,10.0000/752991.904,71,9
f6326929-3bd4-4ac6-bb5c-d4fc2666c473,Modeling long-term investigation of spread,This study reports on the dynamics of variants in a cohort . Our analysis assesses outcomes for covid-19 in a cohort . We assesses the dynamics of pandemic in patients . We evaluates the effectiveness of modeling in a cohort . We reports on the dynamics of transmission in population . The investigation presents the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-04-21,2021,Mary Anderson; Richard Wilson,Unknown,PMC,10.0000/329903.544,70,5
c677cf07-d20e-4cc6-91a7-83c5de7dc747,Diagnostics statistical evaluation of effectiveness,Our analysis reports on trends in vaccine in patients . The investigation assesses the impact of immunity in clinical settings . Here we report presents outcomes for modeling in a cohort . The investigation presents the dynamics of covid-19 in clinical settings . Our analysis reports on the dynamics of clinical in population . The investigation assesses outcomes for serology in a cohort . The investigation presents outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2020-10-04,2020,Mary Johnson,Unknown,PMC,10.0000/457145.226,82,5
fc61ac66-20c7-40ea-afb2-c8aedcb38869,COVID-19 long-term evaluation of effectiveness,Our analysis investigates the impact of sars-cov-2 in hospitalized individuals . Here we report evaluates the impact of transmission in patients . This study investigates the dynamics of genomics in clinical settings . Further work is needed to validate these findings.,2017-05-18,2017,Michael Davis; David Rodriguez; John Anderson; Jessica Hernandez; Susan Smith,BMJ,medRxiv,10.0000/875987.719,41,5
3143490b-a3cd-498b-9d40-b3ca80fcbca3,Diagnostics rapid report of prevalence,We investigates trends in diagnostics in clinical settings . Our analysis investigates the dynamics of outcomes in clinical settings . We assesses the impact of coronavirus in hospitalized individuals . This study assesses the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2021-11-15,2021,Richard Brown; William Garcia; Robert Wilson; John Miller; Patricia Davis,Unknown,bioRxiv,10.0000/176662.111,49,5
6af1d1da-e598-494f-93c7-8e64235afd7d,Serology comprehensive report of patients,We evaluates the effectiveness of sars-cov-2 in clinical settings . The investigation assesses the effectiveness of therapeutics in hospitalized individuals . We investigates outcomes for clinical in patients . Here we report evaluates the effectiveness of therapeutics in patients . The investigation investigates outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-08-08,2015,Linda Smith; Mary Smith; Michael Gonzalez,Nature,PMC,10.0000/426464.741,58,5
606a0b34-b7cb-46b0-a029-68a786d52367,Therapeutics long-term assessment of spread,Our analysis assesses outcomes for immunity in patients . Our analysis assesses the effectiveness of outcomes in clinical settings . Here we report evaluates trends in modeling in clinical settings . Here we report reports on the dynamics of outcomes in hospitalized individuals . Here we report evaluates the impact of immunity in a cohort . Our analysis reports on the effectiveness of epidemiology in patients . The investigation investigates the dynamics of sars-cov-2 in clinical settings . Here we report investigates the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2021-11-28,2021,Robert Davis; Jessica Williams; Richard Williams; Mary Davis,PLOS ONE,PMC,10.0000/856955.289,97,5
3d0e1dab-d956-47a5-afeb-42296c8e443f,Epidemiology rapid investigation of outcomes,Here we report presents the impact of diagnostics in patients . We presents the effectiveness of genomics in patients . Here we report presents trends in coronavirus in patients . This study evaluates the impact of coronavirus in clinical settings . The investigation investigates the effectiveness of clinical in patients . Here we report evaluates trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2022-11-06,2022,William Brown; Mary Smith; Barbara Williams,Nature,medRxiv,10.0000/727785.233,70,5
4a40d116-162e-4751-ba96-bc1c50d43b7c,Vaccine regional report of response,We evaluates the dynamics of outcomes in a cohort . This study evaluates the effectiveness of serology in population . This study evaluates trends in vaccine in hospitalized individuals . Here we report evaluates outcomes for epidemiology in clinical settings . Our analysis assesses the impact of transmission in a cohort . Here we report assesses outcomes for therapeutics in a cohort . We investigates outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2018-07-07,2018,William Gonzalez; John Rodriguez,bioRxiv,ArXiv,10.0000/280565.528,80,5
8a975f37-b9fd-445f-a06f-722b01afdcda,Vaccine statistical evaluation of patients,We assesses the effectiveness of transmission in clinical settings . We investigates outcomes for immunity in clinical settings . We investigates the impact of clinical in a cohort . This study assesses the effectiveness of pandemic in a cohort . We presents the impact of genomics in a cohort . Our analysis evaluates trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2015-05-19,2015,Susan Lopez; Elizabeth Lopez; Joseph Gonzalez,Clinical Infectious Diseases,Publisher,10.0000/432435.886,68,5
9627464d-d6e9-435f-affc-d3d790b0674a,Genomics long-term dynamics of response,The investigation assesses the effectiveness of coronavirus in patients . We presents the effectiveness of outcomes in patients . Here we report assesses the dynamics of variants in a cohort . This study investigates the impact of serology in population . Our analysis evaluates the effectiveness of variants in a cohort . The investigation investigates the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-06-18,2022,Joseph Davis,Nature,Crossref,10.0000/408746.830,71,5
17610656-c291-4195-9e13-927f0cb72959,Coronavirus clinical assessment of patients,The investigation evaluates trends in sars-cov-2 in patients . We assesses the impact of vaccine in a cohort . Our analysis presents the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2015-09-08,2015,Michael Garcia; James Smith,BMJ,Publisher,10.0000/620951.927,38,5
fd5428fe-6564-4582-848c-88b7de180e40,Outcomes long-term impact of spread,This study investigates the dynamics of epidemiology in a cohort . We presents trends in genomics in population . This study reports on trends in modeling in population . We investigates outcomes for variants in patients . This study evaluates the dynamics of outcomes in hospitalized individuals . Here we report investigates trends in variants in hospitalized individuals . Further work is needed to validate these findings.,2018-12-30,2018,Mary Hernandez,Frontiers in Medicine,Publisher,10.0000/769849.965,67,5
52f5db74-fac3-40d2-bf56-f3609f4948f4,Vaccine rapid assessment of outcomes : implications for clinical practice,Our analysis investigates the effectiveness of serology in a cohort . Here we report investigates the impact of epidemiology in population . Our analysis investigates the effectiveness of modeling in hospitalized individuals . This study reports on the effectiveness of genomics in hospitalized individuals . This study evaluates the dynamics of serology in hospitalized individuals . This study reports on outcomes for immunity in clinical settings . Our analysis presents outcomes for clinical in clinical settings . Here we report reports on the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2021-02-02,2021,James Williams; Barbara Davis; Jennifer Lopez; Robert Brown; Richard Williams,BMJ,Publisher,10.0000/385820.730,97,10
53a16009-b97f-4acd-bd37-a070c2d963f1,Immunity comparative investigation of data,This study assesses the dynamics of genomics in a cohort . Our analysis assesses trends in transmission in clinical settings . This study reports on the impact of diagnostics in patients . This study presents the impact of coronavirus in patients . Our analysis assesses the dynamics of immunity in population . We evaluates outcomes for serology in patients . Further work is needed to validate these findings.,2021-03-07,2021,James Martinez; Susan Davis; Jessica Miller; Linda Anderson; Susan Brown,Clinical Infectious Diseases,ArXiv,10.0000/866514.250,68,5
ef501166-8f77-4095-af15-006cc93e62ce,Therapeutics comparative survey of effectiveness : implications for policy,Our analysis assesses the effectiveness of clinical in hospitalized individuals . This study assesses trends in covid-19 in hospitalized individuals . This study reports on the effectiveness of variants in population . We reports on the dynamics of immunity in population . The investigation evaluates the impact of sars-cov-2 in patients . The investigation assesses outcomes for transmission in clinical settings . Further work is needed to validate these findings.,2022-02-21,2022,Richard Davis; Richard Davis; Jennifer Hernandez; Joseph Brown,Unknown,Publisher,10.0000/374147.808,70,9
08686896-9a8b-4b9d-aefe-46363feebf00,Variants clinical analysis of spread,The investigation evaluates the dynamics of epidemiology in hospitalized individuals . This study assesses the effectiveness of sars-cov-2 in patients . Our analysis investigates outcomes for serology in clinical settings . This study assesses the effectiveness of modeling in population . Further work is needed to validate these findings.,2015-10-10,2015,James Rodriguez; Linda Smith,Science,Crossref,10.0000/122592.145,49,5
1d8d29de-9121-4e23-8c71-da339bfbaa9a,Therapeutics regional investigation of trends,This study presents outcomes for vaccine in population . This study evaluates the dynamics of clinical in a cohort . We evaluates outcomes for coronavirus in patients . This study assesses the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2019-09-08,2019,Mary Rodriguez; Joseph Anderson; Linda Hernandez; Mary Garcia; Michael Rodriguez,BMJ,ArXiv,10.0000/724221.157,47,5
f4afd3a2-4f32-4b89-a595-06e6616d0e7e,Epidemiology long-term review of patterns,Here we report assesses the dynamics of genomics in population . This study assesses the dynamics of therapeutics in a cohort . This study assesses the effectiveness of pandemic in a cohort . This study evaluates the effectiveness of covid-19 in hospitalized individuals . Our analysis evaluates the impact of covid-19 in population . We presents outcomes for clinical in clinical settings . The investigation investigates the effectiveness of genomics in population . We investigates the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2020-05-23,2020,John Davis,Clinical Infectious Diseases,ArXiv,10.0000/897588.648,91,5
0bea3c32-4fb7-4ca1-a2a6-78c4f023cec1,Modeling long-term study of spread : implications for policy,We reports on the dynamics of transmission in clinical settings . Our analysis investigates the effectiveness of variants in hospitalized individuals . The investigation reports on the dynamics of diagnostics in patients . Our analysis investigates the dynamics of pandemic in patients . This study reports on the impact of serology in hospitalized individuals . We assesses the effectiveness of pandemic in a cohort . Our analysis evaluates trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2017-10-31,2017,James Davis; Robert Wilson; Jessica Johnson; Barbara Smith,Nature,ArXiv,10.0000/263016.935,83,9
963a0376-d5e9-4d1d-a919-d418498ae1ba,SARS-CoV-2 global review of trends : implications for clinical practice,Our analysis evaluates the impact of clinical in a cohort . Our analysis reports on the impact of vaccine in patients . The investigation reports on outcomes for vaccine in clinical settings . Our analysis assesses the impact of immunity in hospitalized individuals . We assesses trends in serology in clinical settings . Here we report assesses the impact of coronavirus in patients . This study presents outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2017-07-06,2017,Robert Gonzalez; Susan Wilson; David Hernandez; Barbara Hernandez,The Lancet,Crossref,10.0000/381164.904,82,10
c2d1ac47-8625-42a3-bcab-638e0d1d281b,Variants preliminary investigation of incidence,We investigates the dynamics of serology in population . The investigation investigates outcomes for clinical in hospitalized individuals . Here we report assesses trends in clinical in clinical settings . This study assesses the impact of transmission in hospitalized individuals . This study investigates the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2018-01-22,2018,William Miller; John Miller; William Lopez; John Miller,Unknown,medRxiv,10.0000/971124.984,59,5
be42fb3e-336c-4ce9-b4f8-1e6caca7ed22,Variants preliminary impact of outcomes : implications for clinical practice,The investigation assesses outcomes for transmission in clinical settings . This study investigates the effectiveness of pandemic in hospitalized individuals . Our analysis assesses trends in diagnostics in a cohort . This study reports on trends in epidemiology in a cohort . The investigation reports on the dynamics of vaccine in clinical settings . Our analysis reports on the impact of sars-cov-2 in clinical settings . We investigates outcomes for modeling in clinical settings . Here we report evaluates the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2015-05-14,2015,Joseph Jones; James Johnson,Journal of Infectious Diseases,PMC,10.0000/924578.780,95,10
b6273689-8602-4193-ad3e-ebdbb254e786,Modeling long-term study of effectiveness,Here we report investigates the impact of outcomes in population . This study evaluates the dynamics of transmission in clinical settings . This study assesses outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2017-11-10,2017,James Gonzalez; Joseph Brown,Clinical Infectious Diseases,medRxiv,10.0000/637898.430,40,5
ccaa9448-ee4c-46f3-a1aa-6546ed289ee5,Modeling regional dynamics of incidence,The investigation assesses the dynamics of epidemiology in patients . We evaluates outcomes for coronavirus in a cohort . Here we report presents the impact of therapeutics in a cohort . Here we report presents the dynamics of modeling in population . We evaluates the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2016-02-01,2016,Jessica Miller; Elizabeth Brown; David Garcia,PLOS ONE,Crossref,10.0000/512369.847,60,5
64e68a2a-04e4-490d-8bf7-d9bb76f549dd,Variants rapid study of data,The investigation assesses trends in variants in clinical settings . We assesses outcomes for epidemiology in patients . We investigates the impact of covid-19 in patients . Further work is needed to validate these findings.,2020-08-29,2020,James Gonzalez,Unknown,ArXiv,10.0000/990565.482,35,5
279c0674-a332-4afa-8a94-1cdb60b70fe5,Pandemic rapid review of patients : implications for vaccination strategies,Our analysis investigates outcomes for transmission in a cohort . Here we report investigates trends in modeling in patients . We presents the impact of covid-19 in population . The investigation presents the effectiveness of covid-19 in patients . This study evaluates the effectiveness of serology in hospitalized individuals . Our analysis presents the effectiveness of clinical in population . We assesses the impact of pandemic in a cohort . Further work is needed to validate these findings.,2016-08-28,2016,Jennifer Martinez; Richard Jones; Elizabeth Miller,PLOS ONE,PMC,10.0000/628111.467,78,10
1117a071-7819-4d2b-a8fd-0ff48cebf51a,Genomics clinical impact of trends,We investigates the effectiveness of epidemiology in patients . Our analysis reports on the impact of diagnostics in population . This study investigates the dynamics of coronavirus in clinical settings . We assesses the impact of clinical in patients . Further work is needed to validate these findings.,2022-12-10,2022,John Smith; Robert Miller; Richard Wilson; Joseph Wilson,Journal of Infectious Diseases,medRxiv,10.0000/828417.368,48,5
4227671c-e75c-43b4-b7cb-1b337837d1d5,Variants clinical report of effectiveness : implications for public health,We reports on trends in epidemiology in hospitalized individuals . We investigates the dynamics of therapeutics in population . The investigation presents trends in covid-19 in population . The investigation assesses the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-11-16,2020,William Smith,PLOS ONE,ArXiv,10.0000/624584.173,47,10
70f45e6f-1b33-454c-a4a7-6060e3e3c48d,Modeling preliminary impact of prevalence : implications for policy,The investigation investigates the dynamics of immunity in a cohort . Here we report investigates trends in genomics in hospitalized individuals . This study investigates the effectiveness of modeling in hospitalized individuals . The investigation evaluates trends in vaccine in hospitalized individuals . Further work is needed to validate these findings.,2019-04-22,2019,William Jones; Elizabeth Davis; Barbara Lopez; John Davis,The Lancet,PMC,10.0000/798044.778,51,9
cf38da66-ec84-4076-af69-76c09408b94e,Transmission rapid evaluation of incidence,Our analysis investigates trends in pandemic in patients . Our analysis presents the effectiveness of sars-cov-2 in a cohort . Here we report investigates the impact of coronavirus in hospitalized individuals . We assesses outcomes for immunity in hospitalized individuals . We assesses the impact of genomics in patients . This study reports on the dynamics of covid-19 in population . This study evaluates trends in variants in patients . Our analysis reports on outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2022-06-06,2022,Michael Brown; Elizabeth Anderson,Frontiers in Medicine,Publisher,10.0000/486970.778,89,5
fd0c95ea-2805-4007-8160-03e5b3e97ece,Therapeutics preliminary review of prevalence,We assesses the impact of diagnostics in clinical settings . We presents the dynamics of immunity in hospitalized individuals . This study investigates trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2022-08-28,2022,John Brown; Michael Smith; Susan Jones; Jennifer Williams,Nature,Crossref,10.0000/489945.884,38,5
a5d5a391-6ac6-4288-88e5-4fde86cf2889,Diagnostics statistical investigation of trends,Here we report presents trends in modeling in population . This study investigates outcomes for immunity in hospitalized individuals . Our analysis presents outcomes for pandemic in a cohort . Here we report presents outcomes for modeling in patients . This study presents the impact of sars-cov-2 in patients . Here we report reports on outcomes for covid-19 in population . The investigation evaluates the effectiveness of epidemiology in clinical settings . Our analysis evaluates the impact of transmission in population . Further work is needed to validate these findings.,2016-08-07,2016,Barbara Wilson; John Williams; Jennifer Wilson; Elizabeth Smith,Unknown,ArXiv,10.0000/379574.531,90,5
164d0eda-31f0-4d7b-881f-1b876431a619,Transmission comparative investigation of incidence,Here we report reports on the impact of coronavirus in patients . Here we report reports on the impact of clinical in patients . Here we report evaluates the dynamics of sars-cov-2 in a cohort . We presents the effectiveness of serology in clinical settings . Further work is needed to validate these findings.,2016-10-20,2016,David Lopez; Elizabeth Johnson; Barbara Jones; Jessica Rodriguez; Robert Miller,PLOS ONE,Crossref,10.0000/199274.159,54,5
03817027-91f7-492e-8cf1-a4cde404b256,Outcomes comparative assessment of response : implications for policy,The investigation investigates outcomes for sars-cov-2 in clinical settings . This study presents outcomes for coronavirus in clinical settings . This study presents the impact of modeling in hospitalized individuals . This study assesses outcomes for diagnostics in clinical settings . This study presents outcomes for covid-19 in a cohort . Our analysis presents the dynamics of modeling in patients . Further work is needed to validate these findings.,2019-09-29,2019,James Rodriguez; Elizabeth Miller; Joseph Johnson; Jennifer Rodriguez; William Jones,Clinical Infectious Diseases,ArXiv,10.0000/191073.114,69,9
2b060d4a-5ebd-400c-8a63-498a5758c17f,Modeling rapid report of outcomes,Here we report presents the effectiveness of immunity in patients . This study investigates the dynamics of diagnostics in hospitalized individuals . This study reports on the impact of immunity in a cohort . Further work is needed to validate these findings.,2016-02-24,2016,Michael Johnson; Linda Williams; Linda Wilson; Susan Hernandez,Nature,ArXiv,10.0000/628162.281,42,5
b8d9ad80-6887-4ead-8ba3-603d8788dbff,Pandemic comparative dynamics of patients,We presents the dynamics of diagnostics in patients . Here we report reports on the effectiveness of outcomes in population . The investigation evaluates trends in coronavirus in a cohort . The investigation assesses the impact of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2021-06-22,2021,Susan Davis; James Williams,Nature,medRxiv,10.0000/451468.932,50,5
ce4267ff-8653-47da-b9fb-029ef85f8ce8,Outcomes preliminary review of patterns,Our analysis assesses the effectiveness of outcomes in a cohort . Here we report reports on the impact of pandemic in hospitalized individuals . The investigation assesses the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2016-09-30,2016,Joseph Johnson,medRxiv,bioRxiv,10.0000/881154.429,43,5
d2975c30-4324-4211-b281-b3b3b900a8c5,Outcomes preliminary review of prevalence,This study presents the dynamics of variants in hospitalized individuals . This study investigates outcomes for serology in a cohort . We presents trends in epidemiology in a cohort . This study evaluates the effectiveness of covid-19 in patients . Our analysis assesses the dynamics of outcomes in clinical settings . Our analysis investigates the impact of covid-19 in hospitalized individuals . Here we report evaluates the impact of modeling in a cohort . Further work is needed to validate these findings.,2019-05-29,2019,William Rodriguez; Barbara Williams; Barbara Miller; Jessica Brown,Science,Publisher,10.0000/169570.210,82,5
ef08a179-a532-4a0d-bda5-fcc8cef7c878,Genomics regional dynamics of patterns,Our analysis presents the effectiveness of serology in hospitalized individuals . This study investigates trends in vaccine in patients . We presents trends in modeling in population . Here we report assesses the impact of genomics in population . We reports on the effectiveness of immunity in hospitalized individuals . Our analysis assesses outcomes for therapeutics in a cohort . We assesses outcomes for transmission in patients . This study assesses trends in transmission in clinical settings . Further work is needed to validate these findings.,2017-08-29,2017,John Gonzalez; David Hernandez; Linda Jones; John Jones,Unknown,bioRxiv,10.0000/438650.477,86,5
a4129456-3503-4dae-9e31-131b31d486e4,Pandemic long-term review of spread,We presents the impact of modeling in patients . This study reports on the dynamics of variants in patients . We assesses the dynamics of covid-19 in patients . This study evaluates outcomes for variants in a cohort . Our analysis evaluates outcomes for therapeutics in clinical settings . The investigation evaluates the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2018-01-09,2018,Patricia Davis; Richard Gonzalez; William Rodriguez,Journal of Infectious Diseases,Crossref,10.0000/155208.659,68,5
5f2c69d1-1b95-4c47-a5cd-eab7e65b6f38,Serology rapid review of response,This study reports on the impact of transmission in patients . The investigation investigates outcomes for covid-19 in a cohort . Here we report reports on the impact of therapeutics in patients . The investigation assesses the dynamics of epidemiology in hospitalized individuals . Here we report assesses trends in diagnostics in hospitalized individuals . The investigation presents trends in epidemiology in clinical settings . Our analysis investigates trends in transmission in clinical settings . Further work is needed to validate these findings.,2019-05-22,2019,William Davis; Barbara Gonzalez; Joseph Lopez,bioRxiv,bioRxiv,10.0000/655076.954,83,5
66cfa83f-55e1-41a0-9ed2-beb3f757b72a,Diagnostics preliminary survey of patterns,This study reports on the effectiveness of serology in hospitalized individuals . Here we report presents the effectiveness of vaccine in clinical settings . Our analysis assesses the effectiveness of vaccine in clinical settings . Here we report reports on trends in diagnostics in patients . We presents outcomes for outcomes in clinical settings . Our analysis assesses outcomes for genomics in population . We investigates the impact of serology in clinical settings . Further work is needed to validate these findings.,2021-05-24,2021,Jessica Anderson; Linda Lopez; Barbara Miller; Richard Rodriguez,The Lancet,Crossref,10.0000/672451.103,82,5
c99c6931-d46f-46a0-be90-5b1c543338f8,Transmission clinical impact of incidence,Here we report assesses the effectiveness of covid-19 in clinical settings . We reports on outcomes for coronavirus in patients . We investigates the effectiveness of diagnostics in clinical settings . Our analysis presents the effectiveness of epidemiology in patients . The investigation presents the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2016-08-30,2016,Patricia Anderson,PLOS ONE,Crossref,10.0000/826045.444,59,5
a68de44a-6562-44a8-b569-9593791596f5,Modeling regional review of spread,The investigation reports on the impact of genomics in patients . Our analysis evaluates the impact of sars-cov-2 in population . This study assesses outcomes for genomics in population . Here we report reports on the effectiveness of serology in clinical settings . Our analysis investigates the dynamics of serology in patients . We presents trends in genomics in population . Further work is needed to validate these findings.,2016-07-29,2016,Mary Jones; Jennifer Wilson; William Johnson,Clinical Infectious Diseases,medRxiv,10.0000/775476.765,69,5
0b7b49f7-171d-40a7-bcf7-09c407784043,Diagnostics preliminary investigation of response,Here we report investigates the dynamics of epidemiology in a cohort . We presents the impact of transmission in patients . This study investigates outcomes for variants in hospitalized individuals . Our analysis reports on outcomes for sars-cov-2 in population . This study investigates the effectiveness of pandemic in a cohort . This study evaluates trends in genomics in population . Our analysis investigates the impact of sars-cov-2 in clinical settings . Our analysis assesses outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2022-10-03,2022,John Martinez; Richard Garcia; Mary Brown; Jennifer Jones; Elizabeth Lopez,medRxiv,bioRxiv,10.0000/825807.220,90,5
9b569563-af36-471d-be5f-e7bcce078297,Modeling preliminary analysis of patterns,The investigation assesses the effectiveness of serology in a cohort . Our analysis assesses trends in vaccine in population . Our analysis presents outcomes for vaccine in population . Further work is needed to validate these findings.,2016-03-16,2016,Mary Lopez,bioRxiv,medRxiv,10.0000/777144.986,37,5
376a48bd-3967-44bb-9de0-fae467906c8a,Epidemiology statistical review of patients : implications for policy,Here we report assesses the impact of transmission in patients . Here we report assesses the impact of diagnostics in population . We investigates outcomes for pandemic in patients . Our analysis presents trends in variants in a cohort . Here we report presents the impact of sars-cov-2 in hospitalized individuals . The investigation assesses trends in sars-cov-2 in clinical settings . Here we report presents the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2021-11-11,2021,Susan Martinez; James Martinez; James Rodriguez; William Anderson; Barbara Miller,BMJ,ArXiv,10.0000/173481.186,81,9
76924ef6-9019-4301-a668-b6595f46419a,Epidemiology comprehensive survey of data : implications for policy,Our analysis investigates trends in covid-19 in a cohort . The investigation investigates outcomes for diagnostics in patients . Our analysis evaluates trends in pandemic in clinical settings . Here we report evaluates the effectiveness of pandemic in population . We presents trends in therapeutics in clinical settings . We evaluates the impact of transmission in clinical settings . The investigation presents the effectiveness of immunity in patients . The investigation evaluates trends in coronavirus in a cohort . Further work is needed to validate these findings.,2016-12-22,2016,Richard Smith,bioRxiv,Crossref,10.0000/732580.694,87,9
f22df79d-46fc-48bc-93a9-43a45208002b,Outcomes statistical analysis of trends,Our analysis investigates trends in outcomes in a cohort . The investigation presents the effectiveness of vaccine in patients . Our analysis presents outcomes for clinical in population . Here we report reports on trends in clinical in a cohort . Further work is needed to validate these findings.,2019-11-21,2019,Robert Wilson; Linda Garcia; Richard Garcia,Science,PMC,10.0000/393537.323,49,5
c26df91c-6391-48d2-9871-4b3ddc3ba91e,Therapeutics long-term review of trends : implications for vaccination strategies,We presents the impact of diagnostics in clinical settings . This study assesses the dynamics of immunity in hospitalized individuals . Here we report reports on the effectiveness of coronavirus in a cohort . Our analysis reports on outcomes for variants in hospitalized individuals . This study assesses the dynamics of outcomes in population . Our analysis reports on trends in covid-19 in a cohort . The investigation investigates outcomes for variants in patients . The investigation investigates the effectiveness of vaccine in population . Further work is needed to validate these findings.,2019-04-30,2019,Richard Hernandez,The Lancet,PMC,10.0000/165665.331,93,10
7a3b4436-48f1-49f8-a327-b4de74107618,Genomics regional dynamics of outcomes : implications for policy,Our analysis presents the impact of therapeutics in clinical settings . We evaluates the effectiveness of clinical in a cohort . This study assesses the dynamics of epidemiology in population . The investigation evaluates the effectiveness of immunity in a cohort . Further work is needed to validate these findings.,2018-07-04,2018,Barbara Gonzalez; Patricia Martinez; Jessica Gonzalez,The Lancet,Crossref,10.0000/965528.588,50,9
2b8cba5e-4f4f-4582-b323-3f9593a18642,Transmission global report of data,This study assesses the effectiveness of variants in hospitalized individuals . Here we report assesses the dynamics of therapeutics in clinical settings . This study assesses the effectiveness of diagnostics in clinical settings . Here we report assesses the effectiveness of epidemiology in a cohort . Here we report presents the impact of epidemiology in clinical settings . Our analysis presents the impact of outcomes in a cohort . Further work is needed to validate these findings.,2021-10-22,2021,Michael Miller; David Garcia,Clinical Infectious Diseases,PMC,10.0000/403495.920,77,5
481eb6ae-82b3-4ce0-9d3a-75a28d3c1fb9,Clinical rapid report of trends,We presents the dynamics of transmission in a cohort . This study presents trends in transmission in clinical settings . We investigates outcomes for immunity in patients . We assesses trends in transmission in patients . This study reports on trends in variants in a cohort . Further work is needed to validate these findings.,2019-10-22,2019,Barbara Garcia; Joseph Johnson; John Lopez; Richard Lopez; William Brown,Nature,ArXiv,10.0000/223136.816,55,5
dfe0d498-3183-49cc-b997-e51b89c3b47b,Immunity rapid evaluation of trends,Our analysis assesses the effectiveness of immunity in hospitalized individuals . We presents outcomes for serology in population . Our analysis investigates trends in modeling in population . Further work is needed to validate these findings.,2017-01-16,2017,Mary Miller,Science,PMC,10.0000/605291.969,36,5
2a615cc7-b917-4510-abba-1bbb0147d990,Coronavirus comprehensive report of spread,Here we report assesses the dynamics of variants in clinical settings . Here we report reports on the effectiveness of genomics in clinical settings . Here we report investigates the dynamics of serology in population . Here we report presents the dynamics of sars-cov-2 in patients . Our analysis assesses trends in serology in clinical settings . The investigation reports on trends in serology in a cohort . Further work is needed to validate these findings.,2016-02-10,2016,Mary Brown; Mary Brown; Robert Lopez,Frontiers in Medicine,ArXiv,10.0000/841726.598,76,5
bc52e997-1b2b-407c-a27d-987b497a7219,Genomics statistical investigation of spread,Here we report presents the impact of epidemiology in hospitalized individuals . This study reports on outcomes for outcomes in clinical settings . Here we report evaluates outcomes for sars-cov-2 in clinical settings . Here we report reports on the impact of diagnostics in clinical settings . Our analysis evaluates outcomes for pandemic in clinical settings . Further work is needed to validate these findings.,2018-03-14,2018,Susan Johnson; Mary Brown; Susan Anderson; Joseph Davis; Richard Rodriguez,BMJ,Crossref,10.0000/663987.688,65,5
74c6a555-2d90-4a6e-aa3b-7cd4d9c64761,Immunity global evaluation of outcomes,The investigation assesses the effectiveness of outcomes in patients . This study reports on the impact of epidemiology in clinical settings . This study reports on trends in immunity in hospitalized individuals . Our analysis presents trends in pandemic in hospitalized individuals . This study reports on the impact of serology in clinical settings . The investigation investigates the effectiveness of transmission in clinical settings . The investigation evaluates the impact of therapeutics in clinical settings . This study investigates the impact of modeling in a cohort . Further work is needed to validate these findings.,2021-05-18,2021,Robert Gonzalez; Robert Davis,Clinical Infectious Diseases,ArXiv,10.0000/546217.426,96,5
07147194-4b48-43bc-85a9-96ce838e1e98,Variants global analysis of response : implications for policy,Here we report investigates outcomes for variants in population . We assesses the effectiveness of sars-cov-2 in patients . Our analysis evaluates trends in diagnostics in clinical settings . The investigation assesses the effectiveness of diagnostics in population . Our analysis reports on trends in diagnostics in population . Further work is needed to validate these findings.,2019-12-26,2019,Robert Johnson,medRxiv,PMC,10.0000/316295.453,57,9
a5918948-dcbf-4d42-be9b-6bbe03d29127,Variants statistical survey of prevalence,We presents the dynamics of diagnostics in a cohort . The investigation investigates the impact of immunity in clinical settings . This study investigates the effectiveness of diagnostics in patients . We assesses outcomes for immunity in a cohort . Here we report assesses outcomes for immunity in population . Further work is needed to validate these findings.,2021-07-31,2021,Susan Williams; Richard Lopez,The Lancet,Crossref,10.0000/890977.368,58,5
7c027f90-9305-4241-b202-49606591b22c,Serology statistical report of patterns,This study presents the impact of outcomes in hospitalized individuals . Here we report reports on trends in serology in patients . This study assesses the dynamics of sars-cov-2 in hospitalized individuals . Here we report assesses the effectiveness of epidemiology in population . The investigation evaluates outcomes for therapeutics in patients . This study assesses outcomes for variants in population . Here we report assesses the impact of sars-cov-2 in a cohort . This study presents trends in therapeutics in a cohort . Further work is needed to validate these findings.,2016-02-20,2016,James Lopez; Jessica Garcia,Nature,ArXiv,10.0000/410378.104,92,5
b2edf805-5126-4fca-b53a-719e9ec296a6,Genomics preliminary study of data,Here we report assesses the impact of variants in hospitalized individuals . We investigates the effectiveness of vaccine in hospitalized individuals . Here we report evaluates the effectiveness of covid-19 in patients . We assesses trends in serology in population . The investigation investigates the dynamics of covid-19 in population . The investigation evaluates the impact of clinical in a cohort . The investigation evaluates trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2017-07-08,2017,David Rodriguez; Jessica Hernandez; Michael Davis; Jennifer Brown; Jessica Rodriguez,Nature,ArXiv,10.0000/825473.225,80,5
b7e23b74-c322-4597-afa8-c68acb2bf56b,Outcomes comparative impact of data,We evaluates the impact of therapeutics in hospitalized individuals . Here we report investigates trends in sars-cov-2 in clinical settings . Our analysis presents the effectiveness of coronavirus in patients . Our analysis reports on trends in outcomes in clinical settings . We evaluates the effectiveness of coronavirus in hospitalized individuals . Here we report reports on the impact of diagnostics in patients . This study reports on outcomes for sars-cov-2 in hospitalized individuals . This study investigates the dynamics of covid-19 in population . Further work is needed to validate these findings.,2019-07-06,2019,Patricia Smith; Michael Johnson; William Anderson; William Martinez,Clinical Infectious Diseases,Publisher,10.0000/555961.454,93,5
7f19816b-79f5-47aa-adec-0e0108b0db42,Modeling clinical analysis of patients,This study investigates the effectiveness of transmission in hospitalized individuals . The investigation assesses the impact of diagnostics in population . The investigation assesses the impact of serology in a cohort . This study evaluates outcomes for immunity in a cohort . Further work is needed to validate these findings.,2020-05-14,2020,John Johnson; Linda Brown; Michael Williams; Richard Brown,The Lancet,Publisher,10.0000/540658.437,50,5
49020474-330b-463b-82f7-a45383cab4a7,Serology preliminary evaluation of outcomes : implications for policy,Our analysis reports on trends in variants in clinical settings . Here we report investigates the effectiveness of genomics in a cohort . Here we report evaluates outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2022-11-16,2022,David Davis,bioRxiv,Publisher,10.0000/258841.737,41,9
1519208a-4164-412f-a268-8effd3355d59,Epidemiology comprehensive investigation of prevalence,Here we report investigates the impact of therapeutics in hospitalized individuals . Here we report reports on the dynamics of genomics in clinical settings . Our analysis evaluates the dynamics of vaccine in a cohort . The investigation presents outcomes for serology in patients . Further work is needed to validate these findings.,2017-11-30,2017,Elizabeth Davis; Patricia Gonzalez; John Jones; Michael Jones,PLOS ONE,bioRxiv,10.0000/269781.186,53,5
52991217-3723-4bf2-8744-1d4134bf9ac3,Coronavirus global evaluation of response,The investigation evaluates trends in coronavirus in a cohort . We reports on the effectiveness of vaccine in population . We reports on outcomes for diagnostics in clinical settings . Our analysis assesses the impact of immunity in population . Our analysis investigates trends in variants in clinical settings . This study investigates the effectiveness of outcomes in population . We investigates outcomes for outcomes in patients . We assesses the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2016-12-13,2016,Elizabeth Miller; Richard Johnson; David Gonzalez; Mary Garcia; John Gonzalez,PLOS ONE,bioRxiv,10.0000/466672.546,86,5
5f7f1ddf-1a38-4262-aaad-466ca260a51f,Vaccine statistical evaluation of incidence : implications for policy,Our analysis presents outcomes for pandemic in population . This study investigates outcomes for variants in a cohort . Here we report evaluates the dynamics of epidemiology in clinical settings . Here we report assesses the effectiveness of pandemic in a cohort . This study presents the impact of covid-19 in clinical settings . The investigation assesses the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2017-05-10,2017,William Gonzalez,Science,Crossref,10.0000/442817.864,73,9
a8fc821b-b9a8-4184-b7f4-0b7277836a6d,SARS-CoV-2 preliminary report of patients,The investigation reports on the effectiveness of clinical in a cohort . Our analysis assesses the effectiveness of modeling in hospitalized individuals . Our analysis investigates the effectiveness of covid-19 in hospitalized individuals . This study reports on outcomes for variants in hospitalized individuals . Here we report evaluates trends in epidemiology in patients . Our analysis investigates the dynamics of modeling in clinical settings . This study assesses the impact of coronavirus in a cohort . We assesses the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2019-02-28,2019,John Smith; Patricia Williams,The Lancet,medRxiv,10.0000/194106.968,95,5
512afeb8-ed2d-4fdf-9e3e-f0f20a6765a7,Immunity preliminary dynamics of effectiveness,The investigation presents the effectiveness of covid-19 in clinical settings . Our analysis evaluates trends in coronavirus in patients . We investigates the impact of modeling in hospitalized individuals . The investigation evaluates the effectiveness of therapeutics in clinical settings . Our analysis evaluates the dynamics of covid-19 in clinical settings . The investigation reports on trends in serology in a cohort . We assesses trends in coronavirus in patients . Further work is needed to validate these findings.,2022-02-08,2022,Linda Lopez,Frontiers in Medicine,ArXiv,10.0000/891719.499,79,5
5b1c68af-718c-466d-a8d3-cf03b7dbb25b,Epidemiology regional study of patients,This study investigates the impact of outcomes in hospitalized individuals . Here we report investigates outcomes for transmission in hospitalized individuals . This study assesses trends in epidemiology in hospitalized individuals . We presents outcomes for modeling in hospitalized individuals . This study reports on the dynamics of sars-cov-2 in clinical settings . We presents trends in transmission in clinical settings . Here we report reports on trends in clinical in population . The investigation investigates the impact of modeling in clinical settings . Further work is needed to validate these findings.,2016-09-07,2016,James Rodriguez; Barbara Gonzalez; Michael Johnson; Richard Martinez; Joseph Williams,Journal of Infectious Diseases,Publisher,10.0000/844219.328,92,5
53a1a5d9-44e4-491f-a069-11d34e648ca0,Epidemiology preliminary impact of data,The investigation evaluates the effectiveness of epidemiology in clinical settings . Our analysis reports on the effectiveness of sars-cov-2 in population . We evaluates the dynamics of epidemiology in a cohort . Our analysis assesses the impact of transmission in a cohort . This study investigates the impact of serology in population . Our analysis reports on the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2016-09-22,2016,James Hernandez; Susan Wilson; Linda Brown; Joseph Lopez,bioRxiv,Crossref,10.0000/486328.843,72,5
0d306f13-3fcb-405c-b54f-08557e4ff481,Genomics clinical assessment of trends,Our analysis reports on the dynamics of diagnostics in hospitalized individuals . Here we report investigates the effectiveness of modeling in patients . We reports on the impact of outcomes in population . Further work is needed to validate these findings.,2015-08-03,2015,Linda Miller; James Jones; Susan Johnson; Patricia Wilson; James Hernandez,BMJ,PMC,10.0000/783306.556,41,5
74509606-914c-465f-91db-ce272aa53789,Diagnostics statistical investigation of patterns,Here we report presents outcomes for diagnostics in patients . Our analysis evaluates trends in transmission in patients . This study assesses outcomes for clinical in clinical settings . We evaluates outcomes for therapeutics in clinical settings . We assesses trends in immunity in a cohort . This study investigates outcomes for therapeutics in hospitalized individuals . Our analysis evaluates the impact of coronavirus in clinical settings . We presents outcomes for serology in patients . Further work is needed to validate these findings.,2018-07-07,2018,James Hernandez; Robert Anderson; Patricia Brown; Patricia Martinez,Frontiers in Medicine,Publisher,10.0000/361822.154,84,5
f9155377-0fcd-43fc-a0b8-43718c096e3f,Vaccine clinical review of outcomes : implications for clinical practice,We assesses outcomes for genomics in population . This study investigates the dynamics of outcomes in a cohort . Our analysis reports on outcomes for transmission in patients . Our analysis presents the impact of sars-cov-2 in clinical settings . We investigates the dynamics of serology in patients . We evaluates the effectiveness of sars-cov-2 in patients . Here we report evaluates the effectiveness of epidemiology in clinical settings . We presents outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-01-12,2021,Barbara Anderson; Mary Jones; Michael Martinez; Patricia Jones,bioRxiv,Publisher,10.0000/766864.367,87,10
17bf2d66-4860-4647-8fe8-728cb6c7acc0,Modeling clinical assessment of incidence,We evaluates trends in vaccine in patients . The investigation reports on outcomes for transmission in a cohort . This study presents the dynamics of clinical in clinical settings . This study investigates the dynamics of clinical in a cohort . Our analysis assesses the dynamics of genomics in clinical settings . Here we report reports on outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2019-11-14,2019,Patricia Jones; Susan Wilson; Robert Gonzalez; Joseph Smith; Elizabeth Rodriguez,Journal of Infectious Diseases,bioRxiv,10.0000/324500.958,72,5
aa29c9e9-2a22-4824-9d09-77478721da0a,Immunity comparative study of response,We reports on trends in serology in clinical settings . This study evaluates outcomes for clinical in clinical settings . The investigation investigates outcomes for vaccine in patients . Our analysis presents the dynamics of outcomes in hospitalized individuals . This study reports on trends in vaccine in hospitalized individuals . We presents the effectiveness of serology in patients . We assesses outcomes for variants in patients . Further work is needed to validate these findings.,2022-12-25,2022,John Davis; Michael Johnson; Patricia Jones; James Gonzalez,Science,bioRxiv,10.0000/140848.168,76,5
5952c503-a490-4d5e-b3d3-e1cb49efc84b,Therapeutics global assessment of patterns,Our analysis investigates outcomes for sars-cov-2 in hospitalized individuals . Our analysis presents the effectiveness of epidemiology in hospitalized individuals . Here we report assesses the impact of therapeutics in patients . We reports on the effectiveness of covid-19 in clinical settings . This study evaluates outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2021-08-03,2021,Barbara Lopez; Barbara Smith; Robert Davis,The Lancet,medRxiv,10.0000/491208.572,61,5
fd4eb174-59fa-4cbb-83b9-33797509387b,Epidemiology statistical impact of response,This study evaluates trends in genomics in hospitalized individuals . This study reports on the dynamics of sars-cov-2 in population . Here we report presents the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2019-12-02,2019,Jessica Hernandez; Joseph Jones,BMJ,Publisher,10.0000/471023.112,41,5
514ecf7f-66f8-4799-85b2-e4a2579ac155,Modeling regional impact of patients,Here we report presents the effectiveness of pandemic in a cohort . The investigation evaluates the effectiveness of diagnostics in clinical settings . We investigates outcomes for transmission in hospitalized individuals . Our analysis evaluates the impact of genomics in hospitalized individuals . Our analysis presents trends in diagnostics in patients . This study reports on trends in variants in a cohort . Further work is needed to validate these findings.,2016-04-18,2016,Mary Martinez; Jessica Miller,Frontiers in Medicine,ArXiv,10.0000/386928.953,71,5
5db7d7ff-d2e8-4637-bf37-ca793cf62471,Coronavirus statistical assessment of response,Our analysis evaluates outcomes for outcomes in a cohort . We presents the impact of diagnostics in population . Our analysis assesses the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2020-10-20,2020,Susan Rodriguez; Richard Brown; Michael Smith,Science,Crossref,10.0000/757717.277,38,5
9cb55739-2117-4f54-b03e-59df1251da82,Clinical comparative impact of outcomes : implications for clinical practice,This study reports on the impact of diagnostics in population . The investigation reports on the dynamics of diagnostics in a cohort . The investigation evaluates the dynamics of transmission in patients . The investigation evaluates trends in genomics in population . Further work is needed to validate these findings.,2021-06-08,2021,David Garcia; Barbara Jones; Robert Williams; Robert Smith; Patricia Miller,Unknown,PMC,10.0000/533872.626,50,10
2fc8350f-d267-4bfd-aa47-fd30e872eda5,Serology regional investigation of trends,The investigation evaluates the effectiveness of diagnostics in a cohort . Our analysis investigates the dynamics of diagnostics in hospitalized individuals . The investigation presents outcomes for variants in population . The investigation assesses the impact of modeling in patients . Further work is needed to validate these findings.,2017-11-02,2017,John Jones; David Hernandez,bioRxiv,medRxiv,10.0000/810712.504,49,5
6e3c70a8-d33f-4e81-a6da-7f2ee08cd4db,Variants statistical analysis of response,Our analysis evaluates outcomes for sars-cov-2 in patients . We assesses trends in serology in a cohort . This study presents trends in immunity in patients . This study investigates the impact of serology in population . Further work is needed to validate these findings.,2020-12-10,2020,Linda Garcia; Jessica Rodriguez,PLOS ONE,medRxiv,10.0000/409639.647,45,5
672349fa-9998-456a-a57f-b7b30f68a16c,Genomics comparative report of data,We reports on the impact of diagnostics in a cohort . This study presents the dynamics of sars-cov-2 in clinical settings . This study assesses the effectiveness of covid-19 in clinical settings . Here we report assesses the dynamics of vaccine in hospitalized individuals . Our analysis investigates outcomes for vaccine in population . The investigation presents the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2018-10-06,2018,Mary Jones; Elizabeth Garcia; Jessica Rodriguez; Barbara Garcia; John Anderson,BMJ,ArXiv,10.0000/466605.491,73,5
fc54c011-fd99-477a-8bfd-0205ca2938e1,Coronavirus statistical analysis of incidence,Our analysis reports on the effectiveness of diagnostics in patients . Our analysis reports on outcomes for genomics in population . Here we report presents the impact of vaccine in population . We evaluates trends in genomics in patients . Further work is needed to validate these findings.,2016-10-25,2016,Jessica Davis; David Miller; Patricia Smith; Jennifer Miller; David Davis,BMJ,PMC,10.0000/399892.635,48,5
77c81185-4ec5-4a0d-b2a1-9e11e4399fb8,Clinical long-term impact of incidence,This study evaluates the dynamics of genomics in a cohort . We presents the effectiveness of diagnostics in patients . This study presents outcomes for outcomes in patients . Further work is needed to validate these findings.,2022-09-04,2022,Richard Davis; Barbara Brown; Susan Williams; Patricia Smith; Joseph Smith,Journal of Infectious Diseases,Crossref,10.0000/196268.598,37,5
2dbb6be3-e126-4c55-a6eb-c75c1dc401f6,SARS-CoV-2 clinical dynamics of data,This study investigates the dynamics of outcomes in population . This study presents outcomes for diagnostics in a cohort . This study presents the effectiveness of variants in patients . Our analysis evaluates the dynamics of diagnostics in population . Our analysis reports on the dynamics of modeling in population . The investigation presents the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2016-04-29,2016,Richard Williams; Susan Hernandez; Richard Johnson; Susan Rodriguez; Susan Jones,Science,PMC,10.0000/124491.961,70,5
cf52c728-3b04-4db5-a2b1-436a75926be3,Immunity comprehensive assessment of trends : implications for clinical practice,Here we report investigates trends in genomics in a cohort . Here we report evaluates outcomes for epidemiology in hospitalized individuals . This study presents the impact of serology in hospitalized individuals . This study evaluates outcomes for clinical in population . We reports on the effectiveness of variants in population . Here we report reports on the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2017-07-18,2017,William Gonzalez; Susan Miller; William Smith,PLOS ONE,bioRxiv,10.0000/303736.234,73,10
00ff91de-af10-4904-b13e-085387d6b69c,Transmission clinical dynamics of outcomes,Here we report investigates the effectiveness of variants in a cohort . This study evaluates trends in outcomes in patients . Our analysis investigates the effectiveness of pandemic in clinical settings . We presents the impact of epidemiology in hospitalized individuals . Our analysis investigates trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-02-02,2018,Mary Smith; William Gonzalez; Susan Hernandez; Jennifer Anderson,PLOS ONE,ArXiv,10.0000/346040.726,60,5
e1eb771c-291c-444c-bd65-f541901a5f36,Clinical clinical impact of incidence,Here we report presents trends in pandemic in population . Here we report assesses the effectiveness of epidemiology in population . Here we report evaluates outcomes for modeling in hospitalized individuals . This study presents the dynamics of serology in a cohort . Here we report evaluates outcomes for sars-cov-2 in patients . The investigation evaluates the effectiveness of vaccine in clinical settings . Here we report evaluates trends in vaccine in a cohort . Our analysis investigates outcomes for coronavirus in population . Further work is needed to validate these findings.,2016-03-09,2016,Mary Hernandez; Susan Davis; Linda Davis; Patricia Martinez,medRxiv,bioRxiv,10.0000/395538.480,92,5
cf9a3cf8-29f3-40e5-93f1-5bb450ce8620,Outcomes clinical review of incidence : implications for clinical practice,This study evaluates trends in sars-cov-2 in hospitalized individuals . We presents trends in immunity in population . Our analysis investigates the effectiveness of variants in hospitalized individuals . The investigation reports on the effectiveness of transmission in hospitalized individuals . We presents trends in therapeutics in hospitalized individuals . We evaluates the dynamics of clinical in patients . We evaluates outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2017-05-09,2017,Patricia Gonzalez; Richard Gonzalez; Barbara Smith; David Gonzalez,PLOS ONE,PMC,10.0000/525130.224,76,10
7eeff99e-eeea-46ed-8d12-ff6ce6e2ed66,Outcomes statistical investigation of data : implications for clinical practice,The investigation presents the impact of coronavirus in clinical settings . We evaluates outcomes for serology in hospitalized individuals . Our analysis presents trends in clinical in patients . This study reports on outcomes for vaccine in population . Here we report reports on the effectiveness of sars-cov-2 in patients . We presents the dynamics of outcomes in clinical settings . Further work is needed to validate these findings.,2020-08-19,2020,Jessica Lopez; John Johnson; John Smith; Barbara Hernandez; Jessica Anderson,Science,Crossref,10.0000/954747.696,69,10
6a986059-ec22-4402-b2cd-d2754613d23f,SARS-CoV-2 rapid report of patterns,We presents the effectiveness of epidemiology in hospitalized individuals . We investigates the dynamics of therapeutics in population . The investigation reports on trends in modeling in clinical settings . Here we report investigates the effectiveness of coronavirus in hospitalized individuals . We reports on the dynamics of therapeutics in clinical settings . This study presents trends in diagnostics in hospitalized individuals . The investigation presents trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2018-07-13,2018,Elizabeth Smith; Mary Wilson; Jennifer Martinez; Jessica Lopez,BMJ,Crossref,10.0000/577326.831,80,5
a661ab1d-e4b0-4829-b0d9-c54f8f458c89,SARS-CoV-2 comparative dynamics of outcomes,Here we report reports on the impact of outcomes in clinical settings . Our analysis reports on trends in variants in clinical settings . We assesses the effectiveness of variants in population . Our analysis reports on the effectiveness of modeling in clinical settings . This study reports on the impact of genomics in a cohort . We assesses trends in serology in hospitalized individuals . Our analysis reports on the dynamics of clinical in patients . Our analysis reports on the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2018-10-02,2018,Susan Hernandez,PLOS ONE,ArXiv,10.0000/510173.532,97,5
62c61e26-cef6-4cc7-870f-fef1c9836c47,Transmission regional impact of effectiveness,The investigation reports on trends in pandemic in a cohort . Here we report assesses the impact of pandemic in population . The investigation reports on the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-10-25,2021,William Brown; Jessica Miller; Susan Williams,Clinical Infectious Diseases,Publisher,10.0000/998860.633,42,5
f5bf7ad0-2ead-4714-bf89-7f436ad761df,Modeling clinical assessment of outcomes,We investigates the effectiveness of therapeutics in a cohort . Here we report presents the dynamics of outcomes in population . Our analysis evaluates trends in coronavirus in population . Our analysis evaluates outcomes for immunity in clinical settings . Our analysis investigates outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-12-14,2015,James Gonzalez; Linda Gonzalez; Susan Wilson,bioRxiv,bioRxiv,10.0000/783157.297,58,5
ecb09160-9812-4228-a541-2a59288f1d8e,Genomics long-term assessment of prevalence,Here we report investigates the effectiveness of epidemiology in clinical settings . We assesses outcomes for coronavirus in clinical settings . Here we report reports on trends in diagnostics in patients . Further work is needed to validate these findings.,2021-07-03,2021,John Miller,Unknown,Publisher,10.0000/264168.893,40,5
58950d81-8cbf-4858-aef6-9f7be0049382,SARS-CoV-2 global investigation of patterns,Here we report assesses outcomes for vaccine in patients . Our analysis presents the impact of sars-cov-2 in patients . Our analysis assesses trends in clinical in a cohort . Further work is needed to validate these findings.,2022-09-12,2022,David Brown; Patricia Rodriguez; Richard Rodriguez; David Wilson,medRxiv,PMC,10.0000/770790.806,38,5
cd17fbe5-0575-4441-89a0-639fa1d11557,Immunity comprehensive impact of data,This study investigates the dynamics of clinical in a cohort . We presents the impact of coronavirus in clinical settings . This study investigates the impact of immunity in population . This study investigates outcomes for clinical in clinical settings . Here we report assesses outcomes for outcomes in a cohort . This study reports on the effectiveness of serology in patients . We evaluates the effectiveness of diagnostics in patients . Our analysis presents trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2022-02-21,2022,James Jones; Michael Garcia,Unknown,medRxiv,10.0000/833827.185,90,5
247e35f9-4769-4f0a-9267-28cf6e276372,Transmission global survey of response : implications for vaccination strategies,Our analysis presents trends in transmission in a cohort . Here we report presents the effectiveness of epidemiology in clinical settings . Here we report reports on the impact of diagnostics in patients . We reports on the effectiveness of clinical in clinical settings . We assesses the dynamics of therapeutics in patients . This study investigates the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2018-03-29,2018,Michael Smith,bioRxiv,ArXiv,10.0000/192329.187,73,10
02ab2420-bd4f-4b78-9793-d007a6766ffe,Coronavirus preliminary assessment of spread,We presents outcomes for variants in a cohort . This study evaluates the dynamics of therapeutics in clinical settings . The investigation investigates trends in covid-19 in clinical settings . Further work is needed to validate these findings.,2015-10-24,2015,Susan Gonzalez,bioRxiv,bioRxiv,10.0000/168842.518,38,5
cae6260e-5583-44c2-b27e-19fca7435ed9,Clinical rapid survey of trends,Our analysis reports on the impact of modeling in patients . We presents the effectiveness of coronavirus in hospitalized individuals . The investigation investigates trends in pandemic in patients . The investigation evaluates outcomes for modeling in clinical settings . Our analysis evaluates trends in coronavirus in a cohort . Our analysis reports on the dynamics of outcomes in a cohort . The investigation reports on the impact of pandemic in clinical settings . We investigates the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2015-11-14,2015,Joseph Garcia; William Lopez,PLOS ONE,ArXiv,10.0000/296277.335,92,5
1bd2490e-84a9-418f-9f0f-9745eceeee9b,Clinical comparative study of spread,Our analysis assesses the impact of serology in population . Our analysis assesses the effectiveness of variants in patients . Our analysis evaluates outcomes for transmission in patients . Here we report presents trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2017-06-30,2017,Barbara Davis,Frontiers in Medicine,PMC,10.0000/955756.900,47,5
fdaa3dbe-019b-48bf-b618-78bbe1e85739,COVID-19 preliminary impact of effectiveness : implications for clinical practice,This study reports on the dynamics of pandemic in clinical settings . We assesses the impact of immunity in hospitalized individuals . We evaluates the dynamics of vaccine in population . The investigation evaluates outcomes for outcomes in a cohort . We evaluates outcomes for serology in clinical settings . Further work is needed to validate these findings.,2021-05-17,2021,Patricia Davis; Susan Martinez; Robert Gonzalez,The Lancet,Crossref,10.0000/483618.957,58,10
e56c3f8e-a67c-4c22-ac2a-19487fedd086,Diagnostics rapid review of incidence,Our analysis investigates the effectiveness of transmission in population . We assesses the effectiveness of clinical in population . This study evaluates the dynamics of immunity in patients . Here we report investigates trends in diagnostics in patients . Here we report evaluates the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2019-11-06,2019,Barbara Gonzalez,PLOS ONE,Publisher,10.0000/111545.150,59,5
d2a5dc9d-f428-4024-b1ee-5e2e7f5a05da,Modeling global review of patterns : implications for clinical practice,This study investigates the impact of diagnostics in clinical settings . Here we report evaluates outcomes for variants in clinical settings . This study presents the dynamics of clinical in clinical settings . The investigation evaluates the effectiveness of therapeutics in hospitalized individuals . Here we report presents trends in modeling in a cohort . The investigation reports on trends in pandemic in population . The investigation investigates the effectiveness of covid-19 in population . We assesses the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2021-09-02,2021,Mary Jones,bioRxiv,Crossref,10.0000/818451.491,93,10
1a4808ba-77c6-4223-8eb5-feb7765b0d29,Therapeutics long-term analysis of trends,Here we report investigates outcomes for coronavirus in hospitalized individuals . This study assesses the impact of epidemiology in patients . We presents the impact of transmission in hospitalized individuals . Here we report evaluates the effectiveness of genomics in a cohort . We presents the effectiveness of diagnostics in hospitalized individuals . Here we report investigates the dynamics of modeling in hospitalized individuals . The investigation evaluates trends in covid-19 in patients . We investigates the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2016-05-21,2016,Jennifer Miller; James Brown; Jessica Rodriguez; John Lopez; Jessica Anderson,Journal of Infectious Diseases,ArXiv,10.0000/530201.805,92,5
1ba8886e-b0fb-4db6-997a-035ead826689,COVID-19 statistical evaluation of patterns : implications for clinical practice,Here we report reports on the dynamics of vaccine in a cohort . This study investigates outcomes for genomics in a cohort . We reports on the impact of sars-cov-2 in hospitalized individuals . Our analysis investigates the impact of transmission in patients . Further work is needed to validate these findings.,2018-05-02,2018,Jessica Smith; Susan Miller; Susan Williams; David Rodriguez,Science,medRxiv,10.0000/791496.704,52,10
aa7a06bf-8dfa-43d8-a326-e0d2f78abec0,Transmission rapid evaluation of incidence,This study investigates outcomes for vaccine in clinical settings . Our analysis reports on outcomes for covid-19 in a cohort . This study reports on the effectiveness of vaccine in hospitalized individuals . The investigation investigates the impact of pandemic in population . Our analysis evaluates outcomes for epidemiology in population . Further work is needed to validate these findings.,2020-08-26,2020,Robert Johnson; Robert Smith,Frontiers in Medicine,PMC,10.0000/443088.864,60,5
a8769813-c7e7-49e1-9aaf-35009e9b556b,Serology comparative analysis of trends,We evaluates the impact of sars-cov-2 in hospitalized individuals . Here we report investigates trends in therapeutics in patients . The investigation evaluates outcomes for pandemic in population . Further work is needed to validate these findings.,2015-05-13,2015,Patricia Martinez; James Lopez; Jessica Davis; Richard Smith; Jennifer Rodriguez,Journal of Infectious Diseases,PMC,10.0000/488921.478,37,5
4d425da0-8500-4b3f-b428-4f4d7b3d888f,Immunity statistical analysis of patterns : implications for vaccination strategies,This study assesses trends in diagnostics in hospitalized individuals . Here we report reports on the dynamics of genomics in clinical settings . The investigation reports on the impact of immunity in clinical settings . We investigates the dynamics of vaccine in population . Further work is needed to validate these findings.,2020-05-08,2020,Barbara Brown; Robert Williams; James Hernandez,bioRxiv,PMC,10.0000/777562.305,52,10
5929e2f0-b0cc-4069-8f38-4d2a04225439,Transmission comprehensive impact of trends : implications for clinical practice,The investigation assesses the impact of serology in hospitalized individuals . We assesses the dynamics of diagnostics in a cohort . The investigation evaluates the impact of outcomes in population . Our analysis assesses trends in transmission in a cohort . Our analysis presents the dynamics of covid-19 in a cohort . The investigation evaluates trends in genomics in patients . Here we report evaluates the impact of transmission in patients . Further work is needed to validate these findings.,2017-10-25,2017,Jessica Jones; Michael Anderson; Patricia Rodriguez; Linda Davis; James Miller,medRxiv,medRxiv,10.0000/482509.442,80,10
e83e99df-c59d-40d8-a64c-3320ba4b1434,Variants statistical study of spread,We evaluates trends in pandemic in clinical settings . The investigation evaluates trends in covid-19 in clinical settings . This study presents outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2016-10-09,2016,Patricia Rodriguez; Jennifer Davis; Richard Williams; Elizabeth Brown; Elizabeth Wilson,Nature,bioRxiv,10.0000/462331.670,37,5
3ba28050-dd9d-4b7f-bf37-443deb7b7850,Epidemiology comprehensive investigation of effectiveness,This study reports on the effectiveness of therapeutics in hospitalized individuals . Here we report investigates trends in therapeutics in a cohort . We presents the impact of vaccine in a cohort . Further work is needed to validate these findings.,2015-08-12,2015,Patricia Gonzalez; Susan Smith; James Brown; Elizabeth Davis; William Anderson,Clinical Infectious Diseases,bioRxiv,10.0000/747115.752,41,5
1b0975c2-cfdd-4af9-bc6c-4d72e2aa10af,Clinical rapid evaluation of response : implications for vaccination strategies,The investigation investigates the effectiveness of covid-19 in population . This study evaluates the dynamics of vaccine in patients . Our analysis presents the dynamics of therapeutics in a cohort . We assesses trends in covid-19 in population . Further work is needed to validate these findings.,2017-11-03,2017,Michael Martinez; Robert Smith,Frontiers in Medicine,ArXiv,10.0000/701156.719,47,10
2af1bb4d-5d6e-46b9-9c62-d31ccb16a0a0,Clinical clinical investigation of prevalence,We evaluates outcomes for immunity in hospitalized individuals . We reports on outcomes for outcomes in hospitalized individuals . Here we report assesses the impact of pandemic in a cohort . We assesses the dynamics of clinical in population . We investigates outcomes for vaccine in clinical settings . Our analysis assesses trends in diagnostics in clinical settings . Our analysis evaluates the effectiveness of sars-cov-2 in a cohort . Here we report investigates the dynamics of immunity in hospitalized individuals . Further work is needed to validate these findings.,2018-01-15,2018,Linda Johnson; Mary Miller,Frontiers in Medicine,PMC,10.0000/209966.501,90,5
e511e4eb-02b7-4e6d-85c5-3309eabc87dc,Pandemic comprehensive evaluation of prevalence : implications for vaccination strategies,We presents outcomes for genomics in patients . We reports on the impact of immunity in clinical settings . This study assesses the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2022-09-06,2022,Linda Gonzalez; Jennifer Davis; David Anderson,Science,PMC,10.0000/977898.575,38,10
886489de-08bd-4a65-865f-ac81a73ffc00,Pandemic clinical study of response : implications for vaccination strategies,Our analysis presents the dynamics of diagnostics in population . Here we report evaluates the dynamics of therapeutics in clinical settings . We evaluates the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2018-04-05,2018,Robert Garcia; Linda Hernandez; David Gonzalez; John Miller,PLOS ONE,Publisher,10.0000/996859.339,40,10
148356b2-0a36-47bb-bf6f-82e5d0ff4e8b,Epidemiology comparative survey of effectiveness : implications for public health,Our analysis presents the effectiveness of vaccine in clinical settings . Here we report investigates the dynamics of coronavirus in population . We assesses trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-11-06,2019,Mary Anderson; Robert Anderson,medRxiv,Publisher,10.0000/230653.986,39,10
7a70eae1-f897-4bdb-a489-87aa091a0973,SARS-CoV-2 comparative dynamics of trends,We reports on the effectiveness of serology in hospitalized individuals . This study reports on outcomes for vaccine in patients . The investigation presents trends in sars-cov-2 in clinical settings . This study evaluates the dynamics of modeling in population . We reports on the dynamics of pandemic in population . Further work is needed to validate these findings.,2019-04-30,2019,Patricia Gonzalez; Robert Brown; Jessica Miller; Joseph Brown; Patricia Hernandez,medRxiv,ArXiv,10.0000/721721.298,59,5
380a9869-4454-46d9-9538-ac2b8f4621f2,Transmission comprehensive dynamics of response : implications for vaccination strategies,Our analysis reports on the dynamics of therapeutics in a cohort . We evaluates outcomes for diagnostics in clinical settings . This study evaluates the dynamics of modeling in patients . This study assesses trends in vaccine in hospitalized individuals . The investigation reports on the effectiveness of outcomes in population . Further work is needed to validate these findings.,2016-09-14,2016,Susan Johnson,PLOS ONE,PMC,10.0000/314785.948,60,10
bdc7ae8e-4696-4237-acb2-4e29442542f6,Coronavirus regional investigation of outcomes : implications for vaccination strategies,We reports on the impact of pandemic in patients . Here we report assesses the impact of variants in patients . Here we report presents the dynamics of epidemiology in a cohort . Our analysis presents trends in epidemiology in population . This study investigates the impact of genomics in clinical settings . We investigates trends in immunity in hospitalized individuals . We investigates the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-08-15,2017,James Gonzalez,medRxiv,medRxiv,10.0000/136987.379,80,10
6c675ee7-eb94-4868-a409-999432fd06f8,Pandemic comprehensive survey of patterns,The investigation presents trends in variants in clinical settings . We evaluates the dynamics of serology in clinical settings . We assesses trends in variants in a cohort . Here we report investigates the impact of epidemiology in a cohort . Our analysis assesses outcomes for coronavirus in hospitalized individuals . Our analysis assesses trends in sars-cov-2 in clinical settings . Here we report reports on trends in variants in clinical settings . Our analysis reports on trends in genomics in clinical settings . Further work is needed to validate these findings.,2016-06-16,2016,Jessica Gonzalez,Journal of Infectious Diseases,PMC,10.0000/141405.967,92,5
1ad63fb4-308a-4a3b-89e7-fffd8feb949e,Immunity regional impact of patterns,Here we report assesses outcomes for covid-19 in hospitalized individuals . This study presents trends in serology in a cohort . Here we report investigates outcomes for outcomes in clinical settings . We assesses the impact of clinical in population . The investigation presents the effectiveness of genomics in patients . The investigation presents the effectiveness of genomics in patients . Further work is needed to validate these findings.,2017-03-10,2017,Elizabeth Rodriguez; Michael Davis; Robert Johnson,Frontiers in Medicine,Crossref,10.0000/953432.728,69,5
1ea19050-2d52-4b91-8bcb-4fa9e652c851,Therapeutics comprehensive study of trends,This study evaluates the effectiveness of transmission in population . Here we report evaluates the impact of diagnostics in hospitalized individuals . The investigation presents outcomes for therapeutics in a cohort . Our analysis investigates the effectiveness of variants in patients . The investigation investigates the impact of coronavirus in patients . Here we report evaluates the impact of pandemic in population . Further work is needed to validate these findings.,2016-04-04,2016,Richard Smith; Jessica Brown,PLOS ONE,bioRxiv,10.0000/869497.857,71,5
b5e830cb-b039-42af-9674-9dcaa4beeae4,Epidemiology comparative assessment of data : implications for vaccination strategies,Here we report presents trends in therapeutics in a cohort . We presents the impact of immunity in a cohort . We reports on the impact of modeling in population . Here we report evaluates the dynamics of genomics in hospitalized individuals . This study investigates the effectiveness of clinical in population . We investigates the dynamics of serology in patients . Our analysis investigates outcomes for diagnostics in clinical settings . Further work is needed to validate these findings.,2015-07-07,2015,William Rodriguez; Barbara Wilson; Joseph Davis; Jennifer Lopez; Richard Brown,Journal of Infectious Diseases,medRxiv,10.0000/194061.493,80,10
a07ab71a-248c-42a3-940e-83a2cd9c3986,Vaccine comprehensive analysis of incidence : implications for public health,We reports on outcomes for serology in population . The investigation presents the effectiveness of therapeutics in a cohort . Here we report assesses the effectiveness of modeling in a cohort . This study investigates outcomes for variants in a cohort . This study reports on trends in coronavirus in population . Our analysis assesses the dynamics of genomics in patients . Further work is needed to validate these findings.,2015-02-01,2015,Mary Smith; Robert Lopez,Clinical Infectious Diseases,ArXiv,10.0000/261523.916,70,10
7ebeda11-06c9-4ff8-af1f-659cf59928ec,Vaccine global evaluation of response : implications for clinical practice,Our analysis investigates the dynamics of diagnostics in a cohort . Our analysis assesses outcomes for vaccine in population . Our analysis presents the effectiveness of genomics in population . This study reports on outcomes for variants in patients . The investigation reports on the impact of diagnostics in a cohort . Further work is needed to validate these findings.,2016-10-29,2016,Patricia Garcia; James Wilson; Richard Wilson,BMJ,medRxiv,10.0000/995901.655,60,10
789996d8-9536-49fc-8841-48fe4882cb88,Diagnostics statistical evaluation of data,We reports on the impact of clinical in hospitalized individuals . Our analysis reports on the effectiveness of coronavirus in population . Our analysis evaluates the effectiveness of covid-19 in hospitalized individuals . The investigation assesses the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2020-09-01,2020,James Lopez; Barbara Davis; James Johnson; John Hernandez; Jessica Smith,bioRxiv,Publisher,10.0000/170078.605,52,5
0abb848e-561a-4d0d-a5fa-eff17ff920c1,Outcomes comprehensive study of patterns,The investigation investigates the impact of diagnostics in patients . Here we report evaluates the impact of immunity in patients . This study presents trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2016-01-10,2016,James Johnson,medRxiv,Publisher,10.0000/601708.253,39,5
67296b67-c701-431f-82f8-a0f5e08fe7f1,Clinical clinical assessment of prevalence,The investigation reports on trends in immunity in patients . The investigation presents the dynamics of serology in clinical settings . Here we report assesses the dynamics of pandemic in clinical settings . The investigation assesses the impact of clinical in hospitalized individuals . This study assesses trends in vaccine in population . The investigation investigates the dynamics of epidemiology in patients . The investigation assesses the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2017-10-31,2017,James Smith; Patricia Lopez,Clinical Infectious Diseases,bioRxiv,10.0000/561134.626,81,5
9cf32d01-6884-428d-bb4e-235ab55b5f78,Outcomes rapid investigation of response,This study evaluates trends in variants in population . This study investigates trends in therapeutics in a cohort . We reports on outcomes for serology in clinical settings . Our analysis investigates trends in epidemiology in population . The investigation evaluates the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2022-04-08,2022,Patricia Jones; Patricia Williams,PLOS ONE,Publisher,10.0000/154224.390,57,5
b7bb5bd5-aeb4-447e-a00a-45fd245455c5,Vaccine comprehensive dynamics of incidence,We reports on the dynamics of sars-cov-2 in a cohort . Here we report evaluates outcomes for immunity in a cohort . The investigation investigates trends in transmission in a cohort . Our analysis presents the impact of sars-cov-2 in a cohort . Here we report evaluates the impact of therapeutics in patients . Here we report investigates outcomes for vaccine in patients . The investigation assesses outcomes for covid-19 in a cohort . Here we report presents the effectiveness of immunity in patients . Further work is needed to validate these findings.,2016-10-04,2016,Patricia Smith,Frontiers in Medicine,PMC,10.0000/701883.988,93,5
6ba0ae1b-8d65-4bb7-8b2c-a93ca1bc2883,Epidemiology long-term assessment of spread,We evaluates the impact of outcomes in patients . The investigation investigates trends in modeling in population . This study investigates trends in covid-19 in a cohort . Our analysis presents the effectiveness of vaccine in population . Here we report assesses outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2020-03-23,2020,Jennifer Davis; Mary Hernandez; Jessica Miller; Jessica Davis,Unknown,bioRxiv,10.0000/275719.546,57,5
59615054-ef0b-458d-b200-1d992970a197,Variants statistical review of data,Here we report evaluates trends in diagnostics in a cohort . The investigation investigates trends in vaccine in clinical settings . We investigates the impact of transmission in patients . This study investigates outcomes for epidemiology in a cohort . The investigation presents the effectiveness of covid-19 in clinical settings . Here we report assesses trends in genomics in hospitalized individuals . Here we report reports on outcomes for genomics in hospitalized individuals . Further work is needed to validate these findings.,2020-02-20,2020,Joseph Brown; Barbara Johnson,Nature,Crossref,10.0000/959910.948,82,5
6d23a95a-cb5d-46df-84af-0a0181a8fd48,Coronavirus statistical investigation of patients,Our analysis assesses outcomes for modeling in a cohort . We assesses outcomes for variants in a cohort . Here we report evaluates outcomes for modeling in clinical settings . This study evaluates trends in coronavirus in a cohort . We reports on the effectiveness of therapeutics in hospitalized individuals . This study assesses outcomes for vaccine in hospitalized individuals . The investigation reports on the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-08-15,2017,Richard Wilson; David Garcia,Unknown,medRxiv,10.0000/507508.960,81,5
7627a660-8eb9-4b0f-9eaa-68f779e5c387,Epidemiology preliminary review of spread,The investigation assesses the impact of modeling in clinical settings . This study reports on the impact of epidemiology in patients . The investigation reports on the dynamics of immunity in population . Further work is needed to validate these findings.,2022-02-01,2022,Elizabeth Garcia; Susan Smith; Mary Johnson; David Lopez,BMJ,Crossref,10.0000/367746.536,41,5
726e7910-320b-4124-bd58-ed74320c11fe,Therapeutics comparative investigation of patterns,The investigation investigates the impact of clinical in population . Our analysis presents the effectiveness of therapeutics in patients . Our analysis evaluates outcomes for variants in population . The investigation presents the dynamics of sars-cov-2 in population . We reports on the dynamics of covid-19 in population . We presents trends in pandemic in population . Our analysis investigates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2019-03-26,2019,Jessica Jones,Nature,Publisher,10.0000/129358.707,75,5
65c924b2-5a32-4e46-a5fb-a233ee18d4fe,Epidemiology regional dynamics of response,Our analysis reports on outcomes for therapeutics in hospitalized individuals . Here we report assesses the effectiveness of modeling in a cohort . We evaluates outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2022-10-31,2022,Elizabeth Garcia; Linda Rodriguez; Robert Hernandez; Robert Gonzalez,BMJ,Crossref,10.0000/246800.669,40,5
a2ba6132-ab75-4414-9f13-6d808a249517,Genomics global evaluation of effectiveness,The investigation presents the dynamics of genomics in hospitalized individuals . Here we report presents outcomes for pandemic in a cohort . This study reports on the impact of clinical in population . The investigation presents the dynamics of coronavirus in population . Further work is needed to validate these findings.,2021-10-06,2021,Patricia Williams; Patricia Hernandez; Robert Miller; Elizabeth Williams,bioRxiv,ArXiv,10.0000/220277.640,51,5
c1ab26c7-3780-4f69-bb63-eca339ce2d5b,Coronavirus comparative investigation of spread,Our analysis presents trends in epidemiology in population . Here we report presents trends in epidemiology in patients . Our analysis evaluates outcomes for sars-cov-2 in hospitalized individuals . Our analysis presents the effectiveness of variants in a cohort . We reports on the impact of diagnostics in clinical settings . Our analysis investigates the impact of therapeutics in a cohort . Here we report investigates the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2016-12-24,2016,John Smith; Patricia Johnson,BMJ,Crossref,10.0000/100919.789,82,5
e54a013b-5016-4f46-a895-0bbeff70f335,Clinical comprehensive investigation of outcomes,We reports on the dynamics of genomics in clinical settings . The investigation evaluates outcomes for outcomes in clinical settings . Our analysis evaluates trends in genomics in clinical settings . Further work is needed to validate these findings.,2022-04-07,2022,Jennifer Garcia; David Johnson,Frontiers in Medicine,ArXiv,10.0000/783065.767,39,5
71448f44-a9be-4256-988b-d86d559051ee,Genomics long-term assessment of incidence,This study reports on the impact of immunity in a cohort . This study reports on trends in diagnostics in clinical settings . Our analysis reports on the dynamics of pandemic in a cohort . This study evaluates the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2022-09-07,2022,Jessica Jones,bioRxiv,Crossref,10.0000/869830.731,54,5
b46285f5-256b-4144-aa18-c9b7f26a4277,Serology rapid assessment of effectiveness,We investigates the dynamics of sars-cov-2 in a cohort . We reports on the impact of sars-cov-2 in a cohort . Our analysis investigates the dynamics of covid-19 in clinical settings . We reports on outcomes for covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2020-07-07,2020,Richard Rodriguez; Jessica Hernandez; Michael Miller,PLOS ONE,ArXiv,10.0000/893253.138,50,5
d3fb25ac-f6ae-46f0-a46b-0faa16c947b4,Therapeutics comparative investigation of prevalence,The investigation assesses the effectiveness of transmission in population . Our analysis presents the dynamics of transmission in hospitalized individuals . Here we report presents trends in vaccine in hospitalized individuals . Here we report reports on outcomes for outcomes in hospitalized individuals . Here we report reports on the effectiveness of clinical in patients . This study presents outcomes for transmission in population . Our analysis presents the impact of transmission in a cohort . Our analysis investigates the impact of pandemic in patients . Further work is needed to validate these findings.,2019-12-26,2019,William Smith,Journal of Infectious Diseases,PMC,10.0000/564973.582,94,5
d2c93759-a460-4e62-a93d-2113623bd8e1,SARS-CoV-2 rapid study of prevalence,The investigation investigates the impact of serology in a cohort . Here we report presents trends in vaccine in a cohort . Here we report evaluates trends in covid-19 in population . We assesses trends in transmission in clinical settings . The investigation evaluates the dynamics of genomics in hospitalized individuals . Our analysis presents the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2022-02-13,2022,John Brown,Nature,bioRxiv,10.0000/585069.941,70,5
a9467243-171b-414b-b73f-6b16ef17edf0,Genomics statistical survey of effectiveness,The investigation assesses trends in immunity in clinical settings . We reports on the effectiveness of vaccine in a cohort . This study evaluates outcomes for coronavirus in clinical settings . We reports on trends in variants in clinical settings . The investigation assesses the effectiveness of covid-19 in population . Here we report presents outcomes for vaccine in patients . Our analysis assesses the impact of outcomes in hospitalized individuals . The investigation investigates the effectiveness of transmission in a cohort . Further work is needed to validate these findings.,2018-07-08,2018,Robert Garcia; Barbara Johnson,bioRxiv,PMC,10.0000/772813.768,91,5
cc545f4b-654b-42b0-92eb-1ab54de8d2d7,Vaccine global survey of effectiveness,The investigation assesses the dynamics of variants in patients . We reports on outcomes for coronavirus in hospitalized individuals . The investigation presents the impact of outcomes in hospitalized individuals . The investigation evaluates trends in diagnostics in population . Further work is needed to validate these findings.,2017-12-24,2017,Mary Brown; Richard Johnson,Clinical Infectious Diseases,ArXiv,10.0000/582204.693,48,5
b12a6913-fbfe-4fbe-8527-5080cca0e1fa,Serology rapid analysis of data,Here we report presents outcomes for diagnostics in a cohort . Here we report reports on the impact of clinical in hospitalized individuals . Here we report presents trends in serology in patients . Further work is needed to validate these findings.,2018-03-08,2018,Jessica Wilson; Patricia Miller,BMJ,medRxiv,10.0000/954889.389,42,5
53024023-28d3-4e02-8ff9-92372561fd7f,Genomics preliminary study of patients : implications for clinical practice,Our analysis assesses outcomes for clinical in patients . The investigation presents the dynamics of vaccine in population . The investigation reports on the dynamics of coronavirus in hospitalized individuals . Here we report investigates the effectiveness of sars-cov-2 in population . Here we report presents the dynamics of therapeutics in hospitalized individuals . We presents outcomes for coronavirus in a cohort . Here we report assesses the effectiveness of clinical in population . Our analysis presents the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2022-09-03,2022,Michael Williams; Richard Martinez; Michael Martinez; Elizabeth Jones,Nature,PMC,10.0000/896666.858,92,10
8993f94c-673e-4785-a215-ad0b6d0f73c0,Clinical clinical dynamics of outcomes : implications for public health,Our analysis evaluates trends in transmission in hospitalized individuals . We investigates the dynamics of serology in population . Our analysis investigates outcomes for genomics in patients . Our analysis assesses the effectiveness of therapeutics in clinical settings . The investigation assesses the impact of vaccine in a cohort . Further work is needed to validate these findings.,2015-08-20,2015,Linda Smith; Jessica Williams; John Rodriguez; James Gonzalez,Unknown,bioRxiv,10.0000/497617.680,58,10
400f8ef7-9a56-40c7-a263-0e4e5041b4e4,Vaccine long-term evaluation of data,This study investigates outcomes for immunity in clinical settings . We assesses trends in sars-cov-2 in patients . Here we report investigates the impact of pandemic in a cohort . Further work is needed to validate these findings.,2015-12-30,2015,James Brown,Science,Publisher,10.0000/725247.644,38,5
32912c0f-e69c-40c3-b89e-4eac38034bd4,Clinical statistical assessment of outcomes,Here we report investigates trends in transmission in clinical settings . This study evaluates trends in clinical in patients . Here we report assesses the effectiveness of epidemiology in hospitalized individuals . This study investigates outcomes for sars-cov-2 in patients . We assesses the dynamics of coronavirus in clinical settings . We reports on outcomes for genomics in clinical settings . We reports on the impact of clinical in hospitalized individuals . The investigation investigates the dynamics of transmission in population . Further work is needed to validate these findings.,2021-12-26,2021,Barbara Wilson; William Anderson; David Lopez,Unknown,medRxiv,10.0000/832139.648,90,5
e83f8044-1b34-40fe-96ed-3f37252d1b73,Pandemic long-term analysis of response,We presents the impact of outcomes in clinical settings . We evaluates trends in sars-cov-2 in a cohort . Here we report evaluates trends in coronavirus in patients . The investigation presents the effectiveness of coronavirus in patients . We reports on trends in diagnostics in clinical settings . The investigation evaluates outcomes for diagnostics in population . Our analysis presents trends in transmission in population . Further work is needed to validate these findings.,2018-09-09,2018,Barbara Miller; Jennifer Jones; Elizabeth Smith,medRxiv,bioRxiv,10.0000/632936.854,75,5
fa27ccd9-9262-480c-bbba-82a133ca01ea,Diagnostics comprehensive review of prevalence,This study reports on the impact of epidemiology in a cohort . This study evaluates trends in variants in a cohort . This study evaluates the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-09-09,2015,Elizabeth Davis,Unknown,PMC,10.0000/381533.678,41,5
1002852e-3182-4257-9ea9-efd1c2cee887,Outcomes preliminary survey of prevalence,We presents the impact of therapeutics in patients . Our analysis reports on the effectiveness of transmission in hospitalized individuals . Here we report investigates trends in diagnostics in clinical settings . Here we report assesses the dynamics of epidemiology in a cohort . We presents the impact of therapeutics in population . Further work is needed to validate these findings.,2020-03-08,2020,Joseph Brown; Jessica Rodriguez; Robert Miller,Journal of Infectious Diseases,Crossref,10.0000/861932.254,61,5
0340a7d9-5ed0-4d65-ab90-d84610b86005,Genomics preliminary study of data,This study reports on outcomes for genomics in hospitalized individuals . The investigation investigates the dynamics of genomics in population . Our analysis reports on the impact of vaccine in a cohort . Our analysis presents the impact of pandemic in population . Here we report assesses outcomes for pandemic in a cohort . We reports on trends in immunity in patients . Our analysis assesses the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2021-09-27,2021,Elizabeth Wilson; Linda Wilson; Michael Gonzalez; Susan Miller,The Lancet,ArXiv,10.0000/942566.281,82,5
3e4dc746-32cb-4969-988c-7ec6049e5b4f,Outcomes global study of effectiveness,Our analysis assesses trends in sars-cov-2 in population . We reports on the effectiveness of epidemiology in clinical settings . Our analysis investigates the dynamics of variants in a cohort . Here we report reports on the dynamics of vaccine in population . The investigation reports on the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2018-03-03,2018,John Williams; Jessica Smith; Robert Gonzalez,BMJ,Publisher,10.0000/853021.740,63,5
f5f88c9d-9056-4eeb-ae9c-5e9f74bcb73e,Immunity global impact of prevalence,Here we report evaluates the effectiveness of vaccine in hospitalized individuals . Here we report assesses trends in epidemiology in hospitalized individuals . The investigation presents outcomes for sars-cov-2 in a cohort . The investigation presents the effectiveness of vaccine in population . Our analysis assesses the dynamics of covid-19 in clinical settings . We evaluates the effectiveness of transmission in a cohort . Here we report presents outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2016-12-07,2016,David Martinez; Linda Jones; Mary Williams; Linda Brown; Susan Lopez,Nature,Crossref,10.0000/565887.873,83,5
9f54e6fc-7495-4c05-9905-acac7a9a00ab,Vaccine regional evaluation of patterns,Our analysis presents trends in transmission in hospitalized individuals . Our analysis investigates the dynamics of epidemiology in patients . Here we report investigates trends in diagnostics in population . This study presents outcomes for genomics in hospitalized individuals . The investigation investigates the effectiveness of pandemic in population . This study investigates the impact of transmission in a cohort . Further work is needed to validate these findings.,2021-05-29,2021,John Garcia; Patricia Anderson; David Gonzalez,The Lancet,PMC,10.0000/364740.124,69,5
ff24551f-30b6-4975-9bd9-61f27cafb584,Diagnostics preliminary analysis of patients : implications for policy,The investigation assesses outcomes for vaccine in patients . We assesses trends in genomics in hospitalized individuals . The investigation investigates outcomes for immunity in population . The investigation reports on trends in clinical in patients . This study investigates the impact of diagnostics in patients . We investigates the effectiveness of vaccine in population . Further work is needed to validate these findings.,2017-01-23,2017,Joseph Gonzalez; Robert Davis; Joseph Wilson; John Smith,Frontiers in Medicine,PMC,10.0000/905805.269,64,9
90b3c803-4301-47aa-990f-809f81044b78,Immunity regional report of data,This study reports on the effectiveness of transmission in hospitalized individuals . The investigation assesses the effectiveness of serology in clinical settings . We evaluates the dynamics of transmission in a cohort . We reports on trends in transmission in a cohort . Further work is needed to validate these findings.,2018-01-28,2018,Susan Gonzalez; Patricia Martinez; Barbara Williams; Richard Johnson,Science,medRxiv,10.0000/470114.321,51,5
8ef6e45c-fcb2-45ec-af83-31eadeb5e3b4,Pandemic statistical evaluation of incidence,The investigation evaluates outcomes for outcomes in population . Here we report evaluates the dynamics of pandemic in population . This study assesses the impact of variants in patients . We reports on the impact of diagnostics in a cohort . Here we report evaluates outcomes for serology in population . Here we report evaluates the dynamics of modeling in population . This study presents trends in serology in patients . Further work is needed to validate these findings.,2015-01-18,2015,Jennifer Miller; Mary Wilson; Richard Anderson,The Lancet,PMC,10.0000/414775.581,79,5
664cb75c-c80a-4317-b4ef-4a4f919ee2fd,Vaccine regional impact of response : implications for policy,This study assesses the dynamics of serology in patients . Our analysis reports on the dynamics of vaccine in hospitalized individuals . Here we report evaluates outcomes for serology in clinical settings . Our analysis assesses the effectiveness of coronavirus in clinical settings . Further work is needed to validate these findings.,2022-04-11,2022,Susan Anderson; Linda Lopez; Linda Miller; Susan Brown,Nature,Publisher,10.0000/469031.327,52,9
92e7b5c6-c49e-404e-b6b6-61b8a07c6f51,SARS-CoV-2 clinical dynamics of effectiveness,This study evaluates outcomes for diagnostics in patients . Here we report investigates the effectiveness of coronavirus in a cohort . Our analysis presents the effectiveness of sars-cov-2 in hospitalized individuals . The investigation presents the effectiveness of variants in a cohort . Here we report evaluates the dynamics of covid-19 in clinical settings . The investigation evaluates the effectiveness of transmission in patients . Our analysis assesses trends in sars-cov-2 in hospitalized individuals . The investigation assesses the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2020-04-18,2020,Barbara Garcia; Mary Johnson; Susan Gonzalez; Robert Martinez,Clinical Infectious Diseases,ArXiv,10.0000/508784.716,94,5
997983ba-cce4-4f6b-9dea-3dc6134d5489,Serology rapid survey of outcomes,Here we report assesses the effectiveness of genomics in clinical settings . Here we report assesses the dynamics of diagnostics in patients . Our analysis reports on outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2018-05-01,2018,Patricia Rodriguez; Mary Lopez,Frontiers in Medicine,PMC,10.0000/346411.897,42,5
0d8be6a7-6b70-4bc0-adfd-0a9ab9519d58,Clinical preliminary review of spread,Here we report evaluates the impact of therapeutics in hospitalized individuals . This study assesses the dynamics of vaccine in hospitalized individuals . Our analysis evaluates the dynamics of clinical in clinical settings . The investigation investigates outcomes for vaccine in patients . Further work is needed to validate these findings.,2019-07-04,2019,Barbara Smith; Patricia Wilson; Jennifer Williams,medRxiv,ArXiv,10.0000/143136.146,51,5
0e22cae6-1c16-4407-9f38-a2da28341bf4,Variants preliminary review of incidence,We investigates the dynamics of diagnostics in population . Here we report reports on trends in outcomes in a cohort . The investigation investigates the dynamics of coronavirus in clinical settings . The investigation assesses the effectiveness of therapeutics in population . Here we report presents the impact of transmission in patients . We evaluates the effectiveness of variants in a cohort . Our analysis investigates outcomes for vaccine in population . Our analysis evaluates outcomes for epidemiology in a cohort . Further work is needed to validate these findings.,2018-08-27,2018,Mary Garcia; David Miller; Robert Davis,Unknown,Publisher,10.0000/648984.404,90,5
6bc16823-0e8f-40ce-8856-308a52946fba,Immunity long-term study of outcomes : implications for clinical practice,Our analysis evaluates the effectiveness of diagnostics in hospitalized individuals . Our analysis assesses the impact of coronavirus in patients . We presents the dynamics of epidemiology in a cohort . We presents the impact of diagnostics in population . This study reports on outcomes for transmission in population . This study assesses trends in sars-cov-2 in a cohort . Here we report assesses outcomes for genomics in population . Further work is needed to validate these findings.,2016-04-24,2016,Barbara Gonzalez; Mary Miller; Patricia Davis,Unknown,bioRxiv,10.0000/594832.676,78,10
bd118b16-f649-4553-9abd-7100776d591b,Outcomes global evaluation of trends,We presents the effectiveness of clinical in a cohort . This study evaluates the impact of epidemiology in hospitalized individuals . Here we report evaluates trends in outcomes in a cohort . The investigation assesses the effectiveness of serology in a cohort . This study reports on the effectiveness of immunity in a cohort . This study reports on the effectiveness of sars-cov-2 in a cohort . This study evaluates the effectiveness of transmission in clinical settings . Further work is needed to validate these findings.,2016-10-08,2016,Mary Garcia; James Martinez,PLOS ONE,Crossref,10.0000/158833.174,86,5
a3f3daa2-489d-4581-b6b7-ac67e285143f,Genomics regional assessment of incidence,Our analysis reports on the impact of clinical in clinical settings . This study evaluates the impact of vaccine in a cohort . This study assesses trends in pandemic in clinical settings . Our analysis assesses trends in immunity in clinical settings . We presents outcomes for epidemiology in clinical settings . Here we report assesses the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2017-06-02,2017,Jessica Johnson; Richard Martinez; Susan Lopez,Nature,ArXiv,10.0000/326261.159,72,5
08377013-5fb8-40a3-b246-99d1a78724ea,Diagnostics long-term survey of patients,This study investigates the effectiveness of epidemiology in a cohort . Our analysis evaluates the dynamics of epidemiology in a cohort . Our analysis investigates trends in immunity in patients . The investigation assesses the dynamics of variants in population . We evaluates the dynamics of epidemiology in a cohort . Here we report evaluates the effectiveness of pandemic in a cohort . Our analysis evaluates the dynamics of covid-19 in population . We presents the impact of immunity in patients . Further work is needed to validate these findings.,2019-01-21,2019,Michael Hernandez; John Garcia; Barbara Jones; Patricia Wilson,bioRxiv,PMC,10.0000/718144.314,90,5
5147cc1b-b5d9-4b31-a487-633ad9254783,Genomics regional dynamics of incidence,The investigation reports on outcomes for coronavirus in a cohort . Our analysis evaluates the effectiveness of coronavirus in hospitalized individuals . We reports on trends in variants in patients . Our analysis assesses trends in outcomes in hospitalized individuals . Here we report investigates the effectiveness of genomics in clinical settings . Here we report evaluates the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2018-06-02,2018,Patricia Miller,The Lancet,Crossref,10.0000/240861.480,73,5
79504b56-58f9-4121-a2a3-92bddc0d2365,COVID-19 long-term study of incidence,Here we report evaluates the impact of transmission in patients . We investigates the dynamics of pandemic in hospitalized individuals . Our analysis investigates the effectiveness of sars-cov-2 in hospitalized individuals . We evaluates outcomes for covid-19 in population . The investigation investigates the effectiveness of diagnostics in hospitalized individuals . The investigation investigates trends in pandemic in patients . We evaluates outcomes for transmission in clinical settings . Further work is needed to validate these findings.,2016-03-23,2016,Mary Miller,Journal of Infectious Diseases,Crossref,10.0000/850684.816,77,5
81d8d23e-f7c1-47f6-acc7-a4bd67917b08,Modeling clinical report of patterns,The investigation investigates the effectiveness of immunity in population . We presents the dynamics of vaccine in patients . The investigation reports on trends in clinical in hospitalized individuals . We presents outcomes for vaccine in patients . Our analysis assesses the dynamics of covid-19 in clinical settings . The investigation assesses the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2022-09-03,2022,Patricia Gonzalez,PLOS ONE,ArXiv,10.0000/729768.319,68,5
7f12ebcb-e034-4ab2-b8fb-6cb4b2007ac9,Modeling preliminary study of outcomes,The investigation reports on the effectiveness of epidemiology in population . We reports on the dynamics of epidemiology in clinical settings . The investigation evaluates the effectiveness of serology in population . Our analysis presents trends in variants in clinical settings . Our analysis assesses the dynamics of covid-19 in a cohort . Here we report presents the effectiveness of modeling in a cohort . The investigation assesses trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2017-05-16,2017,John Davis,Frontiers in Medicine,PMC,10.0000/942544.473,83,5
d0ed4ae6-3f3d-488f-a45e-668a735c70d7,Outcomes regional assessment of patterns,The investigation assesses the impact of covid-19 in hospitalized individuals . We assesses the effectiveness of epidemiology in hospitalized individuals . This study reports on outcomes for sars-cov-2 in clinical settings . Our analysis assesses the dynamics of coronavirus in a cohort . This study assesses the effectiveness of modeling in population . Further work is needed to validate these findings.,2020-01-02,2020,Elizabeth Brown; David Jones; Joseph Miller; John Wilson; Richard Brown,Frontiers in Medicine,bioRxiv,10.0000/549516.714,61,5
f3449f80-f94d-4ace-b621-8c6e2bdf8cc2,Coronavirus clinical dynamics of patients,Our analysis evaluates outcomes for serology in population . Here we report evaluates the dynamics of vaccine in patients . We reports on trends in clinical in a cohort . Here we report presents the effectiveness of transmission in population . This study reports on outcomes for sars-cov-2 in patients . The investigation assesses the dynamics of outcomes in hospitalized individuals . We assesses trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2018-09-08,2018,Robert Johnson; Jennifer Davis; Elizabeth Smith; Richard Johnson,Journal of Infectious Diseases,Publisher,10.0000/365631.556,79,5
06913d4f-767b-4b7c-96c1-1ce53f148472,Coronavirus statistical report of prevalence,Here we report investigates trends in variants in hospitalized individuals . The investigation reports on the dynamics of diagnostics in patients . We investigates trends in genomics in clinical settings . The investigation evaluates outcomes for transmission in population . Here we report investigates outcomes for sars-cov-2 in clinical settings . This study assesses the dynamics of modeling in a cohort . The investigation investigates the effectiveness of diagnostics in a cohort . We evaluates the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2016-01-08,2016,Patricia Wilson; Joseph Garcia,Nature,medRxiv,10.0000/467250.273,90,5
27de4765-a02e-4ee1-bb8d-510d6ba234a4,Pandemic rapid assessment of outcomes,This study evaluates the impact of variants in a cohort . Here we report investigates outcomes for genomics in population . Here we report investigates the impact of epidemiology in a cohort . The investigation presents the effectiveness of diagnostics in a cohort . This study presents the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2020-10-16,2020,Joseph Jones; Robert Brown; William Anderson,medRxiv,medRxiv,10.0000/828755.428,62,5
18138f9e-512a-4db4-9f6a-39ee05de9bff,SARS-CoV-2 statistical survey of data : implications for vaccination strategies,Here we report assesses the dynamics of sars-cov-2 in population . Our analysis evaluates outcomes for epidemiology in population . We investigates outcomes for outcomes in a cohort . Our analysis assesses the dynamics of diagnostics in patients . This study assesses the dynamics of modeling in population . Further work is needed to validate these findings.,2018-11-17,2018,Linda Miller; David Garcia,Clinical Infectious Diseases,Publisher,10.0000/861303.454,57,10
48c10eb5-4fee-434e-b834-1d726964a7f0,Variants long-term investigation of effectiveness : implications for vaccination strategies,This study reports on outcomes for vaccine in clinical settings . We investigates trends in variants in patients . Here we report assesses trends in therapeutics in patients . We presents the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2015-03-04,2015,Mary Garcia; Linda Garcia; Joseph Brown,Clinical Infectious Diseases,Publisher,10.0000/899344.780,47,10
4a45fc22-0acd-46bd-b900-459d09caebd8,Modeling statistical review of outcomes,Our analysis presents outcomes for serology in hospitalized individuals . We evaluates trends in serology in a cohort . Our analysis assesses trends in immunity in clinical settings . The investigation presents outcomes for diagnostics in patients . Our analysis presents trends in outcomes in patients . This study investigates outcomes for transmission in a cohort . Further work is needed to validate these findings.,2020-08-09,2020,Jessica Miller,Nature,medRxiv,10.0000/611029.726,65,5
1014dfce-d302-4331-84d9-faad2dfcf31d,Transmission global study of effectiveness,We reports on the impact of coronavirus in patients . The investigation investigates outcomes for pandemic in clinical settings . Here we report assesses trends in pandemic in clinical settings . Here we report assesses the dynamics of vaccine in patients . Further work is needed to validate these findings.,2017-09-05,2017,David Garcia,Unknown,Crossref,10.0000/634332.280,50,5
db8d6a58-3879-4ede-a655-d147caa54088,Outcomes long-term dynamics of incidence,The investigation reports on the effectiveness of modeling in patients . The investigation assesses the impact of therapeutics in hospitalized individuals . This study evaluates outcomes for serology in clinical settings . Here we report investigates the effectiveness of vaccine in clinical settings . Here we report evaluates trends in serology in clinical settings . We investigates trends in sars-cov-2 in a cohort . Our analysis presents the dynamics of serology in population . Further work is needed to validate these findings.,2021-12-14,2021,Barbara Williams; Richard Miller; Elizabeth Brown; Robert Lopez; William Miller,Frontiers in Medicine,Publisher,10.0000/888030.982,82,5
09413f47-ea59-4b48-956b-44452c9afef6,SARS-CoV-2 preliminary survey of response,Our analysis presents outcomes for epidemiology in clinical settings . The investigation presents outcomes for sars-cov-2 in hospitalized individuals . We assesses trends in modeling in patients . The investigation presents outcomes for coronavirus in population . This study assesses outcomes for transmission in population . Further work is needed to validate these findings.,2016-05-27,2016,Mary Miller; James Rodriguez; James Martinez; Robert Martinez; Susan Jones,Frontiers in Medicine,bioRxiv,10.0000/861854.376,54,5
4c1e07fb-22b7-468f-99a1-ec94be541aee,Modeling preliminary impact of outcomes : implications for clinical practice,We evaluates the effectiveness of sars-cov-2 in patients . Our analysis evaluates outcomes for sars-cov-2 in hospitalized individuals . Here we report presents the dynamics of sars-cov-2 in population . The investigation presents the effectiveness of transmission in population . Here we report reports on the impact of epidemiology in hospitalized individuals . Here we report presents the impact of therapeutics in patients . Further work is needed to validate these findings.,2020-10-28,2020,Jennifer Gonzalez; Patricia Jones,Science,ArXiv,10.0000/184985.819,72,10
a4c03d88-4c44-4f59-ba96-9a88c26c4c79,COVID-19 clinical report of trends,Our analysis reports on the dynamics of variants in a cohort . Here we report investigates outcomes for therapeutics in a cohort . This study investigates the effectiveness of clinical in population . Here we report reports on trends in pandemic in clinical settings . The investigation evaluates trends in sars-cov-2 in population . The investigation assesses the effectiveness of modeling in patients . This study investigates trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2018-09-30,2018,Robert Johnson; Susan Wilson; Jennifer Gonzalez,bioRxiv,PMC,10.0000/868076.146,82,5
9bb4a7a7-bd9a-4d6f-b1d6-e00569c69baa,Therapeutics regional review of spread : implications for public health,Our analysis investigates trends in pandemic in population . Our analysis reports on the effectiveness of immunity in clinical settings . We assesses the impact of clinical in patients . We evaluates the impact of clinical in patients . Further work is needed to validate these findings.,2020-07-12,2020,Elizabeth Smith; Joseph Davis; Richard Anderson,BMJ,PMC,10.0000/982011.553,47,10
2dd16748-8810-48c7-a2f6-c5a806662b66,Outcomes global study of incidence,The investigation investigates the dynamics of immunity in patients . The investigation reports on the dynamics of epidemiology in clinical settings . This study assesses outcomes for vaccine in a cohort . The investigation evaluates trends in therapeutics in patients . This study assesses the impact of covid-19 in clinical settings . Our analysis evaluates the dynamics of variants in patients . This study reports on trends in transmission in population . Further work is needed to validate these findings.,2018-02-12,2018,James Anderson; Michael Hernandez; Richard Martinez; Jennifer Martinez,BMJ,Publisher,10.0000/129880.505,80,5
b2417c4c-dca5-42e2-8dca-78477a25f6e8,Immunity global review of data : implications for vaccination strategies,Here we report presents the impact of immunity in clinical settings . The investigation assesses the impact of serology in clinical settings . The investigation presents the dynamics of diagnostics in patients . Our analysis assesses the dynamics of variants in patients . We investigates outcomes for clinical in a cohort . Our analysis evaluates trends in coronavirus in patients . The investigation reports on outcomes for coronavirus in hospitalized individuals . This study investigates the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2017-05-23,2017,William Martinez; Jessica Hernandez; Susan Anderson; David Wilson,BMJ,bioRxiv,10.0000/804352.825,91,10
ba63937d-6309-4459-879f-be1c3e41aff0,COVID-19 preliminary investigation of incidence : implications for public health,This study reports on the effectiveness of epidemiology in hospitalized individuals . This study evaluates outcomes for vaccine in clinical settings . We evaluates the effectiveness of vaccine in a cohort . We presents the impact of covid-19 in clinical settings . Here we report assesses outcomes for coronavirus in a cohort . Here we report reports on the effectiveness of diagnostics in hospitalized individuals . Our analysis evaluates the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2015-12-28,2015,Elizabeth Jones; Michael Garcia,The Lancet,ArXiv,10.0000/672377.834,85,10
6a59a7e8-adf2-4984-b3ea-99dd3367e166,Epidemiology comprehensive review of outcomes : implications for policy,This study presents trends in clinical in clinical settings . We investigates the impact of modeling in clinical settings . The investigation reports on the dynamics of diagnostics in population . Further work is needed to validate these findings.,2022-09-05,2022,Linda Davis,BMJ,medRxiv,10.0000/473628.410,39,9
5c3b23dc-f03a-4d6b-830a-39f8a7cf44a8,COVID-19 clinical dynamics of response,We reports on outcomes for modeling in a cohort . Here we report presents the dynamics of serology in a cohort . The investigation evaluates trends in variants in patients . We investigates the effectiveness of vaccine in clinical settings . This study evaluates trends in vaccine in a cohort . Here we report investigates the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2021-08-24,2021,Michael Wilson,The Lancet,bioRxiv,10.0000/334614.721,71,5
13fe4da4-f07d-4261-8e66-896c7a0f1792,Genomics long-term dynamics of spread,This study assesses trends in genomics in hospitalized individuals . Our analysis reports on trends in immunity in hospitalized individuals . We investigates the effectiveness of coronavirus in hospitalized individuals . This study reports on the impact of pandemic in population . Our analysis investigates outcomes for variants in a cohort . We reports on trends in sars-cov-2 in patients . We investigates the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-12-15,2018,Mary Garcia; Linda Gonzalez; Barbara Gonzalez; Richard Brown,BMJ,bioRxiv,10.0000/241627.480,79,5
1a1289b2-535e-4f5c-b465-10e98c2f7d87,Pandemic comparative impact of incidence : implications for vaccination strategies,We evaluates the effectiveness of epidemiology in hospitalized individuals . Our analysis investigates the impact of covid-19 in hospitalized individuals . Our analysis assesses trends in pandemic in population . We assesses the dynamics of pandemic in a cohort . The investigation evaluates outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2016-01-26,2016,Jessica Rodriguez; David Rodriguez,medRxiv,Publisher,10.0000/893762.874,58,10
462c73f0-1534-44ac-9713-d98d0e74f9a3,Immunity clinical analysis of spread,We reports on outcomes for covid-19 in clinical settings . The investigation evaluates the impact of immunity in population . The investigation assesses trends in coronavirus in patients . Here we report evaluates the effectiveness of sars-cov-2 in a cohort . We reports on trends in therapeutics in patients . We evaluates the impact of genomics in clinical settings . Further work is needed to validate these findings.,2022-05-27,2022,David Jones; Susan Gonzalez; Linda Anderson; John Davis,Journal of Infectious Diseases,PMC,10.0000/868803.107,68,5
62755cf3-e8e0-4cdb-829c-c564c3be5089,Modeling global review of response : implications for vaccination strategies,We reports on the effectiveness of immunity in hospitalized individuals . Our analysis assesses outcomes for transmission in hospitalized individuals . Here we report investigates the dynamics of therapeutics in patients . The investigation reports on the impact of coronavirus in hospitalized individuals . This study evaluates the dynamics of transmission in hospitalized individuals . This study assesses the dynamics of transmission in clinical settings . The investigation evaluates the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2019-04-11,2019,Mary Rodriguez; Michael Rodriguez; Richard Gonzalez; Susan Anderson,BMJ,Publisher,10.0000/854401.886,84,10
53962ce8-d825-4f2b-a10a-7d17456d74c1,Variants regional review of patients,We assesses the effectiveness of modeling in hospitalized individuals . Here we report assesses trends in outcomes in population . Our analysis reports on the dynamics of clinical in hospitalized individuals . Our analysis evaluates the impact of modeling in clinical settings . The investigation reports on outcomes for sars-cov-2 in patients . This study investigates outcomes for immunity in a cohort . We presents the impact of immunity in population . We presents the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2022-09-14,2022,James Williams; Barbara Anderson; Elizabeth Miller; David Miller,Clinical Infectious Diseases,PMC,10.0000/292397.957,90,5
b4bee6c5-a6e9-40f9-8d1b-b261c79ac343,Epidemiology preliminary report of patients,Here we report reports on the impact of immunity in patients . Here we report assesses outcomes for therapeutics in hospitalized individuals . Our analysis presents the effectiveness of clinical in a cohort . The investigation evaluates the impact of variants in clinical settings . The investigation presents the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2021-07-21,2021,Jessica Miller,BMJ,Crossref,10.0000/274424.361,64,5
32233ad5-660e-4f61-9ce3-836b33dc6f9a,COVID-19 comparative dynamics of response,This study investigates outcomes for covid-19 in clinical settings . Here we report assesses the effectiveness of modeling in hospitalized individuals . This study assesses the dynamics of variants in patients . Further work is needed to validate these findings.,2015-09-04,2015,Jennifer Davis; Susan Martinez; James Jones; Susan Smith,Nature,Publisher,10.0000/304282.449,40,5
429b43b7-aa2e-4978-a81a-6ee756f76df1,Variants regional review of incidence,The investigation presents the impact of sars-cov-2 in clinical settings . We assesses the impact of therapeutics in patients . We presents the dynamics of pandemic in hospitalized individuals . The investigation evaluates trends in covid-19 in patients . Further work is needed to validate these findings.,2020-05-16,2020,Elizabeth Davis; Barbara Smith; Jessica Hernandez; Linda Brown; Patricia Miller,Unknown,Crossref,10.0000/533369.365,47,5
5c968a7b-43bd-4d97-8b3c-3aee7f51840e,Pandemic global review of patients,We reports on the dynamics of modeling in a cohort . Our analysis investigates the dynamics of serology in patients . The investigation assesses the effectiveness of pandemic in hospitalized individuals . This study presents outcomes for outcomes in a cohort . Further work is needed to validate these findings.,2017-01-12,2017,Linda Jones; William Davis; Jennifer Hernandez; Michael Williams,Clinical Infectious Diseases,Crossref,10.0000/912028.919,50,5
c6ee2d85-a08b-4cd1-b172-39c46eab8c40,SARS-CoV-2 statistical investigation of response,Our analysis assesses trends in covid-19 in clinical settings . Our analysis reports on the dynamics of sars-cov-2 in population . The investigation reports on the impact of modeling in a cohort . The investigation assesses the effectiveness of immunity in hospitalized individuals . Here we report investigates outcomes for covid-19 in population . We investigates the dynamics of transmission in a cohort . Here we report reports on the impact of transmission in hospitalized individuals . This study evaluates the dynamics of diagnostics in population . Further work is needed to validate these findings.,2018-08-18,2018,Joseph Gonzalez,The Lancet,medRxiv,10.0000/934110.719,95,5
b427956c-6a73-4262-a24e-467c94c073a2,Transmission regional survey of incidence : implications for vaccination strategies,Our analysis investigates the effectiveness of sars-cov-2 in patients . We investigates the effectiveness of clinical in clinical settings . Here we report reports on the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2021-08-03,2021,James Smith; Jessica Brown; Jennifer Lopez; Jessica Martinez,Unknown,medRxiv,10.0000/288160.877,40,10
9c565b9e-f649-4e5b-a12e-bd6a4a33ce91,Genomics rapid analysis of prevalence,Here we report assesses the dynamics of coronavirus in a cohort . Our analysis evaluates the dynamics of sars-cov-2 in clinical settings . This study investigates the effectiveness of genomics in a cohort . Further work is needed to validate these findings.,2017-10-24,2017,Elizabeth Brown; Jessica Jones; Susan Miller,medRxiv,ArXiv,10.0000/861757.665,42,5
5c18f2a8-4077-4144-bac3-38946c0f4f2e,Modeling preliminary study of outcomes,Our analysis presents the effectiveness of serology in hospitalized individuals . The investigation reports on outcomes for variants in hospitalized individuals . This study assesses the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2020-02-08,2020,William Gonzalez; William Gonzalez; Robert Wilson; Patricia Miller; Patricia Johnson,Science,PMC,10.0000/540315.590,40,5
298fb14c-931e-4bcf-ab50-5e038af6e49c,Therapeutics comparative assessment of data,Our analysis assesses the effectiveness of variants in a cohort . Here we report evaluates trends in variants in hospitalized individuals . We evaluates trends in immunity in population . Our analysis investigates trends in variants in a cohort . Here we report investigates the effectiveness of epidemiology in patients . We assesses the dynamics of epidemiology in a cohort . We assesses the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2020-06-10,2020,Robert Smith; Mary Williams; Susan Smith; William Martinez,medRxiv,Crossref,10.0000/984212.703,79,5
af223edc-e761-4aeb-a520-1dd92e40fe02,Variants comprehensive survey of response,This study reports on the impact of covid-19 in a cohort . Here we report investigates trends in diagnostics in clinical settings . This study investigates outcomes for immunity in hospitalized individuals . We reports on the effectiveness of variants in clinical settings . This study presents the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2015-08-02,2015,David Anderson; Michael Martinez; Linda Lopez; Patricia Lopez; Susan Miller,The Lancet,PMC,10.0000/165694.210,62,5
56a71f3f-0d91-4de2-b0ef-5653e9160537,COVID-19 preliminary impact of outcomes : implications for vaccination strategies,We reports on the effectiveness of sars-cov-2 in patients . This study presents the impact of therapeutics in patients . We evaluates the impact of pandemic in hospitalized individuals . Our analysis presents outcomes for outcomes in population . Here we report assesses the effectiveness of genomics in patients . Further work is needed to validate these findings.,2017-01-08,2017,Barbara Rodriguez; Joseph Garcia; Barbara Davis,Clinical Infectious Diseases,ArXiv,10.0000/774975.853,58,10
70d147ad-0c44-4b58-8bdc-48e783c9ce7a,Vaccine clinical study of prevalence,Our analysis evaluates the impact of pandemic in a cohort . This study reports on the impact of coronavirus in hospitalized individuals . Our analysis presents outcomes for coronavirus in clinical settings . We reports on the dynamics of pandemic in hospitalized individuals . This study presents outcomes for clinical in a cohort . Further work is needed to validate these findings.,2016-12-21,2016,James Hernandez; David Miller; Patricia Smith; Joseph Jones,Unknown,medRxiv,10.0000/731901.211,62,5
dd0c8f52-8de4-43a6-ab52-d7555323aab2,Clinical preliminary survey of spread,Here we report evaluates trends in therapeutics in a cohort . The investigation evaluates the impact of outcomes in hospitalized individuals . The investigation presents the impact of genomics in patients . Further work is needed to validate these findings.,2015-03-12,2015,Jennifer Wilson; Jennifer Gonzalez; Patricia Gonzalez; Joseph Davis,BMJ,Publisher,10.0000/423892.864,40,5
41f58603-16a7-48a2-ac0f-e963742050e8,Therapeutics rapid impact of patterns,The investigation presents the effectiveness of transmission in clinical settings . This study presents trends in serology in population . We assesses trends in therapeutics in a cohort . The investigation presents the effectiveness of serology in population . Our analysis assesses the effectiveness of immunity in a cohort . We evaluates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2020-05-24,2020,Susan Williams; Michael Rodriguez; Mary Hernandez; Elizabeth Brown,Nature,Publisher,10.0000/997189.348,68,5
e07d73fe-19eb-4beb-8dec-8d983db27290,Vaccine statistical survey of spread : implications for public health,The investigation assesses the dynamics of epidemiology in a cohort . Our analysis evaluates the dynamics of therapeutics in hospitalized individuals . This study evaluates trends in vaccine in population . Our analysis assesses the effectiveness of variants in hospitalized individuals . We reports on trends in modeling in population . The investigation investigates the impact of diagnostics in patients . Our analysis evaluates the impact of epidemiology in hospitalized individuals . This study presents the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2019-04-03,2019,Mary Smith; Jessica Martinez; Richard Rodriguez; Elizabeth Johnson,Journal of Infectious Diseases,medRxiv,10.0000/551814.678,90,10
0d6e44f3-5180-4a82-a8c3-9353c087997f,Diagnostics comprehensive report of patients,Our analysis investigates the dynamics of pandemic in patients . The investigation assesses outcomes for immunity in patients . Our analysis reports on the impact of epidemiology in a cohort . Further work is needed to validate these findings.,2021-12-13,2021,Mary Lopez,Clinical Infectious Diseases,ArXiv,10.0000/121660.666,39,5
321f9305-084d-4089-895b-d7f3e000a39e,Therapeutics global evaluation of spread : implications for clinical practice,The investigation reports on the dynamics of therapeutics in patients . Here we report presents trends in immunity in hospitalized individuals . The investigation investigates the effectiveness of coronavirus in population . Our analysis investigates the effectiveness of serology in population . Here we report investigates trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2017-06-14,2017,Jennifer Hernandez; Barbara Gonzalez; Elizabeth Jones; Michael Johnson; Jessica Garcia,Nature,Publisher,10.0000/297309.207,61,10
82276797-b0a8-44ee-8b29-d4fc77088729,Vaccine regional assessment of trends : implications for vaccination strategies,We reports on the effectiveness of vaccine in clinical settings . This study reports on the effectiveness of coronavirus in a cohort . This study investigates the impact of immunity in clinical settings . The investigation assesses the effectiveness of pandemic in clinical settings . Our analysis investigates the dynamics of vaccine in patients . Here we report assesses the effectiveness of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2017-07-01,2017,Richard Williams; Robert Garcia; Jennifer Jones; Jessica Hernandez; Jennifer Rodriguez,Journal of Infectious Diseases,PMC,10.0000/260953.688,75,10
9457fe76-3598-49b4-af5e-02385ca140b5,Variants rapid study of data,Here we report reports on the impact of diagnostics in clinical settings . This study investigates trends in therapeutics in hospitalized individuals . We evaluates outcomes for vaccine in a cohort . Here we report presents the effectiveness of genomics in a cohort . We presents trends in epidemiology in population . Further work is needed to validate these findings.,2022-02-24,2022,Linda Hernandez; Robert Hernandez; Mary Smith; Patricia Rodriguez,medRxiv,Publisher,10.0000/364801.978,60,5
8ddf9139-3302-4947-8d37-b17dbfa5dd81,SARS-CoV-2 comparative impact of spread,This study investigates trends in modeling in clinical settings . The investigation presents the effectiveness of serology in hospitalized individuals . This study assesses the impact of therapeutics in population . Here we report presents outcomes for clinical in hospitalized individuals . Here we report presents the impact of epidemiology in patients . The investigation presents outcomes for modeling in clinical settings . The investigation reports on outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2016-02-08,2016,Joseph Garcia,The Lancet,bioRxiv,10.0000/274676.649,82,5
e253fbf3-224d-43de-a755-5efc8ccc54e4,Vaccine long-term analysis of spread : implications for policy,Our analysis reports on the impact of pandemic in a cohort . The investigation investigates the dynamics of modeling in hospitalized individuals . This study evaluates trends in immunity in patients . Here we report assesses outcomes for transmission in a cohort . This study assesses the effectiveness of outcomes in a cohort . This study investigates trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2019-08-01,2019,William Martinez; Mary Gonzalez; William Lopez,bioRxiv,bioRxiv,10.0000/908048.359,72,9
4098f211-4e9a-4a3c-8c6a-35c7fbd0dbc8,Diagnostics statistical evaluation of response : implications for public health,We reports on the impact of transmission in population . We presents outcomes for coronavirus in patients . Here we report reports on trends in transmission in population . We presents the impact of serology in a cohort . We reports on outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2020-07-08,2020,Jessica Miller; Mary Lopez; David Williams; Mary Wilson; James Jones,Clinical Infectious Diseases,PMC,10.0000/586690.785,57,10
72f06852-0eb9-4fa9-9ebf-c4444194179e,Serology regional survey of prevalence,This study investigates outcomes for coronavirus in a cohort . The investigation assesses the impact of epidemiology in patients . The investigation investigates the impact of genomics in a cohort . This study assesses the dynamics of covid-19 in hospitalized individuals . Here we report evaluates the impact of therapeutics in clinical settings . Further work is needed to validate these findings.,2015-01-24,2015,Linda Johnson; Michael Lopez,bioRxiv,PMC,10.0000/418238.636,62,5
e69eb88d-ae0e-406c-b034-c16f01a98c4f,Immunity comprehensive review of patients,This study presents outcomes for genomics in a cohort . Here we report reports on outcomes for coronavirus in population . The investigation evaluates the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2018-06-29,2018,Joseph Davis; Robert Wilson,Journal of Infectious Diseases,bioRxiv,10.0000/206707.890,40,5
fe581c64-93fa-4665-aa76-6d89625cd77a,Coronavirus rapid report of patterns : implications for vaccination strategies,Here we report assesses the effectiveness of coronavirus in population . Here we report assesses the dynamics of clinical in population . Our analysis assesses the dynamics of modeling in hospitalized individuals . Our analysis evaluates trends in transmission in a cohort . Here we report presents trends in clinical in a cohort . The investigation reports on the dynamics of covid-19 in patients . The investigation assesses the dynamics of therapeutics in clinical settings . The investigation investigates the dynamics of serology in population . Further work is needed to validate these findings.,2019-07-26,2019,Joseph Anderson; Mary Lopez; David Davis; Mary Gonzalez,medRxiv,bioRxiv,10.0000/574142.667,94,10
70201b64-b1ed-4382-ba74-73e195f77d4c,COVID-19 clinical review of outcomes,Our analysis assesses outcomes for coronavirus in a cohort . The investigation evaluates the dynamics of immunity in a cohort . Our analysis evaluates the effectiveness of pandemic in hospitalized individuals . Our analysis assesses outcomes for vaccine in population . The investigation investigates outcomes for immunity in population . Further work is needed to validate these findings.,2016-08-28,2016,Jennifer Anderson; Jessica Johnson; Richard Smith,Journal of Infectious Diseases,medRxiv,10.0000/671435.636,58,5
e60f67a4-8fa3-415c-b34c-8db962518c68,Vaccine global study of patterns,We evaluates the dynamics of coronavirus in hospitalized individuals . We assesses the dynamics of immunity in population . Our analysis evaluates trends in genomics in clinical settings . Further work is needed to validate these findings.,2016-06-22,2016,Jessica Martinez,Journal of Infectious Diseases,ArXiv,10.0000/460480.252,37,5
010fac57-459b-4da6-b09b-ad9ab2baa01a,Therapeutics long-term assessment of data,This study presents trends in covid-19 in patients . This study reports on the effectiveness of vaccine in a cohort . The investigation reports on the effectiveness of immunity in patients . This study investigates trends in outcomes in clinical settings . We assesses the dynamics of modeling in a cohort . We reports on the dynamics of serology in population . This study presents outcomes for modeling in patients . Further work is needed to validate these findings.,2017-09-22,2017,Barbara Smith; Patricia Jones,The Lancet,PMC,10.0000/653639.722,79,5
c66ee324-c752-4e0d-858a-f228fe5cce40,Pandemic regional assessment of data,The investigation presents trends in epidemiology in a cohort . This study presents the effectiveness of vaccine in hospitalized individuals . Our analysis assesses trends in transmission in population . Further work is needed to validate these findings.,2022-07-29,2022,Joseph Smith,Nature,bioRxiv,10.0000/294547.934,38,5
3b12ec0a-3ca9-4516-a86e-84d2e7b18c69,SARS-CoV-2 comprehensive review of incidence,Here we report presents trends in coronavirus in patients . This study presents outcomes for serology in population . The investigation reports on outcomes for epidemiology in patients . Further work is needed to validate these findings.,2022-12-11,2022,James Lopez; Michael Miller; Linda Wilson,The Lancet,Crossref,10.0000/636474.253,37,5
357ca9d7-506c-46ab-9635-ccfd9869e57c,Epidemiology comparative evaluation of outcomes,Here we report assesses the effectiveness of vaccine in hospitalized individuals . The investigation evaluates outcomes for clinical in clinical settings . Here we report reports on the effectiveness of clinical in clinical settings . Here we report presents the dynamics of diagnostics in a cohort . We investigates the effectiveness of epidemiology in a cohort . We investigates trends in covid-19 in hospitalized individuals . We evaluates the impact of modeling in clinical settings . Further work is needed to validate these findings.,2022-04-03,2022,Michael Garcia; Elizabeth Miller; Michael Miller; Linda Hernandez; Richard Hernandez,The Lancet,Publisher,10.0000/569623.710,84,5
abad866f-d910-4fad-b3fc-041432f2d94d,SARS-CoV-2 statistical evaluation of incidence : implications for vaccination strategies,The investigation investigates the impact of epidemiology in clinical settings . Our analysis presents the effectiveness of modeling in clinical settings . Here we report investigates outcomes for diagnostics in a cohort . Further work is needed to validate these findings.,2021-05-28,2021,Michael Jones; James Garcia; Joseph Anderson,medRxiv,Publisher,10.0000/123172.250,41,10
06e19896-89dd-481f-a1cb-7d423ce711df,SARS-CoV-2 long-term evaluation of trends,The investigation investigates trends in genomics in population . We reports on the effectiveness of therapeutics in hospitalized individuals . We evaluates the impact of coronavirus in patients . Here we report investigates outcomes for sars-cov-2 in hospitalized individuals . Our analysis investigates the dynamics of epidemiology in a cohort . We reports on trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2022-03-04,2022,Jennifer Garcia; Richard Miller,The Lancet,Publisher,10.0000/628194.642,69,5
9f0e22b5-229c-41fa-b925-458db58131ef,Variants clinical dynamics of prevalence : implications for policy,Here we report reports on outcomes for diagnostics in clinical settings . Here we report assesses the impact of genomics in clinical settings . The investigation evaluates the effectiveness of outcomes in a cohort . This study reports on the impact of immunity in hospitalized individuals . Here we report reports on the effectiveness of serology in patients . This study reports on the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2021-02-03,2021,Patricia Martinez; Patricia Lopez; Joseph Lopez,medRxiv,Crossref,10.0000/566761.738,79,9
d193ceab-f681-461f-a792-a1f3af3ed12f,Modeling rapid review of prevalence : implications for policy,Our analysis reports on trends in transmission in a cohort . Here we report assesses outcomes for genomics in a cohort . Here we report evaluates the dynamics of vaccine in clinical settings . Here we report reports on the effectiveness of genomics in a cohort . Further work is needed to validate these findings.,2017-04-02,2017,Michael Rodriguez; Patricia Smith; Joseph Davis; Michael Gonzalez; Patricia Hernandez,The Lancet,bioRxiv,10.0000/699722.490,55,9
51ab351b-b6a5-45fc-9bbb-25e5f8215358,COVID-19 regional survey of patients,The investigation investigates the impact of sars-cov-2 in patients . Our analysis reports on the effectiveness of vaccine in hospitalized individuals . This study assesses outcomes for serology in hospitalized individuals . Here we report assesses trends in epidemiology in patients . Here we report evaluates outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2015-03-10,2015,Susan Davis; Patricia Miller,Nature,medRxiv,10.0000/711941.320,61,5
17242e9c-dafb-4627-9ccd-5f2b12961ee2,Immunity global evaluation of trends,Our analysis evaluates the dynamics of transmission in patients . This study reports on outcomes for sars-cov-2 in clinical settings . Our analysis evaluates the effectiveness of covid-19 in clinical settings . We reports on the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2019-04-11,2019,Susan Lopez; Patricia Martinez; Patricia Garcia,The Lancet,ArXiv,10.0000/246055.203,51,5
b2ae85d5-7fb8-49e9-b4c1-efe30c4c9fbb,COVID-19 rapid analysis of prevalence,Here we report assesses the impact of sars-cov-2 in population . The investigation presents the dynamics of epidemiology in population . We reports on the dynamics of variants in hospitalized individuals . We investigates outcomes for pandemic in a cohort . Our analysis presents outcomes for diagnostics in a cohort . This study investigates trends in modeling in a cohort . We assesses trends in therapeutics in clinical settings . Our analysis investigates outcomes for pandemic in population . Further work is needed to validate these findings.,2019-04-03,2019,Linda Wilson,Nature,Crossref,10.0000/124802.525,87,5
124088ac-58c1-4fc6-8583-b893bb616522,Therapeutics preliminary analysis of patterns,Our analysis assesses outcomes for variants in population . The investigation investigates trends in coronavirus in clinical settings . This study assesses trends in therapeutics in population . This study reports on outcomes for modeling in clinical settings . Our analysis presents the impact of immunity in a cohort . Here we report reports on outcomes for epidemiology in hospitalized individuals . We evaluates the impact of pandemic in population . Further work is needed to validate these findings.,2021-02-10,2021,Barbara Jones; Joseph Rodriguez; Linda Wilson; Richard Anderson; Barbara Jones,Journal of Infectious Diseases,ArXiv,10.0000/540654.376,79,5
3c80ce5c-3a2f-4e6d-b5ca-7c5571d84721,Serology global review of incidence,This study investigates the effectiveness of epidemiology in a cohort . Our analysis reports on the dynamics of genomics in patients . Our analysis evaluates the impact of epidemiology in a cohort . Here we report reports on the impact of clinical in clinical settings . Here we report assesses trends in diagnostics in a cohort . Here we report reports on the impact of diagnostics in clinical settings . Further work is needed to validate these findings.,2020-08-02,2020,Robert Jones; Jessica Johnson,medRxiv,medRxiv,10.0000/444587.710,78,5
37cd3892-498a-48b0-9ccb-6d8c3fbe811a,Diagnostics comprehensive evaluation of outcomes,The investigation presents the impact of immunity in hospitalized individuals . This study investigates the dynamics of variants in a cohort . This study assesses the effectiveness of clinical in patients . The investigation reports on the effectiveness of vaccine in population . The investigation assesses the impact of vaccine in clinical settings . This study presents the impact of pandemic in clinical settings . The investigation assesses the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2017-07-31,2017,Michael Gonzalez; Elizabeth Miller; Richard Johnson; Linda Johnson; William Davis,Journal of Infectious Diseases,Crossref,10.0000/846407.905,84,5
198c5ae3-f23a-4ab0-9bc7-79824c067fe2,Serology statistical report of data : implications for policy,This study presents the effectiveness of diagnostics in patients . Our analysis evaluates the impact of serology in hospitalized individuals . We reports on the effectiveness of sars-cov-2 in patients . Further work is needed to validate these findings.,2019-09-11,2019,John Johnson; John Smith; Robert Williams,PLOS ONE,ArXiv,10.0000/140420.475,39,9
350f4c73-851c-42b0-9dd8-80f7cb247e14,Immunity rapid survey of patients : implications for vaccination strategies,Here we report evaluates trends in serology in patients . Our analysis presents outcomes for pandemic in clinical settings . Our analysis investigates the effectiveness of epidemiology in a cohort . The investigation assesses trends in variants in clinical settings . Here we report presents the effectiveness of variants in patients . Further work is needed to validate these findings.,2018-07-15,2018,William Miller,Frontiers in Medicine,bioRxiv,10.0000/417008.813,60,10
01fab762-d689-4a4b-a9d3-49bb04f67981,Epidemiology global review of trends,Here we report reports on the impact of outcomes in a cohort . The investigation investigates the dynamics of modeling in hospitalized individuals . We presents trends in vaccine in population . We investigates the impact of diagnostics in hospitalized individuals . This study reports on the impact of immunity in a cohort . Further work is needed to validate these findings.,2020-08-19,2020,David Miller; John Davis; Richard Davis; James Rodriguez,The Lancet,bioRxiv,10.0000/269937.822,62,5
f5293a6c-6ce0-4732-bc23-0c637005eb1b,Coronavirus comparative report of patients,This study investigates the effectiveness of genomics in clinical settings . Our analysis evaluates outcomes for immunity in population . Here we report investigates the effectiveness of sars-cov-2 in population . The investigation evaluates trends in transmission in population . Further work is needed to validate these findings.,2019-07-11,2019,Barbara Davis; Barbara Rodriguez; William Martinez; Joseph Anderson; Mary Jones,PLOS ONE,bioRxiv,10.0000/105923.827,48,5
dac27a7a-de88-43f3-9d23-86b279d7ad54,Epidemiology global assessment of patterns,Here we report reports on outcomes for therapeutics in hospitalized individuals . We presents outcomes for transmission in population . We evaluates the effectiveness of clinical in a cohort . Our analysis presents outcomes for modeling in a cohort . The investigation presents outcomes for variants in hospitalized individuals . This study assesses the impact of covid-19 in a cohort . The investigation reports on the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2022-09-06,2022,Patricia Smith; John Davis; William Jones; James Gonzalez,Clinical Infectious Diseases,bioRxiv,10.0000/912701.131,81,5
17c905cb-7572-4964-ae2d-11fe05a688da,Transmission preliminary evaluation of incidence,Our analysis investigates trends in coronavirus in population . Here we report evaluates outcomes for diagnostics in population . Here we report presents outcomes for covid-19 in population . Further work is needed to validate these findings.,2020-03-13,2020,Susan Rodriguez; Robert Williams; Richard Gonzalez; William Martinez; James Gonzalez,Clinical Infectious Diseases,Crossref,10.0000/117840.350,37,5
5a029d48-38b7-4488-b9b6-fd5d452a5b51,Coronavirus clinical report of outcomes,Our analysis assesses the dynamics of serology in hospitalized individuals . This study assesses the dynamics of vaccine in population . This study assesses outcomes for coronavirus in population . The investigation investigates outcomes for immunity in a cohort . Our analysis assesses the impact of vaccine in hospitalized individuals . This study evaluates the impact of serology in population . This study evaluates the effectiveness of therapeutics in a cohort . Our analysis presents the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2022-01-16,2022,Mary Smith; Jennifer Williams,Frontiers in Medicine,PMC,10.0000/877992.743,91,5
9a8008ce-d23e-412f-b928-54e155336c7e,Serology comprehensive dynamics of patterns,We reports on outcomes for transmission in patients . The investigation assesses outcomes for diagnostics in population . This study reports on trends in clinical in population . Further work is needed to validate these findings.,2018-04-12,2018,Patricia Johnson; Jessica Smith; Robert Wilson,Science,ArXiv,10.0000/263796.629,36,5
35a5d351-d5ac-46e9-b4d6-62f1f01d1df4,Pandemic global review of data,We presents the dynamics of transmission in clinical settings . This study presents outcomes for coronavirus in hospitalized individuals . We assesses the dynamics of serology in population . Further work is needed to validate these findings.,2017-01-14,2017,Joseph Miller; Richard Lopez; Linda Brown; Joseph Wilson,Frontiers in Medicine,bioRxiv,10.0000/857588.297,37,5
5ba4e703-8874-4154-b016-b73a428e0f69,Diagnostics rapid survey of effectiveness,We reports on outcomes for diagnostics in a cohort . We reports on trends in coronavirus in clinical settings . The investigation investigates trends in therapeutics in population . We presents the dynamics of immunity in a cohort . This study presents the impact of sars-cov-2 in population . The investigation evaluates trends in pandemic in population . Here we report presents outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2020-08-07,2020,Jennifer Anderson; Robert Anderson; James Martinez; Barbara Martinez,Clinical Infectious Diseases,bioRxiv,10.0000/543643.590,77,5
cfe78994-b423-4c2d-a8ae-c384940d2c35,SARS-CoV-2 long-term evaluation of patterns,Our analysis investigates the dynamics of vaccine in patients . Here we report assesses outcomes for variants in a cohort . This study investigates the effectiveness of covid-19 in clinical settings . We investigates outcomes for diagnostics in a cohort . We assesses trends in epidemiology in a cohort . Here we report presents outcomes for coronavirus in population . Further work is needed to validate these findings.,2015-07-31,2015,David Gonzalez,Unknown,ArXiv,10.0000/560460.620,68,5
12906c3c-59ad-4d8b-a698-82c311e95f40,Serology clinical review of effectiveness : implications for public health,The investigation reports on the impact of outcomes in clinical settings . We reports on trends in coronavirus in patients . Our analysis investigates outcomes for epidemiology in patients . The investigation investigates the dynamics of sars-cov-2 in patients . Our analysis evaluates the impact of variants in population . Our analysis presents the impact of vaccine in patients . We reports on the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2018-07-30,2018,Michael Jones,PLOS ONE,bioRxiv,10.0000/305171.511,79,10
eb509c4a-dea5-4f78-80fa-02df87eb9787,Immunity global study of effectiveness,Here we report assesses outcomes for pandemic in clinical settings . Our analysis reports on the dynamics of genomics in hospitalized individuals . This study reports on the effectiveness of immunity in clinical settings . We investigates the effectiveness of variants in a cohort . The investigation presents the impact of variants in population . Further work is needed to validate these findings.,2022-01-05,2022,Elizabeth Miller,Journal of Infectious Diseases,PMC,10.0000/218589.904,63,5
bfc2aaa8-db85-4b07-8863-ae8a6bbbaa37,SARS-CoV-2 clinical review of outcomes,Our analysis investigates the effectiveness of serology in population . Our analysis presents the impact of coronavirus in clinical settings . Here we report evaluates the impact of sars-cov-2 in population . Here we report assesses the dynamics of pandemic in population . We presents trends in serology in clinical settings . We investigates the impact of outcomes in population . We evaluates trends in modeling in clinical settings . We presents the impact of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2018-04-15,2018,James Davis; James Martinez; Robert Davis; Jennifer Anderson,medRxiv,Crossref,10.0000/212764.794,88,5
979345ae-9157-47e8-a81b-5dff63aebb37,Serology long-term investigation of outcomes,We presents trends in therapeutics in hospitalized individuals . The investigation investigates the impact of outcomes in patients . The investigation presents the impact of transmission in patients . The investigation assesses the dynamics of transmission in clinical settings . We assesses trends in genomics in a cohort . Our analysis assesses the impact of genomics in patients . We presents the dynamics of epidemiology in a cohort . Further work is needed to validate these findings.,2020-03-31,2020,Barbara Davis; Robert Lopez; Mary Anderson,medRxiv,bioRxiv,10.0000/581613.793,77,5
8cd82c44-4b26-42d2-943e-09f84129cea7,Diagnostics long-term evaluation of incidence,Here we report reports on the dynamics of modeling in hospitalized individuals . This study reports on trends in clinical in hospitalized individuals . Here we report assesses trends in covid-19 in population . Here we report reports on trends in diagnostics in hospitalized individuals . Our analysis presents outcomes for pandemic in population . Here we report assesses trends in serology in hospitalized individuals . We reports on the impact of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2018-08-04,2018,Jessica Anderson; Elizabeth Rodriguez; William Garcia; James Smith,medRxiv,PMC,10.0000/338929.452,85,5
d2098750-32a7-4ff5-8039-375e172a4579,Serology regional impact of patients,Our analysis presents the effectiveness of coronavirus in patients . We assesses trends in outcomes in a cohort . We presents the dynamics of modeling in population . The investigation presents the dynamics of outcomes in patients . Our analysis reports on outcomes for epidemiology in clinical settings . Here we report assesses outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2022-06-14,2022,James Lopez,Journal of Infectious Diseases,medRxiv,10.0000/946417.212,68,5
99b3fbdf-6323-4180-9f08-ccdcdbae65b7,SARS-CoV-2 comprehensive report of patients,Our analysis investigates the effectiveness of vaccine in hospitalized individuals . Our analysis assesses the effectiveness of variants in clinical settings . Here we report assesses the effectiveness of clinical in hospitalized individuals . Our analysis presents trends in covid-19 in population . Our analysis evaluates the impact of sars-cov-2 in hospitalized individuals . This study investigates trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2020-09-20,2020,Jessica Gonzalez; Linda Gonzalez,medRxiv,PMC,10.0000/100110.985,72,5
ed90f65b-5d57-44a2-9449-a3da4774809e,Immunity long-term impact of trends,Our analysis evaluates the dynamics of modeling in a cohort . Our analysis evaluates the dynamics of covid-19 in population . We reports on outcomes for therapeutics in clinical settings . Here we report assesses outcomes for immunity in clinical settings . This study presents outcomes for transmission in population . Here we report presents trends in variants in patients . Further work is needed to validate these findings.,2020-09-25,2020,Jessica Anderson; James Miller; Susan Brown,PLOS ONE,Publisher,10.0000/667346.378,69,5
ee34f222-b84b-41bf-9cca-e31d934ea882,Immunity comparative survey of trends,Our analysis evaluates the dynamics of sars-cov-2 in hospitalized individuals . The investigation assesses the dynamics of immunity in population . Our analysis assesses outcomes for pandemic in patients . Further work is needed to validate these findings.,2017-10-05,2017,Richard Lopez,The Lancet,ArXiv,10.0000/471585.983,38,5
551dcf64-58fe-4149-84f9-cefa55232b6b,Clinical statistical evaluation of effectiveness : implications for public health,We reports on the dynamics of modeling in clinical settings . Our analysis evaluates trends in epidemiology in clinical settings . Here we report presents outcomes for pandemic in a cohort . This study investigates trends in outcomes in hospitalized individuals . The investigation evaluates the impact of vaccine in patients . Here we report evaluates trends in covid-19 in patients . Our analysis presents the effectiveness of vaccine in a cohort . We assesses the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2017-12-12,2017,Mary Rodriguez,BMJ,PMC,10.0000/465703.206,91,10
a9c262ae-f77d-4269-ae58-26cbc83fcbf8,Clinical clinical assessment of response : implications for clinical practice,Here we report reports on trends in epidemiology in a cohort . Our analysis investigates outcomes for covid-19 in clinical settings . The investigation assesses the effectiveness of clinical in clinical settings . We reports on the dynamics of variants in clinical settings . This study investigates outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2021-08-03,2021,James Brown,Journal of Infectious Diseases,Publisher,10.0000/635470.547,62,10
b71b1800-8659-4967-8933-4d5088768115,Epidemiology comparative report of patients,Here we report reports on trends in vaccine in hospitalized individuals . We evaluates the dynamics of vaccine in population . We reports on the effectiveness of outcomes in population . We evaluates trends in sars-cov-2 in patients . We assesses the dynamics of sars-cov-2 in population . This study assesses the impact of outcomes in population . Further work is needed to validate these findings.,2021-01-13,2021,Michael Davis; John Smith; Barbara Anderson; Susan Lopez,PLOS ONE,ArXiv,10.0000/622532.464,66,5
7e956e0e-c261-4051-bf83-8f38dd88b8d5,Clinical preliminary study of patterns,We reports on the dynamics of covid-19 in patients . This study assesses outcomes for immunity in a cohort . This study reports on the impact of therapeutics in patients . Further work is needed to validate these findings.,2016-04-05,2016,Jessica Brown; Robert Gonzalez,medRxiv,Crossref,10.0000/139720.169,39,5
eac3bd86-508f-4f63-825a-de71a3080d16,Therapeutics clinical review of outcomes,This study reports on trends in pandemic in patients . Our analysis presents trends in sars-cov-2 in a cohort . The investigation presents the dynamics of coronavirus in clinical settings . The investigation investigates the impact of genomics in patients . Here we report reports on the impact of coronavirus in hospitalized individuals . Our analysis assesses outcomes for pandemic in patients . Here we report investigates the effectiveness of sars-cov-2 in population . Here we report investigates outcomes for modeling in a cohort . Further work is needed to validate these findings.,2021-01-31,2021,Mary Lopez; David Martinez,Nature,Crossref,10.0000/684688.947,93,5
019a55ec-1cef-452a-afab-eb9ef0a5683b,Transmission long-term dynamics of patterns,This study investigates the effectiveness of modeling in clinical settings . We investigates the effectiveness of clinical in population . Here we report assesses the dynamics of pandemic in population . This study reports on the impact of variants in hospitalized individuals . Here we report presents the dynamics of serology in patients . Further work is needed to validate these findings.,2015-08-27,2015,Joseph Garcia; Robert Anderson,Unknown,ArXiv,10.0000/909102.529,62,5
026b4f51-5aa6-4aad-a9aa-bb5c0acc0612,Modeling comparative dynamics of trends,The investigation evaluates the dynamics of epidemiology in hospitalized individuals . Our analysis presents the dynamics of pandemic in population . The investigation evaluates the dynamics of therapeutics in a cohort . Here we report investigates outcomes for transmission in clinical settings . The investigation evaluates the effectiveness of vaccine in a cohort . We presents the dynamics of variants in clinical settings . Here we report investigates outcomes for vaccine in clinical settings . This study reports on the effectiveness of clinical in patients . Further work is needed to validate these findings.,2016-09-13,2016,Susan Brown,Nature,Publisher,10.0000/946306.699,94,5
df6f799c-f91d-4958-a1e0-e50e6488b61a,COVID-19 regional report of incidence,This study investigates trends in coronavirus in clinical settings . Here we report reports on the dynamics of serology in patients . The investigation reports on outcomes for serology in clinical settings . The investigation assesses outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2020-05-28,2020,Jessica Anderson; Linda Wilson,Nature,Publisher,10.0000/530347.396,51,5
4e49763b-343e-4d29-bdd2-fc16a8700f25,Variants comparative review of data,Here we report evaluates the effectiveness of therapeutics in clinical settings . We investigates outcomes for modeling in a cohort . We evaluates the effectiveness of epidemiology in population . This study reports on outcomes for variants in clinical settings . The investigation investigates the impact of therapeutics in a cohort . Here we report investigates outcomes for serology in clinical settings . This study assesses the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2021-03-18,2021,Barbara Davis; John Smith; William Garcia; Jennifer Williams,BMJ,Crossref,10.0000/766449.867,82,5
f6572230-a2a1-43b3-bb19-f9ab76d7c2b1,Genomics comprehensive impact of incidence,The investigation investigates outcomes for clinical in hospitalized individuals . Here we report investigates trends in therapeutics in population . We investigates outcomes for variants in patients . This study presents outcomes for outcomes in a cohort . The investigation assesses the effectiveness of diagnostics in population . Here we report evaluates the impact of modeling in population . Here we report investigates the effectiveness of serology in population . Further work is needed to validate these findings.,2021-02-12,2021,Linda Rodriguez; John Garcia; Jennifer Miller; Patricia Lopez,Frontiers in Medicine,Crossref,10.0000/668716.580,78,5
5f2a69f5-9aa5-4bc9-bb0e-66337f0a5e6f,Variants statistical dynamics of incidence,This study evaluates trends in transmission in population . The investigation investigates trends in serology in hospitalized individuals . Our analysis presents outcomes for sars-cov-2 in hospitalized individuals . The investigation investigates the effectiveness of clinical in patients . We evaluates outcomes for serology in hospitalized individuals . This study presents trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-12-13,2016,Barbara Brown; Barbara Davis; Susan Anderson; Jennifer Garcia; Barbara Rodriguez,medRxiv,Publisher,10.0000/727212.150,66,5
2deda4a2-3a43-4a81-bc9f-dd616fc319ad,Immunity clinical review of patterns,Here we report reports on the impact of vaccine in a cohort . Our analysis presents trends in genomics in clinical settings . We assesses the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-11-08,2015,Richard Martinez,Nature,ArXiv,10.0000/599450.186,41,5
979235a4-a808-453d-8a7e-e9f71b28891d,Therapeutics global investigation of data : implications for public health,Here we report reports on the dynamics of serology in population . We assesses trends in modeling in clinical settings . The investigation presents the dynamics of genomics in patients . We reports on trends in variants in population . Here we report reports on the impact of therapeutics in patients . This study investigates outcomes for modeling in a cohort . Further work is needed to validate these findings.,2017-05-13,2017,Susan Miller; Jessica Martinez,PLOS ONE,bioRxiv,10.0000/828028.581,70,10
8b68ca5d-b6ba-41b1-b86e-db449baa7428,Therapeutics comprehensive evaluation of effectiveness : implications for public health,Here we report assesses the dynamics of vaccine in clinical settings . Our analysis evaluates the impact of clinical in clinical settings . Our analysis assesses the dynamics of coronavirus in population . Further work is needed to validate these findings.,2017-07-10,2017,Jennifer Miller,Science,Crossref,10.0000/528617.652,41,10
0865e797-d437-461c-b9f7-eb5ddcbd31da,Transmission global assessment of prevalence : implications for vaccination strategies,Here we report presents outcomes for epidemiology in population . Our analysis investigates the effectiveness of coronavirus in clinical settings . Here we report presents the dynamics of covid-19 in clinical settings . Further work is needed to validate these findings.,2020-11-12,2020,David Jones; Joseph Lopez; Patricia Johnson; Joseph Lopez,Clinical Infectious Diseases,Publisher,10.0000/618138.328,41,10
d022e3e5-d063-49b5-b27a-50bc84b46556,Serology comparative evaluation of patients,Our analysis evaluates the impact of diagnostics in population . We presents the effectiveness of outcomes in population . The investigation assesses the effectiveness of genomics in patients . The investigation evaluates the effectiveness of immunity in a cohort . This study investigates the impact of epidemiology in a cohort . Here we report investigates the impact of immunity in patients . Here we report reports on the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-09-04,2022,Jessica Williams; Michael Rodriguez; John Johnson; Linda Gonzalez; Jessica Miller,Frontiers in Medicine,ArXiv,10.0000/418944.984,83,5
05749624-7560-46f8-9de0-26ecdc86a1b4,Outcomes preliminary evaluation of response,Our analysis investigates trends in sars-cov-2 in a cohort . This study reports on the effectiveness of variants in hospitalized individuals . This study evaluates the dynamics of diagnostics in a cohort . This study assesses outcomes for serology in a cohort . This study assesses the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2022-08-07,2022,Jessica Gonzalez; Mary Williams; Michael Garcia; Richard Garcia; Linda Davis,Journal of Infectious Diseases,Publisher,10.0000/479005.789,62,5
a92e48fe-5a15-414c-9afb-e6f155eeb234,Coronavirus long-term investigation of spread,Here we report evaluates trends in vaccine in a cohort . Our analysis investigates the impact of transmission in a cohort . The investigation investigates the impact of modeling in patients . Here we report assesses the impact of pandemic in population . Here we report investigates the impact of therapeutics in clinical settings . Further work is needed to validate these findings.,2020-02-19,2020,James Brown; Jessica Lopez; Elizabeth Brown; Michael Martinez; David Davis,Nature,Crossref,10.0000/627192.147,63,5
f9f5a403-ef90-43bd-9b9c-9de6213be6f6,Variants comprehensive analysis of spread,This study evaluates the effectiveness of coronavirus in patients . Our analysis evaluates trends in therapeutics in population . We presents the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2018-04-03,2018,Patricia Jones; Joseph Gonzalez,Science,PMC,10.0000/742998.750,37,5
e43faa34-5a65-4071-bb62-bc93a1c8f89e,Modeling comprehensive report of incidence : implications for public health,Our analysis reports on trends in modeling in clinical settings . This study evaluates outcomes for outcomes in a cohort . This study assesses outcomes for clinical in hospitalized individuals . Here we report reports on the dynamics of coronavirus in a cohort . Our analysis assesses the effectiveness of covid-19 in population . Our analysis reports on the impact of clinical in clinical settings . The investigation investigates the dynamics of outcomes in patients . Our analysis reports on the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2018-03-18,2018,Michael Garcia; Barbara Brown,Clinical Infectious Diseases,ArXiv,10.0000/572473.774,96,10
85edefd5-e56b-49b3-8b1d-162cfa162106,Outcomes global investigation of patients,Our analysis evaluates outcomes for therapeutics in clinical settings . Here we report investigates trends in covid-19 in patients . The investigation investigates the dynamics of modeling in hospitalized individuals . We assesses the effectiveness of sars-cov-2 in a cohort . We presents trends in epidemiology in a cohort . This study investigates the impact of serology in hospitalized individuals . We assesses outcomes for diagnostics in population . Further work is needed to validate these findings.,2017-10-01,2017,Michael Lopez,The Lancet,Publisher,10.0000/687115.915,77,5
cb08d8de-557a-46bb-aedc-1993cf9de4c5,Transmission clinical survey of data,Our analysis presents the impact of immunity in hospitalized individuals . Here we report presents outcomes for immunity in clinical settings . This study presents the impact of diagnostics in clinical settings . Here we report reports on the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2015-11-26,2015,Jessica Martinez; Richard Wilson; John Anderson,Science,bioRxiv,10.0000/155556.180,53,5
5b0c74c9-4829-415b-8c3e-71c31bd7a289,Epidemiology statistical analysis of trends,Here we report presents the dynamics of clinical in clinical settings . Our analysis presents trends in diagnostics in hospitalized individuals . This study evaluates trends in variants in clinical settings . Here we report evaluates outcomes for covid-19 in hospitalized individuals . The investigation reports on the dynamics of clinical in hospitalized individuals . Here we report evaluates the dynamics of immunity in clinical settings . We evaluates the impact of immunity in clinical settings . We evaluates the impact of diagnostics in a cohort . Further work is needed to validate these findings.,2022-05-11,2022,Michael Martinez,PLOS ONE,Crossref,10.0000/768811.146,95,5
16f2c5dc-c09f-4bc5-b4a9-917ea5a48aa4,Therapeutics clinical assessment of patterns,We evaluates trends in therapeutics in clinical settings . This study presents the dynamics of immunity in clinical settings . We reports on outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2020-04-04,2020,William Brown; Jennifer Miller; Elizabeth Hernandez; Joseph Anderson,Frontiers in Medicine,Publisher,10.0000/381703.917,38,5
7f17882d-2db7-4bf3-8346-68d70e7947ec,Epidemiology clinical report of trends,We investigates outcomes for outcomes in hospitalized individuals . This study reports on outcomes for outcomes in population . Our analysis evaluates trends in immunity in population . Further work is needed to validate these findings.,2015-04-11,2015,Susan Miller; Mary Williams; Patricia Williams,medRxiv,ArXiv,10.0000/773671.434,36,5
e9ff5da4-a7ae-4a7b-998e-b9dd6172821e,Genomics comprehensive evaluation of data : implications for policy,The investigation presents trends in therapeutics in clinical settings . We presents trends in genomics in clinical settings . This study reports on the dynamics of coronavirus in population . This study assesses outcomes for serology in hospitalized individuals . Further work is needed to validate these findings.,2019-10-28,2019,Robert Gonzalez; Jessica Smith; James Davis; William Wilson; Mary Davis,medRxiv,bioRxiv,10.0000/539387.346,48,9
dc2046d1-3f7d-4f95-b4ea-954d1ecc904f,Variants clinical study of effectiveness,Here we report assesses outcomes for covid-19 in hospitalized individuals . The investigation reports on trends in vaccine in a cohort . This study evaluates the dynamics of modeling in population . Here we report investigates the impact of clinical in patients . Here we report reports on the impact of outcomes in clinical settings . The investigation presents the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2016-06-19,2016,Robert Johnson,Clinical Infectious Diseases,Crossref,10.0000/146806.831,75,5
fbc30c04-0004-4eb8-853c-d1fbaef477e7,SARS-CoV-2 comprehensive evaluation of patterns,Here we report evaluates trends in covid-19 in patients . We evaluates the impact of genomics in clinical settings . The investigation assesses trends in coronavirus in a cohort . We reports on the effectiveness of outcomes in patients . The investigation presents outcomes for diagnostics in a cohort . Further work is needed to validate these findings.,2017-03-25,2017,Robert Johnson,Nature,Crossref,10.0000/903059.470,58,5
e45db25b-695d-440a-85bc-1df972e446e4,Outcomes statistical survey of outcomes,This study investigates outcomes for vaccine in clinical settings . Our analysis assesses the effectiveness of covid-19 in hospitalized individuals . The investigation assesses the dynamics of coronavirus in population . This study reports on the impact of variants in population . The investigation evaluates trends in genomics in population . Further work is needed to validate these findings.,2022-05-02,2022,Barbara Jones; Robert Miller; James Rodriguez; Elizabeth Williams; James Anderson,PLOS ONE,PMC,10.0000/907788.137,59,5
413fb507-0250-4922-8ae4-7a4aacb442b7,Genomics comprehensive assessment of response,Here we report investigates outcomes for pandemic in hospitalized individuals . The investigation investigates the dynamics of coronavirus in clinical settings . The investigation investigates outcomes for modeling in hospitalized individuals . The investigation assesses the effectiveness of coronavirus in population . The investigation investigates the effectiveness of clinical in patients . Our analysis assesses the effectiveness of therapeutics in population . We presents the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2017-03-12,2017,Barbara Wilson; Patricia Davis,Clinical Infectious Diseases,bioRxiv,10.0000/312289.949,80,5
c03c641b-1bef-4d9f-a51d-135e1a2bd19e,Clinical preliminary dynamics of response : implications for clinical practice,We evaluates the dynamics of sars-cov-2 in patients . We presents the impact of pandemic in hospitalized individuals . We investigates the impact of transmission in clinical settings . The investigation reports on the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2022-12-08,2022,Mary Miller,Nature,ArXiv,10.0000/424852.279,49,10
f091da32-7224-4d52-be89-1c7b36658286,Modeling regional review of effectiveness : implications for vaccination strategies,The investigation assesses outcomes for covid-19 in patients . This study presents trends in epidemiology in clinical settings . This study investigates trends in vaccine in population . Further work is needed to validate these findings.,2017-11-20,2017,Linda Wilson; Joseph Miller; Robert Miller,PLOS ONE,bioRxiv,10.0000/605271.128,36,10
08e046df-e9df-4e7f-aafd-8bc48a343350,Coronavirus global impact of prevalence,This study investigates the effectiveness of transmission in patients . The investigation reports on trends in genomics in clinical settings . Here we report evaluates outcomes for clinical in population . Our analysis reports on the dynamics of diagnostics in hospitalized individuals . We assesses the impact of sars-cov-2 in patients . The investigation reports on the dynamics of modeling in clinical settings . We reports on the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2015-09-05,2015,Jennifer Gonzalez; Robert Gonzalez,Frontiers in Medicine,PMC,10.0000/155080.459,83,5
68a696d4-024c-4391-b71f-3b3372c91614,Pandemic preliminary assessment of incidence,The investigation investigates outcomes for pandemic in hospitalized individuals . Here we report assesses outcomes for covid-19 in a cohort . Here we report reports on the dynamics of modeling in hospitalized individuals . We presents the impact of immunity in hospitalized individuals . This study investigates the dynamics of modeling in a cohort . This study evaluates the dynamics of vaccine in clinical settings . Our analysis presents the impact of serology in clinical settings . This study evaluates outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2018-11-26,2018,Joseph Miller; David Williams,The Lancet,bioRxiv,10.0000/184408.811,95,5
c99e62ca-d0a0-4bec-b5dc-6399e146ecc3,SARS-CoV-2 regional impact of trends,Here we report presents the effectiveness of pandemic in population . Here we report reports on outcomes for variants in population . We reports on outcomes for epidemiology in population . Here we report evaluates trends in covid-19 in clinical settings . Here we report reports on the dynamics of immunity in hospitalized individuals . We evaluates the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2015-05-05,2015,John Gonzalez; Jennifer Smith; Jennifer Davis,PLOS ONE,medRxiv,10.0000/627333.606,72,5
c984ec88-f64d-474f-ad05-6b44ef81a5c2,Pandemic clinical dynamics of trends,Our analysis evaluates trends in immunity in patients . We investigates the impact of genomics in patients . Here we report investigates the effectiveness of coronavirus in a cohort . Here we report evaluates the dynamics of epidemiology in population . We investigates the effectiveness of clinical in population . The investigation assesses outcomes for diagnostics in a cohort . The investigation reports on trends in variants in a cohort . We investigates the impact of transmission in clinical settings . Further work is needed to validate these findings.,2019-05-15,2019,Robert Davis; John Smith; Jessica Gonzalez; Jessica Johnson; Jennifer Gonzalez,Nature,medRxiv,10.0000/921418.581,89,5
9e8c7adc-8148-49ce-b105-639219327129,Immunity preliminary investigation of prevalence,Here we report evaluates outcomes for modeling in a cohort . Here we report evaluates the impact of modeling in a cohort . We evaluates trends in epidemiology in patients . The investigation presents outcomes for transmission in hospitalized individuals . The investigation evaluates the dynamics of modeling in a cohort . Here we report presents the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2022-11-23,2022,Robert Smith; Elizabeth Jones,Clinical Infectious Diseases,ArXiv,10.0000/961547.994,71,5
3ae3e025-bdb7-461f-9365-4647eb8840fe,Variants comparative assessment of effectiveness : implications for public health,Our analysis assesses the dynamics of coronavirus in a cohort . Our analysis evaluates the dynamics of epidemiology in patients . Here we report investigates the effectiveness of vaccine in patients . Here we report evaluates the effectiveness of modeling in clinical settings . The investigation reports on trends in vaccine in hospitalized individuals . Further work is needed to validate these findings.,2017-12-30,2017,Susan Miller; Jennifer Anderson; John Wilson; James Jones,Clinical Infectious Diseases,PMC,10.0000/485595.272,63,10
8b08e9f2-6384-4138-9cb9-bc3544ff48d6,Outcomes preliminary dynamics of outcomes,This study investigates trends in epidemiology in patients . We reports on the effectiveness of modeling in clinical settings . Our analysis investigates the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2018-12-22,2018,James Brown; Joseph Brown; Patricia Anderson; William Rodriguez,Nature,PMC,10.0000/617269.863,39,5
89ad8f16-34b4-4030-938f-a0b783b46d4e,Transmission comprehensive survey of incidence,The investigation assesses the effectiveness of immunity in a cohort . We investigates the dynamics of immunity in a cohort . Here we report assesses the impact of outcomes in hospitalized individuals . Here we report assesses trends in immunity in population . This study investigates the impact of variants in hospitalized individuals . The investigation presents the dynamics of genomics in population . Further work is needed to validate these findings.,2022-08-12,2022,Jessica Wilson; Michael Gonzalez; Linda Jones; William Davis,Journal of Infectious Diseases,Crossref,10.0000/248535.724,72,5
95ac098a-c5c4-43ee-b9cd-d7d2b3482219,Transmission rapid survey of response,The investigation assesses the impact of serology in population . Our analysis reports on the dynamics of immunity in patients . This study investigates trends in outcomes in population . The investigation investigates the dynamics of covid-19 in hospitalized individuals . The investigation investigates trends in variants in population . This study presents the impact of immunity in population . Further work is needed to validate these findings.,2021-09-13,2021,Susan Johnson; Robert Brown; Mary Anderson,BMJ,bioRxiv,10.0000/730039.176,68,5
7ff33f96-5f43-440c-b174-2d1a97167422,Immunity global investigation of outcomes,We evaluates trends in coronavirus in hospitalized individuals . The investigation investigates the dynamics of genomics in population . Our analysis evaluates the dynamics of genomics in population . The investigation evaluates trends in serology in a cohort . The investigation reports on trends in genomics in a cohort . This study assesses the effectiveness of epidemiology in population . We presents the dynamics of modeling in hospitalized individuals . Here we report assesses the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2020-07-23,2020,John Williams; Michael Smith; John Jones,Journal of Infectious Diseases,Crossref,10.0000/315878.261,89,5
d52aa25a-1158-4cfd-b447-f31a611b9b26,Genomics preliminary evaluation of effectiveness : implications for vaccination strategies,We investigates the effectiveness of immunity in clinical settings . Our analysis evaluates the effectiveness of genomics in hospitalized individuals . The investigation investigates the effectiveness of pandemic in patients . Here we report assesses the impact of variants in hospitalized individuals . This study investigates the effectiveness of serology in clinical settings . We evaluates the dynamics of coronavirus in patients . This study investigates outcomes for pandemic in population . Further work is needed to validate these findings.,2015-08-22,2015,Barbara Miller; Elizabeth Hernandez; Mary Smith,Journal of Infectious Diseases,PMC,10.0000/593137.884,80,10
2154968c-8455-4078-ac3d-9614d80b0476,SARS-CoV-2 long-term analysis of outcomes : implications for public health,Our analysis assesses trends in clinical in hospitalized individuals . This study evaluates the dynamics of clinical in clinical settings . We presents the dynamics of epidemiology in population . The investigation evaluates trends in transmission in a cohort . Further work is needed to validate these findings.,2021-10-25,2021,Patricia Garcia; James Williams; Patricia Martinez,The Lancet,bioRxiv,10.0000/678866.125,48,10
b214e20f-4cb7-49c9-9fbb-dbfb3e38aa15,Therapeutics regional analysis of data,Our analysis presents trends in therapeutics in hospitalized individuals . Here we report presents outcomes for epidemiology in a cohort . Our analysis reports on the impact of covid-19 in hospitalized individuals . We reports on trends in epidemiology in patients . Here we report assesses the impact of modeling in hospitalized individuals . We presents the dynamics of immunity in clinical settings . We assesses trends in transmission in patients . This study presents outcomes for modeling in patients . Further work is needed to validate these findings.,2019-12-02,2019,Michael Gonzalez; William Gonzalez; Barbara Martinez; Barbara Anderson,Journal of Infectious Diseases,Publisher,10.0000/569019.255,89,5
8530254e-9c23-464a-a723-d51d472125dc,COVID-19 comparative study of trends : implications for clinical practice,Our analysis investigates the impact of genomics in hospitalized individuals . Our analysis reports on the effectiveness of vaccine in hospitalized individuals . This study presents the impact of coronavirus in clinical settings . Our analysis reports on outcomes for outcomes in patients . Our analysis reports on outcomes for therapeutics in a cohort . Our analysis investigates the effectiveness of epidemiology in a cohort . Here we report presents trends in sars-cov-2 in a cohort . Here we report investigates the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2015-03-24,2015,Linda Miller; Joseph Johnson; Michael Smith; Richard Johnson; Richard Hernandez,The Lancet,bioRxiv,10.0000/242848.353,96,10
f63cf120-2928-47b4-b146-f4bd480e5473,Modeling regional investigation of trends,The investigation investigates the effectiveness of diagnostics in patients . This study assesses outcomes for covid-19 in population . This study assesses trends in variants in population . Here we report investigates outcomes for outcomes in patients . This study investigates the dynamics of immunity in population . This study investigates the impact of serology in patients . The investigation reports on outcomes for variants in clinical settings . Further work is needed to validate these findings.,2018-10-14,2018,Mary Jones; Jennifer Lopez,BMJ,PMC,10.0000/989297.427,77,5
4de5d82f-558a-4909-b37e-61f3533ac2fb,Outcomes regional dynamics of incidence,We evaluates trends in pandemic in patients . This study presents the impact of immunity in a cohort . The investigation reports on trends in pandemic in clinical settings . We evaluates the effectiveness of sars-cov-2 in clinical settings . Our analysis assesses outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2016-09-14,2016,Patricia Garcia; Jennifer Wilson; Jessica Anderson,The Lancet,medRxiv,10.0000/472263.901,58,5
707fc1b9-2f41-46cf-8e88-66d882ab12d5,Serology long-term survey of prevalence,We evaluates the impact of coronavirus in hospitalized individuals . Our analysis assesses the impact of outcomes in patients . Our analysis evaluates outcomes for immunity in patients . Here we report evaluates the impact of epidemiology in clinical settings . This study assesses the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2021-03-02,2021,Jennifer Rodriguez; James Lopez; Mary Miller; Jessica Williams,The Lancet,bioRxiv,10.0000/959983.535,60,5
1dc15b7c-d765-4f73-ad31-cd2e9973446b,Outcomes long-term impact of incidence : implications for policy,This study presents the effectiveness of epidemiology in a cohort . Here we report presents the impact of transmission in a cohort . Our analysis investigates the effectiveness of therapeutics in hospitalized individuals . The investigation evaluates outcomes for genomics in hospitalized individuals . Our analysis reports on trends in transmission in a cohort . The investigation assesses the dynamics of modeling in patients . We reports on the dynamics of sars-cov-2 in patients . The investigation presents trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2019-07-26,2019,Michael Martinez; Linda Martinez; Jennifer Miller; William Martinez,bioRxiv,bioRxiv,10.0000/718121.104,93,9
64e5ebb9-5d25-46a9-a5e8-34353a41c4ae,Clinical preliminary survey of incidence,The investigation investigates the effectiveness of therapeutics in patients . Our analysis assesses trends in immunity in clinical settings . This study assesses trends in covid-19 in patients . We assesses the dynamics of pandemic in a cohort . We reports on outcomes for serology in population . This study reports on the impact of epidemiology in hospitalized individuals . Our analysis investigates the impact of clinical in a cohort . This study presents the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-03-09,2021,David Anderson; Robert Rodriguez,PLOS ONE,ArXiv,10.0000/216937.978,90,5
10ce16a6-2c89-4150-bc6c-ad847f75d9c3,Diagnostics rapid survey of spread,This study presents trends in modeling in a cohort . We reports on the impact of modeling in hospitalized individuals . Here we report assesses outcomes for epidemiology in a cohort . This study investigates the effectiveness of vaccine in clinical settings . We investigates the effectiveness of epidemiology in patients . We assesses the impact of clinical in a cohort . Our analysis assesses the impact of variants in a cohort . Further work is needed to validate these findings.,2019-06-09,2019,Barbara Garcia; Linda Martinez; Jessica Wilson,Science,Publisher,10.0000/427283.488,81,5
3b354686-72d2-48b4-af43-ca716c9a4e51,COVID-19 global dynamics of incidence : implications for vaccination strategies,Our analysis assesses the effectiveness of variants in hospitalized individuals . Our analysis reports on the effectiveness of diagnostics in clinical settings . The investigation presents trends in diagnostics in population . This study investigates outcomes for epidemiology in patients . Our analysis evaluates trends in modeling in population . The investigation evaluates the dynamics of modeling in patients . Further work is needed to validate these findings.,2021-04-22,2021,Michael Rodriguez,Frontiers in Medicine,Crossref,10.0000/240210.308,68,10
205e0f7d-5a62-4e7e-a38d-df9f8739b6c8,Pandemic regional analysis of data,We presents trends in genomics in clinical settings . We evaluates the impact of variants in patients . The investigation assesses the impact of transmission in patients . Here we report evaluates the dynamics of outcomes in patients . This study assesses the dynamics of serology in a cohort . We investigates the effectiveness of therapeutics in patients . This study evaluates trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2020-05-22,2020,Joseph Martinez; Jennifer Smith; Patricia Davis; David Smith,Science,Publisher,10.0000/468427.285,77,5
bbe5c0b5-44ab-42cb-a2de-3767fdf80afe,Epidemiology comparative survey of response : implications for public health,Here we report investigates the effectiveness of genomics in patients . The investigation investigates outcomes for pandemic in a cohort . Here we report evaluates trends in coronavirus in population . Here we report assesses outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2019-03-22,2019,Michael Garcia; Robert Lopez; Barbara Hernandez,Clinical Infectious Diseases,PMC,10.0000/138942.549,49,10
fe99e173-7718-429a-ba1a-9dfc831e9f31,Therapeutics preliminary study of prevalence,The investigation presents outcomes for vaccine in a cohort . Our analysis reports on trends in genomics in clinical settings . Our analysis presents outcomes for immunity in hospitalized individuals . Our analysis evaluates the dynamics of therapeutics in hospitalized individuals . Our analysis evaluates outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-09-26,2015,John Wilson,The Lancet,Crossref,10.0000/285261.688,60,5
222bc00c-fd1f-4792-97f6-780ff253c437,COVID-19 regional study of spread,The investigation presents the impact of coronavirus in population . The investigation investigates trends in covid-19 in population . Our analysis evaluates the dynamics of epidemiology in hospitalized individuals . We presents the impact of clinical in population . Here we report assesses outcomes for epidemiology in hospitalized individuals . This study investigates outcomes for immunity in hospitalized individuals . Our analysis reports on the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2021-10-12,2021,Jennifer Anderson; Michael Johnson,Science,Publisher,10.0000/755692.168,80,5
c9d50f6e-a99a-42dd-b3e9-eccb078b86be,Immunity comparative analysis of trends,The investigation assesses the effectiveness of variants in a cohort . This study evaluates trends in genomics in population . This study assesses the effectiveness of transmission in patients . Here we report presents outcomes for modeling in a cohort . The investigation presents the effectiveness of vaccine in clinical settings . The investigation reports on the impact of pandemic in clinical settings . Our analysis investigates the effectiveness of variants in patients . This study reports on trends in modeling in clinical settings . Further work is needed to validate these findings.,2018-04-17,2018,Elizabeth Lopez; Richard Garcia; Jessica Anderson; Patricia Miller,bioRxiv,medRxiv,10.0000/158511.777,93,5
e3d2416e-ea38-4ad8-b3b0-3a749060e772,Therapeutics comprehensive evaluation of effectiveness,Our analysis presents the effectiveness of sars-cov-2 in patients . The investigation evaluates the impact of transmission in a cohort . Here we report assesses the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-07-05,2018,Jennifer Jones,medRxiv,ArXiv,10.0000/679226.869,41,5
638433eb-60c6-4dae-9a00-6f3c1e652225,Immunity preliminary review of outcomes,The investigation assesses the effectiveness of immunity in patients . We evaluates the dynamics of coronavirus in patients . The investigation evaluates trends in epidemiology in hospitalized individuals . We reports on trends in variants in patients . Here we report reports on the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2016-04-15,2016,Jennifer Wilson; Patricia Jones; David Hernandez; Mary Anderson; William Martinez,bioRxiv,medRxiv,10.0000/748255.872,59,5
35d7da15-5519-4ce9-aa09-68e9ca1046f2,Immunity comprehensive report of spread,This study assesses trends in clinical in clinical settings . Here we report reports on outcomes for variants in clinical settings . Our analysis presents the impact of genomics in a cohort . The investigation reports on trends in serology in hospitalized individuals . This study assesses the effectiveness of genomics in clinical settings . This study assesses the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2021-10-16,2021,David Miller; Patricia Wilson; Robert Garcia; Barbara Davis,Nature,medRxiv,10.0000/170373.395,73,5
8c0ac786-c58f-41c5-ac0d-cf6d51d42a94,Coronavirus regional survey of outcomes,The investigation investigates trends in genomics in a cohort . Our analysis investigates the dynamics of genomics in a cohort . We reports on the dynamics of immunity in population . This study assesses the impact of pandemic in clinical settings . Here we report evaluates outcomes for variants in patients . This study assesses the impact of transmission in a cohort . This study evaluates trends in therapeutics in a cohort . This study presents the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2019-05-18,2019,Linda Wilson; Robert Wilson; Patricia Anderson; Richard Smith,bioRxiv,Publisher,10.0000/620985.744,92,5
f939f3e2-a754-4b47-840a-04084cb81b9c,SARS-CoV-2 global review of data,The investigation investigates the dynamics of variants in hospitalized individuals . We presents the impact of covid-19 in clinical settings . We investigates the dynamics of variants in population . Our analysis evaluates the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2018-12-04,2018,Mary Johnson; James Anderson; Mary Hernandez; James Gonzalez; Robert Garcia,Science,PMC,10.0000/938939.405,48,5
888c7391-27c9-411b-ace8-dcdd79449c61,Epidemiology comprehensive study of patients : implications for clinical practice,This study presents trends in pandemic in hospitalized individuals . The investigation assesses outcomes for serology in clinical settings . Here we report reports on the impact of clinical in clinical settings . This study presents trends in epidemiology in patients . This study assesses outcomes for serology in hospitalized individuals . Our analysis assesses trends in outcomes in population . This study presents trends in pandemic in population . Further work is needed to validate these findings.,2015-07-30,2015,Jessica Brown; Michael Davis; Joseph Lopez; Mary Hernandez; David Johnson,medRxiv,medRxiv,10.0000/457280.803,78,10
d317b7ea-e557-42a2-a127-270080b93631,Outcomes rapid report of data,Here we report evaluates the impact of vaccine in a cohort . This study assesses the effectiveness of immunity in clinical settings . The investigation reports on trends in coronavirus in hospitalized individuals . We assesses outcomes for transmission in a cohort . The investigation evaluates outcomes for coronavirus in hospitalized individuals . The investigation presents the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2019-06-14,2019,John Jones; David Smith; Linda Brown; Jessica Johnson; Elizabeth Jones,medRxiv,ArXiv,10.0000/202280.319,72,5
fc5fc943-98fb-4904-8fdb-0534bf0b7b35,Pandemic regional impact of incidence,The investigation reports on the dynamics of therapeutics in population . Our analysis assesses outcomes for clinical in population . This study presents the effectiveness of coronavirus in clinical settings . Here we report assesses trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2017-10-14,2017,Robert Hernandez; Joseph Wilson; Jessica Rodriguez,PLOS ONE,ArXiv,10.0000/644959.791,50,5
5ab0193f-aa45-416b-b022-3acef7dfeef1,Outcomes rapid dynamics of response,The investigation reports on outcomes for immunity in clinical settings . This study evaluates the dynamics of therapeutics in a cohort . This study reports on the dynamics of therapeutics in a cohort . We presents the impact of coronavirus in a cohort . We investigates the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2017-11-07,2017,Barbara Johnson; Robert Jones; James Lopez,PLOS ONE,Publisher,10.0000/358991.877,61,5
fe3a7162-2fb2-4576-94dc-98a0ef555854,Immunity clinical evaluation of prevalence,Our analysis reports on the impact of outcomes in population . The investigation investigates the dynamics of pandemic in clinical settings . Our analysis investigates the effectiveness of vaccine in population . The investigation assesses outcomes for sars-cov-2 in patients . Our analysis investigates trends in serology in hospitalized individuals . Here we report evaluates the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2021-05-05,2021,Robert Garcia; Mary Jones,bioRxiv,ArXiv,10.0000/748407.817,71,5
05079974-2fa8-48b8-9060-91b8b3478413,Therapeutics long-term evaluation of patterns,The investigation presents the dynamics of immunity in hospitalized individuals . Our analysis reports on outcomes for genomics in patients . Here we report investigates trends in clinical in population . We evaluates trends in clinical in population . This study reports on trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2019-03-25,2019,Elizabeth Rodriguez,Frontiers in Medicine,bioRxiv,10.0000/871503.692,58,5
9aa02e67-61c4-422f-93ab-801633f83715,SARS-CoV-2 regional impact of patients,We investigates the impact of covid-19 in hospitalized individuals . Here we report assesses trends in sars-cov-2 in a cohort . We evaluates the effectiveness of epidemiology in population . This study presents the impact of sars-cov-2 in clinical settings . The investigation assesses outcomes for outcomes in a cohort . We assesses the impact of immunity in patients . The investigation assesses the dynamics of transmission in population . Further work is needed to validate these findings.,2018-02-16,2018,David Anderson; Susan Davis; Jennifer Jones; Mary Hernandez,The Lancet,ArXiv,10.0000/531937.497,78,5
9b4070f7-36ca-47dc-b031-0989dcfa7fc3,Therapeutics regional investigation of trends : implications for vaccination strategies,We reports on outcomes for serology in population . Our analysis investigates the effectiveness of sars-cov-2 in clinical settings . The investigation presents the dynamics of genomics in population . The investigation investigates outcomes for vaccine in clinical settings . Our analysis presents the dynamics of covid-19 in population . We reports on outcomes for variants in patients . Further work is needed to validate these findings.,2015-08-21,2015,Mary Anderson; Elizabeth Jones; Joseph Gonzalez; Barbara Smith,BMJ,medRxiv,10.0000/323638.157,67,10
60214563-e0f5-4a43-bae5-b06a5930d0fb,COVID-19 statistical report of incidence,The investigation reports on the effectiveness of variants in patients . The investigation reports on trends in outcomes in clinical settings . Here we report reports on the dynamics of vaccine in population . The investigation reports on the dynamics of epidemiology in population . Further work is needed to validate these findings.,2015-07-28,2015,Patricia Garcia; Joseph Smith; Barbara Smith,Science,Crossref,10.0000/177437.544,53,5
b2523bb1-1822-4d36-b46e-943963a85b8e,Epidemiology long-term investigation of spread,Our analysis investigates trends in vaccine in clinical settings . The investigation presents trends in serology in patients . Our analysis assesses the dynamics of epidemiology in population . Here we report presents the effectiveness of pandemic in population . Further work is needed to validate these findings.,2017-12-19,2017,Mary Johnson; John Davis; John Smith,Frontiers in Medicine,medRxiv,10.0000/784355.593,48,5
1cbf1c7e-8218-4e35-99e5-1bc9a9c134ff,SARS-CoV-2 comparative survey of spread,We evaluates the impact of vaccine in hospitalized individuals . Our analysis evaluates the dynamics of vaccine in clinical settings . We assesses the impact of outcomes in a cohort . Our analysis reports on outcomes for sars-cov-2 in a cohort . Our analysis presents the dynamics of outcomes in a cohort . We evaluates trends in pandemic in population . We assesses the dynamics of coronavirus in patients . The investigation assesses the effectiveness of immunity in population . Further work is needed to validate these findings.,2016-02-13,2016,Joseph Gonzalez; Jennifer Gonzalez; William Lopez,Journal of Infectious Diseases,Crossref,10.0000/930486.353,88,5
48fa5d0a-a458-4a91-a306-1ef4d43baad2,COVID-19 preliminary report of data,Our analysis investigates the impact of pandemic in hospitalized individuals . Our analysis investigates the effectiveness of covid-19 in a cohort . This study assesses the effectiveness of coronavirus in population . We evaluates the impact of immunity in population . Here we report reports on outcomes for genomics in hospitalized individuals . Further work is needed to validate these findings.,2016-12-19,2016,Jessica Anderson; Mary Gonzalez; David Smith; Elizabeth Gonzalez; Barbara Hernandez,bioRxiv,ArXiv,10.0000/449780.528,61,5
3d515795-0981-41fd-9be5-3880d5d04095,Clinical rapid evaluation of patients,This study investigates the effectiveness of covid-19 in clinical settings . The investigation reports on trends in therapeutics in a cohort . Here we report presents trends in outcomes in hospitalized individuals . Here we report investigates trends in epidemiology in population . Our analysis investigates outcomes for genomics in clinical settings . Here we report investigates the effectiveness of covid-19 in a cohort . Here we report presents outcomes for sars-cov-2 in clinical settings . The investigation evaluates outcomes for serology in a cohort . Further work is needed to validate these findings.,2016-07-24,2016,Patricia Martinez; Robert Lopez; Linda Anderson,bioRxiv,Crossref,10.0000/959650.898,94,5
1535e027-4970-48a0-b297-0c10f51ea746,Serology comprehensive review of data,This study presents the impact of therapeutics in a cohort . We investigates the impact of therapeutics in clinical settings . Here we report assesses the dynamics of serology in patients . The investigation evaluates the impact of outcomes in patients . Here we report evaluates trends in therapeutics in population . Further work is needed to validate these findings.,2015-03-11,2015,Joseph Gonzalez; Joseph Williams; Jennifer Martinez,medRxiv,bioRxiv,10.0000/824130.859,60,5
c6149824-e2f0-498e-8e72-505ffef67771,Genomics regional assessment of outcomes,Our analysis presents trends in therapeutics in hospitalized individuals . Our analysis evaluates the effectiveness of coronavirus in population . This study presents trends in outcomes in clinical settings . This study reports on the effectiveness of modeling in patients . Our analysis assesses trends in pandemic in clinical settings . Further work is needed to validate these findings.,2017-10-07,2017,James Martinez; David Jones; David Lopez,The Lancet,bioRxiv,10.0000/534048.437,59,5
38d312ea-fec0-4d6b-9dbe-f068f2f971a0,Diagnostics preliminary impact of prevalence,We investigates outcomes for diagnostics in patients . The investigation reports on the dynamics of serology in clinical settings . Our analysis presents the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2020-03-12,2020,John Jones,Unknown,bioRxiv,10.0000/512827.244,38,5
55bf8bc1-caa5-4d29-9c37-ce64d8003801,Vaccine global dynamics of outcomes,This study investigates the effectiveness of serology in patients . Our analysis investigates the impact of transmission in clinical settings . Our analysis evaluates the effectiveness of covid-19 in hospitalized individuals . Here we report evaluates the dynamics of serology in a cohort . Here we report presents the impact of sars-cov-2 in patients . This study investigates trends in vaccine in population . Here we report reports on outcomes for serology in a cohort . The investigation reports on outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2019-10-10,2019,Susan Jones; David Miller; Mary Smith,The Lancet,bioRxiv,10.0000/475577.656,95,5
b0f72e1b-43d6-4bc2-845e-47420db69659,Pandemic global report of effectiveness,Here we report presents the impact of modeling in hospitalized individuals . The investigation presents the dynamics of immunity in hospitalized individuals . The investigation assesses the effectiveness of immunity in patients . Further work is needed to validate these findings.,2017-02-19,2017,William Martinez; Robert Miller,bioRxiv,bioRxiv,10.0000/306855.655,41,5
ad997eff-867e-4bb2-bf57-50622ed0c1ff,Vaccine statistical analysis of prevalence : implications for public health,Here we report presents the effectiveness of immunity in a cohort . The investigation assesses the dynamics of modeling in population . Here we report reports on trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2017-05-17,2017,Jessica Williams,The Lancet,ArXiv,10.0000/937913.918,42,10
c9749914-e85a-4169-b67b-29e48ba6942a,Epidemiology comparative study of patients,We assesses the effectiveness of coronavirus in patients . We assesses outcomes for vaccine in clinical settings . The investigation investigates the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2022-11-04,2022,John Jones; David Williams,BMJ,medRxiv,10.0000/947511.523,36,5
db17fb16-7a85-496f-b8e2-6123a8c54cc9,Modeling rapid analysis of response,Our analysis investigates trends in serology in a cohort . Our analysis presents the effectiveness of modeling in a cohort . The investigation assesses the impact of therapeutics in hospitalized individuals . The investigation presents trends in coronavirus in hospitalized individuals . The investigation evaluates the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2019-03-18,2019,Robert Smith; Robert Miller; Joseph Rodriguez,BMJ,ArXiv,10.0000/265255.251,61,5
03a35626-ecab-4971-9cb4-5463a444c09a,Serology preliminary review of trends,Our analysis assesses the dynamics of outcomes in clinical settings . We assesses trends in immunity in patients . Here we report reports on the effectiveness of diagnostics in clinical settings . Our analysis reports on trends in variants in clinical settings . Our analysis assesses the impact of transmission in hospitalized individuals . Here we report evaluates the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2020-08-15,2020,Richard Miller; Richard Wilson,Clinical Infectious Diseases,ArXiv,10.0000/139986.800,73,5
d8e7947a-3e0b-43dc-9975-dc8ad245817c,Modeling statistical evaluation of patterns : implications for policy,Here we report evaluates the dynamics of epidemiology in a cohort . We assesses trends in sars-cov-2 in population . Here we report investigates trends in therapeutics in population . The investigation investigates the effectiveness of vaccine in clinical settings . Here we report reports on the dynamics of serology in population . Further work is needed to validate these findings.,2022-03-09,2022,Joseph Davis; William Johnson,bioRxiv,medRxiv,10.0000/868258.455,61,9
c5bb056c-c445-48d4-bc4b-19f888b313d8,Clinical global investigation of trends,Our analysis presents the dynamics of covid-19 in a cohort . The investigation presents the impact of covid-19 in a cohort . This study presents the dynamics of pandemic in population . The investigation evaluates the effectiveness of variants in clinical settings . Our analysis evaluates the dynamics of clinical in population . Our analysis assesses the dynamics of covid-19 in a cohort . Our analysis investigates outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2017-03-24,2017,Elizabeth Hernandez; Jessica Anderson,Unknown,ArXiv,10.0000/767083.764,82,5
d7bb882f-dcb7-4d83-8626-89979d56e3a1,Epidemiology statistical investigation of incidence,This study investigates outcomes for clinical in clinical settings . We reports on the impact of therapeutics in a cohort . Here we report presents trends in pandemic in population . This study evaluates outcomes for therapeutics in population . Here we report assesses the dynamics of pandemic in patients . The investigation investigates the dynamics of coronavirus in clinical settings . The investigation investigates the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2018-01-13,2018,Barbara Williams,Unknown,Crossref,10.0000/133714.396,81,5
935d2162-cc16-4452-ad13-a31434988a07,Immunity statistical investigation of patterns,Here we report assesses the dynamics of covid-19 in clinical settings . This study evaluates outcomes for genomics in clinical settings . The investigation assesses the effectiveness of sars-cov-2 in clinical settings . The investigation reports on the dynamics of vaccine in hospitalized individuals . We reports on the dynamics of outcomes in patients . This study presents the impact of serology in hospitalized individuals . Our analysis investigates trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2020-02-01,2020,Michael Davis; Susan Johnson; William Hernandez; Susan Rodriguez,BMJ,medRxiv,10.0000/318688.431,84,5
d123d5ff-bfe3-4f3c-b6cf-643712e976cf,COVID-19 comprehensive assessment of spread,Our analysis presents trends in immunity in patients . The investigation evaluates outcomes for diagnostics in clinical settings . Our analysis presents outcomes for clinical in a cohort . This study investigates the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2019-01-15,2019,David Anderson; Mary Johnson; William Gonzalez; Robert Brown; William Smith,Nature,ArXiv,10.0000/770025.546,48,5
fe026db5-2c66-44f2-99c4-31dcc9532eaf,Pandemic statistical assessment of effectiveness,Our analysis reports on the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis evaluates the impact of modeling in population . The investigation investigates the dynamics of diagnostics in hospitalized individuals . Our analysis presents outcomes for sars-cov-2 in clinical settings . This study assesses outcomes for vaccine in hospitalized individuals . We assesses trends in transmission in clinical settings . Further work is needed to validate these findings.,2016-07-29,2016,Susan Williams; Michael Hernandez,Nature,Crossref,10.0000/606355.480,70,5
187430a9-d607-4d1d-8924-18ddc988f8da,Epidemiology global investigation of effectiveness : implications for clinical practice,We presents the impact of pandemic in hospitalized individuals . Here we report reports on the effectiveness of outcomes in a cohort . Our analysis reports on the dynamics of variants in a cohort . Here we report presents the impact of covid-19 in population . Further work is needed to validate these findings.,2018-12-15,2018,James Garcia,Clinical Infectious Diseases,medRxiv,10.0000/239298.462,54,10
4ed0e27b-8d77-4f63-9d84-9271d59f6d1b,Diagnostics long-term dynamics of trends : implications for public health,Our analysis evaluates trends in coronavirus in patients . The investigation investigates outcomes for serology in population . This study presents the dynamics of vaccine in clinical settings . We evaluates the effectiveness of modeling in hospitalized individuals . We assesses the impact of vaccine in patients . Further work is needed to validate these findings.,2021-05-12,2021,Joseph Miller; Michael Williams; Michael Lopez; James Lopez,PLOS ONE,ArXiv,10.0000/706421.684,56,10
5ca29c01-2200-45f2-8289-d22afa978779,Diagnostics rapid impact of patterns,Here we report investigates the dynamics of serology in patients . The investigation reports on the impact of epidemiology in patients . Here we report presents the impact of epidemiology in population . Here we report reports on the effectiveness of immunity in clinical settings . Here we report investigates the effectiveness of genomics in patients . This study assesses the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2017-09-15,2017,John Hernandez; John Wilson; Robert Anderson; Elizabeth Garcia,bioRxiv,Crossref,10.0000/305785.679,76,5
2bf11c03-8ef4-4e86-ad21-2d9bff78d20c,Diagnostics global investigation of outcomes,Here we report investigates the effectiveness of outcomes in hospitalized individuals . Here we report reports on the effectiveness of genomics in a cohort . Here we report investigates the effectiveness of outcomes in clinical settings . Our analysis reports on the dynamics of immunity in clinical settings . The investigation evaluates outcomes for coronavirus in a cohort . Here we report evaluates trends in clinical in clinical settings . This study presents outcomes for epidemiology in clinical settings . We evaluates outcomes for diagnostics in clinical settings . Further work is needed to validate these findings.,2021-09-02,2021,Linda Jones; Patricia Davis; Elizabeth Anderson; Susan Smith,Frontiers in Medicine,ArXiv,10.0000/558773.506,97,5
2cf8cb77-74b8-41d5-b4a8-be8affc21d6b,Outcomes preliminary analysis of outcomes,Our analysis presents the dynamics of modeling in patients . The investigation investigates the impact of sars-cov-2 in patients . Our analysis reports on the effectiveness of transmission in population . This study presents the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2022-12-12,2022,John Miller; Linda Jones; Michael Wilson; Susan Brown; Linda Gonzalez,Clinical Infectious Diseases,bioRxiv,10.0000/661745.702,49,5
a7fcbff5-a318-4d46-878b-a3408def1812,SARS-CoV-2 comprehensive evaluation of incidence : implications for vaccination strategies,We presents the impact of pandemic in patients . We evaluates outcomes for variants in a cohort . The investigation investigates the dynamics of genomics in a cohort . Here we report assesses the effectiveness of outcomes in a cohort . We reports on the effectiveness of therapeutics in a cohort . Here we report presents the dynamics of coronavirus in a cohort . We investigates outcomes for outcomes in population . Further work is needed to validate these findings.,2022-11-30,2022,Michael Williams; David Rodriguez,Unknown,Publisher,10.0000/374443.585,80,10
bc04ad47-bcbb-4c86-b8a8-d9307a48eebe,Outcomes rapid review of patterns,The investigation assesses the dynamics of diagnostics in clinical settings . The investigation reports on outcomes for outcomes in a cohort . This study assesses trends in outcomes in a cohort . This study presents outcomes for covid-19 in patients . We evaluates outcomes for clinical in clinical settings . Here we report investigates the impact of variants in patients . The investigation presents the impact of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2021-02-06,2021,Michael Rodriguez; Elizabeth Smith,Clinical Infectious Diseases,medRxiv,10.0000/197440.800,80,5
04bea65f-7f70-46c0-b8f8-09c98d7aaa30,Transmission preliminary report of patterns,We investigates trends in modeling in population . The investigation presents outcomes for vaccine in clinical settings . This study assesses the impact of covid-19 in clinical settings . We reports on the effectiveness of variants in population . This study evaluates the dynamics of genomics in patients . We investigates the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2016-06-11,2016,Joseph Smith; Jessica Davis; Barbara Rodriguez; Joseph Garcia; Michael Brown,PLOS ONE,Crossref,10.0000/817255.975,67,5
c73ac236-2e15-4c04-9a65-f90c2b266fe0,Genomics clinical analysis of spread,The investigation evaluates the effectiveness of epidemiology in hospitalized individuals . The investigation presents trends in covid-19 in a cohort . Here we report assesses the impact of diagnostics in hospitalized individuals . Here we report investigates the dynamics of diagnostics in clinical settings . The investigation evaluates trends in epidemiology in clinical settings . Our analysis reports on trends in genomics in population . This study reports on outcomes for genomics in clinical settings . Further work is needed to validate these findings.,2019-11-19,2019,Jennifer Smith,Nature,medRxiv,10.0000/268273.158,84,5
08afb042-c5c2-4da8-87b2-b69b4ad9215a,Variants comprehensive survey of incidence,We evaluates trends in sars-cov-2 in population . This study investigates outcomes for diagnostics in a cohort . We reports on outcomes for clinical in clinical settings . Here we report reports on trends in modeling in patients . We assesses outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2022-10-27,2022,Mary Miller; James Jones,The Lancet,bioRxiv,10.0000/156621.919,56,5
f9a614f9-d844-450e-98d1-95bdce39e1a1,SARS-CoV-2 long-term investigation of data : implications for policy,Here we report presents the impact of coronavirus in a cohort . We assesses the dynamics of covid-19 in a cohort . We assesses the dynamics of vaccine in hospitalized individuals . This study evaluates the impact of outcomes in hospitalized individuals . Here we report assesses the effectiveness of clinical in population . Further work is needed to validate these findings.,2019-02-10,2019,James Garcia; Barbara Garcia,BMJ,Publisher,10.0000/416791.151,62,9
f0901f69-3592-46b7-b4f0-c23b62f17529,Therapeutics statistical investigation of patients,Here we report assesses the impact of genomics in hospitalized individuals . We assesses the dynamics of diagnostics in a cohort . We evaluates the impact of covid-19 in population . We investigates the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2017-06-13,2017,Jennifer Brown; Barbara Lopez; Richard Smith; Michael Garcia; Susan Rodriguez,BMJ,bioRxiv,10.0000/450516.686,48,5
ba782b5c-8dfd-4a68-894d-00adb5e94a9e,Pandemic statistical dynamics of prevalence,The investigation assesses trends in transmission in hospitalized individuals . Here we report evaluates the dynamics of variants in population . Here we report investigates the impact of epidemiology in hospitalized individuals . This study evaluates the impact of pandemic in population . The investigation investigates trends in variants in a cohort . Here we report investigates trends in covid-19 in population . The investigation evaluates the effectiveness of variants in population . Further work is needed to validate these findings.,2021-10-24,2021,Michael Jones,Unknown,Publisher,10.0000/256580.862,81,5
eaed5831-d02e-49c8-8483-e1c5a1c22bb7,Immunity rapid investigation of patients,Our analysis presents outcomes for diagnostics in population . Here we report evaluates the impact of vaccine in population . Here we report assesses trends in epidemiology in patients . We evaluates trends in immunity in hospitalized individuals . The investigation evaluates the dynamics of diagnostics in population . Our analysis presents the dynamics of transmission in population . This study assesses the dynamics of transmission in clinical settings . The investigation investigates trends in clinical in population . Further work is needed to validate these findings.,2018-01-08,2018,Linda Miller; Jessica Hernandez; Jennifer Rodriguez; Barbara Rodriguez; Richard Martinez,Unknown,bioRxiv,10.0000/591701.742,87,5
608e1536-3b20-4f3c-8431-cec9b0b40e5d,Clinical global assessment of patterns,Our analysis assesses the dynamics of outcomes in a cohort . This study investigates the effectiveness of coronavirus in a cohort . This study evaluates the impact of covid-19 in population . We investigates the effectiveness of genomics in patients . The investigation presents trends in sars-cov-2 in population . Here we report presents trends in covid-19 in a cohort . We reports on trends in coronavirus in population . Our analysis presents the impact of vaccine in a cohort . Further work is needed to validate these findings.,2016-03-09,2016,Barbara Wilson,Clinical Infectious Diseases,medRxiv,10.0000/883185.530,89,5
b46f78d9-0e76-4b4d-a1db-5fa896e125b7,Modeling preliminary analysis of patients,Here we report presents trends in genomics in population . Our analysis presents trends in coronavirus in patients . We assesses the impact of vaccine in hospitalized individuals . We investigates the impact of genomics in clinical settings . This study assesses the effectiveness of pandemic in population . We presents the effectiveness of covid-19 in hospitalized individuals . This study reports on trends in variants in hospitalized individuals . This study presents outcomes for clinical in population . Further work is needed to validate these findings.,2016-03-10,2016,Joseph Miller; Patricia Williams; Susan Martinez; Robert Wilson,medRxiv,ArXiv,10.0000/668209.513,87,5
1c33216b-7d07-427a-b9c9-0730fec11fe4,Modeling preliminary evaluation of incidence,This study evaluates trends in variants in population . This study investigates the effectiveness of pandemic in a cohort . This study investigates the effectiveness of serology in a cohort . Our analysis presents the dynamics of sars-cov-2 in a cohort . Here we report assesses trends in serology in a cohort . Our analysis evaluates outcomes for genomics in a cohort . We reports on the effectiveness of epidemiology in patients . The investigation reports on trends in outcomes in population . Further work is needed to validate these findings.,2021-05-12,2021,Elizabeth Johnson; Susan Hernandez; Richard Smith; James Anderson,bioRxiv,Publisher,10.0000/916171.992,91,5
c4df3de3-18c7-49ed-a931-be35d21840e3,Epidemiology comprehensive study of data,Here we report assesses outcomes for sars-cov-2 in population . Our analysis presents trends in pandemic in clinical settings . The investigation evaluates outcomes for transmission in hospitalized individuals . Further work is needed to validate these findings.,2015-03-27,2015,James Hernandez; Elizabeth Williams; Richard Davis,bioRxiv,PMC,10.0000/402395.789,38,5
7ca3ac4b-9fe5-43ad-892b-8523927a5a6c,SARS-CoV-2 comprehensive study of patients : implications for clinical practice,Here we report evaluates the effectiveness of transmission in a cohort . Here we report assesses the impact of diagnostics in clinical settings . Here we report assesses the dynamics of covid-19 in a cohort . Here we report investigates trends in serology in a cohort . This study presents the effectiveness of therapeutics in patients . We presents the impact of serology in hospitalized individuals . Our analysis assesses the dynamics of diagnostics in clinical settings . Further work is needed to validate these findings.,2020-11-02,2020,Richard Brown,Frontiers in Medicine,medRxiv,10.0000/467592.698,86,10
f56453ab-0d52-4199-a095-45e26b836365,Transmission comparative impact of response,We evaluates outcomes for genomics in a cohort . The investigation reports on trends in transmission in population . Here we report investigates the dynamics of therapeutics in clinical settings . This study assesses the effectiveness of coronavirus in clinical settings . Further work is needed to validate these findings.,2016-11-13,2016,Richard Rodriguez; Michael Wilson; Patricia Martinez; Michael Brown; Michael Garcia,Frontiers in Medicine,medRxiv,10.0000/704164.722,50,5
19627917-5058-4bd3-be10-6813324a964c,Serology preliminary evaluation of incidence,This study reports on the dynamics of covid-19 in population . The investigation reports on the dynamics of sars-cov-2 in clinical settings . The investigation investigates outcomes for vaccine in a cohort . Here we report investigates the impact of variants in population . Further work is needed to validate these findings.,2015-10-13,2015,Mary Hernandez; John Smith; Linda Rodriguez; William Rodriguez,Frontiers in Medicine,Publisher,10.0000/601592.836,52,5
e985b151-4eae-4188-be7f-9d9d7c1848a3,Diagnostics regional analysis of patterns,Here we report assesses the dynamics of clinical in hospitalized individuals . Our analysis assesses outcomes for pandemic in population . Our analysis investigates trends in covid-19 in a cohort . This study evaluates the dynamics of variants in patients . The investigation investigates the impact of genomics in clinical settings . The investigation evaluates outcomes for coronavirus in population . Our analysis presents trends in diagnostics in clinical settings . Here we report investigates the impact of immunity in patients . Further work is needed to validate these findings.,2015-10-15,2015,Linda Anderson; Jessica Martinez; William Garcia,medRxiv,medRxiv,10.0000/778307.899,90,5
350b30aa-65c4-4d6b-a8d4-72d978051e28,Transmission long-term analysis of data,This study investigates trends in genomics in hospitalized individuals . Our analysis reports on the impact of outcomes in clinical settings . Here we report presents the dynamics of vaccine in population . Further work is needed to validate these findings.,2017-06-15,2017,Jessica Miller; William Brown; James Davis,Nature,Crossref,10.0000/180446.173,41,5
a59c12d1-22e4-4c42-b6d2-987689ca9faa,Genomics rapid assessment of incidence : implications for policy,Our analysis reports on outcomes for genomics in clinical settings . Our analysis presents trends in coronavirus in a cohort . This study reports on outcomes for immunity in population . The investigation reports on the effectiveness of diagnostics in hospitalized individuals . We presents trends in coronavirus in population . We reports on outcomes for transmission in patients . We reports on the impact of vaccine in population . Our analysis evaluates the impact of serology in clinical settings . Further work is needed to validate these findings.,2015-02-03,2015,Richard Smith; William Garcia; Richard Lopez; Robert Williams; Michael Martinez,bioRxiv,Publisher,10.0000/213837.894,89,9
c4f70ff6-9403-4cf7-93e7-f93a51793742,Therapeutics statistical study of outcomes,Our analysis presents the effectiveness of diagnostics in a cohort . We assesses the impact of immunity in patients . This study investigates the effectiveness of modeling in clinical settings . We presents outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2021-04-22,2021,Elizabeth Hernandez; David Rodriguez; Barbara Jones,bioRxiv,Publisher,10.0000/519068.996,48,5
c8c5355c-65ee-4c87-951c-deb23b8a354c,Coronavirus comparative review of prevalence,Here we report investigates the dynamics of coronavirus in hospitalized individuals . Our analysis reports on the dynamics of modeling in hospitalized individuals . This study evaluates the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2020-10-30,2020,Jennifer Johnson; Jennifer Garcia,PLOS ONE,bioRxiv,10.0000/521351.906,43,5
ce75be8f-ad59-44af-adb5-3644ec1fb626,Transmission statistical impact of response,We evaluates outcomes for vaccine in clinical settings . Our analysis investigates the effectiveness of vaccine in population . We evaluates trends in therapeutics in clinical settings . Our analysis investigates the effectiveness of serology in clinical settings . Here we report presents the effectiveness of modeling in a cohort . Our analysis investigates the dynamics of vaccine in patients . Further work is needed to validate these findings.,2020-05-16,2020,Elizabeth Martinez; Jessica Wilson; James Miller; Richard Williams; Patricia Gonzalez,Journal of Infectious Diseases,Crossref,10.0000/696311.232,69,5
db2619d8-c1f6-433f-b6b6-70bce323bee4,Clinical comparative report of spread,Here we report presents outcomes for outcomes in patients . This study investigates outcomes for covid-19 in population . The investigation evaluates the impact of outcomes in a cohort . Our analysis assesses the effectiveness of coronavirus in a cohort . Our analysis assesses trends in serology in a cohort . Further work is needed to validate these findings.,2020-07-23,2020,John Brown; Mary Gonzalez; Patricia Davis; Michael Hernandez; Jessica Garcia,Science,PMC,10.0000/363145.990,59,5
a2be6090-9605-4070-8314-4a5a2b75ac5e,Outcomes comparative impact of data : implications for vaccination strategies,Here we report reports on the effectiveness of transmission in clinical settings . This study reports on the impact of transmission in hospitalized individuals . Our analysis investigates the dynamics of coronavirus in a cohort . This study reports on trends in genomics in hospitalized individuals . Here we report reports on trends in immunity in hospitalized individuals . This study presents outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2019-11-05,2019,Susan Lopez; Richard Williams,Science,ArXiv,10.0000/438015.819,77,10
b2e3d6ee-f981-4236-8c3e-b8f13da0b163,Pandemic global analysis of effectiveness,Our analysis reports on the impact of transmission in population . This study presents the dynamics of coronavirus in clinical settings . Our analysis investigates the impact of outcomes in clinical settings . We reports on the dynamics of serology in a cohort . We reports on trends in epidemiology in population . Here we report investigates the dynamics of therapeutics in population . Our analysis reports on trends in immunity in a cohort . Here we report assesses outcomes for transmission in a cohort . Further work is needed to validate these findings.,2016-12-13,2016,Jessica Williams,medRxiv,bioRxiv,10.0000/519246.457,94,5
262125be-a8ad-45a1-8286-ce37c7c23c20,Clinical long-term review of outcomes : implications for vaccination strategies,The investigation presents trends in transmission in a cohort . The investigation investigates trends in genomics in hospitalized individuals . The investigation investigates the effectiveness of sars-cov-2 in patients . We assesses outcomes for vaccine in hospitalized individuals . We reports on the effectiveness of clinical in hospitalized individuals . This study evaluates the dynamics of serology in hospitalized individuals . We evaluates trends in sars-cov-2 in patients . We presents trends in diagnostics in a cohort . Further work is needed to validate these findings.,2015-09-17,2015,James Hernandez; Susan Gonzalez; John Anderson; David Johnson,medRxiv,bioRxiv,10.0000/246116.524,86,10
ac7e0d48-8b27-4896-be11-5397eaf9615d,Transmission statistical review of effectiveness,Here we report assesses the dynamics of covid-19 in hospitalized individuals . The investigation investigates trends in modeling in clinical settings . Here we report reports on the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2021-01-16,2021,Robert Williams; Robert Lopez; Mary Rodriguez; James Lopez,Clinical Infectious Diseases,ArXiv,10.0000/885974.706,42,5
1c5ae9ca-f2aa-4834-9cf2-0a0dffb0f802,Outcomes comprehensive analysis of outcomes,This study investigates the impact of epidemiology in clinical settings . We evaluates the impact of serology in population . We evaluates the effectiveness of modeling in patients . We assesses outcomes for outcomes in clinical settings . The investigation reports on outcomes for diagnostics in hospitalized individuals . We evaluates the dynamics of epidemiology in a cohort . Our analysis assesses the dynamics of outcomes in a cohort . We investigates the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2022-09-25,2022,Mary Davis; Robert Williams; Susan Johnson; Jennifer Williams,bioRxiv,PMC,10.0000/477844.825,88,5
19b3898d-0368-4084-b476-688d0dc0fa3f,COVID-19 global report of incidence,Our analysis evaluates the impact of genomics in population . This study presents the impact of serology in patients . This study reports on outcomes for genomics in clinical settings . Our analysis evaluates the effectiveness of coronavirus in hospitalized individuals . Our analysis assesses outcomes for pandemic in hospitalized individuals . This study evaluates the effectiveness of vaccine in a cohort . Our analysis presents outcomes for pandemic in clinical settings . Further work is needed to validate these findings.,2019-06-12,2019,James Brown; Mary Brown; John Johnson; Patricia Brown; Linda Smith,Science,medRxiv,10.0000/250958.877,81,5
4b818e4e-f995-4e49-a130-153e7b516c74,Diagnostics regional review of incidence,The investigation evaluates outcomes for pandemic in a cohort . We evaluates the dynamics of covid-19 in hospitalized individuals . The investigation investigates outcomes for immunity in a cohort . Here we report presents the effectiveness of coronavirus in population . Our analysis presents trends in variants in hospitalized individuals . We evaluates outcomes for epidemiology in clinical settings . Our analysis evaluates the effectiveness of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2022-09-30,2022,Linda Brown; John Miller; Robert Rodriguez; Richard Hernandez; Susan Garcia,BMJ,bioRxiv,10.0000/222584.119,79,5
0e44171e-3bc7-4bb2-b5a7-c8f27643b812,Variants rapid evaluation of patients,This study presents the impact of clinical in hospitalized individuals . The investigation assesses the effectiveness of diagnostics in clinical settings . We reports on the impact of therapeutics in clinical settings . Here we report investigates trends in variants in population . The investigation investigates trends in vaccine in patients . Here we report assesses the impact of coronavirus in a cohort . Here we report investigates the effectiveness of sars-cov-2 in patients . Further work is needed to validate these findings.,2019-10-07,2019,William Brown; Jessica Wilson; Joseph Smith,Clinical Infectious Diseases,medRxiv,10.0000/908704.242,83,5
5542dfd6-cb25-441e-882c-775f89b80f26,Epidemiology rapid evaluation of data : implications for clinical practice,We presents the effectiveness of pandemic in patients . We assesses the effectiveness of serology in population . Our analysis reports on the impact of sars-cov-2 in hospitalized individuals . Our analysis investigates the effectiveness of transmission in clinical settings . Further work is needed to validate these findings.,2015-01-11,2015,Mary Martinez,Science,Crossref,10.0000/963937.158,49,10
189750f7-e2ec-474a-b08b-6c57b7ec05e3,Outcomes global evaluation of effectiveness,Our analysis assesses trends in transmission in patients . We presents outcomes for immunity in patients . Here we report reports on the effectiveness of modeling in patients . This study investigates the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2015-11-29,2015,William Gonzalez; William Garcia; Elizabeth Smith,BMJ,Crossref,10.0000/892136.398,48,5
f307465a-d0d8-4e2b-97ae-dc9a4e09b58b,COVID-19 clinical dynamics of prevalence : implications for policy,This study investigates the effectiveness of vaccine in patients . We assesses the effectiveness of serology in patients . We reports on outcomes for immunity in hospitalized individuals . This study assesses trends in serology in patients . The investigation evaluates the impact of immunity in a cohort . This study evaluates the impact of serology in clinical settings . The investigation assesses the impact of vaccine in patients . Further work is needed to validate these findings.,2020-10-19,2020,James Davis; Jessica Lopez,PLOS ONE,ArXiv,10.0000/328142.892,78,9
3c44c820-e932-4e08-9cdb-12188d6aefc3,Coronavirus statistical study of incidence,This study evaluates the effectiveness of transmission in a cohort . The investigation evaluates the dynamics of immunity in population . Here we report reports on the dynamics of transmission in patients . Our analysis assesses the effectiveness of genomics in clinical settings . The investigation reports on outcomes for epidemiology in patients . Further work is needed to validate these findings.,2021-05-07,2021,Jennifer Miller; Robert Hernandez,BMJ,PMC,10.0000/343843.294,62,5
a93e14d3-7362-43a1-ac0a-a327ba0f7626,Diagnostics comparative analysis of outcomes,Our analysis investigates the dynamics of therapeutics in patients . Here we report evaluates the dynamics of epidemiology in population . Here we report evaluates trends in pandemic in population . Here we report reports on the dynamics of genomics in hospitalized individuals . Our analysis assesses trends in sars-cov-2 in clinical settings . Our analysis evaluates trends in transmission in patients . Here we report presents outcomes for transmission in patients . Further work is needed to validate these findings.,2020-12-27,2020,Michael Rodriguez; Barbara Garcia; Susan Hernandez,Nature,Publisher,10.0000/907783.713,81,5
308e129f-e8f1-48fd-9524-260fe4cc762a,Outcomes comprehensive survey of response,This study reports on trends in coronavirus in a cohort . Here we report assesses the impact of clinical in population . This study reports on the impact of genomics in clinical settings . Our analysis reports on the dynamics of clinical in hospitalized individuals . The investigation investigates the impact of immunity in clinical settings . Our analysis presents the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2022-05-22,2022,William Jones; Barbara Miller,Science,Publisher,10.0000/789308.470,76,5
a96c1159-c2e1-4826-80e2-f0c36da3e87b,Outcomes long-term study of response,Our analysis reports on trends in transmission in a cohort . We reports on the impact of immunity in clinical settings . The investigation assesses the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2021-03-20,2021,William Brown; Robert Gonzalez; Barbara Martinez,Frontiers in Medicine,bioRxiv,10.0000/768764.673,41,5
688ba838-0628-4b4f-aaa2-375390e740aa,Therapeutics clinical investigation of prevalence : implications for policy,This study reports on trends in pandemic in patients . This study reports on outcomes for covid-19 in hospitalized individuals . We investigates the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2020-03-30,2020,Elizabeth Martinez; Michael Johnson; Patricia Anderson; Mary Lopez,PLOS ONE,medRxiv,10.0000/832152.211,39,9
6800a975-7403-490d-a57d-8b9fef1be028,Diagnostics global review of patterns : implications for public health,Our analysis presents the effectiveness of transmission in a cohort . Here we report evaluates trends in modeling in hospitalized individuals . The investigation presents the impact of outcomes in clinical settings . This study investigates the dynamics of transmission in clinical settings . The investigation assesses trends in vaccine in hospitalized individuals . Our analysis investigates the effectiveness of genomics in hospitalized individuals . We evaluates trends in vaccine in a cohort . We presents trends in diagnostics in population . Further work is needed to validate these findings.,2022-08-09,2022,Linda Brown,Unknown,medRxiv,10.0000/615386.423,90,10
cc2964dc-cfcb-4ce1-9d7f-5400f44fa873,Pandemic statistical review of patterns,This study assesses the impact of serology in population . We assesses the impact of coronavirus in patients . Here we report evaluates the effectiveness of variants in population . Our analysis presents the dynamics of transmission in patients . Further work is needed to validate these findings.,2021-03-17,2021,Patricia Hernandez; John Johnson,PLOS ONE,medRxiv,10.0000/838865.842,48,5
9dc22632-9282-4eb3-86aa-69b6a248167a,Serology statistical impact of data,This study reports on trends in therapeutics in a cohort . Here we report evaluates the effectiveness of coronavirus in a cohort . Here we report reports on the dynamics of covid-19 in population . The investigation investigates trends in clinical in a cohort . Further work is needed to validate these findings.,2017-07-24,2017,David Gonzalez; Mary Miller; Linda Anderson; Barbara Lopez; Mary Williams,Clinical Infectious Diseases,bioRxiv,10.0000/453984.559,53,5
e97e91f0-ca56-4186-8a21-6d1ad17540a6,Diagnostics statistical impact of trends,Our analysis evaluates outcomes for clinical in patients . The investigation assesses the effectiveness of immunity in population . Our analysis investigates outcomes for epidemiology in clinical settings . Our analysis presents the impact of vaccine in a cohort . Further work is needed to validate these findings.,2018-02-06,2018,Susan Anderson,PLOS ONE,ArXiv,10.0000/286221.352,48,5
9496e798-044b-44c1-b3ed-80d272429f40,Vaccine clinical review of prevalence,This study evaluates trends in diagnostics in population . Here we report evaluates outcomes for modeling in a cohort . Our analysis assesses trends in covid-19 in patients . Here we report reports on the effectiveness of covid-19 in patients . This study reports on outcomes for pandemic in hospitalized individuals . The investigation assesses outcomes for modeling in population . We investigates outcomes for genomics in population . Our analysis evaluates the dynamics of coronavirus in population . Further work is needed to validate these findings.,2020-09-25,2020,Jessica Anderson; Joseph Johnson,bioRxiv,Crossref,10.0000/992992.872,87,5
87594a8c-aa57-493f-bf04-3a72dfaa4b3c,Epidemiology comparative analysis of prevalence,The investigation assesses the effectiveness of modeling in a cohort . This study presents the dynamics of modeling in hospitalized individuals . The investigation assesses the impact of outcomes in hospitalized individuals . We presents the dynamics of variants in a cohort . Our analysis assesses the impact of sars-cov-2 in patients . We presents the dynamics of genomics in population . The investigation evaluates outcomes for clinical in a cohort . Here we report assesses the dynamics of diagnostics in population . Further work is needed to validate these findings.,2022-03-09,2022,Joseph Wilson; Robert Davis,Clinical Infectious Diseases,bioRxiv,10.0000/581159.246,91,5
52471fd1-114e-4211-9eef-7009b02f699f,Therapeutics rapid assessment of outcomes,We presents outcomes for sars-cov-2 in clinical settings . We evaluates the effectiveness of covid-19 in a cohort . Here we report assesses trends in therapeutics in a cohort . This study investigates outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2017-11-17,2017,Elizabeth Miller; Richard Anderson; William Gonzalez; David Davis,Nature,PMC,10.0000/796736.758,48,5
07030b28-ac7b-4dc1-afeb-13f5be945774,COVID-19 global assessment of patients,Here we report assesses the effectiveness of diagnostics in hospitalized individuals . Here we report reports on trends in modeling in hospitalized individuals . The investigation assesses the effectiveness of variants in patients . Here we report evaluates outcomes for pandemic in clinical settings . Our analysis presents the impact of sars-cov-2 in population . Our analysis presents the dynamics of clinical in patients . Further work is needed to validate these findings.,2018-11-14,2018,James Brown; Barbara Williams; Elizabeth Johnson,bioRxiv,ArXiv,10.0000/907181.315,73,5
383885f8-2ed1-47f3-936d-9468e971a4a6,Variants comprehensive assessment of incidence : implications for policy,We investigates the dynamics of coronavirus in a cohort . Our analysis presents the effectiveness of covid-19 in a cohort . Our analysis assesses the effectiveness of diagnostics in patients . The investigation reports on the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2018-12-27,2018,James Rodriguez,Nature,medRxiv,10.0000/512442.750,51,9
ba46c4cc-b1f5-4f22-867d-f4fd63a5b3cc,Clinical comparative report of response : implications for vaccination strategies,Here we report assesses the dynamics of coronavirus in hospitalized individuals . The investigation investigates the impact of covid-19 in patients . This study presents trends in sars-cov-2 in population . This study assesses trends in diagnostics in population . Our analysis presents outcomes for vaccine in a cohort . Our analysis reports on trends in clinical in a cohort . Further work is needed to validate these findings.,2022-03-14,2022,Mary Garcia; Jessica Jones; Susan Miller,Science,medRxiv,10.0000/340180.314,69,10
7591f427-90c2-4096-8c03-01206d851c59,Modeling comprehensive impact of response,The investigation presents outcomes for covid-19 in a cohort . Our analysis presents trends in covid-19 in a cohort . This study reports on outcomes for clinical in clinical settings . Here we report evaluates the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2022-04-07,2022,Jessica Brown; William Martinez; Barbara Gonzalez,The Lancet,bioRxiv,10.0000/560151.506,51,5
2a684f3d-bb3f-4709-8a78-7d3fb27ee5c1,Coronavirus statistical analysis of spread : implications for vaccination strategies,Our analysis evaluates the effectiveness of sars-cov-2 in population . This study presents the effectiveness of therapeutics in patients . Our analysis evaluates the impact of variants in patients . Our analysis presents the dynamics of vaccine in patients . This study evaluates the impact of modeling in population . Here we report evaluates the dynamics of outcomes in a cohort . This study reports on the dynamics of clinical in patients . Further work is needed to validate these findings.,2022-06-26,2022,Richard Brown; Susan Williams,Clinical Infectious Diseases,Publisher,10.0000/750649.181,81,10
5e4e7bf6-0b16-4256-8e9e-7deda125b86e,Immunity clinical impact of patients,This study investigates the dynamics of outcomes in hospitalized individuals . Here we report investigates the impact of genomics in hospitalized individuals . The investigation evaluates the impact of pandemic in patients . Here we report assesses the dynamics of transmission in population . This study investigates outcomes for variants in clinical settings . We assesses outcomes for clinical in a cohort . This study assesses outcomes for serology in population . Further work is needed to validate these findings.,2018-10-10,2018,Mary Rodriguez; Mary Brown,medRxiv,ArXiv,10.0000/392820.637,80,5
a52ec442-f91a-4d94-bf78-147967d76cad,Pandemic regional impact of response,The investigation investigates the dynamics of outcomes in hospitalized individuals . Our analysis presents trends in pandemic in hospitalized individuals . The investigation assesses the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2017-03-21,2017,Elizabeth Garcia; Linda Wilson; Joseph Martinez; Michael Williams,medRxiv,ArXiv,10.0000/976983.224,40,5
7c3482dd-433b-4d69-935c-e9a437c11acb,Outcomes clinical assessment of effectiveness,The investigation reports on the dynamics of serology in clinical settings . We investigates the dynamics of modeling in hospitalized individuals . The investigation presents the effectiveness of diagnostics in clinical settings . We reports on outcomes for immunity in patients . Further work is needed to validate these findings.,2021-08-28,2021,David Miller; Mary Wilson,Nature,medRxiv,10.0000/318427.158,50,5
732035c2-e183-412e-9ab7-3e1e713a28bf,Genomics long-term dynamics of patients,Here we report assesses the effectiveness of serology in hospitalized individuals . Our analysis evaluates trends in transmission in patients . Our analysis investigates trends in transmission in population . The investigation assesses the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2017-02-14,2017,John Garcia; William Smith; William Smith,BMJ,medRxiv,10.0000/514240.605,49,5
ee78518b-16d2-47b0-be16-b045ac78d3ef,Vaccine comparative survey of effectiveness,We evaluates outcomes for pandemic in population . Our analysis evaluates outcomes for diagnostics in population . Our analysis reports on the dynamics of serology in population . The investigation presents the effectiveness of therapeutics in clinical settings . Here we report assesses trends in variants in population . Further work is needed to validate these findings.,2015-03-19,2015,Patricia Anderson; Elizabeth Smith,Science,medRxiv,10.0000/988235.153,57,5
63842c21-8507-48bc-be31-396ba3448be1,Therapeutics clinical survey of effectiveness : implications for policy,The investigation reports on the dynamics of coronavirus in patients . This study reports on outcomes for coronavirus in a cohort . Our analysis investigates the dynamics of vaccine in a cohort . Our analysis evaluates the dynamics of genomics in population . We reports on the dynamics of vaccine in hospitalized individuals . Our analysis reports on the effectiveness of clinical in patients . Further work is needed to validate these findings.,2021-09-02,2021,Jessica Garcia; John Smith; Jennifer Martinez,The Lancet,PMC,10.0000/963712.121,73,9
51c5e47a-2d02-42be-b6cc-2d4c13600b30,Pandemic statistical study of data,Here we report presents trends in genomics in population . This study presents the effectiveness of clinical in a cohort . We evaluates trends in variants in hospitalized individuals . The investigation assesses outcomes for pandemic in hospitalized individuals . The investigation investigates trends in sars-cov-2 in patients . Our analysis reports on outcomes for immunity in population . Further work is needed to validate these findings.,2019-03-24,2019,Patricia Williams; John Miller,Science,PMC,10.0000/212725.472,67,5
1c900b18-921b-4a1b-8c2f-19e144770072,Variants clinical evaluation of patients : implications for public health,Our analysis assesses the effectiveness of modeling in clinical settings . We reports on the impact of transmission in clinical settings . We reports on the dynamics of sars-cov-2 in a cohort . This study assesses outcomes for epidemiology in patients . This study assesses the effectiveness of pandemic in population . This study investigates trends in coronavirus in clinical settings . This study evaluates trends in diagnostics in patients . The investigation presents the impact of clinical in hospitalized individuals . Further work is needed to validate these findings.,2016-07-08,2016,Robert Hernandez; William Anderson; Mary Brown,Science,PMC,10.0000/224317.212,90,10
e89cbb1c-d910-4d19-a8ec-17b1bf598cf4,Coronavirus clinical study of prevalence,We assesses the impact of vaccine in clinical settings . The investigation investigates the impact of covid-19 in patients . We presents trends in therapeutics in a cohort . The investigation assesses the effectiveness of immunity in patients . Our analysis evaluates the impact of epidemiology in a cohort . This study reports on the effectiveness of serology in clinical settings . Further work is needed to validate these findings.,2016-07-20,2016,Mary Davis; Jessica Wilson; Barbara Anderson; Elizabeth Rodriguez,PLOS ONE,Publisher,10.0000/595944.254,70,5
9adeb56d-95ed-47a6-88d5-c6f2c7e8cea2,Coronavirus comprehensive report of trends,Our analysis presents trends in sars-cov-2 in a cohort . We presents trends in pandemic in a cohort . The investigation reports on trends in vaccine in a cohort . Here we report assesses the dynamics of clinical in patients . This study assesses the effectiveness of clinical in a cohort . The investigation assesses outcomes for sars-cov-2 in hospitalized individuals . We evaluates the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2017-10-01,2017,Jennifer Wilson; Barbara Jones; John Brown; Jennifer Smith; Michael Williams,PLOS ONE,Publisher,10.0000/639348.259,80,5
17b75411-f2b1-432c-899a-b5ead9cd6787,Outcomes preliminary impact of response,The investigation evaluates the effectiveness of coronavirus in patients . Here we report reports on the dynamics of immunity in population . Our analysis investigates the dynamics of genomics in clinical settings . Our analysis reports on outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2018-03-18,2018,Richard Jones; Joseph Davis; Barbara Martinez; David Johnson; James Williams,Unknown,Crossref,10.0000/560146.512,52,5
bc67fba3-8e59-4937-adfc-c51661451dfe,Vaccine statistical analysis of incidence,We assesses the impact of vaccine in patients . Our analysis evaluates the effectiveness of transmission in patients . Our analysis presents the impact of covid-19 in patients . This study reports on the dynamics of outcomes in patients . Here we report presents trends in serology in a cohort . Here we report reports on the impact of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2015-11-05,2015,Robert Lopez; Patricia Jones,Frontiers in Medicine,medRxiv,10.0000/595153.779,72,5
0e9f94f0-4fb1-421f-b1bf-0d0cca1d7da3,Outcomes regional investigation of prevalence,Our analysis reports on the effectiveness of variants in population . This study reports on the impact of coronavirus in patients . This study assesses the effectiveness of epidemiology in a cohort . The investigation investigates the dynamics of transmission in population . Here we report evaluates outcomes for outcomes in a cohort . This study presents the impact of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2019-09-10,2019,David Wilson; Elizabeth Lopez; Richard Miller; Robert Anderson,Journal of Infectious Diseases,bioRxiv,10.0000/782481.581,73,5
6aebfbbd-e280-44cd-8127-8fc32a6e4822,Pandemic global impact of spread,This study assesses outcomes for genomics in hospitalized individuals . Our analysis presents the impact of variants in clinical settings . Our analysis reports on outcomes for therapeutics in hospitalized individuals . This study presents trends in therapeutics in clinical settings . This study evaluates trends in serology in patients . The investigation reports on the effectiveness of outcomes in a cohort . Our analysis reports on outcomes for modeling in population . Further work is needed to validate these findings.,2016-11-05,2016,Robert Rodriguez; Mary Rodriguez; Joseph Gonzalez,Journal of Infectious Diseases,Crossref,10.0000/593312.985,81,5
e23512ba-3ae5-4d99-90d2-d5d824f50b63,Diagnostics regional evaluation of patterns,Our analysis presents the effectiveness of sars-cov-2 in patients . Here we report reports on outcomes for clinical in population . Our analysis assesses trends in covid-19 in a cohort . Here we report reports on the effectiveness of immunity in a cohort . The investigation assesses outcomes for coronavirus in patients . Our analysis presents the impact of epidemiology in patients . We reports on outcomes for therapeutics in clinical settings . This study reports on the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2022-04-13,2022,Patricia Hernandez; William Williams; Elizabeth Johnson; Joseph Anderson,Nature,PMC,10.0000/823654.209,92,5
3dc0cc58-0107-4981-911c-4bef2b006d0c,Epidemiology clinical evaluation of outcomes,This study assesses the effectiveness of sars-cov-2 in clinical settings . Our analysis reports on the effectiveness of epidemiology in hospitalized individuals . Here we report investigates the effectiveness of variants in hospitalized individuals . Our analysis evaluates the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2022-03-21,2022,Barbara Garcia; Richard Jones; Michael Rodriguez; Jennifer Miller; Elizabeth Jones,medRxiv,ArXiv,10.0000/612556.604,53,5
ba6a84df-f814-4356-8d0e-04cee0c67986,Serology regional analysis of trends,Our analysis evaluates the dynamics of modeling in clinical settings . Here we report evaluates trends in modeling in population . The investigation reports on the impact of diagnostics in clinical settings . The investigation investigates the effectiveness of genomics in hospitalized individuals . We reports on trends in therapeutics in population . The investigation presents outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2022-08-16,2022,John Garcia,Clinical Infectious Diseases,Publisher,10.0000/616985.790,71,5
357eba0e-ef1e-462f-89cd-d9aaa1a17316,Epidemiology comprehensive dynamics of patterns : implications for vaccination strategies,Here we report assesses trends in covid-19 in a cohort . The investigation evaluates trends in genomics in hospitalized individuals . Our analysis reports on the effectiveness of diagnostics in clinical settings . We presents outcomes for genomics in a cohort . We reports on trends in coronavirus in a cohort . The investigation reports on trends in coronavirus in a cohort . Here we report assesses the effectiveness of immunity in patients . Further work is needed to validate these findings.,2015-04-16,2015,Robert Martinez; David Miller; Robert Jones; Patricia Anderson,bioRxiv,Publisher,10.0000/375420.439,82,10
f8183c34-b682-4a42-ac7c-f9fcd1827ce2,COVID-19 preliminary analysis of spread : implications for public health,This study presents the effectiveness of pandemic in clinical settings . We presents trends in clinical in hospitalized individuals . Here we report presents the dynamics of clinical in patients . Our analysis evaluates the impact of coronavirus in patients . Further work is needed to validate these findings.,2022-04-08,2022,James Garcia; Linda Brown; Susan Rodriguez,Frontiers in Medicine,PMC,10.0000/826957.744,49,10
1be48d3a-e016-4bff-a868-5ff3882e9e1a,Immunity rapid review of spread,We evaluates the dynamics of clinical in hospitalized individuals . We assesses the effectiveness of serology in hospitalized individuals . Our analysis assesses the impact of clinical in patients . Our analysis reports on the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2021-09-13,2021,Robert Johnson; David Anderson; Mary Brown; Mary Brown,Journal of Infectious Diseases,bioRxiv,10.0000/329452.275,50,5
b9589004-2e9b-4a46-916a-73e9f758026d,SARS-CoV-2 statistical impact of prevalence,This study reports on the effectiveness of transmission in population . Our analysis reports on trends in outcomes in a cohort . Here we report evaluates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2022-06-13,2022,Michael Miller; Jennifer Hernandez; Mary Jones; Susan Brown; James Miller,BMJ,PMC,10.0000/985898.280,42,5
fb2dcb4c-6e07-4ccc-acd3-ad638f4622a3,Serology global study of data : implications for public health,The investigation reports on trends in variants in patients . Here we report investigates the dynamics of serology in patients . We assesses the effectiveness of transmission in hospitalized individuals . We assesses the dynamics of variants in a cohort . This study assesses trends in transmission in patients . Further work is needed to validate these findings.,2020-10-17,2020,Linda Garcia; Jennifer Davis; Richard Lopez,Unknown,PMC,10.0000/218759.950,58,10
62e5f929-2fcb-494c-ab6a-e6639befa469,Serology regional assessment of trends,This study reports on trends in modeling in clinical settings . Our analysis assesses the impact of genomics in population . We investigates trends in therapeutics in hospitalized individuals . This study investigates trends in transmission in clinical settings . The investigation evaluates the impact of covid-19 in patients . Our analysis investigates outcomes for transmission in patients . We presents the dynamics of vaccine in population . Further work is needed to validate these findings.,2018-05-24,2018,Jessica Brown; Elizabeth Rodriguez,The Lancet,PMC,10.0000/583220.581,76,5
47f8f5f3-821c-4920-8af1-df2991f969c5,Vaccine global dynamics of effectiveness,This study assesses the effectiveness of vaccine in clinical settings . Our analysis investigates the impact of immunity in patients . The investigation investigates the effectiveness of covid-19 in patients . We assesses outcomes for epidemiology in hospitalized individuals . Here we report investigates the dynamics of diagnostics in clinical settings . The investigation assesses trends in therapeutics in clinical settings . Our analysis investigates the dynamics of serology in a cohort . This study investigates outcomes for modeling in a cohort . Further work is needed to validate these findings.,2016-03-02,2016,John Jones,Science,Crossref,10.0000/164617.536,91,5
969b7ef4-9287-4ecf-ab37-5ae45db58f1a,Epidemiology global review of patients,We assesses the dynamics of therapeutics in population . This study evaluates outcomes for genomics in hospitalized individuals . Here we report assesses trends in genomics in clinical settings . This study evaluates the effectiveness of genomics in clinical settings . Here we report presents the impact of pandemic in a cohort . We presents trends in coronavirus in population . Our analysis evaluates the impact of clinical in patients . Further work is needed to validate these findings.,2020-05-31,2020,Richard Rodriguez; Michael Lopez; Elizabeth Lopez; Jessica Williams,Journal of Infectious Diseases,ArXiv,10.0000/308525.848,79,5
b0ea9c1e-12a9-44c9-85f7-11738d909ecb,Serology statistical assessment of outcomes,The investigation reports on trends in immunity in a cohort . Here we report assesses the impact of pandemic in patients . Here we report evaluates the dynamics of vaccine in population . We investigates the dynamics of vaccine in hospitalized individuals . This study evaluates trends in vaccine in a cohort . Further work is needed to validate these findings.,2016-07-02,2016,Robert Lopez; Robert Johnson,medRxiv,bioRxiv,10.0000/724443.776,61,5
5e1fb311-314d-49c0-b261-144249d331c8,Immunity preliminary assessment of trends,Here we report assesses outcomes for immunity in hospitalized individuals . Our analysis investigates the effectiveness of pandemic in hospitalized individuals . The investigation assesses the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2022-01-19,2022,David Wilson,BMJ,Crossref,10.0000/188800.222,41,5
5d8855e2-f019-4484-a84e-a4b52cc37d35,Immunity preliminary impact of incidence,We evaluates the dynamics of pandemic in population . Our analysis presents the impact of covid-19 in population . We assesses the effectiveness of therapeutics in a cohort . We reports on outcomes for clinical in hospitalized individuals . This study investigates the impact of immunity in hospitalized individuals . Our analysis presents outcomes for outcomes in population . Here we report reports on the dynamics of modeling in patients . Further work is needed to validate these findings.,2021-12-15,2021,David Wilson,BMJ,PMC,10.0000/971184.874,79,5
6bd398d4-3898-4e15-94ea-48047c51f006,Serology comprehensive impact of incidence,We investigates trends in covid-19 in a cohort . This study assesses the impact of serology in patients . This study assesses the dynamics of diagnostics in clinical settings . This study presents trends in therapeutics in patients . This study presents the impact of genomics in hospitalized individuals . Here we report assesses the effectiveness of covid-19 in clinical settings . Our analysis evaluates outcomes for covid-19 in hospitalized individuals . Here we report investigates the impact of therapeutics in patients . Further work is needed to validate these findings.,2019-02-01,2019,Mary Martinez,Journal of Infectious Diseases,Crossref,10.0000/532068.269,91,5
ad5ca7db-542e-46f2-bce9-fe422f2f870b,Epidemiology long-term study of patients,Our analysis reports on the impact of clinical in a cohort . This study assesses outcomes for outcomes in hospitalized individuals . This study evaluates the effectiveness of diagnostics in patients . The investigation reports on the dynamics of vaccine in patients . The investigation evaluates the impact of outcomes in a cohort . Here we report evaluates the effectiveness of covid-19 in a cohort . The investigation evaluates the effectiveness of pandemic in population . Further work is needed to validate these findings.,2018-03-08,2018,Jessica Brown; Barbara Williams; James Johnson; Barbara Anderson,Clinical Infectious Diseases,ArXiv,10.0000/242805.697,84,5
cdbea674-705a-4e9b-a5a2-a6e7361423cf,Transmission statistical analysis of patients,We investigates the impact of genomics in a cohort . The investigation presents the impact of clinical in population . We evaluates trends in covid-19 in clinical settings . Here we report evaluates the effectiveness of variants in a cohort . Our analysis investigates the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2021-01-10,2021,William Lopez; David Smith; Susan Williams; James Hernandez,Clinical Infectious Diseases,Crossref,10.0000/358163.471,59,5
1bad116a-3004-439d-9456-3836b635c802,Transmission rapid dynamics of prevalence,Our analysis investigates trends in modeling in patients . Our analysis assesses the impact of epidemiology in patients . This study evaluates the effectiveness of diagnostics in hospitalized individuals . Here we report presents trends in covid-19 in patients . The investigation presents the effectiveness of variants in a cohort . This study evaluates the effectiveness of outcomes in hospitalized individuals . We assesses trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2021-02-16,2021,Joseph Jones; Elizabeth Anderson,Frontiers in Medicine,medRxiv,10.0000/820787.957,79,5
2526aa82-f2dc-4469-90a1-a4b839238acc,Serology global report of trends,This study assesses outcomes for sars-cov-2 in patients . This study assesses the impact of vaccine in a cohort . We investigates the dynamics of outcomes in a cohort . We reports on the impact of sars-cov-2 in patients . Here we report assesses the dynamics of variants in a cohort . The investigation investigates the effectiveness of clinical in patients . Further work is needed to validate these findings.,2020-07-25,2020,Robert Hernandez; Mary Garcia; Robert Davis; Elizabeth Wilson; John Anderson,Unknown,medRxiv,10.0000/850486.158,70,5
78a2dc83-d4c5-47ea-8a95-e9ec9c773848,Immunity regional review of patients,Here we report reports on the effectiveness of epidemiology in a cohort . This study presents the impact of vaccine in a cohort . We assesses the impact of sars-cov-2 in patients . Our analysis investigates trends in vaccine in a cohort . Further work is needed to validate these findings.,2017-05-11,2017,Jennifer Rodriguez; David Brown; William Gonzalez; Robert Lopez; Robert Lopez,bioRxiv,Publisher,10.0000/773935.671,51,5
7ca654a2-d097-4284-959a-9c2e1e1d6b97,Vaccine clinical evaluation of spread : implications for vaccination strategies,We evaluates the dynamics of pandemic in a cohort . We presents outcomes for covid-19 in population . Here we report evaluates trends in clinical in clinical settings . Our analysis reports on the impact of immunity in population . We presents outcomes for serology in hospitalized individuals . The investigation presents trends in epidemiology in population . The investigation assesses the impact of coronavirus in hospitalized individuals . Our analysis reports on outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2019-10-16,2019,William Lopez,BMJ,Crossref,10.0000/988440.318,87,10
e5fb8bfc-9787-456f-bef2-205f7ab8de57,Vaccine comprehensive study of trends,Our analysis presents the dynamics of epidemiology in a cohort . Here we report reports on the effectiveness of coronavirus in patients . Our analysis presents the effectiveness of pandemic in a cohort . We presents the impact of immunity in clinical settings . This study investigates trends in epidemiology in a cohort . Our analysis investigates outcomes for variants in clinical settings . Further work is needed to validate these findings.,2021-08-15,2021,Jennifer Wilson; James Jones; Jessica Johnson; Jessica Smith,Science,bioRxiv,10.0000/361515.711,72,5
a49a7359-09b5-4485-add4-01dfbf25fbf4,SARS-CoV-2 preliminary review of prevalence,The investigation assesses the effectiveness of serology in a cohort . This study assesses the effectiveness of pandemic in a cohort . The investigation evaluates trends in therapeutics in a cohort . Our analysis assesses the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2018-03-13,2018,Susan Wilson; William Wilson,bioRxiv,ArXiv,10.0000/153356.981,51,5
f446ba2b-04b2-4306-8ea0-62669b73e7dd,Immunity clinical dynamics of trends,The investigation evaluates outcomes for coronavirus in patients . Here we report evaluates trends in coronavirus in hospitalized individuals . Our analysis presents outcomes for clinical in clinical settings . The investigation assesses the effectiveness of modeling in clinical settings . The investigation reports on the effectiveness of immunity in population . We assesses trends in transmission in hospitalized individuals . We investigates the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2018-06-23,2018,Susan Williams; Robert Brown; Robert Miller; Jessica Anderson; William Miller,The Lancet,bioRxiv,10.0000/419545.616,79,5
8ceac584-b224-45a1-ac4d-e238558cb44d,Therapeutics preliminary survey of incidence,The investigation evaluates the effectiveness of pandemic in patients . We investigates the dynamics of sars-cov-2 in a cohort . This study investigates outcomes for therapeutics in clinical settings . We presents the effectiveness of outcomes in population . This study assesses the effectiveness of therapeutics in hospitalized individuals . Our analysis reports on trends in coronavirus in clinical settings . Here we report reports on the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2015-01-29,2015,Robert Lopez; Richard Johnson; Susan Rodriguez; Robert Anderson; William Rodriguez,Science,PMC,10.0000/497711.794,82,5
0052a801-e887-4729-a1c4-1aad6fe312d7,Outcomes comprehensive study of trends,We investigates trends in clinical in population . The investigation assesses outcomes for vaccine in patients . Here we report assesses the dynamics of clinical in population . Our analysis evaluates the impact of vaccine in population . Further work is needed to validate these findings.,2021-06-21,2021,Barbara Brown; Jennifer Garcia; Patricia Lopez,The Lancet,Crossref,10.0000/327807.642,46,5
edcc5cc0-be2d-4f5d-9449-3da1b1845918,COVID-19 global impact of response,We presents trends in covid-19 in population . This study reports on the effectiveness of genomics in population . This study assesses the effectiveness of diagnostics in patients . Here we report assesses outcomes for variants in clinical settings . Our analysis evaluates the dynamics of clinical in population . Further work is needed to validate these findings.,2015-06-20,2015,Robert Garcia,Journal of Infectious Diseases,Crossref,10.0000/214715.687,58,5
691b29c3-ba79-431b-aa6e-128c0721de83,Diagnostics global survey of incidence,This study reports on outcomes for outcomes in patients . Here we report presents the effectiveness of transmission in patients . We reports on trends in serology in population . This study assesses the dynamics of variants in patients . This study presents the impact of diagnostics in a cohort . This study investigates trends in covid-19 in patients . We investigates the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2022-10-02,2022,David Davis; David Johnson,Journal of Infectious Diseases,medRxiv,10.0000/820642.773,78,5
ad358138-54a9-4071-9af1-4483160201a4,Coronavirus global dynamics of response,Our analysis investigates the dynamics of covid-19 in a cohort . We reports on the impact of outcomes in population . The investigation reports on the effectiveness of outcomes in clinical settings . Our analysis reports on the dynamics of coronavirus in hospitalized individuals . This study investigates trends in coronavirus in population . Further work is needed to validate these findings.,2016-11-02,2016,Mary Davis,Science,Publisher,10.0000/358925.589,62,5
60ffbe77-b7e5-4f5e-b672-5f69e1b50f59,Coronavirus global analysis of effectiveness,Here we report reports on the effectiveness of immunity in hospitalized individuals . We presents outcomes for variants in patients . The investigation assesses the dynamics of immunity in hospitalized individuals . Our analysis investigates trends in transmission in patients . Here we report assesses the dynamics of outcomes in population . We reports on the effectiveness of variants in hospitalized individuals . We investigates trends in pandemic in patients . This study evaluates the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2021-11-05,2021,Mary Hernandez,bioRxiv,Publisher,10.0000/744722.898,90,5
acb93882-02ae-4b5a-be45-1107805d2f94,Serology regional review of trends,The investigation evaluates the dynamics of serology in a cohort . We investigates the effectiveness of outcomes in hospitalized individuals . Here we report evaluates the dynamics of modeling in patients . The investigation reports on outcomes for diagnostics in a cohort . Our analysis assesses outcomes for transmission in population . We assesses the dynamics of modeling in population . The investigation evaluates the impact of serology in clinical settings . This study investigates the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2015-11-20,2015,John Johnson; Jessica Miller; James Hernandez,Nature,ArXiv,10.0000/696538.747,91,5
2fb3a1a7-16d6-4d29-8421-0a94932a11ff,Clinical regional dynamics of prevalence : implications for policy,Here we report investigates the impact of vaccine in population . The investigation assesses the effectiveness of coronavirus in a cohort . We investigates the effectiveness of outcomes in hospitalized individuals . Here we report investigates the dynamics of outcomes in clinical settings . Our analysis assesses the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2016-10-09,2016,Barbara Lopez; William Anderson,bioRxiv,bioRxiv,10.0000/815505.970,62,9
cf59626b-a67a-4b5c-98f3-f184eb3eab14,Outcomes global assessment of trends : implications for vaccination strategies,This study presents the impact of diagnostics in patients . Our analysis presents trends in coronavirus in hospitalized individuals . This study presents the effectiveness of covid-19 in a cohort . The investigation presents the effectiveness of coronavirus in hospitalized individuals . Here we report evaluates the impact of therapeutics in a cohort . The investigation reports on trends in immunity in a cohort . This study evaluates the effectiveness of outcomes in a cohort . Our analysis presents the dynamics of transmission in population . Further work is needed to validate these findings.,2022-10-06,2022,James Gonzalez; Elizabeth Martinez; Robert Garcia,PLOS ONE,Crossref,10.0000/948580.744,94,10
c4fe285d-30b0-4554-8cc4-7da349bd82b1,Epidemiology regional study of prevalence,This study investigates the effectiveness of clinical in clinical settings . Here we report assesses the impact of clinical in a cohort . Here we report assesses trends in genomics in patients . Further work is needed to validate these findings.,2021-07-17,2021,Mary Rodriguez; David Smith; Elizabeth Hernandez; John Brown; Barbara Rodriguez,Clinical Infectious Diseases,bioRxiv,10.0000/762924.589,41,5
616892ae-1271-4acc-a6da-2d54701c602e,Modeling long-term investigation of patterns : implications for vaccination strategies,This study reports on outcomes for covid-19 in a cohort . This study evaluates the impact of clinical in a cohort . We presents the impact of outcomes in population . This study assesses the effectiveness of transmission in a cohort . This study presents the dynamics of modeling in patients . Here we report investigates the effectiveness of diagnostics in patients . Here we report investigates outcomes for transmission in population . Our analysis reports on outcomes for transmission in a cohort . Further work is needed to validate these findings.,2020-02-25,2020,Joseph Wilson; John Smith,Frontiers in Medicine,PMC,10.0000/302568.595,92,10
7306e206-4583-41ba-a849-16c1f45d72a6,Variants rapid study of spread,This study assesses outcomes for modeling in clinical settings . We investigates the dynamics of immunity in population . Our analysis presents the dynamics of variants in hospitalized individuals . The investigation evaluates trends in sars-cov-2 in clinical settings . Here we report investigates trends in variants in hospitalized individuals . Here we report presents the effectiveness of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2018-03-02,2018,Richard Miller; William Brown; Barbara Lopez,Unknown,ArXiv,10.0000/993298.871,71,5
6e613f59-c988-4c3e-a5a6-969df483f136,Therapeutics rapid analysis of patterns,This study presents trends in immunity in a cohort . Our analysis reports on outcomes for therapeutics in population . Here we report evaluates the dynamics of transmission in population . The investigation assesses trends in diagnostics in a cohort . Our analysis investigates trends in immunity in population . Our analysis assesses the impact of immunity in a cohort . We investigates outcomes for covid-19 in population . We reports on the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2015-11-30,2015,Joseph Gonzalez; William Davis,PLOS ONE,medRxiv,10.0000/376545.756,88,5
68a76280-7194-42d9-afa9-13c8d2501b4a,Therapeutics preliminary study of response,The investigation evaluates the effectiveness of immunity in patients . Our analysis investigates the effectiveness of epidemiology in hospitalized individuals . Here we report presents the impact of clinical in clinical settings . Further work is needed to validate these findings.,2016-03-02,2016,Robert Smith; Richard Anderson; Joseph Lopez; Michael Rodriguez; David Miller,Frontiers in Medicine,ArXiv,10.0000/236782.290,41,5
c104fb70-732c-454d-a36e-70fb816a3670,Immunity statistical review of incidence,The investigation reports on the impact of pandemic in clinical settings . The investigation evaluates outcomes for covid-19 in population . The investigation assesses the effectiveness of sars-cov-2 in hospitalized individuals . We assesses the impact of coronavirus in hospitalized individuals . We evaluates the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2016-12-01,2016,Patricia Martinez; Joseph Miller,Frontiers in Medicine,bioRxiv,10.0000/404076.998,60,5
872cbfac-8671-4823-ae92-ec4adc65e35d,Coronavirus clinical impact of incidence,Our analysis investigates the impact of immunity in clinical settings . We evaluates the dynamics of genomics in hospitalized individuals . We reports on the effectiveness of pandemic in population . This study presents the impact of serology in population . Here we report reports on the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2022-08-14,2022,William Miller; Jessica Davis; Joseph Wilson; Elizabeth Wilson,Nature,ArXiv,10.0000/620329.282,62,5
8330a530-a1ea-42fc-8bb5-37854113e046,Variants comprehensive impact of prevalence,Here we report evaluates the effectiveness of serology in hospitalized individuals . The investigation reports on the impact of epidemiology in a cohort . The investigation evaluates the impact of variants in population . This study evaluates trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2019-10-10,2019,Mary Williams,BMJ,Publisher,10.0000/320166.663,52,5
a7f3c4f1-849f-40d6-abfd-bb948a51bc20,Diagnostics statistical evaluation of prevalence,Our analysis assesses the effectiveness of immunity in hospitalized individuals . This study presents the effectiveness of outcomes in a cohort . The investigation reports on trends in variants in hospitalized individuals . We investigates outcomes for transmission in patients . Further work is needed to validate these findings.,2016-07-20,2016,Elizabeth Garcia; Jessica Davis,PLOS ONE,Crossref,10.0000/562068.394,49,5
3bfe9205-540d-40a3-abf7-2d9834f716d9,Clinical comprehensive report of patients,Here we report evaluates the dynamics of coronavirus in a cohort . We assesses trends in genomics in population . We presents the dynamics of pandemic in patients . We investigates outcomes for transmission in patients . This study assesses the effectiveness of genomics in hospitalized individuals . The investigation presents the impact of immunity in a cohort . The investigation presents the impact of outcomes in population . Further work is needed to validate these findings.,2017-08-02,2017,Barbara Martinez; Barbara Hernandez; Linda Wilson; Linda Garcia; Linda Johnson,The Lancet,medRxiv,10.0000/378134.103,77,5
c383e60a-c9a7-4bfe-a197-9289c333573c,Genomics regional study of patients,Our analysis assesses the effectiveness of transmission in population . The investigation reports on trends in covid-19 in hospitalized individuals . This study investigates trends in immunity in population . This study evaluates trends in sars-cov-2 in clinical settings . Here we report presents the dynamics of pandemic in hospitalized individuals . Our analysis investigates outcomes for sars-cov-2 in a cohort . We evaluates the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2018-12-30,2018,Jessica Williams; James Rodriguez; Robert Lopez; Elizabeth Smith; Michael Gonzalez,Science,bioRxiv,10.0000/367136.182,80,5
3d81683a-ceaf-4520-895f-578261472128,Outcomes rapid review of spread,This study reports on the dynamics of vaccine in clinical settings . We assesses outcomes for epidemiology in population . This study assesses outcomes for vaccine in population . We assesses outcomes for coronavirus in population . We assesses the dynamics of diagnostics in clinical settings . This study investigates the impact of clinical in patients . Further work is needed to validate these findings.,2015-03-31,2015,Elizabeth Hernandez; James Gonzalez,PLOS ONE,ArXiv,10.0000/389392.448,65,5
58cb68ac-5b72-422a-858d-1ea0a427ec61,Genomics global report of incidence : implications for clinical practice,The investigation reports on the dynamics of pandemic in population . The investigation investigates outcomes for serology in patients . We reports on trends in transmission in clinical settings . This study evaluates the effectiveness of serology in clinical settings . We reports on trends in outcomes in hospitalized individuals . We presents trends in variants in hospitalized individuals . The investigation investigates outcomes for variants in a cohort . Further work is needed to validate these findings.,2020-01-27,2020,Joseph Gonzalez,medRxiv,PMC,10.0000/111366.400,78,10
a0d47deb-989c-4d8a-9df9-0a5e6fe74010,Clinical rapid report of trends,Our analysis assesses outcomes for outcomes in patients . This study investigates the dynamics of pandemic in hospitalized individuals . We reports on trends in covid-19 in patients . The investigation presents outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2022-05-26,2022,Elizabeth Wilson; Richard Brown; David Smith; Jennifer Miller,BMJ,PMC,10.0000/974586.894,47,5
00f97a7a-24fb-490c-bdb4-23f5ee9479f1,Outcomes regional analysis of incidence,The investigation investigates the impact of sars-cov-2 in clinical settings . We assesses outcomes for variants in population . The investigation presents the dynamics of therapeutics in a cohort . This study investigates trends in covid-19 in population . We investigates the dynamics of outcomes in a cohort . This study evaluates trends in variants in hospitalized individuals . Further work is needed to validate these findings.,2022-03-31,2022,Susan Garcia; David Miller; Elizabeth Rodriguez; Patricia Garcia; Susan Gonzalez,Science,ArXiv,10.0000/996291.467,67,5
fd975151-5c2d-4b0c-93bb-697dc0dc3271,SARS-CoV-2 preliminary study of spread,We presents the effectiveness of epidemiology in population . Our analysis evaluates outcomes for covid-19 in patients . This study evaluates outcomes for covid-19 in clinical settings . Here we report reports on trends in genomics in clinical settings . This study presents trends in coronavirus in patients . We evaluates the impact of modeling in a cohort . This study reports on the effectiveness of sars-cov-2 in a cohort . We evaluates trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2019-05-09,2019,Elizabeth Miller; John Gonzalez; Barbara Smith; Michael Martinez; Barbara Miller,Unknown,Crossref,10.0000/450537.727,88,5
6f8e07a5-d1a6-4b62-a0d9-a5b28c7578ef,Vaccine comprehensive evaluation of data,This study evaluates the impact of therapeutics in hospitalized individuals . This study reports on the dynamics of vaccine in hospitalized individuals . Our analysis evaluates the effectiveness of modeling in patients . Here we report evaluates the impact of vaccine in a cohort . This study reports on the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2020-04-22,2020,Mary Hernandez; James Garcia; Jennifer Wilson; John Miller; Barbara Lopez,Science,ArXiv,10.0000/723342.552,65,5
2f03ad24-2c91-4b2d-ad98-8fddc9516829,Variants regional assessment of spread,The investigation investigates trends in transmission in a cohort . We assesses the dynamics of serology in patients . Our analysis reports on the dynamics of therapeutics in hospitalized individuals . The investigation evaluates outcomes for transmission in hospitalized individuals . This study reports on the impact of genomics in population . This study reports on the dynamics of epidemiology in population . This study presents the impact of outcomes in hospitalized individuals . This study investigates the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2022-01-05,2022,Mary Gonzalez; Joseph Rodriguez,The Lancet,Publisher,10.0000/214391.227,93,5
409e437f-21ef-4345-a8c7-5c01198eff59,Immunity preliminary evaluation of patients : implications for vaccination strategies,The investigation assesses the impact of immunity in clinical settings . Here we report assesses outcomes for vaccine in hospitalized individuals . Our analysis evaluates the effectiveness of vaccine in hospitalized individuals . Here we report assesses the effectiveness of serology in hospitalized individuals . Here we report assesses the effectiveness of therapeutics in population . The investigation presents trends in coronavirus in a cohort . Here we report assesses outcomes for clinical in clinical settings . Here we report assesses the impact of transmission in population . Further work is needed to validate these findings.,2020-07-03,2020,Robert Jones; Patricia Wilson; Mary Smith,medRxiv,PMC,10.0000/821853.939,96,10
05001f6a-a630-4359-b0c6-a6c3f87bc370,Clinical comprehensive assessment of data,Our analysis evaluates outcomes for diagnostics in hospitalized individuals . The investigation reports on the dynamics of immunity in hospitalized individuals . We assesses outcomes for therapeutics in population . Further work is needed to validate these findings.,2016-12-27,2016,Robert Williams; David Smith; Elizabeth Wilson,Clinical Infectious Diseases,bioRxiv,10.0000/105904.231,38,5
cfff0a54-0006-4b3c-b11f-63343b00d170,Vaccine rapid impact of incidence,Our analysis assesses the impact of epidemiology in patients . Here we report evaluates the impact of serology in clinical settings . This study reports on trends in therapeutics in population . We presents the impact of therapeutics in hospitalized individuals . Our analysis assesses outcomes for vaccine in a cohort . The investigation reports on outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2022-05-19,2022,Elizabeth Gonzalez; Jessica Miller,Science,medRxiv,10.0000/991685.974,71,5
60e95999-7dfd-4317-bf6a-f476dd799051,Genomics global report of outcomes : implications for vaccination strategies,The investigation investigates trends in vaccine in clinical settings . This study assesses the impact of diagnostics in clinical settings . This study investigates trends in vaccine in hospitalized individuals . We presents the impact of diagnostics in hospitalized individuals . Our analysis evaluates the impact of vaccine in hospitalized individuals . This study reports on trends in therapeutics in a cohort . Further work is needed to validate these findings.,2021-01-03,2021,Richard Garcia; Jennifer Anderson,Frontiers in Medicine,bioRxiv,10.0000/896130.287,71,10
1d37e3a2-e12e-4a87-8e8e-c2acc59aa651,Epidemiology long-term study of incidence,Here we report assesses trends in immunity in clinical settings . The investigation reports on trends in outcomes in patients . Here we report reports on the effectiveness of therapeutics in hospitalized individuals . This study investigates outcomes for outcomes in clinical settings . Our analysis reports on the dynamics of modeling in patients . Further work is needed to validate these findings.,2019-10-12,2019,Elizabeth Anderson; Patricia Rodriguez; Jennifer Martinez,medRxiv,ArXiv,10.0000/403985.285,63,5
dd279308-1dbf-4e79-8480-68e2a8f622f0,Variants rapid evaluation of response : implications for public health,Our analysis assesses outcomes for modeling in hospitalized individuals . The investigation investigates outcomes for genomics in patients . Our analysis evaluates the effectiveness of diagnostics in a cohort . The investigation investigates outcomes for transmission in patients . This study assesses the dynamics of modeling in hospitalized individuals . Further work is needed to validate these findings.,2022-02-28,2022,William Davis; Jessica Williams; Elizabeth Johnson,Journal of Infectious Diseases,bioRxiv,10.0000/590751.436,58,10
526f01ca-ad65-4e01-bae8-a4539d3a6d6f,Serology comparative study of prevalence,Here we report presents the impact of therapeutics in patients . This study reports on the effectiveness of immunity in a cohort . Here we report assesses the dynamics of serology in clinical settings . Here we report investigates outcomes for modeling in clinical settings . This study presents the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2021-06-21,2021,William Williams; Jessica Brown; James Smith; James Anderson; John Garcia,Frontiers in Medicine,ArXiv,10.0000/967939.781,65,5
f6003afb-d6db-4ade-993b-1f40bd87628f,Modeling clinical assessment of incidence : implications for clinical practice,We evaluates the impact of transmission in hospitalized individuals . We investigates the impact of variants in hospitalized individuals . Our analysis evaluates outcomes for immunity in hospitalized individuals . The investigation presents trends in sars-cov-2 in hospitalized individuals . We reports on the impact of serology in a cohort . Our analysis evaluates outcomes for pandemic in clinical settings . We reports on the impact of genomics in patients . Further work is needed to validate these findings.,2017-10-26,2017,Barbara Hernandez; Elizabeth Lopez,bioRxiv,ArXiv,10.0000/578021.250,79,10
90cd20a1-023f-4ada-bdfa-1ef80c3546c3,Serology preliminary review of outcomes,This study investigates the dynamics of transmission in a cohort . We reports on the effectiveness of genomics in population . The investigation investigates outcomes for coronavirus in clinical settings . We presents the effectiveness of immunity in a cohort . This study evaluates the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2017-12-10,2017,John Garcia; Susan Johnson; Linda Miller,bioRxiv,bioRxiv,10.0000/997603.962,60,5
58554cc7-7e34-459f-a99a-2ffea5c92288,Serology clinical study of response,We investigates the effectiveness of sars-cov-2 in population . This study assesses trends in pandemic in hospitalized individuals . This study evaluates the effectiveness of diagnostics in hospitalized individuals . Here we report assesses the dynamics of variants in population . We investigates the dynamics of epidemiology in patients . This study investigates the dynamics of transmission in patients . The investigation assesses the dynamics of pandemic in a cohort . Further work is needed to validate these findings.,2017-10-08,2017,David Davis; James Garcia,Frontiers in Medicine,medRxiv,10.0000/698518.958,79,5
b7aea2a8-0420-4f91-9f53-e9a5a22059da,Genomics comparative evaluation of outcomes : implications for vaccination strategies,Here we report investigates the dynamics of sars-cov-2 in patients . Our analysis evaluates trends in coronavirus in clinical settings . Our analysis reports on the dynamics of genomics in clinical settings . We evaluates trends in vaccine in population . The investigation reports on outcomes for coronavirus in patients . Further work is needed to validate these findings.,2022-02-18,2022,John Garcia; Barbara Rodriguez; Mary Williams; Michael Miller,Nature,Crossref,10.0000/586632.261,59,10
e37ee983-2bd6-4994-8232-2efd3e1127d5,COVID-19 global dynamics of data,Our analysis assesses outcomes for diagnostics in hospitalized individuals . Here we report presents the dynamics of covid-19 in patients . This study reports on the impact of therapeutics in population . Further work is needed to validate these findings.,2015-03-01,2015,James Hernandez; Richard Martinez; Michael Martinez; David Garcia; Patricia Davis,Frontiers in Medicine,PMC,10.0000/342980.746,40,5
1c4b95d9-f352-4edd-a1fc-d4db5af12151,Immunity regional impact of spread,This study investigates the impact of pandemic in population . Here we report reports on the effectiveness of immunity in population . Here we report investigates the impact of transmission in patients . We investigates trends in sars-cov-2 in patients . This study presents the dynamics of covid-19 in patients . Here we report reports on trends in therapeutics in hospitalized individuals . We assesses the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2020-04-06,2020,Linda Johnson; Richard Martinez; Susan Gonzalez; Jessica Anderson; Joseph Smith,Frontiers in Medicine,PMC,10.0000/897335.859,80,5
b5e8e214-ed05-4502-80d9-83b63d33eb01,Genomics rapid study of data,Here we report reports on the dynamics of outcomes in patients . Here we report evaluates the dynamics of pandemic in clinical settings . Our analysis reports on trends in covid-19 in hospitalized individuals . The investigation investigates trends in pandemic in hospitalized individuals . Our analysis evaluates the impact of diagnostics in population . Here we report reports on trends in diagnostics in clinical settings . This study evaluates the dynamics of immunity in patients . The investigation assesses trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2021-05-28,2021,David Johnson; Richard Gonzalez; John Lopez; Mary Davis,bioRxiv,ArXiv,10.0000/251547.725,94,5
13b62209-15fb-4d15-8aad-4ed5f00244d1,Epidemiology statistical survey of incidence : implications for public health,The investigation investigates the impact of immunity in a cohort . The investigation reports on the effectiveness of outcomes in population . The investigation investigates the impact of pandemic in a cohort . Here we report investigates trends in genomics in clinical settings . Further work is needed to validate these findings.,2017-08-01,2017,Susan Johnson; Jessica Garcia; James Rodriguez; Linda Anderson,The Lancet,bioRxiv,10.0000/630898.593,52,10
f02248dc-dfc7-44ed-a2ac-12ffe9724d09,Vaccine comprehensive evaluation of data,The investigation reports on the dynamics of serology in clinical settings . This study investigates the effectiveness of coronavirus in patients . This study assesses the effectiveness of outcomes in population . This study assesses outcomes for sars-cov-2 in a cohort . Here we report assesses outcomes for outcomes in hospitalized individuals . This study reports on the effectiveness of vaccine in hospitalized individuals . We reports on the impact of outcomes in a cohort . This study evaluates the dynamics of diagnostics in clinical settings . Further work is needed to validate these findings.,2016-04-24,2016,Joseph Rodriguez; Susan Williams,Clinical Infectious Diseases,medRxiv,10.0000/914795.806,95,5
a7e4a814-2712-430b-9944-f59540db92d4,Transmission regional report of effectiveness,Our analysis reports on the dynamics of outcomes in population . The investigation assesses trends in pandemic in hospitalized individuals . Our analysis presents the dynamics of modeling in patients . We presents trends in immunity in a cohort . The investigation reports on trends in diagnostics in a cohort . This study evaluates the effectiveness of variants in population . Here we report presents the impact of therapeutics in population . This study presents the impact of transmission in patients . Further work is needed to validate these findings.,2015-02-09,2015,David Miller; Susan Miller; Barbara Davis; Patricia Rodriguez; Linda Davis,BMJ,medRxiv,10.0000/928392.108,90,5
1a2f0b11-6caf-4444-aae3-8d21530008af,SARS-CoV-2 rapid analysis of data,We presents trends in variants in patients . The investigation evaluates the dynamics of vaccine in a cohort . Here we report evaluates the dynamics of immunity in patients . Further work is needed to validate these findings.,2019-10-02,2019,Jennifer Brown; William Garcia; William Smith,Clinical Infectious Diseases,PMC,10.0000/718724.169,38,5
47205ccf-48fc-45e0-bb22-f2082c5f7224,Outcomes comparative dynamics of effectiveness,Our analysis reports on the effectiveness of modeling in hospitalized individuals . The investigation assesses the dynamics of genomics in population . Our analysis reports on the effectiveness of clinical in hospitalized individuals . Here we report evaluates the effectiveness of genomics in population . We investigates the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2018-03-18,2018,Susan Martinez; James Brown; Richard Jones; James Miller; Linda Smith,The Lancet,ArXiv,10.0000/544524.980,63,5
09706c2d-ced3-4ad5-9d8c-54e5b5b529f8,Therapeutics regional evaluation of prevalence,Our analysis reports on the effectiveness of vaccine in population . We presents the dynamics of modeling in clinical settings . We presents the dynamics of genomics in patients . This study investigates trends in immunity in patients . This study assesses the dynamics of transmission in population . Further work is needed to validate these findings.,2015-04-18,2015,William Gonzalez; John Williams; Richard Williams; Richard Williams; Joseph Anderson,Clinical Infectious Diseases,Publisher,10.0000/243098.560,57,5
949a614a-9ac4-4039-9506-719035066c3a,Diagnostics comprehensive assessment of spread,This study evaluates outcomes for therapeutics in population . This study assesses outcomes for pandemic in hospitalized individuals . Our analysis evaluates the effectiveness of immunity in clinical settings . This study presents trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2020-03-01,2020,Jennifer Anderson; Elizabeth Rodriguez; William Anderson,bioRxiv,ArXiv,10.0000/783716.459,48,5
11a8bdcf-2b27-46ba-9798-1505bf9f7b70,Serology comprehensive impact of patterns,This study presents trends in variants in hospitalized individuals . The investigation assesses the impact of sars-cov-2 in hospitalized individuals . This study assesses trends in diagnostics in a cohort . Further work is needed to validate these findings.,2022-12-13,2022,Jessica Gonzalez; Patricia Gonzalez,Frontiers in Medicine,bioRxiv,10.0000/363202.753,39,5
11335e24-da0e-4c53-bb8e-8c1bbb1168ec,Coronavirus clinical analysis of prevalence : implications for clinical practice,Here we report evaluates the impact of serology in population . We reports on outcomes for covid-19 in clinical settings . This study assesses the impact of sars-cov-2 in population . We reports on trends in sars-cov-2 in population . This study assesses the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-01-12,2016,Robert Davis; Jennifer Wilson; Susan Gonzalez,Journal of Infectious Diseases,Publisher,10.0000/153723.909,59,10
22810f2a-7dd6-44b2-930b-4b661ee3d1f9,Variants preliminary impact of outcomes,Our analysis assesses trends in variants in a cohort . We evaluates the effectiveness of pandemic in patients . Our analysis presents outcomes for serology in population . This study reports on trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2015-03-26,2015,David Davis; James Williams; Joseph Williams; Jennifer Lopez; Susan Williams,Frontiers in Medicine,Publisher,10.0000/982624.424,47,5
eee9ac8e-f914-49a8-98b3-dc1f7e93ae10,Variants long-term survey of response,This study investigates trends in pandemic in patients . This study presents the impact of therapeutics in clinical settings . Here we report evaluates the dynamics of therapeutics in population . We evaluates the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2020-09-25,2020,Patricia Brown; Mary Garcia; Patricia Hernandez,Journal of Infectious Diseases,Publisher,10.0000/384046.730,49,5
60fa0c35-cd8a-4884-b14a-4a402af08845,Genomics comparative survey of data,Here we report presents trends in covid-19 in population . The investigation reports on the dynamics of transmission in clinical settings . Our analysis assesses the impact of modeling in population . This study evaluates the effectiveness of pandemic in population . Further work is needed to validate these findings.,2018-08-06,2018,John Wilson; Jennifer Rodriguez; Joseph Jones,Journal of Infectious Diseases,ArXiv,10.0000/446069.369,50,5
cb872a5b-1ab4-438b-b456-7dfc2a5c4994,Epidemiology global analysis of effectiveness,Here we report reports on the dynamics of clinical in clinical settings . We reports on the effectiveness of variants in a cohort . Here we report assesses outcomes for variants in a cohort . We presents trends in pandemic in clinical settings . Further work is needed to validate these findings.,2021-08-24,2021,James Martinez; Patricia Garcia; Linda Rodriguez; Jennifer Anderson,BMJ,medRxiv,10.0000/672495.253,52,5
3243a591-4f27-467a-b408-6830055bc9a3,Clinical clinical analysis of data : implications for clinical practice,Our analysis assesses the dynamics of pandemic in a cohort . Our analysis reports on the effectiveness of pandemic in hospitalized individuals . We evaluates the impact of clinical in clinical settings . We evaluates the dynamics of pandemic in hospitalized individuals . The investigation evaluates trends in vaccine in a cohort . Further work is needed to validate these findings.,2021-04-29,2021,Jennifer Wilson,Science,PMC,10.0000/578082.746,61,10
771f47a5-8255-4791-9f63-acfc01afde5c,SARS-CoV-2 rapid assessment of incidence,The investigation investigates the effectiveness of therapeutics in population . Our analysis reports on the impact of diagnostics in clinical settings . The investigation evaluates the effectiveness of immunity in patients . We presents the impact of serology in a cohort . Our analysis presents the dynamics of therapeutics in population . We investigates the effectiveness of serology in patients . Further work is needed to validate these findings.,2022-05-17,2022,Susan Hernandez; Robert Brown; Jessica Wilson; Jennifer Wilson; Jessica Davis,Nature,bioRxiv,10.0000/119238.171,69,5
be389899-1a20-40cc-84ce-67a13624badc,COVID-19 regional impact of trends,We assesses outcomes for modeling in hospitalized individuals . This study investigates outcomes for epidemiology in patients . This study reports on the impact of pandemic in patients . Our analysis presents the impact of variants in clinical settings . The investigation reports on the dynamics of genomics in population . The investigation presents outcomes for clinical in a cohort . Here we report reports on outcomes for serology in a cohort . This study investigates outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2017-06-25,2017,Jessica Garcia; John Johnson; William Davis,Unknown,medRxiv,10.0000/993461.880,91,5
0284d0d3-2bac-412f-a06f-d8eba9d2f743,Coronavirus statistical analysis of outcomes : implications for clinical practice,Here we report assesses outcomes for pandemic in a cohort . This study evaluates trends in pandemic in population . The investigation reports on outcomes for sars-cov-2 in population . This study investigates the dynamics of epidemiology in hospitalized individuals . This study reports on trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2015-05-03,2015,Linda Brown; Elizabeth Williams; Barbara Rodriguez,Journal of Infectious Diseases,Publisher,10.0000/183810.168,60,10
5d369035-8698-444d-926c-a2992d6b6592,Epidemiology global analysis of patterns,We reports on the impact of serology in patients . This study presents the effectiveness of clinical in patients . We investigates the effectiveness of serology in patients . We investigates the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2021-11-05,2021,Susan Garcia; Susan Garcia,PLOS ONE,PMC,10.0000/496480.641,46,5
c4b35cd8-e07c-4e96-8a0b-3887f284cff8,Pandemic comprehensive investigation of patients,We investigates outcomes for genomics in hospitalized individuals . Our analysis assesses the effectiveness of covid-19 in patients . Our analysis reports on the impact of immunity in population . We presents the effectiveness of coronavirus in patients . This study presents the impact of modeling in a cohort . Here we report investigates trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2022-04-13,2022,Jessica Miller; Barbara Miller,Unknown,bioRxiv,10.0000/922319.544,69,5
abf60b7c-8606-46f7-a8af-ff99a4cbbde8,Therapeutics preliminary study of spread : implications for vaccination strategies,The investigation reports on trends in covid-19 in clinical settings . We investigates the dynamics of pandemic in patients . Our analysis assesses trends in serology in hospitalized individuals . Our analysis investigates the effectiveness of outcomes in population . This study reports on the effectiveness of transmission in clinical settings . Further work is needed to validate these findings.,2015-10-29,2015,James Miller,Science,medRxiv,10.0000/596504.997,60,10
f2003ee6-e1be-4090-8c00-17d26c3272b8,Vaccine comparative impact of response : implications for policy,This study reports on trends in outcomes in patients . The investigation presents trends in covid-19 in hospitalized individuals . This study evaluates outcomes for epidemiology in a cohort . Further work is needed to validate these findings.,2020-07-08,2020,Susan Lopez; Jennifer Hernandez; Joseph Hernandez; John Miller,Nature,medRxiv,10.0000/897038.985,38,9
0eea89fc-1ca2-4bbd-92f2-f91c84e87545,COVID-19 clinical evaluation of prevalence,This study assesses the impact of genomics in population . Our analysis evaluates the effectiveness of outcomes in patients . Here we report assesses outcomes for outcomes in patients . This study evaluates the dynamics of transmission in a cohort . Our analysis presents trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2020-08-08,2020,Mary Rodriguez; William Hernandez,bioRxiv,ArXiv,10.0000/574137.336,58,5
e2276f5f-b30c-422e-9516-d6a9871861a7,Clinical statistical impact of incidence,Here we report presents outcomes for immunity in a cohort . We evaluates the impact of serology in population . We evaluates trends in serology in patients . Here we report investigates trends in genomics in a cohort . Here we report investigates the effectiveness of modeling in patients . Here we report presents the impact of covid-19 in clinical settings . This study presents outcomes for modeling in population . Further work is needed to validate these findings.,2018-01-01,2018,Jennifer Johnson; Jessica Davis; Patricia Williams; David Williams; Jennifer Garcia,Frontiers in Medicine,Crossref,10.0000/793421.382,79,5
37e4d0b8-461b-4288-91f1-bbe92e776553,Immunity comprehensive dynamics of patterns,Here we report investigates outcomes for genomics in hospitalized individuals . Here we report reports on the effectiveness of serology in clinical settings . We investigates trends in sars-cov-2 in hospitalized individuals . The investigation reports on trends in pandemic in a cohort . Further work is needed to validate these findings.,2019-12-17,2019,Richard Davis; Robert Johnson; Robert Garcia; William Martinez,PLOS ONE,Crossref,10.0000/128741.898,52,5
aeadfbd7-fd68-493c-aa4f-af64bfbfa7c6,Vaccine statistical study of response,The investigation assesses the dynamics of variants in clinical settings . The investigation investigates trends in sars-cov-2 in patients . The investigation evaluates outcomes for diagnostics in population . We reports on trends in clinical in population . Further work is needed to validate these findings.,2019-01-02,2019,Jessica Rodriguez; Mary Williams; James Wilson; Jessica Williams,Science,bioRxiv,10.0000/444524.739,46,5
d4bdae3f-c362-4546-a673-9b4c6ba0232f,Serology preliminary impact of effectiveness,We reports on the impact of diagnostics in a cohort . Our analysis investigates the impact of vaccine in hospitalized individuals . We assesses the impact of diagnostics in population . Here we report investigates the impact of variants in patients . Further work is needed to validate these findings.,2015-06-02,2015,Barbara Johnson,Nature,bioRxiv,10.0000/547697.795,50,5
dabde760-7d32-4f99-90b1-f4c2ae089e5a,Pandemic long-term investigation of spread,We reports on the impact of modeling in hospitalized individuals . This study assesses the impact of outcomes in hospitalized individuals . The investigation assesses trends in epidemiology in population . Here we report assesses the effectiveness of pandemic in patients . We investigates the dynamics of genomics in hospitalized individuals . We presents the effectiveness of immunity in hospitalized individuals . Our analysis evaluates the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2019-11-10,2019,David Martinez; William Williams; Barbara Davis,bioRxiv,PMC,10.0000/214180.173,81,5
a8ac2483-78d4-4426-95d1-76156fdd94af,Genomics comprehensive survey of outcomes,We evaluates outcomes for vaccine in patients . This study presents the impact of modeling in patients . Here we report assesses trends in diagnostics in patients . We reports on trends in pandemic in a cohort . This study presents the dynamics of variants in a cohort . The investigation reports on the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2020-01-03,2020,John Wilson; Susan Davis; William Rodriguez; Richard Martinez,Science,ArXiv,10.0000/586102.990,69,5
4527831a-0aa7-46f9-a7a9-a5306dac57e8,Coronavirus global analysis of trends : implications for vaccination strategies,This study investigates the effectiveness of modeling in patients . Here we report evaluates trends in immunity in hospitalized individuals . Here we report investigates the impact of vaccine in hospitalized individuals . We presents trends in serology in population . Further work is needed to validate these findings.,2017-03-07,2017,Robert Hernandez; James Garcia; Barbara Anderson; Barbara Rodriguez; William Brown,bioRxiv,Publisher,10.0000/125912.665,49,10
fe2a648c-914e-47ae-90ae-b00d4e626697,Immunity comparative investigation of patterns,This study reports on the dynamics of covid-19 in clinical settings . We evaluates the impact of vaccine in patients . Here we report presents outcomes for coronavirus in patients . We investigates the effectiveness of variants in population . Further work is needed to validate these findings.,2018-07-02,2018,David Johnson,Journal of Infectious Diseases,medRxiv,10.0000/914707.442,48,5
7759d21a-8a91-491c-9564-205a1fc52467,Modeling regional report of spread,We presents the dynamics of genomics in hospitalized individuals . Here we report assesses the dynamics of clinical in hospitalized individuals . The investigation assesses trends in clinical in clinical settings . The investigation investigates trends in outcomes in hospitalized individuals . Here we report reports on the dynamics of covid-19 in population . We evaluates the effectiveness of modeling in patients . We presents outcomes for modeling in a cohort . Further work is needed to validate these findings.,2015-09-28,2015,Barbara Gonzalez; Susan Gonzalez; John Miller; Elizabeth Rodriguez,BMJ,PMC,10.0000/137490.150,80,5
797c56ab-fda5-4e0a-9fba-4c18e536fe7d,Vaccine long-term impact of patients,Our analysis investigates the dynamics of serology in hospitalized individuals . This study assesses trends in pandemic in patients . Here we report reports on the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2019-01-17,2019,John Davis; Michael Jones; Elizabeth Lopez; Linda Williams,PLOS ONE,medRxiv,10.0000/394593.481,40,5
d2ceb9b9-68e3-4d9c-9186-8f5c0c08565f,COVID-19 rapid analysis of patterns,The investigation presents the impact of transmission in a cohort . We presents the impact of genomics in a cohort . The investigation assesses the effectiveness of immunity in hospitalized individuals . Here we report assesses the impact of transmission in hospitalized individuals . Here we report presents the effectiveness of genomics in patients . We assesses outcomes for therapeutics in patients . Here we report assesses the effectiveness of diagnostics in patients . Our analysis investigates trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-10-26,2021,Michael Brown; Elizabeth Johnson; Patricia Gonzalez; James Martinez; James Williams,Unknown,medRxiv,10.0000/474409.408,92,5
887d1207-87be-4a88-92e1-c1414983d991,Variants regional survey of prevalence,This study assesses outcomes for therapeutics in clinical settings . Here we report investigates outcomes for modeling in a cohort . The investigation investigates trends in therapeutics in a cohort . The investigation assesses the impact of modeling in a cohort . We presents trends in epidemiology in clinical settings . Our analysis assesses trends in pandemic in a cohort . We reports on outcomes for clinical in population . Further work is needed to validate these findings.,2021-12-01,2021,Jessica Jones; Jennifer Miller; Jessica Davis,The Lancet,Crossref,10.0000/546250.903,78,5
df22c317-5729-4afe-b91d-178c6d6aa5ca,Outcomes clinical evaluation of outcomes : implications for vaccination strategies,This study assesses the effectiveness of outcomes in clinical settings . This study assesses the dynamics of diagnostics in patients . Here we report assesses the impact of sars-cov-2 in clinical settings . Here we report reports on the effectiveness of transmission in hospitalized individuals . The investigation reports on outcomes for epidemiology in a cohort . Further work is needed to validate these findings.,2021-07-05,2021,Jennifer Lopez; Elizabeth Williams,Unknown,ArXiv,10.0000/178636.845,65,10
2eced8c3-6336-4e71-8d16-fcce65be5049,Variants statistical report of prevalence,We presents the dynamics of diagnostics in hospitalized individuals . Our analysis investigates the impact of modeling in patients . This study presents trends in vaccine in population . We assesses trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2017-03-12,2017,Mary Rodriguez; William Miller,PLOS ONE,medRxiv,10.0000/413494.206,46,5
ab6f3a62-af90-4eb0-97a6-9f6ebd6282a9,Therapeutics regional report of patterns,This study evaluates the dynamics of pandemic in population . The investigation evaluates the impact of vaccine in population . We reports on the dynamics of variants in clinical settings . Here we report evaluates the impact of serology in population . This study presents the impact of pandemic in a cohort . Further work is needed to validate these findings.,2022-08-24,2022,Elizabeth Martinez; Jennifer Miller; Jessica Brown,Unknown,Publisher,10.0000/617947.764,61,5
677cd17f-7f55-453d-b79b-0b2dc5195ecf,Epidemiology rapid analysis of outcomes,Here we report presents the impact of coronavirus in hospitalized individuals . We assesses outcomes for epidemiology in population . The investigation reports on outcomes for pandemic in population . This study presents the dynamics of sars-cov-2 in patients . This study presents the impact of coronavirus in a cohort . The investigation reports on trends in serology in clinical settings . This study investigates trends in diagnostics in a cohort . Further work is needed to validate these findings.,2022-07-25,2022,Jessica Rodriguez,PLOS ONE,bioRxiv,10.0000/522312.227,80,5
b42d9ed7-84d9-4a59-bbe9-f49f9007a89e,Transmission global report of prevalence : implications for clinical practice,We investigates trends in vaccine in hospitalized individuals . We reports on outcomes for modeling in a cohort . Our analysis assesses the impact of epidemiology in a cohort . We presents the dynamics of covid-19 in population . We assesses outcomes for genomics in population . We investigates outcomes for covid-19 in patients . Our analysis evaluates the dynamics of immunity in patients . Further work is needed to validate these findings.,2015-03-27,2015,Joseph Gonzalez,medRxiv,bioRxiv,10.0000/622419.300,73,10
9e8b6959-86bd-43b0-8c98-3db625e93838,Genomics preliminary assessment of incidence,This study assesses the dynamics of serology in a cohort . Here we report assesses trends in covid-19 in population . Here we report presents trends in therapeutics in patients . We investigates the impact of immunity in clinical settings . Further work is needed to validate these findings.,2021-01-15,2021,James Gonzalez,Journal of Infectious Diseases,bioRxiv,10.0000/688071.241,49,5
2b3abb42-236f-447d-be94-6dd3ce361bff,Diagnostics regional dynamics of incidence,We reports on the effectiveness of coronavirus in patients . Here we report presents the effectiveness of covid-19 in hospitalized individuals . Here we report evaluates the impact of transmission in population . The investigation assesses outcomes for epidemiology in clinical settings . Here we report assesses outcomes for variants in population . Here we report evaluates outcomes for therapeutics in hospitalized individuals . Our analysis reports on the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2020-01-18,2020,William Rodriguez; Jessica Davis,medRxiv,Crossref,10.0000/786143.938,84,5
564c6a5f-4b30-4fa1-a991-9a89d3781ca5,Diagnostics preliminary review of outcomes,The investigation assesses the dynamics of clinical in a cohort . Here we report reports on the effectiveness of therapeutics in hospitalized individuals . Our analysis evaluates the effectiveness of outcomes in hospitalized individuals . We assesses the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2016-03-29,2016,James Jones,Frontiers in Medicine,bioRxiv,10.0000/452495.977,53,5
d925cbc1-399f-4428-8f87-6e47df087487,Therapeutics preliminary study of trends : implications for clinical practice,This study presents the dynamics of covid-19 in hospitalized individuals . This study investigates the impact of covid-19 in population . The investigation reports on the impact of coronavirus in population . Here we report presents trends in genomics in clinical settings . Our analysis assesses the effectiveness of variants in hospitalized individuals . This study reports on the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2020-07-18,2020,Joseph Smith; William Hernandez,Journal of Infectious Diseases,Crossref,10.0000/917568.657,73,10
fb5dcf25-a5be-428f-8840-a9dede30b41f,Epidemiology global investigation of patients,Here we report presents the impact of epidemiology in clinical settings . We investigates outcomes for sars-cov-2 in hospitalized individuals . Our analysis investigates the impact of covid-19 in hospitalized individuals . We presents the impact of sars-cov-2 in a cohort . This study presents outcomes for transmission in population . We investigates the impact of genomics in hospitalized individuals . Here we report investigates the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2020-10-28,2020,Barbara Brown; Susan Smith; Jennifer Anderson; Barbara Miller; Joseph Jones,bioRxiv,Crossref,10.0000/971806.466,81,5
ce227dbd-2bf0-490e-94ca-fda82af11b41,Therapeutics statistical report of spread : implications for vaccination strategies,Here we report evaluates outcomes for pandemic in patients . This study evaluates trends in genomics in clinical settings . Our analysis presents trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2018-10-10,2018,Michael Anderson,PLOS ONE,ArXiv,10.0000/920940.537,38,10
f61e2c61-c6e1-4629-ad89-db00c7a25070,Coronavirus comparative dynamics of effectiveness,This study presents the effectiveness of immunity in population . Our analysis reports on the impact of genomics in population . We evaluates the dynamics of genomics in population . We presents trends in diagnostics in patients . Here we report presents outcomes for therapeutics in patients . Further work is needed to validate these findings.,2016-07-29,2016,Robert Williams; Barbara Williams; Susan Johnson; William Jones,Nature,bioRxiv,10.0000/676539.284,56,5
d11d0723-456d-4dbe-8f53-d8f60a3f53ee,SARS-CoV-2 global review of prevalence,Here we report presents trends in variants in population . The investigation presents trends in sars-cov-2 in population . Our analysis evaluates trends in outcomes in a cohort . Our analysis evaluates outcomes for vaccine in clinical settings . This study reports on trends in sars-cov-2 in hospitalized individuals . Here we report reports on the effectiveness of epidemiology in population . We presents the dynamics of variants in a cohort . The investigation reports on the impact of serology in patients . Further work is needed to validate these findings.,2019-07-20,2019,Linda Hernandez; James Williams; Jessica Anderson; Joseph Gonzalez; Michael Rodriguez,PLOS ONE,bioRxiv,10.0000/722814.233,91,5
848d1bee-c52d-4518-b39e-1284176e248a,Variants statistical survey of trends,This study assesses outcomes for epidemiology in patients . Our analysis presents the effectiveness of genomics in clinical settings . The investigation reports on outcomes for epidemiology in a cohort . Here we report investigates outcomes for clinical in clinical settings . The investigation reports on the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2021-06-17,2021,Mary Lopez; John Wilson; John Williams; Jessica Smith,The Lancet,Publisher,10.0000/643356.811,62,5
a897a8a2-b5f1-4827-8178-8a919e6eba44,Variants preliminary assessment of prevalence,Our analysis presents the impact of sars-cov-2 in population . Here we report assesses outcomes for therapeutics in hospitalized individuals . We assesses the dynamics of epidemiology in population . This study presents the effectiveness of immunity in patients . Our analysis reports on the impact of clinical in clinical settings . We reports on outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2021-07-13,2021,Jennifer Lopez; Joseph Martinez; John Jones; Robert Williams; John Davis,Unknown,bioRxiv,10.0000/523980.644,70,5
2b634b4c-0a22-47ae-95af-ef3a75a22b60,Epidemiology comparative evaluation of outcomes,The investigation investigates the impact of transmission in a cohort . We investigates outcomes for therapeutics in hospitalized individuals . This study reports on outcomes for variants in patients . Our analysis reports on the impact of vaccine in patients . Our analysis investigates the dynamics of genomics in clinical settings . This study reports on the impact of outcomes in patients . Our analysis evaluates trends in vaccine in clinical settings . Our analysis investigates the impact of pandemic in population . Further work is needed to validate these findings.,2022-10-20,2022,Patricia Hernandez; Susan Jones; Jennifer Lopez; Robert Anderson; Mary Smith,Nature,PMC,10.0000/582187.204,91,5
0840d42c-4002-419a-bbb6-ba6a6042bb6e,Outcomes regional survey of patterns,The investigation investigates the impact of clinical in clinical settings . We presents trends in transmission in a cohort . This study assesses the dynamics of pandemic in a cohort . This study investigates the effectiveness of pandemic in hospitalized individuals . Our analysis presents trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2022-06-19,2022,Susan Johnson; Joseph Miller,Science,Publisher,10.0000/509620.614,60,5
90fbae01-b2fc-436e-b108-ed86ad72dd19,Pandemic rapid assessment of patterns : implications for public health,This study presents the dynamics of sars-cov-2 in hospitalized individuals . Here we report reports on the impact of vaccine in hospitalized individuals . The investigation investigates outcomes for pandemic in population . The investigation evaluates trends in modeling in a cohort . We presents the impact of outcomes in clinical settings . The investigation evaluates trends in diagnostics in clinical settings . The investigation assesses the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2022-12-01,2022,David Jones,PLOS ONE,medRxiv,10.0000/745913.853,81,10
a284d161-74ff-4c8b-b668-fa4b3de7a781,Diagnostics comprehensive impact of incidence,Our analysis evaluates the dynamics of modeling in clinical settings . The investigation evaluates the dynamics of therapeutics in patients . Here we report investigates the dynamics of covid-19 in clinical settings . Our analysis investigates trends in modeling in population . Further work is needed to validate these findings.,2015-10-27,2015,Michael Brown; Elizabeth Miller; Patricia Smith,medRxiv,Publisher,10.0000/944695.342,50,5
b6b29965-31d3-4bca-b332-0cf9dc77543b,Coronavirus statistical investigation of data,The investigation investigates the impact of immunity in patients . We presents the effectiveness of diagnostics in a cohort . Our analysis reports on outcomes for clinical in clinical settings . This study presents the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2019-03-12,2019,Michael Gonzalez; Joseph Williams,Clinical Infectious Diseases,medRxiv,10.0000/242265.726,50,5
18f5e298-d9c9-4155-87f2-6fcc4bf27abf,Epidemiology clinical analysis of spread,This study presents the impact of genomics in population . This study evaluates the effectiveness of transmission in a cohort . Our analysis investigates the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2016-11-20,2016,William Wilson,bioRxiv,PMC,10.0000/887830.997,40,5
fed75293-4ad7-44c1-b00b-9841da87f079,Epidemiology preliminary investigation of trends,The investigation presents trends in outcomes in population . The investigation assesses outcomes for immunity in population . Here we report evaluates the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2017-03-24,2017,Mary Lopez,BMJ,ArXiv,10.0000/359688.118,38,5
081d1d2a-dfa4-4d3f-984c-93fbccc8d40b,Transmission rapid assessment of patterns,This study investigates the effectiveness of genomics in a cohort . We investigates outcomes for therapeutics in hospitalized individuals . Our analysis evaluates the dynamics of serology in a cohort . Our analysis evaluates the impact of outcomes in patients . Our analysis evaluates outcomes for diagnostics in patients . We reports on trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2022-10-01,2022,Patricia Williams; Mary Brown,Frontiers in Medicine,medRxiv,10.0000/430888.461,68,5
02e44f78-8ae4-42b4-9ed6-c4d4368093bf,Transmission rapid impact of outcomes : implications for policy,This study reports on trends in coronavirus in patients . We reports on the effectiveness of variants in a cohort . We presents the dynamics of covid-19 in hospitalized individuals . The investigation presents the effectiveness of clinical in population . This study reports on the dynamics of sars-cov-2 in patients . Our analysis reports on trends in covid-19 in population . This study reports on the effectiveness of outcomes in population . This study investigates the impact of covid-19 in patients . Further work is needed to validate these findings.,2019-07-12,2019,Joseph Lopez; Barbara Wilson; Barbara Williams,Nature,Crossref,10.0000/600796.241,91,9
b845af87-a883-42e5-834a-538573e35e2d,Serology comparative survey of prevalence,This study evaluates the dynamics of immunity in patients . Here we report investigates outcomes for modeling in a cohort . Here we report reports on the impact of diagnostics in hospitalized individuals . Here we report investigates the impact of outcomes in patients . We presents the dynamics of vaccine in population . The investigation presents the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-06-25,2018,Patricia Davis; Elizabeth Johnson; Elizabeth Martinez; Patricia Martinez,Unknown,bioRxiv,10.0000/231258.429,73,5
5627afcc-77ab-471b-843c-b7fc4b749a63,Genomics comparative report of spread,We presents trends in coronavirus in clinical settings . Our analysis reports on trends in therapeutics in clinical settings . Our analysis evaluates the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2022-05-25,2022,Michael Wilson; John Williams,medRxiv,Crossref,10.0000/233537.164,39,5
89981a31-9e54-4108-a64b-e3a40fa4919b,Genomics statistical dynamics of incidence,Here we report reports on the effectiveness of modeling in clinical settings . Our analysis reports on outcomes for variants in patients . The investigation reports on the impact of sars-cov-2 in a cohort . We assesses trends in pandemic in hospitalized individuals . Here we report assesses the impact of sars-cov-2 in clinical settings . Here we report assesses the impact of transmission in a cohort . Here we report presents the effectiveness of variants in a cohort . This study reports on the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2019-07-24,2019,Barbara Miller; James Anderson; Robert Garcia; Linda Garcia,The Lancet,medRxiv,10.0000/476216.433,100,5
617d6754-325d-4ee7-ad06-f6c63e26a8cb,Diagnostics comprehensive review of effectiveness,The investigation evaluates the dynamics of clinical in patients . Here we report investigates the dynamics of pandemic in population . The investigation evaluates the dynamics of immunity in a cohort . Our analysis assesses the impact of serology in a cohort . Our analysis assesses outcomes for vaccine in hospitalized individuals . Here we report evaluates the effectiveness of serology in population . Our analysis evaluates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2017-07-17,2017,John Johnson; Linda Miller,PLOS ONE,bioRxiv,10.0000/902190.109,82,5
d55271fc-78ed-436a-bd21-595091d6c80a,COVID-19 comprehensive evaluation of patterns,Our analysis reports on the impact of pandemic in a cohort . This study investigates the effectiveness of immunity in a cohort . This study assesses the effectiveness of diagnostics in patients . This study presents trends in outcomes in a cohort . Further work is needed to validate these findings.,2022-11-01,2022,William Davis; Jennifer Hernandez; Robert Johnson; Susan Gonzalez; Patricia Davis,bioRxiv,Crossref,10.0000/445751.971,51,5
38700d27-a47b-453c-b53e-11d55344c488,Genomics preliminary review of prevalence,The investigation assesses trends in therapeutics in hospitalized individuals . Our analysis reports on the effectiveness of modeling in population . The investigation investigates outcomes for diagnostics in clinical settings . Here we report investigates the effectiveness of immunity in clinical settings . Here we report reports on outcomes for therapeutics in patients . Further work is needed to validate these findings.,2020-11-29,2020,Jennifer Miller; Patricia Jones; Mary Jones; Elizabeth Rodriguez,Journal of Infectious Diseases,ArXiv,10.0000/103332.263,62,5
955180b6-a09b-4bc3-941f-b16792e495f0,Coronavirus global investigation of response : implications for policy,The investigation assesses trends in epidemiology in patients . The investigation reports on the impact of covid-19 in clinical settings . We evaluates the effectiveness of modeling in patients . This study assesses the impact of therapeutics in hospitalized individuals . Our analysis presents trends in covid-19 in patients . We investigates outcomes for variants in clinical settings . Our analysis reports on the impact of genomics in patients . Further work is needed to validate these findings.,2018-01-07,2018,William Williams; Richard Lopez; Barbara Hernandez; Richard Hernandez,Nature,Publisher,10.0000/121733.150,78,9
d59364f0-8a33-467e-bb68-879d0aa4e184,Coronavirus preliminary review of outcomes,Our analysis presents the impact of epidemiology in hospitalized individuals . The investigation reports on the dynamics of sars-cov-2 in population . Our analysis investigates the dynamics of covid-19 in clinical settings . We evaluates the impact of clinical in hospitalized individuals . Here we report reports on the dynamics of clinical in a cohort . Here we report assesses the dynamics of coronavirus in hospitalized individuals . This study presents the effectiveness of outcomes in a cohort . Here we report assesses outcomes for genomics in population . Further work is needed to validate these findings.,2022-01-23,2022,Patricia Rodriguez; Elizabeth Gonzalez; James Lopez,medRxiv,Crossref,10.0000/233978.908,97,5
9cdd5771-1f32-49a2-a98f-8c39258bec14,Modeling clinical study of data,Our analysis reports on the impact of immunity in hospitalized individuals . Here we report assesses outcomes for serology in clinical settings . The investigation evaluates the impact of modeling in population . Here we report presents the effectiveness of modeling in clinical settings . The investigation reports on the effectiveness of pandemic in population . This study presents outcomes for epidemiology in patients . We reports on trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2018-05-12,2018,Susan Miller; Mary Lopez; Linda Davis; Mary Jones; Linda Smith,PLOS ONE,PMC,10.0000/492245.209,83,5
3c10bf51-1648-4b27-81e4-770500621de7,Outcomes statistical analysis of spread,The investigation presents the effectiveness of modeling in patients . We evaluates the dynamics of modeling in hospitalized individuals . This study assesses the impact of coronavirus in hospitalized individuals . We evaluates the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2019-11-14,2019,Elizabeth Garcia,Clinical Infectious Diseases,PMC,10.0000/620442.251,49,5
3037e28b-95aa-4905-974d-dbb4ce737c6a,Clinical comparative dynamics of effectiveness,We evaluates the effectiveness of epidemiology in hospitalized individuals . Here we report presents outcomes for genomics in hospitalized individuals . This study presents the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2015-11-20,2015,Jennifer Williams; Robert Gonzalez,BMJ,Publisher,10.0000/783391.689,39,5
72cb39bc-bcaa-44f8-a875-bac44735c5fd,COVID-19 preliminary review of response,We assesses the impact of clinical in population . Here we report assesses the effectiveness of pandemic in population . The investigation presents outcomes for diagnostics in a cohort . The investigation investigates the effectiveness of pandemic in population . The investigation assesses outcomes for transmission in population . Here we report evaluates trends in therapeutics in a cohort . Further work is needed to validate these findings.,2019-07-19,2019,Patricia Hernandez; Elizabeth Anderson; Mary Smith; Richard Davis,Frontiers in Medicine,Crossref,10.0000/219276.425,68,5
ce7794c5-b751-42f7-bd1d-302bedccbf7d,Epidemiology long-term investigation of trends,We presents the effectiveness of therapeutics in patients . Our analysis reports on trends in genomics in hospitalized individuals . This study evaluates trends in therapeutics in a cohort . This study reports on the effectiveness of outcomes in clinical settings . Our analysis reports on the effectiveness of diagnostics in population . Here we report assesses outcomes for sars-cov-2 in patients . We reports on the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2022-03-26,2022,Joseph Gonzalez; William Gonzalez; David Hernandez; David Wilson,BMJ,Publisher,10.0000/862201.926,82,5
78fbfcd0-98ba-482a-b7a9-9515aabfe671,Therapeutics clinical study of data,This study assesses the dynamics of vaccine in clinical settings . This study presents outcomes for vaccine in patients . Our analysis evaluates the effectiveness of therapeutics in population . The investigation reports on the dynamics of coronavirus in population . Our analysis presents the dynamics of clinical in clinical settings . Our analysis assesses trends in diagnostics in population . Further work is needed to validate these findings.,2020-01-01,2020,Jennifer Anderson; John Miller; Barbara Smith; Barbara Brown,Unknown,Crossref,10.0000/432649.144,69,5
770b1aad-0a10-43a6-8d08-5a6afe6033e7,Coronavirus global evaluation of data,We evaluates the effectiveness of variants in patients . Our analysis presents the effectiveness of transmission in a cohort . We evaluates the effectiveness of therapeutics in hospitalized individuals . This study assesses the impact of pandemic in patients . Here we report investigates outcomes for clinical in patients . Our analysis reports on the dynamics of immunity in population . We reports on the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2022-08-28,2022,Jessica Gonzalez; David Anderson; David Martinez; Michael Wilson; Michael Anderson,BMJ,Publisher,10.0000/240014.499,80,5
2f30174e-2b9e-4261-b55a-f372ccf88e86,Vaccine clinical dynamics of patterns : implications for vaccination strategies,Our analysis investigates the impact of epidemiology in hospitalized individuals . The investigation reports on the dynamics of serology in clinical settings . We assesses outcomes for coronavirus in a cohort . Our analysis evaluates the effectiveness of vaccine in a cohort . The investigation evaluates trends in modeling in patients . We investigates trends in clinical in hospitalized individuals . Our analysis reports on outcomes for immunity in a cohort . We reports on the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2018-02-04,2018,Patricia Miller; Jennifer Brown; William Wilson; Linda Williams; Patricia Davis,medRxiv,bioRxiv,10.0000/261032.881,91,10
90cbf7cd-6022-41c7-8ea5-355d7136149d,Outcomes global report of response,Here we report investigates the effectiveness of outcomes in a cohort . We assesses outcomes for immunity in patients . The investigation investigates outcomes for serology in population . This study reports on the dynamics of genomics in hospitalized individuals . The investigation presents the dynamics of transmission in population . The investigation investigates the effectiveness of therapeutics in population . We reports on the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2015-04-19,2015,David Davis,BMJ,medRxiv,10.0000/350523.694,80,5
ed80d8d7-a624-4a0a-a5ac-78a0f94cc854,COVID-19 comparative evaluation of spread : implications for policy,We assesses the impact of coronavirus in hospitalized individuals . Our analysis reports on the impact of transmission in clinical settings . Our analysis reports on the dynamics of pandemic in clinical settings . We reports on outcomes for sars-cov-2 in hospitalized individuals . Our analysis evaluates outcomes for diagnostics in clinical settings . Further work is needed to validate these findings.,2018-03-16,2018,Barbara Wilson; John Anderson; David Wilson; Robert Smith,The Lancet,Crossref,10.0000/774013.208,62,9
c135b348-829e-4538-862f-c666c8ed372f,COVID-19 comparative assessment of outcomes,We assesses the dynamics of sars-cov-2 in patients . Our analysis investigates the dynamics of clinical in hospitalized individuals . Here we report investigates the impact of sars-cov-2 in hospitalized individuals . This study investigates the impact of therapeutics in patients . The investigation investigates the dynamics of outcomes in patients . Further work is needed to validate these findings.,2015-04-08,2015,Barbara Brown; Barbara Wilson; James Davis; Susan Smith,Frontiers in Medicine,medRxiv,10.0000/496037.574,60,5
4e714d0e-2632-4088-bfce-13c6ed6bb4ac,Epidemiology rapid evaluation of trends : implications for vaccination strategies,Our analysis assesses outcomes for immunity in a cohort . This study assesses the effectiveness of epidemiology in clinical settings . The investigation evaluates the dynamics of sars-cov-2 in clinical settings . The investigation assesses outcomes for clinical in population . Our analysis investigates the dynamics of genomics in a cohort . Our analysis evaluates trends in pandemic in hospitalized individuals . Our analysis investigates trends in transmission in hospitalized individuals . The investigation assesses the impact of diagnostics in patients . Further work is needed to validate these findings.,2018-10-22,2018,William Brown,PLOS ONE,bioRxiv,10.0000/111599.898,90,10
4cbb72f6-5121-4b02-a117-c5c55f199855,Serology global report of patterns : implications for public health,The investigation investigates trends in diagnostics in clinical settings . Here we report evaluates the dynamics of immunity in patients . The investigation investigates the effectiveness of epidemiology in a cohort . The investigation investigates the impact of outcomes in hospitalized individuals . The investigation assesses outcomes for diagnostics in clinical settings . Further work is needed to validate these findings.,2022-10-19,2022,Michael Hernandez; Barbara Rodriguez; Elizabeth Rodriguez; Joseph Garcia,Nature,Crossref,10.0000/339383.888,61,10
a045799c-2a9e-4081-a0ed-bebd9163a742,Modeling comprehensive assessment of response,Our analysis investigates the effectiveness of variants in hospitalized individuals . Our analysis evaluates trends in immunity in hospitalized individuals . Here we report presents the dynamics of coronavirus in hospitalized individuals . We reports on trends in epidemiology in hospitalized individuals . Here we report reports on the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2018-05-07,2018,Jennifer Garcia; William Brown,Science,bioRxiv,10.0000/581233.588,64,5
7c4bb92d-73c7-4782-a072-fa8f388eb6bb,Variants global evaluation of patterns,The investigation reports on outcomes for vaccine in patients . The investigation evaluates the effectiveness of coronavirus in clinical settings . We assesses outcomes for transmission in hospitalized individuals . Our analysis reports on the effectiveness of sars-cov-2 in a cohort . We reports on the impact of therapeutics in hospitalized individuals . We presents outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2021-11-07,2021,Patricia Smith; Joseph Martinez; Robert Garcia,bioRxiv,PMC,10.0000/747581.835,70,5
815da3e6-9136-4851-9655-2913cfc230ad,Epidemiology global impact of response : implications for policy,We assesses the dynamics of genomics in a cohort . This study evaluates outcomes for genomics in hospitalized individuals . Our analysis presents the effectiveness of pandemic in patients . The investigation investigates the effectiveness of genomics in a cohort . The investigation presents the dynamics of covid-19 in a cohort . Our analysis assesses the effectiveness of outcomes in population . Further work is needed to validate these findings.,2020-05-04,2020,Richard Jones; Patricia Gonzalez; Richard Martinez,The Lancet,Crossref,10.0000/272112.425,70,9
45ed0dab-b907-4c48-ab05-121372e14d74,Diagnostics global investigation of trends,Here we report presents trends in serology in patients . The investigation presents trends in genomics in clinical settings . Our analysis assesses the impact of modeling in a cohort . Further work is needed to validate these findings.,2018-01-01,2018,Susan Garcia; Patricia Miller,Frontiers in Medicine,PMC,10.0000/953349.111,39,5
d3be0577-30f2-4d76-90ff-f2cdb5429d0b,Serology preliminary review of outcomes,The investigation assesses trends in transmission in a cohort . Here we report assesses outcomes for pandemic in a cohort . Here we report evaluates the impact of coronavirus in hospitalized individuals . Here we report investigates the dynamics of serology in patients . Our analysis evaluates trends in covid-19 in hospitalized individuals . The investigation evaluates outcomes for vaccine in patients . The investigation assesses the impact of therapeutics in hospitalized individuals . Here we report evaluates the impact of serology in a cohort . Further work is needed to validate these findings.,2018-09-07,2018,Mary Rodriguez,PLOS ONE,medRxiv,10.0000/521846.783,94,5
5eaaf502-ed43-46aa-a3ac-e2374bb29b32,Modeling statistical evaluation of outcomes : implications for vaccination strategies,We presents the dynamics of coronavirus in patients . Here we report investigates the dynamics of epidemiology in hospitalized individuals . This study assesses outcomes for variants in clinical settings . Further work is needed to validate these findings.,2021-11-20,2021,Mary Rodriguez; William Brown; Michael Wilson; David Davis; Richard Brown,Unknown,medRxiv,10.0000/324149.102,39,10
c57f9c45-7f28-4a00-9abc-6d6274eed418,Diagnostics preliminary study of prevalence,Here we report assesses the impact of variants in clinical settings . Our analysis presents the impact of vaccine in clinical settings . Our analysis presents the dynamics of clinical in hospitalized individuals . Our analysis presents the dynamics of clinical in clinical settings . The investigation presents the dynamics of transmission in a cohort . Here we report investigates the dynamics of modeling in population . Further work is needed to validate these findings.,2020-03-28,2020,Richard Garcia; Linda Davis; David Johnson; Robert Gonzalez; Barbara Garcia,bioRxiv,Publisher,10.0000/921468.514,75,5
5ff5ac92-8b2b-4a06-9be4-0332cbf4a0e9,SARS-CoV-2 long-term evaluation of patients : implications for vaccination strategies,The investigation reports on the impact of vaccine in a cohort . The investigation reports on outcomes for transmission in patients . We assesses the dynamics of transmission in clinical settings . This study investigates the dynamics of pandemic in patients . Our analysis investigates the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2020-08-30,2020,Mary Johnson; Elizabeth Anderson; Joseph Anderson; Elizabeth Williams,Science,Publisher,10.0000/532594.232,61,10
1b8fc083-320f-46e7-b541-4967396ebc41,Diagnostics comparative impact of data : implications for policy,We assesses the impact of immunity in clinical settings . Here we report investigates outcomes for clinical in clinical settings . This study evaluates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2015-03-26,2015,David Miller; Richard Garcia; David Anderson; Richard Rodriguez; Elizabeth Williams,Nature,Crossref,10.0000/618338.746,39,9
655653f1-8418-4110-9233-8f832a2b6e7a,Coronavirus global report of patients,The investigation investigates the impact of epidemiology in hospitalized individuals . The investigation evaluates the effectiveness of sars-cov-2 in population . The investigation evaluates the impact of immunity in patients . The investigation investigates trends in transmission in population . The investigation evaluates the effectiveness of serology in population . Our analysis assesses the effectiveness of coronavirus in hospitalized individuals . The investigation reports on the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2015-04-27,2015,Elizabeth Anderson,PLOS ONE,ArXiv,10.0000/417463.150,81,5
8c5dd55e-9a2a-40db-b4e2-3a984e8f9790,Modeling comparative impact of response,Our analysis presents outcomes for epidemiology in patients . We assesses trends in diagnostics in hospitalized individuals . Here we report reports on the dynamics of outcomes in a cohort . This study reports on outcomes for transmission in clinical settings . Our analysis presents outcomes for therapeutics in a cohort . We investigates trends in modeling in population . Our analysis evaluates the dynamics of outcomes in clinical settings . Further work is needed to validate these findings.,2018-07-17,2018,Susan Smith; Richard Garcia; James Jones; William Brown; Mary Lopez,bioRxiv,medRxiv,10.0000/646577.840,79,5
8b3ad740-66f0-44fc-a2e7-978f15bf38eb,Modeling comparative assessment of effectiveness,Our analysis reports on the impact of diagnostics in population . The investigation assesses the dynamics of outcomes in a cohort . The investigation investigates trends in clinical in a cohort . We assesses the effectiveness of outcomes in patients . We investigates outcomes for sars-cov-2 in hospitalized individuals . This study presents outcomes for outcomes in clinical settings . Our analysis investigates trends in outcomes in clinical settings . This study presents the impact of outcomes in patients . Further work is needed to validate these findings.,2020-11-13,2020,Jessica Wilson; James Williams; Linda Jones; Joseph Miller; Joseph Gonzalez,Nature,Publisher,10.0000/841048.144,88,5
c139c9a3-8fc9-4e17-8089-e85c1c6735a0,COVID-19 comparative dynamics of data,Our analysis evaluates trends in covid-19 in hospitalized individuals . We investigates the dynamics of covid-19 in population . Here we report reports on the impact of clinical in clinical settings . This study assesses the dynamics of epidemiology in a cohort . This study presents trends in variants in hospitalized individuals . The investigation reports on the impact of modeling in patients . We investigates trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2022-04-28,2022,Susan Rodriguez; Linda Lopez; Elizabeth Smith; Elizabeth Williams; Richard Hernandez,Clinical Infectious Diseases,bioRxiv,10.0000/616495.854,81,5
a004827f-828a-44c7-a6cd-76ebb7e286c5,Genomics preliminary evaluation of trends,Here we report presents the impact of immunity in population . The investigation investigates trends in epidemiology in a cohort . Here we report assesses the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2021-07-02,2021,Barbara Wilson; Susan Garcia; Jessica Johnson,Nature,medRxiv,10.0000/474480.396,40,5
0b707703-0d9e-44b7-81bb-7ad4b24c0bd8,Transmission regional evaluation of response,Our analysis reports on the effectiveness of serology in population . This study reports on the impact of serology in a cohort . The investigation presents the effectiveness of outcomes in population . Our analysis investigates outcomes for therapeutics in patients . This study investigates trends in variants in a cohort . The investigation presents trends in variants in patients . We assesses trends in vaccine in a cohort . Further work is needed to validate these findings.,2019-02-14,2019,Michael Anderson; David Martinez; William Miller,Unknown,PMC,10.0000/718457.771,78,5
3a12fb1d-1a06-4ee5-97fb-9a84cf048c46,Immunity regional dynamics of incidence,Here we report evaluates the effectiveness of pandemic in population . Our analysis reports on outcomes for coronavirus in population . Our analysis investigates the impact of epidemiology in patients . Here we report evaluates trends in genomics in population . Further work is needed to validate these findings.,2017-03-20,2017,Patricia Hernandez; David Wilson; Jessica Brown; Patricia Martinez; David Brown,PLOS ONE,Publisher,10.0000/468793.520,49,5
510f31dc-36c0-4236-9051-b86d27be495a,Coronavirus clinical evaluation of incidence,Here we report investigates trends in pandemic in hospitalized individuals . We investigates outcomes for vaccine in population . Here we report evaluates trends in vaccine in a cohort . The investigation presents trends in clinical in hospitalized individuals . Here we report evaluates the impact of modeling in hospitalized individuals . This study evaluates the impact of vaccine in a cohort . Here we report presents trends in variants in a cohort . Further work is needed to validate these findings.,2021-09-26,2021,Richard Gonzalez; Richard Hernandez; Mary Johnson,Nature,ArXiv,10.0000/746797.454,82,5
73825806-85a6-475b-aa0e-92601a84401f,Transmission comparative review of outcomes,This study presents the effectiveness of sars-cov-2 in clinical settings . Here we report presents trends in sars-cov-2 in population . This study reports on trends in vaccine in patients . The investigation presents the effectiveness of covid-19 in population . The investigation reports on the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2015-02-07,2015,Joseph Smith; Richard Garcia; Jessica Johnson,Science,Crossref,10.0000/565519.414,61,5
a9cfdd51-ddcd-4b68-809e-906a955de807,Transmission preliminary impact of effectiveness,The investigation evaluates trends in sars-cov-2 in hospitalized individuals . This study investigates the effectiveness of covid-19 in clinical settings . Here we report assesses the dynamics of transmission in clinical settings . Here we report evaluates outcomes for sars-cov-2 in hospitalized individuals . Here we report assesses the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2021-10-24,2021,Jessica Miller; David Rodriguez; Robert Williams; Robert Brown; James Lopez,medRxiv,ArXiv,10.0000/182966.721,64,5
47298afc-07e3-4cf7-80c8-d1e5820c4af1,Serology statistical evaluation of incidence : implications for public health,The investigation reports on outcomes for clinical in population . We evaluates the impact of serology in population . The investigation reports on the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-08-06,2020,Mary Jones; Robert Lopez; Elizabeth Davis,The Lancet,ArXiv,10.0000/399778.527,39,10
f263c3e1-a339-43bd-a8bf-a5dac6b1066a,Outcomes long-term investigation of trends,Our analysis evaluates trends in covid-19 in population . This study presents the effectiveness of modeling in population . The investigation investigates the impact of variants in patients . We assesses the effectiveness of therapeutics in a cohort . This study evaluates trends in transmission in a cohort . Further work is needed to validate these findings.,2022-12-10,2022,Joseph Wilson,Journal of Infectious Diseases,ArXiv,10.0000/431474.178,57,5
aa623322-bbbd-43d2-8062-1d24c5230fff,Immunity comparative report of incidence,Our analysis presents the impact of genomics in population . Here we report evaluates the impact of serology in hospitalized individuals . The investigation reports on the dynamics of diagnostics in patients . Our analysis presents the dynamics of serology in clinical settings . We investigates the dynamics of diagnostics in a cohort . The investigation presents outcomes for pandemic in clinical settings . Further work is needed to validate these findings.,2020-05-05,2020,Susan Miller,BMJ,Publisher,10.0000/722390.736,72,5
a86198e1-4f4d-4947-b1bd-bc5e59f3d57f,Pandemic global survey of response,Here we report investigates the dynamics of pandemic in clinical settings . Here we report reports on the effectiveness of clinical in hospitalized individuals . We investigates the effectiveness of covid-19 in a cohort . Our analysis evaluates the effectiveness of clinical in hospitalized individuals . We evaluates the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-01-25,2016,Patricia Williams; Barbara Wilson,Frontiers in Medicine,Publisher,10.0000/212120.737,64,5
76376fd4-b3fd-41aa-9cff-344f7cbd302f,Modeling statistical review of patients,We evaluates the dynamics of vaccine in a cohort . The investigation reports on trends in covid-19 in a cohort . Our analysis evaluates the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2017-02-01,2017,Elizabeth Anderson,Frontiers in Medicine,ArXiv,10.0000/844094.225,39,5
1f9531bc-c0e4-45c2-8026-8dde96d76805,Pandemic global review of incidence : implications for vaccination strategies,Here we report presents outcomes for transmission in population . This study evaluates trends in sars-cov-2 in patients . We reports on outcomes for genomics in hospitalized individuals . Our analysis presents the dynamics of diagnostics in population . We assesses the impact of serology in patients . This study evaluates the dynamics of epidemiology in a cohort . Here we report reports on the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2016-06-03,2016,Michael Jones; Elizabeth Johnson,bioRxiv,medRxiv,10.0000/443074.917,80,10
400f1a9e-b327-4880-beb5-cf67fefa66ee,Immunity preliminary investigation of effectiveness : implications for policy,This study evaluates trends in epidemiology in population . Here we report assesses outcomes for genomics in a cohort . Our analysis reports on the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2021-05-04,2021,James Williams,Nature,PMC,10.0000/572303.110,40,9
731eab10-e7cc-4366-8057-3bdee9d20118,SARS-CoV-2 statistical dynamics of trends,Here we report reports on the impact of pandemic in patients . Our analysis evaluates outcomes for pandemic in hospitalized individuals . The investigation evaluates the impact of clinical in hospitalized individuals . The investigation assesses the impact of clinical in patients . We investigates outcomes for epidemiology in patients . Our analysis assesses the impact of sars-cov-2 in patients . This study investigates outcomes for diagnostics in population . Here we report assesses trends in modeling in population . Further work is needed to validate these findings.,2019-01-15,2019,Richard Davis; James Gonzalez,PLOS ONE,Publisher,10.0000/839445.628,88,5
81769838-47c2-4896-a722-7964c3ae9797,Vaccine regional survey of data : implications for vaccination strategies,This study assesses outcomes for modeling in population . Our analysis assesses outcomes for variants in a cohort . We assesses outcomes for epidemiology in clinical settings . We investigates the impact of diagnostics in hospitalized individuals . Here we report investigates trends in genomics in patients . This study presents the dynamics of serology in population . Further work is needed to validate these findings.,2019-01-16,2019,David Wilson; Barbara Hernandez,PLOS ONE,PMC,10.0000/318656.716,66,10
32293150-c2d0-469f-b0b4-555e4d3b5738,Epidemiology global review of trends,We reports on trends in immunity in a cohort . We assesses outcomes for therapeutics in clinical settings . We reports on the effectiveness of modeling in patients . We presents the impact of clinical in patients . We evaluates the dynamics of sars-cov-2 in a cohort . Our analysis investigates the effectiveness of modeling in population . The investigation reports on trends in serology in population . Further work is needed to validate these findings.,2020-05-30,2020,Barbara Johnson,The Lancet,medRxiv,10.0000/231489.538,76,5
b8e00a16-7290-46b5-9e21-9cee44393493,Epidemiology comprehensive report of patterns,We investigates the impact of variants in clinical settings . The investigation investigates the effectiveness of diagnostics in population . Here we report assesses outcomes for genomics in patients . The investigation investigates the effectiveness of clinical in hospitalized individuals . Here we report reports on outcomes for immunity in patients . Our analysis presents the impact of transmission in population . We investigates the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2022-07-18,2022,John Johnson; Barbara Wilson; Patricia Rodriguez; Mary Anderson,Frontiers in Medicine,Publisher,10.0000/953344.951,79,5
cddff4f8-fae7-4750-83c9-b0814301dae8,Outcomes comprehensive report of patterns : implications for policy,We investigates trends in pandemic in a cohort . The investigation presents the impact of variants in hospitalized individuals . Here we report presents the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2016-03-04,2016,John Gonzalez; James Williams; Michael Johnson; Michael Jones,Unknown,PMC,10.0000/291682.370,40,9
f2237c44-621e-4a2e-bbe5-46b0f755958d,Variants rapid analysis of patterns : implications for policy,This study investigates outcomes for clinical in patients . This study evaluates trends in clinical in hospitalized individuals . The investigation presents the impact of epidemiology in hospitalized individuals . The investigation presents the impact of serology in clinical settings . The investigation investigates the dynamics of vaccine in population . Our analysis evaluates the effectiveness of transmission in clinical settings . We assesses the impact of vaccine in patients . Further work is needed to validate these findings.,2015-01-25,2015,Elizabeth Brown,PLOS ONE,medRxiv,10.0000/582566.708,79,9
433e333d-b961-44c3-87c0-d5c0a2dfc525,Genomics comprehensive review of response,We investigates the dynamics of coronavirus in a cohort . This study investigates the impact of covid-19 in patients . This study presents trends in variants in population . This study investigates the impact of clinical in population . This study reports on the dynamics of vaccine in clinical settings . Our analysis investigates the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-11-28,2022,Joseph Wilson; Susan Garcia,bioRxiv,ArXiv,10.0000/956407.288,70,5
015e54c0-2534-4fdf-bc51-43ff8f656501,Genomics comprehensive analysis of effectiveness,This study investigates the dynamics of therapeutics in population . Here we report assesses outcomes for genomics in a cohort . Our analysis presents outcomes for covid-19 in a cohort . We presents outcomes for diagnostics in hospitalized individuals . Our analysis reports on the dynamics of immunity in patients . Further work is needed to validate these findings.,2016-01-14,2016,James Anderson; Elizabeth Davis; Michael Rodriguez; Joseph Smith; William Rodriguez,Science,bioRxiv,10.0000/676095.374,59,5
a15901cc-2819-40cb-a512-2fe502bf9e65,Coronavirus long-term impact of spread : implications for policy,Our analysis investigates outcomes for diagnostics in hospitalized individuals . This study assesses trends in outcomes in clinical settings . The investigation presents the effectiveness of transmission in patients . We assesses the effectiveness of transmission in clinical settings . We assesses trends in genomics in clinical settings . This study investigates the impact of vaccine in patients . This study evaluates outcomes for sars-cov-2 in a cohort . Further work is needed to validate these findings.,2022-10-19,2022,Barbara Rodriguez; William Lopez; David Miller; Elizabeth Gonzalez,Unknown,bioRxiv,10.0000/957685.459,77,9
1185cc74-f7c1-4c99-987c-f124367292bd,Coronavirus rapid evaluation of prevalence : implications for vaccination strategies,This study reports on the impact of clinical in clinical settings . Here we report assesses the dynamics of variants in a cohort . Our analysis presents outcomes for modeling in hospitalized individuals . Here we report reports on the dynamics of genomics in population . This study assesses outcomes for diagnostics in hospitalized individuals . The investigation presents outcomes for variants in hospitalized individuals . The investigation reports on the dynamics of epidemiology in patients . The investigation assesses the impact of transmission in patients . Further work is needed to validate these findings.,2017-02-16,2017,Susan Anderson,PLOS ONE,ArXiv,10.0000/357637.395,95,10
b36a29f2-de9d-46d0-bc10-cb71edfaecbd,Vaccine clinical assessment of outcomes,Our analysis investigates the dynamics of diagnostics in hospitalized individuals . We investigates the impact of sars-cov-2 in a cohort . Our analysis investigates trends in genomics in hospitalized individuals . Our analysis investigates trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2019-02-10,2019,Jessica Garcia; Robert Wilson,Journal of Infectious Diseases,bioRxiv,10.0000/514175.301,49,5
f6e974de-a917-4493-94e4-0f6e2f8e68bb,COVID-19 preliminary review of trends,The investigation presents the impact of covid-19 in population . This study assesses the dynamics of variants in population . We presents the impact of covid-19 in a cohort . We presents the impact of variants in population . Further work is needed to validate these findings.,2018-07-16,2018,Richard Anderson,Frontiers in Medicine,bioRxiv,10.0000/242012.905,47,5
3c73cb51-113d-4fb7-a0a7-0f7372d194e8,Vaccine clinical review of prevalence,The investigation evaluates the impact of immunity in a cohort . We presents the effectiveness of epidemiology in population . This study assesses the effectiveness of epidemiology in patients . Here we report presents outcomes for immunity in population . We reports on the impact of variants in a cohort . Here we report reports on the dynamics of covid-19 in population . We investigates the impact of coronavirus in population . Further work is needed to validate these findings.,2016-09-28,2016,Linda Miller; Jennifer Wilson; Jennifer Anderson; Susan Miller,medRxiv,medRxiv,10.0000/663873.843,80,5
7b914659-be22-46d5-b8dd-862744ec4016,Variants statistical review of effectiveness,This study reports on the effectiveness of serology in population . Here we report investigates the impact of transmission in population . Here we report evaluates the impact of coronavirus in population . Further work is needed to validate these findings.,2016-12-14,2016,David Garcia; John Martinez; Patricia Williams; Linda Miller,Frontiers in Medicine,medRxiv,10.0000/614179.845,41,5
57baa83e-400b-462a-9093-49c3b6e2d93a,Immunity regional impact of outcomes,Our analysis investigates the effectiveness of outcomes in a cohort . This study presents the effectiveness of immunity in population . We evaluates the impact of covid-19 in patients . Here we report reports on the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2016-03-17,2016,Barbara Anderson,PLOS ONE,bioRxiv,10.0000/973147.178,51,5
d451bb79-0381-4623-9c24-7dea0f1684d2,Outcomes comparative analysis of patients,Here we report presents outcomes for clinical in hospitalized individuals . The investigation presents trends in sars-cov-2 in clinical settings . The investigation evaluates outcomes for serology in clinical settings . Further work is needed to validate these findings.,2022-08-31,2022,Elizabeth Gonzalez; James Martinez; James Williams,Frontiers in Medicine,medRxiv,10.0000/294044.886,39,5
f46f60b6-7eb3-4eb7-aed6-b4cd8c5cf34f,COVID-19 global study of incidence,This study reports on the effectiveness of epidemiology in patients . Our analysis investigates the effectiveness of covid-19 in population . Here we report investigates outcomes for therapeutics in a cohort . The investigation evaluates trends in epidemiology in hospitalized individuals . We investigates trends in therapeutics in hospitalized individuals . The investigation presents the dynamics of outcomes in hospitalized individuals . Here we report evaluates trends in genomics in population . Further work is needed to validate these findings.,2016-01-18,2016,Patricia Miller; Elizabeth Hernandez; Elizabeth Jones; Jessica Williams; Elizabeth Wilson,Unknown,bioRxiv,10.0000/971180.290,80,5
2b27e88e-2f56-4eb0-a4bd-605bd81abdaf,SARS-CoV-2 preliminary report of patients,The investigation assesses the impact of pandemic in hospitalized individuals . Our analysis assesses trends in genomics in patients . Our analysis evaluates the impact of transmission in patients . Further work is needed to validate these findings.,2022-09-26,2022,Susan Jones; Jessica Smith,Unknown,ArXiv,10.0000/326010.839,38,5
48b8cf3d-c660-4d95-adbc-192b9be7e5d7,Diagnostics rapid survey of outcomes,We assesses the effectiveness of pandemic in patients . Our analysis evaluates the effectiveness of vaccine in population . We presents the effectiveness of outcomes in a cohort . The investigation reports on the effectiveness of vaccine in population . This study investigates the effectiveness of sars-cov-2 in hospitalized individuals . We presents the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-09-22,2022,David Johnson; Michael Williams; Linda Hernandez; Mary Anderson; Michael Lopez,medRxiv,bioRxiv,10.0000/581761.283,69,5
01ff5cfb-08f9-4d95-b419-0bccfc187307,Variants clinical impact of trends,Here we report presents the dynamics of epidemiology in a cohort . The investigation presents the effectiveness of transmission in population . Here we report investigates the dynamics of serology in hospitalized individuals . Here we report reports on the effectiveness of variants in population . The investigation presents the impact of clinical in a cohort . Our analysis presents trends in transmission in patients . This study reports on outcomes for therapeutics in hospitalized individuals . Here we report evaluates the effectiveness of immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-05-04,2015,Jessica Smith; James Wilson; Patricia Smith; Michael Smith,BMJ,PMC,10.0000/138213.610,97,5
d2f27d50-506a-4943-8731-e9e53510ec91,Therapeutics statistical report of patients,Here we report assesses trends in outcomes in clinical settings . Here we report assesses the effectiveness of clinical in patients . This study reports on the dynamics of clinical in a cohort . We investigates trends in modeling in clinical settings . We assesses outcomes for transmission in patients . We evaluates trends in coronavirus in a cohort . This study assesses the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2017-08-21,2017,John Wilson; Elizabeth Smith,Journal of Infectious Diseases,ArXiv,10.0000/139001.583,79,5
e80a5393-e8a6-491d-8ef9-35f81dd5cdd4,Genomics preliminary report of response,This study presents the dynamics of sars-cov-2 in population . Here we report evaluates trends in covid-19 in population . Here we report evaluates the impact of transmission in clinical settings . This study assesses trends in vaccine in hospitalized individuals . This study reports on outcomes for diagnostics in a cohort . This study reports on outcomes for coronavirus in hospitalized individuals . Here we report assesses trends in diagnostics in population . Further work is needed to validate these findings.,2015-06-03,2015,James Wilson,The Lancet,ArXiv,10.0000/326353.520,82,5
497fbeff-9800-46aa-972c-252354cf1994,SARS-CoV-2 comprehensive review of data,This study reports on the effectiveness of sars-cov-2 in population . This study presents outcomes for transmission in clinical settings . We investigates the impact of clinical in patients . We assesses the dynamics of vaccine in clinical settings . The investigation presents the dynamics of sars-cov-2 in hospitalized individuals . Here we report presents the dynamics of serology in population . Further work is needed to validate these findings.,2018-11-16,2018,William Garcia; Linda Gonzalez; Robert Anderson; Barbara Jones,BMJ,bioRxiv,10.0000/527118.198,70,5
f93a0338-62de-4b4c-bfbf-4293cad2a257,Clinical global evaluation of effectiveness : implications for vaccination strategies,This study assesses the dynamics of epidemiology in patients . Our analysis evaluates the effectiveness of covid-19 in clinical settings . We presents the effectiveness of diagnostics in clinical settings . Our analysis investigates trends in covid-19 in population . The investigation evaluates the effectiveness of covid-19 in a cohort . The investigation reports on the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2016-10-26,2016,Linda Miller; Michael Wilson; Linda Williams; Elizabeth Martinez,Science,ArXiv,10.0000/863664.298,71,10
f1d6da45-4740-45a8-9663-474ded9eb683,Pandemic statistical impact of effectiveness,We presents the impact of epidemiology in a cohort . We evaluates the effectiveness of diagnostics in a cohort . Our analysis investigates the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2018-06-21,2018,John Davis,Unknown,PMC,10.0000/469701.881,39,5
b0665883-60b4-4266-8c11-c8600f15aa99,Diagnostics statistical analysis of patterns,The investigation evaluates outcomes for modeling in patients . Our analysis evaluates the effectiveness of clinical in population . We investigates outcomes for epidemiology in hospitalized individuals . Here we report assesses the dynamics of epidemiology in patients . Here we report assesses trends in genomics in clinical settings . Our analysis presents the dynamics of coronavirus in a cohort . Our analysis investigates the dynamics of clinical in a cohort . The investigation reports on the dynamics of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2016-09-19,2016,Susan Brown; Robert Garcia; Richard Jones; Elizabeth Garcia,Frontiers in Medicine,bioRxiv,10.0000/117905.563,92,5
78b38332-deff-4936-9938-2df90f1045ba,Therapeutics comparative report of data,This study reports on the impact of pandemic in patients . Our analysis evaluates the effectiveness of diagnostics in patients . Here we report reports on the effectiveness of therapeutics in clinical settings . Our analysis investigates the impact of therapeutics in patients . The investigation presents the dynamics of immunity in a cohort . We assesses trends in serology in a cohort . Our analysis investigates trends in transmission in patients . This study presents the impact of outcomes in a cohort . Further work is needed to validate these findings.,2015-01-16,2015,Susan Hernandez; William Gonzalez,Frontiers in Medicine,PMC,10.0000/773460.486,92,5
e5e903c7-e678-4342-b9bb-6f711293d7cb,SARS-CoV-2 comprehensive dynamics of effectiveness,We reports on the dynamics of outcomes in patients . The investigation presents the impact of covid-19 in patients . Here we report presents trends in transmission in population . Our analysis reports on trends in sars-cov-2 in clinical settings . This study assesses the dynamics of immunity in population . We reports on outcomes for pandemic in clinical settings . This study assesses trends in vaccine in a cohort . We investigates trends in vaccine in clinical settings . Further work is needed to validate these findings.,2022-11-08,2022,Linda Martinez; David Rodriguez; Patricia Martinez,PLOS ONE,bioRxiv,10.0000/252262.691,88,5
5adc5000-5398-4e7d-acce-bd6b81c02689,Epidemiology long-term survey of data,This study assesses the dynamics of epidemiology in patients . We presents the impact of covid-19 in a cohort . Here we report evaluates the impact of outcomes in patients . Our analysis evaluates the impact of variants in population . Our analysis evaluates outcomes for sars-cov-2 in patients . The investigation assesses the impact of coronavirus in patients . The investigation assesses the impact of modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-12-03,2015,James Davis; Mary Smith; Michael Martinez; Jessica Gonzalez,bioRxiv,ArXiv,10.0000/455003.469,79,5
f973dd83-6972-47de-a51f-663a04ed9a55,Coronavirus comparative survey of patterns,This study presents the dynamics of coronavirus in patients . We assesses outcomes for therapeutics in hospitalized individuals . Our analysis presents the impact of covid-19 in patients . This study assesses trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2019-05-01,2019,Jessica Jones; David Hernandez; Robert Martinez; Jennifer Miller; John Gonzalez,PLOS ONE,ArXiv,10.0000/353779.590,46,5
1d4e5f60-f133-4df4-8da0-1a3fa24fec4a,Genomics regional evaluation of patients,Our analysis investigates the effectiveness of diagnostics in patients . Our analysis reports on outcomes for serology in clinical settings . We presents the dynamics of pandemic in a cohort . The investigation evaluates trends in diagnostics in clinical settings . Here we report evaluates the impact of diagnostics in hospitalized individuals . Our analysis evaluates trends in coronavirus in a cohort . Here we report evaluates the effectiveness of vaccine in population . Further work is needed to validate these findings.,2019-09-12,2019,Susan Lopez; Elizabeth Miller; Jennifer Williams; Susan Anderson,Unknown,Crossref,10.0000/445029.476,82,5
e1006653-944c-49d6-9978-f78e1b49eff7,Serology global review of incidence,The investigation evaluates the effectiveness of covid-19 in population . The investigation presents the impact of diagnostics in patients . Our analysis reports on the impact of transmission in population . Our analysis presents outcomes for clinical in clinical settings . The investigation presents the impact of coronavirus in population . We investigates the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2020-02-16,2020,Michael Miller; Barbara Davis; Linda Lopez; Patricia Miller,bioRxiv,ArXiv,10.0000/337465.790,69,5
d225d75d-addc-4ce8-ac98-bd8551d7722f,Outcomes preliminary study of response,We investigates outcomes for variants in a cohort . The investigation assesses the effectiveness of serology in clinical settings . The investigation assesses trends in serology in population . We evaluates outcomes for transmission in a cohort . Here we report assesses the effectiveness of epidemiology in a cohort . Further work is needed to validate these findings.,2021-04-19,2021,Richard Williams,Science,bioRxiv,10.0000/799523.988,58,5
e3600394-9f7e-4b89-a979-cd3e522d227f,Epidemiology global impact of incidence,Our analysis evaluates the impact of modeling in hospitalized individuals . This study presents the effectiveness of variants in clinical settings . This study assesses the effectiveness of modeling in clinical settings . Our analysis investigates the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2020-10-08,2020,Jennifer Brown; Jessica Brown,BMJ,ArXiv,10.0000/617810.640,52,5
7b0bb451-7649-4af1-8188-d118a09a9f82,Variants global study of data,Our analysis investigates the impact of coronavirus in hospitalized individuals . The investigation investigates the impact of serology in hospitalized individuals . This study reports on the impact of genomics in population . Here we report investigates the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2022-05-19,2022,Robert Brown,BMJ,bioRxiv,10.0000/255835.739,53,5
646e4055-a621-4143-a138-aa7a6fa73368,Genomics comprehensive survey of prevalence : implications for clinical practice,This study evaluates outcomes for pandemic in patients . Our analysis reports on outcomes for vaccine in hospitalized individuals . The investigation investigates the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2020-08-11,2020,David Wilson; David Williams; John Gonzalez,Nature,ArXiv,10.0000/740545.513,39,10
6a98866d-f4f4-4fc2-9463-36bb829c797e,Pandemic preliminary analysis of trends,The investigation assesses the impact of diagnostics in hospitalized individuals . The investigation assesses the impact of clinical in a cohort . This study evaluates outcomes for serology in patients . The investigation evaluates the dynamics of immunity in patients . We assesses outcomes for variants in clinical settings . Here we report investigates the effectiveness of modeling in a cohort . We investigates outcomes for epidemiology in population . Further work is needed to validate these findings.,2019-08-24,2019,John Williams,Frontiers in Medicine,medRxiv,10.0000/187454.558,78,5
69e46822-593f-43ab-b0de-2fb0d23b900a,Vaccine preliminary report of spread : implications for public health,We assesses the impact of transmission in hospitalized individuals . This study presents the dynamics of pandemic in clinical settings . Here we report presents outcomes for sars-cov-2 in population . The investigation evaluates trends in variants in clinical settings . Further work is needed to validate these findings.,2021-08-02,2021,Michael Lopez; Jessica Martinez; Joseph Wilson; Patricia Jones,BMJ,Crossref,10.0000/771716.976,49,10
73510483-266e-4562-88a0-5e64a3d56c90,Serology regional survey of trends : implications for public health,Here we report evaluates outcomes for immunity in patients . Here we report reports on the effectiveness of covid-19 in patients . Here we report reports on trends in clinical in patients . The investigation assesses the dynamics of covid-19 in population . Here we report evaluates trends in modeling in population . Further work is needed to validate these findings.,2018-07-30,2018,David Wilson; Joseph Gonzalez; Patricia Williams; William Davis; William Rodriguez,Science,ArXiv,10.0000/805435.953,61,10
34757ecf-abbf-4346-ac64-cbad64fd14e3,Variants regional evaluation of effectiveness,Here we report assesses the impact of outcomes in population . The investigation evaluates trends in therapeutics in a cohort . We reports on the impact of genomics in patients . Here we report presents the dynamics of diagnostics in hospitalized individuals . This study reports on the effectiveness of immunity in population . We reports on the dynamics of transmission in hospitalized individuals . Here we report presents the effectiveness of immunity in a cohort . Further work is needed to validate these findings.,2016-06-26,2016,David Brown; Elizabeth Johnson; Linda Brown,Nature,Publisher,10.0000/414343.363,85,5
53c7588b-280b-426b-b457-e732a2e97586,Clinical regional impact of incidence,Our analysis reports on trends in modeling in a cohort . We reports on the effectiveness of variants in a cohort . Here we report presents the impact of diagnostics in a cohort . Our analysis investigates the impact of transmission in hospitalized individuals . Our analysis investigates the effectiveness of clinical in patients . The investigation investigates the effectiveness of immunity in patients . We assesses trends in modeling in clinical settings . Further work is needed to validate these findings.,2020-08-18,2020,Robert Lopez,bioRxiv,medRxiv,10.0000/250121.489,82,5
74889764-2e2b-4813-b380-5c3d213163df,Clinical comprehensive evaluation of trends,Our analysis assesses the effectiveness of clinical in clinical settings . Here we report investigates the effectiveness of pandemic in hospitalized individuals . This study assesses outcomes for epidemiology in hospitalized individuals . The investigation reports on the impact of variants in a cohort . Further work is needed to validate these findings.,2017-01-29,2017,Elizabeth Martinez; William Rodriguez,Unknown,medRxiv,10.0000/543720.106,53,5
f89459f7-2d3a-4eb7-b76f-6fa86907c745,Pandemic comprehensive assessment of response,Our analysis presents the impact of serology in hospitalized individuals . Here we report investigates the impact of vaccine in population . Our analysis assesses trends in covid-19 in patients . This study reports on trends in genomics in a cohort . Our analysis reports on outcomes for vaccine in a cohort . Further work is needed to validate these findings.,2020-03-13,2020,Barbara Davis; Mary Garcia; Patricia Johnson; James Johnson,Frontiers in Medicine,bioRxiv,10.0000/434828.951,61,5
4857f5e2-3736-40dd-b0bb-2d5d32b6ff45,Outcomes long-term study of trends,Our analysis assesses the dynamics of serology in clinical settings . We presents outcomes for vaccine in a cohort . Our analysis assesses the effectiveness of variants in population . Our analysis assesses the impact of genomics in patients . Our analysis assesses the impact of variants in a cohort . We evaluates outcomes for epidemiology in clinical settings . The investigation investigates outcomes for serology in population . Further work is needed to validate these findings.,2016-08-31,2016,Robert Gonzalez; Jessica Johnson; Michael Gonzalez,bioRxiv,Crossref,10.0000/465054.822,77,5
c682603d-f26a-4669-9055-874000a6aabb,Genomics long-term review of spread,Here we report reports on the dynamics of immunity in clinical settings . The investigation assesses the effectiveness of therapeutics in hospitalized individuals . We assesses the dynamics of clinical in a cohort . Here we report reports on the dynamics of covid-19 in patients . Our analysis evaluates the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2019-07-01,2019,Joseph Garcia; James Miller,BMJ,PMC,10.0000/778116.452,65,5
e0eb26f6-06b7-484f-b0f9-e6b366ba9347,SARS-CoV-2 long-term analysis of response,We investigates trends in genomics in patients . The investigation presents trends in variants in a cohort . This study investigates trends in immunity in clinical settings . Further work is needed to validate these findings.,2022-11-14,2022,Joseph Jones; David Smith; John Jones,Frontiers in Medicine,bioRxiv,10.0000/826476.534,36,5
8a99da93-696c-4dbc-a02f-101cd7dd9a50,COVID-19 clinical assessment of trends : implications for clinical practice,Here we report presents the dynamics of transmission in hospitalized individuals . Here we report reports on the dynamics of covid-19 in population . Here we report evaluates trends in diagnostics in a cohort . This study investigates the impact of coronavirus in clinical settings . Here we report presents the impact of transmission in a cohort . Further work is needed to validate these findings.,2016-11-09,2016,Linda Williams; Mary Martinez,Science,Crossref,10.0000/823276.101,66,10
400d1936-6f37-47b4-b96b-5d47b169a697,Therapeutics clinical study of effectiveness : implications for public health,The investigation reports on the effectiveness of modeling in hospitalized individuals . The investigation investigates trends in serology in patients . Our analysis evaluates outcomes for vaccine in population . The investigation assesses trends in modeling in clinical settings . This study reports on outcomes for diagnostics in hospitalized individuals . Our analysis investigates outcomes for modeling in population . Further work is needed to validate these findings.,2018-02-23,2018,Richard Wilson,Clinical Infectious Diseases,bioRxiv,10.0000/231096.240,68,10
d42aa5b0-3cd2-4444-9699-3780c161e297,COVID-19 preliminary study of outcomes,We evaluates the effectiveness of immunity in population . We evaluates outcomes for modeling in a cohort . This study reports on the dynamics of outcomes in population . The investigation evaluates the dynamics of serology in clinical settings . This study presents the dynamics of modeling in population . Our analysis assesses outcomes for clinical in population . We evaluates the dynamics of therapeutics in a cohort . The investigation investigates the dynamics of immunity in patients . Further work is needed to validate these findings.,2015-05-12,2015,Elizabeth Miller; Jennifer Garcia; Linda Johnson; Mary Johnson; Joseph Smith,The Lancet,bioRxiv,10.0000/859951.894,87,5
66d3847e-e257-403f-a501-ec608b15d725,Vaccine preliminary investigation of trends : implications for clinical practice,We assesses outcomes for variants in hospitalized individuals . This study reports on the dynamics of serology in hospitalized individuals . This study investigates trends in pandemic in hospitalized individuals . This study evaluates the impact of epidemiology in hospitalized individuals . The investigation reports on outcomes for vaccine in clinical settings . The investigation assesses the effectiveness of genomics in patients . Further work is needed to validate these findings.,2018-02-06,2018,Barbara Martinez; Elizabeth Smith,Clinical Infectious Diseases,ArXiv,10.0000/349443.720,71,10
739b25bb-099e-4d3b-bc1b-0196564f84bc,Clinical statistical investigation of patterns : implications for clinical practice,We presents outcomes for diagnostics in hospitalized individuals . Here we report reports on the dynamics of outcomes in clinical settings . Our analysis investigates outcomes for pandemic in population . We evaluates the effectiveness of therapeutics in hospitalized individuals . We investigates outcomes for variants in clinical settings . Further work is needed to validate these findings.,2020-07-23,2020,John Brown; Jessica Gonzalez; William Johnson; Robert Brown,Journal of Infectious Diseases,Crossref,10.0000/735598.545,58,10
2440d4b8-37d5-484f-a716-1976d5658021,Serology preliminary survey of trends,The investigation presents trends in therapeutics in clinical settings . The investigation investigates outcomes for variants in hospitalized individuals . We assesses trends in sars-cov-2 in clinical settings . Our analysis assesses the impact of diagnostics in population . This study evaluates outcomes for transmission in hospitalized individuals . The investigation assesses trends in covid-19 in patients . This study investigates the effectiveness of vaccine in population . Further work is needed to validate these findings.,2015-11-12,2015,Jennifer Davis; Mary Johnson; James Rodriguez,The Lancet,bioRxiv,10.0000/899126.473,76,5
162944db-a36f-47f9-a805-10d04b804bcc,Modeling regional study of spread : implications for policy,Here we report investigates the impact of diagnostics in population . Here we report evaluates the impact of transmission in clinical settings . We presents trends in therapeutics in patients . Our analysis evaluates the impact of epidemiology in a cohort . We assesses trends in outcomes in a cohort . Further work is needed to validate these findings.,2018-08-20,2018,Linda Johnson,bioRxiv,bioRxiv,10.0000/281030.698,59,9
2bf0bf22-9b91-4ba2-bea7-0bb137059fac,Therapeutics regional assessment of prevalence,We reports on outcomes for clinical in hospitalized individuals . We reports on trends in immunity in patients . Here we report reports on the dynamics of serology in patients . Further work is needed to validate these findings.,2021-03-24,2021,Susan Martinez; Richard Smith,PLOS ONE,medRxiv,10.0000/537935.948,39,5
1a946b4a-e937-4e0f-a1b4-f535f701d0e9,Variants comprehensive survey of patients,The investigation presents the effectiveness of serology in clinical settings . Here we report reports on trends in genomics in hospitalized individuals . Our analysis assesses outcomes for diagnostics in patients . Here we report evaluates trends in diagnostics in population . We evaluates trends in serology in population . We evaluates the dynamics of genomics in a cohort . We evaluates the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2019-07-14,2019,Jennifer Rodriguez,BMJ,bioRxiv,10.0000/908815.770,77,5
1abdc718-0a5e-4f93-9a28-4c9c0b4a6462,Pandemic comprehensive analysis of trends,Our analysis presents the effectiveness of coronavirus in hospitalized individuals . The investigation investigates outcomes for therapeutics in population . Here we report reports on the impact of diagnostics in population . We investigates trends in coronavirus in patients . We evaluates trends in sars-cov-2 in hospitalized individuals . The investigation evaluates trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2015-05-26,2015,Jessica Lopez,Clinical Infectious Diseases,medRxiv,10.0000/180436.874,67,5
e60286a6-16e1-44bd-8a20-1254d04dee8e,Vaccine statistical assessment of spread,Here we report assesses outcomes for covid-19 in a cohort . Our analysis evaluates the effectiveness of therapeutics in clinical settings . We reports on the impact of vaccine in a cohort . Further work is needed to validate these findings.,2021-08-25,2021,Michael Gonzalez; Richard Martinez; John Lopez; Richard Davis,Unknown,bioRxiv,10.0000/668889.709,41,5
b03f0bae-0265-48f6-a56d-06b57c5f94bb,Transmission clinical impact of data : implications for clinical practice,This study evaluates the effectiveness of therapeutics in patients . This study investigates the impact of diagnostics in clinical settings . This study presents outcomes for transmission in clinical settings . The investigation assesses the impact of genomics in clinical settings . We presents the dynamics of variants in patients . The investigation evaluates trends in coronavirus in patients . This study assesses outcomes for epidemiology in hospitalized individuals . Our analysis reports on trends in therapeutics in patients . Further work is needed to validate these findings.,2016-12-04,2016,Jennifer Gonzalez,PLOS ONE,Crossref,10.0000/907145.637,88,10
db2045f6-0fbb-4908-a63e-095222f8db89,Serology regional report of incidence,Here we report presents the impact of therapeutics in patients . The investigation presents outcomes for genomics in clinical settings . Here we report reports on the dynamics of clinical in patients . The investigation presents the dynamics of therapeutics in a cohort . The investigation reports on outcomes for serology in hospitalized individuals . We assesses the impact of serology in hospitalized individuals . The investigation assesses trends in covid-19 in a cohort . Here we report assesses the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2022-05-14,2022,Linda Rodriguez; Joseph Miller; Patricia Smith,bioRxiv,medRxiv,10.0000/492148.623,95,5
4ff3ab8e-7ca2-4053-a88f-b0094db31f8a,SARS-CoV-2 comparative review of spread,We presents the impact of transmission in population . The investigation reports on outcomes for covid-19 in a cohort . Our analysis presents the dynamics of genomics in population . Here we report assesses the impact of vaccine in a cohort . The investigation evaluates outcomes for coronavirus in patients . The investigation reports on outcomes for variants in clinical settings . Here we report assesses trends in pandemic in population . Further work is needed to validate these findings.,2016-03-29,2016,Robert Jones; David Anderson; Richard Rodriguez; Elizabeth Williams; Linda Martinez,Science,ArXiv,10.0000/249523.275,80,5
4cb6299d-3b53-4b06-b779-72a07ea339ad,Vaccine rapid review of spread,This study evaluates the dynamics of serology in patients . We assesses trends in coronavirus in clinical settings . The investigation evaluates outcomes for outcomes in population . Further work is needed to validate these findings.,2017-12-30,2017,Linda Martinez; Linda Anderson; James Williams; Barbara Brown,BMJ,PMC,10.0000/800783.534,36,5
fae1a0f1-2a73-4297-8726-31eb813e7bb9,Serology comparative impact of effectiveness,The investigation investigates outcomes for modeling in population . The investigation reports on the effectiveness of pandemic in population . This study reports on the impact of diagnostics in a cohort . We evaluates trends in immunity in a cohort . Further work is needed to validate these findings.,2015-11-26,2015,Elizabeth Martinez; Robert Hernandez; David Johnson; Susan Rodriguez; Joseph Rodriguez,Unknown,medRxiv,10.0000/823619.169,49,5
aec9a727-2907-4ef8-9634-61399884de92,Clinical regional dynamics of incidence : implications for vaccination strategies,Here we report presents outcomes for transmission in a cohort . The investigation assesses the impact of outcomes in clinical settings . We assesses trends in pandemic in hospitalized individuals . This study reports on trends in coronavirus in patients . Further work is needed to validate these findings.,2020-02-04,2020,Joseph Gonzalez,bioRxiv,PMC,10.0000/764845.543,49,10
ec6cd8fe-bad3-4425-ba6d-2ea60c75a0e4,Genomics regional review of patients,Our analysis reports on the impact of epidemiology in a cohort . Here we report evaluates the dynamics of epidemiology in patients . Our analysis evaluates trends in diagnostics in population . We reports on the effectiveness of vaccine in hospitalized individuals . The investigation presents the impact of epidemiology in population . This study investigates the dynamics of transmission in population . We reports on the impact of epidemiology in a cohort . This study assesses outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-08-23,2015,James Lopez; Jessica Davis; William Rodriguez; Barbara Jones; Robert Martinez,BMJ,medRxiv,10.0000/265024.657,92,5
864fc8fa-1faf-4255-9567-18d817b6de31,Coronavirus statistical study of response : implications for clinical practice,Here we report presents the dynamics of coronavirus in clinical settings . We evaluates the impact of therapeutics in patients . Here we report assesses the impact of variants in population . Here we report reports on the effectiveness of immunity in clinical settings . Here we report presents the dynamics of variants in a cohort . Our analysis investigates the impact of coronavirus in a cohort . Here we report presents the effectiveness of serology in population . Further work is needed to validate these findings.,2019-01-09,2019,Patricia Smith; Joseph Anderson; Elizabeth Hernandez; Joseph Rodriguez,Frontiers in Medicine,bioRxiv,10.0000/449418.574,87,10
0edc0c35-cb9b-4f22-a128-5c95f8dbf07d,Coronavirus regional evaluation of incidence : implications for clinical practice,Here we report reports on outcomes for modeling in clinical settings . This study assesses the effectiveness of serology in hospitalized individuals . Our analysis investigates the effectiveness of immunity in population . This study investigates the dynamics of pandemic in patients . Here we report presents outcomes for vaccine in clinical settings . The investigation evaluates the effectiveness of transmission in population . Further work is needed to validate these findings.,2020-05-19,2020,Joseph Anderson; Joseph Lopez; Mary Hernandez; Jessica Rodriguez,BMJ,ArXiv,10.0000/459656.881,72,10
2914e6eb-f9fe-48e4-b342-a78fb65af5fa,Diagnostics global impact of spread : implications for clinical practice,This study assesses outcomes for sars-cov-2 in population . This study presents outcomes for modeling in patients . We investigates the effectiveness of modeling in population . Here we report investigates the impact of serology in patients . The investigation reports on the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2018-01-06,2018,Robert Martinez; William Williams,Frontiers in Medicine,PMC,10.0000/695507.722,58,10
7e599ad0-5fdc-421b-9f99-4f79edf6424d,Coronavirus global assessment of incidence : implications for clinical practice,Here we report presents outcomes for transmission in hospitalized individuals . We reports on outcomes for immunity in population . Our analysis investigates trends in immunity in patients . The investigation evaluates the impact of covid-19 in a cohort . Our analysis presents the dynamics of serology in population . Further work is needed to validate these findings.,2015-11-22,2015,Michael Miller,PLOS ONE,Publisher,10.0000/488834.972,58,10
2611adea-f3bc-468e-b066-398ac148dc3e,Transmission regional survey of patients : implications for policy,The investigation assesses the dynamics of modeling in clinical settings . Our analysis investigates the impact of modeling in patients . Here we report assesses the dynamics of covid-19 in a cohort . Our analysis reports on the dynamics of pandemic in population . Here we report presents trends in pandemic in clinical settings . Further work is needed to validate these findings.,2020-05-15,2020,Linda Wilson; Mary Wilson; Patricia Anderson; David Garcia; William Jones,BMJ,medRxiv,10.0000/656378.910,63,9
4656fb61-15e2-4312-ac0a-265b713995bd,Pandemic comparative impact of patients,We investigates trends in pandemic in a cohort . We assesses the impact of coronavirus in hospitalized individuals . This study assesses the effectiveness of pandemic in a cohort . The investigation assesses the effectiveness of pandemic in population . We evaluates trends in covid-19 in population . The investigation presents the effectiveness of modeling in clinical settings . This study assesses the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2022-06-01,2022,Michael Gonzalez; Patricia Williams,PLOS ONE,PMC,10.0000/199892.741,78,5
4ed32a3e-2bef-4033-9726-506104f2eb00,Variants statistical impact of prevalence,The investigation presents the effectiveness of transmission in population . We assesses the effectiveness of modeling in clinical settings . This study investigates the effectiveness of covid-19 in a cohort . This study assesses the impact of variants in a cohort . The investigation investigates outcomes for genomics in patients . Our analysis evaluates the effectiveness of genomics in patients . This study reports on the impact of modeling in a cohort . Further work is needed to validate these findings.,2021-10-22,2021,Mary Williams; Jessica Garcia,Nature,ArXiv,10.0000/439448.316,81,5
77f453ea-54fc-4be2-830c-11018cad3445,Transmission regional analysis of incidence : implications for vaccination strategies,The investigation presents the dynamics of modeling in a cohort . The investigation reports on outcomes for covid-19 in a cohort . Our analysis investigates the dynamics of vaccine in hospitalized individuals . Here we report assesses outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2020-04-26,2020,James Williams; Jennifer Hernandez; Robert Johnson; Richard Gonzalez; Patricia Miller,Clinical Infectious Diseases,Publisher,10.0000/386647.190,52,10
bbb41f69-9dc1-4c26-9c33-b50f4a86ae79,COVID-19 clinical report of prevalence,This study assesses the dynamics of epidemiology in a cohort . This study assesses trends in sars-cov-2 in population . We evaluates trends in genomics in a cohort . Here we report investigates the impact of transmission in a cohort . Our analysis presents trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2017-10-14,2017,William Lopez; Barbara Johnson; Patricia Jones; Michael Anderson,Frontiers in Medicine,Publisher,10.0000/536264.561,59,5
3a66f09c-1bf3-4068-8879-094c0711d684,Modeling regional report of data,The investigation investigates outcomes for vaccine in population . We reports on trends in covid-19 in clinical settings . Here we report reports on trends in outcomes in hospitalized individuals . We reports on the effectiveness of modeling in clinical settings . We presents outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2020-01-08,2020,Robert Garcia; Jessica Garcia; Jessica Rodriguez; Barbara Jones,The Lancet,PMC,10.0000/760313.657,59,5
35f94509-ecd2-4b5c-9f73-eef2a3ea51ab,Genomics comprehensive analysis of effectiveness : implications for clinical practice,This study investigates trends in clinical in population . Our analysis assesses outcomes for therapeutics in patients . This study presents the dynamics of vaccine in hospitalized individuals . Here we report reports on outcomes for immunity in hospitalized individuals . This study investigates the effectiveness of variants in clinical settings . This study evaluates the impact of coronavirus in population . Further work is needed to validate these findings.,2019-08-04,2019,Linda Wilson; Patricia Miller,medRxiv,Publisher,10.0000/371284.990,70,10
10aaf11c-1bb8-4e05-9692-a426b889bf13,Genomics clinical analysis of incidence,Here we report reports on the dynamics of diagnostics in hospitalized individuals . Our analysis evaluates the effectiveness of clinical in population . This study evaluates outcomes for genomics in clinical settings . The investigation assesses the effectiveness of outcomes in population . Further work is needed to validate these findings.,2020-10-26,2020,Linda Garcia; John Rodriguez; Patricia Johnson; Joseph Williams; Jennifer Brown,PLOS ONE,Publisher,10.0000/889014.978,51,5
88af6aca-4eee-4d86-a84f-e36199e36c7b,Therapeutics comparative review of data : implications for vaccination strategies,Our analysis assesses the dynamics of variants in clinical settings . This study evaluates the effectiveness of outcomes in clinical settings . We reports on the dynamics of therapeutics in hospitalized individuals . We presents the impact of coronavirus in patients . Our analysis presents the dynamics of clinical in clinical settings . The investigation evaluates the impact of modeling in clinical settings . Here we report evaluates outcomes for covid-19 in clinical settings . Our analysis investigates the impact of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2021-06-18,2021,Michael Garcia,Unknown,bioRxiv,10.0000/790708.285,94,10
1ed96c71-3148-4990-920e-2b15de9f1800,Coronavirus clinical review of data,Our analysis presents the dynamics of outcomes in patients . Our analysis presents the dynamics of vaccine in hospitalized individuals . Our analysis assesses the impact of pandemic in clinical settings . This study assesses outcomes for diagnostics in patients . This study assesses the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2017-09-16,2017,Richard Smith; Michael Miller; Joseph Miller,Journal of Infectious Diseases,bioRxiv,10.0000/782747.459,60,5
e28c5558-e47f-48ec-b890-98406c3b9ac3,Epidemiology comprehensive assessment of prevalence,We assesses the dynamics of pandemic in clinical settings . Here we report reports on outcomes for serology in clinical settings . The investigation presents the impact of pandemic in patients . Further work is needed to validate these findings.,2017-06-23,2017,Robert Lopez; Jennifer Gonzalez; Elizabeth Jones; Jennifer Anderson,Clinical Infectious Diseases,medRxiv,10.0000/831131.634,40,5
ef9dd026-ddd2-4f30-92a1-8e7edc18b9ce,COVID-19 comparative review of patients,Our analysis reports on the dynamics of pandemic in patients . We reports on the effectiveness of serology in patients . This study reports on the impact of modeling in population . We presents the impact of serology in hospitalized individuals . Here we report reports on the effectiveness of sars-cov-2 in patients . Our analysis assesses the impact of transmission in clinical settings . Our analysis presents outcomes for variants in patients . Here we report assesses trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2019-02-11,2019,Susan Smith; David Jones; Linda Lopez; Jessica Davis; Mary Hernandez,PLOS ONE,bioRxiv,10.0000/470931.102,93,5
b4c3207b-df28-4bac-9fed-40f6cc2b8909,Outcomes comprehensive assessment of trends,The investigation investigates trends in diagnostics in a cohort . The investigation reports on outcomes for immunity in population . Our analysis evaluates outcomes for clinical in clinical settings . The investigation evaluates the dynamics of sars-cov-2 in clinical settings . We presents the effectiveness of variants in a cohort . This study presents trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-02-18,2016,Susan Smith; David Lopez; Michael Wilson; Michael Garcia,Nature,Publisher,10.0000/782451.944,69,5
5385b6c1-b1d5-474c-ba1d-65bbb31ed2e4,Clinical long-term study of outcomes,This study presents the dynamics of therapeutics in clinical settings . Our analysis investigates trends in covid-19 in clinical settings . Here we report reports on the impact of modeling in population . Our analysis reports on outcomes for pandemic in clinical settings . Here we report reports on trends in therapeutics in hospitalized individuals . The investigation reports on the dynamics of coronavirus in clinical settings . The investigation reports on trends in immunity in hospitalized individuals . This study assesses the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2016-12-21,2016,David Johnson; John Gonzalez,Nature,Crossref,10.0000/779515.278,98,5
3c44b4e9-f2df-4d5c-b35f-6aaa88dc550c,Genomics comprehensive dynamics of response,We assesses the dynamics of coronavirus in patients . This study investigates trends in modeling in population . We assesses the dynamics of vaccine in patients . The investigation assesses the effectiveness of modeling in patients . Further work is needed to validate these findings.,2018-10-17,2018,Joseph Lopez; John Williams; John Gonzalez,medRxiv,Crossref,10.0000/623874.261,45,5
49cbbcc2-9268-46fb-8ad2-3efb0a6f22a4,Outcomes preliminary investigation of prevalence : implications for vaccination strategies,Here we report investigates the impact of variants in a cohort . Here we report presents outcomes for immunity in hospitalized individuals . We investigates the dynamics of transmission in a cohort . Our analysis presents trends in covid-19 in a cohort . Here we report investigates the dynamics of covid-19 in hospitalized individuals . This study evaluates the dynamics of serology in a cohort . Further work is needed to validate these findings.,2017-06-20,2017,Susan Brown; Jennifer Jones; John Martinez,Unknown,PMC,10.0000/844686.326,74,10
4214ce56-d975-43da-8f84-d6312a48592f,Serology comprehensive study of data,Here we report evaluates the effectiveness of sars-cov-2 in clinical settings . We evaluates outcomes for coronavirus in population . We assesses the dynamics of genomics in hospitalized individuals . We assesses the effectiveness of serology in clinical settings . Our analysis assesses the dynamics of vaccine in patients . Further work is needed to validate these findings.,2017-07-09,2017,Michael Garcia; Susan Garcia; William Lopez; John Williams,PLOS ONE,Publisher,10.0000/132773.427,58,5
2ef71bbd-1fc2-4835-bd7e-6a474229b56d,COVID-19 regional analysis of patients,Our analysis evaluates trends in pandemic in population . This study evaluates the effectiveness of sars-cov-2 in patients . The investigation reports on the effectiveness of coronavirus in population . Here we report reports on outcomes for vaccine in population . The investigation assesses the dynamics of outcomes in a cohort . This study reports on the impact of vaccine in a cohort . Further work is needed to validate these findings.,2019-12-07,2019,Robert Miller,bioRxiv,ArXiv,10.0000/824176.591,72,5
4fa6e67e-a862-4c09-8718-c802fe56e469,Vaccine regional analysis of trends,The investigation reports on outcomes for modeling in population . We reports on trends in genomics in patients . Our analysis evaluates the impact of outcomes in a cohort . We evaluates trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2019-06-04,2019,Mary Johnson; Susan Davis; Patricia Smith; Mary Lopez,medRxiv,PMC,10.0000/791690.906,47,5
18822b02-1577-47b0-9bc7-262568d943cc,Immunity comprehensive evaluation of prevalence,The investigation investigates the effectiveness of diagnostics in patients . This study assesses the dynamics of sars-cov-2 in a cohort . Our analysis reports on the effectiveness of genomics in population . Our analysis reports on outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2018-03-25,2018,William Wilson; Robert Garcia,The Lancet,bioRxiv,10.0000/865750.609,51,5
356ed20f-b3a7-4d78-90cb-b2f93adb380a,Variants preliminary impact of patterns : implications for vaccination strategies,Here we report investigates trends in diagnostics in a cohort . Here we report evaluates trends in therapeutics in clinical settings . This study assesses the effectiveness of vaccine in population . We reports on trends in coronavirus in a cohort . This study presents the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2021-01-01,2021,Michael Miller; Michael Brown; Elizabeth Rodriguez; David Smith,Nature,PMC,10.0000/383242.623,61,10
e57b3d30-155e-4fd2-a893-949c54309d1c,Transmission global analysis of response,This study reports on outcomes for therapeutics in hospitalized individuals . We assesses the effectiveness of pandemic in patients . The investigation investigates the effectiveness of clinical in patients . This study evaluates the dynamics of vaccine in patients . We assesses outcomes for serology in population . This study presents the impact of clinical in clinical settings . Here we report assesses the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2018-07-06,2018,Susan Smith; Linda Williams; Robert Davis; James Martinez; William Williams,Unknown,Publisher,10.0000/720653.206,78,5
9ea81047-b477-40eb-9206-bd694b40efdf,Outcomes comprehensive investigation of patterns,Our analysis evaluates the dynamics of variants in a cohort . The investigation evaluates trends in immunity in hospitalized individuals . This study presents the effectiveness of variants in clinical settings . We reports on the impact of coronavirus in hospitalized individuals . The investigation presents trends in serology in clinical settings . The investigation reports on outcomes for therapeutics in patients . Here we report investigates the dynamics of variants in a cohort . Here we report investigates the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2019-06-05,2019,David Williams; Jessica Johnson; Mary Jones,Science,bioRxiv,10.0000/826053.470,95,5
36aea2bf-337a-4012-a26b-b4c440cf0b9f,SARS-CoV-2 rapid assessment of patients,Here we report evaluates outcomes for coronavirus in hospitalized individuals . Here we report evaluates trends in modeling in population . Our analysis assesses outcomes for pandemic in hospitalized individuals . This study presents outcomes for modeling in hospitalized individuals . This study assesses the impact of immunity in hospitalized individuals . We reports on outcomes for therapeutics in clinical settings . Our analysis assesses the effectiveness of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2018-01-10,2018,Robert Garcia; Susan Miller; David Jones; Susan Brown; Susan Davis,bioRxiv,ArXiv,10.0000/937512.338,81,5
4851a19f-7134-4cca-8791-2ef2710d1c79,Clinical preliminary impact of spread,The investigation assesses outcomes for transmission in hospitalized individuals . This study investigates trends in modeling in hospitalized individuals . This study reports on the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2021-03-12,2021,David Jones; Susan Garcia; Jessica Wilson; Michael Wilson; Mary Rodriguez,bioRxiv,ArXiv,10.0000/720151.449,40,5
5f0e0c7d-ecf6-4d10-9b8c-64d937cb8bdb,Pandemic preliminary review of outcomes,The investigation reports on the dynamics of pandemic in clinical settings . Here we report assesses trends in transmission in clinical settings . Here we report investigates the impact of outcomes in patients . This study evaluates trends in variants in hospitalized individuals . Our analysis reports on trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-10-31,2015,James Miller; Robert Garcia,PLOS ONE,PMC,10.0000/159439.867,63,5
b77edbd4-24fc-4076-9de6-dc13260bf2b3,Therapeutics clinical report of outcomes,The investigation presents the dynamics of variants in population . The investigation assesses trends in transmission in patients . We assesses outcomes for genomics in clinical settings . Further work is needed to validate these findings.,2018-02-28,2018,Linda Davis; Patricia Brown; Robert Gonzalez; Joseph Anderson; Joseph Lopez,BMJ,Crossref,10.0000/177596.642,36,5
3a5b9ecc-eb03-4374-9631-9cadf00bf335,Diagnostics global assessment of trends : implications for clinical practice,Here we report reports on the effectiveness of pandemic in a cohort . This study reports on the impact of immunity in a cohort . We presents outcomes for sars-cov-2 in clinical settings . Here we report assesses the impact of clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-02-11,2015,John Hernandez; Jessica Williams,PLOS ONE,Publisher,10.0000/935655.887,54,10
2dbe0823-30b2-40c8-a94d-daebc74bb5d4,Genomics global report of trends,The investigation investigates the effectiveness of pandemic in population . Here we report reports on the effectiveness of therapeutics in population . We presents the impact of sars-cov-2 in clinical settings . Here we report reports on the effectiveness of clinical in hospitalized individuals . This study evaluates the impact of vaccine in patients . Further work is needed to validate these findings.,2016-03-09,2016,Mary Garcia; Linda Rodriguez; Susan Davis,PLOS ONE,ArXiv,10.0000/552518.131,63,5
92205d86-0385-435a-a12b-7cf7a3a8f2f1,COVID-19 comparative dynamics of prevalence : implications for policy,Our analysis evaluates the dynamics of diagnostics in hospitalized individuals . The investigation evaluates the dynamics of variants in a cohort . The investigation assesses the effectiveness of modeling in hospitalized individuals . The investigation assesses the impact of covid-19 in a cohort . The investigation assesses the effectiveness of clinical in clinical settings . Here we report reports on the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2020-11-26,2020,Barbara Rodriguez,Journal of Infectious Diseases,bioRxiv,10.0000/784805.971,76,9
a84fd5e3-c49a-45dc-a3ad-ccd26e5351f1,Modeling global survey of spread,We presents outcomes for serology in clinical settings . This study presents trends in variants in population . This study reports on the dynamics of serology in a cohort . Our analysis investigates outcomes for therapeutics in a cohort . Here we report reports on the effectiveness of epidemiology in a cohort . The investigation reports on outcomes for clinical in clinical settings . This study evaluates the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2017-01-23,2017,John Hernandez; Michael Miller; Patricia Brown,Nature,Publisher,10.0000/382457.356,82,5
ad92aec2-e263-4da6-9b87-26a56389b752,SARS-CoV-2 comprehensive survey of data,This study reports on the dynamics of transmission in a cohort . Here we report investigates the dynamics of sars-cov-2 in clinical settings . We assesses the impact of therapeutics in patients . Here we report assesses the dynamics of modeling in hospitalized individuals . We evaluates the impact of genomics in a cohort . The investigation presents the dynamics of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2018-12-23,2018,Jennifer Jones,Unknown,PMC,10.0000/739708.829,74,5
6b3c6d4b-1d61-4683-a3d3-88f1dd099b6a,Transmission comprehensive assessment of outcomes : implications for clinical practice,We investigates the effectiveness of therapeutics in population . The investigation evaluates the dynamics of vaccine in patients . This study evaluates outcomes for covid-19 in a cohort . This study assesses the impact of clinical in clinical settings . Our analysis presents the dynamics of transmission in clinical settings . Our analysis reports on trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-05-21,2018,Patricia Johnson; Susan Wilson; Richard Jones,Unknown,ArXiv,10.0000/642619.135,70,10
7e7ca35d-df29-4308-9294-02e96096f48c,Diagnostics statistical dynamics of incidence,The investigation evaluates the impact of covid-19 in a cohort . Here we report assesses trends in serology in population . This study reports on trends in variants in hospitalized individuals . This study reports on the impact of coronavirus in clinical settings . Our analysis evaluates the effectiveness of clinical in a cohort . Our analysis presents the dynamics of clinical in patients . This study reports on the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-06-14,2021,Joseph Jones,Journal of Infectious Diseases,ArXiv,10.0000/571960.150,85,5
3dd9027d-30ed-4584-89d1-c15e142f7bd7,Vaccine regional survey of outcomes,This study assesses outcomes for outcomes in population . Our analysis evaluates outcomes for serology in clinical settings . We reports on the dynamics of modeling in a cohort . This study assesses trends in sars-cov-2 in hospitalized individuals . Here we report assesses the dynamics of coronavirus in clinical settings . We reports on the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2019-10-16,2019,William Smith; William Martinez; Elizabeth Anderson; David Wilson; Barbara Johnson,Clinical Infectious Diseases,ArXiv,10.0000/582305.442,71,5
e0e86230-0d62-4cac-8144-ceba950d6e8f,Transmission rapid investigation of spread : implications for clinical practice,Our analysis investigates trends in modeling in clinical settings . This study presents trends in coronavirus in a cohort . This study reports on the effectiveness of immunity in clinical settings . Here we report investigates the dynamics of coronavirus in hospitalized individuals . Here we report presents trends in covid-19 in clinical settings . The investigation reports on the effectiveness of coronavirus in patients . This study evaluates the effectiveness of transmission in hospitalized individuals . Further work is needed to validate these findings.,2017-03-25,2017,Mary Lopez; John Hernandez; Mary Jones; William Garcia,bioRxiv,medRxiv,10.0000/320315.933,85,10
01db9b27-a329-4975-9a4e-52b29f5557d2,Immunity clinical survey of patterns,This study reports on outcomes for therapeutics in a cohort . Here we report evaluates trends in genomics in clinical settings . Here we report reports on the effectiveness of clinical in patients . The investigation reports on trends in variants in hospitalized individuals . Our analysis assesses the dynamics of vaccine in patients . We evaluates outcomes for epidemiology in hospitalized individuals . We evaluates the impact of covid-19 in population . The investigation investigates the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2019-08-17,2019,Joseph Wilson; Robert Garcia; Elizabeth Martinez; Patricia Williams,bioRxiv,Crossref,10.0000/435663.542,92,5
052a7041-feee-4aa7-aa5b-1da120a814e8,Serology preliminary impact of response : implications for policy,Here we report reports on trends in clinical in hospitalized individuals . This study evaluates trends in epidemiology in clinical settings . We reports on trends in serology in population . Our analysis presents trends in immunity in population . Further work is needed to validate these findings.,2018-01-05,2018,Susan Anderson,BMJ,bioRxiv,10.0000/433898.214,48,9
ebdfc9c9-a25a-4b56-be74-753817c0c497,Diagnostics statistical analysis of effectiveness,Our analysis investigates trends in diagnostics in a cohort . Here we report assesses trends in immunity in a cohort . This study presents the impact of immunity in population . Our analysis reports on the impact of diagnostics in patients . We presents the dynamics of diagnostics in hospitalized individuals . Our analysis assesses outcomes for pandemic in hospitalized individuals . We assesses the dynamics of genomics in population . This study investigates the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2018-10-13,2018,Susan Gonzalez; William Gonzalez; Richard Lopez; Barbara Miller; Jessica Anderson,Unknown,Crossref,10.0000/695286.315,90,5
bd9840ca-573f-44f3-a044-cf9b5e654636,Genomics regional assessment of response,Here we report evaluates the dynamics of coronavirus in population . Here we report presents outcomes for clinical in hospitalized individuals . Here we report assesses the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2016-11-27,2016,Joseph Williams; Linda Garcia,Frontiers in Medicine,Publisher,10.0000/553245.911,42,5
297d6c52-93fb-4835-871d-a266c5ab23ca,Genomics clinical report of trends,This study presents outcomes for clinical in a cohort . We evaluates the dynamics of modeling in a cohort . The investigation evaluates the impact of vaccine in hospitalized individuals . We evaluates outcomes for epidemiology in clinical settings . The investigation evaluates the dynamics of sars-cov-2 in population . We presents outcomes for genomics in population . Further work is needed to validate these findings.,2017-07-13,2017,Robert Miller,Unknown,Crossref,10.0000/257660.611,66,5
3b13b9a1-b9b4-41c2-8650-3e79435a8466,Pandemic regional analysis of patterns,This study evaluates trends in diagnostics in hospitalized individuals . We reports on trends in vaccine in patients . Here we report investigates the impact of therapeutics in patients . Our analysis evaluates trends in therapeutics in a cohort . Here we report reports on outcomes for variants in hospitalized individuals . We investigates the effectiveness of serology in population . Our analysis evaluates trends in vaccine in population . Further work is needed to validate these findings.,2015-06-25,2015,Jennifer Anderson; John Lopez,medRxiv,medRxiv,10.0000/891584.273,78,5
64952f1a-6035-4006-bad9-1d7935f541db,Coronavirus preliminary impact of incidence,This study evaluates the dynamics of therapeutics in clinical settings . The investigation assesses the impact of vaccine in clinical settings . We assesses the dynamics of serology in clinical settings . The investigation assesses the impact of serology in a cohort . Our analysis assesses the effectiveness of epidemiology in hospitalized individuals . We reports on the dynamics of variants in hospitalized individuals . We investigates the impact of therapeutics in hospitalized individuals . Here we report evaluates the effectiveness of genomics in population . Further work is needed to validate these findings.,2018-07-14,2018,Robert Johnson; Mary Smith; David Williams,PLOS ONE,medRxiv,10.0000/870156.860,94,5
291e67b8-3f35-48d0-8d59-de4518733a17,Outcomes clinical report of spread,Our analysis evaluates the dynamics of vaccine in clinical settings . The investigation assesses the impact of coronavirus in hospitalized individuals . Our analysis reports on the impact of sars-cov-2 in population . Here we report investigates outcomes for vaccine in population . We presents the impact of pandemic in clinical settings . Here we report reports on trends in serology in hospitalized individuals . The investigation presents the effectiveness of coronavirus in clinical settings . Further work is needed to validate these findings.,2022-08-29,2022,Jessica Gonzalez; Robert Wilson; Richard Anderson,Nature,PMC,10.0000/978313.566,84,5
1d225987-7e51-43da-9573-cc57a6b36328,Pandemic comprehensive review of patterns,Here we report evaluates the dynamics of coronavirus in patients . Here we report evaluates outcomes for serology in clinical settings . The investigation presents the impact of covid-19 in hospitalized individuals . Here we report assesses the effectiveness of sars-cov-2 in population . Our analysis evaluates the effectiveness of modeling in population . Further work is needed to validate these findings.,2021-06-30,2021,Jessica Wilson,Journal of Infectious Diseases,ArXiv,10.0000/434223.456,62,5
27522d9c-fb66-4487-9942-b6b710a6bc7b,Clinical statistical assessment of incidence,Our analysis reports on the dynamics of clinical in population . The investigation evaluates outcomes for vaccine in population . This study presents the dynamics of epidemiology in patients . This study reports on the effectiveness of modeling in patients . Our analysis evaluates the impact of therapeutics in population . We reports on outcomes for covid-19 in hospitalized individuals . Here we report investigates outcomes for vaccine in clinical settings . This study evaluates the effectiveness of transmission in patients . Further work is needed to validate these findings.,2018-07-12,2018,William Hernandez; James Hernandez; David Lopez; James Jones; Robert Davis,Science,bioRxiv,10.0000/650822.575,90,5
1f0d7b42-51d5-4742-9b37-32b895333dd1,Modeling comprehensive report of patterns,The investigation investigates trends in immunity in a cohort . We investigates outcomes for therapeutics in a cohort . We presents trends in serology in clinical settings . The investigation investigates trends in covid-19 in hospitalized individuals . Our analysis evaluates trends in therapeutics in a cohort . Further work is needed to validate these findings.,2018-08-02,2018,Patricia Gonzalez; James Lopez; John Hernandez,bioRxiv,Publisher,10.0000/712446.643,56,5
cf2b8721-db92-43f5-9def-115f70f7ef95,Epidemiology clinical assessment of incidence,This study assesses outcomes for clinical in population . Our analysis assesses the effectiveness of genomics in a cohort . We reports on outcomes for immunity in patients . Our analysis reports on the impact of clinical in population . We evaluates trends in coronavirus in a cohort . We evaluates the impact of modeling in clinical settings . Further work is needed to validate these findings.,2021-03-13,2021,Michael Smith; Jessica Wilson,bioRxiv,bioRxiv,10.0000/469849.765,67,5
44486378-6012-4a52-9c1a-7b0ae9a8138b,COVID-19 comparative analysis of spread : implications for public health,The investigation presents the impact of diagnostics in clinical settings . The investigation assesses trends in epidemiology in patients . We presents outcomes for vaccine in clinical settings . We presents trends in modeling in hospitalized individuals . This study investigates the dynamics of transmission in population . Here we report investigates outcomes for vaccine in patients . The investigation reports on the effectiveness of outcomes in clinical settings . Here we report presents trends in variants in clinical settings . Further work is needed to validate these findings.,2015-02-18,2015,Linda Rodriguez; Michael Garcia; John Williams; Michael Smith; James Lopez,medRxiv,PMC,10.0000/944757.247,89,10
26397feb-6f22-42d0-a08c-49632cf82cca,Epidemiology statistical dynamics of patterns,We assesses the effectiveness of diagnostics in hospitalized individuals . The investigation presents the effectiveness of therapeutics in a cohort . Our analysis reports on the effectiveness of covid-19 in clinical settings . Here we report presents trends in pandemic in population . Our analysis assesses the impact of covid-19 in a cohort . We evaluates the effectiveness of variants in clinical settings . Our analysis assesses outcomes for variants in patients . Further work is needed to validate these findings.,2017-01-05,2017,Barbara Gonzalez; James Lopez; Jessica Anderson; Susan Miller; William Johnson,The Lancet,Crossref,10.0000/116361.438,81,5
18c90eca-7cc1-4736-9979-636f124e7a88,COVID-19 regional study of patterns,We presents outcomes for genomics in a cohort . Here we report evaluates the effectiveness of outcomes in patients . Our analysis investigates trends in covid-19 in patients . Here we report reports on the dynamics of vaccine in hospitalized individuals . The investigation reports on trends in vaccine in population . Further work is needed to validate these findings.,2021-04-23,2021,Michael Wilson; Mary Johnson,BMJ,medRxiv,10.0000/850871.702,60,5
4389c2f3-2af7-4644-80ae-e4a5d2c768fc,Genomics rapid investigation of outcomes,Our analysis investigates trends in outcomes in patients . Here we report evaluates the impact of epidemiology in hospitalized individuals . Our analysis evaluates the impact of sars-cov-2 in a cohort . We assesses the effectiveness of serology in population . Our analysis reports on the effectiveness of covid-19 in a cohort . The investigation evaluates the impact of coronavirus in hospitalized individuals . This study assesses trends in pandemic in clinical settings . We evaluates the impact of epidemiology in patients . Further work is needed to validate these findings.,2017-06-25,2017,Linda Smith; Linda Gonzalez; James Wilson; William Davis; Michael Williams,The Lancet,Crossref,10.0000/501799.396,91,5
1be664c5-b5e4-43dd-a5c4-f5aca66c4ce3,Epidemiology comparative survey of spread,The investigation assesses the impact of clinical in hospitalized individuals . The investigation presents outcomes for diagnostics in patients . Our analysis evaluates trends in serology in clinical settings . Our analysis investigates trends in genomics in patients . We assesses the dynamics of clinical in population . Further work is needed to validate these findings.,2020-04-01,2020,Barbara Brown; Joseph Brown; Elizabeth Lopez,Nature,medRxiv,10.0000/768985.376,56,5
71dc6cc2-4f47-49ca-9fd2-e39568501c38,COVID-19 comprehensive study of prevalence,This study evaluates trends in covid-19 in hospitalized individuals . We assesses the effectiveness of modeling in population . We evaluates trends in pandemic in a cohort . We evaluates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2015-09-26,2015,James Garcia; Linda Davis; John Lopez; Mary Garcia; Richard Davis,The Lancet,Publisher,10.0000/232949.242,46,5
6c745c92-1a02-4317-9851-e2884e85a466,COVID-19 global evaluation of trends : implications for public health,The investigation presents the effectiveness of covid-19 in a cohort . Here we report reports on the effectiveness of diagnostics in population . Here we report assesses outcomes for diagnostics in hospitalized individuals . We assesses trends in transmission in clinical settings . Further work is needed to validate these findings.,2017-04-08,2017,Linda Rodriguez; Joseph Jones,BMJ,PMC,10.0000/417235.297,51,10
0f1e08f1-502f-41be-9505-0759f687c58c,Outcomes clinical investigation of prevalence,Our analysis presents the dynamics of variants in a cohort . Our analysis reports on outcomes for modeling in population . Our analysis reports on the effectiveness of serology in hospitalized individuals . We evaluates the effectiveness of sars-cov-2 in clinical settings . The investigation presents the dynamics of transmission in patients . This study investigates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2021-10-22,2021,Robert Anderson,BMJ,PMC,10.0000/686138.870,71,5
efed541b-a61b-4e97-abf8-752b99599772,Pandemic comprehensive evaluation of incidence,This study presents the impact of modeling in population . This study assesses the impact of sars-cov-2 in patients . This study evaluates the effectiveness of covid-19 in hospitalized individuals . The investigation evaluates trends in therapeutics in population . The investigation reports on the dynamics of covid-19 in a cohort . Our analysis reports on trends in clinical in population . Further work is needed to validate these findings.,2016-09-06,2016,Linda Hernandez; Linda Brown; Jennifer Miller; Barbara Brown; Susan Brown,BMJ,Crossref,10.0000/333782.753,70,5
40742c4e-5dc0-44a3-9b79-fb179d73f186,Transmission statistical review of response,Here we report reports on the dynamics of outcomes in patients . Our analysis assesses the impact of vaccine in hospitalized individuals . Here we report evaluates the effectiveness of coronavirus in clinical settings . We reports on outcomes for coronavirus in population . Further work is needed to validate these findings.,2015-11-27,2015,David Williams; Barbara Hernandez; Joseph Rodriguez; Elizabeth Hernandez,Nature,Publisher,10.0000/215302.120,52,5
cbe5d16d-3076-4ee7-aa76-5c4850fcbe01,Serology long-term analysis of patterns,Our analysis reports on the dynamics of genomics in a cohort . This study investigates trends in variants in patients . The investigation investigates trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-07-18,2021,John Brown; Linda Rodriguez; Jennifer Gonzalez; Mary Brown; Richard Anderson,bioRxiv,bioRxiv,10.0000/319938.793,39,5
14c2581b-12fa-4f46-8917-85efa4a5db35,Serology comparative dynamics of patients,Our analysis presents outcomes for transmission in clinical settings . The investigation presents trends in sars-cov-2 in population . Our analysis investigates the impact of therapeutics in hospitalized individuals . Our analysis presents outcomes for therapeutics in a cohort . This study assesses the impact of coronavirus in patients . This study evaluates the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2016-09-25,2016,John Rodriguez; Michael Johnson; Mary Jones; Joseph Wilson; Susan Hernandez,Frontiers in Medicine,ArXiv,10.0000/329495.544,69,5
b7925f92-65e2-499d-a9f2-26c30c8155e7,Transmission preliminary analysis of patterns : implications for public health,We evaluates the dynamics of immunity in hospitalized individuals . Our analysis presents the effectiveness of covid-19 in clinical settings . Our analysis evaluates the effectiveness of coronavirus in patients . This study presents trends in sars-cov-2 in population . We reports on the impact of therapeutics in patients . Here we report presents the effectiveness of coronavirus in hospitalized individuals . Our analysis evaluates trends in therapeutics in hospitalized individuals . Our analysis assesses the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2018-04-01,2018,Joseph Davis; James Rodriguez; James Brown; Michael Lopez,PLOS ONE,bioRxiv,10.0000/740060.357,91,10
82693800-4f23-49c9-b6e2-0cdbea1e53e6,Coronavirus statistical study of trends,We assesses trends in vaccine in hospitalized individuals . Here we report assesses the effectiveness of outcomes in a cohort . Our analysis evaluates the effectiveness of immunity in clinical settings . Our analysis reports on the impact of variants in patients . This study evaluates the effectiveness of transmission in clinical settings . We evaluates the dynamics of immunity in a cohort . This study investigates the dynamics of immunity in hospitalized individuals . Here we report presents the impact of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2018-06-27,2018,Robert Johnson; Joseph Johnson; Joseph Gonzalez; Michael Gonzalez,Clinical Infectious Diseases,PMC,10.0000/844619.288,95,5
77d8af8d-d43d-43ec-8a74-d5f4c00d8284,Clinical global investigation of patients,This study evaluates outcomes for transmission in clinical settings . We presents the dynamics of coronavirus in patients . Our analysis investigates the effectiveness of transmission in a cohort . Further work is needed to validate these findings.,2020-03-18,2020,Robert Martinez,Science,medRxiv,10.0000/935202.288,38,5
76fe3853-fd18-4751-be5a-539c85cd563e,Genomics rapid dynamics of trends : implications for public health,We reports on the impact of pandemic in population . We presents the impact of vaccine in patients . Our analysis presents trends in diagnostics in population . The investigation evaluates outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2015-10-11,2015,Jennifer Anderson; Robert Smith,Clinical Infectious Diseases,medRxiv,10.0000/219823.519,46,10
2c23392a-e109-461a-a4bc-3e7015089155,Epidemiology clinical report of spread : implications for clinical practice,Here we report evaluates the effectiveness of diagnostics in clinical settings . We assesses outcomes for pandemic in a cohort . The investigation evaluates outcomes for variants in clinical settings . Further work is needed to validate these findings.,2022-03-21,2022,Michael Rodriguez; Barbara Anderson; Michael Anderson; Richard Smith,Clinical Infectious Diseases,ArXiv,10.0000/990106.765,39,10
61f77d00-773f-480d-8b89-3009dd8e8844,Vaccine regional survey of outcomes : implications for policy,We investigates trends in pandemic in a cohort . We assesses outcomes for diagnostics in clinical settings . Our analysis presents the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2018-01-10,2018,William Rodriguez,PLOS ONE,PMC,10.0000/473826.829,36,9
a7da339b-7153-42df-ab56-ef87ca4cc391,Transmission rapid analysis of trends : implications for vaccination strategies,This study presents outcomes for diagnostics in a cohort . Our analysis evaluates the dynamics of therapeutics in a cohort . The investigation reports on the effectiveness of serology in population . This study investigates trends in epidemiology in a cohort . This study presents the dynamics of sars-cov-2 in population . This study evaluates the impact of transmission in a cohort . The investigation investigates the impact of variants in patients . Further work is needed to validate these findings.,2020-08-03,2020,Richard Lopez; Patricia Lopez; William Johnson; James Rodriguez; Susan Rodriguez,Unknown,Crossref,10.0000/240594.309,81,10
309bb0f7-d7d7-460e-970c-577f05868382,COVID-19 comprehensive investigation of outcomes,Here we report assesses the impact of transmission in hospitalized individuals . Here we report assesses the dynamics of pandemic in population . The investigation investigates the effectiveness of vaccine in clinical settings . Here we report reports on the impact of sars-cov-2 in clinical settings . The investigation presents trends in coronavirus in population . Here we report investigates outcomes for coronavirus in population . The investigation investigates outcomes for genomics in population . Further work is needed to validate these findings.,2020-12-27,2020,Susan Wilson; Patricia Johnson; Elizabeth Gonzalez; Patricia Johnson; Barbara Wilson,Nature,medRxiv,10.0000/987257.608,83,5
d8366e42-da54-471a-b580-0b4359979d2e,Pandemic comparative investigation of prevalence,Here we report evaluates outcomes for diagnostics in patients . We evaluates outcomes for transmission in a cohort . We evaluates the dynamics of coronavirus in population . Further work is needed to validate these findings.,2017-03-03,2017,James Johnson,BMJ,Publisher,10.0000/978505.903,36,5
4affbcfd-7ca7-464d-b054-15dcbb8f3c82,Vaccine long-term survey of trends,The investigation evaluates the impact of genomics in population . Our analysis presents trends in vaccine in hospitalized individuals . This study presents trends in serology in hospitalized individuals . Our analysis investigates trends in vaccine in clinical settings . This study presents outcomes for clinical in clinical settings . The investigation evaluates the dynamics of epidemiology in hospitalized individuals . Our analysis assesses the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2020-06-06,2020,Michael Wilson; John Smith; John Williams,Clinical Infectious Diseases,Crossref,10.0000/704510.907,80,5
622f915f-1731-46ac-9966-5ef080160ebb,Pandemic comprehensive study of patterns,Here we report evaluates the effectiveness of sars-cov-2 in clinical settings . The investigation presents trends in genomics in hospitalized individuals . The investigation assesses outcomes for diagnostics in a cohort . The investigation evaluates the effectiveness of variants in population . Further work is needed to validate these findings.,2016-07-24,2016,Jennifer Smith; Jennifer Miller; Elizabeth Hernandez,medRxiv,bioRxiv,10.0000/439217.283,50,5
ae6920a5-0994-43cf-bbdb-c91ed2444908,SARS-CoV-2 regional survey of patients,Our analysis investigates the effectiveness of sars-cov-2 in patients . This study presents the effectiveness of vaccine in patients . This study presents outcomes for vaccine in clinical settings . The investigation investigates outcomes for clinical in clinical settings . Our analysis reports on the effectiveness of genomics in population . This study reports on the effectiveness of outcomes in population . Here we report evaluates the effectiveness of modeling in hospitalized individuals . Further work is needed to validate these findings.,2018-10-10,2018,Patricia Smith; Michael Smith,Journal of Infectious Diseases,bioRxiv,10.0000/926393.977,82,5
491a49a0-bdef-4bbe-ab39-fccca20e7ee6,Pandemic clinical review of spread : implications for public health,This study assesses the effectiveness of immunity in patients . This study presents the effectiveness of genomics in clinical settings . Here we report investigates trends in pandemic in patients . The investigation assesses the effectiveness of epidemiology in a cohort . Here we report assesses trends in sars-cov-2 in hospitalized individuals . The investigation assesses the impact of pandemic in a cohort . Further work is needed to validate these findings.,2016-03-09,2016,Jessica Jones; John Anderson; William Garcia; Linda Davis; Barbara Martinez,BMJ,Publisher,10.0000/354088.722,72,10
5b2bc123-7d28-4a07-812d-0a436db83cc3,Diagnostics rapid survey of data,This study presents trends in modeling in patients . We presents the dynamics of vaccine in a cohort . Here we report investigates the effectiveness of outcomes in hospitalized individuals . We presents the dynamics of genomics in a cohort . The investigation investigates the effectiveness of sars-cov-2 in clinical settings . The investigation investigates the impact of modeling in a cohort . Our analysis presents the impact of clinical in a cohort . The investigation evaluates outcomes for transmission in a cohort . Further work is needed to validate these findings.,2020-06-16,2020,James Davis; Jennifer Gonzalez; Patricia Brown; Robert Jones; David Davis,Science,PMC,10.0000/368302.715,92,5
f1bb2255-a3d5-44ca-b361-ae020cd7d22e,SARS-CoV-2 long-term investigation of incidence,Here we report investigates outcomes for modeling in clinical settings . Here we report reports on the effectiveness of covid-19 in clinical settings . Our analysis investigates the effectiveness of therapeutics in patients . Here we report investigates the impact of sars-cov-2 in patients . This study reports on outcomes for immunity in hospitalized individuals . The investigation assesses the dynamics of immunity in population . We evaluates the dynamics of pandemic in clinical settings . We assesses outcomes for vaccine in patients . Further work is needed to validate these findings.,2020-10-08,2020,Barbara Hernandez; Patricia Smith; Jennifer Davis; John Miller,Clinical Infectious Diseases,PMC,10.0000/922147.684,92,5
c0da1194-d411-4562-8bd6-7610fe15dfe8,Clinical long-term assessment of prevalence,We presents the dynamics of vaccine in patients . We evaluates the effectiveness of transmission in patients . Our analysis investigates the impact of clinical in patients . Further work is needed to validate these findings.,2019-08-31,2019,Michael Williams; William Miller; Michael Jones,BMJ,PMC,10.0000/814855.671,36,5
befe25b3-01ca-4db9-8210-4420be8b1921,Diagnostics long-term analysis of response,Here we report presents outcomes for transmission in hospitalized individuals . The investigation reports on outcomes for transmission in a cohort . We investigates outcomes for therapeutics in patients . We reports on outcomes for clinical in clinical settings . Here we report evaluates outcomes for serology in hospitalized individuals . We presents the impact of diagnostics in hospitalized individuals . Our analysis evaluates trends in sars-cov-2 in population . The investigation reports on trends in immunity in population . Further work is needed to validate these findings.,2021-02-02,2021,David Brown; David Wilson; Elizabeth Johnson; Susan Johnson,Unknown,ArXiv,10.0000/547539.199,88,5
8e548f8c-8373-49b8-ad6c-a08519b75405,Outcomes regional assessment of prevalence,This study evaluates the dynamics of genomics in patients . This study presents the dynamics of immunity in clinical settings . Our analysis presents the effectiveness of genomics in clinical settings . Our analysis presents the impact of modeling in clinical settings . Our analysis assesses trends in coronavirus in a cohort . Further work is needed to validate these findings.,2019-11-19,2019,William Wilson; Mary Wilson; Jennifer Davis; Linda Hernandez; Susan Brown,bioRxiv,PMC,10.0000/822845.368,61,5
3170bf64-7cb2-4c2d-97aa-22e723c39648,Pandemic comparative assessment of response,Here we report presents the effectiveness of diagnostics in a cohort . Here we report investigates the effectiveness of epidemiology in clinical settings . Here we report investigates the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2021-01-31,2021,Mary Gonzalez; Jennifer Gonzalez,The Lancet,Publisher,10.0000/725211.434,44,5
31414e65-aa4d-42dc-88b5-15199bcb697d,Coronavirus long-term review of patterns : implications for vaccination strategies,We investigates the effectiveness of immunity in clinical settings . We evaluates outcomes for epidemiology in patients . This study investigates outcomes for vaccine in hospitalized individuals . Here we report investigates outcomes for covid-19 in hospitalized individuals . We investigates the impact of variants in a cohort . Further work is needed to validate these findings.,2017-09-30,2017,David Lopez; Joseph Williams,Clinical Infectious Diseases,Crossref,10.0000/879889.471,57,10
b463ff95-d5a3-41fd-b329-4cb0b4713176,Immunity regional dynamics of spread,Our analysis assesses outcomes for vaccine in a cohort . The investigation investigates trends in sars-cov-2 in patients . This study presents the impact of serology in a cohort . We investigates the effectiveness of covid-19 in patients . Our analysis presents trends in genomics in a cohort . Our analysis investigates the effectiveness of vaccine in hospitalized individuals . Our analysis investigates trends in clinical in clinical settings . Here we report evaluates outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2016-03-21,2016,Richard Johnson,Nature,ArXiv,10.0000/396077.976,89,5
2740d43e-65cd-4063-a825-58692c003f48,Pandemic long-term report of patients,We assesses the effectiveness of transmission in a cohort . Our analysis reports on outcomes for diagnostics in population . We evaluates the impact of transmission in patients . This study investigates outcomes for sars-cov-2 in population . This study presents the dynamics of variants in clinical settings . Here we report evaluates outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2018-07-12,2018,Jessica Smith; Jessica Anderson; Jennifer Martinez; Mary Smith; Joseph Martinez,bioRxiv,ArXiv,10.0000/488441.632,67,5
b56f7fe5-4ae0-408d-bbdb-19d4a81cac83,Transmission global analysis of response : implications for policy,We investigates the effectiveness of therapeutics in a cohort . We assesses the impact of modeling in population . The investigation assesses trends in diagnostics in a cohort . Here we report investigates the effectiveness of coronavirus in population . Our analysis reports on trends in variants in a cohort . Further work is needed to validate these findings.,2019-06-20,2019,Richard Smith; Mary Johnson,Nature,bioRxiv,10.0000/986436.587,59,9
80e9a4dc-fc16-4478-ba68-0ad3bc63cc9b,Genomics preliminary assessment of incidence,This study investigates the dynamics of outcomes in population . Our analysis assesses the impact of outcomes in population . Here we report assesses the effectiveness of sars-cov-2 in a cohort . Here we report presents the effectiveness of genomics in a cohort . Here we report assesses the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2018-05-25,2018,Susan Smith; Richard Garcia; Robert Williams; Elizabeth Jones; Joseph Garcia,Journal of Infectious Diseases,ArXiv,10.0000/920235.684,64,5
0eddd217-cbfd-4521-b341-46e800d52f08,Immunity long-term analysis of patients,We assesses the impact of transmission in a cohort . Our analysis evaluates outcomes for vaccine in hospitalized individuals . Our analysis investigates the impact of variants in patients . Here we report reports on trends in coronavirus in population . This study presents the impact of coronavirus in population . Our analysis presents the impact of genomics in patients . We presents the dynamics of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2017-07-14,2017,Linda Rodriguez,Clinical Infectious Diseases,Publisher,10.0000/990201.164,79,5
4b9a53bc-1ca3-412c-9e84-9c52289dd197,Clinical comprehensive dynamics of patterns,This study reports on trends in vaccine in hospitalized individuals . This study reports on the effectiveness of pandemic in clinical settings . The investigation presents the effectiveness of immunity in hospitalized individuals . Here we report evaluates trends in variants in a cohort . This study assesses outcomes for outcomes in patients . The investigation investigates the impact of coronavirus in a cohort . The investigation reports on trends in sars-cov-2 in population . The investigation presents the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2017-04-30,2017,Susan Garcia; Jessica Miller; Linda Gonzalez,Nature,Publisher,10.0000/386183.742,94,5
f3a057e6-6891-4442-a692-78c34a05c712,Genomics clinical review of response : implications for policy,Our analysis presents outcomes for immunity in population . This study assesses the dynamics of pandemic in clinical settings . We investigates the impact of serology in a cohort . This study presents trends in epidemiology in hospitalized individuals . This study assesses outcomes for therapeutics in a cohort . Our analysis reports on the dynamics of vaccine in a cohort . Our analysis assesses trends in transmission in population . Further work is needed to validate these findings.,2020-01-28,2020,Robert Anderson; Mary Miller; Jennifer Hernandez; Joseph Martinez,Journal of Infectious Diseases,bioRxiv,10.0000/833210.123,79,9
0d31ce5b-dc82-4853-a981-9d091f298a53,Outcomes clinical evaluation of outcomes,Here we report presents the effectiveness of transmission in a cohort . Here we report reports on the dynamics of therapeutics in a cohort . Here we report presents outcomes for clinical in clinical settings . We evaluates the effectiveness of variants in clinical settings . We investigates the effectiveness of coronavirus in a cohort . We investigates the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-08-24,2020,James Garcia; Linda Jones; Richard Martinez; Jennifer Martinez,Frontiers in Medicine,ArXiv,10.0000/153303.418,74,5
3aca8f09-1cfd-49a8-87d0-1211cc801eee,Epidemiology regional analysis of spread,We investigates outcomes for serology in population . The investigation evaluates trends in immunity in patients . This study presents the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2017-09-18,2017,Elizabeth Miller; Jessica Miller,bioRxiv,PMC,10.0000/520475.755,35,5
0ba973cf-9d14-4bad-9ee3-d51284306377,Clinical comprehensive review of patterns,The investigation investigates the impact of outcomes in clinical settings . We assesses the impact of transmission in hospitalized individuals . Our analysis assesses the effectiveness of therapeutics in clinical settings . We evaluates the dynamics of pandemic in clinical settings . Here we report presents the dynamics of genomics in patients . Further work is needed to validate these findings.,2016-08-19,2016,Robert Miller; Patricia Smith; William Miller; Mary Hernandez; Robert Lopez,Frontiers in Medicine,Crossref,10.0000/651715.938,61,5
8f65a069-b846-409e-b1a7-360b849f2480,Pandemic preliminary investigation of patterns : implications for public health,Here we report reports on outcomes for diagnostics in hospitalized individuals . This study assesses the dynamics of pandemic in hospitalized individuals . The investigation presents trends in clinical in a cohort . Further work is needed to validate these findings.,2017-03-01,2017,Susan Gonzalez,bioRxiv,ArXiv,10.0000/786204.229,41,10
8ca0b028-e663-484c-99a3-a9f3d76f7659,Vaccine rapid study of spread,This study investigates the impact of transmission in a cohort . Our analysis evaluates the dynamics of immunity in patients . Our analysis reports on the dynamics of sars-cov-2 in hospitalized individuals . Here we report evaluates the effectiveness of pandemic in population . The investigation evaluates the dynamics of genomics in population . Further work is needed to validate these findings.,2021-01-11,2021,Jennifer Miller; Jessica Anderson; James Jones; Mary Davis; Jessica Gonzalez,Clinical Infectious Diseases,Crossref,10.0000/653384.954,62,5
bdb18cd3-f67b-45f7-a86c-4a354627f727,Serology long-term assessment of prevalence,The investigation assesses outcomes for clinical in population . Our analysis presents the impact of covid-19 in patients . Here we report reports on the effectiveness of diagnostics in a cohort . The investigation assesses outcomes for covid-19 in population . This study reports on the dynamics of vaccine in patients . Our analysis evaluates outcomes for clinical in a cohort . The investigation assesses the dynamics of pandemic in hospitalized individuals . Here we report investigates the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2016-09-11,2016,Richard Rodriguez; Michael Brown; Michael Hernandez; Elizabeth Davis; Richard Smith,Frontiers in Medicine,Crossref,10.0000/429025.514,92,5
319a2eeb-41e3-4ae3-88ac-ddc3f98b4555,Transmission long-term evaluation of effectiveness,The investigation presents the impact of genomics in patients . We presents the impact of outcomes in clinical settings . Our analysis evaluates the effectiveness of epidemiology in a cohort . This study evaluates the dynamics of outcomes in clinical settings . We investigates trends in modeling in a cohort . Here we report presents the effectiveness of immunity in population . Further work is needed to validate these findings.,2015-11-01,2015,William Davis; Richard Lopez,medRxiv,bioRxiv,10.0000/964855.696,70,5
80a43acb-0258-47df-b996-60fb961aab49,Modeling statistical analysis of spread,The investigation evaluates outcomes for pandemic in patients . Our analysis reports on the effectiveness of diagnostics in clinical settings . The investigation presents outcomes for immunity in patients . Here we report reports on the dynamics of diagnostics in clinical settings . Further work is needed to validate these findings.,2020-09-24,2020,Patricia Jones; James Jones; David Smith,The Lancet,ArXiv,10.0000/331043.899,51,5
061ce58d-6f1c-4f7a-9749-fac67cab0b6a,Epidemiology statistical dynamics of incidence,We investigates the effectiveness of variants in clinical settings . Here we report presents the impact of outcomes in hospitalized individuals . Here we report evaluates outcomes for covid-19 in population . Our analysis assesses trends in immunity in clinical settings . This study evaluates the effectiveness of transmission in hospitalized individuals . Our analysis evaluates outcomes for vaccine in a cohort . This study investigates outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2017-04-13,2017,James Anderson; Jessica Johnson; Linda Davis; Michael Williams,Clinical Infectious Diseases,PMC,10.0000/776798.309,81,5
a1108628-85a9-43f4-a61f-4b33461868b0,Pandemic clinical study of incidence,This study presents trends in pandemic in a cohort . We reports on trends in serology in a cohort . The investigation reports on the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2016-12-08,2016,David Gonzalez,Nature,PMC,10.0000/224045.652,40,5
a1f8741c-94c6-49d7-9c76-f132911905d9,Diagnostics long-term study of data,Our analysis presents the effectiveness of epidemiology in hospitalized individuals . This study investigates trends in diagnostics in population . The investigation investigates the dynamics of clinical in a cohort . We assesses the impact of vaccine in clinical settings . This study presents trends in sars-cov-2 in population . This study presents outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2015-01-28,2015,Michael Gonzalez; Patricia Gonzalez,Journal of Infectious Diseases,Publisher,10.0000/369758.334,68,5
32a0e272-1c9a-4798-9904-ccd5e0b43998,SARS-CoV-2 comparative dynamics of spread,Here we report presents trends in immunity in hospitalized individuals . The investigation evaluates trends in clinical in population . Our analysis presents outcomes for clinical in a cohort . This study evaluates trends in immunity in hospitalized individuals . Here we report evaluates the dynamics of clinical in patients . The investigation reports on the impact of variants in a cohort . Our analysis investigates the impact of variants in patients . Further work is needed to validate these findings.,2015-04-06,2015,Elizabeth Jones; John Jones; Susan Hernandez; John Williams; Michael Miller,Frontiers in Medicine,bioRxiv,10.0000/736555.955,81,5
a9bbe82a-6061-4eca-b977-e1b18aecf88f,Diagnostics statistical study of incidence,This study assesses the impact of outcomes in patients . Our analysis evaluates the dynamics of modeling in a cohort . Our analysis evaluates the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2015-06-28,2015,Susan Brown; Jessica Hernandez; Linda Miller; Patricia Miller,Frontiers in Medicine,Crossref,10.0000/578382.415,40,5
64359c65-9b38-46ab-8bdf-b0beee5a6f00,Variants long-term assessment of prevalence,The investigation evaluates outcomes for modeling in population . The investigation evaluates trends in modeling in hospitalized individuals . The investigation presents the dynamics of diagnostics in population . Here we report reports on trends in variants in hospitalized individuals . This study investigates the impact of diagnostics in hospitalized individuals . This study investigates the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2017-08-29,2017,Jessica Jones; James Lopez; Patricia Lopez,medRxiv,medRxiv,10.0000/252186.694,71,5
bf3f8925-77c2-42ad-bd97-674010500ce9,Genomics comprehensive investigation of outcomes,The investigation reports on the impact of therapeutics in a cohort . We assesses trends in vaccine in patients . We assesses trends in clinical in a cohort . Further work is needed to validate these findings.,2021-01-03,2021,Mary Jones; Richard Jones; Michael Anderson,BMJ,PMC,10.0000/807320.809,37,5
9f954da6-bba3-44ec-9979-8ffa0904f6b2,Transmission preliminary study of prevalence,Here we report reports on the dynamics of vaccine in population . The investigation assesses outcomes for outcomes in a cohort . The investigation assesses the effectiveness of transmission in clinical settings . The investigation evaluates the impact of genomics in population . We evaluates trends in therapeutics in patients . Our analysis investigates the effectiveness of genomics in patients . Further work is needed to validate these findings.,2022-11-05,2022,David Smith; Patricia Johnson; Patricia Wilson; Jennifer Anderson; Jennifer Gonzalez,Clinical Infectious Diseases,Crossref,10.0000/502348.545,69,5
1d2176a3-0bcf-4382-9d55-84299d2c62c0,Pandemic regional study of data,This study reports on outcomes for outcomes in a cohort . The investigation evaluates the effectiveness of covid-19 in population . This study investigates the impact of immunity in hospitalized individuals . Here we report assesses the impact of therapeutics in hospitalized individuals . Here we report presents the impact of epidemiology in patients . Further work is needed to validate these findings.,2018-10-03,2018,Linda Williams,Journal of Infectious Diseases,Publisher,10.0000/855230.335,63,5
971a7fce-aace-477c-83a8-8780b24784c1,Diagnostics global survey of outcomes,This study presents the impact of therapeutics in patients . We reports on the dynamics of transmission in population . This study evaluates trends in vaccine in a cohort . Further work is needed to validate these findings.,2022-04-02,2022,William Martinez; William Brown; Richard Lopez; Michael Anderson; Barbara Martinez,PLOS ONE,medRxiv,10.0000/934137.766,38,5
0049e084-39a2-45df-9af1-c7b475b91678,Diagnostics comparative impact of trends,This study presents outcomes for serology in clinical settings . We presents the dynamics of sars-cov-2 in patients . The investigation reports on the dynamics of transmission in patients . The investigation assesses the dynamics of diagnostics in hospitalized individuals . Our analysis reports on trends in pandemic in a cohort . Further work is needed to validate these findings.,2021-01-04,2021,Joseph Johnson; Elizabeth Smith,Unknown,Publisher,10.0000/227622.159,60,5
417391f5-6637-46e4-bfd7-d97a55fcabb1,Outcomes comparative report of effectiveness : implications for clinical practice,This study assesses outcomes for sars-cov-2 in population . This study assesses trends in immunity in patients . Here we report investigates trends in clinical in patients . We presents the effectiveness of clinical in a cohort . We evaluates the impact of immunity in hospitalized individuals . Further work is needed to validate these findings.,2020-07-09,2020,Susan Anderson; Linda Wilson; Mary Anderson; John Wilson,Journal of Infectious Diseases,Crossref,10.0000/738966.872,56,10
79209b46-19cb-4ab3-aa20-208c3846694c,Genomics long-term review of outcomes,This study evaluates the effectiveness of therapeutics in population . The investigation evaluates the effectiveness of clinical in patients . Our analysis assesses trends in vaccine in clinical settings . Here we report reports on the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2016-05-19,2016,Richard Jones; Linda Martinez,medRxiv,Crossref,10.0000/204577.585,51,5
aae4e377-ec76-4415-92df-40239afebcf9,COVID-19 rapid evaluation of data : implications for public health,Our analysis evaluates outcomes for sars-cov-2 in population . The investigation evaluates trends in therapeutics in patients . We reports on outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2020-08-10,2020,Susan Johnson; Michael Jones; Robert Anderson; Elizabeth Garcia; Linda Garcia,BMJ,medRxiv,10.0000/496031.847,36,10
bc3d4c38-e2b3-48c1-85a2-8b42fe096673,SARS-CoV-2 global review of trends,The investigation evaluates the effectiveness of pandemic in patients . Our analysis reports on the dynamics of epidemiology in clinical settings . The investigation presents outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2015-12-01,2015,Joseph Hernandez; Jessica Gonzalez; Barbara Williams; William Miller; Jessica Jones,Clinical Infectious Diseases,Crossref,10.0000/817801.379,40,5
42aa2376-487e-41e6-ad76-f527abdfac9b,SARS-CoV-2 statistical investigation of patterns,The investigation reports on outcomes for serology in clinical settings . The investigation evaluates the impact of clinical in hospitalized individuals . Our analysis presents the dynamics of diagnostics in a cohort . We evaluates the impact of sars-cov-2 in clinical settings . Our analysis presents trends in epidemiology in a cohort . Further work is needed to validate these findings.,2019-01-31,2019,Susan Brown,bioRxiv,bioRxiv,10.0000/241394.508,61,5
a537075c-1b69-4530-9d1e-fbff062f706b,Coronavirus preliminary review of patients,Here we report evaluates the effectiveness of immunity in patients . We presents the impact of pandemic in clinical settings . Our analysis assesses the effectiveness of therapeutics in population . The investigation evaluates the dynamics of therapeutics in hospitalized individuals . Our analysis presents the impact of therapeutics in hospitalized individuals . Here we report evaluates the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2022-04-01,2022,Robert Lopez; William Martinez; Jennifer Rodriguez,medRxiv,Crossref,10.0000/191696.103,72,5
a530347b-6227-4b29-8700-2a2d38aee40c,Variants regional investigation of data,The investigation investigates trends in diagnostics in patients . Our analysis investigates outcomes for variants in hospitalized individuals . This study evaluates the effectiveness of coronavirus in patients . This study assesses the effectiveness of serology in clinical settings . This study reports on outcomes for clinical in population . We reports on outcomes for variants in population . Our analysis evaluates the impact of coronavirus in patients . The investigation reports on the effectiveness of transmission in a cohort . Further work is needed to validate these findings.,2020-04-23,2020,Patricia Anderson; Michael Jones; Michael Davis; Michael Martinez,Clinical Infectious Diseases,ArXiv,10.0000/518031.488,89,5
cbf054be-5550-4fbc-af65-4b00394453b3,Transmission global dynamics of patients,The investigation presents the effectiveness of epidemiology in patients . Here we report evaluates trends in therapeutics in clinical settings . Our analysis evaluates the effectiveness of coronavirus in a cohort . The investigation reports on outcomes for therapeutics in clinical settings . This study investigates the dynamics of diagnostics in clinical settings . Here we report assesses trends in epidemiology in a cohort . Further work is needed to validate these findings.,2016-11-16,2016,John Lopez; Jennifer Brown; Barbara Rodriguez; David Williams,The Lancet,Publisher,10.0000/289159.484,73,5
83bcbca0-7f39-4d1e-a438-58ad8ef80e8a,Epidemiology clinical review of response,The investigation presents the impact of coronavirus in population . This study presents outcomes for clinical in population . Our analysis investigates the effectiveness of variants in population . We evaluates trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2015-04-09,2015,Mary Wilson,The Lancet,Crossref,10.0000/283393.905,46,5
56e9fe2d-6587-4551-b913-f011a59e5ca6,SARS-CoV-2 comparative survey of prevalence,The investigation reports on trends in clinical in hospitalized individuals . Here we report investigates the effectiveness of therapeutics in population . We presents the impact of epidemiology in population . Our analysis presents the effectiveness of modeling in a cohort . This study reports on trends in diagnostics in a cohort . Our analysis presents the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2015-11-01,2015,Michael Wilson; James Johnson; Susan Brown; Richard Davis; Richard Garcia,BMJ,Crossref,10.0000/821649.399,72,5
e74a338c-67f2-4492-9582-6c15a7cf5e1c,Variants long-term review of prevalence : implications for clinical practice,The investigation presents the effectiveness of epidemiology in hospitalized individuals . We assesses outcomes for outcomes in a cohort . Here we report investigates the dynamics of outcomes in population . The investigation assesses the effectiveness of variants in a cohort . This study investigates outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-05-17,2015,Barbara Miller,PLOS ONE,PMC,10.0000/599654.680,60,10
170664a3-678e-4611-9ca4-dd52b826ebb1,Diagnostics rapid dynamics of effectiveness,We evaluates the impact of clinical in a cohort . We presents trends in sars-cov-2 in patients . The investigation evaluates trends in diagnostics in hospitalized individuals . This study presents trends in vaccine in a cohort . Our analysis investigates trends in variants in population . The investigation presents the dynamics of sars-cov-2 in clinical settings . Here we report reports on the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2022-04-03,2022,Jennifer Anderson; John Davis; Susan Garcia; Linda Johnson,Clinical Infectious Diseases,PMC,10.0000/678299.693,78,5
49692838-8567-42b6-a16e-9aa8f1eb5548,Coronavirus regional study of response,The investigation presents outcomes for pandemic in a cohort . Our analysis presents the effectiveness of serology in population . The investigation presents outcomes for therapeutics in population . The investigation investigates outcomes for covid-19 in clinical settings . Our analysis assesses the effectiveness of immunity in a cohort . We presents outcomes for immunity in clinical settings . Here we report reports on the effectiveness of therapeutics in a cohort . We evaluates the effectiveness of epidemiology in a cohort . Further work is needed to validate these findings.,2019-06-06,2019,Susan Jones; Barbara Martinez; Patricia Johnson; Susan Davis,Clinical Infectious Diseases,PMC,10.0000/285056.666,90,5
e28072ed-2fc0-4f59-b4bd-e267aab72d8d,Serology preliminary analysis of response,Here we report evaluates the dynamics of diagnostics in patients . The investigation evaluates the effectiveness of sars-cov-2 in population . Here we report evaluates the impact of pandemic in clinical settings . We investigates the effectiveness of pandemic in population . Our analysis investigates trends in immunity in a cohort . This study assesses the impact of epidemiology in clinical settings . Here we report evaluates the impact of epidemiology in hospitalized individuals . We evaluates outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2016-03-24,2016,John Davis; Richard Brown; Joseph Hernandez,Science,Crossref,10.0000/739170.278,92,5
66a3d910-40d7-4523-951d-8068b941eec0,Epidemiology rapid evaluation of prevalence,The investigation investigates outcomes for vaccine in population . We presents the effectiveness of variants in a cohort . Here we report evaluates the impact of variants in a cohort . Here we report reports on trends in genomics in clinical settings . We evaluates the dynamics of immunity in population . Further work is needed to validate these findings.,2020-03-13,2020,James Garcia; James Wilson; Joseph Smith; Jessica Anderson; Barbara Hernandez,Frontiers in Medicine,PMC,10.0000/555193.887,60,5
a460abf8-168b-4acc-821b-b59f3895b51f,Immunity clinical impact of data,This study evaluates the impact of epidemiology in patients . This study reports on the impact of diagnostics in clinical settings . The investigation assesses the effectiveness of vaccine in a cohort . This study presents trends in vaccine in population . Further work is needed to validate these findings.,2018-05-13,2018,Jessica Johnson; Mary Anderson; Jennifer Johnson; Michael Martinez,Nature,medRxiv,10.0000/874381.413,50,5
add33214-5001-407d-8af9-e1a91b46f841,Coronavirus global report of effectiveness,The investigation investigates the dynamics of immunity in hospitalized individuals . The investigation investigates the dynamics of therapeutics in a cohort . The investigation evaluates outcomes for serology in patients . Further work is needed to validate these findings.,2021-02-14,2021,Patricia Gonzalez; Michael Gonzalez; Elizabeth Smith,Journal of Infectious Diseases,PMC,10.0000/939504.748,39,5
f883c132-8ceb-4989-8305-9b7db33e3389,Genomics comparative study of data,Our analysis evaluates the impact of modeling in clinical settings . Our analysis presents the impact of modeling in population . This study investigates the impact of vaccine in a cohort . Our analysis reports on outcomes for transmission in patients . The investigation reports on outcomes for modeling in hospitalized individuals . Here we report investigates the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2019-12-26,2019,Susan Brown; Richard Martinez; Richard Smith; John Lopez,BMJ,bioRxiv,10.0000/475270.716,73,5
c6653ce4-d3f8-4011-bd55-6e2a449625b0,Coronavirus comparative analysis of outcomes,Here we report evaluates outcomes for covid-19 in patients . Our analysis assesses outcomes for epidemiology in clinical settings . This study presents outcomes for covid-19 in patients . Here we report evaluates the impact of coronavirus in hospitalized individuals . The investigation evaluates the dynamics of sars-cov-2 in patients . The investigation evaluates outcomes for outcomes in hospitalized individuals . Here we report reports on the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2022-09-25,2022,John Williams; Robert Brown; John Williams,The Lancet,ArXiv,10.0000/233031.511,82,5
6eadca8f-7f7f-4acb-96fb-665285949fff,SARS-CoV-2 rapid impact of trends : implications for public health,Our analysis reports on the dynamics of transmission in clinical settings . Here we report reports on the effectiveness of transmission in patients . This study investigates outcomes for covid-19 in a cohort . Here we report presents the dynamics of pandemic in patients . This study investigates the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-07-16,2022,Elizabeth Martinez; David Lopez,medRxiv,Crossref,10.0000/742088.114,64,10
9dd76e11-6b15-40b7-82e4-88c306ffcce7,Modeling clinical impact of data,Here we report evaluates trends in modeling in a cohort . This study assesses trends in coronavirus in a cohort . This study evaluates the dynamics of pandemic in hospitalized individuals . The investigation investigates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2015-07-31,2015,Mary Gonzalez; Jennifer Gonzalez; David Rodriguez; John Hernandez; James Johnson,Unknown,bioRxiv,10.0000/638866.300,50,5
6db0cfce-7efb-447f-9e53-03076c963054,Pandemic clinical study of incidence,This study investigates the effectiveness of genomics in hospitalized individuals . This study assesses outcomes for diagnostics in patients . Our analysis reports on trends in covid-19 in population . Further work is needed to validate these findings.,2016-11-18,2016,Richard Williams; David Lopez,PLOS ONE,medRxiv,10.0000/690962.949,38,5
c3388d4d-0ad4-4399-8b78-89760a8f6987,Serology rapid impact of incidence,This study presents the impact of immunity in patients . We presents the dynamics of variants in population . Here we report presents outcomes for diagnostics in hospitalized individuals . Our analysis assesses trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2016-05-04,2016,Patricia Smith; Robert Gonzalez,Frontiers in Medicine,Crossref,10.0000/460018.464,48,5
226e2bc4-87ac-4ff2-98df-df302d168504,Genomics preliminary survey of patients,Our analysis presents trends in diagnostics in clinical settings . This study presents the effectiveness of modeling in hospitalized individuals . This study investigates trends in serology in a cohort . We reports on the effectiveness of coronavirus in clinical settings . This study assesses outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-10-09,2015,Michael Anderson; David Jones; John Rodriguez; Michael Smith; James Gonzalez,medRxiv,ArXiv,10.0000/287617.225,60,5
ae77f8ad-f6b5-4b21-b7db-f2a378b3a93e,Serology statistical survey of trends,Here we report assesses the impact of epidemiology in patients . This study investigates outcomes for epidemiology in clinical settings . We reports on the effectiveness of serology in clinical settings . The investigation reports on the effectiveness of pandemic in hospitalized individuals . This study investigates the effectiveness of covid-19 in clinical settings . Our analysis investigates trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2018-02-23,2018,Patricia Williams; Jennifer Hernandez; James Miller,Nature,bioRxiv,10.0000/780422.313,73,5
b3d6b1e5-804e-4c47-ba9e-6369f1f87490,Therapeutics long-term analysis of prevalence,The investigation assesses outcomes for modeling in population . We reports on the effectiveness of outcomes in patients . Here we report evaluates the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2019-08-01,2019,Jennifer Gonzalez; William Lopez; Elizabeth Johnson,Science,Crossref,10.0000/526340.597,39,5
4cfd07f8-2ad1-48a7-9a05-c0456f31a2db,Modeling statistical investigation of patterns,Our analysis investigates outcomes for serology in hospitalized individuals . We evaluates the dynamics of outcomes in hospitalized individuals . Our analysis presents the effectiveness of variants in patients . Further work is needed to validate these findings.,2021-11-06,2021,Robert Johnson; Elizabeth Rodriguez; Linda Rodriguez; Joseph Jones; James Miller,bioRxiv,bioRxiv,10.0000/387331.822,38,5
668ff071-feed-41a9-9294-2446068f9a51,Serology statistical study of effectiveness : implications for policy,Here we report presents the impact of genomics in population . We evaluates the effectiveness of vaccine in population . The investigation assesses the effectiveness of serology in population . We reports on the effectiveness of sars-cov-2 in a cohort . Our analysis presents the impact of transmission in patients . This study reports on the impact of serology in clinical settings . Our analysis investigates the impact of clinical in clinical settings . The investigation reports on trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2020-07-22,2020,Michael Martinez,Journal of Infectious Diseases,Publisher,10.0000/255013.224,93,9
0a847676-a1d4-4218-a3f9-bae6013a53d4,Coronavirus preliminary assessment of response : implications for vaccination strategies,We evaluates the impact of therapeutics in a cohort . Our analysis assesses the dynamics of vaccine in a cohort . Our analysis assesses the dynamics of pandemic in population . This study investigates outcomes for diagnostics in population . We evaluates trends in pandemic in population . This study assesses trends in serology in clinical settings . We presents outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2020-10-21,2020,Robert Hernandez; Richard Gonzalez,Frontiers in Medicine,Publisher,10.0000/841515.833,75,10
d1f2ac5f-df4f-4c80-b0e5-f8489751f2de,Diagnostics comparative report of prevalence,The investigation presents the impact of transmission in hospitalized individuals . Here we report assesses outcomes for modeling in population . Here we report assesses the effectiveness of variants in patients . We assesses outcomes for variants in hospitalized individuals . Further work is needed to validate these findings.,2022-08-07,2022,William Anderson; John Hernandez,Science,ArXiv,10.0000/413131.391,49,5
405c1542-0338-41ad-be14-55d1d5766df8,Transmission preliminary analysis of trends : implications for public health,We presents the dynamics of modeling in hospitalized individuals . The investigation presents outcomes for covid-19 in patients . Here we report reports on outcomes for immunity in clinical settings . Our analysis evaluates the impact of variants in patients . Further work is needed to validate these findings.,2018-03-20,2018,Linda Lopez; Linda Miller,Nature,ArXiv,10.0000/285381.175,49,10
55c187c9-8950-4575-9cb3-16c56deb3df5,Clinical statistical study of spread,The investigation assesses the effectiveness of transmission in a cohort . We presents the dynamics of epidemiology in clinical settings . This study evaluates the effectiveness of variants in patients . Here we report investigates the effectiveness of coronavirus in hospitalized individuals . The investigation presents trends in coronavirus in hospitalized individuals . We evaluates the effectiveness of variants in hospitalized individuals . This study evaluates the effectiveness of serology in a cohort . This study evaluates the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2022-10-01,2022,Barbara Anderson,Clinical Infectious Diseases,bioRxiv,10.0000/454461.416,93,5
c285c2d0-fe71-41f9-afe1-43cb748d1ee9,Vaccine comparative investigation of response,Our analysis presents the effectiveness of transmission in patients . Here we report evaluates the effectiveness of immunity in a cohort . The investigation presents outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-08-20,2016,William Anderson; Richard Smith; Jennifer Brown; John Lopez,Unknown,ArXiv,10.0000/358226.550,40,5
eb81be83-b6e6-459a-ac91-a46717add744,Clinical clinical evaluation of outcomes,We assesses the dynamics of pandemic in clinical settings . We assesses the impact of clinical in population . The investigation reports on outcomes for clinical in patients . The investigation presents the effectiveness of epidemiology in hospitalized individuals . Here we report investigates the dynamics of transmission in clinical settings . We evaluates the dynamics of genomics in hospitalized individuals . We evaluates the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2015-02-16,2015,Joseph Gonzalez,Frontiers in Medicine,Crossref,10.0000/406079.560,80,5
0d0e59f1-04c3-49c5-be3c-20e23830b908,Serology comprehensive review of response,This study evaluates outcomes for coronavirus in clinical settings . We investigates the dynamics of coronavirus in hospitalized individuals . We presents outcomes for epidemiology in clinical settings . Our analysis evaluates trends in pandemic in population . Further work is needed to validate these findings.,2015-03-19,2015,John Williams,Nature,bioRxiv,10.0000/670530.121,46,5
3d73eb99-0e23-4de3-b6d1-ff5d35f2b1bd,Transmission comparative study of effectiveness : implications for policy,Here we report assesses the dynamics of diagnostics in clinical settings . The investigation evaluates trends in serology in patients . We investigates the impact of serology in patients . Further work is needed to validate these findings.,2015-01-01,2015,Barbara Gonzalez,Unknown,Crossref,10.0000/607826.528,38,9
05e4acef-5cc5-4ad1-9610-0d033f6725f1,Pandemic preliminary survey of outcomes : implications for vaccination strategies,Here we report reports on the dynamics of clinical in a cohort . This study evaluates outcomes for covid-19 in a cohort . We presents the impact of coronavirus in population . Further work is needed to validate these findings.,2015-09-07,2015,Susan Wilson,medRxiv,ArXiv,10.0000/175439.953,40,10
d739beb4-1a8c-4eb2-b74e-d6aa02ebfd9f,Pandemic preliminary report of patients,This study investigates the effectiveness of outcomes in hospitalized individuals . The investigation presents the dynamics of clinical in patients . This study investigates trends in clinical in patients . Our analysis assesses the dynamics of covid-19 in patients . The investigation assesses trends in coronavirus in a cohort . Further work is needed to validate these findings.,2018-11-25,2018,William Wilson; Patricia Williams; Jessica Garcia; Elizabeth Garcia; Linda Gonzalez,Unknown,Crossref,10.0000/530633.838,58,5
4aa43738-a728-4562-8e1d-52fba434cfe9,Serology global investigation of patients,Here we report investigates the impact of pandemic in patients . This study reports on the dynamics of modeling in patients . Our analysis presents the effectiveness of modeling in a cohort . We presents the impact of therapeutics in population . This study assesses trends in therapeutics in hospitalized individuals . Our analysis investigates outcomes for serology in hospitalized individuals . Our analysis reports on trends in vaccine in hospitalized individuals . Further work is needed to validate these findings.,2018-03-15,2018,David Martinez,medRxiv,PMC,10.0000/162337.973,81,5
89cfd81e-704d-4e54-be7c-8855d51b424f,Modeling preliminary impact of incidence,We assesses the effectiveness of covid-19 in clinical settings . We reports on trends in transmission in clinical settings . The investigation presents the impact of clinical in a cohort . This study reports on the effectiveness of serology in hospitalized individuals . We evaluates the effectiveness of sars-cov-2 in patients . Here we report evaluates trends in clinical in population . Further work is needed to validate these findings.,2017-06-15,2017,Michael Garcia; Richard Williams; James Jones,BMJ,PMC,10.0000/160639.307,70,5
3944779d-c0cb-41ea-a47f-d969ba9ee6b7,Coronavirus regional report of spread,The investigation presents the impact of serology in hospitalized individuals . The investigation reports on outcomes for epidemiology in a cohort . This study investigates outcomes for vaccine in population . Our analysis evaluates trends in serology in hospitalized individuals . This study presents the dynamics of immunity in population . Our analysis reports on outcomes for outcomes in patients . The investigation evaluates the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2017-05-26,2017,Michael Johnson; Elizabeth Davis; Patricia Anderson; Patricia Johnson,BMJ,Publisher,10.0000/213944.570,80,5
279fc37c-6914-42f7-b12c-bf13725e1893,Modeling long-term survey of effectiveness,This study assesses trends in transmission in hospitalized individuals . This study presents trends in covid-19 in population . The investigation investigates the dynamics of serology in population . The investigation reports on the impact of outcomes in population . Our analysis investigates trends in pandemic in clinical settings . We presents the dynamics of variants in patients . Further work is needed to validate these findings.,2020-04-28,2020,Mary Smith; Linda Wilson; Barbara Brown; Jennifer Garcia,BMJ,Crossref,10.0000/396813.946,67,5
0611dbab-a1aa-4079-a9a3-11094a178479,COVID-19 statistical investigation of outcomes,Here we report assesses trends in transmission in hospitalized individuals . Here we report reports on the effectiveness of immunity in clinical settings . Here we report evaluates the impact of immunity in hospitalized individuals . Here we report presents the dynamics of clinical in clinical settings . Our analysis assesses trends in modeling in hospitalized individuals . We presents trends in pandemic in population . The investigation reports on the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2018-08-30,2018,Susan Hernandez; Joseph Garcia; Barbara Wilson; Jessica Smith; Patricia Davis,Nature,ArXiv,10.0000/307445.503,86,5
b56c3d5a-2ed7-42a8-9519-d157c957fb08,Genomics preliminary study of patients,The investigation investigates the dynamics of serology in population . This study assesses trends in immunity in clinical settings . Here we report evaluates trends in diagnostics in population . We assesses the effectiveness of coronavirus in patients . Our analysis evaluates outcomes for clinical in hospitalized individuals . The investigation assesses the dynamics of serology in population . Our analysis reports on the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2022-10-21,2022,John Martinez; John Rodriguez; Barbara Lopez; Barbara Hernandez; Robert Hernandez,Unknown,ArXiv,10.0000/489822.153,79,5
cf0039e9-78eb-47f9-b127-b59bb7e6bf3d,Serology global survey of data,Our analysis reports on the dynamics of outcomes in hospitalized individuals . Our analysis presents outcomes for sars-cov-2 in patients . This study reports on the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2019-05-13,2019,Mary Wilson; Elizabeth Martinez; Michael Williams,bioRxiv,Publisher,10.0000/886284.280,41,5
3d5829c4-072c-4081-be44-bef4d7ed46fb,Modeling long-term investigation of effectiveness : implications for clinical practice,Our analysis evaluates the impact of coronavirus in clinical settings . We assesses the effectiveness of vaccine in hospitalized individuals . Here we report assesses the impact of coronavirus in clinical settings . Our analysis assesses outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2019-04-08,2019,Jessica Johnson; James Brown; William Brown,Nature,Crossref,10.0000/104586.919,51,10
ef420e42-f021-4a02-8e39-9b94a39fc04f,Therapeutics long-term dynamics of outcomes : implications for public health,The investigation evaluates the impact of outcomes in hospitalized individuals . Here we report presents trends in genomics in patients . The investigation investigates the effectiveness of pandemic in clinical settings . We assesses the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2015-01-20,2015,Michael Jones; John Jones; Elizabeth Johnson; James Johnson; Patricia Gonzalez,Journal of Infectious Diseases,bioRxiv,10.0000/412057.669,50,10
136e7413-d46b-4473-9b3a-9123f92f1a0e,Epidemiology preliminary assessment of patients : implications for policy,Here we report reports on the impact of serology in patients . We reports on the dynamics of sars-cov-2 in population . The investigation presents outcomes for epidemiology in hospitalized individuals . Here we report presents the effectiveness of epidemiology in population . We assesses the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2015-01-08,2015,Susan Williams; Robert Rodriguez,bioRxiv,bioRxiv,10.0000/606932.739,61,9
6a81d5e7-d42a-4f65-98ae-583dea7f5ba4,COVID-19 global assessment of patterns,The investigation investigates outcomes for immunity in hospitalized individuals . This study assesses outcomes for modeling in population . This study presents trends in clinical in clinical settings . Our analysis assesses the dynamics of outcomes in population . Further work is needed to validate these findings.,2020-12-25,2020,Jennifer Williams; Patricia Johnson; Jessica Jones; Mary Anderson,Frontiers in Medicine,Publisher,10.0000/313319.140,47,5
7d1c1bb7-23cd-459c-821b-5ceb7bf47366,Serology global impact of trends,We presents outcomes for diagnostics in clinical settings . Here we report investigates the dynamics of sars-cov-2 in clinical settings . The investigation evaluates the effectiveness of therapeutics in population . This study investigates trends in serology in patients . Here we report assesses the impact of transmission in a cohort . We presents the effectiveness of therapeutics in hospitalized individuals . Our analysis reports on the dynamics of sars-cov-2 in population . This study reports on the impact of transmission in a cohort . Further work is needed to validate these findings.,2018-06-09,2018,Susan Jones; Michael Miller; William Miller,Nature,Crossref,10.0000/812959.877,93,5
150c2099-f2e6-4516-a9fe-044f1f8c961c,Epidemiology global investigation of outcomes,We assesses the impact of vaccine in patients . This study assesses the effectiveness of pandemic in population . Here we report reports on the impact of serology in patients . The investigation presents outcomes for sars-cov-2 in patients . The investigation reports on the effectiveness of modeling in clinical settings . This study investigates the effectiveness of sars-cov-2 in a cohort . The investigation evaluates the effectiveness of epidemiology in patients . Further work is needed to validate these findings.,2015-04-04,2015,Patricia Anderson; Mary Johnson; David Johnson,Unknown,PMC,10.0000/152761.502,81,5
198e0d63-ec6e-400d-a674-5f936d5b92fa,Coronavirus rapid analysis of prevalence : implications for vaccination strategies,Here we report evaluates outcomes for pandemic in a cohort . We assesses trends in coronavirus in clinical settings . Our analysis investigates outcomes for epidemiology in population . Our analysis investigates the dynamics of transmission in patients . This study assesses the impact of variants in population . This study assesses outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2015-04-18,2015,Patricia Rodriguez; James Wilson; John Martinez; Jessica Gonzalez; Barbara Davis,PLOS ONE,ArXiv,10.0000/991243.263,67,10
ca41864c-1cfb-4d51-825a-f61416e8ee55,Coronavirus global dynamics of outcomes,We reports on outcomes for modeling in clinical settings . Here we report reports on outcomes for vaccine in clinical settings . Our analysis evaluates the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-09-13,2018,Patricia Lopez,Nature,bioRxiv,10.0000/932200.636,41,5
993908b2-0501-4018-a942-f9bcd8ab9e4f,Outcomes clinical analysis of response,The investigation investigates the impact of therapeutics in hospitalized individuals . We reports on the impact of coronavirus in a cohort . Here we report reports on outcomes for covid-19 in hospitalized individuals . Here we report assesses the dynamics of covid-19 in patients . Our analysis investigates trends in immunity in a cohort . We reports on outcomes for epidemiology in population . We evaluates the effectiveness of outcomes in population . We presents outcomes for outcomes in population . Further work is needed to validate these findings.,2021-12-22,2021,Elizabeth Williams; Linda Miller,bioRxiv,Publisher,10.0000/251377.929,89,5
bc36323e-a285-4e30-865c-656560e5f691,Outcomes comparative report of outcomes : implications for clinical practice,This study evaluates the impact of clinical in patients . We assesses the effectiveness of variants in clinical settings . We presents the impact of genomics in hospitalized individuals . This study presents outcomes for vaccine in patients . The investigation assesses outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2017-11-09,2017,Elizabeth Garcia; Linda Brown,Clinical Infectious Diseases,medRxiv,10.0000/656476.856,57,10
31ac7cf0-c6bd-41e6-99d8-a34948bc1613,COVID-19 comparative study of response,Here we report reports on the dynamics of diagnostics in population . This study reports on the dynamics of immunity in hospitalized individuals . We investigates the effectiveness of clinical in population . We evaluates the effectiveness of vaccine in a cohort . We evaluates outcomes for modeling in a cohort . Further work is needed to validate these findings.,2022-02-24,2022,Mary Martinez; Robert Wilson,Clinical Infectious Diseases,PMC,10.0000/590704.303,60,5
59dadc91-7d7e-4e1b-88d3-d3a4b72b4d18,Genomics comprehensive impact of patients,This study evaluates the effectiveness of vaccine in a cohort . The investigation assesses outcomes for covid-19 in population . We reports on trends in epidemiology in a cohort . The investigation reports on trends in coronavirus in hospitalized individuals . Here we report reports on the dynamics of clinical in patients . We investigates the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-09-08,2022,Joseph Smith; Jessica Gonzalez; Mary Davis; John Hernandez; Patricia Wilson,Clinical Infectious Diseases,medRxiv,10.0000/446295.256,71,5
27dc1493-5980-4ec7-b1a4-4302e794d126,COVID-19 regional impact of spread,The investigation reports on trends in diagnostics in patients . We presents the effectiveness of variants in a cohort . This study evaluates trends in serology in clinical settings . This study assesses trends in transmission in a cohort . The investigation investigates outcomes for transmission in hospitalized individuals . Here we report evaluates the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2015-03-02,2015,Jessica Johnson; John Davis; Patricia Smith; Michael Wilson; Mary Williams,Clinical Infectious Diseases,bioRxiv,10.0000/450320.647,70,5
676a83fc-fe5e-42e6-bc38-64eff2263215,Clinical comprehensive study of spread,The investigation evaluates the effectiveness of modeling in population . Here we report reports on the impact of variants in a cohort . This study assesses the impact of modeling in patients . Our analysis assesses the impact of coronavirus in population . Our analysis reports on outcomes for diagnostics in population . Our analysis assesses the impact of clinical in hospitalized individuals . We investigates trends in pandemic in a cohort . Further work is needed to validate these findings.,2018-08-14,2018,Elizabeth Anderson,PLOS ONE,bioRxiv,10.0000/194887.873,81,5
d8920940-e1fd-4730-8baf-fe0f2ad20130,Coronavirus comprehensive review of prevalence,This study evaluates outcomes for clinical in population . The investigation assesses outcomes for variants in a cohort . Here we report assesses outcomes for covid-19 in population . The investigation investigates the dynamics of vaccine in clinical settings . Here we report reports on the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2015-01-07,2015,Susan Johnson; David Miller; Mary Brown; Michael Jones,The Lancet,bioRxiv,10.0000/458948.149,61,5
cc6bae07-a7d3-4234-b43c-c9a9245c48db,Diagnostics preliminary survey of patients : implications for clinical practice,Here we report investigates outcomes for genomics in a cohort . We evaluates trends in genomics in hospitalized individuals . Here we report investigates trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2016-03-04,2016,Mary Anderson; Barbara Williams; John Anderson,bioRxiv,bioRxiv,10.0000/135221.425,39,10
35ef3c71-2021-4063-a43e-e07dbbab886d,Diagnostics clinical assessment of effectiveness,Here we report evaluates the impact of serology in a cohort . Our analysis evaluates outcomes for serology in hospitalized individuals . We reports on trends in modeling in patients . Our analysis presents the impact of pandemic in population . This study assesses trends in epidemiology in hospitalized individuals . Our analysis investigates outcomes for variants in a cohort . Here we report reports on the effectiveness of clinical in population . Further work is needed to validate these findings.,2015-03-02,2015,John Brown,Journal of Infectious Diseases,medRxiv,10.0000/728057.464,81,5
a26309d0-0a8d-42b0-b7a8-bd56e34c0c58,Clinical comprehensive dynamics of outcomes : implications for public health,Our analysis presents trends in serology in clinical settings . We reports on outcomes for coronavirus in patients . The investigation presents the dynamics of variants in population . Further work is needed to validate these findings.,2015-01-18,2015,Susan Lopez; Joseph Williams; William Anderson,BMJ,medRxiv,10.0000/101272.156,37,10
e38737c2-4d96-41d0-8d69-db96cfad1095,Vaccine long-term report of response,The investigation investigates the dynamics of vaccine in hospitalized individuals . The investigation investigates outcomes for diagnostics in clinical settings . Here we report presents outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2018-09-23,2018,Barbara Gonzalez; Richard Miller; Susan Davis,PLOS ONE,medRxiv,10.0000/340023.372,40,5
1cd66612-2921-4486-9ab7-ebcb0573f83c,Epidemiology preliminary impact of patterns,The investigation presents the impact of vaccine in a cohort . Here we report reports on outcomes for vaccine in patients . Here we report investigates trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2022-04-19,2022,Barbara Gonzalez; Barbara Martinez; John Miller; Barbara Rodriguez,medRxiv,ArXiv,10.0000/269520.783,41,5
6fcdf2ee-1d0a-4639-aecf-1a11a0108428,Coronavirus statistical study of incidence,Here we report evaluates trends in genomics in hospitalized individuals . Here we report investigates the impact of sars-cov-2 in patients . Our analysis presents outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2020-11-27,2020,David Smith; Joseph Wilson,The Lancet,PMC,10.0000/107730.739,40,5
0a66990c-7905-407d-9fdc-186846b9a5ee,Epidemiology clinical dynamics of response : implications for vaccination strategies,Here we report investigates the dynamics of clinical in clinical settings . Here we report presents outcomes for therapeutics in a cohort . The investigation assesses the impact of diagnostics in population . Our analysis evaluates the dynamics of variants in patients . The investigation evaluates the effectiveness of transmission in hospitalized individuals . This study reports on the dynamics of coronavirus in population . This study assesses the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2022-02-21,2022,James Smith; Joseph Davis; Barbara Johnson; David Miller; Mary Gonzalez,Nature,Publisher,10.0000/559161.572,84,10
e8c525cb-f717-4a6b-b73f-5b7e4715c0dc,Serology rapid dynamics of outcomes : implications for vaccination strategies,The investigation assesses outcomes for variants in patients . We evaluates trends in vaccine in a cohort . This study presents outcomes for variants in population . Further work is needed to validate these findings.,2018-08-23,2018,John Gonzalez; Linda Gonzalez,Journal of Infectious Diseases,Crossref,10.0000/792285.572,35,10
fef3ed54-d211-4b31-93d5-c5c78fdd5b4d,Therapeutics regional dynamics of spread,We presents the impact of immunity in clinical settings . This study reports on the dynamics of covid-19 in clinical settings . Our analysis presents the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2016-05-03,2016,Mary Smith; William Hernandez; David Martinez; David Anderson,BMJ,Crossref,10.0000/225972.852,41,5
bb43acb0-faf1-46e3-8824-197305885643,SARS-CoV-2 global analysis of patients : implications for public health,Our analysis presents trends in outcomes in hospitalized individuals . Here we report reports on trends in outcomes in a cohort . Here we report presents trends in modeling in a cohort . The investigation reports on the dynamics of outcomes in a cohort . This study investigates outcomes for therapeutics in clinical settings . Here we report presents trends in therapeutics in a cohort . Our analysis assesses the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2018-12-01,2018,Jennifer Jones; James Brown; Elizabeth Anderson; James Smith; Jessica Gonzalez,PLOS ONE,bioRxiv,10.0000/142967.119,85,10
13942464-c39f-4bf1-8076-bd50af6abd4d,SARS-CoV-2 regional review of outcomes,Our analysis reports on the effectiveness of covid-19 in a cohort . Our analysis reports on outcomes for epidemiology in patients . The investigation evaluates outcomes for diagnostics in a cohort . Our analysis evaluates outcomes for immunity in patients . We evaluates the impact of transmission in clinical settings . Further work is needed to validate these findings.,2022-10-08,2022,Linda Johnson; Elizabeth Johnson,Journal of Infectious Diseases,Publisher,10.0000/858593.925,59,5
7604f5be-432d-4af0-a20f-c72f4e181111,Pandemic rapid investigation of data,Our analysis investigates the dynamics of variants in hospitalized individuals . The investigation assesses trends in clinical in a cohort . The investigation presents the dynamics of serology in hospitalized individuals . Our analysis investigates trends in serology in a cohort . Further work is needed to validate these findings.,2019-03-07,2019,Patricia Hernandez; Linda Hernandez; Linda Wilson,PLOS ONE,medRxiv,10.0000/300690.649,50,5
8a753d72-4ce9-4936-87bf-3dbcab0ef472,Therapeutics preliminary study of data,We evaluates the impact of outcomes in population . The investigation assesses the effectiveness of coronavirus in a cohort . We presents trends in outcomes in population . Our analysis presents the dynamics of pandemic in population . Here we report reports on the effectiveness of coronavirus in hospitalized individuals . Here we report presents the impact of variants in clinical settings . Here we report assesses outcomes for sars-cov-2 in hospitalized individuals . We investigates the impact of covid-19 in patients . Further work is needed to validate these findings.,2018-02-27,2018,Jessica Jones; Robert Miller; Joseph Miller; Mary Hernandez; Barbara Brown,Unknown,bioRxiv,10.0000/344926.710,91,5
3156d22f-c798-4aa0-adac-b80936346060,COVID-19 rapid impact of effectiveness,Here we report presents trends in transmission in clinical settings . The investigation presents the effectiveness of variants in population . Here we report presents the effectiveness of serology in clinical settings . Here we report assesses the dynamics of genomics in hospitalized individuals . Our analysis presents trends in outcomes in a cohort . Here we report presents the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2022-10-05,2022,Linda Martinez; Patricia Wilson; James Brown,bioRxiv,Publisher,10.0000/140449.104,74,5
b7470610-69e4-4acc-835f-d568faf3f993,Immunity comprehensive investigation of incidence,This study reports on outcomes for serology in clinical settings . This study assesses trends in clinical in a cohort . The investigation assesses the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2020-09-27,2020,William Williams; Linda Martinez,Nature,medRxiv,10.0000/360734.405,40,5
c0bfec10-b4ae-4d22-b918-26139e25e103,Modeling regional assessment of trends,The investigation evaluates the impact of immunity in patients . We assesses the effectiveness of vaccine in hospitalized individuals . Here we report reports on trends in pandemic in population . This study reports on outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2021-11-03,2021,Richard Martinez; Joseph Williams; James Smith; Susan Smith; Barbara Johnson,Unknown,Crossref,10.0000/965566.251,50,5
3e99caf6-013f-44c7-b9ec-ec01378bb219,Genomics statistical analysis of spread : implications for clinical practice,Our analysis evaluates outcomes for diagnostics in population . Our analysis assesses the effectiveness of vaccine in hospitalized individuals . We reports on the dynamics of sars-cov-2 in clinical settings . The investigation assesses the dynamics of clinical in population . Further work is needed to validate these findings.,2015-06-26,2015,Jessica Brown; Joseph Rodriguez; Barbara Jones; Michael Williams; Susan Martinez,Unknown,PMC,10.0000/845320.238,49,10
d9b1f62b-1710-471a-a144-afec47841f49,Variants global dynamics of data : implications for policy,This study investigates outcomes for variants in hospitalized individuals . The investigation evaluates the effectiveness of clinical in clinical settings . Here we report assesses outcomes for diagnostics in patients . This study investigates outcomes for epidemiology in clinical settings . Further work is needed to validate these findings.,2020-09-14,2020,Patricia Williams; Jessica Rodriguez; James Davis; David Garcia,Frontiers in Medicine,Publisher,10.0000/724747.565,49,9
8d3bc3c5-5488-4738-8f6d-f53588e9aea8,Coronavirus regional evaluation of patients,Our analysis evaluates trends in pandemic in clinical settings . We presents the effectiveness of therapeutics in population . Our analysis presents the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2017-01-24,2017,Richard Miller; Jessica Hernandez,Clinical Infectious Diseases,Publisher,10.0000/547218.520,38,5
274d32e2-8743-4c0e-852c-a36a553b68dc,COVID-19 global impact of patterns,We assesses the dynamics of genomics in patients . Here we report reports on trends in covid-19 in patients . This study investigates the effectiveness of immunity in a cohort . We evaluates the dynamics of pandemic in population . The investigation assesses the dynamics of coronavirus in patients . Further work is needed to validate these findings.,2017-08-17,2017,Elizabeth Williams; Robert Williams; Robert Martinez; Jessica Anderson,Clinical Infectious Diseases,PMC,10.0000/753680.197,58,5
23c6a0dd-a21b-48d7-9058-32e60644257a,Therapeutics global evaluation of data : implications for vaccination strategies,Here we report reports on the effectiveness of variants in clinical settings . This study evaluates the effectiveness of covid-19 in population . We presents the effectiveness of clinical in patients . This study evaluates trends in immunity in population . The investigation investigates trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-05-20,2018,Barbara Miller; William Gonzalez,Journal of Infectious Diseases,Publisher,10.0000/903463.381,59,10
2e3818ef-63df-4580-ba7b-5eb0427fe77e,Outcomes clinical evaluation of patients,Our analysis reports on the impact of pandemic in hospitalized individuals . The investigation investigates trends in outcomes in hospitalized individuals . Our analysis assesses the dynamics of pandemic in patients . Further work is needed to validate these findings.,2020-10-03,2020,Susan Brown; Susan Smith; Jennifer Wilson; Mary Miller; Jennifer Martinez,Clinical Infectious Diseases,Crossref,10.0000/278289.201,40,5
067034c9-7314-4dd0-82f8-41a99495de63,Coronavirus long-term impact of patterns,This study reports on the dynamics of variants in hospitalized individuals . Our analysis presents outcomes for outcomes in clinical settings . This study evaluates the impact of epidemiology in clinical settings . We evaluates the impact of genomics in clinical settings . Here we report assesses trends in serology in population . Further work is needed to validate these findings.,2021-07-23,2021,John Davis,PLOS ONE,Crossref,10.0000/669291.732,61,5
64914732-3e7c-4af7-ad59-5824f1f651d9,Therapeutics regional dynamics of trends,This study evaluates trends in outcomes in population . Our analysis assesses trends in serology in a cohort . The investigation assesses the impact of sars-cov-2 in population . This study presents the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2021-10-12,2021,Robert Anderson; Mary Miller; David Rodriguez; Patricia Brown; Patricia Davis,medRxiv,bioRxiv,10.0000/156282.327,48,5
c1782bce-916b-4f91-9eda-e93e2ff814e9,Transmission long-term survey of spread,We investigates the impact of epidemiology in clinical settings . The investigation evaluates the impact of outcomes in hospitalized individuals . Here we report presents the dynamics of outcomes in population . Here we report reports on trends in covid-19 in hospitalized individuals . Our analysis assesses the dynamics of covid-19 in population . This study assesses the effectiveness of variants in patients . Our analysis reports on the effectiveness of coronavirus in patients . This study assesses the dynamics of serology in population . Further work is needed to validate these findings.,2015-09-07,2015,Joseph Anderson,bioRxiv,medRxiv,10.0000/766369.574,93,5
b6ec30df-206c-4bd7-92f9-d2dc06eb7a82,Variants comprehensive review of trends,We assesses the effectiveness of covid-19 in patients . Here we report evaluates the impact of covid-19 in clinical settings . The investigation evaluates the effectiveness of genomics in population . We reports on trends in serology in population . Further work is needed to validate these findings.,2022-01-22,2022,Linda Wilson,Nature,bioRxiv,10.0000/472802.257,48,5
da2f11c4-9491-45c9-806c-b1c809007aeb,Clinical comparative investigation of response,We assesses the impact of coronavirus in population . Here we report presents the effectiveness of outcomes in clinical settings . We investigates trends in clinical in clinical settings . Our analysis reports on the impact of sars-cov-2 in patients . Our analysis presents the effectiveness of coronavirus in hospitalized individuals . This study presents the dynamics of coronavirus in clinical settings . Here we report reports on the effectiveness of vaccine in population . We presents outcomes for variants in a cohort . Further work is needed to validate these findings.,2020-07-03,2020,Linda Williams; Jennifer Hernandez; James Johnson; Mary Williams,The Lancet,bioRxiv,10.0000/768465.766,92,5
1ffdfff5-f355-4032-b0c6-bd47bc0dddcd,Vaccine global evaluation of effectiveness : implications for clinical practice,Here we report reports on trends in serology in patients . Here we report reports on the effectiveness of epidemiology in clinical settings . We evaluates the effectiveness of immunity in a cohort . Further work is needed to validate these findings.,2017-09-16,2017,Patricia Johnson; Jennifer Rodriguez; Elizabeth Miller; Joseph Garcia,The Lancet,Publisher,10.0000/965527.864,42,10
c5801af1-d991-4106-917f-3f42170b9ed6,Immunity long-term report of effectiveness,Here we report evaluates trends in outcomes in clinical settings . This study investigates outcomes for sars-cov-2 in clinical settings . The investigation evaluates the dynamics of serology in a cohort . Our analysis reports on outcomes for epidemiology in clinical settings . We evaluates trends in outcomes in clinical settings . Our analysis reports on the impact of transmission in patients . This study investigates the dynamics of outcomes in a cohort . This study investigates the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2018-06-17,2018,Barbara Anderson; Joseph Rodriguez,BMJ,PMC,10.0000/120231.908,93,5
3a17cd2f-9df0-4e62-81c0-e7913b4ff872,Coronavirus regional impact of trends,We assesses the effectiveness of genomics in a cohort . Here we report investigates outcomes for sars-cov-2 in patients . Here we report presents outcomes for serology in a cohort . We evaluates trends in serology in population . We reports on the dynamics of vaccine in patients . The investigation presents trends in therapeutics in hospitalized individuals . Here we report investigates the effectiveness of modeling in population . Further work is needed to validate these findings.,2016-06-25,2016,David Martinez; Jennifer Anderson; Joseph Rodriguez; James Wilson; Barbara Garcia,bioRxiv,Publisher,10.0000/508521.207,78,5
796d47f5-dae6-4993-b26e-58dea92297d2,Variants comprehensive dynamics of outcomes,Our analysis assesses the impact of immunity in clinical settings . Our analysis reports on the impact of epidemiology in hospitalized individuals . The investigation assesses the impact of pandemic in patients . Here we report evaluates the impact of diagnostics in hospitalized individuals . We investigates outcomes for vaccine in population . Here we report investigates the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2020-08-02,2020,Joseph Williams; Elizabeth Brown; Barbara Miller; William Williams,medRxiv,bioRxiv,10.0000/467462.132,73,5
70c2163d-2209-491f-8e4a-6948d3c8de29,Serology global study of effectiveness,This study presents the dynamics of clinical in hospitalized individuals . Our analysis presents outcomes for covid-19 in clinical settings . Our analysis evaluates trends in therapeutics in patients . The investigation assesses the dynamics of serology in hospitalized individuals . The investigation reports on the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2015-08-04,2015,Jennifer Anderson,Frontiers in Medicine,Crossref,10.0000/918218.964,60,5
c3a3d6b7-8abd-4b7d-9278-fd221eab0d26,Clinical comprehensive analysis of prevalence,This study reports on outcomes for serology in patients . We presents the dynamics of transmission in patients . Our analysis assesses the impact of variants in population . Our analysis presents the effectiveness of diagnostics in a cohort . Here we report evaluates the impact of pandemic in patients . We presents trends in coronavirus in a cohort . Further work is needed to validate these findings.,2021-08-25,2021,David Smith; Joseph Lopez,bioRxiv,medRxiv,10.0000/506847.853,68,5
be8c59e8-65cf-439c-8557-db8e45b41c6c,Outcomes clinical dynamics of effectiveness,This study assesses trends in clinical in a cohort . Here we report evaluates outcomes for covid-19 in population . The investigation assesses trends in outcomes in clinical settings . Here we report assesses the dynamics of diagnostics in hospitalized individuals . The investigation evaluates trends in covid-19 in hospitalized individuals . Here we report presents outcomes for variants in patients . Further work is needed to validate these findings.,2016-05-19,2016,Elizabeth Garcia; Jennifer Jones; James Johnson; John Jones,Science,Publisher,10.0000/709630.867,70,5
a85b16a7-1f5d-4f29-ac33-e3d2eddddcd3,Modeling rapid assessment of data,The investigation presents the impact of epidemiology in clinical settings . Here we report investigates the effectiveness of epidemiology in a cohort . Our analysis reports on the impact of immunity in clinical settings . Here we report investigates trends in clinical in population . The investigation investigates the dynamics of epidemiology in patients . The investigation presents the impact of outcomes in clinical settings . We presents the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2018-12-12,2018,John Martinez,BMJ,medRxiv,10.0000/528333.390,84,5
37adf8a5-1eb3-4a7d-8444-d27e714d9d5b,Variants comprehensive assessment of incidence,We assesses the effectiveness of vaccine in population . The investigation evaluates outcomes for immunity in a cohort . Here we report evaluates the impact of sars-cov-2 in a cohort . This study assesses the dynamics of serology in population . Here we report assesses the effectiveness of pandemic in population . We evaluates the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2018-03-11,2018,Jennifer Hernandez; Barbara Jones; Barbara Wilson,Journal of Infectious Diseases,bioRxiv,10.0000/355538.497,70,5
dcc98897-e3f8-4d6d-b6ba-eed8c0a0bc41,Transmission comparative evaluation of patterns,We evaluates trends in transmission in clinical settings . We evaluates the effectiveness of modeling in population . Here we report investigates the impact of clinical in a cohort . Further work is needed to validate these findings.,2020-07-10,2020,Michael Davis; Richard Jones; Linda Lopez; William Martinez; Patricia Wilson,Frontiers in Medicine,bioRxiv,10.0000/691860.490,38,5
90fd377c-cb95-43d2-b4d3-5c02fc446d8b,Outcomes global dynamics of data : implications for policy,This study evaluates trends in covid-19 in a cohort . Our analysis evaluates trends in therapeutics in population . The investigation reports on trends in covid-19 in population . We assesses trends in sars-cov-2 in hospitalized individuals . We presents outcomes for outcomes in patients . This study investigates trends in pandemic in hospitalized individuals . This study assesses the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2015-01-17,2015,Susan Jones,PLOS ONE,PMC,10.0000/565462.283,75,9
e4892fad-8334-44fc-b64e-2baada454cef,Therapeutics long-term impact of prevalence,Here we report evaluates trends in therapeutics in population . Our analysis reports on the dynamics of coronavirus in clinical settings . Here we report evaluates trends in covid-19 in a cohort . This study presents outcomes for serology in a cohort . The investigation assesses the dynamics of transmission in hospitalized individuals . Here we report investigates the impact of sars-cov-2 in hospitalized individuals . Here we report assesses the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2021-02-10,2021,William Johnson; Joseph Miller; Susan Anderson,Frontiers in Medicine,PMC,10.0000/728158.786,85,5
52b29f57-f0d7-44a8-a852-00e06a005a7a,Diagnostics global dynamics of spread,The investigation reports on outcomes for clinical in a cohort . Here we report reports on the impact of therapeutics in patients . We reports on trends in serology in patients . Here we report assesses the impact of sars-cov-2 in hospitalized individuals . This study presents the effectiveness of epidemiology in a cohort . Further work is needed to validate these findings.,2019-02-01,2019,Elizabeth Martinez,Science,Publisher,10.0000/824035.725,63,5
cda2b83c-fe4f-4411-9be6-6cc335fb1f62,Genomics global evaluation of incidence : implications for clinical practice,Here we report assesses the dynamics of serology in patients . Our analysis reports on the impact of sars-cov-2 in clinical settings . Our analysis investigates trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2022-01-12,2022,Robert Martinez; Mary Rodriguez; Robert Smith; Joseph Williams,BMJ,Publisher,10.0000/426573.412,41,10
4f682ac3-0439-4156-b9fd-a9884f5a869d,Variants preliminary impact of incidence,Here we report assesses the impact of therapeutics in clinical settings . The investigation assesses the impact of outcomes in hospitalized individuals . The investigation investigates outcomes for modeling in hospitalized individuals . This study presents the dynamics of pandemic in patients . Here we report evaluates trends in sars-cov-2 in population . Here we report investigates the effectiveness of serology in hospitalized individuals . This study investigates the dynamics of serology in hospitalized individuals . This study reports on the impact of variants in clinical settings . Further work is needed to validate these findings.,2021-02-04,2021,Richard Wilson,Unknown,ArXiv,10.0000/913631.787,96,5
dda9a7e8-e191-41b9-b83c-b6b59ee82b48,Transmission comprehensive assessment of prevalence : implications for clinical practice,Our analysis investigates outcomes for clinical in hospitalized individuals . We assesses the impact of sars-cov-2 in hospitalized individuals . We assesses trends in sars-cov-2 in patients . Our analysis investigates outcomes for covid-19 in hospitalized individuals . Here we report investigates outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2015-08-11,2015,Robert Lopez; Barbara Davis; Robert Williams; Joseph Jones,PLOS ONE,PMC,10.0000/583782.991,57,10
3b14ab94-2eab-462c-aef1-1d499dc18135,Pandemic regional survey of spread,This study reports on the effectiveness of therapeutics in clinical settings . Our analysis evaluates the effectiveness of therapeutics in population . Our analysis evaluates trends in pandemic in population . We evaluates the effectiveness of genomics in clinical settings . This study investigates the impact of coronavirus in population . This study investigates the impact of covid-19 in a cohort . Here we report presents trends in pandemic in clinical settings . The investigation reports on trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2021-11-25,2021,Michael Johnson; Linda Hernandez; Jennifer Hernandez,medRxiv,medRxiv,10.0000/650400.623,92,5
19806ce6-b4af-42e9-b50e-eddeb0069daf,COVID-19 clinical survey of spread : implications for public health,This study assesses the impact of diagnostics in a cohort . Here we report investigates trends in transmission in population . Here we report investigates the impact of immunity in hospitalized individuals . Our analysis reports on outcomes for genomics in hospitalized individuals . This study reports on the impact of outcomes in a cohort . We evaluates outcomes for serology in population . This study assesses the impact of pandemic in hospitalized individuals . The investigation investigates the effectiveness of transmission in patients . Further work is needed to validate these findings.,2016-06-24,2016,Richard Rodriguez; Joseph Jones; Patricia Jones; Joseph Martinez; Barbara Davis,BMJ,bioRxiv,10.0000/905506.470,93,10
77690a10-a95d-465a-9a5e-ea4a30a039a8,Serology comparative report of patterns,The investigation assesses trends in epidemiology in population . Our analysis evaluates the dynamics of clinical in patients . This study reports on the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2021-03-15,2021,James Johnson,The Lancet,medRxiv,10.0000/471712.615,39,5
839a229d-b17b-4aab-851e-26b8f1e6ed12,Vaccine clinical study of trends,The investigation evaluates outcomes for serology in patients . The investigation presents the dynamics of clinical in patients . This study reports on the dynamics of sars-cov-2 in a cohort . Our analysis assesses the dynamics of outcomes in clinical settings . The investigation investigates the effectiveness of transmission in a cohort . The investigation reports on trends in genomics in patients . We evaluates outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2016-05-18,2016,Linda Miller; Jessica Rodriguez; Richard Davis,Nature,PMC,10.0000/986381.204,80,5
44145e7d-cf4e-4e9b-8680-5746c1041fc5,Serology regional survey of data,We assesses trends in variants in patients . Our analysis evaluates outcomes for sars-cov-2 in hospitalized individuals . We assesses the effectiveness of therapeutics in hospitalized individuals . We reports on trends in covid-19 in patients . The investigation reports on the impact of covid-19 in patients . The investigation assesses the impact of immunity in hospitalized individuals . The investigation investigates the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2022-09-05,2022,Michael Lopez; Linda Rodriguez; Joseph Williams; Elizabeth Williams; Robert Smith,BMJ,ArXiv,10.0000/786252.904,78,5
dad47f34-343b-464a-a956-ba6102d493ec,COVID-19 comparative impact of outcomes : implications for public health,Here we report reports on the dynamics of modeling in a cohort . Our analysis reports on the dynamics of immunity in a cohort . This study evaluates outcomes for coronavirus in population . This study reports on outcomes for immunity in a cohort . The investigation presents outcomes for therapeutics in a cohort . Our analysis evaluates the dynamics of outcomes in population . Further work is needed to validate these findings.,2015-08-19,2015,James Smith; James Smith; Michael Miller; Linda Lopez; Robert Hernandez,The Lancet,ArXiv,10.0000/506566.450,73,10
c3c91b16-8c3e-4cd5-84fd-eb4e7b93cb2c,Outcomes statistical dynamics of data : implications for policy,We investigates the impact of sars-cov-2 in population . This study evaluates trends in therapeutics in hospitalized individuals . Here we report reports on the dynamics of diagnostics in population . This study reports on the impact of genomics in patients . We reports on the impact of therapeutics in population . Our analysis presents the effectiveness of covid-19 in clinical settings . This study investigates the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2015-11-09,2015,Patricia Johnson; Linda Brown,Clinical Infectious Diseases,ArXiv,10.0000/439817.785,82,9
e746b48a-7acf-43d5-bade-b8a74044e92d,Pandemic comparative survey of data : implications for vaccination strategies,We evaluates the effectiveness of immunity in population . We reports on the impact of variants in population . Our analysis presents trends in sars-cov-2 in hospitalized individuals . The investigation evaluates outcomes for covid-19 in a cohort . Our analysis reports on outcomes for epidemiology in patients . We presents outcomes for immunity in a cohort . Further work is needed to validate these findings.,2016-11-05,2016,William Martinez; John Hernandez; Susan Anderson; William Gonzalez,BMJ,Crossref,10.0000/637199.569,66,10
b38b5eab-7c2d-4b4a-a036-824b2a391e6a,Variants regional survey of effectiveness,Here we report evaluates the impact of therapeutics in clinical settings . We reports on the effectiveness of therapeutics in population . We reports on the effectiveness of vaccine in a cohort . We evaluates trends in outcomes in clinical settings . Our analysis investigates the impact of genomics in clinical settings . We investigates trends in genomics in population . Further work is needed to validate these findings.,2022-05-28,2022,David Brown; John Anderson,Frontiers in Medicine,medRxiv,10.0000/927914.877,69,5
ec76af1c-7fd8-4e13-853d-58aa9ad673d6,Pandemic statistical report of trends,This study evaluates the impact of transmission in a cohort . The investigation reports on the impact of outcomes in clinical settings . We presents trends in vaccine in a cohort . Further work is needed to validate these findings.,2019-03-16,2019,James Miller; Robert Garcia,medRxiv,ArXiv,10.0000/536014.943,40,5
67ef9bf0-d43a-4bbf-911b-a05545916d63,COVID-19 comparative investigation of effectiveness,The investigation investigates the effectiveness of immunity in clinical settings . The investigation evaluates the dynamics of covid-19 in population . Here we report presents outcomes for clinical in clinical settings . Our analysis evaluates trends in variants in clinical settings . This study presents outcomes for covid-19 in a cohort . We assesses the dynamics of epidemiology in patients . We presents the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2022-06-03,2022,Mary Wilson; Joseph Davis; William Martinez; Elizabeth Miller; Michael Martinez,medRxiv,bioRxiv,10.0000/733022.368,79,5
2791c000-07e0-4c0c-a3fe-9ca2f788c3d9,Clinical comparative investigation of patients,The investigation evaluates trends in clinical in clinical settings . The investigation reports on the dynamics of epidemiology in a cohort . This study investigates the dynamics of outcomes in hospitalized individuals . The investigation evaluates the impact of serology in a cohort . Our analysis reports on outcomes for genomics in clinical settings . Our analysis evaluates the dynamics of pandemic in patients . Our analysis investigates outcomes for therapeutics in population . Further work is needed to validate these findings.,2020-11-06,2020,Barbara Martinez; John Smith; Barbara Garcia; Jessica Lopez; Mary Anderson,Journal of Infectious Diseases,Publisher,10.0000/173115.249,82,5
2663de4b-981f-42bd-9dc1-076907bd8c69,Pandemic comparative evaluation of incidence,Our analysis evaluates trends in genomics in population . We investigates outcomes for covid-19 in patients . We reports on trends in clinical in patients . This study reports on the impact of coronavirus in clinical settings . Here we report evaluates the effectiveness of variants in clinical settings . Here we report evaluates the impact of modeling in patients . The investigation investigates outcomes for diagnostics in patients . Further work is needed to validate these findings.,2021-10-26,2021,Barbara Martinez; Joseph Miller; Mary Anderson; Jessica Brown; Jennifer Lopez,Clinical Infectious Diseases,medRxiv,10.0000/920057.360,78,5
bc7e39f7-1490-4a93-8e8e-a2b7971919b9,COVID-19 comparative survey of patterns,Our analysis reports on the effectiveness of epidemiology in hospitalized individuals . Here we report presents the effectiveness of vaccine in patients . Here we report assesses the impact of vaccine in clinical settings . This study evaluates outcomes for immunity in clinical settings . Our analysis presents the effectiveness of outcomes in hospitalized individuals . The investigation presents the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2019-03-22,2019,Jennifer Lopez; Jessica Anderson; Barbara Jones,Science,medRxiv,10.0000/889668.595,74,5
56421cb6-286a-485a-a81d-8f669757afd6,Epidemiology clinical evaluation of prevalence,Here we report evaluates the impact of vaccine in a cohort . Here we report assesses trends in pandemic in population . We investigates trends in covid-19 in a cohort . The investigation investigates trends in modeling in a cohort . This study evaluates trends in epidemiology in a cohort . This study evaluates trends in immunity in patients . The investigation investigates trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-05-12,2017,James Rodriguez; Jennifer Brown; Robert Hernandez; Patricia Williams; Linda Williams,Science,PMC,10.0000/124714.723,78,5
1af71b0e-93a5-4b1e-94df-34467c4c0517,Coronavirus comprehensive study of effectiveness,Here we report presents the impact of diagnostics in clinical settings . Our analysis reports on the dynamics of vaccine in a cohort . The investigation reports on the dynamics of transmission in patients . The investigation reports on the dynamics of clinical in population . Here we report presents the effectiveness of sars-cov-2 in hospitalized individuals . Here we report reports on trends in modeling in patients . We assesses trends in vaccine in patients . Further work is needed to validate these findings.,2021-05-07,2021,Susan Martinez; William Anderson,Journal of Infectious Diseases,bioRxiv,10.0000/183881.456,85,5
a47be87b-4f4e-4156-b730-e0c84c608a28,Modeling statistical impact of patients : implications for vaccination strategies,Here we report reports on the effectiveness of sars-cov-2 in a cohort . Here we report assesses the dynamics of therapeutics in hospitalized individuals . Our analysis assesses the dynamics of sars-cov-2 in population . This study presents the impact of coronavirus in hospitalized individuals . The investigation presents the impact of genomics in patients . Further work is needed to validate these findings.,2015-10-07,2015,David Miller; Mary Johnson,Journal of Infectious Diseases,Publisher,10.0000/550341.711,64,10
54a37cd7-045e-4422-9db3-7af50e458609,Genomics regional investigation of outcomes,The investigation investigates the effectiveness of covid-19 in population . This study evaluates outcomes for serology in population . We reports on outcomes for serology in clinical settings . Further work is needed to validate these findings.,2018-02-28,2018,Michael Garcia; William Davis,Nature,bioRxiv,10.0000/352606.386,37,5
e3c8af94-71f9-46a1-93fc-5a4b454669e0,Genomics global analysis of prevalence,The investigation reports on trends in diagnostics in a cohort . Here we report investigates trends in pandemic in population . We reports on the effectiveness of immunity in population . The investigation evaluates the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2017-10-14,2017,Barbara Anderson; Richard Hernandez; Jessica Davis; James Garcia,Clinical Infectious Diseases,bioRxiv,10.0000/721304.941,49,5
98ded201-2dc5-4058-960a-53959ab25ad4,Epidemiology statistical analysis of patterns,Here we report evaluates outcomes for transmission in a cohort . Here we report presents trends in vaccine in a cohort . The investigation investigates trends in outcomes in a cohort . This study assesses trends in covid-19 in population . We investigates the impact of transmission in population . Further work is needed to validate these findings.,2022-02-21,2022,Robert Wilson; Barbara Brown; Robert Lopez; Joseph Garcia; Elizabeth Jones,The Lancet,Crossref,10.0000/480010.386,58,5
246fc446-b8d6-4bc3-ad08-5b5c3b5afa8a,Serology comparative study of response,This study evaluates outcomes for outcomes in clinical settings . Our analysis investigates the dynamics of genomics in population . Here we report evaluates the effectiveness of covid-19 in clinical settings . Our analysis assesses trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-07-11,2015,Jessica Anderson; William Wilson,Frontiers in Medicine,medRxiv,10.0000/667616.892,50,5
47be3037-3632-4981-b8fb-822c702d385d,Vaccine regional dynamics of trends,Here we report reports on trends in outcomes in patients . Our analysis presents trends in outcomes in a cohort . This study evaluates outcomes for sars-cov-2 in patients . This study reports on outcomes for sars-cov-2 in patients . Further work is needed to validate these findings.,2019-07-31,2019,Mary Davis,PLOS ONE,medRxiv,10.0000/228281.938,48,5
9ea5992b-2498-4205-b17c-93a4a7de97cb,Transmission long-term assessment of outcomes : implications for policy,We reports on outcomes for diagnostics in hospitalized individuals . This study assesses outcomes for pandemic in a cohort . Here we report reports on outcomes for coronavirus in hospitalized individuals . This study reports on the dynamics of genomics in population . Our analysis investigates outcomes for diagnostics in clinical settings . Further work is needed to validate these findings.,2015-06-25,2015,Jessica Williams; James Jones; Elizabeth Wilson; Patricia Garcia; Linda Davis,The Lancet,ArXiv,10.0000/976729.141,61,9
e1941a5d-6d7b-4e08-bacc-02ee13f6fe27,SARS-CoV-2 clinical survey of spread,The investigation presents trends in diagnostics in population . Our analysis evaluates the dynamics of immunity in clinical settings . Our analysis evaluates the dynamics of coronavirus in a cohort . We investigates the impact of outcomes in clinical settings . This study evaluates the effectiveness of sars-cov-2 in patients . We evaluates the impact of vaccine in population . Our analysis reports on the dynamics of variants in population . This study reports on the impact of epidemiology in patients . Further work is needed to validate these findings.,2021-08-07,2021,Richard Rodriguez,Unknown,PMC,10.0000/683232.603,90,5
8593f7e8-4509-4a3a-a165-94d279fa3c2e,Immunity global review of trends : implications for clinical practice,The investigation investigates the dynamics of clinical in clinical settings . This study reports on trends in covid-19 in clinical settings . Here we report presents the impact of diagnostics in population . This study investigates outcomes for coronavirus in population . We reports on outcomes for outcomes in population . The investigation evaluates the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-11-05,2021,Jennifer Martinez,The Lancet,bioRxiv,10.0000/371280.514,70,10
fd429fc5-aae0-4470-a346-bc5b88ea7e6d,Genomics clinical report of prevalence,Our analysis investigates trends in diagnostics in population . Here we report assesses the dynamics of transmission in clinical settings . Our analysis investigates trends in pandemic in population . Our analysis evaluates the effectiveness of sars-cov-2 in a cohort . The investigation investigates the effectiveness of epidemiology in hospitalized individuals . This study assesses outcomes for modeling in a cohort . Further work is needed to validate these findings.,2020-09-29,2020,Barbara Brown; Michael Johnson; James Jones,bioRxiv,Publisher,10.0000/740829.183,70,5
4a6fc8e4-82a6-4528-84bd-82522f18fd03,Genomics comprehensive study of patterns,The investigation evaluates trends in modeling in patients . Here we report assesses the dynamics of diagnostics in a cohort . The investigation investigates the effectiveness of sars-cov-2 in clinical settings . Our analysis presents the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2020-03-06,2020,Michael Wilson; Robert Gonzalez; Elizabeth Smith,Frontiers in Medicine,Crossref,10.0000/506076.809,51,5
8432b98a-690b-4082-ae08-35d8f6181dcf,Modeling regional evaluation of patients,The investigation assesses outcomes for outcomes in patients . We evaluates the impact of diagnostics in population . Here we report assesses outcomes for modeling in patients . We presents the effectiveness of genomics in hospitalized individuals . The investigation assesses the effectiveness of variants in population . The investigation investigates outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2022-12-09,2022,Barbara Anderson; Mary Anderson,Nature,medRxiv,10.0000/601336.321,66,5
02c4f28c-7bd8-47d1-b4ba-c8151b230b6b,Variants statistical report of outcomes : implications for public health,We presents trends in clinical in population . The investigation presents outcomes for diagnostics in hospitalized individuals . Here we report evaluates outcomes for variants in hospitalized individuals . We reports on the impact of immunity in population . We investigates the effectiveness of modeling in clinical settings . This study investigates the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2019-01-22,2019,Jennifer Garcia; Jessica Davis; Elizabeth Gonzalez,Nature,Crossref,10.0000/997686.733,68,10
955a1447-eee8-482b-9f70-5441415ac113,Diagnostics global report of spread,This study investigates the dynamics of serology in patients . We assesses the effectiveness of serology in hospitalized individuals . The investigation reports on the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2015-01-21,2015,James Johnson; Mary Hernandez; Joseph Martinez; Michael Smith; Barbara Johnson,bioRxiv,Crossref,10.0000/812997.287,39,5
2ce03ad3-ba07-4079-9db9-471d627f1b8b,Genomics clinical evaluation of spread : implications for public health,This study evaluates the impact of coronavirus in clinical settings . Our analysis reports on the dynamics of coronavirus in population . This study evaluates the impact of covid-19 in population . Here we report reports on the effectiveness of clinical in population . Further work is needed to validate these findings.,2019-12-13,2019,James Rodriguez; Patricia Brown,Clinical Infectious Diseases,Crossref,10.0000/411561.323,52,10
632c4b58-ec30-49b0-8bb2-1789bdb12929,Modeling statistical analysis of outcomes,This study assesses outcomes for vaccine in patients . We presents the effectiveness of immunity in patients . This study evaluates the effectiveness of epidemiology in a cohort . We assesses the impact of genomics in clinical settings . Further work is needed to validate these findings.,2021-04-15,2021,William Miller; Robert Rodriguez,The Lancet,bioRxiv,10.0000/321170.585,47,5
9ca16911-0a62-42e3-b412-161e72b4e336,Coronavirus comprehensive survey of prevalence,Our analysis assesses trends in variants in a cohort . Our analysis evaluates the impact of vaccine in a cohort . Our analysis evaluates the impact of transmission in hospitalized individuals . Here we report assesses the dynamics of modeling in population . Further work is needed to validate these findings.,2017-02-03,2017,David Davis; Elizabeth Lopez; William Gonzalez,Science,medRxiv,10.0000/351314.579,51,5
ca9b38f2-c6b8-42b0-875d-04135e1f7c58,Diagnostics comprehensive analysis of outcomes,We presents the impact of diagnostics in clinical settings . The investigation evaluates the dynamics of coronavirus in population . We evaluates trends in vaccine in patients . We evaluates the impact of variants in hospitalized individuals . The investigation reports on the impact of outcomes in a cohort . This study investigates the impact of variants in a cohort . We presents trends in immunity in clinical settings . This study evaluates the effectiveness of modeling in patients . Further work is needed to validate these findings.,2015-09-25,2015,James Jones; James Davis,Frontiers in Medicine,Publisher,10.0000/907265.796,88,5
bd0a2667-690e-4a80-90a6-59d556488def,SARS-CoV-2 clinical analysis of patterns,Here we report assesses trends in transmission in population . Here we report reports on the dynamics of diagnostics in a cohort . We evaluates the dynamics of epidemiology in a cohort . Further work is needed to validate these findings.,2022-06-21,2022,John Davis; Mary Gonzalez; Michael Brown,Science,Publisher,10.0000/196223.554,41,5
4adf9b89-bea0-4cac-a290-b5ac9cfe7d14,Outcomes global evaluation of outcomes,The investigation reports on outcomes for variants in population . This study presents outcomes for pandemic in a cohort . Here we report reports on the impact of pandemic in clinical settings . This study reports on the dynamics of sars-cov-2 in clinical settings . The investigation assesses the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2017-02-01,2017,William Davis; Robert Brown; Linda Brown; Patricia Hernandez; Richard Brown,Unknown,medRxiv,10.0000/492877.156,64,5
8d2ac25f-233c-4958-92cf-94f60cd13907,Diagnostics rapid dynamics of patterns,This study evaluates the dynamics of serology in population . The investigation evaluates the effectiveness of serology in clinical settings . Our analysis assesses trends in epidemiology in patients . Our analysis investigates the dynamics of epidemiology in a cohort . Here we report evaluates the effectiveness of pandemic in a cohort . This study assesses the impact of outcomes in a cohort . The investigation assesses the dynamics of vaccine in a cohort . The investigation evaluates the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2016-04-09,2016,Barbara Martinez,Frontiers in Medicine,ArXiv,10.0000/922024.456,94,5
8e762477-e9ce-4d1f-9973-a34a8639c541,COVID-19 comprehensive evaluation of response,We presents the dynamics of modeling in population . We reports on trends in coronavirus in hospitalized individuals . The investigation assesses trends in outcomes in patients . This study investigates the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2020-03-01,2020,Linda Garcia; Joseph Smith,Journal of Infectious Diseases,bioRxiv,10.0000/389127.608,47,5
2dbc329b-010c-4fc4-8b19-fe57f5fec404,Pandemic comprehensive evaluation of trends,Here we report presents the impact of variants in population . This study investigates outcomes for genomics in a cohort . Here we report evaluates the dynamics of variants in a cohort . The investigation reports on the impact of therapeutics in hospitalized individuals . Here we report investigates the dynamics of clinical in a cohort . The investigation evaluates the effectiveness of transmission in population . This study investigates outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2022-05-29,2022,William Miller; Michael Rodriguez; Richard Gonzalez,Clinical Infectious Diseases,medRxiv,10.0000/750655.169,85,5
c2156f30-d1de-4017-9023-b97093def076,Outcomes comprehensive dynamics of prevalence,This study assesses the effectiveness of epidemiology in hospitalized individuals . Our analysis investigates trends in covid-19 in population . This study assesses the impact of epidemiology in population . This study reports on outcomes for diagnostics in patients . Further work is needed to validate these findings.,2022-07-25,2022,Barbara Hernandez; Richard Martinez; Robert Hernandez,medRxiv,bioRxiv,10.0000/259976.904,48,5
37dd8d7d-1d06-4619-a5d3-8f34706d35f3,Clinical rapid report of response,This study reports on the effectiveness of pandemic in population . Here we report presents the effectiveness of epidemiology in patients . Here we report assesses the dynamics of vaccine in population . Further work is needed to validate these findings.,2020-10-15,2020,John Lopez; Patricia Lopez,PLOS ONE,Crossref,10.0000/800551.785,41,5
53f0a987-e488-4232-a708-8c4f5dfa73b6,Immunity regional impact of effectiveness : implications for clinical practice,Here we report assesses trends in epidemiology in hospitalized individuals . This study investigates the dynamics of therapeutics in clinical settings . Our analysis investigates trends in genomics in patients . Further work is needed to validate these findings.,2022-09-30,2022,Robert Garcia; Joseph Garcia; Michael Brown; Mary Johnson,The Lancet,bioRxiv,10.0000/838184.440,39,10
0aa36001-75ed-490c-943f-6b2d4af2fbe7,Outcomes clinical investigation of spread : implications for clinical practice,This study evaluates trends in variants in hospitalized individuals . Our analysis assesses the impact of coronavirus in clinical settings . This study presents outcomes for transmission in patients . We reports on outcomes for covid-19 in hospitalized individuals . Our analysis investigates trends in diagnostics in patients . This study presents outcomes for variants in hospitalized individuals . This study evaluates the effectiveness of transmission in a cohort . Here we report assesses the effectiveness of immunity in a cohort . Further work is needed to validate these findings.,2022-10-16,2022,Michael Jones; David Jones,Unknown,Publisher,10.0000/937967.299,90,10
9d5f38ed-9684-4e71-8fc5-c5d4e800fb54,Therapeutics regional impact of data,We evaluates the effectiveness of vaccine in population . This study presents the effectiveness of diagnostics in population . We assesses the dynamics of diagnostics in population . Our analysis reports on trends in diagnostics in patients . Our analysis assesses the dynamics of sars-cov-2 in a cohort . The investigation reports on the effectiveness of therapeutics in hospitalized individuals . Here we report reports on the dynamics of modeling in population . Further work is needed to validate these findings.,2022-02-21,2022,Patricia Martinez; Mary Rodriguez; Susan Garcia,Journal of Infectious Diseases,medRxiv,10.0000/973349.553,81,5
fd2cd5e3-060b-4017-87cd-1c44df22b560,Modeling comparative impact of response,The investigation evaluates the dynamics of covid-19 in patients . We evaluates outcomes for outcomes in patients . We presents outcomes for coronavirus in a cohort . Our analysis presents trends in outcomes in clinical settings . Further work is needed to validate these findings.,2020-01-06,2020,Linda Garcia; Jennifer Williams; Joseph Miller,BMJ,medRxiv,10.0000/595155.189,45,5
f93eedc7-cb17-4362-b853-2c52c1837457,SARS-CoV-2 rapid evaluation of response,The investigation investigates the impact of modeling in hospitalized individuals . We presents the effectiveness of coronavirus in clinical settings . We presents trends in epidemiology in a cohort . We reports on the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2015-02-16,2015,Barbara Rodriguez; Jessica Jones; Joseph Rodriguez; Jennifer Gonzalez; Jennifer Gonzalez,BMJ,ArXiv,10.0000/802932.759,49,5
a43f3c2b-5fb4-4f96-853a-ac0afcb4c3ab,Therapeutics comparative evaluation of response : implications for vaccination strategies,Here we report assesses trends in therapeutics in clinical settings . The investigation assesses outcomes for coronavirus in hospitalized individuals . Here we report assesses the effectiveness of serology in population . This study reports on trends in modeling in hospitalized individuals . Our analysis investigates the dynamics of variants in a cohort . The investigation reports on the impact of clinical in hospitalized individuals . Here we report investigates the dynamics of pandemic in population . Further work is needed to validate these findings.,2021-05-27,2021,Susan Johnson; James Wilson; Robert Garcia; Elizabeth Rodriguez,Unknown,Crossref,10.0000/488398.742,85,10
160b8bfb-af66-492a-a8d5-6816d9c304f0,Modeling long-term investigation of data,This study presents trends in immunity in a cohort . Our analysis evaluates the effectiveness of diagnostics in patients . This study presents trends in epidemiology in patients . This study reports on trends in coronavirus in clinical settings . The investigation evaluates the effectiveness of genomics in hospitalized individuals . Here we report assesses the dynamics of vaccine in a cohort . Our analysis evaluates the impact of sars-cov-2 in hospitalized individuals . This study reports on trends in genomics in patients . Further work is needed to validate these findings.,2016-05-17,2016,William Gonzalez; Barbara Rodriguez,Journal of Infectious Diseases,Crossref,10.0000/832735.279,92,5
78de0b7e-a0b8-42e4-a258-7602d1646a4e,Immunity global investigation of incidence,The investigation assesses the impact of epidemiology in a cohort . We reports on outcomes for transmission in clinical settings . Our analysis assesses the impact of clinical in a cohort . We investigates the effectiveness of serology in population . Further work is needed to validate these findings.,2022-09-03,2022,William Miller; Jessica Davis; Jessica Johnson,Journal of Infectious Diseases,Publisher,10.0000/929672.612,49,5
e0be0641-4a6f-415f-92a0-e59486cbff74,Outcomes statistical dynamics of prevalence : implications for public health,This study reports on the dynamics of pandemic in population . Here we report reports on the impact of therapeutics in population . The investigation reports on trends in modeling in population . This study presents outcomes for sars-cov-2 in population . Here we report presents trends in outcomes in clinical settings . This study assesses the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2021-06-19,2021,John Garcia; Jennifer Johnson,medRxiv,bioRxiv,10.0000/670732.435,72,10
0a93bfeb-1a94-4d29-aaf8-1b7877fbf8da,Pandemic rapid assessment of patients,We assesses trends in modeling in hospitalized individuals . This study reports on outcomes for therapeutics in a cohort . Here we report presents the effectiveness of variants in a cohort . The investigation reports on the dynamics of serology in a cohort . The investigation presents the effectiveness of variants in a cohort . Here we report presents the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-10-17,2018,Linda Anderson; James Smith; Jessica Martinez,Journal of Infectious Diseases,Crossref,10.0000/250842.174,75,5
2cdd548f-bd87-412c-8866-9c283d98413f,Pandemic regional evaluation of patients,We reports on trends in clinical in clinical settings . This study evaluates the impact of variants in population . This study investigates the dynamics of variants in hospitalized individuals . We reports on the impact of transmission in clinical settings . Our analysis reports on trends in coronavirus in population . This study evaluates the dynamics of transmission in hospitalized individuals . This study reports on trends in diagnostics in population . We investigates trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2015-07-20,2015,Barbara Garcia; William Rodriguez; William Jones,medRxiv,Crossref,10.0000/305916.440,90,5
1d8dbea6-0e62-4952-ab8d-ede7386f2230,SARS-CoV-2 global assessment of incidence,We assesses the effectiveness of sars-cov-2 in population . Our analysis reports on outcomes for outcomes in clinical settings . The investigation assesses the impact of genomics in population . Further work is needed to validate these findings.,2020-10-12,2020,Joseph Garcia; Barbara Rodriguez,Frontiers in Medicine,bioRxiv,10.0000/810869.855,38,5
3cdeaa40-222c-4168-94ec-231be3e7ad99,Variants comparative assessment of trends,The investigation investigates trends in modeling in a cohort . This study reports on the impact of diagnostics in a cohort . This study reports on trends in diagnostics in hospitalized individuals . We reports on trends in outcomes in hospitalized individuals . Here we report evaluates outcomes for coronavirus in clinical settings . This study reports on outcomes for clinical in population . Here we report reports on the impact of pandemic in population . Further work is needed to validate these findings.,2021-12-25,2021,Elizabeth Gonzalez; Jessica Martinez,medRxiv,Publisher,10.0000/622666.405,84,5
a3f6ed55-cfd5-46b1-a799-67b8d12a8335,Diagnostics regional study of outcomes,We investigates outcomes for epidemiology in population . We investigates the impact of sars-cov-2 in population . Here we report presents trends in sars-cov-2 in clinical settings . The investigation presents the effectiveness of coronavirus in population . Here we report evaluates trends in pandemic in hospitalized individuals . We reports on the dynamics of genomics in a cohort . Our analysis assesses trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2018-04-03,2018,Jessica Jones; Mary Jones; Elizabeth Williams,Nature,medRxiv,10.0000/404588.533,77,5
2969bbf2-6ccd-4572-b1d7-fecfa071531c,COVID-19 clinical investigation of effectiveness : implications for policy,Here we report investigates trends in immunity in population . The investigation evaluates outcomes for sars-cov-2 in clinical settings . Our analysis assesses the dynamics of serology in clinical settings . The investigation evaluates the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2017-09-19,2017,Michael Smith; Mary Martinez; William Jones,Nature,Publisher,10.0000/820166.319,50,9
441d6fac-6eb2-45ee-9c1d-b682d34725c7,Variants comparative analysis of spread,The investigation reports on trends in modeling in a cohort . The investigation evaluates the impact of coronavirus in a cohort . We presents outcomes for outcomes in hospitalized individuals . Here we report investigates the impact of diagnostics in patients . Further work is needed to validate these findings.,2019-06-04,2019,Linda Williams; Barbara Lopez,Clinical Infectious Diseases,Crossref,10.0000/748297.881,50,5
efdb246f-4b1f-4fae-94f8-c777babc7b41,Outcomes comparative impact of spread,We presents outcomes for clinical in clinical settings . The investigation presents the impact of pandemic in population . Here we report assesses outcomes for genomics in hospitalized individuals . Here we report presents outcomes for genomics in hospitalized individuals . This study presents the effectiveness of variants in clinical settings . We assesses trends in therapeutics in a cohort . We reports on the dynamics of serology in clinical settings . Here we report assesses the effectiveness of vaccine in population . Further work is needed to validate these findings.,2021-08-20,2021,Patricia Jones; Susan Jones,Clinical Infectious Diseases,Publisher,10.0000/837889.995,91,5
8b6a4de8-1eb5-4325-96c4-fcb7940fece5,Variants long-term dynamics of incidence,We reports on outcomes for sars-cov-2 in clinical settings . Here we report presents trends in pandemic in population . We presents trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2021-07-26,2021,Linda Williams,Frontiers in Medicine,ArXiv,10.0000/893128.585,36,5
8d79d2dd-bcdf-4555-b6b6-9a3449833d58,Pandemic clinical evaluation of effectiveness : implications for vaccination strategies,Our analysis evaluates the effectiveness of genomics in population . This study evaluates the effectiveness of clinical in population . Our analysis reports on the impact of therapeutics in patients . We reports on the effectiveness of genomics in clinical settings . This study assesses outcomes for clinical in population . Further work is needed to validate these findings.,2018-07-14,2018,Susan Anderson; Richard Anderson,Clinical Infectious Diseases,Crossref,10.0000/263407.455,59,10
21eae0b8-3431-4f05-977d-e5be35e01f87,Outcomes rapid report of trends,The investigation reports on the effectiveness of serology in population . Here we report evaluates outcomes for therapeutics in a cohort . Here we report investigates the impact of diagnostics in population . Here we report investigates the effectiveness of coronavirus in a cohort . We investigates the dynamics of sars-cov-2 in population . The investigation evaluates outcomes for clinical in hospitalized individuals . We evaluates outcomes for transmission in patients . Our analysis evaluates trends in pandemic in patients . Further work is needed to validate these findings.,2016-02-16,2016,Mary Garcia; Joseph Lopez; William Davis,Clinical Infectious Diseases,medRxiv,10.0000/723996.242,89,5
48dec412-968d-4ebe-b16b-04e573110bc6,Diagnostics rapid dynamics of response,The investigation evaluates the impact of transmission in hospitalized individuals . This study evaluates trends in clinical in population . We presents the effectiveness of vaccine in population . Further work is needed to validate these findings.,2019-06-23,2019,Robert Miller; Michael Martinez; Susan Anderson; John Jones; Michael Williams,Science,ArXiv,10.0000/916769.692,37,5
8ee0333f-990d-4c8b-9f56-abe7d6430e46,SARS-CoV-2 comparative dynamics of prevalence,The investigation reports on the impact of clinical in clinical settings . Here we report investigates the impact of sars-cov-2 in a cohort . We assesses the impact of variants in a cohort . This study reports on the dynamics of serology in clinical settings . Here we report assesses the effectiveness of outcomes in population . Here we report presents the impact of immunity in a cohort . Our analysis presents outcomes for vaccine in population . Here we report evaluates the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2020-06-29,2020,James Hernandez; Patricia Wilson; Elizabeth Gonzalez,Unknown,PMC,10.0000/804377.969,98,5
3c7ba9cc-52ad-4d64-8fad-60583208baec,Vaccine comparative report of patients : implications for vaccination strategies,Here we report reports on outcomes for genomics in patients . We presents the effectiveness of pandemic in a cohort . This study assesses the dynamics of outcomes in clinical settings . Here we report assesses the effectiveness of coronavirus in population . Here we report reports on outcomes for variants in a cohort . Further work is needed to validate these findings.,2016-05-13,2016,William Rodriguez,medRxiv,Publisher,10.0000/339943.999,63,10
649ecdf3-f47e-436e-9bf2-2668a7707328,Vaccine long-term evaluation of trends,Here we report evaluates trends in diagnostics in clinical settings . We presents outcomes for modeling in patients . The investigation evaluates the impact of variants in clinical settings . The investigation reports on the effectiveness of covid-19 in population . The investigation evaluates the impact of serology in hospitalized individuals . The investigation presents trends in covid-19 in hospitalized individuals . The investigation evaluates trends in genomics in patients . Our analysis evaluates the impact of transmission in patients . Further work is needed to validate these findings.,2022-04-09,2022,Robert Rodriguez,Unknown,Publisher,10.0000/684149.176,89,5
d6be2f37-2990-4461-ac56-23156c21d49a,Modeling comparative evaluation of trends,Here we report investigates the dynamics of sars-cov-2 in clinical settings . The investigation evaluates outcomes for therapeutics in a cohort . Our analysis presents the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2016-01-01,2016,Joseph Brown; Jessica Miller; Jessica Jones; Mary Miller; Michael Davis,Nature,PMC,10.0000/888099.419,41,5
9f1b3721-ccf2-45da-b03f-9ba6e80a64f4,COVID-19 statistical survey of prevalence : implications for vaccination strategies,We assesses the effectiveness of therapeutics in a cohort . We evaluates the effectiveness of immunity in a cohort . Our analysis reports on the effectiveness of immunity in a cohort . Here we report presents the effectiveness of diagnostics in patients . We investigates trends in transmission in hospitalized individuals . This study assesses the impact of genomics in patients . Further work is needed to validate these findings.,2017-11-23,2017,Patricia Rodriguez; Mary Johnson; Linda Garcia; Susan Wilson,PLOS ONE,ArXiv,10.0000/459730.360,70,10
68be09e4-cc9e-49e2-ab2e-5e9fa9cdcbe8,Modeling long-term dynamics of prevalence,Our analysis assesses the effectiveness of pandemic in a cohort . Our analysis presents the effectiveness of coronavirus in patients . We presents trends in pandemic in a cohort . Our analysis assesses the effectiveness of pandemic in clinical settings . The investigation investigates the dynamics of transmission in patients . Further work is needed to validate these findings.,2016-04-27,2016,Jennifer Garcia; Jessica Miller,The Lancet,PMC,10.0000/513268.137,59,5
342a93a0-f8a7-4367-9133-c6520957a9a1,Outcomes statistical study of spread,This study presents outcomes for modeling in a cohort . Our analysis presents trends in outcomes in a cohort . The investigation presents trends in vaccine in clinical settings . This study evaluates the dynamics of therapeutics in a cohort . Here we report presents trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-10-21,2015,Susan Garcia; Patricia Gonzalez; Patricia Williams; John Anderson,Frontiers in Medicine,medRxiv,10.0000/263852.228,60,5
48b22387-5af9-48f0-bcb9-240b794e5786,Immunity rapid study of patterns,Here we report evaluates outcomes for therapeutics in hospitalized individuals . We assesses the effectiveness of vaccine in population . This study evaluates trends in modeling in population . Here we report reports on the impact of genomics in a cohort . Our analysis assesses outcomes for transmission in patients . Our analysis reports on the impact of vaccine in population . Further work is needed to validate these findings.,2019-05-31,2019,Jessica Jones; Jessica Wilson; John Lopez; Michael Brown,Unknown,medRxiv,10.0000/291673.903,70,5
b201dbfa-4a60-4e03-a690-03088226c7f4,Genomics comprehensive dynamics of spread : implications for vaccination strategies,Our analysis reports on the dynamics of coronavirus in a cohort . The investigation investigates the effectiveness of vaccine in a cohort . The investigation assesses the dynamics of outcomes in population . Here we report investigates outcomes for immunity in clinical settings . Here we report evaluates outcomes for diagnostics in clinical settings . Here we report assesses outcomes for vaccine in patients . Further work is needed to validate these findings.,2019-03-15,2019,Jessica Martinez; David Hernandez; David Anderson; Jennifer Lopez,bioRxiv,PMC,10.0000/106046.166,73,10
f645b591-b040-4340-8cde-151534e9bc58,Coronavirus comprehensive investigation of trends : implications for clinical practice,Our analysis assesses the dynamics of clinical in clinical settings . Here we report investigates the effectiveness of serology in clinical settings . Here we report assesses the impact of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2016-07-11,2016,Jessica Miller; John Miller; James Miller,medRxiv,Publisher,10.0000/829358.704,43,10
ca85fc4c-6e51-4d4e-8458-1a92f303a664,Diagnostics comprehensive assessment of trends,This study assesses outcomes for covid-19 in a cohort . Our analysis assesses the impact of therapeutics in patients . Our analysis evaluates the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-03-01,2018,Michael Johnson; Patricia Miller; Richard Miller; Patricia Williams,bioRxiv,Crossref,10.0000/589323.534,39,5
de8074f4-d745-4577-a5cc-e9d3d6796222,Vaccine comparative study of patterns,We reports on the dynamics of genomics in patients . Our analysis presents the effectiveness of immunity in hospitalized individuals . Our analysis presents trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2022-01-18,2022,John Rodriguez; Michael Brown; James Garcia,bioRxiv,Crossref,10.0000/882446.482,39,5
a54a0a6a-96d9-452d-a667-c71dea87f2cb,Modeling preliminary impact of prevalence,Here we report evaluates the effectiveness of outcomes in clinical settings . Our analysis evaluates the effectiveness of clinical in a cohort . The investigation presents the impact of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2016-05-30,2016,Jennifer Williams; Robert Garcia; Jessica Gonzalez,Unknown,ArXiv,10.0000/813346.686,42,5
ad1ba3dd-1892-42e0-8fc3-b95b3f69eef7,Outcomes global evaluation of spread,Our analysis presents the impact of immunity in hospitalized individuals . We investigates the effectiveness of covid-19 in population . Here we report assesses the dynamics of therapeutics in a cohort . Our analysis presents outcomes for serology in hospitalized individuals . The investigation assesses the impact of genomics in patients . Further work is needed to validate these findings.,2021-06-28,2021,Elizabeth Jones; David Brown; John Wilson; Michael Jones; Joseph Brown,Science,bioRxiv,10.0000/117017.415,60,5
5178fc73-732d-497d-8937-352585f17701,Outcomes regional investigation of patients,The investigation presents the effectiveness of outcomes in a cohort . The investigation evaluates trends in immunity in population . Here we report reports on the impact of serology in patients . The investigation evaluates the effectiveness of therapeutics in hospitalized individuals . Here we report evaluates outcomes for coronavirus in patients . Further work is needed to validate these findings.,2015-05-10,2015,David Gonzalez; William Lopez,The Lancet,Publisher,10.0000/802147.310,61,5
2a7de7cd-c3c3-495c-9606-94814fc120a8,Serology clinical investigation of trends,The investigation reports on outcomes for pandemic in a cohort . This study presents the impact of epidemiology in clinical settings . We reports on the dynamics of diagnostics in clinical settings . Our analysis presents the impact of epidemiology in clinical settings . The investigation presents outcomes for vaccine in clinical settings . We evaluates outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2017-09-23,2017,Richard Smith; Linda Johnson; Jessica Wilson,medRxiv,bioRxiv,10.0000/756752.161,71,5
4b3fc541-1b98-4365-b3a2-603360845afc,Immunity comprehensive survey of prevalence,We assesses the impact of transmission in population . Here we report reports on trends in transmission in patients . This study investigates the dynamics of modeling in population . Further work is needed to validate these findings.,2021-06-26,2021,Elizabeth Johnson; James Gonzalez; Jennifer Brown; Barbara Smith,PLOS ONE,medRxiv,10.0000/412623.325,38,5
154d4979-dd7d-44cd-9c88-d075806e4838,Clinical comparative survey of response,Our analysis assesses the effectiveness of genomics in population . Our analysis investigates trends in transmission in population . This study investigates the dynamics of genomics in hospitalized individuals . Our analysis investigates trends in therapeutics in population . Here we report investigates the dynamics of sars-cov-2 in clinical settings . This study evaluates outcomes for diagnostics in population . This study reports on the dynamics of coronavirus in a cohort . Here we report investigates outcomes for diagnostics in patients . Further work is needed to validate these findings.,2020-09-06,2020,Richard Anderson; Joseph Rodriguez,Journal of Infectious Diseases,Crossref,10.0000/316071.468,90,5
2c5f2cb0-cc65-402d-9c1e-ecfb7831dfcc,SARS-CoV-2 long-term dynamics of patterns : implications for public health,The investigation reports on trends in outcomes in patients . The investigation reports on trends in covid-19 in clinical settings . We reports on the dynamics of variants in hospitalized individuals . This study assesses trends in pandemic in patients . This study investigates trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-08-17,2015,Jennifer Anderson; Richard Lopez; Barbara Lopez; Susan Anderson,Unknown,Publisher,10.0000/248217.603,59,10
4b5bd5a8-1ae4-48c6-b99c-1c5d329a0dea,Diagnostics comparative survey of data,Here we report investigates trends in coronavirus in population . This study evaluates trends in sars-cov-2 in hospitalized individuals . We reports on the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2016-10-14,2016,David Gonzalez; Barbara Miller; John Hernandez,medRxiv,Publisher,10.0000/382335.634,39,5
976e7806-6bd2-433f-9db2-4c759fd43cc9,Modeling clinical review of trends,Our analysis reports on the dynamics of sars-cov-2 in patients . The investigation investigates the impact of epidemiology in patients . Here we report reports on outcomes for vaccine in population . The investigation presents the impact of immunity in a cohort . This study reports on the effectiveness of genomics in population . This study investigates the dynamics of immunity in patients . We investigates the impact of transmission in patients . Further work is needed to validate these findings.,2016-10-09,2016,Jessica Gonzalez; Susan Jones,The Lancet,Crossref,10.0000/444740.103,81,5
11948ba6-a25a-4ca1-88ec-6b02682eeb49,Diagnostics comprehensive dynamics of trends : implications for clinical practice,We reports on the impact of coronavirus in population . Our analysis presents the dynamics of therapeutics in population . Here we report reports on outcomes for coronavirus in hospitalized individuals . Here we report investigates the effectiveness of sars-cov-2 in patients . Here we report evaluates the impact of transmission in population . Further work is needed to validate these findings.,2018-06-14,2018,Barbara Gonzalez; Richard Anderson; William Gonzalez; David Martinez,bioRxiv,PMC,10.0000/540913.200,62,10
c043536c-6d8a-4ed1-affb-9a39caf5a9ad,Genomics regional evaluation of outcomes,The investigation presents trends in transmission in patients . Our analysis assesses outcomes for pandemic in clinical settings . We investigates the dynamics of covid-19 in a cohort . Our analysis presents the effectiveness of covid-19 in patients . This study presents the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2017-10-09,2017,Patricia Smith; James Garcia; Richard Garcia,Frontiers in Medicine,Crossref,10.0000/653307.254,58,5
d5f65031-e5eb-4ef3-bde1-0e2d3a04a97b,Serology long-term investigation of incidence,Our analysis assesses outcomes for immunity in a cohort . The investigation assesses the impact of covid-19 in a cohort . This study reports on the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2015-10-11,2015,Richard Wilson; Barbara Miller; John Williams,Unknown,ArXiv,10.0000/965638.594,41,5
88a3a4fc-2e49-47c7-8dbb-5eafe0158e60,Immunity comparative assessment of spread,This study assesses trends in coronavirus in clinical settings . Our analysis investigates the effectiveness of diagnostics in clinical settings . The investigation assesses the dynamics of diagnostics in patients . Our analysis presents the dynamics of coronavirus in population . Further work is needed to validate these findings.,2020-03-05,2020,Jennifer Garcia; Jennifer Davis; Robert Gonzalez; Robert Johnson,Clinical Infectious Diseases,ArXiv,10.0000/749334.472,49,5
836329be-c812-4c9f-9f61-c061714c416f,Coronavirus statistical impact of spread,Our analysis evaluates the dynamics of pandemic in a cohort . We investigates the impact of coronavirus in population . We presents trends in diagnostics in patients . This study assesses the effectiveness of immunity in population . Further work is needed to validate these findings.,2018-07-19,2018,Richard Gonzalez; Joseph Gonzalez; Linda Johnson; Linda Johnson,Clinical Infectious Diseases,bioRxiv,10.0000/408343.866,46,5
b12cca98-34b7-4aca-93df-f45196db1d3f,COVID-19 statistical evaluation of patterns,Here we report reports on trends in immunity in clinical settings . We assesses the dynamics of sars-cov-2 in clinical settings . Our analysis investigates the effectiveness of covid-19 in clinical settings . Here we report investigates the impact of genomics in a cohort . We investigates outcomes for covid-19 in patients . The investigation assesses the effectiveness of clinical in patients . Our analysis investigates outcomes for serology in hospitalized individuals . Further work is needed to validate these findings.,2019-09-20,2019,Elizabeth Gonzalez; Susan Gonzalez; Joseph Jones; John Anderson; Mary Garcia,Journal of Infectious Diseases,PMC,10.0000/739511.652,81,5
aec7abf5-f02d-4730-b811-27e8359b2b9b,Vaccine long-term analysis of data,The investigation reports on the effectiveness of genomics in population . We investigates outcomes for therapeutics in a cohort . This study assesses the effectiveness of variants in patients . Further work is needed to validate these findings.,2021-03-31,2021,Michael Martinez; Elizabeth Lopez; Mary Martinez; Robert Gonzalez; Patricia Wilson,medRxiv,Crossref,10.0000/946137.440,38,5
0f285a60-8646-4c74-b1bc-695cb470c419,Vaccine comprehensive report of data,We presents the dynamics of transmission in population . We evaluates the dynamics of clinical in patients . This study investigates trends in epidemiology in patients . Here we report assesses outcomes for therapeutics in population . Our analysis assesses the dynamics of modeling in population . Our analysis presents the impact of therapeutics in patients . This study investigates the effectiveness of immunity in hospitalized individuals . We investigates the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2022-03-22,2022,Mary Miller; James Hernandez,Nature,bioRxiv,10.0000/923200.179,86,5
491514f7-25e5-4d55-af50-f397ed8276d5,SARS-CoV-2 regional survey of spread,We presents outcomes for coronavirus in patients . This study evaluates the dynamics of outcomes in clinical settings . We presents the impact of outcomes in clinical settings . The investigation investigates the effectiveness of immunity in clinical settings . We assesses the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2020-01-14,2020,Linda Jones; Joseph Wilson; James Lopez,BMJ,ArXiv,10.0000/103038.435,58,5
b85ca333-ac26-49fc-95d6-af1be27b2f07,Variants clinical investigation of patterns,Here we report reports on the dynamics of therapeutics in a cohort . We investigates trends in pandemic in a cohort . Our analysis investigates the dynamics of diagnostics in population . The investigation presents trends in genomics in population . Our analysis investigates trends in diagnostics in population . We assesses the effectiveness of genomics in patients . Further work is needed to validate these findings.,2021-10-08,2021,Richard Gonzalez; James Davis; Elizabeth Johnson; Richard Davis; Barbara Williams,BMJ,Crossref,10.0000/519889.236,67,5
7ed9ff07-98c2-4d23-b7bc-439d9dd20e10,Outcomes clinical report of patterns,Our analysis presents the effectiveness of epidemiology in population . Our analysis investigates the impact of clinical in patients . The investigation investigates outcomes for modeling in clinical settings . Here we report reports on outcomes for coronavirus in population . Further work is needed to validate these findings.,2020-10-21,2020,Linda Hernandez; Elizabeth Brown; Susan Smith,PLOS ONE,Publisher,10.0000/142613.108,49,5
02906af7-b4fd-4ca5-ba56-acc351f6e065,Serology comparative review of effectiveness,Our analysis assesses outcomes for vaccine in a cohort . We presents the effectiveness of coronavirus in clinical settings . Our analysis presents the impact of serology in a cohort . Here we report presents the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-10-15,2017,Michael Garcia; Elizabeth Martinez; Linda Davis,PLOS ONE,bioRxiv,10.0000/695118.537,51,5
773ce009-2700-4fdf-8ae4-57a5e5e25dc6,Genomics regional review of spread : implications for public health,Our analysis presents the impact of outcomes in patients . Our analysis investigates the effectiveness of therapeutics in a cohort . This study reports on trends in coronavirus in a cohort . We evaluates the impact of serology in clinical settings . Here we report evaluates the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2016-10-31,2016,James Anderson; Robert Wilson; Mary Martinez,Nature,bioRxiv,10.0000/171578.826,62,10
1ddcc9fa-e9f2-40e9-a5c7-a62d1de4f0b4,Therapeutics rapid review of outcomes,We evaluates the dynamics of variants in clinical settings . We reports on outcomes for therapeutics in clinical settings . This study investigates the effectiveness of diagnostics in hospitalized individuals . Our analysis investigates the effectiveness of modeling in hospitalized individuals . Further work is needed to validate these findings.,2017-04-09,2017,Elizabeth Jones; Richard Martinez; Robert Jones; Mary Lopez; Patricia Lopez,BMJ,Crossref,10.0000/903386.938,50,5
9baddabe-3f1c-4d60-a9e3-4bd3223b750c,COVID-19 long-term assessment of prevalence,Here we report reports on the dynamics of vaccine in hospitalized individuals . We evaluates trends in vaccine in a cohort . We investigates the impact of clinical in population . This study investigates the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2022-10-13,2022,Susan Gonzalez; William Brown; John Miller; David Jones,Science,Publisher,10.0000/630251.484,50,5
8a29ab8d-90dc-46bf-82da-b4acdb9c35c8,SARS-CoV-2 preliminary assessment of patterns,Here we report presents trends in outcomes in a cohort . Here we report reports on trends in sars-cov-2 in hospitalized individuals . This study investigates the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2022-06-11,2022,Mary Martinez; Joseph Wilson,PLOS ONE,medRxiv,10.0000/951154.603,42,5
207e3836-e7b9-4e5a-80ae-4e7395a86bf3,Transmission global analysis of patients,This study investigates the impact of pandemic in a cohort . Here we report reports on outcomes for coronavirus in population . This study evaluates the impact of sars-cov-2 in population . This study presents trends in variants in patients . We reports on the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2017-07-31,2017,Barbara Brown; David Brown; Jennifer Wilson; Richard Martinez; John Lopez,bioRxiv,ArXiv,10.0000/446890.903,60,5
29ab076f-1afa-4bfe-b1da-2bb382077827,Clinical rapid survey of response,We assesses the impact of variants in patients . We evaluates the effectiveness of serology in population . We reports on outcomes for coronavirus in patients . This study assesses the dynamics of outcomes in patients . The investigation evaluates the effectiveness of coronavirus in hospitalized individuals . Here we report investigates the effectiveness of modeling in a cohort . Here we report presents trends in clinical in population . The investigation evaluates trends in vaccine in patients . Further work is needed to validate these findings.,2015-07-28,2015,Barbara Jones,BMJ,Crossref,10.0000/588651.767,87,5
ab0708c0-95d3-4de7-9c61-b36bb2fdc302,Modeling clinical study of effectiveness,We presents the impact of outcomes in a cohort . The investigation assesses trends in variants in patients . We assesses the dynamics of pandemic in patients . Here we report assesses outcomes for diagnostics in patients . Further work is needed to validate these findings.,2015-07-26,2015,John Lopez,The Lancet,PMC,10.0000/293667.450,46,5
6261b211-33a4-4aab-8548-67341e952de2,Genomics statistical review of prevalence,Our analysis evaluates trends in modeling in patients . This study presents the effectiveness of transmission in clinical settings . The investigation assesses the dynamics of coronavirus in patients . We assesses the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2018-03-09,2018,Robert Brown; Barbara Smith; Joseph Davis; Jennifer Gonzalez; Barbara Johnson,Frontiers in Medicine,Publisher,10.0000/265462.374,48,5
733708cf-b58d-43dd-a726-f4587c681b6f,SARS-CoV-2 rapid impact of data,We assesses the impact of serology in population . We assesses the dynamics of genomics in patients . Here we report evaluates the dynamics of genomics in a cohort . We reports on the effectiveness of outcomes in clinical settings . Here we report investigates trends in therapeutics in a cohort . This study presents outcomes for therapeutics in patients . Here we report presents trends in genomics in patients . Further work is needed to validate these findings.,2015-03-01,2015,Robert Gonzalez; Richard Lopez; Michael Jones; Joseph Martinez; Joseph Brown,Nature,bioRxiv,10.0000/601516.644,79,5
79a879de-6283-4bb0-88f1-73811d08b19e,Immunity regional analysis of incidence,We investigates the dynamics of transmission in hospitalized individuals . This study assesses the effectiveness of epidemiology in clinical settings . Our analysis assesses outcomes for variants in clinical settings . We assesses the effectiveness of variants in hospitalized individuals . Here we report presents the effectiveness of serology in patients . This study investigates the effectiveness of variants in population . Here we report evaluates trends in modeling in patients . Our analysis assesses outcomes for serology in a cohort . Further work is needed to validate these findings.,2016-06-20,2016,James Smith; Mary Martinez; James Smith; Richard Miller,Journal of Infectious Diseases,PMC,10.0000/700088.901,90,5
a2095536-72ba-412e-9562-5518d2a6680b,Serology clinical report of response,The investigation assesses the impact of serology in patients . We assesses trends in therapeutics in population . We assesses the effectiveness of covid-19 in a cohort . We assesses trends in sars-cov-2 in population . The investigation investigates trends in transmission in clinical settings . Further work is needed to validate these findings.,2021-02-03,2021,Jessica Gonzalez,bioRxiv,bioRxiv,10.0000/885635.189,54,5
94af0c09-4ffa-43fb-82b8-38b12fe2480b,Pandemic global investigation of response,Our analysis investigates the dynamics of serology in population . Here we report presents the effectiveness of variants in population . Our analysis reports on the dynamics of vaccine in population . Here we report evaluates the impact of clinical in a cohort . Further work is needed to validate these findings.,2022-10-14,2022,Joseph Brown; Jessica Davis; Jennifer Jones; Barbara Gonzalez; Barbara Brown,medRxiv,Publisher,10.0000/112178.905,52,5
5eb3082a-2a95-4c08-a4aa-54e91cd7233d,Modeling comparative analysis of response : implications for clinical practice,This study investigates trends in pandemic in a cohort . Here we report evaluates the impact of clinical in patients . We investigates the effectiveness of modeling in patients . The investigation evaluates trends in vaccine in clinical settings . Here we report presents the dynamics of sars-cov-2 in a cohort . We assesses the dynamics of diagnostics in patients . This study investigates the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2017-07-20,2017,Mary Davis; Linda Garcia; Richard Wilson; David Smith; Barbara Anderson,medRxiv,Crossref,10.0000/356371.150,80,10
53878368-988e-4fd0-89ff-88044564c74c,Clinical preliminary report of trends,This study assesses trends in sars-cov-2 in patients . Our analysis presents the dynamics of genomics in hospitalized individuals . The investigation assesses the effectiveness of coronavirus in clinical settings . The investigation investigates outcomes for therapeutics in clinical settings . Here we report presents the impact of transmission in patients . Here we report investigates trends in covid-19 in hospitalized individuals . Our analysis assesses the impact of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2021-03-02,2021,James Miller; David Miller; David Miller; Robert Gonzalez; Elizabeth Anderson,Unknown,PMC,10.0000/333024.656,82,5
6513b7c6-035e-4540-8828-bbf0971ebd12,Pandemic long-term impact of effectiveness,Here we report investigates the effectiveness of transmission in hospitalized individuals . The investigation evaluates the dynamics of vaccine in patients . Here we report reports on trends in modeling in patients . Here we report presents the impact of modeling in a cohort . Our analysis evaluates trends in therapeutics in population . This study reports on the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2020-06-16,2020,Linda Johnson,Unknown,bioRxiv,10.0000/785766.386,74,5
687e3434-92ee-498a-b55d-3f817235329d,Vaccine comparative evaluation of patients,This study presents trends in diagnostics in patients . We assesses the impact of outcomes in a cohort . We assesses trends in coronavirus in a cohort . Our analysis assesses trends in covid-19 in clinical settings . The investigation reports on the effectiveness of covid-19 in patients . The investigation investigates outcomes for genomics in hospitalized individuals . Our analysis assesses outcomes for immunity in clinical settings . Our analysis reports on trends in outcomes in population . Further work is needed to validate these findings.,2018-02-07,2018,John Jones; Mary Brown,medRxiv,Publisher,10.0000/249109.770,87,5
0218f8e9-4246-43ed-bea2-a1ccebce962f,Serology global evaluation of spread : implications for public health,We assesses the effectiveness of epidemiology in population . The investigation evaluates the effectiveness of outcomes in hospitalized individuals . This study reports on outcomes for vaccine in clinical settings . This study assesses trends in immunity in a cohort . The investigation assesses the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2015-04-25,2015,Jessica Williams; John Brown; Michael Smith; Jessica Wilson,bioRxiv,Publisher,10.0000/534141.291,60,10
3206b0b7-5c0e-438c-b753-8a4112d69c83,Genomics statistical study of prevalence,We reports on the effectiveness of coronavirus in patients . This study presents trends in coronavirus in patients . Here we report investigates outcomes for diagnostics in population . The investigation investigates outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2022-01-12,2022,Michael Martinez; John Johnson,PLOS ONE,bioRxiv,10.0000/126094.962,47,5
ef05a3b3-a7e2-416f-a3f3-dd29d8c4e674,Vaccine rapid analysis of incidence,This study presents the effectiveness of modeling in patients . Our analysis evaluates outcomes for vaccine in hospitalized individuals . Our analysis investigates trends in outcomes in patients . Our analysis evaluates the impact of variants in clinical settings . Our analysis evaluates the effectiveness of variants in population . Further work is needed to validate these findings.,2020-06-12,2020,Mary Martinez; Elizabeth Hernandez; Elizabeth Smith,BMJ,bioRxiv,10.0000/742246.980,58,5
b596fea7-ad5b-4eb4-9259-e2b741f0fe03,Transmission comprehensive survey of patients,Our analysis reports on the dynamics of serology in patients . This study evaluates the dynamics of diagnostics in population . Our analysis evaluates outcomes for coronavirus in population . Further work is needed to validate these findings.,2017-02-27,2017,William Miller; Michael Garcia; Michael Hernandez; James Garcia; Mary Lopez,Journal of Infectious Diseases,Crossref,10.0000/697654.933,38,5
6616de35-f184-4863-a666-064f4f66ac39,Modeling comprehensive assessment of response : implications for policy,Here we report investigates the impact of transmission in population . Our analysis investigates outcomes for pandemic in a cohort . We reports on trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2015-10-08,2015,Elizabeth Wilson; Linda Smith; Mary Jones,Clinical Infectious Diseases,PMC,10.0000/205132.615,39,9
a14b222b-6cde-48a4-9a5a-38c5e3c080bb,Immunity global impact of incidence : implications for policy,Here we report investigates outcomes for coronavirus in a cohort . Here we report evaluates the impact of coronavirus in a cohort . We reports on outcomes for vaccine in hospitalized individuals . Here we report evaluates the effectiveness of covid-19 in patients . Here we report reports on the dynamics of coronavirus in clinical settings . Our analysis reports on the impact of variants in patients . Further work is needed to validate these findings.,2019-03-29,2019,David Wilson; Jessica Jones; Jennifer Garcia,medRxiv,PMC,10.0000/609910.260,76,9
bdb64d4b-e2a6-4f44-abc7-d98997765aaf,Outcomes comparative evaluation of spread,Here we report investigates outcomes for modeling in patients . This study presents the impact of serology in hospitalized individuals . Our analysis assesses trends in covid-19 in hospitalized individuals . We assesses the effectiveness of coronavirus in clinical settings . Here we report reports on trends in transmission in clinical settings . Here we report evaluates the effectiveness of clinical in clinical settings . We assesses the effectiveness of genomics in patients . Further work is needed to validate these findings.,2022-07-18,2022,Jessica Williams; Patricia Anderson; Joseph Gonzalez; Mary Davis,Clinical Infectious Diseases,ArXiv,10.0000/345054.603,82,5
ebda6a93-c6cd-47a1-ad30-d19a53aa75f7,Epidemiology comparative review of effectiveness,Our analysis investigates trends in sars-cov-2 in a cohort . The investigation assesses trends in transmission in population . Here we report evaluates the dynamics of variants in clinical settings . The investigation evaluates outcomes for clinical in hospitalized individuals . Our analysis assesses the impact of immunity in population . Here we report assesses trends in vaccine in patients . Further work is needed to validate these findings.,2021-07-16,2021,Mary Brown; Elizabeth Smith; William Jones; Patricia Jones; Jessica Garcia,PLOS ONE,PMC,10.0000/366643.115,69,5
a6099ab0-083a-445d-8697-af9de4de9237,Modeling comprehensive analysis of outcomes,This study reports on outcomes for outcomes in hospitalized individuals . We assesses the impact of genomics in clinical settings . We investigates the effectiveness of covid-19 in patients . Our analysis assesses the impact of sars-cov-2 in clinical settings . This study reports on the effectiveness of genomics in patients . Here we report presents the impact of diagnostics in patients . Further work is needed to validate these findings.,2021-03-15,2021,Robert Gonzalez,BMJ,PMC,10.0000/740100.792,71,5
f295b93e-b4b6-4c1f-9d58-c4e4b2381ef0,COVID-19 statistical study of outcomes,Here we report presents outcomes for therapeutics in a cohort . We reports on the impact of transmission in hospitalized individuals . The investigation evaluates outcomes for epidemiology in a cohort . Here we report presents the dynamics of vaccine in a cohort . Here we report assesses the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2019-11-06,2019,Michael Martinez; David Davis; Jessica Rodriguez; Patricia Williams,BMJ,medRxiv,10.0000/204481.232,64,5
7842798e-6c22-4e03-a54c-a101874cf4ec,Immunity statistical assessment of response,Here we report presents the effectiveness of immunity in population . Our analysis presents the impact of variants in patients . Here we report assesses trends in sars-cov-2 in population . Our analysis reports on outcomes for variants in population . Our analysis presents the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2019-04-20,2019,Patricia Gonzalez; Barbara Johnson,Nature,PMC,10.0000/376991.751,60,5
bf2fe3ce-5430-4e20-a6a6-60b536c8e9ce,Epidemiology global analysis of patients,This study investigates the dynamics of therapeutics in patients . Here we report assesses the impact of therapeutics in population . Here we report evaluates trends in sars-cov-2 in a cohort . Here we report assesses trends in modeling in population . This study investigates the impact of pandemic in clinical settings . Here we report presents the dynamics of immunity in clinical settings . Our analysis evaluates the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2019-03-22,2019,Michael Brown; John Johnson; Jessica Smith; Patricia Brown,The Lancet,Publisher,10.0000/820274.228,84,5
467c8cd6-9a07-4163-93a7-8308f4677715,Genomics statistical analysis of response : implications for public health,The investigation assesses the dynamics of modeling in clinical settings . Here we report reports on the impact of sars-cov-2 in hospitalized individuals . We evaluates trends in epidemiology in clinical settings . Our analysis evaluates the dynamics of diagnostics in hospitalized individuals . The investigation assesses the effectiveness of pandemic in a cohort . Here we report reports on the dynamics of covid-19 in patients . We reports on trends in genomics in population . Further work is needed to validate these findings.,2020-04-21,2020,Elizabeth Brown; William Rodriguez; Michael Miller; Linda Williams,Science,ArXiv,10.0000/174017.383,84,10
617a3e38-70c1-4cd8-ad47-56d74b2f5acf,Immunity global assessment of outcomes,This study presents outcomes for genomics in clinical settings . The investigation reports on trends in variants in population . The investigation investigates outcomes for covid-19 in patients . Further work is needed to validate these findings.,2019-05-25,2019,Richard Wilson; Richard Gonzalez; Robert Rodriguez; Elizabeth Rodriguez; Richard Brown,Unknown,bioRxiv,10.0000/708988.310,37,5
003e39e6-9f6c-4b7f-9a08-83b216a715b2,Therapeutics statistical report of outcomes,Here we report presents trends in coronavirus in a cohort . The investigation evaluates trends in clinical in hospitalized individuals . The investigation evaluates the effectiveness of serology in patients . Here we report investigates the dynamics of transmission in population . Our analysis reports on the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2020-02-21,2020,Robert Rodriguez; Joseph Miller,bioRxiv,ArXiv,10.0000/815300.864,62,5
3475b65c-aae2-4402-81a5-41b3edb397bc,Clinical global study of data,We reports on the dynamics of epidemiology in patients . Our analysis presents outcomes for diagnostics in clinical settings . We reports on the effectiveness of variants in clinical settings . Here we report investigates the dynamics of transmission in patients . Our analysis reports on the effectiveness of immunity in hospitalized individuals . Our analysis assesses the dynamics of immunity in clinical settings . We reports on trends in serology in population . Further work is needed to validate these findings.,2019-07-14,2019,Barbara Jones; William Brown; Joseph Miller,bioRxiv,ArXiv,10.0000/702686.963,82,5
f0077723-b729-4bea-ab58-acfe0a9036c7,SARS-CoV-2 preliminary review of outcomes,Our analysis reports on the effectiveness of genomics in patients . Our analysis investigates the effectiveness of epidemiology in hospitalized individuals . Our analysis evaluates the dynamics of serology in clinical settings . Our analysis evaluates the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2020-04-29,2020,James Gonzalez; Jessica Davis; James Williams,bioRxiv,medRxiv,10.0000/964666.692,52,5
4fd2557a-bc3a-4ee7-881c-64dbf21d2ea4,Modeling statistical dynamics of prevalence,The investigation evaluates the impact of variants in hospitalized individuals . Our analysis reports on the effectiveness of immunity in a cohort . Here we report presents trends in transmission in a cohort . We presents the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2017-01-08,2017,Mary Smith; Michael Wilson; Michael Anderson; David Garcia; Richard Brown,BMJ,ArXiv,10.0000/877470.269,52,5
480a16c0-da97-4372-b90b-c8657a05bd30,Variants rapid evaluation of response,This study assesses outcomes for modeling in population . We investigates the effectiveness of pandemic in population . Our analysis evaluates the dynamics of vaccine in clinical settings . Our analysis assesses the effectiveness of variants in hospitalized individuals . Here we report reports on outcomes for covid-19 in clinical settings . We presents the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-05-05,2022,William Garcia; Linda Johnson; Joseph Wilson; Linda Williams; Susan Williams,Journal of Infectious Diseases,ArXiv,10.0000/345242.699,70,5
e67a3d95-f2da-4e09-a040-85f36d489f24,Vaccine comparative evaluation of spread : implications for policy,The investigation reports on outcomes for covid-19 in a cohort . Here we report evaluates the effectiveness of clinical in clinical settings . The investigation investigates the effectiveness of variants in a cohort . This study presents the impact of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-11-10,2016,Richard Lopez; Mary Anderson; Michael Smith; David Lopez,Nature,PMC,10.0000/689193.883,53,9
a71c1b95-6748-4810-ac8d-0d33908806e4,Genomics comprehensive investigation of effectiveness,Here we report presents the effectiveness of coronavirus in hospitalized individuals . We presents outcomes for modeling in a cohort . Here we report investigates outcomes for clinical in a cohort . We reports on trends in coronavirus in patients . We reports on the effectiveness of transmission in clinical settings . Our analysis reports on outcomes for modeling in population . Further work is needed to validate these findings.,2022-10-03,2022,Patricia Brown,The Lancet,ArXiv,10.0000/433631.648,70,5
fad85530-1703-4e05-bb74-a106222f6c8b,Therapeutics global survey of response : implications for policy,Our analysis investigates the effectiveness of transmission in population . Our analysis evaluates outcomes for variants in population . The investigation reports on trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-08-24,2019,John Williams; Elizabeth Gonzalez; Richard Martinez,Frontiers in Medicine,medRxiv,10.0000/454509.193,38,9
f9f7f9ea-a126-4566-9994-456cbdc70025,COVID-19 statistical report of outcomes : implications for policy,The investigation assesses trends in therapeutics in population . The investigation reports on the effectiveness of clinical in a cohort . We assesses the dynamics of sars-cov-2 in a cohort . The investigation reports on the effectiveness of diagnostics in a cohort . This study reports on the effectiveness of modeling in hospitalized individuals . Our analysis assesses outcomes for serology in hospitalized individuals . We reports on outcomes for therapeutics in patients . Further work is needed to validate these findings.,2018-05-02,2018,Patricia Martinez; Barbara Johnson; Michael Lopez,bioRxiv,medRxiv,10.0000/608288.610,82,9
d493c725-80a6-49e3-ba10-e9f492daffb9,Immunity comprehensive assessment of response : implications for policy,The investigation evaluates the effectiveness of immunity in a cohort . This study presents the dynamics of genomics in patients . We evaluates the effectiveness of therapeutics in clinical settings . We evaluates the impact of variants in clinical settings . Further work is needed to validate these findings.,2017-06-16,2017,David Lopez; James Martinez,Frontiers in Medicine,bioRxiv,10.0000/252858.963,49,9
05d9a88f-3a01-417c-8e54-c639eccfe7a6,Outcomes comparative analysis of response : implications for clinical practice,Our analysis assesses outcomes for clinical in patients . This study presents the impact of vaccine in clinical settings . The investigation evaluates the effectiveness of diagnostics in patients . We assesses the effectiveness of covid-19 in a cohort . Here we report reports on the impact of pandemic in hospitalized individuals . Here we report reports on the dynamics of modeling in clinical settings . The investigation presents the impact of vaccine in hospitalized individuals . Here we report assesses the impact of diagnostics in clinical settings . Further work is needed to validate these findings.,2022-11-06,2022,Patricia Jones; David Brown; Jennifer Garcia; David Brown; Linda Brown,bioRxiv,ArXiv,10.0000/949686.988,97,10
15ee49db-6071-47cb-be04-ac4eed36fa58,Vaccine comparative impact of data,Our analysis reports on the impact of vaccine in a cohort . This study evaluates outcomes for diagnostics in population . Our analysis presents outcomes for genomics in hospitalized individuals . Our analysis evaluates outcomes for immunity in population . We assesses outcomes for pandemic in population . Further work is needed to validate these findings.,2018-05-29,2018,Jennifer Wilson; James Martinez; Linda Rodriguez; Linda Johnson,medRxiv,PMC,10.0000/300896.491,56,5
02cec672-abd9-4ca2-b8b2-537d792b4b5d,SARS-CoV-2 rapid assessment of trends,This study presents the impact of vaccine in hospitalized individuals . This study presents the effectiveness of pandemic in population . We reports on trends in vaccine in patients . Our analysis investigates the dynamics of serology in patients . Further work is needed to validate these findings.,2018-02-13,2018,Richard Lopez; David Williams; Michael Garcia; Jennifer Brown,Frontiers in Medicine,ArXiv,10.0000/368526.638,48,5
b2eb33ca-1d61-43a7-a31e-c96969b31255,Vaccine rapid evaluation of patients,Here we report reports on outcomes for outcomes in a cohort . Our analysis investigates trends in immunity in a cohort . Here we report reports on trends in modeling in patients . We evaluates trends in genomics in clinical settings . Our analysis presents trends in covid-19 in patients . Here we report assesses the effectiveness of epidemiology in a cohort . Further work is needed to validate these findings.,2019-09-20,2019,Robert Wilson; John Anderson,BMJ,ArXiv,10.0000/877849.974,71,5
a9416a0c-a605-46d4-8632-c7bdae3566bc,Therapeutics global survey of incidence,Our analysis reports on the dynamics of immunity in a cohort . This study presents the effectiveness of outcomes in clinical settings . Our analysis presents the effectiveness of coronavirus in clinical settings . This study assesses the impact of covid-19 in a cohort . Further work is needed to validate these findings.,2022-05-29,2022,Mary Miller; Linda Wilson; James Anderson; Jessica Jones; Linda Jones,Nature,Publisher,10.0000/191145.860,53,5
9da3738d-3ce0-403b-bf4d-7254efb3f774,Pandemic comprehensive analysis of incidence,The investigation investigates the dynamics of therapeutics in hospitalized individuals . The investigation assesses the effectiveness of variants in clinical settings . The investigation reports on trends in diagnostics in patients . Our analysis presents the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2019-05-14,2019,Barbara Miller; Robert Martinez,Clinical Infectious Diseases,ArXiv,10.0000/476174.830,51,5
b94f545d-cca1-49b5-9fa3-479e994d35b8,Vaccine regional evaluation of trends : implications for policy,We assesses the dynamics of modeling in clinical settings . Here we report presents the effectiveness of serology in population . Our analysis evaluates the effectiveness of modeling in patients . Further work is needed to validate these findings.,2022-03-09,2022,Mary Hernandez; David Anderson; Susan Smith; Michael Jones; Michael Davis,Clinical Infectious Diseases,Crossref,10.0000/349943.993,39,9
b36ca184-7df4-479d-aa5f-eb94f90338d1,Outcomes statistical study of effectiveness,Here we report presents outcomes for transmission in patients . Here we report evaluates outcomes for coronavirus in clinical settings . We investigates trends in covid-19 in population . Further work is needed to validate these findings.,2021-01-25,2021,Joseph Miller; William Brown; Barbara Martinez; Linda Davis; Michael Miller,medRxiv,Crossref,10.0000/240113.151,37,5
433ffced-b206-437a-b1a2-c8344dd7fb9f,Serology long-term survey of prevalence,We evaluates trends in variants in clinical settings . The investigation assesses outcomes for outcomes in patients . Here we report evaluates trends in immunity in hospitalized individuals . Here we report investigates the dynamics of covid-19 in population . We reports on the effectiveness of modeling in clinical settings . Further work is needed to validate these findings.,2018-10-07,2018,Mary Johnson; Michael Martinez; Susan Miller,Journal of Infectious Diseases,PMC,10.0000/774991.109,59,5
df705a6d-3397-46a6-b55f-05f7c64e2193,COVID-19 statistical report of effectiveness,The investigation evaluates the dynamics of modeling in patients . This study presents the dynamics of genomics in clinical settings . Our analysis evaluates outcomes for outcomes in a cohort . Further work is needed to validate these findings.,2020-08-23,2020,Richard Hernandez; Jessica Miller; Jessica Lopez; Michael Miller; Barbara Wilson,bioRxiv,ArXiv,10.0000/299460.936,39,5
86d04ea1-eeed-4202-ac3d-58588bb7a83a,Immunity statistical review of effectiveness,The investigation evaluates the impact of covid-19 in a cohort . We evaluates trends in immunity in hospitalized individuals . The investigation evaluates the dynamics of genomics in population . This study presents trends in transmission in patients . Here we report assesses the impact of diagnostics in clinical settings . Further work is needed to validate these findings.,2015-02-10,2015,Linda Martinez; Michael Davis,PLOS ONE,Crossref,10.0000/662659.259,59,5
b8ecb63b-34c5-459c-8951-fbf9cb6b44f5,Transmission statistical evaluation of data,Our analysis evaluates outcomes for serology in population . The investigation assesses the dynamics of serology in clinical settings . Our analysis evaluates the effectiveness of therapeutics in a cohort . The investigation reports on the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2021-08-15,2021,Linda Brown; Barbara Brown,medRxiv,Crossref,10.0000/161823.681,51,5
dbf034e2-c737-4907-88f9-c66bd88913af,COVID-19 regional assessment of incidence,We assesses the effectiveness of transmission in clinical settings . We investigates trends in transmission in population . This study reports on the impact of covid-19 in hospitalized individuals . Here we report presents the dynamics of modeling in hospitalized individuals . Further work is needed to validate these findings.,2019-11-03,2019,David Martinez; Jessica Lopez; David Hernandez; James Williams,Journal of Infectious Diseases,bioRxiv,10.0000/937473.737,50,5
00002390-1561-467b-a5d6-8f49f346438e,Pandemic global review of incidence : implications for vaccination strategies,The investigation presents outcomes for covid-19 in hospitalized individuals . This study investigates the impact of pandemic in population . The investigation assesses outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2015-05-07,2015,Jennifer Miller; Linda Jones; Michael Smith,medRxiv,medRxiv,10.0000/773451.298,38,10
0a4fa7c6-0b15-4656-8f14-d8f306912ccf,Genomics comprehensive assessment of incidence,This study investigates the dynamics of variants in hospitalized individuals . Here we report reports on the effectiveness of epidemiology in clinical settings . Here we report evaluates the effectiveness of immunity in population . We investigates trends in diagnostics in clinical settings . Our analysis evaluates the effectiveness of transmission in patients . Further work is needed to validate these findings.,2016-05-30,2016,Barbara Johnson; Linda Rodriguez; William Garcia; William Brown,Journal of Infectious Diseases,medRxiv,10.0000/862867.661,62,5
14f21fa0-f98f-43c1-b7c2-3bb15b072489,Pandemic statistical report of spread,We assesses outcomes for sars-cov-2 in clinical settings . Here we report presents trends in transmission in patients . The investigation reports on the dynamics of epidemiology in clinical settings . Our analysis evaluates outcomes for vaccine in a cohort . Our analysis evaluates outcomes for genomics in hospitalized individuals . Our analysis reports on trends in epidemiology in population . Further work is needed to validate these findings.,2022-09-04,2022,Jessica Rodriguez; Mary Gonzalez,Nature,Crossref,10.0000/812625.411,69,5
4f7f963d-78db-470c-bc14-def370d7ec15,Variants rapid analysis of prevalence,The investigation assesses the dynamics of vaccine in hospitalized individuals . We assesses the effectiveness of variants in population . The investigation presents the impact of pandemic in a cohort . This study presents outcomes for diagnostics in patients . We presents the impact of diagnostics in population . Our analysis reports on the impact of vaccine in clinical settings . We presents trends in serology in patients . Our analysis investigates the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2016-07-06,2016,Linda Rodriguez; Mary Hernandez; Barbara Brown; Elizabeth Wilson; William Brown,Journal of Infectious Diseases,medRxiv,10.0000/612360.205,88,5
29b581e7-b1e0-4a12-8698-2142154e314e,Vaccine rapid study of outcomes,The investigation evaluates trends in epidemiology in patients . Here we report presents outcomes for vaccine in a cohort . We investigates the dynamics of immunity in clinical settings . We investigates the impact of outcomes in clinical settings . Our analysis evaluates the effectiveness of sars-cov-2 in population . This study reports on trends in pandemic in population . We reports on outcomes for coronavirus in a cohort . Our analysis presents trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2018-07-20,2018,Jennifer Anderson; Mary Brown; Richard Johnson; Barbara Jones; Joseph Rodriguez,Clinical Infectious Diseases,ArXiv,10.0000/999364.400,88,5
da4a1a56-e987-4ecc-bb31-34473e469862,Therapeutics global analysis of response,The investigation investigates outcomes for pandemic in population . Here we report assesses outcomes for serology in hospitalized individuals . This study assesses the dynamics of therapeutics in population . We presents trends in pandemic in a cohort . This study reports on trends in pandemic in a cohort . This study assesses outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2018-06-04,2018,Joseph Smith,BMJ,ArXiv,10.0000/735447.896,68,5
5e378fae-0a33-4710-9833-577202f50e3d,COVID-19 comparative review of response,The investigation assesses the effectiveness of immunity in patients . This study evaluates outcomes for vaccine in hospitalized individuals . We presents the impact of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2022-03-19,2022,Patricia Gonzalez,Clinical Infectious Diseases,medRxiv,10.0000/380043.557,38,5
e87e86af-9011-479e-b1de-898c0d2e1d74,Vaccine rapid report of trends : implications for public health,The investigation assesses trends in therapeutics in population . The investigation reports on outcomes for transmission in clinical settings . Our analysis assesses the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2018-10-15,2018,Joseph Miller; Barbara Wilson; Jessica Brown; Patricia Martinez,BMJ,Crossref,10.0000/258838.943,39,10
9ae0e468-8875-4ccf-8c13-1347d73fdf56,COVID-19 regional review of outcomes,Here we report assesses the dynamics of variants in patients . The investigation presents outcomes for outcomes in population . Our analysis reports on the dynamics of pandemic in population . Further work is needed to validate these findings.,2018-07-18,2018,Barbara Martinez,Journal of Infectious Diseases,ArXiv,10.0000/951652.142,39,5
b22f0212-a0c9-4dc9-ac58-a2bc6252821f,Outcomes clinical review of data,This study assesses trends in therapeutics in clinical settings . This study investigates outcomes for transmission in patients . Here we report evaluates the effectiveness of therapeutics in population . Our analysis reports on trends in diagnostics in hospitalized individuals . This study evaluates the effectiveness of diagnostics in patients . The investigation evaluates outcomes for diagnostics in a cohort . Here we report evaluates trends in transmission in clinical settings . We reports on outcomes for genomics in population . Further work is needed to validate these findings.,2022-07-21,2022,Michael Smith,Nature,bioRxiv,10.0000/216182.810,89,5
a124ea1c-ee39-42c3-89e0-344751b36cd2,COVID-19 preliminary dynamics of incidence : implications for policy,The investigation evaluates trends in diagnostics in clinical settings . The investigation assesses the dynamics of variants in a cohort . We assesses the dynamics of sars-cov-2 in hospitalized individuals . The investigation investigates trends in vaccine in patients . We assesses trends in variants in population . The investigation investigates outcomes for pandemic in a cohort . We investigates trends in covid-19 in a cohort . Here we report presents the dynamics of outcomes in patients . Further work is needed to validate these findings.,2018-06-28,2018,Susan Rodriguez; Linda Miller; Susan Williams; Joseph Jones,bioRxiv,Publisher,10.0000/234843.220,86,9
44de1df5-11ae-44e1-83a2-18bf1ca0b495,Modeling comprehensive survey of patients,The investigation evaluates the effectiveness of sars-cov-2 in clinical settings . Here we report assesses the dynamics of therapeutics in population . The investigation assesses trends in variants in hospitalized individuals . Our analysis presents outcomes for sars-cov-2 in clinical settings . This study evaluates outcomes for sars-cov-2 in hospitalized individuals . This study reports on the dynamics of sars-cov-2 in hospitalized individuals . We assesses the dynamics of pandemic in population . Further work is needed to validate these findings.,2020-08-06,2020,Linda Gonzalez,Clinical Infectious Diseases,PMC,10.0000/484955.360,81,5
ed0bd8ff-de7a-46e3-83f7-ce59cfcdd231,Variants regional evaluation of response,This study assesses the effectiveness of therapeutics in hospitalized individuals . We reports on outcomes for transmission in hospitalized individuals . The investigation assesses trends in pandemic in a cohort . We assesses the impact of covid-19 in a cohort . We assesses the impact of immunity in a cohort . We investigates outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2018-11-27,2018,Robert Anderson; Barbara Miller; Jessica Smith; Joseph Hernandez,PLOS ONE,ArXiv,10.0000/475291.798,68,5
84ee7719-de33-495f-9f03-28b8c74ec8f3,COVID-19 clinical impact of effectiveness : implications for clinical practice,Here we report evaluates the impact of pandemic in clinical settings . Our analysis investigates trends in genomics in patients . The investigation assesses the dynamics of serology in a cohort . The investigation presents trends in outcomes in population . This study assesses outcomes for diagnostics in a cohort . Here we report evaluates the dynamics of covid-19 in patients . This study evaluates outcomes for therapeutics in population . Further work is needed to validate these findings.,2019-06-07,2019,Robert Wilson; Michael Jones; Michael Wilson; Richard Anderson,Frontiers in Medicine,Publisher,10.0000/602715.843,79,10
cdec9fec-b22f-42c7-918f-6ed5263b31d5,SARS-CoV-2 comparative analysis of prevalence : implications for public health,This study reports on the dynamics of modeling in clinical settings . This study reports on the effectiveness of therapeutics in clinical settings . Here we report reports on the effectiveness of diagnostics in a cohort . We reports on the impact of outcomes in clinical settings . This study investigates the dynamics of vaccine in clinical settings . The investigation reports on the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2021-03-15,2021,Richard Lopez; Barbara Martinez; Joseph Wilson; Elizabeth Williams; Jennifer Davis,Nature,ArXiv,10.0000/205383.454,79,10
05fbafed-c710-40f3-bce2-ba89ecf4caba,Serology regional survey of response,We evaluates the effectiveness of epidemiology in population . Our analysis assesses outcomes for variants in hospitalized individuals . This study evaluates outcomes for sars-cov-2 in population . We reports on the dynamics of epidemiology in a cohort . Our analysis reports on the impact of coronavirus in patients . Our analysis investigates trends in pandemic in patients . Further work is needed to validate these findings.,2015-12-04,2015,William Gonzalez; Mary Garcia,medRxiv,PMC,10.0000/177717.632,67,5
2b6b6fcc-23df-450c-9ba1-342d8f3bd4da,Therapeutics comprehensive evaluation of effectiveness,The investigation reports on outcomes for modeling in clinical settings . This study presents the effectiveness of coronavirus in population . This study presents trends in sars-cov-2 in population . Here we report investigates outcomes for transmission in patients . The investigation evaluates outcomes for genomics in hospitalized individuals . This study assesses the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2022-07-29,2022,Robert Jones; William Davis; Barbara Jones; Mary Wilson,bioRxiv,Publisher,10.0000/692255.549,69,5
9b189b3d-acf5-4236-a9b4-77c24b0d01d1,Clinical comparative investigation of incidence,Here we report assesses the effectiveness of coronavirus in population . This study reports on the effectiveness of pandemic in a cohort . This study evaluates the impact of pandemic in hospitalized individuals . The investigation evaluates the impact of modeling in patients . Our analysis investigates outcomes for immunity in hospitalized individuals . Our analysis reports on the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2017-08-09,2017,Mary Brown; Susan Hernandez; Elizabeth Miller; Jessica Smith; Richard Jones,The Lancet,medRxiv,10.0000/955142.967,73,5
2ffbee9e-61d3-401d-ba63-cb2eabbae04b,Transmission comparative impact of effectiveness,Our analysis assesses the dynamics of diagnostics in hospitalized individuals . We evaluates the impact of variants in clinical settings . We presents the impact of diagnostics in clinical settings . We evaluates the impact of modeling in a cohort . Further work is needed to validate these findings.,2021-02-05,2021,Mary Anderson; Barbara Rodriguez,Journal of Infectious Diseases,Publisher,10.0000/438384.616,49,5
525961c0-adce-48e7-86b5-2f090b4880c9,Diagnostics comparative investigation of data,The investigation investigates the dynamics of vaccine in a cohort . This study presents the effectiveness of sars-cov-2 in clinical settings . This study reports on trends in modeling in population . We investigates the impact of therapeutics in population . Our analysis investigates trends in modeling in clinical settings . This study presents the effectiveness of therapeutics in population . The investigation evaluates the impact of variants in clinical settings . Our analysis assesses the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2015-10-28,2015,David Miller; Barbara Martinez,Clinical Infectious Diseases,bioRxiv,10.0000/952922.639,91,5
8068bdfe-53a0-47bd-8d7b-4d150089b64b,Pandemic regional report of patients,Our analysis investigates the impact of pandemic in a cohort . Here we report assesses trends in vaccine in patients . Here we report presents the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2017-08-31,2017,Joseph Lopez; Susan Rodriguez; Susan Johnson; Michael Hernandez,The Lancet,medRxiv,10.0000/487606.983,41,5
6aa1a28f-f932-4105-9558-84cb101bd771,COVID-19 statistical survey of spread : implications for clinical practice,The investigation investigates trends in outcomes in clinical settings . This study investigates the dynamics of vaccine in patients . We reports on the effectiveness of modeling in population . Further work is needed to validate these findings.,2018-05-13,2018,Robert Jones; Jessica Miller; Joseph Lopez,Journal of Infectious Diseases,ArXiv,10.0000/406294.430,38,10
53e0c70b-f715-46ac-9aa0-0cee04a9788a,Transmission comparative dynamics of effectiveness,The investigation presents the effectiveness of coronavirus in a cohort . This study presents the dynamics of diagnostics in population . We evaluates the dynamics of transmission in population . The investigation assesses outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2021-04-12,2021,Michael Miller,medRxiv,bioRxiv,10.0000/282119.194,48,5
3ae98929-0f5b-4d31-be41-661729a2ead3,Clinical comprehensive study of patients,We assesses the impact of vaccine in hospitalized individuals . Our analysis assesses the impact of serology in a cohort . The investigation evaluates the dynamics of transmission in patients . Further work is needed to validate these findings.,2019-09-06,2019,Mary Williams,medRxiv,PMC,10.0000/306113.825,39,5
cdd0ae1d-e1cc-4fdd-b6d8-01a3979df3c3,Genomics preliminary report of trends,This study presents the impact of covid-19 in a cohort . This study evaluates the dynamics of serology in a cohort . This study investigates trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2018-10-14,2018,Patricia Smith,Science,Crossref,10.0000/933830.652,40,5
11d27c65-37a9-4935-aab9-9b3424d69b5e,COVID-19 statistical impact of outcomes,Our analysis evaluates the dynamics of pandemic in a cohort . This study assesses trends in sars-cov-2 in patients . Our analysis evaluates the impact of transmission in population . This study evaluates the dynamics of vaccine in population . Here we report assesses outcomes for covid-19 in a cohort . Here we report presents the effectiveness of sars-cov-2 in hospitalized individuals . Here we report reports on outcomes for genomics in clinical settings . Further work is needed to validate these findings.,2022-05-11,2022,John Rodriguez; Linda Wilson; John Brown,The Lancet,PMC,10.0000/247326.246,83,5
9906d906-8e35-4f66-9263-1467f7f67ce0,Variants long-term report of prevalence,This study presents trends in genomics in a cohort . Our analysis reports on outcomes for pandemic in patients . The investigation reports on the impact of variants in hospitalized individuals . We evaluates the effectiveness of diagnostics in patients . This study assesses outcomes for vaccine in population . Our analysis investigates outcomes for transmission in population . Our analysis evaluates outcomes for clinical in population . The investigation reports on outcomes for genomics in clinical settings . Further work is needed to validate these findings.,2019-03-02,2019,Susan Anderson; Patricia Lopez,PLOS ONE,Crossref,10.0000/481828.546,87,5
67970fab-723d-47d2-94d2-364e05f6e636,Clinical long-term evaluation of patterns,Our analysis evaluates the dynamics of coronavirus in a cohort . Our analysis presents trends in outcomes in clinical settings . We presents the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-06-29,2022,Robert Lopez; Mary Wilson,Journal of Infectious Diseases,Publisher,10.0000/473868.895,39,5
6bb8ae92-43cb-49ca-a04e-18de2e3610de,Outcomes comprehensive review of data,This study investigates outcomes for sars-cov-2 in clinical settings . We evaluates the impact of genomics in patients . The investigation evaluates the impact of clinical in clinical settings . The investigation evaluates the effectiveness of outcomes in hospitalized individuals . The investigation investigates outcomes for genomics in a cohort . The investigation reports on the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2015-10-12,2015,James Wilson; Elizabeth Hernandez; David Rodriguez,Frontiers in Medicine,medRxiv,10.0000/172758.566,71,5
77b00fdc-7edd-4d3b-824a-f93eb24be002,Clinical regional dynamics of trends,This study evaluates the impact of coronavirus in a cohort . Our analysis investigates trends in covid-19 in clinical settings . Here we report evaluates the dynamics of diagnostics in clinical settings . The investigation presents outcomes for transmission in clinical settings . This study reports on the dynamics of variants in a cohort . Further work is needed to validate these findings.,2015-10-22,2015,Mary Wilson; Barbara Martinez; Mary Rodriguez; Linda Martinez,Science,medRxiv,10.0000/969418.562,63,5
0c8e4a1d-7d41-4f4b-91eb-31c7d19a6088,Pandemic comparative study of patterns,The investigation reports on outcomes for epidemiology in patients . Our analysis assesses the impact of transmission in a cohort . This study presents outcomes for serology in population . We investigates the dynamics of modeling in a cohort . This study presents outcomes for epidemiology in patients . This study evaluates the dynamics of covid-19 in population . Further work is needed to validate these findings.,2019-01-11,2019,Joseph Rodriguez; John Smith; Robert Davis,PLOS ONE,PMC,10.0000/474855.818,67,5
62d37e89-fdc2-4b29-98de-4df231ca6532,Therapeutics comprehensive evaluation of patients,Our analysis presents outcomes for immunity in patients . Here we report presents the dynamics of epidemiology in patients . The investigation assesses trends in outcomes in clinical settings . Our analysis evaluates the effectiveness of vaccine in a cohort . The investigation investigates the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2015-09-02,2015,John Miller; Jessica Smith; Jessica Gonzalez; James Lopez; Susan Johnson,Unknown,Publisher,10.0000/657043.774,60,5
bbe00f11-5916-4c3b-b40e-c303a4b09d87,Serology long-term investigation of outcomes,Here we report evaluates outcomes for therapeutics in hospitalized individuals . This study presents the impact of pandemic in hospitalized individuals . The investigation assesses outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2020-11-05,2020,Joseph Gonzalez; Michael Rodriguez; Mary Hernandez; Jennifer Jones; Richard Jones,The Lancet,medRxiv,10.0000/836498.209,40,5
951e5843-629e-4de4-ab3c-3dd4a4064ec7,Therapeutics comparative evaluation of outcomes,Here we report reports on trends in diagnostics in population . We reports on the effectiveness of therapeutics in clinical settings . The investigation evaluates trends in clinical in hospitalized individuals . This study presents the effectiveness of variants in patients . The investigation evaluates the dynamics of clinical in a cohort . The investigation reports on the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2020-11-15,2020,James Davis; Mary Garcia,bioRxiv,medRxiv,10.0000/629129.879,72,5
1434fbf3-3415-4e1e-a57a-cca00997b947,SARS-CoV-2 comprehensive study of data : implications for vaccination strategies,Our analysis assesses outcomes for sars-cov-2 in patients . We reports on outcomes for sars-cov-2 in population . Our analysis presents the impact of transmission in population . We reports on the dynamics of covid-19 in clinical settings . Further work is needed to validate these findings.,2016-07-04,2016,Jennifer Rodriguez,Clinical Infectious Diseases,Publisher,10.0000/569776.270,47,10
d5b66d01-6d87-40c7-a45b-6154a7121de4,Immunity statistical report of spread,Our analysis assesses outcomes for sars-cov-2 in population . This study reports on the dynamics of variants in population . Our analysis presents the effectiveness of immunity in population . Our analysis evaluates trends in variants in patients . The investigation presents the impact of coronavirus in hospitalized individuals . We presents the effectiveness of variants in population . The investigation assesses trends in serology in clinical settings . Further work is needed to validate these findings.,2016-11-01,2016,William Gonzalez; Jessica Anderson; James Martinez; Patricia Davis,medRxiv,ArXiv,10.0000/620448.717,77,5
80f4a9c4-1783-40dd-b719-fe8ba7b5f5db,SARS-CoV-2 regional review of patterns,We evaluates the impact of pandemic in population . Here we report evaluates trends in vaccine in population . We evaluates the effectiveness of clinical in clinical settings . We assesses the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2022-07-01,2022,Mary Wilson; Richard Miller,Nature,PMC,10.0000/125419.295,47,5
2f4819a2-b8c6-444a-9a90-5015a8a40e5b,Vaccine rapid study of incidence,Here we report presents the impact of variants in clinical settings . Our analysis evaluates the effectiveness of therapeutics in population . Here we report assesses the impact of genomics in clinical settings . We reports on the impact of serology in hospitalized individuals . Here we report presents outcomes for modeling in a cohort . Further work is needed to validate these findings.,2019-05-10,2019,William Wilson,Science,Publisher,10.0000/880882.280,64,5
8ba79093-2462-41c5-95dd-b8913e554e04,Vaccine long-term evaluation of incidence,Here we report presents the dynamics of outcomes in clinical settings . This study reports on the dynamics of outcomes in patients . We assesses outcomes for outcomes in population . Further work is needed to validate these findings.,2018-02-13,2018,Susan Johnson; Linda Garcia; James Brown; Jessica Martinez,medRxiv,bioRxiv,10.0000/329693.344,39,5
680ca0af-ecea-454b-a2c7-f565d445e1a5,Coronavirus clinical analysis of trends,Here we report evaluates the dynamics of serology in a cohort . We reports on the dynamics of modeling in clinical settings . Here we report evaluates outcomes for serology in patients . Our analysis presents the effectiveness of epidemiology in patients . This study presents outcomes for pandemic in population . The investigation assesses the effectiveness of clinical in population . We evaluates the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2019-01-26,2019,Jessica Martinez; Mary Williams; Jessica Lopez,Clinical Infectious Diseases,ArXiv,10.0000/588203.929,80,5
f81790ac-9514-4629-b042-199798808fbc,Vaccine preliminary investigation of incidence,We investigates the impact of vaccine in population . This study investigates the dynamics of covid-19 in a cohort . This study assesses trends in vaccine in hospitalized individuals . This study investigates the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2021-12-31,2021,Susan Garcia; Jennifer Rodriguez; Barbara Martinez; Susan Brown,Nature,bioRxiv,10.0000/493813.280,49,5
e47cffdf-9e6b-4911-82ad-76ce1645114b,Clinical clinical review of effectiveness,We assesses trends in outcomes in patients . This study investigates outcomes for vaccine in hospitalized individuals . Here we report evaluates the impact of sars-cov-2 in a cohort . Our analysis investigates trends in covid-19 in hospitalized individuals . This study reports on the impact of epidemiology in population . Further work is needed to validate these findings.,2019-01-21,2019,Susan Hernandez; Susan Gonzalez; Richard Hernandez; Mary Wilson; Susan Gonzalez,PLOS ONE,Crossref,10.0000/360782.128,59,5
4508a097-2c6b-49fb-88d1-09429f56e47b,Epidemiology global report of data : implications for vaccination strategies,The investigation presents the impact of modeling in population . We evaluates trends in clinical in clinical settings . This study evaluates outcomes for serology in population . Here we report evaluates the impact of covid-19 in patients . The investigation evaluates the impact of transmission in patients . The investigation reports on the effectiveness of immunity in clinical settings . The investigation investigates the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2015-07-06,2015,Barbara Hernandez; Patricia Hernandez,Journal of Infectious Diseases,PMC,10.0000/131287.944,80,10
1b8cef72-be29-4e62-8728-16c5aca3492e,Diagnostics rapid evaluation of spread,Our analysis assesses outcomes for serology in clinical settings . The investigation investigates the effectiveness of clinical in clinical settings . This study reports on outcomes for epidemiology in patients . We presents trends in transmission in hospitalized individuals . We reports on the dynamics of therapeutics in clinical settings . This study reports on outcomes for pandemic in population . Here we report investigates the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-05-16,2016,Barbara Williams; Elizabeth Williams; Jennifer Smith; William Rodriguez; James Wilson,PLOS ONE,Crossref,10.0000/984255.150,81,5
f7a90217-38fc-45a9-8dec-2c2c26b539fd,Modeling rapid report of prevalence,The investigation reports on outcomes for diagnostics in patients . This study assesses the impact of immunity in patients . Here we report evaluates the effectiveness of genomics in a cohort . This study presents the impact of sars-cov-2 in hospitalized individuals . The investigation presents the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-10-20,2016,Jessica Hernandez; Robert Miller,PLOS ONE,PMC,10.0000/622956.470,62,5
d0b06187-fe60-4f6d-b4ce-97ce479a1106,Coronavirus regional analysis of patients,We reports on the effectiveness of clinical in a cohort . Here we report reports on the dynamics of modeling in population . This study evaluates the effectiveness of variants in hospitalized individuals . Our analysis assesses the impact of therapeutics in hospitalized individuals . The investigation reports on outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2020-06-18,2020,Robert Lopez,The Lancet,ArXiv,10.0000/666773.847,64,5
05bd3d22-1e3f-47bd-ac0f-21995e72c035,Epidemiology comprehensive study of prevalence : implications for vaccination strategies,We reports on the dynamics of modeling in clinical settings . Our analysis presents the impact of coronavirus in patients . The investigation reports on the impact of transmission in population . This study evaluates outcomes for epidemiology in patients . Further work is needed to validate these findings.,2019-12-22,2019,Richard Davis; David Jones; Robert Gonzalez; James Wilson; John Jones,Science,Publisher,10.0000/187332.998,49,10
a43d2b2b-1eb4-459a-92b3-243d91bf1d76,Clinical comparative survey of response,The investigation reports on the effectiveness of diagnostics in population . Our analysis reports on outcomes for clinical in a cohort . The investigation reports on the impact of covid-19 in clinical settings . Our analysis evaluates the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2015-01-06,2015,Michael Smith; Michael Williams; David Lopez,BMJ,medRxiv,10.0000/806310.801,53,5
27631834-5eb1-447d-96b5-30212298f640,Immunity statistical evaluation of patterns : implications for public health,We presents the effectiveness of pandemic in clinical settings . This study assesses the effectiveness of epidemiology in a cohort . We presents the impact of vaccine in population . This study presents the impact of serology in clinical settings . Our analysis reports on trends in immunity in patients . The investigation presents trends in immunity in population . The investigation assesses trends in immunity in population . We evaluates the impact of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2016-03-15,2016,Richard Williams; Richard Wilson; Linda Williams,BMJ,ArXiv,10.0000/817131.286,87,10
6fd43d51-d774-44f5-9f44-6f3cc11e57d5,Transmission preliminary dynamics of effectiveness,This study evaluates the effectiveness of coronavirus in clinical settings . The investigation presents the dynamics of clinical in clinical settings . Here we report assesses outcomes for vaccine in clinical settings . We reports on the dynamics of transmission in clinical settings . The investigation investigates the dynamics of coronavirus in a cohort . This study assesses the dynamics of clinical in hospitalized individuals . This study evaluates outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2018-06-14,2018,Linda Rodriguez; Jessica Garcia; Joseph Jones; Elizabeth Miller; John Davis,BMJ,PMC,10.0000/209984.245,84,5
2e05c1e3-3b5b-46f1-be6b-0148f063690e,Immunity comprehensive assessment of data,This study investigates outcomes for pandemic in a cohort . This study presents the impact of genomics in hospitalized individuals . Our analysis investigates outcomes for immunity in hospitalized individuals . The investigation investigates outcomes for diagnostics in patients . We reports on the dynamics of clinical in population . This study presents trends in epidemiology in a cohort . We evaluates the dynamics of vaccine in hospitalized individuals . The investigation investigates the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2015-09-09,2015,Joseph Garcia; Joseph Brown; David Johnson; Linda Wilson; Patricia Anderson,The Lancet,bioRxiv,10.0000/515072.529,89,5
801bd2a6-3420-4f59-9349-46a4e5a3fdbd,Transmission comprehensive investigation of response,Our analysis presents outcomes for immunity in population . This study presents the effectiveness of immunity in patients . Here we report investigates trends in pandemic in population . This study investigates trends in vaccine in hospitalized individuals . We investigates outcomes for covid-19 in patients . Here we report evaluates the effectiveness of therapeutics in a cohort . This study evaluates the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-07-07,2016,Robert Miller,Unknown,Publisher,10.0000/599115.374,78,5
230c5af1-1c56-4166-a18d-45189f523d6d,Epidemiology comparative dynamics of outcomes : implications for policy,The investigation assesses the impact of outcomes in patients . Our analysis investigates trends in covid-19 in hospitalized individuals . We reports on the dynamics of serology in a cohort . The investigation evaluates the dynamics of clinical in a cohort . This study assesses trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-05-10,2021,Elizabeth Wilson; James Johnson; Patricia Anderson; Jennifer Jones; Joseph Johnson,Journal of Infectious Diseases,bioRxiv,10.0000/499977.972,60,9
a3a477a6-73d5-4741-a92c-4f16f66ce649,Epidemiology statistical analysis of data,We reports on the dynamics of serology in population . We reports on the effectiveness of clinical in patients . We presents outcomes for coronavirus in a cohort . This study presents the impact of transmission in a cohort . The investigation reports on the impact of covid-19 in clinical settings . Our analysis presents the dynamics of vaccine in patients . We evaluates the dynamics of clinical in clinical settings . Here we report evaluates the dynamics of clinical in patients . Further work is needed to validate these findings.,2015-07-25,2015,David Brown; Richard Wilson; Michael Martinez,Unknown,bioRxiv,10.0000/792641.259,91,5
40d2bc43-f918-4629-a3ee-1464da334d72,Diagnostics regional impact of incidence,Our analysis assesses the impact of serology in patients . Here we report investigates outcomes for transmission in population . Our analysis evaluates the dynamics of pandemic in hospitalized individuals . Our analysis assesses the dynamics of outcomes in patients . This study evaluates outcomes for coronavirus in clinical settings . Further work is needed to validate these findings.,2021-11-18,2021,James Lopez; Mary Lopez; Linda Johnson,medRxiv,Crossref,10.0000/636263.382,59,5
c2e4bf1a-d1f3-44ba-8852-e1ec8f9408a4,Outcomes clinical dynamics of incidence : implications for public health,Our analysis evaluates trends in clinical in clinical settings . This study assesses the dynamics of serology in clinical settings . The investigation evaluates outcomes for variants in clinical settings . The investigation evaluates trends in modeling in clinical settings . This study investigates the effectiveness of clinical in clinical settings . This study evaluates the impact of diagnostics in patients . The investigation evaluates the dynamics of clinical in hospitalized individuals . Our analysis investigates the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2020-06-15,2020,Patricia Williams; Jennifer Wilson; Michael Johnson; Elizabeth Garcia; Michael Anderson,The Lancet,Publisher,10.0000/396568.923,92,10
43e0846b-4f73-4375-94cb-02b0208771df,Outcomes preliminary evaluation of patients,Our analysis evaluates outcomes for diagnostics in a cohort . Here we report evaluates the effectiveness of serology in a cohort . Our analysis evaluates the impact of modeling in hospitalized individuals . Our analysis reports on trends in pandemic in patients . The investigation evaluates trends in modeling in hospitalized individuals . Our analysis investigates the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2015-09-25,2015,Barbara Davis; David Davis; Joseph Rodriguez,Science,PMC,10.0000/836456.920,72,5
dda55387-cf83-4440-9d20-492a1439efe9,Coronavirus regional analysis of spread : implications for vaccination strategies,Our analysis assesses the dynamics of vaccine in clinical settings . The investigation evaluates the effectiveness of outcomes in hospitalized individuals . The investigation evaluates the impact of diagnostics in hospitalized individuals . The investigation presents trends in sars-cov-2 in patients . Our analysis investigates trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2021-09-22,2021,Richard Brown; Patricia Anderson; James Hernandez,bioRxiv,medRxiv,10.0000/755737.433,60,10
3c7749b8-8246-4be1-be8a-0bfb22a1cd26,Pandemic clinical investigation of prevalence,Our analysis reports on trends in modeling in hospitalized individuals . This study assesses outcomes for therapeutics in population . Our analysis assesses trends in vaccine in hospitalized individuals . We reports on the dynamics of covid-19 in population . We evaluates trends in sars-cov-2 in patients . We investigates the impact of transmission in patients . Further work is needed to validate these findings.,2016-09-22,2016,Joseph Brown,BMJ,bioRxiv,10.0000/455683.201,65,5
428750dc-ce2e-4ea9-917b-b0c00ff49a9a,Diagnostics long-term evaluation of patterns : implications for vaccination strategies,Our analysis presents the dynamics of coronavirus in patients . We evaluates the dynamics of modeling in patients . Our analysis evaluates the dynamics of pandemic in population . This study investigates outcomes for variants in clinical settings . Our analysis evaluates the effectiveness of serology in population . Our analysis presents outcomes for sars-cov-2 in population . The investigation investigates trends in therapeutics in population . Here we report presents outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2016-03-14,2016,Jennifer Martinez; Jessica Jones; Mary Wilson; Jessica Smith,Clinical Infectious Diseases,Publisher,10.0000/864773.538,86,10
7936c521-203e-41af-8c52-348a546f36d6,Immunity rapid analysis of patients : implications for vaccination strategies,Here we report investigates outcomes for serology in a cohort . This study presents the impact of outcomes in clinical settings . Our analysis investigates trends in modeling in patients . Further work is needed to validate these findings.,2020-04-19,2020,Jennifer Anderson; Elizabeth Gonzalez; Mary Johnson; Patricia Martinez; Elizabeth Williams,Frontiers in Medicine,ArXiv,10.0000/961335.442,39,10
9d8fb758-99cd-4e23-9d75-3dceeab6fbcd,Modeling rapid study of incidence : implications for clinical practice,This study investigates the impact of modeling in population . We assesses trends in pandemic in patients . Our analysis assesses the impact of outcomes in population . Our analysis evaluates outcomes for vaccine in hospitalized individuals . This study evaluates the dynamics of variants in hospitalized individuals . Here we report investigates the dynamics of diagnostics in patients . Here we report reports on trends in transmission in a cohort . Further work is needed to validate these findings.,2021-04-27,2021,Elizabeth Brown; Richard Hernandez; Michael Martinez; Susan Williams; Barbara Lopez,Journal of Infectious Diseases,Publisher,10.0000/335476.673,80,10
e37e0ec2-7d7d-4d2a-a94b-904568dfa7b6,Therapeutics clinical survey of prevalence,Here we report assesses outcomes for variants in clinical settings . This study assesses the effectiveness of immunity in hospitalized individuals . The investigation evaluates the effectiveness of outcomes in a cohort . This study reports on trends in vaccine in patients . Here we report evaluates the dynamics of clinical in patients . Further work is needed to validate these findings.,2019-12-31,2019,Mary Brown; Barbara Davis,Nature,bioRxiv,10.0000/785900.491,62,5
464345d2-83bb-4ff5-a18b-63957fcba32f,Epidemiology comprehensive investigation of data : implications for clinical practice,Our analysis evaluates trends in covid-19 in hospitalized individuals . Our analysis investigates the dynamics of therapeutics in clinical settings . The investigation assesses outcomes for diagnostics in patients . Here we report assesses the impact of immunity in hospitalized individuals . We evaluates trends in vaccine in population . Our analysis assesses the impact of vaccine in population . Further work is needed to validate these findings.,2015-03-08,2015,Susan Smith; Elizabeth Williams; William Martinez,BMJ,medRxiv,10.0000/370362.459,68,10
5a62dfda-dcb1-4ac9-8e2b-bff88daf6db1,Diagnostics clinical review of patterns : implications for vaccination strategies,The investigation investigates the impact of clinical in hospitalized individuals . Our analysis assesses trends in clinical in population . Our analysis presents the effectiveness of outcomes in patients . Here we report presents outcomes for vaccine in population . Here we report presents outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2016-10-28,2016,Joseph Davis; Patricia Smith; Barbara Jones; James Smith; William Garcia,Clinical Infectious Diseases,ArXiv,10.0000/799440.886,59,10
6a546054-6760-413a-9602-0a5dcdf2def0,Vaccine statistical study of effectiveness,Our analysis reports on trends in modeling in hospitalized individuals . Our analysis assesses trends in immunity in clinical settings . We assesses the impact of transmission in population . This study assesses the dynamics of sars-cov-2 in clinical settings . This study assesses outcomes for variants in a cohort . This study reports on trends in transmission in clinical settings . The investigation reports on the impact of serology in patients . Further work is needed to validate these findings.,2019-04-17,2019,John Garcia; James Davis; Michael Wilson; Michael Davis; Richard Johnson,Science,Publisher,10.0000/602820.402,81,5
17d52bf4-4b38-466c-a335-8e3da1bb71cd,Outcomes global dynamics of spread,The investigation evaluates the dynamics of diagnostics in population . We reports on outcomes for therapeutics in population . This study presents the dynamics of pandemic in population . Our analysis investigates trends in epidemiology in a cohort . Here we report presents the effectiveness of outcomes in population . The investigation investigates the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2020-08-28,2020,Robert Rodriguez; David Wilson; James Gonzalez,Journal of Infectious Diseases,Crossref,10.0000/325556.830,69,5
c9194557-5982-4197-b3ab-36aa0b518b00,Epidemiology clinical survey of data : implications for policy,We reports on outcomes for therapeutics in a cohort . This study investigates trends in outcomes in hospitalized individuals . We investigates the effectiveness of diagnostics in population . The investigation presents the impact of diagnostics in hospitalized individuals . We reports on outcomes for coronavirus in hospitalized individuals . This study reports on trends in sars-cov-2 in population . Further work is needed to validate these findings.,2022-12-12,2022,Jessica Martinez,Science,PMC,10.0000/728261.359,68,9
7eca39d5-53cf-4887-9bd0-2c993ad3a75f,Epidemiology rapid assessment of patterns,Here we report presents the effectiveness of transmission in patients . Our analysis assesses the impact of transmission in population . The investigation reports on the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2018-09-08,2018,Jessica Smith; Robert Hernandez; William Rodriguez,The Lancet,Crossref,10.0000/898311.386,41,5
ba7e1e3b-8c44-4fb8-982a-226eba121375,Coronavirus global survey of spread,Here we report reports on trends in clinical in clinical settings . We reports on the dynamics of genomics in hospitalized individuals . The investigation assesses the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2021-03-18,2021,Barbara Williams; Michael Miller; Barbara Brown; Jennifer Rodriguez,The Lancet,Crossref,10.0000/462262.256,41,5
0ba27e28-2785-4873-8235-6d4b88ef324b,Vaccine comparative assessment of outcomes : implications for policy,Here we report investigates the impact of diagnostics in hospitalized individuals . This study presents outcomes for coronavirus in patients . We assesses the impact of therapeutics in population . This study assesses the impact of transmission in clinical settings . We reports on the impact of transmission in a cohort . Our analysis presents the effectiveness of clinical in clinical settings . Here we report evaluates trends in modeling in population . Further work is needed to validate these findings.,2015-03-14,2015,Mary Garcia; Robert Lopez; Elizabeth Davis,bioRxiv,Crossref,10.0000/522691.369,81,9
1006deb5-1677-4a92-bcd9-4982aa21d0b8,Clinical comprehensive dynamics of response,We presents the effectiveness of modeling in a cohort . The investigation assesses trends in transmission in hospitalized individuals . The investigation evaluates outcomes for outcomes in hospitalized individuals . The investigation investigates the effectiveness of transmission in hospitalized individuals . This study evaluates the effectiveness of vaccine in clinical settings . The investigation evaluates outcomes for outcomes in population . Our analysis presents trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2020-10-05,2020,Mary Johnson; Joseph Jones; Joseph Smith,Journal of Infectious Diseases,medRxiv,10.0000/214631.927,79,5
1dfdb59c-d4ef-45ce-81f6-cca92a589a85,Modeling preliminary survey of outcomes : implications for policy,This study assesses the dynamics of diagnostics in hospitalized individuals . The investigation presents the dynamics of covid-19 in population . Our analysis evaluates the dynamics of outcomes in a cohort . Further work is needed to validate these findings.,2020-11-14,2020,David Williams,medRxiv,Crossref,10.0000/243895.614,40,9
3369a1b9-b6e8-4c78-9ebf-87da6d16a87b,COVID-19 global assessment of patients,The investigation investigates trends in epidemiology in population . The investigation presents the dynamics of variants in a cohort . We reports on the dynamics of vaccine in a cohort . The investigation presents outcomes for diagnostics in population . We investigates outcomes for immunity in population . Our analysis evaluates the dynamics of genomics in clinical settings . Our analysis reports on the effectiveness of modeling in a cohort . Further work is needed to validate these findings.,2016-06-22,2016,Robert Rodriguez; James Johnson,PLOS ONE,medRxiv,10.0000/984969.953,79,5
c407b773-b934-4986-9cc6-535f641e50f7,Pandemic regional study of patients : implications for vaccination strategies,The investigation reports on outcomes for diagnostics in patients . We reports on trends in diagnostics in population . This study investigates outcomes for diagnostics in population . Further work is needed to validate these findings.,2017-01-27,2017,James Smith; Richard Jones; Linda Wilson,Journal of Infectious Diseases,Publisher,10.0000/252695.656,36,10
0c9a6d17-8d17-48e3-9727-1887e2beb278,Clinical preliminary review of data : implications for vaccination strategies,This study investigates the dynamics of immunity in hospitalized individuals . Here we report assesses the effectiveness of clinical in hospitalized individuals . The investigation assesses the impact of clinical in population . We assesses the effectiveness of modeling in clinical settings . The investigation evaluates outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2015-05-08,2015,Linda Wilson; Barbara Williams; James Smith; Linda Williams; Elizabeth Hernandez,Unknown,bioRxiv,10.0000/535218.645,61,10
0aa228d9-4903-47c3-89e2-4740da54bc7c,SARS-CoV-2 preliminary report of effectiveness,The investigation investigates outcomes for variants in patients . The investigation evaluates trends in outcomes in population . This study evaluates outcomes for covid-19 in clinical settings . Here we report assesses outcomes for modeling in population . We presents trends in serology in a cohort . Our analysis reports on the impact of covid-19 in patients . Our analysis assesses the effectiveness of outcomes in population . Further work is needed to validate these findings.,2022-08-08,2022,Mary Smith; Richard Lopez,Journal of Infectious Diseases,Publisher,10.0000/224177.722,76,5
11701bb0-f635-4880-ace1-4c2a0e69cc01,Genomics long-term report of patterns,Here we report assesses the effectiveness of clinical in population . Here we report presents the impact of modeling in hospitalized individuals . The investigation investigates trends in pandemic in a cohort . Further work is needed to validate these findings.,2015-10-07,2015,William Rodriguez,medRxiv,medRxiv,10.0000/984704.656,41,5
4357b849-f4db-48dd-a9a2-a83594f33adb,Epidemiology clinical review of trends,Here we report presents outcomes for transmission in clinical settings . Our analysis presents the dynamics of transmission in a cohort . Our analysis reports on trends in immunity in patients . Here we report evaluates the dynamics of sars-cov-2 in patients . Here we report investigates trends in therapeutics in a cohort . This study presents outcomes for sars-cov-2 in a cohort . We investigates the dynamics of covid-19 in clinical settings . We investigates the impact of genomics in clinical settings . Further work is needed to validate these findings.,2021-05-30,2021,Susan Smith; Robert Johnson; Patricia Rodriguez; William Johnson; Barbara Martinez,Unknown,medRxiv,10.0000/380719.739,92,5
d3f47330-c232-4917-8b4d-4c70d4070187,Modeling comparative review of patients,We reports on the dynamics of modeling in population . The investigation assesses trends in epidemiology in clinical settings . We reports on outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2020-03-20,2020,John Brown; Elizabeth Hernandez; Michael Anderson,The Lancet,PMC,10.0000/988203.818,38,5
3be5fb64-3935-4eda-b071-7116680e3fda,Modeling clinical investigation of incidence,The investigation evaluates trends in vaccine in hospitalized individuals . This study presents the dynamics of sars-cov-2 in clinical settings . This study assesses the dynamics of clinical in clinical settings . We assesses the dynamics of serology in a cohort . This study investigates the dynamics of therapeutics in patients . We reports on the effectiveness of pandemic in patients . We assesses the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2021-06-11,2021,Robert Brown; Jessica Davis; Joseph Brown,bioRxiv,ArXiv,10.0000/271415.415,80,5
0555b2fc-34ca-4aae-8eb5-aa4b9415ba04,Modeling rapid impact of data,The investigation reports on the effectiveness of coronavirus in a cohort . The investigation evaluates the dynamics of therapeutics in patients . This study presents outcomes for vaccine in patients . We evaluates trends in immunity in clinical settings . Our analysis assesses trends in pandemic in patients . Further work is needed to validate these findings.,2015-12-16,2015,William Lopez; David Jones,Science,Publisher,10.0000/245981.724,57,5
12512389-39b8-4d63-ae99-caa917d40cca,Genomics clinical dynamics of patterns,We investigates the effectiveness of modeling in hospitalized individuals . We assesses the impact of vaccine in population . This study investigates the dynamics of vaccine in patients . The investigation presents the dynamics of serology in patients . We presents the dynamics of vaccine in patients . Our analysis reports on trends in covid-19 in hospitalized individuals . The investigation assesses the dynamics of clinical in hospitalized individuals . This study assesses trends in diagnostics in patients . Further work is needed to validate these findings.,2016-01-06,2016,Linda Gonzalez; John Brown,medRxiv,Crossref,10.0000/990470.345,87,5
49a708b9-9e36-429e-8726-7925c0474e38,Vaccine comparative report of response,The investigation reports on trends in diagnostics in population . This study presents the dynamics of sars-cov-2 in a cohort . Here we report evaluates outcomes for clinical in a cohort . Further work is needed to validate these findings.,2021-07-12,2021,Jessica Anderson,Unknown,PMC,10.0000/129648.335,40,5
b7c0e5be-4bf7-4d8c-9b97-8ce4195329cc,Outcomes comparative dynamics of data,This study investigates trends in sars-cov-2 in clinical settings . Here we report presents outcomes for covid-19 in hospitalized individuals . This study evaluates the impact of sars-cov-2 in patients . Our analysis assesses outcomes for therapeutics in clinical settings . This study assesses outcomes for vaccine in clinical settings . Here we report investigates outcomes for outcomes in hospitalized individuals . Our analysis investigates the impact of outcomes in population . The investigation evaluates the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2015-05-03,2015,John Jones,medRxiv,PMC,10.0000/425779.280,91,5
fb020ca8-c8ec-46cf-9b61-c0f893ac396e,Clinical preliminary report of incidence,The investigation investigates the effectiveness of covid-19 in hospitalized individuals . The investigation evaluates the dynamics of pandemic in a cohort . This study presents the dynamics of epidemiology in hospitalized individuals . This study investigates the impact of outcomes in a cohort . Our analysis investigates trends in clinical in patients . This study reports on outcomes for epidemiology in a cohort . We reports on the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2022-12-19,2022,Patricia Garcia; Patricia Hernandez; Barbara Miller; Michael Gonzalez; Elizabeth Lopez,Journal of Infectious Diseases,bioRxiv,10.0000/990812.362,83,5
7b6bf653-41b9-4939-b8f3-39cc57a76746,Modeling regional analysis of spread,The investigation investigates the dynamics of clinical in a cohort . We investigates the impact of genomics in patients . Here we report presents the dynamics of therapeutics in population . Further work is needed to validate these findings.,2015-02-17,2015,Patricia Davis; Barbara Garcia; James Jones; Jessica Wilson,Clinical Infectious Diseases,medRxiv,10.0000/711866.939,39,5
98658c95-3723-437f-9ee2-37544d9dd7a0,Modeling preliminary study of prevalence,Our analysis investigates the effectiveness of modeling in population . Here we report presents trends in covid-19 in hospitalized individuals . Here we report reports on the dynamics of clinical in clinical settings . Our analysis evaluates the effectiveness of clinical in patients . Further work is needed to validate these findings.,2015-12-10,2015,John Wilson; Robert Smith; Mary Smith; William Smith; Linda Smith,Journal of Infectious Diseases,PMC,10.0000/414470.530,52,5
c0713cda-bede-4a9d-bebf-a8159656ed72,Outcomes comparative impact of patterns,The investigation investigates outcomes for immunity in clinical settings . This study evaluates the dynamics of pandemic in hospitalized individuals . Our analysis investigates outcomes for epidemiology in population . Further work is needed to validate these findings.,2018-01-31,2018,Jessica Smith,PLOS ONE,Crossref,10.0000/920323.718,38,5
064bbb47-967f-418b-948e-5e1ed6c33f32,Therapeutics rapid investigation of effectiveness : implications for clinical practice,Our analysis evaluates outcomes for epidemiology in clinical settings . Our analysis evaluates the dynamics of therapeutics in patients . This study investigates the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2017-12-09,2017,Richard Gonzalez; Susan Garcia,Nature,medRxiv,10.0000/862819.965,39,10
fb89ec52-2681-466c-8549-a9dd2c097596,Outcomes comprehensive report of incidence : implications for clinical practice,Here we report reports on outcomes for transmission in patients . Here we report evaluates the dynamics of epidemiology in patients . The investigation presents the dynamics of epidemiology in clinical settings . We investigates the dynamics of covid-19 in patients . Here we report presents trends in therapeutics in population . This study assesses the impact of transmission in a cohort . This study reports on the impact of modeling in patients . The investigation assesses trends in immunity in patients . Further work is needed to validate these findings.,2016-11-11,2016,Barbara Smith; Susan Garcia; Richard Davis; Joseph Lopez; Michael Hernandez,bioRxiv,Publisher,10.0000/634197.472,91,10
21d34baf-2de3-4641-8a88-58c3f1bdbfa7,SARS-CoV-2 statistical investigation of outcomes,Our analysis reports on trends in diagnostics in patients . The investigation assesses the effectiveness of vaccine in a cohort . We evaluates the dynamics of sars-cov-2 in hospitalized individuals . Our analysis assesses the dynamics of sars-cov-2 in population . Our analysis assesses trends in outcomes in clinical settings . We investigates trends in diagnostics in population . This study assesses trends in sars-cov-2 in population . Further work is needed to validate these findings.,2018-07-17,2018,Jennifer Anderson,PLOS ONE,PMC,10.0000/187186.481,76,5
ab01693d-f544-4eea-80d2-5c304615a248,Variants comparative investigation of spread,Here we report assesses outcomes for sars-cov-2 in a cohort . Our analysis evaluates trends in vaccine in population . Our analysis evaluates outcomes for transmission in a cohort . Our analysis investigates the dynamics of transmission in patients . Further work is needed to validate these findings.,2021-06-24,2021,Elizabeth Wilson; David Johnson; Robert Jones,The Lancet,PMC,10.0000/638686.513,48,5
8c7b7201-2149-4d67-8989-b9a6c7076b07,Coronavirus statistical dynamics of patients : implications for vaccination strategies,Here we report reports on outcomes for diagnostics in hospitalized individuals . We reports on the effectiveness of coronavirus in a cohort . The investigation presents trends in modeling in clinical settings . We assesses the effectiveness of modeling in a cohort . Here we report evaluates the dynamics of transmission in hospitalized individuals . This study reports on outcomes for sars-cov-2 in a cohort . We evaluates trends in therapeutics in population . Further work is needed to validate these findings.,2015-07-08,2015,William Lopez; John Rodriguez,Science,PMC,10.0000/154463.587,82,10
e18e68da-9c03-46c4-9ce1-5546f29593de,Outcomes comparative investigation of response,This study assesses the impact of variants in patients . Here we report investigates the effectiveness of covid-19 in population . The investigation investigates trends in vaccine in a cohort . Here we report presents outcomes for therapeutics in clinical settings . This study presents the dynamics of variants in hospitalized individuals . The investigation investigates outcomes for modeling in population . Further work is needed to validate these findings.,2016-10-27,2016,Joseph Brown; Richard Wilson; John Miller,Science,Crossref,10.0000/588661.455,70,5
82b869f4-e9e2-4632-9856-1f8f64a47eb8,Modeling global report of patterns : implications for policy,Here we report reports on outcomes for genomics in patients . This study assesses the dynamics of immunity in clinical settings . Our analysis presents outcomes for variants in clinical settings . Our analysis presents the effectiveness of genomics in patients . We assesses the dynamics of serology in clinical settings . This study investigates outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2016-04-23,2016,Robert Gonzalez; David Jones; John Davis; Elizabeth Miller; Michael Anderson,Nature,Publisher,10.0000/401221.547,70,9
b8def6c1-0670-4a81-8969-565000b118cc,Vaccine clinical assessment of incidence,We assesses the dynamics of genomics in patients . This study evaluates trends in clinical in a cohort . This study presents the impact of outcomes in clinical settings . We evaluates trends in transmission in patients . Our analysis evaluates outcomes for immunity in population . Further work is needed to validate these findings.,2016-01-26,2016,Jessica Anderson; Robert Jones; David Martinez,The Lancet,bioRxiv,10.0000/826686.222,55,5
74ffd640-4c28-42de-9830-1b669e3a3bb6,Pandemic global analysis of data,We presents the dynamics of genomics in hospitalized individuals . Our analysis presents outcomes for immunity in a cohort . The investigation reports on the effectiveness of coronavirus in population . This study reports on the impact of vaccine in patients . The investigation presents trends in serology in patients . We investigates the impact of coronavirus in a cohort . The investigation investigates outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2016-12-19,2016,Linda Brown; Michael Miller; Jessica Williams; Barbara Brown; James Miller,The Lancet,PMC,10.0000/978147.924,79,5
eb7df3e6-d96a-4a5e-bf68-8119fdf197b1,COVID-19 rapid assessment of spread,We reports on the effectiveness of serology in patients . We evaluates trends in outcomes in hospitalized individuals . This study presents the effectiveness of epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2015-04-19,2015,Joseph Johnson; Joseph Jones,Journal of Infectious Diseases,medRxiv,10.0000/479197.699,38,5
ad36cc11-30b6-4366-972d-db94703f7579,Therapeutics comparative study of data,The investigation presents the impact of outcomes in patients . We assesses outcomes for outcomes in hospitalized individuals . We investigates trends in immunity in a cohort . The investigation reports on the effectiveness of serology in population . This study evaluates outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2021-02-25,2021,John Brown; Patricia Williams; Robert Garcia; David Jones,The Lancet,bioRxiv,10.0000/759456.633,57,5
38bc1735-f674-4956-82a7-4176776ed12e,Outcomes comprehensive investigation of trends,Here we report evaluates outcomes for diagnostics in hospitalized individuals . Our analysis investigates the impact of variants in a cohort . We reports on trends in genomics in hospitalized individuals . This study reports on the effectiveness of serology in a cohort . Our analysis investigates the impact of therapeutics in a cohort . Here we report presents the impact of coronavirus in population . Further work is needed to validate these findings.,2015-05-02,2015,John Wilson; Barbara Rodriguez; Michael Anderson; William Wilson,BMJ,bioRxiv,10.0000/429962.596,74,5
136ca457-8825-4d92-87ab-9dfcd8a816a8,Diagnostics regional evaluation of patients,Here we report reports on the impact of pandemic in population . We presents the dynamics of outcomes in clinical settings . The investigation assesses outcomes for variants in patients . Here we report evaluates the dynamics of variants in population . The investigation investigates trends in pandemic in clinical settings . Our analysis investigates trends in coronavirus in hospitalized individuals . The investigation evaluates trends in clinical in a cohort . Here we report reports on trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2015-05-30,2015,Robert Gonzalez; John Miller,Unknown,Crossref,10.0000/543877.928,92,5
6a2d0021-e155-4a24-9054-b1378b678e2b,Serology comprehensive evaluation of response : implications for public health,We evaluates the effectiveness of outcomes in hospitalized individuals . Here we report presents the effectiveness of pandemic in population . Our analysis assesses outcomes for variants in hospitalized individuals . The investigation presents outcomes for therapeutics in population . Here we report presents the impact of genomics in patients . Here we report investigates the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2020-01-25,2020,Jennifer Gonzalez; James Garcia; Joseph Anderson; Elizabeth Miller,The Lancet,medRxiv,10.0000/234198.123,71,10
b1283215-de2c-4d1d-9eb6-5c46e5986d2a,Coronavirus comparative survey of outcomes : implications for policy,Here we report presents the effectiveness of pandemic in patients . We presents outcomes for serology in a cohort . Here we report presents the dynamics of pandemic in population . Here we report presents trends in covid-19 in clinical settings . We reports on the dynamics of serology in clinical settings . This study investigates the impact of sars-cov-2 in patients . The investigation assesses the impact of diagnostics in a cohort . We assesses trends in variants in clinical settings . Further work is needed to validate these findings.,2021-04-13,2021,Robert Anderson; Patricia Anderson; Joseph Wilson,Frontiers in Medicine,medRxiv,10.0000/883454.871,91,9
0ca8c9b5-cd83-42f3-8060-95593bf1de3c,COVID-19 regional dynamics of spread,We presents outcomes for immunity in hospitalized individuals . Here we report investigates outcomes for serology in clinical settings . Our analysis presents the effectiveness of diagnostics in hospitalized individuals . We investigates the impact of serology in a cohort . This study presents trends in outcomes in population . Here we report investigates the effectiveness of variants in clinical settings . The investigation presents trends in pandemic in population . We reports on outcomes for modeling in patients . Further work is needed to validate these findings.,2017-11-26,2017,Elizabeth Anderson; Jennifer Rodriguez; Robert Jones; Mary Johnson,Science,PMC,10.0000/933209.850,88,5
8b21cf49-0088-475e-ae7e-c690c4c1ce58,Transmission rapid evaluation of data,This study assesses the dynamics of pandemic in population . The investigation assesses the dynamics of genomics in population . The investigation reports on the dynamics of modeling in population . Our analysis assesses the dynamics of immunity in population . This study presents the effectiveness of transmission in a cohort . The investigation evaluates the dynamics of modeling in a cohort . The investigation presents trends in pandemic in patients . Our analysis assesses the effectiveness of clinical in population . Further work is needed to validate these findings.,2020-11-15,2020,Susan Miller; Michael Martinez; Patricia Gonzalez; William Johnson; James Davis,Nature,bioRxiv,10.0000/919760.443,90,5
4db9cec5-1a26-4fed-bd3a-bf9b4b84f434,Diagnostics comprehensive assessment of data,The investigation investigates outcomes for diagnostics in a cohort . The investigation evaluates the impact of immunity in clinical settings . The investigation investigates the impact of modeling in hospitalized individuals . Our analysis evaluates trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2015-09-09,2015,Joseph Martinez,bioRxiv,Crossref,10.0000/123582.106,50,5
139b642a-7ce5-4a67-82fa-ff3d00df54cc,Vaccine statistical dynamics of response : implications for clinical practice,This study assesses trends in epidemiology in a cohort . The investigation presents outcomes for immunity in population . Our analysis evaluates the impact of covid-19 in patients . Our analysis investigates the effectiveness of modeling in clinical settings . We assesses the effectiveness of genomics in clinical settings . We assesses outcomes for sars-cov-2 in hospitalized individuals . Our analysis investigates outcomes for outcomes in population . Our analysis evaluates trends in diagnostics in population . Further work is needed to validate these findings.,2022-03-27,2022,John Hernandez,Clinical Infectious Diseases,bioRxiv,10.0000/317572.169,85,10
48d66a02-c51e-42c5-9332-d686bbe2a9ad,Immunity rapid investigation of spread,This study evaluates the dynamics of outcomes in a cohort . Here we report assesses the impact of coronavirus in population . The investigation investigates trends in serology in patients . The investigation reports on the effectiveness of genomics in population . This study reports on trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2021-09-26,2021,Mary Lopez; William Hernandez,The Lancet,medRxiv,10.0000/136343.360,61,5
e61a1a5c-3a29-4c54-a015-07d48c53f75a,Clinical clinical report of trends : implications for policy,Our analysis reports on the impact of clinical in patients . This study reports on the dynamics of covid-19 in patients . The investigation reports on the effectiveness of diagnostics in hospitalized individuals . Here we report evaluates the impact of modeling in patients . Here we report investigates outcomes for pandemic in population . Here we report reports on outcomes for coronavirus in patients . We assesses trends in transmission in a cohort . Here we report presents the impact of transmission in clinical settings . Further work is needed to validate these findings.,2017-11-29,2017,Susan Hernandez; William Garcia,medRxiv,ArXiv,10.0000/869323.641,95,9
d6b517ec-1b3a-4800-8311-c40389acdf3d,SARS-CoV-2 comparative study of data,This study investigates the effectiveness of transmission in hospitalized individuals . The investigation presents the impact of serology in population . The investigation reports on the effectiveness of modeling in population . We reports on the dynamics of outcomes in hospitalized individuals . This study evaluates outcomes for variants in population . We reports on the impact of transmission in patients . Our analysis reports on outcomes for variants in a cohort . This study assesses the dynamics of variants in a cohort . Further work is needed to validate these findings.,2016-03-26,2016,Robert Anderson; Jennifer Garcia; Mary Wilson; Robert Rodriguez,The Lancet,medRxiv,10.0000/246900.803,92,5
64f86d96-f144-407c-b095-4bd0e6013414,Transmission comparative study of data,Our analysis presents the dynamics of immunity in population . Our analysis assesses the impact of variants in population . We assesses the effectiveness of sars-cov-2 in a cohort . We investigates the impact of clinical in patients . Further work is needed to validate these findings.,2019-06-29,2019,David Brown; Linda Hernandez,PLOS ONE,medRxiv,10.0000/621695.740,47,5
30c4aa73-c2c0-42fe-84ea-33ac28fbfa98,Pandemic regional impact of incidence : implications for policy,The investigation reports on the impact of immunity in patients . This study assesses outcomes for diagnostics in patients . We investigates trends in outcomes in patients . Here we report assesses trends in sars-cov-2 in patients . Our analysis reports on the impact of modeling in hospitalized individuals . This study reports on the impact of outcomes in patients . The investigation investigates the impact of vaccine in population . Further work is needed to validate these findings.,2015-05-13,2015,John Wilson; Joseph Martinez; Linda Gonzalez; Elizabeth Smith; James Davis,Unknown,PMC,10.0000/335848.607,79,9
789c8ce0-9660-4f4e-8f91-1fba6e570fc7,Coronavirus preliminary survey of patterns,We presents trends in pandemic in hospitalized individuals . Here we report investigates the dynamics of sars-cov-2 in clinical settings . This study assesses the dynamics of coronavirus in patients . Further work is needed to validate these findings.,2021-11-13,2021,Jessica Lopez; Elizabeth Johnson,The Lancet,ArXiv,10.0000/727679.784,39,5
c8659646-89a0-4fc3-a902-ed5aeb389b8e,Outcomes regional investigation of patterns,The investigation investigates trends in variants in patients . The investigation investigates the impact of transmission in clinical settings . The investigation presents the impact of genomics in clinical settings . The investigation evaluates trends in modeling in population . Our analysis evaluates the effectiveness of outcomes in population . This study presents trends in transmission in clinical settings . We investigates the effectiveness of serology in clinical settings . Further work is needed to validate these findings.,2019-07-13,2019,Jennifer Johnson; Jennifer Martinez; William Lopez,Frontiers in Medicine,Crossref,10.0000/848647.246,78,5
67845443-ea33-41ea-b5c3-b480b5da8c27,Clinical long-term evaluation of spread,Here we report investigates outcomes for epidemiology in clinical settings . This study assesses the dynamics of covid-19 in patients . This study assesses trends in clinical in population . This study investigates trends in immunity in population . Further work is needed to validate these findings.,2018-03-17,2018,Susan Gonzalez,PLOS ONE,Crossref,10.0000/857621.419,47,5
8d2a9104-54bd-4619-894d-544aa53e5822,Outcomes clinical dynamics of data,Here we report presents outcomes for diagnostics in population . Our analysis reports on the impact of genomics in clinical settings . Here we report assesses the dynamics of covid-19 in patients . Our analysis reports on trends in sars-cov-2 in hospitalized individuals . We reports on the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2016-12-30,2016,James Martinez; Barbara Anderson; Patricia Wilson,Unknown,medRxiv,10.0000/102118.806,62,5
00b69063-3ae3-406e-8c9f-9ce3708e6e8f,Therapeutics statistical review of effectiveness : implications for policy,This study presents trends in immunity in patients . The investigation presents the effectiveness of transmission in a cohort . This study investigates trends in genomics in clinical settings . The investigation reports on the effectiveness of sars-cov-2 in hospitalized individuals . The investigation assesses outcomes for vaccine in population . This study evaluates the effectiveness of coronavirus in clinical settings . This study presents the dynamics of variants in a cohort . Further work is needed to validate these findings.,2015-03-30,2015,William Rodriguez,PLOS ONE,PMC,10.0000/262558.837,81,9
dc8e44f7-e778-4fae-bc3c-d882e95f9646,Coronavirus preliminary investigation of patients,The investigation assesses outcomes for outcomes in a cohort . Our analysis presents the dynamics of variants in hospitalized individuals . We evaluates the impact of vaccine in clinical settings . The investigation investigates the dynamics of clinical in hospitalized individuals . Our analysis investigates the impact of covid-19 in population . This study evaluates the impact of sars-cov-2 in clinical settings . The investigation assesses the effectiveness of diagnostics in clinical settings . Our analysis reports on the effectiveness of genomics in patients . Further work is needed to validate these findings.,2018-06-18,2018,Elizabeth Gonzalez; Robert Davis,Unknown,bioRxiv,10.0000/834208.504,93,5
3e1c2eea-4b65-4dc4-9822-9abc1cd2c887,Transmission clinical assessment of incidence : implications for public health,This study reports on outcomes for epidemiology in a cohort . This study investigates the dynamics of pandemic in a cohort . Here we report assesses the dynamics of variants in population . Our analysis evaluates outcomes for clinical in a cohort . The investigation investigates the effectiveness of diagnostics in population . This study presents outcomes for modeling in population . Our analysis presents the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-09-11,2022,Barbara Wilson; John Davis; Patricia Miller; Joseph Brown; Mary Anderson,Unknown,Crossref,10.0000/507831.427,81,10
c9aedd5d-3c95-431b-a4cd-8f65ca5b6d17,SARS-CoV-2 rapid impact of spread,Here we report evaluates the impact of variants in clinical settings . The investigation investigates trends in outcomes in population . This study presents the dynamics of covid-19 in hospitalized individuals . Our analysis presents the impact of pandemic in hospitalized individuals . Here we report presents the effectiveness of immunity in clinical settings . Our analysis assesses the impact of transmission in population . Further work is needed to validate these findings.,2021-02-01,2021,William Anderson,Nature,Crossref,10.0000/565690.285,73,5
f2cc7f68-215e-485b-ad24-985898cf25a2,COVID-19 global survey of trends : implications for clinical practice,This study presents outcomes for therapeutics in clinical settings . Here we report presents the dynamics of variants in a cohort . This study presents the effectiveness of immunity in a cohort . Our analysis presents trends in sars-cov-2 in patients . Our analysis evaluates trends in serology in patients . The investigation presents the dynamics of pandemic in a cohort . Further work is needed to validate these findings.,2019-03-03,2019,Jessica Johnson,Journal of Infectious Diseases,medRxiv,10.0000/409125.943,70,10
8d7cc640-e8a9-49e5-b9ab-85de6c128a23,Modeling clinical investigation of outcomes,This study presents trends in clinical in hospitalized individuals . The investigation evaluates the impact of serology in hospitalized individuals . This study evaluates the effectiveness of outcomes in patients . Our analysis investigates trends in genomics in patients . This study investigates trends in therapeutics in clinical settings . Here we report evaluates trends in coronavirus in a cohort . Further work is needed to validate these findings.,2021-06-18,2021,Jennifer Hernandez,medRxiv,ArXiv,10.0000/772843.279,69,5
84103269-8c54-4e02-a34e-2a08a58dc8ce,Outcomes comparative assessment of patterns : implications for vaccination strategies,We assesses the effectiveness of sars-cov-2 in patients . This study investigates the effectiveness of outcomes in hospitalized individuals . The investigation evaluates the effectiveness of modeling in population . We assesses the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2019-09-07,2019,Mary Miller; Jessica Jones; Michael Williams; Richard Johnson; Elizabeth Anderson,Journal of Infectious Diseases,medRxiv,10.0000/803403.192,48,10
315b014a-d18f-4000-be56-eaa2dd9e56e8,Pandemic clinical evaluation of prevalence,This study assesses the dynamics of transmission in hospitalized individuals . Here we report investigates the dynamics of vaccine in population . This study evaluates outcomes for variants in a cohort . Further work is needed to validate these findings.,2015-02-15,2015,William Jones,Frontiers in Medicine,bioRxiv,10.0000/365436.369,40,5
6352f5f7-998a-4d99-bfec-6ffc291f279d,Transmission comparative assessment of data,The investigation assesses the dynamics of outcomes in a cohort . We reports on the dynamics of therapeutics in clinical settings . The investigation assesses the dynamics of coronavirus in hospitalized individuals . The investigation evaluates trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2019-03-25,2019,David Davis; David Williams; William Hernandez,BMJ,ArXiv,10.0000/801154.601,51,5
8630d6a2-7029-4144-9c93-d9f3a8a649b0,Therapeutics statistical survey of trends,This study investigates the impact of serology in clinical settings . Here we report presents the dynamics of modeling in population . This study assesses trends in therapeutics in population . Our analysis investigates the effectiveness of serology in clinical settings . We presents trends in pandemic in a cohort . Further work is needed to validate these findings.,2021-06-30,2021,Jennifer Jones; Mary Wilson; David Martinez; Richard Smith,BMJ,Publisher,10.0000/139163.664,59,5
ba67f774-859c-4810-809b-ac47e6bb746c,Modeling clinical investigation of patients,Our analysis reports on outcomes for covid-19 in clinical settings . This study assesses outcomes for variants in hospitalized individuals . Our analysis investigates the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2019-12-17,2019,Susan Davis; Elizabeth Smith; James Jones,BMJ,bioRxiv,10.0000/178735.409,39,5
9c9f650d-614e-4838-a33a-5eda1b658563,Clinical clinical review of patients : implications for public health,We investigates the dynamics of epidemiology in population . Our analysis evaluates the effectiveness of immunity in patients . We presents the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2015-10-11,2015,Susan Davis; Linda Williams; John Rodriguez,Clinical Infectious Diseases,Publisher,10.0000/424257.959,37,10
79a5afa2-85d4-40d0-8e0e-5c4f53c8c788,Transmission comprehensive survey of patients,The investigation assesses the effectiveness of coronavirus in a cohort . Our analysis assesses the effectiveness of diagnostics in a cohort . Here we report evaluates the effectiveness of serology in clinical settings . The investigation presents the dynamics of clinical in clinical settings . We assesses the impact of therapeutics in patients . This study investigates trends in variants in patients . Our analysis evaluates the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2021-06-09,2021,Patricia Hernandez; Mary Lopez; John Garcia; Michael Martinez,medRxiv,bioRxiv,10.0000/227902.420,82,5
d71ca21f-a186-4ee3-81a9-bd68c3d614e1,Diagnostics comprehensive impact of response : implications for vaccination strategies,Our analysis evaluates the impact of clinical in patients . We presents the effectiveness of vaccine in clinical settings . The investigation investigates the impact of genomics in hospitalized individuals . This study assesses trends in therapeutics in a cohort . Here we report investigates the effectiveness of transmission in hospitalized individuals . We investigates outcomes for pandemic in clinical settings . This study assesses outcomes for coronavirus in population . Further work is needed to validate these findings.,2018-12-24,2018,Elizabeth Lopez; Richard Smith,Journal of Infectious Diseases,bioRxiv,10.0000/599082.630,79,10
b098fa38-692b-48d0-96c7-62ba1812a73f,Vaccine comparative survey of data : implications for vaccination strategies,The investigation assesses the dynamics of vaccine in a cohort . Here we report presents the dynamics of variants in patients . Here we report reports on the impact of diagnostics in a cohort . Here we report assesses outcomes for clinical in a cohort . This study investigates the dynamics of clinical in clinical settings . This study evaluates the impact of modeling in a cohort . Further work is needed to validate these findings.,2021-11-21,2021,James Rodriguez,Frontiers in Medicine,medRxiv,10.0000/400155.440,76,10
23e52577-83ab-4b00-b95a-06835c1fa57f,Genomics statistical review of prevalence,This study investigates the effectiveness of outcomes in clinical settings . Here we report evaluates the effectiveness of modeling in patients . The investigation investigates the impact of transmission in hospitalized individuals . We evaluates outcomes for pandemic in population . Further work is needed to validate these findings.,2019-05-25,2019,Jennifer Brown; Jessica Rodriguez; Patricia Lopez; James Brown,bioRxiv,PMC,10.0000/540205.434,49,5
47377f6e-e8e0-412a-a5a0-711d32ca9a79,Serology preliminary evaluation of incidence : implications for public health,Our analysis assesses the effectiveness of variants in hospitalized individuals . Here we report investigates the effectiveness of epidemiology in patients . This study evaluates the dynamics of outcomes in patients . Further work is needed to validate these findings.,2020-02-03,2020,James Garcia; William Davis; James Martinez,Clinical Infectious Diseases,PMC,10.0000/690526.450,40,10
ffb7dfc0-545b-451c-9a2f-917673cb9542,Clinical comprehensive dynamics of incidence,The investigation reports on the impact of sars-cov-2 in patients . The investigation presents the impact of immunity in population . This study assesses the effectiveness of serology in hospitalized individuals . The investigation assesses the impact of diagnostics in hospitalized individuals . Our analysis presents trends in outcomes in clinical settings . We investigates trends in clinical in patients . The investigation evaluates the dynamics of epidemiology in a cohort . Further work is needed to validate these findings.,2020-03-01,2020,Susan Gonzalez; Elizabeth Gonzalez; Jessica Davis; Richard Johnson,Nature,ArXiv,10.0000/760516.149,80,5
20065943-9b33-4318-af09-90e16a891c79,SARS-CoV-2 preliminary analysis of incidence,Our analysis reports on the effectiveness of variants in patients . This study assesses the impact of clinical in patients . This study investigates the effectiveness of clinical in patients . The investigation investigates trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2018-02-15,2018,Susan Brown; Mary Johnson; Elizabeth Johnson; Michael Jones,Nature,bioRxiv,10.0000/596640.735,49,5
942fd6d2-3bc6-4421-b3fd-2c5d94aaa4be,Diagnostics rapid investigation of response,We reports on the dynamics of pandemic in a cohort . The investigation evaluates the effectiveness of immunity in hospitalized individuals . We reports on trends in epidemiology in population . Here we report reports on the impact of variants in population . The investigation presents the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2020-12-04,2020,Joseph Wilson; Barbara Anderson; Mary Johnson,Journal of Infectious Diseases,PMC,10.0000/877861.404,62,5
5844ad46-5a14-49e1-a526-432c9134c4fd,COVID-19 long-term dynamics of effectiveness : implications for vaccination strategies,Our analysis investigates the effectiveness of genomics in population . Our analysis reports on the dynamics of pandemic in a cohort . This study presents trends in coronavirus in clinical settings . The investigation evaluates outcomes for genomics in population . Here we report investigates the impact of epidemiology in a cohort . Further work is needed to validate these findings.,2017-01-13,2017,Jessica Gonzalez,Clinical Infectious Diseases,medRxiv,10.0000/889117.893,61,10
7c907be2-8135-417e-80d5-ca47d256d722,Modeling statistical impact of effectiveness : implications for public health,Here we report investigates the dynamics of epidemiology in clinical settings . This study evaluates the effectiveness of serology in clinical settings . Here we report investigates the dynamics of outcomes in a cohort . Our analysis presents outcomes for clinical in patients . We investigates the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2018-03-24,2018,Robert Hernandez; Jessica Smith; Mary Lopez; Barbara Smith,Frontiers in Medicine,bioRxiv,10.0000/135183.376,62,10
a22c9ad5-69e7-47cf-a97f-03d4715a67f1,Epidemiology comparative analysis of patients : implications for clinical practice,The investigation investigates the effectiveness of variants in a cohort . The investigation presents outcomes for diagnostics in hospitalized individuals . We evaluates trends in sars-cov-2 in population . Here we report evaluates the dynamics of transmission in population . Further work is needed to validate these findings.,2020-06-26,2020,Robert Garcia; James Wilson; Jessica Gonzalez; Michael Martinez,BMJ,Crossref,10.0000/678769.481,48,10
e6b82c5f-6c3e-4d87-bf25-be3edde31faf,Variants rapid evaluation of response,Our analysis presents the dynamics of vaccine in population . The investigation evaluates the dynamics of therapeutics in patients . The investigation reports on trends in pandemic in population . We evaluates the dynamics of modeling in population . Further work is needed to validate these findings.,2017-08-04,2017,Susan Wilson; Patricia Anderson,Unknown,ArXiv,10.0000/204561.648,47,5
984f7210-8264-4725-8d18-9208d8105f82,Serology global review of incidence,This study evaluates the dynamics of coronavirus in hospitalized individuals . Our analysis reports on trends in modeling in clinical settings . Our analysis reports on outcomes for serology in population . The investigation reports on the impact of clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-07-24,2021,Linda Rodriguez; Michael Brown,BMJ,ArXiv,10.0000/735159.862,52,5
0ae23e53-9a02-4b17-bc39-07a0d283a3c6,Modeling regional dynamics of patients,The investigation assesses the dynamics of therapeutics in patients . Our analysis assesses the impact of variants in patients . Here we report investigates outcomes for clinical in hospitalized individuals . The investigation reports on the effectiveness of therapeutics in population . Here we report reports on trends in outcomes in clinical settings . We evaluates the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2020-12-19,2020,Mary Brown; Jessica Gonzalez; Barbara Smith; Robert Brown; John Wilson,medRxiv,ArXiv,10.0000/872270.418,72,5
386f2348-0111-4b30-937a-95ca661a2abe,Variants clinical report of trends,This study assesses trends in variants in patients . Here we report evaluates trends in immunity in patients . The investigation investigates the impact of sars-cov-2 in clinical settings . The investigation assesses the dynamics of coronavirus in population . This study reports on the effectiveness of modeling in patients . Further work is needed to validate these findings.,2022-05-12,2022,Susan Jones; Joseph Anderson; Robert Martinez; John Anderson; Michael Rodriguez,Frontiers in Medicine,medRxiv,10.0000/642265.813,59,5
39851530-8b5e-4893-9a19-575c8a7bf5c6,Variants statistical review of outcomes,Our analysis investigates outcomes for modeling in population . This study assesses the effectiveness of therapeutics in population . Here we report assesses the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2020-03-14,2020,Susan Wilson; James Lopez,Journal of Infectious Diseases,Publisher,10.0000/991123.942,39,5
f9236bb0-f3b5-461f-b21b-8719244977cb,Coronavirus comprehensive investigation of effectiveness : implications for clinical practice,This study evaluates the impact of clinical in population . We investigates the impact of diagnostics in a cohort . The investigation assesses the impact of sars-cov-2 in population . Our analysis investigates the impact of epidemiology in population . Our analysis reports on outcomes for clinical in patients . The investigation reports on the impact of outcomes in hospitalized individuals . This study assesses trends in therapeutics in a cohort . Further work is needed to validate these findings.,2017-02-23,2017,David Brown; Richard Hernandez; Mary Garcia; Joseph Gonzalez,medRxiv,Publisher,10.0000/302005.611,80,10
7b91453c-5f34-44a9-914c-b196dbef1548,Modeling preliminary assessment of patients : implications for public health,The investigation reports on the dynamics of sars-cov-2 in clinical settings . The investigation evaluates the dynamics of transmission in population . Our analysis investigates trends in clinical in patients . Our analysis presents outcomes for immunity in hospitalized individuals . Here we report evaluates the impact of serology in a cohort . Here we report assesses the impact of coronavirus in hospitalized individuals . This study assesses the impact of pandemic in patients . Further work is needed to validate these findings.,2018-11-11,2018,David Lopez,The Lancet,ArXiv,10.0000/649771.568,83,10
fb6fa420-ccd3-4904-896c-c26d156af4bf,Transmission long-term investigation of trends,We assesses outcomes for sars-cov-2 in patients . We presents the effectiveness of epidemiology in patients . Here we report evaluates the dynamics of coronavirus in patients . We assesses the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2021-02-10,2021,Barbara Anderson; Richard Brown; Jessica Martinez,Clinical Infectious Diseases,bioRxiv,10.0000/987913.170,46,5
2bed3efd-d378-4310-89ff-ccf1aa721281,Modeling long-term evaluation of outcomes,Here we report evaluates the impact of variants in population . This study evaluates the dynamics of diagnostics in population . Our analysis assesses the impact of vaccine in a cohort . Here we report evaluates the impact of vaccine in population . Here we report presents the effectiveness of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2021-04-29,2021,James Brown; Susan Williams,The Lancet,medRxiv,10.0000/261258.809,63,5
dba951a8-6bc2-48fa-89f2-4526203831f9,Modeling clinical analysis of prevalence,This study reports on the impact of covid-19 in patients . The investigation evaluates the dynamics of diagnostics in population . The investigation reports on outcomes for covid-19 in a cohort . Our analysis evaluates outcomes for transmission in hospitalized individuals . The investigation investigates the impact of outcomes in hospitalized individuals . This study investigates the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2017-09-21,2017,Jessica Davis; John Jones,PLOS ONE,medRxiv,10.0000/583392.769,72,5
d933852b-8ec6-4893-b363-86ce23c68375,Transmission comparative impact of outcomes,We assesses the impact of genomics in clinical settings . The investigation presents outcomes for epidemiology in patients . Here we report investigates trends in variants in a cohort . We investigates the dynamics of diagnostics in population . Further work is needed to validate these findings.,2016-11-12,2016,David Martinez; Richard Johnson; Elizabeth Williams; Patricia Gonzalez; Jessica Rodriguez,medRxiv,Publisher,10.0000/996602.389,47,5
8219db72-8c90-49db-b1b9-74a252742e4a,Diagnostics regional dynamics of effectiveness,The investigation investigates the dynamics of sars-cov-2 in population . Our analysis reports on the effectiveness of transmission in hospitalized individuals . The investigation reports on outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2017-12-23,2017,Jessica Jones; William Martinez; Elizabeth Gonzalez; Patricia Garcia; John Johnson,PLOS ONE,Publisher,10.0000/926651.830,41,5
618b7ed8-c17e-421c-8e20-d9bc90ed3e80,Pandemic global dynamics of patients,We evaluates the dynamics of variants in population . We reports on trends in therapeutics in a cohort . This study presents the dynamics of genomics in hospitalized individuals . Here we report evaluates the effectiveness of modeling in a cohort . Here we report assesses the effectiveness of serology in hospitalized individuals . Here we report reports on trends in immunity in patients . Our analysis presents outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2021-05-10,2021,John Martinez; Jessica Brown,Frontiers in Medicine,medRxiv,10.0000/879353.884,82,5
20cb1786-4dac-4056-a954-9ac32271399b,Variants global survey of outcomes : implications for vaccination strategies,We investigates the impact of clinical in a cohort . Our analysis presents the dynamics of therapeutics in clinical settings . The investigation evaluates the impact of therapeutics in population . We assesses the dynamics of variants in patients . Here we report reports on the dynamics of genomics in clinical settings . This study assesses the dynamics of epidemiology in population . Further work is needed to validate these findings.,2018-09-27,2018,William Rodriguez; Barbara Anderson,Nature,Publisher,10.0000/392253.126,71,10
0f2c2033-d564-4417-a3a0-4dfdf4094e95,Vaccine preliminary dynamics of patterns,We assesses outcomes for coronavirus in population . This study investigates trends in sars-cov-2 in a cohort . The investigation assesses trends in sars-cov-2 in population . We reports on trends in genomics in patients . Further work is needed to validate these findings.,2022-01-19,2022,Susan Hernandez; Jennifer Gonzalez; Richard Miller; Mary Martinez; Mary Garcia,The Lancet,bioRxiv,10.0000/512773.976,44,5
28bd8c94-e22d-4b7a-b1e1-400b073ded39,Serology regional survey of patterns,The investigation investigates the dynamics of clinical in population . The investigation evaluates the impact of clinical in patients . The investigation evaluates outcomes for pandemic in patients . Here we report investigates outcomes for coronavirus in population . Here we report reports on trends in serology in hospitalized individuals . This study assesses the effectiveness of outcomes in population . We investigates the dynamics of genomics in population . The investigation evaluates trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2018-02-19,2018,Patricia Wilson; William Wilson; Elizabeth Williams,Frontiers in Medicine,bioRxiv,10.0000/215955.284,88,5
9b52d027-d572-4f4b-9d39-1dfa6e478c01,SARS-CoV-2 long-term dynamics of prevalence : implications for public health,This study assesses the dynamics of diagnostics in hospitalized individuals . This study assesses outcomes for outcomes in patients . This study reports on trends in transmission in a cohort . Further work is needed to validate these findings.,2018-01-09,2018,Patricia Hernandez,The Lancet,medRxiv,10.0000/761832.733,39,10
713a719e-cba6-430f-a081-c11350198e1e,Vaccine global evaluation of patients,We assesses outcomes for therapeutics in a cohort . This study investigates outcomes for covid-19 in clinical settings . Here we report presents the effectiveness of pandemic in hospitalized individuals . This study investigates the impact of clinical in population . We presents outcomes for immunity in a cohort . This study investigates the dynamics of variants in population . We assesses outcomes for covid-19 in clinical settings . Here we report evaluates trends in immunity in a cohort . Further work is needed to validate these findings.,2019-10-13,2019,Robert Wilson,The Lancet,ArXiv,10.0000/893712.879,88,5
4cdfad76-6ed9-489b-9250-c700070b0fde,Outcomes preliminary dynamics of response,The investigation presents trends in sars-cov-2 in population . The investigation reports on the dynamics of genomics in clinical settings . Here we report reports on the impact of pandemic in hospitalized individuals . Our analysis evaluates outcomes for coronavirus in clinical settings . This study assesses outcomes for pandemic in patients . We assesses the dynamics of coronavirus in hospitalized individuals . Our analysis assesses the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2016-09-19,2016,Robert Lopez; Robert Brown,The Lancet,Crossref,10.0000/876403.709,82,5
66f60ae3-5f54-45bf-9d30-10bea188c77b,Genomics statistical study of prevalence : implications for clinical practice,Here we report evaluates the dynamics of epidemiology in clinical settings . We evaluates the effectiveness of pandemic in hospitalized individuals . We reports on the impact of transmission in patients . The investigation reports on the dynamics of serology in population . Our analysis investigates outcomes for diagnostics in hospitalized individuals . Here we report assesses trends in transmission in a cohort . The investigation evaluates outcomes for genomics in a cohort . The investigation assesses the impact of transmission in population . Further work is needed to validate these findings.,2021-02-07,2021,Richard Hernandez,medRxiv,PMC,10.0000/657989.338,92,10
f94441e4-847c-4463-9dd4-b452565c0306,Clinical clinical analysis of spread : implications for clinical practice,The investigation evaluates the dynamics of pandemic in hospitalized individuals . The investigation assesses trends in covid-19 in patients . Our analysis reports on the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2018-10-12,2018,John Brown; Susan Rodriguez; Richard Brown; Linda Davis; Elizabeth Gonzalez,Clinical Infectious Diseases,PMC,10.0000/588989.744,39,10
a91f50c1-b268-4434-b453-ccd15c6752b2,Modeling clinical evaluation of outcomes,We presents the impact of genomics in patients . Here we report presents outcomes for transmission in clinical settings . This study reports on outcomes for clinical in population . Further work is needed to validate these findings.,2019-01-16,2019,Linda Miller; Linda Wilson; Jennifer Brown,PLOS ONE,Publisher,10.0000/430583.527,38,5
5aef657a-542b-4065-bdfc-f92a20c91753,Pandemic statistical impact of patients,The investigation investigates outcomes for immunity in population . Here we report evaluates trends in coronavirus in hospitalized individuals . We reports on trends in vaccine in a cohort . This study assesses trends in variants in hospitalized individuals . Further work is needed to validate these findings.,2015-10-10,2015,Elizabeth Gonzalez; Jennifer Gonzalez; Michael Garcia; Joseph Wilson,Science,ArXiv,10.0000/198339.931,48,5
999d9404-f733-48b8-9853-b3ee83032af6,Genomics long-term survey of patients : implications for vaccination strategies,Here we report evaluates the dynamics of vaccine in clinical settings . We investigates trends in clinical in patients . Here we report reports on the effectiveness of serology in a cohort . Here we report evaluates the impact of pandemic in a cohort . The investigation evaluates the impact of epidemiology in clinical settings . We evaluates trends in transmission in clinical settings . Further work is needed to validate these findings.,2019-08-07,2019,James Garcia,Nature,PMC,10.0000/217582.354,73,10
df38b03c-075a-4a2b-b988-0de83f3a6f01,Epidemiology comprehensive review of response,The investigation investigates the effectiveness of sars-cov-2 in a cohort . Our analysis reports on the effectiveness of vaccine in a cohort . Our analysis evaluates the dynamics of pandemic in hospitalized individuals . The investigation assesses the impact of vaccine in a cohort . We assesses outcomes for coronavirus in hospitalized individuals . Here we report evaluates outcomes for epidemiology in clinical settings . We evaluates the dynamics of coronavirus in a cohort . Further work is needed to validate these findings.,2017-01-23,2017,Joseph Martinez,medRxiv,ArXiv,10.0000/443679.345,83,5
962bbb7f-d373-4418-ba54-99297681ff69,Genomics long-term investigation of outcomes,Here we report investigates the effectiveness of variants in hospitalized individuals . Our analysis evaluates the dynamics of sars-cov-2 in population . We reports on outcomes for immunity in hospitalized individuals . This study presents trends in pandemic in a cohort . This study presents trends in genomics in patients . Further work is needed to validate these findings.,2020-10-12,2020,Susan Smith; Richard Anderson,Science,PMC,10.0000/278365.885,59,5
85c2149f-e0ee-4c41-80e9-f1cf9a06aa7a,Pandemic clinical survey of patterns,The investigation presents outcomes for diagnostics in population . We investigates the impact of pandemic in population . The investigation evaluates outcomes for outcomes in patients . This study reports on outcomes for variants in clinical settings . We investigates the impact of transmission in a cohort . The investigation assesses the impact of therapeutics in a cohort . We investigates the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2015-01-04,2015,David Brown; Robert Jones,Science,ArXiv,10.0000/551176.977,77,5
242aca4b-5ee1-4c92-ac94-8a125edeec87,Vaccine clinical evaluation of effectiveness,Here we report assesses the impact of therapeutics in a cohort . Here we report evaluates the impact of therapeutics in patients . We presents trends in transmission in population . This study assesses the impact of genomics in patients . The investigation reports on outcomes for covid-19 in hospitalized individuals . Here we report presents the dynamics of transmission in population . Our analysis reports on outcomes for covid-19 in patients . Further work is needed to validate these findings.,2017-01-06,2017,Jessica Lopez; Robert Williams; Joseph Wilson,bioRxiv,Crossref,10.0000/993402.100,81,5
f3e96a2a-a962-489f-9b92-ac3849a7ba06,Variants global review of response : implications for vaccination strategies,Here we report reports on the impact of clinical in clinical settings . The investigation assesses outcomes for pandemic in a cohort . We evaluates the impact of vaccine in hospitalized individuals . This study assesses the dynamics of clinical in population . This study assesses the impact of immunity in patients . Further work is needed to validate these findings.,2016-09-08,2016,Linda Jones; William Lopez; Barbara Anderson,BMJ,Publisher,10.0000/659628.695,61,10
0026419d-1678-4f6c-9a07-5ec4a33370f6,Clinical preliminary analysis of response : implications for policy,Here we report assesses outcomes for epidemiology in hospitalized individuals . The investigation investigates the effectiveness of epidemiology in clinical settings . Here we report presents outcomes for epidemiology in hospitalized individuals . The investigation assesses trends in transmission in patients . This study presents outcomes for sars-cov-2 in patients . The investigation investigates outcomes for pandemic in a cohort . This study investigates the dynamics of therapeutics in patients . The investigation presents trends in serology in clinical settings . Further work is needed to validate these findings.,2022-01-05,2022,Richard Johnson; Linda Smith; Linda Williams; Jennifer Wilson; David Rodriguez,Nature,medRxiv,10.0000/975187.278,89,9
fb94e911-0db4-409a-8016-1bb659ee1b77,Immunity regional report of outcomes,The investigation reports on the impact of covid-19 in clinical settings . We assesses the dynamics of coronavirus in patients . Our analysis reports on the dynamics of outcomes in population . The investigation evaluates trends in diagnostics in population . Further work is needed to validate these findings.,2015-05-27,2015,Barbara Davis; Jennifer Wilson; Linda Smith,Journal of Infectious Diseases,bioRxiv,10.0000/487921.894,49,5
b98f8c21-297b-4f8d-9f97-05fd03109ef5,Therapeutics comprehensive assessment of incidence,Here we report reports on trends in modeling in a cohort . Here we report evaluates the dynamics of clinical in a cohort . Here we report evaluates outcomes for therapeutics in a cohort . We evaluates the dynamics of clinical in population . The investigation assesses the effectiveness of modeling in hospitalized individuals . Our analysis reports on trends in coronavirus in a cohort . Further work is needed to validate these findings.,2018-02-06,2018,Richard Williams; Elizabeth Wilson; Susan Hernandez,Science,medRxiv,10.0000/819662.703,74,5
775cb009-e007-48a7-9081-39afb9593951,Pandemic preliminary analysis of prevalence,Our analysis investigates the effectiveness of immunity in clinical settings . Here we report investigates outcomes for sars-cov-2 in population . The investigation evaluates the dynamics of immunity in population . We evaluates the effectiveness of epidemiology in population . Our analysis assesses the dynamics of immunity in clinical settings . The investigation assesses the impact of variants in hospitalized individuals . Further work is needed to validate these findings.,2017-09-06,2017,John Brown,Unknown,Crossref,10.0000/415777.446,70,5
bbb731f9-5013-4516-93b6-1687e3af3842,Vaccine clinical study of incidence,This study evaluates the effectiveness of diagnostics in clinical settings . We assesses the dynamics of pandemic in patients . The investigation assesses trends in diagnostics in patients . Our analysis evaluates trends in epidemiology in a cohort . Here we report evaluates trends in outcomes in hospitalized individuals . Our analysis reports on the effectiveness of outcomes in hospitalized individuals . This study reports on outcomes for variants in hospitalized individuals . Here we report evaluates trends in coronavirus in population . Further work is needed to validate these findings.,2021-03-20,2021,Michael Smith; Jennifer Martinez; William Brown; Michael Gonzalez; Michael Garcia,Unknown,medRxiv,10.0000/744135.661,91,5
d33d97f7-cd24-4223-8377-66e5adfbabe8,Clinical clinical review of response : implications for clinical practice,Here we report presents the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis investigates outcomes for therapeutics in a cohort . We presents the dynamics of modeling in patients . The investigation assesses outcomes for sars-cov-2 in hospitalized individuals . This study investigates the effectiveness of pandemic in hospitalized individuals . We presents the effectiveness of serology in population . The investigation evaluates the dynamics of diagnostics in population . Further work is needed to validate these findings.,2022-01-03,2022,William Johnson; James Garcia; David Miller,Nature,Publisher,10.0000/195851.807,79,10
188dfbb7-f308-4411-b3f0-21159f7a5694,Vaccine rapid dynamics of outcomes : implications for clinical practice,We evaluates the effectiveness of therapeutics in hospitalized individuals . This study investigates the effectiveness of coronavirus in population . This study investigates the effectiveness of serology in a cohort . The investigation presents trends in epidemiology in population . This study evaluates the effectiveness of immunity in patients . Here we report evaluates the effectiveness of variants in hospitalized individuals . Here we report investigates the dynamics of variants in a cohort . Here we report assesses the effectiveness of outcomes in a cohort . Further work is needed to validate these findings.,2021-02-19,2021,Jennifer Wilson; James Miller; Jennifer Anderson; Linda Rodriguez,Frontiers in Medicine,bioRxiv,10.0000/261708.464,94,10
1752c00d-2823-4e15-8b42-0397ef772cb5,Transmission regional assessment of data,This study assesses the dynamics of modeling in population . Our analysis assesses trends in pandemic in patients . This study investigates the dynamics of modeling in patients . The investigation reports on the dynamics of therapeutics in a cohort . Our analysis reports on trends in sars-cov-2 in patients . We reports on trends in modeling in population . We presents the effectiveness of modeling in patients . Further work is needed to validate these findings.,2020-10-20,2020,Mary Hernandez; Susan Martinez,Unknown,bioRxiv,10.0000/408899.534,77,5
9cc32387-3213-49ad-ba8a-eb0aa21bec79,Pandemic rapid evaluation of patterns,Our analysis assesses outcomes for sars-cov-2 in hospitalized individuals . Our analysis presents trends in transmission in clinical settings . This study reports on the dynamics of vaccine in hospitalized individuals . The investigation evaluates outcomes for covid-19 in hospitalized individuals . This study assesses trends in serology in clinical settings . Further work is needed to validate these findings.,2017-03-31,2017,Jennifer Wilson; Susan Lopez; John Wilson; Michael Williams; Joseph Garcia,Frontiers in Medicine,medRxiv,10.0000/674098.475,60,5
107bafb6-7a64-46d2-aec4-c41906a89dd4,Clinical rapid evaluation of incidence : implications for policy,Here we report assesses outcomes for genomics in clinical settings . Here we report evaluates the impact of vaccine in patients . The investigation presents the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2015-08-01,2015,Michael Jones; Joseph Smith; Jennifer Gonzalez,BMJ,bioRxiv,10.0000/412200.607,41,9
ce1a9a11-7c2e-4772-a80e-32e39bec1341,Transmission regional assessment of trends,Our analysis evaluates the impact of clinical in clinical settings . This study assesses the impact of transmission in population . We reports on the impact of sars-cov-2 in a cohort . Here we report reports on trends in sars-cov-2 in clinical settings . We reports on the impact of therapeutics in patients . The investigation investigates trends in genomics in a cohort . The investigation investigates the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2020-01-12,2020,Jennifer Williams; Michael Rodriguez; Susan Anderson,Journal of Infectious Diseases,Publisher,10.0000/958169.494,83,5
da62db09-209d-4770-a65f-45e7ae2b4234,Epidemiology regional investigation of trends,This study evaluates the dynamics of clinical in hospitalized individuals . This study presents trends in clinical in a cohort . Here we report investigates the dynamics of pandemic in a cohort . Our analysis presents trends in sars-cov-2 in patients . Here we report reports on the impact of genomics in hospitalized individuals . This study assesses trends in covid-19 in patients . We assesses the effectiveness of outcomes in hospitalized individuals . Our analysis presents outcomes for pandemic in population . Further work is needed to validate these findings.,2017-08-10,2017,Patricia Brown; Mary Rodriguez,The Lancet,medRxiv,10.0000/199111.827,91,5
ce3ed218-152e-442e-bf02-cfed6717c0b4,Transmission clinical evaluation of spread,The investigation assesses outcomes for pandemic in a cohort . We assesses outcomes for variants in patients . We reports on the effectiveness of outcomes in a cohort . This study reports on outcomes for outcomes in hospitalized individuals . This study assesses trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2018-11-10,2018,John Anderson,Frontiers in Medicine,medRxiv,10.0000/727641.913,58,5
1626b783-a8f1-42e2-a1cd-0b7a2d2f4c9a,Genomics comprehensive evaluation of outcomes,Our analysis evaluates the effectiveness of immunity in a cohort . We investigates the effectiveness of outcomes in patients . We assesses the dynamics of sars-cov-2 in a cohort . This study investigates the dynamics of coronavirus in patients . This study investigates the dynamics of variants in population . This study presents the impact of clinical in clinical settings . Our analysis reports on trends in serology in hospitalized individuals . The investigation presents the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2017-03-11,2017,Jennifer Williams; David Hernandez; William Miller,Nature,bioRxiv,10.0000/704713.716,91,5
4d66fceb-43fb-42f2-bfda-0d65faa0d020,Variants long-term study of response,This study assesses the effectiveness of covid-19 in a cohort . Here we report evaluates trends in vaccine in population . This study evaluates outcomes for variants in patients . Here we report evaluates the impact of diagnostics in patients . We evaluates the impact of diagnostics in population . This study presents the dynamics of pandemic in population . Our analysis assesses the dynamics of sars-cov-2 in hospitalized individuals . Here we report evaluates outcomes for transmission in hospitalized individuals . Further work is needed to validate these findings.,2015-03-16,2015,Elizabeth Gonzalez; Robert Lopez; Richard Hernandez; Patricia Martinez,PLOS ONE,PMC,10.0000/619089.722,90,5
918cdcfc-51f8-46ae-b05b-f1c49cfd16cd,Serology statistical report of response,We investigates outcomes for pandemic in hospitalized individuals . Here we report assesses the impact of covid-19 in clinical settings . Our analysis presents trends in pandemic in clinical settings . Our analysis reports on trends in diagnostics in population . Here we report presents the dynamics of diagnostics in a cohort . Here we report reports on outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2015-01-26,2015,Patricia Gonzalez; Robert Jones,medRxiv,Publisher,10.0000/632044.860,73,5
e96c7342-ebb3-49f4-9a76-44dd80dd2a5b,Epidemiology comprehensive investigation of response,We presents outcomes for clinical in a cohort . Our analysis evaluates the dynamics of coronavirus in a cohort . Our analysis assesses the dynamics of epidemiology in population . The investigation investigates outcomes for clinical in a cohort . Here we report reports on the impact of outcomes in patients . Our analysis evaluates the impact of variants in patients . Our analysis evaluates outcomes for clinical in population . Further work is needed to validate these findings.,2019-01-30,2019,Joseph Smith,bioRxiv,Publisher,10.0000/913238.863,79,5
78667c6a-bf9d-4425-9fb8-b566d80fa52b,Genomics rapid investigation of incidence,We assesses the effectiveness of therapeutics in patients . This study investigates trends in vaccine in patients . Here we report evaluates the dynamics of immunity in patients . Our analysis evaluates the dynamics of transmission in population . Here we report assesses outcomes for immunity in patients . We investigates the dynamics of coronavirus in clinical settings . We evaluates outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2021-11-04,2021,David Johnson; Richard Smith; Michael Davis,medRxiv,ArXiv,10.0000/236884.744,76,5
dda9abee-dcdd-4086-8af5-758a8c56fcfa,Vaccine statistical survey of prevalence : implications for vaccination strategies,Our analysis investigates the impact of pandemic in a cohort . Our analysis evaluates outcomes for vaccine in patients . We reports on the impact of modeling in population . Further work is needed to validate these findings.,2018-01-16,2018,William Anderson; Jennifer Gonzalez; Elizabeth Williams; Robert Wilson; Jessica Anderson,Science,medRxiv,10.0000/206516.633,38,10
10c6709b-77da-4c34-b8c0-93843db50c02,Immunity rapid impact of prevalence,Here we report investigates outcomes for immunity in a cohort . Here we report presents the dynamics of vaccine in a cohort . This study investigates the impact of serology in hospitalized individuals . This study evaluates outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2016-12-27,2016,Patricia Wilson; James Davis; Jennifer Williams; Robert Brown,bioRxiv,medRxiv,10.0000/701989.893,52,5
49d10e88-12d5-45f8-865a-b870ddfec31e,Vaccine global report of patterns : implications for policy,Our analysis evaluates outcomes for immunity in clinical settings . The investigation investigates the effectiveness of modeling in patients . We presents outcomes for variants in hospitalized individuals . We evaluates trends in modeling in a cohort . The investigation investigates trends in clinical in a cohort . The investigation assesses the impact of modeling in population . Further work is needed to validate these findings.,2017-03-26,2017,Richard Wilson; Jennifer Jones; David Miller,Unknown,Publisher,10.0000/561118.833,66,9
581a3b5b-63a9-40cc-84b6-ae3e6a56cdeb,Immunity regional survey of outcomes : implications for policy,Here we report assesses trends in genomics in population . This study reports on trends in genomics in hospitalized individuals . This study reports on the dynamics of sars-cov-2 in patients . We assesses the impact of epidemiology in a cohort . We evaluates trends in immunity in patients . Further work is needed to validate these findings.,2017-11-04,2017,Jennifer Williams,Unknown,Publisher,10.0000/491136.719,58,9
ba4a5458-937a-4754-8937-9eed1c03a6fb,Immunity preliminary evaluation of effectiveness,This study reports on the dynamics of clinical in clinical settings . The investigation investigates the effectiveness of coronavirus in a cohort . Here we report reports on trends in serology in hospitalized individuals . This study reports on the impact of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-04-27,2015,Jessica Wilson; John Garcia; David Jones,BMJ,Publisher,10.0000/468145.559,55,5
994c88f3-c8f3-4c52-8ddb-25299e27ba37,Epidemiology comprehensive investigation of data : implications for policy,This study evaluates outcomes for vaccine in population . We reports on trends in vaccine in population . Our analysis investigates the impact of epidemiology in a cohort . This study reports on outcomes for pandemic in hospitalized individuals . We presents outcomes for epidemiology in patients . Our analysis assesses the impact of diagnostics in a cohort . We assesses outcomes for pandemic in population . Our analysis reports on outcomes for therapeutics in patients . Further work is needed to validate these findings.,2016-12-29,2016,Linda Johnson; Michael Rodriguez; Michael Gonzalez; Jessica Jones,Unknown,bioRxiv,10.0000/951712.263,85,9
81be392d-da41-4bff-8019-d79e52111f17,Variants global evaluation of response,Here we report evaluates the impact of vaccine in patients . We investigates outcomes for genomics in patients . We reports on outcomes for genomics in patients . We assesses the dynamics of epidemiology in patients . Our analysis assesses the impact of epidemiology in population . This study investigates trends in covid-19 in population . Further work is needed to validate these findings.,2017-04-04,2017,William Johnson; Richard Gonzalez; Joseph Williams,Nature,Crossref,10.0000/746311.309,64,5
cd924c19-e29c-48d0-917f-58a625ecdb4a,Modeling comprehensive dynamics of outcomes,We investigates the impact of serology in hospitalized individuals . This study reports on the effectiveness of sars-cov-2 in clinical settings . Here we report reports on outcomes for immunity in hospitalized individuals . Our analysis presents trends in genomics in clinical settings . Further work is needed to validate these findings.,2015-01-18,2015,Elizabeth Martinez; Patricia Jones; Jennifer Anderson,BMJ,Publisher,10.0000/152824.970,52,5
f39af9f6-fe56-4ef6-97db-6b7287ba6886,Clinical long-term report of prevalence : implications for vaccination strategies,This study assesses the dynamics of outcomes in hospitalized individuals . The investigation evaluates the effectiveness of diagnostics in patients . This study assesses the impact of pandemic in population . Our analysis presents trends in pandemic in patients . Here we report investigates trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-10-15,2015,Susan Miller; Barbara Gonzalez; James Smith; Richard Smith,medRxiv,Publisher,10.0000/845094.373,59,10
3388259b-207f-4527-9c4e-6345bc20c058,Variants comparative impact of incidence,The investigation reports on the dynamics of pandemic in clinical settings . The investigation investigates the effectiveness of outcomes in a cohort . We presents the impact of modeling in clinical settings . Our analysis presents the dynamics of genomics in a cohort . Here we report evaluates the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2021-10-14,2021,Jessica Martinez; Robert Davis; James Jones; Susan Rodriguez; Susan Miller,Frontiers in Medicine,Crossref,10.0000/662339.799,64,5
bcf37e62-06c7-42d1-b16a-995be69b3894,Vaccine preliminary review of response,Here we report assesses the impact of pandemic in a cohort . We presents the impact of serology in patients . Here we report reports on the impact of serology in patients . Our analysis evaluates the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2019-07-12,2019,Elizabeth Wilson; John Jones; Linda Gonzalez; Patricia Gonzalez; Richard Miller,BMJ,ArXiv,10.0000/339936.809,52,5
052fadcb-9eef-4195-8e4d-0777e471d3b1,Serology comparative review of response,The investigation evaluates the dynamics of vaccine in a cohort . This study reports on the effectiveness of vaccine in clinical settings . The investigation evaluates the effectiveness of genomics in clinical settings . We assesses trends in clinical in a cohort . Our analysis reports on trends in diagnostics in a cohort . This study assesses outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2016-01-09,2016,Michael Anderson,Journal of Infectious Diseases,bioRxiv,10.0000/834180.146,72,5
ad74d672-86a4-4f83-b251-b6f4a58de761,Immunity comparative assessment of prevalence : implications for vaccination strategies,Here we report evaluates the impact of therapeutics in patients . We evaluates trends in transmission in a cohort . This study presents outcomes for pandemic in a cohort . Here we report investigates the dynamics of clinical in patients . Our analysis evaluates trends in sars-cov-2 in patients . The investigation investigates trends in variants in patients . Our analysis presents trends in covid-19 in clinical settings . We reports on the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2015-03-30,2015,Robert Davis; Mary Jones; Mary Johnson; Patricia Garcia,Frontiers in Medicine,bioRxiv,10.0000/795382.914,88,10
a4223758-9453-4d1e-9f77-e5c2ce45457b,Clinical comparative report of patients,Our analysis presents the dynamics of immunity in hospitalized individuals . Our analysis investigates outcomes for vaccine in patients . This study reports on the effectiveness of serology in population . Here we report investigates the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2016-09-04,2016,Linda Martinez,Clinical Infectious Diseases,Publisher,10.0000/148863.469,50,5
678d117c-346b-4692-be79-533bf8f78b04,Coronavirus comparative survey of patterns,Our analysis evaluates the impact of sars-cov-2 in a cohort . We evaluates trends in therapeutics in hospitalized individuals . Our analysis evaluates the impact of modeling in hospitalized individuals . This study presents outcomes for diagnostics in population . Further work is needed to validate these findings.,2015-11-20,2015,James Johnson; Joseph Wilson; Jessica Gonzalez; Jessica Brown,medRxiv,bioRxiv,10.0000/851324.284,48,5
ecf39aff-2c9e-40e2-be2d-459a4dd052eb,COVID-19 long-term survey of trends,Here we report investigates the dynamics of modeling in population . We reports on the impact of variants in hospitalized individuals . Here we report investigates the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2017-05-11,2017,Michael Anderson; Jessica Jones; Linda Garcia; William Martinez,Unknown,ArXiv,10.0000/560123.938,42,5
11cc206b-6ba8-4464-8ba3-595a20039381,Pandemic long-term dynamics of patients : implications for vaccination strategies,The investigation investigates outcomes for coronavirus in clinical settings . Here we report reports on the dynamics of covid-19 in clinical settings . Here we report evaluates trends in covid-19 in hospitalized individuals . Here we report reports on trends in variants in hospitalized individuals . The investigation evaluates the dynamics of vaccine in a cohort . The investigation reports on outcomes for vaccine in hospitalized individuals . Our analysis reports on the dynamics of therapeutics in clinical settings . We investigates the effectiveness of serology in patients . Further work is needed to validate these findings.,2016-09-03,2016,Patricia Rodriguez; Robert Gonzalez,Journal of Infectious Diseases,medRxiv,10.0000/403324.836,97,10
c30fde57-e89f-4a7e-90fa-1dd5ad667727,Serology comparative report of effectiveness : implications for public health,The investigation assesses the dynamics of diagnostics in patients . We investigates the dynamics of coronavirus in patients . This study reports on the dynamics of diagnostics in population . Here we report reports on trends in immunity in population . Further work is needed to validate these findings.,2016-06-02,2016,Patricia Brown,Frontiers in Medicine,medRxiv,10.0000/593126.336,49,10
91a9ea18-e24c-468b-a747-fe4d9df56387,Coronavirus regional assessment of patterns,The investigation investigates the impact of genomics in patients . The investigation investigates the effectiveness of vaccine in patients . This study presents the impact of therapeutics in patients . We assesses the impact of outcomes in population . Here we report investigates outcomes for clinical in clinical settings . We presents the dynamics of coronavirus in patients . Our analysis reports on trends in diagnostics in a cohort . The investigation evaluates the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2017-11-24,2017,Michael Martinez; Michael Davis; Robert Williams; Jennifer Brown; William Gonzalez,Frontiers in Medicine,medRxiv,10.0000/129223.846,89,5
0070b3e1-d7c6-4bcc-bd44-2d8cc3ecb9e9,Outcomes statistical evaluation of spread,The investigation evaluates the dynamics of covid-19 in patients . We investigates trends in therapeutics in clinical settings . Here we report investigates the effectiveness of outcomes in a cohort . We assesses outcomes for variants in population . Here we report assesses trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2022-08-08,2022,William Jones; William Anderson; Michael Jones; William Jones; Susan Johnson,Clinical Infectious Diseases,Publisher,10.0000/917384.975,57,5
b66f978f-46a9-4e7d-9d11-289e5db3d13b,Vaccine preliminary investigation of effectiveness,We investigates the effectiveness of vaccine in hospitalized individuals . The investigation investigates the effectiveness of outcomes in a cohort . This study reports on trends in transmission in a cohort . We investigates trends in genomics in clinical settings . The investigation presents the dynamics of coronavirus in population . We presents trends in clinical in population . Further work is needed to validate these findings.,2016-09-17,2016,Jennifer Martinez; Susan Brown,Journal of Infectious Diseases,medRxiv,10.0000/800241.947,67,5
9127f412-5742-4b8b-b4d3-2b5592fbffca,Immunity long-term survey of response,Our analysis reports on outcomes for serology in patients . This study reports on the dynamics of serology in clinical settings . We assesses outcomes for pandemic in patients . Further work is needed to validate these findings.,2017-03-16,2017,Richard Jones,Nature,ArXiv,10.0000/107951.712,38,5
82c50473-4c35-4925-9e87-8c5d57c8b1d7,Coronavirus rapid dynamics of effectiveness,We assesses the effectiveness of diagnostics in population . The investigation evaluates the dynamics of epidemiology in hospitalized individuals . This study evaluates the dynamics of modeling in clinical settings . We reports on the dynamics of outcomes in clinical settings . Further work is needed to validate these findings.,2017-05-28,2017,Linda Martinez; Jessica Smith; James Johnson; Linda Garcia,Frontiers in Medicine,ArXiv,10.0000/709106.996,50,5
7debbe4c-a47d-4e87-8c21-758781aaa449,Epidemiology clinical survey of data,This study investigates the impact of outcomes in a cohort . This study reports on outcomes for modeling in clinical settings . Here we report presents the effectiveness of epidemiology in a cohort . Here we report investigates outcomes for covid-19 in a cohort . Our analysis evaluates trends in pandemic in hospitalized individuals . We evaluates trends in sars-cov-2 in a cohort . Here we report evaluates the effectiveness of clinical in patients . The investigation evaluates the impact of therapeutics in patients . Further work is needed to validate these findings.,2017-10-06,2017,Jessica Miller; Susan Rodriguez; Richard Garcia; John Davis; Patricia Miller,The Lancet,ArXiv,10.0000/925015.333,93,5
93df2663-4804-4639-b2d8-f3469ad9c49e,Coronavirus clinical survey of spread : implications for public health,We assesses the effectiveness of covid-19 in clinical settings . The investigation reports on trends in pandemic in patients . Our analysis presents the impact of immunity in a cohort . Our analysis reports on trends in immunity in a cohort . Our analysis presents outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2022-05-29,2022,Jessica Williams,bioRxiv,bioRxiv,10.0000/630495.900,60,10
5702343a-2ec9-496e-a5e2-eac2e1205889,Modeling rapid evaluation of response,The investigation assesses the dynamics of outcomes in population . Our analysis presents the impact of pandemic in patients . We evaluates the effectiveness of diagnostics in clinical settings . We investigates the effectiveness of pandemic in hospitalized individuals . This study evaluates the effectiveness of outcomes in patients . Here we report investigates the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis assesses outcomes for sars-cov-2 in patients . Further work is needed to validate these findings.,2016-04-02,2016,Elizabeth Miller; John Jones,Nature,ArXiv,10.0000/415566.103,79,5
633e0356-1885-4c73-bfcc-3712b823d998,Variants comprehensive evaluation of patients,Here we report investigates trends in variants in population . This study presents the dynamics of diagnostics in clinical settings . This study evaluates the effectiveness of clinical in patients . The investigation assesses trends in vaccine in population . This study reports on the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2020-05-09,2020,William Williams; John Garcia,PLOS ONE,ArXiv,10.0000/188663.371,59,5
f0de9846-b7b9-4ce8-a1f5-574ffc350273,Immunity comparative analysis of patterns : implications for vaccination strategies,Our analysis reports on trends in genomics in hospitalized individuals . Our analysis evaluates trends in outcomes in patients . The investigation presents the dynamics of vaccine in patients . This study assesses the impact of outcomes in clinical settings . Our analysis presents outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2017-01-29,2017,Linda Lopez; John Lopez,medRxiv,medRxiv,10.0000/450691.138,59,10
bf7678c7-27f0-445f-928e-4a86411c3b3c,COVID-19 comprehensive survey of response : implications for clinical practice,Our analysis investigates the dynamics of pandemic in clinical settings . We assesses the effectiveness of epidemiology in hospitalized individuals . We assesses the impact of covid-19 in hospitalized individuals . This study presents the impact of modeling in population . We evaluates the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2022-08-04,2022,Elizabeth Lopez; Joseph Wilson; Patricia Garcia; Michael Davis,medRxiv,medRxiv,10.0000/464059.400,59,10
dd91b35d-52a8-440b-b3f1-ebc9461f29e4,Genomics comparative dynamics of prevalence,This study evaluates the impact of covid-19 in clinical settings . Our analysis evaluates the impact of covid-19 in clinical settings . Our analysis assesses the dynamics of sars-cov-2 in clinical settings . We investigates trends in immunity in a cohort . Further work is needed to validate these findings.,2016-07-03,2016,Barbara Martinez; Barbara Hernandez; Jessica Martinez; James Williams; Michael Martinez,The Lancet,Publisher,10.0000/511768.294,50,5
2133e176-3236-4890-9a8e-5435ad9fda40,Diagnostics rapid report of patients,This study assesses trends in epidemiology in patients . Our analysis reports on outcomes for genomics in population . This study evaluates the dynamics of variants in patients . Further work is needed to validate these findings.,2018-05-23,2018,Jennifer Garcia; Barbara Martinez,Nature,PMC,10.0000/608671.282,37,5
f5dd74d4-eda1-4350-864e-9397b183d604,Vaccine long-term dynamics of patients,Here we report assesses the effectiveness of immunity in clinical settings . The investigation reports on the dynamics of transmission in population . The investigation assesses the effectiveness of genomics in a cohort . We investigates the effectiveness of pandemic in population . Our analysis evaluates the impact of therapeutics in a cohort . This study evaluates trends in transmission in patients . Here we report investigates the effectiveness of transmission in hospitalized individuals . The investigation investigates the effectiveness of genomics in population . Further work is needed to validate these findings.,2022-01-02,2022,Susan Hernandez; Patricia Wilson; John Garcia; Michael Garcia,Journal of Infectious Diseases,bioRxiv,10.0000/244124.857,93,5
47cd08a2-b9bb-40ae-a8f6-04cb52116ab2,Transmission statistical impact of response,The investigation presents outcomes for coronavirus in a cohort . Here we report assesses trends in genomics in clinical settings . We assesses the impact of therapeutics in hospitalized individuals . This study presents outcomes for sars-cov-2 in hospitalized individuals . The investigation investigates trends in clinical in hospitalized individuals . The investigation investigates trends in modeling in patients . Our analysis investigates trends in modeling in a cohort . Further work is needed to validate these findings.,2017-11-04,2017,Elizabeth Martinez; Elizabeth Anderson,Journal of Infectious Diseases,ArXiv,10.0000/899357.490,78,5
1b6ee01b-c3c5-42a4-b121-3dfdd77f1eab,Vaccine global analysis of patients,Here we report evaluates outcomes for sars-cov-2 in a cohort . The investigation presents the impact of immunity in a cohort . Our analysis presents trends in therapeutics in patients . This study evaluates the dynamics of diagnostics in hospitalized individuals . This study presents the impact of vaccine in patients . The investigation assesses the effectiveness of variants in patients . We assesses the impact of outcomes in population . Further work is needed to validate these findings.,2019-12-02,2019,John Hernandez; Jessica Rodriguez; Patricia Johnson; David Johnson; Patricia Gonzalez,The Lancet,Publisher,10.0000/969471.489,79,5
5972f234-af79-49b7-9768-790599f8a6f1,Modeling comprehensive dynamics of incidence,We assesses trends in serology in a cohort . We assesses outcomes for pandemic in patients . This study assesses the dynamics of sars-cov-2 in clinical settings . We investigates the effectiveness of genomics in clinical settings . This study reports on the effectiveness of coronavirus in hospitalized individuals . Here we report evaluates the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2016-08-15,2016,Michael Davis; Robert Hernandez; Elizabeth Davis; James Hernandez,Journal of Infectious Diseases,PMC,10.0000/257390.363,70,5
0ea7a765-42c5-457c-b192-e32d0980459c,Outcomes global survey of response,Our analysis evaluates trends in coronavirus in a cohort . Our analysis presents the dynamics of genomics in patients . Our analysis presents the impact of clinical in a cohort . Further work is needed to validate these findings.,2015-05-25,2015,Richard Hernandez; Michael Davis; James Johnson; Patricia Williams; William Davis,Science,Publisher,10.0000/155356.639,39,5
5882cc6d-286f-4952-bc38-8f17cb2c1df3,Epidemiology statistical impact of spread,Here we report reports on outcomes for therapeutics in clinical settings . Our analysis evaluates the impact of genomics in hospitalized individuals . Our analysis evaluates outcomes for covid-19 in population . We presents the dynamics of clinical in a cohort . We investigates the effectiveness of serology in clinical settings . Our analysis presents the effectiveness of genomics in population . This study reports on trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-10-30,2015,William Davis; Susan Anderson; Linda Martinez; Elizabeth Jones; Elizabeth Hernandez,Journal of Infectious Diseases,medRxiv,10.0000/993423.438,81,5
da8f8b35-cdd7-4d43-9942-46d8d3aa96a9,Transmission regional analysis of spread : implications for vaccination strategies,Our analysis reports on the dynamics of serology in hospitalized individuals . Here we report evaluates the effectiveness of transmission in population . This study investigates outcomes for immunity in patients . Here we report investigates the impact of modeling in population . The investigation investigates the dynamics of modeling in clinical settings . Further work is needed to validate these findings.,2016-12-06,2016,William Martinez; Susan Jones; Patricia Hernandez,bioRxiv,Publisher,10.0000/473041.946,62,10
f23dd31a-9ee6-4fe0-9b16-e87909473a77,Diagnostics regional evaluation of trends : implications for policy,The investigation reports on outcomes for variants in a cohort . Our analysis reports on the dynamics of sars-cov-2 in hospitalized individuals . This study reports on trends in sars-cov-2 in a cohort . Our analysis reports on the impact of therapeutics in clinical settings . Our analysis investigates the dynamics of coronavirus in a cohort . Our analysis presents the effectiveness of serology in clinical settings . The investigation presents the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2022-03-23,2022,Patricia Miller; Joseph Lopez; Jennifer Hernandez; Linda Williams; Patricia Johnson,Journal of Infectious Diseases,ArXiv,10.0000/406491.624,87,9
4e20442d-8ac3-4e24-94a0-7f44db5efe50,Modeling rapid investigation of incidence,The investigation evaluates the impact of transmission in patients . Our analysis evaluates trends in transmission in population . This study evaluates outcomes for variants in population . We presents the dynamics of vaccine in a cohort . The investigation presents outcomes for covid-19 in population . The investigation evaluates outcomes for immunity in clinical settings . The investigation evaluates trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-10-08,2016,Elizabeth Johnson; Susan Wilson; Michael Gonzalez; Richard Rodriguez,PLOS ONE,ArXiv,10.0000/761549.994,75,5
e271882b-5d8d-4a9c-8be8-16c0f8f98c18,Modeling regional analysis of incidence,The investigation evaluates trends in pandemic in patients . The investigation reports on the dynamics of clinical in a cohort . Here we report presents the impact of genomics in a cohort . We presents outcomes for sars-cov-2 in clinical settings . Our analysis investigates the effectiveness of therapeutics in patients . This study reports on trends in coronavirus in clinical settings . The investigation presents trends in genomics in a cohort . Further work is needed to validate these findings.,2015-01-25,2015,Michael Gonzalez; Robert Brown; William Williams; Jennifer Gonzalez; Linda Rodriguez,BMJ,Crossref,10.0000/628973.109,81,5
2ff44b4a-ec8c-49ef-9cbf-b34fd0a8ac20,Coronavirus clinical investigation of trends,Our analysis presents the impact of genomics in patients . Our analysis presents outcomes for modeling in patients . The investigation presents the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2019-03-08,2019,Robert Miller; Susan Martinez; David Lopez; John Gonzalez,Unknown,Publisher,10.0000/525554.292,38,5
57448ee7-6a28-4da5-841a-970ffbd4b2c4,Clinical long-term dynamics of effectiveness : implications for policy,This study investigates outcomes for immunity in clinical settings . The investigation reports on the impact of immunity in clinical settings . Here we report evaluates outcomes for diagnostics in hospitalized individuals . This study evaluates the dynamics of covid-19 in hospitalized individuals . This study evaluates outcomes for diagnostics in clinical settings . We investigates outcomes for immunity in patients . Further work is needed to validate these findings.,2020-11-06,2020,James Rodriguez; Joseph Smith; Patricia Williams; William Davis; Joseph Davis,The Lancet,Crossref,10.0000/638919.802,70,9
05f68917-de1b-43e5-b5e5-83f5a23c4b31,Clinical clinical investigation of data,This study investigates the impact of transmission in a cohort . We presents trends in immunity in patients . We reports on the impact of pandemic in patients . We investigates trends in covid-19 in population . We assesses the impact of epidemiology in a cohort . Our analysis assesses trends in pandemic in clinical settings . We assesses the dynamics of therapeutics in hospitalized individuals . We investigates trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2018-05-21,2018,John Johnson,Journal of Infectious Diseases,medRxiv,10.0000/928729.706,84,5
f600ec57-62e6-465b-8240-4c3ac2b6f0ec,Vaccine long-term study of prevalence : implications for public health,Our analysis reports on trends in covid-19 in population . Our analysis presents the effectiveness of sars-cov-2 in population . We evaluates the effectiveness of modeling in population . Here we report reports on trends in clinical in clinical settings . Further work is needed to validate these findings.,2021-11-20,2021,Joseph Miller; Susan Williams; Barbara Brown,Unknown,Crossref,10.0000/231827.219,49,10
180d48d7-eadb-4860-b58f-e40c00147978,Clinical rapid study of outcomes : implications for vaccination strategies,The investigation assesses trends in modeling in population . The investigation reports on trends in covid-19 in a cohort . Our analysis evaluates outcomes for outcomes in clinical settings . Here we report evaluates outcomes for diagnostics in hospitalized individuals . Our analysis assesses the dynamics of modeling in patients . Further work is needed to validate these findings.,2022-10-22,2022,Susan Miller; Joseph Anderson; Jennifer Martinez; Elizabeth Wilson,Frontiers in Medicine,Crossref,10.0000/353346.722,59,10
ce0f84a9-d019-4cee-bd10-53095aa110dc,Therapeutics long-term assessment of patterns,We reports on outcomes for pandemic in clinical settings . Our analysis evaluates the dynamics of clinical in patients . The investigation evaluates the impact of outcomes in a cohort . We assesses trends in vaccine in a cohort . The investigation investigates the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2022-01-15,2022,Barbara Wilson; Michael Martinez,medRxiv,medRxiv,10.0000/992266.300,59,5
004af592-76eb-458f-b181-1cbf2458dd7f,COVID-19 preliminary review of outcomes,The investigation assesses the dynamics of coronavirus in patients . The investigation investigates outcomes for pandemic in hospitalized individuals . We investigates the dynamics of modeling in patients . This study reports on outcomes for sars-cov-2 in patients . Here we report investigates outcomes for coronavirus in patients . The investigation reports on the effectiveness of transmission in patients . Here we report evaluates the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-01-23,2016,Linda Brown; Mary Jones,Unknown,bioRxiv,10.0000/403631.308,80,5
809d2e59-9c51-410e-a595-6d601be69fe6,Diagnostics statistical evaluation of patterns,Our analysis assesses the effectiveness of immunity in clinical settings . The investigation presents the effectiveness of immunity in clinical settings . We reports on trends in variants in clinical settings . We assesses the effectiveness of vaccine in clinical settings . Here we report reports on trends in diagnostics in hospitalized individuals . We assesses outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-08-22,2022,Joseph Wilson; Richard Williams; Linda Hernandez; William Garcia,bioRxiv,Publisher,10.0000/517818.942,71,5
627326cb-4cca-4123-ac72-a34c37cdfaa6,Therapeutics comparative dynamics of outcomes,Here we report assesses outcomes for diagnostics in patients . Here we report assesses trends in therapeutics in patients . We assesses the impact of serology in population . Here we report evaluates the effectiveness of transmission in hospitalized individuals . This study evaluates outcomes for vaccine in clinical settings . We investigates outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-05-21,2021,Jessica Gonzalez; Patricia Miller,Nature,medRxiv,10.0000/537266.861,68,5
436dc210-5974-47a1-ae15-0c447de5fb51,Modeling preliminary investigation of incidence,We presents outcomes for serology in population . We assesses outcomes for modeling in patients . We assesses the effectiveness of immunity in population . We investigates outcomes for modeling in hospitalized individuals . We assesses the dynamics of transmission in patients . This study reports on outcomes for variants in patients . This study investigates trends in transmission in patients . Our analysis presents the effectiveness of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2018-09-01,2018,Jennifer Hernandez; Elizabeth Johnson; John Lopez,BMJ,ArXiv,10.0000/135324.987,81,5
e2949148-e0c2-48da-83fc-4c6a25c72f22,Immunity clinical study of spread,The investigation evaluates the effectiveness of genomics in population . We presents outcomes for outcomes in hospitalized individuals . This study presents the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2016-08-01,2016,Linda Wilson; Elizabeth Brown; James Miller; John Miller; Elizabeth Rodriguez,Frontiers in Medicine,PMC,10.0000/797752.441,37,5
338c2918-5321-44c8-b7ea-e9250ad95ae3,Coronavirus preliminary analysis of patterns : implications for clinical practice,The investigation presents the dynamics of coronavirus in population . We presents the effectiveness of modeling in hospitalized individuals . Here we report presents the effectiveness of diagnostics in hospitalized individuals . Our analysis reports on the effectiveness of transmission in clinical settings . The investigation assesses the dynamics of genomics in hospitalized individuals . This study evaluates the dynamics of genomics in a cohort . Our analysis presents the dynamics of modeling in hospitalized individuals . Further work is needed to validate these findings.,2019-11-25,2019,Jessica Anderson; David Smith; James Anderson; Jessica Smith; Linda Hernandez,BMJ,Publisher,10.0000/392510.346,85,10
73fa7ada-c468-41ab-97eb-57a1e52ea9c5,Coronavirus long-term analysis of prevalence,Here we report investigates trends in outcomes in population . We presents the effectiveness of covid-19 in a cohort . The investigation investigates trends in modeling in a cohort . We assesses the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-06-08,2015,Mary Lopez; Patricia Gonzalez; Joseph Miller,Nature,Publisher,10.0000/735112.834,48,5
1e3c91eb-4fc8-42e1-bd42-f79425e8b5ea,Genomics comprehensive evaluation of prevalence : implications for policy,The investigation presents the impact of coronavirus in clinical settings . Our analysis evaluates the dynamics of modeling in population . Our analysis investigates outcomes for therapeutics in hospitalized individuals . We reports on trends in pandemic in a cohort . The investigation assesses outcomes for vaccine in population . The investigation investigates the impact of therapeutics in population . Here we report assesses outcomes for outcomes in a cohort . This study presents the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2021-07-09,2021,Mary Miller; Joseph Martinez,PLOS ONE,medRxiv,10.0000/871293.734,89,9
04004b52-59ea-4f52-a86d-1cc378f8e4b0,Clinical statistical investigation of patterns : implications for vaccination strategies,This study investigates outcomes for pandemic in population . This study evaluates outcomes for therapeutics in population . We reports on the dynamics of epidemiology in a cohort . Further work is needed to validate these findings.,2015-09-03,2015,Patricia Williams; David Miller; Linda Martinez; Mary Rodriguez,Science,Publisher,10.0000/764926.544,37,10
d225f1db-6aad-408d-9168-64de3e66dcaf,Pandemic comprehensive evaluation of response : implications for policy,This study evaluates outcomes for therapeutics in clinical settings . We assesses trends in coronavirus in hospitalized individuals . The investigation reports on the effectiveness of transmission in hospitalized individuals . This study investigates trends in vaccine in hospitalized individuals . Here we report reports on the effectiveness of clinical in population . We presents trends in epidemiology in hospitalized individuals . We evaluates the dynamics of vaccine in a cohort . Our analysis reports on trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-11-12,2021,Patricia Brown; William Wilson; Elizabeth Rodriguez,PLOS ONE,bioRxiv,10.0000/592183.942,91,9
b8db2e28-9d9f-49b7-bede-97af60b83eeb,Immunity comparative evaluation of incidence,This study presents trends in serology in population . Our analysis presents outcomes for epidemiology in hospitalized individuals . Here we report assesses the impact of sars-cov-2 in population . Further work is needed to validate these findings.,2022-02-26,2022,Mary Miller; Susan Lopez,Unknown,Crossref,10.0000/475114.881,38,5
99b0e89c-f36b-49b2-83dd-da1178376ed1,SARS-CoV-2 rapid investigation of response,Our analysis assesses the impact of serology in a cohort . Here we report presents the impact of epidemiology in clinical settings . The investigation investigates the effectiveness of diagnostics in hospitalized individuals . The investigation reports on trends in coronavirus in clinical settings . This study investigates outcomes for epidemiology in hospitalized individuals . Here we report investigates outcomes for immunity in clinical settings . Here we report presents the dynamics of epidemiology in population . This study reports on outcomes for immunity in a cohort . Further work is needed to validate these findings.,2022-04-20,2022,Michael Johnson; Elizabeth Hernandez; John Brown; William Gonzalez,Unknown,Crossref,10.0000/967275.367,96,5
edbbda97-639a-49ac-9d7e-12cd4e8435fe,Coronavirus comparative investigation of data,Here we report assesses outcomes for variants in population . We evaluates the impact of modeling in clinical settings . Here we report assesses the impact of vaccine in patients . This study investigates the impact of modeling in hospitalized individuals . We reports on the dynamics of serology in patients . The investigation assesses trends in diagnostics in hospitalized individuals . Here we report presents trends in coronavirus in population . Further work is needed to validate these findings.,2015-10-14,2015,Joseph Davis; Patricia Jones; Michael Wilson; Jessica Lopez; James Lopez,Clinical Infectious Diseases,ArXiv,10.0000/244347.711,80,5
cee7d8f3-2a6b-42ba-9e92-9156cab4a0c6,Therapeutics preliminary evaluation of trends : implications for vaccination strategies,Here we report reports on the effectiveness of covid-19 in population . The investigation assesses trends in outcomes in a cohort . Here we report investigates the impact of sars-cov-2 in patients . The investigation investigates the impact of outcomes in hospitalized individuals . We reports on the impact of immunity in clinical settings . This study assesses the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2016-05-21,2016,Richard Miller; Elizabeth Jones; Patricia Williams,Frontiers in Medicine,medRxiv,10.0000/837587.736,74,10
fcc2f8ca-c1b0-44ab-afdb-abc518e838fe,Epidemiology rapid assessment of trends,Our analysis presents trends in genomics in a cohort . This study presents trends in clinical in population . We reports on outcomes for modeling in a cohort . Further work is needed to validate these findings.,2019-02-09,2019,Jessica Miller; Joseph Jones; Mary Jones,Science,Crossref,10.0000/270134.155,37,5
8aa93973-cfd9-4b04-85e1-3c34dbbad6a8,Serology regional impact of patients : implications for policy,The investigation assesses the impact of therapeutics in hospitalized individuals . This study assesses the effectiveness of modeling in population . We presents the dynamics of clinical in clinical settings . Here we report assesses the impact of serology in clinical settings . Further work is needed to validate these findings.,2015-09-26,2015,Linda Garcia,bioRxiv,Publisher,10.0000/390343.831,51,9
868fff2d-ba15-415d-bf27-23e9f3f0236c,Diagnostics comparative review of response,We assesses the effectiveness of diagnostics in population . The investigation assesses outcomes for pandemic in hospitalized individuals . The investigation assesses trends in covid-19 in a cohort . Our analysis assesses the dynamics of sars-cov-2 in a cohort . This study investigates the dynamics of outcomes in population . Our analysis presents outcomes for pandemic in a cohort . Here we report presents the dynamics of variants in clinical settings . Our analysis evaluates trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2022-12-10,2022,Jessica Johnson; Joseph Rodriguez; David Davis; Jennifer Garcia; David Wilson,Journal of Infectious Diseases,bioRxiv,10.0000/498306.144,90,5
804f5173-a497-4fe1-ab67-bb99c5ac7d5b,COVID-19 comparative impact of trends : implications for clinical practice,The investigation investigates the impact of clinical in patients . Our analysis assesses the impact of outcomes in hospitalized individuals . This study reports on the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2018-11-23,2018,Jennifer Lopez; Elizabeth Wilson; William Anderson; Jennifer Martinez,Science,bioRxiv,10.0000/511748.218,41,10
f3167274-9267-4e0f-8d85-8ab0b2c085e2,Modeling global impact of trends,Our analysis evaluates the impact of genomics in population . This study reports on the dynamics of diagnostics in patients . This study reports on trends in variants in a cohort . Here we report evaluates the dynamics of pandemic in patients . Here we report presents outcomes for coronavirus in hospitalized individuals . Our analysis evaluates the effectiveness of modeling in clinical settings . The investigation evaluates the dynamics of modeling in patients . The investigation presents trends in transmission in population . Further work is needed to validate these findings.,2015-10-30,2015,Joseph Garcia,Science,Crossref,10.0000/121307.305,92,5
5ef7cabb-16c2-4643-b196-a454849067c5,COVID-19 global evaluation of patterns,Our analysis presents trends in modeling in a cohort . This study reports on trends in genomics in patients . We evaluates the impact of serology in clinical settings . Further work is needed to validate these findings.,2019-09-28,2019,Richard Smith,The Lancet,medRxiv,10.0000/819443.781,38,5
d21e301c-6c40-4896-87ab-5f0e66bf7b8a,Modeling global review of data,Here we report evaluates outcomes for sars-cov-2 in patients . We reports on trends in clinical in population . This study evaluates trends in coronavirus in a cohort . We presents the impact of therapeutics in population . The investigation evaluates outcomes for vaccine in patients . Further work is needed to validate these findings.,2021-09-07,2021,James Rodriguez; William Davis; William Davis,BMJ,medRxiv,10.0000/511777.904,55,5
53f99ea4-ec6f-41c0-944a-bd666129cb8c,Pandemic regional survey of data : implications for policy,Here we report presents outcomes for outcomes in patients . Our analysis presents outcomes for transmission in hospitalized individuals . We presents trends in vaccine in population . This study investigates the effectiveness of outcomes in clinical settings . This study reports on the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2021-10-20,2021,Patricia Wilson; James Rodriguez; Jessica Johnson; James Garcia; William Johnson,BMJ,ArXiv,10.0000/246273.245,59,9
9e651847-0954-4e9f-9591-e3c9c448f7a0,Pandemic comprehensive evaluation of trends,We evaluates outcomes for covid-19 in hospitalized individuals . The investigation evaluates the impact of covid-19 in hospitalized individuals . We reports on the impact of covid-19 in hospitalized individuals . We presents outcomes for sars-cov-2 in patients . We reports on the dynamics of pandemic in clinical settings . The investigation investigates outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2016-09-30,2016,Mary Anderson; Joseph Davis,Nature,Crossref,10.0000/707947.903,68,5
18a58553-91a4-4194-9a3a-7b170d41b36b,Serology statistical analysis of patients : implications for policy,The investigation investigates the dynamics of immunity in a cohort . This study presents outcomes for vaccine in patients . We reports on outcomes for modeling in a cohort . We presents the dynamics of variants in patients . This study assesses the effectiveness of serology in a cohort . We investigates trends in pandemic in clinical settings . The investigation investigates trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2018-05-13,2018,Jessica Hernandez; Barbara Smith,Frontiers in Medicine,Publisher,10.0000/782121.486,77,9
8388f768-897a-4726-8d97-bac5b4087fe4,Transmission comprehensive assessment of spread,This study investigates trends in diagnostics in a cohort . This study reports on the effectiveness of outcomes in patients . This study presents trends in covid-19 in a cohort . Further work is needed to validate these findings.,2019-03-22,2019,Joseph Johnson; Jennifer Miller; Patricia Gonzalez; Joseph Wilson,Nature,Publisher,10.0000/651804.655,39,5
71b51755-dbcb-4174-8883-940c74d05e50,Transmission preliminary dynamics of prevalence,We assesses trends in variants in patients . We assesses trends in diagnostics in population . We presents outcomes for vaccine in clinical settings . We investigates the effectiveness of variants in patients . This study presents the effectiveness of sars-cov-2 in patients . Our analysis assesses the impact of transmission in clinical settings . Here we report reports on trends in coronavirus in clinical settings . The investigation investigates the dynamics of vaccine in clinical settings . Further work is needed to validate these findings.,2020-12-02,2020,Jennifer Davis; Barbara Anderson; Linda Rodriguez; Linda Jones; Barbara Miller,Unknown,medRxiv,10.0000/310310.145,86,5
6f34d634-2076-4dc7-866d-cf0cd281535d,Serology preliminary report of data,The investigation investigates the effectiveness of variants in hospitalized individuals . Here we report presents the impact of pandemic in hospitalized individuals . The investigation reports on the dynamics of therapeutics in hospitalized individuals . Here we report presents trends in vaccine in clinical settings . Further work is needed to validate these findings.,2017-07-27,2017,William Lopez; Jessica Anderson; Michael Martinez; Patricia Brown,The Lancet,PMC,10.0000/305687.958,54,5
ace71ace-0e1f-4ce6-842d-eab1d5f4c8c0,Transmission comparative investigation of patterns,Here we report assesses the effectiveness of epidemiology in a cohort . This study reports on the impact of sars-cov-2 in a cohort . This study presents the effectiveness of covid-19 in population . This study investigates the effectiveness of modeling in a cohort . Further work is needed to validate these findings.,2022-08-27,2022,Mary Wilson,bioRxiv,medRxiv,10.0000/961706.726,53,5
8baf7af5-2c36-4494-9569-7fccd36bcfae,Genomics comparative assessment of response,Our analysis investigates trends in coronavirus in hospitalized individuals . We assesses the impact of serology in clinical settings . Here we report presents the impact of variants in population . This study assesses outcomes for outcomes in a cohort . We investigates the impact of pandemic in population . Here we report investigates outcomes for covid-19 in hospitalized individuals . Our analysis investigates the impact of diagnostics in a cohort . Our analysis assesses outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2016-08-11,2016,Richard Johnson; Mary Smith; Barbara Anderson; Michael Davis,Science,Crossref,10.0000/609732.433,90,5
742670ac-c027-4007-af4f-f3a7429d326a,Genomics rapid dynamics of trends,We presents trends in coronavirus in patients . We reports on the effectiveness of vaccine in a cohort . This study presents the impact of diagnostics in patients . This study reports on the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2018-12-20,2018,Barbara Garcia; Elizabeth Jones; Michael Rodriguez,BMJ,Publisher,10.0000/627568.383,49,5
4a8de19c-cc1b-4144-b91c-d53a3a1d8b2c,SARS-CoV-2 preliminary report of patients,Our analysis evaluates the impact of transmission in clinical settings . The investigation presents the dynamics of vaccine in patients . We reports on the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2020-04-06,2020,Jessica Davis; Patricia Hernandez; John Rodriguez; Richard Martinez; Patricia Anderson,BMJ,Publisher,10.0000/883419.622,39,5
ea41afc6-005a-498f-a951-1821c6316776,Outcomes preliminary assessment of spread,This study reports on the effectiveness of diagnostics in patients . This study assesses outcomes for clinical in patients . Our analysis investigates trends in modeling in clinical settings . The investigation assesses trends in diagnostics in a cohort . Here we report presents outcomes for vaccine in a cohort . This study presents trends in serology in clinical settings . Further work is needed to validate these findings.,2019-07-03,2019,Susan Jones; John Miller; Robert Jones,PLOS ONE,ArXiv,10.0000/786123.961,69,5
39a0fc78-4e1e-4165-a8e5-e942333380dc,Modeling statistical assessment of effectiveness : implications for clinical practice,Our analysis presents the dynamics of sars-cov-2 in clinical settings . This study investigates trends in diagnostics in clinical settings . Here we report assesses outcomes for immunity in hospitalized individuals . The investigation evaluates the impact of immunity in hospitalized individuals . This study evaluates the effectiveness of clinical in population . Further work is needed to validate these findings.,2017-12-25,2017,David Hernandez; William Johnson; Michael Jones; Michael Gonzalez,Clinical Infectious Diseases,Publisher,10.0000/402584.387,61,10
bd66c0c5-5db3-426d-9b76-603dd1fad67e,Clinical statistical impact of patterns : implications for public health,This study assesses the effectiveness of therapeutics in clinical settings . The investigation reports on the dynamics of vaccine in patients . Here we report investigates the impact of clinical in clinical settings . Our analysis evaluates outcomes for vaccine in hospitalized individuals . Our analysis assesses the dynamics of covid-19 in population . The investigation reports on outcomes for genomics in clinical settings . This study presents the effectiveness of vaccine in a cohort . We reports on trends in vaccine in population . Further work is needed to validate these findings.,2017-08-08,2017,Patricia Hernandez; Susan Martinez; Jennifer Gonzalez,The Lancet,Crossref,10.0000/424990.453,93,10
7f7fa64a-2a53-4c34-b84e-74f7442f4183,Serology rapid report of trends,Our analysis presents the effectiveness of modeling in clinical settings . Our analysis evaluates the dynamics of transmission in population . This study presents the effectiveness of modeling in population . Further work is needed to validate these findings.,2019-01-18,2019,Jennifer Wilson; Richard Brown; Jessica Williams; Richard Jones; Barbara Rodriguez,The Lancet,Publisher,10.0000/500894.926,39,5
23c4764e-4b6d-48e2-8646-eef4f9afb46f,Modeling long-term report of response,Here we report investigates trends in variants in population . The investigation evaluates the effectiveness of outcomes in a cohort . This study presents outcomes for variants in population . We assesses the impact of therapeutics in a cohort . Here we report reports on trends in variants in population . The investigation evaluates the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2021-01-03,2021,Jennifer Martinez; Michael Anderson; James Rodriguez; Robert Hernandez,Clinical Infectious Diseases,ArXiv,10.0000/305280.914,69,5
803f2d58-446e-436a-8176-6bd25ef90c9b,Pandemic rapid survey of patterns,We evaluates trends in epidemiology in hospitalized individuals . Our analysis assesses trends in epidemiology in clinical settings . This study investigates the effectiveness of transmission in population . This study evaluates outcomes for genomics in a cohort . Our analysis evaluates the effectiveness of outcomes in patients . This study evaluates the dynamics of outcomes in a cohort . This study assesses the dynamics of epidemiology in population . Further work is needed to validate these findings.,2021-04-26,2021,Robert Martinez; Mary Garcia; Elizabeth Williams; William Gonzalez; John Anderson,Nature,Publisher,10.0000/160758.964,78,5
0683f409-8c62-4aec-86cb-6b0b290d3ab4,COVID-19 global review of prevalence,We presents the effectiveness of therapeutics in hospitalized individuals . Here we report investigates the effectiveness of covid-19 in hospitalized individuals . Here we report investigates the impact of outcomes in patients . Here we report presents trends in serology in a cohort . Further work is needed to validate these findings.,2019-06-03,2019,Barbara Gonzalez; David Jones; James Smith,Frontiers in Medicine,PMC,10.0000/386724.729,52,5
39d0dec8-da66-48f2-ae3e-ebd8516d25bf,Serology long-term study of response,We presents the impact of clinical in clinical settings . Here we report evaluates the impact of epidemiology in clinical settings . Our analysis assesses the dynamics of genomics in patients . Further work is needed to validate these findings.,2021-08-12,2021,James Jones; John Miller; Robert Gonzalez,Nature,Crossref,10.0000/525012.397,40,5
90d7c35d-c406-4f58-bad2-74636eac44fd,Modeling rapid report of prevalence,The investigation investigates the impact of immunity in clinical settings . We presents the dynamics of outcomes in a cohort . Our analysis reports on the effectiveness of genomics in patients . This study evaluates the impact of clinical in population . Further work is needed to validate these findings.,2020-10-24,2020,James Garcia; Linda Anderson; Barbara Davis,Science,Publisher,10.0000/201405.491,50,5
96f1b1f5-104a-4907-9558-2b564d9610ce,Therapeutics comprehensive report of prevalence,We evaluates the impact of pandemic in population . Our analysis investigates trends in immunity in a cohort . The investigation presents trends in coronavirus in hospitalized individuals . The investigation assesses the impact of clinical in clinical settings . This study assesses trends in serology in a cohort . Further work is needed to validate these findings.,2018-07-15,2018,James Rodriguez; Jennifer Johnson; Patricia Hernandez; Linda Davis; James Williams,medRxiv,bioRxiv,10.0000/537702.563,58,5
7aa838c7-ae45-4a2a-9ee8-875a2ac3446a,Epidemiology comparative report of response,The investigation investigates outcomes for coronavirus in population . Here we report presents the dynamics of genomics in a cohort . This study investigates trends in covid-19 in patients . Our analysis evaluates trends in genomics in clinical settings . This study evaluates trends in clinical in patients . Our analysis evaluates the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2016-10-14,2016,Robert Davis,BMJ,medRxiv,10.0000/823720.618,68,5
3f53180c-e1c3-4c82-8a90-5a3aa1643769,Vaccine preliminary review of response : implications for vaccination strategies,This study presents the effectiveness of genomics in a cohort . Here we report reports on the effectiveness of sars-cov-2 in a cohort . This study investigates the dynamics of pandemic in a cohort . Further work is needed to validate these findings.,2019-03-25,2019,Mary Anderson; Jennifer Smith; Patricia Miller; Richard Brown,Nature,bioRxiv,10.0000/116526.729,43,10
9eda9426-0047-4171-8bef-992cc5eeb606,Genomics rapid report of patterns,Our analysis evaluates the impact of clinical in hospitalized individuals . The investigation investigates outcomes for transmission in population . Here we report assesses the effectiveness of transmission in hospitalized individuals . This study reports on trends in epidemiology in population . Further work is needed to validate these findings.,2019-07-29,2019,Elizabeth Davis; Michael Gonzalez; Richard Brown; Linda Wilson,The Lancet,PMC,10.0000/506666.714,50,5
066c688e-1440-46e6-ab61-44919589a7f6,Coronavirus statistical dynamics of patients,The investigation presents the dynamics of outcomes in population . Here we report presents outcomes for pandemic in population . Our analysis reports on the effectiveness of pandemic in population . This study evaluates outcomes for epidemiology in patients . This study evaluates trends in therapeutics in hospitalized individuals . We evaluates the dynamics of epidemiology in population . We investigates the effectiveness of pandemic in patients . Our analysis assesses outcomes for diagnostics in population . Further work is needed to validate these findings.,2017-02-28,2017,Richard Jones,Clinical Infectious Diseases,Publisher,10.0000/483219.946,85,5
624e8080-d3ce-4450-8b06-44bce34e63bc,Diagnostics clinical analysis of patterns : implications for vaccination strategies,This study investigates the impact of serology in patients . This study investigates outcomes for modeling in population . This study assesses the impact of clinical in hospitalized individuals . Here we report presents the effectiveness of diagnostics in hospitalized individuals . Here we report investigates the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2022-03-14,2022,James Davis; Richard Lopez,Journal of Infectious Diseases,bioRxiv,10.0000/518639.987,62,10
ccb270e1-45cd-4146-a8ff-52f497354147,Therapeutics regional investigation of effectiveness,Our analysis assesses the effectiveness of therapeutics in a cohort . The investigation investigates the effectiveness of epidemiology in hospitalized individuals . The investigation presents the effectiveness of variants in hospitalized individuals . This study reports on the dynamics of modeling in hospitalized individuals . We evaluates the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2017-05-31,2017,Susan Wilson; John Lopez; Richard Davis,Science,PMC,10.0000/415696.437,62,5
823e8dec-2134-4481-a44f-f6c1967f77c2,Pandemic clinical dynamics of trends,This study reports on the impact of genomics in clinical settings . We assesses the effectiveness of vaccine in clinical settings . Our analysis presents trends in immunity in patients . We investigates the dynamics of transmission in a cohort . Here we report presents outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-05-18,2021,Robert Gonzalez; Joseph Lopez; James Wilson,Science,PMC,10.0000/587568.791,60,5
c303f648-f5ee-4629-87b6-55f6c49fc782,Outcomes long-term report of prevalence : implications for clinical practice,Here we report evaluates the impact of variants in clinical settings . This study assesses the impact of serology in population . Our analysis presents the dynamics of epidemiology in clinical settings . The investigation assesses the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2022-10-29,2022,Susan Brown; Susan Hernandez; Susan Anderson; Elizabeth Martinez,PLOS ONE,PMC,10.0000/168714.704,51,10
0d080afc-9973-4f80-88a0-5a1ced5e7847,Epidemiology comprehensive impact of spread,This study investigates the effectiveness of transmission in hospitalized individuals . The investigation assesses trends in modeling in hospitalized individuals . We presents outcomes for modeling in hospitalized individuals . This study investigates trends in epidemiology in a cohort . Our analysis evaluates outcomes for immunity in population . This study presents trends in clinical in clinical settings . Further work is needed to validate these findings.,2017-10-18,2017,William Garcia,Science,Crossref,10.0000/449558.844,67,5
632acabb-aacd-4579-94c7-f587ea00d6e9,Modeling rapid analysis of patients,This study reports on the impact of vaccine in clinical settings . Here we report reports on trends in therapeutics in hospitalized individuals . The investigation evaluates the effectiveness of therapeutics in population . We evaluates the effectiveness of epidemiology in population . Further work is needed to validate these findings.,2020-06-27,2020,Barbara Anderson; Barbara Brown; Robert Miller,PLOS ONE,PMC,10.0000/315961.224,51,5
cea8ed91-f1ae-4ff6-912b-480070bceb7e,Coronavirus regional investigation of response,We evaluates the dynamics of variants in a cohort . We evaluates the effectiveness of variants in clinical settings . We assesses the effectiveness of coronavirus in hospitalized individuals . We assesses trends in immunity in a cohort . The investigation assesses the effectiveness of pandemic in a cohort . Our analysis presents the dynamics of clinical in patients . Further work is needed to validate these findings.,2016-08-15,2016,Barbara Martinez,The Lancet,Publisher,10.0000/206079.340,68,5
748d0285-f01a-4582-a2ed-f111047b93f9,SARS-CoV-2 preliminary study of trends,This study assesses outcomes for serology in a cohort . Our analysis presents outcomes for variants in hospitalized individuals . Here we report presents the impact of genomics in population . Here we report investigates the dynamics of immunity in a cohort . This study reports on trends in serology in clinical settings . We assesses trends in serology in population . This study investigates the effectiveness of covid-19 in clinical settings . Our analysis presents outcomes for modeling in population . Further work is needed to validate these findings.,2015-08-17,2015,Jessica Smith; Richard Jones,medRxiv,medRxiv,10.0000/794253.773,90,5
60df4986-8c65-4292-b00d-1e0fbcdb19bd,Therapeutics clinical review of incidence,The investigation evaluates the dynamics of genomics in clinical settings . The investigation investigates the dynamics of coronavirus in patients . The investigation reports on outcomes for coronavirus in hospitalized individuals . Here we report presents trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2020-07-07,2020,Richard Miller,Journal of Infectious Diseases,Crossref,10.0000/745341.356,51,5
7cb25728-11ce-4fc8-a704-502b09993341,Immunity global dynamics of data : implications for public health,The investigation presents the dynamics of pandemic in patients . The investigation evaluates trends in sars-cov-2 in population . This study presents the dynamics of sars-cov-2 in hospitalized individuals . The investigation investigates the impact of genomics in clinical settings . Further work is needed to validate these findings.,2020-08-11,2020,Jessica Lopez; Linda Williams; John Anderson; William Johnson,Unknown,Publisher,10.0000/319376.921,49,10
e93423ba-a4a2-4794-aef4-5d659b2e26a0,Therapeutics statistical investigation of outcomes : implications for policy,This study presents the impact of immunity in hospitalized individuals . Our analysis presents the impact of transmission in patients . We investigates the effectiveness of clinical in hospitalized individuals . This study evaluates the impact of outcomes in hospitalized individuals . The investigation evaluates outcomes for immunity in patients . Further work is needed to validate these findings.,2017-03-18,2017,Mary Wilson; Jessica Davis,Unknown,medRxiv,10.0000/832959.545,59,9
8aca2a1d-246c-41ea-b1d8-86e90fa50016,SARS-CoV-2 comprehensive investigation of incidence,The investigation presents the impact of therapeutics in population . The investigation investigates the dynamics of genomics in hospitalized individuals . Our analysis investigates trends in diagnostics in patients . We presents trends in outcomes in a cohort . Further work is needed to validate these findings.,2020-11-15,2020,Michael Lopez; Robert Jones; Susan Davis; Susan Williams,Nature,Crossref,10.0000/885937.176,47,5
6c7461db-fdf2-4755-aa4a-c8b61cceca59,COVID-19 long-term report of incidence,Here we report assesses the effectiveness of therapeutics in clinical settings . The investigation investigates the dynamics of diagnostics in population . We reports on trends in diagnostics in clinical settings . Here we report presents trends in modeling in population . Our analysis evaluates the dynamics of serology in hospitalized individuals . The investigation reports on the dynamics of therapeutics in patients . Further work is needed to validate these findings.,2020-10-31,2020,John Brown; Richard Williams; John Williams; Mary Smith; Jessica Brown,Nature,ArXiv,10.0000/312526.983,72,5
41a3570f-cc7b-440f-87c7-aef4286fce0e,Transmission clinical review of patterns,The investigation assesses outcomes for modeling in clinical settings . Our analysis investigates the impact of variants in hospitalized individuals . Here we report presents outcomes for serology in clinical settings . Further work is needed to validate these findings.,2022-02-03,2022,Elizabeth Rodriguez,Clinical Infectious Diseases,ArXiv,10.0000/106530.851,40,5
2bced441-6ec4-4098-9c01-bff2e870c304,Pandemic clinical investigation of patients,This study evaluates trends in pandemic in clinical settings . We investigates the effectiveness of modeling in clinical settings . The investigation assesses outcomes for epidemiology in patients . We evaluates the effectiveness of covid-19 in hospitalized individuals . Our analysis investigates trends in transmission in patients . We evaluates outcomes for modeling in population . Our analysis evaluates the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2017-03-17,2017,Jessica Lopez; Robert Hernandez; Barbara Davis,PLOS ONE,PMC,10.0000/613049.868,74,5
e43188ea-86f5-44cf-bcb8-8c3854b24caa,Immunity preliminary evaluation of outcomes,We evaluates the effectiveness of immunity in patients . Here we report evaluates the impact of clinical in hospitalized individuals . This study presents trends in covid-19 in hospitalized individuals . We presents the dynamics of immunity in hospitalized individuals . The investigation reports on the dynamics of variants in hospitalized individuals . Further work is needed to validate these findings.,2017-02-03,2017,Barbara Gonzalez,PLOS ONE,medRxiv,10.0000/405969.270,61,5
c08ef443-18b9-413b-aed5-7bfae4dfda2e,Outcomes comprehensive investigation of spread,We presents trends in therapeutics in clinical settings . We investigates the dynamics of genomics in a cohort . This study evaluates outcomes for vaccine in a cohort . Here we report evaluates outcomes for diagnostics in clinical settings . Our analysis evaluates the dynamics of sars-cov-2 in population . We evaluates the dynamics of clinical in a cohort . We evaluates the effectiveness of diagnostics in clinical settings . This study presents trends in vaccine in a cohort . Further work is needed to validate these findings.,2020-12-21,2020,Michael Garcia; Jennifer Hernandez; Patricia Anderson; Elizabeth Jones; Jennifer Hernandez,PLOS ONE,medRxiv,10.0000/692524.919,88,5
39a1a800-d64c-422e-ab26-62197cfddfc4,Coronavirus rapid analysis of outcomes,We presents the effectiveness of therapeutics in hospitalized individuals . The investigation presents the impact of variants in clinical settings . This study assesses outcomes for sars-cov-2 in clinical settings . This study presents the effectiveness of serology in patients . Our analysis reports on trends in variants in hospitalized individuals . Our analysis investigates the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2016-07-01,2016,Robert Anderson; Michael Jones,The Lancet,medRxiv,10.0000/235324.350,71,5
570c872c-d1e5-4846-b819-b26b02cacaa6,SARS-CoV-2 comparative assessment of data,Here we report evaluates the dynamics of outcomes in clinical settings . This study assesses the effectiveness of coronavirus in population . This study assesses outcomes for coronavirus in population . Here we report evaluates the impact of vaccine in patients . Our analysis reports on the impact of epidemiology in population . The investigation presents the impact of therapeutics in population . We evaluates the dynamics of transmission in a cohort . The investigation presents the dynamics of vaccine in population . Further work is needed to validate these findings.,2016-03-28,2016,William Rodriguez; Joseph Johnson; Michael Anderson; Patricia Garcia,The Lancet,Crossref,10.0000/855826.173,91,5
5a27c789-ad57-4e07-bba5-970d3186c00d,Diagnostics long-term analysis of patients,We presents trends in pandemic in patients . Here we report investigates the effectiveness of serology in patients . Our analysis reports on the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2015-01-15,2015,Elizabeth Lopez,Science,PMC,10.0000/634450.555,39,5
8ae6587f-231b-4e55-a535-7f3afc0ed66b,Outcomes comparative analysis of trends,Here we report evaluates outcomes for therapeutics in a cohort . Here we report investigates the effectiveness of pandemic in a cohort . The investigation assesses the impact of genomics in patients . Our analysis evaluates the impact of immunity in population . We reports on outcomes for variants in clinical settings . The investigation reports on the impact of sars-cov-2 in hospitalized individuals . This study reports on the effectiveness of sars-cov-2 in clinical settings . This study evaluates the impact of pandemic in population . Further work is needed to validate these findings.,2015-11-16,2015,Jessica Rodriguez; John Jones,Nature,ArXiv,10.0000/255930.606,95,5
89aefeca-40d3-4e37-97ac-7f44368ef60c,Serology regional study of outcomes,We presents trends in modeling in hospitalized individuals . Our analysis evaluates the effectiveness of sars-cov-2 in a cohort . We reports on the effectiveness of vaccine in patients . Here we report reports on trends in modeling in a cohort . Further work is needed to validate these findings.,2016-03-03,2016,James Brown; David Wilson; Susan Lopez,Unknown,ArXiv,10.0000/897125.710,50,5
c021cb97-2152-4ece-9741-8b9f99d096fb,Vaccine comprehensive investigation of prevalence,Here we report investigates the effectiveness of diagnostics in population . We investigates the dynamics of vaccine in hospitalized individuals . The investigation presents trends in serology in population . Our analysis assesses the dynamics of clinical in hospitalized individuals . Our analysis reports on the effectiveness of clinical in patients . Our analysis presents the impact of sars-cov-2 in patients . Our analysis assesses the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-09-18,2016,David Hernandez; Robert Hernandez,Journal of Infectious Diseases,Crossref,10.0000/626588.586,81,5
9167863f-2b31-4493-ae61-b58a630be494,Transmission preliminary study of spread,Here we report investigates trends in outcomes in clinical settings . The investigation evaluates trends in transmission in a cohort . We investigates the dynamics of transmission in hospitalized individuals . Our analysis evaluates outcomes for modeling in patients . The investigation evaluates the dynamics of clinical in hospitalized individuals . This study reports on the impact of epidemiology in population . Here we report evaluates the impact of clinical in clinical settings . Our analysis reports on the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2021-01-29,2021,John Davis; Robert Rodriguez; Michael Williams,medRxiv,Publisher,10.0000/447148.522,94,5
ba77e718-beba-4c19-8941-edce1dcf4920,Variants preliminary impact of patients : implications for clinical practice,Here we report assesses the effectiveness of immunity in clinical settings . The investigation presents the dynamics of epidemiology in patients . This study presents trends in outcomes in clinical settings . Here we report investigates the impact of genomics in clinical settings . The investigation investigates outcomes for immunity in clinical settings . Our analysis presents the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2020-09-23,2020,Elizabeth Garcia; David Lopez; Michael Rodriguez; Robert Johnson,Science,Publisher,10.0000/271951.134,73,10
39987b0c-09c6-406b-90da-40e2b629db87,Serology regional assessment of patients,The investigation investigates trends in outcomes in patients . The investigation presents the dynamics of immunity in patients . Here we report investigates the dynamics of diagnostics in population . This study presents outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2017-12-26,2017,Patricia Davis; William Jones; Michael Lopez; Richard Gonzalez,Science,medRxiv,10.0000/344407.570,48,5
a5f17915-e991-441b-b622-fadd6be0a468,Coronavirus comprehensive study of trends,This study reports on outcomes for immunity in population . Our analysis investigates the impact of transmission in hospitalized individuals . Our analysis assesses outcomes for modeling in clinical settings . Our analysis reports on outcomes for variants in population . This study investigates outcomes for transmission in population . Further work is needed to validate these findings.,2022-03-27,2022,William Martinez; Michael Jones; Robert Anderson,bioRxiv,Crossref,10.0000/335435.866,58,5
721ef67d-b248-4421-a9b1-c3a864f0257a,Immunity comprehensive dynamics of spread,We presents trends in serology in clinical settings . Our analysis evaluates trends in modeling in population . Our analysis investigates the dynamics of sars-cov-2 in population . The investigation reports on the dynamics of modeling in clinical settings . The investigation investigates the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2015-07-02,2015,John Williams; Joseph Lopez; John Gonzalez; Jessica Jones; Mary Anderson,PLOS ONE,PMC,10.0000/149691.824,59,5
b5780ccb-d125-4642-b46e-3979ab88dc42,SARS-CoV-2 regional survey of effectiveness,Here we report reports on the effectiveness of pandemic in patients . We investigates the effectiveness of outcomes in hospitalized individuals . We assesses trends in diagnostics in population . The investigation investigates the dynamics of immunity in hospitalized individuals . Our analysis presents the impact of pandemic in clinical settings . This study presents the effectiveness of serology in clinical settings . Our analysis presents the impact of serology in clinical settings . This study reports on outcomes for serology in a cohort . Further work is needed to validate these findings.,2017-11-10,2017,Patricia Williams; Susan Brown; Barbara Jones; Jennifer Anderson,Unknown,bioRxiv,10.0000/242841.139,93,5
09bb33f6-0e03-4815-86df-61742571e4a8,Outcomes comprehensive investigation of prevalence : implications for policy,Our analysis assesses the dynamics of therapeutics in patients . Our analysis investigates the dynamics of variants in a cohort . We presents the impact of diagnostics in clinical settings . We evaluates the effectiveness of epidemiology in clinical settings . We investigates the impact of genomics in population . We presents the impact of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2016-09-24,2016,Michael Garcia; Jessica Martinez; Elizabeth Jones; David Williams; Jessica Brown,The Lancet,medRxiv,10.0000/998680.497,68,9
a1f9ad71-e084-42ad-b911-6c5f1197b491,Immunity comprehensive review of trends : implications for clinical practice,The investigation assesses the impact of epidemiology in patients . We presents the impact of serology in a cohort . Here we report assesses trends in immunity in hospitalized individuals . This study reports on outcomes for modeling in hospitalized individuals . Here we report reports on trends in covid-19 in population . Our analysis evaluates outcomes for serology in population . The investigation evaluates the impact of pandemic in clinical settings . Our analysis reports on trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2019-07-09,2019,Mary Johnson,The Lancet,medRxiv,10.0000/392596.494,92,10
4eb44139-76f6-4af6-9c5a-b000af283647,Serology comparative survey of data : implications for policy,Here we report assesses outcomes for modeling in patients . Here we report reports on outcomes for sars-cov-2 in hospitalized individuals . We reports on the impact of epidemiology in population . The investigation reports on the dynamics of covid-19 in patients . Further work is needed to validate these findings.,2018-09-29,2018,Elizabeth Hernandez,BMJ,ArXiv,10.0000/394764.265,51,9
b0f51ecd-6498-4cfd-af88-8bf32378de47,Epidemiology preliminary dynamics of patterns,Our analysis assesses outcomes for sars-cov-2 in a cohort . We investigates the impact of genomics in clinical settings . Our analysis assesses the effectiveness of immunity in clinical settings . Our analysis presents outcomes for epidemiology in population . Further work is needed to validate these findings.,2022-11-23,2022,David Garcia; Jessica Wilson,bioRxiv,bioRxiv,10.0000/151136.553,48,5
0f107864-0396-4c40-922d-80978e509489,Pandemic comprehensive dynamics of data : implications for policy,Here we report presents the dynamics of diagnostics in a cohort . Our analysis reports on the impact of therapeutics in patients . This study assesses the dynamics of vaccine in patients . The investigation presents the impact of sars-cov-2 in population . The investigation presents the effectiveness of covid-19 in patients . Our analysis presents the impact of sars-cov-2 in clinical settings . Here we report assesses the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2019-06-19,2019,Barbara Davis; Linda Martinez; Jessica Jones; William Johnson,bioRxiv,PMC,10.0000/791401.637,84,9
402ed86c-6138-4649-a89b-9811dd124b74,Pandemic regional review of patterns,Here we report evaluates trends in serology in patients . We evaluates trends in immunity in hospitalized individuals . Here we report presents the effectiveness of modeling in a cohort . Here we report reports on outcomes for genomics in clinical settings . Here we report assesses the dynamics of serology in hospitalized individuals . We evaluates trends in diagnostics in a cohort . Further work is needed to validate these findings.,2015-10-18,2015,Jennifer Davis; Patricia Jones; Patricia Smith; Linda Gonzalez,PLOS ONE,Publisher,10.0000/324505.940,72,5
9bd1f057-f914-452e-9471-a1189ffe6471,Clinical rapid impact of incidence,The investigation reports on the dynamics of covid-19 in clinical settings . Our analysis presents the impact of epidemiology in population . Our analysis assesses trends in genomics in population . Further work is needed to validate these findings.,2017-11-08,2017,Michael Gonzalez; David Rodriguez; Jessica Williams; Patricia Gonzalez,Unknown,ArXiv,10.0000/840514.906,39,5
41c8b384-f20c-4fc6-8dde-34f1076d46ae,Diagnostics rapid review of outcomes : implications for public health,Here we report reports on outcomes for outcomes in hospitalized individuals . The investigation reports on the impact of sars-cov-2 in patients . We investigates the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2017-07-18,2017,Jennifer Gonzalez; Joseph Hernandez; Barbara Wilson; Patricia Williams,Journal of Infectious Diseases,PMC,10.0000/216132.491,41,10
47ecfe89-b56b-466b-be30-857d5521a1c4,SARS-CoV-2 clinical survey of effectiveness,We reports on trends in immunity in patients . This study evaluates trends in coronavirus in hospitalized individuals . We reports on trends in vaccine in hospitalized individuals . Further work is needed to validate these findings.,2020-09-05,2020,Mary Johnson; Jessica Smith,Journal of Infectious Diseases,Publisher,10.0000/149985.380,37,5
7d2db002-e741-42ec-b791-adf4eb3cddac,SARS-CoV-2 preliminary assessment of patients,The investigation assesses the impact of therapeutics in patients . We reports on the dynamics of variants in population . Our analysis investigates outcomes for clinical in clinical settings . The investigation investigates outcomes for outcomes in population . Our analysis presents the effectiveness of therapeutics in population . This study reports on outcomes for pandemic in population . Further work is needed to validate these findings.,2021-03-07,2021,Susan Garcia; Jennifer Williams; William Martinez; John Miller; James Lopez,PLOS ONE,Crossref,10.0000/498163.534,67,5
0a93e744-7fa5-47a3-aaf0-510c32f11890,Clinical comprehensive study of patients,The investigation assesses trends in coronavirus in patients . This study evaluates the dynamics of pandemic in clinical settings . The investigation assesses the dynamics of pandemic in clinical settings . This study investigates outcomes for pandemic in patients . The investigation investigates outcomes for immunity in hospitalized individuals . This study reports on the impact of variants in population . Our analysis reports on the effectiveness of sars-cov-2 in clinical settings . The investigation reports on the dynamics of transmission in patients . Further work is needed to validate these findings.,2018-05-17,2018,John Jones; Robert Jones; Elizabeth Rodriguez,Unknown,Crossref,10.0000/652446.913,92,5
0be127db-7548-4375-be03-3a1a0e4c1833,Diagnostics clinical dynamics of spread : implications for vaccination strategies,Here we report assesses outcomes for vaccine in hospitalized individuals . Our analysis assesses the impact of outcomes in a cohort . Our analysis evaluates outcomes for covid-19 in patients . We investigates trends in serology in clinical settings . Here we report investigates the effectiveness of outcomes in patients . Further work is needed to validate these findings.,2015-07-12,2015,Elizabeth Wilson,The Lancet,medRxiv,10.0000/166525.358,59,10
9aa3e380-7c2c-454e-bec1-d769674ee1d7,Modeling comparative impact of outcomes : implications for vaccination strategies,Our analysis reports on the impact of serology in population . We assesses outcomes for variants in hospitalized individuals . This study investigates outcomes for outcomes in a cohort . Here we report presents the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-07-18,2016,Richard Martinez,PLOS ONE,medRxiv,10.0000/160278.876,50,10
0896ddbf-2c40-4a3a-9257-df57dc161ee9,Genomics comprehensive impact of prevalence,The investigation evaluates outcomes for serology in population . Here we report assesses the dynamics of serology in hospitalized individuals . Our analysis evaluates outcomes for pandemic in population . We presents the impact of variants in clinical settings . Our analysis evaluates trends in covid-19 in hospitalized individuals . We investigates the impact of genomics in clinical settings . Further work is needed to validate these findings.,2015-03-10,2015,Elizabeth Smith,PLOS ONE,medRxiv,10.0000/960004.588,68,5
babda476-1479-4442-b1f3-ab50802568d5,SARS-CoV-2 global study of trends,This study assesses outcomes for immunity in hospitalized individuals . This study assesses the effectiveness of immunity in hospitalized individuals . Here we report reports on the impact of epidemiology in clinical settings . Further work is needed to validate these findings.,2022-02-07,2022,William Johnson; Susan Brown; James Jones,The Lancet,Publisher,10.0000/913944.209,42,5
c5536338-212c-497a-bc3e-0b0fc20465ef,Modeling clinical report of patterns,The investigation presents the impact of variants in hospitalized individuals . Our analysis reports on trends in modeling in population . Here we report reports on the dynamics of transmission in a cohort . Our analysis evaluates trends in diagnostics in population . We presents trends in therapeutics in patients . Here we report presents trends in epidemiology in clinical settings . We presents outcomes for coronavirus in a cohort . Here we report investigates the dynamics of coronavirus in patients . Further work is needed to validate these findings.,2015-11-14,2015,William Davis,PLOS ONE,ArXiv,10.0000/155092.730,90,5
c40a0b9c-cd76-4ffe-bbc7-c9272f93dc8a,Therapeutics global analysis of response,Our analysis presents the dynamics of sars-cov-2 in patients . Our analysis presents the impact of vaccine in patients . The investigation reports on outcomes for transmission in clinical settings . Further work is needed to validate these findings.,2018-10-15,2018,Robert Davis; Jennifer Hernandez; Barbara Smith; Susan Miller; Jessica Jones,The Lancet,Crossref,10.0000/129760.884,39,5
df204579-54e3-4074-9783-7f2551c21b74,Coronavirus comparative impact of prevalence,This study reports on trends in covid-19 in a cohort . Here we report presents the effectiveness of transmission in population . Our analysis evaluates trends in genomics in hospitalized individuals . This study presents the effectiveness of outcomes in patients . We investigates outcomes for transmission in a cohort . We assesses the impact of diagnostics in patients . This study reports on the impact of clinical in hospitalized individuals . This study investigates the effectiveness of therapeutics in patients . Further work is needed to validate these findings.,2022-07-25,2022,Mary Anderson; John Davis; Jennifer Smith; Linda Jones,Frontiers in Medicine,medRxiv,10.0000/143564.538,90,5
1f33a751-e88b-4d1a-adfd-3294d9a2d8fe,SARS-CoV-2 rapid study of trends,Our analysis presents the dynamics of clinical in population . The investigation evaluates outcomes for modeling in clinical settings . This study evaluates the impact of serology in population . This study evaluates outcomes for epidemiology in hospitalized individuals . This study investigates trends in pandemic in clinical settings . This study presents outcomes for modeling in patients . Here we report presents the dynamics of coronavirus in clinical settings . Further work is needed to validate these findings.,2018-05-08,2018,Patricia Williams; William Johnson; James Hernandez; Linda Jones,medRxiv,medRxiv,10.0000/637806.111,79,5
667c89a1-726f-4aca-968e-2341e6d7eddc,SARS-CoV-2 long-term analysis of incidence : implications for policy,This study presents outcomes for epidemiology in hospitalized individuals . We reports on the dynamics of transmission in a cohort . This study assesses trends in outcomes in a cohort . This study presents outcomes for vaccine in a cohort . We presents the impact of modeling in patients . Our analysis investigates the effectiveness of vaccine in clinical settings . The investigation investigates the dynamics of variants in patients . Our analysis assesses outcomes for variants in a cohort . Further work is needed to validate these findings.,2020-09-24,2020,William Smith; Patricia Davis; Elizabeth Smith; Susan Hernandez; Linda Brown,bioRxiv,Crossref,10.0000/589936.203,89,9
5f9494f1-97a5-4b1d-8fe6-c27a8f769f55,COVID-19 comparative analysis of spread : implications for clinical practice,We investigates the dynamics of vaccine in clinical settings . This study presents trends in genomics in a cohort . Our analysis evaluates the dynamics of covid-19 in hospitalized individuals . Here we report presents the dynamics of immunity in patients . Further work is needed to validate these findings.,2018-09-30,2018,Joseph Martinez,Journal of Infectious Diseases,Publisher,10.0000/533700.226,50,10
caad0cac-7896-4375-8ece-36a8e9c6af04,COVID-19 comprehensive report of trends,Here we report investigates outcomes for diagnostics in population . Here we report reports on the dynamics of serology in hospitalized individuals . We evaluates the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-03-15,2015,Linda Gonzalez; Linda Martinez; William Garcia; Patricia Hernandez; Barbara Smith,Science,ArXiv,10.0000/452447.100,41,5
cc465d83-ad80-4165-9f79-32b02ea32b38,Outcomes long-term assessment of incidence,Here we report investigates the dynamics of genomics in clinical settings . This study investigates outcomes for covid-19 in population . The investigation evaluates outcomes for pandemic in hospitalized individuals . This study investigates outcomes for serology in clinical settings . Our analysis investigates trends in vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-08-18,2022,Jennifer Anderson,medRxiv,PMC,10.0000/568594.839,59,5
96e6cebb-624d-4bbb-bf2a-9cdd11031041,Genomics statistical investigation of outcomes,The investigation reports on outcomes for sars-cov-2 in population . Our analysis reports on the dynamics of therapeutics in patients . Our analysis evaluates the dynamics of covid-19 in hospitalized individuals . This study presents the impact of epidemiology in a cohort . Our analysis evaluates trends in variants in a cohort . Further work is needed to validate these findings.,2016-11-29,2016,Richard Hernandez,Frontiers in Medicine,ArXiv,10.0000/560081.433,61,5
dbc8b264-2ba3-47b6-852e-713238175518,Epidemiology clinical analysis of incidence,We reports on outcomes for outcomes in clinical settings . We investigates the impact of clinical in clinical settings . Our analysis investigates the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2016-11-12,2016,Mary Gonzalez; William Anderson; Jessica Lopez; Linda Jones; Mary Smith,Unknown,ArXiv,10.0000/319716.931,39,5
242eaddf-3357-4a1e-935b-62f1cb8913ee,Therapeutics preliminary dynamics of trends : implications for policy,The investigation evaluates outcomes for therapeutics in population . Here we report assesses the dynamics of clinical in population . The investigation investigates trends in immunity in a cohort . Further work is needed to validate these findings.,2016-06-01,2016,James Wilson; William Davis; Jessica Williams,Frontiers in Medicine,Publisher,10.0000/763695.170,38,9
2435df35-491f-4508-808f-d3aee9a97865,Variants statistical investigation of response : implications for public health,This study investigates the dynamics of covid-19 in clinical settings . The investigation evaluates the effectiveness of sars-cov-2 in clinical settings . We reports on the dynamics of diagnostics in a cohort . Here we report reports on the effectiveness of transmission in a cohort . Further work is needed to validate these findings.,2021-04-26,2021,Elizabeth Martinez; Elizabeth Hernandez; Robert Jones,PLOS ONE,bioRxiv,10.0000/284901.393,54,10
924cecce-db89-46c0-b1a3-7f08d2409cc3,Coronavirus clinical dynamics of spread : implications for policy,Here we report evaluates the effectiveness of serology in a cohort . We investigates trends in pandemic in patients . Our analysis reports on trends in clinical in a cohort . This study investigates the effectiveness of coronavirus in a cohort . The investigation presents the impact of pandemic in hospitalized individuals . This study presents trends in pandemic in patients . Further work is needed to validate these findings.,2015-04-07,2015,Jessica Rodriguez; David Hernandez,medRxiv,medRxiv,10.0000/510205.599,70,9
ae2e7658-f02d-4fb4-971d-76770ef5eb55,Genomics comparative review of spread : implications for vaccination strategies,Our analysis reports on the effectiveness of modeling in hospitalized individuals . The investigation presents outcomes for modeling in a cohort . Here we report assesses the impact of serology in patients . Further work is needed to validate these findings.,2015-07-19,2015,Michael Rodriguez; James Rodriguez; Barbara Garcia,Frontiers in Medicine,ArXiv,10.0000/206395.896,41,10
810867fb-5e7f-4f3f-9484-894b20940891,Therapeutics clinical assessment of prevalence : implications for vaccination strategies,This study evaluates the impact of modeling in clinical settings . Here we report evaluates the impact of outcomes in a cohort . The investigation assesses trends in clinical in patients . Here we report investigates outcomes for genomics in clinical settings . The investigation investigates the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2020-06-24,2020,John Miller,The Lancet,Publisher,10.0000/270943.465,62,10
d347c5d1-b8d0-405e-8330-4f412c3045ed,Serology comparative analysis of response,The investigation evaluates the impact of coronavirus in a cohort . We reports on the impact of sars-cov-2 in clinical settings . We investigates trends in genomics in population . This study evaluates the dynamics of clinical in a cohort . Here we report reports on the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2020-05-16,2020,Joseph Hernandez,Frontiers in Medicine,Publisher,10.0000/685515.161,62,5
d514a840-5919-485c-8b90-f5e0a086a01e,Genomics statistical assessment of patients,We investigates outcomes for diagnostics in hospitalized individuals . Our analysis evaluates the dynamics of transmission in patients . The investigation presents trends in outcomes in clinical settings . We investigates the impact of covid-19 in clinical settings . We presents the impact of serology in clinical settings . Here we report evaluates the impact of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2022-06-13,2022,Richard Jones,BMJ,ArXiv,10.0000/975533.735,69,5
2f3df248-4d97-43bd-92e6-64a83ec3df6a,Clinical global survey of incidence,The investigation investigates outcomes for genomics in patients . The investigation investigates the impact of genomics in patients . The investigation evaluates the impact of epidemiology in patients . The investigation evaluates the dynamics of clinical in a cohort . Our analysis reports on the impact of therapeutics in a cohort . Our analysis evaluates outcomes for coronavirus in population . We investigates the impact of outcomes in a cohort . Here we report presents the effectiveness of modeling in a cohort . Further work is needed to validate these findings.,2015-05-27,2015,Richard Garcia; Jennifer Hernandez; Susan Gonzalez; Patricia Hernandez,Journal of Infectious Diseases,medRxiv,10.0000/760827.123,91,5
dff8140a-95dc-4456-be27-252e9c285286,COVID-19 global investigation of prevalence : implications for public health,This study assesses outcomes for genomics in hospitalized individuals . This study presents the dynamics of serology in clinical settings . This study presents outcomes for vaccine in hospitalized individuals . Here we report evaluates the impact of outcomes in clinical settings . The investigation assesses the dynamics of epidemiology in patients . The investigation investigates the dynamics of diagnostics in clinical settings . Our analysis assesses the effectiveness of clinical in hospitalized individuals . Further work is needed to validate these findings.,2016-01-19,2016,James Rodriguez; Linda Martinez,Science,ArXiv,10.0000/793748.699,83,10
173f5c54-1e18-4131-b125-b1206709c2cc,Genomics long-term evaluation of outcomes,We investigates trends in therapeutics in clinical settings . Here we report reports on the impact of covid-19 in population . We reports on trends in clinical in a cohort . This study evaluates the impact of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2019-07-10,2019,Richard Garcia; Elizabeth Johnson; Joseph Williams,Frontiers in Medicine,medRxiv,10.0000/620465.966,50,5
ce091f6b-2377-43f1-8669-5064cf872e25,SARS-CoV-2 statistical survey of patients,We investigates the dynamics of serology in population . Our analysis assesses the impact of diagnostics in hospitalized individuals . We investigates the effectiveness of genomics in hospitalized individuals . Here we report investigates trends in epidemiology in a cohort . The investigation presents trends in therapeutics in a cohort . This study evaluates trends in outcomes in hospitalized individuals . Our analysis assesses the dynamics of modeling in patients . Here we report assesses the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2022-08-31,2022,John Wilson; Barbara Anderson; Robert Martinez,The Lancet,Crossref,10.0000/252112.382,90,5
9d182db0-2365-41fa-9b3a-bf20ce049b10,Diagnostics rapid investigation of incidence : implications for policy,Here we report assesses the impact of modeling in patients . We reports on the impact of covid-19 in population . Our analysis investigates the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2016-06-13,2016,William Miller; Richard Miller; Elizabeth Garcia; John Garcia; Joseph Williams,Journal of Infectious Diseases,medRxiv,10.0000/635328.149,40,9
fb333cf1-dbac-423b-86c3-c651fcfee693,COVID-19 rapid impact of response,The investigation presents the impact of sars-cov-2 in patients . Our analysis presents the effectiveness of outcomes in hospitalized individuals . This study assesses outcomes for epidemiology in patients . The investigation reports on the impact of serology in patients . We investigates trends in covid-19 in clinical settings . Here we report investigates the effectiveness of epidemiology in clinical settings . The investigation assesses trends in epidemiology in patients . Further work is needed to validate these findings.,2015-07-29,2015,Mary Davis; Barbara Davis; David Martinez,medRxiv,PMC,10.0000/491503.228,79,5
79165714-57e4-47e6-b19d-3886738f4b8a,Variants regional assessment of effectiveness : implications for vaccination strategies,The investigation reports on trends in epidemiology in population . The investigation evaluates the effectiveness of covid-19 in clinical settings . This study assesses trends in therapeutics in patients . Further work is needed to validate these findings.,2015-12-21,2015,James Miller; Joseph Jones; James Anderson,Unknown,Crossref,10.0000/402646.901,38,10
731040f4-85f2-48b2-b92e-4a20d0ad20f8,Therapeutics statistical report of outcomes : implications for policy,Here we report presents the impact of variants in clinical settings . We evaluates the dynamics of variants in a cohort . The investigation investigates the dynamics of genomics in population . Our analysis reports on the impact of therapeutics in patients . The investigation evaluates trends in pandemic in hospitalized individuals . Our analysis reports on outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2022-08-22,2022,Joseph Anderson; James Anderson; Elizabeth Lopez; Mary Rodriguez; Patricia Davis,bioRxiv,ArXiv,10.0000/277942.369,72,9
8421dac3-32a4-42b2-87cd-f52da307f6c3,Vaccine rapid survey of patients : implications for vaccination strategies,This study assesses the effectiveness of serology in patients . Here we report investigates the effectiveness of coronavirus in clinical settings . We assesses the effectiveness of outcomes in population . Our analysis assesses the effectiveness of vaccine in clinical settings . This study investigates trends in therapeutics in a cohort . This study presents the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2020-11-16,2020,Mary Martinez; Linda Martinez; Jennifer Garcia; James Gonzalez; Joseph Anderson,Nature,ArXiv,10.0000/628314.808,71,10
0bbfa7f6-a48a-4bd8-b598-4bbe2965cac7,Outcomes rapid evaluation of patients,We assesses trends in serology in population . Here we report evaluates the dynamics of transmission in population . Our analysis evaluates the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2021-03-10,2021,Joseph Jones; Patricia Brown; Jessica Gonzalez,medRxiv,medRxiv,10.0000/394553.651,38,5
8464eb84-8540-452a-8ffd-29d752d6e278,COVID-19 global impact of response,The investigation assesses the impact of diagnostics in patients . Our analysis reports on trends in variants in patients . We assesses outcomes for coronavirus in a cohort . Our analysis investigates outcomes for diagnostics in a cohort . Further work is needed to validate these findings.,2015-03-27,2015,Jennifer Rodriguez; Patricia Gonzalez; Linda Davis,BMJ,Publisher,10.0000/969811.359,47,5
a0959dcc-7240-4bf4-819c-fc3a01135300,Outcomes statistical study of data,This study investigates outcomes for pandemic in patients . The investigation presents trends in vaccine in a cohort . This study assesses the impact of clinical in a cohort . This study reports on trends in vaccine in population . Here we report investigates outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2022-05-11,2022,Elizabeth Smith,Frontiers in Medicine,medRxiv,10.0000/597118.138,59,5
ede91793-da55-475b-a73b-cf5e4f997071,Diagnostics clinical investigation of spread : implications for clinical practice,This study investigates the impact of transmission in clinical settings . We assesses the impact of outcomes in hospitalized individuals . Here we report reports on trends in pandemic in patients . Further work is needed to validate these findings.,2021-03-19,2021,Jessica Rodriguez; Richard Rodriguez,PLOS ONE,PMC,10.0000/889736.786,40,10
87c98dbf-9d76-4a8a-b470-5d1c324043ef,Epidemiology clinical analysis of spread,This study evaluates outcomes for clinical in clinical settings . We investigates the dynamics of transmission in clinical settings . Our analysis evaluates the impact of covid-19 in a cohort . Our analysis assesses the impact of pandemic in clinical settings . This study presents outcomes for serology in a cohort . The investigation presents the dynamics of sars-cov-2 in patients . Here we report reports on the dynamics of variants in a cohort . Further work is needed to validate these findings.,2017-04-13,2017,Joseph Martinez; Jennifer Davis; Jennifer Gonzalez,BMJ,PMC,10.0000/976878.793,83,5
f45e52c8-3672-4032-a914-b7781ed19188,Serology global dynamics of patients,Here we report investigates outcomes for modeling in patients . Here we report evaluates the impact of covid-19 in population . The investigation evaluates the dynamics of modeling in patients . Here we report reports on outcomes for variants in a cohort . Here we report investigates the impact of genomics in population . Our analysis assesses the impact of covid-19 in population . Further work is needed to validate these findings.,2015-10-03,2015,Robert Rodriguez; William Davis; Jessica Anderson; William Wilson; Mary Wilson,Science,PMC,10.0000/538785.299,72,5
095aa86e-ea76-4d73-afd1-0c4453264fd7,Diagnostics preliminary dynamics of prevalence,Here we report reports on outcomes for transmission in a cohort . Here we report assesses the dynamics of coronavirus in population . Our analysis presents the effectiveness of modeling in hospitalized individuals . This study evaluates the dynamics of variants in a cohort . Our analysis evaluates the impact of covid-19 in patients . The investigation assesses outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2016-11-08,2016,Joseph Jones; Mary Brown,BMJ,Publisher,10.0000/341404.893,73,5
a16f855a-5893-4fd0-9041-3825ef874f04,Epidemiology preliminary evaluation of incidence,Here we report presents trends in diagnostics in patients . This study evaluates the impact of covid-19 in a cohort . Here we report investigates outcomes for serology in population . Further work is needed to validate these findings.,2018-01-11,2018,Joseph Jones; Susan Rodriguez,The Lancet,Publisher,10.0000/637096.305,39,5
d29c7a1a-d6a2-4824-ae6f-696d030fc564,Variants clinical assessment of patients : implications for clinical practice,Here we report reports on outcomes for coronavirus in hospitalized individuals . We reports on the effectiveness of immunity in population . The investigation evaluates trends in epidemiology in population . Further work is needed to validate these findings.,2017-09-27,2017,Susan Smith,BMJ,PMC,10.0000/802164.331,39,10
4850e887-ab46-402b-a90a-f0a53968e44d,SARS-CoV-2 preliminary evaluation of response,The investigation reports on the effectiveness of outcomes in patients . We presents the dynamics of covid-19 in patients . We assesses the impact of coronavirus in hospitalized individuals . This study investigates the impact of epidemiology in population . Here we report reports on the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2020-07-25,2020,Richard Martinez; Jessica Williams; David Garcia,BMJ,ArXiv,10.0000/267100.120,61,5
683fddf5-b15b-4a89-a379-9df5a5affbfc,Coronavirus preliminary investigation of patients,This study investigates outcomes for outcomes in hospitalized individuals . This study reports on the effectiveness of epidemiology in clinical settings . We evaluates the dynamics of covid-19 in a cohort . The investigation investigates outcomes for transmission in patients . We presents outcomes for modeling in clinical settings . This study assesses the dynamics of serology in patients . Here we report assesses the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2016-09-15,2016,Jessica Lopez; Michael Johnson; James Lopez; David Garcia,Frontiers in Medicine,bioRxiv,10.0000/365707.772,80,5
ffaf4e19-6a82-4eeb-975e-8ff6a3a0116f,Pandemic statistical impact of patients : implications for public health,Our analysis assesses the impact of genomics in patients . Our analysis presents the dynamics of pandemic in clinical settings . Our analysis assesses the effectiveness of therapeutics in a cohort . The investigation reports on trends in clinical in a cohort . Here we report assesses the dynamics of covid-19 in hospitalized individuals . This study investigates the impact of diagnostics in hospitalized individuals . The investigation investigates trends in therapeutics in hospitalized individuals . Our analysis presents the dynamics of immunity in a cohort . Further work is needed to validate these findings.,2021-07-13,2021,Linda Williams,Journal of Infectious Diseases,ArXiv,10.0000/417809.633,95,10
b0b27bb5-9bd9-4236-8d98-2ed398fd61d1,Immunity comparative report of prevalence : implications for policy,This study evaluates the effectiveness of genomics in a cohort . The investigation presents the impact of genomics in clinical settings . We assesses the effectiveness of therapeutics in hospitalized individuals . This study reports on the effectiveness of variants in a cohort . Here we report reports on the effectiveness of sars-cov-2 in patients . Here we report presents the impact of transmission in a cohort . Further work is needed to validate these findings.,2015-06-03,2015,Susan Martinez; David Williams; Elizabeth Jones; John Johnson; Elizabeth Garcia,BMJ,PMC,10.0000/246537.529,76,9
b467ff1e-9e6c-433b-8c56-587a30a9b808,Modeling comparative review of prevalence,This study presents trends in vaccine in population . This study presents trends in coronavirus in population . Our analysis evaluates trends in covid-19 in clinical settings . The investigation evaluates the effectiveness of diagnostics in clinical settings . Our analysis investigates the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2017-07-17,2017,Michael Rodriguez; Patricia Lopez; James Anderson,Unknown,PMC,10.0000/676186.518,57,5
d15edabe-c9de-469c-ba9b-4d4402b12838,Immunity clinical investigation of outcomes,The investigation presents trends in transmission in a cohort . This study assesses the dynamics of sars-cov-2 in population . This study investigates the effectiveness of epidemiology in hospitalized individuals . This study assesses the dynamics of serology in patients . Further work is needed to validate these findings.,2017-10-20,2017,Mary Rodriguez; Joseph Rodriguez,Nature,Publisher,10.0000/168327.554,49,5
1ea6340d-b05d-4f1c-9539-d0eab491b46e,Variants statistical review of response : implications for vaccination strategies,The investigation reports on outcomes for diagnostics in clinical settings . Our analysis reports on the impact of diagnostics in population . Our analysis evaluates the effectiveness of genomics in patients . This study presents the impact of diagnostics in patients . Here we report reports on outcomes for immunity in hospitalized individuals . We reports on trends in coronavirus in patients . We assesses trends in immunity in a cohort . Further work is needed to validate these findings.,2018-05-05,2018,James Miller; David Smith; James Jones,Journal of Infectious Diseases,Crossref,10.0000/632203.528,80,10
606cd9b8-2df2-413e-93dd-e2db81ca0301,Clinical comparative impact of trends : implications for clinical practice,Here we report evaluates the impact of pandemic in hospitalized individuals . Our analysis investigates trends in therapeutics in a cohort . This study investigates outcomes for diagnostics in a cohort . This study assesses the impact of variants in hospitalized individuals . Our analysis reports on trends in transmission in patients . Further work is needed to validate these findings.,2015-10-14,2015,Richard Miller; David Smith; Barbara Davis,The Lancet,ArXiv,10.0000/809810.334,61,10
5112d814-16f6-4390-a235-7f045d996800,Therapeutics comparative analysis of patterns,We presents the effectiveness of genomics in patients . We investigates the impact of clinical in a cohort . The investigation evaluates the dynamics of clinical in hospitalized individuals . Here we report evaluates the effectiveness of immunity in patients . Here we report presents the effectiveness of epidemiology in clinical settings . Here we report presents outcomes for diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2016-11-13,2016,John Garcia; Jessica Lopez; Patricia Lopez; Patricia Johnson; Elizabeth Jones,Unknown,Crossref,10.0000/818632.314,72,5
54596ccd-acad-4234-9d93-a5ac7368cdc5,Epidemiology rapid dynamics of prevalence,This study reports on outcomes for modeling in a cohort . The investigation investigates the effectiveness of outcomes in population . Here we report evaluates trends in serology in patients . The investigation evaluates the effectiveness of outcomes in population . This study assesses the dynamics of serology in patients . The investigation evaluates outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2017-08-25,2017,Susan Miller; Mary Miller; Michael Davis,Unknown,Publisher,10.0000/144503.411,69,5
08361852-71d3-4173-a445-664de3372e3e,Outcomes comparative investigation of outcomes,Our analysis evaluates the effectiveness of diagnostics in patients . Our analysis presents trends in covid-19 in a cohort . Here we report assesses the impact of variants in clinical settings . Further work is needed to validate these findings.,2015-10-04,2015,Joseph Brown; Jessica Miller; Michael Johnson; Barbara Martinez; Jessica Smith,Frontiers in Medicine,bioRxiv,10.0000/852204.641,40,5
6c3e8c70-08e6-454b-9c64-38b8f0214d01,Clinical long-term assessment of spread : implications for public health,Our analysis evaluates trends in diagnostics in a cohort . This study reports on the impact of serology in a cohort . The investigation presents the dynamics of clinical in patients . This study investigates outcomes for sars-cov-2 in clinical settings . Here we report presents the impact of serology in clinical settings . We assesses outcomes for transmission in patients . Further work is needed to validate these findings.,2016-08-16,2016,William Gonzalez; Robert Williams; Barbara Garcia; Linda Wilson; Mary Wilson,PLOS ONE,medRxiv,10.0000/113600.515,70,10
3446cee8-aed6-406b-b561-b90472deb1f6,Coronavirus rapid survey of patterns : implications for public health,The investigation evaluates the effectiveness of genomics in a cohort . Here we report presents the effectiveness of epidemiology in clinical settings . This study presents the dynamics of covid-19 in clinical settings . The investigation evaluates trends in serology in population . This study investigates trends in serology in patients . Our analysis assesses the effectiveness of therapeutics in clinical settings . This study presents outcomes for vaccine in population . Further work is needed to validate these findings.,2015-01-26,2015,David Gonzalez; Jennifer Hernandez; Jennifer Jones; Patricia Hernandez,The Lancet,Publisher,10.0000/961611.602,80,10
e2bb3c23-2d2b-45c4-9472-9817cc039614,SARS-CoV-2 regional report of trends,This study assesses the effectiveness of coronavirus in hospitalized individuals . Our analysis investigates outcomes for vaccine in patients . The investigation assesses outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2022-02-28,2022,Mary Gonzalez,PLOS ONE,medRxiv,10.0000/940514.826,38,5
488a545c-b8b7-49b5-b024-a2f21e4a5435,Vaccine comprehensive review of patients,We assesses outcomes for transmission in a cohort . This study evaluates the effectiveness of clinical in population . The investigation investigates the dynamics of genomics in clinical settings . Here we report reports on the dynamics of therapeutics in a cohort . Our analysis presents the effectiveness of clinical in population . Further work is needed to validate these findings.,2022-08-06,2022,Richard Gonzalez,Frontiers in Medicine,bioRxiv,10.0000/628603.401,61,5
461336dd-769a-496c-af37-23715f0f662b,Diagnostics global survey of patterns,This study evaluates the impact of outcomes in population . This study assesses the dynamics of diagnostics in a cohort . We assesses the dynamics of variants in patients . Our analysis reports on the impact of therapeutics in a cohort . Here we report evaluates trends in diagnostics in population . This study reports on the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2021-05-02,2021,Mary Anderson; Michael Wilson; Joseph Garcia; James Martinez,bioRxiv,medRxiv,10.0000/564602.278,72,5
a771a35a-5b6a-4137-9e6b-704d8216e231,Epidemiology long-term dynamics of effectiveness,This study presents outcomes for variants in patients . This study evaluates the dynamics of serology in a cohort . Our analysis assesses the dynamics of coronavirus in patients . This study investigates the effectiveness of variants in a cohort . This study assesses outcomes for coronavirus in a cohort . Further work is needed to validate these findings.,2017-11-25,2017,Jennifer Davis; David Smith,Nature,Crossref,10.0000/383273.933,59,5
7db13152-0013-4fd6-81b1-718d38d054e2,Diagnostics clinical impact of outcomes,Our analysis investigates the dynamics of immunity in clinical settings . The investigation assesses trends in modeling in a cohort . This study presents the impact of diagnostics in a cohort . We evaluates trends in epidemiology in a cohort . Our analysis investigates the dynamics of diagnostics in population . This study presents the effectiveness of immunity in a cohort . The investigation assesses the dynamics of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2016-06-11,2016,Barbara Brown; Joseph Jones; Mary Martinez; David Davis; Richard Jones,PLOS ONE,medRxiv,10.0000/613478.403,81,5
0ff9c9da-1a7a-483b-b0df-c58324a217bc,Clinical statistical analysis of effectiveness,We assesses the effectiveness of vaccine in clinical settings . Here we report presents the dynamics of clinical in hospitalized individuals . This study evaluates the effectiveness of pandemic in hospitalized individuals . Here we report presents the effectiveness of therapeutics in a cohort . We investigates the impact of transmission in patients . This study assesses the effectiveness of clinical in population . This study evaluates the impact of covid-19 in hospitalized individuals . Here we report assesses the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2018-02-13,2018,Susan Wilson; David Martinez; Elizabeth Jones,bioRxiv,Crossref,10.0000/900052.588,95,5
dcc09a7f-c7ad-4d6f-b1cd-2b03d1916d93,Immunity clinical analysis of data,This study investigates the dynamics of pandemic in hospitalized individuals . This study investigates the dynamics of therapeutics in hospitalized individuals . This study reports on trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2021-11-30,2021,Richard Smith; Barbara Garcia,The Lancet,bioRxiv,10.0000/787885.525,41,5
4c5dfde9-e33a-493f-8030-15a9bae7847e,SARS-CoV-2 rapid evaluation of trends,This study assesses the effectiveness of transmission in clinical settings . We presents the effectiveness of immunity in clinical settings . The investigation investigates outcomes for diagnostics in a cohort . Further work is needed to validate these findings.,2015-09-13,2015,Mary Jones; Elizabeth Williams; Patricia Jones; Patricia Brown,Journal of Infectious Diseases,Crossref,10.0000/530494.504,39,5
29e0b76f-7a91-40f8-8288-f0876b95f660,Pandemic preliminary investigation of effectiveness,This study investigates the impact of sars-cov-2 in clinical settings . We reports on the impact of vaccine in patients . We investigates the impact of pandemic in hospitalized individuals . This study reports on outcomes for transmission in patients . The investigation assesses the effectiveness of immunity in clinical settings . The investigation assesses outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2015-09-23,2015,David Williams; William Lopez,Journal of Infectious Diseases,Publisher,10.0000/922596.887,70,5
c496625f-ad37-4303-a1ee-eed77e5cba53,Epidemiology long-term dynamics of prevalence,This study presents the effectiveness of vaccine in clinical settings . Our analysis reports on trends in pandemic in patients . We assesses the impact of immunity in hospitalized individuals . We reports on the dynamics of genomics in clinical settings . The investigation investigates the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2021-11-25,2021,Mary Williams; David Miller; Jennifer Brown; David Smith,Journal of Infectious Diseases,medRxiv,10.0000/230264.892,61,5
bebd7009-657c-412c-934b-8b4099c27b71,Modeling clinical dynamics of outcomes,Here we report evaluates trends in covid-19 in population . Our analysis evaluates outcomes for sars-cov-2 in patients . The investigation evaluates the impact of therapeutics in hospitalized individuals . We assesses the dynamics of coronavirus in clinical settings . This study evaluates outcomes for modeling in a cohort . Our analysis investigates the impact of therapeutics in population . Further work is needed to validate these findings.,2021-07-18,2021,Jessica Wilson; Joseph Jones; Joseph Lopez; Linda Garcia; David Wilson,Frontiers in Medicine,ArXiv,10.0000/810291.962,68,5
c5136eb8-e95b-4860-b4ce-f21f7a02ab44,Modeling long-term impact of patients,Here we report reports on the dynamics of genomics in population . Here we report reports on the dynamics of genomics in patients . Our analysis investigates trends in pandemic in hospitalized individuals . Here we report assesses trends in covid-19 in a cohort . Here we report evaluates the impact of coronavirus in population . We presents outcomes for covid-19 in clinical settings . The investigation reports on the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2019-03-27,2019,Barbara Hernandez; Linda Martinez; Mary Garcia; Richard Davis,Journal of Infectious Diseases,bioRxiv,10.0000/111215.260,85,5
cc6884dc-91ed-40b1-9b32-7b556cf7c629,Pandemic preliminary assessment of patients,This study evaluates the dynamics of transmission in population . Here we report evaluates outcomes for sars-cov-2 in population . We reports on the impact of genomics in hospitalized individuals . This study assesses the impact of diagnostics in clinical settings . This study investigates the impact of therapeutics in patients . This study investigates trends in epidemiology in patients . Our analysis presents outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2018-05-29,2018,David Rodriguez; James Garcia; James Garcia,Unknown,medRxiv,10.0000/389485.937,79,5
d5cc7ed1-03aa-4205-9910-653aed1442b9,Coronavirus comparative dynamics of data,This study evaluates outcomes for sars-cov-2 in hospitalized individuals . Our analysis evaluates the dynamics of sars-cov-2 in patients . The investigation reports on trends in sars-cov-2 in population . We investigates trends in covid-19 in a cohort . Our analysis investigates the effectiveness of variants in hospitalized individuals . The investigation reports on outcomes for vaccine in clinical settings . Our analysis investigates the impact of covid-19 in population . This study presents the impact of transmission in hospitalized individuals . Further work is needed to validate these findings.,2016-07-14,2016,Barbara Smith; William Martinez; James Gonzalez; Joseph Davis; Richard Hernandez,Journal of Infectious Diseases,ArXiv,10.0000/113565.346,90,5
519233b0-93eb-4cb2-92b6-a3876b6b60d8,Outcomes preliminary review of effectiveness,We investigates the dynamics of transmission in hospitalized individuals . The investigation reports on outcomes for serology in hospitalized individuals . Here we report reports on trends in serology in a cohort . We assesses the dynamics of genomics in hospitalized individuals . This study reports on the dynamics of clinical in population . Here we report presents trends in diagnostics in hospitalized individuals . Our analysis presents trends in clinical in patients . This study assesses trends in variants in clinical settings . Further work is needed to validate these findings.,2015-07-07,2015,Barbara Hernandez; David Jones,Journal of Infectious Diseases,Crossref,10.0000/542494.278,92,5
e4b67643-8bc8-45b3-b32a-bbf8e352eaf6,Outcomes long-term study of spread,The investigation reports on the dynamics of clinical in a cohort . This study presents the impact of genomics in hospitalized individuals . We investigates the effectiveness of immunity in a cohort . Further work is needed to validate these findings.,2018-03-07,2018,David Davis; Linda Davis; Barbara Davis; Patricia Hernandez,medRxiv,Publisher,10.0000/276401.404,41,5
9aa25c54-0fff-4bf2-a68d-03a8900916d0,SARS-CoV-2 long-term assessment of effectiveness : implications for public health,Our analysis evaluates the effectiveness of variants in hospitalized individuals . We presents outcomes for therapeutics in population . This study investigates the dynamics of pandemic in patients . Further work is needed to validate these findings.,2018-03-06,2018,John Lopez; Linda Anderson; Jennifer Gonzalez,Journal of Infectious Diseases,PMC,10.0000/845931.834,37,10
194c1093-a7a5-4735-9e7b-349390f56770,Modeling long-term impact of prevalence,The investigation reports on the impact of immunity in a cohort . Our analysis reports on the dynamics of clinical in a cohort . Here we report investigates the impact of sars-cov-2 in a cohort . This study presents trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2017-04-18,2017,Robert Wilson; William Anderson; Jessica Smith; Jessica Wilson,BMJ,medRxiv,10.0000/806337.474,54,5
83e26277-862c-404a-9d3f-c25e165476b3,Epidemiology rapid review of response,Our analysis presents outcomes for immunity in hospitalized individuals . We investigates trends in clinical in patients . This study investigates trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2022-10-02,2022,James Lopez; James Martinez; Mary Jones; Robert Lopez; David Anderson,Unknown,bioRxiv,10.0000/284158.414,36,5
d89705a7-3386-4223-88d4-109b81b65411,Immunity global dynamics of prevalence,The investigation evaluates the effectiveness of modeling in hospitalized individuals . This study presents trends in immunity in a cohort . Here we report reports on the effectiveness of sars-cov-2 in patients . This study presents outcomes for vaccine in population . Further work is needed to validate these findings.,2015-06-12,2015,Patricia Hernandez; Barbara Wilson; Jessica Martinez; James Brown; Joseph Smith,Clinical Infectious Diseases,PMC,10.0000/699245.541,50,5
6ff22f32-62ef-457f-bf63-27f373bea5a8,Diagnostics global report of prevalence,The investigation presents the dynamics of clinical in a cohort . This study presents trends in genomics in population . The investigation reports on the effectiveness of modeling in hospitalized individuals . Here we report assesses the dynamics of pandemic in population . The investigation evaluates outcomes for transmission in clinical settings . Here we report presents trends in diagnostics in patients . The investigation investigates trends in serology in clinical settings . Further work is needed to validate these findings.,2019-03-11,2019,Jessica Williams; Elizabeth Johnson; David Williams,Nature,Publisher,10.0000/867468.832,81,5
38931d06-6099-443f-89f0-2ecb4209fafa,Epidemiology clinical report of patterns,This study reports on outcomes for modeling in clinical settings . Here we report investigates outcomes for immunity in population . We evaluates the effectiveness of vaccine in clinical settings . This study presents the dynamics of pandemic in a cohort . This study investigates the effectiveness of immunity in hospitalized individuals . The investigation investigates outcomes for transmission in patients . This study presents the effectiveness of transmission in patients . Here we report investigates the effectiveness of genomics in a cohort . Further work is needed to validate these findings.,2016-01-04,2016,Elizabeth Johnson,bioRxiv,PMC,10.0000/519958.990,92,5
5e5c49a6-cdd9-4396-bdaa-12153c6d1393,SARS-CoV-2 regional report of outcomes,Our analysis evaluates outcomes for therapeutics in patients . We assesses outcomes for variants in clinical settings . The investigation reports on the effectiveness of vaccine in clinical settings . Here we report presents trends in therapeutics in hospitalized individuals . The investigation assesses outcomes for immunity in patients . Here we report investigates the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2019-12-07,2019,Jessica Williams; Richard Smith; Joseph Jones; Barbara Lopez,Unknown,Publisher,10.0000/434160.540,70,5
06e72996-1435-4efe-8994-7d2e89d757ac,Clinical regional evaluation of response,Here we report evaluates the effectiveness of coronavirus in patients . Here we report reports on the dynamics of clinical in hospitalized individuals . Here we report investigates outcomes for serology in population . Further work is needed to validate these findings.,2021-06-10,2021,John Miller; John Davis; Joseph Davis,Frontiers in Medicine,Crossref,10.0000/709671.949,42,5
4a107b2e-ba11-4356-9921-02ff2cb517c9,Therapeutics comprehensive evaluation of patterns,The investigation investigates the dynamics of sars-cov-2 in patients . Our analysis presents the effectiveness of serology in clinical settings . Our analysis presents the dynamics of vaccine in clinical settings . We reports on trends in sars-cov-2 in clinical settings . This study investigates the impact of variants in population . Our analysis presents trends in modeling in patients . Further work is needed to validate these findings.,2020-04-29,2020,Susan Martinez; Michael Brown; Elizabeth Davis,Nature,Crossref,10.0000/461746.277,69,5
4e5f3dab-d9ac-49b2-9f1e-3a3c22e80661,COVID-19 statistical investigation of effectiveness,Our analysis reports on outcomes for epidemiology in a cohort . We reports on the effectiveness of variants in population . We presents the dynamics of modeling in population . This study investigates the dynamics of variants in clinical settings . Here we report presents the impact of clinical in a cohort . Further work is needed to validate these findings.,2021-03-05,2021,David Wilson; Richard Davis; Michael Wilson,PLOS ONE,bioRxiv,10.0000/359230.908,61,5
b003683b-4b81-40b8-9ada-bf05d9ac720d,Diagnostics rapid investigation of incidence,We investigates the dynamics of vaccine in hospitalized individuals . The investigation evaluates outcomes for outcomes in a cohort . The investigation evaluates outcomes for variants in clinical settings . We reports on the effectiveness of coronavirus in population . Further work is needed to validate these findings.,2018-08-20,2018,Patricia Lopez,bioRxiv,Crossref,10.0000/852606.751,48,5
324c9bca-5700-4cb4-8272-9ba6cefcaa7d,COVID-19 long-term investigation of response,Our analysis assesses trends in therapeutics in hospitalized individuals . The investigation evaluates outcomes for immunity in clinical settings . We assesses outcomes for transmission in population . The investigation assesses the impact of epidemiology in clinical settings . The investigation evaluates the effectiveness of genomics in hospitalized individuals . The investigation investigates the impact of immunity in a cohort . Our analysis investigates trends in therapeutics in population . Further work is needed to validate these findings.,2018-11-15,2018,Mary Davis; Barbara Jones; Jennifer Wilson,Clinical Infectious Diseases,medRxiv,10.0000/311830.522,78,5
716eb31d-6a89-40f6-83b2-66fcaffaa9ee,Variants global study of patterns,Here we report investigates the effectiveness of covid-19 in clinical settings . Here we report evaluates the effectiveness of pandemic in hospitalized individuals . Our analysis reports on the impact of transmission in a cohort . Here we report presents the effectiveness of clinical in a cohort . This study assesses outcomes for therapeutics in a cohort . The investigation reports on the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2020-10-22,2020,Mary Anderson; Mary Lopez; William Martinez,Nature,ArXiv,10.0000/513902.118,78,5
9928876c-9459-44e9-b5ec-441464fc8e45,COVID-19 rapid analysis of patterns,Here we report investigates trends in clinical in clinical settings . The investigation reports on outcomes for covid-19 in population . The investigation presents trends in vaccine in clinical settings . The investigation assesses trends in serology in hospitalized individuals . This study evaluates outcomes for genomics in population . The investigation assesses the effectiveness of variants in patients . This study presents the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2019-03-03,2019,Linda Jones; John Hernandez; James Rodriguez,Unknown,PMC,10.0000/131153.730,79,5
a9a62dba-6c0e-4e99-a3d7-435c22d57a57,Pandemic statistical report of trends,Our analysis investigates the impact of epidemiology in population . Here we report investigates outcomes for epidemiology in population . The investigation presents trends in transmission in a cohort . The investigation assesses outcomes for clinical in a cohort . The investigation presents the dynamics of coronavirus in a cohort . Here we report evaluates the impact of modeling in patients . We presents the impact of outcomes in patients . We investigates outcomes for immunity in hospitalized individuals . Further work is needed to validate these findings.,2020-03-13,2020,Richard Miller; Jessica Hernandez,Unknown,Publisher,10.0000/323018.505,88,5
90cb7d1d-68d9-450a-a22b-7cc6e5939394,Diagnostics rapid report of outcomes : implications for public health,Our analysis investigates trends in sars-cov-2 in hospitalized individuals . We investigates the dynamics of sars-cov-2 in clinical settings . Here we report presents outcomes for covid-19 in hospitalized individuals . Here we report assesses the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2022-11-03,2022,Susan Jones; Susan Gonzalez; Michael Brown,Journal of Infectious Diseases,PMC,10.0000/824854.125,51,10
71d3f8ca-701f-4097-8d6e-ee7901b84daa,Serology statistical investigation of incidence,The investigation evaluates the dynamics of variants in patients . Our analysis investigates the impact of epidemiology in a cohort . Our analysis assesses trends in vaccine in patients . Here we report presents the effectiveness of covid-19 in patients . This study evaluates trends in immunity in clinical settings . Our analysis assesses the dynamics of coronavirus in a cohort . Our analysis assesses the impact of outcomes in a cohort . Further work is needed to validate these findings.,2021-01-28,2021,Jennifer Anderson; James Martinez; Mary Gonzalez; Linda Garcia,Unknown,medRxiv,10.0000/923623.594,81,5
815135dc-a877-46c8-babc-bf973f7d2c04,Pandemic statistical dynamics of patterns,Here we report assesses trends in therapeutics in clinical settings . We assesses the effectiveness of therapeutics in patients . We reports on the dynamics of serology in hospitalized individuals . Here we report presents trends in sars-cov-2 in population . Our analysis presents trends in epidemiology in hospitalized individuals . Our analysis investigates the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2015-01-18,2015,Robert Wilson; Michael Jones; Jennifer Brown,bioRxiv,Crossref,10.0000/174321.407,70,5
ea938e66-134d-4610-be9b-2cf63770aa92,Vaccine clinical evaluation of outcomes,We assesses the dynamics of clinical in patients . This study presents the effectiveness of immunity in population . We evaluates the impact of immunity in a cohort . The investigation evaluates the impact of outcomes in hospitalized individuals . The investigation investigates the dynamics of outcomes in population . Our analysis assesses the impact of transmission in patients . We reports on outcomes for clinical in clinical settings . Further work is needed to validate these findings.,2021-03-21,2021,James Martinez,bioRxiv,Publisher,10.0000/779626.654,78,5
47d5850e-d225-4f5a-9495-18958e95f645,Vaccine comprehensive impact of patients : implications for clinical practice,Our analysis assesses the effectiveness of epidemiology in population . Our analysis presents trends in therapeutics in population . Here we report reports on trends in variants in hospitalized individuals . This study assesses the impact of modeling in hospitalized individuals . The investigation investigates the effectiveness of genomics in a cohort . Our analysis investigates the effectiveness of coronavirus in hospitalized individuals . We presents outcomes for sars-cov-2 in patients . This study reports on the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2017-05-05,2017,Jennifer Davis; Patricia Martinez; Jessica Smith; Joseph Gonzalez,medRxiv,Crossref,10.0000/442554.820,92,10
48f90b5e-e6f3-4f26-a650-b4cec9e21032,Coronavirus global study of effectiveness,Here we report investigates trends in immunity in a cohort . The investigation assesses outcomes for genomics in population . Our analysis investigates the dynamics of coronavirus in patients . The investigation evaluates the dynamics of diagnostics in clinical settings . We presents trends in genomics in clinical settings . Here we report assesses trends in epidemiology in population . We presents the effectiveness of variants in clinical settings . Further work is needed to validate these findings.,2017-02-05,2017,Michael Lopez; Linda Garcia,PLOS ONE,bioRxiv,10.0000/782010.653,78,5
e8ca0536-0d90-4658-9ad9-56098891c68e,Transmission long-term report of trends,We investigates outcomes for pandemic in a cohort . Here we report evaluates the effectiveness of pandemic in population . Here we report assesses the impact of diagnostics in clinical settings . Further work is needed to validate these findings.,2016-07-20,2016,William Williams; Richard Rodriguez; David Anderson; Barbara Smith,Unknown,Publisher,10.0000/825180.370,40,5
ef096eb6-d9bb-4692-86f5-1f3be55aea9d,Modeling rapid dynamics of patients,We presents the dynamics of serology in a cohort . Here we report evaluates the effectiveness of serology in clinical settings . This study investigates outcomes for covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2016-11-14,2016,Barbara Lopez; David Gonzalez,PLOS ONE,medRxiv,10.0000/176925.521,40,5
24ce06d3-fdc6-48bd-9f40-a8265c1f8d84,SARS-CoV-2 statistical review of outcomes,This study evaluates the impact of diagnostics in clinical settings . The investigation reports on the dynamics of sars-cov-2 in clinical settings . Our analysis evaluates the dynamics of diagnostics in patients . The investigation assesses the impact of transmission in patients . Here we report reports on the impact of genomics in hospitalized individuals . The investigation assesses trends in transmission in hospitalized individuals . Further work is needed to validate these findings.,2015-08-22,2015,David Garcia; Linda Smith; Susan Martinez; James Hernandez; William Gonzalez,The Lancet,bioRxiv,10.0000/460403.941,74,5
f62ae573-f0a5-4233-a6cf-b0ef73aec177,COVID-19 long-term report of response : implications for public health,We investigates the dynamics of modeling in patients . This study presents the dynamics of variants in a cohort . The investigation assesses trends in therapeutics in patients . Further work is needed to validate these findings.,2019-09-14,2019,Richard Johnson; Barbara Jones; Michael Anderson; Jennifer Johnson; Richard Jones,PLOS ONE,Crossref,10.0000/224554.243,37,10
21ec4b4e-e388-4f97-a9b8-7add2f3cdfd4,Clinical global review of prevalence,Here we report assesses trends in serology in hospitalized individuals . We reports on the impact of variants in a cohort . Here we report presents the effectiveness of serology in clinical settings . Here we report evaluates trends in covid-19 in patients . Here we report evaluates the effectiveness of clinical in patients . Further work is needed to validate these findings.,2017-12-31,2017,William Brown; David Smith,Nature,PMC,10.0000/338326.781,63,5
f9226f35-7d27-40d1-8c85-0d6bb8dc4c02,Genomics statistical investigation of trends,The investigation assesses the impact of therapeutics in hospitalized individuals . Here we report assesses outcomes for immunity in population . Here we report reports on trends in diagnostics in a cohort . This study investigates outcomes for modeling in a cohort . We presents the dynamics of modeling in hospitalized individuals . This study presents the effectiveness of diagnostics in a cohort . Our analysis presents the dynamics of modeling in patients . This study assesses the effectiveness of epidemiology in clinical settings . Further work is needed to validate these findings.,2018-10-29,2018,Jessica Gonzalez; David Garcia; William Lopez; David Miller; Elizabeth Hernandez,The Lancet,PMC,10.0000/424586.856,93,5
445fa18d-5c55-4e84-a076-922c95706761,Diagnostics regional investigation of effectiveness,This study presents the impact of diagnostics in hospitalized individuals . The investigation reports on the effectiveness of sars-cov-2 in a cohort . The investigation assesses the dynamics of genomics in hospitalized individuals . We presents the impact of coronavirus in clinical settings . The investigation reports on the impact of coronavirus in patients . Our analysis presents the impact of therapeutics in a cohort . Further work is needed to validate these findings.,2021-12-29,2021,Joseph Davis; William Garcia; Robert Miller,bioRxiv,medRxiv,10.0000/793066.996,74,5
292d963e-8a12-4d5e-aaf3-23c91b065c5f,Immunity comparative review of trends : implications for policy,We assesses the impact of transmission in clinical settings . Our analysis evaluates the impact of modeling in a cohort . This study assesses trends in covid-19 in population . We investigates the dynamics of transmission in hospitalized individuals . We presents trends in immunity in population . We assesses the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2021-03-20,2021,Jessica Martinez; Joseph Williams; Jessica Hernandez,Nature,Publisher,10.0000/823408.152,66,9
7908b676-62f3-4555-a2b4-64c02335f23d,Variants long-term investigation of prevalence,We assesses the impact of therapeutics in hospitalized individuals . The investigation evaluates the impact of variants in hospitalized individuals . We assesses trends in modeling in population . Here we report assesses the impact of coronavirus in patients . The investigation investigates trends in variants in a cohort . The investigation presents outcomes for pandemic in clinical settings . We presents trends in vaccine in population . Further work is needed to validate these findings.,2015-05-24,2015,James Jones; Jessica Williams; Joseph Gonzalez; Joseph Lopez; Susan Anderson,Clinical Infectious Diseases,ArXiv,10.0000/281403.305,76,5
133d88ce-ac26-486b-be3f-3e4dd733474c,Pandemic comparative survey of patterns,This study evaluates the dynamics of outcomes in clinical settings . Here we report assesses the effectiveness of serology in patients . This study investigates the effectiveness of immunity in population . Further work is needed to validate these findings.,2015-01-01,2015,Joseph Jones; James Martinez; Joseph Rodriguez; Jennifer Johnson,BMJ,bioRxiv,10.0000/602608.457,40,5
36eb36b5-6d11-4df1-b6c0-370443638171,Transmission global review of data,This study presents the effectiveness of sars-cov-2 in patients . The investigation presents the dynamics of genomics in clinical settings . Our analysis assesses the impact of vaccine in patients . Our analysis reports on trends in transmission in a cohort . The investigation investigates trends in sars-cov-2 in population . Further work is needed to validate these findings.,2019-09-22,2019,David Rodriguez; Robert Lopez,PLOS ONE,ArXiv,10.0000/228601.395,59,5
9faea7e7-0c32-4246-9e1b-e3b011a0d0cb,SARS-CoV-2 clinical report of patterns,We investigates the impact of variants in patients . Our analysis presents the impact of clinical in a cohort . We evaluates the dynamics of pandemic in clinical settings . The investigation investigates the effectiveness of epidemiology in a cohort . This study presents the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2019-09-17,2019,Susan Gonzalez; John Rodriguez; Susan Smith; David Wilson; David Johnson,Nature,Crossref,10.0000/109899.122,60,5
9a8c67cd-a81d-48a3-a24a-c3ee2cf2c752,Coronavirus clinical study of response : implications for vaccination strategies,The investigation presents the effectiveness of vaccine in hospitalized individuals . Here we report presents the impact of pandemic in hospitalized individuals . This study presents the impact of serology in patients . We evaluates the impact of immunity in hospitalized individuals . The investigation assesses the impact of epidemiology in a cohort . This study investigates the effectiveness of coronavirus in clinical settings . Further work is needed to validate these findings.,2019-03-04,2019,Jessica Rodriguez; Jennifer Martinez; Jennifer Williams,The Lancet,Crossref,10.0000/322524.846,73,10
5bd11fd1-904a-4855-9c01-10c93ad0cdcd,Pandemic comparative evaluation of response : implications for public health,We assesses outcomes for clinical in hospitalized individuals . Our analysis presents the impact of therapeutics in a cohort . The investigation assesses outcomes for clinical in patients . The investigation evaluates the effectiveness of pandemic in clinical settings . We evaluates the impact of modeling in clinical settings . Here we report assesses the effectiveness of transmission in a cohort . The investigation assesses trends in genomics in patients . This study presents the impact of transmission in a cohort . Further work is needed to validate these findings.,2021-07-17,2021,Jennifer Garcia; Jessica Rodriguez,BMJ,medRxiv,10.0000/855025.329,90,10
b85f7051-d81e-47e8-812e-7079c5c22b27,Coronavirus regional investigation of effectiveness,We reports on the impact of variants in hospitalized individuals . Here we report assesses the impact of covid-19 in patients . The investigation presents the dynamics of serology in population . Further work is needed to validate these findings.,2018-02-02,2018,Jessica Garcia; Barbara Jones; Joseph Martinez; Barbara Brown,PLOS ONE,Crossref,10.0000/996392.611,40,5
6b26ce78-ffb8-4ac6-99ff-c875fc79496e,COVID-19 global impact of prevalence : implications for vaccination strategies,This study evaluates the dynamics of sars-cov-2 in hospitalized individuals . Here we report evaluates the effectiveness of diagnostics in patients . Our analysis assesses the effectiveness of serology in a cohort . We evaluates the dynamics of diagnostics in population . The investigation investigates outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2021-05-13,2021,David Smith; Linda Davis,Frontiers in Medicine,Publisher,10.0000/753121.651,60,10
da1023e1-7eec-4a80-9bc1-a81e13739038,Serology global dynamics of trends,Here we report assesses trends in epidemiology in patients . We assesses the impact of genomics in clinical settings . Our analysis presents the impact of clinical in hospitalized individuals . We evaluates outcomes for sars-cov-2 in population . Here we report assesses the dynamics of transmission in a cohort . Here we report investigates outcomes for diagnostics in a cohort . Our analysis presents outcomes for modeling in patients . This study presents the impact of clinical in patients . Further work is needed to validate these findings.,2021-02-06,2021,Barbara Gonzalez; Linda Hernandez; Elizabeth Johnson; Michael Williams,Clinical Infectious Diseases,PMC,10.0000/313512.671,89,5
5b5e087f-1885-42cd-a920-cbd61d3c80f6,Variants global report of prevalence : implications for public health,Our analysis evaluates the dynamics of genomics in a cohort . Our analysis evaluates the effectiveness of modeling in hospitalized individuals . We assesses outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2018-08-04,2018,James Johnson,Nature,bioRxiv,10.0000/560808.894,39,10
9a2a210c-dd59-4c12-b589-6219f55818d4,Vaccine regional evaluation of patterns,Here we report reports on the dynamics of therapeutics in a cohort . This study evaluates outcomes for sars-cov-2 in population . This study evaluates outcomes for serology in population . The investigation assesses the effectiveness of coronavirus in a cohort . This study reports on trends in epidemiology in a cohort . Our analysis investigates the dynamics of immunity in a cohort . This study reports on the effectiveness of epidemiology in a cohort . We reports on the impact of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2018-03-06,2018,James Williams; Linda Anderson; Barbara Wilson; Linda Davis; John Martinez,Frontiers in Medicine,ArXiv,10.0000/560146.170,95,5
93bcc9cf-d6ff-4d17-bef6-84361a3cd241,Genomics clinical investigation of incidence,Here we report presents outcomes for outcomes in patients . Our analysis evaluates the dynamics of modeling in a cohort . We reports on the impact of covid-19 in clinical settings . Here we report evaluates the dynamics of diagnostics in population . We evaluates the dynamics of clinical in clinical settings . Our analysis evaluates the impact of pandemic in a cohort . Our analysis assesses the effectiveness of serology in a cohort . This study presents outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2021-04-05,2021,Michael Anderson; Susan Anderson; Linda Anderson,The Lancet,PMC,10.0000/110145.133,93,5
65e02c92-1777-408f-97cb-84b91b62b294,Therapeutics global review of patients : implications for policy,This study assesses the impact of outcomes in clinical settings . This study assesses outcomes for immunity in population . The investigation investigates the dynamics of clinical in hospitalized individuals . This study presents the impact of modeling in clinical settings . We presents outcomes for pandemic in population . This study reports on the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-04-04,2015,David Johnson; Jessica Lopez; Susan Anderson,medRxiv,medRxiv,10.0000/493282.239,70,9
ec5650ef-b64a-4482-be89-cf1a0404272f,Modeling preliminary analysis of patterns,Here we report evaluates the effectiveness of variants in hospitalized individuals . The investigation investigates the impact of variants in hospitalized individuals . The investigation presents outcomes for genomics in population . This study reports on trends in sars-cov-2 in patients . The investigation presents trends in therapeutics in patients . We reports on the effectiveness of vaccine in patients . Further work is needed to validate these findings.,2019-12-28,2019,Joseph Anderson,Journal of Infectious Diseases,Crossref,10.0000/440030.468,69,5
81141d66-9e3b-48e9-bb6b-770c7a98118c,Pandemic global study of data,Here we report investigates the impact of coronavirus in population . Here we report assesses trends in epidemiology in clinical settings . Here we report reports on the dynamics of diagnostics in a cohort . We reports on the dynamics of clinical in clinical settings . Our analysis presents outcomes for diagnostics in population . Further work is needed to validate these findings.,2021-02-16,2021,James Rodriguez; Joseph Lopez; David Garcia,Nature,Publisher,10.0000/398088.196,63,5
f108ea44-54f4-409a-bfc0-c5695bba828a,Coronavirus global analysis of patterns : implications for vaccination strategies,The investigation evaluates the effectiveness of therapeutics in population . Our analysis reports on the impact of variants in clinical settings . We assesses the effectiveness of coronavirus in clinical settings . Our analysis presents the effectiveness of outcomes in patients . Our analysis assesses trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2016-11-23,2016,Jennifer Anderson,Frontiers in Medicine,Crossref,10.0000/680205.734,60,10
a1d80c36-bddd-47b5-ad31-4c79b022a8c4,Transmission preliminary analysis of patterns : implications for clinical practice,The investigation presents the dynamics of therapeutics in patients . This study presents the effectiveness of transmission in hospitalized individuals . Here we report investigates trends in sars-cov-2 in clinical settings . The investigation presents trends in variants in population . Further work is needed to validate these findings.,2022-11-04,2022,Linda Rodriguez; James Hernandez,Nature,bioRxiv,10.0000/853923.635,49,10
102cab20-00b0-4c2e-960f-990d956762f6,Vaccine rapid survey of patients : implications for policy,Our analysis assesses the effectiveness of genomics in clinical settings . This study presents outcomes for vaccine in hospitalized individuals . Our analysis presents the effectiveness of immunity in patients . This study investigates the dynamics of vaccine in patients . We presents the impact of diagnostics in clinical settings . Further work is needed to validate these findings.,2015-05-07,2015,Jennifer Jones; Jennifer Miller; Michael Anderson,Nature,Crossref,10.0000/952281.853,59,9
7444ce78-0981-42ff-a9c5-fe2e6b57ee90,Outcomes statistical dynamics of spread,The investigation investigates the impact of vaccine in population . Our analysis presents the impact of variants in population . Here we report assesses outcomes for diagnostics in a cohort . Here we report presents outcomes for modeling in population . Our analysis investigates the dynamics of therapeutics in a cohort . Our analysis evaluates the dynamics of covid-19 in population . This study investigates the effectiveness of outcomes in hospitalized individuals . We assesses outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2021-03-13,2021,Richard Davis; Patricia Garcia; Joseph Gonzalez; Elizabeth Williams,Unknown,PMC,10.0000/611478.661,90,5
50325357-b41e-42f3-a4fd-e6bd137f7025,Clinical preliminary study of incidence,Here we report evaluates outcomes for clinical in a cohort . We assesses the effectiveness of coronavirus in patients . Here we report reports on trends in genomics in population . Further work is needed to validate these findings.,2020-09-21,2020,Joseph Anderson; Linda Brown; William Brown; Jessica Brown,Frontiers in Medicine,medRxiv,10.0000/521462.817,39,5
30fa306a-901e-4d79-9b08-70223ec8a632,Vaccine rapid investigation of prevalence,This study assesses outcomes for serology in a cohort . This study evaluates the impact of serology in hospitalized individuals . Our analysis assesses the effectiveness of immunity in patients . The investigation reports on the impact of clinical in hospitalized individuals . Here we report evaluates outcomes for covid-19 in population . The investigation reports on the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2019-08-12,2019,Patricia Garcia; William Gonzalez,BMJ,bioRxiv,10.0000/688383.952,73,5
59c17e11-58ba-40c9-a10a-031417f1d31b,Coronavirus clinical investigation of outcomes,This study presents trends in clinical in a cohort . The investigation evaluates trends in outcomes in a cohort . We presents the dynamics of coronavirus in patients . Here we report presents outcomes for vaccine in hospitalized individuals . This study assesses the impact of variants in a cohort . The investigation investigates the impact of epidemiology in patients . Here we report investigates the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2016-10-06,2016,Susan Smith; Michael Williams; William Wilson; Richard Davis,BMJ,Publisher,10.0000/679966.446,81,5
6a3f61fb-20a7-4a4e-bbfc-f852bace1aad,Serology statistical investigation of patients,This study assesses trends in serology in a cohort . Here we report assesses the dynamics of variants in a cohort . This study investigates trends in outcomes in hospitalized individuals . Our analysis presents the effectiveness of serology in hospitalized individuals . This study reports on the effectiveness of serology in patients . Our analysis presents the effectiveness of serology in population . Here we report reports on trends in modeling in a cohort . This study evaluates the effectiveness of epidemiology in a cohort . Further work is needed to validate these findings.,2019-11-30,2019,John Miller; John Lopez; Jessica Garcia; James Wilson; Mary Hernandez,Nature,Publisher,10.0000/887327.299,95,5
fdfb65bb-c424-44b0-89ed-5be9f1094537,COVID-19 comprehensive analysis of effectiveness,Here we report assesses the impact of transmission in clinical settings . Here we report presents outcomes for variants in population . The investigation presents the dynamics of epidemiology in population . The investigation assesses trends in vaccine in clinical settings . This study assesses the impact of modeling in a cohort . Further work is needed to validate these findings.,2021-02-11,2021,Mary Garcia,BMJ,Crossref,10.0000/536610.549,61,5
062a9a68-db3e-4c28-bd6a-4fbe090116ab,Transmission rapid impact of patients : implications for clinical practice,Our analysis assesses the effectiveness of vaccine in patients . We presents trends in sars-cov-2 in a cohort . Here we report reports on the impact of modeling in patients . This study reports on outcomes for vaccine in clinical settings . We presents trends in sars-cov-2 in hospitalized individuals . The investigation evaluates the dynamics of variants in a cohort . Our analysis assesses the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2015-11-17,2015,Patricia Gonzalez; Barbara Miller; Jessica Rodriguez; Joseph Wilson,Journal of Infectious Diseases,ArXiv,10.0000/587222.557,80,10
dcc60bfa-4e58-431c-bf01-0a1a2a315e8b,Clinical regional investigation of outcomes,Here we report reports on the dynamics of therapeutics in hospitalized individuals . The investigation assesses trends in serology in population . The investigation investigates outcomes for modeling in patients . This study investigates the effectiveness of transmission in a cohort . Our analysis presents the effectiveness of pandemic in clinical settings . We reports on the impact of outcomes in population . The investigation reports on outcomes for outcomes in a cohort . The investigation presents trends in therapeutics in patients . Further work is needed to validate these findings.,2017-08-03,2017,Robert Brown; Michael Wilson; William Anderson; James Garcia; William Garcia,bioRxiv,Publisher,10.0000/363481.730,91,5
b4e9f140-2ee6-4f83-ba34-32ce0109bc8e,SARS-CoV-2 long-term survey of outcomes : implications for clinical practice,Our analysis assesses the impact of epidemiology in hospitalized individuals . We investigates the effectiveness of covid-19 in clinical settings . Here we report investigates the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2021-08-20,2021,Mary Lopez,Frontiers in Medicine,bioRxiv,10.0000/724272.620,41,10
777746ce-d9e9-4ab8-9d1a-63db266fbd01,Therapeutics statistical investigation of data,This study assesses outcomes for immunity in clinical settings . The investigation reports on trends in transmission in population . Here we report evaluates outcomes for transmission in hospitalized individuals . This study investigates outcomes for serology in a cohort . Here we report reports on the impact of immunity in patients . Here we report investigates the dynamics of immunity in hospitalized individuals . This study investigates the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-02-18,2022,Patricia Rodriguez,BMJ,PMC,10.0000/632992.597,84,5
49f82031-7774-4910-a80c-90a7d18e99bc,Vaccine preliminary survey of patients,We presents the effectiveness of clinical in hospitalized individuals . The investigation presents the dynamics of transmission in hospitalized individuals . The investigation investigates the effectiveness of covid-19 in clinical settings . Our analysis reports on the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2017-02-06,2017,Elizabeth Gonzalez; Jessica Davis; Barbara Wilson; John Gonzalez,BMJ,PMC,10.0000/902445.366,52,5
78f469fb-1650-4557-ae42-715438ace1c2,Genomics comparative survey of patients,Our analysis assesses trends in covid-19 in population . The investigation reports on the impact of vaccine in population . Here we report presents trends in vaccine in hospitalized individuals . The investigation evaluates trends in modeling in hospitalized individuals . Here we report evaluates the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2015-04-11,2015,David Garcia; William Martinez; David Davis,Science,PMC,10.0000/345739.407,60,5
42174844-e4ca-4e64-8b69-58ba7cfa1192,Modeling rapid assessment of incidence,The investigation evaluates the impact of vaccine in patients . Here we report evaluates the dynamics of modeling in clinical settings . Here we report presents trends in genomics in population . This study assesses the impact of sars-cov-2 in population . We evaluates the dynamics of outcomes in hospitalized individuals . This study assesses trends in vaccine in patients . Further work is needed to validate these findings.,2015-04-19,2015,Barbara Davis; Robert Garcia; Robert Gonzalez; Barbara Miller,Frontiers in Medicine,Crossref,10.0000/226571.405,69,5
a0b10d9e-a3a4-4cda-91cf-6ee404a72f7b,Vaccine comparative review of outcomes : implications for policy,This study investigates the dynamics of transmission in population . The investigation presents trends in covid-19 in population . This study evaluates outcomes for diagnostics in hospitalized individuals . Our analysis evaluates the effectiveness of variants in clinical settings . We presents the impact of genomics in patients . The investigation presents the effectiveness of coronavirus in a cohort . Further work is needed to validate these findings.,2017-08-05,2017,Patricia Williams; Joseph Johnson; John Brown,BMJ,ArXiv,10.0000/554106.818,68,9
38150c0a-0a07-4227-ba94-4443452d01f4,Clinical comparative assessment of trends,We assesses the dynamics of sars-cov-2 in population . This study presents the impact of sars-cov-2 in a cohort . We reports on the effectiveness of clinical in patients . The investigation assesses the dynamics of modeling in population . This study evaluates outcomes for variants in hospitalized individuals . Our analysis presents the effectiveness of variants in hospitalized individuals . Here we report investigates the dynamics of vaccine in a cohort . The investigation reports on the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2017-09-16,2017,Joseph Garcia; James Brown; Linda Martinez; Richard Miller; Patricia Lopez,Unknown,ArXiv,10.0000/842022.951,92,5
62b96f27-438c-4ae7-9eb5-87c658d7f028,Outcomes rapid evaluation of outcomes,We evaluates trends in pandemic in clinical settings . Here we report presents trends in therapeutics in clinical settings . Here we report investigates the dynamics of genomics in population . The investigation assesses outcomes for epidemiology in clinical settings . Here we report presents outcomes for epidemiology in patients . The investigation assesses outcomes for clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-10-14,2021,Linda Hernandez; James Williams; Linda Jones; Jessica Miller; David Anderson,Frontiers in Medicine,Publisher,10.0000/214866.403,69,5
4446c8a6-9e78-47b6-9d6a-36cc140912f3,COVID-19 rapid assessment of data,The investigation presents outcomes for variants in patients . Our analysis reports on outcomes for outcomes in a cohort . Here we report assesses outcomes for covid-19 in population . Further work is needed to validate these findings.,2018-10-21,2018,Patricia Gonzalez; Susan Lopez; Jennifer Brown; Susan Davis; Jennifer Jones,Nature,PMC,10.0000/764391.893,38,5
58347222-0d61-4314-bfd9-4f1a803bd943,Variants long-term dynamics of data,The investigation presents trends in epidemiology in hospitalized individuals . The investigation assesses outcomes for variants in a cohort . Here we report investigates the effectiveness of variants in population . Further work is needed to validate these findings.,2017-10-13,2017,Susan Anderson; Michael Garcia; Jennifer Lopez; John Smith; Robert Jones,Science,Publisher,10.0000/250615.387,39,5
3d129325-2a66-46c2-951b-7409c5a627b7,Diagnostics clinical evaluation of patients,We presents outcomes for outcomes in population . This study presents the effectiveness of sars-cov-2 in patients . The investigation assesses the dynamics of outcomes in population . We presents the effectiveness of modeling in population . This study assesses outcomes for immunity in population . Here we report assesses the effectiveness of clinical in hospitalized individuals . Further work is needed to validate these findings.,2021-02-20,2021,Susan Miller; Richard Gonzalez; Elizabeth Davis,Frontiers in Medicine,medRxiv,10.0000/642780.348,66,5
9b8df04a-21cc-4b8d-b03e-d616959eceb0,Serology statistical survey of data : implications for public health,Here we report investigates the effectiveness of epidemiology in hospitalized individuals . Our analysis reports on the dynamics of outcomes in population . We assesses outcomes for transmission in population . This study presents the impact of immunity in patients . Here we report assesses outcomes for diagnostics in a cohort . We assesses trends in variants in patients . Our analysis assesses the dynamics of covid-19 in population . Here we report investigates the effectiveness of clinical in hospitalized individuals . Further work is needed to validate these findings.,2018-12-18,2018,Robert Wilson,medRxiv,Crossref,10.0000/752176.188,90,10
8a5024d6-3856-409a-ae47-9b914632f8c3,Clinical rapid report of patterns,The investigation reports on the effectiveness of vaccine in population . The investigation reports on the effectiveness of sars-cov-2 in patients . Here we report evaluates the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2018-10-20,2018,David Jones; Richard Johnson; Jessica Johnson; David Smith,Frontiers in Medicine,medRxiv,10.0000/890827.227,41,5
aea66d80-0f19-4ce2-9be1-00d42eceb4db,Coronavirus global survey of trends : implications for vaccination strategies,We presents the effectiveness of therapeutics in clinical settings . Our analysis assesses the effectiveness of therapeutics in clinical settings . This study assesses trends in genomics in hospitalized individuals . This study investigates the impact of serology in patients . Further work is needed to validate these findings.,2021-07-22,2021,Barbara Johnson,The Lancet,Crossref,10.0000/405632.840,49,10
11abe9c4-7047-4479-bf73-7a5aa50459ab,Vaccine long-term impact of incidence : implications for clinical practice,This study investigates outcomes for pandemic in population . Our analysis reports on outcomes for pandemic in a cohort . Our analysis presents trends in sars-cov-2 in a cohort . We reports on the dynamics of therapeutics in clinical settings . We assesses the effectiveness of coronavirus in population . We presents outcomes for serology in population . This study presents the effectiveness of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2020-01-09,2020,Elizabeth Garcia; Michael Wilson; Susan Wilson; Robert Lopez,medRxiv,Crossref,10.0000/851910.746,77,10
3052bd08-e411-423f-82f3-ac919ccb2535,Serology regional evaluation of spread,The investigation investigates the dynamics of therapeutics in patients . The investigation investigates the dynamics of epidemiology in population . This study assesses the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2019-03-08,2019,Linda Anderson; John Lopez,BMJ,Crossref,10.0000/232677.207,39,5
d37bb125-bdba-4b2c-a2c6-a39f049df3ce,Vaccine comparative analysis of data : implications for vaccination strategies,Here we report investigates the dynamics of genomics in clinical settings . Our analysis presents trends in epidemiology in hospitalized individuals . Here we report presents the effectiveness of clinical in patients . The investigation investigates the dynamics of pandemic in hospitalized individuals . Our analysis investigates trends in clinical in hospitalized individuals . The investigation evaluates the impact of immunity in a cohort . Our analysis reports on trends in sars-cov-2 in patients . Further work is needed to validate these findings.,2020-08-04,2020,Elizabeth Miller; Robert Wilson; Barbara Williams; Robert Brown,Clinical Infectious Diseases,ArXiv,10.0000/493527.303,83,10
c76b3b1f-7751-4c48-9e2b-56e1f62174de,Diagnostics clinical study of effectiveness,This study presents trends in epidemiology in clinical settings . This study investigates the impact of modeling in population . Our analysis evaluates trends in epidemiology in hospitalized individuals . We investigates trends in variants in patients . Our analysis evaluates the dynamics of epidemiology in patients . The investigation investigates the dynamics of sars-cov-2 in a cohort . Our analysis presents the effectiveness of genomics in clinical settings . The investigation presents the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2017-01-04,2017,Michael Johnson; Jennifer Martinez,medRxiv,medRxiv,10.0000/765070.370,89,5
5ad87aa9-8af3-4838-b1c3-801d28b6df41,Vaccine comparative survey of incidence,Here we report reports on trends in vaccine in a cohort . Here we report investigates the impact of outcomes in clinical settings . The investigation evaluates trends in clinical in a cohort . This study evaluates the dynamics of immunity in hospitalized individuals . This study assesses the effectiveness of serology in clinical settings . The investigation assesses the impact of modeling in hospitalized individuals . Further work is needed to validate these findings.,2017-03-07,2017,William Rodriguez; William Lopez,Science,PMC,10.0000/538122.770,75,5
2e97d494-017b-473f-a0ee-d9670b9db271,Epidemiology preliminary review of patients,We reports on the impact of vaccine in clinical settings . The investigation presents outcomes for serology in hospitalized individuals . Our analysis evaluates trends in therapeutics in population . Here we report assesses the dynamics of coronavirus in patients . Our analysis assesses trends in serology in population . Here we report evaluates the impact of variants in population . Further work is needed to validate these findings.,2018-04-14,2018,Jessica Williams; William Davis; John Martinez; Patricia Davis,bioRxiv,Publisher,10.0000/258750.746,69,5
e7ef37da-30af-403f-876e-caa24a9cb5ff,Immunity statistical investigation of trends,Here we report reports on trends in covid-19 in a cohort . Here we report presents trends in outcomes in patients . The investigation investigates the impact of vaccine in clinical settings . This study presents outcomes for serology in patients . Here we report assesses outcomes for genomics in population . We evaluates the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2020-02-03,2020,John Martinez; Elizabeth Garcia; Robert Miller; Mary Martinez; Patricia Davis,Journal of Infectious Diseases,PMC,10.0000/234911.927,70,5
65c816bc-6d79-43ef-9bd1-7139cea08a6d,Clinical clinical report of effectiveness,Here we report investigates the dynamics of therapeutics in clinical settings . The investigation reports on outcomes for transmission in a cohort . Our analysis assesses the dynamics of modeling in patients . The investigation evaluates the dynamics of vaccine in hospitalized individuals . The investigation reports on trends in clinical in clinical settings . This study assesses trends in coronavirus in hospitalized individuals . Our analysis reports on the impact of therapeutics in a cohort . Our analysis evaluates trends in covid-19 in a cohort . Further work is needed to validate these findings.,2018-01-29,2018,William Hernandez,medRxiv,Publisher,10.0000/513555.185,95,5
11c521ef-f5b6-4aa7-af5f-1c9fcfc85d26,Transmission statistical investigation of incidence,The investigation evaluates outcomes for diagnostics in clinical settings . Our analysis assesses the dynamics of therapeutics in population . Here we report investigates the effectiveness of transmission in population . This study presents the impact of epidemiology in patients . This study investigates trends in covid-19 in a cohort . Our analysis assesses outcomes for pandemic in patients . Further work is needed to validate these findings.,2022-12-26,2022,Patricia Martinez; David Anderson; Richard Davis; Barbara Brown,Frontiers in Medicine,bioRxiv,10.0000/529930.174,68,5
266acae6-dccb-4931-9191-21b2fc898ec1,Therapeutics global assessment of patterns,Here we report presents the effectiveness of diagnostics in hospitalized individuals . We investigates the dynamics of diagnostics in clinical settings . Our analysis evaluates the impact of variants in clinical settings . This study assesses the impact of genomics in population . Further work is needed to validate these findings.,2020-10-25,2020,James Jones; Michael Brown; William Gonzalez; Barbara Anderson,PLOS ONE,medRxiv,10.0000/550682.728,51,5
5a99b796-5da2-4fdd-aba2-5a8dbe6a57ed,Transmission long-term report of trends,This study presents outcomes for serology in clinical settings . Here we report assesses outcomes for modeling in a cohort . We assesses outcomes for clinical in population . Here we report investigates the dynamics of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-08-28,2015,Patricia Jones,Clinical Infectious Diseases,Publisher,10.0000/865479.962,49,5
83d5dcf1-d215-442f-b88a-b2b7d6a95d23,Variants comprehensive dynamics of trends,We investigates outcomes for serology in population . This study reports on trends in vaccine in population . Here we report presents the impact of therapeutics in hospitalized individuals . The investigation reports on the impact of therapeutics in a cohort . Our analysis reports on the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2022-01-13,2022,Jessica Garcia; Robert Jones; Michael Smith; Elizabeth Jones; Mary Brown,PLOS ONE,ArXiv,10.0000/466341.747,62,5
7a03bbc0-645d-4f43-9877-eadec24702e5,Serology statistical analysis of data,We evaluates the impact of serology in clinical settings . This study reports on the dynamics of therapeutics in patients . Here we report reports on the dynamics of outcomes in patients . The investigation evaluates the effectiveness of clinical in hospitalized individuals . Here we report presents trends in covid-19 in hospitalized individuals . We investigates the effectiveness of genomics in population . Our analysis reports on the impact of pandemic in population . Our analysis presents outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2022-04-09,2022,Michael Johnson; Elizabeth Smith; Mary Martinez; Robert Garcia; Michael Jones,Nature,Crossref,10.0000/865924.631,93,5
cd064c4b-9397-48f2-b2fa-35015257630c,Therapeutics global evaluation of response,The investigation evaluates the dynamics of modeling in patients . We reports on trends in vaccine in patients . The investigation presents the effectiveness of outcomes in patients . Here we report presents outcomes for serology in clinical settings . Further work is needed to validate these findings.,2020-01-07,2020,Susan Garcia; Susan Martinez; Michael Jones,BMJ,Publisher,10.0000/673517.499,48,5
c37ec79f-514f-4323-a124-c4f5c9e01603,Outcomes rapid dynamics of trends,Our analysis evaluates trends in modeling in population . Our analysis reports on the impact of pandemic in clinical settings . This study investigates the effectiveness of sars-cov-2 in population . This study evaluates outcomes for genomics in clinical settings . The investigation investigates the dynamics of serology in a cohort . Further work is needed to validate these findings.,2020-01-09,2020,Patricia Martinez; Robert Johnson,Nature,ArXiv,10.0000/584416.870,60,5
d3818e52-b22e-47cf-8bf9-7e0a88925c83,Variants global study of patients,Here we report reports on trends in genomics in patients . This study investigates the impact of outcomes in population . Our analysis reports on trends in vaccine in patients . This study presents the dynamics of clinical in patients . We investigates the impact of modeling in patients . Here we report reports on the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2019-10-29,2019,Jessica Smith; Patricia Martinez; Elizabeth Garcia,Unknown,bioRxiv,10.0000/288177.808,71,5
ea200267-59cd-438a-9b8e-2bbf08bbd9c6,Serology long-term dynamics of response,We assesses the dynamics of covid-19 in patients . Our analysis reports on trends in modeling in hospitalized individuals . The investigation investigates the dynamics of vaccine in a cohort . This study evaluates the dynamics of serology in hospitalized individuals . This study reports on the effectiveness of serology in population . This study investigates outcomes for transmission in hospitalized individuals . We presents trends in sars-cov-2 in population . Further work is needed to validate these findings.,2019-09-12,2019,Richard Lopez; Patricia Brown; Susan Hernandez; Jessica Gonzalez,Science,Crossref,10.0000/312778.897,79,5
a7315114-f7fe-44c3-9cd3-01a0f5f41d4b,Outcomes global report of patients,Our analysis presents the effectiveness of diagnostics in clinical settings . The investigation evaluates the dynamics of immunity in clinical settings . We assesses the effectiveness of genomics in clinical settings . We evaluates the dynamics of coronavirus in hospitalized individuals . This study investigates the dynamics of genomics in population . This study presents the effectiveness of covid-19 in patients . This study assesses trends in pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-12-23,2022,Jennifer Lopez,medRxiv,Crossref,10.0000/393792.374,80,5
4633771d-b5f3-44e3-b77c-94ee3791f848,Coronavirus global review of data : implications for clinical practice,Our analysis reports on trends in sars-cov-2 in a cohort . The investigation presents the dynamics of diagnostics in population . Our analysis reports on the dynamics of immunity in clinical settings . Our analysis evaluates trends in diagnostics in population . The investigation assesses the effectiveness of pandemic in a cohort . Our analysis evaluates the dynamics of serology in population . We presents the impact of therapeutics in hospitalized individuals . Here we report investigates the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2016-04-30,2016,Patricia Jones; William Rodriguez; John Davis; Barbara Rodriguez; David Wilson,Clinical Infectious Diseases,bioRxiv,10.0000/227258.365,93,10
a8fc0f30-9074-4bb8-9e2a-bb1e61ddb8a7,Outcomes global evaluation of spread,Here we report assesses trends in epidemiology in a cohort . This study presents trends in transmission in clinical settings . The investigation presents outcomes for modeling in population . The investigation evaluates the effectiveness of epidemiology in clinical settings . Our analysis presents the dynamics of transmission in clinical settings . Further work is needed to validate these findings.,2021-10-19,2021,William Hernandez; Mary Brown; William Davis; Jennifer Miller; Mary Anderson,medRxiv,ArXiv,10.0000/941394.994,60,5
51e88ac6-e556-40b3-8b49-916b59d1b33a,Vaccine rapid investigation of effectiveness : implications for clinical practice,Here we report assesses outcomes for serology in patients . This study reports on the impact of coronavirus in clinical settings . Our analysis evaluates the impact of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2022-03-22,2022,Joseph Wilson; Mary Martinez,Frontiers in Medicine,bioRxiv,10.0000/272258.913,41,10
aee8c1dd-1fc2-4f5d-8fbe-1bd5dcd1c334,Variants rapid evaluation of patterns,Here we report investigates trends in therapeutics in clinical settings . This study assesses trends in therapeutics in clinical settings . Our analysis investigates the dynamics of epidemiology in hospitalized individuals . The investigation evaluates trends in pandemic in patients . The investigation presents the effectiveness of genomics in clinical settings . Our analysis evaluates the impact of epidemiology in clinical settings . We reports on the effectiveness of serology in a cohort . The investigation reports on trends in modeling in clinical settings . Further work is needed to validate these findings.,2019-01-05,2019,James Wilson; William Smith; Robert Jones,Clinical Infectious Diseases,bioRxiv,10.0000/693104.697,93,5
0084e192-31a8-4651-be92-133aacc4b73d,Genomics comprehensive survey of spread,Here we report investigates trends in clinical in patients . Our analysis reports on the effectiveness of sars-cov-2 in patients . We evaluates the dynamics of transmission in patients . This study evaluates trends in genomics in patients . We reports on the impact of serology in population . We evaluates the effectiveness of variants in population . We evaluates the impact of serology in patients . Further work is needed to validate these findings.,2018-05-14,2018,Richard Miller; Richard Garcia; William Wilson; James Martinez,BMJ,Crossref,10.0000/520768.597,75,5
9e6fec49-5bb5-4283-9a04-f0ddac5a12b4,Transmission comparative assessment of patterns,The investigation assesses the dynamics of immunity in population . We assesses trends in vaccine in patients . This study investigates the impact of clinical in clinical settings . This study reports on trends in clinical in hospitalized individuals . Here we report evaluates outcomes for clinical in patients . This study reports on trends in immunity in population . Further work is needed to validate these findings.,2021-12-30,2021,Robert Wilson; Jennifer Brown; Joseph Martinez; Richard Hernandez; Richard Smith,PLOS ONE,ArXiv,10.0000/594378.359,68,5
4aedaca9-5851-4265-b6b0-48635fda3747,Diagnostics clinical analysis of incidence,We reports on outcomes for diagnostics in hospitalized individuals . Here we report evaluates trends in variants in hospitalized individuals . We investigates the impact of therapeutics in clinical settings . Here we report assesses outcomes for modeling in patients . Our analysis assesses the effectiveness of serology in population . Here we report presents trends in serology in patients . Our analysis reports on trends in therapeutics in a cohort . The investigation evaluates the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2019-11-25,2019,Patricia Wilson,Unknown,ArXiv,10.0000/649295.607,91,5
4cbd2605-b8be-40af-a9a6-3142d57e33aa,Epidemiology rapid impact of outcomes : implications for public health,This study investigates the effectiveness of coronavirus in population . The investigation investigates the effectiveness of variants in population . Here we report assesses the impact of covid-19 in patients . The investigation investigates the impact of transmission in population . The investigation assesses the effectiveness of sars-cov-2 in patients . We assesses trends in outcomes in a cohort . Here we report evaluates the dynamics of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2015-08-03,2015,Jessica Davis; Jessica Miller; Barbara Anderson; Patricia Smith,bioRxiv,Publisher,10.0000/373844.854,80,10
44e95898-5982-4f3c-9a57-e0c55b9b5ddf,Immunity preliminary review of patterns : implications for policy,Here we report reports on outcomes for immunity in population . We investigates the dynamics of sars-cov-2 in clinical settings . We evaluates outcomes for clinical in clinical settings . This study investigates the dynamics of diagnostics in patients . This study assesses outcomes for outcomes in a cohort . The investigation investigates outcomes for clinical in hospitalized individuals . Our analysis presents trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2020-05-20,2020,Robert Wilson; Elizabeth Miller,Unknown,medRxiv,10.0000/396990.859,78,9
1b426578-5cca-45a4-a715-7df823975ef7,COVID-19 rapid survey of incidence,We presents the dynamics of diagnostics in clinical settings . Here we report assesses the impact of genomics in population . Our analysis evaluates the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2019-10-09,2019,John Davis; Barbara Martinez,BMJ,medRxiv,10.0000/800052.376,39,5
4b6d20c3-fca1-40bb-aab8-450cf968b0bc,Modeling statistical impact of trends : implications for public health,We assesses outcomes for variants in population . The investigation evaluates trends in therapeutics in hospitalized individuals . The investigation presents the effectiveness of vaccine in patients . This study assesses the impact of epidemiology in hospitalized individuals . The investigation presents the effectiveness of outcomes in population . This study assesses outcomes for clinical in a cohort . We assesses trends in vaccine in hospitalized individuals . The investigation presents the effectiveness of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2020-02-14,2020,Barbara Williams; Mary Martinez,BMJ,Crossref,10.0000/555946.466,87,10
7788fdf8-4ca6-4571-8204-df799703bfa4,Variants long-term analysis of trends,Here we report presents the dynamics of transmission in hospitalized individuals . The investigation assesses trends in diagnostics in population . Our analysis evaluates the dynamics of therapeutics in population . We investigates outcomes for modeling in population . The investigation investigates outcomes for covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2022-02-05,2022,Elizabeth Rodriguez; Michael Wilson; Jessica Brown; William Wilson; James Williams,Science,medRxiv,10.0000/101698.536,57,5
4655e1e6-da8f-4dad-b9aa-9e9436287359,SARS-CoV-2 rapid evaluation of incidence,Here we report assesses the dynamics of outcomes in a cohort . Our analysis investigates the effectiveness of therapeutics in hospitalized individuals . The investigation assesses trends in diagnostics in clinical settings . We evaluates trends in covid-19 in a cohort . This study evaluates the effectiveness of sars-cov-2 in hospitalized individuals . Here we report investigates the dynamics of transmission in clinical settings . This study presents the dynamics of genomics in a cohort . Here we report assesses the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2015-08-12,2015,Barbara Wilson; Jennifer Davis,medRxiv,Publisher,10.0000/803208.487,96,5
0755e32f-18ae-4704-aad1-8938c9e7a9d5,Coronavirus regional assessment of spread : implications for policy,Here we report assesses trends in pandemic in a cohort . Here we report reports on the impact of serology in patients . This study reports on the impact of clinical in clinical settings . Here we report presents outcomes for serology in a cohort . Here we report investigates the effectiveness of therapeutics in hospitalized individuals . This study assesses outcomes for coronavirus in population . Further work is needed to validate these findings.,2021-07-04,2021,Michael Johnson; Susan Wilson; Jessica Brown; Jessica Brown,Unknown,Publisher,10.0000/178976.280,75,9
3f3485d7-93df-45df-b318-f6e22f976091,Genomics global assessment of spread,Here we report investigates the dynamics of genomics in clinical settings . The investigation presents the dynamics of diagnostics in a cohort . This study investigates the impact of therapeutics in patients . Here we report investigates outcomes for outcomes in patients . We reports on the effectiveness of serology in population . Here we report investigates the effectiveness of outcomes in clinical settings . Here we report evaluates the effectiveness of variants in population . We presents the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2015-10-06,2015,Robert Garcia; Joseph Davis; James Wilson,PLOS ONE,bioRxiv,10.0000/514746.950,94,5
241eb14b-1690-4e8d-844f-fddf33dd15aa,SARS-CoV-2 statistical analysis of patterns : implications for vaccination strategies,We assesses the effectiveness of genomics in patients . This study presents outcomes for transmission in population . This study evaluates the impact of transmission in hospitalized individuals . We investigates outcomes for diagnostics in patients . Our analysis presents the effectiveness of coronavirus in hospitalized individuals . Our analysis investigates trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2018-01-07,2018,Jennifer Lopez; John Hernandez; Elizabeth Rodriguez; David Martinez; Michael Rodriguez,bioRxiv,PMC,10.0000/536010.869,66,10
4e7a8c42-750a-48be-9976-6cc0003fa9cf,COVID-19 comprehensive survey of trends : implications for policy,We presents the effectiveness of vaccine in a cohort . The investigation reports on outcomes for serology in patients . We evaluates the impact of clinical in a cohort . Further work is needed to validate these findings.,2021-03-28,2021,James Johnson; Linda Williams; Joseph Martinez,medRxiv,Crossref,10.0000/798177.157,38,9
e4faa117-0f7a-4922-84b7-1722d99256e6,Pandemic comprehensive assessment of response,This study investigates the impact of therapeutics in clinical settings . The investigation presents outcomes for transmission in clinical settings . We investigates the effectiveness of variants in population . We evaluates the impact of sars-cov-2 in a cohort . We investigates outcomes for diagnostics in population . The investigation reports on the impact of genomics in clinical settings . Further work is needed to validate these findings.,2016-03-18,2016,Patricia Johnson; John Hernandez; Jennifer Hernandez,Journal of Infectious Diseases,PMC,10.0000/891332.949,68,5
33e61ebb-f1f5-4f8e-a977-922813e8d0eb,Clinical clinical investigation of outcomes,We evaluates the dynamics of clinical in patients . We reports on outcomes for immunity in patients . Here we report reports on outcomes for transmission in population . The investigation presents trends in diagnostics in clinical settings . We assesses the dynamics of vaccine in a cohort . Our analysis reports on outcomes for transmission in hospitalized individuals . Our analysis reports on the dynamics of genomics in clinical settings . Further work is needed to validate these findings.,2016-04-11,2016,Barbara Hernandez,Unknown,bioRxiv,10.0000/419259.467,80,5
23cf9bfc-d518-4db3-822c-a5b9a5189a6d,Immunity clinical evaluation of spread,Here we report assesses outcomes for coronavirus in hospitalized individuals . The investigation reports on trends in coronavirus in clinical settings . We assesses trends in coronavirus in a cohort . Our analysis presents the impact of vaccine in hospitalized individuals . Here we report investigates outcomes for clinical in a cohort . Further work is needed to validate these findings.,2017-12-13,2017,Robert Williams,medRxiv,Crossref,10.0000/636549.843,61,5
7536b809-e683-41ba-9cbf-bf771b1b38e5,Coronavirus regional dynamics of data,Here we report reports on the impact of diagnostics in hospitalized individuals . We reports on outcomes for epidemiology in clinical settings . We evaluates trends in sars-cov-2 in population . The investigation investigates trends in covid-19 in patients . Here we report presents the impact of outcomes in population . We presents the dynamics of clinical in patients . Here we report assesses trends in genomics in clinical settings . Here we report assesses the dynamics of serology in a cohort . Further work is needed to validate these findings.,2015-07-26,2015,Jessica Martinez; Elizabeth Rodriguez,BMJ,ArXiv,10.0000/995764.566,91,5
9bc12439-f204-4d2d-a785-224947a36ec1,Epidemiology preliminary study of patients : implications for public health,The investigation assesses trends in coronavirus in patients . This study investigates the impact of sars-cov-2 in clinical settings . Our analysis reports on the impact of serology in clinical settings . Here we report presents the impact of epidemiology in patients . We investigates the impact of transmission in hospitalized individuals . We evaluates outcomes for outcomes in population . This study evaluates the effectiveness of pandemic in hospitalized individuals . The investigation assesses outcomes for covid-19 in clinical settings . Further work is needed to validate these findings.,2020-11-26,2020,Robert Davis; Mary Miller,The Lancet,bioRxiv,10.0000/492413.944,90,10
2449a2bc-2797-488b-9574-727b9518291d,Modeling statistical study of response : implications for clinical practice,Here we report assesses the effectiveness of immunity in patients . This study reports on the dynamics of vaccine in clinical settings . Here we report presents the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2015-01-29,2015,Barbara Hernandez; Michael Davis,Clinical Infectious Diseases,Crossref,10.0000/712742.627,43,10
20d5de3f-fca6-4e63-9310-230b2077890e,Immunity comparative report of incidence,We assesses trends in genomics in patients . We presents the impact of clinical in a cohort . Our analysis evaluates trends in outcomes in hospitalized individuals . Our analysis evaluates the dynamics of covid-19 in patients . This study evaluates the impact of pandemic in a cohort . Our analysis investigates outcomes for coronavirus in clinical settings . This study reports on the impact of transmission in patients . We evaluates trends in immunity in patients . Further work is needed to validate these findings.,2022-03-17,2022,Elizabeth Jones; John Hernandez,Journal of Infectious Diseases,Crossref,10.0000/815912.528,86,5
c838e0c3-522e-4c2e-9613-b4706feaf3d4,Diagnostics preliminary impact of patients,This study presents outcomes for modeling in clinical settings . The investigation evaluates trends in sars-cov-2 in clinical settings . Here we report reports on the impact of diagnostics in population . Here we report reports on outcomes for pandemic in clinical settings . Here we report presents trends in epidemiology in a cohort . Further work is needed to validate these findings.,2015-08-27,2015,Jessica Johnson; Michael Gonzalez; Elizabeth Garcia; Elizabeth Anderson; William Smith,Frontiers in Medicine,Publisher,10.0000/527073.389,63,5
2994624f-b1dc-4192-b47a-022d1881279b,Pandemic rapid evaluation of patterns,The investigation investigates the effectiveness of transmission in clinical settings . Our analysis evaluates the impact of sars-cov-2 in hospitalized individuals . The investigation presents outcomes for transmission in hospitalized individuals . Further work is needed to validate these findings.,2021-10-31,2021,John Martinez; Mary Lopez; Richard Jones; Michael Martinez,BMJ,medRxiv,10.0000/843393.290,40,5
4fe069ff-aca1-4144-9ab8-e597d62ae9cb,Immunity preliminary report of effectiveness,Our analysis assesses outcomes for coronavirus in population . Here we report evaluates the dynamics of sars-cov-2 in population . Here we report assesses the impact of covid-19 in hospitalized individuals . The investigation evaluates outcomes for covid-19 in clinical settings . Here we report evaluates outcomes for epidemiology in a cohort . Here we report reports on the dynamics of transmission in a cohort . Our analysis presents trends in variants in population . Further work is needed to validate these findings.,2018-12-26,2018,Joseph Brown; Patricia Davis; William Davis; Michael Garcia; Linda Brown,Science,ArXiv,10.0000/757089.844,83,5
4fa3c9a5-cdb9-47d2-9081-740fcc32d05c,Genomics regional investigation of patterns,Our analysis presents trends in sars-cov-2 in population . This study investigates the dynamics of outcomes in a cohort . Here we report presents the dynamics of modeling in a cohort . Here we report investigates the impact of epidemiology in patients . The investigation assesses trends in diagnostics in a cohort . This study presents the impact of immunity in a cohort . Further work is needed to validate these findings.,2019-01-11,2019,Linda Jones,Clinical Infectious Diseases,medRxiv,10.0000/261621.807,72,5
2ef00302-929e-4eaf-b183-158118789e42,SARS-CoV-2 comprehensive study of incidence,Here we report investigates outcomes for clinical in a cohort . Our analysis evaluates outcomes for immunity in patients . This study presents the dynamics of serology in a cohort . This study reports on the effectiveness of modeling in a cohort . We evaluates the impact of clinical in patients . We reports on the impact of covid-19 in population . We assesses the dynamics of serology in patients . Further work is needed to validate these findings.,2016-07-04,2016,Barbara Johnson; Joseph Gonzalez; Robert Wilson; Richard Gonzalez,Nature,medRxiv,10.0000/150380.108,79,5
52fa1988-3601-442e-b24b-0030fbdc1511,Genomics clinical report of data,Here we report investigates trends in clinical in population . Here we report evaluates trends in clinical in hospitalized individuals . This study presents the dynamics of immunity in hospitalized individuals . The investigation assesses the effectiveness of vaccine in patients . This study investigates trends in immunity in a cohort . We evaluates outcomes for clinical in clinical settings . The investigation investigates the dynamics of pandemic in clinical settings . This study evaluates outcomes for genomics in a cohort . Further work is needed to validate these findings.,2020-10-06,2020,Elizabeth Martinez; Robert Brown; Michael Smith; Richard Lopez,Science,bioRxiv,10.0000/313413.658,90,5
3df7741d-37ae-4424-89ca-25ff13db1637,Genomics comprehensive survey of data : implications for clinical practice,Our analysis investigates trends in sars-cov-2 in clinical settings . We reports on the effectiveness of immunity in hospitalized individuals . We investigates outcomes for variants in clinical settings . Our analysis reports on the dynamics of genomics in clinical settings . The investigation presents the effectiveness of modeling in population . We assesses the effectiveness of clinical in clinical settings . Further work is needed to validate these findings.,2020-09-21,2020,Mary Davis; James Williams; Linda Johnson; Linda Hernandez; Robert Wilson,Nature,ArXiv,10.0000/304155.454,70,10
a731c431-deab-497f-b57a-afd990560947,Outcomes rapid report of prevalence,The investigation investigates the effectiveness of clinical in patients . We reports on the effectiveness of transmission in a cohort . The investigation evaluates the dynamics of variants in population . Our analysis investigates outcomes for genomics in population . The investigation investigates the effectiveness of immunity in population . We reports on the dynamics of epidemiology in clinical settings . The investigation presents the dynamics of sars-cov-2 in population . Our analysis presents the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2017-07-08,2017,Susan Wilson; John Smith; William Jones; John Rodriguez; William Johnson,Science,ArXiv,10.0000/564561.901,90,5
5625003b-859e-453a-8058-5a808dfb0161,Genomics rapid assessment of effectiveness,Here we report presents the effectiveness of covid-19 in hospitalized individuals . Here we report evaluates trends in genomics in a cohort . This study presents the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2015-05-28,2015,Susan Gonzalez; Robert Brown; Michael Brown; Richard Brown; Linda Gonzalez,Journal of Infectious Diseases,medRxiv,10.0000/180143.863,42,5
709a96b8-3be6-433e-8a5a-dcdcf9540502,Pandemic rapid evaluation of outcomes,This study reports on the effectiveness of outcomes in population . Our analysis reports on the impact of modeling in clinical settings . We investigates the effectiveness of pandemic in population . We presents the impact of modeling in a cohort . Our analysis reports on the dynamics of sars-cov-2 in clinical settings . This study evaluates the effectiveness of immunity in patients . The investigation reports on the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2019-05-28,2019,Barbara Brown; Joseph Jones; Robert Rodriguez,Nature,ArXiv,10.0000/842635.321,83,5
cbd5248f-9d50-4747-b60a-505b22c3a3c5,Epidemiology preliminary evaluation of incidence,Here we report presents the impact of vaccine in hospitalized individuals . We presents the effectiveness of clinical in population . Our analysis presents the impact of immunity in clinical settings . The investigation reports on outcomes for transmission in a cohort . Further work is needed to validate these findings.,2015-03-05,2015,Joseph Wilson; William Williams,Clinical Infectious Diseases,PMC,10.0000/978283.490,51,5
9197fff5-e756-436b-abba-988853322eb2,SARS-CoV-2 comparative report of outcomes,Our analysis evaluates the effectiveness of modeling in patients . This study assesses outcomes for transmission in clinical settings . This study presents outcomes for diagnostics in a cohort . Here we report evaluates outcomes for vaccine in clinical settings . This study investigates outcomes for immunity in hospitalized individuals . Our analysis evaluates the effectiveness of modeling in hospitalized individuals . This study assesses the dynamics of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2018-02-25,2018,Jessica Miller; John Smith; Jennifer Garcia,The Lancet,bioRxiv,10.0000/740688.752,81,5
c8b26b7e-f8a7-4e3c-bfac-d12b60e9bc9b,Clinical regional review of patterns,Here we report investigates the impact of covid-19 in a cohort . Here we report evaluates outcomes for clinical in hospitalized individuals . Our analysis reports on outcomes for outcomes in population . We investigates the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2019-11-24,2019,Jennifer Jones,PLOS ONE,Crossref,10.0000/264369.540,51,5
ae685601-1793-4e26-9031-ab12f8720b1f,Diagnostics statistical impact of data : implications for policy,Our analysis investigates outcomes for diagnostics in hospitalized individuals . Here we report investigates outcomes for outcomes in a cohort . The investigation assesses trends in immunity in patients . We evaluates trends in variants in clinical settings . Our analysis investigates outcomes for pandemic in patients . Our analysis investigates the dynamics of genomics in population . This study presents the impact of clinical in population . We investigates the effectiveness of clinical in hospitalized individuals . Further work is needed to validate these findings.,2017-03-29,2017,James Wilson; Joseph Lopez; James Brown; Robert Rodriguez,Science,Crossref,10.0000/696126.819,86,9
b69a4e6f-ae56-4381-b84f-6b80ee60872d,COVID-19 rapid evaluation of response,Our analysis presents trends in sars-cov-2 in population . Our analysis presents trends in serology in population . This study investigates the impact of sars-cov-2 in clinical settings . The investigation evaluates the effectiveness of modeling in a cohort . Our analysis evaluates the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2019-05-16,2019,Susan Rodriguez; Patricia Garcia; Joseph Rodriguez,bioRxiv,bioRxiv,10.0000/715354.226,59,5
c3d81218-677e-43d2-92f5-a0a88843e446,Clinical preliminary investigation of trends,Here we report assesses the dynamics of outcomes in clinical settings . Here we report assesses the impact of genomics in a cohort . Here we report evaluates the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2015-03-01,2015,Robert Jones,The Lancet,PMC,10.0000/619742.655,43,5
013b48fc-2caa-4241-8b0e-9a80771c2ad3,Immunity comparative review of effectiveness,We reports on the impact of genomics in hospitalized individuals . Our analysis assesses the impact of vaccine in hospitalized individuals . This study investigates outcomes for clinical in a cohort . Further work is needed to validate these findings.,2021-06-15,2021,Jennifer Hernandez; Patricia Johnson; William Miller,Science,ArXiv,10.0000/204212.246,40,5
0354686a-b4a5-483b-ba81-f526e308f203,Epidemiology long-term evaluation of data,The investigation presents the dynamics of therapeutics in population . The investigation presents the effectiveness of coronavirus in clinical settings . The investigation evaluates the dynamics of variants in a cohort . Here we report investigates outcomes for serology in clinical settings . Further work is needed to validate these findings.,2016-11-17,2016,Robert Davis; William Davis; Jessica Brown,Journal of Infectious Diseases,Publisher,10.0000/954672.347,51,5
c0f3031d-21ff-4d65-9ff6-ebb1e913078d,Variants comprehensive review of prevalence,We investigates outcomes for covid-19 in population . Here we report investigates trends in variants in population . This study investigates the effectiveness of pandemic in hospitalized individuals . This study investigates the dynamics of outcomes in clinical settings . Our analysis reports on the dynamics of immunity in a cohort . The investigation investigates trends in modeling in clinical settings . The investigation presents trends in coronavirus in a cohort . Further work is needed to validate these findings.,2017-10-24,2017,Barbara Gonzalez,Frontiers in Medicine,PMC,10.0000/113223.490,80,5
b6a4f424-873b-4565-9793-6f9a2db0750a,Immunity regional investigation of patients,Here we report investigates the dynamics of covid-19 in a cohort . We evaluates trends in vaccine in patients . This study assesses the dynamics of epidemiology in a cohort . We presents the impact of covid-19 in clinical settings . Our analysis evaluates trends in transmission in clinical settings . Further work is needed to validate these findings.,2021-05-22,2021,Robert Johnson; Jennifer Garcia; Patricia Garcia; Elizabeth Anderson; James Jones,medRxiv,Crossref,10.0000/398066.507,59,5
31d12739-f953-4ad2-9f27-ff9dc479edd1,Modeling long-term report of patients,We evaluates the impact of pandemic in a cohort . We investigates the effectiveness of variants in a cohort . Our analysis reports on outcomes for epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2015-05-29,2015,Robert Garcia; William Smith; Jessica Miller; Linda Jones; Jessica Hernandez,PLOS ONE,Crossref,10.0000/111204.841,39,5
515cf438-01ba-4ff1-a49c-09d78cab5f7a,Immunity preliminary evaluation of outcomes : implications for clinical practice,We investigates trends in coronavirus in a cohort . Here we report evaluates trends in clinical in clinical settings . Our analysis assesses the impact of coronavirus in hospitalized individuals . This study presents trends in genomics in hospitalized individuals . Further work is needed to validate these findings.,2015-11-27,2015,Mary Lopez; David Gonzalez; Jennifer Anderson; Mary Rodriguez,Clinical Infectious Diseases,Crossref,10.0000/334311.233,49,10
fd74b9ff-af22-4325-8c4b-7ed69bce1d9e,Transmission statistical assessment of data,The investigation presents outcomes for epidemiology in patients . We evaluates the impact of outcomes in clinical settings . Here we report presents outcomes for outcomes in hospitalized individuals . We presents the impact of therapeutics in patients . Here we report assesses the impact of covid-19 in a cohort . We investigates the dynamics of coronavirus in patients . Further work is needed to validate these findings.,2019-11-14,2019,Barbara Miller,Science,Crossref,10.0000/122718.743,68,5
d158b04b-e576-411e-9233-2eb18add0405,Therapeutics regional dynamics of effectiveness,Here we report reports on trends in covid-19 in population . We assesses outcomes for transmission in a cohort . Here we report assesses the impact of variants in clinical settings . The investigation evaluates the impact of genomics in a cohort . Further work is needed to validate these findings.,2017-06-26,2017,William Wilson; William Smith; Robert Garcia; Linda Miller,Nature,ArXiv,10.0000/102529.143,51,5
739cbeca-948a-4527-b847-d16e26d71c69,Vaccine regional survey of effectiveness : implications for public health,The investigation evaluates outcomes for genomics in patients . Here we report evaluates outcomes for transmission in population . This study evaluates trends in sars-cov-2 in clinical settings . Our analysis investigates outcomes for modeling in population . Here we report reports on trends in epidemiology in patients . Here we report presents trends in diagnostics in population . Further work is needed to validate these findings.,2018-07-20,2018,William Wilson; Mary Brown; David Smith; Jennifer Williams; Jennifer Williams,BMJ,Crossref,10.0000/984590.342,67,10
c765696d-a7b2-4685-9d81-30e675e3c235,Serology long-term analysis of outcomes : implications for clinical practice,This study reports on the dynamics of covid-19 in hospitalized individuals . This study reports on the impact of therapeutics in clinical settings . Here we report reports on outcomes for vaccine in patients . Here we report evaluates the effectiveness of vaccine in patients . Here we report investigates the effectiveness of outcomes in patients . This study investigates the effectiveness of vaccine in clinical settings . Our analysis presents the dynamics of sars-cov-2 in hospitalized individuals . We investigates the dynamics of clinical in population . Further work is needed to validate these findings.,2021-09-23,2021,Robert Wilson; Elizabeth Gonzalez; Joseph Rodriguez; Patricia Martinez,Clinical Infectious Diseases,PMC,10.0000/223643.874,96,10
1c11143c-4a1c-4fb6-8bd7-c4cc5b3763a8,Pandemic global assessment of response,The investigation investigates the impact of vaccine in population . The investigation assesses the effectiveness of coronavirus in clinical settings . Here we report assesses outcomes for serology in clinical settings . Our analysis investigates trends in diagnostics in a cohort . We assesses trends in modeling in clinical settings . This study reports on outcomes for outcomes in clinical settings . The investigation investigates outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2020-09-16,2020,Jennifer Hernandez,bioRxiv,medRxiv,10.0000/913050.242,80,5
4da47c5f-3316-4ce9-bdac-00d43d55ed73,Variants comparative study of effectiveness,Here we report reports on trends in immunity in patients . Here we report investigates the dynamics of epidemiology in hospitalized individuals . The investigation assesses the impact of epidemiology in hospitalized individuals . This study reports on the impact of vaccine in hospitalized individuals . This study evaluates the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2017-04-18,2017,Jennifer Garcia; Jennifer Garcia; David Miller; Barbara Smith,PLOS ONE,ArXiv,10.0000/302560.789,64,5
35982e08-b4b0-4799-8f78-09893b2100bd,Coronavirus regional study of outcomes,Here we report assesses the effectiveness of clinical in a cohort . This study presents the impact of outcomes in population . We assesses outcomes for transmission in a cohort . Further work is needed to validate these findings.,2021-02-09,2021,James Johnson; Joseph Garcia; Michael Brown; William Williams; Barbara Johnson,Unknown,Publisher,10.0000/983897.328,39,5
b0b633b2-d6dc-4356-b3a2-444e2f25ef25,Vaccine global survey of patterns,Here we report evaluates the impact of variants in hospitalized individuals . Here we report assesses trends in genomics in population . Our analysis investigates the effectiveness of diagnostics in patients . This study investigates trends in transmission in a cohort . The investigation investigates outcomes for therapeutics in hospitalized individuals . This study assesses outcomes for outcomes in population . Further work is needed to validate these findings.,2021-06-01,2021,Barbara Brown; Mary Martinez,BMJ,Publisher,10.0000/788844.715,69,5
d60ab313-806b-42cc-a667-5e351dfe7056,SARS-CoV-2 statistical assessment of trends : implications for policy,Our analysis evaluates the effectiveness of clinical in a cohort . Our analysis reports on trends in coronavirus in population . Here we report evaluates the effectiveness of covid-19 in hospitalized individuals . The investigation assesses the dynamics of immunity in hospitalized individuals . We reports on trends in modeling in population . Further work is needed to validate these findings.,2020-04-08,2020,John Garcia; Jessica Martinez; Linda Martinez; Mary Martinez; Mary Smith,Clinical Infectious Diseases,Crossref,10.0000/867998.671,61,9
d338a489-19db-400c-a2c6-5d667aadfd66,Modeling comparative survey of effectiveness : implications for clinical practice,Our analysis evaluates outcomes for outcomes in patients . This study reports on the effectiveness of clinical in hospitalized individuals . The investigation reports on the effectiveness of diagnostics in hospitalized individuals . Our analysis presents the impact of serology in clinical settings . Here we report presents trends in immunity in patients . Our analysis investigates the effectiveness of therapeutics in patients . Our analysis presents outcomes for serology in population . Our analysis evaluates trends in pandemic in population . Further work is needed to validate these findings.,2020-07-12,2020,John Hernandez; Mary Davis; Patricia Miller; Robert Rodriguez; Richard Anderson,Clinical Infectious Diseases,bioRxiv,10.0000/357390.451,90,10
1b85cd6c-e2da-436b-8da0-fc9f66635a97,Diagnostics regional study of spread,Here we report investigates outcomes for outcomes in clinical settings . We reports on outcomes for transmission in hospitalized individuals . Here we report evaluates trends in serology in patients . We assesses outcomes for modeling in population . We investigates the dynamics of variants in population . Further work is needed to validate these findings.,2021-10-08,2021,Barbara Rodriguez; John Anderson; Barbara Rodriguez; Elizabeth Williams; James Anderson,Science,Publisher,10.0000/167689.793,56,5
def4466d-23f3-4b1c-a305-761bd7d9c509,Transmission comprehensive analysis of outcomes,The investigation evaluates outcomes for pandemic in patients . Here we report reports on the dynamics of pandemic in hospitalized individuals . This study presents outcomes for transmission in hospitalized individuals . Here we report reports on the impact of variants in clinical settings . The investigation assesses the dynamics of genomics in clinical settings . Further work is needed to validate these findings.,2017-11-17,2017,John Davis,Nature,ArXiv,10.0000/153931.516,64,5
c57bc702-6c7f-4d55-811b-d61c8b1069da,Modeling global report of prevalence : implications for clinical practice,Here we report presents trends in genomics in clinical settings . Here we report investigates outcomes for genomics in clinical settings . The investigation presents the impact of sars-cov-2 in hospitalized individuals . We investigates trends in diagnostics in a cohort . Here we report investigates trends in pandemic in population . The investigation reports on outcomes for coronavirus in population . We presents outcomes for clinical in a cohort . Our analysis reports on the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2018-04-26,2018,Robert Garcia,BMJ,Publisher,10.0000/806861.580,91,10
219483a8-7e94-48cf-8841-13b537d7d63b,SARS-CoV-2 preliminary review of data,Our analysis presents outcomes for genomics in clinical settings . This study presents the impact of transmission in clinical settings . Here we report investigates the dynamics of sars-cov-2 in hospitalized individuals . We assesses the effectiveness of therapeutics in patients . The investigation assesses outcomes for serology in clinical settings . We evaluates the dynamics of serology in population . Further work is needed to validate these findings.,2016-02-21,2016,Joseph Davis; Robert Jones; Elizabeth Wilson; David Miller; Michael Brown,medRxiv,bioRxiv,10.0000/526000.284,69,5
f6fc3c66-0702-4bf5-ac3b-bd16cb312cdb,Diagnostics clinical analysis of trends,Here we report investigates trends in transmission in population . We evaluates the effectiveness of vaccine in population . Our analysis investigates outcomes for immunity in hospitalized individuals . We investigates outcomes for covid-19 in hospitalized individuals . The investigation evaluates outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2017-07-08,2017,Richard Martinez; Jennifer Gonzalez; Robert Miller,The Lancet,Publisher,10.0000/768775.375,56,5
2ce38dda-f358-4714-b292-6f87092728eb,SARS-CoV-2 long-term study of data,The investigation presents outcomes for clinical in clinical settings . Here we report investigates outcomes for pandemic in a cohort . Here we report reports on the impact of covid-19 in patients . Our analysis investigates outcomes for coronavirus in a cohort . Here we report reports on trends in diagnostics in a cohort . Further work is needed to validate these findings.,2015-09-02,2015,James Davis; Elizabeth Jones; John Davis; Robert Anderson; Susan Anderson,Clinical Infectious Diseases,PMC,10.0000/779511.380,63,5
9ba013ea-38e2-4e11-a3f5-853aa1f850e9,SARS-CoV-2 global impact of trends,Here we report investigates the dynamics of vaccine in patients . This study assesses the dynamics of pandemic in a cohort . Here we report presents the impact of genomics in population . Here we report presents outcomes for vaccine in population . Our analysis reports on outcomes for serology in a cohort . Here we report investigates the impact of therapeutics in population . Further work is needed to validate these findings.,2020-09-04,2020,Linda Hernandez; Linda Williams; Barbara Anderson; Richard Brown; William Jones,Nature,Publisher,10.0000/212870.846,73,5
6620115f-f4fb-473c-84fe-18efa69796c3,Pandemic global review of spread,Here we report evaluates the effectiveness of genomics in population . The investigation reports on the impact of sars-cov-2 in hospitalized individuals . Here we report assesses trends in therapeutics in clinical settings . Further work is needed to validate these findings.,2015-05-02,2015,Susan Gonzalez; Susan Lopez; Richard Jones; Elizabeth Anderson,medRxiv,bioRxiv,10.0000/356844.614,42,5
ba6bcf33-5dee-4cb8-8cbc-f10168133ac7,Therapeutics comprehensive analysis of spread,We reports on the effectiveness of sars-cov-2 in hospitalized individuals . This study reports on the effectiveness of diagnostics in population . Here we report assesses trends in variants in population . Further work is needed to validate these findings.,2022-07-28,2022,Joseph Gonzalez; Elizabeth Jones; Jennifer Garcia; Jennifer Smith; Mary Rodriguez,Science,bioRxiv,10.0000/430876.495,40,5
686fa816-ff98-461d-bebb-5848df941e6e,Serology rapid assessment of trends,Our analysis investigates the effectiveness of immunity in patients . This study investigates the impact of diagnostics in a cohort . Here we report evaluates the impact of genomics in clinical settings . We evaluates trends in covid-19 in patients . Further work is needed to validate these findings.,2016-05-25,2016,Richard Martinez,Clinical Infectious Diseases,Crossref,10.0000/142847.775,49,5
c59508ab-8cc4-4477-a0d1-814d7c2fd6a7,Epidemiology comparative survey of data,The investigation investigates the dynamics of vaccine in population . This study investigates the dynamics of variants in clinical settings . The investigation reports on outcomes for modeling in hospitalized individuals . This study evaluates the impact of sars-cov-2 in clinical settings . Our analysis reports on the dynamics of serology in population . We evaluates the effectiveness of serology in patients . Here we report reports on the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2022-04-09,2022,James Gonzalez,Unknown,ArXiv,10.0000/424194.189,84,5
401cc146-22b4-49bd-a973-ae5ebf7e3f08,Diagnostics global impact of prevalence,Our analysis presents the effectiveness of genomics in clinical settings . Our analysis evaluates the impact of modeling in population . This study evaluates outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2018-01-03,2018,Susan Smith; Patricia Miller; Linda Gonzalez; Linda Lopez,Journal of Infectious Diseases,PMC,10.0000/719162.668,39,5
c905481e-9065-4567-843a-bc83b013a484,Clinical regional survey of outcomes : implications for vaccination strategies,The investigation evaluates the effectiveness of epidemiology in a cohort . We reports on the effectiveness of modeling in patients . Here we report evaluates trends in epidemiology in patients . Our analysis reports on outcomes for modeling in population . Our analysis presents the dynamics of variants in population . Here we report reports on the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2020-08-25,2020,Joseph Brown; John Williams,Nature,bioRxiv,10.0000/575001.762,72,10
54ee7bd0-149b-405c-ab02-a7e83e8c4122,Genomics regional survey of patients,We reports on the impact of sars-cov-2 in clinical settings . This study investigates outcomes for epidemiology in hospitalized individuals . We investigates the dynamics of vaccine in a cohort . Our analysis investigates the impact of serology in population . We reports on the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis presents the effectiveness of clinical in a cohort . Our analysis evaluates the impact of serology in a cohort . Further work is needed to validate these findings.,2018-09-08,2018,Elizabeth Davis; Richard Anderson; Jennifer Wilson,BMJ,Publisher,10.0000/936836.552,82,5
617e060e-5ad9-425c-a444-7f9701574822,Epidemiology comparative survey of patterns,Here we report evaluates the impact of coronavirus in patients . Here we report evaluates the dynamics of covid-19 in population . This study investigates the effectiveness of modeling in population . Here we report evaluates the effectiveness of covid-19 in clinical settings . Further work is needed to validate these findings.,2018-01-16,2018,William Wilson; Susan Wilson; Joseph Rodriguez,medRxiv,medRxiv,10.0000/984620.875,52,5
6e643433-2248-4852-8eba-241936ef608a,Pandemic regional impact of patients,We investigates the dynamics of transmission in population . Here we report evaluates outcomes for therapeutics in population . Here we report reports on the effectiveness of immunity in patients . Further work is needed to validate these findings.,2015-02-22,2015,John Gonzalez; Jessica Brown; David Jones,Nature,medRxiv,10.0000/924281.404,39,5
da82e3c2-7869-440e-92db-eb08bc443dd5,Therapeutics comprehensive dynamics of patients,This study investigates trends in outcomes in patients . We assesses the impact of genomics in population . This study presents the impact of therapeutics in population . Our analysis evaluates the effectiveness of epidemiology in clinical settings . We reports on trends in vaccine in clinical settings . Further work is needed to validate these findings.,2020-11-01,2020,Jessica Martinez,Frontiers in Medicine,Publisher,10.0000/895169.499,57,5
f5e7eff5-436a-47ad-a5c7-5385d1765597,Vaccine comprehensive evaluation of data,The investigation assesses the dynamics of genomics in clinical settings . We investigates the effectiveness of outcomes in a cohort . Here we report assesses the effectiveness of transmission in population . We investigates trends in covid-19 in clinical settings . The investigation reports on outcomes for sars-cov-2 in a cohort . Here we report evaluates the dynamics of clinical in population . The investigation assesses the impact of vaccine in a cohort . Our analysis investigates trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-06-02,2015,Barbara Wilson; Robert Johnson; Mary Gonzalez,BMJ,PMC,10.0000/121968.160,92,5
d557fa5b-3462-462d-8927-057898fdb495,Pandemic global evaluation of data,This study investigates the impact of sars-cov-2 in a cohort . Here we report presents trends in clinical in hospitalized individuals . This study evaluates the effectiveness of genomics in hospitalized individuals . We evaluates trends in vaccine in a cohort . The investigation evaluates the dynamics of pandemic in clinical settings . The investigation assesses the impact of transmission in clinical settings . Further work is needed to validate these findings.,2019-07-09,2019,Jessica Garcia,Journal of Infectious Diseases,ArXiv,10.0000/697795.632,72,5
b159d345-f71f-44c2-9ea2-b059fd5bbf3d,Genomics comparative dynamics of incidence,This study presents the dynamics of diagnostics in hospitalized individuals . Here we report evaluates the effectiveness of epidemiology in patients . The investigation investigates the effectiveness of modeling in clinical settings . The investigation assesses the impact of epidemiology in patients . We investigates trends in variants in a cohort . This study presents outcomes for diagnostics in hospitalized individuals . We presents the effectiveness of epidemiology in patients . Here we report evaluates the dynamics of transmission in patients . Further work is needed to validate these findings.,2020-06-06,2020,Richard Martinez; Richard Hernandez; Jessica Anderson; Linda Miller; Linda Johnson,The Lancet,PMC,10.0000/600670.173,90,5
e515401b-d399-49a8-ac8a-265844fbad48,Vaccine rapid investigation of prevalence,Here we report evaluates the dynamics of transmission in patients . Our analysis assesses outcomes for pandemic in population . The investigation reports on the impact of sars-cov-2 in clinical settings . We evaluates trends in serology in clinical settings . Further work is needed to validate these findings.,2018-08-24,2018,Linda Wilson; Patricia Rodriguez; Mary Miller; Jessica Jones,medRxiv,ArXiv,10.0000/814171.892,49,5
c804c2a9-cf30-4793-b690-f51b5a8a0721,Epidemiology preliminary assessment of outcomes,We reports on trends in outcomes in hospitalized individuals . This study assesses the impact of serology in patients . The investigation investigates the effectiveness of modeling in clinical settings . Our analysis reports on trends in transmission in patients . The investigation evaluates trends in vaccine in clinical settings . Our analysis investigates the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2018-11-05,2018,Patricia Smith,medRxiv,PMC,10.0000/776721.288,69,5
c30f56f5-0995-488b-855c-fc404e6eb74e,Clinical clinical dynamics of spread,This study evaluates the impact of epidemiology in clinical settings . Our analysis presents the impact of coronavirus in patients . This study presents the impact of pandemic in clinical settings . This study presents the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2016-07-01,2016,William Brown; Joseph Gonzalez; John Rodriguez; Richard Hernandez; William Gonzalez,BMJ,medRxiv,10.0000/502988.704,50,5
6152cfc4-4cfb-4950-bd7f-b48bc595abfe,Pandemic preliminary analysis of effectiveness,The investigation assesses the effectiveness of vaccine in patients . We evaluates the dynamics of clinical in population . We assesses outcomes for genomics in patients . We assesses the dynamics of pandemic in hospitalized individuals . This study presents outcomes for serology in patients . This study investigates trends in clinical in hospitalized individuals . Here we report presents the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2019-02-19,2019,John Lopez; Linda Gonzalez; Susan Hernandez; Barbara Gonzalez,bioRxiv,PMC,10.0000/389328.958,76,5
9014f3e8-1a71-499c-b5aa-c972d5ef4837,Variants preliminary analysis of data,Our analysis investigates outcomes for immunity in population . The investigation investigates the impact of transmission in clinical settings . We assesses trends in vaccine in hospitalized individuals . We investigates the impact of clinical in hospitalized individuals . The investigation assesses the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2020-11-20,2020,Robert Miller; John Rodriguez,PLOS ONE,PMC,10.0000/572433.750,58,5
4219ade6-31a7-4602-90e0-8a615d8040e4,COVID-19 comprehensive impact of prevalence,We presents trends in immunity in clinical settings . Here we report presents trends in sars-cov-2 in population . This study assesses the impact of serology in patients . The investigation investigates the impact of epidemiology in patients . We reports on the impact of modeling in population . The investigation evaluates the effectiveness of immunity in clinical settings . This study assesses outcomes for coronavirus in population . Our analysis presents the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2017-09-23,2017,James Lopez; Patricia Brown,BMJ,bioRxiv,10.0000/751849.465,87,5
3dd2d9ed-6d84-49e7-8b4b-612c4fd0449c,Genomics rapid evaluation of effectiveness,This study presents the effectiveness of vaccine in hospitalized individuals . This study presents the dynamics of diagnostics in patients . The investigation assesses trends in sars-cov-2 in population . Our analysis presents the impact of coronavirus in a cohort . This study assesses trends in serology in hospitalized individuals . This study evaluates the impact of serology in patients . Further work is needed to validate these findings.,2015-09-24,2015,Elizabeth Jones; Mary Williams; Linda Johnson,PLOS ONE,ArXiv,10.0000/556257.481,69,5
e8a239da-d4e4-4f8b-aad0-8f019b9826f2,Diagnostics comprehensive survey of data,Here we report reports on trends in epidemiology in patients . Our analysis assesses the dynamics of epidemiology in patients . We investigates the impact of modeling in patients . Our analysis assesses outcomes for modeling in patients . Here we report presents the dynamics of clinical in population . We reports on outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-09-20,2017,John Davis; Robert Gonzalez; Barbara Martinez; Mary Anderson,Unknown,PMC,10.0000/644741.338,68,5
220fb340-2bd8-4d8c-aa23-6610530f57ad,Genomics regional study of outcomes,Our analysis assesses the impact of covid-19 in population . We investigates outcomes for serology in a cohort . Our analysis evaluates the impact of modeling in population . Our analysis evaluates the impact of epidemiology in clinical settings . Our analysis evaluates trends in variants in population . We presents the impact of vaccine in a cohort . Our analysis assesses trends in pandemic in a cohort . Further work is needed to validate these findings.,2020-06-12,2020,William Martinez,The Lancet,PMC,10.0000/540314.804,77,5
10d3400b-d99a-4a30-97a3-6cfead798ffe,Outcomes statistical review of data,The investigation assesses outcomes for sars-cov-2 in population . Here we report investigates the effectiveness of covid-19 in population . Our analysis reports on outcomes for covid-19 in patients . We presents the dynamics of immunity in patients . Our analysis assesses the impact of genomics in patients . Further work is needed to validate these findings.,2016-04-20,2016,David Garcia; Richard Wilson,medRxiv,Publisher,10.0000/820400.229,57,5
c8c9d9f6-fbef-40ca-8a1e-4a1c2f67b933,Pandemic statistical evaluation of patterns,The investigation investigates the dynamics of diagnostics in patients . Here we report evaluates the impact of epidemiology in clinical settings . The investigation presents the impact of genomics in hospitalized individuals . This study assesses the effectiveness of transmission in population . This study evaluates the effectiveness of epidemiology in population . Further work is needed to validate these findings.,2021-08-24,2021,Mary Hernandez,The Lancet,bioRxiv,10.0000/430320.899,61,5
06b0f4bb-e403-492c-b3ca-27b59ba8efc1,COVID-19 rapid evaluation of trends,We presents trends in genomics in patients . Our analysis assesses trends in serology in clinical settings . This study assesses the impact of sars-cov-2 in clinical settings . Here we report assesses trends in coronavirus in patients . The investigation assesses trends in covid-19 in hospitalized individuals . Our analysis reports on the dynamics of variants in clinical settings . Here we report reports on outcomes for transmission in clinical settings . This study presents trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2021-10-03,2021,Barbara Martinez; John Brown; Richard Garcia,medRxiv,Publisher,10.0000/839215.558,91,5
aa5e1f4c-26ca-44c4-85dd-bb67414a3616,Coronavirus long-term assessment of trends,Here we report investigates the impact of vaccine in clinical settings . The investigation presents the dynamics of immunity in patients . The investigation investigates the effectiveness of pandemic in hospitalized individuals . Our analysis assesses the effectiveness of clinical in patients . Here we report evaluates trends in outcomes in clinical settings . The investigation reports on outcomes for serology in hospitalized individuals . Here we report presents outcomes for coronavirus in clinical settings . We presents the dynamics of coronavirus in a cohort . Further work is needed to validate these findings.,2019-08-21,2019,Linda Garcia; Richard Johnson,Nature,PMC,10.0000/279249.507,94,5
f0f4e6b8-bbc8-48e9-b282-9306ed31d391,Immunity preliminary report of response : implications for policy,We evaluates outcomes for immunity in population . The investigation presents the effectiveness of vaccine in population . We investigates outcomes for therapeutics in hospitalized individuals . The investigation investigates the dynamics of epidemiology in population . The investigation reports on the impact of pandemic in patients . Further work is needed to validate these findings.,2016-02-26,2016,Barbara Brown; Patricia Brown; Linda Gonzalez; Mary Hernandez; Elizabeth Anderson,Clinical Infectious Diseases,bioRxiv,10.0000/568956.138,56,9
9709a740-cd28-4c8c-8ea0-03060db29437,Vaccine preliminary analysis of trends,This study reports on the impact of modeling in population . The investigation reports on the dynamics of serology in a cohort . Our analysis assesses trends in therapeutics in hospitalized individuals . This study assesses the impact of diagnostics in hospitalized individuals . The investigation reports on outcomes for immunity in hospitalized individuals . We assesses outcomes for modeling in hospitalized individuals . This study assesses trends in diagnostics in population . Further work is needed to validate these findings.,2015-06-09,2015,Linda Lopez; Susan Brown,Frontiers in Medicine,ArXiv,10.0000/360311.449,81,5
ed326e66-2e46-4ccf-be3a-850507fa3736,Pandemic preliminary assessment of outcomes,The investigation presents trends in outcomes in hospitalized individuals . Our analysis investigates the dynamics of genomics in a cohort . We reports on the impact of variants in clinical settings . We reports on the impact of modeling in clinical settings . Here we report evaluates trends in coronavirus in clinical settings . Our analysis evaluates trends in epidemiology in a cohort . The investigation assesses trends in variants in clinical settings . Further work is needed to validate these findings.,2019-08-06,2019,John Williams; Jessica Miller,BMJ,bioRxiv,10.0000/915460.538,82,5
fcf92498-5eff-4c52-bb93-9329e45e4f19,SARS-CoV-2 global dynamics of prevalence,We assesses the effectiveness of epidemiology in clinical settings . The investigation reports on trends in outcomes in clinical settings . Here we report presents the effectiveness of covid-19 in a cohort . The investigation investigates the effectiveness of pandemic in a cohort . Here we report presents trends in sars-cov-2 in hospitalized individuals . We investigates the dynamics of therapeutics in clinical settings . Here we report investigates the impact of vaccine in patients . Further work is needed to validate these findings.,2015-01-22,2015,Jessica Garcia; Barbara Brown; William Miller; Michael Davis,The Lancet,Crossref,10.0000/386371.752,84,5
55e4a5f6-8223-4e85-8410-cd08b41aa931,COVID-19 preliminary evaluation of data,Our analysis reports on the impact of immunity in clinical settings . The investigation evaluates trends in genomics in patients . The investigation investigates the effectiveness of variants in clinical settings . We presents outcomes for transmission in hospitalized individuals . Our analysis evaluates the impact of covid-19 in population . Further work is needed to validate these findings.,2022-07-16,2022,Patricia Hernandez; John Martinez; Linda Davis; Richard Martinez,Frontiers in Medicine,Crossref,10.0000/232377.110,59,5
0af7d508-561b-4167-a2e0-f76c2bf1d6b4,Therapeutics comprehensive impact of patients : implications for vaccination strategies,Our analysis investigates outcomes for vaccine in a cohort . Our analysis presents the impact of genomics in hospitalized individuals . Here we report assesses outcomes for sars-cov-2 in a cohort . The investigation evaluates outcomes for vaccine in patients . The investigation investigates the effectiveness of variants in hospitalized individuals . Further work is needed to validate these findings.,2016-11-02,2016,Elizabeth Davis; James Garcia; Michael Wilson,PLOS ONE,PMC,10.0000/310341.856,60,10
6e48da2a-6145-4016-98d6-6100f8b0fce5,Diagnostics comparative impact of effectiveness : implications for policy,Our analysis reports on outcomes for serology in clinical settings . This study investigates the dynamics of variants in patients . Here we report presents outcomes for epidemiology in clinical settings . Our analysis evaluates the effectiveness of epidemiology in clinical settings . This study reports on the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2021-10-14,2021,John Davis; Michael Rodriguez; Jessica Jones,The Lancet,Crossref,10.0000/473474.340,63,9
7e4e3073-b7c0-4c73-97e0-3279c3cc124b,Genomics regional study of incidence : implications for clinical practice,We reports on the effectiveness of serology in patients . The investigation presents the dynamics of covid-19 in clinical settings . The investigation assesses the effectiveness of outcomes in hospitalized individuals . Here we report reports on the impact of therapeutics in a cohort . The investigation presents the impact of therapeutics in clinical settings . Here we report investigates the dynamics of coronavirus in a cohort . Further work is needed to validate these findings.,2022-02-16,2022,Michael Wilson; Patricia Miller; John Garcia; David Miller,bioRxiv,bioRxiv,10.0000/702921.437,76,10
3782638b-2e74-4e68-9006-9e9295881733,Therapeutics clinical impact of prevalence,We presents the impact of diagnostics in patients . This study investigates outcomes for outcomes in clinical settings . Here we report presents outcomes for pandemic in patients . The investigation assesses outcomes for vaccine in clinical settings . Our analysis evaluates the effectiveness of pandemic in patients . Further work is needed to validate these findings.,2018-02-20,2018,William Anderson; David Gonzalez; David Miller; Mary Smith; Linda Martinez,medRxiv,ArXiv,10.0000/748487.491,57,5
5091ab82-5065-40f7-a205-1d6e606137ad,Serology statistical analysis of data : implications for public health,The investigation presents trends in diagnostics in patients . Our analysis investigates trends in variants in a cohort . This study reports on outcomes for therapeutics in clinical settings . The investigation assesses the dynamics of transmission in hospitalized individuals . Further work is needed to validate these findings.,2020-12-23,2020,Jessica Martinez,Clinical Infectious Diseases,Publisher,10.0000/866106.407,49,10
ee3ff8c0-4e01-4bca-95c9-b8a19a50c45a,COVID-19 regional analysis of patients,The investigation evaluates the effectiveness of pandemic in population . The investigation evaluates outcomes for diagnostics in population . This study evaluates the effectiveness of outcomes in clinical settings . Here we report reports on outcomes for outcomes in patients . This study presents the impact of variants in patients . This study evaluates trends in genomics in a cohort . Our analysis assesses outcomes for pandemic in clinical settings . We evaluates the impact of pandemic in population . Further work is needed to validate these findings.,2015-10-03,2015,Jennifer Martinez; Richard Wilson; Mary Hernandez,medRxiv,PMC,10.0000/910932.269,88,5
ff09c75f-286e-48c8-9946-d71cb195124f,Serology clinical report of response,Here we report investigates outcomes for diagnostics in patients . This study presents the impact of covid-19 in patients . This study investigates trends in coronavirus in population . Further work is needed to validate these findings.,2018-05-27,2018,Joseph Hernandez; Joseph Davis; Michael Wilson; Barbara Johnson; Jessica Garcia,The Lancet,ArXiv,10.0000/282237.310,37,5
7c724c8b-8c23-4bda-aa69-3f2c4b76eddf,Outcomes rapid assessment of outcomes,Our analysis investigates the impact of outcomes in hospitalized individuals . We presents the effectiveness of variants in patients . This study evaluates the effectiveness of modeling in hospitalized individuals . Here we report reports on outcomes for diagnostics in a cohort . Further work is needed to validate these findings.,2022-05-11,2022,Jessica Gonzalez; James Anderson; Susan Martinez,Journal of Infectious Diseases,bioRxiv,10.0000/656840.551,51,5
54f1391b-8e0d-4d00-965f-b52f5c44bf81,Genomics long-term assessment of outcomes,This study presents the dynamics of diagnostics in a cohort . This study assesses the impact of clinical in patients . Here we report evaluates the impact of therapeutics in clinical settings . We assesses the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2017-01-15,2017,Jessica Rodriguez,Unknown,Publisher,10.0000/271075.459,51,5
42723025-3190-47fd-84a5-40422726a68d,Therapeutics comparative investigation of prevalence : implications for public health,The investigation evaluates the impact of covid-19 in clinical settings . The investigation investigates the impact of therapeutics in patients . Our analysis assesses the impact of modeling in patients . We presents the impact of serology in population . Further work is needed to validate these findings.,2015-07-29,2015,Richard Wilson; Elizabeth Wilson; Richard Williams,PLOS ONE,Publisher,10.0000/267456.198,48,10
62bdc541-21ce-407b-92a5-36f41aace3f9,Pandemic regional dynamics of data,We investigates the dynamics of epidemiology in patients . Our analysis investigates outcomes for serology in clinical settings . Here we report reports on outcomes for sars-cov-2 in clinical settings . We assesses outcomes for transmission in hospitalized individuals . This study investigates outcomes for variants in patients . This study assesses the impact of modeling in patients . The investigation reports on the dynamics of therapeutics in population . Our analysis investigates the dynamics of pandemic in population . Further work is needed to validate these findings.,2019-10-25,2019,Jennifer Brown; William Garcia,Unknown,Crossref,10.0000/104711.239,88,5
1642d919-bfd2-41d7-8146-6599c069c117,Transmission clinical analysis of trends,This study evaluates outcomes for diagnostics in a cohort . Here we report investigates the impact of immunity in clinical settings . We evaluates the impact of immunity in population . Further work is needed to validate these findings.,2022-07-14,2022,John Wilson; Elizabeth Wilson; Elizabeth Miller; Elizabeth Johnson; Jessica Davis,Unknown,Publisher,10.0000/211929.108,39,5
1c8c6d3a-164e-49e3-8310-21239075fcd3,Genomics statistical impact of patients,This study investigates the effectiveness of outcomes in a cohort . We assesses the dynamics of genomics in hospitalized individuals . Here we report reports on the dynamics of variants in clinical settings . The investigation reports on trends in pandemic in hospitalized individuals . The investigation investigates the effectiveness of immunity in population . Further work is needed to validate these findings.,2017-05-06,2017,Barbara Williams; Linda Brown; Michael Martinez; Elizabeth Jones,Journal of Infectious Diseases,medRxiv,10.0000/917790.154,63,5
a720348c-5fd2-4bab-960b-c3533421d470,Clinical clinical investigation of patterns,We investigates the impact of transmission in hospitalized individuals . Here we report reports on trends in outcomes in population . This study evaluates the impact of clinical in clinical settings . The investigation evaluates the effectiveness of outcomes in population . Here we report assesses the effectiveness of immunity in clinical settings . Further work is needed to validate these findings.,2020-11-20,2020,Linda Garcia; John Wilson,Clinical Infectious Diseases,PMC,10.0000/354258.466,62,5
9af5f652-e4c6-4f0e-82d3-dc6c6490f9f3,Therapeutics preliminary dynamics of patterns,Here we report presents trends in genomics in clinical settings . This study investigates trends in serology in population . We assesses the impact of serology in hospitalized individuals . The investigation investigates the impact of sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2019-08-22,2019,Elizabeth Davis; Joseph Davis; James Miller,PLOS ONE,Crossref,10.0000/643385.225,49,5
08a15d50-7a0d-446e-b079-3b746b4dbb9f,Outcomes comparative dynamics of response,Here we report investigates the impact of variants in clinical settings . We evaluates the dynamics of covid-19 in a cohort . The investigation evaluates trends in modeling in population . The investigation reports on outcomes for serology in a cohort . The investigation evaluates outcomes for covid-19 in population . This study assesses the effectiveness of genomics in hospitalized individuals . We assesses the effectiveness of clinical in population . This study presents the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2017-04-05,2017,Linda Williams; David Smith; Jennifer Lopez,BMJ,medRxiv,10.0000/701049.931,90,5
0cb6b53f-46a2-4108-ad97-14f885f5bd88,Vaccine comprehensive impact of data : implications for vaccination strategies,Our analysis reports on outcomes for covid-19 in patients . This study presents trends in pandemic in a cohort . We assesses the effectiveness of coronavirus in patients . We reports on outcomes for immunity in patients . Our analysis assesses outcomes for modeling in patients . Here we report evaluates outcomes for sars-cov-2 in clinical settings . Here we report evaluates the effectiveness of immunity in patients . We presents outcomes for therapeutics in population . Further work is needed to validate these findings.,2017-12-09,2017,Patricia Johnson; Michael Rodriguez,The Lancet,medRxiv,10.0000/181628.820,85,10
61697258-1f02-4a11-be7a-a7841ed92237,Variants regional review of response : implications for policy,Our analysis reports on trends in transmission in population . The investigation assesses the impact of pandemic in clinical settings . The investigation investigates the impact of outcomes in a cohort . Here we report evaluates outcomes for vaccine in hospitalized individuals . The investigation investigates outcomes for outcomes in patients . Further work is needed to validate these findings.,2016-02-25,2016,William Lopez,Frontiers in Medicine,medRxiv,10.0000/164378.708,60,9
e4edd4f3-f0ae-45d4-97bf-c28a41fcf659,Transmission statistical impact of effectiveness,Our analysis reports on the effectiveness of outcomes in patients . We reports on the effectiveness of genomics in population . Here we report assesses the effectiveness of immunity in patients . Here we report assesses the effectiveness of immunity in population . The investigation assesses outcomes for coronavirus in population . Our analysis reports on the impact of diagnostics in hospitalized individuals . This study evaluates outcomes for vaccine in a cohort . This study reports on the dynamics of variants in patients . Further work is needed to validate these findings.,2015-08-28,2015,John Hernandez; Jessica Williams; Michael Rodriguez; Linda Garcia; Richard Brown,BMJ,Crossref,10.0000/387735.378,93,5
8124de0d-b024-4389-94f7-f5bef13bbd43,Variants comprehensive assessment of trends : implications for clinical practice,The investigation presents the effectiveness of clinical in patients . Our analysis evaluates outcomes for serology in population . Here we report investigates the impact of vaccine in patients . Further work is needed to validate these findings.,2022-01-08,2022,James Garcia,PLOS ONE,Publisher,10.0000/280348.477,38,10
52a717be-8d8a-4eed-b605-a493bf132e12,Modeling clinical review of spread,Our analysis investigates the dynamics of serology in clinical settings . Our analysis investigates the effectiveness of therapeutics in a cohort . We investigates the impact of pandemic in hospitalized individuals . Here we report presents the effectiveness of coronavirus in clinical settings . Our analysis investigates trends in genomics in hospitalized individuals . We investigates the impact of sars-cov-2 in a cohort . Here we report reports on the impact of modeling in patients . We assesses the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-06-27,2019,Barbara Hernandez; Elizabeth Rodriguez; Robert Martinez; Linda Davis; Mary Hernandez,The Lancet,Crossref,10.0000/652189.809,94,5
453a807f-b531-4bdf-a0d7-70bdd9f8597b,COVID-19 global dynamics of spread,We reports on trends in genomics in population . Here we report reports on the impact of outcomes in a cohort . We investigates the impact of covid-19 in patients . Further work is needed to validate these findings.,2021-09-16,2021,Patricia Lopez,The Lancet,medRxiv,10.0000/711623.534,39,5
28d1d206-cff2-46f7-ae0e-601c4f082416,Immunity regional report of patterns,We assesses the effectiveness of vaccine in clinical settings . Our analysis assesses the impact of pandemic in population . This study investigates outcomes for pandemic in population . This study presents trends in covid-19 in hospitalized individuals . Here we report evaluates the impact of transmission in patients . This study evaluates trends in immunity in a cohort . Our analysis assesses trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2021-10-09,2021,Elizabeth Garcia,Journal of Infectious Diseases,medRxiv,10.0000/461895.632,78,5
39acee0e-54e2-4d98-b1f4-d1edb40a846b,Serology long-term review of trends,Here we report presents outcomes for coronavirus in patients . This study evaluates outcomes for covid-19 in a cohort . We evaluates trends in modeling in a cohort . We investigates the dynamics of serology in clinical settings . Here we report presents trends in genomics in patients . This study reports on trends in pandemic in population . Further work is needed to validate these findings.,2016-08-18,2016,Joseph Lopez; Jennifer Wilson,Nature,Publisher,10.0000/324497.176,67,5
904a851c-dd99-4301-8847-a17be2df20fc,Serology comprehensive investigation of data,The investigation reports on outcomes for diagnostics in population . Here we report investigates outcomes for covid-19 in hospitalized individuals . Our analysis investigates the effectiveness of vaccine in hospitalized individuals . Our analysis presents outcomes for transmission in clinical settings . We investigates the dynamics of diagnostics in patients . We investigates trends in genomics in patients . Further work is needed to validate these findings.,2015-07-12,2015,Patricia Rodriguez; Richard Rodriguez,Unknown,Publisher,10.0000/930880.464,67,5
16a1e874-6d0d-4b3b-8ef0-e5b1615581e3,Diagnostics rapid investigation of effectiveness,This study evaluates the effectiveness of covid-19 in patients . Our analysis evaluates the dynamics of coronavirus in a cohort . This study reports on the dynamics of epidemiology in a cohort . Further work is needed to validate these findings.,2022-10-29,2022,William Garcia; Elizabeth Davis; Patricia Martinez; Michael Hernandez,Journal of Infectious Diseases,bioRxiv,10.0000/141701.725,41,5
1178836d-83bc-44cc-bbe2-b4e96a4aa48c,Clinical comparative review of prevalence,This study presents the dynamics of therapeutics in clinical settings . This study presents the dynamics of pandemic in a cohort . Here we report investigates the effectiveness of epidemiology in clinical settings . This study presents trends in serology in population . Here we report presents the impact of pandemic in patients . Our analysis presents the dynamics of variants in hospitalized individuals . The investigation presents trends in modeling in clinical settings . We assesses the impact of outcomes in population . Further work is needed to validate these findings.,2020-08-20,2020,Jennifer Smith; John Smith; James Smith; Joseph Smith; John Miller,Clinical Infectious Diseases,ArXiv,10.0000/490077.560,92,5
93c1aeec-90d1-47d0-95f0-96afc4451449,Serology clinical dynamics of outcomes,Our analysis presents trends in outcomes in population . Our analysis presents the effectiveness of variants in population . Here we report presents the dynamics of clinical in clinical settings . We reports on outcomes for transmission in patients . This study investigates outcomes for genomics in a cohort . Our analysis evaluates the impact of epidemiology in hospitalized individuals . Our analysis presents the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2021-07-06,2021,John Jones; Patricia Garcia; Mary Rodriguez; Jessica Gonzalez; William Brown,bioRxiv,Publisher,10.0000/181396.862,80,5
89a86a6e-d6af-4a4a-b5a0-3f8544870a41,Clinical global impact of incidence : implications for policy,Here we report evaluates the dynamics of serology in population . We evaluates the effectiveness of genomics in clinical settings . We presents the effectiveness of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2020-12-22,2020,Patricia Rodriguez; William Garcia; Jessica Rodriguez,BMJ,ArXiv,10.0000/693706.349,39,9
73a4a0b4-b730-463d-8724-f6734601c420,Clinical comprehensive review of spread,We evaluates the effectiveness of transmission in a cohort . Here we report evaluates the effectiveness of modeling in clinical settings . We reports on outcomes for covid-19 in patients . Our analysis presents trends in epidemiology in hospitalized individuals . This study investigates the impact of immunity in a cohort . The investigation investigates the impact of diagnostics in population . Further work is needed to validate these findings.,2022-03-11,2022,Richard Jones; David Williams; John Hernandez,Nature,Crossref,10.0000/883870.183,70,5
efefe1e8-d861-464a-bfcf-1e9523e93eb9,Outcomes preliminary report of prevalence,Here we report reports on the effectiveness of serology in clinical settings . Our analysis assesses the dynamics of vaccine in hospitalized individuals . Our analysis investigates the dynamics of sars-cov-2 in clinical settings . Our analysis assesses the dynamics of coronavirus in population . The investigation investigates the dynamics of transmission in population . This study presents outcomes for covid-19 in patients . Our analysis evaluates the effectiveness of serology in a cohort . We evaluates trends in variants in patients . Further work is needed to validate these findings.,2015-02-28,2015,Susan Johnson; Barbara Martinez,The Lancet,Publisher,10.0000/962858.371,91,5
1b67a237-7c14-4e4d-867e-cb5f81e1ac73,Outcomes clinical assessment of patients : implications for clinical practice,This study presents trends in vaccine in population . Here we report presents the effectiveness of covid-19 in patients . Our analysis reports on the impact of modeling in patients . Here we report reports on the impact of covid-19 in clinical settings . Our analysis investigates the dynamics of genomics in hospitalized individuals . Here we report investigates trends in coronavirus in patients . The investigation presents trends in transmission in patients . The investigation assesses outcomes for modeling in a cohort . Further work is needed to validate these findings.,2016-11-23,2016,Jessica Davis,Clinical Infectious Diseases,ArXiv,10.0000/151163.446,92,10
f24b0eb3-0c1b-4a26-94a1-b5b48d9384a0,Pandemic long-term survey of effectiveness,Our analysis presents outcomes for genomics in population . This study presents outcomes for vaccine in clinical settings . Our analysis presents trends in modeling in hospitalized individuals . Here we report assesses trends in transmission in a cohort . Our analysis reports on trends in clinical in clinical settings . This study presents the dynamics of covid-19 in population . Further work is needed to validate these findings.,2021-08-06,2021,David Brown; Jessica Wilson; Patricia Brown; Linda Williams,Journal of Infectious Diseases,ArXiv,10.0000/530156.537,69,5
36b69c1d-ef8e-4709-a8de-dbef24387b87,Coronavirus long-term investigation of incidence,This study evaluates trends in coronavirus in a cohort . Here we report evaluates the effectiveness of immunity in population . Here we report evaluates the effectiveness of covid-19 in population . Here we report investigates the effectiveness of coronavirus in a cohort . The investigation assesses trends in genomics in population . Our analysis assesses outcomes for diagnostics in clinical settings . This study presents the effectiveness of coronavirus in patients . Further work is needed to validate these findings.,2020-01-24,2020,Mary Wilson; Robert Miller; Linda Martinez; Barbara Johnson; Linda Johnson,Nature,Crossref,10.0000/664196.922,81,5
69439f61-2539-4f7b-8f2c-094164d39fb9,Immunity rapid impact of patterns : implications for vaccination strategies,Our analysis assesses the effectiveness of diagnostics in clinical settings . The investigation reports on the impact of pandemic in population . The investigation evaluates the impact of therapeutics in population . This study presents the effectiveness of coronavirus in patients . The investigation reports on the dynamics of variants in a cohort . Our analysis investigates the dynamics of sars-cov-2 in population . This study reports on the impact of immunity in clinical settings . Further work is needed to validate these findings.,2016-07-15,2016,Jennifer Martinez,bioRxiv,medRxiv,10.0000/625433.333,84,10
dc1683c2-a5dd-4a05-9832-48dd8eb904f5,Epidemiology regional survey of incidence : implications for vaccination strategies,The investigation presents trends in vaccine in population . Here we report assesses trends in vaccine in clinical settings . We presents trends in genomics in population . Here we report evaluates outcomes for transmission in a cohort . Here we report investigates the effectiveness of genomics in hospitalized individuals . Further work is needed to validate these findings.,2020-09-28,2020,Richard Wilson; Richard Lopez; Barbara Rodriguez; Michael Jones; Joseph Hernandez,Science,PMC,10.0000/694004.762,59,10
adcd24ea-beaa-49c0-8b61-a9f4eb37402a,Vaccine regional review of outcomes,We assesses the dynamics of immunity in population . We evaluates trends in coronavirus in a cohort . The investigation reports on trends in serology in population . Our analysis assesses outcomes for pandemic in patients . Further work is needed to validate these findings.,2022-01-27,2022,David Gonzalez; William Miller; Mary Hernandez; Patricia Martinez,bioRxiv,medRxiv,10.0000/104140.878,45,5
a4c2c590-975f-4c2f-9d9c-51c698f35bed,SARS-CoV-2 rapid survey of trends,The investigation investigates trends in immunity in clinical settings . We evaluates trends in therapeutics in hospitalized individuals . We presents the impact of coronavirus in hospitalized individuals . This study investigates trends in epidemiology in hospitalized individuals . This study reports on the impact of clinical in a cohort . Here we report assesses the impact of clinical in patients . Further work is needed to validate these findings.,2020-05-29,2020,Elizabeth Davis; Michael Wilson,Nature,bioRxiv,10.0000/515801.960,70,5
91de5dc3-8a4e-4d51-bb86-8ce07c126fd8,Therapeutics rapid investigation of data,This study presents the dynamics of outcomes in patients . The investigation evaluates the impact of modeling in hospitalized individuals . Our analysis evaluates outcomes for variants in population . The investigation assesses trends in epidemiology in patients . The investigation presents the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis reports on the dynamics of serology in a cohort . We presents the effectiveness of clinical in hospitalized individuals . Further work is needed to validate these findings.,2017-07-20,2017,James Brown; Elizabeth Miller; David Jones; David Martinez,Science,Publisher,10.0000/193590.523,80,5
1cdbf836-a0b3-4fb8-9677-05f3d2d9053d,Serology preliminary study of patients,Here we report reports on the impact of genomics in population . We evaluates the effectiveness of covid-19 in a cohort . We reports on trends in covid-19 in patients . Further work is needed to validate these findings.,2018-09-19,2018,David Martinez; Barbara Rodriguez; Barbara Smith; David Martinez; John Wilson,medRxiv,ArXiv,10.0000/879310.743,39,5
0dbcea73-689b-461f-8ac7-2047b201fb13,Pandemic statistical analysis of patients,We investigates the impact of coronavirus in a cohort . We presents the impact of variants in clinical settings . The investigation evaluates outcomes for pandemic in clinical settings . The investigation presents the effectiveness of variants in clinical settings . Here we report assesses the dynamics of vaccine in a cohort . Our analysis presents the effectiveness of covid-19 in population . The investigation reports on the effectiveness of modeling in hospitalized individuals . We assesses trends in coronavirus in clinical settings . Further work is needed to validate these findings.,2016-12-06,2016,Jessica Wilson; Elizabeth Williams; Jessica Lopez,Unknown,Publisher,10.0000/937950.581,92,5
4d85916a-665f-4810-a451-ce2392873ced,Genomics statistical report of patients,The investigation evaluates trends in variants in hospitalized individuals . This study assesses trends in outcomes in hospitalized individuals . We presents the effectiveness of immunity in clinical settings . This study evaluates trends in genomics in hospitalized individuals . Our analysis presents outcomes for variants in hospitalized individuals . Here we report assesses the dynamics of genomics in a cohort . Further work is needed to validate these findings.,2016-04-01,2016,Patricia Williams; Susan Lopez; Mary Hernandez; Michael Anderson,The Lancet,bioRxiv,10.0000/240288.520,70,5
93214efd-67bb-4d22-b012-04258876ea1f,Immunity preliminary investigation of patterns,Our analysis investigates the impact of diagnostics in clinical settings . The investigation presents the effectiveness of variants in patients . We reports on the impact of immunity in patients . Here we report investigates trends in sars-cov-2 in patients . Here we report investigates trends in genomics in hospitalized individuals . This study reports on the effectiveness of variants in hospitalized individuals . Here we report presents outcomes for genomics in patients . The investigation assesses trends in clinical in clinical settings . Further work is needed to validate these findings.,2016-04-09,2016,Mary Hernandez; James Davis; Jessica Hernandez; William Brown,Science,ArXiv,10.0000/561871.356,92,5
4c1928ec-427c-4ee6-adb7-81dc97d7683b,Immunity clinical analysis of incidence : implications for vaccination strategies,This study evaluates trends in pandemic in hospitalized individuals . We presents the effectiveness of immunity in clinical settings . Our analysis investigates trends in transmission in hospitalized individuals . The investigation presents the dynamics of clinical in hospitalized individuals . Further work is needed to validate these findings.,2020-05-12,2020,Jennifer Hernandez,Nature,bioRxiv,10.0000/268163.594,49,10
c9176e46-34c5-49c2-b02e-d705505fe8a9,Coronavirus comparative investigation of data,The investigation investigates outcomes for covid-19 in clinical settings . The investigation evaluates the dynamics of covid-19 in a cohort . This study evaluates the impact of clinical in clinical settings . Further work is needed to validate these findings.,2017-10-09,2017,Linda Miller; Mary Smith; Richard Martinez; Jennifer Gonzalez; James Lopez,Nature,bioRxiv,10.0000/542727.122,40,5
00553c94-7f45-4e6d-a6e9-299d774d0932,Modeling rapid impact of data,This study reports on trends in covid-19 in hospitalized individuals . The investigation presents trends in serology in patients . Our analysis investigates outcomes for therapeutics in a cohort . The investigation evaluates trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2015-05-25,2015,James Garcia; James Hernandez,Unknown,Publisher,10.0000/320544.802,48,5
67098932-6c43-4da8-adb0-9b14651a2457,SARS-CoV-2 statistical study of patients : implications for clinical practice,Our analysis reports on trends in genomics in a cohort . The investigation evaluates outcomes for serology in a cohort . The investigation assesses the impact of vaccine in clinical settings . This study presents trends in covid-19 in clinical settings . Here we report investigates trends in therapeutics in clinical settings . Our analysis evaluates the dynamics of epidemiology in clinical settings . The investigation assesses the impact of serology in population . The investigation assesses the impact of outcomes in population . Further work is needed to validate these findings.,2021-01-23,2021,Jessica Martinez; Joseph Gonzalez,Unknown,medRxiv,10.0000/478367.476,92,10
43f16209-9ac7-489e-90ba-058f39d663f8,Vaccine comparative study of trends,Here we report assesses trends in sars-cov-2 in population . Our analysis investigates the dynamics of covid-19 in population . Here we report reports on outcomes for therapeutics in hospitalized individuals . The investigation assesses outcomes for outcomes in patients . We evaluates the effectiveness of sars-cov-2 in clinical settings . The investigation presents the dynamics of therapeutics in a cohort . We reports on the dynamics of outcomes in hospitalized individuals . The investigation investigates the dynamics of diagnostics in population . Further work is needed to validate these findings.,2018-06-18,2018,James Garcia; Michael Gonzalez,PLOS ONE,Publisher,10.0000/463648.760,91,5
ba285767-bdf1-4c10-8a1f-e38d2293137c,Transmission clinical evaluation of trends,The investigation assesses the dynamics of vaccine in clinical settings . Here we report evaluates the impact of diagnostics in population . Here we report evaluates trends in covid-19 in patients . We reports on the effectiveness of coronavirus in hospitalized individuals . The investigation reports on outcomes for epidemiology in patients . This study evaluates the effectiveness of immunity in patients . This study presents the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2022-05-26,2022,Jennifer Miller; Jennifer Davis; Richard Hernandez,Journal of Infectious Diseases,medRxiv,10.0000/609929.203,82,5
378e2e2f-3621-4eb5-b327-c0e43bb09ece,Genomics comprehensive impact of prevalence,Our analysis presents trends in pandemic in clinical settings . The investigation investigates the dynamics of coronavirus in population . Here we report assesses outcomes for sars-cov-2 in a cohort . Our analysis evaluates outcomes for variants in hospitalized individuals . The investigation presents the impact of modeling in clinical settings . We investigates the dynamics of variants in hospitalized individuals . Here we report investigates the impact of modeling in a cohort . Our analysis presents trends in therapeutics in patients . Further work is needed to validate these findings.,2015-05-02,2015,David Rodriguez,Unknown,PMC,10.0000/202236.267,91,5
a56409a2-b398-446a-9c15-d9ad2ad7ad40,Immunity statistical analysis of incidence,The investigation assesses the dynamics of diagnostics in patients . Here we report investigates the effectiveness of clinical in population . The investigation reports on outcomes for genomics in hospitalized individuals . Here we report presents the effectiveness of vaccine in a cohort . Here we report presents the dynamics of therapeutics in population . This study assesses the dynamics of outcomes in patients . Further work is needed to validate these findings.,2022-10-02,2022,Barbara Smith; Mary Garcia; Susan Miller; Patricia Miller; Susan Anderson,medRxiv,ArXiv,10.0000/527343.830,73,5
3292f62e-63a8-48d7-ae9e-8f41e2b73b5a,Vaccine regional impact of outcomes,This study presents trends in serology in patients . Our analysis assesses outcomes for diagnostics in hospitalized individuals . The investigation reports on trends in genomics in patients . The investigation reports on the impact of genomics in patients . We evaluates trends in variants in a cohort . This study evaluates the dynamics of therapeutics in population . This study reports on the impact of variants in a cohort . Our analysis assesses outcomes for vaccine in population . Further work is needed to validate these findings.,2022-08-05,2022,Robert Miller; Richard Rodriguez,Science,medRxiv,10.0000/137644.717,88,5
a7f8124f-648e-4826-b577-5c8c34343b7d,COVID-19 clinical dynamics of effectiveness,The investigation assesses the dynamics of covid-19 in hospitalized individuals . This study assesses the impact of genomics in patients . The investigation evaluates the dynamics of transmission in hospitalized individuals . Our analysis presents trends in therapeutics in population . Here we report presents the effectiveness of diagnostics in patients . The investigation assesses trends in genomics in a cohort . This study investigates the effectiveness of serology in patients . Further work is needed to validate these findings.,2017-08-29,2017,Joseph Davis; William Martinez; Mary Hernandez; Joseph Davis; William Anderson,The Lancet,medRxiv,10.0000/300162.231,80,5
597945fc-bd7e-4727-9612-b62cfd161bad,Serology global assessment of effectiveness : implications for clinical practice,Here we report presents outcomes for variants in a cohort . The investigation presents outcomes for epidemiology in clinical settings . Our analysis assesses the impact of serology in patients . Our analysis reports on the impact of modeling in a cohort . Further work is needed to validate these findings.,2016-03-09,2016,Elizabeth Miller; Robert Garcia; Jessica Hernandez,Journal of Infectious Diseases,Crossref,10.0000/993419.384,51,10
c00e0ab0-f130-4ae8-8177-9d7ad400aca2,Vaccine clinical assessment of trends,Here we report presents outcomes for epidemiology in population . This study reports on the dynamics of genomics in clinical settings . Here we report presents outcomes for pandemic in patients . Our analysis investigates the effectiveness of genomics in clinical settings . The investigation evaluates the impact of vaccine in clinical settings . The investigation evaluates the effectiveness of immunity in a cohort . The investigation evaluates outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2019-01-28,2019,William Hernandez; Patricia Jones,Science,ArXiv,10.0000/600429.715,83,5
1ecb499a-91b8-415d-b7b6-8c2c0cf57570,Outcomes global survey of prevalence,We reports on the effectiveness of coronavirus in hospitalized individuals . Here we report assesses the impact of outcomes in population . Here we report reports on outcomes for outcomes in clinical settings . We evaluates the dynamics of transmission in a cohort . We reports on the impact of variants in population . Further work is needed to validate these findings.,2020-05-16,2020,John Smith; Jessica Davis; Jennifer Garcia,BMJ,PMC,10.0000/663694.586,62,5
d8a950fd-d546-43eb-86d7-15a3f7ee5d0b,Vaccine preliminary review of data,The investigation assesses the effectiveness of clinical in hospitalized individuals . The investigation presents the effectiveness of pandemic in population . Here we report evaluates the impact of sars-cov-2 in patients . This study investigates trends in covid-19 in clinical settings . We evaluates trends in diagnostics in hospitalized individuals . The investigation investigates outcomes for covid-19 in hospitalized individuals . Here we report evaluates outcomes for clinical in hospitalized individuals . The investigation reports on trends in variants in patients . Further work is needed to validate these findings.,2018-01-04,2018,William Smith; Susan Davis; Richard Jones; Richard Davis; Joseph Garcia,PLOS ONE,Crossref,10.0000/658399.662,90,5
1b2ebdee-6373-42fe-becc-5732ae272fec,Pandemic comparative dynamics of effectiveness,Here we report investigates outcomes for vaccine in a cohort . We presents outcomes for sars-cov-2 in clinical settings . Our analysis investigates the impact of genomics in hospitalized individuals . Here we report evaluates the effectiveness of serology in population . We evaluates the dynamics of modeling in hospitalized individuals . This study assesses the impact of pandemic in a cohort . Further work is needed to validate these findings.,2021-05-06,2021,Patricia Miller; James Hernandez; Patricia Anderson; William Anderson,Nature,ArXiv,10.0000/418697.160,71,5
47d7e718-2669-4fd1-8adc-5103fd994b6b,Epidemiology statistical assessment of response : implications for public health,The investigation assesses the dynamics of modeling in clinical settings . Our analysis evaluates the impact of serology in hospitalized individuals . Here we report assesses outcomes for transmission in a cohort . We investigates outcomes for coronavirus in patients . Further work is needed to validate these findings.,2015-12-15,2015,Elizabeth Brown; Barbara Gonzalez; Linda Miller; John Brown; Richard Anderson,bioRxiv,medRxiv,10.0000/461420.610,49,10
703b5cad-4cc8-4514-8944-72354cda8273,Genomics preliminary survey of patients,We assesses the impact of vaccine in population . This study assesses outcomes for epidemiology in hospitalized individuals . We reports on the effectiveness of serology in a cohort . We investigates trends in therapeutics in clinical settings . Here we report evaluates the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2021-01-01,2021,Elizabeth Smith; James Martinez; Jennifer Hernandez; Jessica Hernandez; Robert Wilson,Clinical Infectious Diseases,bioRxiv,10.0000/830095.800,59,5
c4721686-0dd1-4fe1-9d7c-7ad2d14dad94,Serology regional assessment of prevalence,We reports on the effectiveness of sars-cov-2 in clinical settings . Our analysis evaluates trends in coronavirus in clinical settings . We investigates trends in clinical in clinical settings . The investigation assesses the dynamics of outcomes in hospitalized individuals . Here we report reports on outcomes for clinical in hospitalized individuals . This study evaluates the impact of genomics in patients . Further work is needed to validate these findings.,2020-12-29,2020,Joseph Johnson; David Jones; Mary Williams,Frontiers in Medicine,Crossref,10.0000/993349.553,71,5
d82e1480-121e-4eb2-af30-a866757d32c4,Transmission global impact of outcomes,The investigation evaluates trends in serology in population . Our analysis reports on trends in serology in patients . Here we report evaluates the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2020-11-18,2020,Jessica Wilson; Jennifer Wilson; John Gonzalez; Jessica Brown,BMJ,PMC,10.0000/875334.929,39,5
841536dd-d214-4d03-8a3c-6f4c77f7301d,COVID-19 regional study of patterns,We evaluates outcomes for variants in clinical settings . We assesses outcomes for outcomes in population . The investigation evaluates the impact of diagnostics in hospitalized individuals . We reports on the impact of genomics in a cohort . Our analysis assesses outcomes for serology in population . Here we report reports on trends in vaccine in population . The investigation presents trends in clinical in hospitalized individuals . The investigation presents the dynamics of variants in a cohort . Further work is needed to validate these findings.,2022-10-23,2022,William Smith; William Hernandez,Unknown,Publisher,10.0000/810844.435,88,5
dc9219cd-f227-4382-8eb3-595e203d7f1a,Pandemic clinical investigation of prevalence,Our analysis evaluates the effectiveness of sars-cov-2 in a cohort . This study evaluates the dynamics of pandemic in hospitalized individuals . The investigation reports on trends in sars-cov-2 in patients . Our analysis reports on the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2017-08-03,2017,Barbara Smith; James Smith; James Hernandez,medRxiv,bioRxiv,10.0000/371926.708,52,5
3aa560d3-a954-4a43-abee-1453a74d1ded,Pandemic clinical report of trends : implications for vaccination strategies,We investigates outcomes for sars-cov-2 in population . We assesses the impact of modeling in clinical settings . We presents the impact of serology in hospitalized individuals . The investigation reports on the dynamics of pandemic in a cohort . We reports on the impact of variants in hospitalized individuals . The investigation assesses outcomes for transmission in hospitalized individuals . Our analysis evaluates trends in variants in a cohort . We evaluates the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2022-02-28,2022,Patricia Brown; John Garcia; Elizabeth Wilson; Robert Johnson,Clinical Infectious Diseases,medRxiv,10.0000/680758.729,89,10
e9b54393-63b7-4fca-adf7-38c417997960,Transmission clinical dynamics of incidence : implications for policy,Here we report assesses trends in coronavirus in a cohort . We presents trends in vaccine in a cohort . Our analysis presents outcomes for diagnostics in hospitalized individuals . We reports on the impact of covid-19 in clinical settings . This study evaluates the dynamics of clinical in population . This study evaluates the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2018-04-29,2018,Barbara Gonzalez; Jessica Smith,The Lancet,bioRxiv,10.0000/777893.165,70,9
7e08c75c-8eec-4858-a36d-73be4a999c24,COVID-19 preliminary dynamics of prevalence,The investigation investigates the dynamics of genomics in patients . The investigation evaluates outcomes for epidemiology in patients . Our analysis investigates the effectiveness of diagnostics in patients . This study investigates trends in covid-19 in population . This study evaluates the impact of immunity in population . The investigation investigates trends in coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2016-03-10,2016,Jennifer Wilson; James Lopez,bioRxiv,PMC,10.0000/796112.230,66,5
6ad1e66d-0846-44f3-86cd-243a7dec94f6,Pandemic long-term report of trends : implications for clinical practice,Our analysis evaluates the effectiveness of vaccine in a cohort . Our analysis investigates trends in outcomes in clinical settings . Here we report assesses the effectiveness of clinical in clinical settings . Our analysis reports on the impact of outcomes in patients . Further work is needed to validate these findings.,2021-08-09,2021,James Garcia,Frontiers in Medicine,bioRxiv,10.0000/990488.487,52,10
0ac179aa-3402-4fed-a16f-f16a6346b4b1,COVID-19 regional review of effectiveness : implications for policy,Here we report assesses outcomes for modeling in population . We evaluates the effectiveness of pandemic in a cohort . Our analysis investigates trends in variants in population . This study assesses trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2021-06-02,2021,Jessica Lopez; Linda Smith; Joseph Miller; John Garcia; John Gonzalez,Frontiers in Medicine,bioRxiv,10.0000/228515.251,47,9
f6231679-6139-448e-b8cc-7bd1471b535c,Immunity comprehensive analysis of data,Here we report investigates the impact of modeling in hospitalized individuals . Here we report evaluates trends in modeling in clinical settings . We assesses the dynamics of vaccine in hospitalized individuals . Here we report investigates the effectiveness of sars-cov-2 in patients . The investigation presents the effectiveness of immunity in hospitalized individuals . This study presents outcomes for covid-19 in a cohort . Further work is needed to validate these findings.,2022-01-03,2022,Joseph Martinez; Michael Hernandez; Joseph Garcia; Robert Smith; Robert Rodriguez,The Lancet,Publisher,10.0000/416302.969,73,5
178dd61d-1ac4-4088-990f-ed58af5b2e83,Immunity long-term dynamics of patterns,We assesses outcomes for covid-19 in population . We assesses outcomes for outcomes in population . This study reports on outcomes for clinical in patients . Here we report reports on outcomes for coronavirus in a cohort . Here we report presents the impact of diagnostics in patients . Further work is needed to validate these findings.,2021-12-01,2021,Jessica Rodriguez; Susan Jones; William Hernandez,The Lancet,medRxiv,10.0000/514863.624,57,5
8ab6f7a8-e592-4533-ab44-f4fe7f6a1095,Genomics global review of prevalence,We assesses trends in genomics in a cohort . This study assesses the dynamics of variants in patients . We investigates the dynamics of transmission in patients . Our analysis evaluates the effectiveness of transmission in clinical settings . Further work is needed to validate these findings.,2022-11-13,2022,Michael Miller; Barbara Lopez; James Rodriguez; Richard Jones,Journal of Infectious Diseases,Publisher,10.0000/950007.806,47,5
7ac1ad8b-51d4-47c8-9913-e7b604f9784c,Serology global review of prevalence,We assesses the impact of transmission in patients . This study reports on the effectiveness of immunity in patients . Here we report reports on the dynamics of pandemic in a cohort . Our analysis investigates the dynamics of clinical in clinical settings . Further work is needed to validate these findings.,2015-08-21,2015,David Anderson; Joseph Wilson,medRxiv,Publisher,10.0000/401926.142,52,5
ab0afee7-7dcd-44d6-8f94-95e2c7370ab5,Vaccine comprehensive assessment of patterns : implications for vaccination strategies,We assesses the dynamics of diagnostics in a cohort . We reports on trends in sars-cov-2 in a cohort . Our analysis assesses the dynamics of clinical in a cohort . We assesses the effectiveness of pandemic in population . Further work is needed to validate these findings.,2020-08-19,2020,Linda Hernandez; Mary Hernandez; Joseph Rodriguez; David Miller; Patricia Rodriguez,Clinical Infectious Diseases,ArXiv,10.0000/747507.548,48,10
e8fb2682-d9ac-4e0d-954e-060b999c97eb,Therapeutics global assessment of data,We assesses the dynamics of therapeutics in a cohort . This study investigates outcomes for sars-cov-2 in patients . Our analysis evaluates the impact of sars-cov-2 in clinical settings . We evaluates the effectiveness of modeling in hospitalized individuals . This study evaluates trends in therapeutics in hospitalized individuals . Our analysis investigates trends in modeling in hospitalized individuals . Here we report reports on outcomes for serology in patients . The investigation presents outcomes for vaccine in a cohort . Further work is needed to validate these findings.,2021-02-08,2021,Elizabeth Anderson; Susan Wilson; Jessica Johnson,bioRxiv,ArXiv,10.0000/467469.928,89,5
358ee847-0c6e-4518-8ab5-4d8aa405658a,Variants global assessment of outcomes,The investigation investigates the effectiveness of outcomes in population . Our analysis reports on outcomes for modeling in clinical settings . We presents the dynamics of sars-cov-2 in hospitalized individuals . Here we report assesses outcomes for epidemiology in clinical settings . Our analysis reports on the impact of immunity in a cohort . Our analysis investigates trends in serology in hospitalized individuals . The investigation presents the impact of variants in clinical settings . Further work is needed to validate these findings.,2020-12-31,2020,David Gonzalez; Jennifer Garcia; William Anderson; James Davis,BMJ,medRxiv,10.0000/629484.774,83,5
c83fad32-53d7-47eb-856e-ad096c7bc7ae,SARS-CoV-2 preliminary report of patients,We presents the effectiveness of vaccine in hospitalized individuals . Our analysis evaluates trends in sars-cov-2 in hospitalized individuals . Our analysis assesses the impact of variants in a cohort . We evaluates outcomes for transmission in a cohort . The investigation evaluates the dynamics of covid-19 in patients . We presents the dynamics of serology in hospitalized individuals . Here we report evaluates the dynamics of modeling in hospitalized individuals . We presents the effectiveness of outcomes in population . Further work is needed to validate these findings.,2015-11-11,2015,Robert Smith; James Brown,Science,Publisher,10.0000/553286.397,89,5
83c1b60e-79c8-4913-b119-837ba672f744,Serology statistical assessment of effectiveness,Here we report assesses the effectiveness of covid-19 in hospitalized individuals . The investigation presents the dynamics of outcomes in hospitalized individuals . Our analysis evaluates the impact of modeling in population . We investigates the effectiveness of therapeutics in hospitalized individuals . We assesses trends in therapeutics in hospitalized individuals . Our analysis presents the impact of covid-19 in population . The investigation evaluates trends in diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2020-05-11,2020,William Davis; Jennifer Davis; Jessica Lopez; Richard Brown,medRxiv,Crossref,10.0000/667047.663,80,5
9dbe1dd4-6071-43fe-af53-e81529b809de,Immunity regional investigation of data,Here we report evaluates the impact of epidemiology in hospitalized individuals . Our analysis presents outcomes for modeling in population . Our analysis investigates trends in pandemic in clinical settings . We presents trends in therapeutics in clinical settings . Our analysis investigates the effectiveness of diagnostics in hospitalized individuals . This study assesses the dynamics of pandemic in patients . This study reports on outcomes for outcomes in hospitalized individuals . We evaluates outcomes for serology in patients . Further work is needed to validate these findings.,2017-06-10,2017,William Brown; David Rodriguez; Patricia Williams; David Garcia; Robert Anderson,The Lancet,PMC,10.0000/167724.269,88,5
0ab96e24-2757-450d-8b51-a5494c1c8931,Modeling rapid investigation of response,The investigation evaluates the impact of immunity in patients . Here we report investigates the effectiveness of genomics in population . Our analysis presents the dynamics of variants in hospitalized individuals . This study reports on trends in immunity in hospitalized individuals . This study reports on outcomes for epidemiology in patients . This study evaluates the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2020-08-19,2020,Patricia Anderson; Robert Martinez; Barbara Williams; Jennifer Hernandez; David Davis,BMJ,PMC,10.0000/324134.480,71,5
2b6b40f1-d9cf-43c9-93e0-8cce3fc6eb66,Coronavirus regional review of trends,Here we report evaluates the effectiveness of vaccine in hospitalized individuals . We evaluates the dynamics of outcomes in population . This study assesses trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2020-11-23,2020,Richard Smith; Richard Martinez,Clinical Infectious Diseases,Crossref,10.0000/353938.402,39,5
330542da-406f-4d61-ac06-8a77cce4bc8b,Pandemic comparative assessment of prevalence : implications for clinical practice,We presents the impact of clinical in a cohort . Our analysis presents the impact of serology in clinical settings . Our analysis reports on trends in coronavirus in clinical settings . Here we report reports on trends in epidemiology in clinical settings . Here we report assesses the impact of vaccine in population . Further work is needed to validate these findings.,2021-10-15,2021,Patricia Smith,The Lancet,Publisher,10.0000/293949.872,63,10
7b79c544-cf65-4c96-9353-7fc73d535686,Transmission rapid dynamics of effectiveness : implications for policy,Here we report evaluates trends in therapeutics in population . Here we report evaluates the dynamics of diagnostics in clinical settings . Here we report evaluates the impact of modeling in hospitalized individuals . We assesses the dynamics of pandemic in hospitalized individuals . We assesses the effectiveness of clinical in a cohort . Further work is needed to validate these findings.,2016-08-02,2016,Elizabeth Lopez; Elizabeth Rodriguez; Jessica Rodriguez; Joseph Smith,Frontiers in Medicine,ArXiv,10.0000/770860.702,62,9
6c0e8792-1f63-48e4-be24-482696b16899,Transmission comparative assessment of incidence,The investigation evaluates trends in sars-cov-2 in population . The investigation presents outcomes for pandemic in a cohort . Our analysis reports on the dynamics of immunity in patients . This study assesses the effectiveness of modeling in a cohort . This study assesses outcomes for immunity in clinical settings . This study presents outcomes for genomics in patients . We assesses the impact of genomics in a cohort . Further work is needed to validate these findings.,2016-10-16,2016,William Gonzalez; Robert Wilson,Clinical Infectious Diseases,bioRxiv,10.0000/890432.374,78,5
41a9190d-1eb3-4801-ae12-780eb925d38c,Coronavirus long-term investigation of trends,This study reports on the effectiveness of transmission in a cohort . Our analysis assesses the effectiveness of diagnostics in hospitalized individuals . This study presents outcomes for therapeutics in population . We reports on the dynamics of therapeutics in a cohort . Our analysis assesses the dynamics of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2019-02-04,2019,James Garcia; Joseph Davis; Robert Lopez,medRxiv,PMC,10.0000/868600.488,62,5
f68c44b8-b6d6-4124-af38-6b0d6783947a,Outcomes comparative evaluation of patients,This study assesses the dynamics of epidemiology in clinical settings . Our analysis evaluates outcomes for outcomes in hospitalized individuals . The investigation presents trends in epidemiology in patients . The investigation presents outcomes for variants in clinical settings . Further work is needed to validate these findings.,2015-01-07,2015,Susan Jones; Linda Wilson; Mary Wilson; David Gonzalez; Jessica Brown,bioRxiv,Publisher,10.0000/720405.720,48,5
7c5bc45c-3908-4858-b32e-6e60caf69d8d,Outcomes global evaluation of patients,The investigation assesses the effectiveness of genomics in hospitalized individuals . We presents trends in immunity in clinical settings . The investigation assesses the dynamics of variants in hospitalized individuals . This study evaluates trends in genomics in a cohort . Further work is needed to validate these findings.,2017-06-16,2017,Barbara Smith; Elizabeth Hernandez; James Rodriguez; Linda Wilson; Linda Garcia,Science,bioRxiv,10.0000/980408.739,49,5
8ef58c70-aeb9-48a5-bf8b-b1998f42cd7e,Vaccine long-term evaluation of effectiveness : implications for policy,The investigation evaluates the dynamics of diagnostics in a cohort . The investigation reports on the effectiveness of pandemic in population . Our analysis presents the dynamics of serology in hospitalized individuals . This study presents the dynamics of coronavirus in patients . We reports on outcomes for transmission in population . Further work is needed to validate these findings.,2018-12-22,2018,James Hernandez; James Johnson; Elizabeth Anderson; William Davis,Unknown,medRxiv,10.0000/134295.508,60,9
d1cbace1-11a8-4ff0-aa72-e21fc00497b5,Pandemic clinical investigation of trends,The investigation presents the effectiveness of pandemic in a cohort . Here we report reports on the effectiveness of epidemiology in population . Here we report assesses the dynamics of clinical in a cohort . Here we report assesses the effectiveness of modeling in patients . Our analysis evaluates the effectiveness of outcomes in a cohort . Here we report investigates trends in genomics in a cohort . Here we report evaluates the dynamics of coronavirus in patients . Further work is needed to validate these findings.,2018-03-05,2018,Susan Brown; Patricia Gonzalez; Joseph Hernandez; Patricia Johnson; Jennifer Williams,BMJ,medRxiv,10.0000/624754.327,87,5
50e24943-132f-4ef7-8c38-5fc4480dd8c9,Outcomes rapid assessment of response,The investigation investigates the impact of clinical in patients . The investigation evaluates trends in serology in clinical settings . Here we report investigates the effectiveness of clinical in clinical settings . We assesses the impact of epidemiology in patients . Our analysis presents the impact of vaccine in a cohort . Here we report assesses the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2021-02-13,2021,Patricia Martinez; Michael Miller; Robert Hernandez; David Smith; Linda Brown,Clinical Infectious Diseases,Crossref,10.0000/967730.911,72,5
8dedca3f-2a99-479e-b918-87de931b83a3,Outcomes global survey of spread,Here we report assesses the effectiveness of covid-19 in clinical settings . We investigates the dynamics of variants in a cohort . Our analysis reports on the impact of covid-19 in clinical settings . Further work is needed to validate these findings.,2015-09-10,2015,Richard Wilson; Elizabeth Johnson; William Anderson; James Miller; Patricia Rodriguez,Nature,Publisher,10.0000/885863.300,42,5
be36c09e-3784-4c11-bd1b-83353304d90f,Transmission preliminary report of patients,We evaluates trends in diagnostics in a cohort . This study presents outcomes for transmission in hospitalized individuals . This study assesses the dynamics of immunity in a cohort . The investigation investigates outcomes for serology in hospitalized individuals . This study investigates the impact of therapeutics in a cohort . The investigation presents outcomes for vaccine in patients . Our analysis presents the effectiveness of immunity in patients . Further work is needed to validate these findings.,2019-03-01,2019,Robert Anderson; Patricia Jones,bioRxiv,Publisher,10.0000/998113.237,78,5
4592aef1-bcd3-4d74-94cf-0c4321236fb8,Outcomes statistical dynamics of spread,We presents the dynamics of outcomes in clinical settings . This study reports on the impact of coronavirus in population . Our analysis presents the dynamics of outcomes in a cohort . Our analysis assesses the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2020-06-09,2020,William Gonzalez; Richard Garcia,Journal of Infectious Diseases,bioRxiv,10.0000/725938.744,51,5
6c406c6d-e10e-4353-8afd-fda2175187d9,Epidemiology rapid survey of spread,We investigates outcomes for covid-19 in population . The investigation investigates the dynamics of immunity in a cohort . Here we report presents the impact of clinical in hospitalized individuals . The investigation assesses the impact of transmission in a cohort . We assesses trends in serology in population . We assesses the dynamics of transmission in patients . Our analysis assesses the impact of modeling in hospitalized individuals . Our analysis presents the impact of coronavirus in population . Further work is needed to validate these findings.,2017-05-06,2017,Jennifer Davis; Richard Johnson; Linda Hernandez,medRxiv,Crossref,10.0000/862601.631,88,5
f260f8cd-b7f5-43d5-9b8f-340efe61f896,Modeling statistical investigation of data,The investigation assesses the impact of clinical in population . Our analysis evaluates the effectiveness of covid-19 in clinical settings . Our analysis evaluates trends in pandemic in patients . The investigation evaluates trends in pandemic in a cohort . This study presents the impact of modeling in patients . Further work is needed to validate these findings.,2021-10-24,2021,Jessica Johnson,BMJ,ArXiv,10.0000/453079.487,58,5
fa29cd23-6573-432c-aa79-f7b4539af02b,Immunity clinical impact of prevalence,We investigates the dynamics of coronavirus in population . We presents the impact of transmission in hospitalized individuals . This study presents outcomes for immunity in population . We assesses the dynamics of epidemiology in clinical settings . Further work is needed to validate these findings.,2015-07-31,2015,Mary Anderson; Joseph Johnson; David Johnson; James Jones; Susan Williams,Unknown,ArXiv,10.0000/107909.329,46,5
d926865f-0c23-4ef2-89b4-7414d3ca41ea,Clinical long-term survey of prevalence,We reports on the dynamics of clinical in population . Here we report presents the effectiveness of clinical in patients . The investigation presents the effectiveness of outcomes in population . Here we report reports on the effectiveness of genomics in a cohort . Our analysis evaluates the dynamics of genomics in patients . Further work is needed to validate these findings.,2021-08-30,2021,Linda Jones; James Martinez; Barbara Anderson,BMJ,bioRxiv,10.0000/868290.929,62,5
557e1306-a21a-43d6-aca2-ed7ef7aaaed0,COVID-19 statistical review of data,Our analysis presents the effectiveness of serology in a cohort . The investigation assesses the effectiveness of immunity in patients . We assesses the effectiveness of clinical in hospitalized individuals . Our analysis evaluates the effectiveness of vaccine in clinical settings . Our analysis presents the impact of sars-cov-2 in population . We investigates outcomes for covid-19 in patients . Here we report reports on trends in serology in a cohort . We investigates the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2017-07-04,2017,Jennifer Anderson,Nature,ArXiv,10.0000/736013.555,90,5
e9304e84-40ef-42b3-bfa7-7b5441f0be12,COVID-19 preliminary evaluation of spread,Our analysis evaluates the effectiveness of immunity in hospitalized individuals . The investigation investigates the effectiveness of transmission in hospitalized individuals . Here we report investigates the dynamics of modeling in a cohort . We presents outcomes for diagnostics in patients . This study evaluates the effectiveness of immunity in clinical settings . Our analysis assesses the impact of clinical in a cohort . We reports on the dynamics of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2020-10-22,2020,Michael Williams; David Martinez; Jessica Smith; Barbara Lopez; David Smith,Science,Publisher,10.0000/155962.495,83,5
50d2fac9-c504-43cb-af56-113112c3c4ee,Modeling rapid assessment of data,Here we report assesses trends in sars-cov-2 in a cohort . Our analysis reports on the dynamics of sars-cov-2 in a cohort . This study evaluates the effectiveness of covid-19 in hospitalized individuals . Our analysis presents the impact of modeling in hospitalized individuals . Further work is needed to validate these findings.,2018-09-08,2018,Barbara Johnson; Michael Williams,The Lancet,medRxiv,10.0000/772343.782,53,5
370493f7-dc00-4b3a-9afd-47882ce10a04,Genomics preliminary assessment of patterns,The investigation investigates the dynamics of genomics in hospitalized individuals . The investigation reports on the effectiveness of immunity in hospitalized individuals . We presents the effectiveness of transmission in population . This study presents the impact of pandemic in clinical settings . Here we report reports on the effectiveness of transmission in hospitalized individuals . This study reports on the impact of genomics in clinical settings . Further work is needed to validate these findings.,2020-03-15,2020,David Martinez; Robert Anderson,medRxiv,Crossref,10.0000/126666.560,76,5
33888d84-ebe1-444f-b9f4-5c68d90c6de2,Genomics clinical dynamics of data,Our analysis presents trends in covid-19 in patients . Here we report assesses trends in vaccine in hospitalized individuals . Here we report reports on trends in genomics in hospitalized individuals . Here we report investigates outcomes for serology in hospitalized individuals . Further work is needed to validate these findings.,2015-08-18,2015,William Martinez; John Smith,Science,ArXiv,10.0000/536228.184,51,5
ebc2d7d4-e548-472f-a0c1-b1ae34564204,Diagnostics global analysis of incidence : implications for clinical practice,Here we report evaluates the dynamics of therapeutics in hospitalized individuals . Here we report investigates trends in variants in hospitalized individuals . Here we report investigates the impact of outcomes in a cohort . The investigation reports on outcomes for epidemiology in patients . This study presents outcomes for coronavirus in patients . The investigation investigates outcomes for variants in a cohort . Our analysis evaluates the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2015-03-11,2015,Joseph Anderson; James Rodriguez; Elizabeth Williams,PLOS ONE,ArXiv,10.0000/780335.284,83,10
9f6dc947-c2ca-4b0c-aedb-fb38f2b15c87,Transmission statistical dynamics of patients : implications for public health,We evaluates the effectiveness of variants in hospitalized individuals . Here we report assesses outcomes for diagnostics in patients . Here we report reports on the impact of vaccine in a cohort . Our analysis evaluates the impact of variants in hospitalized individuals . The investigation investigates the impact of serology in population . We investigates the impact of genomics in clinical settings . We reports on the impact of modeling in population . We investigates trends in variants in patients . Further work is needed to validate these findings.,2016-10-19,2016,Susan Davis; Elizabeth Garcia; Michael Davis; Barbara Garcia; William Miller,Nature,Publisher,10.0000/433141.974,90,10
156256e3-6b62-4dab-8ce3-7d0aff8756e1,Variants regional dynamics of response,Here we report evaluates the effectiveness of covid-19 in a cohort . The investigation assesses outcomes for variants in hospitalized individuals . This study assesses the effectiveness of genomics in hospitalized individuals . Our analysis evaluates outcomes for diagnostics in clinical settings . The investigation reports on the effectiveness of epidemiology in clinical settings . Here we report presents outcomes for clinical in a cohort . Our analysis investigates outcomes for transmission in clinical settings . The investigation assesses outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2018-09-30,2018,Susan Smith; Michael Johnson; Robert Wilson; Patricia Martinez; Jessica Garcia,BMJ,ArXiv,10.0000/880223.231,94,5
619af98b-95d8-4702-aefd-709d044e01d1,Pandemic comprehensive evaluation of response,The investigation presents the effectiveness of diagnostics in patients . Our analysis reports on the effectiveness of diagnostics in clinical settings . The investigation reports on outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2022-03-17,2022,Michael Gonzalez,Science,Publisher,10.0000/235018.810,41,5
1873b2c0-ec9e-48cf-9dbb-a9e3662d19b3,Diagnostics global review of prevalence,We assesses the effectiveness of therapeutics in a cohort . We evaluates the impact of genomics in clinical settings . We presents the effectiveness of variants in population . Here we report presents outcomes for sars-cov-2 in a cohort . This study presents outcomes for diagnostics in clinical settings . Our analysis presents the effectiveness of modeling in population . Our analysis investigates trends in outcomes in clinical settings . Further work is needed to validate these findings.,2020-08-21,2020,Elizabeth Smith,Frontiers in Medicine,Publisher,10.0000/812147.619,78,5
9832d4f8-cd7f-44ba-b26b-291dea035351,Vaccine comparative review of response : implications for vaccination strategies,Our analysis evaluates outcomes for epidemiology in patients . We investigates outcomes for immunity in population . The investigation evaluates the impact of variants in a cohort . Our analysis assesses the effectiveness of modeling in a cohort . Further work is needed to validate these findings.,2021-02-26,2021,Elizabeth Jones,Frontiers in Medicine,medRxiv,10.0000/457485.829,47,10
3ae1ff19-71b8-446f-8694-368521a1a1c9,Genomics statistical survey of outcomes,This study presents trends in clinical in clinical settings . The investigation assesses the impact of covid-19 in clinical settings . We presents the impact of modeling in a cohort . Here we report evaluates trends in vaccine in clinical settings . We presents trends in outcomes in hospitalized individuals . Our analysis reports on trends in therapeutics in population . This study presents outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2018-09-08,2018,Barbara Gonzalez; John Jones; John Brown,Journal of Infectious Diseases,PMC,10.0000/966665.216,79,5
fbcb555b-0603-4c50-9707-15e2f9a6fe17,SARS-CoV-2 rapid analysis of effectiveness,This study assesses trends in coronavirus in a cohort . Here we report presents trends in clinical in clinical settings . Here we report reports on the dynamics of therapeutics in hospitalized individuals . Here we report assesses the effectiveness of pandemic in patients . Here we report reports on outcomes for serology in hospitalized individuals . Our analysis investigates the effectiveness of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-07-04,2019,John Smith; James Jones; James Miller; William Wilson; Linda Jones,BMJ,bioRxiv,10.0000/931823.284,76,5
19a40663-8138-4f9b-a78a-cf5659c482ad,Clinical long-term study of trends,Here we report assesses the effectiveness of covid-19 in a cohort . This study investigates the effectiveness of sars-cov-2 in clinical settings . Our analysis presents the effectiveness of genomics in population . We evaluates outcomes for therapeutics in patients . We evaluates outcomes for epidemiology in a cohort . We assesses outcomes for variants in population . We reports on the impact of diagnostics in population . We investigates the dynamics of variants in a cohort . Further work is needed to validate these findings.,2020-12-16,2020,John Johnson; Michael Wilson; Joseph Williams,Journal of Infectious Diseases,medRxiv,10.0000/587890.650,86,5
1bed786c-1795-4772-adba-bf6f983d069e,Modeling global review of spread,We investigates outcomes for vaccine in a cohort . The investigation presents the dynamics of vaccine in clinical settings . Here we report reports on the dynamics of outcomes in hospitalized individuals . Here we report reports on trends in vaccine in a cohort . We assesses the effectiveness of outcomes in hospitalized individuals . Further work is needed to validate these findings.,2022-02-14,2022,James Miller; Mary Wilson; James Williams; Mary Williams,Journal of Infectious Diseases,bioRxiv,10.0000/265260.597,63,5
901aed23-cf8f-486b-adcb-128f7f139bce,COVID-19 long-term evaluation of incidence,Here we report assesses the effectiveness of epidemiology in a cohort . We assesses the dynamics of variants in population . Here we report investigates the impact of transmission in clinical settings . This study evaluates the effectiveness of pandemic in clinical settings . Further work is needed to validate these findings.,2022-01-04,2022,Elizabeth Rodriguez; Linda Davis,PLOS ONE,bioRxiv,10.0000/525634.867,52,5
33a2ff31-4e00-4b89-ad0c-47a8bcc8bed1,Variants global evaluation of trends,Our analysis presents the effectiveness of therapeutics in patients . We assesses the impact of pandemic in population . We assesses the dynamics of coronavirus in population . Our analysis investigates the effectiveness of diagnostics in patients . Further work is needed to validate these findings.,2016-05-11,2016,Elizabeth Jones; William Jones; Patricia Smith,PLOS ONE,bioRxiv,10.0000/370762.342,46,5
53535a9b-acdf-4c21-aff4-01544c9e86ca,Diagnostics statistical evaluation of response,Here we report evaluates outcomes for vaccine in patients . The investigation assesses the effectiveness of pandemic in a cohort . We reports on outcomes for outcomes in hospitalized individuals . Further work is needed to validate these findings.,2019-02-22,2019,James Martinez; David Miller,Unknown,PMC,10.0000/324922.696,39,5
8e58378b-6526-4819-bd1f-4ad7611efc28,Serology statistical evaluation of trends,This study assesses the dynamics of pandemic in patients . Our analysis investigates trends in serology in population . Our analysis evaluates the impact of sars-cov-2 in population . Here we report investigates the dynamics of clinical in population . Our analysis presents the dynamics of vaccine in hospitalized individuals . We presents outcomes for genomics in hospitalized individuals . We presents the dynamics of epidemiology in a cohort . This study assesses the dynamics of immunity in clinical settings . Further work is needed to validate these findings.,2022-12-07,2022,Elizabeth Jones; Richard Brown; Susan Martinez; Barbara Lopez,PLOS ONE,PMC,10.0000/837174.259,89,5
4910b755-2fa1-48ae-bcf5-04a9c5d17a2f,Serology regional evaluation of spread,Our analysis evaluates the impact of modeling in clinical settings . Our analysis presents the impact of covid-19 in hospitalized individuals . This study presents outcomes for transmission in population . Our analysis investigates the impact of coronavirus in population . Our analysis assesses outcomes for modeling in clinical settings . This study investigates the impact of clinical in clinical settings . This study reports on the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2020-05-03,2020,Susan Davis; William Anderson; Jessica Hernandez; Susan Martinez; James Miller,The Lancet,medRxiv,10.0000/579811.737,82,5
f30de603-1c8a-4a00-a029-86258897a293,SARS-CoV-2 comprehensive investigation of patients,Our analysis presents the dynamics of epidemiology in patients . The investigation reports on trends in clinical in population . This study presents the dynamics of vaccine in hospitalized individuals . Here we report presents the effectiveness of epidemiology in clinical settings . Our analysis reports on outcomes for therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2019-01-28,2019,Joseph Anderson; Barbara Anderson; Jessica Miller; William Smith,Clinical Infectious Diseases,ArXiv,10.0000/967569.627,62,5
f76ea05d-947c-47e3-89b6-a3d299932c75,Clinical rapid survey of patterns,We assesses the effectiveness of diagnostics in patients . This study presents the effectiveness of coronavirus in a cohort . The investigation evaluates outcomes for clinical in patients . Further work is needed to validate these findings.,2019-11-14,2019,William Rodriguez; John Garcia,PLOS ONE,medRxiv,10.0000/437635.361,37,5
78787b5d-e149-46d8-bac4-401b68d578bd,SARS-CoV-2 statistical survey of incidence,Here we report reports on the dynamics of covid-19 in hospitalized individuals . This study presents trends in coronavirus in clinical settings . The investigation assesses outcomes for pandemic in a cohort . This study reports on the impact of transmission in population . Our analysis presents outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2015-10-10,2015,Michael Davis,Science,PMC,10.0000/403288.347,62,5
0682688e-b42a-4b5e-bdd1-b45b2ca8d3b1,Therapeutics preliminary investigation of effectiveness,Here we report assesses outcomes for immunity in a cohort . Here we report evaluates trends in pandemic in clinical settings . This study assesses the impact of outcomes in patients . Here we report evaluates outcomes for serology in hospitalized individuals . We reports on trends in outcomes in patients . Our analysis assesses trends in epidemiology in clinical settings . Further work is needed to validate these findings.,2022-12-19,2022,David Miller; Joseph Anderson,The Lancet,medRxiv,10.0000/388834.898,70,5
fbab3877-e790-4563-aa42-96a9da405b64,Modeling clinical report of response : implications for vaccination strategies,The investigation assesses the effectiveness of therapeutics in a cohort . The investigation reports on the effectiveness of serology in a cohort . This study investigates outcomes for therapeutics in hospitalized individuals . We presents the impact of diagnostics in population . The investigation assesses the dynamics of coronavirus in a cohort . We assesses the effectiveness of therapeutics in clinical settings . Our analysis evaluates outcomes for clinical in clinical settings . Here we report presents trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2022-08-21,2022,James Davis; Patricia Hernandez; Jessica Gonzalez,bioRxiv,Publisher,10.0000/278914.558,92,10
977cf0a8-f32e-4f41-993c-0ca10565c307,Variants comparative survey of patients,We presents the dynamics of clinical in population . Our analysis reports on the impact of pandemic in clinical settings . This study investigates the dynamics of outcomes in patients . This study reports on the impact of variants in hospitalized individuals . This study assesses the impact of diagnostics in hospitalized individuals . The investigation evaluates the impact of genomics in a cohort . Here we report presents the effectiveness of clinical in patients . The investigation reports on the effectiveness of sars-cov-2 in population . Further work is needed to validate these findings.,2020-11-28,2020,Robert Johnson; Jessica Smith; Richard Brown; Barbara Wilson,Clinical Infectious Diseases,bioRxiv,10.0000/356410.506,95,5
db1a47cd-0d4e-4f03-9c6d-9955d821e8da,Pandemic comprehensive impact of effectiveness,This study presents the dynamics of epidemiology in clinical settings . This study evaluates the impact of genomics in population . The investigation assesses trends in serology in patients . Here we report evaluates the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis presents the dynamics of clinical in clinical settings . Our analysis evaluates outcomes for immunity in population . We evaluates the dynamics of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2020-06-06,2020,Robert Davis; Jessica Williams,Nature,Crossref,10.0000/330440.902,80,5
e2461efc-6810-4418-935d-e8aee6262d76,Variants comprehensive survey of trends,Our analysis assesses the effectiveness of variants in clinical settings . This study investigates trends in coronavirus in hospitalized individuals . Here we report investigates the impact of clinical in hospitalized individuals . Here we report investigates the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2019-09-20,2019,Elizabeth Williams,medRxiv,Publisher,10.0000/519409.105,53,5
7f3dd0e5-2f5f-4420-92f0-0d85844962b1,Clinical long-term dynamics of patients,The investigation reports on the impact of transmission in population . We investigates the impact of variants in clinical settings . We presents outcomes for pandemic in patients . Further work is needed to validate these findings.,2019-03-10,2019,Richard Lopez; Jessica Rodriguez,Science,bioRxiv,10.0000/449378.374,37,5
d0e64cb7-5e81-4352-a4b5-a6c40609112c,Outcomes rapid investigation of data,Our analysis assesses trends in clinical in population . Here we report evaluates the effectiveness of diagnostics in a cohort . Our analysis investigates the dynamics of vaccine in population . Our analysis reports on outcomes for therapeutics in population . The investigation evaluates the impact of coronavirus in patients . Our analysis reports on the effectiveness of sars-cov-2 in patients . Further work is needed to validate these findings.,2015-04-01,2015,Elizabeth Williams; Barbara Smith,medRxiv,Publisher,10.0000/224465.349,70,5
52c32c8c-911c-4d2f-9936-889fa5e19003,Clinical statistical evaluation of incidence,Our analysis investigates the effectiveness of genomics in patients . We evaluates the dynamics of clinical in patients . The investigation evaluates outcomes for pandemic in patients . The investigation reports on the impact of modeling in a cohort . This study evaluates the impact of sars-cov-2 in a cohort . This study presents outcomes for pandemic in a cohort . We presents the impact of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2018-06-24,2018,Michael Hernandez; Jennifer Hernandez; James Williams,PLOS ONE,Publisher,10.0000/513566.784,79,5
40bef5ce-4bf1-4799-8f1f-f8bb440a28f6,Vaccine preliminary analysis of patients,This study evaluates outcomes for genomics in hospitalized individuals . Here we report presents trends in epidemiology in patients . This study reports on the effectiveness of modeling in population . Our analysis reports on trends in variants in a cohort . Our analysis reports on trends in variants in patients . Our analysis investigates outcomes for diagnostics in hospitalized individuals . We investigates trends in genomics in a cohort . Further work is needed to validate these findings.,2018-09-12,2018,Robert Davis; Robert Miller; Linda Smith,medRxiv,bioRxiv,10.0000/381712.923,79,5
dae39395-b870-4b97-a1c0-77fd2bd38cb7,Vaccine long-term assessment of trends : implications for vaccination strategies,The investigation investigates the effectiveness of transmission in population . This study investigates trends in clinical in patients . Our analysis evaluates the dynamics of epidemiology in population . Further work is needed to validate these findings.,2016-07-20,2016,James Martinez; Jennifer Rodriguez; Joseph Gonzalez,Unknown,PMC,10.0000/287551.594,37,10
0b894885-804d-4d38-a855-3b614da68414,Pandemic global study of trends,The investigation assesses trends in vaccine in hospitalized individuals . This study evaluates the effectiveness of transmission in patients . Here we report reports on the dynamics of therapeutics in hospitalized individuals . Here we report reports on the dynamics of clinical in hospitalized individuals . The investigation reports on outcomes for epidemiology in patients . Here we report evaluates the impact of transmission in population . Further work is needed to validate these findings.,2015-05-16,2015,Jennifer Martinez; Robert Garcia; David Garcia,Clinical Infectious Diseases,Crossref,10.0000/592688.519,75,5
8dc6025b-161f-4d1a-aca6-6ce9ce93dcac,Diagnostics comprehensive dynamics of prevalence,Our analysis reports on the impact of therapeutics in clinical settings . Our analysis assesses trends in genomics in hospitalized individuals . Our analysis reports on the dynamics of transmission in hospitalized individuals . Here we report evaluates outcomes for transmission in clinical settings . This study presents the dynamics of diagnostics in clinical settings . Our analysis presents the impact of serology in population . Our analysis evaluates the impact of diagnostics in a cohort . This study reports on the impact of modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-11-11,2015,Mary Jones; Jennifer Gonzalez; Jennifer Gonzalez; Linda Rodriguez,Science,ArXiv,10.0000/886692.515,97,5
21d02fbb-410b-470c-8877-321c3d00c25e,SARS-CoV-2 comparative analysis of spread : implications for vaccination strategies,This study evaluates the impact of epidemiology in patients . Here we report investigates trends in diagnostics in a cohort . Our analysis evaluates outcomes for transmission in hospitalized individuals . Our analysis evaluates trends in vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-01-29,2022,Joseph Miller; Mary Brown; John Lopez; Patricia Gonzalez,Clinical Infectious Diseases,Publisher,10.0000/556231.260,49,10
7a17b5a0-5d38-44d1-a0c6-a45ff7479eff,Variants global report of response,Here we report evaluates the dynamics of pandemic in a cohort . This study reports on outcomes for serology in a cohort . We assesses trends in outcomes in population . Our analysis investigates trends in therapeutics in patients . Here we report evaluates trends in sars-cov-2 in a cohort . We reports on the dynamics of immunity in hospitalized individuals . We reports on the effectiveness of immunity in population . Here we report evaluates outcomes for covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2015-06-15,2015,Elizabeth Garcia; Barbara Miller; Michael Martinez,Clinical Infectious Diseases,Crossref,10.0000/165652.497,91,5
a7e1ade7-cae8-4be3-a612-81b161615f71,Epidemiology long-term survey of patients,We assesses trends in sars-cov-2 in a cohort . Our analysis evaluates the dynamics of clinical in patients . Here we report investigates the effectiveness of coronavirus in a cohort . This study investigates the effectiveness of transmission in a cohort . Here we report presents the impact of immunity in a cohort . Further work is needed to validate these findings.,2021-01-23,2021,Susan Martinez; William Johnson,The Lancet,Publisher,10.0000/854453.364,62,5
13431f63-4213-4010-9a13-6ebfa6befdcc,Serology preliminary assessment of response,The investigation reports on the effectiveness of modeling in a cohort . Here we report presents the effectiveness of pandemic in population . The investigation evaluates the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2018-05-25,2018,Joseph Garcia,PLOS ONE,ArXiv,10.0000/881797.454,42,5
a35ba79e-4368-4139-817f-9594ee7a4beb,Outcomes statistical analysis of spread,The investigation reports on trends in coronavirus in clinical settings . The investigation reports on the dynamics of vaccine in patients . Our analysis reports on the effectiveness of clinical in patients . We evaluates the impact of covid-19 in patients . Further work is needed to validate these findings.,2022-11-05,2022,James Jones; Jennifer Garcia; John Lopez; Richard Lopez,Clinical Infectious Diseases,medRxiv,10.0000/231371.643,50,5
6d88db99-60b4-4428-93a2-5992d6015f9c,COVID-19 global investigation of response,Here we report evaluates trends in vaccine in patients . Here we report investigates outcomes for transmission in population . We presents outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2018-02-06,2018,John Davis; Elizabeth Martinez; Elizabeth Davis; Michael Hernandez; Mary Miller,bioRxiv,medRxiv,10.0000/258845.704,37,5
2df323f3-5acc-4b89-85a7-91dd6241dc7a,Outcomes statistical analysis of data : implications for vaccination strategies,The investigation reports on the effectiveness of epidemiology in patients . This study evaluates the effectiveness of therapeutics in population . We investigates the dynamics of outcomes in population . We reports on trends in outcomes in population . This study presents trends in vaccine in population . Further work is needed to validate these findings.,2017-07-22,2017,Robert Davis,PLOS ONE,bioRxiv,10.0000/254615.560,56,10
b662decc-409c-4d8a-8765-262c52fdaea8,Diagnostics long-term review of patients : implications for clinical practice,This study evaluates trends in coronavirus in a cohort . We evaluates the effectiveness of sars-cov-2 in population . Our analysis assesses the effectiveness of therapeutics in a cohort . This study assesses trends in immunity in patients . Our analysis assesses outcomes for serology in hospitalized individuals . Further work is needed to validate these findings.,2015-12-22,2015,Elizabeth Wilson; James Anderson; Jennifer Miller,Journal of Infectious Diseases,Crossref,10.0000/620777.676,57,10
e2432a96-15ef-4e9c-9cce-c358867038e5,Therapeutics comparative assessment of prevalence,This study assesses trends in clinical in a cohort . The investigation presents the effectiveness of modeling in population . This study presents the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis evaluates the dynamics of therapeutics in population . Our analysis evaluates outcomes for therapeutics in a cohort . This study assesses the effectiveness of vaccine in clinical settings . Further work is needed to validate these findings.,2021-02-28,2021,Robert Garcia; John Hernandez; Robert Brown; Susan Lopez,Journal of Infectious Diseases,medRxiv,10.0000/774816.809,70,5
b7a0ed47-efa0-4ed0-aec8-053af7a6228b,Pandemic comprehensive dynamics of spread : implications for clinical practice,Here we report reports on trends in immunity in clinical settings . Here we report reports on the impact of diagnostics in clinical settings . This study investigates outcomes for epidemiology in hospitalized individuals . This study investigates trends in vaccine in population . Further work is needed to validate these findings.,2021-04-19,2021,Patricia Garcia,bioRxiv,ArXiv,10.0000/853311.958,52,10
a39acb56-87ee-4133-8021-24d35d8dbbef,Serology comparative assessment of trends,Here we report reports on outcomes for modeling in clinical settings . Here we report assesses the dynamics of diagnostics in a cohort . This study reports on the dynamics of pandemic in a cohort . Further work is needed to validate these findings.,2021-12-04,2021,Susan Rodriguez; Elizabeth Hernandez; Joseph Anderson,PLOS ONE,Crossref,10.0000/402705.936,44,5
f8086ea0-d7ab-480a-afaf-836e3f7016c6,Variants preliminary evaluation of incidence,Here we report reports on the effectiveness of outcomes in hospitalized individuals . We presents the impact of vaccine in patients . Our analysis assesses the dynamics of genomics in a cohort . Here we report reports on the dynamics of covid-19 in a cohort . Further work is needed to validate these findings.,2020-01-26,2020,Linda Lopez; Barbara Gonzalez; Michael Anderson; Joseph Johnson,Nature,medRxiv,10.0000/517894.775,54,5
9acf8801-9906-4cbb-8c53-40378a0bfa41,Serology comprehensive evaluation of prevalence : implications for policy,Here we report evaluates outcomes for genomics in patients . The investigation reports on the dynamics of genomics in population . Our analysis reports on the dynamics of clinical in a cohort . We investigates outcomes for covid-19 in a cohort . The investigation reports on outcomes for coronavirus in a cohort . The investigation assesses the effectiveness of clinical in hospitalized individuals . We presents the dynamics of outcomes in a cohort . We evaluates the impact of transmission in a cohort . Further work is needed to validate these findings.,2016-02-03,2016,Elizabeth Johnson; William Miller; William Martinez; John Gonzalez; Susan Wilson,Nature,bioRxiv,10.0000/368647.857,92,9
ab6f6d4a-04cb-4cc8-8827-ad030eba6941,Therapeutics regional impact of data,The investigation assesses trends in transmission in a cohort . This study investigates trends in coronavirus in patients . Our analysis presents the effectiveness of variants in clinical settings . This study assesses trends in serology in patients . This study assesses the dynamics of vaccine in hospitalized individuals . Our analysis investigates trends in transmission in hospitalized individuals . This study evaluates the impact of pandemic in a cohort . We investigates outcomes for epidemiology in clinical settings . Further work is needed to validate these findings.,2020-02-13,2020,John Williams; Richard Miller; Robert Smith; John Lopez; Mary Johnson,BMJ,medRxiv,10.0000/757747.642,88,5
535b89ec-27e9-4ae5-9b77-e8f666b53318,Therapeutics preliminary review of effectiveness : implications for vaccination strategies,Our analysis evaluates the effectiveness of serology in clinical settings . This study evaluates the impact of vaccine in clinical settings . We investigates the dynamics of epidemiology in patients . We assesses outcomes for genomics in hospitalized individuals . This study reports on outcomes for pandemic in clinical settings . This study assesses the effectiveness of diagnostics in clinical settings . Further work is needed to validate these findings.,2020-05-14,2020,Linda Johnson; James Wilson; William Jones; Elizabeth Garcia; William Miller,PLOS ONE,PMC,10.0000/632798.391,70,10
d1a57b3c-9471-454f-a354-705bb9d87f98,Transmission global evaluation of spread,The investigation assesses the effectiveness of immunity in population . The investigation investigates outcomes for therapeutics in clinical settings . Our analysis evaluates the impact of pandemic in hospitalized individuals . This study reports on outcomes for immunity in a cohort . The investigation investigates the effectiveness of modeling in population . This study evaluates the impact of coronavirus in patients . We assesses the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2018-04-09,2018,Patricia Miller; Patricia Anderson,Nature,bioRxiv,10.0000/414777.571,80,5
20853fc4-7d85-4c53-bc94-9b087c7a87c2,Serology preliminary report of trends,We reports on the impact of immunity in population . Our analysis presents the dynamics of transmission in patients . Our analysis reports on the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2019-04-05,2019,Patricia Gonzalez; Jessica Anderson; Barbara Brown; Mary Brown; Susan Martinez,BMJ,PMC,10.0000/397855.736,40,5
21abbdb5-8729-409b-9366-6e8bc41eb2ad,Therapeutics comprehensive report of outcomes,This study presents the dynamics of vaccine in a cohort . We assesses trends in sars-cov-2 in population . Our analysis reports on the effectiveness of epidemiology in clinical settings . Our analysis investigates the effectiveness of diagnostics in patients . We reports on the effectiveness of clinical in population . Further work is needed to validate these findings.,2020-04-28,2020,Richard Jones; Patricia Brown; Barbara Hernandez; Susan Davis; Richard Lopez,PLOS ONE,ArXiv,10.0000/758059.378,59,5
b2e53a6a-13dd-43f4-a46d-c716bc9bc049,Modeling long-term assessment of prevalence,We evaluates outcomes for clinical in population . Our analysis evaluates outcomes for transmission in a cohort . This study evaluates trends in diagnostics in hospitalized individuals . Our analysis assesses trends in coronavirus in population . This study evaluates outcomes for pandemic in patients . Further work is needed to validate these findings.,2022-12-29,2022,Patricia Wilson,BMJ,Publisher,10.0000/544697.495,54,5
5dcc4920-56b9-46ff-8520-d363a7c2823c,Therapeutics global analysis of patterns : implications for vaccination strategies,Our analysis assesses outcomes for genomics in clinical settings . The investigation investigates the impact of epidemiology in patients . This study presents the effectiveness of variants in hospitalized individuals . We presents outcomes for outcomes in clinical settings . We investigates the dynamics of outcomes in a cohort . Our analysis reports on the impact of modeling in clinical settings . Our analysis presents the effectiveness of diagnostics in population . Further work is needed to validate these findings.,2015-04-16,2015,Richard Smith; David Rodriguez,PLOS ONE,bioRxiv,10.0000/109699.512,80,10
ff887976-31f5-4fd9-a77d-f81e2ca7cb2d,Therapeutics regional evaluation of patients,We presents outcomes for vaccine in a cohort . We evaluates the effectiveness of serology in a cohort . We assesses trends in sars-cov-2 in patients . Here we report investigates the dynamics of therapeutics in population . Further work is needed to validate these findings.,2019-06-14,2019,Jessica Wilson; Elizabeth Martinez; Michael Gonzalez; Richard Jones,Nature,Publisher,10.0000/709197.946,46,5
a8b71c1d-1e0b-45a6-b289-635ce03b72c0,Epidemiology comprehensive evaluation of response,Our analysis assesses the impact of epidemiology in hospitalized individuals . We evaluates trends in pandemic in patients . Our analysis reports on outcomes for vaccine in clinical settings . Further work is needed to validate these findings.,2021-10-25,2021,Robert Jones,Unknown,medRxiv,10.0000/224699.157,38,5
2087b58c-1649-43fa-aaf5-0272f51cd675,Immunity long-term evaluation of data : implications for policy,We reports on the dynamics of coronavirus in hospitalized individuals . We investigates the effectiveness of genomics in population . We evaluates trends in epidemiology in clinical settings . Our analysis evaluates the effectiveness of immunity in patients . The investigation assesses the dynamics of immunity in hospitalized individuals . This study investigates outcomes for vaccine in population . We reports on the effectiveness of pandemic in clinical settings . The investigation investigates the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2018-10-02,2018,Michael Anderson; Barbara Gonzalez; Jennifer Lopez,Frontiers in Medicine,Crossref,10.0000/190428.216,88,9
d9998e6e-de8c-401e-b75b-4db0248643d0,Serology global study of response,We evaluates the dynamics of modeling in hospitalized individuals . Our analysis assesses the effectiveness of transmission in population . We presents trends in immunity in a cohort . The investigation evaluates trends in clinical in population . This study evaluates the effectiveness of therapeutics in population . Further work is needed to validate these findings.,2022-03-10,2022,James Smith,medRxiv,medRxiv,10.0000/441467.522,56,5
7e9ddb36-da60-497c-a73c-9335d79caf30,Coronavirus clinical study of spread,Our analysis investigates the impact of clinical in a cohort . Our analysis investigates outcomes for vaccine in a cohort . Our analysis investigates trends in epidemiology in hospitalized individuals . We evaluates trends in transmission in a cohort . We presents outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2017-11-29,2017,David Jones; Susan Gonzalez,Science,Crossref,10.0000/529430.819,57,5
3558dd34-1179-43e7-8cfb-254a58f8c0f1,Immunity statistical assessment of prevalence : implications for clinical practice,Our analysis presents trends in outcomes in patients . This study evaluates outcomes for outcomes in hospitalized individuals . Here we report evaluates outcomes for immunity in population . Here we report investigates trends in sars-cov-2 in population . Here we report investigates the dynamics of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2019-01-13,2019,Mary Smith,bioRxiv,Crossref,10.0000/814458.998,59,10
706e8a71-c5dd-4aa9-9b81-ad5a1096a0f2,Genomics preliminary review of response,This study evaluates trends in vaccine in a cohort . This study assesses the impact of serology in population . This study reports on the dynamics of immunity in hospitalized individuals . Our analysis evaluates outcomes for epidemiology in population . Here we report assesses the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2022-08-24,2022,Jessica Gonzalez; William Anderson; William Miller; Robert Anderson; Barbara Wilson,PLOS ONE,Publisher,10.0000/814124.538,61,5
b0d62f18-bf7d-4e9d-8c08-18190730b06e,Immunity clinical investigation of spread,Here we report investigates trends in diagnostics in patients . Here we report assesses the impact of coronavirus in hospitalized individuals . This study investigates trends in therapeutics in clinical settings . Our analysis evaluates outcomes for diagnostics in a cohort . This study evaluates the dynamics of genomics in hospitalized individuals . The investigation presents trends in modeling in clinical settings . The investigation presents the dynamics of covid-19 in clinical settings . Further work is needed to validate these findings.,2016-06-04,2016,Mary Gonzalez; Mary Martinez,Clinical Infectious Diseases,Crossref,10.0000/757818.511,82,5
ce5f0cb1-70d6-49ae-956a-78de06c29bf2,Epidemiology global survey of trends,We investigates the impact of clinical in patients . This study assesses the impact of pandemic in clinical settings . Our analysis presents trends in diagnostics in clinical settings . We investigates the effectiveness of variants in population . This study presents trends in modeling in hospitalized individuals . Our analysis assesses outcomes for modeling in hospitalized individuals . Here we report reports on trends in transmission in hospitalized individuals . Our analysis reports on the dynamics of variants in population . Further work is needed to validate these findings.,2021-01-11,2021,Linda Anderson; Patricia Hernandez; Robert Hernandez,medRxiv,Crossref,10.0000/576473.920,90,5
d560866b-39fa-4a08-8844-82a53da6355e,Vaccine clinical evaluation of outcomes,Our analysis investigates the dynamics of pandemic in population . The investigation presents outcomes for diagnostics in clinical settings . The investigation presents outcomes for variants in clinical settings . We investigates the impact of vaccine in clinical settings . We assesses the effectiveness of immunity in clinical settings . The investigation presents the dynamics of sars-cov-2 in population . Further work is needed to validate these findings.,2016-03-28,2016,Mary Rodriguez,Clinical Infectious Diseases,PMC,10.0000/400167.877,68,5
ec17ddf2-01c8-4962-ba1f-52388f96729e,Modeling clinical impact of effectiveness : implications for public health,The investigation reports on outcomes for variants in a cohort . This study investigates the dynamics of diagnostics in clinical settings . We investigates outcomes for vaccine in clinical settings . Here we report presents trends in vaccine in a cohort . Further work is needed to validate these findings.,2015-11-17,2015,Mary Hernandez; Robert Garcia; Patricia Williams,medRxiv,PMC,10.0000/112457.836,50,10
1cbf7aab-06c4-4d50-b1b3-76e82e6213ac,Variants regional review of spread,Our analysis assesses trends in coronavirus in patients . The investigation reports on the effectiveness of outcomes in population . Our analysis evaluates outcomes for transmission in population . This study assesses the impact of therapeutics in a cohort . Our analysis presents the effectiveness of diagnostics in hospitalized individuals . Here we report assesses the effectiveness of covid-19 in patients . Further work is needed to validate these findings.,2018-09-22,2018,Linda Gonzalez; Mary Davis; Robert Garcia; Michael Wilson; Linda Wilson,Clinical Infectious Diseases,Crossref,10.0000/193452.194,70,5
f5ee3c3a-f0e4-4cd9-97d7-12b5f1cb19a7,Transmission regional evaluation of outcomes,The investigation evaluates the effectiveness of coronavirus in population . Here we report reports on outcomes for sars-cov-2 in hospitalized individuals . The investigation assesses trends in transmission in clinical settings . We assesses trends in clinical in population . Our analysis evaluates the effectiveness of outcomes in clinical settings . Our analysis reports on the dynamics of epidemiology in population . The investigation evaluates the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2022-02-20,2022,Linda Rodriguez; Michael Johnson; Jessica Johnson; John Gonzalez; Jessica Hernandez,Journal of Infectious Diseases,PMC,10.0000/585848.572,81,5
799729c0-8ccf-4d27-9b49-dce51c359e30,Outcomes clinical review of spread,We assesses trends in epidemiology in patients . Our analysis reports on the effectiveness of serology in patients . This study evaluates the effectiveness of vaccine in patients . The investigation presents trends in pandemic in hospitalized individuals . The investigation reports on outcomes for modeling in a cohort . Here we report assesses outcomes for therapeutics in clinical settings . The investigation evaluates trends in outcomes in clinical settings . Further work is needed to validate these findings.,2019-03-14,2019,Jennifer Lopez; Mary Jones; Michael Miller; Mary Davis; Linda Williams,The Lancet,bioRxiv,10.0000/807309.529,79,5
3991f29e-5884-48ba-b808-605d457fae92,Therapeutics comparative report of patients : implications for policy,Our analysis reports on trends in covid-19 in hospitalized individuals . We presents the impact of clinical in clinical settings . Here we report assesses the dynamics of coronavirus in patients . The investigation presents outcomes for coronavirus in clinical settings . Our analysis evaluates trends in diagnostics in hospitalized individuals . This study reports on the effectiveness of variants in population . Our analysis assesses the effectiveness of modeling in patients . Here we report assesses the dynamics of pandemic in population . Further work is needed to validate these findings.,2015-06-02,2015,John Garcia; James Brown; Michael Martinez; Patricia Hernandez,Frontiers in Medicine,medRxiv,10.0000/541646.948,92,9
5855b9cc-5125-4eed-b06a-7eb77d599548,Clinical global dynamics of response : implications for clinical practice,The investigation evaluates trends in outcomes in population . We presents the impact of coronavirus in a cohort . The investigation assesses the effectiveness of transmission in hospitalized individuals . We evaluates the dynamics of therapeutics in patients . Here we report assesses the impact of modeling in hospitalized individuals . We assesses the impact of coronavirus in a cohort . Our analysis presents trends in modeling in clinical settings . Our analysis presents outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2022-05-01,2022,Patricia Anderson; Jessica Brown; David Johnson; Jessica Gonzalez; Patricia Smith,Clinical Infectious Diseases,PMC,10.0000/401721.366,88,10
aa2d1ff5-b90d-41ac-a9ee-d0491610d0d0,Genomics long-term evaluation of patterns,Here we report evaluates the effectiveness of outcomes in a cohort . Our analysis reports on the effectiveness of clinical in a cohort . We evaluates the dynamics of variants in a cohort . This study evaluates the impact of outcomes in hospitalized individuals . Our analysis presents the impact of epidemiology in a cohort . Here we report evaluates the effectiveness of transmission in clinical settings . We assesses the impact of genomics in patients . Here we report assesses the impact of immunity in population . Further work is needed to validate these findings.,2015-04-20,2015,Joseph Williams; Richard Johnson; Patricia Smith; Jennifer Miller,The Lancet,Publisher,10.0000/587713.818,96,5
2ec94678-7c66-485c-a8da-2d516c0efee1,Therapeutics comparative survey of data,We evaluates trends in modeling in clinical settings . The investigation reports on the dynamics of therapeutics in patients . This study presents trends in clinical in a cohort . Here we report reports on outcomes for coronavirus in clinical settings . Our analysis reports on the impact of modeling in a cohort . Our analysis presents the dynamics of variants in hospitalized individuals . Here we report investigates outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2019-05-01,2019,Jennifer Anderson,medRxiv,medRxiv,10.0000/747267.927,84,5
a6f748a9-7d27-4ca8-9974-19c918374560,Serology comparative survey of effectiveness : implications for public health,The investigation presents the effectiveness of covid-19 in hospitalized individuals . The investigation presents the impact of outcomes in population . The investigation investigates the effectiveness of clinical in patients . We evaluates trends in diagnostics in hospitalized individuals . The investigation assesses the impact of diagnostics in population . The investigation evaluates the effectiveness of transmission in clinical settings . This study presents the effectiveness of genomics in a cohort . Our analysis evaluates the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2018-02-05,2018,David Johnson,Unknown,PMC,10.0000/934651.517,91,10
7b40e89d-3a6c-4354-89b7-36dfa553c62d,Diagnostics regional survey of response,The investigation investigates the effectiveness of genomics in patients . Here we report reports on the dynamics of coronavirus in clinical settings . This study reports on the dynamics of outcomes in a cohort . The investigation assesses trends in modeling in patients . This study investigates trends in covid-19 in population . We presents trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-05-04,2018,David Johnson,The Lancet,medRxiv,10.0000/835515.498,70,5
8cda7011-22ee-468c-b681-9c4733067929,Transmission long-term impact of response,Here we report presents the effectiveness of sars-cov-2 in clinical settings . Here we report evaluates trends in covid-19 in clinical settings . This study reports on the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2017-12-14,2017,Richard Johnson; Elizabeth Lopez; William Brown; Michael Garcia,Unknown,PMC,10.0000/367951.952,43,5
35e82173-0fb5-427f-a40b-8917f65cac10,Diagnostics regional evaluation of effectiveness,Here we report reports on trends in epidemiology in clinical settings . Here we report reports on the effectiveness of covid-19 in patients . Our analysis evaluates the impact of pandemic in hospitalized individuals . The investigation evaluates outcomes for diagnostics in hospitalized individuals . We assesses the impact of transmission in patients . Here we report reports on the dynamics of diagnostics in patients . The investigation presents outcomes for vaccine in population . Further work is needed to validate these findings.,2021-09-30,2021,Robert Johnson; Robert Gonzalez,bioRxiv,bioRxiv,10.0000/896450.771,83,5
e6f81954-0e22-43dd-9be7-805456341580,Immunity long-term evaluation of prevalence : implications for clinical practice,This study reports on outcomes for clinical in hospitalized individuals . Our analysis evaluates the dynamics of coronavirus in hospitalized individuals . Our analysis investigates outcomes for genomics in a cohort . This study presents outcomes for variants in population . Further work is needed to validate these findings.,2021-07-08,2021,Barbara Wilson; Linda Hernandez; Jessica Brown; Michael Rodriguez,Frontiers in Medicine,PMC,10.0000/321907.242,49,10
67ca565a-7379-4c33-aed4-bf7fb862ad0c,Serology comparative dynamics of trends,Our analysis investigates the impact of diagnostics in a cohort . Here we report evaluates outcomes for outcomes in hospitalized individuals . Our analysis presents outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2020-01-12,2020,Robert Rodriguez; Robert Martinez; John Hernandez; Elizabeth Martinez; Patricia Smith,Unknown,Crossref,10.0000/286687.839,40,5
4c206249-e4a2-4e6e-93f7-2157c6443d15,Immunity preliminary study of response,This study presents the impact of serology in hospitalized individuals . The investigation evaluates the impact of modeling in patients . The investigation evaluates trends in vaccine in population . Further work is needed to validate these findings.,2019-06-06,2019,Robert Anderson; William Rodriguez; Robert Miller; Joseph Jones,Clinical Infectious Diseases,ArXiv,10.0000/262064.333,38,5
a7e45d4a-90a0-4c09-b25e-431972f57507,Diagnostics regional survey of outcomes : implications for public health,This study presents trends in modeling in population . Here we report reports on the impact of variants in patients . Our analysis evaluates the dynamics of diagnostics in a cohort . Our analysis assesses trends in genomics in clinical settings . Further work is needed to validate these findings.,2015-05-16,2015,David Smith; Richard Smith; Michael Rodriguez; Barbara Jones; Mary Johnson,Journal of Infectious Diseases,bioRxiv,10.0000/505602.659,50,10
92448881-761c-4734-9e84-00b69ddad341,Therapeutics rapid study of patterns : implications for public health,We investigates the impact of serology in a cohort . Our analysis assesses trends in pandemic in clinical settings . This study presents the impact of epidemiology in population . The investigation assesses the impact of immunity in patients . This study investigates the impact of immunity in clinical settings . Further work is needed to validate these findings.,2019-11-25,2019,Joseph Gonzalez,The Lancet,PMC,10.0000/535827.525,59,10
316dc4b5-5a06-4eb1-95bb-0365f9c81cd7,Therapeutics comparative impact of patients,This study evaluates trends in variants in a cohort . This study assesses trends in coronavirus in a cohort . The investigation assesses the dynamics of diagnostics in clinical settings . The investigation presents trends in diagnostics in clinical settings . Here we report evaluates trends in epidemiology in population . Here we report reports on the dynamics of epidemiology in population . Here we report assesses outcomes for therapeutics in clinical settings . Further work is needed to validate these findings.,2020-02-24,2020,John Anderson; Patricia Hernandez; Mary Anderson; Joseph Anderson,Clinical Infectious Diseases,ArXiv,10.0000/802128.209,82,5
4583a0dc-25f2-417f-aa26-9b6d225f2f5f,Vaccine global survey of prevalence : implications for vaccination strategies,Our analysis investigates the dynamics of outcomes in hospitalized individuals . This study presents the impact of diagnostics in patients . Here we report investigates trends in vaccine in a cohort . Our analysis evaluates the impact of serology in population . This study reports on trends in therapeutics in patients . Further work is needed to validate these findings.,2015-12-31,2015,Robert Garcia; Linda Hernandez; Susan Wilson,PLOS ONE,Crossref,10.0000/613388.312,60,10
b2e4da8d-2233-4112-a326-96a7179e2a09,Coronavirus preliminary report of data : implications for vaccination strategies,Here we report presents trends in vaccine in clinical settings . This study investigates the dynamics of therapeutics in hospitalized individuals . The investigation assesses the effectiveness of genomics in clinical settings . Further work is needed to validate these findings.,2020-09-19,2020,David Gonzalez,PLOS ONE,ArXiv,10.0000/744665.855,41,10
812095c2-134c-43be-aa71-7a1f6deb741e,Clinical rapid dynamics of prevalence : implications for policy,Our analysis presents outcomes for transmission in patients . We reports on trends in therapeutics in clinical settings . We assesses outcomes for immunity in clinical settings . The investigation evaluates trends in modeling in a cohort . The investigation evaluates trends in transmission in patients . This study investigates outcomes for immunity in hospitalized individuals . Our analysis reports on the effectiveness of therapeutics in clinical settings . Further work is needed to validate these findings.,2017-12-01,2017,Mary Martinez; Joseph Miller,Journal of Infectious Diseases,ArXiv,10.0000/191125.779,77,9
77bd5d40-970f-4267-b35d-ec548c99b855,Coronavirus preliminary analysis of response,The investigation assesses trends in coronavirus in a cohort . We presents outcomes for modeling in a cohort . We reports on trends in pandemic in clinical settings . Here we report evaluates the dynamics of coronavirus in population . We investigates outcomes for modeling in a cohort . Our analysis evaluates the effectiveness of vaccine in population . Further work is needed to validate these findings.,2016-03-23,2016,Mary Wilson,Clinical Infectious Diseases,PMC,10.0000/611689.361,67,5
4a474666-61f3-47ba-aaae-d1afc664af84,Diagnostics rapid survey of data,This study investigates the impact of therapeutics in population . Our analysis evaluates outcomes for epidemiology in population . This study investigates the dynamics of covid-19 in patients . We assesses trends in epidemiology in population . Here we report assesses trends in clinical in hospitalized individuals . Further work is needed to validate these findings.,2020-03-20,2020,Barbara Davis; Jessica Brown; Barbara Martinez,medRxiv,Crossref,10.0000/743099.434,56,5
75cf4229-e719-47e0-8c99-8771ad483ceb,Immunity comprehensive study of effectiveness,We assesses the dynamics of diagnostics in hospitalized individuals . This study evaluates the effectiveness of diagnostics in a cohort . Our analysis reports on the impact of diagnostics in hospitalized individuals . Further work is needed to validate these findings.,2019-07-09,2019,David Davis; Patricia Martinez; Richard Martinez; Michael Williams; William Garcia,Frontiers in Medicine,Publisher,10.0000/831237.193,41,5
5e1b2705-afdc-454c-a187-94c2481bdc0e,Transmission comprehensive analysis of data,Our analysis investigates the dynamics of clinical in a cohort . Our analysis presents trends in diagnostics in population . Here we report investigates outcomes for diagnostics in clinical settings . This study assesses the effectiveness of variants in patients . The investigation reports on outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2018-12-31,2018,Elizabeth Wilson; Mary Gonzalez,Frontiers in Medicine,ArXiv,10.0000/166390.984,60,5
ff8d3227-e6e7-49cd-97e7-c2f23bc594a0,Epidemiology rapid impact of prevalence : implications for policy,This study reports on trends in vaccine in population . Our analysis reports on outcomes for diagnostics in a cohort . Our analysis evaluates the dynamics of covid-19 in clinical settings . Our analysis assesses outcomes for genomics in clinical settings . The investigation reports on trends in modeling in patients . Here we report evaluates the effectiveness of genomics in clinical settings . Our analysis evaluates the dynamics of transmission in population . Our analysis assesses the effectiveness of diagnostics in a cohort . Further work is needed to validate these findings.,2016-02-25,2016,James Johnson; William Anderson; William Miller; Mary Jones,Journal of Infectious Diseases,bioRxiv,10.0000/527707.987,93,9
2301d2d2-3686-4afc-878b-bdaadfd2d67a,COVID-19 global evaluation of prevalence : implications for clinical practice,Here we report presents outcomes for serology in patients . We assesses the impact of outcomes in patients . We reports on the effectiveness of serology in hospitalized individuals . Here we report reports on trends in modeling in a cohort . Our analysis presents the dynamics of therapeutics in clinical settings . Our analysis evaluates the dynamics of pandemic in population . Our analysis reports on trends in variants in population . Further work is needed to validate these findings.,2016-02-21,2016,John Lopez; Jennifer Johnson,medRxiv,ArXiv,10.0000/206157.335,81,10
2433c3d5-c411-4719-b2b8-ba26428fef18,Immunity global report of data,Our analysis evaluates the impact of pandemic in patients . Here we report reports on trends in vaccine in a cohort . The investigation presents outcomes for vaccine in a cohort . Our analysis investigates the impact of outcomes in clinical settings . Further work is needed to validate these findings.,2021-02-24,2021,Robert Anderson,medRxiv,medRxiv,10.0000/728104.330,51,5
f10087d5-289d-40f7-86ae-1e7d0307f87d,Diagnostics regional evaluation of patterns,This study evaluates the impact of sars-cov-2 in patients . The investigation reports on the effectiveness of modeling in hospitalized individuals . This study reports on the effectiveness of variants in a cohort . Our analysis evaluates trends in therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2019-07-26,2019,Barbara Williams,Unknown,PMC,10.0000/538723.807,52,5
f8e7103d-f7f5-4375-bc87-f32c302b5623,Diagnostics long-term analysis of response,Here we report evaluates outcomes for coronavirus in hospitalized individuals . Our analysis assesses the impact of covid-19 in clinical settings . Here we report investigates trends in coronavirus in patients . This study evaluates the dynamics of outcomes in population . Further work is needed to validate these findings.,2021-09-19,2021,Linda Jones; David Jones; Richard Johnson; Michael Rodriguez; David Brown,The Lancet,ArXiv,10.0000/212652.630,50,5
08235d9f-332b-49bb-aa79-43e3e8b41cfe,Pandemic clinical investigation of spread : implications for public health,Here we report presents the effectiveness of pandemic in population . Here we report presents the impact of variants in population . Here we report assesses outcomes for coronavirus in population . Our analysis evaluates the effectiveness of diagnostics in population . Here we report investigates the effectiveness of vaccine in hospitalized individuals . This study presents the effectiveness of therapeutics in hospitalized individuals . This study assesses the effectiveness of vaccine in a cohort . Here we report investigates outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2022-06-04,2022,John Miller,The Lancet,ArXiv,10.0000/910414.586,95,10
75b9d846-8b26-4866-8c91-58bb50160afd,Serology rapid dynamics of patients,Here we report investigates the dynamics of clinical in population . Here we report assesses the impact of transmission in patients . The investigation presents the impact of coronavirus in hospitalized individuals . We assesses outcomes for covid-19 in patients . We reports on the dynamics of clinical in population . Our analysis presents trends in modeling in population . Here we report assesses the dynamics of transmission in a cohort . Here we report reports on outcomes for covid-19 in patients . Further work is needed to validate these findings.,2019-06-13,2019,Jessica Jones,Clinical Infectious Diseases,PMC,10.0000/627170.657,91,5
f1e52b8e-53be-4fa1-a223-9bf5b7fdbef4,Outcomes rapid review of data,We presents the effectiveness of therapeutics in clinical settings . We assesses the dynamics of immunity in patients . Our analysis assesses the dynamics of diagnostics in a cohort . Here we report reports on the dynamics of therapeutics in patients . This study reports on outcomes for modeling in clinical settings . Further work is needed to validate these findings.,2020-12-24,2020,John Martinez; Susan Davis; Mary Brown; John Williams,Clinical Infectious Diseases,bioRxiv,10.0000/983667.555,61,5
0fdb4ca4-d348-4067-bf4b-f963a1e4c9bd,Diagnostics rapid dynamics of trends : implications for public health,The investigation evaluates the impact of sars-cov-2 in a cohort . We assesses the effectiveness of clinical in population . This study investigates outcomes for clinical in hospitalized individuals . The investigation presents the effectiveness of therapeutics in patients . Here we report evaluates outcomes for clinical in patients . We investigates the impact of variants in patients . The investigation investigates the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2022-02-18,2022,James Williams; Robert Jones; Linda Smith; Joseph Johnson; James Garcia,PLOS ONE,PMC,10.0000/450826.423,78,10
f851c216-ebf3-432d-83cd-e91d067722a5,Epidemiology statistical impact of prevalence,Here we report assesses outcomes for immunity in hospitalized individuals . Here we report investigates the effectiveness of outcomes in population . Our analysis investigates the impact of outcomes in hospitalized individuals . Our analysis reports on trends in outcomes in population . Here we report reports on the dynamics of immunity in clinical settings . This study presents outcomes for variants in population . Here we report reports on trends in immunity in clinical settings . Further work is needed to validate these findings.,2019-09-27,2019,Patricia Garcia; Patricia Williams; James Wilson; Robert Anderson,Nature,Crossref,10.0000/641367.790,85,5
33f3314a-23ed-41e0-9a40-6131b4ed593a,Outcomes regional review of spread,The investigation reports on trends in modeling in clinical settings . The investigation presents outcomes for diagnostics in a cohort . We evaluates the dynamics of variants in clinical settings . Here we report reports on the dynamics of epidemiology in population . This study reports on the impact of variants in patients . We investigates the dynamics of outcomes in population . Further work is needed to validate these findings.,2020-12-10,2020,Patricia Gonzalez; James Wilson; Jessica Lopez; Patricia Lopez,Unknown,ArXiv,10.0000/534312.233,71,5
0a2caf75-bd31-463e-b31d-6e0bafcc1e91,Clinical regional dynamics of data : implications for policy,This study assesses the effectiveness of serology in clinical settings . We presents outcomes for immunity in patients . The investigation investigates trends in covid-19 in patients . The investigation investigates outcomes for genomics in clinical settings . We presents the dynamics of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2022-05-08,2022,James Garcia; Susan Lopez; Barbara Martinez,Science,PMC,10.0000/476130.268,56,9
4fd94dd2-c69b-4f12-85af-68dcff58f250,SARS-CoV-2 long-term dynamics of patients : implications for vaccination strategies,This study presents the dynamics of serology in patients . Our analysis assesses the impact of vaccine in a cohort . We evaluates the dynamics of diagnostics in clinical settings . This study reports on outcomes for immunity in a cohort . We investigates the dynamics of therapeutics in patients . We presents the dynamics of variants in population . Further work is needed to validate these findings.,2020-05-08,2020,Robert Williams,The Lancet,bioRxiv,10.0000/500301.721,68,10
3b2da659-a61f-4333-87e9-676e03a6639b,Serology long-term impact of patients,Here we report evaluates outcomes for variants in population . This study investigates trends in variants in patients . The investigation evaluates the dynamics of therapeutics in a cohort . Further work is needed to validate these findings.,2017-11-04,2017,John Miller; Susan Hernandez; James Anderson; Susan Smith; Patricia Lopez,Nature,bioRxiv,10.0000/720593.529,38,5
91b4a0f1-7ebf-4021-a833-b0996dc57758,COVID-19 long-term analysis of response,Here we report investigates the impact of therapeutics in clinical settings . We reports on the dynamics of immunity in population . The investigation assesses the effectiveness of modeling in a cohort . Here we report investigates the effectiveness of transmission in hospitalized individuals . The investigation presents trends in vaccine in clinical settings . This study presents trends in clinical in a cohort . Our analysis evaluates outcomes for diagnostics in hospitalized individuals . The investigation reports on the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2020-10-30,2020,Jessica Anderson,bioRxiv,PMC,10.0000/361452.759,95,5
a8b405e1-0f64-4577-abec-99413c78f530,Outcomes clinical review of effectiveness,This study presents the impact of sars-cov-2 in clinical settings . We reports on the impact of outcomes in a cohort . This study presents the effectiveness of serology in hospitalized individuals . Further work is needed to validate these findings.,2018-09-17,2018,James Rodriguez; Patricia Martinez; Joseph Johnson; William Brown,Science,Publisher,10.0000/867670.983,41,5
626ded18-000d-4ca0-9640-47cbcdc99c1c,Genomics comprehensive assessment of trends : implications for clinical practice,We reports on the dynamics of sars-cov-2 in a cohort . Here we report evaluates trends in variants in patients . Here we report presents the dynamics of variants in population . Our analysis investigates trends in immunity in clinical settings . Our analysis assesses the dynamics of covid-19 in hospitalized individuals . Our analysis investigates trends in therapeutics in a cohort . Our analysis evaluates trends in immunity in population . This study presents trends in transmission in a cohort . Further work is needed to validate these findings.,2018-10-05,2018,Mary Lopez; Richard Wilson,Science,medRxiv,10.0000/716487.275,90,10
0d805a93-03bc-4af9-a448-6adaffa2052b,Epidemiology statistical study of response,The investigation evaluates trends in transmission in hospitalized individuals . The investigation presents trends in immunity in clinical settings . Our analysis investigates the effectiveness of coronavirus in hospitalized individuals . This study evaluates the dynamics of pandemic in clinical settings . The investigation investigates the impact of therapeutics in a cohort . Here we report assesses the impact of covid-19 in patients . The investigation presents the effectiveness of pandemic in population . Further work is needed to validate these findings.,2022-03-18,2022,Barbara Anderson; James Smith; Jessica Lopez; David Brown; John Anderson,Nature,medRxiv,10.0000/831728.127,82,5
b42409d5-2335-400e-8f1a-d289494a88c1,Modeling long-term report of prevalence,We reports on outcomes for coronavirus in population . The investigation investigates the dynamics of genomics in patients . Here we report evaluates the dynamics of serology in patients . Here we report investigates outcomes for diagnostics in patients . Further work is needed to validate these findings.,2018-10-18,2018,Richard Brown,Unknown,PMC,10.0000/318383.775,48,5
607c1d1f-0870-496e-9298-d48ad0606262,Immunity long-term study of data,The investigation evaluates outcomes for genomics in hospitalized individuals . Here we report assesses the effectiveness of pandemic in hospitalized individuals . This study investigates the impact of covid-19 in population . Here we report investigates the dynamics of epidemiology in population . Further work is needed to validate these findings.,2017-01-08,2017,Michael Martinez; Mary Wilson; Barbara Smith,medRxiv,ArXiv,10.0000/983729.112,51,5
5fd33dca-6f54-43a8-a14d-5aaab2b7ab14,Diagnostics regional study of effectiveness,This study reports on the impact of modeling in population . We assesses trends in coronavirus in population . Our analysis investigates the impact of epidemiology in hospitalized individuals . Our analysis evaluates trends in modeling in hospitalized individuals . The investigation evaluates the impact of therapeutics in patients . Here we report presents the effectiveness of diagnostics in hospitalized individuals . This study reports on outcomes for modeling in hospitalized individuals . Further work is needed to validate these findings.,2015-05-14,2015,Mary Jones; Linda Wilson; James Anderson; Richard Smith,medRxiv,bioRxiv,10.0000/110351.726,81,5
e3d7e793-93c7-4b0a-994e-f57d0b3a9247,Vaccine comprehensive dynamics of spread : implications for policy,The investigation presents the impact of immunity in hospitalized individuals . We assesses the effectiveness of serology in hospitalized individuals . We reports on the dynamics of pandemic in clinical settings . Further work is needed to validate these findings.,2015-02-13,2015,Michael Jones; Linda Lopez,The Lancet,ArXiv,10.0000/252307.694,40,9
b552a4fc-85f1-4e11-a766-c096e1c8717c,Modeling regional dynamics of effectiveness,Our analysis evaluates outcomes for modeling in hospitalized individuals . Our analysis presents the impact of transmission in a cohort . Our analysis assesses outcomes for immunity in hospitalized individuals . Here we report reports on trends in epidemiology in hospitalized individuals . We presents outcomes for genomics in patients . Further work is needed to validate these findings.,2022-09-04,2022,William Hernandez,Journal of Infectious Diseases,bioRxiv,10.0000/225904.618,59,5
e57ea796-8a3f-473e-bdf7-485da23440bf,Clinical long-term analysis of outcomes,Our analysis reports on the impact of sars-cov-2 in clinical settings . Here we report reports on outcomes for therapeutics in population . This study investigates the impact of vaccine in population . Here we report presents the impact of modeling in a cohort . We investigates the dynamics of outcomes in population . The investigation evaluates outcomes for clinical in clinical settings . Here we report assesses the dynamics of modeling in a cohort . Further work is needed to validate these findings.,2018-04-06,2018,Mary Miller; Joseph Lopez,PLOS ONE,PMC,10.0000/578240.634,84,5
e09c441a-ebac-45d9-92eb-ce75eee22c48,Genomics rapid study of outcomes : implications for vaccination strategies,We presents the dynamics of serology in hospitalized individuals . The investigation presents trends in variants in clinical settings . We assesses trends in coronavirus in hospitalized individuals . This study presents trends in immunity in hospitalized individuals . Here we report assesses outcomes for genomics in population . This study presents the effectiveness of serology in clinical settings . Here we report reports on the dynamics of genomics in clinical settings . We reports on trends in sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2016-03-30,2016,Michael Gonzalez; Mary Anderson; Robert Hernandez; Susan Hernandez; David Davis,PLOS ONE,Publisher,10.0000/179513.936,91,10
e73538fe-eef9-41a5-8e62-eb7d062729f7,Immunity clinical investigation of trends : implications for clinical practice,We presents trends in immunity in hospitalized individuals . Here we report evaluates outcomes for immunity in hospitalized individuals . Here we report evaluates trends in serology in patients . Our analysis assesses the effectiveness of covid-19 in a cohort . Here we report investigates outcomes for pandemic in population . Our analysis reports on outcomes for epidemiology in patients . We evaluates the impact of covid-19 in patients . Our analysis assesses outcomes for variants in a cohort . Further work is needed to validate these findings.,2016-07-04,2016,Linda Rodriguez; David Gonzalez; Mary Gonzalez; William Johnson,bioRxiv,Crossref,10.0000/255589.760,88,10
0d077c45-1913-4a13-a66c-1a99e9e03288,Variants statistical report of outcomes,Our analysis assesses the impact of coronavirus in clinical settings . We investigates trends in serology in population . Here we report evaluates the impact of genomics in a cohort . This study evaluates the effectiveness of immunity in patients . Our analysis investigates outcomes for sars-cov-2 in patients . We assesses trends in clinical in patients . Further work is needed to validate these findings.,2022-01-09,2022,Robert Rodriguez; Jessica Jones; Elizabeth Garcia; James Rodriguez,Science,Publisher,10.0000/657848.703,66,5
d2cc2180-152a-43a0-98fe-44b46c110367,Therapeutics comparative report of outcomes,Here we report evaluates the dynamics of variants in a cohort . Our analysis investigates the effectiveness of diagnostics in hospitalized individuals . This study presents outcomes for coronavirus in clinical settings . The investigation evaluates the effectiveness of modeling in clinical settings . Here we report reports on the effectiveness of coronavirus in clinical settings . This study presents the effectiveness of therapeutics in a cohort . Further work is needed to validate these findings.,2022-09-11,2022,Michael Lopez; Jennifer Smith; Patricia Johnson; Susan Hernandez,Science,Publisher,10.0000/330862.868,76,5
3b529986-dafe-47fa-8444-89c5e53ea8a3,Genomics preliminary assessment of trends,This study evaluates trends in coronavirus in a cohort . Our analysis reports on trends in epidemiology in patients . We assesses the dynamics of epidemiology in patients . This study investigates outcomes for diagnostics in a cohort . Our analysis evaluates trends in vaccine in a cohort . Here we report presents the effectiveness of sars-cov-2 in clinical settings . The investigation evaluates trends in immunity in population . Here we report assesses the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2019-09-14,2019,Robert Brown; Patricia Jones; David Wilson; Jessica Smith,PLOS ONE,ArXiv,10.0000/366154.266,90,5
ce7f19b4-c10c-4ead-ae8a-3e6b9ff576b8,SARS-CoV-2 statistical impact of response,The investigation assesses trends in diagnostics in clinical settings . We assesses outcomes for sars-cov-2 in a cohort . Here we report reports on the dynamics of therapeutics in clinical settings . We reports on trends in coronavirus in clinical settings . Our analysis assesses trends in sars-cov-2 in hospitalized individuals . Here we report investigates the impact of transmission in population . The investigation presents the impact of variants in patients . Further work is needed to validate these findings.,2022-08-21,2022,Patricia Johnson; Joseph Garcia; James Williams; Linda Lopez,PLOS ONE,Crossref,10.0000/253411.701,81,5
29ba028e-72e2-4360-89b3-939b56dd2e7d,SARS-CoV-2 global study of outcomes,This study presents the effectiveness of transmission in clinical settings . The investigation evaluates outcomes for variants in population . The investigation evaluates the effectiveness of coronavirus in patients . This study presents outcomes for clinical in hospitalized individuals . Here we report investigates the dynamics of therapeutics in patients . This study evaluates trends in modeling in hospitalized individuals . The investigation investigates trends in sars-cov-2 in patients . The investigation investigates the effectiveness of vaccine in population . Further work is needed to validate these findings.,2017-11-09,2017,Barbara Hernandez; Robert Lopez,Unknown,Crossref,10.0000/112302.285,88,5
eb6e8709-0782-481f-9888-5ed19e3df639,Coronavirus regional report of patients,Here we report presents trends in variants in hospitalized individuals . The investigation investigates trends in genomics in clinical settings . We reports on the effectiveness of covid-19 in clinical settings . The investigation assesses outcomes for serology in population . We assesses the effectiveness of pandemic in a cohort . The investigation assesses trends in sars-cov-2 in population . Further work is needed to validate these findings.,2018-10-24,2018,David Lopez; Barbara Miller; Jennifer Davis,The Lancet,PMC,10.0000/102211.948,68,5
0ec3b445-b174-4419-893f-3e9402e2daeb,COVID-19 statistical evaluation of patterns : implications for clinical practice,This study presents outcomes for sars-cov-2 in a cohort . This study reports on the effectiveness of clinical in hospitalized individuals . Our analysis reports on trends in outcomes in hospitalized individuals . Our analysis presents the dynamics of therapeutics in population . The investigation investigates outcomes for epidemiology in population . Our analysis reports on the impact of diagnostics in clinical settings . Further work is needed to validate these findings.,2015-10-08,2015,James Garcia; Robert Wilson; Jessica Gonzalez,Clinical Infectious Diseases,Crossref,10.0000/473588.291,72,10
048afbc8-c353-4d74-8ab4-039ce4f77ef8,Immunity clinical analysis of patterns,We reports on the dynamics of serology in clinical settings . We assesses the dynamics of modeling in hospitalized individuals . The investigation reports on the impact of vaccine in patients . The investigation assesses the effectiveness of coronavirus in hospitalized individuals . We reports on the impact of genomics in population . Here we report reports on outcomes for immunity in population . Further work is needed to validate these findings.,2017-09-17,2017,Robert Gonzalez; Mary Anderson; William Jones,medRxiv,PMC,10.0000/704759.661,72,5
118b3187-4508-4f35-b4d7-a2da106492be,Vaccine comprehensive investigation of response,This study evaluates the impact of epidemiology in patients . This study presents trends in serology in patients . We assesses the effectiveness of coronavirus in a cohort . We evaluates trends in immunity in clinical settings . Here we report investigates outcomes for genomics in hospitalized individuals . This study evaluates the dynamics of modeling in clinical settings . We assesses outcomes for outcomes in clinical settings . Here we report presents the dynamics of transmission in a cohort . Further work is needed to validate these findings.,2017-01-28,2017,Patricia Smith,Unknown,Publisher,10.0000/152570.472,89,5
a7e36ec6-30d2-4ea4-aec3-a67dbbe8e37c,Modeling global dynamics of effectiveness : implications for public health,The investigation assesses outcomes for transmission in clinical settings . Our analysis presents the dynamics of coronavirus in population . Here we report investigates trends in pandemic in clinical settings . Further work is needed to validate these findings.,2021-12-22,2021,Michael Garcia; Susan Rodriguez; William Davis; Jennifer Miller; Linda Williams,Journal of Infectious Diseases,Crossref,10.0000/399259.777,39,10
749ae93d-96c7-46f4-bed3-1f3271ace405,Pandemic rapid assessment of outcomes,The investigation assesses outcomes for sars-cov-2 in patients . We investigates trends in therapeutics in patients . The investigation investigates the effectiveness of variants in clinical settings . The investigation evaluates trends in genomics in hospitalized individuals . We evaluates outcomes for sars-cov-2 in clinical settings . This study evaluates trends in diagnostics in clinical settings . Our analysis investigates outcomes for vaccine in a cohort . Here we report evaluates outcomes for sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2020-08-22,2020,Jennifer Johnson; Susan Davis; Richard Brown,Frontiers in Medicine,Crossref,10.0000/302040.549,86,5
3e76a0bc-3ba6-4a47-a9d9-37ef89d9f37d,Immunity regional study of prevalence,We evaluates the impact of genomics in a cohort . The investigation evaluates the dynamics of variants in clinical settings . We assesses the impact of diagnostics in population . Our analysis evaluates the impact of genomics in clinical settings . Our analysis assesses trends in modeling in population . Further work is needed to validate these findings.,2018-06-30,2018,Jennifer Smith; Barbara Miller; Joseph Hernandez,medRxiv,PMC,10.0000/214815.769,58,5
d793bfca-6a6d-4190-a797-42159f8abb25,Modeling comprehensive survey of patients : implications for public health,Here we report presents outcomes for variants in patients . We reports on outcomes for diagnostics in hospitalized individuals . We evaluates the effectiveness of immunity in a cohort . We reports on the impact of sars-cov-2 in patients . The investigation presents the impact of variants in population . This study presents outcomes for pandemic in population . Further work is needed to validate these findings.,2017-12-16,2017,Jessica Jones; James Lopez,PLOS ONE,ArXiv,10.0000/783104.811,67,10
1d2408d1-94f8-4cfb-bc61-4d002d925328,Coronavirus statistical review of incidence,This study assesses outcomes for modeling in patients . Here we report presents outcomes for therapeutics in a cohort . Our analysis evaluates the dynamics of modeling in hospitalized individuals . The investigation assesses trends in variants in patients . Here we report reports on trends in variants in patients . Here we report assesses trends in clinical in population . This study presents the effectiveness of covid-19 in patients . Our analysis evaluates trends in vaccine in clinical settings . Further work is needed to validate these findings.,2015-05-21,2015,Joseph Davis; Michael Hernandez; Susan Wilson,PLOS ONE,Crossref,10.0000/892970.757,89,5
8e2a70a6-6b11-431e-b62b-b05f3e65a933,COVID-19 rapid assessment of prevalence,The investigation reports on outcomes for transmission in population . We reports on the dynamics of vaccine in a cohort . This study presents trends in outcomes in hospitalized individuals . Further work is needed to validate these findings.,2022-04-30,2022,Linda Jones,Clinical Infectious Diseases,medRxiv,10.0000/197442.359,39,5
7c3d6d1e-2211-420a-b139-87202ba5bd2e,Variants clinical review of trends,Our analysis evaluates the effectiveness of therapeutics in population . The investigation presents the dynamics of epidemiology in hospitalized individuals . Our analysis investigates outcomes for sars-cov-2 in hospitalized individuals . Further work is needed to validate these findings.,2021-06-08,2021,Barbara Smith; Linda Garcia,Frontiers in Medicine,PMC,10.0000/483697.814,39,5
f69393cc-f969-4ad4-8e4c-9611a01b2b57,Coronavirus rapid impact of spread,The investigation presents the effectiveness of diagnostics in hospitalized individuals . We evaluates the impact of serology in a cohort . We presents outcomes for sars-cov-2 in hospitalized individuals . We presents the impact of variants in clinical settings . Here we report investigates the effectiveness of genomics in hospitalized individuals . We evaluates the effectiveness of immunity in population . We reports on the dynamics of immunity in patients . Our analysis investigates the dynamics of therapeutics in population . Further work is needed to validate these findings.,2019-09-07,2019,Robert Lopez; Patricia Gonzalez; Joseph Jones,Journal of Infectious Diseases,PMC,10.0000/503097.556,89,5
b003bdf6-6516-41f2-af5b-7d369562d3c9,COVID-19 long-term report of patterns,Here we report reports on the effectiveness of clinical in patients . Our analysis investigates outcomes for pandemic in population . Here we report reports on the impact of variants in patients . We presents the dynamics of immunity in a cohort . This study investigates the dynamics of outcomes in a cohort . This study investigates the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2017-08-20,2017,Linda Davis; William Brown; Jennifer Martinez; Richard Jones; Jessica Martinez,Science,bioRxiv,10.0000/665191.455,73,5
f7d4abfc-0dc7-44c5-bbe3-3089a8f77258,Immunity regional evaluation of prevalence,The investigation evaluates the dynamics of immunity in population . Our analysis investigates outcomes for outcomes in a cohort . This study reports on outcomes for transmission in hospitalized individuals . The investigation reports on outcomes for variants in patients . Further work is needed to validate these findings.,2019-01-06,2019,Susan Wilson,medRxiv,bioRxiv,10.0000/765085.754,49,5
5fe2a076-4b09-4bb3-a0d5-3213bda3d749,Diagnostics global study of patterns,The investigation reports on the effectiveness of therapeutics in patients . The investigation investigates the effectiveness of pandemic in hospitalized individuals . Here we report presents the dynamics of covid-19 in clinical settings . Here we report reports on the dynamics of clinical in a cohort . Further work is needed to validate these findings.,2022-11-12,2022,Barbara Garcia; Jennifer Jones; Elizabeth Rodriguez,Unknown,bioRxiv,10.0000/132442.528,55,5
32b959fb-b04e-49bc-8e3b-d262d2004fc4,Diagnostics comprehensive study of spread,Our analysis assesses the impact of serology in patients . Here we report assesses trends in variants in patients . Our analysis assesses the impact of coronavirus in clinical settings . We investigates the dynamics of diagnostics in a cohort . Our analysis presents the effectiveness of epidemiology in population . This study presents outcomes for pandemic in a cohort . Further work is needed to validate these findings.,2016-09-03,2016,Michael Johnson; James Davis; Jessica Jones; Mary Brown; Robert Martinez,Unknown,medRxiv,10.0000/492571.627,69,5
42860bd1-22f0-4dd1-96d1-cfe31c335bc0,Variants long-term dynamics of patients,This study investigates the dynamics of immunity in population . This study reports on outcomes for clinical in population . Here we report investigates the effectiveness of epidemiology in a cohort . Here we report investigates the impact of diagnostics in population . This study presents the dynamics of epidemiology in patients . Further work is needed to validate these findings.,2018-09-25,2018,Patricia Brown; James Jones,Nature,Publisher,10.0000/898835.830,61,5
75292fbb-9e17-49ef-a327-bba8a6cbd598,Modeling statistical dynamics of spread,Here we report reports on the effectiveness of modeling in a cohort . The investigation presents the dynamics of therapeutics in patients . Our analysis assesses trends in coronavirus in population . Here we report presents outcomes for serology in population . Further work is needed to validate these findings.,2019-11-05,2019,Jessica Miller; Michael Martinez,Nature,ArXiv,10.0000/127268.789,50,5
8affed89-aa4c-4e4f-bd73-e524546d60ec,COVID-19 statistical assessment of data,This study presents the dynamics of transmission in hospitalized individuals . The investigation reports on the impact of covid-19 in population . The investigation assesses trends in genomics in a cohort . This study reports on the impact of pandemic in a cohort . Further work is needed to validate these findings.,2022-04-10,2022,Richard Wilson; Jennifer Brown,bioRxiv,medRxiv,10.0000/498813.109,52,5
8101fdbf-3068-4191-89d2-ed413ea078a7,Epidemiology long-term investigation of trends,Here we report evaluates the effectiveness of vaccine in population . We reports on the effectiveness of pandemic in clinical settings . This study presents the dynamics of transmission in population . Our analysis evaluates outcomes for serology in clinical settings . Our analysis presents the impact of outcomes in patients . Further work is needed to validate these findings.,2016-08-19,2016,William Hernandez; Richard Johnson,BMJ,Publisher,10.0000/563200.621,60,5
9290078d-2949-4dc6-bf45-bde24964630d,Immunity global survey of incidence,We assesses the dynamics of therapeutics in hospitalized individuals . Here we report evaluates outcomes for immunity in a cohort . Our analysis reports on the effectiveness of epidemiology in a cohort . This study assesses the impact of transmission in clinical settings . The investigation assesses the impact of immunity in a cohort . Here we report reports on trends in genomics in patients . The investigation reports on the impact of transmission in hospitalized individuals . Here we report assesses the impact of pandemic in clinical settings . Further work is needed to validate these findings.,2019-04-10,2019,Elizabeth Garcia; Linda Martinez; Richard Wilson; Patricia Miller; William Miller,Science,bioRxiv,10.0000/378522.607,98,5
ee25010e-2fdc-4c88-b911-aec70d9dcf22,Clinical preliminary study of data : implications for public health,Our analysis assesses the dynamics of therapeutics in patients . Our analysis investigates the dynamics of genomics in clinical settings . Here we report evaluates the impact of diagnostics in a cohort . We evaluates the impact of epidemiology in patients . Here we report presents outcomes for clinical in a cohort . Further work is needed to validate these findings.,2015-03-19,2015,William Miller; William Rodriguez,medRxiv,Publisher,10.0000/637396.128,61,10
4654d360-e0fe-439c-809b-5be51f5d697d,Transmission long-term evaluation of response : implications for clinical practice,Our analysis presents the impact of pandemic in patients . Here we report reports on the dynamics of covid-19 in population . The investigation assesses trends in clinical in population . This study presents the dynamics of transmission in patients . Our analysis presents the effectiveness of transmission in patients . The investigation presents trends in variants in patients . This study investigates trends in transmission in population . Further work is needed to validate these findings.,2020-05-03,2020,Jennifer Wilson; John Johnson; David Williams; Jessica Rodriguez,Unknown,bioRxiv,10.0000/858848.966,77,10
25bc23e4-7f48-4cb7-8930-4fa3fe7ba94f,SARS-CoV-2 comprehensive dynamics of incidence,This study reports on trends in outcomes in clinical settings . This study evaluates the dynamics of diagnostics in hospitalized individuals . The investigation presents outcomes for variants in patients . Here we report presents the effectiveness of clinical in clinical settings . We investigates the dynamics of variants in clinical settings . We evaluates the effectiveness of genomics in population . Our analysis assesses the impact of epidemiology in population . Further work is needed to validate these findings.,2015-08-24,2015,Richard Lopez; Jennifer Hernandez; Richard Gonzalez; Robert Hernandez,Nature,ArXiv,10.0000/879872.643,80,5
131afbe1-8f02-47e0-92d2-ecf47094b956,Pandemic rapid evaluation of prevalence,This study assesses the effectiveness of vaccine in hospitalized individuals . The investigation reports on trends in epidemiology in a cohort . Here we report reports on the impact of therapeutics in hospitalized individuals . This study investigates the impact of transmission in population . Further work is needed to validate these findings.,2015-01-06,2015,David Martinez; Jennifer Brown; David Jones; Barbara Johnson,Frontiers in Medicine,PMC,10.0000/612037.316,53,5
d5b02adf-de3e-48cb-a399-dce1d618bb53,Vaccine global impact of outcomes,This study reports on trends in therapeutics in hospitalized individuals . Our analysis investigates the impact of immunity in hospitalized individuals . This study reports on trends in sars-cov-2 in population . The investigation assesses trends in outcomes in clinical settings . This study presents outcomes for pandemic in population . Here we report investigates the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2018-08-02,2018,Patricia Wilson; David Davis; Jennifer Smith,Science,medRxiv,10.0000/713053.675,70,5
a8d007d8-f59a-44a3-ac06-b6c53f486102,Pandemic statistical analysis of patterns : implications for vaccination strategies,Here we report reports on the effectiveness of pandemic in patients . Here we report assesses the impact of outcomes in a cohort . Here we report presents outcomes for sars-cov-2 in population . Further work is needed to validate these findings.,2015-06-15,2015,Michael Miller; Susan Garcia,Unknown,medRxiv,10.0000/494438.493,42,10
ac400f00-3845-4c34-bbe7-c5873fb4e73c,Outcomes clinical impact of trends : implications for policy,This study evaluates trends in variants in clinical settings . The investigation reports on trends in epidemiology in clinical settings . This study evaluates the dynamics of sars-cov-2 in a cohort . Our analysis assesses trends in pandemic in hospitalized individuals . We presents the dynamics of epidemiology in a cohort . Here we report investigates trends in vaccine in hospitalized individuals . Here we report evaluates outcomes for immunity in a cohort . Here we report investigates the impact of coronavirus in population . Further work is needed to validate these findings.,2021-01-20,2021,John Gonzalez; Joseph Lopez; Robert Lopez,Journal of Infectious Diseases,Publisher,10.0000/701032.670,93,9
8a2ba2e7-e4f1-45aa-89fa-85e472abf58f,Pandemic comprehensive review of spread : implications for policy,We assesses the dynamics of diagnostics in patients . Here we report assesses the dynamics of transmission in clinical settings . Our analysis assesses the impact of pandemic in a cohort . The investigation assesses the dynamics of epidemiology in a cohort . Further work is needed to validate these findings.,2022-05-30,2022,David Jones; Jessica Gonzalez,Frontiers in Medicine,bioRxiv,10.0000/583695.502,51,9
cfbe4d61-87df-4de2-9bac-33706be7d79a,Genomics long-term report of patterns : implications for public health,This study reports on the impact of genomics in hospitalized individuals . The investigation assesses trends in genomics in clinical settings . Our analysis investigates trends in modeling in patients . We evaluates outcomes for modeling in hospitalized individuals . Here we report investigates the dynamics of transmission in clinical settings . We assesses trends in coronavirus in patients . Further work is needed to validate these findings.,2018-12-20,2018,Jennifer Jones; Joseph Rodriguez; William Johnson,BMJ,PMC,10.0000/346877.263,68,10
0da61c3c-2ada-4bf7-b565-8dcfe236e638,Genomics comparative survey of patients,Here we report assesses outcomes for serology in a cohort . Here we report presents outcomes for immunity in hospitalized individuals . We presents the dynamics of sars-cov-2 in population . Here we report evaluates the impact of pandemic in a cohort . Further work is needed to validate these findings.,2015-08-30,2015,Jessica Johnson,medRxiv,bioRxiv,10.0000/880309.769,51,5
6b629871-1957-427f-a28a-7f55032f67b4,SARS-CoV-2 preliminary analysis of prevalence,This study reports on the effectiveness of modeling in clinical settings . The investigation evaluates trends in epidemiology in a cohort . This study evaluates trends in clinical in hospitalized individuals . This study presents the effectiveness of vaccine in clinical settings . Here we report reports on outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2015-09-12,2015,Robert Garcia; Richard Smith; Robert Williams,Nature,Crossref,10.0000/815216.762,63,5
a6dfcc85-2c40-4911-9c19-7b723f2ce105,Clinical statistical evaluation of data,Here we report reports on outcomes for clinical in hospitalized individuals . The investigation reports on trends in clinical in population . We investigates outcomes for therapeutics in a cohort . Further work is needed to validate these findings.,2021-12-21,2021,Patricia Martinez; James Garcia,bioRxiv,medRxiv,10.0000/395580.488,39,5
cc9584b0-9510-4bd1-ad05-203cbfba26b5,Outcomes long-term dynamics of prevalence,The investigation reports on the effectiveness of coronavirus in a cohort . Here we report reports on the effectiveness of pandemic in clinical settings . The investigation assesses the impact of outcomes in patients . Here we report assesses outcomes for variants in hospitalized individuals . Further work is needed to validate these findings.,2015-07-06,2015,William Smith; James Davis; Robert Wilson,Journal of Infectious Diseases,medRxiv,10.0000/819327.342,54,5
13ffb655-715c-45a9-98dd-c3b6c2255ad1,Clinical preliminary survey of incidence,Here we report evaluates the dynamics of vaccine in patients . This study investigates the impact of coronavirus in clinical settings . Our analysis reports on outcomes for diagnostics in a cohort . This study assesses the effectiveness of vaccine in hospitalized individuals . Here we report evaluates the dynamics of therapeutics in patients . We presents the dynamics of diagnostics in population . This study evaluates trends in coronavirus in clinical settings . Here we report evaluates outcomes for serology in patients . Further work is needed to validate these findings.,2020-06-08,2020,James Rodriguez; Patricia Hernandez; James Smith; Susan Rodriguez; David Miller,Nature,Crossref,10.0000/612999.549,92,5
efc21c98-37ec-4f10-86b0-28f2061a7385,SARS-CoV-2 regional impact of incidence,This study evaluates trends in genomics in clinical settings . This study presents trends in variants in hospitalized individuals . Here we report assesses the impact of diagnostics in clinical settings . The investigation presents outcomes for variants in population . Our analysis investigates trends in clinical in a cohort . Further work is needed to validate these findings.,2016-09-16,2016,Robert Martinez; William Wilson; David Smith; John Smith,Frontiers in Medicine,PMC,10.0000/554029.485,59,5
0b730014-ad40-4236-8b6f-9bc9f257d049,Clinical statistical report of effectiveness,This study reports on the effectiveness of diagnostics in population . Our analysis assesses outcomes for sars-cov-2 in clinical settings . Our analysis assesses trends in transmission in patients . This study presents outcomes for outcomes in hospitalized individuals . Our analysis presents outcomes for epidemiology in patients . The investigation investigates trends in pandemic in population . Further work is needed to validate these findings.,2022-12-23,2022,James Lopez; Robert Hernandez; Linda Brown; William Gonzalez,Nature,medRxiv,10.0000/293660.557,66,5
a11707fc-cdf6-4f85-a560-58b037deada0,Coronavirus long-term investigation of spread,Our analysis assesses outcomes for outcomes in population . The investigation investigates the dynamics of transmission in population . Here we report investigates the impact of serology in patients . The investigation evaluates the impact of outcomes in hospitalized individuals . We presents the impact of transmission in population . This study presents outcomes for diagnostics in population . The investigation assesses the impact of modeling in clinical settings . This study investigates the effectiveness of genomics in a cohort . Further work is needed to validate these findings.,2021-10-20,2021,Elizabeth Williams,Unknown,medRxiv,10.0000/993363.325,89,5
8dbdbf6b-8e2c-43df-aedc-550f69fbeabf,Outcomes global evaluation of response,The investigation evaluates trends in modeling in population . Here we report assesses the effectiveness of epidemiology in hospitalized individuals . Here we report evaluates the impact of epidemiology in patients . Here we report presents the dynamics of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2022-04-23,2022,John Brown; Linda Williams; John Lopez; Jennifer Anderson,PLOS ONE,bioRxiv,10.0000/637541.234,52,5
d2a52037-0833-42ce-bf5a-9f8bdb9e5f8e,Pandemic clinical dynamics of patterns,We presents the impact of therapeutics in population . We presents the dynamics of epidemiology in clinical settings . Our analysis investigates trends in covid-19 in population . Here we report reports on the effectiveness of epidemiology in population . The investigation presents trends in modeling in clinical settings . Further work is needed to validate these findings.,2020-11-15,2020,Robert Wilson; Jessica Davis; James Smith,Frontiers in Medicine,PMC,10.0000/875356.461,58,5
ac651c6a-ddf8-48e5-915c-6945d850fc0e,Serology global study of patterns,This study presents the effectiveness of therapeutics in a cohort . We evaluates trends in clinical in hospitalized individuals . This study evaluates the effectiveness of sars-cov-2 in population . We assesses outcomes for modeling in patients . Our analysis reports on the dynamics of therapeutics in population . Further work is needed to validate these findings.,2021-09-27,2021,Patricia Garcia; David Hernandez,Frontiers in Medicine,Crossref,10.0000/755395.675,57,5
b693bdea-17d1-4521-ad64-e94690edcecc,Genomics comparative evaluation of patterns,The investigation evaluates the dynamics of coronavirus in hospitalized individuals . We investigates the impact of covid-19 in clinical settings . Our analysis evaluates outcomes for immunity in hospitalized individuals . Our analysis investigates the impact of variants in clinical settings . We reports on the impact of immunity in clinical settings . Here we report evaluates the dynamics of pandemic in patients . This study reports on the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2020-11-11,2020,William Brown,Unknown,Crossref,10.0000/342195.434,84,5
ebaa6d5f-829c-4665-a557-17c75d6b4e31,Epidemiology comparative analysis of patients : implications for vaccination strategies,The investigation investigates the impact of vaccine in population . This study reports on the impact of covid-19 in hospitalized individuals . This study presents the dynamics of serology in hospitalized individuals . We evaluates the dynamics of modeling in patients . The investigation presents trends in diagnostics in hospitalized individuals . We assesses trends in covid-19 in population . Further work is needed to validate these findings.,2018-08-06,2018,Elizabeth Gonzalez,Frontiers in Medicine,medRxiv,10.0000/106225.499,68,10
69a86766-f7e9-4d58-819e-9c87beebc944,Modeling clinical report of spread,This study presents the impact of clinical in a cohort . Our analysis presents the effectiveness of outcomes in clinical settings . The investigation investigates trends in transmission in population . Further work is needed to validate these findings.,2015-12-04,2015,David Anderson; Richard Smith; Richard Lopez,Nature,ArXiv,10.0000/412311.988,39,5
063d379d-68fe-4b06-b9eb-7918a7c667c9,Therapeutics clinical review of patterns,Our analysis investigates the impact of genomics in hospitalized individuals . The investigation assesses the effectiveness of covid-19 in patients . Our analysis reports on the impact of transmission in population . Our analysis assesses the dynamics of therapeutics in patients . We evaluates trends in pandemic in a cohort . This study reports on the dynamics of transmission in patients . Our analysis presents trends in genomics in patients . Further work is needed to validate these findings.,2017-12-20,2017,James Davis; David Gonzalez,PLOS ONE,ArXiv,10.0000/177390.913,79,5
83d7228c-c922-450f-bc27-1ced97e5c9c8,Pandemic comprehensive dynamics of trends,The investigation evaluates the impact of modeling in a cohort . We reports on the dynamics of pandemic in clinical settings . Our analysis reports on the dynamics of epidemiology in patients . The investigation reports on outcomes for sars-cov-2 in a cohort . Here we report reports on trends in clinical in population . Further work is needed to validate these findings.,2020-01-08,2020,Elizabeth Davis,The Lancet,ArXiv,10.0000/299672.858,63,5
e6b1a1ab-a176-4169-9af2-11fe9bae8224,Immunity comprehensive analysis of patients : implications for clinical practice,Here we report reports on the effectiveness of transmission in patients . The investigation reports on trends in clinical in hospitalized individuals . This study presents trends in transmission in population . This study assesses outcomes for covid-19 in hospitalized individuals . The investigation evaluates outcomes for vaccine in hospitalized individuals . Further work is needed to validate these findings.,2022-03-18,2022,John Wilson,Journal of Infectious Diseases,bioRxiv,10.0000/206831.666,60,10
fbc210d7-7428-44d5-b963-818c12d917cd,Variants regional analysis of patients,Our analysis presents trends in coronavirus in hospitalized individuals . This study reports on the effectiveness of immunity in clinical settings . We presents the effectiveness of covid-19 in patients . We investigates the impact of serology in a cohort . Here we report presents trends in genomics in a cohort . This study investigates outcomes for therapeutics in patients . Further work is needed to validate these findings.,2021-04-17,2021,Elizabeth Miller; David Miller; Robert Williams,Nature,ArXiv,10.0000/988899.882,69,5
256456e1-9dcc-4deb-8d03-908b30d205a7,Coronavirus comparative study of trends,We reports on the dynamics of genomics in population . We assesses the dynamics of therapeutics in clinical settings . Our analysis evaluates the impact of diagnostics in population . Our analysis investigates the dynamics of therapeutics in a cohort . Here we report investigates the dynamics of coronavirus in clinical settings . We presents outcomes for serology in a cohort . Further work is needed to validate these findings.,2017-08-25,2017,Joseph Martinez; William Brown; Mary Lopez,Journal of Infectious Diseases,Publisher,10.0000/338435.662,70,5
a6631332-e216-431d-98f6-3b0310bb3a71,Modeling statistical analysis of outcomes,Our analysis evaluates outcomes for transmission in a cohort . Here we report assesses the dynamics of immunity in population . We reports on the impact of variants in patients . This study reports on the effectiveness of diagnostics in population . We reports on the impact of immunity in population . We reports on the impact of outcomes in clinical settings . We presents the effectiveness of vaccine in hospitalized individuals . The investigation presents the dynamics of epidemiology in population . Further work is needed to validate these findings.,2020-09-27,2020,James Martinez; William Garcia; David Johnson; Susan Martinez,The Lancet,Publisher,10.0000/253181.635,91,5
ee0a90ef-2a2f-4c9d-96df-d8ca1094c620,Modeling regional review of spread : implications for public health,The investigation investigates the effectiveness of serology in hospitalized individuals . This study reports on the impact of genomics in population . This study reports on the impact of sars-cov-2 in patients . Further work is needed to validate these findings.,2022-11-12,2022,Barbara Miller,Unknown,ArXiv,10.0000/813332.863,41,10
5cb08acc-9cf1-4204-bdf4-989717b69270,Coronavirus preliminary investigation of incidence,The investigation presents trends in variants in a cohort . Here we report presents the effectiveness of covid-19 in hospitalized individuals . We reports on trends in variants in patients . This study assesses trends in immunity in clinical settings . Further work is needed to validate these findings.,2018-02-12,2018,David Martinez; Robert Garcia; John Anderson,Journal of Infectious Diseases,bioRxiv,10.0000/683385.873,49,5
2218de2c-0add-4b41-8d21-e9736f15d015,Diagnostics preliminary assessment of data,The investigation presents outcomes for diagnostics in patients . We reports on trends in vaccine in patients . The investigation assesses the effectiveness of outcomes in hospitalized individuals . This study evaluates outcomes for transmission in a cohort . Our analysis reports on trends in vaccine in a cohort . Further work is needed to validate these findings.,2016-06-03,2016,Richard Brown; Susan Brown,Science,PMC,10.0000/153052.505,58,5
0f7897c1-a0bb-4d0c-bc9a-1d7c40a1be12,Serology clinical study of incidence,Here we report evaluates the effectiveness of coronavirus in population . This study presents outcomes for variants in a cohort . The investigation presents outcomes for pandemic in patients . Further work is needed to validate these findings.,2015-01-29,2015,Patricia Lopez; James Jones; Richard Miller,Clinical Infectious Diseases,Crossref,10.0000/289758.815,38,5
a211a963-ba71-4150-9bbb-7145f93c9fec,Variants long-term survey of prevalence,Our analysis assesses the impact of vaccine in population . Here we report evaluates outcomes for therapeutics in population . The investigation evaluates the effectiveness of immunity in hospitalized individuals . Our analysis reports on outcomes for coronavirus in patients . We evaluates the impact of vaccine in patients . We assesses the impact of sars-cov-2 in patients . The investigation reports on outcomes for transmission in population . Further work is needed to validate these findings.,2021-09-19,2021,Robert Brown; Susan Hernandez; Patricia Martinez; Michael Wilson; Richard Williams,bioRxiv,Crossref,10.0000/858990.522,77,5
8b153c70-0cab-44b9-bd76-b2192cabe93f,Modeling rapid dynamics of prevalence,We presents outcomes for modeling in hospitalized individuals . The investigation assesses outcomes for therapeutics in population . The investigation assesses the dynamics of variants in population . Here we report reports on the dynamics of epidemiology in clinical settings . The investigation investigates the effectiveness of covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2018-05-25,2018,Patricia Martinez,Journal of Infectious Diseases,Crossref,10.0000/564340.714,60,5
36d4a8d9-7343-4ce3-ae36-69b3bec41af9,Outcomes statistical dynamics of trends,This study evaluates the effectiveness of diagnostics in hospitalized individuals . We reports on the impact of coronavirus in hospitalized individuals . Here we report presents the dynamics of therapeutics in patients . Here we report reports on the dynamics of outcomes in hospitalized individuals . The investigation investigates the dynamics of outcomes in patients . Our analysis presents the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2015-08-09,2015,Joseph Jones,Unknown,ArXiv,10.0000/585291.886,75,5
3c69e535-87df-4aff-ada7-d0a17eb8e3b9,Immunity long-term assessment of patients : implications for policy,This study reports on outcomes for immunity in patients . Here we report presents the dynamics of genomics in population . This study investigates trends in epidemiology in patients . Our analysis presents the dynamics of serology in population . Further work is needed to validate these findings.,2019-03-20,2019,Richard Martinez; Michael Williams,Frontiers in Medicine,Publisher,10.0000/282785.970,48,9
058213f9-c0e8-482a-9ada-33f5c44b9930,Diagnostics clinical impact of spread,This study presents the effectiveness of outcomes in patients . Here we report evaluates outcomes for serology in patients . Our analysis presents the dynamics of coronavirus in population . The investigation investigates the dynamics of genomics in patients . Our analysis evaluates trends in transmission in patients . Further work is needed to validate these findings.,2018-10-25,2018,Robert Davis; William Hernandez; Joseph Brown; Elizabeth Johnson,medRxiv,Crossref,10.0000/301561.813,57,5
4b2ad48b-c6e8-489d-bede-3d9b27d12c85,Therapeutics long-term evaluation of response : implications for clinical practice,Here we report reports on the effectiveness of genomics in population . We assesses the effectiveness of variants in population . Here we report evaluates the effectiveness of clinical in patients . Our analysis presents the impact of variants in a cohort . Further work is needed to validate these findings.,2017-07-01,2017,David Hernandez; William Smith; Susan Miller; Jessica Anderson; James Anderson,BMJ,ArXiv,10.0000/508222.772,51,10
a2a06d8c-7d72-4772-b211-3aed20196984,Diagnostics statistical review of response,Our analysis assesses outcomes for vaccine in clinical settings . This study assesses the effectiveness of variants in population . This study reports on the effectiveness of sars-cov-2 in clinical settings . The investigation reports on the effectiveness of immunity in population . Further work is needed to validate these findings.,2018-04-22,2018,David Hernandez; Richard Williams; Jennifer Martinez,Journal of Infectious Diseases,Publisher,10.0000/369830.322,51,5
40b0bc0f-05b3-4492-8c2e-6eff52012852,SARS-CoV-2 preliminary survey of data,This study assesses the impact of pandemic in clinical settings . The investigation evaluates the dynamics of diagnostics in clinical settings . The investigation evaluates outcomes for coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2017-07-09,2017,Susan Miller; Linda Anderson,medRxiv,medRxiv,10.0000/966431.702,40,5
3cac60ee-3345-4793-89fa-0496b2d15398,Modeling statistical survey of data,Here we report presents the impact of serology in patients . We reports on the impact of genomics in clinical settings . The investigation investigates the effectiveness of pandemic in clinical settings . Here we report presents outcomes for epidemiology in patients . Further work is needed to validate these findings.,2018-02-18,2018,Barbara Hernandez; Barbara Brown; Joseph Miller; Susan Wilson; Mary Davis,BMJ,bioRxiv,10.0000/459756.804,51,5
94365ffd-d3b8-48dd-a571-3ea133d9a095,Clinical global investigation of patients,Our analysis evaluates the dynamics of transmission in a cohort . Our analysis presents outcomes for epidemiology in patients . This study investigates the dynamics of therapeutics in clinical settings . Our analysis evaluates the dynamics of outcomes in hospitalized individuals . We reports on trends in serology in population . Further work is needed to validate these findings.,2022-10-06,2022,Richard Rodriguez; Michael Jones,Science,Publisher,10.0000/190636.709,59,5
6fda9b45-c01e-4806-9642-b5dfe81c2769,Serology long-term impact of incidence,This study reports on the effectiveness of serology in patients . Our analysis presents trends in outcomes in a cohort . The investigation investigates the effectiveness of outcomes in clinical settings . Our analysis presents trends in outcomes in patients . We investigates the effectiveness of covid-19 in population . Here we report evaluates the impact of clinical in patients . Here we report reports on trends in modeling in clinical settings . Further work is needed to validate these findings.,2019-03-29,2019,Susan Brown,Unknown,medRxiv,10.0000/349420.601,81,5
37fad4bc-cb39-488c-821b-96371ebc2b0b,SARS-CoV-2 statistical impact of data : implications for public health,Our analysis assesses outcomes for variants in patients . Here we report investigates trends in immunity in hospitalized individuals . Our analysis investigates outcomes for modeling in clinical settings . This study evaluates the effectiveness of coronavirus in population . Our analysis assesses outcomes for pandemic in patients . Further work is needed to validate these findings.,2018-11-12,2018,Jennifer Miller; Barbara Jones; Elizabeth Johnson,Frontiers in Medicine,Crossref,10.0000/547767.162,57,10
c29b3c72-dce2-4ffc-8498-5ca125f23d3d,SARS-CoV-2 global dynamics of effectiveness,This study reports on outcomes for variants in population . Here we report assesses outcomes for clinical in patients . We assesses the dynamics of covid-19 in population . This study evaluates the impact of epidemiology in population . Further work is needed to validate these findings.,2022-02-01,2022,Susan Davis,Unknown,ArXiv,10.0000/935111.660,47,5
4b8d171c-e709-49f3-a023-2d55f70ec78a,Pandemic statistical review of response,Our analysis evaluates the effectiveness of serology in a cohort . Here we report evaluates the effectiveness of diagnostics in a cohort . The investigation presents trends in diagnostics in population . We presents the dynamics of diagnostics in population . We assesses trends in variants in population . Further work is needed to validate these findings.,2022-04-12,2022,Patricia Anderson; David Garcia; Joseph Rodriguez; Joseph Garcia,Science,medRxiv,10.0000/806953.418,57,5
32105ff3-3be5-43bd-84fb-19a2811460b8,Epidemiology statistical investigation of incidence,Our analysis reports on the effectiveness of immunity in patients . Here we report reports on the dynamics of modeling in hospitalized individuals . Our analysis assesses outcomes for variants in a cohort . We investigates the dynamics of variants in hospitalized individuals . This study evaluates the impact of outcomes in hospitalized individuals . Our analysis presents outcomes for epidemiology in population . Further work is needed to validate these findings.,2017-08-31,2017,Linda Brown,PLOS ONE,Crossref,10.0000/102867.480,72,5
4b2d8c7e-e3ef-456c-be69-64d5aff73d88,SARS-CoV-2 preliminary investigation of effectiveness,This study investigates trends in transmission in clinical settings . We presents the dynamics of outcomes in patients . The investigation presents the dynamics of genomics in population . Further work is needed to validate these findings.,2017-07-20,2017,William Williams; Barbara Wilson; William Hernandez; Patricia Anderson,bioRxiv,Publisher,10.0000/684106.471,37,5
78f87ebc-ca80-4aab-936b-58f3f719332b,Modeling statistical evaluation of response,The investigation evaluates the effectiveness of transmission in clinical settings . The investigation assesses the dynamics of serology in patients . The investigation reports on the dynamics of pandemic in patients . Here we report presents trends in epidemiology in patients . We reports on the dynamics of modeling in clinical settings . This study evaluates trends in vaccine in clinical settings . Here we report evaluates the impact of modeling in patients . Further work is needed to validate these findings.,2018-07-08,2018,Barbara Rodriguez; Richard Rodriguez; Patricia Davis; Barbara Wilson; William Smith,Frontiers in Medicine,medRxiv,10.0000/557091.936,82,5
dad54b2d-fd9c-458a-bb47-9467d0f243a9,Immunity preliminary investigation of outcomes,The investigation evaluates the effectiveness of clinical in a cohort . The investigation reports on trends in pandemic in patients . Our analysis reports on trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2019-04-04,2019,Robert Anderson; Patricia Hernandez,PLOS ONE,ArXiv,10.0000/592382.974,40,5
b6730914-ae37-4e50-a7b4-a07162190f65,Diagnostics global dynamics of data,Here we report assesses trends in variants in population . We reports on the effectiveness of sars-cov-2 in population . This study presents the dynamics of transmission in population . Further work is needed to validate these findings.,2015-02-27,2015,Mary Jones; Elizabeth Garcia; Michael Martinez; Jessica Williams; Joseph Anderson,medRxiv,Crossref,10.0000/364754.735,38,5
9d1ed0da-162e-4cfa-8ce9-4a22e57c293d,Modeling regional impact of patients,Our analysis presents trends in covid-19 in a cohort . We reports on the effectiveness of sars-cov-2 in a cohort . Here we report investigates trends in sars-cov-2 in clinical settings . Our analysis presents the effectiveness of transmission in clinical settings . We presents outcomes for outcomes in clinical settings . Our analysis investigates trends in vaccine in population . The investigation presents the dynamics of vaccine in a cohort . Further work is needed to validate these findings.,2022-05-26,2022,Michael Johnson,Clinical Infectious Diseases,PMC,10.0000/119239.740,80,5
0e1c1904-d279-488b-973f-605c637988e7,SARS-CoV-2 statistical survey of prevalence,Here we report assesses outcomes for covid-19 in clinical settings . We investigates outcomes for genomics in clinical settings . Our analysis assesses the dynamics of genomics in patients . Further work is needed to validate these findings.,2019-09-24,2019,James Miller; James Williams,Nature,bioRxiv,10.0000/519634.147,38,5
22c9d83c-d191-4d7c-b0da-d1280b729f09,Clinical comprehensive analysis of effectiveness : implications for policy,Our analysis presents trends in variants in hospitalized individuals . This study evaluates the dynamics of diagnostics in hospitalized individuals . The investigation evaluates the dynamics of therapeutics in patients . This study reports on the dynamics of diagnostics in patients . Further work is needed to validate these findings.,2019-12-26,2019,Linda Brown; Linda Anderson; Linda Lopez; Barbara Williams; Jessica Jones,medRxiv,bioRxiv,10.0000/521768.201,50,9
449dc761-d2a7-4cd9-92d0-c1a375650a1b,Genomics statistical evaluation of incidence,Our analysis evaluates the dynamics of coronavirus in a cohort . The investigation assesses the impact of vaccine in patients . We investigates outcomes for serology in patients . The investigation assesses the effectiveness of immunity in clinical settings . Our analysis investigates trends in diagnostics in clinical settings . Further work is needed to validate these findings.,2021-03-05,2021,Elizabeth Gonzalez; Mary Lopez; Mary Brown; David Rodriguez; David Lopez,Nature,ArXiv,10.0000/724508.559,58,5
a89f7b0c-03cd-430d-b409-007b5ee296a4,Clinical rapid dynamics of prevalence,Here we report investigates outcomes for serology in clinical settings . The investigation reports on the dynamics of sars-cov-2 in clinical settings . This study assesses the effectiveness of sars-cov-2 in a cohort . This study assesses trends in vaccine in a cohort . This study assesses the effectiveness of immunity in clinical settings . Our analysis presents outcomes for genomics in population . Further work is needed to validate these findings.,2015-02-12,2015,Mary Hernandez,PLOS ONE,Crossref,10.0000/670715.992,72,5
d3d7e039-b2a5-424b-b720-701bed12e48c,SARS-CoV-2 statistical report of effectiveness,Our analysis presents trends in clinical in population . This study assesses the effectiveness of therapeutics in a cohort . Our analysis reports on outcomes for covid-19 in population . Further work is needed to validate these findings.,2015-07-12,2015,Richard Rodriguez; Jessica Johnson,BMJ,Crossref,10.0000/855669.926,38,5
c3c428f1-5bf8-439f-823c-1abfe3867382,Genomics rapid study of incidence,Our analysis reports on the effectiveness of epidemiology in hospitalized individuals . Here we report reports on trends in modeling in hospitalized individuals . This study presents the dynamics of modeling in population . This study presents trends in clinical in population . The investigation presents the impact of pandemic in a cohort . Further work is needed to validate these findings.,2017-04-02,2017,Susan Anderson,BMJ,PMC,10.0000/615723.529,62,5
7968f207-6f76-4ac6-8338-d5d91e554a76,Outcomes comprehensive report of spread,We reports on the effectiveness of vaccine in hospitalized individuals . The investigation investigates the effectiveness of diagnostics in patients . Here we report investigates trends in clinical in hospitalized individuals . Here we report assesses the dynamics of vaccine in clinical settings . We presents the dynamics of coronavirus in a cohort . This study presents the impact of diagnostics in clinical settings . Further work is needed to validate these findings.,2020-05-31,2020,John Miller; Susan Miller; Linda Rodriguez; Susan Smith; Joseph Johnson,Nature,ArXiv,10.0000/461773.678,73,5
a16c368c-c543-47fb-a9d7-21d17564c36c,Vaccine global study of patients,Our analysis reports on the effectiveness of pandemic in hospitalized individuals . The investigation presents outcomes for covid-19 in a cohort . Here we report assesses trends in variants in population . The investigation evaluates the dynamics of transmission in a cohort . Here we report presents trends in covid-19 in clinical settings . Our analysis assesses the dynamics of pandemic in a cohort . The investigation reports on the impact of vaccine in clinical settings . Further work is needed to validate these findings.,2017-09-12,2017,David Anderson,PLOS ONE,bioRxiv,10.0000/547912.924,85,5
7e42df89-b2ab-41ae-97d1-f02d731dceb4,Therapeutics preliminary analysis of spread,The investigation presents trends in vaccine in clinical settings . We evaluates the impact of genomics in patients . Here we report investigates outcomes for therapeutics in population . We presents the dynamics of genomics in hospitalized individuals . Further work is needed to validate these findings.,2017-08-30,2017,Jennifer Johnson,Nature,Crossref,10.0000/631992.836,47,5
07c6d098-6a60-4e74-b881-9c3b6b58948a,Clinical preliminary dynamics of patterns : implications for clinical practice,Here we report presents trends in covid-19 in population . Our analysis presents outcomes for sars-cov-2 in hospitalized individuals . This study investigates the impact of transmission in population . Our analysis presents outcomes for outcomes in clinical settings . Further work is needed to validate these findings.,2017-10-28,2017,Robert Brown; Mary Davis,PLOS ONE,Crossref,10.0000/639179.260,48,10
843e083b-fc36-47bb-909d-d3bcae9b6ae7,Transmission clinical analysis of patterns : implications for policy,We presents trends in immunity in patients . Here we report assesses trends in sars-cov-2 in a cohort . Our analysis reports on trends in variants in hospitalized individuals . The investigation reports on the effectiveness of sars-cov-2 in population . The investigation evaluates the impact of coronavirus in a cohort . The investigation presents the effectiveness of diagnostics in clinical settings . Here we report presents outcomes for immunity in a cohort . Further work is needed to validate these findings.,2015-05-27,2015,Jessica Miller; Joseph Gonzalez; Richard Wilson; Jennifer Rodriguez; John Johnson,Frontiers in Medicine,medRxiv,10.0000/982291.462,82,9
179ccd54-c6c7-4a8a-b5d0-50bb28a7ef96,Coronavirus clinical survey of effectiveness,The investigation evaluates outcomes for pandemic in a cohort . The investigation presents trends in clinical in patients . We investigates outcomes for epidemiology in a cohort . This study assesses trends in clinical in hospitalized individuals . This study investigates the impact of pandemic in hospitalized individuals . This study presents the impact of clinical in clinical settings . This study investigates trends in sars-cov-2 in a cohort . Our analysis reports on the impact of coronavirus in clinical settings . Further work is needed to validate these findings.,2017-06-03,2017,Richard Williams; Jessica Miller; James Smith,Unknown,Crossref,10.0000/767815.318,90,5
ac6e542f-d9af-45cf-9fc5-02622c3e433c,COVID-19 long-term study of incidence,Our analysis presents outcomes for variants in a cohort . Here we report presents outcomes for covid-19 in a cohort . The investigation reports on the dynamics of epidemiology in clinical settings . This study investigates the impact of outcomes in patients . Here we report reports on the effectiveness of clinical in population . The investigation reports on outcomes for coronavirus in population . This study investigates trends in pandemic in a cohort . Here we report presents the effectiveness of epidemiology in population . Further work is needed to validate these findings.,2017-06-06,2017,Jessica Garcia; Linda Hernandez,The Lancet,Publisher,10.0000/972247.234,94,5
2b22018a-0e88-4e99-908a-9751ef118b7b,SARS-CoV-2 long-term report of effectiveness,Our analysis assesses the impact of immunity in population . Here we report reports on trends in therapeutics in clinical settings . This study presents the dynamics of covid-19 in hospitalized individuals . We presents the dynamics of vaccine in a cohort . We evaluates the effectiveness of therapeutics in a cohort . Our analysis assesses the impact of pandemic in patients . Further work is needed to validate these findings.,2018-12-15,2018,Richard Williams; James Lopez; Michael Hernandez; Patricia Anderson,BMJ,Publisher,10.0000/292946.640,71,5
a9baf406-e8a0-493d-9713-153d5c0e8b3b,Immunity statistical report of incidence,The investigation investigates outcomes for diagnostics in population . Here we report assesses trends in genomics in clinical settings . Our analysis evaluates outcomes for serology in patients . Our analysis presents the dynamics of variants in a cohort . This study investigates outcomes for epidemiology in patients . This study presents the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2015-10-18,2015,Jennifer Williams,PLOS ONE,Crossref,10.0000/675434.751,68,5
9d4d8835-37f8-4bd9-95c9-81af3da2795f,Serology rapid report of prevalence,Our analysis presents the dynamics of vaccine in patients . Our analysis investigates the effectiveness of sars-cov-2 in hospitalized individuals . Our analysis reports on the dynamics of epidemiology in population . Here we report assesses the impact of clinical in patients . Here we report evaluates the impact of diagnostics in a cohort . We investigates trends in vaccine in clinical settings . Our analysis presents the dynamics of serology in hospitalized individuals . Further work is needed to validate these findings.,2016-11-18,2016,Patricia Hernandez; Patricia Rodriguez,medRxiv,Publisher,10.0000/492950.145,83,5
620f8c2e-899c-4765-bc5a-5bd54be2f6e2,Immunity comprehensive study of outcomes : implications for public health,Our analysis evaluates outcomes for diagnostics in a cohort . Here we report reports on the impact of vaccine in clinical settings . Here we report reports on the impact of transmission in a cohort . Our analysis reports on outcomes for transmission in population . Further work is needed to validate these findings.,2022-03-27,2022,Susan Rodriguez; Joseph Jones; Jessica Miller; Elizabeth Brown,bioRxiv,PMC,10.0000/368399.644,54,10
4b1a9940-5cb7-4ffe-8b0f-5f3083fb8fde,Serology global assessment of trends,Our analysis investigates trends in pandemic in patients . This study investigates trends in variants in population . This study presents trends in clinical in hospitalized individuals . Here we report presents outcomes for modeling in patients . Further work is needed to validate these findings.,2020-08-17,2020,Susan Lopez; Mary Gonzalez; Susan Brown; David Davis; John Smith,BMJ,bioRxiv,10.0000/385688.624,46,5
51d1ae11-48d4-4250-b0bc-7d43edc77dd4,Variants comprehensive survey of spread,Our analysis presents the effectiveness of vaccine in a cohort . This study presents trends in covid-19 in population . Our analysis reports on the impact of vaccine in clinical settings . Our analysis evaluates outcomes for modeling in hospitalized individuals . This study presents outcomes for clinical in population . Further work is needed to validate these findings.,2021-09-11,2021,William Miller,The Lancet,Crossref,10.0000/127555.766,59,5
144de755-4b7e-4872-bc66-8b15968ff426,COVID-19 statistical investigation of patterns,Our analysis evaluates the dynamics of variants in population . We evaluates outcomes for epidemiology in a cohort . Here we report evaluates the dynamics of transmission in a cohort . Our analysis assesses trends in sars-cov-2 in clinical settings . We assesses outcomes for variants in hospitalized individuals . Here we report assesses the impact of genomics in population . Further work is needed to validate these findings.,2017-12-05,2017,Robert Williams,Clinical Infectious Diseases,Publisher,10.0000/249736.496,69,5
92e8eefb-9f72-43e9-9751-e188c2e1d123,Modeling preliminary review of patients,Here we report investigates the impact of therapeutics in hospitalized individuals . Our analysis investigates outcomes for sars-cov-2 in population . We assesses the dynamics of clinical in a cohort . Here we report assesses trends in diagnostics in patients . Further work is needed to validate these findings.,2018-12-01,2018,Elizabeth Anderson; John Lopez; Mary Wilson; Joseph Lopez; Patricia Garcia,Clinical Infectious Diseases,medRxiv,10.0000/947064.557,49,5
f769f033-4d3d-423d-b63b-e8eb32721189,Genomics long-term dynamics of incidence,Our analysis presents the dynamics of vaccine in clinical settings . We presents outcomes for sars-cov-2 in hospitalized individuals . The investigation presents the effectiveness of vaccine in hospitalized individuals . This study assesses the effectiveness of diagnostics in population . Here we report presents outcomes for pandemic in population . Further work is needed to validate these findings.,2017-08-18,2017,Elizabeth Anderson; William Anderson; Michael Davis; Elizabeth Miller; Richard Johnson,The Lancet,ArXiv,10.0000/176472.576,59,5
6f429ea8-e8ee-4e5c-b588-dff933ebdf07,Genomics clinical analysis of data,Here we report reports on outcomes for therapeutics in a cohort . Our analysis reports on the effectiveness of transmission in patients . Here we report assesses the effectiveness of serology in hospitalized individuals . Our analysis reports on trends in immunity in a cohort . This study evaluates the effectiveness of epidemiology in a cohort . Further work is needed to validate these findings.,2020-06-21,2020,Elizabeth Davis; Michael Jones; Elizabeth Hernandez; Joseph Wilson; Susan Garcia,Journal of Infectious Diseases,ArXiv,10.0000/936385.958,65,5
280cfe99-c012-45cc-9b80-af6035263bc8,Pandemic clinical review of effectiveness,We presents outcomes for pandemic in population . Our analysis assesses the dynamics of vaccine in a cohort . Here we report investigates the impact of outcomes in population . The investigation assesses trends in variants in clinical settings . Further work is needed to validate these findings.,2018-04-23,2018,Patricia Davis; Michael Miller; Jennifer Martinez; David Williams; Jennifer Lopez,Frontiers in Medicine,PMC,10.0000/561853.615,48,5
5d138693-904b-4110-a6c4-c632244b6fc9,Diagnostics rapid impact of patients : implications for public health,This study presents the impact of variants in clinical settings . The investigation assesses the effectiveness of outcomes in hospitalized individuals . We evaluates the impact of epidemiology in population . We reports on trends in outcomes in population . Our analysis presents outcomes for pandemic in hospitalized individuals . Here we report reports on the impact of coronavirus in a cohort . Further work is needed to validate these findings.,2021-02-01,2021,Mary Anderson; Jessica Davis,Clinical Infectious Diseases,Crossref,10.0000/966973.519,71,10
8c6091dd-61c4-48ab-b3fe-59120aa43e87,Transmission long-term report of effectiveness : implications for vaccination strategies,We reports on outcomes for vaccine in population . This study assesses outcomes for transmission in a cohort . Here we report investigates the impact of coronavirus in hospitalized individuals . Here we report presents the dynamics of diagnostics in clinical settings . The investigation presents the effectiveness of sars-cov-2 in population . This study investigates trends in serology in hospitalized individuals . Here we report assesses trends in transmission in a cohort . Further work is needed to validate these findings.,2017-05-06,2017,Linda Lopez; Mary Jones; James Gonzalez; Jessica Lopez,Unknown,bioRxiv,10.0000/845404.108,82,10
71acad7d-ad0b-4a3a-8862-d8396772f21e,Epidemiology global dynamics of patients,We reports on the dynamics of modeling in hospitalized individuals . Our analysis evaluates the effectiveness of therapeutics in clinical settings . We presents trends in immunity in hospitalized individuals . Further work is needed to validate these findings.,2020-12-17,2020,Barbara Johnson; Richard Gonzalez; Jennifer Williams,Frontiers in Medicine,medRxiv,10.0000/829766.579,39,5
35c68197-4c71-4c4f-9cc0-9d633aa5affc,Variants global review of patterns,Here we report reports on the dynamics of pandemic in clinical settings . The investigation evaluates trends in diagnostics in patients . We presents the impact of immunity in clinical settings . Further work is needed to validate these findings.,2016-01-21,2016,Susan Anderson; Linda Miller; Patricia Brown; Linda Garcia; John Jones,BMJ,ArXiv,10.0000/626946.805,40,5
bc00cbfa-c565-47be-8e02-1c1d5cecfc6d,Diagnostics comprehensive dynamics of incidence,We presents trends in modeling in clinical settings . We investigates the dynamics of modeling in a cohort . Here we report reports on the dynamics of outcomes in population . Our analysis presents outcomes for sars-cov-2 in a cohort . This study evaluates the effectiveness of immunity in clinical settings . The investigation investigates outcomes for diagnostics in population . Further work is needed to validate these findings.,2017-10-22,2017,Linda Gonzalez,bioRxiv,Publisher,10.0000/176482.670,69,5
8647b3d4-34f0-42c3-be66-dc96449c6a17,Serology comprehensive impact of data,Here we report investigates trends in pandemic in population . We investigates the impact of modeling in a cohort . Our analysis assesses the effectiveness of covid-19 in population . Further work is needed to validate these findings.,2021-05-26,2021,Joseph Jones; Michael Gonzalez; Barbara Smith,Science,medRxiv,10.0000/664936.522,38,5
28f90411-da36-4c39-b787-22c149bd200a,Epidemiology rapid assessment of patterns,Our analysis presents the impact of pandemic in clinical settings . The investigation investigates trends in immunity in a cohort . Our analysis investigates trends in diagnostics in population . We reports on the effectiveness of vaccine in a cohort . Further work is needed to validate these findings.,2016-12-05,2016,Richard Johnson; Richard Anderson; Robert Hernandez,BMJ,medRxiv,10.0000/877117.806,49,5
456c7ba8-6975-4526-a914-d778230530c8,Variants regional study of patterns : implications for clinical practice,We assesses trends in clinical in hospitalized individuals . We assesses outcomes for variants in patients . The investigation evaluates the impact of therapeutics in patients . We evaluates the impact of vaccine in hospitalized individuals . Here we report assesses the effectiveness of immunity in a cohort . Here we report assesses the effectiveness of clinical in patients . We reports on the dynamics of transmission in clinical settings . Here we report evaluates the dynamics of vaccine in patients . Further work is needed to validate these findings.,2015-08-20,2015,Jessica Miller; Robert Wilson,Science,Publisher,10.0000/297005.697,90,10
af4f7e15-86fb-47a3-beee-822253c2d91b,Pandemic rapid analysis of outcomes,Here we report evaluates trends in epidemiology in a cohort . We reports on the dynamics of epidemiology in a cohort . This study assesses trends in epidemiology in a cohort . We reports on the dynamics of genomics in a cohort . Our analysis presents outcomes for diagnostics in population . The investigation investigates trends in diagnostics in a cohort . Further work is needed to validate these findings.,2016-06-14,2016,Richard Miller; Linda Smith; Elizabeth Anderson; Jennifer Johnson; Mary Wilson,Journal of Infectious Diseases,ArXiv,10.0000/174162.315,70,5
dc57a0eb-783d-4a0b-8ede-d6dfd23fbe24,Genomics regional survey of response,The investigation evaluates outcomes for transmission in patients . This study presents the dynamics of modeling in a cohort . Our analysis investigates the effectiveness of modeling in population . This study presents trends in immunity in a cohort . Further work is needed to validate these findings.,2020-04-01,2020,Jessica Williams; Richard Smith; Jennifer Gonzalez; Barbara Johnson; Jennifer Smith,Journal of Infectious Diseases,PMC,10.0000/721436.635,48,5
e7e15ae6-687c-4245-9d0b-4f7115d3e784,Clinical long-term assessment of spread,We investigates the impact of variants in a cohort . Our analysis investigates trends in therapeutics in hospitalized individuals . This study assesses the dynamics of outcomes in a cohort . We investigates the effectiveness of epidemiology in clinical settings . This study assesses trends in immunity in population . The investigation presents the effectiveness of outcomes in clinical settings . Further work is needed to validate these findings.,2016-12-02,2016,Patricia Brown; Susan Rodriguez; Elizabeth Wilson; Linda Anderson,The Lancet,PMC,10.0000/828344.169,69,5
51c05cb5-e4fe-4826-9d5f-b84502da9e15,Vaccine long-term study of spread : implications for policy,Here we report presents the impact of diagnostics in patients . We evaluates trends in serology in hospitalized individuals . Our analysis investigates the effectiveness of immunity in hospitalized individuals . This study assesses the dynamics of diagnostics in patients . We evaluates the effectiveness of serology in hospitalized individuals . The investigation evaluates outcomes for epidemiology in hospitalized individuals . The investigation reports on the dynamics of coronavirus in a cohort . The investigation presents the dynamics of sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2018-07-11,2018,Susan Davis; Robert Miller,Clinical Infectious Diseases,PMC,10.0000/321159.811,92,9
bc076b72-ed85-4612-8049-3657ca54faaf,Variants rapid dynamics of effectiveness,Our analysis presents the effectiveness of coronavirus in population . Here we report presents the dynamics of serology in population . The investigation assesses the impact of genomics in a cohort . We reports on the impact of clinical in hospitalized individuals . Our analysis presents the dynamics of diagnostics in a cohort . Further work is needed to validate these findings.,2018-02-16,2018,Susan Davis; David Lopez; John Smith; Susan Johnson; Linda Brown,bioRxiv,PMC,10.0000/525375.851,62,5
c48d98b4-1496-4a26-acda-24162a4add70,COVID-19 clinical evaluation of patients : implications for public health,Our analysis investigates the effectiveness of immunity in population . Here we report evaluates outcomes for variants in a cohort . Our analysis presents outcomes for modeling in clinical settings . The investigation investigates the impact of therapeutics in patients . Further work is needed to validate these findings.,2016-11-16,2016,Richard Gonzalez,bioRxiv,Publisher,10.0000/947586.253,49,10
19982b46-2b3d-4489-808e-36c63ec492c6,Variants preliminary review of data,Our analysis presents the impact of vaccine in patients . Here we report evaluates outcomes for clinical in population . Here we report evaluates outcomes for transmission in population . This study presents outcomes for covid-19 in clinical settings . The investigation presents the effectiveness of clinical in hospitalized individuals . This study presents the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2015-02-09,2015,Patricia Lopez; Barbara Davis; Joseph Smith; Richard Wilson; Jessica Garcia,Frontiers in Medicine,bioRxiv,10.0000/921386.124,70,5
9bce83f7-57e8-4602-be40-d3d66dd0f0ab,Immunity preliminary analysis of data,Our analysis reports on the effectiveness of serology in a cohort . This study assesses the impact of covid-19 in a cohort . Our analysis evaluates trends in outcomes in a cohort . The investigation evaluates trends in pandemic in a cohort . We presents the dynamics of immunity in clinical settings . Here we report assesses the impact of diagnostics in a cohort . The investigation investigates outcomes for modeling in clinical settings . We assesses the impact of serology in hospitalized individuals . Further work is needed to validate these findings.,2019-03-11,2019,John Martinez,bioRxiv,bioRxiv,10.0000/599021.440,93,5
0a4e6b45-77bc-4d0f-a5e6-b97a1f0bd3a1,Immunity global report of effectiveness,Our analysis evaluates trends in serology in population . Our analysis assesses the effectiveness of vaccine in patients . Our analysis evaluates the dynamics of sars-cov-2 in clinical settings . This study presents outcomes for immunity in clinical settings . Here we report assesses outcomes for pandemic in hospitalized individuals . Further work is needed to validate these findings.,2021-07-02,2021,Mary Wilson; Barbara Davis; Mary Williams; John Brown,BMJ,bioRxiv,10.0000/317217.790,59,5
04079e64-7b94-4239-91dd-3af02a32a80a,Therapeutics global evaluation of data,We reports on outcomes for epidemiology in patients . We reports on the impact of diagnostics in clinical settings . Our analysis presents outcomes for clinical in population . Our analysis presents the impact of covid-19 in population . Further work is needed to validate these findings.,2021-11-18,2021,Joseph Lopez; Michael Anderson,Unknown,Publisher,10.0000/326267.565,47,5
6ce1e271-b8a4-4124-bd40-791b2c21e7f7,Coronavirus global report of spread,Here we report investigates outcomes for pandemic in clinical settings . The investigation reports on the impact of coronavirus in a cohort . Our analysis presents the effectiveness of coronavirus in hospitalized individuals . Further work is needed to validate these findings.,2016-03-10,2016,David Garcia; Barbara Smith,BMJ,ArXiv,10.0000/849255.539,42,5
238b59e4-5bc5-441f-9a74-78d174220d72,SARS-CoV-2 preliminary assessment of outcomes,Here we report investigates the impact of sars-cov-2 in clinical settings . The investigation presents the impact of diagnostics in a cohort . Our analysis reports on the dynamics of immunity in a cohort . The investigation evaluates outcomes for pandemic in a cohort . This study presents outcomes for immunity in patients . Further work is needed to validate these findings.,2022-07-06,2022,Susan Hernandez; Robert Hernandez,Clinical Infectious Diseases,Crossref,10.0000/565143.198,62,5
0bad8315-2df4-42e0-b94e-92765ac93973,Variants comprehensive evaluation of patients,The investigation investigates the impact of variants in clinical settings . The investigation evaluates outcomes for clinical in hospitalized individuals . Here we report presents outcomes for serology in patients . Further work is needed to validate these findings.,2020-12-30,2020,Elizabeth Smith; Jessica Jones; James Martinez; Elizabeth Brown,Journal of Infectious Diseases,medRxiv,10.0000/205398.351,39,5
ccbdca7a-28a9-4dfe-a2e2-2ec2f6c1b24d,Pandemic regional analysis of prevalence : implications for clinical practice,The investigation investigates the effectiveness of modeling in a cohort . Our analysis investigates the effectiveness of coronavirus in hospitalized individuals . Here we report assesses outcomes for variants in hospitalized individuals . Here we report presents outcomes for variants in clinical settings . We investigates outcomes for clinical in a cohort . Further work is needed to validate these findings.,2021-01-29,2021,Elizabeth Smith,The Lancet,PMC,10.0000/670213.939,61,10
56ee0496-7391-4099-985c-7d702414ad66,Diagnostics rapid survey of trends,Our analysis investigates the impact of covid-19 in hospitalized individuals . Here we report evaluates the impact of diagnostics in patients . This study evaluates the impact of therapeutics in patients . We evaluates outcomes for vaccine in patients . We assesses the impact of genomics in a cohort . The investigation assesses trends in sars-cov-2 in a cohort . Further work is needed to validate these findings.,2019-10-14,2019,Patricia Wilson; Jessica Garcia; David Martinez; William Brown,The Lancet,ArXiv,10.0000/638072.896,68,5
f9cd21e5-95f3-49d3-bb53-30bb93ee8312,Serology statistical analysis of trends,Our analysis assesses the effectiveness of modeling in clinical settings . The investigation presents the dynamics of clinical in a cohort . We evaluates the impact of epidemiology in population . This study reports on the effectiveness of covid-19 in a cohort . Further work is needed to validate these findings.,2015-08-31,2015,John Miller; Patricia Wilson; Mary Gonzalez; Mary Hernandez,Journal of Infectious Diseases,PMC,10.0000/635536.363,51,5
c670a6b0-ec04-4357-91ab-164634721d18,Diagnostics regional study of data,This study evaluates the dynamics of pandemic in hospitalized individuals . Here we report investigates the impact of diagnostics in hospitalized individuals . This study evaluates the effectiveness of modeling in population . Our analysis investigates the impact of sars-cov-2 in a cohort . This study assesses trends in serology in clinical settings . Further work is needed to validate these findings.,2022-04-13,2022,Mary Williams; Mary Anderson; William Anderson; Linda Johnson; Mary Miller,Clinical Infectious Diseases,Crossref,10.0000/602925.738,62,5
22ec69ea-e171-45e0-b234-e66eb1531c70,Vaccine preliminary report of effectiveness,The investigation reports on the dynamics of modeling in clinical settings . Our analysis reports on trends in coronavirus in patients . The investigation evaluates trends in transmission in hospitalized individuals . Our analysis reports on the impact of coronavirus in hospitalized individuals . We reports on the impact of vaccine in hospitalized individuals . Further work is needed to validate these findings.,2016-09-24,2016,David Rodriguez; Patricia Rodriguez,Science,Publisher,10.0000/924921.761,63,5
98638a4d-db6f-4490-9fdd-657e8bbd72d7,Variants comprehensive review of outcomes,This study reports on the dynamics of genomics in clinical settings . Our analysis reports on trends in clinical in population . We assesses outcomes for diagnostics in a cohort . The investigation presents outcomes for vaccine in clinical settings . This study assesses trends in modeling in hospitalized individuals . Further work is needed to validate these findings.,2018-10-03,2018,Mary Brown; William Hernandez; James Rodriguez; Susan Johnson,Clinical Infectious Diseases,PMC,10.0000/589257.962,59,5
c092c425-6108-42d9-a76b-a726cb71b252,Vaccine global analysis of outcomes,The investigation reports on the dynamics of diagnostics in a cohort . The investigation assesses outcomes for coronavirus in patients . Here we report investigates the dynamics of vaccine in a cohort . Here we report evaluates the impact of covid-19 in patients . We evaluates the effectiveness of pandemic in a cohort . Further work is needed to validate these findings.,2019-11-28,2019,James Anderson; Joseph Miller; Barbara Davis; Robert Brown,Science,PMC,10.0000/935441.860,62,5
be08b11b-5ca8-476f-abf7-70b58ebeab06,Vaccine clinical evaluation of response : implications for public health,Here we report presents the effectiveness of coronavirus in clinical settings . This study presents outcomes for sars-cov-2 in a cohort . We investigates outcomes for genomics in patients . This study assesses the effectiveness of transmission in hospitalized individuals . We presents outcomes for diagnostics in patients . We assesses the effectiveness of genomics in a cohort . We investigates the effectiveness of serology in a cohort . Further work is needed to validate these findings.,2019-06-01,2019,Elizabeth Wilson; Michael Brown; Jessica Rodriguez; Susan Jones; Elizabeth Garcia,Science,Crossref,10.0000/839341.984,77,10
a35c4a8e-e2c0-45d9-9cff-41a00d855c07,Modeling comprehensive review of spread,This study evaluates outcomes for pandemic in patients . We investigates outcomes for epidemiology in patients . Our analysis reports on the effectiveness of sars-cov-2 in a cohort . Our analysis investigates the dynamics of clinical in hospitalized individuals . The investigation assesses trends in epidemiology in population . Our analysis assesses trends in immunity in population . The investigation assesses trends in serology in hospitalized individuals . Further work is needed to validate these findings.,2020-08-19,2020,David Miller; Michael Hernandez; Jennifer Miller,Frontiers in Medicine,ArXiv,10.0000/747417.259,76,5
a005fe70-9fb1-4d6d-8134-42b2b4fb25e7,Diagnostics preliminary report of patterns,We assesses the effectiveness of pandemic in a cohort . Our analysis presents trends in therapeutics in clinical settings . Our analysis assesses the impact of therapeutics in patients . Our analysis investigates the effectiveness of epidemiology in a cohort . This study investigates the dynamics of therapeutics in hospitalized individuals . This study reports on the impact of sars-cov-2 in clinical settings . Our analysis presents the dynamics of serology in population . Further work is needed to validate these findings.,2016-01-15,2016,Joseph Lopez,Nature,bioRxiv,10.0000/997087.806,82,5
c2e04bb0-6296-43e9-b143-a04dcccce54f,Vaccine global investigation of effectiveness,Our analysis evaluates the effectiveness of pandemic in population . The investigation reports on trends in transmission in hospitalized individuals . The investigation assesses trends in outcomes in hospitalized individuals . Here we report reports on trends in variants in clinical settings . Our analysis reports on the effectiveness of diagnostics in a cohort . We evaluates the dynamics of sars-cov-2 in patients . Further work is needed to validate these findings.,2019-05-17,2019,David Williams,Unknown,ArXiv,10.0000/996519.157,72,5
70b610c9-a7ce-4b72-b0d8-f63e842380fa,Vaccine rapid assessment of outcomes,Our analysis evaluates the impact of serology in population . Here we report presents the effectiveness of pandemic in population . We evaluates outcomes for immunity in clinical settings . Our analysis presents the impact of transmission in a cohort . Here we report assesses trends in covid-19 in population . This study investigates the impact of therapeutics in patients . The investigation investigates the impact of transmission in population . Here we report reports on trends in immunity in patients . Further work is needed to validate these findings.,2018-09-19,2018,Barbara Gonzalez,bioRxiv,Publisher,10.0000/889150.376,90,5
caed91da-13fc-4c67-8642-a15b4894f3e7,Transmission statistical survey of trends,We investigates the impact of genomics in patients . This study investigates the effectiveness of vaccine in clinical settings . This study assesses trends in coronavirus in population . This study reports on the impact of outcomes in clinical settings . This study investigates the effectiveness of therapeutics in hospitalized individuals . Further work is needed to validate these findings.,2017-04-10,2017,Jessica Wilson,Frontiers in Medicine,Publisher,10.0000/740414.563,60,5
f58b18ef-3395-4fbb-965e-fc2a5848cae1,Pandemic regional dynamics of effectiveness,This study evaluates trends in sars-cov-2 in hospitalized individuals . Here we report investigates the impact of pandemic in clinical settings . We assesses trends in genomics in clinical settings . We investigates the impact of modeling in hospitalized individuals . We presents the impact of genomics in patients . The investigation evaluates trends in covid-19 in hospitalized individuals . This study evaluates the dynamics of pandemic in patients . Our analysis evaluates the effectiveness of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2017-04-06,2017,Barbara Williams; Jessica Davis; Robert Lopez,BMJ,medRxiv,10.0000/276709.372,89,5
0a19538f-dacc-44bc-b54d-fbd21c23b7c0,COVID-19 global analysis of incidence,Here we report evaluates the impact of transmission in patients . The investigation reports on the dynamics of coronavirus in clinical settings . Our analysis assesses the effectiveness of clinical in patients . This study assesses trends in genomics in population . Further work is needed to validate these findings.,2015-09-28,2015,Joseph Davis; Patricia Miller,bioRxiv,PMC,10.0000/203104.162,50,5
c702d1fc-823f-4ade-8588-a3a0563ce548,Coronavirus global review of spread,We assesses the impact of covid-19 in population . We reports on the impact of outcomes in patients . Our analysis reports on outcomes for vaccine in population . Our analysis presents the impact of modeling in a cohort . Further work is needed to validate these findings.,2021-01-31,2021,Michael Rodriguez; John Davis; Robert Hernandez,bioRxiv,medRxiv,10.0000/379479.168,48,5
28ccf4c8-87b3-485e-b32a-98b17cedb58f,SARS-CoV-2 rapid assessment of incidence : implications for vaccination strategies,Our analysis presents the effectiveness of immunity in a cohort . Here we report reports on the effectiveness of coronavirus in hospitalized individuals . We evaluates outcomes for immunity in clinical settings . Further work is needed to validate these findings.,2016-03-21,2016,Robert Davis; Mary Smith,Unknown,medRxiv,10.0000/450327.409,41,10
a65de605-098d-4411-8148-930894126dea,SARS-CoV-2 statistical study of patterns,We investigates trends in covid-19 in a cohort . Here we report investigates the effectiveness of modeling in patients . Our analysis evaluates outcomes for outcomes in a cohort . We presents trends in pandemic in clinical settings . We investigates the dynamics of serology in clinical settings . Further work is needed to validate these findings.,2021-02-14,2021,Jessica Davis; Joseph Martinez; David Wilson; James Lopez; Michael Lopez,PLOS ONE,PMC,10.0000/528082.105,57,5
475da022-cd81-41b0-a757-b47439113c05,Epidemiology global survey of patients,We presents the effectiveness of immunity in population . Our analysis reports on the impact of modeling in patients . We investigates the impact of therapeutics in clinical settings . Further work is needed to validate these findings.,2018-01-17,2018,Susan Williams; Susan Anderson; Linda Gonzalez; Susan Johnson,PLOS ONE,bioRxiv,10.0000/593343.166,38,5
0df4fd73-ed9b-4e12-b516-e3c75fe07cee,Outcomes preliminary analysis of response : implications for public health,This study assesses the dynamics of immunity in hospitalized individuals . Here we report assesses outcomes for coronavirus in hospitalized individuals . We evaluates the impact of immunity in hospitalized individuals . This study assesses outcomes for sars-cov-2 in clinical settings . The investigation assesses outcomes for immunity in hospitalized individuals . The investigation presents the impact of epidemiology in patients . Further work is needed to validate these findings.,2018-05-31,2018,Robert Brown; Susan Miller; John Johnson; Elizabeth Anderson,Journal of Infectious Diseases,medRxiv,10.0000/299787.969,70,10
bdeabcc6-0c5b-45cb-a70f-1fd1c80164a7,SARS-CoV-2 rapid dynamics of data,Here we report assesses trends in clinical in population . Here we report reports on the effectiveness of outcomes in a cohort . This study reports on outcomes for serology in population . The investigation investigates the effectiveness of pandemic in population . We reports on trends in sars-cov-2 in hospitalized individuals . This study presents outcomes for serology in clinical settings . Here we report evaluates outcomes for serology in population . Further work is needed to validate these findings.,2016-06-23,2016,Elizabeth Garcia,BMJ,ArXiv,10.0000/890247.197,81,5
865d420a-3970-4128-ae03-b0bc6acb9b73,Epidemiology rapid investigation of response,Our analysis assesses trends in variants in population . Our analysis reports on the dynamics of coronavirus in clinical settings . We investigates the impact of immunity in patients . Further work is needed to validate these findings.,2021-09-14,2021,John Hernandez; Patricia Rodriguez,PLOS ONE,ArXiv,10.0000/736907.279,38,5
9b40701f-4b00-4a68-a051-cdce9b96c9d5,Clinical preliminary assessment of incidence,Our analysis investigates outcomes for modeling in patients . The investigation investigates outcomes for immunity in a cohort . Here we report investigates the dynamics of variants in a cohort . Here we report investigates outcomes for genomics in patients . Our analysis investigates trends in vaccine in patients . Our analysis assesses trends in modeling in patients . The investigation evaluates outcomes for variants in hospitalized individuals . The investigation investigates trends in epidemiology in hospitalized individuals . Further work is needed to validate these findings.,2015-06-01,2015,Jennifer Brown,Science,Crossref,10.0000/735249.697,87,5
94bf891c-d0ea-4286-b867-eeb35a5eac0b,Vaccine clinical report of patients,Here we report evaluates the effectiveness of genomics in a cohort . Our analysis assesses the impact of immunity in patients . This study reports on trends in epidemiology in clinical settings . The investigation investigates the dynamics of diagnostics in population . Our analysis assesses the impact of coronavirus in patients . We presents trends in immunity in patients . This study assesses trends in immunity in patients . Further work is needed to validate these findings.,2018-06-27,2018,John Brown,medRxiv,Crossref,10.0000/750409.666,78,5
ac17af66-e007-41a0-96d3-030501904a76,Epidemiology statistical impact of spread,Our analysis reports on outcomes for serology in clinical settings . This study reports on the dynamics of pandemic in hospitalized individuals . We assesses the effectiveness of outcomes in hospitalized individuals . Our analysis assesses the dynamics of modeling in a cohort . This study presents the impact of sars-cov-2 in clinical settings . We assesses trends in sars-cov-2 in hospitalized individuals . Here we report assesses trends in covid-19 in hospitalized individuals . Further work is needed to validate these findings.,2020-09-08,2020,Jessica Miller; Richard Lopez,BMJ,bioRxiv,10.0000/234196.536,83,5
346ce32e-ee1a-4aa4-bed1-ebcdf09f642f,Diagnostics comparative analysis of patterns,Here we report presents the effectiveness of pandemic in hospitalized individuals . The investigation evaluates trends in variants in hospitalized individuals . Here we report evaluates the dynamics of covid-19 in a cohort . The investigation reports on trends in variants in clinical settings . Our analysis assesses the dynamics of variants in clinical settings . Further work is needed to validate these findings.,2020-09-04,2020,Michael Smith,The Lancet,PMC,10.0000/106875.991,64,5
4722670a-2352-4e1b-a996-fe6ba9f25ce1,Diagnostics clinical study of prevalence,Our analysis investigates the effectiveness of outcomes in hospitalized individuals . Our analysis assesses the impact of epidemiology in a cohort . The investigation presents the effectiveness of vaccine in patients . Our analysis evaluates the effectiveness of immunity in a cohort . Here we report presents outcomes for clinical in hospitalized individuals . This study assesses outcomes for immunity in a cohort . We reports on trends in vaccine in hospitalized individuals . Our analysis evaluates trends in immunity in clinical settings . Further work is needed to validate these findings.,2016-04-16,2016,Mary Davis; Linda Anderson; Jessica Davis; Barbara Jones; Michael Gonzalez,Clinical Infectious Diseases,ArXiv,10.0000/652881.908,92,5
747ac883-ff2f-4a60-8eea-f93816f16d32,Immunity long-term impact of patterns,Our analysis reports on the impact of diagnostics in a cohort . Our analysis evaluates trends in outcomes in a cohort . This study evaluates trends in coronavirus in patients . Here we report investigates the impact of diagnostics in hospitalized individuals . This study assesses the impact of genomics in hospitalized individuals . Further work is needed to validate these findings.,2018-11-17,2018,William Anderson; Patricia Lopez; Jessica Rodriguez; Patricia Jones,BMJ,medRxiv,10.0000/886269.154,62,5
d5f3306e-700a-445e-8a61-69dec85df7a3,COVID-19 global investigation of outcomes,The investigation assesses trends in clinical in clinical settings . Our analysis presents the effectiveness of outcomes in population . This study presents trends in serology in population . The investigation assesses the effectiveness of diagnostics in hospitalized individuals . We assesses the effectiveness of immunity in population . We presents the dynamics of genomics in clinical settings . Here we report presents outcomes for outcomes in hospitalized individuals . Our analysis investigates the impact of serology in patients . Further work is needed to validate these findings.,2018-08-21,2018,John Jones,PLOS ONE,Crossref,10.0000/814366.458,88,5
2097ab7d-1f47-4081-9a8f-03bbf5a0b7f4,Serology clinical evaluation of outcomes : implications for policy,Here we report evaluates trends in pandemic in hospitalized individuals . Here we report reports on trends in modeling in population . Our analysis reports on the effectiveness of outcomes in hospitalized individuals . This study investigates outcomes for transmission in clinical settings . Our analysis investigates the dynamics of clinical in a cohort . We investigates outcomes for pandemic in population . Further work is needed to validate these findings.,2018-10-03,2018,Joseph Gonzalez; Patricia Garcia; Richard Wilson; Michael Brown; John Brown,The Lancet,bioRxiv,10.0000/151461.663,71,9
a0950666-e60a-4c3a-9a83-93fe02ead2fc,Outcomes regional evaluation of incidence,Here we report evaluates the dynamics of genomics in a cohort . Here we report reports on the impact of epidemiology in patients . The investigation reports on outcomes for genomics in clinical settings . The investigation investigates the impact of transmission in a cohort . Our analysis assesses the impact of immunity in population . Our analysis reports on trends in immunity in hospitalized individuals . We evaluates the effectiveness of epidemiology in hospitalized individuals . This study evaluates outcomes for genomics in clinical settings . Further work is needed to validate these findings.,2021-08-23,2021,Mary Gonzalez; Jessica Gonzalez,Science,Crossref,10.0000/587318.559,95,5
2334b9a6-4a43-465f-adce-e5f652e53cce,Coronavirus regional analysis of effectiveness,Our analysis evaluates the impact of outcomes in clinical settings . The investigation presents the impact of immunity in patients . Our analysis investigates the dynamics of therapeutics in population . Further work is needed to validate these findings.,2021-07-22,2021,Linda Rodriguez; John Anderson; Jennifer Martinez,Frontiers in Medicine,medRxiv,10.0000/535462.746,39,5
b3b5c258-eefa-425f-b496-e39a883bb3be,Genomics comparative dynamics of patterns : implications for policy,The investigation reports on trends in vaccine in population . We evaluates the dynamics of genomics in patients . The investigation investigates the impact of diagnostics in clinical settings . Here we report investigates the dynamics of transmission in a cohort . This study assesses the impact of diagnostics in population . The investigation reports on the effectiveness of clinical in a cohort . The investigation assesses trends in serology in hospitalized individuals . We assesses trends in vaccine in population . Further work is needed to validate these findings.,2015-08-15,2015,Robert Rodriguez; Joseph Johnson; William Garcia; Richard Lopez,Frontiers in Medicine,ArXiv,10.0000/562857.634,90,9
4a1ff6da-37c7-4e64-82b0-27025fd29848,Pandemic clinical investigation of patients,This study investigates the effectiveness of vaccine in clinical settings . Our analysis assesses trends in diagnostics in a cohort . Our analysis investigates the effectiveness of covid-19 in clinical settings . This study assesses the effectiveness of immunity in patients . The investigation presents outcomes for serology in clinical settings . Further work is needed to validate these findings.,2022-07-22,2022,Robert Williams; Barbara Williams; Richard Smith; Jennifer Johnson,Frontiers in Medicine,PMC,10.0000/204452.133,60,5
504e8875-8862-4650-afd8-be3538c93ea4,Modeling statistical dynamics of data,Our analysis reports on outcomes for pandemic in a cohort . Our analysis investigates trends in serology in a cohort . This study assesses trends in immunity in patients . Our analysis evaluates the effectiveness of immunity in a cohort . Further work is needed to validate these findings.,2020-01-13,2020,Elizabeth Wilson; Linda Hernandez,Journal of Infectious Diseases,Publisher,10.0000/813247.615,49,5
7b672235-6cb8-4798-901f-c7346afe7178,Vaccine statistical investigation of spread,This study investigates the impact of coronavirus in hospitalized individuals . We investigates the dynamics of serology in population . We investigates the dynamics of sars-cov-2 in a cohort . Further work is needed to validate these findings.,2017-05-25,2017,Barbara Garcia; Joseph Smith; William Hernandez; Susan Rodriguez; David Johnson,Frontiers in Medicine,Crossref,10.0000/391479.840,38,5
1093eabd-3aea-4516-96ed-1004b4d4c5ec,Outcomes preliminary impact of trends : implications for clinical practice,We investigates outcomes for diagnostics in a cohort . The investigation reports on the dynamics of genomics in clinical settings . We assesses outcomes for sars-cov-2 in hospitalized individuals . We reports on outcomes for variants in clinical settings . Here we report assesses trends in variants in population . Here we report assesses trends in diagnostics in population . The investigation investigates the impact of therapeutics in patients . Further work is needed to validate these findings.,2018-02-27,2018,Robert Hernandez; John Hernandez; Jessica Martinez; Joseph Rodriguez,bioRxiv,medRxiv,10.0000/821422.595,78,10
2dcbaabf-8b89-4a96-bc88-ccf98160ea85,Genomics comparative assessment of effectiveness : implications for vaccination strategies,The investigation reports on trends in diagnostics in clinical settings . The investigation assesses the effectiveness of therapeutics in clinical settings . We presents the impact of outcomes in a cohort . Further work is needed to validate these findings.,2017-11-01,2017,Michael Johnson; Barbara Anderson; Linda Lopez; Elizabeth Lopez,Unknown,PMC,10.0000/920465.698,40,10
907a7df9-baef-41e1-8a3a-8a20128da479,Diagnostics rapid survey of incidence,The investigation evaluates the impact of covid-19 in population . The investigation investigates outcomes for sars-cov-2 in hospitalized individuals . The investigation reports on outcomes for immunity in patients . Further work is needed to validate these findings.,2022-05-02,2022,Susan Miller; William Rodriguez; Jennifer Rodriguez,Frontiers in Medicine,Publisher,10.0000/922713.668,38,5
80cad574-6705-4b73-b2fa-93063f58d0c2,Coronavirus rapid survey of response,The investigation reports on the effectiveness of vaccine in population . The investigation investigates trends in therapeutics in clinical settings . This study evaluates the dynamics of outcomes in a cohort . This study assesses outcomes for variants in clinical settings . This study reports on the impact of genomics in population . Further work is needed to validate these findings.,2019-07-11,2019,William Brown; Joseph Garcia; Linda Wilson,medRxiv,Publisher,10.0000/994820.850,61,5
1e2d8edf-a34f-4e1d-b8a3-a16bd4f23c46,Serology clinical assessment of spread,We reports on the effectiveness of pandemic in hospitalized individuals . Our analysis investigates trends in outcomes in patients . Our analysis assesses outcomes for diagnostics in population . The investigation reports on the dynamics of therapeutics in a cohort . The investigation investigates the impact of clinical in patients . Our analysis evaluates outcomes for sars-cov-2 in a cohort . We investigates the impact of diagnostics in clinical settings . This study evaluates the effectiveness of variants in a cohort . Further work is needed to validate these findings.,2018-04-25,2018,Michael Hernandez,Unknown,Publisher,10.0000/983623.951,90,5
f4fe7638-d021-461b-98bb-743e48b7ebf3,COVID-19 comparative study of data,Our analysis assesses outcomes for coronavirus in patients . We reports on the effectiveness of diagnostics in patients . The investigation assesses trends in epidemiology in patients . The investigation assesses outcomes for epidemiology in hospitalized individuals . The investigation evaluates the dynamics of genomics in population . Our analysis presents the dynamics of therapeutics in clinical settings . Further work is needed to validate these findings.,2017-01-19,2017,Patricia Wilson,Journal of Infectious Diseases,medRxiv,10.0000/422501.228,67,5
d6141ce6-fa1a-4183-8246-951e414f94b5,Vaccine comprehensive assessment of outcomes : implications for policy,The investigation presents the dynamics of sars-cov-2 in clinical settings . The investigation evaluates the dynamics of serology in population . The investigation presents outcomes for transmission in hospitalized individuals . The investigation investigates outcomes for variants in a cohort . Further work is needed to validate these findings.,2015-08-04,2015,Barbara Martinez; Mary Garcia; Richard Miller; Michael Hernandez; David Garcia,bioRxiv,Crossref,10.0000/299088.191,49,9
0016a86c-b1a0-4910-a547-74706f3b312e,Modeling long-term evaluation of trends,We assesses outcomes for covid-19 in hospitalized individuals . We presents trends in clinical in patients . We investigates outcomes for variants in population . This study presents the impact of epidemiology in population . Here we report investigates the impact of coronavirus in patients . Our analysis evaluates the effectiveness of sars-cov-2 in patients . Our analysis assesses trends in sars-cov-2 in clinical settings . Further work is needed to validate these findings.,2017-06-13,2017,Michael Hernandez; Richard Brown; Linda Smith; Richard Anderson; Susan Smith,Clinical Infectious Diseases,medRxiv,10.0000/493196.600,74,5
bcdc8606-3b3b-4249-a920-ad902c59b156,Outcomes regional report of outcomes,This study investigates the dynamics of vaccine in clinical settings . Our analysis reports on trends in genomics in patients . This study assesses the effectiveness of pandemic in hospitalized individuals . Further work is needed to validate these findings.,2017-03-15,2017,Richard Anderson; Elizabeth Miller; David Johnson; Michael Martinez,Unknown,Crossref,10.0000/652621.776,40,5
